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Iron chelators inhibit VCAM-1 induction in dermal endothelial cells by acting as hypoxia
mimetics
RA Swerlick,1,2 K Casper1 and S Caughman1 1 Dermatology, Emory University, Atlanta, GA and
2 Dermatology, Atlanta Veterans Affairs Hospital, Decatur, GA
Previous studies have demonstrated profound inhibitory effects of iron chelators on NF-kB-depend-
ent, cytokine-mediated induction of cell adhesion molecules (CAMs) in human dermal endothelial
cells (HDMEC). We hypothesized that iron chelators inhibit induction of CAMs such as vascular
cell adhesion molecule-1 (VCAM-1) via induction of hypoxia inducible factors (HIF)- 1α and/or
2α, thus acting as hypoxia mimetics. Treatment of HDMEC with the iron chelator 2,2-dipyridyl
resulted in inhibition of VCAM-1 induction by TNFα. DP treatment resulted in concomitant robust
induction and stabilization of HIF-2α protein expression as detected by western blot, consistent with
the required presence of intracellular iron for the constitutive function of the HIF-2α destabilizing
enzyme prolyl hydroxylase (PHD) in HDMEC. Since PHD activity requires three cofactors-iron, α-
ketoglutarate (α-KG), and oxygen-to mediate HIF-2α degradation, we predicted that α-KG antag-
onists, like iron chelators, should also induce HIF-2α protein expression and inhibit TNFαmediated
induction of VCAM-1 expression. Treatment of HDMEC with dimethyloxalylglycine (DMOG), an
α-KG antagonist and PHD inhibitor, induced HIF-2α expression. In addition, pretreatment of HDMEC
with DMOG inhibited TNFα-mediated induction of VCAM-1 protein and mRNA in HDMEC in a
time- and concentration-dependent fashion. Similarly, pretreatment of HDMEC with hypoxia prior
to TNFα stimulation inhibited TNFα induction of VCAM-1, but inhibition required continuous
hypoxia during cytokine stimulation, which is also required for the continuous stabilization of the
labile oxygen sensitive factor HIF-2α. These data provide novel evidence that that hypoxia- induced
regulatory protein HIF-2α may inhibit proinflammatory responses by inhibition of NF-kB depend-
ent gene expression. Thus, although stabilization of HIF proteins may stimulate proinflammatory
responses through VEGF expression, they may also provide a negative feedback loop through inhi-
bition of expression of NF-kB dependent genes such as VCAM-1. 
003
Simultaneous inhibition of VEGFR1 and VEGFR2 signaling is required for suppression of
experimental melanoma metastases
B Boehme,1 A Aicher,2 K Spieth,1 A Gaumann,3 DJ Hicklin,4 P Bohlen,4 S Dimmeler,2
R Kaufmann,1 G Breier3 and J Gille1,3 1 Dept. of Dermatology, J.W. Goethe-University, Frankfurt
am Main, Germany, 2 Molecular Cardiology, Dept. of Internal Medicine IV, J.W. Goethe-
University, Frankfurt am Main, Germany, 3 Dept. of Molecular Biology, Max-Planck-Institute, Bad
Nauheim, Germany and 4 Dept. of Immunology, ImClone Systems Incorporated, New York, NY
Formation of blood-borne metastases depends on a series of events, including survival and initial
proliferation of cancer cells after extravasation from the capillary bed of secondary organs. Accu-
mulating evidence suggests that the host microenvironment as critical determinant of the prolifera-
tive behavior of tumor cells is affected by bone marrow-derived hematopoietic and endothelial
stem/progenitor cells. In addition, incorporation of stem/progenitor cells may facilitate angiogene-
sis-dependent tumor growth. We herein show that experimental lung metastasis formation (B16
melanoma cells) induces proliferation and mobilization of VEGF receptor (VEGFR)-1+ hematopoi-
etic and VEGFR-2+ endothelial progenitor cells. In transplantation studies, in which mice were recon-
stituted with bone marrow from LacZ-overexpressing animals to trace bone marrow-derived cells in
experimental lung metastasis, the majority of incorporated bone marrow-derived cells displayed a
monomyelocytic phenotype. In addition, lacZ-positivity was frequently detected in tumor-associ-
ated fibrin clots and thrombi, also suggesting mobilization of megakaryocytic cells and platelets from
the bone marrow. In approaches to determine the potential significance of VEGFR-1- and VEGFR-
2-dependent signaling in blood-borne metastasis formation, the impact of anti-VEGFR antibodies
on experimental lung melanoma metastasis was analyzed. These studies showed that both VEGFR-
2 and VEGFR-1 signaling were functionally important for hematogenous metastasis, as only simul-
taneous antibody-mediated inhibition of VEGFR-1 and VEGFR-2 signaling suppressed lung
melanoma metastasis formation. Hence, both VEGFR-1 and VEGFR-2 signaling appear to be crit-
ically involved in blood-borne melanoma lung metastasis. 
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Overexpression of vascular endothelian growth factor receptors in epidermis of psoriasis vul-
garis
M Zheng, F Zhu, S Cai and Z Lu Dermatology, Second Affiliated Hospital Zhejiang
University,School of Medicine, Hangzhou, Zhejiang, China
To study the expression of vascular endothelial growth factor receptors (FLT-1 and KDR) in psori-
atic lesions.Tissue sections from 28 psoriasis patients were examined by immunohistochemical and
in situ hybridization methods for the expression of the two VEGF receptors. Microvessal density
(MVD) was counted through immunohistochemical staining by anti-CD34 antibody monoclonal
antibody.
Two receptors are expressed on papillary dermal endothelial cells and their expression is positively
correlated with the MVD in lesional skin. The hyperplastic epidermis expresses high amounts of the
receptors, which is far more abundant than those on the dermal endothelial cells. The receptor dis-
tribution pattern on epidermis of psoriatic lesion is quite different from that of normal skin, although
there was no significant difference between the total expression level of the receptors in psoriatic
epidermis and that of the normal controls. It is also found that KDR/FLT-1 was expressed casually
on inflammatory cells, fibroblasts, sebaceous glands and hair follicles. 
The up-regulation expression of FLT-1/KDR on the lesional papillary dermal microvessels may
play an important role in pathogenesis of psoriasis. For the first time we have demonstrated that
KDR/FLT-1 is strongly expressed on human keratinocytes by an autocrine mechanism. The abnor-
mal distribution of VEGFR on keratinocytes could be related to the disturbance of inflammatory cas-
cade on psoriatic lesions. The mechanism concerning KDR/FLT-1 expression on keratinocytes,
inflammatory cells, fibroblasts, sebaceous glands and hair follicles are still unknown, further explo-
rations are needed. 
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IL-6-induced basic fibroblast growth factor 2 dependent angiogenesis in basal cell carcinoma
cells (BCC) via STAT3 and PI3-Kinase/Akt Pathway
S Jee,1,2 C Chu1 and M Kuo3 1 Department of Dermatology, National Taiwan University Hospital,
Taipei, Taiwan, 2 Department of Dermatology, National Taiwan University, Taipei, Taiwan and 3
Institute of Toxicology, National Taiwan University, Taipei, Taiwan
We have previously demonstrated the xenograft of IL-6 over-expressing basal cell carcinoma cells
(BCC/IL-6) into nude mice developed tumor with high vasculature. Here we asked whether IL-6
could induce angiogenic activity in BCC cells by using in vivo chorioallantoic membrane (CAM)
and Matrigel plug assay. Conditioned medium (CM) from IL-6-overexpressing BCC cells (BCC/IL-
6 and BCC/IL-6/8D) exhibited much stronger angiogenic activities in either CAM or Matrigel plug
assay when compared to CM from vector control or parental BCC cells. The increase of bFGF-2
mRNA and secreted bFGF-2 protein in IL-6-overexpressing cells and in BCC cells treated with
recombinant IL-6 suggesting that IL-6 can up-regulate bFGF-2 expression in BCC cells. Using anti-
bFGF antibody to block bFGF-2 function significantly inhibited CM-induced HUVEC tube forma-
tion as well as Matrigel plug formation. To dissect the mechanism by which IL-6 up-regulates bFGF-
2 in BCC cells, we using various pharmacological inhibitors to examine the signaling pathways
involved. The experimental results show that AG490 (JAK inhibitor) and LY294002 (PI3-kinase
inhibitor) inhibit IL-6-mediated transcriptional up-regulation of bFGF-2 mRNA and secretion of
bFGF-2 protein. Meanwhile, blocking STAT3 pathway with dominant negative mutants, STAT3F
and STAT3D, all effectively abolished IL-6-mediated expression of bFGF-2 mRNA and secreted
protein. Similar inhibition on IL-6-induced up-regulation of bFGF-2 was observed when BCC cells
were transfected with dominant negative Akt (dnAkt). Together, our data suggest that bFGF-2 is a
functional downstream effector of IL-6-induced angiogenesis in BCC cells. The IL-6-mediated bFGF-
2 up-regulation is through activation of STAT3 and PI3-Kinase/Akt pathways. 
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The chemokine expression of human dermal microvascular endothelial cells and umbilical vein
endothelial cells by tumor necrosis factor-alpha and interferon-gamma
Y Okubo,1,2 MA Fernandez1,2 and AJ Connolly1,2 1 Medicine, Stanford University, Stanford, CA
and 2 Cardiovascular Biology, Palo Alto Medical Foundation, Palo Alto, CA
Activation of endothelial cells (ECs) plays a critical role in the pathogenesis of inflammatory skin
diseases, such as psoriasis. Adhesion molecules and cytokines are induced and promote binding to
activated leukocytes and homing into the inflammatory sites from the circulation. However, little is
known about the skin site-specific recruitment of leukocytes. The objectives were to characterize
alterations of chemokine regulation by cytokines at the gene expression level in human dermal micro-
versus macrovascular ECs. Human dermal blood vessel endothelial cells (BEC) were isolated from
neonatal human foreskins and purified using anti-PECAM-1 affinity beads and followed by nega-
tive selection for a lymphatic specific marker. Human umbilical vein endothelial cells (HUVEC)
were used as macrovascular endothelial cells. BEC and HUVEC were stimulated with tumor necro-
sis factor-alpha (TNF-α) and/or interferon-gamma (IFN-γ) for 4 hours and analyzed with DNA
microarray comprised of 54,000 probe sets including 38,500 known genes. Unstimulated BEC
expressed microvascular markers, such as C17. About 9%, 6% and 15% of probe sets underwent
statistically significant change with treatment by TNF-α, IFN-γ and both, respectively. Upon stim-
ulation with TNF-α and/or IFN-γ, the chemokine gene expression of BEC was quite similar to that
of HUVEC. CCL20, IL8 and GRO3 were up-regulated by TNF-α, but not IFN-γ. MIG was induced
by IFN-γ, but not TNF-α. The combination with TNF-α and IFN-γ induced strong RANTES and
MCP-2 expression indicating a synergy. Some gene up-regulation was slightly different between
BEC and HUVEC. GCP-2 was more up-regulated by TNF-α in HUVEC than in BEC. MCP-2 and
Fractalkine expression levels induced by IFN-γ were higher in BEC than in HUVEC. Our data indi-
cate that chemokine gene up-regulation by activated dermal microvascular ECs is quite similar to
HUVEC, but dermal microvascular ECs have different baseline gene expression and responses to
IFN-γ.
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Topical application of ex vivo expanded endothelial progenitor cells promotes wound healing
in diabetic mice
H Takenaka,1,2 J Asai,1,2 M Ii,2 S Kishimoto1 and DW Losordo2 1 Dermatology, Kyoto Prefectural
University of Medicine, Kyoto, Japan and 2 Cardiovascular Research, St Elizabeth’s Medical
Center, Boston, MA
Impaired wound healing, leading to skin ulceration, is one of the most serious complications of dia-
betes. Defective angiogenesis is considered to be a major contributing factor. Endothelial progeni-
tor cells (EPCs) have been shown to augment neovascularization in ischemic tissue. Accordingly,
we performed experiments to test the hypothesis that locally administered EPCs can promote wound
healing in diabetes. In genetically diabetic db /db mice, full-thickness skin wounds (0.8 cm) were
created on the dorsum using a skin biopsy punch tool. EPCs were obtained from bone marrow
mononuclear cells after 7 days culture. 5X104 EPCs were directly applied to the wound immedi-
ately after surgery. For EPC tracking, cells were marked with red fluorescent carbocyanine DiI-acety-
lated LDL. PBS and non-selective bone marrow mononuclear cells were used as control. Wounds
were covered with an occlusive dressing. Wound size was measured at day 5, 10, or 14 after the treat-
ment followed by resection, histological analysis, and quantification of vascularity. Topical appli-
cation of ex vivo expanded EPCs significantly promoted wound healing as assessed by closure rate
and wound vascurality. Immunostaining and Western blot analyses revealed that transplanted EPCs
resulted in increased local expression of vascular endothelial growth factor and basic fibroblast growth
factor in the wounds. Few DiI labeled EPCs were observed in the neovasculature, assessed by in vivo
staining of the functional vasculature with FITC-labeled Bandeiraea simplicifolia lectin I. Ex vivo
expanded EPCs promote wound healing in diabetic mice via mechanisms involving increased local
cytokine expression and enhanced neovascularization of the wound. This strategy, exploiting the
therapeutic capabilities of autologously derived EPCs represents a novel approach to diabetic skin
repair. 
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Ultrastructural evidence of dermal microvascular alterations in an animal model of atopic der-
matitis
R Agha Majzoub,1 RP Becker2 and LS Chan1,3 1 Dermatol, UIC, Chicago, IL, 2 Anatomy and Cell
Biology, UIC, Chicago, IL and 3 Micro/Immunol, UIC, Chicago, IL
We previously established an animal model of atopic dermatitis, a chronic inflammatory skin dis-
ease, by transgenic expression of IL-4 to the epidermis. To elucidate the microvascular changes asso-
ciated with this inflammatory disease, transmission electron microscopy (TEM) was performed on
ear dermal blood vessels in four conditions: non-transgenic (non-Tg) mice, Tg mice before onset
(BO), acute (AL) and chronic disease (CL) states (n= 5 each). The number of vessels examined in
these conditions ranges from 13 to 27 (capillaries) and from 7 to 23 (post-capillary venules (PCV)).
Compared to non-Tg mice, the microvasculature of Tg mice BO showed no statistically significant
changes, except for an increase in the number of endothelial junctional clefts (EJC) in PCV (p<0.0001).
The most significant changes were documented in the PCV of the AL and the newly formed capil-
laries of the CL. In particular, TEM features that are characteristic of leaky microvasculature were
found in the AL, with some reaching statistical significance when compared to non-Tg mice: red
blood cell congestion, disruption of EJC, presence of fenestrations, and increases in number of
parajunctional complexes of plasmalemmal vesicles, convoluted clefts (p<0.0001), and length of
EJC (p=0.0017). In the CL, TEM features characteristic of angiogenesis were revealed, with some
reaching statistical significance when compared with non-Tg mice: sprouting, transcapillary pillars
of intussusception, presence of hypertrophic nuclei (none of these present in capillaries of non-Tg
mice), increases of rough endoplasmic reticulum, ribosomes, endothelial cell thickness, number of
EJC (p=0.0045), and decrease of the length ratio of inter-endothelial tight junction to EJC (p<0.0001).
Our data provided evidence of dermal microvascular leakage and angiogenesis in this animal model
of AD. We suggest that microvascular leakage may play a role in the pathogenesis of the cutaneous
migration of inflammatory cells and that this inflammatory disease is associated with angiogenesis. 
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Topical pimecrolimus transiently induces neuropeptide release and mast cell degranulation in
murine skin
S Staender,1 H Staender,1 S Seeliger,1 A Stuetz,2 TA Luger1 and M Steinhoff1 1 Dermatology,
University Hospital Muenster, Muenster, Germany and 2 Novartis-Pharma, Vienna, Austria
Pimecrolimus (SDZ ASM 981) has been demonstrated to be effective and safe for the treatment of
AD. The only side effect reported is an initial transient burning. In order to understand the underly-
ing mechanism of this effect, healthy Balb/c mice were treated on the shaved back twice daily with
1% pimecrolimus cream for 2, 4 and 8 days, respectively. Untreated or vehicle-treated mice served
as controls. Skin specimens were investigated by light, immunofluorescence and electron microscopy.
Following pimecrolimus application, mast cells were found to be degranulated following 8 days after
pimecrolimus application. Immunofluorescence revealed a reduced staining for SP and CGRP in
papillary nerve fibers. At the ultrastructural level, nerve fibers were found to be regular without signs
of degeneration or inflammation. In addition, pimecrolimus cream (1%) alone, cream vehicle, and
the topical irritant benzalkonium chloride followed by pimecrolimus tretment after 6 hours were
applied on right mouse ears. Mouse ears were harvested for ELISA (SP, CGRP) after 30 min. Expres-
sion of neurokinin receptors were quantified from mouse ears 2-8 h after treatment by quantitative
RT PCR. Pimecrolimus cream induces enhanced release of SP (275 % +/- 41 SEM) and CGRP (114
% +/- 56 SEM) in the early phase after pimecrolimus treatment. Protein concentrations for SP were
slightly enhanced in the contact dermatitis model indicating higher release of SP in inflammatory
skin as compared to controls. In contrast, no statistically significant changes on neurokinin receptor
expression were observed after treatment at all time points investigated. Thus, transient early side
effects of pimecrolimus such as burning and itching may be due to mast cell degranulation leading
to release of neuropeptides from sensory nerve fibers. Whether this is a direct or indirect effect and
whether long treatment with pimecrolimus results in a decreased release of cutaneous neuropep-
tides is currently under investigation. 
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VEGF-A induced psoriatic skin inflammation and the associated lymphangiogenic response
are ameliorated by systemic blockage of VEGF receptor-1 and -2
R Kunstfeld,1 S Hirakawa,1 Y Hong,1 B Lange-Asschenfeldt,1 P Velasco,1 E Fiebiger,2 Y Wu,3
D Hicklin,3 P Bohlen3 and M Detmar1 1 Cutaneous Biology Research Center, Massachusetts
General Hospital, Boston, MA, 2 Dept. of Pathology, Harvard Medical School, Boston, MA and 3
Imclone Systems Incorporated, New York, NY
Previous studies have shown that the expression of VEGF-A and its receptors is elevated in patients
with chronic inflammatory diseases including psoriasis. To directly investigate the biological role
of VEGF in inflammation, we induced experimental delayed-type hypersensitivity reactions in the
ear skin of mice that overexpress VEGF-A in the epidermis and in wild-type controls. Whereas in
control mice, inflammation returned to baseline levels within one week, in VEGF-A overexpressing
mice inflammation persisted for more than one month and displayed hallmarks of human psoriasis
including epidermal hyperplasia and accumulation of dermal CD4-positive and epidermal CD8-pos-
itive lymphocytes. Double immunofluorescence stains for the lymphatic specific marker podoplanin
and the proliferation associated antigen Ki67 revealed active lymphatic endothelial cell prolifera-
tion and persistently enlarged lymphatic vessels exclusively in the chronic inflamed skin of VEGF-
A overexpressing mice. In striking similarity, skin biopsies obtained from human psoriatic lesions
showed highly enlarged lymphatic vessels whereas in adjacent, clinically non-involved skin, lym-
phatic vessels were collapsed. Inhibition of VEGF-A signaling through systemic application of block-
ing antibodies against VEGFR-1 and VEGFR-2 significantly reduced experimental skin inflamma-
tion and lymphatic enlargement. Our findings identify VEGF-A as a novel target for the treatment
of inflammatory skin diseases. 
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Mouse epidermal progenitor cells have unique proangiogenic properties compared to differ-
entiated cells
S Hakimi, C Oberley and M Dunnwald Dermatology, The University of Iowa, Iowa City, IA
We have previously shown that mouse epidermal progenitor cells (EPC) accelerate the restoration
of blood flow in the ischemic limbs of diabetic mice and that some of them incorporate into the vas-
culature. However the transient amplifying (TA) cells (daughters of the EPC) did not have a signif-
icant effect on the regeneration of the vasculature. These findings suggest that EPC may secrete pro-
angiogenic factors at a greater level than the TA cells. In order to test our hypothesis we performed
migration assays using the membrane invasion culture system (MICS). Conditioned medium from
EPC, TA cells and control medium were put in the lower compartment of the MICS then covered
by a 10um polycarbonate membrane. Above the membrane human umbilical vein endothelial cells
(HUVEC) were added. After six hours media from the bottom of the well was collected and the num-
ber of HUVEC cells that migrated across the membrane to the bottom wells were counted. Data
showed that the percent invasion of HUVEC cells in the EPC conditioned medium was 3 to 20 times
greater than TA or the control medium. To determine the nature of these factors, we evaluated the
level of vascular endothelial growth factor (VEGF) in the different media. EPC-conditioned medium
contained 4 to 6 times more VEGF compared to TA-conditioned medium. Results from these exper-
iments indicate that EPC secrete medium with greater chemoattractive properties for HUVEC cells
than the TA- and control-conditioned medium, and that some of this property can be attributed to a
higher level of VEGF. This suggests that within the epidermis, the chemoattractive property and
VEGF production are dominated by EPC. Thus, EPC may be proangiogenic, a unique characteris-
tic that could be used to treat ischemia. 
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SOCS 1 is a negative regulator of the MyD88-independent signaling pathway of the LPS-
induced TLR4 natural immune response in HDMEC
Y Yahata, K Yamasaki, Y Shirakata, M Tohyama, K Sayama and K Hashimoto Dermatology, Ehime
University School of Medicine, Ehime, Ehime, Japan
Recently, several groups have reported that LPS causes endotoxin shock via toll-like receptor (TLR)4,
a central part of the natural immune response. However, these studies examined lymphocytes,
macrophages, and dendritic cells. Human dermal microvascular endothelial cells (HDMEC) are also
damaged in endotoxin shock. Nevertheless, LPS-induced TLR4 activation in HDMEC has not been
examined. First, we confirmed the expression of TLR4 in HDMEC using RT-PCR. In general, LPS-
induced TLR4 stimulation results in the activation of two intracellular signaling pathways: the MyD88-
dependent and -independent pathways. The typical downstream molecule of the MyD88-dependent
pathway is IκBα, while that of the MyD88-independent pathway is STAT1. Therefore, we studied
whether IκBα and SATA1 are phosphorylated in HDMEC after LPS stimulation. LPS induced the
phosphorylation ofIκBα, with a maximum at 1 h. LPS induced the phosphorylation of STAT1 opti-
mally at 3 h. The SOCS family is implicated in the negative regulation of the STAT signaling path-
way. It is of interest to determine whether the SOCS family regulates the LPS-induced MyD88-
independent signaling pathway. To investigate the expression of the SOCS family, we performed
real-time PCR. SOCS1 is induced by LPS stimulation in HDMEC. Western blot analysis confirmed
the increase in SOCS1 by LPS. Next, the role of SOCS1 in the LPS-induced HDMEC reaction was
studied using an adenovirus vector expressing wild-type SOCS1 (Adex-SOCS1). Transfection of
Adex-SOCS1 abolished the LPS-induced phosphorylation of STAT1, while the phosphorylation of
IκBα was not inhibited. Since IL-6 production in LPS-stimulated HDMEC is reported to be MyD88-
independent, the effect of SOCS1 on LPS-induced IL-6 production in HDMEC was examined. Trans-
fection of Adex-SOCS1 reduced LPS-induced IL-6 production in HDMEC markedly. Combined,
these data demonstrate that SOCS1 is a negative regulator of the MyD88-independent signaling path-
way of the LPS-induced TLR4 natural immune response in HDMEC. 
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The curative effect of histamine on cutaneous wound healing process
Y Numata,1 T Terui,1 R Okuyama,1 H Tagami,1 S Aiba1 and H Ohtsu2 1 Dermatology, Graduate
School of Medicine, Tohoku University, Sendai, Miyagi, Japan and 2 Applied Quantum Medical
Engineering, School of Engineering, Tohoku University, Sendai, Miyagi, Japan
During cutaneous repair, a new tissue formation starts with reepithelialization and is followed by a
granulation tissue formation, including neutrophils and macrophage accumulation, fibroblast pro-
liferation, matrix deposition, and angiogenesis. We analyzed roles of histamine for skin wound
healing using our histidine decarboxylase gene-knockout mice (HDC-KO (-/-) mice), which were
deficient in histamine production. Our study disclosed that the impaired histamine production in
HDC (-/-) mice resulted in the delayed wound healing and that exogenous histamine compensation
normalized healing process. While keratinocyte migration in HDC (-/-) mice was similar to that in
HDC ( / ) mice, macrophage recruitment and angiogenesis at the wound edge were markedly impaired
in HDC (-/-) mice, suggesting insufficiency in macrophages and endothelial cells in the HDC-KO
mice. In a few days after skin wounding, the amount of bFGF was higher in HDC ( / ) mice than that
detected in HDC (-/-) mice. Single topical administration of SU5402, an inhibitor of bFGF, reduced
new vessel formation at the wound edge and delayed wound closure of HDC (-/-) mice. From the
present analysis, deficient angiogenesis in HDC-KO mice caused the delay in the wound closure
probably due to the reduction in bFGF production and macrophage accumulation. We can conclude
that histamine is an accelerator in cutaneous repair. 
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Functional analysis of human vascular endothelial growth factor using a transgenic approach:
the possible implication in establishing psoriasis model mouse
H Yanagihori,1 K Nakamura,1 N Oyama,1 Y Tsunemi,2 H Saeki,2 K Tamaki,2 K Kobayashi,3
K Kobayashi3 and F Kaneko1 1 Dermatology, Fukushima Medical University School of Medicine,
Fukushima, Fukushima, Japan, 2 Dermatology, Graduate School of Medicine and Faculty of
Medicine, the University of Tokyo, Bunkyo-ku, Japan and 3 Molecular Genetics, Fukushima
Medical University School of Medicine, Fukushima, Fukushima, Japan
Vascular endothelial growth factor (VEGF) has a crucial role in angiogenesis and leukocyte recruit-
ment to the sites of inflamed skin. A transgenic study using murine VEGF has recently demon-
strated that increasing microvascular density and enhanced leukocyte rolling and adhesion in the
skin; however, only a little knowledge for human counterpart are yet available. In this study, we first
generated the transgenic mice carrying the keratin 14 promoter-human VEGF transgene, to investi-
gate the skin biology associated with the interrelationship between epidermis and dermal epithelium.
The VEGF transgenic mice showed mild swelling of the ear auricle and hyper vascularity in the skin.
Histological examination revealed a marked increase of dermal blood vessels and infiltrates as com-
pared to the wild type. The vessel walls were immunostained with VEGF, and its cell surface recep-
tors. Moreover, skin injury resulted in histologically acanthosis, parakeratosis and rete ridge forma-
tion with lymphocytic infiltration, resembling psoriatic skin. These results suggest that transgenic
mice for human VEGF may provide a new insight not only for underlying disease pathogenesis of
psoriasis but also for a potential candidate as therapeutic targets in this common inflammatory skin
disease.
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An animal model of atopic dermatitis: morphological, serological, and molecular biological
evidence of angiogenesis in dermal microvasculature
D Marble,1 L Chen,1 T Jin,2 T Lin2 and L Chan1,3 1 Dermatol, UIC, Chicago, IL, 2 Oral Biol, UIC,
Chicago, IL and 3 Micro/Immunol, UIC, Chicago, IL
To investigate the dermal microvasculature underlying the inflammatory process of a keratin 14-IL-
4-transgenic (Tg) mouse model of atopic dermatitis, morphological, serological, and molecular bio-
logical methods were employed on samples from 4 groups: non-Tg mice (NT), Tg mice before dis-
ease onset (BO), acute disease (AL), and chronic disease (CL).  Immunofluorescence microscopy
using anti-CD31 on ear samples followed by computer-assisted photometric analysis showed increases
in the following parameters as disease progresses: percent area occupied by vessels (NT 11±4%,
BO 12±3%, AL 20±3%, and CL 27±11%); number of vessels per mm skin length (NT 36±6.5, BO
44±10, AL 63±17, CL 72±31); diameter (µm) of vessels (NT 2.2±0.4, BO 5.9±2.2, AL 9.3±1.9, CL
6.9±2.1). Skin stained with anti-VEGFR2 showed increased vascular expression: percent area with
expression (NT 1.6±0.4%, CL 6±4.2%); VEFGR2+ vessel number per mm skin length (NT 23±3.1,
CL 79±29).  ELISA analysis of serum VEGF demonstrates increases of protein concentration (pg/ml)
as the disease progresses (NT 367±291, BO 459±457, AL 1096±771, CL 1430±892), correlated with
increased VEGF protein in skin extract by Western blot. Reverse transcription real-time PCR was
performed on skin extract to quantify known angiogenic factors: VEGF, VEGFR1, VEGFR2, CD31,
Cadherin (Cad),Angiopoietin-1 (Ang-1),Angiopoietin-2 (Ang-2), Tie-1, and Tie-2. Increased mRNAs
were detected in CL group when compared with NT group: VEGF (1.2 fold), VEGFR2 (3 fold),
CD31 (5 fold), Cad (4 fold), Ang-1(4 fold), and Ang-2 (5 fold). Similarly VEGFR2 mRNA was
increased by 5 fold in the AL group. Statistically significant differences (p<0.02 to p<0.0001) were
found between CL and NT groups in the following parameters: area/number/diameter of vessels,
endothelial VEGFR2 expression, serum VEGF concentration, and angiogenic factor mRNAs
(VEGFR2, CD31, Cad, Ang-1, Ang-2). Together, these changes in diseased mice support the occur-
rence of angiogenesis and suggest that angiogenesis may play a role in the pathogenesis. 
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Keratinocyte- and sebocyte-derived factors modify UVB activity on endothelial cells: a possi-
ble mechanism for the development of vascular changes in rosacea
S Fimmel,1 A Schnittger,1 E Glass,1 K Seiffert,2 RD Granstein2 and CC Zouboulis1 1 Dept. of
Dermatology, Charite University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany
and 2 Dept. of Dermatology, J. & S.I. Weill Medical College, Cornell University, New York, NY
Rosacea, a chronic inflammatory skin disorder and vascular dilatation, a major clinical sign, have
not been adequately explained. We have raised and investigated the hypothesis that soluble factors
may mediate inflammation and vascular dilatation in rosacea. In this part of the study we evaluated
the paracrine influence of epithelial skin cells and/or UVB irradiation on the release of the major
angiogenic factor VEGF and of IL8 by dermal microvascular endothelial cells (HMEC-1). We demon-
strated by ELISA that VEGF protein levels were upregulated and pro-inflammatory IL8 levels were
down-regulated in HMEC-1 supernatants after irradiation with a physiological UVB dosis (7.5
mJ/cm2). In contrast, secretion of both VEGF and IL8 by keratinocytes (human foreskin cells) and
sebocytes (SZ95 cell line) was reduced under identical conditions. VEGF reduction was annulled
by increasing sebocyte density. The relatively high levels of VEGF in sebocyte supernatants remained
unchanged even under high UVB doses (30-90 mJ/cm2). IL8 release was reduced after UVB irradi-
ation not depended to the cell density but in proportion to UVB dosis. Paracrine regulation was
adressed by maintaining HMEC-1 in keratinocyte or sebocyte supernatants and subsequent UVB
irradiation. The UVB effect on VEGF release by HMEC-1 in sebocyte conditioned medium was neg-
ligible and independent of the irradiation dosis (7.5-50 mJ/cm2), but IL8 secretion was inhibited by
UVB at a dosis of 15 mJ/cm2. Maintained in keratinocyte conditioned medium, HMEC-1 released
25% less VEGF under UVB. IL8 was strongly upregulated but could be reduced with increasing
UVB dosis. These data let us assume that UVB may directly induce vascular dilatation, e.g. in rosacea,
but sebocytes and possibly keratinocytes produce factors which have a protective role in the devel-
opment of vascular dilatation in UV irradiated skin. 
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Skin specific chemokines and cell recruitment by skin microvascular endothelial cells
J Franchi,1 C Crola,2 C Lardin,2 C Marteau,1 M Mitterrand,2 S Schnebert,1 C Mahe,1 P Andre1 and
C Kieda2 1 R&D, LVMH Parfums et Cosmetiques, Saint Jean de Braye, France and 2 Centre de
Biophysique Moleculaire UPR CNRS, Orleans, France
As demonstrated (Kieda, 2002, Endothelium, 9, 247-61), the endothelium is highly selective organ,
which reflects the biological state of the tissue and microenvironment. The cell recruitment and the
molecular targeting strategies can take advantage of such a specificity to design organ directed ther-
apies. The skin model which consists of cocultures of the main cellular partners interact in normal
situation as well as injured or activated situations. In such conditions the critical role for reparation
is played by endothelial cells which are able to recruit competent cells and necessary molecules in
a microenvironment and specific receptor way. Chemokines are desicive molecules which could be
presented in a restricted way to help make endothelial cells to be very strictly selective. Here, we
demonstrate the restricted activity of two chemokines :fractalkine (neurotactine) and especially
CTACK towards endothelial cells from skin as opposed to endothelial cells from other non related
organs. Furthermore, other chemokines as 6Ckine which is lymph node selective, was not able to
activate skin endothelial cells in functional assays as adhesion (flow cytometry) and circulating cell
rolling.
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Genetic control of cellular production of vascular endothelial growth factor in psoriasis
HS Young,1,2 AM Summers,2 PE Brenchley2 and CE Griffiths1 1 The Dermatology Centre, The
University of Manchester, Manchester, United Kingdom and 2 Manchester Institute of Nephrology
and Transplantation, Manchester, United Kingdom
Vascular endothelial growth factor (VEGF) promotes angiogenesis, is produced by epidermal ker-
atinocytes (KCs) and PBMCs and elevated levels are found in plaques of psoriasis. We have shown
significant associations between VEGF +405 CC and the C allele and severe, early onset psoriasis;
and between +405 and VEGF production in healthy subjects. +405 is close to the functional AP-1
site (+419) through which retinoids may block production of VEGF. Retinoids are an established
treatment for severe psoriasis. We used cell culture to investigate whether KC and PBMC produc-
tion of VEGF in patients with psoriasis exhibit the same polymorphic control. 14 patients with early
onset psoriasis (7 +405 CC and 7 +405 GG genotypes) were recruited. Freshly-isolated PBMCs and
KCs (passage 1) were cultured with all-trans retinoic acid (RA), lipopolysaccharide (LPS) or phor-
bol ester (PMA). Experiments were performed in triplicate. VEGF protein was measured using
ELISA. BMCs from patients with CC genotype demonstrated significantly (all p=0.04) increased
VEGF production at baseline and after stimulation with LPS or RA as compared to patients with
GG genotype. PBMC incubation with PMA resulted in no significant VEGF production for either
genotype group. It was only possible to stimulate production of VEGF from KCs of the CC geno-
type (with PMA). In marked contrast to PBMCs, RA reduced VEGF production for both genotype
groups (even after stimulation of VEGF production with PMA for the CC group; p=0.04). In sum-
mary, PBMCs and KCs from patients with chronic plaque psoriasis demonstrate significant geno-
type dependent production of VEGF; furthermore regulation of VEGF production is different for
both cell types. This is the first analysis of differential cellular control of VEGF gene expression sug-
gesting that the +405 polymorphism dictates VEGF expression in psoriasis and that retinoids may
exert an antiangiogenic effect in psoriasis via modulation of VEGF production. 
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Processing of proopiomelanocortin peptides by dermal microvascular endothelial cell extra-
cellular peptidases: implication for endothelial cell biologic functions and skin inflammation
TE Scholzen,1 S Koenig,2 M Fastrich1 and TA Luger1 1 Dermatology & Ludwig-Boltzmann
Institute, University of Muenster, Muenster, Germany and 2 Integrated Functional Genomics,
University of Muenster, Muenster, Germany
Dermal microvascular endothelial cells (EC) are both source and target of the proopiomelanocortin
(POMC) peptides ACTH and α-melanocyte-stimulating hormone (α-MSH). The availability of
neuropeptides as important modulators of innate and adaptive immune responses is controlled by
neuropeptide-specific Zinc metalloproteases such as neutral endopeptidase (NEP) or angiotensin-
converting enzyme (ACE). In this study, we have tested the possibility that NEP or ACE expressed
by EC may influence the local bioavailability of POMC peptides. Incubation of ACTH1-39 with cell
membranes prepared from the high NEP/low ACE expressing microvascular EC line 1 (HMEC-1)
or from low NEP/high ACE expressing primary human dermal EC (HDMEC) for 30 - 480 min
resulted in a decrease in ACTH immunoreactivity (IR) over time in membrane supernatants that could
be partially blocked with NEP inhibitors as detected by radioimmunoassay. In parallel, α-MSH IR
temporarily increased peaking after 60 min. Functionally, incubation of EC membranes with ACTH
altered its ability to induce interleukin 10 release from U937 monocytes. Fragments generated by
incubation of HMEC-1 or HDMEC membranes with ACTH1-39, ACTH1-24 or α-MSH for 1 - 120
min were further analyzed by mass spectroscopy. ACTH1-39 and ACTH1-24, but not ACTH18-39 was
rapidly bound to HMEC-1 and HDMEC membranes. HMEC-1 membranes generated peptide prod-
ucts, which could be altered by inhibition of NEP, but not ACE. Likewise, HDMEC membranes frag-
mented ACTH similar to HMEC-1 membranes in the presence of NEP inhibitors. Some of the pro-
teins can be assigned to regular proteolytic cleavage while others seem to be modified. Thus, these
novel data suggest that EC proteolytic peptidases locally control the bioavailability of stress hor-
mones and anti-inflammatory peptides such as ACTH or α-MSH to melanocortin receptors, which
may be important in controlling cutaneous inflammation 
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Gene gun-mediated delivery of full-length cDNA encoding the human lymphatic endothelial
cell selective marker, LYVE-1, to skin yields function-blocking mouse antibodies that recog-
nize native structure for flow cytometry and immunohistochemistry
AR Cardones, WW Leitner and ST Hwang Dermatology Branch, NIH, Bethesda, MD
LYVE-1 is a surface bound receptor for hyaluronic acid (HA) that is preferentially expressed by lym-
phatic (vs. blood vascular) endothelial cells. The biology of lymphatic endothelial cells is poorly
understood relative to blood vascular endothelial cells, in part, because of the paucity of reagents
that specifically recognize lymphatic endothelial cell proteins. Moreover, while several anti-LYVE-
1-specific antibodies have been reported, none have been shown to recognize native structure or block
function.  To circumvent this problem, cDNA encoding the full-length sequence of human LYVE-
1 was coated on gold particles that were subsequently delivered via a helium-driven, biolistic-propul-
sion system (gene gun) into the skin of 10 Balb/C mice every 3 weeks. After 3 immunizations, mouse
sera were collected for analysis. Specificity of the antisera for LYVE-1 was demonstrated by posi-
tive staining of LYVE-1-transfected 293T cells compared with mock-transfected 293T controls by
flow cytometry (FACS).  In addition, 70-90% of heterologous, cultured human dermal microvascu-
lar endothelial cells (HDMEC) derived from neonatal foreskin showed LYVE-1 staining by FACS.
Antisera from one mouse completely inhibited binding of FITC-HA to HDMEC at 20 deg. C. By
immunohistochemistry, LYVE-1 antisera detected lymphatic channels in both normal and psoriatic
skin sections. Lymphatic vessels were generally increased in psoriasis and were weakly CD31 pos-
itive compared to blood vascular endothelial cells. LYVE-1 antisera did not react with SDS-dena-
tured LYVE-1 in Western blots. In summary, function-blocking antisera that recognizes native human
LYVE-1 was obtained after repeated gene gun-mediated, cutaneous immunization of mice with
full-length cDNA encoding LYVE-1.  The LYVE-1 antisera may be useful for studies of lymphatic
dysregulation in human skin disease and for studies of the potential biologic roles of LYVE-1 in
immune cell trafficking. 
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Thrombospondin 1 modulates inflammation and vascular remodeling during experimental
delayed-type hypersensitivity reactions
P Velasco,1 R Huegel,1 J Harder,1 E Christophers,1 JM Schroder,1 J Lawler,2 M Detmar3 and
B Lange-Asschenfeldt1 1 Department of Dermatology, University of Kiel, Kiel, S-H, Germany, 2
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA and 3 Cutaneous
Biology Research Center, Department of Dermatology, Massachusetts General Hospital and
Harvard Medical School, Boston, MA
Thrombospondin 1 (TSP-1) is a potent endogenous angiogenesis inhibitor that is thought to play an
important role in maintaining cutaneous vascular quiescence. However, TSP-1 has been detected in
inflammatory diseases such as arthritis and has been described as pro-angiogenic and pro-inflam-
matory in some experimental models. To elucidate the function of TSP-1 in a cutaneous inflamma-
tion, we studied the expression of TSP-1 in human allergic contact dermatitis (ACD) induced by
patch testing. 72 hours after the onset of the inflammation, both TSP-1 protein and mRNA expres-
sion were potently upregulated in the inflamed lesions when compared to normal skin taken from
the same patient. In-situ hybridization revealed that keratinocytes and endothelial cells were the main
source of TSP-1 in ACD although some inflammatory cells were also positive. To functionally char-
acterize the role of TSP-1 in inflammation, we induced delayed-type hypersensitivity reactions by
topical application of oxazolone to the skin of mice with targeted epidermal TSP-1 overexpression,
in TSP-1-deficient mice and in wildtype mice. We found decreased edema formation in the inflamed
ears of TSP-1 transgenic mice associated with a significant decrease in the number of enlarged blood
vessels when compared to wildtype littermates. Conversely, TSP-1-deficient mice exhibited a per-
sistent reaction, characterized by a delayed resolution of the inflammation, when compared to wild-
type mice. Our data indicate that TSP-1 suppressed vascular remodeling during an ACD and thereby
decreased the extent of the experimental cutaneous inflammation, probably by downmodulating the
effects of pro-angiogenic factors such as vascular endothelial growth factor A and by aiding in the
resolution phase of the inflammation. 
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Vimentin intermediate filaments and focal contacts in endothelial cells
M Boehringer,1 D Tsuruta2 and J Jones1 1 Cell and Molecular Biology, Northwestern University,
Chicago, IL and 2 Dermatology, Osaka City University Medical School, Osaka, Japan
In human dermal microvascular endothelial cells (HMVEC), matrix adhesion mediated by focal con-
tacts (FCs) plays a crucial role in processes leading to vasculogenesis and angiogenesis. FCs, rich
in αvβ3 integrin heterodimers, typically interact with the actin cytoskeleton. Remarkably, vimentin
intermediate filaments also associate with 50-60% of FCs in HMVECs. Moreover, when endothe-
lial cells are subjected to shear stress (flowing medium at 12 dynes/cm2), large bundles of vimentin
establish connection to FCs. Using vimentin “knock-down” RNA interference (RNAi) methodol-
ogy, we have shown that vimentin regulates FC size and adhesive function in endothelial cells sub-
jected to flow. Moreover, knock-down of vimentin expression in endothelial cells leads to a collapse
of cytoplasmic staining of plectin, a member of the plakin family of cytolinker proteins. Plectin has
been implicated in vimentin-FC association. Hence, we tested the possibility that vimentin-FC inter-
action is mediated by plectin by using a plectin RNAi strategy. Cells transfected with plectin siRNA
were fixed and processed for immunofluorescence and cell extracts were prepared for immunoblot-
ting. The latter reveals that cells expressing the plectin siRNA show a significant knock-down in
plectin expression. The knock-down cells show no changes in their overall vimentin, microtubule
and microfilament cytoskeleton networks. However, although FCs in cells deficient in plectin are
smaller than those treated with a control siRNA, there is no obvious change in the percentage of FCs
showing an association with vimentin. Furthermore, the plectin knock-down cells show no abnor-
malities with respect to control transfected cells in their adhesion to various substrates, spreading or
motile behavior. When subjected to shear stress, plectin knock-down cells, unlike their vimentin
knock-down counterparts, fail to show decreased substratum adhesion. In summary, the vimentin
cytoskeleton plays a role in FC structure/function but its association with FCs is not dependent on
plectin.
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ICAM-1 as a basis for vascular leak induced by cytokine-mediated endothelial cell activation
MS Kluger, T Manes and JS Pober Department of Dermatology and Program in Vascular Biology
and Transplantation, Yale University School of Medicine, New Haven, CT
Cytokine-based immunotherapy for treatment of skin malignancy (e.g., melanoma or cutaneous T
cell lymphoma) has proven efficacy but is limited by capillary leak syndrome, a form of vascular
leak resulting in hypotension, tachycardia, and edema. Vascular leak may arise from damage to
endothelial cells (EC) or from cytokine (e.g., TNF)-related EC activation. In our hands TNF treat-
ment (24-72 h) of cultured human dermal microvascular EC causes cell elongation, actin reorgani-
zation from dense peripheral bands to longitudinal stress fibers and a decrease in monolayer elec-
trical resistance. These changes in EC morphology and barrier function are accompanied by
TNF-induced upregulation of E-selectin and ICAM-1 protein expression. Similar changes occur
without any requirement for TNF treatment in EC transduced to express ICAM-1, but not in EC
expressing E-selectin. To determine whether morphological changes induced by TNF are mediated
by ICAM-1, we inhibited TNF-induced ICAM-1 expression by transfection with two different siRNA
constructs. Remarkably, TNF-induced cell elongation and actin reorganization were each reduced
proportionately with the extent of siRNA-mediated inhibition of ICAM-1 expression in comparison
to a scrambled control siRNA. Based on nuclear morphology the reduction in TNF effects was not
due to apoptosis. These observations suggest that ICAM-1 up-regulation followed by cytoskeletal
reorganization may contribute to the type of vascular leak induced by cytokine-mediated endothe-
lial cell activation. 
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Kaposi’s sarcoma-associated herpesvirus (KSHV) infection of human dermal microvascular
endothelial cells (HDMEC) causes increased cellular proliferation, decreased cellular adhe-
sion, and marked up-regulation of angiogenic growth factors
W Liao, D Borris and A Blauvelt Dermatology Branch, NCI, Bethesda, MD
KSHV is an oncogenic γ-herpesvirus associated with all clinical forms of KS. Histologically, KS is
characterized by proliferation of KSHV-infected tumor spindle cells of endothelial origin and for-
mation of slit-like vascular spaces, both features of dysregulated angiogenesis. In order to gain fur-
ther insight into how KSHV cause KS, we studied the biology and function of HDMEC following
in vitro infection by KSHV. Placed in basal medium with low serum (2% FBS) and no supplemen-
tal growth factors, KSHV-infected HDMEC survived and proliferated significantly better than unin-
fected cells for 1 week following infection. Infected HDMEC (compared to uninfected cells) also
demonstrated decreased adhesion to extracellular matrix proteins, including fibronectin, vitronectin,
and collagen IV. Using real-time RT-PCR to detect and quantify mRNA, we detected up-regulation
of numerous angiogenic growth factors and growth factor receptors in KSHV-infected HDMEC,
including VEGF-B, PlGF-1, VEGFR-1, -2, -3, Ang-2, Tie-1, -2, and bFGF. VEGFR-1 and Ang-2
mRNA levels were increased most dramatically (>10-fold). In summary, we found that KSHV infec-
tion of HDMEC caused increased cellular proliferation, decreased cellular adhesion, and marked up-
regulation of angiogenic growth factor mRNA expression. These results strongly suggest that KSHV
directly causes dysregulated angiogenesis in KS tumors by causing infected cells to proliferate, sur-
vive well, and produce and respond to pro-angiogenic environmental signals. 
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Enhanced acute photosensitivity and chronic UVB-induced cutaneous photodamage in VEGF
transgenic mice
S Hirakawa,1 S Fujii,1 K Kajiya,1 K Yano2 and M Detmar1 1 Dermatology, Massachusetts General
Hospital, Charlestown, MA and 2 Shiseido Life Science Research Center, Shiseido, Yokohama,
Japan
Acute ultraviolet B (UVB) irradiation of the skin results in erythema, vasodilation, enhanced vas-
cular permability and edema formation. Previous studies have found that UVB irradiation promotes
the expression of vascular endothelial growth factor (VEGF) by epidermal keratinocytes in vivo and
in vitro. To directly investigate the biological importance of VEGF for the cutaneous UVB response,
we subjected 8-week-old male VEGF overexpressing transgenic mice (n=5) and their wild-type lit-
termates (n=5) to acute UVB irradiation. VEGF overexpressing mice were characterized by a two-
fold lower minimal erythema dose (MED = 3.6x10-2 J/cm2), as compared with wild-type mice (MED
= 7.2x10-2 J/cm2), after a single UVB exposure. Acute UVB irradiation with 3.6x10-2 J/cm2 induced
proliferation of epidermal keratinocytes and endothelial cells, dermal edema, vascular dilation, and
inflammatory cell infiltration in the skin of VEGF transgenic mice but not in wild-type mice. Sys-
temic treatment with an anti-VEGF blocking antibody or with blocking antibodies against VEGF
receptors-1 and -2 reduced the sensitivity of 8-week-old male wild-type mice to acute UVB irradi-
ation. In additional studies, 8-week-old male mice were subjected to 10 weeks (3 times/week) of
chronic UVB irradiation with 1.8x10-2 J/cm2. Whereas no major changes were observed in wild-
type mice (n=10) subjected to this regimen, VEGF transgenic mice (n=10) showed formation of wrin-
kles after 10 weeks, associated with pronounced neo-vascularization and matrix degradation in the
skin. Our results indicate that VEGF promotes cutaneous photo-damage and that the VEGF/VEGF
receptor pathway might serve as a novel target for the prevention of photo-aging of the skin. 
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Lack of thrombospondin-1 (TSP-1) and thrombospondin-2 (TSP-2) dramatically enhances skin
carcinogenesis and lymph node metastasis in double TSP-1/TSP-2-null mice
SS Dadras,1,2 L Lu,1 L Janes,1 J Lawler,3 P Bornstein4 and M Detmar1 1 CBRC/Dermatology,
MGH/Harvard Medical School, Charlestown, MA, 2 Pathology, MGH/Harvard Medical School,
Boston, MA, 3 Pathology, BIDM/Harvard Medical School, Boston, MA and 4 Biochemistry,
University of Washington, Seattle, WA
It is thought that the angiogenic switch during tumorigenesis is induced by a change in the balance
of proangiogenic and anti-angiogenic molecules. To investigate the individual and the combined role
of the endogenous angiogenesis inhibitors TSP-1 and TSP-2 in skin cancer development and pro-
gression, we subjected TSP-1 (n=26), TSP-2 (n=33) and TSP-1/TSP-2 (n=25) deficient mice, as well
as wild-type mice (n=25) to a two-step chemical skin carcinogenesis regimen. For initiation, all mice
were treated once with 25 ug DMBA, applied to the dorsal skin, followed by 20 weekly topical appli-
cations of 5 ug of the tumor promoter PMA. Mice deficient in TSP-2 and mice deficient in TSP-1
and TSP-2 exhibited accelerated papilloma and squamous cell carcinoma (SCC) development, com-
pared to wild-type mice. Surprisingly, TSP-1 deficiency had no major effect on either papilloma or
SCC development. At 29 weeks after tumor initiation, TSP-1/TSP-2 double deficient mice exhib-
ited a 3-fold increase and TSP-2 deficient mice exhibited 2-fold increase in the number of SSC/mouse,
as compared to TSP-1 deficient and wild-type mice. TSP-1/TSP-2 deficient mice (75%) and TSP-2
deficient mice (78%) also developed significantly more clinically visible metastases to regional lymph
nodes, compared to the wild-type mice (25%). Our results indicate that TSP-2 plays a more impor-
tant protective role against tumor development than TSP-1 in multistep skin carcinogenesis. 
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An in vivo model of venous malformation induced by Tie-2 activation in human endothelial
cells
DR Enis,2 JS Pober2,1 and JS Schechner1 1 Dermatology, Yale School of Medicine, New Haven, CT
and 2 Pathology, Yale School of Medicine, New Haven, CT
Signaling through the Tie-2 receptor is known to play a critical role in human physiologic and
pathologic vascular remodeling. However, the relative importance of specific signaling pathways
downstream of Tie-2 (such as the PI-3 kinase-Akt pathway) are not fully understood. We have pre-
viously shown that human umbilical vein endothelial cells (HUVEC) retrovirally-transduced to over-
express Akt, suspended in collagen/fibronectin gels, and implanted subcutaneously in SCID/beige
mice form a human EC-lined microvascular network of dilated, highly-branched vessels with dis-
organized smooth muscle/pericyte investment. In contrast, control-transduced EC produce a sparse
bed of narrow vessels with little branching. Since these Akt-HUVEC-lined vessels resembled hered-
itary venous malformations induced by activating mutations in Tie-2, we sought to determine if Tie-
2 activation could reproduce the Akt phenotype. To do this, we transduced primary HUVEC with
retroviral constructs expressing either wild-type Tie-2 or Tie-2 R849W, an activating mutation pres-
ent in some familial venous malformations. In vitro, the HUVEC overexpressing either wild-type or
mutant Tie-2 contained increased levels of phospho-Akt after serum withdrawal, and were resistant
to apoptosis induced by serum starvation or C6-ceramide. After 14-21 days in vivo, both Tie-2-wt-
HUVEC and Tie-2 R849W-HUVEC gave rise to dense networks of dilated, highly-branched vas-
cular structures with irregular investment by smooth muscle cells/pericytes. These vessels appeared
similar to Akt-HUVEC, suggesting that signaling through Akt alone is sufficient to mediate the patho-
logic effects of Tie-2 over-activation. Therefore, we have generated a humanized in vivo model of
venous malformations/vascular tumors, which should be useful in studying signaling through the
angiopoietin-Tie-2 pathway. We are currently investigating the contribution of upstream (Ang-1/2)
and downstream (eNOS) components of this pathway to these phenotypes. 
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Beneficial effects of Pimecrolimus in the Mrl/lpr mouse lupus model
U McKeever, K Baier and A Rot Pharmacology, Novartis Institute for Biomedical Research,
Vienna, Austria
Clinical studies with oral Pimecrolimus (ASM) treatment for up to 3 months in psoriasis and atopic
dermatitis patients have demonstrated high efficacy and safety. In addition, results from studies in
animal models of arthritis and inflammatory bowel disease have shown that ASM may also have
therapeutic potential in chronic inflammatory conditions beyond dermatology. Here we report on the
effect of oral ASM and cyclophosphamide (CP) on amelioration of symptoms in a MRL/MpJ-Tnfrsf6lpr
(MRL/lpr) mouse prophylactic model of systemic lupus erythematosus (SLE). Data from 2 inde-
pendent studies where mice were given 30 (ASM 30) or 50 (ASM 50) mg/kg/d ASM orally during
an 8 week period (between 3 and 5 months of age) when disease symptoms develop, suggest that
both ASM and CP are equally effective in reducing disease progression and severity. Proteinuria
scores were significantly reduced at ASM 50 (p〈0.01) and ASM 30 (p〈0.05) doses compared with
placebo treated control scores. Glomerulopathology severity scores were similarly reduced: ASM
50 (p〈0.001) and ASM 30 (p〈0.05).  In MRL/lpr treated mice both CP and ASM 50 significantly
decreased (p〈0.001) the lymph node population of CD4-CD8-CD3+, double negative T cells which
is an abnormal T cell subset that accumulates over time due to the lpr mutation. The reduction in the
generalized hypergammaglobulinemia characteristic of MRL/lpr mice which was greatly reduced
by CP compared to placebo controls (p〈0.001) was seen as a trend with ASM 50 as was the pro-
duction of anti-ds DNA antibodies. A trend to lower levels of Rheumatoid Factor was evident in the
ASM 50 and CP groups versus placebo treated controls. Thus, Pimecrolimus can effectively inhibit
disease in a dose-dependent manner in our MRL/lpr model and hence, could be useful for primary
or adjunct therapy of human SLE. 
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Sequence analysis of immunoglobulin E isotype switch in scleroderma skin tissue
T Ohtsuka and S Yamazaki Department of Dermatology, Dokkyo University School of Medicine,
Mibu, Tochigi, Japan
The involvement of mast cell, which is activated by immunoglobulin E (IgE), has been reported in
the formation of SSc abnormality. IgE is generated with isotype switch. During isotype switch, switch
circles resulting from direct µ-ε or from sequential µ-γ-ε switching with be created, and thus the cir-
cles can be used to assess the presence of isotype switch. We studied whether switch circular DNAs
are excised via looping out and deletional recombination in SSc. We used nested polymerase chain
reaction to analyze the S fragments from switch circles. Fifty-two patients with SSc, and 62 healthy
women were studied. The occurrence rate of direct class switch (3/52) and sequential switch (2/52)
in SSc skin tissue showed no significant difference with that of normal skin tissue (0/62) and with
that of SSc whole blood cells (0/42), respectively. The occurrence rate of IgE isotype switch in SSc
skin tissue (5/52) was significantly elevated compared with normal skin tissue (0/62) (P<0.02) and
with that of SSc whole blood cells (0/42) (P<0.02). DNA sequencing confirmed the results. These
results demonstrated that isotype switch to the ? locus achieved by direct and/or sequential switch
are involved in the formation of SSc skin tissue abnormality. 
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In vivo perfusion of human skin equivalents with circulating endothelial progenitor cells
EF Kung, SM Chavel, F Wang, JS Pober and JS Schechner Yale School of Medicine, New Haven,
CT
The performance of engineered skin substitutes is likely limited by inadequate perfusion in the post
transplantation period. We have accelerated vascularization of human skin equivalents in vivo by
incorporating endothelial cells (EC) differentiated from umbilical cord or adult peripheral blood
derived endothelial progenitor cells (EPC). Circulating CD34+ EPC were isolated using MACS and
cultured using selective media. After 14 days, the EPC were expanded and differentiated into EC as
assessed by morphology and flow cytometric detection of CD31, VEGFR-2, Tie-2, and TNF-induced
E-selectin expression. Skin equivalents were constructed by first seeding keratinocytes derived
from neonatal foreskins onto the epidermal side of split thickness decellularized human cadaveric
dermis and inducing stratification. EPC-derived EC were then seeded on the underside of the der-
mis and allowed to invade residual vessel channels. The resultant skin equivalents were orthotopi-
cally grafted onto the backs of SCID/beige mice. Grafts (4 seeded with cord blood- and 6 seeded
with adult blood derived EPC) harvested 2 weeks after implantation demonstrated numerous der-
mal vascular profiles that contained erythrocytes and were reactive with anti-human CD31 antibod-
ies and UEA-1 lectin, indicating these vessels were lined with human EC and inosculated with the
mouse circulation. Anti-smooth muscleα-actin antibody reactivity with these vessels showed smooth
muscle/pericyte investiture. Restriction of anti-murine CD31 reactivity to the edges of the grafts indi-
cated an ineffective murine angiogenic response by 2 weeks. Human EC lined vessels were also
observed to persist in 4 cord- and 2 adult blood derived EPC seeded grafts harvested at 4 weeks.
These data demonstrate that circulating human EPC can be used to enhance early perfusion of human
skin equivalents and describe a strategy for vascularizing engineered tissues with a source of EC
autologous to the recipient that can be obtained non-invasively. 
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IL-5 in human bullous pemphigoid blisters is more significant than IL-8 and neutrophil elas-
tase, but is unrelated to serum IgG antibodies to NC16A and tissue eosinophil major basic pro-
tein
M Dmochowski, A Danczak-Pazdrowska and M Bowszyc-Dmochowska Dermatology, University
School of Medicine, Poznan, Poland
It is believed that the NC16A domain of type XVII collagen comprises the most important autoepi-
topes in pathogenesis of bullous pemphigoid (BP). The majority of rodent and some human studies
suggest that neutrophils, but not eosinophils, are key cells in BP. The aim of this study was to com-
pare the involvement of IL-5, IL-8, eosinophil-derived major basic protein (MPB) and neutrophil
elastase (NE) in human BP at the tissue level in relation to the level of serum IgG antibodies to
NC16A (IgG anti-NC16A). Altogether 48 BP cases and 77 control patients with other autoimmune
and non-autoimmune bullous diseases were studied. The MBP in fresh blister-containing skin was
detected by immunohistochemical streptavidin/peroxidase technique. Blister fluid levels of IL-5, IL-
8 and NE, serum level of IL-5 and level of IgG anti-NC16A were examined by ELISA. The MBP
deposits were detected in blistering skin in 55% of BP cases, but in only 13% of control cases. The
level of IL-5 in blister fluid was significantly higher than that in serum in BP cases. The level of IL-
5 in blister fluid in BP cases was significantly higher than that in blister fluid in controls, whereas
levels of IL-8 and NE in blister fluid in BP cases did not differ significantly from those in blister
fluid in controls. There were no statistically significant associations between the presence of MBP
in lesional BP skin and levels of IL-5 in BP blister fluid and IgG anti-NC16A. There were no sta-
tistically significant correlations between BP blister fluid level of NE and levels of IL-8 in BP blis-
ter fluid and IgG anti-NC16A. There were no statistically significant correlations between IgG anti-
NC16A and levels of IL-5 and IL-8 in BP blister fluid. Thus, in human BP tissue the actions of IL-5
and MBP seem to be more disease-specific/significant than those of IL-8 and NE. However, the action
of IL-5 appears to be unrelated to IgG anti-NC16A and presence of MBP in lesional BP skin. 
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The role of intra-molecular epitope spreading in the development and transition of pemphi-
gus vulgaris
VK Salato, MK Foegen, Z Lazarova, JA Fairley and M Lin Dermatology, Medical College of
Wisconsin, Milwaukee, WI
Pemphigus vulgaris (PV) is an immunobullous disease. Patients at the earlier stage (mPV) display
only autoimmunity to desmoglein (Dsg) 3 and blisters in the mucosal tissues, while patients at the
later stage (mcPV) exhibit response to both Dsg3 and Dsg1 and blisters in mucosal and cutaneous
tissues. Recently, we found that autoantibodies from these two subsets of patients exhibit distinct
tissue staining and antigenic profiles, indicating that epitope spreading may play a role in the dis-
ease transition from mPV to mcPV. To examine this hypothesis, domain swapped Dsg3/Dsg1 pro-
teins were used in immunoprecipitation (IP), indirect immunofluorescence (IF) and ELISA. Using
IP, we discovered that mPV patients (12 out of 14) recognize an epitope located at Dsg3:87-566 but
not an epitope located at the first 87 amino acids. By competition Dsg3 ELISA and inhibitory indi-
rect IF, we showed that the anti-Dsg3 activity to Dsg3:88-566 was blocked by Dsg11-87/Dsg388-566,
but not by Dsg31-88/Dsg189-496. A longitudinal analysis of sera from patients who transitioned from
mPV to mcPV (n=5) revealed that anti-Dsg3 from mPV recognize an epitope within Dsg3:87-566,
while autoantibodies from the mcPV stage recognize an epitope located in the first 87 amino acids
of Dsg3. To clarify the epitope recognized by anti-Dsg3 from mcPV patients, a competition Dsg3
ELISA was employed. Here, we showed that the anti-Dsg3 activity in mcPV patients was blocked
by Dsg31-88/Dsg189-496 but not by Dsg11-87/Dsg388-566, suggesting that anti-Dsg3 from mcPV patients
recognize an epitope within the first 87 amino acids of Dsg3. In summary, our results suggest that
a Dsg3 intramolecular epitope spreading event is associated with the transition of disease from
mPV to mcPV and the production of antibodies to Dsg31-87 is critical for developing cutaneous lesions
in PV. Identification of detailed epitopes recognized by anti-Dsg3 at both disease stages may reveal
the relationship of epitope spreading with the development of cutaneous lesions in PV. 
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Analysis of autoimmune T cell repertoire in an active pemphigus vulgaris animal model
MK Hacker-Foegen, VK Salato, EB Olaz, JA Fairley, Z Lazarova and M Lin Dermatology, Medical
College of Wisconsin, Milwaukee, WI
Pemphigus vulgaris (PV) is a bullous disease characterized by autoimmunity against desmoglein-3
(Dsg3). Previously, we have demonstrated that Dsg3-specific T cells play an essential role in the
development of this disease. Dsg3-specific T cells expressing a CD4 memory T cell phenotype and
secreting a Th2 cytokine profile, are critical in promoting the production of pathogenic anti-Dsg3.
These T cells were shown to preferentially express certain T cell receptor (TCR) genes. It is diffi-
cult to fully assess the autoimmune T cell repertoire in human patients due to the complexity of their
therapeutic regimens. To better characterize Dsg3-specific T cells, we recently established an active
animal model of PV by transferring splenocytes from Dsg3 knockout mice (Dsg3KO) previously
challenged with skin grafts from gender-matched Dsg3+ siblings (skin immunization) to Rag2-/-
mice. This modified method avoids the potential immune skewing effect caused by adjuvant in the
previously reported animal model and ensures that the primary and secondary immune response to
Dsg3 are established in a physiological condition in vivo. In this study, we found that Rag2-/- mice
developed clinical, immunological, and histological features of PV 5-14 days after receiving spleno-
cytes from skin immunized Dsg3KO. PV phenotype development in our animal model is depend-
ent on the number of cells transferred and the titer of anti-Dsg3 in the skin immunized Dsg3KO. To
investigate the characteristics of disease-related autoimmune T lymphocytes, cells from the spleen
and lymph nodes of Rag2-/- mice developing PV were harvested and RNA purified. Subsequently,
cDNA was prepared and used as template with specific murine TCR beta chain primer sets in PCR
and their spectratypes were analyzed. Interestingly, we observed that there is a significant oligoclonal
expansion of T cells expressing BV5.2 and BV8.3 genes in these diseased mice. These results sug-
gest that these two T cell populations may respond to Dsg3 and participate in the development of
PV in this active animal model. 
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Blocking-type anti-melanin-concentrating hormone receptor antibodies in patients with vitiligo 
RV Gottumukkala,1 S Akhtar,1 DJ Gawkrodger,2 PF Watson,1 AP Weetman1 and EH Kemp1 1
Division of Clinical Sciences (North), University of Sheffield, Sheffield, South Yorkshire, United
Kingdom and 2 Department of Dermatology, Royal Hallamshire Hospital, Sheffield, South
Yorkshire, United Kingdom
Vitiligo is a common depigmenting skin disorder resulting from the loss of melanocytes in the cuta-
neous epidermis. Although the cause of the disease remains obscure, autoimmune mechanisms are
thought to be involved. Recently, our group has been identified the melanin-concentrating hormone
receptor (MCHR) as an autoantigen in 16.4% of vitiligo patients using a radiobinding assay. In the
present study, we aimed to determine if IgG samples from vitiligo patients were able to inhibit MCHR
function. Briefly, a stable CHO-K1 cell line expressing the MCHR receptor was isolated by trans-
fection of CHO-K1 cells with MCHR cDNA. Expression of MCHR in the stable cell line was analysed
by flow cytometry and also by measuring intracellular Ca2+ levels in response to MCH addition
using fluorimetry. The transfected cell line exhibited elevated levels of intracellular Ca2+ following
MCH addition, compared with untransfected cells, indicating receptor expression and flow cytom-
etry also demonstrated MCHR expression on the isolated cell line. In order to analyse for the pres-
ence of MCHR autoantibodies that block functioning of the receptor, cells expressing MCHR were
incubated with either control IgG (n=20), MCHR antibody-positive (in a radiobinding assay) vitiligo
patient IgG (n=9), MCHR1 antibody-negative (in a radiobinding assay) vitiligo patient IgG (n=9)
and SLE IgG (n=10). Our results showed that none of the control IgG samples blocked receptor func-
tion. In contrast, seven out of nine MCHR antibody-positive vitiligo patient IgG samples and three
out of nine MCHR antibody-negative vitiligo patient IgG samples inhibited the function of the recep-
tor. Incubation of the stable cell line with SLE IgG did not demonstrate blocking of MCHR activ-
ity. The results indicate that MCHR function blocking antibodies are specific to patients with vitiligo. 
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Evaluation of histamine-releasing activity in the sera of patients with chronic urticaria
W Sun,1 Z Bi,1 B Yan2 and Y Wan3 1 Nanjing Medical University, Nanjing, China, 2 University of
Rhode Island, Kingston, RI and 3 Biology, Providence College, Providence, RI
Chronic urticaria has a spectrum of clinical presentations but less well specified causes. Some of
patients with this disease have detectable histamine-releasing autoantibodies in their sera, which
have been considered as the cause of intolerance of nonsteroidal anti-inflammatory drugs. The term
autoimmune urticaria is increasingly being accepted for this subgroup of patients, in whom immuno-
suppressive therapies may be useful when conventional treatments are unsuccessful. To evaluate the
histamine-releasing activity in the sera of patients with chronic urticaria and to further explore the
pathogenesis of chronic urticaria, we studied 62 chronic urticaria patients by in vivo skin test with
autologous serum and in vitro histamine release assay using human cutaneous mast cells incubated
with the sera of patients. Our results demonstrated that among those tested twenty-four patients
showed a weal response to autologous serum (38.71%). Sera from patients with chronic urticaria
released a significant amount of histamine compared with control subjects (p<0.01), the percentage
of histamine released varied from 3.1% to 79.5% with a mean of 16.44% and a standard deviation
(SD) of 14.26%, and sera of 27 among 62 chronic urticaria patients (43.55%) elicited histamine
release more than 15%. The percentage of histamine release was also elevated in ASST+ chronic
urticaria patients compared to ASST- chronic urticaria patients (p<0.01). We conclude that hista-
mine-releasing activity, which was demonstrated in the sera of some patients with chronic urticaria,
is important in the pathogenesis of chronic urticaria by stimulating or facilitating degranulation of
cutaneous mast cells. 
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Ability to induce keratinocyte apoptosis determines pathogenicity of pemphigus IgGs
SA Grando, A Chernyavsky, K Records and J Arredondo Dermatology, University of California,
Davis, CA
Pemphigus vulgaris (PV) is associated with IgG antibodies against keratinocytes (KCs). Since autoan-
tibody titers do not always correlate with disease severity, it remains to find out what determines
pathogenicity of PVIgG. Apoptosis has been shown to precede acantholysis in PV patients’ skin,
PV patients’ sera to cause KC apoptosis, and PVIgG to upregulate proapoptotic genes in KCs. We
asked if the apoptotic and acantholytic activities of PVIgG correlate. PVIgGs were isolated by FPLC
protein G affinity chromatography from sera of patients with different severity of PV but similar
autoantibody titers. Apoptotic activity of PVIgGs was characterized by caspase-3 (Cs-3) assay, and
acantholytic activity by extent of intraepidermal splitting in neonatal mice and cell-cell dyshesion
in KC monolayers treated with test PVIgGs vs normal IgG. Time-course study revealed maximal
Cs-3 activity in KC monolayers 12-24 h after addition of PVIgGs. Antibody from a patient with
extensive mucocutaneous lesions exhibited highest activity. Similar correlation was observed in quan-
titative assays of acantholysis. At 24 h, the “apoptotic” and “nonapoptotic” PVIgGs produced 52±7
and 20±2% of acantholysis in vitro, and 76±14 and 35±9% in vivo, respectively (p<0.05). Effects
of PVIgG vs normal IgG on gene expression along the apoptosis pathway were analyzed by RT-
PCR and western blot. In the Fas signaling pathway, most pronounced changes occurred with Fas
receptor (FasR), Fas ligand (FasL), FLIP long (FLIPl), Cs-8 and Cs-3. PVIgG upregulated FasL and
Cs-3 and downregulated FLIPl, whereas normal IgG decreased Cs-8. The peak of PVIgG-induced
changes occurred at 24 h, when both FasL and Cs-3 increased >200%. FasR decreased by ~40%,
which might be a result of overstimulation of KCs with FasL. Thus, the pathogenicity of PVIgG
reflects, at least in part, their ability to activate Fas pathway in KCs, whereas the effect of normal
IgG suggests that IVIg may improve PV by blocking Fas signaling. Further studies of KC death
receptor signaling in PV may clarify pathophysiology and suggest novel treatments of this disease. 
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Skin inflammation is enhanced by sodium dodecyl sulphate-treatment in transgenic mice
expressing type I interleukin-1 receptor under the control of keratin 14 promoter
M Shibata,1,2 RC Fuhlbrigge1 and TS Kupper1 1 Harvard Skin Disease Research Center, Brigham
and Women’s Hospital, Boston, MA and 2 Cutaneous Biology Research Center, MGH/Harvard
Medical School, Charlestown, MA
The role of IL-1-inducible keratinocyte cytokines in irritant contact dermatitis (ICD) is currently
unknown. Using previously characterized transgenic mice expressing type I interleukin-1 receptor
on basal keratinocytes (K14/IL-1RI transgenic mice), we carried out experiments with two strong
irritants: sodium dodecyl sulphate (SDS) and phorbol 12-myristate 13-acetate (PMA). We meas-
ured ear swelling and cytokine production as an index of ICD. PMA and SDS increased ear swelling
in both K14/IL-1RI transgenic mice and non-transgenic littermates; however, ear swelling in K14/IL-
1RI transgenic mice was 50% and 100% greater than in non-transgenic littermates after 3 days or 7
days of consecutive application, respectively. The degree of neutrophil infiltration and epidermal
hyperproliferation observed in PMA and SDS treated K14/IL-1RI transgenic mice was also much
greater than in non-transgenic littermates. Gene expression of several inflammatory cytokines and
chemokines in mouse ear was quantitated by real-time PCR. SDS- and PMA-treatment markedly
induced several cytokine and chemokine genes tested, such as macrophage inflammatory protein
(MIP)-2, KC, monocyte chemotactic protein (MCP)-1/CCL2, IL-1α, TNF-α, but not RANTES/CCL5,
TARC/CCL17 or eotaxin/CCL11. Moreover, gene expression of MIP-2, MCP-1, IL-1α and TNF-α
induced by SDS-treatment were significantly enhanced in K14/IL-1RI transgenic mice compared
with those in non-transgenic littermates. Induced expression of MIP-2 and KC, which are ligands
of chemokine receptors CXCR1 and CXCR2, was consistent with large number of neutrophils in
inflammatory ICD sites of K14/IL-1RI transgenic mice. These results suggest that simple irritant
SDS can cause skin inflammation through the IL-1-mediated, keratinocyte cytokine specific mech-
anism in fashion similar to PMA. 
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Haplotype associations of the MHC with psoriasis vulgaris in Chinese Hans
S Yang, H Ge, A Zhang, S Wei, M Gao, H Wang, J Chen, M Li, Y Liang, P He, J Yang and X Zhang
Institute of Dermatology & Dept.of Dermatology in 1st Affiliated Hospital, Anhui Medical
University, Hefei, Anhui, China
The objective of this study was to demonstrate the differential haplotype associations of the major
histocompatibility complex (MHC) in psoriasis vulgaris (PV) patients in Chinese population strat-
ified by the type of onset and sex. One hundred and thirty-eight PV patients and 149 normal con-
trols were genotyped for HLA- A, B, C, DQA1, DQB1, and DRB1 using the polymerase chain reac-
tion with sequence specific primers (PCR-SSP). The results showed: (1) HLA-A*26 (26.09% vs.
12.08%, Pc<10-5), B*27 (17.03% vs. 1.01%, Pc<10-7), Cw*0602 (15.58% vs. 5.03 %, Pc<10-2),
DQA1*0104 (19.93% vs. 9.40%, Pc<10-3), DQA1*0201 (22.40% vs. 10.74%, Pc<10-3), DQB1*0303
(18.12% vs. 9.73%, Pc<10-7), and DRB1*0701/02 (26.09% vs. 9.73%, Pc<10-7) were significantly
increased in PV. HLA-Cw*0304 (5.07% vs. 14.43%, Pc<10-3), DQA1*0501 (5.79% vs. 14.09%,
Pc<0.05) were negatively associated with PV. (2) HLA-A*26-B*27 (P<10-7), A*26-Cw*0602, (P<10-
4), B*27-Cw*0602 (P<10-7), DRB1*0701/02-B*27 (P<10-7), DRB1*0701/02-DQA1*0104 (P<10-
3), DRB1*0701/02-DQB1*0303 (P<10-4), DQA1*0201-DQB1*0303 (P<10-3),A*26-B*27-Cw*0602
(P<10-3), A*26 -DRB1*0701/02 -DQA1*0201-DQB1*0303 (P<0.01) were identified as risk halpo-
types for PV patients. (3) HLA-A*26-B*27 (P<10-4), DQA1*0201-DQB1*0303 (P<10-4),
DRB1*0701/02 -DQA1*0104 (P<10-3), DRB1*0701/02-DQB1*0303 (P<10-5) and A*26-
DRB1*0701 -DQA1*0201 -DQB1*0303 (P<0.01) were only significantly associated with type I
psoriasis compared with controls. (4) These associated haplotypes with PV were not affected by
sex, except that the frequencies of DRB1*0701/02-DQB1*0303 (P<10-6) which was higher in male
than in female patients. To summary, this study demonstrated the differential association of HLA
and identified some special risk haplotypes in Chinese PV patients compared with other ethnic or
racial populations. 
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Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with
anti-epiligrin cicatricial pemphigoid (AECP)
Z Lazarova,1 C Sitaru,2 D Zillikens2 and KB Yancey1 1 Department of Dermatology, Medical
College of Wisconsin, Milwaukee, WI and 2 Department of Dermatology, University of Wuerzburg,
Wuerzburg, Germany
AECP is a subepidermal blistering disease characterized by circulating anti-basement membrane
autoantibodies to laminin 5. Recent studies showed that AECP is associated with an increased rela-
tive risk for fatal solid cancers. To study this and other potential associations further, practical yet
sensitive methods to establish the diagnosis of AECP are needed. To evaluate the relative sensitiv-
ity of immunoblotting and immunoprecipitation techniques for the detection of anti-laminin 5 anti-
bodies, comparative studies using reference laminin 5 antisera as well as sera from patients with
AECP, other immunobullous diseases, and normal volunteers were performed. Equivalent amounts
of protein from five different substrates (specifically, human keratinocyte [HK] extracts, HK extra-
cellular matrix [ECM], A-431 cell extracts, HaCat cell extracts, and extracts of epidermal sheets
[ES]) were immunoblotted using serial dilutions of reference laminin 5 antisera. HK ECM was the
most sensitive substrate for detection of antibodies to laminin 5; extracts of HKs, A-431, and HaCat
cells represented alternative test substrates (though the latter required higher amounts of protein
input). ES extracts were a poor source of laminin 5. Sera from patients with AECP showed reactiv-
ity to laminin 5 in HK ECM at end titers exceeding those identified in indirect immunofluorescence
microscopy studies of 1 M NaCl split skin. Studies of biosynthetically radiolabeled HK extracts
found that a 10,000-fold dilution of reference laminin 5 antisera retained the ability to immunopre-
cipitate laminin 5. Maximal dilutions of sera from AECP patients retaining the ability to immuno-
precipitate laminin 5 ranged from 500 to 5000. While immunoprecipitation was the most sensitive
technique for detection of anti-laminin 5 antibodies, immunoblotting of HK ECM and HK extracts
represents a practical alternative. 
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A novel murine model of ocular cicatricial pemphigoid (OCP) mediated by anti-laminin 5 IgG 
Z Lazarova, E Olasz, M Lin and K Yancey Dermatology, Medical College of Wisconsin,
Milwaukee, WI
OCP is an autoimmune subepithelial blistering disease that often causes chronic ocular injury and/or
blindness. Like other forms of CP, OCP is characterized by in situ deposits of IgG and/or comple-
ment in ocular epithelial basement membranes (BMs). Patients with one form of CP that features
ocular involvement have IgG anti-BM autoantibodies directed against laminin 5 (L5); prior studies
have shown that such autoantibodies are pathogenic in vivo. To devise an animal model of OCP,
high titer rabbit anti-L5 antisera was produced for use in passive transfer experiments. This antisera
bound murine epidermal BM (titer=20,480), immunoblotted all subunits of isolated murine L5, and
immunoprecipitated L5 from biosynthetically radiolabeled murine keratinocytes. IgG in L5 antis-
era (as well as normal rabbit sera, control) was purified on protein G columns, concentrated by
ultrafiltration, and injected into subcutaneous facial tissue 1 cm below the lower eyelid of adult
BALB/c mice (n=9) (thus avoiding frank physical ocular injury as occurs in OCP models using
wounding or caustics). Diffusion of L5 IgG (2.5 to 5 mg, single doses) into ocular tissues prompted
erosion of corneal epithelia and eye closure within 48 hours; immunofluorescence and light microscopy
studies identified in situ deposits of rabbit IgG and murine C3 in ocular epithelial BMs as well as
noninflammatory subepithelial blisters within 24 and 48 hours, respectively. Mice treated with 5 mg
of anti-L5 IgG weekly x 4 (n=5) or daily x 7 (n=4) regularly showed these same alterations as well
as periocular hair loss, an apparent reduction in ocular diameter, and reduced numbers of conjunc-
tival goblet cells. Control mice (n=9) receiving identical amounts of nonimmune purified rabbit IgG
(single and repeated injection protocols) did not develop clinical, histologic, or immunopathologic
alterations. These studies established a novel murine model of OCP that can be used to study how
antibody-mediated ocular injury results in conjunctival blisters, unstable tear films, mucosal fibro-
sis, and compromised vision. 
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Di-PPG-2-Myreth-10 Adipate reduces irritation and inflammation caused by cosmetic prod-
ucts
LB Joseph,1 L DeShields,2 AG Pereira,1 MJ Stoudemayer2 and NA Langley1 1 Croda Inc, Edison,
NJ and 2 S.K.I.N. Inc, Conshohocken, PA
RL Goldemberg has stated that nonionic surfactants - particularly ethoxylated esters - act as counter
irritants in amphoteric/anionic shampoo systems; several studies in our laboratories have demon-
strated this desirable property (ethoxylated modified glycerides, and PEG-150 Pentaerythrityl
Tetrastearate). In the search for new molecules, we synthesized an alkoxylated myristyl alcohol deriv-
ative Di-PPG-2-Myreth-10 Adipate (DMA). DMA is both ethoxylated and propoxylated, which
accounts for its multifunctionality. This emollient di-ester has multifunctional properties including
broad solvent compatibility, a wide solubility range, and irritation mitigation. To study the irritation
and inflammation mitigation properties of DMA 3 different surfactant based systems were investi-
gated using 2 in vitro assays and 1 clinical trial. The addition of 5% DMA to 10% SLS significantly
decreased the SLS induced cell death by 30% in the EpiOcular™ Model. Very mild surfactant sys-
tems cause intercellular permeability, the addition of 5% DMA significantly decreased the irritation
potential in the TransEpithelial Permeability Model. Finally, female volunteers were patched using
Occlusive Hill Top® chambers containing 1% SLS plus 0, 1, 5, 10% DMA, 100% DMA or dd water
for 24H then examined using a chromameter (Minolta CR 200) and scanning laser doppler imager
(Moor LDI). 100% DMA is less irritating than dd water. In 75% of the subjects DMA, at all con-
centrations, decreases the irritation of 1% SLS to that of dd water. From this data we can conclude
DMA to be a potent mitigator of surfactant-induced irritation and inflammation. Future experimen-
tation will try to elucidate the underlying mechanisms, which account for DMA’s ability to decrease
the irritation and inflammation potential of surfactant based cosmetic products. 
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Thalidomide inhibits the induction of tumor necrosis factor-α by ultraviolet B irradiation of
human keratinocytes
JH Lin,1 W Zhang1 and VP Werth1,2 1 U. of Pennsylvania, Philadelphia, PA and 2 Philadelphia VA
Medical Center, Philadelphia, PA
TNF-α is induced by UV and contributes to UV-induced apoptosis of keratinocytes (KCs). Apop-
totic antigens likely trigger a photosensitive immune response in subacute cutaneous LE (SCLE). In
support of this model, we recently showed that a promoter polymorphism causing TNF-α overpro-
duction is associated with SCLE (Werth et al. JID, 2000). Because Thalidomide is beneficial in dis-
eases where TNF-α plays a pathogenic role, the purpose of the current study was to determine the
effect of Thalidomide on ultraviolet B (UVB)−induced TNF-α secretion from cultured primary human
KCs. Recent studies in mice have shown inhibition of UVB-induced TNF-α production in KCs in
mice (Lu and Gaspari, Photoderm, 2003). Primary human KCs were cultured in serum-free medium,
then pre-treated for 2 h with 0, 10, 25, 50, 200, or 800 µg of Thalidomide/ml. TNF-α secretion was
then induced by 30 mJ UVB/cm2. TNF-α protein in conditioned medium was quantified by ELISA
at 6h and 16h. KCs were harvested, and real-time PCR was used to quantify TNF-α mRNA, nor-
malized to levels of cyclophilin mRNA. Consistent with prior work, TNF-α gene expression 16 h
after UVB irradiation had increased 13.1 fold (range =12.0−14.4) over sham-irradiated controls.
Thalidomide treatment of UV-treated KCs reduced the induction of TNF-α mRNA by two-thirds at
all doses of 10 µg/ml and above. During a time course experiment, UVB-irradiated KCs at 6 hours
showed a 15.6 (13.6−17.8) fold increase in TNF-α mRNA relative to no-drug, no-UV controls, and
Thalidomide inhibited this mRNA level to 0.124 (0.109−0.141) of the no-drug, no-UV controls,
i.e., far lower than control.Thalidomide also inhibited UV induced secretion of TNF-α protein in a
dose dependent fashion. By 16 hours, a concentration of 50µg of Thalidomide/ml inhibited TNF-α
secretion by 93%+/−4%(p=0.002), compared to cells treated with UV without drug. Overall, our
results indicate that Thalidomide inhibits UV-induced TNF-α production from human KCs, an action
that may explain the drug’s therapeutic effects in photosensitive diseases. 
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Development of Rag2-/-/hBPAG2 transgenic (Tg) mice for the study of in vivo unbiased immune
responses to human bullous pemphigoid antigen 2 (hBPAG2) in skin
E Olasz, C Lanschuetzer and K Yancey Dermatology, Medical College of Wisconsin, Milwaukee,
WI
Previously, C57BL/6 Tg mice expressing hBPAG2 under the control of a K14 promoter were pro-
duced and characterized. Grafts of Tg skin to syngeneic Wt mice elicited hBPAG2-specific IgG of
high and durable titer whose kinetics of production and localization in skin corresponded with blis-
ter formation within, and loss of, Tg grafts. To develop an adoptive transfer animal model where in
vivo unbiased immune responses to hBPAG2 in skin can be characterized, Tg mice were crossed
with syngeneic recombinase-activating gene-2-null (Rag2-/-) mice and bred to double homozygos-
ity. Intravenous injection of large numbers (≥108) of lymph node (LN) cells and splenocytes from
naive Wt mice resulted in only transient levels of low titer (e.g., 40) IgG specific for hBPAG2. Con-
versely, adoptive transfer of 1-5x107 LN cells and/or splenocytes from Wt mice previously grafted
with hBPAG2 skin (i.e. immune lymphocytes) resulted in high titer (≥5120) and durable (〉210 days)
hBPAG2-specific IgG in Rag2-/-/hBPAG2 Tg mice. Adoptive transfer of CFSE-labeled immune lym-
phocytes showed that T and B cells proliferated in both Rag2-/-/hBPAG2 Tg and control Rag2-/-
mice while hBPAG2-specific IgG only appeared in the former. Moreover, epidermal BM deposits
of murine IgG were seen in Rag2-/-/hBPAG2 Tg, but not in Rag2-/- recipients. These findings showed
that expression and presentation of hBPAG2 in recipients was required for durable production of
hBPAG2-specific IgG. Interestingly, adoptive transfer of immune lymphocytes depleted of CD11c+
cells to Rag2-/-/hBPAG2 Tg mice resulted in high titer and durable hBPAG2-specific IgG, indicat-
ing that donor Wt dendritic cells were not required to maintain specific antibody production in Rag2-
/-/hBPAG2 Tg mice. These studies have yielded an adoptive transfer animal model in which a trans-
gene-encoded neoantigen in skin (i.e., hBPAG2) is processed and presented by host APCs to elicit
and maintain model humoral immune responses that can be modulated and/or blocked in vivo. 
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The regulation of toll-like receptor 2 expression in immortalized keratinocyte cell culture
E Shnitkind, Y E, S Geen, WS Lee and AR Shalita Dermatology, SUNY-Downstate Medical Center,
Brooklyn, NY
Toll-like receptors are a family of pattern recognition receptors that constitute the first line of defense
against many pathogens and play a crucial role in the function of the innate immune system. Although
toll-like receptor 2 (TLR-2) expression has been demonstrated in a number of myeloid cells, much
less is known about the expression and function of these receptors on nonleukocytes. This study was
conducted to investigate the expression of TLR-2 on keratinocytes and its regulation by Propioni-
bacterium acne and cytokines, as well as the effect of drugs and UVB. 
hTERT keratinocytes, obtained by stable transfection of primary cell culture with human telom-
erase reverse transcriptase, were treated with various concentrations of LPS, P.acne cell wall com-
ponent, INF-γ, TNF-α and IL-1α. Hydrocortisone was used at 1uM, 10uM and 100uM and cells
were exposed to UVB (310nm). The expression of TLR-2 was determined by immunofluorescence
using quantitative CytoFluor reader at 48 hours. 
The results showed that IL-1α, INF-γ, TNF-α and the combination of INF-γ and TNF-α upregulate
the expression of TLR-2 in hTERT cells. TLR-2 levels were increased by 11, 13, 19 and 23%
respectively, each producing a linear dose-response curve. UVB also appears to modulate TLR-2
activity. However, P.acne and LPS did not show significant effect on TLR-2 expression in ker-
atinocytes. In addition, hydrocortisone was found to elevate the levels of TLR-2 up to 40% at the
highest concentration tested. It has been shown that P. acne can directly induce the expression of
pro-inflammatory cytokines such as IFN-γ and TNF-α from monocytes, thereby contributing to the
inflammatory nature of acne. In this study, we demonstrate that human keratinocytes are capable of
constitutively expressing TLR-2 that was augmented by exposure to various cytokines, including
IFN-γ and TNF-α, as well as IL-1α. The expression of TLR-2 in keratinocytes indicates that acti-
vation of TLR-2 can contribute to inflammation at the site of disease activity and clarify the molec-
ular mechanism by which P. acne induces inflammation. 
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CD40/CD40L blockade prevents experimental immune responses to human bullous pemphigoid
antigen 2 in epidermal basement membrane in vivo
C Lanschuetzer,1,2 E Olasz1 and K Yancey1 1 Dermatology, Medical College of Wisconsin,
Milwaukee, WI and 2 Dermatology, Paracelsus Private Medical University, Salzburg, Austria
CD40/CD40 ligand (CD40L) interaction is required for the development of T cell-dependent anti-
body responses in vivo and thus is an attractive target for therapeutic interventions in many autoim-
mune disorders. Previously we developed and characterized C57BL/6 Tg mice expressing hBPAG2
in skin under the control of a K14 promoter. Tg skin placed on syngeneic Wt mice consistently elicited
hBPAG2-specific IgG of high and durable titer as well as graft loss. Graft loss in this model was
dependent upon CD4+ T cells and correlated with the production and tissue deposition of hBPAG2
IgG. To examine the relative contribution of the CD40/CD40L pathway to immune responses in our
murine model, grafts of Tg skin were placed on CD40L -/- as well as hamster anti-CD40L mono-
clonal antibody (MR1)-treated mice to block hBPAG2-specific IgG production in vivo. In contrast
to matching controls, CD40L -/- mice grafted with Tg skin did not develop hBPAG2-specific IgG
or graft loss. Similarly, Wt mice grafted with Tg skin and treated with MR1 (days 0, 2, 4, 7, and 14)
did not develop hBPAG2-specific IgG or graft loss (in contrast to grafted Wt mice treated with equiv-
alent doses of control IgG). Successful inhibition of hBPAG2-specific IgG production and Tg graft
loss following blockade of the CD40-CD40L pathway in this model provides opportunities to study
induced operational tolerance and generate regulatory cells. These findings have direct relevance to
blocking unwanted immune responses in patients with pemphigoid as well as patients undergoing
gene replacement therapy for GABEB, a form of junctional epidermolyis bullosa characterized by
null mutations in the gene encoding hBPAG2. 
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Gene expression profiling of skin and peripheral blood in vitiligo
M Mallavarapu,1 JZ Xiang2 and AA Sinha1 1 Dermatology, Weill Medical College of Cornell
University, New york, NY and 2 Microbiology and Immunology, Weill Medical College of Cornell
University, New York, NY
The cellular and molecular disease mechanisms involved in vitiligo, which affects 2% of the world
population, are yet to be elucidated. Microarray analysis and new emerging bioinformatics tools have
enabled genome wide screening to enhance our understanding of complex disease. In previous work,
we compared skin (lesional and non-lesional) samples from 6 vitiligo patients using DNA chips and
found 63 genes that were differentially expressed. To study systemic alterations in disease we then
collected peripheral blood from 8 patients affected with vitiligo and matched normals (age, ethnic-
ity, gender). Affymetrix Hu95Aver2 chips were used to search for significant alterations in periph-
eral blood gene expression profiles of patients. Image data was first obtained and analyzed using
MAS v5.0, and metrics files were subsequently exported and analyzed using GeneSpring TM v6.0
using a nonparametric test with p cutoff of 0.05. Three hundred and fifty-five genes were found to
be differentially regulated comparing vitiligo vs normal blood samples. Of these, 211 were up-reg-
ulated and 144 were down-regulated in disease. We observe the dysregulation of genes involved in
oxidative stress (DUSP1, PIP3-E, GSS), stress response (MAPK14, MAP3K4, CGR19), apoptosis
(DED, CASP10, TRAF5. DAP3) and immune response (RI58, PF4, TMSB4X, PVRL1, HLA-DRA,
IL6ST, IFIT4, Ccl2, MRPL28, GATA3, KLRD1, TACTILE, XP1, EBI2, KLRC3, KLRC1, ANXA1,
KLRB1, CHS1, MGEA6). We further observe differentially expressed genes functionally relevant
in signal transduction, enzyme activity, DNA repair, transcription, transport, protein modification,
RNA binding, and cell cycle, growth and maintenance. Comparison of differentially expressed genes
in the skin (lesional and non-lesional) and peripheral blood (vitiligo blood and matched normal blood)
reveals an overlap of 6 genes (MLC1, TGFB1, SARS, EIF3S6, MAP3K4, SH2BP1). These findings
are being confirmed by real time RT-PCR. Supplementary samples are being collected to increase
the sample size. 
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Disturbed enzymatic antioxidant defense and increased oxidative damage repair in lichen scle-
rosus
CS Sander,1,2 I Ali,1 D Dean,1 JJ Thiele3 and F Wojnarowska1 1 Dermatology Department,
Churchill Hospital, Oxford, United Kingdom, 2 Department of Dermatology, Friedrich Schiller
University, Jena, Germany and 3 Department of Dermatology, NorthwesternUniversity, Chicago,
IL
Lichen sclerosus (LS) is a chronic inflammatory skin disease of unknown aetiology. The mecha-
nisms which lead to the immunological changes in all levels of the skin and the alterations of the
dermal extracellular matrix are poorly understood. We have recently demonstrated an involvement
of oxidative stress in the pathogenesis of LS. In this study, we investigated antioxidant defense mech-
anisms and the expression of the oxidative damage repair enzyme methionine sulfoxide reductase
A (MSRA) in LS. Skin biopsies from 16 patients with untreated, histologically confirmed vulval LS
were examined immunohistochemically. Antioxidant enzyme expression of catalase (Cat), copper-
zinc superoxide dismutase (CuZnSOD) and manganese SOD (MnSOD) was investigated as well as
the distribution of the oxidative damage repair enzyme methionine sulfoxide reductase A (MSRA).
Normal vulval tissue from 16 subjects served as control. In lichen sclerosus tissue the enzymatic
antioxidant defense was disturbed as demonstrated by a significantly reduced expression of MnSOD
within the stratum corneum and epidermis, and an increased expression of Cat in epidermal and
dermal layers. Furthermore, MSRA was shown to be increased in dermal layers of LS lesions sug-
gesting the implication of a recently described oxidative protein damage repair mechanism. This is
the first study investigating the antioxidant defense and oxidative damage repair capacities in LS.
Further studies are required to elucidate the role of the observed modulation in the enzymatic antiox-
idant system in order to provide new insight into the possibilities of antioxidant therapeutic strate-
gies.
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Th-1 cytokines in alopecia areata pathogenesis: IFN-γ is essentially involved while IL-2 plays
a minor role
P Freyschmidt-Paul,1 M Zoeller,2 KJ McElwee,1 JP Sundberg3 and R Hoffmann1 1 Philipp-
University Marburg, Marburg, Germany, 2 German Cancer Research Centre, Heidelberg,
Germany and 3 The Jackson Laboratory, Bar Harbor, ME
Alopecia areata (AA) was regarded as a Th-1 mediated autoimmune disease of the hair follicle,
because the Th-1 cytokines IFN-γ and IL-2 are expressed in AA-skin. Recently we have shown, that
also the Th-2 cytokine IL-10 is expressed in skin infiltrating leucocytes in AA of C3H/HeJ mice and
that IL-10-/- mice are resistant to the development of AA, pointing towards an involvement of Th-
2 cytokines in AA pathogenesis. To prove the functional relevance of Th-1 cytokines in AA, we
induced AA in IFN-γ-/- mice and in IL-2+/- mice by grafting lesional AA skin from AA-affected
mice. After experimental induction by skin-grafting 90% of normal C3H/HeJ mice (control) devel-
oped AA, while none of the IFN-γ-/- mice and 47% of IL-2+/- mice developed AA. Immunhisto-
chemistry showed dense peri- and intrafollicular infiltrates of CD4+ and CD8+ cells and an aber-
rant expression of MHC-I on hair follicle epithelium in control mice with AA, while infiltrates and
MHC-I-expression were absent in IFN-γ-/- and IL-2+/- mice without AA. FACS-analysis of skin-
draining lymph node cells revealed a significant reduction of T-cell activation markers and co-stim-
ulatory molecules in IFN-γ -/- mice (CD25, CD69, CD28, CD86) and IL-2+/- mice (CD25, CD28,
CD80) and a reduced expression of pro-inflammatory cytokines in IFN-γ-/- mice (IL-6, TNF-α) and
IL-2+/- mice (IL-4, IL-5, IL-6, IFN-γ, TNF-α). Our data show that IFN-γ-/- mice are resistant to the
development of AA, pointing towards an essential role of IFN-γ in AA pathogenesis. FACS-analy-
sis and immunohistochemistry demonstrate that IFN-γ is irreplaceable for activation of autoreactive
T-cells in the lymph nodes. A pathogenetic role for IL-2 in AA could also be demonstrated, but the
expressiveness of our data is limited because only heterozygous IL-2+/- mice were available for these
experiments. FACS-analysis and immunohistochemistry point towards an involvement of IL-2 in the
activation of autoreactive T-cells in the lymph nodes. 
048
Macrophage migration inhibitory factor is important for eosinophil migration in vivo
T Shimizu,1 J Nishihira,2 H Watanabe,1 R Abe,1 A Honda,1 Y Zhao1 and H Shimizu1 1 Dermatology,
Hokkaido University Graduate School of Medicine, Sapporo, Japan and 2 Molecular Biochemistry,
Hokkaido University Graduate School of Medicine, Sapporo, Japan
Eosinophils are thought to mediate inflammatory and cytotoxic events associated with allergic dis-
orders, including atopic dermatitis, urticaria and bronchial asthma. To investigate the effects of MIF,
a pleuripotent cytokine on the allergic disorders, we engineered transgenic (Tg) mice that overex-
press MIF. We first examined its effects on antigen-induced eosinophilia in vivo. MIF Tg mice were
sensitized subcutaneously with ragweed pollen and were challenged intraperitoneally with the aller-
gen 24 hours later. The eosinophilia induced by ragweed pollen extract was quantitatively evalu-
ated. Eosinophilia in response to ragweed pollen extract exacerbated in MIF Tg mice compared
with that of wild-type mice. The MIF and eotaxin contents of the peritoneal fluid were increased in
the MIF Tg mice compared with wild-type mice, respectively. Moreover, we found that the eosinophilia
induced by ragweed pollen extract was suppressed by the treatment with neutralizing anti-MIF anti-
body i.p. prior to the challenge. Furthermore, eosinophilia induced by ragweed pollen extract were
found to be significantly reduced by orally treated cetirizine of 20 mg/kg, a putative H1-receptor
antagonist. MIF and eotaxin were also significantly decreased at 24 hours in the peritoneal fluid by
cetirizine treatment. Based on these results, it is suggested that MIF is profoundly involved in the
eosinophil accumulation, and blockade of MIF may become a promising therapeutic treatment for
allergic diseases. 
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Humoral immunity to extracellular matrix protein 1 in lichen sclerosus
I Chan,1 N Oyama,2 SM Neill,2 F Wojnarowska,3 MM Black2 and JA McGrath1 1 Genetic Skin
Disease Group, St Johns Institute of Dermatology, London, United Kingdom, 2 Department of
Immunofluorescence, St Johns Institute of Dermatology, London, United Kingdom and 3
Department of Dermatology, The Churchill Hospital, Oxford, United Kingdom
Lichen sclerosus is a chronic inflammatory dermatosis of unknown etiology. Evidence for an autoim-
mune basis to the disorder is emerging with circulating autoantibodies to the glycoprotein extracel-
lular matrix protein 1 (ECM1) recently demonstrated in the sera of about 75% of affected individu-
als. In this study, we determined the site(s) of autoantibody targeting of ECM1 in lichen sclerosus
sera, established the immunoglobulin sub-type profile of the anti-ECM1 antibodies, and looked for
clinicopathological correlation. Immunoblotting was performed using a series of bacterial recom-
binant proteins spanning different domains of ECM1 and 90 lichen sclerosus sera. Blotting revealed
multiple antigenic reactive sites within both the amino-terminus (50/90, 55.6%) and the protein
loop cysteine-rich domain (54/90, 60%), although few sera reacted to the distal carboxyl-terminus
(7/90, 7.8%). Immunoabsorption studies using affinity-purified lichen sclerosus sera showed no anti-
body cross-reactivity with other ECM1 epitopes. IgG subclass analysis revealed that the anti-ECM1
autoantibodies were mainly IgG2 (48/54, 88.9%), either IgG2 alone (28/54, 51.9%) or in combina-
tion with one or more other IgG subclasses. Clinical appraisal of 26 subjects (including 3 with
extragenital disease) showed no relationship between extent and duration of disease or skin histol-
ogy findings and any specific ECM1 epitope nor any particular type of IgG response, although in
those with lichen sclerosus of 5-10 years’ duration, a solitary IgG2 response predominated. Overall,
these findings expand insight into humoral autoimmune responses and possible disease mecha-
nisms in lichen sclerosus. 
051
CX3CR1 single nucleotide polymorphisms are associated with type 1 psoriasis
D Plant,1 J Lear,2 HS Young,2 S Marsland,2 S John,1 J Worthington1 and C Griffiths2 1 CIGMR,
University of Manchester, Manchester, United Kingdom and 2 The Dermatology Centre, Hope
Hospital, University of Manchester, Manchester, United Kingdom
The purpose of this study was to investigate the association of polymorphisms of the fractalkine
receptor gene (CX3CR1) with Type 1 psoriasis. Five single nucleotide polymorphisms (SNPs)
(rs3732378 G/A, rs3732379 C/T, rs2669843 G/A, Hcv468342 G/C and Hcv11578468 T/C) were
genotyped in 669 psoriasis cases and 184 unrelated controls. A fluorescence based primer extension
method (SNaPshot, PE-ABI) (Applied Biosystems, Warrington, UK) was used with products elec-
trophoresed on an ABI PRISM 3100 Genetic Analyser. Case and control cohorts were tested for pop-
ulation stratification. Single-marker associations between SNPs and the disease phenotype were
analysed using the statistical package Stata 7 (StataCorp. 2001). The frequency of the G allele for
the (non synonymous Met > Thr) SNP marker rs3732378 was increased in the case cohort (85%)
compared with the controls (80%) (p = 0.04). In addition, using the Expectation Maximization
(EM) algorithm as implemented in SNPHAP statistical software (Clayton, D. http://www-
gene.cimr.cam.ac.uk/clayton/software/ 2002), estimated haplotype frequencies were generated, and
these frequencies were compared between the case and control groups. A 2-marker haplotype,
rs3732378 G and Hcv11578468 C, was over represented in the case cohort (50%) compared with
the controls (43%)(p = 0.03). In conclusion, these results suggest a possible involvement of the
CX3CR1 gene in the pathogenesis of psoriasis. 
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An active animal model of skin basement membrane antigens-induced autoimmune alopecia
resembling human alopecia areata is mediated by autoreactive T cells
LS Chan,1,2 L Xu,3 SD Miller4 and L Chen1 1 Dermatol, UIC, Chicago, IL, 2 Micro/Immunol, UIC,
Chicago, IL, 3 Rheumatol, Northwestern Univ., Chicago, IL and 4 Micro/Immunol, Northwestern
Univ., Chicago, IL
In order to develop a currently unavailable animal model of active autoimmune hair loss disease to
study the pathogenesis of human alopecia areata (AA), mouse skin basement membrane zone (BMZ)
proteins, components of hair follicle, were used to immunize mice for inducing hair loss. Immu-
nization of BMZ antigens (four times, three weeks apart) resulted in progressive hair loss in 78% of
C57BL/6 mice and 11% of SJL/j and BALB/c mice, with feature of exclamation point hair but with-
out blister formation. Histopathology documented the presence of peri- and intra-follicular mononu-
clear cell infiltrates in mice with hair loss, but not in normally haired mice. Adoptive transfer of BMZ
antigens autoreactive spleen cells (30 millions/mouse) from skin BMZ antigens-immunized mice to
naïve syngeneic mice intra-peritoneally resulted in hair loss in all recipient mice in four weeks,
whereas none of mice received spleen cells from mice immunized with control protein mouse serum
albumin developed hair loss. The mice received spleen cells from BMZ antigens-immunized mice,
but not the mice received spleen cells from albumin-immunized mice, demonstrated both humoral
and cellular autoimmunity to the BMZ antigens: possess circulating IgG autoantibodies to the BMZ
antigens (by ELISA) and exhibit positive autoreactive T cell responses to the BMZ antigens (by T
cell proliferation assays). Moreover immunopathology detected a CD4+ T cell-dominated perifol-
licular infiltrate in the hair loss skin of mice receiving BMZ antigens-immunized spleen cells, but
not in the normally haired skin of mice receiving albumin-immunized spleen cells. Our data sup-
ports a novel mouse model of active, experimentally induced, autoimmune hair loss disease resem-
bling human AA clinically, histopathologically, and immunopathologically. Although autoimmune
response to skin BMZ proteins has not been demonstrated in human patients with AA, this model
may be useful in shedding light to the pathomechanism of autoimmune alopecia. 
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Topical bexarotene 1% gel is anti-inflammatory in the mouse ear model of inflammation
Y Lee, M Wardlow, R Christopher and V Stevens Ligand Pharmaceuticals, San Diego, CA
The mouse ear model of irritation or allergic response has been used to profile the potential anti-
inflammatory activity of topical drug candidates. A standard concentration of the phorbol ester, 12-
O-tetradecanoyl phorbol acetate (TPA) is applied to the ears to induce a standardized inflammation
via the cascade of eicosinoids and prostaglandins derived from arachidonic acid. Objective meas-
ures of the degree of inflammation can be made with measures of ear thickness (edema), weight from
a standardized biopsy of the ear, and the leukocyte infiltration into the tissue. The RXR-selective
retinoid, bexarotene, was evaluated for its anti-inflammatory potential in the mouse ear model to
identify potential mechanisms associated with its clinical activity. Male CD-1 mice were used in a
standard test protocol that included the high potency steroid, clobetasol 0.05%, as a positive control
and the acetone vehicle for TPA as a negative control. Reductions in     TPA-induced inflammation
with bexarotene 0.1-1.0% were dose-related. Reductions with bexarotene 1% were 66% for the TPA-
induced ear thickness and 50% for biopsy weight. This result was comparable to clobestasol 0.05%
(54% for ear thickness and 45% for biopsy weight). The anti-inflammatory action of bexarotene is
likely to be mediated through modulation of gene expression via RXR activation. 
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Flexible docking of self-epitopes to HLA class II DR and DQ alleles in pemphigus vulgaris
J Tong,2 J Bramson,1 D Kanduc,1 T Tan,2 S Ranganathan2,3 and AA Sinha1 1 Dermatology, Weill
Medical College of Cornell University, New York, NY, 2 Biochemistry, National University of
Singapore, Singapore, Singapore and 3 Research Institute for Biotechnology, Macquarie
University, NSW, NSW, Australia
The strongest genetic influence on PV susceptibility maps to the MHC II region. Over 95% of PV
patients serotype as either HLADR4 and/or HLADR6, and the strongest associations are with the
DRB1∗0402 and DQB1∗0503 allelic subtypes. In an attempt to further elucidate the functional cor-
relation between MHC class II alleles and PV, we constructed atomic models of DRB1 subtypes
(∗04011, ∗0402, ∗0404, ∗0406, ∗1401, ∗1404, ∗1405) and one DQB1 subtype (∗0503). In subse-
quent analysis, eight fifteen-residue Dsg3 peptides (Dsg3 341-355, Dsg3 809-823, Dsg3 962-976,
Dsg3 206-220, Dsg3 190-204, Dsg3 251-265, Dsg3 762-786 and Dsg3 380-396) capable of elicit-
ing T cell responses in PV patients were modeled into the binding groove of each HLA model using
a novel MHC-peptide docking protocol. Our modeling procedure first applies a sliding window input
of size 9 to each peptide to generate all combinations of core residues to be modeled into the bind-
ing groove of each allele. Docking of peptides was subsequently performed in four steps as follows:
(i) pseudo-Brownian rigid body docking of core peptide fragments at the ends of the binding groove,
(ii) loop closure by satisfaction of spatial constraints, (iii) refinement of the backbone and side-chains
of peptide core residues as well as atomic clash regions at receptor; and finally, (iv) extension of
flanking residues. These studies provide further evidence that the DRB1∗0402 allele is directly
involved in the selection of specific self-peptides in PV. Moreover, these data indicate that a non-
overlapping set of self-epitopes are associated with the DRB1∗0402 vs. DQB1∗0503 linked responses.
Our modeling results are consistent with previous functional data obtained from in vitro competi-
tive binding assays and T cell proliferation studies in PV patients and provide structural insights
into the molecular basis of MHC-linked control of the autoimmune response in PV. 
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A case of IgA pemphigus with dual autoantigen-reactivity against desmoglein 1 and desmo-
collin 1
T Kopp,1 F Pieczkowski,1 C Sitaru,2 D Zillikens,2 G Stingl1 and F Karlhofer1 1 Dermatology,
Vienna Medical University, Vienna, Austria and 2 Dermatology, University of Wurzburg, Wurzburg,
Germany
The IgA pemphigus is an uncommon vesiculo-pustular autoimmune bullous disease with IgA anti-
keratinocyte cell surface antibody reactivity. Two subtypes can be discerned; in the subcorneal pus-
tular dermatosis type desmocollin 1 (Dsc 1) was identified as a target autoantigen, while in few
cases of the intraepidermal neutrophilic type desmoglein 1 (Dsg 1) reactivity was observed. We report
a 48 year-old Caucasian male with generalized pustular blistering lesions. Histopathology revealed
subcorneal pustules. Direct immunofluorescence (IF) exclusively showed in vivo bound IgA anti-
keratinocyte cell surface antibodies, while circulating autoantibodies were undetectable by indirect
IF and by immunoblotting. Enzyme-linked immunosorbent assays using baculovirus-expressed
recombinant Dsg 1 revealed anti-Dsg 1 IgA but not IgG reactivity. No IgA anti-Dsg 3 reactivity was
present. Sequential absorption with immobilized Dsg 1, but not with Dsg 3 completely abrogated
IgA anti-Dsg 1 reactivity. Moreover, Dsc 1 was revealed as a target of IgA autoantibodies by indi-
rect IF utilizing Dsc 1 transfected COS-7 cells.
In summary, these data identify desmoglein 1 and desmocollin 1 as autoantigens in a patient with
IgA pemphigus. To our knowledge this is the first IgA pemphigus case with a dual autoantigen-
reactivity. 
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Antigen-specific ELISA for detection of circulating autoantibodies to extracellular matrix pro-
tein 1 in lichen sclerosus
N Oyama,1,2 I Chan,2 SM Neill,3 AP South,2 F Kaneko,1 MM Black,3 F Wojnarowska4 and
JA McGrath2 1 Department of Dermatology, Fukushima Medical University School of Medicine,
Fukushima, Japan, 2 Genetic Skin Disease Group, Division of Skin Sciences, GKT Medical School,
St Thomas Hospital, London, United Kingdom, 3 Department of Immunofluorescence, GKT
Medical School, St Thomas Hospital, London, United Kingdom and 4 Department of Dermatology,
The Churchill Hospital, Oxford, United Kingdom
Lichen sclerosus is a common mucocutaneous scarring disease of unknown etiology. However, accu-
mulating evidence suggests an autoimmune component. Recently, circulating autoantibodies to the
glycoprotein, extracellular matrix protein 1 (ECM1), have been reported in the sera in the majority
of subjects with lichen sclerosus. However, very little is known about the potential clinical rele-
vance of these anti-ECM1 antibodies. In this study, we examined ECM1 epitopes in lichen sclero-
sus sera to develop an ELISA for the serologic diagnosis of the disease, and correlated the ELISA
titer with clinicopathological parameters. Using a series of bacterial recombinant proteins, most
lichen sclerosus sera (28/39, 72%) recognized the distal second tandem repeat domain and carboxyl-
terminus of ECM1. By antigen-specific ELISA, we analyzed serum autoantibody reactivity against
the most immunodominant ECM1 epitope in 413 individuals (95 with lichen sclerosus, 161 normal
controls, and 157 with other autoimmune basement membrane or sclerosing diseases). The results
showed that the ECM1-ELISA is highly sensitive as 76 of 95 patients with lichen sclerosus (83%)
exhibited IgG reactivity, and also highly specific (94%) in discriminating lichen sclerosus from other
disease/control sera. Higher ELISA titers correlated with more longstanding and refractory disease,
as well as cases complicated by squamous cell carcinoma (n=3). Our findings suggest that the ECM1-
ELISA is a valuable tool for the accurate detection and quantification of anti-ECM1 autoantibodies,
which may be relevant to the clinical status of patients with lichen sclerosus. 
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CGRP induces nitric oxide in human keratinocytes through modification of intracellular
nitrosothiols
MS Matsui,1 Y E,2 W Lee,2 A Shalita2 and D Maes1 1 Biological Research, The Estee Lauder
Companies, Melville, NY and 2 Dermatology, SUNY, Brooklyn, Brooklyn, NY
We previously showed that calcitonin gene-related peptide (CGRP) induced intracellular nitric oxide
(NO) in immortalized human keratinocytes. This NO production was biphasic, with an initial peak
within minutes, and an additional upregulation from 24 to 48 hrs. Late NO could be attributed to the
observed CGRP induction of iNOS. However, early (within 15 min) NO could not be attributed to
induction of iNOS. We therefore investigated a possible source of early NO. S-nitrosothiols have
been considered to be a NO reservoir, and can be important for intercellular signaling and vasodi-
lation as well as in intracellular signaling mechanisms. Our hypothesis was that the early burst of
CGRP-induced NO was due to release of NO from nitrosothiols.  Human telomerase immortalized
keratinocytes were treated with CGRP (0.1nM to 100nM), for time periods up to 48 hrs. This treat-
ment decreased levels of nitrosothiols in a dose related manner during the time frame corresponding
to non-iNOS associated NO. Nitrosothiols were decreased significantly by CGRP within 15 min.
The levels were remained lower than control for at least one hour but returned to control by 3 hours.
UVB did not have this effect. Neither NO production during this time nor nitrosothiol depletion was
affected by an iNOS inhibitor. Nitrotyrosine levels were not affected at any time point examined up
to 24 hrs by CGRP at the concentrations used. This data suggests that CGRP may exert subtle but
meaningful effects on keratinocyte intracellular signaling or cytokine expression by means of NO
release from pre-stored nitrosothiols. 
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Lysophosphatidic acid induces chemotaxis, oxygen radical production, CD11b up-regulation,
Ca2+-mobilization and actin reorganization in human eosinophils via G proteins
J Norgauer,1 M Laut,2 JW Fluhr,1 P Elsner1 and M Idzko2 1 Dermatology, Friedrich-Schiller-Univ.,
Jena, Germany and 2 Pneumology, Univ. of Freiburg, Freiburg, Germany
Eosinophils play a major role in the pathopysiology of atopic diseases. Lysophosphatidic acid (LPA)
is a bioactive lipid mediator, which is generated by secretory type II phospholipase A2 and is thought
to play a major role in the pathogenesis of atopic diseases. Here, the biological activity of LPA on
human eosinophils was characterized. We showed by reverse transcription and polymerase chain
reaction that human eosinophils express the mRNA of the LPA receptors EDG-2 and EDG-7. Exper-
iments revealed that LPA has chemotactic activity towards eosinophils, stimulates the production of
reactive oxygen metabolites, and induces up-regulation of the integrin CD11b. Signal pathway meas-
urements indicated Ca2+-mobilization from intracellular stores and transient actin polymerization
upon stimulation with LPA. Cell responses elicited by LPA were inhibited by pertussis toxin indi-
cating that in eosinophils the LPA receptor(s), presumable EDG-2 or/and EDG-7, couple to Gi/o pro-
teins. Moreover, LPA-induced activation of esosinophils could be completely blocked with the EDG-
2/EDG-7 antagonist diacylglycerol pyrophophate. These results indicate that LPA is a strong
chemotaxin and activator of eosinophils. These findings point to a novel role of LPA in the patho-
genesis of diseases with eosinophilic inflammation such as atopic diseases as chemotaxin as well as
activator of proinflammatory effector functions. 
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Inosine stimulates chemotaxis, Ca2+-transients and actin polymerization in immature human
dendritic cells via a pertussis toxin-sensitive mechanism independent of adenosine receptors
I Marco,2 JW Fluhr,1 P Elsner,1 G Girolomoni3 and J Norgauer1 1 Dermatology, Univ. of Jena, Jena,
Germany, 2 Pneumonology, Univ. of Freiburg, Freiburg, Germany and 3 Istituto Dermopatico dell
Immacolata, IRCCS, Rome, Rome, Italy
Inosine is an endogenous purine nucleoside, which is formed by adenosine deaminidase during adeno-
sine breakdown and is released into the extracellular space from the sympathetic nervous system or
injured cells. Here, we studied the biological activity of inosine on human dendritic cells (DC), which
are specialized antigen presenting cells characterized by their ability to migrate from the blood to
peripheral tissues, and then to secondary lymphoid organs where they initiate adaptive immune
responses. In immature DC, inosine concentration-dependently stimulated Ca2+ transients, actin
polymerization and chemotaxis. Experiments with adenosine receptor antagonists and pertussis toxin
as well as desensitization studies suggested that the activity of inosine was mediated by a G protein-
coupled receptor pathway independent of adenosine receptors. DC induced to mature by lipopolysac-
charide lost their ability to respond towards inosine with these activities. Moreover, inosine did nei-
ther influence membrane expression of CD54, CD80, CD83, CD86, HLA-DR and MHC class I
molecules nor modulated secretion of interleukin (IL)-12, IL-10 and tumor necrosis factor alpha in
immature and lipopolysaccharide-matured DC. In aggregate, our study indicates that inosine may
be involved in the trafficking control system of immature DC, and mediates its chemotactic activity
by a pertussis toxin-sensitive mechanism independent of adenosine receptors. 
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Alopecia areata induced in young C3H/HeJ mice by interferon-gamma
A Gilhar,1 B Assy1 and RS Kalish2 1 Skin Research Laboratory, Flieman Med Ctr & Technion
Institute of Technology, Haifa, Israel and 2 Dermatology, SUNY@Stony Brook, Stony Brook, NY
Hair follicle epithelium is an immune privileged site, with minimal expression of MHC class I and
II. Paus proposed that alopecia areata results from loss of immune privilege with induction of MHC
class I and II, followed by loss of tolerance to autoantigens. Interferon-gamma (INF-g) is known to
induce MHC class I and II on hair follicle epithelium. C3H/HeJ mice develop spontaneous alope-
cia areata with age (20% at 12 months). It was hypothesized that injection of INF-g would induce
loss of tolerance and alopecia areata in genetically susceptible young C3H/HeJ mice. C3H/HeJ
mice (4 mice/group; 8 wks old) were injected intravenously with INF-g 2 X 10e4 U or saline for 3
consecutive days, and at days 7 and 14. Generalized alopecia was observed in all 4 mice injected
with INF-g, and in none of the mice injected with saline. Histology demonstrated peri-follicular
mononuclear cell infiltrate with dystrophic hair follicles. Regrowth of white hairs was noted 2 wks
after the last injection of INF-g. The histology, and regrowth of white hairs supports alopecia areata,
rather than telogen effluvium as the cause of hair loss. This data supports the hypothesis that alope-
cia areata results from loss of immune privilege, and provides a new model for induction of the dis-
ease.
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Correlation of anti-desmoglein-1 epitope profiles with disease status in endemic pemphigus
foliaceus
N Li,1 BF Qaqish2 and LA Diaz1 1 Dermatology, University of North Carolina at Chapel Hill,
Chapel Hill, NC and 2 Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC
Fogo Selvagem (FS) is an endemic form of pemphigus foliaceus caused by pathogenic autoanti-
bodies against desmoglein-1 (Dsg1). Autoantibody titers in the sera of patients roughly correlate
with disease severity. Using eight chimeric recombinant proteins that contained different ectodomains
(EC1, EC1-2, EC1-3, EC1-4, EC2-5, EC3-5, EC4-5, and EC5) of Dsg1, we have previously found
that patients with active disease all have anti-Dsg1 antibodies specific for the EC1 and/or EC2
domains, whereas patients in clinical remission have anti-Dsg1 specific for EC5 only. Two major
epitope profiles of anti-Dsg1 antibodies were revealed in patients with active disease. About 50% of
sera showed reactions predominately with the chimerias containing either the EC1 or EC2 domain
of Dsg1 (profile 1). The other half of the sera recognized all eight chimeras (profile 2), indicating
reactivity with the EC1 and EC5 domains. The aim of this study was to analyze the relationship
between the anti-Dsg1 epitope profiles, the antibody immunofluorecent titers and the disease status.
We found that sera with higher antibody titers were prone to have epitope profile 1, whereas sera
with low antibody titers predominantly showed epitope profile 2. Of the 15 sera with antibody titers
> 1:160, 12 sera (80%) displayed epitope profile 1. On the contrary, 10 of 11 sera (91%) with neg-
ative or antibody titers < 1: 80 presented epitope profile 2. This trend was statistically significant
when analyzed by McNemar test. Interestingly, sera showing epitope profile 1 were all collected
from patients with severe disease. Sera showing epitope profile 2 were obtained from patients with
mild disease who were at: 1) early stage of FS, 2) FS entering remission, or 3) early relapse of FS.
This study demonstrates that determination of anti-Dsg1 epitope profiles is a novel tool to assess dis-
ease activity in FS. Profile 1 is a feature of patients with extensive disease whereas profile 2 reflects
disease with minimal skin involvement. 
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Minocycline inhibits antigen processing for presentation to human T lymphocytes: possible
anti-inflammatory mechanism
RS Kalish and S Koujak Dermatology, SUNY@Stony Brook, Stony Brook, NY
Minocycline (MINO) has long been used for acne as an anti-inflammatory agent. Recent clinical
trials suggest it has anti-inflammatory action in rheumatoid arthritis and multiple sclerosis. MINO
has 4 ionizable groups with pKa1=2.8; pKa2=5.0; pKa3=7.8; and pKa4=9.3 and an isoelectric point
of 6.4 which should buffer a pH4.7 lysosome. Chloroquine inhibits antigen processing, and T-cell
responses by interfering with acidification of lysosomes in antigen presenting cells. The ability of
MINO to inhibit processing of tetanus toxoid (TT) for presentation to human T-cells was tested.
Peripheral blood monocytes were incubated with TT for 1hr then fixed with 0.12% paraformalde-
hyde and added to an autologous TT responsive T-cell line. T-cell proliferation was determined by
3H-thymidine uptake. MINO (0.1 - 0.4mM) or chloroquine (0.4mM) were added to test groups for
4hr incubation prior to addition of TT, and fixation. MINO gave significant inhibition (65-100%) of
T-cell response to TT and was epi-potent to chloroquine. Inhibition was not observed when TT was
added for 1hr prior to the MINO, indicating that presentation of processed antigen was not inhib-
ited. MINO and chloroquine have a high tissue distribution in lysosomes, and chloroquine is known
to be inhibitory in humans. Both drugs are administered at similar doses, suggesting that the in vitro
inhibition by MINO has relevance to clinical use. 
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A novel flow cytometry-based assay for direct enumeration and characterization of human
autoantigen-specific T cells in pemphigus vulgaris
C Rizzo and AA Sinha Dermatology, Weill Medical College of Cornell University, New York, NY
Pemphigus vulgaris (PV) is a blistering skin disorder mediated by autoantibodies targeting the epi-
dermal adhesion molecule desmoglein 3 (Dsg3). Dsg3-specific T cells, responsible for coordination
of the humoral immune response, have been identified in the peripheral circulation of PV patients
and it has been suggested that a shift from Th1- to Th2-predominant activity is associated with active
disease (Veldman et al. JI170:635,2003). Accurate data characterizing these cells is not yet avail-
able, however, due to limitations in technologies for the analysis of antigen-specific T cells. We
have developed a novel technique combining cell surface matrix technology with flow cytometry to
enumerate and characterize autoreactive T cells. Our method enables simultaneous detection of mul-
tiple cytokines secreted by single cells and enumeration of rare cells present at a frequency as low
as 1 in 106 cells, compared with a resolution of 1 in 104 cells for intracellular cytokine staining. Using
this method, peripheral blood mononucleocytes sampled from PV patients stratified by active (n=10)
or remittive disease (n=4) and healthy HLA-matched controls (n=4) were tested for activation by
recombinant extracellular Dsg3. We evaluated IFN-γ-producing CD4+ cells (Th1), IL-10 or IL-4-
producing CD4+ cells (Th2), and the non-standard populations of CD4+ IFN-γ and IL-4 or IL-10-
producing cells. An autoantigen-specific CD4+ IL-10 response and a CD4+ IL-4 response were each
detected in 1 patient with active disease, while CD4+ IFN-γ responses were detected in 2 patients
with remittive disease. One patient with remittive disease was shown to convert from Th1 to Th2
response with the initiation of disease activity. IFN-γ secretion by CD4- cells was detected in 4
patients. These results are consistent with the prevailing ideology that Th1 cells exert a restraining
role on Th2 lymphocytes that may be overpowered by a rampant Th2 response during the course of
disease development. The CD4- T cell response is provocative and warrants further investigation. 
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Molecular characterization of OAS1 overexpression in cutaneous LE suggests a novel apop-
totic pathway relevant in disease
SS Chow, C Wei and AA Sinha Dermatology, Weill Medical College of Cornell University, New
York, NY
The molecular basis for disease initiation and mechanisms of progression in systemic and cuta-
neous LE are not well understood. Experimentally there is a generalized immune dysregulation that
is at least in part genetically based, resulting in a broad spectrum of autoantibody specificities asso-
ciated with a combination of humoral and cellular abnormalities that ultimately lead to tissue destruc-
tion. There is mounting evidence that abnormal apoptotic pathways contribute to the immune dys-
regulation in LE. Apoptosis is crucial for maintaining cellular homeostasis and occurs as a part of
normal keratinocyte differentiation. However, increased apoptosis is observed in keratinocytes pres-
ent in the basal and suprabasal layers of cutaneous LE lesions. Release of apoptotic debris locally
within tissues or into the circulation could then result in heightened autoantigen display and support
the generation of and/or preservation of autoimmune lymphocytes. Moreover, there is evidence for
resistance to apoptosis in LE peripheral lymphocytes with autoreactive potential. However, the exact
mediators of altered apoptosis in cutaneous LE remain to be elucidated. In microarray analysis of
global gene expression in cutaneous LE, we observed the up-regulation of a number of apoptotic
genes - including the interferon-inducible pro-apoptotic OAS1 gene encoding the small (p42) 2′-5′-
oligoadenylate synthetase - in the skin and peripheral blood of patients. This observation is of
potential significance to disease as recent work suggests a link between small (OAS1) 2′-5′-oligoad-
enylate synthetase gene expression and isozyme activity with apoptosis in vitro. Molecular analysis
reveals the 9-2 isoform of the OAS1 gene is overexpressed in cutaneous LE skin and blood. To our
knowledge, our data provide the first experimental evidence demonstrating an increased expression
of the small 2′-5′-oligoadenylate synthetase gene OAS1 in human autoimmune disease, suggesting
novel apoptotic pathways of relevance in cutaneous LE. 
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A passive transfer model of epidermolysis bullosa acquisita using antibodies generated against
the noncollagenous (NC1) domain of human type VII collagen on human skin grafted onto
mice
M Chen, P Saadat, T Atha, K Lipman, R Ram and DT Woodley Dermatology, University of
Southern California, Los Angeles, CA
Epidermolysis bullosa acquisita (EBA) is an autoimmune subepidermal blistering disease associated
with autoantibodies to type VII collagen, a major component of anchoring fibrils. EBA autoanti-
bodies recognize four major immunodominant epitopes localized within the amino-terminal non-
collagenous (NC1) domain of type VII collagen. We previously showed that passive transfer of a
high titer rabbit polyclonal antibody against the NC1 domain of type VII collagen into SKH 1 hair-
less mice induced skin blisters. To develop a more relevant animal model that would better mimic
the EBA disease process, full-thickness human skin was grafted onto either immunodeficient nude
mice or immunocompetent SKH 1 hairless mice. IgG purified from a rabbit immunized with NC1
was injected intradermally into the skin grafts (total dose of 10 mg of IgG per graft) every 24 hours
for up to 5 days. Human skin grafted on either immunodeficient or immunocompetent mice injected
with anti-NC1 IgG developed widespread erosions and crusted lesions. By clinical, histological,
and immunological criteria, the induced lesions were reminiscent of human EBA. Tissue sections
from lesion sites demonstrated epidermal-dermal separation in the sub-lamina densa zone. Injected
antibodies bound to the basement membrane zone (BMZ) of human skin grafts in vivo by direct
immunofluorescence. Serum samples from mice receiving anti-NC1 IgG antibodies had high titers
of circulating antibodies that labeled the BMZ of human skin. Human skin grafts injected with sim-
ilar concentrations of control IgG purified from normal rabbits showed no pathological changes. We
conclude that antibodies to the NC1 domain of type VII collagen play an important role in the
pathogenesis of EBA. This experimental mouse model can be used to identify pathogenically rele-
vant epitopes on NC1 and may provide a useful tool for dissecting the molecular and immunologi-
cal mechanisms of subepidermal blister formation in EBA. 
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Passive transfer of epidermolysis bullosa acquisita antibodies induces blisters in human skin
grafted onto nude mice
R Ram, M Chen, P Saadat, T Atha, Y Huang and DT Woodley Dermatology, University of Southern
California, Los Angeles, CA
Epidermolysis bullosa acquisita (EBA) is an antibody-mediated autoimmune blistering disease in
which patients develop subepidermal blisters and antibodies directed against type VII (anchoring
fibril) collagen. The dysfunction of anchoring fibrils caused by these autoantibodies to type VII col-
lagen may play an important role in the pathogenesis of EBA. However, direct evidence for a path-
ogenic role of EBA autoantibodies has not been demonstrated. To develop an animal model that
would duplicate the findings in the skin of patients more closely, full-thickness normal human skin
was grafted onto nude mice. Purified IgG fractions prepared from two EBA patients and two nor-
mal control sera were injected into the dermis of the human grafts (total dose of 10 mg of IgG per
graft) every 24 hours for one week. Human skin grafts injected with either fraction of purified EBA
IgG autoantibodies developed widespread erosions, crusted lesions and blisters. By clinical, histo-
logical, and immunological parameters, the induced lesions were reminiscent of human EBA. His-
tological examination of tissue sections from lesion sites demonstrated epidermal-dermal separa-
tion in the sub-lamina densa zone. Direct immunofluorescence of biopsies obtained from human skin
grafts injected with purified EBA IgG antibodies showed IgG deposits at the basement membrane
zone (BMZ). Indirect immunofluorescence of sera from mice injected with EBA IgG antibodies
showed high titers of circulating antibodies that labeled the BMZ of human skin even 3 weeks after
the termination of injections. Similar concentrations of control normal IgG did not induce any pathol-
ogy when injected into human skin grafts. We conclude that antibodies to type VII collagen play an
important role in the pathogenesis of EBA. This experimental human skin graft mouse model may
provide a useful tool for dissecting the molecular and immunological mechanisms of subepidermal
blister formation in EBA and for developing novel strategies for treatment of EBA. 
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Divergent dose-dependent responses to arachidonic acid in normal human keratinocytes
A Meves, MR Pittelkow and SN Stock Dermatology, Mayo Clinic, Rochester, MN
Arachidonic acid (AA), a C20:4 ∆5,8,11,14-eicosatetraenoic acid, is a precursor fatty acid in the
synthesis of many pro-inflammatory lipid mediators. In recent years, oxidative stress and inflam-
mation have been recognized as inseparable phenomena. Similarly, inflammation and malignancy
seem to be related biological responses. Chronic inflammation causes loss of epithelial polarity,
altered deposition of extracellular matrix proteins, enhanced cellular migration and dedifferentiation
of epithelial cells. We have therefore investigated the pro-inflammatory mediator, AA, and its effect
on keratinocyte viability, stress-activated signaling and cell morphology. To assess cell viability,
fluorescent markers, calcein-AM and ethidium homodimer-1, identifying live and dead cells, respec-
tively, were used. Keratinocytes were exposed to AA concentrations ranging from 1 to 100 µM.
Live/dead read-outs obtained by flow cytometry were highly reproducible. 100% of cells exposed
to 100 µM AA and 70% of cells exposed to 30 µM AA died within 24 hours post exposure. In con-
trast, 0% of cells exposed to 10 µM AA or less died within 24 hours, even if they were re-exposed
hourly to AA. Instead, these cells exhibited impressive morphologic alteration with lamellipodia and
filopodia formation. Adenoviral overexpression of catalase but not superoxide dismutase completely
inhibited these morphology changes. Moreover, catalase-overexpressing keratinocytes were more
prone to AA-induced cell death than βGal-infected controls. These findings implicate divergent dose-
dependent oxidative/survival vs. pro-oncogenic roles for AA, where lower concentrations of AA
facilitate migratory responses and cell survival in cultured human keratinocytes. 
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Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies
Y Takae, M Amagai and T Nishikawa Dermatology, Keio University School of Medicine, Shinjuku,
Japan
Pemphigus vulgaris (PV) is an autoimmune bullous skin disease caused by IgG autoantibodies against
a cadherin type adhesion molecule, desmoglein 3 (Dsg3). We have generated an active disease mouse
model for PV by adoptive transfer of lymphocytes from immunized Dsg3-/- mice to Rag2-/- mice.
The mice stably produce anti-Dsg3 IgG without general immune activation and show weight loss
due to inhibition of food intake by mucosal erosions. In this study, we used this model to evaluate
effects of two kinds of corticosteroids and five immunosuppressive agents on the pathogenic anti-
body production and development of the PV phenotype. Treatment was initiated at the time of the
adoptive transfer and continued for 4 weeks and the mice were evaluated for 8 weeks in general. Five
PV model mice were treated along with five untreated control mice. We used dexthamethasone (DEX),
methylprednisolone (m-PSL), azathioprine (AZP), cyclophosphamide (CPA), cyclosporine A (CYA),
tacrolimus hydrate (FK506), and mycophenolate mofetil (MMF). Compared to untreated control
mice at week 2, the titers of anti-Dsg3 IgG and the degree of weight loss were, respectively, 0.83
and 0.88 in mice treated with DEX (i.p. 10 mg/kg daily), 0.70 and 0.88 in mice treated with m-PSL
(i.p. 100 mg/kg daily), 0.33 and 0.75 in mice treated with AZP (p.o. 30 mg/kg daily), 0.03 and 0.03
in mice treated with CPA (i.p. 40 mg/kg three-times a week), 0.20 and 0.27 in mice treated with CYA
(i.p. 40 mg/kg daily), 0.68 and 1.42 in mice treated with FK506 (i.p. 5mg/kg daily), 1.22 and 0.81
in mice treated with MMF (p.o. 80 mg/kg daily). Thus, we could grade various immunosuppressive
therapies on their effects to pemphigus model mice. Throughout the course of this study, CPA showed
the most significant therapeutic effect on the pathogenic anti-Dsg3 IgG production as well as the
appearance of the PV phenotype. Although there is difference between mice and human, this model
provides a unique tool to evaluate and compare in vivo effects of various therapeutic strategies against
organ-specific autoimmune diseases. 
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Non-pathogenic anti-Dsg3 monoclonal IgG antibodies become pathogenic and induce pem-
phigus vulgaris phenotype in combination
T Hata,1,2 H Kawasaki,1 K Tsunoda,1,3 K Ishii,1,4 T Yamada,5 T Nishikawa1 and M Amagai1 1
Dermatology, Keio University School of Medicine, Tokyo, Japan, 2 R&D Division, KOSE
Corporation, Tokyo, Japan, 3 Dentistry and Oral Surgery, Keio University School of Medicine,
Tokyo, Japan, 4 Dermatology, Tokyo Electric Power Company Hospital, Tokyo, Japan and 5
Pathology, Keio University School of Medicine, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune blistering disease caused by anti-desmoglein3 (Dsg3)
IgG antibodies. We have obtained 8 AK and 10 NAK anti-Dsg3 IgG monoclonal antibodies (mAbs)
from PV model mice receiving immunized and naive splenocytes from Dsg3-/- mice, respectively.
In this study we evaluated the blister-inducing activity of NAK mAbs in monoclonal vs. polyclonal
condition in two different assays; in vitro keratinocyte dissociation assay and ascites formation assay.
In dissociation assay normal mouse primary keratinocytes were incubated with NAK mAbs and
obtained a dissociation index by comparing numbers of cell particles after mechanical stress by pipet-
ting. In ascites formation assay, hybridoma cells were inoculated in peritoneum of Rag2-/- mice and
development of the PV phenotype was evaluated. The dissociation assay showed that all the NAK
mAbs had low activities. None of the NAK mAbs induced the PV phenotype when single clones
were inoculated in mice. In contrast, when several clones recognizing different Dsg3 epitopes were
mixed the dissociation assay showed high activities equivalent to that of AK23, which was previ-
ously shown to be pathogenic. Furthermore, when several clones of NAK mAbs were combined and
inoculated in mice, the mice developed the PV phenotype, including oral erosions with suprabasi-
lar acantholysis in histology. These findings indicated that non-pathogenic anti-Dsg3 mAbs show
the pathogenic activity in inducing the loss of cell adhesion of keratinocytes with resultant PV blis-
ter formation when combined. Considering patients’ sera are polyclonal, these mAbs provide a
valuable tool to mimic the human disease and dissect molecular mechanism of blister formation in
PV. 
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Desmogleins expression in regulating pemphigus activity
H Fujiwara, T Imura, S Suzuki and M Ito Dermatology, Niigata University, Niigata, Niigata, Japan
Pemphigus is an autoimmune disease caused by anti-desmogleins autoantibodies, toward the com-
ponents of desmosome, cell adhesion structure between keratinocytes. Systemic administration of
glucocorticoid has been used effectively for the treatment of pemphigus patients. Glucocorticoid can
reduce serum concentration of anti-desmogleins antibodies through its immunosuppressive effect in
a long term. Although its effect usually appears within a few days of administration, clinically, the
mechanism of its effect in a short period remains to be elucidated. We compared mRNA and protein
tissue expression of desmoglein 1 and desmoglein 3 by means of in situ hybridization and immunos-
tain, in three pemphigus patients before and one or two weeks after the treatment. Also, the change
of the amount of desmogleins mRNA in serum were analyzed with semiquantitative RT-PCR in
nine pemphigus patients. The mRNA and protein tissue expression of desmoglein 1 and 3 decreased
markedly in two patients in whom glucocorticoid treatment was effective. In another patient who
did not respond to glucocorticoid treatment the desmogleins expression increased, instead. The RT-
PCR analysis also revealed that the serum concentration of desmogleins mRNA decreased in whom
glucocorticoid treatment was effective. In all patients serum concentration of anti-desmogleins anti-
bodies, measured in ELISA, were not changed significantly within one or two weeks after the treat-
ment. We speculated that glucocorticoid showed its immediate effect by suppressing desmogleins
expression transcriptionally, then reducing the immunecomplex formation in situ and halting the
acantholytic change of keratinocytes. Searching the regulator of desmoglein expression other than
glucocorticoid may lead a new class of pemphigus treatment. 
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Low-producing polymorphisms of mannose binding lectin but not the C1qA SNP are associ-
ated with DM
ML Colavincenzo,1 M Rosenbaum,1 M Bashir,1 W Zhang,1 KE Sullivan3 and VP Werth1,2 1
University of Pennsylvania, Philadelphia, PA, 2 Philadelphia V.A. Hospital, Phildelphia, PA and 3
Children’s Hospital of Philadelphia, Philadelphia, PA
Mannose binding lectin (MBL) and C1q are structurally related molecules that bind apoptotic blebs
and are thought to play a role in the non-inflammatory clearance of autoantigens on apoptotic cells.
Deficiencies of these two molecules may contribute to photosensitive cutaneous autoimmune dis-
eases: dermatomyositis (DM), but not subacute cutaneous lupus erythematosus (SCLE), is associ-
ated with low-producting MBL single nucleotide polymorphisms (SNPs) (Werth et al, 2002), and
SCLE has been associated with C1qA, a low-producing C1q SNP (Racila et al, 2003). We now sought
to compare in a single study the frequencies of low-producing MBL and C1q SNPs in four groups:
adult DM (n = 73), SCLE (n = 53), discoid LE (DLE, n = 52), and healthy controls (n = 75). DNA
was isolated from buffy coats, and allele-specific polymerase chain reactions (PCR) were used to
genotype the MBL (Asp54, Glu57, and the LX promoter polymorphism at −221) and C1qG/A
(Gly70GGGGly 70GGA) polymorphisms in each patient and control. We found that the incidence of
lowest-producing combinations of MBL polymorphisms (group 3) was increased in DM, with 27%
of DM patients having lowest-producing variants vs. 12% of SCLE, 17% of DLE, and 9% of con-
trols (p≤0.025 by χ2 test, 4x2 table). We found the incidence of the low-producing C1qA SNP geno-
type was 36% in SCLE, 22% in DM, 21% in DLE, and 35% in controls (NS). To compare the con-
tributions of individual low-producing SNPs, we found significant differences between diseases in
the numbers of patients with low-producing MBL SNPs but wild-type C1q (47% of DM, 24% of
SCLE, 25% of controls) vs. low-producing C1q SNPs but wild-type MBL (10% DM, 19% of SCLE,
17% controls; p=0.034). Thus, low-producing MBL SNPs, but not the low-producing C1qA poly-
morphism is associated with DM. 
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Detection of serum IgE auto-antibodies against epidermal proteins in severe forms of atopic
dermatitis
S Altrichter, SJ Graffi, T Kopp and G Stingl Department of Dermatology, Division of Immunology,
Allergy and Infectious Diseases (DIAID), University of Vienna Medical School, Vienna, Austria
Many symptoms of atopic diseases result from events initiated by cross-linking of cell-bound IgE
specific for exogenous allergens. Previous studies showed that sera of patients with severe forms of
atopic dermatitis might also contain IgE specific for self-proteins, supporting the hypothesis of autore-
activity as pathogenic factor in atopy. Because these studies were mainly performed with extracts of
cell lines and peripheral blood-derived mononuclear cells, it remained unknown whether sensitiza-
tion to skin-derived self-proteins may occur in atopic dermatitis. Addressing this question, we ana-
lyzed the sera of 21 atopic dermatitis patients and 10 healthy donors for specific IgE antibodies
against protein extracts of normal epidermis, dermis and the epithelial cell-line A431. No specific
reactivity against these extracts was detectable when sera derived from healthy persons were tested
in western-blots. In contrast, four patients with severe forms of atopic dermatitis (defined by high
levels of total serum IgE and a high investigator global assessment score) exhibited IgE-reactivity
against A431-derived proteins, thus confirming previous findings. Importantly, serum IgE of two of
these four patients recognized also proteins in epidermal extracts. These latter proteins exhibited
molecular weights different from those detected in A431 extracts indicative of distinct IgE speci-
ficities. Interestingly, all analyzed sera failed to react with dermal protein extracts. These results sug-
gest that elicitation of auto-reactive IgE against epidermal self-proteins occurs in severe forms of
atopic dermatitis, possibly contributing to the chronicity of the disease. 
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Fas ligand-mediated keratinocyte apoptosis in fixed drug eruption
Y Park, H Choi, J Ku, M Kim and H Kim Dermatology, Kangnam St. Mary’s Hospital, Seoul,
South Korea
The pathogenesis of fixed drug eruption (FDE) is not fully understood. Histologically, like lichen
planus, graft-versus host reaction, Stevens-Johnson syndroma, and toxic epidermal necrolysis, FDE
is characterized by keratinocyte apotosis. The aim of this study is to clarify the role of cytotoxic T
cells and Fas/Fas ligand (L) pathway in keratinocyte apoptosis of FDE. Lesional punch biopsy spec-
imens and normal skin samples of 32 patients with established FDE were evaluated. Apoptosis was
assessed by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling(TUNEL).
Immunohistochemistry for Fas, FasL, and caspase-3 as well as CD4 and CD8 was performed. In
contrast to normal skin showing focal apoptosis confined to stratum corneum and/or granulosum,
there was marked apoptosis of lesional keratinocytes. Evaluation of the subpopulation of T cells infil-
trated into the epidermis demonstrated the dominant CD8+ T cells. Compared to normal skin and
old lesions, FasL expression was higher in the early acute lesional keratinocytes and some dermal
lymphocytes. These FasL positive cells were also positive for caspase-3. Our results strongly sug-
gest that a potential mechanism of keratinocyte death in FDE is apoptosis, which may be mediated
by CD8+ cytotoxic T cells and the Fas/FasL pathway. 
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V-gamma-5 dendritic epidermal T cells are required for optimal regulation of cutaneous inflam-
mation and protection of the epidermal barrier
M Girardi,1 S Roberts,1 R Filler,1 A Hayday2 and R Tigelaar1 1 Dermatology, Yale University
School of Medicine, New Haven, CT and 2 Immunobiology, GKT Hospital, London, United
Kingdom
We have previously demonstrated that mice deficient in all γδ T cells demonstrate augmented der-
matitis responses, as well as a defective transepidermal water barrier (TEWB). To investigate the
role of Vγ5+ dendritic epidermal T cells (DETC) in the regulation of cutaneous inflammation and
maintenance of the TEWB, we backcrossed (10+ generations) the T cell receptor (TCR)δ-/- and Vγ5-
/- mutations each onto the FVB background. While the TCRδ-/- mice show no intraepidermal γδ(+)
T cells, the Vγ5-/- mice demonstrate normal numbers of Vγ5(-) γδ(+) DETC. Ear swelling responses
to irritant (tetradecanoylphorbol acetate; TPA) and allergen (dinitrofluorobenzene; DNFB) chal-
lenges were assessed, and skin surface hydration (SSH) was determined as instantaneous (t = 0 sec)
skin surface electrical capacitance (SSEC; NOVA Dermaphase Meter 2003) while transepidermal
water loss (TEWL) was measured as the change in SSEC over time (1 to 10 sec). At 24hrs after expo-
sure to a 40 nmol TPA irritant challenge, both TCRδ-/- and Vγ5-/- mice showed increased ear swelling
(19.4±1.2 mm-2 and 16.6±1.2 vs 10.3±0.9 in controls, p<0.00001), as well as increased SSH (138.6±7.7
picoFarads and 124.6±2.4 vs 112.2±3.4 in controls; p<0.004 for both). TEWL was significantly
greater in the TCRδ-/- (3.64±0.52, p<0.005) but not the Vγ5-/- mice (2.14±0.23), relative to controls
(1.86±0.30). Following challenge with 0.2% DNFB to ear skin, one week after sensitization with
0.5% DNFB to abdominal skin, both TCRδ-/- (25.7±2.4, p<0.0001) and Vγ5-/- mice (17.2±3.0,
p=0.01) showed increased ear swelling relative to controls (10.2±0.9). Hence, a major component
of the capacity of γδ T cells to regulate cutaneous inflammation and maintain epidermal integrity is
mediated by Vγ5(+) DETC; however, other non-Vγ5 γδ(+) DETC may also have functional activ-
ity. 
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Role of TNF-α, IL-1, and IL-6 in experimental autoimmune bullous pemphigoid
M Zhao, KE Carter, LA Diaz and Z Liu Dermatology, University of North Carolina at Chapel Hill,
Chapel Hill, NC
Bullous pemphigoid (BP) is an autoimmune inflammatory disease characterized by subepidermal
blisters and autoantibodies against two hemidesmosomal proteins - BP230 and BP180. Inflamma-
tory cells, including eosinophils, neutrophils, lymphocytes, and monocytes/macrophages are iden-
tified in the upper dermis and bullous cavity. Various inflammatory mediators that can recruit and
activate inflammatory and residential cells are present in lesional skin and/or blister fluids of BP
patients. We previously showed that passive transfer of anti-BP180 IgG into neonatal mice induces
a BP-like disease in the animals. Subepidermal blistering in experimental BP depends on comple-
ment activation, mast cell degranulation, and neutrophil infiltration. TNF-a released by activated
mast cells plays a critical role in neutrophil recruitment and subsequent blistering. In this study we
investigated the role of IL-1 and IL-6 and their functional relationship with TNF system using the
BP mouse model. Mice deficient in TNF-α were resistant to experimental BP with minimal neu-
trophil infiltration. Levels of IL-1 and IL-6 in the skin of TNF-α-deficient mice at the pathogenic
IgG-injection site were significantly reduced compared to wild-type (WT) control. TNF-α-deficient
mice when reconstituted locally with recombinant IL-1 or IL-6 became susceptible to experimental
BP. Pretreatment of WT mice with IL-1 or IL-6 neutralizing antibody blocked the pathogenic activ-
ity of anti-BP180 IgG. Furthermore, mice deficient in IL-1 receptor or IL-6 were resistant to exper-
imental BP. These results suggest that TNF-αupregulates levels of IL-1 and IL-6, which in turn
leads to neutrophil recruitment causing subepidermal blistering triggered by anti-BP180 IgG. 
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Innate immunity in the development of murine sclerodermatous GVHD, a model for sclero-
derma
D Askew,1 D Zhou,1 C Wu,1 G Cheng1 and AC Gilliam1,2 1 Dermatology, Case University,
Cleveland Ohio, OH and 2 Dermatology, University Hospitals of Cleveland, Cleveland Ohio, OH
Molecular mimicry due to bacterial/viral infection has been proposed as a possible explanation of
autoimmune diseases such as scleroderma, a Th2 predominant immune process. In addition to pro-
viding cross-reactive proteins, viruses and bacteria also provide components that can interact with
innate immunity through toll-like receptors (TLRs). We are modeling human scleroderma with murine
sclerodermatous graft versus host disease (Scl GVHD), in which transplantation of bone marrow and
spleen cells of B10.D2 (H2d) mice into lethally irradiated BALB/c (H-2d) mice across minor his-
tocompatability loci (MiHC) produces skin thickening and lung fibrosis rather than classic cyto-
toxic GVHD. In scleroderma and Scl GVHD, monocytes/macrophages are prominant in cutaneous
inflammatory infiltrates. Examining the MiHC reaction in vivo in Scl GVHD, and in vitro, in mixed
leukocyte reactions (MLR) of spleen cells using donor T cells with host antigen presenting cells
(APCs), we have identified activated CD4 T cells as the major responding cell. When TLR agonists
CpG oligonucleotide and lipopolysaccharides are added to MLR we see an increase in T cell pro-
liferation when either dendritic cells (DCs) or macrophage are used as APCs. CD4 T cells stimu-
lated by splenic DCs show 2-fold increase in the number of T cells producing Th1-like cytokine IFN-
gamma, while there is a 9-fold increase in the number of T cells producing Th2-like cytokines IL-4
and IL-10 when incubated with splenic macrophages. These data suggest that MiHC-reactive T
cells appear to be differentially responsive to TLR agonists depending on the dominant APC pres-
ent, and that the interactions between macrophages and TLR agonists may be essential for initiat-
ing the events leading to Scl GVHD. 
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Cutaneous gene expression by DNA microarray in murine sclerodermatous graft versus host
disease, a model for human scleroderma
L Zhou Dermatology, Case University, Cleveland, OH
Chronic graft versus host disease (GVHD) is a major complication of allogeneic bone marrow
transplantation that can have autoimmune features resembling scleroderma (sclerodermatous GVHD).
The molecular mechanisms governing skin fibrosis in Scl GVHD are not known. We used DNA
microarrays representing > 14,000 mouse genes to characterize global gene expression in skin dur-
ing early stages of GVHD from irradiated BALB/c (H-2d) mice transplanted with B10.D2 (H-2d)
bone marrow and spleen cells. These mice develop skin thickening, while control mice transplanted
with BALB/c (H-2d) bone marrow and spleen cells do not develop skin thickening. We found con-
sistent differences in gene expression between mice with Scl GVHD and controls. Cytokine mRNA
for both Th1 (IFN gama) and Th2 (IL-6, IL-13, IL-4) processes and chemokine mRNA (MCP-1,
RANTES) were elevated. TGF beta 1, CTGF and PDGF mRNA were elevated, similar to results in
human scleroderma. This validates the murine model and identifies potential markers for the dis-
ease. Such marker will help to understand sclerodermatous pathogenesis and to devise more effec-
tive strategies for intervention in early scleroderma and GVHD. 
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Estradiol and the C1QA G288>A (AF 135157) exonic single nucleotide polymorphism control
SC35 splicing factor activity in the processing of C1QA pre-mRNA
DM Racila,1 EV Racila2 and RD Sontheimer1 1 Dermatology, Univ. of Iowa Carver College of
Medicine, Iowa City, IA and 2 The Holden Comprehensive Cancer Center, Univ. of Iowa Carver
College of Medicine, Iowa City, IA
Complete congenital deficiency of C1q, the first component of the classical pathway of complement,
is the strongest single genetic risk factor for the development of systemic lupus erythematosus (SLE)
yet identified. Greater than 90% of individuals so affected develop SLE. In addition to its regulatory
roles in immune complex diseases such as SLE (immune complex solubilization, modulation of B
cell and T cell function), C1q is being increasingly recognized to play a multifunctional role in the
innate immune response. Functional human C1q consists of 6 subunits of a heterotrimer formed by
the association of three related but distinct gene products: C1qA, C1qB, and C1qC. Using a candi-
date gene approach, we recently observed that a new SNP in the second exon of the C1QA gene
(C1QA G288>A [AF 135157])(C1QA G288>A) is strongly associated with photosensitive subacute
cutaneous LE (SCLE) skin lesions and relatively low serum C1q levels (Lupus 12:124-132, 2003).
A web-based exonic splicing enhancer (ESE) identification algorithm (ESE Finder) predicted that
the C1QA G288>A SNP disrupts an ESE that serves as a binding site for the estradiol-regulated
SC35 splicing factor (syn. SFRS2). Using 5’/3’ RACE PCR and Southern blotting, we now have
evidence that C1qA pre-mRNA does in fact undergo alternative splicing. In homozygous C1QA
G288>A individuals, the resulting spliced mRNA appears to encode a truncated form of C1qA that
is missing the first exon. We speculate that this truncated variant of the C1qA polypeptide is less
efficient in associating with C1qB and C1qC polypeptides to form fully functional C1q molecules.
Relatively deficient C1q levels in homozygous C1QA G288>A individuals could interfere with C1q’s
immunoregulatory functions including participation in the physiologic clearance of apoptotic cells
thereby potentiating the development female-dominant autoimmune diseases such as SLE and SCLE. 
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IgG4 anti-basement membrane zone (BMZ) antibody is the first and last antibody in prodro-
mal bullous pemphigoid (PBP)
P Lamb,1 DW Kress1 and J Deng1,2 1 Dermatology, University of Pittsburgh, Pittsburgh, PA and 2
Dermatology, VA Medical Center, Pittsburgh, PA
This study was performed to investigate the role of IgG4 subclass anti-BMZ Ab in PBP patients by
using DIF and IIF. Skin specimens were obtained from 45 PBP patients, with sera being available
from 26 patients. Among these 26 patients, serial serum specimens were available from 5 PBP patients.
RESULTS: Using DIF, 36 patients had IgG and C3 staining at the BMZ, while 9 patients had only
C3 staining. When skin samples from these 9 patients were evaluated for IgG subclass deposition
by IIF, 4 demonstrated linear IgG4 staining along the BMZ. BMZ Ab were found in 10 PBP patients,
while it was negative in the remaining16 PBP patients. By using IIF for IgG subclass BMZ Ab, 4 of
these 16 PBP patients were found to have IgG4 BMZ Ab. When the serial serum samples from the
5 PBP patients were analyzed by IgG subclass IIF, antibody titers were found to be higher at the
beginning of their disease and most of the IgG subclasses were present. However, as the condition
of the PBP patients improved, serum BMZ Ab titers decreased slowly and IgG4 BMZ Ab was the
last subclass to disappear. If the patient relapsed or had a worsening of their disease, IgG4 was the
first IgG subclass BMZ Ab to be detected and detection of other IgG subclasses BMZ Ab would
subsequently follow.  CONCLUSION: IgG4 is the predominant BMZ Ab in PBP patients and per-
sists throughout the course of the disease.  IgG4 is the first IgG subclass to appear and the last to
disappear. There is a switching of circulating BMZ Ab from IgG4 to other subclasses back and
forth.
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Crucial role for intraepidermal T cells expressing the collagen-binding integrin α1β1 in pso-
riasis
C Conrad,1 O Boyman,2 A de Fougerolles,3 V Kotelianski,3 H Gardner4 and FO Nestle1 1
Dermatology, University Hospital of Zurich, Zurich, Switzerland, 2 The Scripps Research Institute,
La Jolla, CA, 3 Alnylam Pharmaceuticals, Cambridge, MA and 4 Biogen Inc., Cambridge, MA
Psoriasis is a chronic relapsing T cell-mediated skin disorder. Activated T cells migrating into the
epidermis seem to be required for disease formation. Trafficking of leukocytes within tissue and
thereby generating an inflammatory response is critically dependent on interactions with extracel-
lular matrix (ECM) proteins such as collagens. We investigated the functional expression of a major
collagen-binding receptor: α1β1 integrin (VLA-1) in psoriasis. VLA-1 was exclusively expressed
by infiltrating epidermal but not dermal CD8+ and CD4+ T cells in active psoriasis lesions. To deter-
mine the in vivo relevance of VLA-1 expression on activated T cells in psoriasis we took advantage
of a recently described xenotransplantation model with spontaneous development of psoriasis (JEM,
in press). Uninvolved human skin from patients with psoriasis was engrafted onto AGR mice, defi-
cient in type I and II interferon receptors in addition to being RAG-/-. Upon transplantation, mice
were treated with either murine anti-human α1-integrin mAb or isotype control antibody. Skin grafts
on mice receiving control antibody developed a fully-fledged psoriasis after 6 weeks as expected.
Blockade of VLA-1 inhibited psoriasis formation in 6 out of 6 mice (n=3 patients). Anti-VLA-1 treat-
ment resulted in a significant reduction of both acanthosis and papillomatosis index. A significant,
more than two-fold expansion of epidermal and dermal T cells during disease formation was observed
in transplanted grafts treated with control antibody. Expression of VLA-1 was restricted to the pool
of expanded epidermal T cells in converted psoriatic skin. Expansion of intraepidermal VLA-1
expressing T cells was completely blocked after anti-VLA-1 treatment. Our findings suggest a cru-
cial role for intraepidermal VLA-1 expressing T cells in psoriasis and might provide the basis for
new strategies in psoriasis treatment focusing on T cell/ECM interactions. 
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Dissecting the role of NF-κB and TNFα on cutaneous inflammation in K5-PKCα overexpressing
mice
C Cataisson, A Pearson, S Torgerson, SA Nedospasov and SH Yuspa Laboratory of Cellular
Carcinogenesis and Tumor Promotion, NCI, Bethesda, MD
Protein kinase C (PKC) isoforms are major regulators of cutaneous homeostasis and mediate inflam-
mation in response to 12-0-tetradecanoylphorbol-13-acetate (TPA). We have previously reported that
transgenic mice overexpressing PKCα in the basal layer of epidermis exhibit severe intraepidermal
neutrophilic inflammation and keratinocyte apoptosis when treated topically with TPA. Depletion
of granulocytes in K5-PKCα mice by ip administration of mAb Ly-6G abolishes intraepidermal neu-
trophilic infiltrates but does not prevent epidermal apoptosis suggesting that these processes are inde-
pendently regulated. Activation of PKCα increases the production of TNFα and the transcription of
chemotactic factors (MIP-2, S100A8/A9), VEGF and GM-CSF in K5-PKCα keratinocytes. In
response to PKCα activation, NF-κB translocates to the nucleus, and this is associated with IκB
phosphorylation and degradation. Preventing IκB degradation in K5-PKCα keratinocytes using an
adenoviral IκBα mutant prevents NF-κB nuclear translocation and reduces both the expression of
inflammation associated genes and chemoattractant release. To determine if TNFα mediated NF-
kB translocation and subsequent expression of pro-inflammatory factors, mice were treated sys-
temically with a dimeric soluble form of p75 TNF receptor (Etanercept) and keratinocytes were cul-
tured in the presence of TNFα neutralizing antibodies. The in vivo treatment did not prevent
inflammation, and the in vitro treatment did not prevent TNFα nuclear translocation after TPA. These
results were confirmed using TNFR null primary keratinocytes adenovirally transduced to overex-
press PKCα and suggest that PKCα can activate NF-κB independently of secreted TNF. Together
these results implicate PKCα as a regulator of a subset of cutaneous cytokines and chemokines
responsible for intraepidermal inflammation independent of soluble TNFα. Understanding the func-
tion of TNFα in this model will await the outcome of current studies using K5-PKCα mice geneti-
cally ablated for TNF receptors. 
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Circulating IgA autoantibodies to epidermal transglutaminase 3 can not distinguish dermati-
tis herpetiformis from celiac disease
AS Ghahestani,1 N Nikbakht,1 L Fry,2 T Reunala,3 J Uitto1 and R Ghohestani1 1 Dermatology and
Cutaneous Biology, Jefferson Medical College, Philadelphia, PA, 2 Dermatology Research,
Imperial College of Science, London, United Kingdom and 3 Dermatology, University of Tampere,
Tampere, Finland
The discovery of tissue transglutaminase (TGase) as the main endomysial autoantigen failed to
explain why only a proportion of gluten sensitive patients show symptoms of dermatitis herpeti-
formis (DH). By comparing the antibody responses to TGase 2 and 3, a recent study suggested that
target antigens in DH and celiac disease (CD) are distinct: TGase 2 is the target in CD and TGase 3
in DH. We here provide evidence that TGase 3 is also recognized by IgA antibodies in sera from
patients with CD. We examined IgA reactivity of DH and CD sera against a human recombinant
TGase 3 and a purified guinea pig TGase 2 by Elisa assay. Selected sera were also tested by West-
ern blot using recombinant TGase 3 and purified TGase 2. The diagnosis of CD was confirmed by
presence of anti-endomysial antibody and jejunal biopsy while DH was diagnosed by skin biopsy
using both light and immunofluorescence microscopy. Sera were obtained from 69 patients with
DH and 45 with CD, as well as 10 with linear IgA disease (LAD) and 10 with cicatrical pemphigoid
(CP). Sera from 31 healthy individual and rabbit antibodies to TGase 2 and 3 were used as controls.
By Elisa, IgA to TGase 3 was present in 39 of 45 (87%) CD and 62 of 69 (90%) DH sera. IgA to
TGase 2 was present in 41 of 45 (91%) CD and 61 of 69 (88%) DH sera. One of 10 CP sera also
contained IgA to both TGase 2 and 3. No sera from healthy individuals or LAD contained IgA to
TGase 2 or 3. IgA reactivity to TGase 2 and 3 was also confirmed by Western blot assay using selected
DH and CD sera.These data provide strong evidence that IgA autoimmune response to TGase 3 is
not exclusively present in DH. CD sera also contain IgA to TGase 3. Accordingly, autoimmune
response to TGase alone may not explain presence of two clinically distinct forms of gluten sensi-
tive disease, i.e., DH and CD. 
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Anti-interleukin-5 decreases dermal eosinophilia but increases epidermal hyperplasia in chronic
proliferative dermatitis (cpdm) mice
ML Renninger,1 JP Sundberg2 and H HogenEsch1 1 Veterinary Pathobiology, Purdue University,
West Lafayette, IN and 2 The Jackson Laboratory, Bar Harbor, ME
Chronic proliferative dermatitis (cpdm) mice develop chronic eosinophilic inflammation in tissues,
most prominently in the skin. To evaluate the role of cutaneous eosinophilia, mutant mice were treated
with anti-IL-5 and examined for changes in phenotype. Monoclonal rat anti-mouse IL-5 (TRFK5)
was generated from hybridoma cells in serum free medium, concentrated, checked for endotoxin,
and diluted in phosphate buffered saline (PBS). Lyophilized rat IgG was diluted in PBS and used as
a control. Five pairs of gender-matched cpdm/cpdm littermates, 3-4 weeks of age, were injected
intraperitonealy three times with 0.2 mL (0.3 mg) of anti-IL-5 or IgG control with 3 day intervals.
Mice were euthanized 3 days after the last injection, and blood and skin collected. Absolute and dif-
ferential leukocyte counts were determined. The number of eosinophils in the blood was decreased
9-fold in mice treated with anti-IL-5 versus controls. The number of eosinophils in the dermis of
mice treated with anti-IL-5 was half that of the controls (790 ± 180 /mm2 versus 1860 ± 120 /mm2).
While the eosinophils decreased in mice treated with anti-IL-5, epidermal thickness was unexpect-
edly and significantly increased (46.8 ± 1.2 µm versus 40.4 ± 2.5 µm). The number of mast cells
was not significantly affected. The concentrations of eotaxin (CCL11), IL-4, and IL-5 in skin
homogenates were determined by ELISA. The concentrations of eotaxin, IL-4, and IL-5 were sig-
nificantly increased in the skin of mice treated with anti-IL-5. These results indicate that treatment
with IL-5 neutralizing antibodies is less effective in decreasing the accumulation of eosinophils in
the skin than in the blood, and causes an unexpected increase of IL-4, IL-5, and eotaxin in the der-
mis. The increased thickness of the epidermis suggests that eosinophils may inhibit keratinocyte pro-
liferation in the skin of cpdm/cpdm mice.
083
Corticosteroids prevent acantholysis by strengthening keratinocyte cell-cell adhesion
KM Setoodeh, S Yoo and M Kolodney Dermatology, Harbor-UCLA Medical Center, Torrance, CA
Pemphigus Vulgaris (PV) is a disease of skin fragility caused by autoantibodies to the desmoglein
class of cell-cell adhesion molecules. To determine the mechanism of corticosteroid therapy in PV,
we examined the effect of methylprednisolone on keratinocyte cell-cell adhesion strength. Primary
keratinocytes (HEK) or a non-transformed keratinocyte (HaCaT) cell line were treated with methyl-
prednisolone for 24 hours. Monolayers of keratinocytes were detached from the plates by dispase,
and then subjected to mechanical disruption (adhesion assay). The ratio of released single cells to
total cells was used as an indication of cell-cell adhesive strength. Corticosteroids were found to
increase keratinocyte adhesive strength in both HEK and HaCaT cultures. PV IgG dramatically
reduced keratinocytes adhesion strength. To determine if corticosteroids could block the effects of
PV antibodies on keratinocytes adhesion, cultures were pretreated with methylprednisolone for 24
hours and then incubated with PV or normal IgG (control) for 24 hours. Pretreatment with methyl-
prednisolone inhibited the PV IgG induced decrease in cell-cell adhesion. Our data show that pre-
treatment with corticosteroids prevents the acantholysis that occurs following incubation with PV
antibodies, and also increases keratinocyte cell-cell adhesive strength. The findings that corticos-
teroids increase keratinocyte adhesive strength irrespective of PV antibody treatment, indicate that
the enhancement in desmosomal adhesion is a generalized effect of corticosteroids and not specific
to the pathophysiology of PV. 
084
Profiling Staphylococcus aureus-mediated pro-inflammatory cytokine response in keratinocytes
Z Duanmu, BM Aufiero and GJ Murakawa Dermatology, Wayne State Univeristy, Detroit, MI
Skin infections caused by S. aureus continue to pose a serious medical problem and are associated
with numerous skin diseases. Keratinocytes, the predominant cell type found in the epidermis and
an important part of the immune system, produce a great variety of cytokines. While cytokines are
implicated in the development and persistence of inflammatory immune responses and S. aureus is
known to induce cytokines, the full scope of cytokine responses to S. aureus infection in primary
human keratinocytes is unknown. To elucidate the response of pro-inflammatory cytokines in the
pathogenesis of S. aureus infection, we determined cytokine expression by real-time reverse tran-
scription polymerase chain reaction (real-time RT-PCR), an approach that reveals the sequential order
of expressed genes. Five pro-inflammatory cytokines were selected: tumor necrosis factor-α (TNF-
α), interferon-gamma (IFN-γ), interleukin 1-alpha (IL-1α), IL-1β. These cytokines were tested for
their response to S. aureus at a multiplicity of infection (MOI) 100:1 (bacteria:keratinocytes). RNA
was extracted at a serial of time points including (t = 0, 2, 4, 6, 8 h) and reverse transcribed to pre-
pare cDNA. Real-time PCR was performed for each time point and β-actin was used as an internal
control and for standardization. Our results revealed that TNF-α increased rapidly (2h) and signifi-
cantly (55x). In contrast, IL-1α, IL-1β increased slowly (6h) and modestly (3-6x). No induction of
IFN-γ was observed. Soluble TNF-α was detected by enzyme linked immunoassays in the super-
natants of S. aureus infected cells, confirming PCR results. The rapid and significant induction of
TNF-α suggests that it plays a critical role in the S. aureus-mediated inflammatory response. TNF-
α, a known inducer of other cytokines, is primed to initiate the induction of other inflammatory
cytokines (IL-1). Furthermore, these results suggest that persistent TNF-α secretion as a result of S.
aureus infection is likely to cause tissue damage and systemic spread of infection. 
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Caspase activity in inflammatory skin disease
MK Kuechle and K Erickson Medicine/Dermatology, University of Washington, Seattle, WA
Caspases have emerged as pivotal mediators in many aspects of tissue homeostasis by controlling
cell numbers and eliminating abnormal cells. They, therefore, have been investigated as potential
therapies, both for inhibiting apoptosis in cells with limited proliferation, as well as initiating apop-
tosis in tumor cells. The duality of scheduled death during epidermal terminal differentiation and
premature death of keratinocytes in pathologic skin conditions make the study of caspase-mediated
events in the skin particularly relevant. It has been proposed that the dyskeratotic keratinocytes seen
in areas of lichenoid inflammation in certain inflammatory dermatoses are keratinocytes dying an
apoptotic death. Additional investigators have described other findings of apoptosis in the basal and
lower spinous layer of involved skin of lichenoid dermatoses such as lupus erythematosus (LE), graft-
vs-host disease (GVHD), erythema multiforme (EM), and lichen planus (LP). These studies have
used the morphologic features of the dying keratinocytes combined with the demonstration of nick-
ended DNA to classify the death as apoptotic. The role of caspases or other proteolytic events lead-
ing to death in these disorders has not been delineated. In this study, we have measured caspase activ-
ity in involved and non-involved skin from patients with LE, EM, and LP. Using a panel of
fluorimetrically-labeled caspase tetrapeptide substrates, we find that DEVD-ase (the preferred sub-
strate of caspase-3) activity is increased 1000 fold in lesional compared to non-lesional skin in patients
with EM and LE. Patients with LP did not have increased DEVD-ase activity compared to normal
controls or to non-lesional skin. Further, substrates for caspases-1,-2,-6,-8, and -9 were not cleaved
differentially in either the disease skin specimens or in non-involved skin. These studies show that
despite similar histologic features, keratinocyte death in LE and EM differs from that of LP in the
proteolytic pathway to cell death. These studies establish the rationale for use of specific caspase
inhibitors as therapies for certain inflammatory skin diseases. 
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Negative feedback regulation of phosphatidylinositol 3-kinase pathway by overexpressed
cyclooxygenase-2 in human epidermal cancer cells
K Takeda, T Kanekura and T Kanzaki Department of Dermatology, Kagoshima University
Graduate School of Medical and Dental Sciences, Kagoshima, Japan
While enhanced expression of cyclooxygenase (COX)-2 has been observed in human skin epider-
mal cancer, the mechanisms underlying COX-2 expression have not been completely elucidated.
Recently, a role of the phosphatidylinositol-3 (PI3) kinase pathway in COX-2 expression has attracted
attention. We investigated COX-2 expression, PI3 kinase activity, and the phosphorylation level of
Akt, a downstream effector of PI3 kinase, in human skin cancer cells HSC-5. Compared to the non-
tumorigenic keratinocytes HaCaT, in HSC-5 cells, COX-2 protein expression and PI3 kinase activ-
ity were increased. The PI3 kinase inhibitor LY294002 reduced COX-2 expression in HSC-5 cells
and contrary to our expectation, the phosphorylation of Akt was significantly decreased. The expres-
sion of Bcl-2, which is regulated by Akt, was reduced and apoptosis was induced in HSC-5 cells
compared to HaCaT cells. COX-2 inhibitor NS398 up-regulated PI3 kinase activity and Akt phos-
phorylation. These results imply that constitutively over-expressed COX-2 down-regulates the PI3
kinase/Akt pathway through a negative feedback mechanism. 
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The role of PAR-1 and PAR-2 in corneal epithelial inflammatory responses
JL Strande,1 PI Song,1 Y Kang,1 A Kolot,1 R Lang,2 CA Armstrong1 and JC Ansel1 1 Dermatology,
Northwestern University Feinberg School of Medicine, Chicago, IL and 2 Dermatology, General
Hospital Salzburg, Salzburg, Austria
Proteinase-activated receptors (PARs) are a novel class of cell surface receptors that are activated by
the cleavage of their N-terminal domain by serine proteases such as the PAR-1 activating thrombin
and the PAR-2 activating trypsin. PAR activating proteases are widely distributed in a variety of tis-
sues and are released locally after tissue injury and inflammation. Previous studies indicate that the
activation of keratinocyte PARs can modulate cytokines production, cellular proliferation and dif-
ferentiation. In this report we examined the role of PAR-1 and PAR-2 in mediating inflammatory
responses of human corneal derived HCE-T epithelial cells which, like keratinocytes, are exposed
to a wide variety of external insults and infectious agents. Our results indicate that the activation of
both HCE-T PAR-1 and PAR-2 induces the production of IL-1 alpha and IL-1 beta, whereas only
PAR-1 but not PAR-2 activation stimulates increased HCE-T sICAM-1 secretion. Next the effect of
PAR activation on HCE-T MMP and TIMP expression was examined. These proteins play a key
role in tissue inflammation, repair, and remodeling. Our results again demonstrated a differential
effect between PAR-1 and PAR-2 activation on HCE-T MMP and TIMP production. Thrombin (PAR-
1 activator) but not trypsin (PAR-2 activator) induced increased expression of MMP-1, MMP-2,
TIMP-1 and TIMP-2. The results of this study indicate that like closely related keratinocytes, corneal
epithelial PARs may serve as important modulators of tissue inflammation and repair in this impor-
tant ocular barrier tissue. Modulation of these receptors may provide to be a useful therapeutic tar-
get for a variety of epithelial diseases. 
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Redox targeted therapeutic approach for inflammatory skin diseases
SS Boddupalli,1 C Saliou,2 F Liebel,2 M Southhall,2 B Wang,1 S Gilat1 and G Miller1 1 Galileo
Pharmaceuticals Inc, Santa Clara, CA and 2 Johnson and Johnson Consumer & Personal Products
Worldwide, Skillman, NJ
Recent data suggest that a subset of the triggers of inflammatory cascades resides in redox signal-
ing pathways. While a body of literature linking these processes to dermatological diseases is emerg-
ing and our understanding of redox signaling and inflammation-mediated dermatological disease is
increasing, a paucity of data remains about developing concerted drug discovery paradigms target-
ing redox pharmacology. As physical-chemical properties such as charge recognition and transfer
are critical in modulating activity of redox-based targets, a counterpart to Structure Activity Rela-
tionships, PAR (Physical Chemical Activity Relationships) has been developed focusing on both
structural and charge transfer parameters of biological activity. To test this hypothesis, a subset of
compounds, diversified based on structure and redox attributes, were selected from a large library
of compounds and their in vitro and cell-based anti-inflammatory and redox activities were deter-
mined. Compounds representing a distinct redox class demonstrated maximum activity across an
assay panel. An expanded set of compounds were selected around the active redox class and further
screened in secondary in vitro and in vivo assays of oxidative stress and inflammation. A robust
anti-inflammatory activity was noticed with inhibition of ear edema. In addition, the lead compounds
significantly reduced production of cytokines by PHA-activated human peripheral blood lympho-
cytes. The overall hit rate of this subset was ~30%. Herein, we suggest that PAR may be a useful
tool to explore redox properties required for biological activity in inflammation-mediated dermato-
logical diseases. 
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Detection of human Papilloma virus DNA in Bowen disease, Bowenoid papulosis and squa-
mous cell carcinoma
N Hama, T Ohtsuka and S Yamazaki Department of Dermatology, Dokkyo University School of
Medicine, Mibu, Tochigi, Japan
It is well known that Human papilloma virus(HPV) induce benign warts. In the recently, however,
HPV has been shown to be detected in malignant tumors of the skin. We tried to detect HPV DNA
in Bowen disease(BD), Bowenoid papulosis(BP) and squamous cell carcinoma(SCC) of the skin.
One of 21 cases of BD, 1 case showed?HPV 31. In 3 cases of BP, 1 case showed HPV 16 and
another case 31. In 26 cases of SCC, 1 case showed HPV 16, 1 case HPV 34, and 4 cases HPV 31.
In the present study, we showed that cervical type of HPV was detected in SCC. These results were
different from the former ones that showed no detection of cervical type of HPV was detected in
SCC.
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Inhibitory effect of topical applications of non-denatured soymilk on the formation and growth
of UVB-induced skin tumors
M Huang,1 J Xie,1 CB Lin,2 M Kizoulis,2 M Seiberg,2 S Shapiro2 and AH Conney1,2 1 Susan
Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario
School of Pharmacy, The State University of New Jersey, Piscataway, NJ and 2 Skin Research
Center, Johnson & Johnson, Skillman, NJ
Treatment of female SKH-1 hairless mice with ultraviolet B light twice a week for 20 weeks resulted
in a population of tumor-free mice with a high risk of developing skin tumors during the next sev-
eral months in the absence of additional UVB treatment (high risk mice). Topical applications of
non-denatured soymilk but not heat-denatured soymilk once a day 5 days a week to these high risk
mice inhibited the formation and growth of skin tumors. Similar topical applications of Soybean
Trypsin Inhibitor or Bowman-Birk Inhibitor also inhibited the formation and growth of skin tumors,
but these agents were less active than non-denatured soymilk. Treatment of miniswine skin with non-
denatured soymilk once a day for 5 days prior to UVB irradiation reduced or completely eliminated
UVB-induced formation of thymine dimers and apoptotic cells in the epidermis. These data suggest
that non-denatured soymilk could be applied to humans to prevent sunlight-induced skin damage
and to reduce the risk of skin tumor formation and progression. 
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Analysis of gene mutations in six cases of dermatofibrosarcoma protuberans
H Saeki,1 Y Tamada,2 Y Matsumoto2 and K Tamaki1 1 Dermatology, Tokyo University, Tokyo,
Japan and 2 Dermatology, Aichi Medical University, Aichi, Japan
Fusion of the collagen type I alpha 1 (COL1A1) gene with the platelet-derived growth factor B-chain
(PDGFB) gene has been pointed out in dermatofibrosarcoma protuberans (DFSP). Various exons
(exon 7, 8, 10, 11, 18, 22, 24, 25, 29, 32, 33/34, 37, 38, 39, 40, 43, 45, 46, 47) of the COL1A1 gene
have been shown to be involved in the fusion with exon 2 of the PDGFB gene. We studied the break-
points of the COL1A1 gene using the tumor specimens from six patients with DFSP. Reverse tran-
scriptase - polymerase chain reaction (PCR) was performed using frozen or paraffin-embedded tis-
sues. To amplify the COL1A1-PDGFB fusion transcript, PCR was carried out using 16 COL1A1
forward primers and a specific PDGFB reverse primer. Nucleotide sequence analysis was carried out
using the PCR products to identify the breakpoints. Cases 1, 2, 3 and 4 were diagnosed as ordinary
DFSP, case 5 as DFSP with fibrosarcomatous lesion (DFSP-FS), and case 6 as lung metastasis of
DFSP-FS. The COL1A1-PDGFB fusion transcripts were detected from the tumor specimens.
Sequence analysis revealed that the ends of exons 18, 42, 38, 44, 29 and 38 in the COL1A1 gene
were fused with the start of exon 2 in the PDGFB gene in case 1, 2, 3, 4, 5 and 6, respectively. This
study identified two novel COL1A1 breakpoints, namely, exon 42 and 44 of the COL1A1 gene.
Detection of the aberrant fusion transcript seems to be useful at differential diagnosis both in pri-
mary and metastatic lesions. 
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Reciprocal regulation of DEC1 and HIF1 in response to UV irradiation in cultured human ker-
atinocytes
A Turlington,3 C Chiu,3 P Myne,3 Z Bi,1 Y Li,2 B Yan2 and Y Wan3 1 Nanjing Medical University,
Nanjing, China, 2 University of Rhode Island, Kingston, RI and 3 Biology, Providence College,
Providence, RI
UV radiation represents the most significant risk to human skin, causing skin cancer. AP1 and
NFκB among others transcription factors play critical roles in UV signal transduction pathways,
knowingly from EGFR, to PI3 kinase and MAP kinase, leading to expression of various genes involved
in skin cancer. Recently, another transcription factor, hypoxia inducible factor or HIF, involved in
cellular response to low oxygen tension or hypoxia, attracts unprecedented attention. Our prelimi-
nary study showed that UV irradiation also induces expression of HIF1α, one of the members of HIF
complex. HIF1α expression is reportedly to be modulated by EGFR/PI3K/AKT pathway in human
prostate cancer cells. However, the question whether this very pathway mediates UV-induced expres-
sion of HIF1α remains to be addressed. In addition to HIF, other two transcription factors DEC1
and DEC2, recently known to interact with HIF, have been shown to be involved in cell prolifera-
tion and survival. Our recent findings suggest that over-expression of DEC1 provides cells with an
unusual survival mechanisms under hypoxia condition. While data from others indicated that HIF1α
up-regulates DEC1, our preliminary studies showed that UV-induced HIF1 expression requires DEC1.
The question whether DEC1 and HIF1 are reciprocally regulated in response to UV irradiation is
yet to be answered. We tested the hypothesis that EGFR and Rac1/PI3K/AKT mediate UV-induced
HIF1α expression and its target genes and DEC1 and HIF1α are reciprocally regulated in response
to UV irradiation. We found that EGFR plays critical role in UV-induced HIF1α expression and
Rac1/PI3K/AKT mediates this signaling pathway. Using DEC1 knockout cells, we observed that
UV- and hypoxia- but not chemical-induced HIF1α expression is DEC1 dependent. Collectively,
we conclude that reciprocal regulation of DEC1 and HIF1α in response to UV radiation is mediated
by EGFR/Rac1/PI3k/AKT pathway. 
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Insensitivity to oxidative stress and hyper-activation of AKT contribute to anomalous inva-
siveness of human melanoma cells
A Turlington,1 P Myne,1 C Chiu,1 A Blanco,2 Z Bi,3 B Yan4 and Y Wan1 1 Providence College,
Providence, RI, 2 Cornell University, Ithaca, NY, 3 Nanjing Medical University, Nanjing, China
and 4 University of Rhode Island, Kingston, RI
Among other types of skin cancer, melanoma is highly invasive and poorly manageable, with the
mechanisms of invasiveness unaccountable. Human skin cells including mutated cells are constantly
under oxidative stress, and yet the responding mechanisms of different cell types vary dramatically.
We observed that human melanoma cells sustain oxidant treatment much better than keratinocytes
in vitro, although arsenite and H2O2 both induced cell death of both types to certain extent. In ker-
atinocytes, arsenite induced CDC25C degradation but not CDC25A, and H2O2 induced CDC25A
degradation but not CDC25C. In melanoma cells, arsenite induced CDC25A degradation but not
CDC25C, and H2O2 induced CDC25C degradation but not CDC25A. Arsenite induced MAP kinase
activation in both human keratinocytes and melanoma cells. However, interestingly, H2O2 induced
MAP kinase activation in keratinocytes, but did not induce MAP kinase activation in melanoma cells.
Further, arsenite-induced MAP kinase activation was inhibited by NADPH oxidase inhibitor DPI in
human keratinocytes, but not in melanoma cells. In addition, although both arsenite and H2O2 induced
phosphorylation of AKT in both human keratinocytes and melanoma cells in a time and dose depend-
ent manner, AKT activation occurred much earlier and stronger in melanoma cells. Arsenite- and
H2O2 -induced AKT activation was inhibited by PI3 Kinase inhibitor LY294002 in human ker-
atinocytes and melanoma cells. Collectively, our data indicate that melanoma cells survive oxida-
tive stress with inactivation of MAP kinase pathways and protection from CDC25A degradation
and hyper-activation of AKT cell survival pathway. These results provide insights into understand-
ing of the molecular mechanisms that underlie the invasiveness of melanoma cells especially under
oxidative stress or hypoxia. 
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Nicotine modulates gene expression in oral keratinocytes
J Arredondo,1 A Chernyavsky,1 DL Jolkovsky,1 LM Marubio,3 KE Pinkerton,2 AL Beaudet3 and
SA Grando1 1 Dermatology, University of California, Davis, CA, 2 Center for Health and the
Environment, University of California, Davis, CA and 3 Molecular and Human Genetics, Baylor
College of Medicine, Houston, TX
Tobacco causes various kinds of mucocutaneous morbidly, such as precocious aging, delayed wound
healing, and cancer, but the mechanisms remain elusive. Nicotine (Nic) is a likely mediator of the
pathobiologic effects, since it displaces the local hormone acetylcholine from the nicotinic recep-
tors (nAChRs) expressed by keratinocytes (KCs). To gain a mechanistic insight into tobacco-induced
morbidity, we studied effects of environmental tobacco smoke (ETS) vs. pure Nic on oral KCs.
Both ETS and Nic upregulated expression of the cell cycle and apoptosis regulators p53, p21, Bcl-
2 and caspase-3, the differentiation marker filaggrin and the signal transduction factors NF-κB, JAK-
1, STAT-1 and GATA-3 at both the mRNA and protein levels. These changes could be abolished due
to transfection of KCs with anti-α3 small interfering RNA or treatment with α-conotoxin MII, an
α3β2 prefererring antagonist. Functional inactivation of the α3 gene in receptor knock-out KCs
also prevented most of the ETS/Nic-dependent changes in gene expression. To determine relevance
of the in vitro findings to the in vivo situation, we studied gene expression in wild-type and α3-/-
littermates delivered by heterozygous mice soon after their exposures to ETS or pure Nic in drink-
ing water. In addition to RT-PCR and western blot, the ETS/Nic-dependent alterations in the gene
expression were also detected by semi-quantitative immunofluorescence directly in KCs residing in
the oral epithelium. Only wild-type mice developed changes in the expression of p21, Bcl-2, filag-
grin, NF-κB and STAT-1. These results identified α3β2 nAChR as a major receptor mediating effects
of tobacco products on KC gene expression. The ETS/Nic exposures also upregulated α5 and β2
nAChR subunits and downregulated M2 and M3 muscarinic receptor subtypes, suggesting that a
switch in the repertoire of KC cholinergic receptors mediate, at least in past, pathobiologic effects
of tobacco products in the mucocutaneous epithelia. 
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Role of protein kinase C δ as a tumor suppressor for human squamous cell carcinomas
AM D’Costa,1 JK Robinson1 and MF Denning1,2 1 Oncology Institute, Loyola University Chicago,
Maywood, IL and 2 Pathology, Loyola University Chicago, Maywood, IL
Carcinogenesis is a multi-step process involving the loss or silencing of tumor suppressor genes that
permit the outgrowth of malignant cells. For human skin cancers, inactivation of genes involved in
UV apoptosis (i.e. p53) can provide a selective growth advantage since the surrounding normal ker-
atinocytes are preferentially killed by repeated sunlight exposure. Protein kinase C (PKC) δ is required
for the induction of apoptosis by UV radiation in human keratinocytes, and is down-regulated or
inactivated in keratinocytes expressing the activated Ha-ras oncogene making it a candidate tumor
suppressor gene for squamous cell carcinoma. To determine if PKCδ is reduced in sunlight-induced
human skin cancers, we examined Bowen’s Disease and squamous cell carcinomas for PKCδ expres-
sion by immunohistochemistry. We found that 29% (12/42) had lost or reduced PKCδ when com-
pared to normal skin or epidermis surrounding the tumor. Although there was no correlation between
PKCδ loss and tumor histology, PKCδ was reduced in 4 of 10 Bowen’s Disease samples and one
solar keratosis indicating that loss of PKCδ may be an early event. To explore the significance of
PKCδ loss in transformed human keratinocytes, we used the tumorigenic HaCaT Ras-II-4 clone
that forms highly differentiated, locally invasive squamous cell carcinomas in nude mice. HaCaT
Ras II-4 cells have reduced PKCδ levels, and re-expression of PKCδ by retrovirus transduction caused
a modest increase in apoptosis (6% increase) and growth retardation in culture. However PKCδ re-
expression dramatically suppressed the tumorigenicity of HaCaT Ras II-4 cells in nude mice (p <
0.05), with PKCδ-transduced cells producing much smaller tumors and/or cysts only. Together, these
results indicate that PKCδ may function as a tumor suppressor in human squamous cell carcinomas
where its loss could provide a growth advantage to pre-malignant cells by affording them resistance
to UV-induced apoptosis. 
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Stage-specific regulation of skin tumor development by apoptosis: survivin enhances mutage-
nesis yet suppresses clonal expansion
AN Hanks,2 W Zhang,3 SR Florell,1 K Boucher,2 DE Brash3 and D Grossman1,2 1 Dermatology,
University of Utah, Salt Lake City, UT, 2 Huntsman Cancer Institute, University of Utah, Salt Lake
City, UT and 3 Therapeutic Radiology, Yale University, New Haven, CT
Apoptosis is one of many obstacles to tumor formation, but its role in regulating individual stages
of multi-step carcinogenesis has not been defined. For example, it is possible that once apoptosis-
resistant mutant cells have arisen, pro-apoptotic conditions will aid their clonal expansion. Using a
transgenic mouse (K14-survivin Tg) with epidermis-specific expression of survivin, an inhibitor of
apoptosis, we investigated the impact of apoptosis on initiation, clonal growth of p53-mutant ker-
atinocytes, creation and growth of benign papillomas, and conversion to squamous carcinoma after
ultraviolet-B (UVB) irradiation. At carcinogenic UVB doses, the survivin transgene led to a 2-fold
reduction in UVB-induced epidermal apoptosis. After 5 wks of UVB irradiation, small p53-mutant
keratinocyte clones (<1/3 stem cell compartment) were 1.5-fold more frequent in K14-survivin Tg
mice (p=6x10-4), reflecting the anti-mutagenic effect of apoptosis. Strikingly, the effect of survivin
was reversed for existing clones growing by clonal expansion (>2 stem cell compartments), which
were ~1.7-fold rarer in the Tg (p=0.047). At 10 wks, the genotypic differential for large clones
approached the apoptosis differential (~2-fold, p=4x10-5), consistent with apoptosis facilitating clonal
expansion. After 20 wks, 95% of animals carried tumors, primarily papillomas. Tumors were 1.6-
fold rarer in apoptosis-defective Tg mice (p=0.03), a paradoxical result if apoptosis were solely
anti-tumorigenic. In contrast, a 2-fold higher percentage of tumors in K14-survivin mice attained a
size of 3 mm (p=0.048) or converted to carcinoma. Thus survivin-inhibitable apoptosis suppresses
initiation and malignant conversion, two stages that involve new mutations, yet enhances clonal
expansion of existing p53-mutant and papilloma cells. 
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Gli1 co-operates with EGFR-Src signalling to induce a fibroblastoid phenotype in primary ker-
atinocytes
G Neill, MS Ikram, JL Green, AG Quinn, E O’Toole and MP Philpott Centre for Cutaneous
Research, Queen Mary University of London, London, United Kingdom
The transcription factor Gli1 is implicated in the development of basal cell carcinoma (BCC) and
other neoplasms due to constitutive activation of the Sonic hedgehog signalling pathway. Despite
the identification of many target genes, the cellular mechanisms by which Gli1 induces neoplasia
are poorly understood. We show that EGF stimulation of Gli1-expressing human primary keratinocytes
induces a fibroblastoid morphology characterised by cell elongation and the formation of extensive
membrane protrusions that is not observed in control cells. The EGF-induced change in cell mor-
phology was also observed in keratinocytes expressing a Gli1 mutant protein localised to the nucleus
suggesting that the phenotype is dependent upon Gli1 transcriptional activity. Using pharmacolog-
ical inhibitors we identified that the change in cell morphology is mediated by Src kinase(s), but not
Ras-ERK or PI3K signalling. More specifically, Gli1 co-operates with EGFR-Src signalling to reg-
ulate the cytoskeleton, probably through inhibition of the Rho-ROCK pathway as shown by increased
activity of the actin remodelling protein cofilin. Indeed, exposure to the ROCK inhibitor Y27632
alone is sufficient to induce a spindle phenotype in Gli1 keratinocytes. Interestingly, the phenotype
of Gli1 cells exposed to EGF or Y27632 is dependent upon microtubule remodelling as it is negated
in the presence of nocodazole. As cytoskeletal remodelling is required for tumour invasion, these
data suggest a novel role for Gli1 that may be relevant to BCC aetiology. 
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Up-regulation of the lymphatic marker podoplanin in human squamous cell carcinomas and
germ cell tumors
V Schacht,1 SS Dadras,1,2 L Johnson,3 DG Jackson,3 YK Hong1 and M Detmar1 1 Cutaneous
Biology Research Center and Department of Dermatology, Massachusetts General Hospital and
Harvard Medical School, Charlestown, MA, 2 Department of Pathology, Massachusetts General
Hospital and Harvard Medical School, Boston, MA and 3 Weatherall Institute of Molecular
Medicine, John Radcliffe Hospital, Oxford, United Kingdom
The mucin-type glycoprotein podoplanin is specifically expressed by lymphatic, but not blood vas-
cular endothelial cells in culture and in tumor-associated lymphangiogenesis. Our previous studies
showed that podoplanin deficiency results in congenital lymphedema and impaired lymphatic vas-
cular patterning, and that podoplanin enhances migration and adhesion of endothelial cells by reor-
ganization of the cytoskeleton. However, its expression in normal tissues and in human malignan-
cies has remained unknown. Using tissue arrays of normal human tissues and of a number of human
cancers, we found that - in addition to lymphatic endothelium - podoplanin is also expressed by bile
duct cells of the liver, peritoneal mesothelial cells, osteocytes, glandular myoepithelial cells, ependyma
cells and by stromal reticular cells and follicular dendritic cells of lymphoid organs. These findings
were confirmed in normal mouse tissue arrays. Podoplanin was also strongly expressed by granu-
losa cells in normal ovarian follicles, and by ovarian dysgerminomas and granulosa cell tumors.
Although podoplanin was largely absent from normal human epidermis, its expression was strongly
induced in 22 out of 28 squamous cell carcinomas studied. The expression pattern of podoplanin was
dependent on the level of differentiation of squamous cell carcinomas. Together, these findings sug-
gest a potential role of podoplanin in epithelial tumor progression. 
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Overexpression of akt converts radial growth melanoma to vertical growth melanoma
JL Arbiser,1 B Govindarajan,1 J Slingerland,2 RS Arnold3 and DJ Lambeth3 1 Dermatology, Emory
University, Atlanta, GA, 2 Department of Medicine, University of Miami, School of Medicine,
Miami, FL and 3 Pathology and Laboratory Medicine, Emory University School of Medicine,
Atlanta, GA
Melanoma is the major cause of death due to a dermatologic disorder, and transformation of radial
growth melanoma to vertical growth is required for invasive disease and metastasis. We have previ-
ously shown that MAP kinase is activated in radial growth melanoma, suggesting that further sig-
naling events are required for vertical growth melanoma. The molecular events that accompany this
transformation are not well understood. We introduced active akt, a signaling molecule downstream
of phosphoinositol 3 kinase into the radial growth WM35 melanoma in order to see whether akt over-
expression was sufficient to accomplish this transformation. Overexpression of akt led to upregula-
tion of vascular endothelial growth factor (VEGF), and increased production of the reactive oxygen
species superoxide. Superoxide has been previously implicated in aggressive melanoma. Implanta-
tion of WM35 cells overexpressing akt lead to rapidly growing tumors in vivo, while vector control
cells do not form tumors. Akt thus serves as a molecular switch that allows increased angiogenesis
and generation of superoxide, thus allowing aggressive behavior. Targeting akt and reactive oxygen
may be of therapeutic importance in treatment of advanced melanoma 
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Malignant transformation of human cells through an autocrine loop between platelet derived
growth factor-BB (PDGF-BB) and PDGFRβ
B Govindarajan,1 A Shah,1 JL Arbiser,1 C Cohen,2 J Schechner,3 J Chung,5 A Mercurio5 and
R Alani4 1 Dermatology, Emory University, Atlanta, GA, 2 Pathology and Laboratory Medicine,
Emory University, Atlanta, GA, 3 Dermatology, Yale University, New Haven, CT, 4 Dermatology,
Johns Hopkins University, Baltimore, MD and 5 Division of Signal Transduction, Beth Israel
Deaconness Hospital, Harvard Medical School, Boston, MA
Tuberous sclerosis (TS) is a common autosomal dominant disorder, characterized by benign tumors
of the skin, and benign and malignant tumors of the brain and kidney. We have previously estab-
lished a cell line (SV7tert) from an angiomyolipoma and found that it expresses functional PDGFRβ.
In order to determine whether autocrine PDGF-PDGFRβ signaling could result in malignant trans-
formation, we retrovirally transduced PDGF-BB into SV7tert cells. Overexpression of PDGF-BB
led to activation of MAP kinase and phosphoinositol-3 kinase/akt, upregulation of vascular endothe-
lial growth factor, and reactive oxygen species, as well as resistance to apoptosis under hypoxic
conditions. Implantation of SV7tert cells expressing PDGF-BB led to the development of tumors in
nude mice, while tumors were not observed in vector control cells. Tumors took several months to
appear, suggesting further epigenetic events. We have previously shown that reactive oxygen medi-
ated carcinogenesis leads to downregulation of the tumor suppressor gene p16ink4a, and cells derived
from tumors showed decreased expression of p16ink4a compared with cells prior to injection into
mice. Thus, autocrine expression of PDGF-BB leads to transformation in part through downregula-
tion of p16ink4a and upregulation of angiogenesis through MAP kinase and phosphoinositol-3 kinase
signaling. These observations represent the first known example of malignant transformation of
human cells through autocrine signaling. 
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Caspase 3 dependent apoptosis induction by resveratrol in B16F10 melanoma cells
O Plotkin, S Pae and R Kumar Dermatology, University of Illinois, Chicago, IL
Resveratrol (RES), a natural phytoalexine present in red grapes and wines, has been reported to
induce apoptosis in murine and human melanoma cells. Our previous studies of chromatin conden-
sation, an early marker of apoptosis, have been observed by fluorescence microscopy using B16F10
murine melanoma cells. Previous analysis of B16F10 treatment with RES by flow cytometry using
AnnexinV staining (probe to measure translocation of phosphatidyl serine) and TUNEL assay (meas-
ure of DNA fragmentation) suggested induction of apoptosis. This prompted a more detailed exam-
ination of RES induced apoptosis. Therefore, we measured the intracellular caspase activity using
a cell permeable fluorogenic substrate with DEVD sequence recognized by caspase 3. We also
observed cell size changes using flow cytometry. Flow cytometry analysis indicates that B16F10
cells undergo cell shrinkage and increased cell granularity after treatment with RES. We have also
explored the concentration and time dependence of RES to induce apoptosis via caspase 3 mea-
hanism. RES (150 µM) at 1 hr, 2 hr, and 3hr showed caspase 3 activation in 11.3% of cells vs. 6.7%
vehicle control, 8.8% vs. 8.7% control, and 22.4% vs. 15.8% control, respectively. Data for RES
(200 µM) at 1 hr showed 17.3% caspase 3 activity vs. 6.7% control, at 2hr 20.3% vs. 8.7% control,
and at 3 hr 51% vs. 15.8% control. Data for RES (250 µM) at 1 hr showed 21.2% vs. 6.7% control,
at 2 hr 24.9% vs. 8.7% control, and at 3 hr 73.2% vs. 15.8% control. Thus, RES induces caspase 3
activation in B16F10 cells in time and dose dependent manner. We are currently investigating RES
effect on other caspase-induced mechanisms of apoptosis. 
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Senescent, but not proliferating, keratinocytes suppress tumorigenesis
BJ Nickoloff and P Bacon Oncology, Loyola, Maywood, IL
The phenotype and function of senescent keratinocytes (sKCs) remains poorly understood. Clones
of mutant p53 containing KCs are detected in aged skin, but the majority fail to progress to invasive
carcinoma. We postulate sKCs present in aged epidermis restrain tumorigenesis in flanking regions.
Thus, varying numbers of normal proliferating KCs (pKCs) vs sKCs were combined with malig-
nant cells bearing p53 mutations at initial seeding in soft agar. KCs were derived from foreskins,
grown in serum-free medium and harvested either as rapidly proliferating cells, or weeks later when
they underwent replicative senescence (ceased cell division despite feeding). Addition of 3x104 malig-
nant cells to soft agar produced approximately 200 colonies/cm2 by day 12. Addition of pKCs (5x103,
10x103, 30x103) at time of seeding did not significantly reduce colony formation. However, addi-
tion of sKCs impacted colony formation in a concentration dependent fashion. A typical result is as
follows: tumor cells alone (213+/-15), or tumor cells containing the following number of sKCs: 5x103
(167+/-20); 10x103 (104+/-15); and 30x103 (65+/-10). Similar results were observed in 4 independent
experiments(p< 0.01). To address mechanisms by which sKCs mediated reduction in tumorigene-
sis, Western blots of proliferating versus sKCs were performed, and 2 highly upregulated proteins
were TGF-β1 and TGF-β2. Furthermore, addition of recombinant human TGF-β1 to tumor cells pro-
duced a dose dependent reduction in colony formation at doses of 0.1, 1.0, and 10 ng/ml compara-
ble to degree of inhibition by sKCs. Based on these results we conclude: a) sKCs, but not pKCs,
strongly suppress colony formation in a density dependent fashion, b) sKCs are not decrepit, but are
metabolically active and over produce TGF-β compared to pKCs, c) TFG-β represents a potential
molecular mediator by which sKCs can suppress tumorigenesis. In summary, we suggest irreversibly
growth arrested sKCs accumulating during aging may not only resist transformation themselves,
but by remaining viable and metabolically active serve as a barrier to expansion of flanking KCs
that acquire p53 mutations. 
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Telomere homolog oligonucleotide-induced signaling in adenocarcinoma
N Ohashi, M Yaar, MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
DNA damage due to UV irradiation, oxidative stress or chemical adducts, as well as telomere short-
ening due to aging, is hypothesized to expose the single-stranded telomere 3’-overhang sequence
(tandem repeats of TTAGGG). Exposure of this sequence is the initial signal leading to a variety of
physiologic DNA damage responses, including senescence, apoptosis or adaptive differentiation.
However, although these responses are present in normal cells, they are often muted in malignant
cells, possibly because of failure of the cells to expose and/or recognize the exposed overhang.
Interestingly, addition of an 11-base oligonucleotide (GTTAGGGTTAG), homologous to the 3’-over-
hang sequence (T-oligo), leads to identical DNA damage responses, presumably because it mimics
the exposure of the 3’ overhang. To determine the T-oligo effect on adenocarcinoma cells, 40uM T-
oligo or the complementary (control) oligonucleotide or diluent alone were introduced into adeno-
carcinoma cell line (CRL-2119). By western blot, compared to controls, T-oligo induced p53 level
and phosphorylation on serine 15 by 142% and 2160% respectively, within 48 hours, indicating p53
activation, and lead to S-phase arrest of 54%±0.1% of the cells (FACScan analysis, p<0.001). Within
96 hours 7.7%±0.02% of cells were apoptotic as determined by the sub-G0/G1 DNA content (FAC-
Scan analysis), compared to 0.6%±0.1% of controls (p<0.001). Furthermore, TUNEL analysis showed
that only T-oligo treated cells displayed increased fluorescence, indicating DNA fragmentation and
apoptosis. Also, within 96 hours T-oligo decreased cell yields by 67%±0.1% (p<0.01). Interestingly,
even after T-oligo removal from the medium, cell growth inhibition persisted for at least 6 days,
suggesting it was irreversible. These findings suggest that T-oligo mimics the exposure of the 3’
telomere overhang, and in malignant cells, otherwise only partially responsive to DNA damage, it
induces DNA damage responses leading to cell cycle arrest and apoptosis. We propose that T-oligo
is a promising novel approach to cancer treatment. 
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Inhibition of hydrogen peroxide- generated lipid peroxidation product 4-hydroxy-2-nonenal
by green tea polyphenols in human fibroblast WS-1 cells
SM Bradu,1 J Jagdeo,4 E Bajor,2 C Shwereb,1 R Hannan3 and N Brody1 1 Dermatology, SUNY-
Brooklyn, Brooklyn, NY, 2 Immunology, SUNY-Brooklyn, Brooklyn, NY, 3 Pathology, SUNY-
Brooklyn, Brooklyn, NY and 4 Brown Medical School, Providence, RI
The exact role of hydrogen peroxide generated in the human skin during oxidation events such as
solar ultraviolet radiation and aging is not well understood. A novel FACS based method was used
to show for the first time that hydrogen peroxide is able to upregulate cellular lipid peroxidation 4-
hydroxy-2-nonenal (HNE) protein adducts in WS-1 fibroblasts derived from human skin. HNE is a
highly reactive second messenger aldehyde that is generated during lipid peroxidation of fatty acids
from cellular membranes, being released intracellularly and extracellularly. HNE was previously
reported to have genotoxic and neutrophil chemotactic effects. HNE protein adducts have been
described in the past to co-localize with areas of actinic elastosis in sun-damaged human skin. Recent
reports showed that topical green tea polyphenols are able to inhibit UV-generated lipid peroxida-
tion products in the skin of mice. Our current results suggest that green tea polyphenols are able to
inhibit the formation of HNE protein adducts induced by hydrogen peroxide in human skin fibrob-
last cells WS-1. Unlike alpha- lipoic acid, green tea polyphenols were also able to inhibit both endoge-
nous and hydrogen peroxide- generated reactive oxygen species as shown by FACS analysis of WS-
1 cells stained with Dihydrorhodamine 123. These findings have possible mechanistic implications
for the rational development of anti-oxidant agents that are able to inhibit relevant cellular oxidative
damage occurring during carcinogenesis and aging in the human skin. 
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Expression of chemokine receptor CXCR4 enhances tumorigenesis of basal cell carcinoma
M Wu,1 G Chen2 and H Yu3 1 Dermatolgy, China Medical University, Taichung, N/A, Taiwan, 2
Dermatology, Kaohsiung Medical University, Kaohsiung, Taiwan and 3 Dermatology, National
Taiwan University, Taipei, Taiwan
Beside the well-known role to regulate leukocyte trafficking, chemokines and their receptors also
play important roles in the regulation of mitosis, apoptosis, survival and angiogenesis, which may
enhance tumor growth or metastasis. Herein we investigated the possible involvements of chemokine
receptors in the pathogenesis of basal cell carcinoma (BCC). In previous study, we found high expres-
sion of CXCR4 in a human BCC cell line and tissue samples from BCC lesions. Furthermore, we
addressed whether overexpression of CXCR4 may alter BCC tumor progression. By retroviral trans-
duction, CXCR4 gene was transferred into BCC cells (CXCR4-BCC) and functionally expressed.
In WST-1-based tumor proliferation assay in vitro, CXCR4-BCC cells were cultured under low serum
concentration (0.5%) and subject to CXCL12 or PBS treatments. CXCL12 treatments resulted in
significant increase of CXCR4-BCC proliferation compared to PBS treatments (24-hr, ~1.2-fold
p=0.027; 48-hr, ~2.2-fold, p=0.02), which could be neutralized by co-treatments with anti-CXCR4
mAb. In apoptosis-resistance assay in vitro, ultraviolet radiation B was used to induce apoptosis in
CXCR4-BCC and vector-transduced BCC cells (pLNCX2-BCC), evaluated by caspase-3 activity.
Treatments with CXCL12 led to decreased apoptosis level (~38%, p=0.042) in CXCR4-BCC, which
could be negated by CXCR4-blocking peptide, T22. Moreover, xenograft tumor transplants were
performed to test whether CXCR4 overexpression may affect BCC tumor progression in vivo.
pLNCX2-BCC and CXCR4-BCC cells were injected subcutaneously into the flanks of nude mice.
Injections of CXCR4-BCC tumor cells alone yielded significant tumor progression, whereas addi-
tional serial injections of T22 resulted in significant tumor regression. pLNCX2-BCC injections only
gained insignificant tumor growth. Thus, CXCR4 expression may play critical roles in BCC tumori-
genesis, and functional blockade of CXCR4 could be a potentially promising therapeutic strategy. 
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Tumor as wound: gene expression signature of fibroblast serum response predicts human
cancer progression
HY Chang,1,2 JB Sneddon,2 M van de Rijn3 and PO Brown2 1 Dermatology, Stanford University
School of Medicine, Stanford, CA, 2 Biochemistry, Stanford University School of Medicine,
Stanford, CA and 3 Pathology, Stanford University School of Medicine, Stanford, CA
Cancer invasion and metastasis have been likened to wound healing gone awry. Despite parallels in
cellular behavior between cancer progression and wound healing, the molecular relationships between
these two processes, and their prognostic implications, are unclear. Here, based on gene expression
profiles of fibroblasts from 10 anatomic sites, we identify a stereotyped gene expression program in
response to serum exposure that appears to reflect the multifaceted role of fibroblasts in wound
healing. The genes comprising this fibroblast common serum response are coordinately regulated in
many human tumors, allowing us to identify tumors with gene expression signatures suggestive of
active wounds. Genes induced in the fibroblast serum-response program are expressed in tumors by
the tumor cells themselves, by tumor-associated fibroblasts, or both. The molecular features that
define this wound-like phenotype can be evident at an early clinical stage, persist during treatment,
and predict increased risk of metastasis and death in squamous cell, breast, lung, and gastric carci-
nomas. Thus, the transcriptional signature of the response of fibroblasts to serum provides a possi-
ble link between cancer progression and wound healing, as well as a powerful predictor of the clin-
ical course in several common carcinomas. 
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Trans-sectional tumor microdissection mutation analysis: a new tool for evaluation of genetic
instability and heterogeneity as well as tumor cell evolution
A Ruebben Dermatology, RWTH Aachen, Aachen, Germany
Genetic instability is a hallmark of malignant and premalignant clonal cell proliferations. Trans-
sectional tumor microdissection mutation (TTMM) analysis is a new method which has been devel-
oped in order to quantify genetic instability and heterogeneity in routine formalin-fixed and paraf-
fin-embedded histological sections of individual tumors. After staining, histological tissue slides
are embedded with a liquid coverslip. The section is then laser-microdissected at multiple (8-12)
areas in a linear configuration across the tumor. Each microdissected area contains approx. 100-200
cells each. Extracted DNA is then analyzed by PCR for loss of heterozygosity (LOH) of microsatel-
lite DNA or for the presence of mutated microsatellite alleles (MSI). The frequency of LOH or MSI
is an indication of genetic instability within the lesion. 10 benign melanocytic nevi, 10 dysplastic
nevi, 10 malignant melanomas as well as 10 early mycosis fungoides (MF) cases have been analyzed
in order to evaluate this new technique. Moles and melanomas have been screened for MSI at
microsatellite markers D9S162 and D14S53 while MF cases were analyzed at microsatellite mark-
ers D9S162 and D18S62. The frequency of MSI in microdissected tissue was higher in dysplastic
melanocytic nevi (0.30) and in melanomas (0.29) as compared to benign moles (0.05, p< 0.05). An
elevated frequency of MSI in microdissected tissue was also found in MF (0.32) as compared to
control lichen planus tissue (0.05, p<0.01). Further studies are necessary to determine the role of
TTMM analysis in the diagnosis of genetic instability in malignant and premalignant tumors. 
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AKT status controls susceptibility of malignant keratinocytes to the early-activated and UVB-
induced apoptotic pathway
D Decraene and M Garmyn Department of Dermatology, University of Leuven, Leuven, Belgium
In previous work we demonstrated the existence of an early-activated and UVB-induced apoptotic
pathway in human keratinocytes, which can be completely inhibited by IGF-1 mediated AKT acti-
vation. This apoptotic pathway stands in marked contrast to the commonly described UVB-induced
pathway of apoptosis, which occurs several hours later and is impervious to IGF-1 signaling. As the
IGF-1 - AKT axis is a frequent target for mutation, we now compared the apoptotic response of pri-
mary, healthy human keratinocytes with the apoptotic response of two p53-mutated squamous cell
carcinoma-derived cell lines (A431 and A253) to an apoptotic UVB dose. In these cell lines, both
the basal AKT phosphorylation status and the apoptotic response to UVB diverged strongly from
the response of healthy primary keratinocytes. Even more, a remarkable correlation was found between
the two. While a constitutive dual phosphorylation of AKT rendered the A253 SCC cell line com-
pletely resistant to the early-activated and UVB-induced apoptotic pathway, deficient T308 phos-
phorylation of AKT in the SCC cell line A431 led to a greatly augmented sensitivity to the early-
activated, UVB-induced apoptotic pathway. These results indicate that the preservation of a healthy
AKT pathway is essential for a wild-type UVB-induced apoptotic response in skin and suggest that
AKT-mediated dysregulation of the early-activated apoptotic response to UVB is an important
event in the oncogenic transformation of keratinocytes. 
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Tuberous sclerosis skin tumors overexpress MCP-1
S Li,1 F Takeuchi,1 J Wang,1 J Moss2 and TN Darling1 1 Dermatology, Uniformed Services
University, Bethesda, MD and 2 P-CCMB, National Heart Lung and Blood Institute, NIH,
Bethesda, MD
Tuberous sclerosis (TSC) tumors contain multiple cell types - neoplastic cells with loss of either the
TSC1 or TSC2 tumor suppressor gene mixed with reactive cells. The goal of this study was to iden-
tify paracrine growth factors overexpressed in TSC skin tumors that stimulate the proliferation or
recruitment of reactive cells. Cells cultured from angiofibromas, periungual fibromas, and shagreen
patches contained 12-28% neoplastic cells, as demonstrated by allelic deletion of TSC2 (no sample
showed deletion of TSC1). Nylon-membrane based cDNA arrays comparing angiofibromas cells to
normal-appearing skin fibroblasts from 2 patients revealed overexpression of monocyte chemotac-
tic protein-1 (MCP-1). MCP-1 mRNA, measured using real-time PCR, was increased in cells from
4/4 angiofibromas, 3/3 periungual fibromas, and 2/4 shagreen patches from 5 patients (2.9- to 33-
fold relative to control patient fibroblasts, normalized to 18S rRNA). MCP-1 protein, measured in
culture supernatants by ELISA, was increased in 4/4 angiofibromas, 2/3 periungual fibromas, and
2/4 shagreen patches (1.9- to 48-fold relative to control patient fibroblasts). The relationship between
increased MCP-1 production and loss of TSC2 gene function was investigated using Eker rat embry-
onic fibroblasts null for Tsc2 (EEF Tsc2-/-). MCP-1 levels in 24-hour culture supernatants were
2075±280 pg/ml for EEF Tsc2-/- cells and 73±28 pg/ml for EEF Tsc2+/+ cells. Transient transfec-
tion of full-length human TSC2 into EEF Tsc2-/- cells inhibited MCP-1 production by 33%.
Rapamycin (20nM), a drug that inhibits the mTOR signaling pathway hyperactivated upon loss of
TSC2, inhibited MCP-1 production by 90% in EEF Tsc2-/- cells. In contrast, rapamycin inhibited
MCP-1 production by human angiofibroma cells by only 23%. These studies indicate increased MCP-
1 production by TSC skin tumor cells, possibly as a consequence of loss of TSC2. MCP-1 may play
important roles in TSC tumorigenesis by stimulating angiogenesis, fibrogenesis and recruiting tumor-
associated macrophages. 
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Inhibition of C/EBP family function in the mouse epidermis suppresses skin tumor formation
and induces irreversibly hair loss
W Oh,1 M Gerdes,2 A Orosz,1 S Yuspa2 and C Vinson1 1 Laboratory of Metabolism, NCI, NIH,
Bethesda, MD and 2 Laboratories of Cellular Carcinogenesis and Tumor Promotion, NCI, NIH,
Conshohocken, PA
CCAAT/enhancer binding proteins (C/EBP) are members of B-ZIP family of DNA binding pro-
teins/transcription factors that regulate the differentiation of keratinocytes. To examine the role of
C/EBP in skin, we have generated a conditional transgenic mouse that expresses dominant negative
form of C/EBP protein (named A-C/EBP) in epidermis under the control of doxycycline (dox) reg-
ulatable Keratin-5 promoter. There are no dramatic phenotypes following expression of the domi-
nant-negative in either the developing or adult skin. However, following a two step carcinogenesis
protocol using 7, 12-dimethylbenz(a)anthracene (DMBA) and TPA, A-C/EBP transgenic mice had
dramatically fewer tumors after 10th week which completely disappeared after 30th week. Addi-
tionally, after 8 weeks of treatment, there was systemic hair loss. Histological examination of both
the tumors and skin indicated a dramatic immunological infiltrate that extended into the epidermis.
This is reminiscent of the human condition of alopecia areatra. The hair loss could not be reversed
by suppressing A-C/EBP expression. The molecular characterization of the “hairless skin” indicates
that the expression level of AP-1 (activator protein-1) protein, which is essential for tumor promo-
tion, was decreased in transgenic mice. In contrast, the level of p53 protein, which induces apopto-
sis, as well as p21 protein, which is downstream target of p53, was highly up-regulated. Also, it has
been demonstrated that the apoptotic level following TPA treatment was increased in transgenic mice
expressing A-C/EBP protein. These findings suggest that the C/EBP family has a critical role in
tumorigenesis, cell survival, and hair follicle growth through the regulation of p53 level and impli-
cate C/EBP as a target for tumor inhibition and hair loss. 
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Senescence induced by telomere 3’ overhang requires either the p53 or pRb pathway
G Li, MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine, Boston, MA
Senescence, a major defense against cancer, is largely dependent on the p53 and pRb pathways. In
normal human fibroblasts (hFb), suppressing both of these pathways is necessary to bypass senes-
cence due to critical telomere shortening or experimental telomere disruption. We recently reported
that treatment with an oligonucleotide homologous to the telomere 3’ overhang (T-oligo) activates
both the p53 and pRb pathways and leads to hFb senescence, reproducing the cellular and molecu-
lar phenotype resulting from serial passage or telomere disruption. To further characterize T-oligo-
induced senescence, we treated a hFb line and derived cell lines lacking functional p53 and/or pRb
pathways with 40 µM T-oligo (pGTTAGGGTTAG) for 7 days. T-oligo induced senescence-associ-
ated β-galactosidase (S.A. β-gal) activity in cells deficient in either the p53 or pRb pathways, 45±4%
and 60±5%, respectively, compared to 65±7% for wild-type cells. However, hFb deficient in both
pathways failed to induce S.A. β-gal activity compared to diluent-treated controls (6±2% and 5±3%,
respectively). Therefore, inactivation of both the p53 and pRb pathways is necessary to suppress T-
oligo-induced senescence. Similarly, in Saos-2 human osteosarcoma cells with non-functional p53
and pRb pathways, T-oligo failed to induce S.A. β-gal activity or the large, spread morphology
characteristic of senescent cells. However, in A375 human melanoma cells expressing a functional
p53 but not pRb pathway, T-oligo activated p53, (serine 15 phosphorylation), induced p21, and rap-
idly induced senescence. Also, in HT-1080 human fibrosarcoma cells with functional pRb but not
p53, T-oligo activated pRb, shown by resistance of pRb to phosphorylation in response to serum,
and induced senescence. These data demonstrate that T-oligo-induced senescence parallels that
induced by telomere loss or disruption, strongly suggesting that exposure of the telomere 3’ over-
hang is the initiating signal for telomere-based DNA damage responses. Also, T-oligos have thera-
peutic potential to induce senescence in cancer cells mutated in one of these pathways. 
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Decreased expression of Srcasm in actinic keratoses and squamous cell carcinomas
M Dans, W Li, L Mei and JT Seykora Department of Dermatology, University of Pennsylvania,
Philadelphia, PA
Srcasm, Src activating and signaling molecule, is a recently discovered substrate and activator of
Src family kinases. Increased Src-kinase activity has been associated with keratinocyte differentia-
tion in murine systems. Our recent work has shown that Srcasm can activate intracellular Src-kinases,
associate with the Grb2 and the p85 subunit of phosphoinositide 3-kinase, and that it is a compo-
nent of the EGF signaling pathway in human keratinocytes. As Srcasm can effect keratinocyte sig-
naling pathways important for regulating growth and differentiation, we hypothesized that Srcasm
expression may be downregulated in keratinocytic neoplasia. The purpose of this study was to
determine if Srcasm expression was decreased in the spectrum of keratinocytic lesions spanning
actinic keratoses (AK) to squamous cell carcinoma (SCC). Srcasm expression in formalin-fixed
sections of AK, SCC in-situ (SCC-IS), and SCC from up to 15 different patients each was deter-
mined by immunohistochemisty using a polyclonal affinity-purified anti-Srcasm antibody. The expres-
sion of Srcasm in lesional tissue was compared to unremarkable peri-lesional skin of the same biopsy
specimen or normal skin from separate biopsies. Srcasm expression was decreased in approxi-
mately 50% of the AK and SCC-IS samples and in over 90% of the SCC samples. This increased
prevalence of Srcasm downregulation in more advanced lesions of keratinocytic neoplasia supports
the hypothesis that Srcasm may be important in promoting keratinocyte differentiation, possible by
increasing intracellular Src-kinase activity. 
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Identification of critical domains of β4 integrin and laminin-5 required for human SCC devel-
opment
BA Horst, P Nokelainen, EF Fincher, NT Nguyen, AJ Russell and MP Marinkovich Derm & PAVA,
Stanford Univ, Stanford, CA
β4 integrin and its extracellular ligand laminin-5 are strongly expressed at the invading margins of
squamous cell carcinoma (SCC) tumors, and expression has been shown to correlate with tumor
severity and patient prognosis. Recently it has been shown that human KC transformed with Ras
and IKB produce tumors that closely resemble SCC after SQ injection into nude mice. β4 integrin
or laminin-5 negative KC derived from patients with epidermolysis bullosa (EB) fail to produce
tumors in this system, however retroviral transfer of wild type laminin-5 or β4 integrin cDNA to
these cells restored tumor formation. In the current study, we have utilized mutational analysis to
identify domains on β4 integrin and laminin-5 which are critical to SCC development. A laminin α3
cDNA coding for a protein truncated at aa 1337 (the putative processing site) was introduced into
laminin α3 negative KC. The truncated laminin-5 (which lacks the G4/5 domain) was expressed at
normal levels in transduced cells and assembled into a trimeric structure which supported cell attach-
ment and migration. Interestingly Ras/IKB transformed 1337Tr KC showed a complete lack of tumor
formation in our animal model system. In contrast cells expressing full length laminin a3 cDNA
produced large tumors equivalent to wild type controls. These results suggest that the laminin α3
G4/5 domain (which is normally absent in skin after processing) appears to play a critical role in
SCC development. In addition, we introduced mutant β4 integrin cDNA constructs into β4 integrin
negative EB KC and analyzed these cells after Ras/IKB transformation in vivo. Two well charac-
terized β4 integrin mutations (R1281W and D230A/P232A/ E233A), that interfere with plectin-β4
integrin binding and laminin-5 ligation respectively, significantly inhibited SCC tumor growth. These
results suggest that interaction of β4 integrin with laminin-5 and plectin is also critical for SCC tumor
development. 
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Molecular mechanisms of arsenic on keratinocyte cell cycle regulation
H Yu1 and W Liao2 1 Department of Dermatology, National Taiwan University Hospital, Taipei,
Taiwan and 2 Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
Exposure to arsenic is associated with Bowen’s disease, a carcinoma in situ of skin. The character-
istics of abnormal cell cycle regulation, abnormal cell proliferation, carcinogenesis and apoptotsis
are observed in the lesions of Bowen’s disease. However, the molecular mechanism of arsenic in ker-
atinocytes is poorly understood. In this study, the regulatory proteins were detected to elucidate
arsenic-induced cell cycle changes and apoptosis in keratinocytes. We found increased NF-κB
activity and the expression of cyclin D1/CDK4 and cyclin B1/CDK1 at low concentrations of arsenic
(lower than 1 µM), which results in keratinocyte proliferation. In contrast, the high concentrations
(higher than 1 µM) of arsenic suppressed NF-κB activity, enhanced AP-1 activity and caused a p53
dependent cell cycle arrest. Western blot analysis showed that G1-S check point proteins (cyclin
D1/CDK4) and G2-M check point proteins (cyclin B1/CDK1) were suppressed in the high arsenic
concentration treatments. Furthermore, expression of cell cycle inhibitory proteins p21 and 14-3-3σ
were enhanced. Taken together, keratinocyte cell cycle was arrested at G0/G1 and G2/M phase in
high concentrations of arsenic. In addition, Fas/FasL pathway plays a major role in arsenic-induced
keratinocyte apoptosis. Our results indicate that arsenic-induced alternations of keratinocyte cell
cycle are correlated with arsenic concentrations. At low concentrations, arsenic induces survival
signals and enhances keratinocyte proliferation. At high concentrations, arsenic reveals inhibitory
effects on cell cycle progression and induces keratinocyte apoptosis. 
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Imaging of skin tumor-peripheral nerve interactions by laser scanning confocal microscopy
JK Lander,1 M Ericson,1 C Baker,1 M Hordinsky1 and WD Tope2 1 Dermatology, University of
Minnesota, Minneapolis, MN and 2 Dermatologic Surgery, University of California, San
Francisco, CA
Purpose of the study: Interactions between skin cancers and peripheral nerves are not well under-
stood. Our purpose was to demonstrate a method for three-dimensional imaging of skin tumor-periph-
eral nerve interactions and to describe the patterns of nerves, neuropeptides, and blood vessels within
common skin cancer types. Experimental design and methods: Immunofluorescent staining and laser
scanning confocal microscopy (LSCM) were used to generate high-resolution maps of nerve struc-
ture and distribution in basal (BCC) and squamous (SCC) cell carcinomas obtained from tumor
debulking prior to Moh’s micrographic surgery. Patterns of nerves, neuropeptides, and blood ves-
sels in tumors were described and compared to those in unaffected skin. Results: The BCC-selec-
tive antibodies Ber-EP4, agglutinin UEA-I, pan-neuronal marker PGP 9.5, and nerve subtype selec-
tive antibodies against Substance P and CGRP demonstrated numerous nerve fibers adjacent to
(within several microns) but not clearly within BCC and SCC tumor lobules. In a micronodular
BCC demonstrating perineural spread on light microscopy, tumor lobules were detected adjacent to
large nerve bundles. In at least one BCC, previously undescribed large PGP 9.5-reactive cells were
visualized. Summary of conclusions: LSCM can be used to image peripheral nerves in skin cancers.
Results suggest that if relevant neuronal interactions occur in BCC and SCC, it appears likely to
occur within the tumor-stromal interface through soluble factor signaling. This method applying
immunofluorescence labeling and LSCM can be extended to studying a variety of skin tumor types
and may have application in studies of perineural tumor access and spread, cutaneous sensory func-
tion, and the cutaneous neuroimmune system. 
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Gene expression profiles of primary cutaneous T cell lymphoma with focus on CD 30+ anaplas-
tic large cell lymphoma (ALCL): unique clustering pattern of ALCL with extensive limb pres-
entation
MN Storz,1 YH Kim,2 M van de Rijn,1 S Dick,2 RT Hoppe,3 M Diehn4 and S Kohler1,2 1 Pathology,
Stanford University, Stanford, CA, 2 Dermatology, Stanford University, Stanford, CA, 3 Radiation
Oncology, Stanford University, Stanford, CA and 4 Biochemistry, Stanford University, Stanford, CA
We used cDNA microarrays to characterize global gene expression patterns in the most common
subtypes of primary CTCL including tumor stage mycosis fungoides (MF), +/- large cell tranfor-
mation (MF LT), peripheral T-cell lymphoma unspecified (PTCL), primary cutaneous ALCL and
cutaneous NK-/T-cell lymphoma (NK/TCL). We also included samples of normal skin and a NK/TCL
nasal-tissue specimen. Unsupervised hierarchical clustering of all 50 specimens collected from 31
patients identified two readily evident gene expression signatures unique to cutaneous NK/TCL and
to normal skin samples. MF +/- LT specimens clustered separately. The case of NK/TCL nasal-tis-
sue presented with a different gene expression profile compared to its cutaneous counterparts. The
other subtypes of CTCL did not separate into distinct groups by unsupervised clustering alone. Using
SAM multiclass analysis, we found 40 genes that were able to distinguish the different subtypes of
CTCL. For further analysis, we focused on 14 cases of CD30+ ALCL and performed separate hier-
archical clustering. Two distinct groups could be identified, that correlated with clinical data. The
group with a typical indolent clinical behaviour clustered separately from the group with an uncom-
mon, extensive limb presentation, who had a more aggressive clinical course. STAT5A and HIPK2
(both inhibitors of apoptosis) and IL2RA were among the small group of genes that were more highly
expressed in the extensive limb ALCL subtype compared to the other ALCL group.
Conclusion: Unsupervised and supervised analysis of gene array studies reveal distinct subsets in a
variety of CTCL. 
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Nucleotide excision repair responses in UV-irradiated human keratinocytes deficient in p53
BE Ferguson,1,2 K Yeh1,2 and DH Oh1,2 1 Department of Dermatology, University of California, San
Francisco, San Francisco, CA and 2 Dermatology Research Unit, VA Medical Center, San
Francisco, CA
Although the tumor suppressor protein, p53, plays a central role in coordinating the cellular response
to DNA damage, its involvement in regulating DNA repair in human keratinocytes is less clear. We
used an immunoblot assay of UV-induced cyclobutane pyrimidine dimers (CPD) and pyrimidine
(6-4) pyrimidone photoproducts (6-4 PP) as well as quantitative real-time RT-PCR to measure the
global nucleotide excision repair response of human keratinocytes deficient in p53 following UV
radiation. Human keratinocytes expressing the human papillomavirus 16 E6 and E7 proteins have
barely detectable p53 levels by Western blotting. These cells, however, have normal repair of 6-4 PP
and near-normal repair of CPD at early times, and are not significantly different from normal ker-
atinocytes by 24 hours following UV. Similar results were seen in SCC-25 cells possessing inacti-
vating mutations in p53 as well as in cells treated with pifithrin-α, a chemical inhibitor of p53.
When mRNA of proteins involved in damage recognition was measured following UV, induction of
mRNA encoding p48 or DDB2 is diminished several-fold in E6/E7-expressing keratinocytes rela-
tive to normal cells while induction of mRNA encoding XPC is preserved. These results indicate
that human keratinocytes deficient in p53 preserve basal and certain inducible DNA repair responses
in keratinocytes following UV radiation. In addition, these results suggest that human keratinocytes
may be able to regulate global nucleotide excision repair activity, including induction of XPC, through
mechanisms in addition to p53. 
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Mechanisms facilitating escape of HPV-harboring tumor cells from the host immunosurveil-
lance
S Majewski,1 M Malejczyk,1 T Grzela,2 J Jozwiak,2 J Malejczyk2 and S Jablonska1 1 Department
of Dermatology and Venereology, Warsaw School of Medicine, Warsaw, Poland and 2 Department
of Histology, Warsaw School of Medicine, Warsaw, Poland
Immunosurveillance plays an important role in the control of progression of HPV-associated anogen-
ital tumors. We studied expression of various mediators of immune reactions and cell adhesion mol-
ecules by non-tumorigenic keratinocytes (HaCat cells and HPV16-harboring SKv-e2 human ker-
atinocytes) and HPV16-transformed tumor cells (Skv-e1, CaSki and SiHa). The production of
chemokines (IL-8, GROα? MCP-1 and RANTES) and cytokines (TNFα??IL-18), as well as expres-
sion of ICAM-1 and LFA-3 were evaluated by ELISA. Specific mRNAs were studied by ribonu-
clease-protection assay or Northern blot using specific RNA probes. We found that non-tumori-
genic cells expressed constitutively high amounts of ICAM-1 (but not LFA-3) and all chemokines
studied, as compared to tumorigenic keratinocytes. Expression of these proteins in non-tumorigenic
cells could be stimulated by exogenous TNFα? whereas tumorigenic cells did not respond to this
cytokine. Addition of neutralizing monoclonal antibodies against TNFα to the cultures of non-tumori-
genic cells led to a significant decrease in spontaneous ICAM-1 expression suggestive of an autocrine
effect of endogenous TNFα. Functional studies revealed that non-tumorigenic cells exerted strong
chemotactic activity towards both neutrophils and monocytes, and were highly sensitive to natural
killer (NK)-mediated cell lysis. Conditioned media from cultures of tumorigenic HPV16-transformed
cells significantly decreased NK cell activity and production of immunostimulatory INFγ by normal
human peripheral blood mononuclear cells stimulated by anti CD3 antibodies, due to IL-18 inacti-
vation by E6 oncoprotein of HPV16. The study showed that HPV16-transformed tumorigenic cells
have evolved various mechanisms, such as inhibition of chemoattraction of leukocytes and their cyto-
toxicity, which could be responsible for local immunosuppression facilitating tumor progression. 
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Delta-like 4 in T cell lymphoma
JM Latkowski1 and J Lafaille2 1 Dermatology, New York Unversity School of Medicine, New York,
NY and 2 Pathology, Skirball Institute, NYU School of Medicine, New York, NY
In the thirty years since the term cutaneous T cell lymphoma (CTCL) was first introduced, our knowl-
edge of this malignancy has greatly increased; yet the molecular mechanism continues to elude the
scientific community. In the case of mycosis fungoides (MF), the most common type of cutaneous
T cell lymphoma, the role of oncogenes and tumor suppressor genes have been investigated but the
data has been inconsistent and nonconclusive.  We have a murine model of T cell lymphoma (referred
to as Tg8) that resulted from the fortuitous integration of a transgene (T cell receptor alpha) into the
mouse genome. 100% of Tg8 mice develop lymphoma at approximately three months of age and
given the fulminant nature of the malignancy, die within one month. Analysis of Tg8 mice located
the transgene insertion site in chromosome 2 between two novel genes of unknown function,
MGC4504 and KIAA1259. The closest known gene to the insertion site is Dll4, a newly identified
ligand of Notch receptors. Our working hypothesis is that the transgene inserted into chromosome
2 and leads to an aberrant effect on the neighboring genes. Since the notch pathway has been impli-
cated in human and murine T cell lymphomas, Dll4 appears to be the likely oncogene in our mouse
model. The expression levels of genes at the insertion site were evaluated by real time PCR. Dll4
expression is highly upregulated in Tg8 mice as compared to wildtype littermates. MGC4504 and
KIAA1259 also appear to be upregulated in Tg8 mice but to a lesser extent then Dll4. In order to
determine the relevance of Dll4 overexpression in the development of T cell lymphoma in Tg8
mice, human samples of T cell lymphoma were analyzed. Our preliminary results show that a frac-
tion of T cell lymphoma samples, including MF samples, overexpress Dll4, strengthening our hypoth-
esis that Dll4 can act as an oncogene. This data provides the first evidence for Notch ligand-medi-
ated malignancy. 
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V beta expression in the leukemic phase of cutaneous T cell lymphoma
EC Vonderheid,1 C Boselli,2 M Conroy,2 L Cassin,2 L Cheley,2 P Venkataramani2 and S Hou2 1
Dermatology, Johns Hopkins University, Baltimore, MD and 2 Pathology, Drexel University,
Philadelphia, PA
The goal of this study was to identify cases of leukemic phase cutaneous T cell lymphoma (CTCL)
that reacted with monoclonal antibodies directed against the beta region of the variable chain of the
T cell receptor (TCR Vb) for use in other studies. Viably frozen peripheral blood lymphocytes from
patients with leukemic involvement (B2 rating) were studied with T cell markers (CD3, CD4, CD7,
CD8, CD26) and 20 TCR Vb antibodies conjugated with fluorescein isothiocyanate:Vb1.1-2 (BL37.2),
Vb2 (MPB2D5), Vb3 (CH92), Vb5.1 (IMMU157), Vb5.2 (36213), Vb5.2-3 (MH3-2), Vb7.1 (ZOE),
Vb8.1-2 (56C5.2), Vb9 (AMKB1-2), Vb11 (C21), Vb12 (VER2.32.1), Vb13.1 (IMMUN222), Vb13.6
(JU74.3), Vb14 (CAS1.1.3), Vb16 (TAMAYA1.2), Vb17 (E17.5F3.15.13), Vb20 (ELL1.4), Vb21.3
(IG125), Vb22 (IMMUN546), and Vb23 (AHUT7). To clarify results, additional staining of selec-
tive cases was performed with antibodies Vb5a/Vb52-3 (1C1), Vb5b/Vb5.3 (W112), and Vb5c/Vb5.1
(LC4). Of 49 samples studied, 31(63%) were identified as having a neoplastic cell population that
reacted with an anti-Vb antibody. The median percentage of Vb positive cells in the lymphocyte
gate was 66% (range, 28% to 97%). Correlation was made with other measures of neoplastic T
cells: Sezary cell counts and the percentage of CD4+CD7- and CD4+CD26- subsets, and the only
significant correlation was between Vb positive cells and CD4+CD7- (r= 0.501, p= 0.006). The
neoplastic cells were positive for Vb1, Vb7, Vb21.3 and Vb22 from one patient each; for Vb6.7, Vb8,
and Vb23 in 2 patients; for Vb3.1, Vb12, and Vb13.6 in 3 patients; and for Vb5 segments in 13 patients
(Vb5.1, 9 patients; Vb5.2-3, 4 patients). The high frequency of Vb5 restriction suggests that neo-
plastic T cell clones in CTCL may be prone to arise from skin-homing T cells that are selected or
stimulated to expand through the action of staphylococcal exotoxins or other antigens in the skin on
V beta 5 segments. 
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The role of ATR and the replication checkpoint in vitro and in vivo in skin
A Angle-Zahn,2 S Koo,2 Y Kim,2 J Bradner,3 I Longo2 and P Nghiem2,3 1 Dermatology, Harvard
Medical School, Charlestown, MA, 2 Dermatology, Cutaneous Biology Research Center,
Charlestown, MA and 3 Dana-Farber Cancer Institute, Boston, MA
The replication checkpoint is required for the response to UV and other forms of DNA damage by
ensuring that DNA replication is complete prior to mitosis. Here we describe studies that reveal
greater detail of the role of the protein kinase ATR (ataxia telangiectasia and Rad3-related) in the
replication checkpoint and genomic fidelity. We have employed three approaches to modulate ATR
activity: inducible expression of a dominant negative ATR mutant or, siRNA targeting ATR both
diminish ATR function while a cre-lox mediated deletion of ATR ablates its function. Our initial
studies showed that suppression of ATR activity increased sensitivity to caffeine (an inhibitor of the
replication checkpoint), augmented premature chromatin condensation, and induced chromosomal
gaps and breaks at classically defined chromosomal ‘fragile sites’ (Cell 111:779). Because cancer
cells often have insertions and translocations at these same fragile sites, this finding suggests that
ATR function may be critical in malignant cells. To study ATR’s role in skin in vivo we generated
transgenic mice using a keratin-14 promoter linked to dominant negative alleles of either ATR or its
downstream target Chk-1. Five independent founders carrying one of these transgenes (3 of ATR; 2
of Chk-1) are viable and without spontaneous defects in skin or hair at >6 months of age. While pro-
tein expression studies suggest these initial founders display only low level expression, some lines
are experiencing significantly diminished survival. We are currently generating more founders and
investigating the apoptotic response to UV radiation in vivo in these mice. 
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Time course of DNA repair, cytokine release and cellular redox state in UVB-irradiated recon-
stituted epidermis
I Isabelle, G Tercero and J Nicolay Biology, Exsymol, Monaco, Monaco
The purpose of this study is to evidence strategic phases in the repair of UVB-induced DNA dam-
ages by monitoring markers indicative of DNA repair, inflammation, and cellular redox state to
improve design and evaluation of new photoprotective agents. Human Reconstituted Epidermis (HRE)
were exposed to UVB (300 mJ.cm-1), and a kinetic study spanning on 48h was carried out. Sun Burn
Cells (SBC) and TT dimers formation, were monitored by Hematoxylin-Eosin and immunostain-
ing. Expression profiles of P53, GADD45 and IL-12, indicative of DNA repair mechanisms pro-
gression, were analyzed by RT-PCR. Inflammatory cytokines release (IL-1?, IL-8, TNF-?) was deter-
mined by ELISA. Cellular redox-state disregulation was evidenced by the dosage of glutathione
(GSH) and glucose-6-phosphate-deshydrogenase (G6PDH). Cell viability was assessed by MTT test.
3 strategic phases following UVB irradiation were identified: Phase 1, from 0 to 6h, characterized
by an important increase in transcriptional activity of GADD45 and P53 genes, related to a rapid
set-up of DNA repair mechanisms. TT dimers formation and GSH redox-state disbalance were imme-
diate consequences of UVB exposure. Phase 2, from 6 to 24h, characterized by the increasing release
of IL-1, TNF-a and IL-8 correlated with cells entering in apoptosis to escape malignant transfor-
mation caused by DNA damage. Phase 3, from 24h to 48h, characterized by an important release of
pro-inflammatory cytokines, and a significant decrease in cell viability due to apoptotic and necrotic
death. This study evidences the time course of DNA repair events and necessary destructive processes
for the removal of potential cancer cells in UVB-irradiated HRE. Study of the cellular redox state
outlines that DNA repair is dependant of other biological mechanisms such as energy production
and detoxification. This experimental model enables to design new photoprotective associations for
an improved management of the photocarcinogenesis risk associated with sun exposure. 
124
Discovery of small molecules that modulate cell cycle replication checkpoint function
Y Kim,1 J Bradner,2 A Koehler,2 X Li,2 S Schreiber2 and P Nghiem1 1 Dermatology, Cutaneous
Biology Research Center, Charlestown, MA and 2 Harvard Chemistry Department, Cambridge,
MA
ATR is a protein kinase involved in the replication checkpoint for which a potent specific small mol-
ecule inhibitor would be of great interest. However, discovery of small molecules that inhibit spe-
cific target proteins is typically a costly process requiring abundant purified protein and a robust
bioassay. We have taken a novel approach to discover inhibitors for ATR, a large (301 kDa) protein
that is not readily purified and for which no simple bioassay exists. Approximately 15,000 com-
pounds from three diversity-oriented synthetic chemical libraries were robotically arrayed onto
activated glass microscope slides to form covalently captured compounds. Cellular extracts were
prepared from 293T cells that over-expressed Flag (epitope)-tagged ATR and from mock-transfected
cells. After sequential incubation with a mouse anti-Flag antibody and a fluorescently-labeled anti-
mouse antibody, slides were read in a fluorescence scanner. Six small molecules reproducibly yielded
a signal with lysates from Flag-ATR transfected cells but not with mock-transfected lysates. Posi-
tive compounds were structurally similar to each other suggesting that they might recognize a com-
mon target (presumably ATR). The six compounds were tested for functional activity in a cell-based
premature chromatin condensation assay and four of the six demonstrated inhibition of the ATR path-
way. A chromosomal fragility assay for replication checkpoint function also demonstrated similar
effects of these compounds. Studies are ongoing to characterize the biochemical effects of these
small molecules on the phosphorylation of Chk1, a key event in the replication checkpoint. This is
the first application of this new technology to a target protein in a cellular lysate—a general approach
that may allow discovery of small molecules relevant to diverse biological systems. 
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Association of p53 arginine polymorphism at codon 72 with development of skin cancer in
epidermodysplasia verruciformis patients from Brazil
JJ Wu,1 KR Pang,1 WR de Oliveira,2,3 PL Rady,3 J Grady,4 TK Hughes,3 CF Neto,2 EA Rivitti2 and
SK Tyring3,5 1 Center for Clinical Studies, Houston, TX, 2 Dermatology, University of Sao Paulo,
Sao Paulo, Brazil, 3 Microbiology/Immunology, University of Texas Medical Branch, Galveston,
TX, 4 Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston,
TX and 5 Dermatology, University of Texas Medical Branch, Galveston, TX
The prevalence of p53 polymorphism at codon 72 is proposed to be a risk factor in human papillo-
mavirus-related carcinogenesis. We studied the prevalence of p53 polymorphism at codon 72 in
skin biopsies of epidermodysplasia verruciformis patients compared to DNA samples from healthy
individuals. DNA samples extracted from normal skin and tumor biopsies of 22 Brazilian patients
with epidermodysplasia verruciformis and blood samples from 27 healthy Brazilian individuals were
studied for p53 codon 72 polymorphisms using restriction fragment length polymorphism analysis.
All epidermodysplasia verruciformis patients with the malignant form of epidermodysplasia verru-
ciformis were homozygous for arginine (Arg/Arg) at codon 72 of the p53 gene, in contrast to none
with the benign form (P < 0.0001). p53 arginine polymorphism is likely to be associated with the
development of skin malignancies in epidermodysplasia verruciformis patients from Brazil. 
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Cell and isoform specific roles of protein kinase C isoenzymes in regulating in vitro and in vivo
proliferation of keratinocytes and skeletal muscle cells
T Biro,1 G Czifra,1 E Bodo,1 J Lazar,1 H Papp,1 I Kovacs,2 I Juhasz3 and L Kovacs1 1 Department
of Physiology, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary, 2
Department of Pathology, University of Debrecen, Medical and Health Science Center, Debrecen,
Hungary and 3 Department of Dermatology, University of Debrecen, Medical and Health Science
Center, Debrecen, Hungary
The protein kinase C (PKC) system plays a crucial role in the regulation of proliferation, differen-
tiation, and tumor formation of several cell types. In this study, we examined the specific roles of
the conventional cPKCα and β and the novel nPKCδ and ε isoforms in the in vitro and in vivo growth
of HaCaT keratinocytes and C2C12 skeletal muscle cells stably overexpressing the above isoforms.
In vitro proliferation was assessed by a bromo-deoxy-uridine cell proliferation ELISA kit and growth
curve analysis, whereas in vivo growth (tumor genesis) by was investigated by intradermally inject-
ing the PKC overexpresser cells to immunodeficient (SCID) mice. In the HaCaT keratinocytes, over-
expression of cPKCα or nPKCδ decreased in vitro proliferation and resulted in smaller and more
differentiated tumors in SCID mice. However, the overexpression of cPKCβ or nPKCε stimulated
proliferation and (less differentiated) tumor growth yet did not alter the benign phenotype of the
developed tumors. As a marked contrast, in the muscle cells, overexpression of cPKCα or cPKCβ
decreased proliferation and tumor development whereas the presence of nPKCε had no effect on in
vitro and in vivo growth. Of great importance, however, overexpression of nPKCδ dramatically
increased proliferation rate of the cells and resulted in the development of large and malignantly
transformed tumors in SCID mice. These findings, therefore, strongly argue for pivotal yet antago-
nistic roles of certain PKC isozymes in the regulation of cellular proliferation and tumor formation.
In addition, our results clearly highlight that the regulatory role of the given PKC isoform in the
above processes possesses marked cell specificity. 
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Loss of cell adhesion overcomes microenvironmental suppression of early carcinoma progres-
sion in 3D models of premalignancy
W Zhang,1 A Margulis,1 A Alt-Holland,1 NE Fusenig2 and J Garlick1 1 School of Dental Medicine,
SUNY at Stony Brook, Stony Brook, NY and 2 German Cancer Research Center, Heidelberg,
Germany
To study the role of adhesive interactions between premalignant and normal keratinocytes (NK)
during early cancer progression, we developed 3-D human tissue models to investigate how loss of
E-Cadherin-mediated adhesion influences the fate of intraepithelial (IE) tumor cells (HaCaT-II-4)
in premalignant disease. II-4 cells were transduced with a retrovector that generated a dominant-neg-
ative disruption of E-Cadherin function (H-2Kd-Ecad). As controls, II-4 cells were infected either
with retrovectors expressing an empty vector (pBabe) or an H-2Kd-Ecad fusion protein with a loss
of function deletion in its β-catenin-binding domain (H-2Kd-Ecad∆C25). These three II-4 variants
were β-gal-marked and mixed with NK at ratios 4:1 and 12:1 (NK:II-4) and the fate of IE tumor
cells was determined before and after transplantation of 3-D tissues to nude mice. Four weeks after
grafting, mixtures of adhesion-competent II-4 cells (pBabe and H-2Kd-Ecad∆C25) generated nor-
mal-appearing grafts. In contrast, grafts containing mixtures with adhesion-deficient II-4 cells (H-
2Kd-Ecad) demonstrated rapidly growing malignant tumors after 4 weeks. To explain the ability of
these H-2Kd-Ecad-expressing II-4 cells to invade, the IE dynamics between tumor cells and NK
was studied by double-immunofluoresence for Bromodeoxyuridine/β-gal and β-catenin/β-gal of
mixtures before grafting. H-2Kd-Ecad-expressing II-4 cells were found at the basement membrane
(BM) where they showed redistribution of β-catenin and active proliferation. In contrast, adhesion-
competent II-4 cells were growth-suppressed by adjacent NK and were found in the suprabasal cell
layers. Adhesion assays showed that selective adhesion of H-2Kd-Ecad-expressing II-4 cells to BM
was mediated by the augmented adhesion to Type IV collagen. This study suggests that loss of E-
Cadherin-mediated adhesion contributes to the transition from precancer to carcinoma by overcoming
microenvironmental constraints induced by adjacent normal cells. 
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Acquisition and evasion of host anti-tumor immune responses following rapid accumulation
of immunogenic B16 murine melanoma cells in skin-draining lymph nodes
T Kakinuma,1 T Murakami,1 H Nadiminti,1 H Kobayashi2 and ST Hwang1 1 Dermatology Branch,
National Cancer Institute, Bethesda, MD and 2 Metabolism Branch, National Cancer Institute,
Bethesda, MD
B16/F1 melanoma cells are poorly immunogenic and readily form tumors after dermal implantation.
To understand the requirements for effective anti-B16 immune responses, we rendered B16 cells
more immunogenic through retroviral transduction with luciferase (LUC). LUC-B16 cells showed
rapid (as early as 5 min), pertussis toxin-insensitive accumulation at the draining cervical LN of mice
following inoculation into the ear skin. Mice mounted a potent host response that prevented forma-
tion of tumor in the ear and, later, at other skin sites upon rechallenge. Interestingly, small numbers
of tumor cells could be detected by in vitro LUC assay 4 weeks after injection in the absence of
overt tumor formation. By contrast, B16 cells expressing the chemokine receptor CCR10 (but not
CXCR4) formed progressive tumors in the ear with cervical LN metastasis within 14 days follow-
ing injection, suggesting that CCR10-expressing tumor cells can escape host tumor control. By LUC
analysis, accumulation of LUC-positive B16 cells in the popliteal LN following footpad injection
was 8-10 fold less efficient (vs. ear skin injection) and did not result in anti-tumor responses. Indeed,
MRI-lymphangiography revealed that transport of a low molecular weight, Gd (III)-labeled contrast
agent was markedly slower and less intense following injection of contrast agent into the footpad as
compared to the ear skin. Finally, ear vaccination of mice (N=10) with LUC-B16 cells delayed for-
mation of parental B16/F1 tumors that did not express luciferase (p<0.001), suggesting that reac-
tivity to endogenous melanoma antigens had occurred. Thus, effective host anti-tumor responses that
extend to less immunogenic tumor strains can be initiated by accumulation of sufficiently immuno-
genic tumor cells in secondary lymphoid organs. Moreover, expression of specific chemokine recep-
tors allows tumor cells a means of evading host anti-tumor responses. 
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Correlation of hypoxia inducible factor-1α expression with worsening grades of squamous dys-
plasia
WG Stebbins, RN Saladi, JO Moore, RG Phelps, MG Lebwohl and H Wei Dermatology, Mount
Sinai School of Medicine, New York, NY
Cellular hypoxia is a commonly occurring phenomenon during tumor growth. The blood vessels cre-
ated within tumors are often malformed, leading to insufficient blood flow and tissue hypoxia. When
exposed to hypoxic conditions, cancer cells respond by inducing a variety of signaling pathways to
allow for survival and tumor progression. Hypoxia Inducible Factor-1α (HIF-1α) is a transcription
factor that is induced by cellular hypoxia. In addition, many reports have found that HIF-1α upreg-
ulation can be due to genetic alterations without any intratumoral hypoxia involved. It has been linked
to critical pathways involved in regulation of angiogenesis, cell proliferation, and programmed cell
death. The aim of this experiment was to establish the presence or lack of HIF-1α expression in var-
ious grades of squamous dysplasia ranging from pre-malignant to malignant lesions. We evaluated
HIF-1α expression in skin sections obtained from patients with confirmed histological diagnoses of
Actinic Keratosis (AK), Bowen’s Disease (BD), Superficial Squamous Cell Carcinoma (SCC) and
Invasive SCC. HIF-1α expression was quantified with a polyclonal HIF-1α antibody using immuno-
histochemistry. Our results showed a consistent, gradual increase of HIF-1α, from low expression
in actinic dysplasia to high levels of expression in invasive SCC. No HIF-1α expression was noted
in normal human skin. We conclude that upregulation of HIF-1α is directly correlated with wors-
ening cellular dysplasia and dermal invasion. Furthermore, we have found that immunohistochem-
istry is both a sensitive and specific assay for the presence of HIF-1α. As a result, it may be a use-
ful prognostic tool and helpful in determining approaches to treatment for certain types of skin cancer.
As inhibition of HIF-1α activity has been shown to decrease expression of genes associated with
increased angiogenesis and cellular metabolism, this transcription factor may prove to be a useful
target against carcinogenesis. 
130
AP-1 transcriptional activity determines keratinocyte lineage commitment during tumorige-
nesis
MJ Gerdes,1 NA Frost,1 MR Levy,1 J Moitra,2 AB Glick,1 C Vinson2 and SH Yuspa1 1 Lab Cell.
Carc. Tum Promo, NCI, Bethesda, MD and 2 Lab Metabolism, NCI, Bethesda, MD
To investigate the collective role of AP-1 transcriptional activity in skin differentiation and tumori-
genesis, transgenic mice were produced that express a dominant-negative Fos protein (A-FOS) under
the control of a tetracycline operon (tet-O-A-FOS). These mice were crossed with K5-tet-Transac-
tivator (K5-tTA) mice such that A-FOS is targeted to the basal epidermis and hair follicle outer root
sheath in the absence of Doxycycline (Dox) in bigenic mice (K5-tTA/A-FOS). Inhibition of AP-1
activity was confirmed in vivo and in vitro by crossing K5-tTA/A-FOS mice with TRE-luciferase
mice and measuring activity in skin and keratinocytes . Transgenic mice expressing A-FOS develop
sebaceous adenomas during the course of 2-stage carcinogenesis and mixed sebaceous and squa-
mous tumors when A-FOS expression is either induced or suppressed by changing Dox treatment
during tumorigenesis. A-FOS expression prevents malignant conversion of benign tumors. Two
proteins were identified to be specific for sebocytes in the sebaceous lesions- Indian Hedgehog and
Adipocyte Differentiation Related Protein (ADRP). Further, ADRP was noted in keratinocytes sur-
rounding sebaceous lesions, suggesting this is an early marker for sebocyte differentiation. Both
markers were found to be expressed and specific for sebocytes in normal epidermis.
In cultured transgenic keratinocytes large lipid droplets formed in A-FOS expressing cells, and
these cells contained a significantly higher lipid content when quantified by flow cytometry using
Nile Red. Linoleic acid treatment increased lipid content in K5-tTA/A-FOS cultures as well as in
cultures expressing a ras oncogene. These results suggest AP-1 is involved in determining the line-
age commitment of multipotential keratinocyte precursors and may be required to maintain a squa-
mous cell phenotype under conditions of high proliferation such as in cultured keratinocytes or epi-
dermal tumors. 
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CD4−CD25+ tumor-infiltrating T cells are associated with enhanced cutaneous tumor growth
observed in CD4-deficient mice
SJ Roberts, R Filler, J Lewis, RE Tigelaar and M Girardi Dermatology, Yale University School of
Medicine, New Haven, CT
We have previously demonstrated decreased tumor growth in mice genetically deficient in αβ T cells
undergoing two-stage chemical carcinogenesis with DMBA initiation and TPA promotion. Other
investigators have observed the enhancement of tumor development in Harvey ras transgenic mice
pre-immunized to elicit an anti-ras response. Taken together, these results demonstrate the capacity
of αβ T cells to stimulate tumor growth under certain conditions. Therefore, we assessed tumor
growth in CD4-/- mice, deficient in CD4 but not CD8αβ T cells, relative to TCRβ-/- mice which
lack all αβ T cells. While the numbers of tumors per mouse (N=14) were comparable between
CD4-/- and TCRβ-/- mice (18.4±1.6 vs 14.9±1.9, p=0.09) at week 15 post-initiation, tumor area
(190.8±23.2 vs 74.1±9.9 mm2, p=0.0001) and numbers of carcinomas per mouse (11.1±1.1 vs 5.0±0.6,
p<0.0001) were markedly greater in the CD4-/- group, implicating either the absence of a protec-
tive CD4+ population and/or the presence of a tumor-promoting CD4− population. Four-color FACS
analyses of lymphocytes isolated from papillomas and carcinomas growing in CD4-/- mice revealed
tumor-infiltrating CD8+ T cells as well as a striking population of CD4−CD25+αβ+ T cells (of which
only a small minority were CD8+). Thus, one potential explanation for the enhanced tumor growth
in CD4-/- mice is that the tumor infiltrating CD4−CD25+αβ+ T cells are suboptimal T regulatory
cells, incapable of suppressing a CD8+ tumor-promoting population. Future studies will be aimed
at delineating the mechanism by which T cell subsets may stimulate tumor growth in the skin as such
findings have important implications for immunotherapy in strategies. 
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No association between p53 codon 72 polymorphisms and ultraviolet B induced erythema
L Naysmith,1 C Manson,1 K Waterston,1 DW Melton2 and JL Rees1 1 Dermatology, University of
Edinburgh, Edinburgh, United Kingdom and 2 Molecular Medicine Centre, University of
Edinburgh, Edinburgh, United Kingdom
Any association between allelic variants of the p53 gene and acute ultraviolet radiation (UVR) sen-
sitivity is important as it may provide insight into the mechanism underpinning the reported associ-
ation of p53 with cutaneous malignancy. Although there is conflicting evidence, recent work has
shown a link between p53, sunburn and both melanoma and non-melanoma skin cancer, with Pro/Pro
homozygotes having a higher minimal erythema dose (MED) and thus less UV sensitive (J Invest
Dermatol 119:84-90,2002; J Invest Dermatol 121:1510-1514). We had the opportunity to examine
the same p53 variants and UVR sensitivity, measured not as a threshold measurement (MED), but
by objective reflectance spectrophotometry at a range of UVR doses in 2 groups of patients. In group
1, 74 healthy Northern European residents were irradiated on the lower back with a range of UVB
doses 119-300mJ/cm2 (Philips 9w/12). In group 2, 31 psoriasis patients, prior to phototherapy,
were irradiated on the inner forearm with 6 doses of UVB (0.47-1.5J/cm2) from a TL01 Philips
tube. Triplicate reflectance readings from each site, including baseline, were taken at 48 hrs and 24
hrs in groups 1 and 2 respectively. Genotyping of the p53-72 polymorphism was carried out by PCR
and RFLP analysis. Neither study group showed an association between erythemal response and
allelic variation at codon 72. Mean erythema (+/- SEM) at 300mJ/cm2 for group 1 Arg/Arg, Arg/Pro
and Pro/Pro was 145(7.3), 162(6.8) and 149(18.7) respectively (p=0.249). And for the same poly-
morphisms at 1.5J/cm2 in the second group, 162(24.4), 159(23.1) and 169(29), (p=0.986). We
found no evidence to support any increase in sun sensitivity at either body site at any dose exam-
ined. In the absence of further study we believe there is little compelling evidence to implicate p53
codon 72 alleles with sensitivity to UVR. 
A22 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
133
Aggressive behavior of Merkel cell carcinoma of the skin may be related to tumor microvas-
culature density
C Parrado,1 V Bjorhagen,2 I Perez de Vargas,1 F Rius,1 UG Falkmer,3 S Falkmer3 and S Gonzalez4
1 University of Malaga, Malaga, Spain, 2 Karolinska Hospital, Stockholm, Sweden, 3 St Olav
University Hospital, Trondheim, Norway and 4 Harvard Medical School, Boston, MA
This study was undertaken to: (1)assess Langerhans cell population, that of their precursor, stromal
microvasculature density, and epidermal proliferative index in Merkel Cell Carcinoma (MCC) and
(2) to evaluate the prognostic value of these parameters in its metastasis occurrence. This is a retro-
spective study investigating twenty-five subjects aged between 20 and 90 (mean 70) years with
biopsy-proven MCC. Patients were distributed into several groups according to the occurrence of
metastasis. Diagnosis was based on the positive identification of a specific immunohistochemical
profile including CK 20, NSE and Chromogranin. Langerhans cells were identified using an anti-
body directed against membrane CD1a while their precursors were characterized by human CD34
positive immunostaining. Proliferation index was quantified using MIB-1 antibody. As expected,
surface density of CD1a+ cells was significantly reduced in epidermis overlaying the tumor, as
compared with normal skin. CD34+ dendritic cells were not present within the tumoral stroma. On
the other hand, proliferation index of MCC cells and overlaying keratinocytes was very high (41%
and 13%, respectively). No correlation was found between these parameters and the clinical out-
come of patients. Immunohistochemical staining labeling with CD34 also showed a higher number
of intratumoral blood vessels compared with other skin malignancies such as melanoma among oth-
ers. The median observation period was 38 months. Together, these results indicate that intratu-
moral microvasculature density may be the one of these quantitative parameters that correlates with
metastasis occurrence. 
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Activation of TNFα/TRAF-2 and downstream effector molecules by 12-O-tetradecanoylphor-
bol-13-acetate (TPA) in mouse skin
M Saleem, VM Adhami, F Afaq and H Mukhtar Dermatology, University of Wisconsin, Madison,
WI
In animal models, TPA is reported to promote skin carcinogenesis by upregulation of ornithine decar-
boxylase (ODC) activity and difluoromethyl-ornithine (DFMO), a suicidal inhibitor of ODC, par-
tially inhibits it, thus suggesting involvement of other pathways in skin tumor promotion. In this
study we investigated alternate pathways that are activated by TPA and contribute to the process of
tumorigenesis in mouse skin. CD-1 mice were treated topically with TPA and skin samples were col-
lected 6, 12, 24 and 48 h later. In another group, mice were pretreated with DFMO 30 min prior to
TPA application and skin samples were collected for immunoblot analysis. We observed that TPA
induces expression of TRAF1/2 through the induction of TNFα. While the induction of TRAF-1 was
observed only at 6 hr post TPA treatment, there was a sustained expression of TRAF-2 observed at
all time points. We observed that concomitant with the inhibition of ODC expression DFMO treat-
ment inhibited TRAF-1 expression. However, no change in the expression of TRAF-2 was observed
in DFMO treated mice. We next evaluated the role of TNFα receptors viz., TNFR1 and TNFR2 in
TPA induced TNFα signaling pathway. While a sustained induction of TNFR1 was observed, TNFR2
showed an increased expression only at 6 h post TPA, suggesting that TRAF2 interacts with TNFR1
in TPA induced signaling. Pretreatment of mice with DFMO showed no inhibition of either recep-
tor suggesting that TNFα/TRAF1/2 signaling continues to be active despite the inhibition of polyamine
biosynthesis. TRAF-2 is reported to associate with TRADD and RIP to activate the MAPKs path-
way. We observed increasing expression of TRADD, RIP, p38 and JNK by TPA application. Treat-
ment of mice with DFMO prior to TPA application inhibited TRADD and RIP expression, however,
p38 and JNK were not affected by DFMO pre-treatment suggesting that TRAF-2/TNFR1 complex
activates MAPK pathway independent of TRADD and RIP in TPA induced tumor promotion. In
summary, we identified a novel pathway of TPA-induced skin tumor promotion. 
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Effects of ultraviolet B exposure on the expression of proliferating cell nuclear antigen in murine
skin
JO Moore, SR Palep, RN Saladi, D Gao, Y Wang, R Phelps, MG Lebwohl and H Wei Dermatology,
Mount Sinai School of Medicine, New York, NY
Proliferating Cell Nuclear Antigen (PCNA) is an active nuclear protein involved in DNA replica-
tion, recombination, and repair. PCNA is found throughout the basal layer in normal skin, and seen
in all layers of the epidermis in malignancy. This study evaluates PCNAs patterns of expression at
specific timepoints following acute and chronic UVB irradiation. Mice exposed to 1.5 kJ/m2 and
4.5 kJ/m2 were sacrificed at 6, 12, 24, 48, 72hrs, and 7days. Single and repeated exposure groups
were maintained for the aforementioned doses. Immunohistochemical analysis performed on paraf-
fin sections revealed PCNA expression throughout the basal layer of normal skin with diminished
expression upon initial ultraviolet exposure. In subsequent timepoints, in the1.5 kJ group, PCNA
immunoreactivity progressively increased, with appreciable upward epidermal migration upon chronic
exposure. The 4.5 kJ group exhibited prolonged recovery in staining and also demonstrated this
altered migratory pattern with chronic exposure. We hypothesize that the diminished expression in
PCNA immunoreactivity associated with initial ultraviolet exposure, is representative of the imme-
diacy of harmful effects that ultraviolet light imposes on cutaneous cellular repair mechanics. Pro-
gressive reactivation of PCNA expression results from protective events, elicited by the cells in
response to ultraviolet damage. PCNA migration to upper layers of the epidermis, indicate prolifer-
ation, and subsequent transformation toward an increased malignant potential. We conclude that
PCNA can serve as a marker of DNA repair and indirectly as an indicator of UVB induced damage,
expression being time dependent and dose related. Specific immunoreactivity patterns and observ-
able atypia in keratinocytes are relevant in elucidating malignant potentiation. 
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Mast cells contribute to host anti-tumor defense
F Siebenhaar, J Knop and M Maurer Dermatology, Johannes Gutenberg-University, Mainz,
Germany
Mast cells (MC) accumulate at sites of tumor formation where they are suspected to be involved in
growth promotion and angiogenesis. To test whether MC modulate the development of epidermal
tumors, MC-deficient KitW/KitW-v mice, normal Kit+/+ mice and KitW/KitW-v+MC mice that had
been repaired of their cutaneous MC-deficiency by adoptive transfer of bone marrow-derived cul-
tured MC to the skin of KitW/KitW-v mice were subjected to classical two-stage chemical carcino-
genesis. Unexpectedly, Kit+/+ mice proceeded to develop tumors significantly slower than KitW/KitW-
v mice when treated topically with a carcinogen (DMBA, once) followed by a promotor (TPA, 2x/week
for 15 weeks). After 12 weeks of treatment only 48.6 ± 4.2% of Kit+/+-mice, but 78.2 ± 4.7% of
KitW/KitW-v mice showed ≥ 1 papilloma (p<0.005). Interestingly, Kit+/+ mice also exhibited reduced
numbers of papillomas per treatment site (0.31 ± 0.05 papillomas/cm2 skin as compared to KitW/KitW-
v mice (0.62 ± 0.09 papillomas/cm2 skin, p<0.005). Susceptibility to skin carcinogenesis in KitW/KitW-
v+MC mice was comparable to that seen in normal Kit+/+ mice (week 12: ≥ 1 papilloma in 35.6 ±
10.9% of KitW/KitW-v+MC mice, 0.22 ± 0.05 papilloma/cm2 skin). Most notably, MC appear to also
regulate tumor growth. After 20 weeks of treatment the average tumor volume per papilloma was
markedly increased in KitW/KitW-v mice as compared to Kit+/+ mice and KitW/KitW-v+MC mice: 9.2
± 2.8 vs. 3.8 ± 0.8 and 6.6 ± 3.0 mm3/papilloma, respectively. Suspecting that MC release products
required for resistance to de novo carcinogenesis, we tested whether MC undergo degranulation after
TPA application. As assessed by histomorphometric analysis, virtually all subepidermal MC exhib-
ited signs of extensive (54.2 ± 10.4%) or moderate (43.8 ± 10.4%) degranulation. These data sup-
port a dual role for activated MC in murine epithelial carcinogenesis: MC protect from skin tumor
development and suppress tumor growth. 
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∆Np63 isotypes differentially regulate keratinocyte proliferation and differentiation
WC Weinberg,1 T Yamashita,2 T Tokino,2 M Young,3 R Ponnamperuma1 and K King1 1 Laboratory
of Immunobiology, OBP/FDA, Bethesda, MD, 2 Sapporo Medical University, Sapporo, Japan and
3 NIDCR/NIH, Bethesda, MD
The p53 homologue p63 is required for squamous development and is expressed as multiple isotypes
of two major subclasses: TA and ∆N. We have previously shown that in vitro overexpression of the
∆Np63α isotype in primary murine keratinocytes inhibits Ca2+-induced growth arrest and differen-
tiation. These findings, along with the reported overexpression of ∆Np63 in squamous cell carcino-
mas, suggest a role for ∆Np63α in the maintenance of the basal cell phenotype in normal and neo-
plastic epithelium. Here we address the importance of the α-terminus within ∆Np63α, and compare
the effects of TA and ∆N isotypes. Using primary murine keratinocytes as a model of squamous
epithelium, we overexpressed ∆Np63α, ∆Np63p40, TAp63α, TAp63γ, or β-gal via adenoviral trans-
duction. Both ∆N isotypes inhibit G1 growth arrest mediated by elevated (0.12mM) extracellular
[Ca2+], as determined by FACS analysis. These findings are supported by western blotting using an
anti-PCNA antibody, and suggest that the p63 core domain and ∆N terminus are sufficient for pro-
moting keratinocyte proliferation. However, unlike ∆Np63α, ∆Np63p40 overexpression allows Ca2+-
mediated induction of the differentiation markers keratin 10 and filaggrin. Thus, aberrant expres-
sion of ∆Np63p40 dissociates growth regulation from differentiation. No alterations in cell cycle
distribution or expression of keratin 10 were observed in keratinocytes overexpressing the TAp63
isoforms TAp63α or TAp63γ. Thus the C-terminal α-terminus is capable of modulating early mark-
ers of keratinocyte differentiation only within the context of the ∆Np63 subclass of isotypes. Ongo-
ing analysis of the downstream similarities and differences between the ∆N isotypes may provide
mechanistic insight into hyperproliferative skin disorders. 
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Human skin equivalent: a reliable in vitro model for carcinogenic experiments
JO Moore, WG Stebbins, D Guevara, RN Saladi, Y Zhu, MG Lebwohl and H Wei Dermatology,
Mount Sinai School of Medicine, New York, NY
EpiDerm FT (MatTek Co., MA) is an in vitro model for human skin derived from keratinocytes of
human neonatal foreskin. The epidermal component is cultured to form a highly differentiated model
of metabolically and mitotically active cells that are arranged analogous to those found in human
epidedrmal skin. This advanced full-thickness model incorporates a fibroblast-containing dermis
with epidermal keratinocytes. Epiderm has been used in dermatological research to test the irritancy
of various consumer products, and the reactivity of specific biomarkers. In this study, we evaluate
the capacity of this human skin equivalent to express cyclobutane-pyrimidine dimers(CPD)and Pro-
liferating Cell Nuclear Antigen(PCNA)using immunohistochemical analysis. CPD represents one of
the most abundant mutagenic and cytotoxic DNA photoproduct lesions, and current literature sup-
ports this biomarkers reliability in assessing ultraviolet-induced cutaneous DNA damage in human
skin. PCNA is an active nuclear protein involved in cellular proliferation and repair that can be used
indirectly to assess damage to cutaneous cellular mechanics. This report is the first to describe the
immunohistochemical expression profiles of these biomarkers in human reconstituted skin. We
observed a dose dependent increase in CPD expression from 20 mJ/m2 to 60 mJ/m2 of UVB for Epi-
derm specimens harvested six hours post-irradiation, with no CPD immunoreactivity in sham radi-
ation specimens. PCNA expression was noted throughout sham radiation control specimens, with
subsequent diminished expression upon ultraviolet exposure from 20 mJ/m2 to 60 mJ/m2, consis-
tent with our previously reported results with similar UVB exposure levels in mouse skin. All spec-
imens showed disrupted architecture at 100 mJ/m2. We conclude that Epiderm FT represents a for-
midable alternative to human and animal skin models. This viable in vitro option offers compelling
relevance in the elucidation of ultraviolet induced biomarker evaluation and stands to serve as suit-
able substitute in cutaneous carcinogenesis experimentation. 
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Lupeol inhibits TPA-induced activation of nuclear factor kappa B (NFκB) and phosphatidyl
inositol 3-kinase (PI3K) /Akt and skin tumor promotion in CD-1 mouse
H Mukhtar, M Saleem, F Afaq and VM Adhami Dermatology, University of Wisconsin, Madison,
WI
Since primary prevention such as the use of sunscreens or wearing of protective clothing has proved
inadequate in reducing skin cancer incidence, chemopreventive agents that act on multiple molecu-
lar targets may prove useful in association with primary prevention. Lupeol [Lup-20 (29)-en-3 ?-ol]
is abundant in fruit plants such as olive, mango, strawberry and fig. In current study, we show that
Lupeol modulates NFκB and PI3K /Akt pathways and inhibits skin tumorigenesis in mouse skin.
We first determined the effect of topical application of Lupeol to CD-1 mouse against 12-O-tetrade-
canoyl- phorbol-13-acetate (TPA) -induced alterations in various molecules involved in tumor pro-
motion and then determined its effect on mouse skin chemical carcinogenesis. We found that topi-
cal application of Lupeol (1- 2 mg / mouse) 30 min prior to TPA (3.2 nmole/mouse) application
onto the skin of mice afforded significant inhibition, in a time and dose-dependent manner, against
TPA-mediated increase in (i) skin edema and hyperplasia (ii) ornithine decarboxylase (ODC) activ-
ity and (iii) protein expression of ODC, cycloxygenase-2 and nitric oxide synthase. We also found
that Lupeol treatment to mouse skin resulted in inhibition of TPA-induced (i) activation of PI3K, (ii)
phosphorylation of Akt at Thr306? (iii) activation of?NFκB and IKKα and (iv) degradation and
phosphorylation of IκBα. The animals pretreated with Lupeol showed significantly reduced tumor
incidence, lower tumor body burden and a significant delay in the latency period for tumor appear-
ance. At the termination of the experiment at 28 weeks, 100% of the animals in TPA treated group
exhibited 6-7 tumors / mouse whereas only 53% of the mice receiving Lupeol prior to TPA treat-
ment exhibited 1-2 tumors /mouse. These results for the first time provide evidence that Lupeol pos-
sesses anti-skin-tumor promoting effects in mouse and could be used as an emollient or patch for
chemoprevention or treatment of skin cancer. 
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Induction of apoptosis by procyanidins from grape seeds is mediated by p53, Bcl-2 and cas-
pase pathways
SK Katiyar, A Mittal and CA Elmets Dermatology, University of Alabama at Birmingham,
Birmingham, AL
The use of dietary botanical supplements has received considerable interest to prevent the risk of
skin disorders including skin cancer. We have shown that dietary feeding of procyanidins from
grape seeds (GSP) prevents ultraviolet (UV) light induced tumor promotion in mice. Since tumor
promotion stage is reversible, it is better to target the molecular and cellular events for the preven-
tion of skin cancer at this stage. Therefore, we determined the molecular mechanism involved in
prevention of tumor promotion events by GSP treatment. For this purpose, we used mouse epider-
mal JB6 Cl41 cells, a well developed cell culture model for studying the molecular events in tumor
promotion. JB6 cells are sensitive to the promotion by phorbol esters and other tumor promoters.
Here we report that treatment of GSP dose (20-100 µg/ml)-dependently resulted in significant induc-
tion of apoptosis (12-70%) which was determined by FACS analysis, DNA ladder assay and immuno-
fluorescence staining. Western blot analysis showed that treatment of GSP dose-dependently (20-
80µg/ml) induced phosphorylation of p53 at Ser15 in JB6 Cl41 cells, and thus induction of apoptosis
appeared to be p53 dependent because cells lacking p53 (p53-/-) showed no signs of apoptosis whereas
p53+/+ cells underwent apoptosis after treatment with GSP. Further, treatment of GSP to JB6 cells
resulted in dose-dependent decrease in anti-apoptotic proteins Bcl-2 and Bcl-xl levels accompanied
with the increased expression of caspases. These data indicated that GSP induced p53-dependent
apoptosis in JB6 Cl41 cells through Bcl-2 and caspases pathways, and suggesting that procyanidins
from grape seeds could be developed as a chemopreventive agent for skin disorders which are asso-
ciated with the dysregulation of p53, a tumor suppressor protein. 
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Activation of oncogenic KrasG12D induces oral tumor formation
C Caulin,1 GA Lang,2 G Lozano2 and DR Roop1 1 Departments of Molecular and Cellular Biology
and Dermatology, Baylor College of Medicine, Houston, TX and 2 Department of Molecular
Genetics, University of Texas M. D. Anderson Cancer Center, Houston, TX
Mouse models for sporadic human cancer represent powerful tools to analyze how mutations fre-
quently found in human cancer regulate specific properties of tumor development. One of the key
features of sporadic human cancer is the accumulation of mutations in the tumor cells but not in the
surrounding normal tissue. We have developed a novel system that allows us to activate mutations
in selected areas of stratified epithelia. This technology also overcomes the embryonic or neonatal
lethality associated with the activation of oncogenes or inactivation of tumor suppressor genes using
conventional transgenic/knockout approaches. We confirmed that gene activation/inactivation in this
system occurs in the stem cells that regenerate stratified epithelia, including skin, oral mucosa, tongue
and palate. We are currently using this system to assess the consequences of focal accumulation of
somatic mutations such as activation of a mutant Kras allele and/or a mutant p53 allele. We found
that inducible activation of the oncogenic KrasG12D allele in stratified epithelia induces oral tumor
formation in all mice that were analyzed. These tumors arise in the oral mucosa, tongue and palate.
However, skin tumors only appear after treatment with the tumor promoter TPA. Interestingly, pre-
liminary genetic analysis of the oral tumors showed activation of the mutant KrasG12D allele in the
presence of the wild type allele. However, only the mutant allele is present in skin tumors, suggest-
ing that loss of the wild type allele is required for the appearance of skin tumors but not for oral can-
cers. We have initiated studies to assess the impact of activation of the gain of function mutant
p53R172H allele in the presence or absence of oncogenic Kras. Preliminary data suggest that expres-
sion of mutant p53 accelerates the appearance of KrasG12D-dependent oral tumors. We are currently
monitoring these mice for tumor progression. 
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The capacity for Ras-driven tumorigenesis in primary human skin cells is lineage-dependent
T Ridky2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA and 2 Stanford, Stanford, CA
A central question in cancer biology concerns the relative roles of tissue-specific tumor induction
mechanisms versus universally acting oncogenic pathways that drive neoplasia in all cell types. In
human epidermis, oncogenic Ras can act in concert with IkBa to trigger invasive epidermal neopla-
sia indistinguishable from squamous cell carcinoma (SCC), thereby inducing cancer by directly alter-
ing only 2 signaling pathways. The efficiency with which deregulation of these 2 pathways drives
tumorigenesis, coupled with the fact that both pathways play functionally critical roles in nearly all
cells, raises the possibility that Ras-IkBa might serve as globally active oncogenes capable of facil-
itating malignant transformation of any primary human cell type. To address this, we studied pri-
mary human skin cells from a number of discrete lineages, including endodermal (endothelial cells),
mesenchymal (fibroblasts), neuroectodermal (melanocytes) as well as epithelial control (ker-
atinocytes). Ras and IkBa were co-expressed in each of these cell types via high efficiency retrovi-
ral transduction, as confirmed by immunoblotting. Each of these transduced cell populations was
injected subcutaneously into nude mice (1x106 cells/mouse) to assay for tumor formation (n=5
mice/cell type). While transduced keratinocytes formed tumors within 2-4 weeks, no tumors were
observed with any of the other cell types over the course of 6 months, indicating that Ras and IkBa
are not universally active triggers of malignant transformation in human cells. To identify potential
mechanisms contributing to these cell lineage differences, cell types are being examined for resist-
ance to Ras triggered growth arrest, alterations in cell cycle regulators and the ability to invade
extracellular matrix. These data indicate that requirements for carcinogenesis in skin vary depend-
ing on cellular lineage and indicate that, within human cutaneous tissue, keratinocytes are uniquely
susceptible to tumorigenesis via Ras induction and NF-kB blockade. 
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Specific sequences within type VII collagen are required for epidermal carcinogenesis
S Ortiz-Urda,2 Q Lin,2 J Garcia,2 L Chen,2 D Veitch,2 T Cai,2 M Marinkovich1,2 and P Khavari1,2 1
VA Palo Alto, Palo Alto, CA and 2 Stanford, Stanford, CA
Collagen VII disruption causes recessive dystrophic epidermolysis bullosa (RDEB), a disorder
often accompanied by early-onset squamous cell carcinoma (SCC). The mechanism underlying
increased SCC in RDEB is unknown and has been attributed to factors such as chronic wounding or
a role for collagen VII in tumor suppression. However, the lack of comparable increases in SCC in
other inherited chronic blistering diseases and the observation that collagen VII protein is over-
expressed in sporadic SCCs, casts doubt on these explanations. To determine directly whether col-
lagen VII enables or antagonizes carcinogenesis, we examined Ras-driven tumorigenesis in primary
epidermal cells from 12 unrelated RDEB patients using co-expression of Ras and IkBa, which
transforms normal keratinocytes into invasive SCC tumors in immune-deficient mice. Unexpectedly,
cells from 4/12 patients failed to form SCCs in vivo. Collagen VII protein was entirely absent in this
non-tumorigenic subset, in contrast to cells from the 8 tumorigenic RDEB patients, which all retained
expression of a specific collagen VII sub-domain. Re-expressing both full-length collagen VII as
well as this sub-domain restored tumorigenicity to collagen VII-null cells in a non-cell autonomous
fashion. Collagen VII sequences lacking this sub-domain failed to restore the capacity for tumori-
genesis to null cells, indicating they are required for neoplasia in this setting. Purified sub-domain
fragments enhanced cell invasiveness and proliferation in a manner dependent on specific integrins,
while retroviral sub-domain co-expression with Ras induced epidermal tumors in vivo. Polyclonal
and monoclonal antibodies raised to sub-domain epitopes abolished invasion and hyperproliferation
by transformed keratinocytes in culture and, when administered in vivo, blocked tumor formation
by Ras and IkBa expressing wild-type human keratinocytes. These data indicate that specific colla-
gen VII sequences are necessary for invasive human epidermal neoplasia and underscore their ther-
apeutic potential in SCC. 
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The effects of chemopreventive agents on DNA damage and PCNA expression on mouse skin
treated with BaP-UVA
SR Palep, D Guevara, JO Moore, RN Saladi, D Gao, MG Lebwohl and H Wei Dermatology, Mount
Sinai School of Medicine, New York, NY
We have previously reported that topical administration of BaP substantially enhances UVA-induced
formation of oxidized DNA bases, DNA photoproducts, and potentiates skin tumorigenesis by UVA.
The goal of our study was to assess the initial protective benefits of several naturally occurring chemo-
preventive agents: Genistein, Baicalein, and sandalwood oil (SWO), against synergistic enhance-
ment of skin carcinogenesis by BaP-UVA. This was done using immunohistochemical staining for
several molecular markers such as PCNA (proliferating cell nuclear antigen), 8-OHdG (8-hydroxy-
2-deoxyguanosine), and (6-4) DPs (dipyrimidine photoproducts). PCNA is a marker for cell prolif-
eration and DNA repair after damage. 8-OHdG is a marker for oxidative DNA damage. 6-4 DPs are
a marker for UV-induced DNA damage. Eight groups of mice (5 female SKH-1/group) were treated
with BaP(2g) and 60 min. later followed by different comparable concentrations of either Genistein,
Baicalein, SWO, or acetone (control), which was applied 30 min prior to, or 5 min post appropriate
doses of UVA (20 kJ/m2). Mice were sacrificed 24 hrs post-UVA irradiation, and the mouse skin
was paraffin embedded for immunohistochemical analysis. In conclusion, all the chemopreventive
agents showed significant inhibition of DNA damage caused by BaP-UVA, in comparison to the ace-
tone (control) groups. More specifically, SWO showed to be the most potent agent for the inhibition
of DNA damage and activation of DNA repair as demonstrated by having the most PCNA positively
stained cells. Baicalein was the most potent agent for the inhibition of 6-4 DP formation, and Genis-
tein was the most scavenging of ROS, as was demonstrated by having the least amount of 6-4 DP
and 8-OHdG positively stained cells, respectively. These results suggest, that the naturally occur-
ring genistein, baicalein, and SWO may have a protective benefit against chemical and photocar-
cinogenesis in vivo, by interfering at the level of DNA damage. 
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Role of suprabasal α6β4 integrin expression in squamous cell carcinoma formation
DM Owens and X Qiao Dermatology, Columbia University, New York, NY
Squamous cell carcinoma (SCC) is the second most common malignancy in Caucasians and has a
relatively high capacity for metastasis making the current rise in SCC incidence a major health issue.
Inappropriate α6β4 integrin expression correlates with a high risk of tumor progression in stratified
squamous epithelial tumors such as SCC. However, the impact of aberrant α6β4 expression in oth-
erwise normal epithelium on the initiation and course of epithelial tumorigenesis is relatively unknown.
Targeted expression of α6β4 in the suprabasal layers of transgenic mouse epidermis dramatically
increases the frequency of papillomas, squamous cell carcinomas and metastases induced by chem-
ical carcinogenesis. Suprabasal α6β4 expression also perturbs transforming growth factor β (TGFβ)
signal transduction and relieves TGFβ-mediated growth inhibition of basal cells. The disruption of
TGFβ signaling by suprabasal α6β4 has been shown to require E-cadherin-mediated intercelluar
adhesion and PI 3-kinase activity. Here we show evidence that α6β4 integrin is linked to the actin
cytoskeleton in suprabasal cells suggesting a possible role for Rho GTPases and actin cytoskeleton
reorganization in the effects of α6β4 on TGFβ signaling and epidermal tumor formation. In addi-
tion, Rac1 expression and activity is dramatically upregulated in the basal and suprabasal layers in
α6β4 transgenic epidermis compared to wt epidermis in response to tumor promoter treatment.
Manipulation of Rho GTPase-mediated actin cytoskeleton reorganization may represent a novel
mechanism of regulation of growth factor signaling pathways by epidermal tumor cells. Overall these
results illustrate how differentiated cells can influence the tumor microenvironment and the impact
of changes in the tumor microenvironment on the outgrowth and progression of SCC. 
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Hypoxia-inducible factor 1α (HIF-1α) involves in activation of transcription responses to tumor
growth as well as cellular apoptosis
RN Saladi,1,2 Y Wang,1 RG Phelps,1,2 MG Lebwohl1 and H Wei1 1 Dermatology, Mount Sinai
School of Medicine, New York, NY and 2 Dermatopathology, Mount Sinai School of Medicine, New
York, NY
In the process of tumorigenesis, lack of oxygen (hypoxia) often suppresses the tumor growth. Unfor-
tunately, many tumors adapt to this situation through the activation of hypoxia inducible factor-1α
(HIF-1α), a transcription factor which controls a series of genes (VEGF, p53, ras, p21, bcl-2 etc)
that play a key role in tumors survival and development. Chronic exposures to UV radiation, involves
the loss of wild type p53 function, subsequently forming p53 mutation. Furthermore, unrestrained
cell proliferation and clonal expansion leads to skin cancer. p53 has also been implicated in the reg-
ulation of Bcl-2 family expressed apoptotic pathways. We hypothesize that HIF-1α promotes tumor
growth by regulating transcription factors and also induces apoptosis by modulating balances between
p53 and bcl-2 genes. A series of observations on UVB induced mice skin tumors (Squamous cell
carcinomas), were stained with HIF-1α, p53 (wild type & mutant) and bcl-2 family (i.e. bcl-2, bax
and bcl-x) using immunohistochemistry and immunofluorescence. The results showed that the expres-
sion of HIF-1α correlates with wild type p53 as well as induction of mutanted p53. The anti-apop-
totic member bcl-2 diminished significantly with an increased bax and bcl-x expression, the pro-
apoptotic members. These results show a strong correlation that HIF-1α modulates p53 transcriptional
activities promoting uncontrolled cell proliferation and tumor growth, furthermore activating apop-
totic responses by regulating the balances of bcl-2 family anti and pro-apoptotic members. Based
on the observations, HIF-1α activation promotes tumor growth as well as cellular apoptosis. 
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DNA homologous to the telomere 3’ overhang induces cell senescence independent of genomic
telomere structure
BA Gilchrest,1 S Stewart,2 G Li,1 I Ben-Porath3 and MS Eller1 1 Dermatology, Boston University
School of Medicine, Boston, MA, 2 Cell Biology and Physiology, Washington University, St. Louis,
MO and 3 Whitehead Institute, Massachusetts Institute of Technology, Boston, MA
Telomeres are located at the end of linear chromosomes and consist of ~ 10,000 base pairs of TTAGGG
repeats and an ~ 100-400 base 3’ single strand overhang (ssOH) that inserts within the telomere
duplex, forming a large “T-loop” at the chromosome end. Disruption of the telomere loop structure
exposes the ssOH and rapidly induces apoptosis or senescence, both acknowledged anti-cancer mech-
anisms. It was recently demonstrated that telomeres of fibroblasts (fb) serially passed to senescence
lack the ssOH, suggesting that a blunt end may constitute the critical feature of an “uncapped” telom-
ere in senescent cells. However, treatment of human fb with oligonucleotides homologous to the
telomere overhang (T-oligos) also induces apoptosis or senescence, suggesting that exposure of the
overhang itself “uncaps” a telomere. In order to distinguish between these two possibilities, we exam-
ined the ssOH on telomeres of fb rendered senescent by treatment with T-oligo for one week, and
in fb then maintained an additional week in the absence of T-oligo. In contrast to diluent-treated
controls, over 60% of fb treated with T-oligo for one week exhibited senescence-associated β-galac-
tosidase (S.A. β-Gal) activity; expressed increased levels of p53, p53 phosphoserine 15, p21 and
p16; and were unable to phosphorylate pRb after serum stimulation. Even after an additional week
in the absence of T-oligo, the fb continued to express these protein markers and S.A. β-Gal positiv-
ity, characteristic of senescent cells. Analysis of the ssOH showed that the telomeres of these cells,
in contrast to fb serially passed to senescence, were not disrupted and the 3’ overhang was intact in
T-oligo-treated fb. These data demonstrate that a blunt-end telomere is not a prerequisite for senes-
cence and suggest that exposure of the overhang is likely the critical event in telomere “uncapping”
that initiates DNA damage responses. 
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Mre11 is central to telomere-based DNA damage responses
MS Eller, D Yao and BA Gilchrest Dermatology, Boston University School of Medicine, Boston,
MA
Telomeres are repeats of TTAGGG, ~ 10, 000 base pairs long, that cap and protect the ends of chro-
mosomes. Critically short or experimentally disrupted telomeres lose their protective function and
initiate DNA damage signaling, leading to apoptosis or senescence. Telomeres end in a 3’ overhang
normally protected within a loop structure in intact, “capped” telomeres. “Uncapped” telomeres asso-
ciate with many proteins involved in DNA repair and/or damage signaling and elicit DNA damage
responses. One such protein is the 3’ to 5’ exonuclease Mre11, mutated in the radiation-sensitive,
cancer-prone disease, Ataxia-Telangiectasia (AT)-Like Disorder (ATLD). We have shown that treat-
ment of human cells with DNA oligonucleotides homologous to the telomere overhang act through
ATM to induce DNA damage responses, presumptively by mimicking exposure of the overhang.
Only T-oligos with hydrolysable internucleotide bonds are active, suggesting a role for a nuclease
in mediating their effects. We investigated the role of Mre11 in T-oligo responses using RNAi tech-
nology, selectively “knocking-down” this protein by 50-90% compared to a negative control siRNA,
as shown by Western blot analysis. In the Mre11-depleted cells, T-oligo-induced phosphorylation of
the ATM substrates p95/Nbs1 and p53 was reduced: p95/Nbs1 serine 343 by 42% and p53 serine 15
by 90%. Furthermore, T-oligo-induced phosphorylation of p53 serine 37, a substrate for the ATR
and DNA-PK kinases, but not for ATM, was reduced in Mre11 knockdown cells by ~ 40%, sug-
gesting a role for these signaling kinases as well. Also, the induction of senescence by T-oligo was
blocked; senescence-associated β-galactosidase activity increased 18-fold with T-oligo treatment in
control siRNA cells (p<0.01, compared to diluent-treated controls) but decreased by 7% in Mre11
siRNA cells (p>0.8). These data strongly suggest that Mre11 “senses” and hydrolyses the exposed
telomere overhang at times of telomere loop disruption, signaling through ATM and likely through




Chemical inhibition of nuclear factor kappa B (NFκB) prevents UVB-induced squamous cell
carcinomas (SCCs) in SKH-1 mice
X Tang,1 AL Kim,1 L Kopelovich,2 DR Bickers1 and M Athar1 1 Dermatology, Columbia
University, New York, NY and 2 Division of Cancer Prevention, NCI, Bethesda, MD
Constitutive activation of NFκB augments tumor resistance to apoptosis and may contribute to the
induction of carcinogenesis. Paradoxically in skin, blockade of NFκB by overexpessing IκB and ras
promotes the growth of lesions resembling SCCs. We tested the chemopreventive effects of sul-
fasalazine and pyrrolidine dithiocarbamates (PDTC) chemical agents known to inhibit NFκB against
UVB-induced SCCs in SKH-1 mice. Oral administration of these agents substantially delayed tumor
formation, resulting in 1.6-fold and 4-fold decreases in tumor incidence after 25 weeks in mice receiv-
ing sulfasalazine and PDTC respectively, as compared to UVB-irradiated, non-treated animals. By
week 35, the UVB-irradiated, non-treated group had more than 20 tumors per mouse whereas the
average tumor number in the sulfasalazine and PDTC-treated groups was 9 and 2, respectively. Fur-
thermore, UVB-induced NFκB DNA binding activity was decreased by sulfasalazine and PDTC
treatment as assessed by electrophoretic mobility shift assay (EMSA). Both NFκB inhibitors decreased
the levels of cell cycle regulatory proteins (cyclins A/B1/D/E, cdk2/4/6, p53, and chk1) and prolif-
eration markers (ODC and PCNA) to levels comparable to unirradiated controls. Our results demon-
strate that pharmacological inhibition of NFκB substantially abrogates UVB-induced skin carcino-
genesis in tumor-susceptible mice. 
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Identification of putative novel genomic loci involved in sporadic basal cell carcinoma tumori-
genesis
X Cha,1 T Naylor,2 J Seykora,1 B Weber2 and S Fakharzadeh1 1 Dermatology, University of
Pennsylvania, Philadelphia, PA and 2 Abramson Cancer Research Institute, University of
Pennsylvania, Philadelphia, PA
Mutations in the PTCH or SMO genes, which are components of the SHH signaling pathway, have
been observed frequently in sporadic basal cell carcinoma (BCC). However, a significant propor-
tion of sporadic BCCs lack mutations in these or other known SHH pathway genes. We hypothesize
that alternative or additional genes may contribute to the pathogenesis of some BCCs. We screened
a panel of 24 tumors using array-based comparative genomic hybridization (aCGH) to identify loci
that are commonly lost or gained in sporadic BCCs, which may harbor tumor suppressor genes or
oncogenes, respectively. Tumor-derived genomic DNA and patient-matched normal reference DNA
were differentially-labeled with Cy3 and Cy5 fluorescent dyes and co-hybridized to a human genomic
DNA bacterial artificial chromosome (BAC) library spotted in triplicate on a glass slide. Each BAC
clone carries roughly 150 Kb of insert DNA and the genomic map position of each clone is known.
The library, which was optimized specifically for aCGH, is composed of 4134 clones that span the
human genome at a spacing interval of approximately 1 Mb. After hybridization, slides were scanned
to detect fluorescence signal intensities for each BAC clone. The ratio of the fluorescence intensi-
ties is used to calculate DNA copy number, enabling analysis of genome wide copy number in
tumor DNA. Using aCGH, we observed loss of the PTCH region at 9q22.3 in 8 of 24 (33%) sam-
ples. This finding is comparable to previously reported rates for loss of heterozygosity for PTCH in
sporadic BCC and validates our capacity to detect alterations in copy number in tumor DNA. In addi-
tion, we detected losses at 20q (29%), 17p (25%), and 19q (25%), as well as gains at 15q (25%).
These results indicate that changes in copy number at regions other than the PTCH locus are com-
mon in sporadic BCC and are likely to be non-random. We are screening additional BCC samples
to define the minimal critical regions of gain or loss at these loci and identify candidate genes that
may contribute to BCC tumorigenesis. 
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UVA modifies UVB-induced skin carcinogenesis in vivo
D Guevara, W Chi, D Gao, X Zhou, Y Wang, Y Zhu, M Lebwohl and H Wei Dermatology, Mount
Sinai School of Medicine, New York, NY
Ultraviolet (UV) irradiation has long been involved in photocarcinogenesis. UVB (290-320 nm) in
particular has been extensively reported as an initiating and promoting agent for skin carcinogene-
sis. On the other hand, UVA (330-400 nm) is considered to be a very weak initiator and promoter
of photocarcinogenesis. There have been reports showing that long wavelength UVA exposure can
increase levels of certain antioxidant enzymes. The present study has investigated combinational
effects of non-carcinogenic UVA (>360 nm) and UVB on mouse skin carcinogenesis. SKH1 hair-
less mice were irradiated with non-carcinogenic UVA at 10 and 30 KJ/m2 respectively 2 hr prior to
UVB (0.3 J/m2) treatment. The exposure combination was repeated thrice a week for 25 weeks. No
tumors were observed in UVA alone groups, whereas UVB alone groups exhibited significant tumor
incidence and multiplicity. In UVA and UVB combination groups, both tumor incidence and multi-
plicity were remarkably lower than the UVB alone group. This study suggests that UVA treatment
prior to UVB exposure significantly decreases skin carcinogenesis. The mechanism of photopro-
tective action of UVA remains unknown and requires further investigation. 
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Multiple cutaneous and uterine leiomyomata: identification of germline fumarate hydratase
mutations and evidence for a founder splicing mutation
A Martinez-Mir,1 GS Chuang,1 L Horev,3 B Glaser,3 A Geyer,1 M Landau,4 A Waldman,5
D Gordon,1 LJ Spelman,9 I Hatzibougias,11 DE Engler,1 PB Cserhalmi-Friedman,1 J Green,8
MP Garcia Muret,10 M Prieto Cid,10 S Brenner,6 E Sprecher,7 AM Christiano1,2 and A Zlotogorski3
1 Dermatology, Columbia University, New York, NY, 2 Genetics & Development, Columbia
University, New York, NY, 3 Hadassah Medical Center, Jersusalem, Israel, 4 Wolfson Medical
Center, Holon, Israel, 5 Haemek Medical Center, Afula, Israel, 6 Sourasky Medical Center, Tel-
Aviv, Israel, 7 Rambam Medical Center, Haifa, Israel, 8 St Vincent’s, Melbourne, VIC, Australia, 9
South East Dermatology, Brisbane, WA, Australia, 10 Hospital Sant Pau, Barcelona, Spain and 11
Institute of Pathology, Thessaloniki, Greece
Germline mutations in the fumarate hydratase gene (FH) predispose to multiple cutaneous and uter-
ine leiomyoma syndrome (MCL) and MCL associated with renal cell cancer (HLRCC). MCL is
inherited in an autosomal dominant manner and is characterized by the presence of concurrent benign
tumors of smooth muscle origin (leiomyoma) in the skin and uterus. In HLRCC, patients can develop
papillary renal cell carcinoma and uterine leiomyosarcoma in addition to leiomyomas. The genetic
locus for MCL and HLRCC was recently mapped to chromosome 1q42.3-43 and subsequently, muta-
tions in the fumarate hydratase gene (FH) were identified. The analysis of the FH gene in tumors of
MCL/HLRCC patients suggests that FH may function as a tumor suppressor gene. Here we report
the clinical and genetic analysis of 16 families with MCL. Mutational analysis of the FH gene revealed
13 different mutations accounting for the disease in all families. All of them are unique to single fam-
ilies, with the exception of the splicing mutation 905-1G>A, identified in four families of Iranian
origin. The analysis of highly polymorphic microsatellite markers in the vicinity of the FH gene
showed a shared haplotype in these four families, suggesting that 905-1G>A represents a founder
mutation. Collectively, we have identified 10 novel and three previously described FH mutations,
providing further evidence for the role of FH in the pathogenesis of MCL. 
154
Combined treatment with cisplatinum and HA14-1, a small molecule Bcl-2 inhibitor, results
in synergistic cell death of WM35 melanoma cells
DG Marr, YG Shellman, Y Xu, D Ribble and DA Norris Dermatology, University of Colorado
Health Sciences Center, Denver, CO
We have previously shown that stable transfection of activated H- or N-ras into the low invasive
potential, radial growth phase (RGP) melanoma cell line, WM35, produces cell lines with charac-
teristics typical of vertical growth phase (VGP) melanoma. Ras expression decreases both sponta-
neous apoptosis and cisplatinum-induced apoptosis when WM35 cells are grown in spheroid cul-
ture. Growth of melanoma cells on tissue culture plastic induces expression of Bcl-2, while anchorage
independent growth in spheroid culture does not. Ras expression, however, maintains elevated lev-
els of Bcl-2 protein and differences in susceptibility to apoptosis correlate inversely with the level
of Bcl-2 expression. HA14-1 is a small molecule nonpeptidic ligand that binds and inhibits the anti-
apoptotic activity of Bcl-2. It has also been described that HA14-1 induces translocation of Bax, a
proapoptotic Bcl-2 analog, from the cytosol to the mitochondria. We used HA14-1 to pretreat WM35
control and mutant ras-expressing cells grown in spheroid culture before exposing them to low-dose
cisplatinum. Cell death was measured using an MTS assay for viability. Apoptosis was measured
using annexin V and ethidium bromide acridine orange staining. When exposing WM35 cells to
either cisplatinum or HA14-1 alone, the level of cell death was always less than 30%. However, com-
bining HA14-1 and cisplatinum resulted in greater than 60% cell death. Mutant ras-expressing
cells, while sensitive to the effects of the Bcl-2 inhibitor on cisplatinum-induced death, appeared to
be somewhat resistant compared to the control cells. Malignant melanoma is resistant to therapy
using single drugs or radiotherapy. However, these experiments raise the possibility that Bcl-2 inhi-
bition may make melanoma susceptible to low-dose chemotherapy. 
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Ultraviolet B radiations cause an upregulation of survivin in human keratinocytes and mouse
skin
MH Aziz, AS Ghotra and N Ahmad Dermatology, University of Wisconsin, Madison, WI
Excessive exposure to solar UV radiation, particularly its UVB component (290-320 nm), to human
skin is the major cause for more than a million new cases of non-melanoma skin cancer diagnosed
annually in the USA. Understanding of the mechanism of UVB-mediated cutaneous damages is far
from complete. Here, we evaluated the involvement of survivin, which is a structurally unique
member of the inhibitors of apoptosis protein family and is known to be involved in the control of
cell division and apoptosis. The cancer-specific expression of survivin, coupled with its importance
in inhibiting cell death and in regulating cell division, makes it a target for cancer treatment. This
study was designed to investigate role of survivin in UVB-mediated damages in normal human epi-
dermal keratinocytes (NHEK) (in vitro) and in SKH-1 hairless mouse model (in vivo). For in vitro
studies, NHEKs were treated with UVB (50 mJ/cm2) and samples were processed at 5 min, 15 min,
30 min, 1 h, 3 h, 6 h, 12 h and 24 h post-treatment. Immunoblot and real-time quantitative RT-PCR
analyses showed a time-dependent increase in the levels of survivin protein and mRNA. We also
observed a time-dependent i) decrease in Smac/DIABLO, and ii) increase in p53, in NHEK. To study
the relevance of our in vitro findings to in vivo situations, we employed SKH-1 hairless mice as a
model. The mice were subjected to a single exposure of UVB (180 mJ/cm2) and samples were
processed at 3 h, 6 h, 12 h and 24 h post-UVB exposure. UVB treatment resulted in a time-depend-
ent increase in protein and RNA levels of survivin, phospho-survivin and p53 and a concomitant
decrease in Smac/DIABLO in mouse skin. We also found that UVB treatments to NHEK as well as
SKH-1 hairless mouse skin resulted in a time dependent increase in protein tyrosine kinase phos-
photransferase activity, a marker for cell cycle progression. Our results, for the first time show the
involvement of survivin (and the associated events) in UVB response. We suggest that survivin could
serve as a target for the management of UVB exposure-mediated damages including skin cancer. 
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Correlative analysis of microarrays for characterizing basal cell carcinoma: NDUFA1 and the
anaerobic tumor environment
AJ Mamelak,1 J Kowalski,2 N Yadava,3 K Murphy,4 DL Cummins,1 DJ Kouba,1 A De Benedetto,1
I Freed,1 C Esche,1 B Wang,1 IE Scheffler,3 K Berg4 and DN Sauder1 1 Dermatology, Johns
Hopkins, Baltimore, MD, 2 Oncology, Johns Hopkins, Baltimore, MD, 3 Molecular Biology
Section, UCSD, La Jolla, CA and 4 Pathology, Johns Hopkins, Baltimore, MD
Numerous mechanisms have been implicated in the development of basal cell carcinoma (BCC).
These include aberrations in tumor suppressor (PTCH and p53) and oncogene (ras) activity, UV-
induced DNA mutation, DNA mismatch repair defects, immune dysregulation and free radical induc-
tion. Furthermore, BCCs demonstrate heterogeneity with genetic polymorphisms, cytogenetic dif-
ferences and histological diversity. To elucidate the genes dysregulated in BCC while addressing
these forms of heterogeneity, we developed a novel, correlative analysis of microarrays (CAM) for
the selection of candidate genes that are commonly (among all tumors) differentially expressed.
CAM is a nested, nonparametric method designed to qualitatively select candidate genes based on
their individual, similar effects upon an array-wide closeness measure. We applied the CAM method
to a two-channel microarray experiment where individual arrays were performed on 21 BCC and
patient-matched, normal skin specimens. We selected 19 candidate genes (7 over- and 12 under-
expressed) in all represented BCCs versus normal skin. The expression of several genes in the oxida-
tive phosphorylation pathway, including the 7.5kDa NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex, 1 (NDUFA1), was consistently downregulated among tumor samples. NDUFA1 is an
accessory component of complex I that is essential for functional respiratory activity. Our findings
further support the hypothesis that irregularities in normal mitochondrial function are involved in
neoplastic disease. Our data indicates suppression of NDUFA1 represents a common and poten-
tially key pathogenic mechanism in the development of BCC. Maintaining this cornerstone of cel-
lular aerobic energy production could prevent the hypoxic stress and free radical induction that is
associated with the malignant growth and tumor progression. 
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Conditional expression of Gli2 in skin reveals a requirement for sustained hedgehog signaling
in basal cell carcinoma growth
ME Hutchin,1 T Kariapper,1 M Grachtchouk,1 A Wang,1 L Wei,1 D Cummings,1 J Liu,1
LE Michael,1,2 A Glick3 and AA Dlugosz1,2 1 Department of Dermatology, University of Michigan,
Ann Arbor, MI, 2 CMB Graduate Program, University of Michigan, Ann Arbor, MI and 3 LCCTP,
NCI/NIH, Bethesda, MD
Transient hedgehog signaling regulates epithelial growth during hair follicle morphogenesis, and
constitutive activation of this pathway has been implicated in the development of essentially all basal
cell carcinomas (BCCs). We have previously shown that the major transcriptional effector of this
pathway in skin is Gli2, which is sufficient to produce BCCs when overexpressed in mice. To exam-
ine the role of continued hedgehog signaling activity in tumor maintenance, we generated tetracy-
cline transactivator (tTA) responsive Gli2 transgenic mice (TRE Gli2). While TRE Gli2 mice were
indistinguishable from controls, bitransgenic mice that also harbored a K5 promoter driven tTA (tet
off) transgene produced multiple BCCs by 6 months of age with 100% penetrance. Administration
of doxycycline resulted in efficient deinduction of transgenic Gli2 mRNA; reduced expression of
the upregulated hedgehog target genes Ptch1, Gli1, and Hip1; and dramatic tumor regression, char-
acterized by a 90% reduction in tumor volume by three weeks. Tumor regression was associated with
a rapid inhibition of cell proliferation and striking increase in apoptosis. Although tumors did not
recur even after 5 months of transgene deinduction, a small fraction of residual keratinocytes was
detected in regressed BCCs. These cells were non-proliferative and expressed keratins K5 and K17,
similar to hair follicle keratinocytes in the resting phase of the hair cycle, but could resume prolif-
eration to form BCCs upon reactivation of Gli2 expression. Our findings demonstrate the require-
ment of sustained hedgehog/Gli2 signaling for continued growth of established BCCs. Moreover,
the residual, non-proliferative keratinocytes in regressed BCCs share several features in common
with epithelial hair follicle stem cells, and may represent tumor stem cells. 
159
T-Oligo treatment down-regulates constitutive and UV-induced COX-2 expression in cultured
cells and in murine and human skin
DA Goukassian,1 V Marwaha,1 S Arad,1 B Helms,1 H Inoue,3 R Der Sarkissian2 and BA Gilchrest1
1 Dermatology, Boston University, Boston, MA, 2 Plastic and Reconstructive Surgery, Boston
University, Boston, MA and 3 National Cardiovascular Center Research Institute, Osaka, Japan
Chronically irradiated murine skin and UV-induced SCC overexpress the inducible isoform of
cyclooxygenase (COX-2), and COX-2 inhibition reduces photocarcinogenesis in mice. p53 has been
reported to regulate COX-2 expression both positively and negatively, with discrepancies likely
related to protein level vs activity. We have previously reported that DNA oligonucleotides sub-
stantially homologous to the 3’ telomere sequence (T-oligos) enhance DNA repair capacity (DRC)
and multiple other cancer prevention responses, in part through up-regulation and activation of p53.
To determine if T-oligos affect COX-2 expression, human newborn fibroblasts were pretreated with
T-oligos (pTT or pGAGTATGAG) or diluent alone for 24 hours, then UV irradiated and processed
for western blotting. Within 24 hrs T-oligos markedly down-regulated baseline COX-2 expression,
coincident with p53 activation (phospho- p53ser15). Transcriptional repression of COX-2 gene expres-
sion by p53 was further confirmed by transfecting WT and p53DN cells with a COX-2/Luciferase
reporter plasmid. In WT but not in p53DN cells, within 48 hrs T-oligos decreased constitutive COX-
2 expression (luciferase activity) by >50% (WT - 125±30 vs 58±8, p<0.04; p53DN - 100±6 vs 94±30,
p=NS, diluent vs T-oligos n=3/group in triplicate). To examine the effect of T-oligos on COX-2
expression in intact skin, mice were pretreated topically and human skin explants were provided with
T-oligos or diluent alone in culture medium, and then irradiated 24 hrs later. Compared to controls,
T-oligos markedly decreased COX-2 immunostaining in murine and human skin both pre- and post-
UV. This coincided with increased p53 immunostaining. We conclude that T-oligos transcription-
ally down-regulate COX-2 expression by activating and up-regulating p53. This may contribute to
the observed ability of T-oligos to reduce photocarcinogenesis. 
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Deregulated p63 expression accelerates skin carcinogenesis
M Koster1 and DR Roop2,3 1 Program in Developmental Biology, Baylor College of Medicine,
Houston, TX, 2 Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX and 3
Dermatology, Baylor College of Medicine, Houston, TX
Genes that are active during normal development are frequently found to be deregulated during neo-
plastic transformation. An example of a gene that is both required for normal development and
involved in tumorigenesis is p63, a transcription factor that is required for the initiation of a strati-
fication program. While mutations in p63 are rare in human cancers, deregulated expression of dif-
ferent p63 isoforms is frequently observed in human epithelial cancers. To better understand the
role of p63 in carcinogenesis, we used inducible mouse models to target TAp63α expression to sin-
gle-layered lung epithelia or the epidermis. We found that ectopic expression of TAp63α in single-
layered lung epithelia resulted in hyperproliferation. In addition, squamous metaplastic lesions devel-
oped in the bronchioles, suggesting that TAp63 expression predisposes to neoplastic transformation.
We further targeted TAp63α expression to the basal layer of the epidermis and hair follicles. Skin
biopsies demonstrated that deregulated TAp63α expression resulted in hyperproliferation, hyper-
plasia, and a delayed onset of terminal differentiation. To determine if deregulated p63 expression
predisposed mice to develop skin cancer, we subjected our inducible mouse model to a two-stage
chemical carcinogenesis protocol. We found that deregulated TAp63α expression greatly increased
susceptibility to skin carcinogenesis. In addition, deregulated TAp63α expression caused acceler-
ated conversion to squamous cell carcinoma (SCC). Moreover, the tumors that developed in this
model rapidly progressed to spindle cell carcinoma (SPCC) and metastasized to the lung. Interest-
ingly, we found that tumor progression in this model does not appear to involve genetic instability.
Taken together, these data demonstrate that deregulated TAp63α expression induces hyperprolifer-
ation and inhibits terminal differentiation, resulting in accelerated tumorigenesis associated with
rapid progression and metastasis. 
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Benign and malignant mouse epidermal tumors have distinct transcriptional responses to
TGFβ1 in vivo reflecting tumor suppressor to oncogene switch
AB Glick, A Ryscavage and N Blazanin LCCTP, National Cancer Institute, Bethesda, MD, MD
Transforming growth factor beta (TGFβ1) has both tumor suppressive and oncogenic roles in epithe-
lial cancer progression that is dependent on the cancer stage. Our aim is to test the hypothesis that
this switch in outcome reflects altered responsiveness at the transcriptional level. We have gener-
ated tumors in mice expressing a conditionally regulated active TGFβ1 and identified TGFβ1 reg-
ulated targets in papillomas and squamous cell carcinomas (SCC) using microarray analysis. With
the TGFβ1 transgene suppressed the latency and yield of benign and malignant tumors was similar
in single transgenic (ST) and double transgenic (DT) mice. Tumor bearing mice were given dox for
48 hrs to induce TGFβ1 in tumors. Nuclear localization of Smad3 was observed in double transgenic
papillomas and some SCC after induction of TGFβ1, suggesting that the TGFβ1 signaling pathway
was intact. In papillomas induction of TGFβ1 caused a rapid shutdown of DNA synthesis while there
was no effect or a slight increase in SCC.  Microarrays were done comparing RNA from DT to ST
papillomas and DT to ST SCC, 48 hrs after addition of dox.  Surprisingly, very few genes were sim-
ilarly regulated by TGFβ in both tumor types. Of 211 genes identified as differentially expressed (p
<.02), 63% were upregulated in papillomas expressing TGFβ1 but downregulated in SCC, while
37% were upregulated in SCC expressing TGFβ1 but downregulated in papillomas. In SCC, eleva-
tion of TGFβ1 rapidly caused an expression profile consistent with a more progressed phenotype:
upregulation of genes involved in wnt signaling, a reactive stroma and invasion; downregulation of
genes involved in adhesion, apoptosis, inflammation and interferon signaling. These data are the first
to show that at the gene expression level, benign and malignant tumors respond differently to TGFβ1,
and that the acquisition of a more aggressive phenotype is a rapid transcriptional response of malig-
nant tumors to elevated TGFβ1.
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Cripto-1 induces keratin 8 and 18 expression in primary mouse keratinocytes
X Liu, A Llanso, D Salomon and A Glick National Cancer Institute, Bethesda, MD
Cripto-1, an EGF-CFC family member that is frequently overexpressed in human epithelial can-
cers, is both a coreceptor for the TGFbeta superfamily member nodal and a direct inhibitor of activin
signaling. Cripto-1 also stimulates mitogen-activated protein kinase and AKT phosphorylation. We
have identified Cripto-1 as a target of Smad7 that could mediate Smad7 induced malignant pro-
gression of v-rasHa expressing keratinocytes. Cripto-1 is rapidly induced in keratinocytes infected
with a Smad7 adenovirus, and in tumors from keratinocytes transduced with a Smad7 retrovirus.
TGFb1 superfamily members downregulated Cripto-1 expression, while Smad7 induced promoter
activity from a cotransfected human Cripto-1 promoter-luciferase construct, suggesting that Smad7
counteracts inhibitory effects of TGFb superfamily signaling on Cripto-1 expression. Similar to over-
expression of Smad7, treatment of primary mouse keratinocytes with soluble Cripto-1 induced expres-
sion of keratins 8 and 18, markers of simple epithelial dedifferentiation and malignant conversion.
However, Cripto-1 did not block the induction of keratin 1 or 10 by elevated calcium. Since ker-
atinocytes do not express nodal and activin A and activin B suppress expression of keratin 8, it is
possible that the effect of Cripto-1 on keratin 8 expression is through inhibition of endogenous activin
signaling. However, treatment of primary keratinocytes with soluble Cripto-1 induced phosphory-
lation of AKT and ERK1/2. The PI3-kinase inhibitor Wortmannin but not the MEK inhibitor UO126
blocked keratin 8 induction by Cripto-1, suggesting additional involvement of the PI3 kinase path-
way in the regulation of keratin 8 by Cripto-1. These results suggest that the simple epithelial con-
version in Smad7 expressing cells may be mediated through induction of Cripto-1. 
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Activation of p44/42 MAP kinase in keratinocytic neoplastic lesions
B Jackson and JT Seykora Department of Dermatology, University of Pennsylvania, Philadelphia,
PA
Squamous cell carcinoma (SCC) arises from a series of genetic changes that result in a clone of ker-
atinocytes with enhanced growth characteristics. The p44/42 Map kinase (Erk 1/2) pathway is a
highly conserved growth regulatory pathway that helps relay critical signals from the cell mem-
brane to the nucleus. Evidence demonstrating activation of the p44/42 pathway in the development
of human cutaneous SCC has not been established. This study was conducted to determine if p44/42
MAP kinase is activated in lesions of keratinocytic neoplasia. Lesions from the defined stages of
keratinocytic neoplasia, normal skin, actinic keratoses, proliferative actinic keratoses, squamous cell
carcinoma in situ, and squamous cell carcinoma, were randomly selected from archived material and
studied. Antibodies that detect human p44/42 (phosphorylated and unphosphorylated) and only phos-
phorylated, activated, human p44/42 were applied to lesional tissue. The intensity and prevalence of
cytoplasmic and nuclear staining was evaluated in the lesional cells. The results suggest that there
is a not a simple linear relationship between the amount of nuclear staining and the type of lesion.
However, the results suggested that there was a significant increase in the level of nuclear phospho-
rylated p44/42 staining progressing from a proliferative actinic keratoses to a sqaumous cell carci-
noma in situ. These findings suggest that p44/42 MAP kinase may be activated in the latter stages
of keratinocytic neoplasia. 
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Early occurrence of H-ras gene mutations by synergistic benzo(a)pyrene and UVA at subcar-
cinogenic levels in the skin of SKH-1 mice
Y Wang, D Gao, R Saladi, J Moore, M Lebwohl and H Wei Dermatology, Mount Sinai School of
Medicine, New York, NY
Melanoma and Non-melanoma squamous carcinoma are closely associated with UV and certain
chemicals such as benzo(a)pyrene (BaP), one of polycyclic aromatic hydrocarbons. Both UV and
BaP can cause gene mutations which are believed to be the part of initial events of carcinogenesis.
The pattern of mutations of oncogene ras remains unclear in chemo-photocarcinogenesis model. In
this study, we demonstrated that subcarcinogenic BaP and UVA caused the very early H-ras gene
mutations in skin hairless SKH-1 mice. The epidermis were collected after mice were treated with
UVA (40 kJ/m2) and/or BaP (8 nmol/mouse, topical application) thrice a week for 2, 6, and 10 weeks.
UVA or BaP alone did not induce any tumors over 25-week experiment but the combination of two
agents synergistically increased tumor incidence and multiplicity. For comparison, DNA from tumors
induced by UVB (30 mJ/cm2 thrice a week for 25 weeks) or the combination of UVA and BaP were
also investigated. Our results indicated that four types of point mutations, GAC, GCC, GTC and
CGC, occurred in UVB-induced tumors at H-ras codon 13, compared with the wild type GGC and
one type of point mutation GAA at codon 12, compared with wild type GGA. The treatment of BaP
alone and the combination of UVA plus BaP for 10 weeks have caused one type of mutation, GGA
to GAA at codon 12, and GGC to GAC at codon 13 in normal-appearance skin tissues, respectively,
as well as in BaP-UVA induced tumors. However, there were no mutations detectable in the treat-
ments with UVA alone during the 30-week period of experiment and in all the treatments with BaP
or the combination of BaP plus UVA for 2 or 6 weeks. No mutations were detected at codon 61 in
all 10-week period of treatments. In conclusion, H-ras mutation is a very early event 8 weeks before
the emergence of tumors by subcarcinogenic BaP and UVA. G—>A transversion at ras gene codon
13 was not reported previously. 
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Phorbol 12-Myristate 13-acetate (TPA) inhibits the induction of basal cell carcinomas in Ptch1+/-
mice
J Hebert,1 Y Khaimskiy,1 M Athar,2 L Kopelovich,3 D Bickers2 and E Epstein1 1 University of
California, San Francisco, San Francisco, CA, 2 Columbia University, New York, NY and 3
National Cancer Institute, Bethesda, MD
Ptch1+/- mice exposed to UV irradiation or ionizing radiation (IR) from Cesium 137 develop basal
cell carcinomas (BCCs). Ptch1 wildtype mice subjected to a standard 2-stage chemical carcinogen-
esis protocol using the polycyclic hydrocarbon 7,12-dimethylbenz[a]anthracene (DMBA) and TPA
develop papillomas and carcinomas of the squamous lineage, but not BCCs. We investigated the
tumorigenic effects of topically applied DMBA and/or TPA on the skin of Ptch1+/- mice. We have
found that a single application of DMBA (40?g) enhanced induction of BCCs, thus paralleling the
effects of UV irradiation or IR. TPA (2.5?g 3X/week) applied to otherwise untreated skin of Ptch+/-
mice had no effect on tumorigenesis, whereas application to Ptch1+/- mice previously initiated with
DMBA induced benign papillomas as occurs in Ptch1 wildtype mice. Unexpectedly, TPA reduced
the number of microscopic BCCs by ~50% in standard skin biopsies as compared to treatment with
DMBA or IR alone. The effect of TPA as an inhibitor of the induction of BCCs appears to be directly
opposite to its enhancement of SCC carcinogenesis. Elucidation of the mechanism of BCC inhibi-
tion by TPA may provide clues for development of novel chemopreventive and chemotherapeutic
agents for this most common of human cancers. 
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Deregulated hedgehog signaling in extracutaneous basaloid squamous cell carcinomas
M Grachtchouk,1 A Wang,1 L Wei,1 J Liu,1 M Hutchin,1 L Lowe,1,2 A Glick3 and AA Dlugosz1 1
Dermatology, University of Michigan, Ann Arbor, MI, 2 Pathology, University of Michigan, Ann
Arbor, MI and 3 LCCTP/NCI/NIH, Bethesda, MD
There is compelling evidence implicating uncontrolled activation of the hedgehog signaling path-
way, operating through Gli transcription factors, in the pathogenesis of basal cell carcinoma (BCC).
In contrast, little is known about the molecular basis of the biologically distinct basaloid tumors
arising in non-cutaneous sites. We have generated mice carrying a conditional Gli2 transgene, TRE-
Gli2, which is activated in the presence of the tetracycline transactivator tTA. Bitransgenic K5-
tTA;TRE-Gli2 mice thus express Gli2 in the proliferative compartment of several epithelia. In addi-
tion to BCCs in skin, a substantial proportion of these mice develop rapidly-growing tumors in the
maxilla, mandible, or nasopharynx by 4-5 months of age. These tumors consist of monomorphous,
basaloid cells with a high mitotic index; scattered foci of keratinization; and comedo necrosis: fea-
tures that are strikingly similar to those seen in human basaloid squamous cell carcinomas (BSCCs),
which also arise in the upper aerodigestive tract and elsewhere. In contrast to BCC, BSCC is a high-
grade malignancy with frequent regional metastasis and a 40-50% mortality. Like human BSCC,
the basaloid cells in odontogenic tumors from K5-tTA;TRE-Gli2 mice express keratins K5 and K17,
and cells in keratinizing foci express K1. In situ analysis revealed high-level expression of mRNA
encoding Gli2 and the hedgehog target genes Gli1 and Ptch1 in mouse BSCCs. Moreover, in two of
six human BSCCs examined, GLI1 and PTCH1 mRNA levels were upregulated to a level compa-
rable to that seen in BCCs. Early tumors in Gli2-expressing mice arose either from quiescent epithe-
lial rests within the periodontal ligament or from gingival epithelium. Our data support the concept
that in addition to typically indolent BCCs arising in skin, constitutive hedgehog pathway activity
may play a role in the pathogenesis at least some highly-aggressive extracutaneous BSCCs, which
carry a particularly poor prognosis. 
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Identification of putative genomic loci involved in the pathogenesis of Sezary syndrome
R Anolik,1 T Naylor,2 X Cha,1 M Wysocka,1 AH Rook,1 B Weber2 and S Fakharzadeh1 1
Dermatology, University of Pennsylvania, Philadelphia, PA and 2 Abramson Cancer Research
Institute, University of Pennsylvania, Philadelphia, PA
Sezary syndrome is the leukemic phase of cutaneous T cell lymphoma and represents an advanced
stage of disease. However, little is known about specific genes involved in the pathogenesis of Sezary
syndrome. Our goal is to identify genomic loci that commonly undergo gains or losses in malignant
Sezary T cells and which harbor oncogenes or tumor suppressor genes, respectively, that may con-
tribute to the pathogenesis of Sezary syndrome. Towards this end, we are using the approach of array-
based comparative genomic hybridization (aCGH). Genomic DNA from patient blood samples and
sex-matched, pooled reference DNA from normal blood samples are differentially-labeled with
Cy3 and Cy5 fluorescent dyes and co-hybridized to a human genomic DNA bacterial artificial chro-
mosome (BAC) library spotted in triplicate on a glass slide. Each BAC clone carries approximately
150 Kb of insert DNA and the genomic map position of each clone is known. The library, which was
optimized specifically for aCGH, is composed of 4134 clones that span the human genome at a
spacing interval of approximately 1 Mb. After hybridization, slides are scanned to detect fluores-
cence signal intensities for each BAC clone. The ratio of the fluorescence intensities is used to cal-
culate DNA copy number, enabling analysis of genome wide copy number in tumor cell-derived
DNA. To date, we have screened a panel of 14 high tumor burden blood samples from Sezary syn-
drome patients using aCGH. We have observed gains at 8q and 17q in 50% of the samples tested, as
well as losses at 17p (50%), 10q (43%), and 11p (29%). These results indicate that some genomic
loci are frequently subject to copy number changes in malignant Sezary T cells. We are screening
additional samples to define the minimal critical regions of gain or loss at these loci and identify can-
didate genes that may contribute to the pathogenesis of Sezary syndrome. 
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Coenzyme Q10 inhibits the proliferation of oncogenic cells while stabilizing growth in primary
cells in vitro 
NR Narain,1 J Li,1 KJ Russell,1 KV Woan,1 J He,1 I Persaud,1 CA Ricotti,1 ES Fenjves2 and
SL Hsia1 1 Dermatology & Cutaneous Surgery, University of Miami School of Medicine, Miami,
FL and 2 Diabetes Research Institute, University of Miami School of Medicine, Miami, FL
Coenzyme Q10 (Q10) is present in most human cells and is essential for the production of ATP
required for cellular activities. Q10 is a lipophilic substance thereby making it difficult to dissolve
in cell culture media. For this reason, in vitro experiments involving Q10 have often been unsuc-
cessful. Our laboratory has discovered a novel protocol that permits solubilizing Q10 in cell culture
media resulting in a homogeneous mixture. This allows studies to test the effects of various con-
centrations of Q10 on different cell lines. Human neonatal fibroblasts (nFIB) and keratinocytes (KC)
were used as primary cell models while human malignant melanoma (SKMEL28) and squamous
cell carcinoma (SCC) were used as oncogenic models. Each cell line was seeded into 6-well tissue
culture plates containing media supplemented with various concentrations of Q10 (0-100µM) under
physiologic conditions. After appropriate incubation, cells were trypsinized and counted using a
Coulter cell counter. A significant (p<0.01) increase in cell number as compared to the control for
nFIB and KC was observed, yielding a maximum increase of 20% at 50µM Q10 and 25% at 20µM
Q10, respectively. In contrast, a significant (p<0.01) inhibition of proliferation was shown to corre-
late with Q10 concentrations in the malignant cell lines. Optimal inhibition was observed at 100µM
Q10 for SKMEL28 (63%) and at 50µM Q10 for SCC (50%). The vehicle that allows for the solu-
bilization of Q10 exhibited no influence on the proliferation of any cell type. Our results demon-
strate that Q10 exerts an inhibitory effect on oncogenic cell lines while stabilizing growth of normal
cells. This implies that Q10 may be used as an effective treatment for malignancies. 
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Retinoid receptor expression in basal cell carcinoma of the skin
P So and EH Epstein Dermatology, UCSF, San Francisco, CA
Basal cell carcinoma (BCC) of the skin is the most common form of human cancer. Humans with
basal cell nevus syndrome (BCNS) develop large numbers of BCCs, and the PATCHED 1 (PTCH1)
gene is the site of the causative mutations. PTCH1 protein functions by inhibiting hedgehog signal-
ing. BCNS patients are heterozygous for a functioning PTCH1 allele, and Ptc1 heterozygous mice
develop cutaneous BCCs after exposure to ionizing or ultraviolet radiation. We have identified strong
chemopreventive efficacy of the RARβ/γ-specific retinoid, tazarotene: topical tazarotene application
reduced UV-induced BCC number and size by approximately 85%.  Similarly, in a controlled study,
we found that tazarotene was also highly effective against ionizing radiation (IR)-induced BCCs. To
begin to investigate the mechanism of this responsiveness, we assessed murine BCCs and Ptc1+/-
skin for retinoid receptor gene and protein expression. Ptc1 +/- mice were exposed to a single dose
of 5 Gy IR and skin biopsies were taken 7 months after exposure, a time when all skin specimens
contained microscopic BCCs. Visible BCC tumors that developed on the same animals were excised,
and RNA and protein extracts from all samples were analyzed by real-time PCR and Western blot-
ting, respectively. As reported by others, we find that in human and mouse skin, the predominant
retinoid receptors expressed are RARα, RARγ and RXRα. Unlike the reported decrease in RAR
gene expression in SCCs, we find that the majority of BCCs retained expression of RARα, RARγ
and RXRα. Receptor mRNA levels did not differ between untreated skin of Ptc1+/- and Ptc1 wild-
type mice and receptor mRNA levels in treated skin with microscopic tumors were intermediate
between those of visible tumors with increased expression and those of untreated skin. Similarly, at
the protein level, all SCCs examined showed loss or RARα and RXRα expression, while the major-
ity of BCCs maintain expression of both receptors. Retention of receptors is consistent with the strong
chemopreventive effects of tazarotene against BCCs and suggests that at least part of tazarotene′s
anti-BCC effect may be via a receptor-mediated mechanism. 
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Non-denatured soybean extracts enhance skin elasticity
R Zhao,1 J Liu,2 C Bertin,3 J Ortonne,4 M Seiberg 1 and V Iotsova1 1 Skin Research Center, Johnson
& Johnson Consumer Products Worldwide, Skillman, NJ, 2 Global Skin Care Growth Platform,
Johnson & Johnson Consumer & Personal Products Worldwide, Skillman, NJ, 3 Scientific affairs,
J&J Consumer Europe, Les Moulineaux, France and 4 CPCAD, Hopital L’Archet II, Nice, France
Elastic fibers are essential extracellular matrix components of the skin, which contribute to its resilience
and elasticity. During chronological aging, synthesis of elastic fibers is reduced, and the existing
elastic fibers are degraded by elastases. Non-denatured soybean extracts were found to protect the
elastic network from degradation, and to restore elastic fiber synthesis. Using a luciferase reporter
assay, non-denatured soybean extracts were shown to induce elastin promoter activity in a dose
dependent manner. Non-denatured soybean extracts inhibited the activity of human leukocyte elas-
tase in vitro, and protected elastic fibers of fibroblast cultures from degradation by exogenous elas-
tase. Human facial skins were treated with non-denatured soy extracts for 8 and 12 weeks, respec-
tively, in two independent clinical trials. Monthly cutometer measurements demonstrated statistically
significant increase in skin firmness as early as 4 weeks, and sustained to the end of treatment in
each study. These data suggest the possible use of non-denatured soybean extracts in skin care, to
improve skin elasticity. 
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Ganglioside GM3 exerts reciprocal effects on MMP-9 and MMP-2 expression in the presence
of uPA
P Sun, X Wang, L Go and AS Paller Dermatology and Pediatrics, Northwestern Univ. Med School,
Chicago, IL
Proteolytic degradation of the extracellular matrix plays a crucial role in cancer invasion and wound
healing, in which expression of urokinase-type plasminogen activator (uPA), its receptor, and matrix
metalloproteinases (MMPs) is known to be up-regulated. Two MMPs produced by squamous carci-
noma cells, MMP-9 and MMP-2, are increased during early and late wound healing, respectively.
Yet, the factors that differentially regulate the expression of these MMPs are unclear. We hypothe-
sized that endogenous alterations in ganglioside expression may differentially affect the expression
and activity of these MMPs. Expression of GM3, the predominant ganglioside of epithelial cell mem-
branes, was modified genetically or biochemically in SCC12 squamous carcinoma cells, and the
effect of GM3 expression on uPA-induced MMP expression and activity was studied. In the pres-
ence of uPA, endogenous overexpression of GM3 inhibited, and depletion of GM3 stimulated, MMP-
9 expression and activity. In contrast, endogenous overexpression of GM3 augmented MMP-2 expres-
sion and activity, but depletion of GM3 had no effect. The increase in MMP-2 expression by GM3
was inhibited by incubation of cells with either 100 nM rapamycin (inhibits p70 S6 kinase activity)
or 20 uM LY294002 (inhibits PI3K activity). The augmentation of MMP-2 expression by GM3 was
also suppressed by transient transfection with mutated protein kinase B (PKB)/Akt or kinase-dead
integrin-linked kinase (ILK), while transient transfection with wild type PKB/Akt or ILK promoted
the stimulation by GM3. Neither PKB/Akt nor ILK affected the expression of MMP-9 triggered by
depletion of GM3 in the presence of uPA. Instead, depletion of GM3 increased MMP-9 expression
and activity via activation of EGFR/Ras/mitogen-activated protein kinase signaling. These studies
implicate gangliosides as regulators of the temporal expression of MMP-9 and MMP-2 during wound
healing.
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MMP-26 (matrilysin-2/endometase) co-localizes with laminin-5 in migrating epithelial cells
and is up-regulated by cell-matrix interactions in culture
K Ahokas,1 SK Suomela,1 L Jeskanen1 and U Saarialho-Kere2 1 Dermatology, Helsinki University
Central Hospital, Helsinki, Finland and 2 Karolinska Institute, Stockholm Soder Hospital,
Stockholm, Sweden
MMP-26 was recently cloned from placenta/endometrial tumor libraries. It degrades in vitro
fibronectin, type IV collagen, vitronectin and gelatins. In vivo MMP-26 has been reported in human
cytotrophoblasts, normal endometrial glands and prostate cancer and it is widely expressed in can-
cer cell lines of epithelial origin in culture. It is autocatalytically activated and activates MMP-9. Our
objective was to investigate the expression and role of MMP-26 in skin biology. We assessed by
immunoanalysis expression of MMP-26 in benign hyperproliferative disorders of the epidermis, dur-
ing wound repair, and in basal (BCC) and squamous cell cancers (SCC). Both primary keratinocytes
and HaCaT cells were cultured in the presence of various cytokines and mRNA levels were meas-
ured using quantitative Taqman RT-PCR. In normally healing wounds, MMP-26 was detected in
migrating keratinocytes colocalizing with cytoplasmic staining for laminin-5. Mere keratinocyte
hyperproliferation, as seen in psoriasis, did not induce MMP-26. Analogously, in various tissue sam-
ples its expression did not correlate with Ki67 staining. In actinic keratoses, MMP-26 was expressed
by keratinocytes with cellular atypia in E-cadherin negative areas. BCC islands were negative, but
intensive staining was found in the invasive front of grade I SCCs, where MMP-26 also colocalized
with laminin-5. More dedifferentiated SCCs were negative for MMP-26. Unstimulated keratinocytes
and HaCat cells do not express MMP-26 mRNA. It is upregulated in keratinocyte cultures via cell-
matrix interactions. We conclude that MMP-26 may function in wound repair and influence the ini-
tial phase of skin carcinogenesis. 
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Desmogleins 1 and 3 in the companion layer are necessary to anchor the anagen hair to the
follicle
Y Hanakawa, H Li, C Lin, JR Stanley and G Cotsarelis Dermatology, University of Pennsylvania,
Philadelphia, PA
Desmogleins (Dsgs) 1 and 3 are critical for maintaining the structural integrity of epidermis through
cell-cell adhesion. Recent studies showing that, in areas where both are normally expressed, one Dsg
can compensate if the other is inactivated either by antibodies in pemphigus or exfoliative toxin
(ET) in bullous impetigo, have elucidated the pathophysiology of these diseases. Much less is known
about the role of Dsgs in hair follicles. Dsg3-/- (knockout) mice lose hair during telogen, but their
anagen hairs remain anchored to the follicle. To determine if Dsg1 compensates for the loss of Dsg3
in the anagen hair of these Dsg3-/- mice, we used ET to inactivate their Dsg1. Four hours after injec-
tion of ET, Dsg3 -/- mice, but not Dsg3 / or Dsg3 /- mice, showed striking loss of anagen hair, which
was confirmed and quantitated by gentle tape stripping. Histology of the skin of these mice as well
as of the tape-stripped hair showed separation between the outer root sheath and inner root sheath
of the hair follicle, at the plane of the companion layer. Immunostaining with AE13 for trichohyalin
and K6, a companion layer marker, in skin and stripped hair confirmed the plane of separation. Fur-
thermore, labeling of proliferating cells by BrdU demonstrated that the matrix keratinocytes respon-
sible for producing the hair shaft were below the split and remained in the follicle after anagen hair
loss. Consistent with the companion layer being the major target for loss of anchorage of anagen
hair in these mice, immunofluorescence of normal mouse follicles showed Dsg1 and Dsg3 overlap-
ping only in the companion layer. These findings demonstrate the importance of the companion layer,
and particularly the Dsg 1 and 3 in this layer, in anchoring the anagen hair to the follicle. In addi-
tion, these results may have implications for the human disease loose anagen hair syndrome, in which
anagen hair may also separate at the companion layer. 
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Co-expression of p16INK4A and laminin 5 gamma 2 in keratinocytes: a normal wound heal-
ing response that goes awry during neoplastic progression to carcinoma
E Natarajan,1 AJ Lazar,2 J Omobono,1 S Browne1 and JG Rheinwald1 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA and 2 Pathology, Brigham and Women’s Hospital, Boston, MA
We recently reported that p16INK4A (p16) and the gamma 2 chain of Laminin 5 (Lam5g2) are
coordinately expressed in early invasive regions of neoplastic epithelium in vivo, at the edges of
wounds made in confluent cultures of normal primary keratinocytes, and by senescent keratinocytes,
associated with directional hypermotility (Natarajan et al. (2003) Am J Path 163: 477-491). These
results led us to investigate whether p16/Lam5g2 coexpression occurs in wounds in vivo and to deter-
mine the cause and effect relationships between expression of these proteins and the hypermotile
phenotype. We examined 16 skin ulcers immunohistochemically for p16 and Lam5g2. In 13 of the
specimens, p16 and Lam5g2 were coordinately expressed at the normal epithelium/ulcer border and
in reepithelialized regions lacking normal basal cell layer morphology. To investigate causal rela-
tionships between Lam5 and p16 expression and hypermotility, we plated keratinocytes at low den-
sity on surfaces coated with extracellular matrix proteins secreted by the tumor cell line 804G, shown
by others to be comprised predominantly of Lam5. Normal keratinocytes plated on such a surface
expressed p16, arrested growth, and exhibited enhanced directional motility. Two cell lines cultured
from neoplastic epithelium—-one p16-deleted and the other expressing mutant p16, became direc-
tionally motile when plated on such Lam5 surfaces. In contrast, precoating culture dishes with serum,
which contains fibronectin, produced no effect. We conclude that contact with endogenously pro-
duced or exogenous Lam5 induces p16 expression and hypermotility in normal keratinocytes, but
that p16 is not essential for the hypermotile phenotype. These results suggest that p16/Lam5g2 co-
expression is an important feature of normal epidermal wound healing, causing growth arrest of the
motile cells that lead wound closure. Loss of p16 during neoplastic progression permits motile cells
to continue proliferating, thereby resulting in invasive growth. 
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FLICE/caspase-8 activation triggers anoikis induced by β1-integrin blockade in human ker-
atinocytes
A Marconi,1 C Fila,1 C Panza,1 R Tiberio,2 T Wacter,3 M Leverkus3 and C Pincelli1 1 Dermatology,
University of Modena and Reggio Emilia, Modena, Italy, 2 Medical Science, University of
Piemonte Orientale, Vercelli, Italy and 3 Dermatology, University of Wurzburg, Wurzburg,
Germany
Anoikis is a mode of cell death that occurs after detachment from the extracellular matrix. Ker-
atinocyte stem cells (KSC) leave their “niche” after disruption of β1-integrin signal. We have previ-
ously shown that KSC, but not transit amplifying (TA) cells are protected from anoikis via an inte-
grin signaling pathway. The aim of the present study was to further evaluate the mechanisms involved
in keratinocyte anoikis. KSC were selected through adherence to type IV collagen and cultured in
serum-free medium. We first demonstrated that, upon suspension, poly(ADP-ribose)polymerase
(PARP) cleavage was present in TA cells but not in KSC. In suspended cells, caspases are activated
earlier in TA than in KSC. All caspases were activated to a greater extent in keratinocytes treated
with anti-β1-integrin antibody, as compared to suspended cells. We evaluated the hierarchical acti-
vation of caspases after treatment with anti-β1-integrin. Caspase-8 activation and cytochrome c release
from mitochondria were observed at 3 hrs, while caspase-9 was activated at 6 hrs. Caspase-9 inhibitor
zLEDH-fmk failed to block caspase-8, -10, -3 and Bid activation. On the contrary, caspase-8 inhibitor
zIETD-fmk delayed the activation of caspase-9 and -3, and blocked the activation of Bid. Anti-β1-
integrin failed to cleave BID, to release cytochrome c and to activate caspase-9 in c-FLIP (FLICE/cas-
pase-8 inhibitory protein) overexpressing keratinocytes. Finally, anti-β1-integrin induced anoikis in
c-FLIP keratinocytes to a lesser degree, as compared to mock cells (p<0.01). These results demon-
strate that anoikis induced in keratinocytes by b1integrin disruption is triggered by caspase-8, which
in turn activates the executioner caspase-3 (extrinsic pathway). Anoikis seems also to be amplified
through the caspase-8-induced mitochondrial release of cytochrome c and the activation of caspase-
9 (intrinsic pathway). 




Pemphigus autoantibody binding to keratinocyte cell surfaces disrupts desmosomes and causes
Dsg3 endocytosis through an endo-lysosomal pathway
SV Setzer,1 S Summers,1 JM Jennings,1 K Tsunoda,2 M Amagai2 and AP Kowalczyk1 1 Emory
University, Atlanta, GA and 2 Keio University, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune disease characterized by the loss of epidermal cell-cell
adhesion and by the presence of autoantibodies directed against the desmosomal cadherin Dsg3. To
investigate the mechanisms by which PV autoantibodies compromise keratinocyte cell-cell adhe-
sion, primary cultures of human keratinocytes were exposed to normal human sera or to PV sera. In
addition, monoclonal antibodies directed against various epitopes of the Dsg3 extracellular domain
were used to verify that keratinocyte responses were caused by antibody ligation of Dsg3. Using an
in vitro assay to measure adhesive strength, both PV sera and a pathogenic monoclonal antibody spe-
cific to Dsg3 were found to severely compromise keratinocyte cell-cell adhesion. In contrast, nor-
mal human sera and a control Dsg3 monoclonal antibody had no effect on keratinocyte adhesion.
Immunofluorescence analysis demonstrated that PV sera caused internalization of cell sufrace Dsg3
and trafficking of Dsg3 to early endosomes. Similarly, biotinylation experiments demonstrated that
PV IgG caused a dramatic depletion of cell surface Dsg3. By 6 hrs after exposure to PV sera, Dsg3
co-localized with markers for late endosomes and lysosomes. Importantly, only PV sera and the path-
ogenic monoclonal Dsg3 antibody caused Dsg3 endocytosis, wheras a control Dsg3 monoclonal
antibody failed to cause Dsg3 internalization. Both plakoglobin and Dsc2 were co-internalized with
Dsg3, whereas desmoplakin did not colocalize with the internalized cadherin complex. However,
Dsg3 internalization was associated with the disassembly of desmosomes and with the retraction of
keratin filaments from the cell surface. Furthermore, sequential detergent extraction experiments
revealed a loss of both membrane and cytoskeletal associated Dsg3 by 24h. These findings raise the
possibility that PV autoantibodies cause changes in Dsg3 membrane trafficking and that these alter-
ations are mechanistically tied to PV pathogenicity. 
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Overexpression of MsrA protects WI38 SV40-T fibroblasts against oxidative stress
C Picot,2,1 I Petropoulos,2 M Perichon,2 C Nizard,1 S Schnebert,1 C Mahe1 and B Friguet2 1
Branche Parfums & Cosmetiques, LVMH, Saint Jean de Braye Cedex, France and 2 Laboratoire
de Biologie et Biochimie Cellulaire du Vieillissement, Universite Paris 7-Denis Diderot, Paris,
France
Proteins are modified by reactive oxygen species and oxidation of specific aminoacid residues can
impair their biological functions leading to an alteration of cellular homeostasis. Oxidized proteins
can be rapidly eliminated through either degradation or repair. Degradation of oxidized proteins is
achieved by the proteasome, a multicatalytic proteolytic system, while repair is limited to few mod-
ifications such as methionine oxidation that can be reversed by the Msr system. This system is com-
posed of MsrA and MsrB, which reduce the methionine-S-sulfoxide and the methionine-R-sulfox-
ide, respectively. However, accumulation of oxidized proteins occurs during aging, replicative
senescence, neurological disorders or after an oxidative stress while MsrA activity is impaired. MsrA
was shown to be involved in antioxidant defense in several organisms such as bacteria, yeast, drosophila
as well as mammals. To analyse more precisely the relationship between oxidative stress and MsrA,
we stably overexpressed the MsrA full-length cDNA in SV40 T antigen-immortalized human fibrob-
lasts WI38. We showed that MsrA overexpressing cells are more resistant than control cells to hydro-
gen peroxyde-induced oxidative stress at concentrations from 250 up to 500 µM. Moreover, in the
transfected cells, Msr activity is stimulated by addition of H2O2 while an H2O2-dose dependent
inhibition of the Msr activity is observed in control cells For higher concentration of hydrogen per-
oxide (750 µM), the overexpression of MsrA is no more able to protect cells from oxidative dam-
age and apoptosis. These results suggest that MsrA may play an important role in cellular defenses
against oxidative stress and in protection against apoptosis by limiting, at least in part, the accumu-
lation of oxidatively modified proteins. 
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Differential expression of cutaneous lymphocyte antigen in lymphomatoid papulosis and lym-
phomas is a potential marker for diagnosis and tumor progression
ME Kadin,1,2 H Naeem,3,2 D Kieffer,3 S King,3 P Severy,5 JL Pinkus,4 GS Pinkus4,1 and
TS Kupper3,1 1 Pathology, Harvard Medical School, Boston, MA, 2 Pathology, Beth Israel
Deaconess Medical Center, Boston, MA, 3 Dermatology, Brigham and Women’s Hospital, Boston,
MA, 4 Pathology, Brigham and Women’s Hospital, Boston, MA and 5 Medicine, Beth Israel
Deaconess Medical Center, Boston, MA
LyP is a self-healing CD30+ cutaneous lymphoproliferative disorder (CLPD) associated with lym-
phoma in 10-20% cases. Anaplastic large cell lymphoma (ALCL) is a tumor of CD30+ lymphocytes.
In normal T lymphocytes, the CLA carbohydrate epitope, expressed primarily on the PSGL-1 pro-
tein backbone, is believed to be a skin-homing receptor. We compared CLA expression in LyP, ALCL
and Hodgkin lymphoma (HL).CLA, defined as immunoreactivity with mAb HECA 452, was exam-
ined in biopsies of 15 LyP cases, 7 primary cutaneous ALCL, 2 ALCL secondary to LyP and one
HL of an LyP patient, by immunohistochemistry. CLA expression was studied in CD30+, anaplas-
tic lymphoma kinase (ALK)+ systemic, and ALK- cutaneous, ALCL lines by FACS and Western
blot. In 17 LyP skin lesions, CLA was expressed on 82+/-6% of CD30+ cells. In contrast, CLA was
displayed on 13+/-7% of tumor cells in 13 ALCL lesions, (p<.002, Mann-Whitney U test. CLA was
absent on HL tumor cells. CLA was low on ALCL lines. ALK- Mac-1 and 2B, but not 2A cutaneous
lymphoma cells, expressed PSGL-1. On blots, PSGL-1 migrated at the expected MW (240 kDa
dimer/140 kDa monomer), but all observed CLA immunoreactivity migrated at >300 kDa. CLA
expression is high on CD30+ cells in LyP but is usually low or absent in cutaneous and systemic
ALCL and HL which may provide a differential diagnostic marker for LyP and lymphoma. CLA on
ALCL lines is expressed as a >300 kd glycoprotein not yet identified but of higher MW than PSGL-
1 and CD44. Decreased CLA expression can precede progression of LyP to ALCL and should be
investigated as a new prognostic marker. 
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Fibronectin expression is post-trancriptionally up-regulated by epidermal growth factor in
human dermal fibroblasts via protein kinase C-delta signaling pathway
Y Mimura, H Ihn, M Jinnin, Y Asano, K Yamane and K Tamaki Department of Dermatology,
Faculty of Medicine, University of Tokyo, Tokyo, Japan
In the present study, we demonstrated that epidermal growth factor (EGF) up-regulates the expres-
sion of fibronectin mRNA and protein in human dermal fibroblasts. Actinomycin D, an RNA syn-
thesis inhibitor, significantly blocked basal mRNA expression, but the addition of EGF compensated
the blockage. In addition, the treatment with EGF significantly reduced the degradation rate of
fibornectin mRNA. However, EGF did not increase fibronectin promoter activity. EGF-mediated
induction of fibronectin expression was inhibited by the treatment of fibroblasts with non-selective
protein kinase C (PKC) inhibitor, Calphostin C, and selective PKC delta inhibitor, Rottlerin. The
transfection of a dominant negative mutant of PKC delta into fibroblasts significantly reduced the
induction of fibronectin protein expression by EGF. Rottlerin blocked the EGF-mediated reduction
of mRNA degradation rate. These results indicate that EGF-mediated induction of fibronectin expres-
sion occurs at the post-transcriptional level and involves PKC delta signaling pathway. 
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Expression of cutaneous lymphocyte-associated antigen on human bone-metastatic prostate
tumor cells
CJ Dimitroff Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical
School, Boston, MA
Human prostate tumors characteristically metastasize to bone marrow (BM), where prostate tumor
cells exhibit an enhanced adhesiveness to BM endothelial cells compared with adhesion to other
microvascular endothelial cells. Since E-selectin is constitutively expressed on BMEC, we hypoth-
esized that E-selectin ligand(s) on metastasizing prostate tumor cells help initiate their adhesion to
BMEC under blood flow conditions. To identify human prostate tumor cell lines expressing E-selectin
ligand activity, we performed parallel-plate flow analysis and observed robust rolling of human bone-
metastatic prostate MDA PCa 2b cells on E-selectin-Ig and on native E-selectin expressed by BMEC
cells. Furthermore, to identify prospective E-selectin glycoprotein ligands, we performed flow cyto-
metric analysis of known human hematopoietic E-selectin ligands CD44 and PSGL-1 and found that
MDA PCA 2b cells express PSGL-1 (75% positive) and low levels of CD44 (1% positive). By
Western blot analysis, we found that anti-PSGL-1 immunoprecipitate from MDA PCa 2b mem-
brane protein was stainable with moAb HECA-452, which defines cutaneous lymphocyte-associ-
ated antigen (CLA) expression, E-selectin-binding function and capacity of T-cells to enter skin. We
also identified PSGL-1 expression on five other bone-metastatic prostate tumor cell lines; however,
they did not express HECA-452-reactive PSGL-1 and coincidentally did not show remarkable E-
selectin ligand activity. These data show for the first time that human bone-metastatic prostate
tumor cells express E-selectin ligand activity and, interestingly, express CLA. Studies examining
chemokine receptor expression are underway to further elucidate BM-homing specificity. These
results establish a new prospective into the migratory mechanism of human prostate tumor metas-
tasis to BM. 
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Development of human skin equivalent by using a culture of keratinocytes and fibroblasts with-
out exogenous materials
D Lee,1,2 S Yang,2 J Lee,1 E Lee1 and J Yang1,2 1 Department of Dermatology, Samsung Medical
Center, Sungkyunkwan University School of Medicine, Seoul, South Korea and 2 Clinical Research
Center, Samsung Biomedical Research Institute, Seoul, South Korea
During the past decade, several skin equivalents have been widely used in various fields of skin
biology. However, they contain exogenous materials for dermal substrates, which may be difficult
to obtain and a source of infections. The purpose of this study was to reconstruct a human skin equiv-
alent (HSE) consisting of both epidermis and dermis by using only a culture of keratinocytes and
fibroblasts without exogenous materials. After culturing dermal fibroblasts in the medium contain-
ing several supplements for only 3 weeks fibrous matrix was formed. Then, keratinocytes were cul-
tured on the top of the fibrous matrix in air-liquid interface for 2 weeks. Histology, immunohisto-
chemistry and electron microscopy for the fibrous matrix and HSE were performed. In the fibrous
matrix, many fibroblasts were found between extracellular matrix. Collagen fibers were present by
Masson-trichrome staining and electron microscopy. In HSE multilayered epidermis with horny layer
was formed similarly to normal epidermis in vivo. Differentiated markers (keratin 1 and 10, involu-
crin) were expressed in the epidermis and the components of basement membrane (beta 4 integrin,
laminin 5, type 4 and 7 collagens) were all expressed at the dermo-epidermal junction. Ultrastruc-
turally, BMZ such as hemidesmosomes, lamina lucida and lamina densa were formed, although it
was still incomplete. These findings show that a fibrous matrix can be made by using a culture of
dermal fibroblasts for a period of 3 weeks. In addition, HSE can be constructed by culturing ker-
atinocytes on this fibrous matrix as a dermal substrate without exogenous materials, suggesting that
this model may be useful for the study of skin biology. 
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Proliferation and onset of differentiation in cultured epidermal keratinocytes : pre-programmed
pathways independent of calcium?
C Kolly, L Williamson, MM Suter and EJ Mueller Animal Pathology, University of Bern, Bern,
Switzerland
Cultured mouse and human keratinocytes are believed to require low extracellular Ca2+ to prolifer-
ate, and conversely to depend on high extracellular Ca2+ to commit to differentiation. We initially
observed that cultured canine keratinocytes proliferate equally well in low (0.09 mM) or high (1.8
mM) Ca2+-containing medium. This prompted us to complete in depth analyses on the effects of
extracellular Ca2+ on proliferation and onset of differentiation in cultured canine as well as mouse
keratinocytes. A proliferation assay confirmed that canine keratinocytes proliferate without signifi-
cant difference under both high and low Ca2+ conditions. Most interestingly, results obtained with
the cultured canine cells were reproduced with murine keratinocytes. Moreover, at confluency, both
canine and murine keratinocytes exited the cell cycle and initiated differentiation independent of the
Ca2+ concentration, as exemplified by upregulation of mRNA encoding cell cycle regulators like
p21WAF and differentiation markers like involucrin and desmosomal cadherins. Steady-state levels
of the corresponding proteins also increased in both high and low Ca2+, with the only difference that
protein levels remained lower in canine and murine cells held in low extracellular Ca2+. In conclu-
sion, our results demonstrate that extracellular Ca2+ is not crucial for proliferation and the onset of
differentiation of cultured murine and canine keratinocytes. In contrast it is the cell-cell contact that
appears to be in control of the switch from proliferation to onset of the epidermal differentiation
program.
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Collagen-like peptide exhibits a very interesting stimulating effect on the extra cellular matrix
of human skin: histological studies
A Perrin, E Bauza, C Dal Farra and N Domloge Skin Research, Vincience, Sophia Antipolis, Sophia
Antipolis, France
Recent studies of a newly developed synthetic oligo collagen-like peptide have shown that it enhances
cultured cell adhesion and differentiation, and improves ex vivo skin morphology. Consequently,
we were interested in furthering the investigation of the effects of collagen-like peptide using his-
tological studies on human ex vivo skin, and by comparing the peptide with vitamin C, which is
known for its ability to enhance the synthesis of ECM molecules such as collagen. In time course
studies that included 16h to 72h of application, we performed various immunostaining studies on
human ex vivo skin samples treated with collagen-like peptide at 1%. Comparative experiments with
vitamin C at 20 ?g/ml were conducted in parallel. The immunostaining studies included evaluations
of collagen I, III, IV, laminin 5, beta 1 integrin, filaggrin and pan keratin. The results showed that
application of collagen-like peptide to the skin enhanced the synthesis of these ECM molecules, and
this effect was seen as early as 16h after application for some molecules such as laminin 5, collagen
III, IV and pan keratin. The expression of the other molecules increased after different periods of
time of application of the peptide. Interestingly, comparative studies with vitamin C showed that the
synthesis response of some ECM molecules, such as laminin 5, collagen III, IV and pan keratin,
was greater and more rapid when prompted by collagen-like peptide than by vitamin C. The stud-
ies also demonstrated that after a longer period of time, both active ingredients stimulated ECM mol-
ecule synthesis to a similar degree, with the exception of some molecules, such as collagen IV and
beta 1, which maintained a superior synthesis after a longer period of time in response to the pep-
tide. These histological studies demonstrate the remarkable and rapid stimulating effect of the col-
lagen-like peptide on ECM molecule synthesis, revealing a property that can be of great use in anti-
aging and photoaging skin care products. 
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Age-related differences in reconstructed skin containing fibroblasts provided by donors of var-
ious ages
H Pageon and D Asselineau Life Sciences, L’Oreal, Clichy, France
Skin aging can be explained (at least in part) by the glycation reaction leading to AGEs products
(Advanced Glycosylation Ends Products) which modify the dermal architecture. To study the effect
of chronologic aging in skin, we have isolated different fibroblast populations (papillary and retic-
ular) from donors of various ages. These fibroblasts were incorporated separately in dermal equiv-
alents made either with native collagen or collagen modified by glycation. Several modifications
were observed in this system which were age dependent. I) In the epidermis, the glycation reaction
had an effect on the thickness if the dermal compartment was populated with fibroblasts extracted
from a young donor as compared to the unglycated control. The thickness of the epidermis increased
in the presence of papillary fibroblasts and decreased in the presence of reticular fibroblasts. No mod-
ifications were observed in the thickness with fibroblasts extracted from donors of advanced age. II)
While terminal differentiation was delayed in the presence of reticular fibroblasts in the dermis espe-
cially with a young donor, we observed normal filaggrin immunostaining with old donor only when
collagen modified by glycation was used. In the dermal compartment, several markers were differ-
ently expressed and were fibroblast type, age and glycation dependent. For example, chondroitin
dermatan sulfate chains were more abundant in the native collagen of the dermal compartment pop-
ulated by reticular fibroblasts as compared to papillary fibroblasts. The detection was more obvious
when the dermal compartment was made of collagen modified by glycation, especially when retic-
ular fibroblasts extracted from young donors were used. These results demonstrate, that AGEs in the
skin in vitro may modulate responses in a cell type and age dependent manner. These results also
suggest that modifications provoked by aging in skin in vivo could be explained, in part, by changes
in fibroblasts of the two populations (papillary versus reticular) like their relative proportions or their
reactivity with the environnement. 
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Differences between papillary and reticular fibroblasts in reconstructed skin
H Pageon and D Asselineau Life Sciences, L’Oreal, Clichy, France
The dermis of human skin - whose major resident cell is the fibroblast - is made of two compart-
ments : the papillary dermis (thin and close to the epidermis) and the reticular dermis (deeper and
thicker). It is possible to isolate specific fibroblast population (papillary versus reticular) from each
of these compartments. Only a few reports describe differences between papillary and reticular fibrob-
lasts in terms of proliferation, gel contraction and macromolecule synthesis. After isolation of both
fibroblast populations from the same site, we have reconstructed an in vitro skin system containing
in the dermal part either papillary or reticular fibroblast populations in order to investigate and com-
pare their biological properties. Several unexpected differences were observed, in particular epider-
mal or dermal markers were differently expressed depending on the fibroblast population. I) In the
epidermis we observed a delay in terminal differentiation when the dermal compartment contained
only reticular fibroblasts ( granular layer, filaggrin and loricrin immunostainings decrease, while ker-
atin 10 was delayed in the upper layer ) as compared to the epidermis obtained when the dermal part
contained only papillary fibroblasts. The expression of syndecan 4 in the basal layer was also more
pronounced in the presence of papillary fibroblasts as compared to reticular fibroblasts. II) In the
dermis reticular fibroblasts seemed to express more macromolecules of basement membrane zone
and extracellular matrix than papillary fibroblasts (a more intense staining of collagen IV, procolla-
gen I and procollagen III was observed in the matrix containing reticular fibroblasts as compared to
the matrix containing papillary fibroblasts). These studies strongly suggest a different influence and
specialized role of these populations in the organization and differentiation of both dermal and epi-
dermal tissues in skin. 
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Laminins 8 and 10 in skin basement membrane reconstitution and wound healing
J Li,1 L Zhu,1 RS Kirsner,1 SC Davis,1 PM Mertz,1 WH Eaglstein,1 JH Miner,2 MP Marinkovich3
and Y Zhang1 1 Dermatology and Cutaneous Surgery, University of Miami, Miami, FL, 2 Renal
Division, Washington University, St Louis, MO and 3 Dermatology, Stanford University, Stanford,
CA
Laminins are the major non-collagenous extracellular matrix components in basement membrane
zones (BMZ). Laminins influence a variety of important biological processes including cell attach-
ment, migration and tissue development. Two newly discovered laminins, laminin 8 (alpha4, beta1
and gamma1) and laminin 10 (alpha5, beta1 and gamma1), are found the major laminins produced
by human dermal microvascular endothelial cells. Laminin 10 is also found in human skin ker-
atinocytes and is present at the dermal-epidermal junction. We examined the role of laminin 8 and
laminin 10 in cutaneous wound repair. In vitro analysis showed that over-expression of laminin 8 in
dermal microvascular endothelial cells strongly promoted cell attachment, migration and capillary
tubule formation via various integrin receptors. Purified laminin 10 protein promoted keratinocyte
spreading and attachment, also mediated by integrins. Using a laminin 10 alpha5 chain knockout
mouse, excisional wounds in this model had decreased granulation tissue formation as well as abnor-
mal reepithelialization. In human wound lesions, immuno-peroxidase staining, with specific anti-
body 4C7, stained strongly positive for laminin 10 in newly formed microvascular blood vessels. In
a porcine burn wound model, Reverse Transcription and Polymerase Chain Reaction analysis found
significant increased expression of laminin 8 shortly after wounding and reached peak at the day 4.
The higher expression of laminin 10 was also seen soon after wounding and persisted through day
21, peaking at day 10. These expression patterns are consistent with the reconstitution of BMZs in
the epidermis and microvascular blood vessels within the dermis. These studies indicate laminins 8
and 10 play an important role in wound healing by promoting angiogenesis and reepithelialization. 
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Plakoglobin strengthens adhesion and suppresses keratinocyte motility via both adhesion-
dependent and -independent mechanisms
T Yin,1 S Getsios,1 R Caldelari,2 AP Kowalczyk,3 E Muller4 and KJ Green1 1 Pathology,
Northwestern University Feinberg School of Medicine, Chicago, IL, 2 CELLnTEC Advanced Cell
Systems AG, Bern, Switzerland, 3 Dermatology, Emory University School of Medicine, Atlanta, GA
and 4 Institute of Animal Pathology, University of Bern, Bern, Switzerland
Plakoglobin (PG) is a member of the Armadillo family of adhesion/signaling proteins that is criti-
cal in the organization of desmosomes. We analyzed its role in regulating intercellular adhesive
strength and cell motility using keratinocytes derived from PG-null mice. PG-/- cells exhibited weak-
ened adhesion compared to PG+/- cells in a mechanical dissociation assay, which correlated with a
reduction in desmoglein1/2 but not adherens junction proteins at cell-cell contacts. We then tested
whether weakened adhesion in PG-/- cells leads to increased motility. PG-/- cells migrated up to 9-
times faster than the PG+/- cells at 0.2mM calcium and ~4-times at 1.2mM calcium in Transwell
migration assays. Re-expressing PG via adenoviral infection restored adhesive strength and desmo-
some status, and reduced motility in PG-/- cells. Surprisingly, the effect of PG on keratinocyte
motility was not due solely to its effect on cell-cell adhesion, as single PG-/- cells migrated ~6-
times faster than PG+/- cells in colloidal gold migration assays, regardless of calcium concentra-
tion. Alterations in FAK distribution, elevated Src activity and decreased matrix adhesion were
observed in PG-/- cells, possibly contributing to the increased motility, which was inhibited by the
Src kinase inhibitor PP2. Furthermore, N-terminally truncated and full-length PG, but not C-termi-
nally truncated PG, reversed motility of PG-/- cells to the level of PG+/- cells. Thus, PG regulates
cell-cell adhesion and motility in mouse keratinocytes. Its suppression of motility involves both adhe-
sion-dependent and -independent mechanisms, the latter requiring the PG C-terminus previously
shown to harbor transcriptional transactivation activity. 
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(-)-muscone up-regulates hyaluronan synthesis at hyaluronan synthase 2 mRNA level in cul-
tured human fibroblasts
H Yoshida,1 T Sayo,1 A Kusaka,1 M Furukawa,1 Y Sugiyama,1 M Okui,2 R Komaki2 and S Inoue1
1 Basic Research Laboratory, Kanebo LTD., Odawara, Japan and 2 Cosmetic Laboratory, Kanebo
LTD., Odawara, Japan
Musk, a dried secretion from the preputial follicles of male musk deer, has been reported to have the
general pharmacological properties. In this study, we discovered that (-)-muscone, a major odorif-
erous constituent of natural musk, specifically up-regulated hyaluronan (HA) synthesis at a µM order
of concentration in cultured human skin fibroblasts, but not in keratinocytes. Northern blot analysis
showed that the expression of HA synthase 2 (HAS2) mRNA was induced in fibroblasts immediately
after the stimulation with (-)-muscone. So far, we reported that N-methyl-L-serine up-regulated HA
synthesis by increasing membrane-associated HA synthase activity of cultured fibroblasts1) without
HAS2 mRNA up-regulation. We found that the co-presence of (-)-muscone with N-methyl-L-serine
exerted a synergistic effect of HA production in fibroblasts. To date, we reported that TGF-β1 up-
regulated HA synthesis in human skin fibroblasts by inducing the expression of HAS mRNAs, gen-
erally HAS2 mRNA2). For that reason, we expect that the regulation of HAS2 expression by (-)-mus-
cone might be concerned with a TGF-β signaling pathway. In order to confirm this possibility, we
investigated that the effect of (-)-muscone on collagen synthesis in fibroblasts which has been known
to be up-regulated by TGF-β1. But the stimulation of fibroblasts with (-)-muscone did not increase
the production of collagen, suggesting that (-)-muscone might control the HA synthesis by the dif-
ferent mechanism from that of TGF-β. Study on the control of HAS2 expression by (-)-muscone may
provide a new regulation system of HA synthesis in human skin fibroblasts.
1) Sakai S., et al., (1999) Skin Pharmacol. Appl. Skin Physiol. 12, 276-283
2) Sugiyama Y., et al., (1998) J. Invest. Dermatol. 110, 116-121
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Stretch induced transactivation of EGF-receptors by integrins
Y Knies,1,2 S Kippenberger,1 J Bereiter-Hahn,2 R Kaufmann1 and A Bernd1 1 Dermatology, JW
Goethe University, Frankfurt/M., Germany and 2 Kinematic Cell Research Group, JW Goethe
University, Frankfurt/M, Germany
Testing the hypothesis of a functional and spatial association of integrins and epidermal growth fac-
tor (EGF)-receptors in cell adhesion, we studied the distribution and co-localization between beta-
1-integrins and EGF-receptors under cell stretch using immunocytochemistry and confocal laser
scanning microscopy (CLSM). Cell adhesion was tested in an usual adhesion assay and the phos-
phorylation of both, MAP kinase ERK 1/2 and EGF receptor was measured using western blotting.
We found that in most of the stretched cells beta-1-integrins were assembled in clusters at the basal
cell membrane. Such clusters were seen rarely in controls. In stretched cultures of human keratinocytes
the frequency of beta-1-integrin-clusters increased about 3 fold compared to controls. Immunocy-
tochemically, we found a co-localization of beta-1-integrins and EGF receptors after stretching, which
occurred mostly in cluster areas. Concomitantly, the application of cell stretch increased cell adhe-
sion and induced the phosphorylation of both, EGF receptors and ERK 1/2. Blocking antibodies
against beta-1-integrins as well as an inhibitor of EGF receptor tyrosine kinase prevented the stretch
induced phosphorylation of ERK 1/2. Our results show an enhancement of the adhesion properties
of stretched keratinocytes resulting in an increase of focal contacts. Co-localization of clustered beta-
1-integrins with EGF receptors indicates possible receptor interactions. From functional experiments
it could be assumed that EGF receptor activation is mediated by integrins. Finally, these findings
suggest the regulation of integrin adhesiveness via an “inside-out signaling”, namely the shift from
a low affinity to a high affinity state of the fibronectin-receptor. 
190
Study of basement membrane regeneration and epithelial cells migration during wound heal-
ing process
V Fortin,1 L Germain,1 A Deschambeault,1 P Rousselle,2 FA Auger1 and V Moulin1 1 Surgery/Laval
University, LOEX/Hopital du Saint-Sacrement, Quebec, QC, Canada and 2 IBCP, Lyon, France
Because the basement membrane is an important structure of human skin, our study investigated its
reconstruction in addition to epithelial cell migration. Epithelial cell migration was first studied by
seeding keratinocytes in six well plates coated with collagen or polylysine. After cell confluence is
reached, wounds are made with a pipet tip and healing is observed under three different conditions:
with human serum, with human plasma or calf serum as control. Cell migration was visualized on
movie from Time Lapse results. We have developed a new in vitro model of human skin reconstructed
by tissue engineering and its use simplifies the study of the wound healing process as well as recon-
struction of the basement membrane. The human reconstructed skin was first built by seeding ker-
atinocytes on two superposed fibroblast sheets. The keratinocytes differentiated and formed an epi-
dermis histologicaly similar to normal human skin. We next used a punch biopsy to create wounds
in our reconstructed tissues. Each wounded reconstructed skin was then deposited on an intact fibrob-
last sheet in order to allow healing and re-epithelialisation by keratinocytes. The basement mem-
brane formation was analyzed and characterized by immunohistochemistry. The Time Lapse results
permitted to characterize and compare the wound healing process for the three culture conditions
tested. The healing process was found to be slower in human plasma in comparison to that observed
with human serum that contain more growth factors. Expression of various constituents (laminin,
collagen, nidogen and perlecan) of the basement membrane indicated a reconstitution of a functional
basement membrane that occurs in an orderly step-by-step sequence. For example, the first con-
stituent to be deposited was laminine 5, followed by integrin α6β4, collagen IV, perlecan, collagen
VII and, nidogen. The results of the present study should help better understand the mechanisms
involved in wound healing. 
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Identification of a mutation in β4 integrin in tumor keratinocytes in vivo and its impact on α6β4
integrin-ligand binding and hemidesmosome assembly
SB Hopkinson,1 R Hasina,2 M Lingen2 and J Jones1 1 Cell and Molecular Biology, Northwestern
University, Chicago, IL and 2 Department of Pathology, University of Chicago Hospitals, Chicago,
IL
In normal keratinocytes, the α6β4 integrin regulates cell adhesion to laminin-5 in the basement mem-
brane zone (BMZ) and nucleates formation of hemidesmosomes. A motif termed the specificity deter-
mining loop (SDL) composed of 25 amino acids in the extracellular domain of the β4 integrin sub-
unit regulates α6β4 integrin interaction with laminin-5. Moreover, engineered β4 integrin subunits
containing point mutations within the SDL act as dominant negative regulators of hemidesmosome
assembly in cultured cells. Here we tested an hypothesis that tumor cells express β4 integrin con-
taining one or more mutations within the SDL. Human oral tumor specimens were subjected to
laser capture microdissection to obtain homogeneous keratinocyte tumor cell populations from which
RNA was isolated. Single stranded cDNA, generated from this RNA, was amplified by PCR using
primers encoding a portion of the extracellular domain of the β4 integrin containing the SDL. Sequence
analyses reveal that three out of four tumor cell specimens contained a Q to K mutation at residue
155 in the SDL of the β4 integrin subunit. We propose that expression of the mutated β4 integrin
leads to a loss of hemidesmosome-mediated adhesion in tumor cells. This facilitates escape of car-
cinoma cells from the constraints of the BMZ. Furthermore, unligated α6β4 integrin containing a
mutated β4 integrin subunit likely triggers signaling cascades that enhance tumor cell survival. 
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Hyaluronan synthase 2 compensates for deficiency of hyaluronan synthases 1 and 3 in skin
ME Mummert, DI Mummert, L Ellinger and A Takashima UT Southwestern, Dallas, TX
Hyaluronan (HA) is a glycosaminoglycan expressed in both epidermis and dermis. HA is synthe-
sized by HA synthases (HAS) 1, 2 and 3 which differ from one another in terms of catalytic activi-
ties and molecular sizes of products. HA has a number of roles in skin including maintenance of
architecture, wound healing and inflammation. Despite the importance of HA, little is known regard-
ing the relative contributions of the individual HAS enzymes. Using HAS1/3 double knockout (DKO)
mice, we have studied the functions of HAS2. Unlike HAS2 KO mice, showing embryonic lethal-
ity, HAS1/3 DKO mice exhibited no apparent abnormality. Skin morphology of HAS1/3 DKO mice
was indistinguishable from that of wild-type (WT) animals as assessed by histology. Organ cultures
of HAS1/3 DKO skin and WT skin showed similar capabilities to synthesize HA as measured by
3H-glucosamine uptake. By contrast, HA content was reduced in the epidermis of HAS1/3 DKO ani-
mals compared with WT counterparts based on the staining of cryostat sections with a HA-binding
peptide (termed Pep-1). Since keratinocytes (KC) represent the major HA expressing cell type in
the epidermis, we established KC lines from HAS1/3 DKO animals and WT mice to assess their
ability to synthesize HA. We observed that: a) KC from HAS1/3 DKO mice expressed mRNA only
for HAS2 whereas KC from WT animals expressed HAS1 and HAS3 (but not HAS2) mRNA, b)
HAS1/3 DKO KC were morphologically indistinguishable from WT KC, c) growth rates of HAS1/3
DKO KC were comparable to WT KC, d) HA synthesis by HAS1/3 DKO KC and WT KC were vir-
tually identical, and e) surface expression of HA was comparable between HAS1/3 DKO KC and
WT KC. Our findings that HAS1/3 DKO mice had less HA in the epidermis compared with WT
animals may suggest that HAS1 and/or HAS3 products are more efficiently maintained in the epi-
dermis than HA synthesized by HAS2. On the other hand, failure to detect differences in skin archi-
tecture, HA synthesis and KC phenotype suggests that HAS2 can compensate for HAS1 and 3 defi-
ciencies under basal conditions. 
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Elevated cystein-rich 61 (CYR61/CCN1) mediates reduced collagen production in chronolog-
ically-aged human skin fibroblasts in vitro and in vivo
T Quan, T He,Y Shao, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor,
MI
Chronological aging results in decreased synthesis of type I procollagen and increased matrix met-
alloproteinase (MMP)-mediated degradation of fibrillar collagen in human skin. Aged human skin
is thin and fragile as a consequence of this age-related reduction of collagen. Molecular mecha-
nisms responsible for the observed aberrant collagen homeostasis are not fully understood. Cystein-
rich protein 61 (CYR61/CCN1), a novel mediator of collagen homeostasis, is substantially increased
in chronologically aged, compared to young, human skin in vivo. We report that CYR61 mRNA is
predominantly expressed in the dermis of normal adult human skin (11-fold vs epidermis), meas-
ured by laser capture microdissection coupled quantitative real-time RT/PCR (p<0.05). Immuno-
histology revealed that CYR61 protein was expressed primarily in dermal fibroblasts and vascular
cells. In human skin fibroblasts, overexpression of CYR61 caused reduced type I procollagen expres-
sion (60%, p<0.05) and increased MMP-1 (6-fold) expression. To explore the relationship between
age-related increases of CYR61 and aberrant collagen homeostasis, we employed replicative senes-
cent dermal fibroblasts as an in vitro aging model. Type I procollagen mRNA and protein were
reduced 83% and 81%, respectively, in senescent cells, compared to subject-matched pre-senescent
cells (p<0.05). In contrast, MMP-1 mRNA and protein were increased 3.7-fold and 3.5-fold, respec-
tively, in senescent cells, compared to subject-matched pre-senescent cells (p<0.05). Importantly,
CYR61 mRNA and protein were increased in senescent cells 2.9-fold and 3.1-fold, respectively,
compared to subject-matched pre-senescent cells (p<0.05). Thus, in vitro cellular aging, like aging
in vivo, is associated with elevated CYR61 expression. Given the ability of CYR61 to regulate both
synthesis and degradation of collagen, it is likely that elevated-expression of CYR61 is a critical
mediator of collagen deficiency observed in chronologically aged human skin. 
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Is desmoglein 4 involved in the blister formation in pemphigus or impetigo?
K Nishifuji,1 T Nagasaka,1 T Ota,1 NV Whittock2 and M Amagai1 1 Department of Dermatology,
Keio University School of Medicine, Tokyo, Japan and 2 Institute of Biomedical and Clinical
Science, Peninsula Medical School, Exeter, United Kingdom
Desmogleins (Dsgs) are cadherin-type transmembrane components in desmosomes. In addition to
the three known isoforms of Dsg (Dsg1, Dsg2 and Dsg3), Dsg4 has been recently identified as a
new isoform. The purpose of this study is to determine the pathogenic involvement of Dsg4 in the
blister formation of pemphigus and impetigo. A secreted form of the entire extracellular domains of
Dsg4 (Dsg4-His) was produced by baculovirus expression. Dsg4-His was immunoprecipitated by
17/20 (85%) pemphigus foliaceus sera and 13/19 (68%) mucocutaneous pemphigus vulgaris sera,
both of which contained anti-Dsg1 IgG autoantibodies, but was not immunoprecipitated by either
the 16 mucosal dominant pemphigus vulgaris sera that contained only anti-Dsg3 IgG autoantibod-
ies or the 34 normal control sera. The Dsg4 immunoreactivities of these sera were completely abol-
ished by immunoadsorbing anti-Dsg1 IgG with Dsg1-His. IgG affinity-purified on Dsg4-His from
pemphigus foliaceus sera immunoprecipitated Dsg1. Conversely, the removal of anti-Dsg4 IgG from
pemphigus foliaceus sera did not significantly reduce the immunoreactivity against Dsg1. Further-
more, the removal of anti-Dsg4 IgG from pemphigus foliaceus sera did not significantly affect the
pathogenic activity of blister formation as determined by passive transfer model using neonatal mice.
IgG affinity-purified on rDsg4-His did not cause apparent blister formation in neonatal mice. In addi-
tion, Dsg4-His was not cleaved by the three known isoforms of exfoliative toxin (ETA, ETB, and
ETD) that are known to cause bullous impetigo and staphylococcal-scalded skin syndrome. These
data indicate that many of pemphigus foliaceus and mucocutaneous pemphigus vulgaris sera react
with Dsg4 due to cross-reactivity by a subset of anti-Dsg1 IgG, and that Dsg4 is not directly involved
in pathogenic process of blister formation in pemphigus or impetigo. 
197
Role of reactive oxygen species in TGF-β1 -induced tropoelastin gene expression in dermal
fibroblasts 
A Mitsumoto,2 W Choi2 and IE Kochevar2 1 Dermatology, Harvard Medical School, Boston, MA
and 2 Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical
School, Boston, MA
Photoaged skin contains markedly increased levels of elastin but the mechanisms underlying this
accumulation are only poorly understood. In vitro, TGF-β1 induces tropoelastin synthesis by der-
mal fibroblasts and, in a murine model of photoaging, antioxidants inhibited solar elastosis. Since
UVB induces TGF-β1 production in skin and binding of TGF-β1 to its receptor stimulates rapid for-
mation of reactive oxygen species (ROS) in many cell types, we hypothesized that these ROS may
contribute to upregulation of tropoelastin (TE) by TGF-β1 in dermal fibroblasts. Treatment of fibrob-
lasts with TGF-β1 (3 ng/ml) stimulated TE mRNA accumulation, measured using real time PCR,
with a maximum at 6-8 h and measurable levels to 24 h. Accumulation of TE mRNA was inhibited
by DRB, a transcription inhibitor, but not by cyclohexamide, a translation inhibitor, suggesting tran-
scriptional regulation without a role for new protein synthesis. The antioxidant, N-acetylcysteine, at
a non-toxic level (10 mM) delayed and inhibited the TGF-β1 -induced accumulation of TE mRNA
but did not influence the mRNA level of TGF-β1 induced early gene (TIEG). An inhibitor of flavin-
containing enzymes including NADPH oxidase, DPI (10µM), delayed the TGF-β1-induced TE
mRNA accumulation and reduced the level by 70% when added within 1 h of TGF-β1. DPI did not
affect the TIEG mRNA level under the same conditions. Pre-treatment of cells with NAC or DPI did
not reduce the level of TGF-β1-induced phosphorylation of Smad2. These results indicate that ROS
participate in the non-Smad signaling pathways leading to TGF-β1 upregulation of TE gene expres-
sion in human skin fibroblasts. 
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Establishing the molecular determinants for desmoglein 1-mediated adhesion
S Getsios,1 EV Amargo,1 RL Dusek,1 K Ishii,2,3 LM Godsel1 and KJ Green1 1 Pathology,
Northwestern University Feinberg School of Medicine, Chicago, IL, 2 Dermatology, Keio
University School of Medicine, Tokyo, Japan and 3 Dermatology, Tokyo Electric Power Company
Hospital, Tokyo, Japan
The targeting of desmoglein 1 (Dsg 1) by autoimmune antibodies or bacterial exfoliative toxins
(ET) promotes epidermal blister formation, presumably by disrupting desmosomal-based intercel-
lular adhesion. Previous attempts to reconstitute adhesion in normally non-adherent fibroblastic L
cells by overexpressing a variety of desmosomal proteins, including Dsg 1, have yielded mixed
results. We adopted two complementary approaches to better resolve the molecular determinants
for Dsg 1-mediated adhesion: 1) stable L cell lines containing desmocollin 1 (Dsc 1) and plakoglo-
bin (Pg) along with a tetracycline-inducible Dsg 1 construct were used to tightly regulate the ratio
of desmosomal cadherins expressed by these fibroblasts and 2) adhesion-competent primary human
keratinocytes were forced to overexpress Dsg 1. The ability of single L cell suspensions expressing
Dsc 1 and Pg to form aggregates was directly dependent on the level of Dsg 1 expressed by these
cultures and occurred in a time- and calcium-dependent fashion. ETA, which specifically cleaves
the Dsg 1 ectodomain, abrogated this Dsg1-mediated adhesion but did not alter the ability of L cells
expressing E-cadherin to aggregate. The simple introduction of Dsg 1 alone in keratinocytes was
sufficient to increase the aggregation of single cells and further enhanced the adhesive strength of
intact epithelial sheets in a manner that could be inhibited by ETA. Whereas the induction of Dsg 1
expression had little effect on the levels of Dsc 1 present in aggregated L cells, the introduction of
Dsg 1 was capable of increasing endogenous Dsc 1 expression in keratinocytes. Taken together, these
observations demonstrate that Dsg 1 promotes the formation of functional intercellular adhesion
complexes and suggest that the relative ratio of desmosomal cadherins expressed at the cell surface
regulates this adhesive process. 
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Keratinocytes deficient in β4 integrin assemble normal arrays of laminin-5, display hyper-
motility but fail to show directed migration
S Matzno, SB Hopkinson and J Jones Cell and Molecular Biology, Northwestern University,
Chicago, IL
The α6β4 integrin plays a crucial role in epidermal cell adhesion by binding to laminin-5 in the base-
ment membrane zone (BMZ) and by inducing assembly of hemidesmosomes. It has also been pro-
posed that α6β6 integrin mediates formation of the BMZ as well as epidermal cell migration since
b4 integrin-null keratinocytes show deficiencies in motility in vivo and in vitro. To investigate these
α6β4 functions further, we have induced expression of a YFP-tagged β3 laminin subunit in normal
and β4 integrin-deficient keratinocytes and followed the fate of the labeled laminin subunit in live
cells using a spinning disk confocal microscope and by immunochemistry. YFP-β3 molecules are
secreted with their γ2 and α3 subunit partners by both cell types. Moreover, the resulting tagged
laminin-5 trimers are organized into the same intricate arrays in the matrix of the cells suggesting
that β4 integrin is not involved in laminin-5 matrix assembly. However, the most prominent feature
of the β4 integrin-deficient keratinocytes is their epidermal growth factor-dependent hypermotility
in comparison with their wild-type counterparts. Indeed, groups of the β4 integrin-deficient ker-
atinocytes show rotation around a central axis. Dramatically, they lack movement in a directed fash-
ion. In summary, our data reveal that the β4 integrin is involved in the signaling pathway(s) regu-
lating directed cell migration that is necessary for re-epithelialization of wounds. 
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Urokinase plasminogen activator (uPA) receptor/α5β1 integrin interaction and uPA-depend-
ent epithelial cell migration is regulated by gangliosides
AS Paller, P Sun, A Cowen and X Wang Dermatology and Pediatrics, Northwestern Univ. Med
School, Chicago, IL
The interaction of the urokinase-type plasminogen activator receptor (uPAR) with integrins plays a
critical role in the regulation of cell proliferation, adhesion and migration. However, the molecular
events underlying the formation of a complex comprised of uPAR and integrin are poorly under-
stood. Gangliosides have been implicated in regulating cell proliferation, adhesion and migration
by modulation of epidermal growth factor receptor (EGFR) and α5β1 integrin signaling. Both
uPAR and gangliosides are known be localized to lipid rafts, sphingolipid-cholesterol microdomains
on the plasma membrane that concentrate signaling molecules. We hypothesized that gangliosides
act as modulators of uPAR signal transduction by integrin and/or EGFR. Expression of gangliosides
GM3 and GT1b was modified genetically or biochemically in SCC12 squamous carcinoma cells,
and the effect of GM3 and GT1b expression on the association of uPAR with both α5β1 integrin
and EGFR was studied. Using immunoprecipitation and immunoblotting techniques, we have found
that endogenous increases in the expression of ganglioside GT1b or GM3 affect uPA-dependent cell
migration by preventing the complex formation of uPAR with α5β1 integrin or of uPAR/α5β1 inte-
grin with EGFR, respectively, thereby modulating focal adhesion kinase (FAK) or integrin-mediated
EGFR signaling. Although both gangliosides GT1b and GM3 inhibit uPAR-stimulated migration
through inhibition of phosphotidylinositol 3-kinase activation, GT1b affects uPAR-directed FAK
activation while GM3 inhibits uPAR-stimulated EGFR phosphorylation. Elucidation of the mecha-
nisms by which specific gangliosides modulate uPAR signaling will help us to understand uPAR
function and to develop novel ganglioside-based cancer therapies. 
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Platelet-activating factor down-regulates E-cadherin expression of melanoma cells
T Takahashi,1 I Ando,2 K Tamaki3 and F Otsuka1 1 Department of Dermatology, University of
Tsukuba, Tsukuba, Ibaraki, Japan, 2 Dermatology, Mizonokuchi Branch Hospital of Teikyo
University, Kawasaki, Japan and 3 Department of Dermatology, University of Tokyo, Tokyo, Japan
Platelet-activating factor (PAF) has been reported to have a motogenic effect on some tumor types,
leading to tumor cells invasion into connective tissue and distant metastasis.  Although the putative
involvement of PAF in the progression of malignant melanoma has been shown, the mechanism
responsible for the process of invasion and metastasis has not fully been elucidated.  In this study,
the possible role of PAF in melanoma progression was assessed by analyzing the regulatory effect
of PAF on E-cadherin expression and the motile activity in melanoma cells.  Flow cytometry analy-
sis showed that PAF dose- and time-dependently reduced cell surface expression of E-cadherin in
melanoma cell lines expressing PAF-R but failed to regulate that of a PAF-R negative cell line. The
down-regulation of E-cadherin expression was maximal at a concentration of 10-10 to 10-9 M and
after 36 h exposure of PAF.  In accordance to the down-regulation of E-cadherin expression, 10-9
M PAF reduced cohesive activity of melanoma cells, as shown by aggregation assay. Furthermore,
PAF effect on E-cadherin expression enhanced the motile activity of PAF-R positive melanoma
cells in the invasion assay using modified Boyden chambers. PAF-R antagonist TCV309 drastically
attenuated the regulatory effects of PAF on E-cadherin expression, cellular cohesion and motile activ-
ity.  E-cadherin is an adhesion molecule important for cell-cell binding and maintaining the struc-
ture of epidermal tissue. Its regulation may be responsible for pathogenesis of melanoma cells inva-
sion into dermis, which is initiated by the dissociation from the primary tumor nest and surrounding
keratinocytes in epidermal tissue. Our results suggest that PAF is a possible candidate promoting
dermal invasion of melanoma cells via E-cadherin down-regulation, and that PAF-R antagonist can
be a useful agent to suppress PAF-mediated activation of melanoma progression. 
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Pemphigus vulgaris IgG induces desmosomal transmembrane signaling
D Rubenstein,1 P Berkowitz,1 P Hu,1 Z Liu,1 L Diaz1 and J Enghild2 1 Dermatology, University of
North Carolina-Chapel Hill, Chapel Hill, NC and 2 Molecular and Structural Biology, University
of Aarhus, Aarhus, Denmark
Pemphigus vulgaris (PV) is a human autoimmune blistering disease in which pathogenic autoanti-
bodies directed against the desmosomal cadherin desmoglein-3 (dsg3) cause acantholysis, the loss
of cell-cell adhesion. Using human keratinocytes in tissue culture, we have previously demonstrated
that PV autoantibodies rapidly induce phosphorylation of intracellular proteins in a time and dose
dependent fashion. To investigate the biologic significance of these phosphorylation events, we
have approached the identification of these phosphoproteins by MALDI-TOF mass spectrosocopy
of in gel tryptic digests. Identification of these cellular phosphoproteins has enabled us to extend
these studies to an in vivo model. Using both one and two dimensional gel electrophoresis and
immunochemical techniques, we now show that the proteins first identified in tissue culture are
similarly phosphorylated when PV IgG is passively transferred to neonatal mice. The observation
that the same phosphorylation events occur both in human keratinocyte tissue culture and in vivo
mouse models provide support for the hypothesis that structural changes in the desmosomes induced
by PV autoantibodies activate cellular signal transduction cascades. Additionally, it is possible that
the observed transmembrane signaling may have a pathogenic role in PV IgG induced acantholysis. 
201
Epidermal morphogenesis and survival require basement membrane components in 3-D, organ-
otypic culture
F Andriani,1 N Segal,1 L Pfeiffer,1 L Nguyen,1 N Lin,1 A Margulis,1 U Rodeck2 and J Garlick1 1
SUNY at Stony Brook, Stony Brook, NY and 2 Thomas Jefferson University, Philadelphis, PA
The role of basement membrane components (BMC) or extracellular matrix components (EMC) on
the normalization of epidermal phenotype is not well-understood. The goal of this study was to
develop human organotypic tissue models to study the role of these components on epidermal archi-
tecture and keratinocyte differentiation, survival and growth. Human keratinocytes were grown on
polycarbonate membranes coated with purified BMC or EMC and placed on contracted Type I col-
lagen gels populated with dermal fibroblasts. Only keratinocytes grown on membranes coated with
BMC (Type IV collagen or laminin 1) generated well-stratified epithelia demonstrating all mor-
phologic layers. In contrast, tissues grown on EMC which are usually not found in basement mem-
brane (fibronectin, Type I collagen and fibrillar Type I collagen) demonstrated aberrant tissue archi-
tecture. Furthermore, only keratinocytes grown on BMC demonstrated a normalized, linear pattern
of deposition of laminin 5 and an elevated synthesis and processing of the γ2 chain of laminin 5
upon Western analysis. This demonstrated that while pre-existing BMC enabled proper organiza-
tion of basement membrane, EMC were not permissive for such assembly.  In situ TUNEL assay
revealed that no TUNEL-positive keratinocytes were seen in the basal layer when cultures were
grown on BMC in comparison to high levels of TUNEL-stained cells seen in tissues generated on
EMC. This showed that BMC supported keratinocyte survival. Expression of keratinocyte differen-
tiation markers were normalized for tissues grown on both BMC and EMC, suggesting that ker-
atinocyte differentiation was independent of these components. These studies have demonstrated
that BMC are critical microenvironmental factors that sustain keratinocyte survival and optimize
epithelial architecture. Moreover, this human culture model allows dissection of the role of connec-
tive tissue components that regulate epidermal phenotype and is a valuable tool for future studies in
epidermal biology. 
202
Characterization of the initial response of engineered human skin to sulfur mustard
P Prabhu,1 S Greenberg,1 N Lin,1 J Garfield,3 T Hamilton,2 J Petrali2 and J Garlick1 1 School of
Dental Medicine, SUNY at Stony Brook, Stony Brook, NY, 2 US Army Medical Research and
Materiel Command, Fort Detrick, MD and 3 LifeCell Inc, Branchburg, NJ
Sulfur mustard (SM) is a chemical warfare weapon known to cause blisters in human skin. Models
used in skin biology may play an important role in further understanding the pathogenesis of SM-
induced skin lesions and lead to new prophylactic measures to prevent SM injury. We have used a
new approach to identify initiating events in SM-induced injury by exposing three-dimensional (3-
D), engineered, human skin to SM and determining the morphologic, apoptotic, ultrastructural and
basement membrane (BM) alterations that lead to dermal-epidermal separation. Skin equivalents
transplanted to nude mice were exposed to SM vapor for 5,8,10 and 12 minutes and grafts were
removed 6, 24, 28 and 120 hours after exposure.  Distinct prevesication and post-vesication phases
of damage were identified 6 and 24 hours after SM exposure respectively. Prevesication injury (6
hr), characterized by apoptotic cell death, was restricted to focal groups of basal cells in a dose-
independent manner.  Electron microscopy and immunofluorescent studies have revealed the pres-
ence of intact BM during the prevesication stage, suggesting that BM may be associated with the
initiating events in SM injury. The post-vesciation stage (24hr) demonstrated dermal-epidermal
separation, dose-dependent induction of apoptosis in basal and supra-basal cells and loss of BM
integrity. In vitro skin equivalents also demonstrated similar dermal-epidermal separation and basal
cell apoptosis when exposed to 150 ug/ml SM for 7 minutes. These studies provide important proof
of concept that these human tissue models mimic tissue alterations previously observed in animal
models of SM injury and further our understanding of the mechanisms that initiate SM-induced
blisters that can advance the development of new countermeasures designed to limit SM injury. 
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K6PC-5 stimulated the proliferation and collagen synthesis in cultured human fibroblast, but
suppressed HaCaT cell proliferation in vitro
J Youm,1 H Gwak,1 M Kwon,1 K Kim,2 C Lee,2 H Kim,2 Y Lee,3 S Lee4 and B Park1 1 NeoPharm
Co., Ltd., Daejeon, South Korea, 2 Korea Research Institute of Bioscience and Biotechnology,
Taejeon, South Korea, 3 Chungbuk National University College of Pharmacy, Cheongju, South
Korea and 4 Dermatology, Yonsei University College of Medicine, Seoul, South Korea
Sphingosine-1-phosphate (S1P), the initial product of catabolism of sphigosine by sphingosine kinase,
has been implicated as an intracellular second messenger in many studies. Previous studies suggested
a positive role of S1P in the process of cutaneous wound healing, such as stimulation of prolifera-
tion and matrix formation in fibroblast, and differentiation and migration of keratinocytes. Since the
S1P is increased by activation of the sphingosine kinase, we have synthesized many novel mole-
cules, and examined the effect on the activity of sphingosine kinase. Among the various tested mol-
ecules, K6PC-5 showed high activating effect on the sphingosine kinase. In this study, we have inves-
tigated the effects of K6PC-5 on the proliferation and differentiation of fibroblast and keratinocyte
in vitro. The proliferation of cultured normal human fibroblast was enhanced by the K6PC-5 in a
dose-dependent manner and more that 30% of enhancement was observed at a concentration of
3mg/ml. The collagen synthesis in fibroblast was also increased and about 3-folds increase was seen
at a concentration of 10mg/ml. While the treatment of K6PC-5 on fibroblast showed a significant
increase in proliferation and collagen synthesis, the addition of K6PC-5 to HaCaT cells at 10mg/ml
concentration significantly suppressed the proliferation of the cells. Involucrin expression, as a marker
for terminal differentiation of keratinocytes, was increased by K6PC-5 in a dose-dependent manner.
These results suggest that the newly synthesized K6PC-5 act as a novel sphingosine kinase activa-
tor. 
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Viability and apoptosis of dermal fibroblasts after cryopreservation
J Falanga,1 D Fiore,1 N Kouttab,2 C Paiva1 and T Yufit1 1 Dermatology, Roger Williams Medical
Center, Boston University, Providence, RI and 2 Pathology, Roger Williams Medical Center,
Providence, RI
The optimal serum concentration for cryopreserving cells has not been properly defined. In this study,
using flow cytometry, we determined whether human dermal fibroblasts from adult skin display dif-
ferences in viability and apoptosis depending on the percent of fetal calf serum (FCS) used for their
cryopreservation. Cultures were cryopreserved for 4 weeks in DMEM plus DMSO and 0,10,20,50,
or 80% FCS. After thawing, cells were allowed to attach to tissue culture plastic for 4 hours, and
flow cytometry using propidium chloride (PI) to test for cell viability and annexin V (AV) for early
apoptosis were performed on attached cells and those still in the culture supernatant. Attached cells
showed no differences in viability (>90%) or apoptosis (<5%) at the various FCS concentrations.
However, in unattached fibroblasts, increasing FCS concentrations were associated with with up to
30% more viability and less apoptosis (p=0.0203 and p=0.0317; two-way ANOVA). Dermal fibrob-
lasts cultured from chronic wounds have a low proliferative capacity and are difficult to cryopre-
serve. Using the same methodology with these cells, we found that high FCS concentrations had no
effect on viability and apoptosis. We conclude that maximum FCS concentrations, up to 80%, may
be best for cryopreserving normal dermal fibroblasts. Alternate strategies are needed to properly cry-
opreserve wound cells. 
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Ultrastructural details of a protein membrane that forms at the medium surface of keratinocyte
cultures closely resemble elements of basement membranes
S Inoue,1 C Reinisch,2 E Tschachler2,3 and L Eckhart2 1 Department of Anatomy and Cell Biology,
McGill University, Montreal, QC, Canada, 2 Department of Dermatology, University of Vienna
Medical School, Vienna, Austria and 3 CE.R.I.E.S., Neuilly, France
Recently we have reported that a previously undetected proteinaceous membrane forms at the
medium/air interface of keratinocyte cultures (Eckhart, L, Reinisch, C, Inoue, S, Messner, P, Dockal,
M, Mayer, C, Tschachler, E (2003) A basement membrane-like matrix formed by cell-released pro-
teins at the medium/air interface supports growth of keratinocytes. Eur J Cell Biol 82, 549-55). The
immunohistochemical detection of collagen IV, laminins 1 and 5, the results of preliminary ultra-
structural investigations and the observation of keratinocyte growth on this matrix indicated its sim-
ilarity to basement membranes (BMs) in vivo. Here we describe the detailed ultrastructural charac-
terization of the novel membrane with the method of negative staining. A dense network of 8-10 nm
wide irregular rod-like elements formed the basic structure of the membrane. Immunolabeling showed
that these rod-like structures were composed of a core of a type IV collagen filament and that type
IV collagen filaments were arranged as a network. Heparan sulfate proteoglycan (HSPG), in the form
of 4.5-5 nm wide ribbon-like “double tracks”, was associated with the rod-like structures as a sheath
material. These features strongly resembled the structure of basement membranes in vivo. In addi-
tion to this basic structure, the membrane also contained other structures including numerous small
aggregates of HSPG “double tracks” and small loose assemblies of laminin 5 with their mode of
integration still to be clarified. The similarities in the ultrastructure of the novel keratinocyte-derived
membrane to BMs suggest that membranes forming at the medium/air interface of in vitro cell cul-
tures may be useful models for the investigation of BM structures and functions. 
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Characterization of epiplakin as an intermediate filament-associated cytolinker
A Kalinin, K Takahashi and S Jang NIAMS, NIH, Bethesda, MD
Epiplakin is a member of the plakin protein family of cytolinkers and it contains 13-16 plakin-
repeat domains (PRD) homologous to the B subdomain of desmoplakin. The last 5-8 copies of PRD
together with the linker domain are highly conserved in both human and mouse epiplakin. Epi-
plakin is expressed in various tissues such as liver, digestive tract, salivary gland, as well as skin. We
studied the subcellular distribution and interaction of human epiplakin by overlay binding assays,
immunostaining and transfection in keratinocytes and HeLa cells. Epiplakin distributed in a fila-
mentous pattern and decorated the K8/K18, K5/K14 networks, but also partially co-aligned with
vimentin intermediate filament (IF) networks. Epiplakin was also found in cell-cell contacts and
focal adhesions where it co-localized with actin. In vitro binding assays showed that the PRD of epi-
plakin interacted modestly with keratins and vimentin whereas the linker alone did not show any
binding. However, the presence of both linker and PRD fragments showed strong interaction and
preferentially associated with the assembled IF rather than keratin monomer. In addition, transient
transfection of EGFP-tagged PRD resulted in the formation of perinuclear aggregates in HeLa cells.
On the other hand, expression of linker alone produced an even distribution throughout the cyto-
plasm, accentuated at focal adhesion contacts. The expression of PRD plus linker gave a filamen-
tous pattern suggesting that both domains are required to decorate IF networks. Furthermore, West-
ern blotting showed that the level of epiplakin increased with time in primary epidermal human
keratinocytes after the calcium concentration of the media was raised. By using real-time RT-PCR,
we showed that the expression of epiplakin was up-regulated at the transcription level. Together,
these results indicate that epiplakin is a versatile cytolinker involved in (1) the interaction with ker-
atins and vimentin IFs, (2) the formation of focal adhesion complex, and (3) the process of ker-
atinocyte differentiation. 
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The β2 integrin CD11b/CD18 plays a critical role in neutrophil infiltration and elimination in
the skin in experimental autoimmune bullous pemphigoid
Z Liu,1 M Zhao,1 LA Diaz1 and TN Mayadas2 1 Dermatology, University of North Carolina at
Chapel Hill, Chapel Hill, NC and 2 Department of Pathology, Brigham and Women’s Hospital and
Harvard Medical School, Boston, MA
Bullous pemphigoid (BP) is an autoimmune bullous disease characterized by subepidermal blisters
with an inflammatory infiltrate and in vivo deposition of autoantibody and complement components
at the basement membrane. BP autoantibodies recognize two hemidesmosomal proteins, the BP230
and BP180. Inflammatory cells, including eosinophils, neutrophils, lymphocytes, and mono-
cytes/macrophages are identified in the upper dermis and bullous cavity. Using an IgG passive
transfer model, we previously showed that neonatal mice injected with rabbit anti-mouse BP180 IgG
developed a BP-like disease. Infiltrating neutrophils play a key role in subepidermal blistering in this
animal model. β2 intergrins are crucial for neutrophil recruitment in inflammation. In this study we
investigated the role of the β2 integrin CD11b/CD18 (Mac-1, CR3) in experimental BP. Wild-type
(WT) and Mac-1-deficient (Mac-1-/-) mice were injected i.d. with pathogenic anti-mBP180 IgG
and examined 24 h later. We found that Mac-1-/- mice were resistant to experimental BP with sig-
nificant reduction of neutrophil infiltration at the skin. Pretreatment of WT mice with neutralizing
antibodies against CD11b or CD18 block the pathogenic activity of anti-BP180 IgG. In addition,
Mac-1-/- mice reconstituted locally with neutrophils from Mac-1-/- mice became susceptible to
experimental BP. Time course study showed that although neutrophil infiltration in Mac-1-/- mice
were severely impaired at 24 h more infiltrating neutrophils were found in the skin of Mac-1-/- mice
compared to WT mice at early time points (2-4 h). Moreover, more neutrophils survived in the skin
of WT mice reconstituted with Mac-1-/- neutrophil than WT neutrophils. Thus, Mac-1 mediates neu-
trophil recruitment to the inflamed skin and regulates inflammation by accelerating the clearance of
infiltrating neutrophils. 
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Truncation of the distal C-terminus of collagen XVII impacts the physiologic adhesion func-
tions
C Franzke,1 D Hoeping,1 C Has,1 B Balda2 and L Bruckner-Tuderman1 1 Dept of Dermatology,
Univ. of Freiburg, Freiburg, Germany and 2 Dept of Dermatology, Augsburg Hospital, Augsburg,
Germany
Collagen XVII is a transmembrane protein in the hemidesmosomes, which mediates the adhesion
of the epidermis to the basal membrane by binding to laminin 5. Genetic defects of collagen XVII
are associated with epidermal detachment in junctional epidermolysis bullosa (JEB), but little is
known about the molecular disease mechanisms. Here we analyzed the biologic consequences of a
spontaneous deletion of the distal C-terminus of collagen XVII in a JEB patient. The underlying
mutation was a homozygous duplication of four nucleotides in exon 54 of the COL17A1 gene. It
resulted in a frame shift, an adjacent nonsense sequence of 18 amino acids, and a premature termi-
nation and elimination of 43 most C-terminal amino acids of collagen XVII, including the collage-
nous subdomain COL1. Unexpectedly, the mutation did not lead to nonsense-mediated mRNA decay,
but allowed expression of a truncated molecule, albeit at a somewhat lower level. IF staining with
antibodies to N-terminal domains of collagen XVII resulted in a positive signal in JEB skin, but the
use of an antibody directed against the distal C-terminus of collagen XVII remained negative, indi-
cating that a deleted molecule was stable in situ. Immunoblot analysis revealed both truncated col-
lagen XVII forms in JEB keratinocyte cultures, the transmembrane form and the shed ectodomain.
Analysis of the thermal stability by limited trypsin digestion showed that the helix-to-coil transition
temperature was significantly lower for the truncated collagen XVII than for wild type controls, indi-
cating abnormal folding of this molecule. These findings demonstrate that the deletion of the distal
extracellular domain of collagen XVII causes abnormal folding, inhibits physiologic ligand binding
of collagen XVII to laminin 5, and possibly increases the susceptibility to proteolytic degradation.
The findings underline the role of the distal ectodomain of collagen XVII as a basement membrane
ligand and its role in epidermal adhesion and etiopathogenesis of JEB. 
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Delta-tocopheryl glucopyranoside (tocopherol precursor) in the skin: an antioxidant that pro-
tects the extracellular matrix
C Baudouin, M Haure, M Aries and M Charveron Cell Biology Research Laboratory, Pierre Fabre
Research Institute, Toulouse, France
The extracellular matrix of the dermis, undergoes permanent remodeling due to the balance between
the synthesis and degradation of the matrix macromolecules. Matrix proteins can be broken down
by the matrix metalloproteinases (MMPs). These MMPs belong to a family of zinc-dependent
endopeptidases with a highly conserved structure. They are involved in the physiological or patho-
logical remodeling processes of the extracellular matrix. The expression and the activity of the MMPs
are closely controlled to avoid unordered degradation of the extracellular matrix. Numerous studies
have shown a correlation to occur between the overexpression of the MMPs and intrinsic skin aging
skin. MMP-1 is a collagenase that degrades dermal collagen of types I, III, VII, VIII and X. Its expres-
sion and activity are increased during time-dependent and photo-induced aging. It is also known
that the massive release of reactive oxygen species (ROS) causes oxidative stress and that the ROS
are precocious mediators of tissue aging. Overexposure to ROS, whether of intrinsic or external ori-
gin, damages essential constituents of the skin. To analyze the activity of δtocopheryl glucopyra-
noside in comparison to that of α and δtocopherol, we explored the expression of the MMP-1 gene
in human skin fibroblasts stimulated with PMA. In addition, we evaluated its effect on the peroxi-
dation of the membrane lipids and on genomic DNA damage caused by various oxidative stimuli on
cutaneous cells. In our experimental conditions, δtocopheryl glucopyranoside lowered MMP-1
gene expression by more than 50%. In addition, the antiradical action of δtocopheryl glucopyra-
noside was also shown with a massive 40% reduction of lipoperoxidation and 65% inhibition of DNA
strand breaks. These results support δtocopheryl glucopyranoside as an important antioxidant and
highlight its ability to protect the dermal matrix from external aggression. Overall, these findings
argue in favour of a probable role of δtocopheryl glucopyranoside in the prevention of cellular skin
aging.
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Genetic ablation of syndecan-1 increases proliferation and cell adhesion and delays senescence
of mouse keratinocytes
M Stepp,1 S Pal-Ghosh,1 MJ Gerdes,2 M Larsen3 and S Yuspa2 1 Anatomy and Cell Biology, George
Washington University Medical School, Washington, DC, 2 LCCTP/NCI, NIH, Bethesda, MD and
3 CDBRB/NIDCR, NIH, Bethesda, MD
Syndecan-1 null mice show signs of delayed corneal and epidermal healing (Stepp, et al., J. Cell
Science, 115, 4517-4531, 2002). Using primary epidermal keratinocytes derived from syndecan-1
null mice, we have begun to investigate the mechanisms underlying the epithelial healing defects.
Primary mouse keratinocytes from wt and syndecan-1 null 1-3 day old pups on a Balb/c background
were cultured in standard low Ca2+-(0.05mM) medium and grown for times ranging from 1 to 18
days. Cell proliferation, adhesion, and cellular senescence were assessed as well as the response of
the cells to Ca2+- induced cell differentiation. Increased cell proliferation, assessed by 3H-thymidine
incorporation, was observed in null cells compared to wt cells and was accompanied by increased
cell density at confluence. Cell adhesion was assessed on several different matrices and found to be
greater in the null keratinocytes, and this difference was accompanied by altered integrin localiza-
tion. Integrin β1 and β4 expression in null cells was increased and keratinocyte migration was reduced
in vitro, as measured by time lapse microscopy. Between 10 and 14 days after plating, the number
of senescent wt cells increased from 20% to over 90% as determined by senescence associated β-
galactosidase staining. In contrast, the senescent fraction of null keratinocytes increased from 18%
to 58% during the same time period and reached 70% only at day 18. Paradoxically, TGFβ1 secre-
tion into the media, previously associated with increased senescence, is greater in the null cells than
the wt cells suggesting that responsiveness to TGFβ1 may be altered by the loss of syndecan-1. These
data suggest that the loss of syndecan-1 impacts on several responses required for wound healing
but further studies will be required to determine which of these pathways is responsible for the
delay in healing observed when this heparan sulfate is absent. 
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Alcohol dehydrogenase decreases the ability of C. albicans to form biofilm on tunneled catheters
J Chandra,1 S Mohamed,1 PK Mukherjee,1 M Schinabeck,1 G Zhou,1 A Mitchell2 and
MA Ghannoum1 1 Dermatology, Case Western Reserve University, Cleveland, OH and 2 Columbia
Univ., New York, NY
Biofilm formed by Candida albicans (CA) at catheter skin insertion sites, hubs, skin wounds and
chronic skin ulcers is the major cause of bloodstream infections. Recently, using proteomics and
Western Blot analyses, we showed that the levels of CA alcohol dehydrogenase (Adh1p) was 3 times
lower in CA biofilms than in planktonic cells. Based on these data, we hypothesize that Adh1p plays
an inhibitory role in CA biofilm formation. To test this hypothesis, we investigated expression of
ADH1 gene (encoding Adh1p) in biofilm and planktonic CA cells (grown to 6, 12, 24 and 48h)
using Northern Blot analyses (NBA) and determined the effect of: (a) disulfiram (DF,Adh1p inhibitor),
and (b) disruption of ADH1 (adh1 strain) on CA biofilm formation. Biofilm formation was quan-
titated using tetrazolium-based metabolic activity (MA)/dry weight assays, and visualized using con-
focal microscopy (CM). NBA revealed that ADH1 levels decreased temporally in biofilm and reached
a minimal level at 48h. At the early phase (6h), the presence of DF increased biofilm formation by
5 times (Mean±SD; 0.964±0.259 MA/mg) compared to control biofilms (CB, 0.193±0.029 MA/mg,
P= 0.007). CM showed that biofilm formed in the presence of DF has more polysaccharide-rich extra-
cellular material (ECM), were much thicker and with more complex architecture than CB. Quanti-
tative analysis of 6h biofilm formed by the adh1 strain showed that deletion of the ADH1 gene
resulted in significantly greater biofilm formation than the parent strain (0.093±0.011 vs. 0.049±0.007
MA/mg respectively, P = 0.005). CM revealed that biofilm formed by the adh1 strain secreted more
ECM, was thicker and had more complex architecture (with more filaments and metabolically
active cells) than the wild type strain. Similar pattern in the increase in biofilm formation was detected
at later time points (12, 24 and 48h). These results clearly demonstrate that Adh1p has an inhibitory
role in CA biofilm formation and suggest an anti-biofilm role for this protein. 
212
Epithelial-mesenchymal interactions of cylindroma cells
M Holland, N Baksh, CJ Fitchett, IM Leigh and E O’toole Queen Mary, University of London,
London, United Kingdom
The dermal cylindroma, a tumour thought to be derived from sweat duct epithelium, is charac-
terised by an excess of basement membrane(BM). Laminin 5 is present throughout the BM-like zone
and accumulates in an unprocessed form, which might promote migration.  In this study, the migra-
tion of normal keratinocyte and cylindroma cell lines on a collagen substrate was investigated. Both
cell lines were immortalized with HPV16, E6 and E7. Migration and the migratory response to an
inhibitory laminin 5 antibody were assessed by the colloidal gold assay. Expression of laminin 5,
MMP-2, MMP-9 and MT1-MMP was assessed using immunostaining, gelatin zymography and West-
ern blotting. The expression of BM markers, keratins and wnt signalling components was studied
by immunostaining of three-dimensional organotypic cultures generated on de-epidermalized der-
mis (DED). Cylindroma cells detached faster and migrated further when compared to the control
cell line (p<0.001). The increased migration of the cylindroma cell line was inhibited by a func-
tional antibody to laminin 5, but not by a control vimentin antibody. Western blotting for MT1-MMP
demonstrated increased expression of a self-processed form of MT1-MMP in cylindroma cell lysates.
Immunostaining of the raft cultures demonstrated cylindroma cells were able to form an epithelium
and generate hair follicle-like structures that descended into the dermis. Increased expression of
laminin 5 and type VII collagen was observed in the cylindroma BM. Cylindroma raft cultures demon-
strated strong K1, K14, and K16 expression suggesting that the cylindroma cell was transdifferen-
tiating into an epidermal keratinocyte on de-epidermalized dermis with intact BM. Increased lef-1
expression was observed in cylindroma epithelium suggesting activation of the wnt pathway. In sum-
mary, these data demonstrate that laminin 5 is necessary for cylindroma cell migration, possibly
linked to the proteolytic activity of MT1-MMP. The expression profile of the cylindroma cells on
BM also suggest a role for the cylindroma gene in wnt signalling and transdifferentiation. 
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Effect of NGF on matrix metalloproteinases and tissue inhibitors of metalloproteinases pro-
duced by human dermal fibroblasts and myofibroblasts
C Gondran,1 M Dumas,1 A Marconi,2 S Schnebert,1 F Bonte1 and C Pincelli2 1 Laboratoires
L.V.M.H., Saint Jean de Braye, France and 2 Dermatology, University of Modena & Reggio Emilia,
Modena, Italy
Neurotrophin (NT) family comprises a group of functionally and structurally related proteins that,
together with their receptors, play a fundamental role in the development and survival of neuronal
cells. NT family includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF),
neurotrophin-3 (NT-3) and NT-4/5. NGF is synthesized and released by human keratinocytes as a
neurotrophic molecule for skin innervation and as a growth/survival factor for keratinocytes them-
selves. We demonstrated previously that human dermal fibroblasts (DF) and myofibroblasts (MF)
synthesize and release all neurotrophins. They express the neurotrophin high affinity receptor p75,
and the low affinity forms trkA and trkB, but not trkC. Focusing on the functional role of these neu-
rotrophins in the dermis, we observed that NGF decreased collagen I and III secretion by these
cells. We investigated therefore the effects of NGF (100 ng/ml, 48 h) on matrix metalloproteinases
(MMP) -1, -2, -3, -9, -10, -13, and their inhibitors TIMP-1 and -2 both on DF and MF using a mul-
tiplex proteome ELISA array coupled with chemiluminescent signal detection. MF were obtained
in vitro after 6 days treatment of DF with TGFb1 (1 ng/ml) expressing then alpha-smooth muscle
actin marker. DF release higher levels of MMP-3, MMP-10, MMP-13 and TIMP-1 than MF. NGF
decreases significantly MMP-2 secretion on both DF and MF since MMP-9 was only decreased in
myofibroblasts. Regarding MMP-3, NGF exhibits opposite effects, increasing and decreasing it in
DF and MF respectively. We conclude that DF and MF express different MMPs and TIMPs profiles
and that NGF and more generally neurotrophins, are involved in the extracellular matrix remodel-
ling and repair, by regulating collagens, MMPs and TIMPs synthesis and may therefore play a key
role in fibrotic processes and skin aging. 
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Estradiol down-regulates matrix metalloproteinase expression in dermal fibroblasts
SY Sevrain-Verdier, R Huo, L Zhu and J Li Dermatology and Cutaneous Surgery, University of
Miami, Miami, FL
Aged fibroblasts (FB) display a matrix degrading phenotype with increased expression of matrix
metalloproteinase-1 (MMP1) and matrix metalloproteinase-3 (MMP3) leading to a loss of dermal
collagen. It is known that estrogens increase collagen dermal content but the effect of estrogens on
dermal FB function and MMP expression is not well elucidated. By Western blot analysis, we showed
that dermal fetal fibroblasts (FB) expressed both estrogen receptors (ERs): 66 kDa- ERα and 59 kDa-
ER β proteins. To determine the estrogen effect on FB proliferation, normal human fetal FB were
placed in either DMEM supplemented with 1% dextran charcoal fetal bovine serum (FBS) or DMEM
with serum replacement (human serum albumin, human transferrin, human recombinant insulin) and
stimulated with estradiol at physiologic concentration (10-10M). Proliferation was assessed by cell
counts on day 1, 3, 6. Estradiol had no effect on FB proliferation in either DMEM supplemented
with 1% FBS or DMEM with serum replacement. Then, we studied by RT-PCR the effect of estro-
gen treatment on c-fos mRNA level. In basal conditions, FB expressed low level of c-fos mRNA,
addition of 20% FBS for 20 min induced significantly c-fos mRNA, addition of estradiol (10-10M)
did not induce c-fos mRNA demonstrating that estradiol had no direct effect on proliferation of der-
mal FB. By RT-PCR, we found that in basal conditions the expression of MMP3 in normal human
fetal FB was low. Treatment with interleukine 1 beta (IL1 beta) for 24 hours increased significantly
MMP-3 mRNA level and estradiol treatment (10-10M) down-regulated significantly the IL1 beta
induced MMP-3 mRNA level. MMP1, MMP2, tissue inhibitor of metalloproteinase -1 (TIMP1), col-
lagen I and collagen III mRNA levels were not modified by 24 hours treatment with estradiol (10-
10M). Our study suggests that estrogens could mitigate the age associated extracellular matrix degra-
dation by regulating the transcription of some matrix metalloproteinases. 
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Assembly of elastic fibers: elastin and MFAP3 interactions determined by yeast two-hybrid
genetic system
N Fujimoto, J Terlizzi, K Li, S Aho and J Uitto Dermatology and Cutaneous Biology, Jefferson
Medical College, Philadelphia, PA
Elastic fibers comprise a central elastin core associated with microfibrils which consist of 10-12
distinct proteins. The microfibrils play a critical role in elastin fibrillogenesis during development
and tissue repair by forming a scaffold into which the elastin molecules align, however, the interac-
tions between elastin and the microfibrillar proteins are not well characterized. In this study, we
examined the interactions of elastin and MFAP3, a major microfibril-associated protein, by yeast
two-hybrid genetic system. First, full-length human elastin cDNA was cloned into the GAL4 DNA
binding domain vector and MFAP3 cDNA into the GAL4 activation domain vector. Interactions were
detected by selection in Ade-, His-, Trp-, Leu- plates and using assay of β-glactosidase as reporter.
Secondly, subclones of elastin, including the C-terminal half as well as 3′-deletion clones devoid of
one or both of the two cysteines residing at the carboxyl-end of the protein, were tested. The results
showed that the elastin/MFAP3 interactive sites reside at the C-terminal half of elastin but the inter-
actions do not require the presence of cysteines. The elastin/MFAP3 interactions were confirmed by
GST-pull down assays. Thirdly, MFAP3 cDNA was divided into four approximately equal subclones
(A-D) each corresponding to a distinct α-helical region, and tested with the C-terminal fragment of
the elastin cDNA. Strong interaction was detected with the N-terminal component (A) of MFAP3.
The results indicate that defined protein domains are critical for elastin/MFAP3 interactions, and
perturbations in these sequences may result in diseases of abnormal elastin fibrillogenesis. 
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Abrogation of E-cadherin function initiates MMP-mediated transition from premalignancy
to highly invasive carcinoma
A Margulis,1 W Zhang,1 N Lin,1 J Garfield,3 HC Crawford,1 J Cao,1 S Zucker,1 NE Fusenig2 and
J Garlick1 1 SUNY at Stony Brook, Stony Brook, NY, 2 German Cancer Research Center,
Heidelberg, Germany and 3 LifeCell Inc, Branchburg, NJ
The goal of the current study was to understand how loss of E-cadherin-mediated adhesion influ-
ences the earliest stages of carcinoma progression in three-dimensional (3D) tissue models of pre-
malignant disease. This was accomplished by characterizing the behavior of early-stage, tumor
cells (HaCaT-II-4) after abrogation of E-Cadherin function in 3D, organotypic cultures containing
structured basement membrane (BM) and later transplanted to nude mice. Retroviral expression of
a fusion protein consisting of an H-2Kd extracellular domain and cytoplasmic domain of E-cadherin
(H-2Kd-Ecad) generated a dominant-negative (DN) effect on E-Cadherin function in II-4 cells result-
ing in the complete disruption of cell-cell adhesion, cytoplasmic redistribution of β-catenin and
increased cell migration. In contrast, cell-cell adhesion and subcellular distribution of β-catenin were
not altered either in cells transduced with an empty vector (pBabe) or in a fusion protein with a loss
of function deletion in its β-catenin-binding domain (H-2Kd-Ecad∆C25). When grown in 3D cul-
tures, cells expressing H-2Kd-Ecad showed loss of adherens junctional proteins from cell junctions
and underwent transition to invasive squamous cell carcinoma, which was associated with loss of
Type IV collagen and laminin 5 at the BM interface. Tumor cell invasion was blocked by the pres-
ence of MMP inhibitors, demonstrating that loss of E-cadherin function activated MMP-mediated
degradation of BM proteins. Surface transplantation of 3D cultures to nude mice demonstrated that
only H-2Kd-Ecad cells underwent accelerated tumorgenesis and generated highly invasive, aggres-
sive carcinomas that dissected through the connective tissue as single cells in vivo. These findings
provide the first evidence that loss of microenvironmental control, resulting from abrogation of E-
Cadherin-mediated adhesion, can direct the transition from precancer to highly aggressive squamous
cell carcinoma. 
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Epidermal keratinocytes utilize edogenous glutathione to modify the advanced glycation end-
product intermediate, methylglyoxal, as a mode for cytoprotection
K Goldgraben,1 T Mammone,1 M Ingrassia,1 J Mc Carthy,1 S Simon2 and D Maes1 1 Skin Biology,
Estee Lauder Co., Melville, NY and 2 Dept. of Pathology, SUNY Stony Brook, Stony Brook, NY
Proteins exposed to reducing sugars can undergo non-enzymatic glycosylation yielding the forma-
tion of Advanced Glycation Endproducts (AGE). These AGE proteins have been implicated in var-
ious pathologies including diabetes, retinopathy, aging and photoaging. Intermediates of AGE’s such
as methylglyoxal are also detrimental to cells. The reaction between methylglyoxal and amino acids,
particularly lysine and arginine, leads to the production of free radicals such as superoxide anion,
which can damage cells and structural proteins.  Glutathione has been reported to act as a cofactor
in the detoxification of methylglyoxal in vitro via the glyoxylase pathway. In these experiments, we
wanted to determine if epidermal keratinocytes utilize this pathway to provide cytoprotection from
these toxic intermediates. Viability assays were performed on normal human keratinocyte cells
challenged with methylglyoxal either with or without glutathione, or buthionine sulfoximine (BSO).
The addition of exogenous glutathione provides statistically significant increases in cell viability dis-
playing methylglyoxal detoxification by this antioxidant. The addition of BSO exacerbated the effects
of methylglyoxal displaying the need for endogenous glutathione to counteract the effects of methyl-
glyoxal. Antioxidants were investigated as well to determine the mode of action of glutathione. Treat-
ment of keratinocyte cells with Resveratrol and Butylated Hydroxytoluene did not significantly pro-
tect against methylglyoxal toxicity. 
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The absence of detectable anti-desmoglein antibodies in patients with myasthenia gravis
GW Elgart,1 H Bakshandeh1 and R Shebert2 1 Dermatology & Cutaneous Surgery, University of
Miami, Miami, FL and 2 Neurology, University of Miami School of Medicine, Miami, FL
Both pemphigus vulgaris and myasthenia gravis are diseases considered to have an autoimmune
basis. While the presence of one autoimmune process is generally believed to correlate with an
increased risk of other autoimmune diseases, the association of both pemphigus vulgaris and myas-
thenia gravis has been reported in patients at a rate greater than that expected by chance alone. In
most of the reported cases, myasthenia gravis preceded the development of pemphigus. Pemphigus
is known to be associated with antibodies directed against desmogleins 1 (DSG-1) and 3 (DSG-3),
two cell surface keratinocyte proteins which are part of the cadherin superfamily of proteins. 
We have evaluated the serum of 13 patients with documented myasthenia gravis using a commer-
cially avaliable elisa kit to evaluate for the presence of antibodies to DSG-1 or DSG-3. While there
was a trend for some of the patient sera to have non-zero levels of antibody, documented levels con-
sistent with a diagnosis of pemphigus were not observed. In this small sample, serological evidence
of anti DSG-1 and DSG-2 antibodies was not detected. 
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BP180 (type XVII collagen) triple helix assembly: evidence for multiple nucleation sites
F Van den Bergh,1 C Fu1 and GJ Giudice1,2 1 Dermatology, Med Coll Wisc, Milwaukee, WI and 2
Biochem, Med Coll Wisc, Milwaukee, WI
BP180 is a key constituent of the epidermal anchoring complex and a member of the collagen pro-
tein family. Efficient assembly of a collagen triple helix requires a nucleation step involving inter-
subunit binding that usually occurs within a terminal non-collagen domain. Previously published
reports have provided support for the hypothesis that BP180’s nucleation site resides within NC16A,
the amino-terminal non-collagenous stretch of the extracellular domain (ECD). To further examine
this issue, we have generated and structurally analyzed a series of recombinant forms of BP180,
which includes the full-length ECD (sec180e) and its counterpart with the NC16A domain removed
(sec180-delN16), as well as a pair of truncated proteins comprising the COL15-NC15 stretch expressed
either with (designated sec180-trunc) or without the NC16A domain (sec180-trunc-delN16). The
two constructs containing NC16A, i.e. sec180e and sec180-trunc, were shown to form stable homo-
trimers by chemical cross-link and gel filtration analyses. As expected for collagen triple helices,
these trimers were resistant to proteolysis and each denaturation curve showed a sharp transitional
phase with a melting temp in the range of 42-46°C. Sec180-trunc-delN16 was also able to form a
triple helix, but only at a high protein concentration or when incubated at a low temperature for an
extended time. In contrast with its counterpart containing NC16A, the denaturation of the sec180-
trunc-delN16 trimer occurred over a much broader temperature range (20-40°C), suggestive of struc-
tural heterogeneity. Unexpectedly, the construct composed of the entire BP180 ECD minus NC16A
formed a stable collagen triple helix with properties quite similar to those of its NC16A-containing
counterpart, sec180e. In summary, our findings with the shorter constructs provide strong support
for the hypothesis that NC16A functions as a nucleation site for triple helix assembly, while the
results from the longer constructs are indicative of a secondary nucleation site located within the C-
terminal portion of the BP180 ECD. 
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Skin cell attachment to an implanted transcutaneous biomaterial: a mouse model
SN Isenhath,1 ML Usui,1 RA Underwood,1 Y Miyashita,1 CA Irvin,2 WA Ciridon,2 KD Hauch,2
P Fleckman,1 BD Ratner2 and JE Olerud1 1 Medicine (Division of Dermatology), University of
Washington, Seattle, WA and 2 Bioengineering, University of Washington, Seattle, WA
Transcutaneous devices such as catheters and cannulas have become integral in the management
and treatment of disease. Currently, keratinocytes (KC) travel down along the transcutaneous devices,
creating a space between the epidermis and the device, and establishing a haven for bacterial inva-
sion and biofilm formation. Up to 250,000 cases of catheter-associated blood stream infections occur
annually with an attributable mortality rate of 12%-25% for each infection. “The development and
application of new technology holds the greatest promise for a quantum reduction in the incidence
of nosocomial infections in general, and bloodstream infections derived from devices used for intravas-
cular access in particular” (Safdar N et. al., 2002). The purpose of this study was to develop advanced
biomaterials that could be studied in an in vivo model that would permit attachment of skin cells
where transcutaneous devices penetrate the skin. Porous poly(2-hydroxyethylmethacrylate) (pHEMA)
rods of approximately 2-mm in diameter were implanted at two separate sites on the backs of twelve,
8-week-old C57 black mice. The pHEMA rods were treated with: 1) PBS, 2) carbonyldiimidazole
(CDI), and 3) CDI plus laminin-5. Dorsal skin containing the implanted biomaterial was harvested
at seven days after implantation and processed for light microscopy and immunohistochemical analy-
sis. There was evidence of KC migration into the pores of the pHEMA in the CDI and CDI plus
laminin-5 treated samples, while the KCs migrated parallel to the pHEMA in the PBS treated con-
trol samples. This in vivo model permitted examination of the pHEMA/skin interface in both paraf-
fin and O.C.T. embedded frozen tissue. These preliminary findings are encouraging for future stud-
ies to facilitate skin cell attachment where transcutaneous devices penetrate the skin. 
222
Complexity of Dsg1-a, -b, and -g expression in diverse mouse tissues and during hair follicle
formation
DM Brennan,1 Y Hu,1 A Kljuic,2 J Uitto,1 A Panteleyev,2 AM Christiano2 and MG Mahoney1 1
Dermatology, Thomas Jefferson U., Philadelphia, PA and 2 Dermatology, Columbia U., New York,
NY
The four isotypes of desmogleins (Dsg1-4) are expressed in a differentiation- and keratinization-spe-
cific manner. Recently, we reported cloning of two novel mouse Dsg1 genes, Dsg1-b and -g, flank-
ing Dsg1-a on chromosome 18. Sequence conservation between the Dsg1 isoforms is extremely high,
however diverges significantly at the extracellular anchoring (EA) domains. Here, we generate anti-
bodies using synthetic peptides and recombinant proteins localized within the EA domains. These
antibodies were used to demonstrate differential expression of Dsg1 isoforms in specific compart-
ments of embryonic and adult mouse skin. Unexpectedly, expression of Dsg1-b is observed also in
some non-epithelial tissues including the testis. Dsg1-b and -g but not Dsg1-a are detected in the
sebaceous gland epithelium. In the hair follicle, all Dsg1 isoforms are present throughout the entire
process of its development and cycling. In anagen, Dsg1-a and -b are expressed in the outer root
sheath while Dsg1-g is also detected in the inner root sheath. During anagen-catagen transition,
expression of both Dsg1-a and -b is up-regulated in diminishing hair matrix but later, in mid cata-
gen, dramatically reduced in cells within the epithelial strands that undergo active apoptosis. In late
catagen, Dsg1-a and -g are actively expressed in the zone of club hair formation while Dsg1-b is
mostly expressed in the outermost cells of permanent hair follicle portion. In telogen, Dsg1-b expres-
sion in hair follicle declines but Dsg1-a and -g levels are still high thus suggesting their significant
role in club hair formation. Also during telogen, follicular papilla cells express Dsg1-a but not
Dsg1-b or -g, however, this expression is abolished at onset of early anagen. Thus, expression of
Dsg1 isoforms is a subject of significant hair cycle-dependent changes being up-regulated in stable,
differentiating cellular compartments and declining significantly with the onset of proliferation/remod-
eling associated with elevated cell motility. 
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Melanocortin receptors in fibroblastic cell types of the skin - in vitro and in vivo expression
and functional relevance
M Boehm,1 S Staender,1 M Eickelmann,1 Z Li,1 U Blume-Peytavi,2 DJ Tobin3 and TA Luger1 1
Dept. of Dermatology, University of Muenster, Muenster, Germany, 2 Dept. of Dermatology,
University Medical Center Charite, Berlin, Germany and 3 Dept. of Biomedical Sciences,
University of Bradford, Muenster, United Kingdom
In contrast to the well established role of melanocortins on melanocyte function expression and rel-
evance of melanocortin receptors (MC-Rs) in skin fibroblasts is incompletely understood. We recently
showed that human dermal fibroblasts derived from foreskin express functional MC-1Rs which medi-
ate an inhibitory action of alpha-melanocyte-stimulating hormone (alpha-MSH) on collagen metab-
olism (Bohm et al, J. Biol. Chem. 2004, in press). Here we show by RT-PCR, immunofluorescence,
immunohistochemistry and immune electron microscopy that MC-1R expression is conserved in
vitro and in vivo in additional human fibroblastic cell types of the skin including adult dermal fibrob-
lasts, fibrosarcoma cells, connective tissue sheath fibroblasts and dermal papilla cells of the hair fol-
licle. In vitro expression of MC-1R declines as a matter of cellular senescence in dermal fibroblasts.
Interestingly, alpha-MSH inhibits the inductive effect of gamma-interferon, an important proin-
flammatory mediator in inflammatory and fibrotic skin diseases, on expression of adhesion mole-
cules such as intercellular adhesion molecule-1 in human dermal fibroblasts. These data point towards
an additional biological role of alpha-MSH as a modulator of inflammatory reactions in the con-
nective tissue compartment of the skin. 
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Chronic UVB exposure inhibits collagen gel contraction by normal human dermal fibrob-
lasts: a model for photoaging and a possible mechanism for chronologic aging 
M Ingrassia, T Mammone, R Foyouzi-Youseffi, J Mc Carthy and D Maes Skin Biology, Estee
Lauder Co., Melville, NY
The formation of a wrinkle in human skin involves multiple mechanisms including environmental
factors, chronologic aging, as well as mechanical stresses (e.g. gravitational forces, musculature fold-
ing). We investigated these various mechanisms on the ability of Normal Human Dermal Fibrob-
lasts (NHDF) to contract three dimensional collagen gels, and measured concomitant cytokine release
(IL1-?α, IL1?α receptor antagonist, IL1-?β) by these cells.  NHDF cells grown in three dimensional
collagen gels, and exposed to UVB (10, 20, 30, 40, and 50 mJ/cm2), yielded a dose dependent decrease
in contraction (35, 50, 65, 69, and 85 % respectively) with a concomitant increase in IL1 alpha and
beta. Additionally, when donor aged (45 and 92 year old) fibroblasts were seeded in three dimen-
sional collagen gels, we observed much less contraction, and contraction occurred at a slower rate.
Similarly, cytokine production was increased in these aged donors. Lastly, as a measure of mechan-
ical stress, full thickness organotypic cultures were subjected to continuous folding and cytokine lev-
els were determined. In those tissue undergoing mechanical folding, increases were observed in IL1
alpha and beta. Histologically, gross increases in apoptotic bodies were observed. These data sug-
gest that both chronologically aged fibroblasts, and UV exposed fibroblasts produce cytokines which
are involved in the decrease in cell contractility, and this decrease may contribute to the develop-
ment of a wrinkle. Similarly, mechanical stress increases cytokine production providing another
means toward the development of wrinkles. 
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Characterization of ECM-1 protein interactions by yeast two-hybrid system 
J Terlizzi,1 K Li,1 S Aho,1 N Fujimoto,1 N Oyama,2 T Hamada,2 I Chan,2 JA McGrath2 and J Uitto1
1 Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA and 2 Genetic
Skin Disease Group, St Thomas, London, United Kingdom
Lipoid proteinosis (LP), an autosomal recessive disorder affecting the skin and mucous membranes,
is characterized by deposition of hyaline material in the extracellular spaces, and results from loss-
of-function mutations in the extracellular matrix protein 1 (ECM-1), a glycoprotein expressed in the
skin and other tissues. Since the function of ECM-1 has not been fully determined, we used the
yeast two-hybrid genetic system to explore its interactions with other extracellular matrix compo-
nents. We cloned two full-length ECM-1 cDNAs into the GAL4 DNA-binding domain vector to be
used as bait vectors for two-hybrid library screening. One construct starts at the translation initia-
tion codon and continues through the stop codon, and the other lacks the secretory signal peptide.
We also generated five different partial ECM-1 bait constructs corresponding to the N-terminal cys-
teine-free domain, the central two tandem repeat domain, and the C-terminal region. From the screen-
ing of human placental cDNA library in the GAL4 activation domain vector and selection on Trp-,
Leu-, His- plates, we found that legumain, matrix metalloproteinase 9 (MMP-9, type IV collage-
nase), and epidermal growth factor (EGF) interacted with full length ECM-1. Further studies with
the partial ECM-1 bait vectors revealed that legumain and MMP-9 interact only with the two tan-
dem repeat domain, while EGF interacts with the cysteine-free and C-terminal regions of ECM-1.
These interactions were further confirmed by beta-galatosidase assays. Overall, these findings increase
the understanding of the potential mechanisms underlying dermal pathology in lipoid proteinosis as
well as the putative role of ECM-1 in normal human skin. 
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Pemphigus vulgaris antibody targets antigen that are not limited to desmogleins
P Sun,1 S Reynolds,2 N Cassai,1 G Sidhu1 and J Bystryn2 1 Pathology, NYU School of Medicine,
New York, NY and 2 Dermatology, NYU School of Medicine, New York, NY
It is currently believed that pemphigus vulgaris is caused by autoantibodies directed to antigen that
are localized strictly in the desmosomes. However, some prior immunoelectron microscopic stud-
ies have shown that the antibodies also react with keratinocyte cell membrane components other than
desmosomes. To further explore the anatomical site targeted by pemphigus antibodies, we reacted
the serum of a patient with pemphigus vulgaris and with high titer of pemphigus antibodies against
monkey esophageal epithelium using antihuman antibodies and the diaminobenzidine peroxidase
system. We then utilized electron microscopy to visualize the anatomical location of the antigen(s)
targeted by the pemphigus vulgaris antibody. We found that there was continuous staining along the
external cell membrane, including sites other than desmosomes. Control study with normal human
serum were negative for cell membrane staining. This observation suggests that in addition to
desmogleins, pemphigus antibodies target keratinocyte surface antigens that are not limited to desmo-
somes.
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BEG4 is a novel actin bundling protein
R Gonzales-Quevedo, L Horng and AE Oro Program in Epithelial Biology, Stanford University,
Stanford, CA
While it is well known that Shh controls organ growth by altering cell shape and migration, the molec-
ular basis is unknown. The Shh target gene BEG4 (Basal Cell Carcinoma Enriched Gene 4), which
is expressed in basal cell carcinomas of the skin (BCCs), shares a conserved WH2 domain with the
human Wiskott-Aldrich Syndrome protein (WASP), suggesting it may regulate actin dynamics and
consequently cell shape, adhesion and migration. Here we show that overexpression of BEG4 in the
mouse embryonic cell line C3H10T1/2 results in an altered actin cytoskeleton with reduced actin
stress fibers and the production of long cytoplasmic extensions.  This activity localizes to the con-
served 408 amino acids of the protein and does not require the G-actin binding WH2 domain. in vitro
assays and electron microscopy techniques demonstrate that this conserved region of BEG4 pro-
motes the creation of actin filament bundles. Deletions of BEG4 that lose bundling activity fail to
stimulate cytoplasmic extensions in vivo. These data demonstrate that human BEG4 is a novel actin
bundling protein expressed in BCCs that might link this tumor type to alterations in the actin cytoskele-
ton.
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Compound heterozygosity for mutations in the type VII collagen gene (COL7A1) results in
severe dystrophic epidermolysis bullosa
M Masse,1 PB Cserhalmi-Friedman,1 V Falanga,2 J Tok Celebi,1 A Martinez-Mir1 and
AM Christiano1,3 1 Dermatology, Columbia University, New York, NY, 2 Dermatology, Roger
Williams Medical Center, Providence, RI and 3 Genetics and Development, Columbia University,
New York, NY
Dystrophic epidermolysis bullosa (DEB) is a rare hereditary bullous disease caused by mutations in
the type VII collagen gene (COL7A1), the main component of anchoring fibrils. Blister formation
in DEB occurs at the level of the anchoring fibrils located at the dermal-epidermal junction. DEB is
inherited through both autosomal dominant and recessive transmission. The nature of the mutation
in the COL7A1 gene, its location, and the presence of either dominant or recessive inheritance
determines the clinical phenotype of each patient. In this work, we studied the proband in a small
nuclear family of Chinese and Dutch/German descent and identified two novel mutations in COL7A1
leading to severe recessive dystrophic epidermolysis bullosa (RDEB). The maternal mutation is a
single base pair deletion of a cytosine nucleotide in exon 26, designated 3472delC, resulting in a
frameshift and a premature termination codon (PTC) within the same exon, 7 bp downstream from
the site of the mutation. The paternal mutation is a GÇA transition located at the 5’ donor splice
site within intron 51, designated IVS51+1GÇA. This mutation is predicted to lead to activation of
a cryptic splice site, 32 bp downstream of the mutation site and to subsequent aberrant out-of-frame
splicing, leading to an unstable mRNA and a downstream termination codon. These findings extend
the body of evidence for compound heterozygous mutations leading to severe RDEB and provide
the basis for prenatal diagnosis in this family. 
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Understanding mechanical factors in bullous disease using a novel suction blister instrument
MD Lopez, AJ Bonilla and MS Kolodney Dermatology, Harbor-UCLA, Torrance, CA
Bullous pemphigoid (BP) is a blistering disease resulting from auto-immune disruption of hemidesmo-
some mediated keratinocyte adhesion of to the epidermal basement membrane. BP predominantly
affects the elderly. Negative pressure, applied to the skin surface causes suction blisters through
successive detachment of hemidesmosomes from the basement membrane. Thus, susceptibility to
suction blistering reflects the strength of hemidesmosomal adhesion. In order to understand the role
of basement membrane mechanical properties in blistering disease, we have developed a novel device
to quantitatively measure basement membrane breaking strength under precisely defined negative
pressure. We measured the time needed to induce a suction blister on the ventral forearm of 10 sub-
jects using an average negative pressure of −524mmHg. Volunteers tolerated the procedure without
complaints of pain, but did describe a sensation of mild discomfort and pruritis to the area being
tested approximately 5 minutes prior to developing a small vesicle at the test site. Subject age showed
a strong inverse correlation with time to blistering. Male subjects exhibited longer blistering times
than female subjects. Topical application of a high potency topical steroid (clobetasol) 24 hours prior
to measurement did not significantly effect blistering time. The decreased mechanical stability of
the basement membrane in older subjects may help explain the increased prevalence of bullous
pemphigoid in this age group. 
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Knock-in of the mouse lamc2 gene defines the functional role of the unprocessed laminin γ2
chain in keratinocyte adhesion, migration and proliferation
O Pommeret,1 C Baudoin,1 M Kreft,2 A Sonnenberg2 and G Meneguzzi1 1 INSERM 634, University
of Nice-Sophia Antipolis Medical School, Nice, France and 2 Division of Cell Biology, The
Netherlands Cancer Institute, Amsterdam, Netherlands
Laminin-5 (α3β3γ2), the primary keratinocyte adhesion ligand, is secreted in the extracellular matrix
to provide a specific substrate for adhesion of proliferating and migrating cells. The multifunctional
role of extracellular laminin 5 is governed by the proteolytic processing of the α3 and γ2 chains. To
elucidate the biological function of the γ2 chain, we have generated knock-in (ki) mice lacking the
γ2 amino acid sequence YSGD required for the proteolytic cleavage of the γ2 N-terminal short arm
using site-directed mutagenesis of the lamc2 gene and the CRE-loxP technology. The ki YSGD-/-
mice exclusively express laminin 5 molecules harbouring an unprocessed γ2 chain. The animals are
viable, fertile, affected by slight growth retardation, and present no evident morphological and his-
tological abnormality. Immunohistochemical analysis disclosed abnormal accumulation of laminin
5 and other basement membrane components in the epithelial basement membranes, which, at the
structural level, correlated with an irregular thickening of the lamina densa of the dermal-epidermal
junction. Analysis of primary ki mouse keratinocyte cultures confirmed the enhanced deposition of
laminin in the extracellular matrix, which induces formation of anchoring structures, an improved
cell adhesion capacity that results in the flattened shape and reduced scattering of these keratinocytes.
Expression of unprocessed laminin 5 was found to exert an inhibitory effect on cell proliferation both
in vitro and in vivo, and to enhance cell migration at the wound edge of scraped confluent cell
monolayers. These results for the first time clearly define the functional role of the unprocessed extra-
cellular form laminin 5 in adhesion and migration of keratinocyte in physiological processes like
wound healing. 
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Effect of fibronectin functional domains and substrate crosslinking density on the morphol-
ogy and dynamics of human dermal fibroblasts
K Ghosh,1 X Shu,3 S Ge,2 M Rafailovich,2 G Prestwich3 and RA Clark1,4 1 Biomedical
Engineering, SUNY Stony Brook, Stony Brook, NY, NY, 2 Materials Science, SUNY Stony Brook,
Stony Brook, NY, 3 Medicinal Chemistry, University of Utah, Salt Lake City, UT and 4
Dermatology, SUNY Stony Brook, Stony Brook, NY, NY
Tissue development depends largely on how cells sense and respond to extracellular matrix (ECM).
Coupling of cell integrins with ECM ligands generates both, a ligation-induced signaling and a state
of isometric tension, within the cell cytoskeleton (CSK). The extent to which ECM supports this pre-
stress governs cell shape and function. In this study, we formulated hydrogels by coupling the three
recombinant fibronectin functional domains (rFNfs) to cross-linked thiolated HA backbone using a
polyethylene glycol diacrylate (PEGDA) crosslinker. We investigated cell stiffness and the corre-
sponding actin CSK arrangement as a function of hydrogel stiffness and adhesiveness. Hydrogel
stiffness was controlled by the amount of crosslinker added, while the adhesiveness was controlled
by the nature and amount of the rFNfs coupled to the hydrogel backbone. AFM was used to deter-
mine the surface modulus of live cells. Confocal microscope was used to obtain images of the actin
CSK of fixed and stained cells. It was found that cells seeded on either stiffer or more adhesive sur-
faces had larger surface moduli and more stretched actin CSK than those seeded on softer or less
adhesive substrates. This indicated that the cortical tension was able to sense both, the underlying
substrate stiffness and adhesiveness. Diffusion dynamics of cells seeded on these substrates was
also monitored and correlated with cell morphology, substrate stiffness and nature of rFNfs. 
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Crosslinked hyaluronan with PEG nanostents inhibits collagen gel contraction: a potential pre-
ventative of burn contracture
T Mehra,1 K Ghosh,1 X Shu,2 G Prestwich2 and RA Clark1,3 1 Biomedical Engineering, SUNY
Stony Brook, Stony Brook, NY, NY, 2 Medicinal Chemistry, University of Utah, Salt Lake City, UT
and 3 Dermatology, SUNY Stony Brook, Stony Brook, NY, NY
Burns are difficult to treat wounds, with complex local and systemic pathology and high mortality,
which often heal slowly with scars and contractures. Fetal wound healing is a remarkable process
that occurs in a unique environment that triggers a complex cascade of tightly controlled events cul-
minating in a scarless wound phenotype of fine reticular collagen and abundant Hyaluronic Acid
(HA). Contraction of wounds has been modeled in vitro by blending fibroblasts into collagen gels
and then adding a stimulus such as serum or platelet-derived growth factor (PDGF). We tested the
effect of high molecular weight (HMW) HA, thiolated HA (HA-DTPH) and HA Poly (ethylene gly-
col) diacrylate (HA-PEGDA) on the contraction of collagen gels. The effect of different crosslink-
ing ratios of PEGDA functional groups to HA thiol groups was also studied. None of these constructs
were cytotoxic, nor did they inhibit cell proliferation. As previously reported, high molecular weight
(HMW)HA (0.125% - 0.25% w/v) facilitated contraction of gels with the higher concentration being
more active. HA-DTPH (0.125% w/v) had no effect on contraction. In contrast, HA-DTPH (0.25%
w/v) and HA-PEGDA (0.125% w/v) inhibited and HA-PEGDA (0.25% w/v) strongly inhibited
contraction. Inhibition by HA-PEGDA increased as the crosslinking ratio was increased. Biomate-
rials, which inhibit collagen gel contraction in vitro, may also prevent wound contraction in vivo.
Hence, PEGDA may be used as nanostents in patients to prevent collagen contraction, thereby pre-
venting contracture. 
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Dysregulation of genes encoding cytoskeletal and signal transduction proteins in desmocollin
1 mutant mice
X Cheng,1 K Mihindukulasuriya,1 Z Den1 and P Koch1,2 1 Dermatology, Baylor College of
Medicine, Houston, TX and 2 Molecular & Cellular Biology, Baylor College of Medicine, Houston,
TX
The desmocollin 1 (dsc1) gene is expressed in the suprabasal layers of the skin where dsc1 is a com-
ponent of the desmosomal cell adhesion complex. We have recently generated mice in which the
endogenous dsc1 gene is replaced by a mutant gene that encodes a COOH-terminally truncated pro-
tein. This adhesion receptor does not bind the desmosomal plaque proteins plakoglobin and
plakophilin. Nevertheless, it is sufficient to maintain cell adhesion since mutant mice do not show a
gross phenotype. However, we did observe a dramatic increase in dsc2 mRNA synthesis in these
mice, although dsc2 protein levels were normal. In the present study, we analyzed the effects of the
dsc1 mutation on genes encoding cytoskeletal components using Affymetrix gene chip arrays. Inter-
estingly, the expression levels of several genes that are expressed in the hair follicles were affected
in dsc1 mutants; whereas keratins 19 (K19) and K15 were up-regulated, several hair keratin and
keratin-associated proteins were down-regulated (high-sulfur and glycine/tyrosine-rich keratins).
What triggered these expression changes in dsc1 mutants? As a first step to address this question,
we analyzed the expression of the major signal transduction pathways genes that affect the skin. We
found that the expression levels of components of the WNT pathway (frizzled 3, Wnt 6, dishevelled
3) and several transcription factors (s-myc, c-rel) were affected. Furthermore, a sequence analysis
predicted putative binding sites for TCF/Lef, myc and NFκB in the dsc2 promoter. In summary, we
have identified gene regulatory pathways that might affect dsc2 expression in our mice, providing a
first glance into the regulation of this desmosomal cadherin. 
234
Infiltration of CD4+ T cells and dendritic cells is associated with imiquimod-induced regres-
sion of actinic keratosis
T Ooi,1 R Barnetson,1 L Zhuang,1 S McKane,2 JH Lee,2 HB Slade2 and GM Halliday1 1 Royal
Prince Alfred Hospital, Camperdown, NSW, Australia and 2 3M Pharmaceuticals, St. Paul, MN
Imiquimod 5% cream is a topically applied immune response modifier that has been shown to effec-
tively treat actinic keratosis (AK). The therapeutic effects of imiquimod likely involve the provoca-
tion of an immune response against abnormal cells; however no clinical studies have conclusively
proved this mechanism. The objective of this study was to investigate the mechanism of action of
imiquimod when applied to AK lesions by relating cellular infiltrates to lesion clearance. A total of
18 subjects participated in this phase I, randomized, double-blind, parallel group, vehicle-con-
trolled study. Enrolled subjects were randomized to receive imiquimod cream or vehicle cream in a
2:1 ratio and applied study cream to 5 lesions on the scalp, forearm, or upper trunk once daily, 3
days per week for 16 weeks or until clear. Each subject had two 5 mm punch biopsies of AK lesions:
at prestudy to establish baseline biomarker levels and after 2 weeks of treatment to determine which
cellular infiltrates were induced by the application of imiquimod. Biopsy specimens were examined
using routine and immunohistochemical staining. Complete clearance of all treated AK lesions was
achieved by 41.7% (5/12) of imiquimod subjects and 0% (0/6) of vehicle subjects. The imiquimod
group showed statistically significant increases in biomarker levels from baseline to week 2 for CD3,
CD4, CD8, CD11c, CD86/CD11c, CD68, HLA-DR, and TUNEL. No significant differences were
seen for the vehicle group. The increases seen for the imiquimod group suggest that imiquimod stim-
ulated both the immune response and apoptosis. However, no significant correlations between clear-
ance and week 2 biomarker levels were seen for the imiquimod group. This was most likely due to
the small sample size and the choice of a single time point for the biopsy. Further studies are needed
to elucidate the exact mechanism of imiquimod, however these data provide preliminary evidence
that imiquimod stimulates both the innate and adaptive immune responses. 
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Carbon dioxide laser treatment of pyogenic granuloma
MA Aldhalimi1 1 Dermatology, Faculty of Medicine-Kufa University-Iraq, Najaf, Najaf, Iraq and
2 Dermatology, Faculty of Medicine, Najaf, Najaf, Iraq
Background: Pyogenic granuloma is a frequently encountered benign vascular lesion .The present
study was designed to describe the use of CO2 laser(continuous mode) as a treatment method,to
compare it with established methods and to assess its results. Patients and methods :prospective
observational study between July 2001-Nov. 2003.sixty-three patients with pyogenic granuloma were
selected randomly for treatment with CO2 laser (continuous mode),power 15 W in one treatment
session .Major outcome measures including complete resolution of treated pyogenic granuloma dur-
ing the follow up period. follow up visits were done 1 week,1 month,three months and six months.
Results: Pyogenic granuloma was removed completely in one treatment session in 61(95.5%) patients
without recurrence .In 56(88.8%) patients there were no scar and in 3(4.7%) patients only slight tex-
tural changes of the skin were observed. Atrophic scars were found in 2(3.6%) patients. Hypertrophic
scar or keloid did not occur. No permanent hpopigmentation, hyperpigmentation or erythema was
detected. Conclusion: Continuous mode CO2 laser is a good choice for treating pyogenic granu-
loma as this kind of laser is widely available with easy manipulation and good haemostasis,low recur-
rence rate and few adverse effects . 
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Marked improvement in staging accuracy in mycosis fungoides/sezary syndrome (MF/SS) using
integrated positron emission tomography and computed tomography
EY Tsai,1 R Hoppe,3 L Espinosa,2 A Taur,2 S Kohler,4 S Dick,1 S Chow,1 R Warnke,4 R McDougall2
and Y Kim1 1 Derm, Stanford Univ, Stanford, CA, 2 Rad/Nuc Med, Stanford Univ, Stanford, CA, 3
Rad Onc, Stanford Univ, Stanford, CA and 4 Path, Stanford Univ, Stanford, CA
Staging of MF/SS, the most common cutaneous T cell lymphoma (CTCL), is primarily based on
type/extent of skin involvement and presence/absence of extracutaneous disease. Traditional stag-
ing uses CT to look for visceral or lymph node (LN) disease followed by biopsy of enlarged LN
(axillary/inguinal LN > 1.5 cm). PET detects various tumors with hypermetabolic activity but its role
in staging MF/SS has not been investigated. We assessed the utility of integrated PET and CT (PET/CT)
in staging 10 patients with MF (T2=1,T3=3,T4=1) or SS (T4B2=5) at high-risk for LN disease. Based
on anatomic data from the CT component alone, only 3 of 10 had enlarged LNs and would have
been referred for biopsy. In comparison, PET showed that all 10 patients had hypermetabolic activ-
ity in at least 1 LN region. All patients had excisional LN biopsy and the extent of LN involvement
was classified according to NCI criteria. Four patients had dermatopathic lymphadenitis (LN1-2)
and 6 had effacement of LN architecture by lymphoma cells (LN4). Of the 6 patients with LN4, 4
had SS and 2 had tumor MF. In all 6 patients, PET/CT helped determine the pathologic LN for biopsy,
which led to the accurate stage of IVA. Furthermore, we quantified the intensity of PET activity using
standard uptake value (SUV) and correlated this with LN grade. Patients with LN1-2 had a median
SUV of 2.2 (2.0-3.0); patients with LN4 had a median SUV of 5.1 (3.2- 11.8). This suggested that
the threshold on PET between dermatopathic lymphadenitis and frank neoplasia was around 3 SUV.
Also, large cell transformation and higher Ki67 showed a trend toward higher SUVs. Thus, for stag-
ing MF/SS, PET/CT was more sensitive and specific in detecting malignant LNs compared to CT
alone and thus led to improved patient management. A larger scale study would be essential to con-
firm the superior staging capability of PET/CT over CT alone. 
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Damage and recovery of skin barrier function after diamond microdermabrasion
M Kim, J Song, Y Park and H Kim Department of Dermatology, Kangnam St. Mary’s Hospital,
Seoul, South Korea
Microdermabrasion had become an extremely popular method for superficial resurfacing. But, pub-
lished studies of skin barrier function changes following diamond microdermabrasion are rare. The
aim of this study is to objectively evaluate the degree of skin damage induced by diamond micro-
dermabrasion and time to recovery of skin barrier. For twenty three normal volunteers, the right side
of the face was treated with diamond peeling and the left side untreated. Transepidermal water
loss(TEWL), stratum corneum hydration and erythema were taken from both sides of the face before
peeling and at 24 hour-interval after peeling. The results showed that compared to the controls, the
treated area demonstrated a statistically significant increase in TEWL caused by peeling returned to
a baseline value after 1 day. In addition, erythema induced by peeling was also normalized after 1
day. Skin hydration values were widely varied among the patients. In conclusion, the skin barrier is
recovered in 1 day after diamond microdermabrasion, which is earlier than recovery after other forms
of microdermabrasion such as glycolic acid peel or crystal peel. Therefore, clinically, diamond
peeling done at one or two weeks’interval may not cause a significant damage to the skin barrier. 
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In vitro skin penetration/permeation of pimecrolimus and tacrolimus from their marketed for-
mulations (Elidel and Protopic)
A Billich, H Aschauer and S Anton Novartis Institute for Biomedical Research Vienna, Vienna,
Austria
Recent in vitro studies have shown that pimecrolimus permeates less through human skin than
tacrolimus when applied in 1% solutions (Billich et al, Int J Pharm, in press). Here, we report on
comparative studies with the marketed formulations of pimecrolimus (Elidel cream 1%) and tacrolimus
(Protopic 0.1% and 0.03% ointment). The formulations were applied to split-thickness human cadaver
skin and the penetration/ permeation of the active compounds was evaluated in vitro. The concen-
tration of the two drugs in the skin was similar when comparing Elidel 1% and Protopic 0.1% (4.4±2.6
and 3.6±0.6 µg/g, respectively), while Protopic 0.03% yielded about two-fold lower levels (1.7±0.4
µg/g). The permeation rate through the skin of pimecrolimus from the 1% cream was about 6-fold
lower than from the 0.1% tacrolimus ointment (0.67±0.35 vs. 4.1±0.7 ng/ml/hr). Comparing Elidel
1% with Protopic 0.03% (2.9±0.3 ng/ml/hr), pimecrolimus permeation was still lower by a factor of
4.3. To conclude, permeation of pimecrolimus from the 1% cream through human skin in vitro is
considerably lower than that of tacrolimus from 0.1% and 0.03% ointments, despite the higher drug
concentration in Elidel cream. Thus, the intrinsically lower permeation of pimecrolimus as compared
to tacrolimus is also reflected in its lower permeation from the galenical formulations. These in vitro
findings are in line with results from clinical studies. 
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Pulsed dye laser treatment is very sufficient in recalcitrant viral warts
W Gerber, AT Ha and HM Ockenfels Dept. of Dermatology and Allergy, Klinikum Stadt Hanau,
Hanau, Germany
Various therapeutical approaches including surgical and Co2 laser excision have been tried to remove
verrucae vulgares, but a treatment of choice has not been developed. Therefore, over a period of 12
months, 56 patients (29 female, 27 male)with with recalcitrant verrucae vulgares on their hands or
feet (1:2) were treated with a flashlamp pumped dye laser (FPDL) every 2 weeks until completly
clearance. We used a laser energy desity of 8J/cm2, spot size 5 mm, pulse duration 450 microsec-
onds. 14% cleared after 1 session and 44% after 2-5 sessions, so that a remission was seen in 58%
after 5 treatment and additionally in 94% after 6-9 treatments. Only 3 patients failed and 1 patients
stopped the therapy because of pain. There were no relapses in a period of 6 months after treatment.
FPDL therapy is very effective and safety in treatment of viral warts. 
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In vivo mechanism of action of corticosteroids in psoriatic plaques
AB Gottlieb,1 F Victor,1 D Lewkowicz,1 S Masud,1 G Solodkina,1 I Cardinale2 and JG Krueger2 1
Clinical Research Center, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ and
2 Investigative Dermatology, The Rockefeller Univ., NY, NY
Although topical corticosteroids (CSs) are the mainstay of psoriasis treatment, their mechanism of
action is primarily based on in vitro studies. These demonstrate CS-induced, increased IKBα syn-
thesis that leads to decreased NFκB activity. By different mechanisms, decreased activity of a vari-
ety of other inflammation-related nuclear transcription factors are also observed in vitro. In order to
better understand which mechanisms are clinically relevant, we treated psoriatic plaques with clo-
betasol propionate 0.05% foam (OLUX®) twice daily for 2 weeks, assessed clinical response (tar-
get lesion scoring) and studied skin biopsies by immunocytochemistry and RT-PCR for a panel of
inflammatory cytokines and chemokines many of which are overexpressed in plaques. Lab scien-
tists were blinded to clinical outcome. The genes studied included IKBα, IKBκ. iNOS, granzyme
B, TNFα, IFNγ, STAT-1, IL-20 and IL-8. CD3+ T cell infiltration, K-16 keratin and keratinocyte I-
CAM-1 protein expression were studied by immunocytochemistry. We correlated gene expression
and immunocytochemistry data with clinical response, T cell infiltration and decreases in epidermal
thickness. Clinical response correlated best with decreased epidermal CD3+ T cell infiltration (r=0.65),
increased IKBα (r=0.48) and decreased STAT-1 mRNA expression (r=0.43). Histologic response,
(i.e., decreased epidermal thickness), correlated best with decreased K-16 protein and mRNA (r=0.88,
r=0.67), ICAM-1 protein (r=0.84), iNOS (r=0.71), granzyme B (r=0.71), IL-20 (r=0.70), IL-8 (r=0.69)
and STAT-1 (r=0.57) mRNA. Decreased total CD3+ T cell infiltration correlated best with decreased
IKBβ (r=0.77) and STAT-1 (r=0.62) mRNA and ICAM-1 protein (r=0.63). The accumulated data
suggest that although increasing IKBα expression is important in vitro, CS-induced effects on a panel
of psoriasis-associated lymphocytes, cytokines and chemokines are also clinically relevant mecha-
nisms of action and merit further investigation. 
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Segmental hemangiomas are metameric: image analysis and classification
AN Haggstrom1 and IJ Frieden1,2 1 Dermatology, University of California, San Francisco, CA and
2 Pediatrics, University of California, San Francisco, CA
Hemangiomas of infancy can be classified as “segmental”, “indeterminate”, and “localized”. Some
authors postulate that segmental hemangiomas are metameric. Our aim was to identify patterns of
facial segmental hemangiomas by pattern analysis, and to define them using anatomic criteria. Dig-
ital images of hemangiomas from a cohort from 5 U.S. pediatric dermatology centers were utilized.
Lesions were mapped onto a facial template. Frequently observed patterns were defined using anatomic
landmarks. Three independent observers were given criteria for the proposed classification scheme
with a diagram and text description. A series of 108 digital images (50% segmental and 50% inde-
terminate) were presented to each observer for site/segment classification. Inter-rater reliability was
assessed using a kappa statistic. Four primary segmental patterns were identified. Two of these were
easily recognizable as the accepted distribution of the maxillary (M2)and mandibular (M3) metameres.
Two additional facial segments were identified: the laterotemporal segment (M1) and the frontonasal
segment (M4). M1 (laterotemporal segment) encompassed the lateral forehead, anterior temporal
scalp and lateral frontal scalp. M4 resembled the previously accepted frontonasal metamere, but dif-
fered significantly in its pattern. It includes the medial forehead, scalp, nasal bridge, nasal tip, ala,
and philtrum, but in contrast to classic embryologic teaching, does not extend onto the lateral fore-
head. A very high degree of agreement was observed between 3 independent observers utilizing this
classification schema with a kappa statistic = 0.845 for segmental hemangiomas and 0.863 for inde-
terminate hemangiomas. Our conclusions are that facial hemangioma segments were easily identi-
fied;inter-rater reliability was high; pattern analysis supports the metameric origin of hemangiomas;
previous depiction of the frontonasal metamere may be incorrect; indeterminate hemangiomas rep-
resent partial (forme fruste) segmental HOI. 
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Skin permeability in pigs is less for pimecrolimus than for tacrolimus under normal and dis-
eased conditions
JG Meingassner, H Aschauer, A Billich and A Stuetz Novartis Institutes for BioMedical Research,
Vienna, Austria
The barrier function of the skin plays a pivotal role in the percutaneous absorption of epicuta-
neously applied drugs. Various inflammatory conditions are associated with an impaired skin bar-
rier and can therefore result in increased skin permeability and consequent enhanced systemic expo-
sure to topically applied drugs. In a side-by-side comparison we evaluated the penetration and
permeation of pimecrolimus and tacrolimus in normal and inflamed, barrier-disturbed porcine skin.
Inflammation was induced locally by a 48-hr occlusive treatment with 5% sodium lauryl sulfate prior
to dissection of skin samples. These specimens and and normal pig skin were then used in Franz-
type diffusion chambers in vitro. Both compounds were applied epicutaneously at 1.0%, prepared
in propylene glycol/oleyl alcohol (9:1). While inflammation did not significantly enhance the lev-
els of the two drugs in the skin, impaired barrier function was associated with immediate passing
through of the compounds (as opposed to a latency period of approx. 17 hrs in normal skin) and a
significantly higher permeation rate. Although the permeation rates were increased for both com-
pounds, the rate for pimecrolimus was 2.5 times lower than for tacrolimus. Thus, at 24 hrs pime-
crolimus concentrations in the receptor fluid were 2.8-fold lower than tacrolimus levels, when using
inflamed skin. The permeation rate of pimecrolimus through irritated skin was similar to the rate of
tacrolimus through normal skin (173 vs. 166 ng/ml/hr). The present in vitro data suggest that in dis-
eased skin, permeation of pimecrolimus might be lower than that of tacrolimus, particularly in atopic
dermatitis patients, whose skin barrier function is typically impaired. 
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Presence of “inflammatory” dendritic cells in psoriasis vulgaris lesions and modulation by
Efalizumab (anti-CD11a) 
F Chamian,1 S Lin,1 I Novitskaya,1 H Carbonaro,1 I Cardinale,1 T Kikuchi,1 P Gilleaudeau,1
KM Wittkowski,2 K Papp,3 M Garovoy,4 W Dummer5 and JG Krueger1 1 Laboratory for
Investigative Dermatology, Rockefeller University, New York, NY, 2 Department of Biostatistics,
Rockefeller University, New York, NY, 3 Probity Medical Research, Waterloo, ON, Canada, 4
XOMA (US) LLC, Berkeley, CA and 5 Genentech, Inc., South San Francisco, CA
Dendritic antigen presenting cells (DCs) may be key inflammation-inducing cells in psoriasis vul-
garis. In this study, we quantified the number of CD1a+, CD11c+, and CD83+ DCs in normal vs.
psoriatic skin and also determined the impact of efalizumab on DCs. In lesional skin we identified
a 54-fold increase in CD83+ DCs (p<10-10) and a 5-fold increase in CD11c+ DCs (p<10-10). The
overall number of infiltrating DCs in psoriasis lesions is similar to T-cell infiltrates, with 407 CD11c+
cells as compared to 335 CD3+ cells per analysis field. “Inflammatory” DCs were located in both
epidermis and dermis of psoriasis plaques. Patients who responded well to treatment had an 88%
reduction in CD83+ cells (p<10-3) and 56% decrease in CD11c+ cells (p<10-3) within skin lesions
after 8 weeks of efalizumab therapy. Reduction in CD11c+ and CD83+ cells correlate well with a
response score composed of difference in epidermal acanthosis and keratin 16 immunohistochem-
istry at the end of treatment (r=0.75 and 0.53, respectively). Surprisingly, disease improvement is
more correlated with changes in “activated” dendritic cell subsets than overall changes in lesion-
infiltrating T-cells (r=0.40), with the exception of the CD8+ T-cell subset, the reduction of which
correlated well with disease improvement (r=0.52). These results suggest that dendritic cells may
have important direct effects in psoriasis disease pathogenesis and may be significantly impacted
even with presumptive “T-cell-targeted” therapeutics. 
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Phaeodactylum tricornutum extract protection effect on human stratum corneum oxidized pro-
teins level 
C Nizard,1 P Sylvie,2 C Heusele,1 A Bulteau,2 M Moreau,1 C Mahe,1 S Schnebert1 and B Friguet2
1 Branche Parfums & Cosmetiques, LVMH, Saint Jean de Braye Cedex, France and 2 Laboratoire
de Biologie et Biochimie du Vieillissement, Paris 7- Denis Diderot Univ., Paris, France
Modification of proteins by reactive oxygen species is implicated in different disorders. The pro-
teasome is a multicatalytic proteinase in charge of intracellular protein turnover and of oxidized
proteins degradation. Consequently, proteasome function is very important in controlling the level
of altered proteins in eukaryotic cells. Evidence for a decline in proteasome activity during skin
photo-aging has been provided by us in Bulteau et al. (2002). We previously described the ability of
a lipid algae extract (Phaeodactylum tricornutum) to stimulate 20S proteasome peptidase activities
(Nizard et al. 2002). Furthermore, keratinocytes treated with Phaeodactylum tricornutum extract and
then UVA and UVB irradiated, exhibited a sustained level of proteasome activitiy comparable to the
one of non-irradiated cells. The level of modified proteins can be quantified by measurement of pro-
tein carbonyl content (Oxyblot technique), which has been shown to increase with aging and other
disorders. Here, we describe that, in the presence of this lipid algae extract, the level of oxidized
proteins is reduced as assessed by the Oxyblot technique. These results are obtained both with cul-
ture human keratinocytes and stratum corneum skin cells (obtained by stripping) from human vol-
unteers. Altogether, these results argue for the presence of compounds in this algae extract that have
a stimulating and/or protective effect on proteasome activity resulting in a decrease level of protein
oxidation.
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Histone deacetylation and DNA methylation: novel epigenetic therapeutic targets in cutaneous
T cell lymphomas
C Zhang,1 X Ni,1 R Talpur,1 V Richon2 and M Duvic1 1 Dermatology, U. T. M. D. Anderson Cancer
Center, Houston, TX and 2 Aton Pharma, Inc., Tarrytown, NY
Histone deacetylase (HDAC) inhibitors suppress the activities of multiple HDACs, leading to an
increase in histone acetylation. This histone acetylation modulates the expression of specific genes
that cause growth arrest, differentiation and apoptosis. DNA methyltransferase (DNMT) inhibitors
reactivate tumor suppressor genes silenced by methylation-mediated mechanisms. Since histones
are connected to DNA by both physical and functional interactions, the combination of HDAC
inhibitors with demethylating agents has become attractive. Suberoylanilide hydroxamic acid (SAHA),
an orally administered inhibitor of class I and II HDACs, is currently in phase II clinical trials for
malignancies, including CTCL. 5-aza-2’-deoxycytidine (5-aza-CdR), a DNMT inhibitor, is also in
phase II clinical trials for solid and hematological malignancies. In this study, we investigated the
anti-tumor effects of SAHA, 5-aza-CdR, and their synergism in CTCL cell lines and/or freshly iso-
lated PBL from patients with circulating atypical T-cells. SAHA treatment (2.5 & 5 µM for 48 hrs)
induced dose-dependent apoptosis over vehicle control in all three CTCL cell lines: MJ (9 & 24%),
Hut78 (40 & 56%), and HH (61 & 75%). SAHA (0.5-5 µM for 48 hrs) also induced apoptosis up to
59% in 13 of 14 CTCL patients’ PBL. SAHA treatment (2.5 µM for 24 hrs) resulted in the accu-
mulation of acetylated histones (H2B, H3, and H4) and an increase in expression of the cyclin-
dependent kinase inhibitor p21 protein in Hut78 and HH cells. Gene profiling of mRNAs induced
by SAHA in HH cells confirmed the up-regulation of p21. 5-aza-CdR (0.1-10 µM for 48 hrs) also
induced dose-dependent apoptosis in three CTCL cell lines and was synergistic with sub-therapeu-
tic concentrations of SAHA (0.5-1 µM) resulting in apoptosis of 46-70% in the HH cell line. In con-
clusion, both SAHA and 5-aza-CdR induce apoptosis with synergism in CTCL cells. Our findings
thus provide a rationale for using SAHA or 5-aza-CdR alone and their combination as novel treat-
ments for CTCL. 
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Sub-cellular high resolution optical coherence tomography: a novel non-invasive diagnostic
tool in dermatology
F Abuzahra,1 Y Marquardt,1 F Spoeler,2 M Foerst,2 HF Merk1 and J Frank1 1 Dept. of Dermatology
and Allergology, University Clinic of the RWTH, Aachen, Germany and 2 Institute of
Semiconductor Electronics, RWTH Aachen University, Aachen, Germany
Using low coherent superluminescent diodes, conventional optical coherence tomography (OCT)
non-invasively generates two dimensional microscopical tomograms of human skin in vivo. Tomo-
grams are available almost in real time with an axial resolution of 15 µm and a lateral one of 12 µm.
Here, we used the OCT technique for the preoperative characterization of different skin tumors, e.g.
basal cell carcinoma and bowen′s disease. We could demonstrate the lateral tumor borders and patho-
logical changes in tumor vascularization. However, currently available conventional OCT can not
visualize the basement membrane zone (BMZ) nor single cells. Demonstration of the BMZ, how-
ever, is crucial to differ between precarcinomatous and invasive skin tumors, the latter ones usually
showing penetration of malignant cells through the BMZ. Thus, the success of modern non-invasive
therapeutic strategies, e.g. immunomodulators or photodynamic therapy, to treat precarcinomatous
skin tumors could not be visualized non-invasively to date. Further, we are currently not able to show
if these therapies indeed lead to complete tumor eradication without taking a skin biopsy. To over-
come the aforementioned problems, we have developed a refined high resolution OCT system (HR-
OCT) using a broadband femtosecond Ti sapphire laser. Hereby, we accomplished a sub-cellular res-
olution of 3.1 µm when studying human three dimensional skin equivalents in different states of
differentiation. Results were confirmed by histological examination and immunohistochemical analy-
sis, indicating that HR-OCT is a powerful tool to visualize and characterize the BMZ as well as a
single epidermal keratinocyte layer. Consequently, HR-OCT is expected to provide us with in vivo-
insights into the skin to reliably diagnose malignant tumors non-invasively and to confirm the suc-
cess of non-invasive treatment strategies. 
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Treatment of superficial basal cell carcinoma with 595 nm pulsed-dye laser: a clinical and his-
tological study
S Silapunt,1 M Alam,2 S Peterson,1 A Kimyai-Asadi,1 MH Jih,1 PM Friedman1,3 and LH Goldberg1,4
1 DermSurgery Associates, Houston, TX, 2 Department of Dermatology, Feinberg School of
Medicine, Northwestern University, Chicago, IL, 3 Department of Dermatology, University of
Texas Medical School, Houston, TX and 4 Department of Medicine (Dermatology), University of
Texas, MD Anderson Cancer Center, Houston, TX
Basal cell carcinoma (BCC) is the most common skin malignancy in Caucasians. The pulsed-dye
laser selectively destroys vessels using hemoglobin as a chromophore. The objective of this study is
to determine the therapeutic response of 595nm pulsed-dye laser (V-Beam laser, Candela Corp., Way-
land, MA) on BCC. Clinical and histological responses after laser exposure were studied in 24 super-
ficial BCCs (in 14 patients who had previous BCCs) using 4 sets of laser parameters varying in energy
(J/cm2) and cooling mode (DCD on/off): A) 3 J/cm2, DCD on, B) 7 J/cm2, DCD on, C) 15 J/cm2,
DCD on, and D) 15 J/cm2, DCD off. Pulse duration 3 msec, spot size 7 mm, one pass of laser, 10%
overlapping pulses, and 4 mm treatment margins were used in all groups. At 3-8 weeks after laser
exposure, the treated BCCs were clinically evaluated, excised, and examined histologically. Clini-
cal response was evaluated as: no change, flattening, less erythema, or disappearance of tumor. The
clinical response was: group A no change (100%), group B no change (50%), and slight flattening
and less erythema (50%), group C marked flattening and less erythema (28.6%), and slight flatten-
ing and less erythema (71.4%), and group D disappearance of tumor (100%). Therapeutic response
was determined by histological findings and graded as: failure (tumor seen) or success (no tumor
seen). The therapeutic response was success in 0% of group A and B, 28.6% of group C, and 100%
of group D. Pulsed-dye laser, 595 nm, 15 J/cm2 without cooling mode, provides a significant ther-
apeutic response with histological proof of absence of tumor for superficial BCC. 
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Low-energy helium-neon laser irradiation induces repigmentation in segmental-type vitiligo
lesions and has some biostimulatory effects on nerve repair and control
C Wu,1 G Chen1 and H Yu1,2 1 Department of Dermatology, Kaohsiung Medical University,
Kaohsiung, Taiwan and 2 Department of Dermatology, National Taiwan University, Medical
College, Taipei, Taiwan
Segmental-type vitiligo (SV) results from the dysfunction of sympathetic nerves in the affected areas.
Its recalcitrant treatment response is indeed an ardous challenge for all dermatologist. Low-energy
helium-neon laser (He-Ne laser) has been employed in a variety of clinical treatments including
vitiligo management and repair of nerve injury. The purpose of this study is to determine the effec-
tiveness of He-Ne laser in treating SV and its biostimulatory effect on nerve repair and control.
Forty patients with SV on the head and/or neck were enrolled in this study. He-Ne laser light was
administered locally at 3.0 Joules/cm2 with point stimulation once or twice weekly. Laser Doppler
flowmetry and iontophoresis with sympathomimetic drugs were used for evaluating the cutaneous
blood flow and adrenoceptor function. After an average of 17 treatment sessions, initial repigmen-
tation was noticed. Marked repigmentation (>50%) was observed in 60% of patients with succes-
sive treatments. Tendency of gradually normalizing cutaneous blood flow and adrenoceptor responses
were found in 6 patients after regular He-Ne laser treatment. So we concluded that He-Ne laser can
effectively treat SV and have some repairing effect on damaged sympathetic nerve. 
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Perilesional versus lesional skin changes in senile lentigo
M Cario-Andre,3 S Lepreux,2 C Pain,3 C Nizard,4 E Noblesse,4 S Schnebert,4 C Mahe4 and
A Taieb3,1 1 Department of Dermatology, Hopital Saint Andre, University Hospitals of Bordeaux,
Bordeaux, France, 2 Department of Pathology, Hopital Pellegrin, University Hospitals of
Bordeaux, Bordeaux, France, 3 Inserm E 217, Victor Segalen University, Bordeaux, France and 4
Branche Parfums et Cosmetiques, LVMH, Saint Jean de Braye Cedex, France
Senile lentigo (SL) (lentigo senilis, aging spot, liver spot, solar lentigine) is a common component
of photoaged skin. It is characterized by hyperpigmented macules which affects chronically irradi-
ated skin mostly after age 50. This study was undertaken to assess the basic morphology of SL on
dorsum of hands. A systematic comparison between lesional vs perilesional skin using immunohis-
tochemistry and electron microscopy was done to detect precursor lesions of SL and to determine
whether melanocytes or keratinocytes were first affected in the evolution of lesions. In 12 cases stud-
ied, the main findings show that clusters of perilesional keratinocytes accumulate melanin in large
melanosomial complexes, and that melanocytes counts are increased respective to total length of sec-
tion in lesional skin, but the increment is probably due to the development of characteristic epider-
mal rete ridges. Melanocytes had overall a normal ultrastructure, with mostly quiescent features in
perilesional skin, and melanosomial transport seeming more active in lesional skin. Dermal changes
were comparable between lesional and perilesional skin. Our data indicate that SL may represent a
loss of epidermal melanin unit homeostasia due to chronic irradiation, where keratinocytic changes
predominate over melanocytic changes. Non -UV related similar histopathologic changes are noted
in monogenic Dowling Degos disease, suggesting common pathogenetic pathways. We hypothesize
that abnormal pigment retention in keratinocytes is the primary defect in SL, which may partly explain
the therapeutic effect of retinoids. 
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SCORTEN accurately predicts mortality in toxic epidermal necrolysis patients in the United
States
J Trent,1 R Kirsner,1,2 P Romanelli1 and F Kerdel1 1 Department of Dermatology, University of
Miami, Miami, FL, 2 Department of Epidemiology and Public Health, University of Miami, Miami,
FL and 3 Veterans Administration Medical Center, University of Miami, Miami, FL
Toxic epidermal necrolysis (TEN) is a severe hypersensitivity reaction to certain medications, with
associated mortality upwards of 40%.  SCORTEN, a TEN-specific illness severity score, which pre-
dicts mortality based on 7 criteria: blood urea nitrogen, glucose, carbon dioxide, age, malignancy,
body surface area involved, and pulse, has been reported in Europe to accurately predict mortality,
but has not been studied in the United State. Therefore, we retrospectively analyzed our population
of patients with TEN prior to determine if SCORTEN would accurately predict the mortality in
these patients and determine whether SCORTEN is applicable to patients in the United States.
Twenty four patients were treated in our intensive care unit with supportive care, including wound
care, nutritional support, fluid and electrolyte monitoring, and prevention of infection. There were
16 women and 8 men with an average age of 52.7 years. Eight were Hispanic, 9 were Black and 7
were White. There were 5 SJS/TEN overlap patients, 11 TEN with spots, and 8 TEN. For each patient,
the 7 SCORTEN risk factors, the causes of TEN and other medical problems were documented.
Based on SCORTEN, 8.77 patients were expected to die. Of the 24 patients, 8 patients died. The
expected and actual mortalities were compared using Standardized Mortality Ratio (SMR)
(SMR=(?observed deaths/?expected deaths) x 100) to determine the applicability of SCORTEN to
a United States population of TEN patients. Using SMR, we determined that our TEN patients had
a mortality risk of 9% less than the original SCORTEN patients, which was not found to be statis-
tically significant (SMR 0.912, 95%CI 0.393-1.8). Based on the comparison of expected and actual
mortalities using SMR, We have found that SCORTEN is applicable to a United States population
of TEN patients. 
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Collagen-like peptide exhibits a remarkable anti-wrinkle effect on the skin when topically
applied: in vivo study
E Bauza, G Oberto, A Berghi, C Dal Farra and N Domloge Skin Research, Vincience, Sophia
Antipolis, Sophia Antipolis, France
Collagen is an essential molecule that plays a crucial role in skin regeneration, wound healing, and
in maintaining the structural integrity of the skin. Moreover, collagen synthesis and degradation
play a central role in skin appearance and in wrinkle formation caused by aging and photoaging.
Consequently, in the following 
double-blind clinical study, we were interested in developing a synthetic oligo collagen-like peptide
and evaluating its effect on wrinkles. 20 healthy women volunteers, age 40 to 62, participated in the
study. Volunteers applied either a gel formula containing 3% of this collagen-peptide and 1% of a
booster molecule that stimulates general cell metabolism with no specific effect on wrinkles, or a
placebo gel, on the eye zone area twice a day for 4 weeks. Control visits were performed at the begin-
ning and end of the study. Skin wrinkles were evaluated clinically and by silicon replica analysis
followed by statistical treatment using the matched paired student test. Silicon replica results showed
that application of the collagen-peptide on the skin significantly reduced the total surface of wrin-
kles, and this effect was observed in 75% of the replicas. Similarly, according to student test, the
decrease in number and average depth of wrinkles was significant, observed in 65% and 70% of the
replicas, respectively. The effect of collagen-peptide on reducing the total length of wrinkles was
also remarkable. This effect was estimated highly significant by student test, and was observed in
75% of the replicas. Moreover, these results were supported by volunteer questionnaires and clini-
cal observation. This study reveals that the rapid effect of collagen-like peptide on reducing skin
wrinkles, within only four weeks of application, is remarkable and very significant. The results also
demonstrate that collagen-like peptide acts deeply and intensely on wrinkles, properties that are of
great interest in the field of anti-aging skin care products. 
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Synergistic inhibition of T-cell proliferation in human peripheral blood mononuclear cells by
combinations of pimecrolimus with corticosteroids
AP Winiski, B Schwendinger and A Stuetz Novartis Institute for Biomedical Research Vienna,
Vienna, Austria
T-cell activation plays a key role in inflammatory skin diseases, such as atopic dermatitis and pso-
riasis, as well as in other chronic inflammatory conditions. Although corticosteroids have been the
mainstay of therapy of these indications, corticosteroid resistance has been reported frequently. Pime-
crolimus is an ascomycin macrolactam derivative specifically designed and developed to treat inflam-
matory skin diseases. In this study we examined the effects of corticosteroids and pimecrolimus on
T-cell proliferation in strongly stimulated human peripheral blood mononuclear cells (PBMC). PBMC
(50,000—200,000 cells/well in a 96-well plate) were stimulated with the superantigen staphylo-
coccal enterotoxin B (SEB) or with the combination of anti-CD3 plus anti-CD28 monoclonal anti-
bodies for 72 hr, and proliferation was measured via incorporation of 5-bromo-2′-deoxyuridine
(BrdU). SEB- and anti-CD3/CD28-stimulated T-cell systems have been documented to exhibit resist-
ance to corticosteroids and/or calcineurin inhibitors. Indeed, when used as single agents in the pres-
ent study, the corticosteroids dexamethasone (Dex) at 300 nM, betamethasone 17-valerate (Beta) at
300 nM and hydrocortisone (HC) at 10,000 nM, as well as pimecrolimus (PI) at 30 nM exerted, at
most, only partial inhibitory effects on T-cell proliferation. However, combinations of the corticos-
teroids with pimecrolimus (at the concentrations indicated above) exhibited strong and synergistic
inhibition of proliferation. The following ranges of inhibition (stimulated control = 0%) were observed:
SEB-induced proliferation: Dex (≤14%), Beta (≤15%), HC (≤11%), PI (4—33%), Dex+PI (94—
98%), Beta+PI (93—97%), HC+PI (93—94%). Anti-CD3+anti-CD28-induced proliferation: Dex
(13—14%), Beta (≤25%), HC (≤8%), PI (≤21%), Dex+PI (82—95%); Beta+PI (70—95%), HC+PI
(61—87%). These results suggest that combination therapy may be effective for the case of corti-
costeroid resistance and/or indications, where corticosteroid or pimecrolimus monotherapy is insuf-
ficient.
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Quercus suber cork extract displays tensor and smoothing effect on human skin: in vivo study
A Berghi,1 G Oberto,1 E Bauza,1 T Marchand,1 C Coquet,1 E Ferre,2 C Dal Farra1 and N Domloge1
1 Skin Research, Vincience, Sophia Antipolis, Sophia Antipolis, France and 2 Faculte St Jerome,
Aix-Marseille, France
Recently, it has become indispensable for anti-aging active ingredients to give a lifted and renewed
tension to the skin in order to offer a visible and immediate smoothing anti-wrinkle effect. Quercus
suber is the aliphatic part of suberin, the most important structural component of cork cell walls.
Studies have shown that Quercus suber is made up mostly of hydroxycarbonylic acids and is endowed
with many special mechanical and chemical properties which evoke a possible smoothing effect on
the surface of the skin. Therefore, we were interested in investigating the effect of cork extract on
the skin surface in the following double blind clinical study. The study was conducted on 15 healthy
women, age 22 to 52. The volunteers applied a gel formula with 3% of cork extract, or placebo gel,
on a delimited zone of 30cm2 on each forearm. Skin surface roughness was evaluated visually by
pictures, and by silicon replicas one and two hours after application, followed by statistical treat-
ment using matched paired McNemar statistical test. McNemar treatment of the pictures revealed
that application of cork extract on the skin resulted in a very significant reduction of roughness after
one hour of application. This effect was observed in 73.3% of volunteers. After two hours of cork
extract application, a highly significant improvement of skin roughness was found in 78.6% of vol-
unteers. Moreover, silicon replica treatment confirmed the significant improvement of the average
of roughness at two hours. These results demonstrate that cork extract provides for a remarkable
and very significant tensor and smoothing effect on the skin, which can be of great use in anti-aging
skin care products. 
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A novel therapy for tumors of epithelial origin
M Yaar, I Panova, C Rinaldi, MS Eller and BA Gilchrest Dermatology, Boston University School
of Medicine, Boston, MA
Mammalian cells are protected from malignant transformation via adaptive DNA damage responses
resulting in senescence or apoptosis. We hypothesize that in normal cells, DNA damage disrupts the
telomere loop, exposing the single-stranded TTAGGG repeat sequence of the 3’ telomere overhang,
otherwise concealed in the telomere loop structure. We further hypothesize that the overhang then
interacts with a nuclear sensor protein to initiate senescence or apoptosis, responses abrogated in
malignant cells. To examine our hypothesis, 40uM of GTTAGGGTTAG, an oligonucleotide homol-
ogous to the 3’ overhang sequence (T-oligo), or its complementary sequence or diluent alone as con-
trols were provided to well differentiated (MCF-7) or poorly differentiated (BT-20) epithelial carci-
noma lines. Within 3-7 days, T-oligo decreased MCF-7 yield by 64±17% (p<0.008) and BT-20 yield
by 56±18% (p<0.03), an effect comparable to cisplatin (10uM). T-oligo induced apoptosis of cells
and senescence of the remaining cells, as determined respectively by TUNEL and induction of the
senescence-associated β galactosidase activity (MCF-7) and inability to phosphorylate the retinoblas-
toma protein despite fresh medium supplementation (BT-20). By western blot analysis, within 24-
48 hrs T-oligo induced ATM (480%), p53 (2451%), p95/Nbs1 (557%) and BRCA1 phosphorylation
(243%), as well as p53 (545%) and p21 (205%) level, suggesting that T-oligo acts through the ATM
kinase and its effector proteins, a known DNA damage response pathway. Furthermore, T-oligo
decreased yields of adriamycin resistant, multidrug resistant gene-1 (MDR1)-overexpressing MCF-
7 cells by 53%, decreased MDR1 expression by 47% and induced differentiation-associated gene
products in BT-20 cells by 356% to 1563%. Moreover, T-oligo administered intralesionally to MCF-
7 tumors implanted into the flanks of athymic nude mice reduced tumor volume by 88% (p<0.003)
without detectable toxicity. We propose that T-oligo activates physiologic DNA damage signaling
pathways ordinarily blocked in malignant cells and is thus a promising novel cancer therapy. 
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Study of skin penetration of vitamin E submicron emulsion
X Lin,1 D Luo,1 Q Ma2 and N Gu2 1 Dermatology and Venereology, Nanjing Medical University,
Nanjing, Jiangsu, China and 2 Chemical Engineering, Southeast University, Nanjing, China
Alpha-tocopherol is a lipophilic vitamin that exhibits an antiaging, antioxidative activity and antipho-
todamage.The particle diameter of tocopherol submicron emulsion is within 200 nanometer. In our
study, we focus on the penetrating capacity of vitamin E submicron emulsion through rabbit skin.Toco-
pherol-loaded submicron emulsion was prepared by high pressure homogenization and the concen-
tration was measured by HPLC method. The penetrating capacity test was conducted on the rabbit
skin with the experimental device. The absorbance of collected samples at different intervals was
measured by spectrophotometry. The sample concentration was determined according to vitamin E
standard curve. The penetrating accumulation was calculated by the specific formula and the pene-
trating coefficient was evaluated by regression equation between the accumulation and the different
intervals.The regression equation of vitamin E standard curve was y = 0.0241x + 0.0128, R2 =0.9994.
The absorbance of samples at different intervals was 0.113 at 0.5h and increased gradually,up to
0.386 at 24 h. The corresponding concentration and accumulation was also increasing with experi-
mental duration. The regression equation between the accumulation and the time was y=30.059x +
231.64, R2 =0.9907; the penetrating coefficient was 30.059.Tocopherol-loaded submicron-emulsion
is of better skin penetrating capacity  because of its perfect vehicle approach and its small particle
diameter. The sample concentration and the accumulation penetrating through rabbit skin is time-
dependent. The penetrating efficiency of vitamin E submicron emulsion is stable. 
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Ultra pure medical grade lanolin enhances wound healing
NA Langley,1 LB Joseph,1 AM Kligman,2 I Steel,3 M Stoudemayer2 and MJ Stoudemayer2 1 Croda
Inc, Edison, NJ, 2 S.K.I.N. Inc, Conshohocken, PA and 3 Croda Chemicals Europe Ltd, Snaith,
Goole, East Yorkshire, United Kingdom
Ultra pure medical grade lanolin has been designed for the treatment of superficial wounds and a
range of dermatological disorders. The purpose of this clinical research study was to evaluate ultra
pure medical grade lanolin versus white petrolatum (USP), the “gold standard” for promoting heal-
ing of minor wounds, on the healing rate of cantharidin induced blisters. Cantharidin blisters are
intra-epidermal clefts, which form above the basement membrane and are a prime example of com-
mon superficial wounds. Twenty-four hours after blister induction on the forearm, the blisters were
de-roofed, no treatment (control), ultra pure medical grade lanolin, and white petrolatum (USP) were
inoculated directly onto the blisters b.i.d. and covered until day 4. The wounds were treated b.i.d.
and left uncovered through day 10. Photographs were taken on days 3, 6, 7, 8, 9, and 10 using a Hi-
scope 20x prior to morning treatment. There were no adverse events and all subjects completed the
study. As early as day 2 the ultra pure medical grade lanolin treated blisters were less swollen and
less inflamed as compared to the white petrolatum (USP) treated blisters or the controls.  By day 8,
glyphic lines were becoming visible in some subjects treated with the ultra pure medical grade lano-
lin. Glyphic lines are a measure of the stratum corneum barrier restoration. It was evident by day 10
that glyphic lines were more developed with the ultra pure medical grade lanolin treatment as com-
pared to the white petrolatum (USP) or the untreated control. It can be concluded from this data that
ultra pure medical grade lanolin is far superior at promoting superficial wound healing than white
petrolatum (USP). Future experiments will include a full stratum corneum restoration (3 week) study
evidenced by return of TEWL to baseline and original geographic pattern of intersecting furrows. 
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The efficacy of etanercept in psoriasis patients with varying treatment histories
B Strober,1 P Yamauchi,2 N Korman,3 H Xia4 and S Stevens4 1 New York University School of
Medicine, New York, NY, 2 Clinical Research Specialists, Santa Monica, CA, 3 Case Western
Reserve University, Cleveland, OH and 4 Amgen Inc., Thousand Oaks, CA
Psoriasis patients with a history of systemic therapy or phototherapy may represent a cohort with
unique baseline demographics and disease characteristics. The purpose of this analysis was to deter-
mine if such patients respond differently to etanercept therapy than those without a history of sys-
temic therapy or phototherapy. Patients from 3 placebo-controlled, randomized studies were pooled.
The 415 psoriasis patients included in this analysis initiated etanercept 25 mg twice weekly after a
washout of systemic therapy and phototherapy. Patients with a history of systemic therapy or pho-
totherapy had more severe psoriasis at baseline than those without such a history, as indicated by
greater body surface area involved (30% vs 21%, p<0.01), longer duration of disease (21 vs 17 yrs,
p<0.01), higher Psoriasis Area and Severity Index [PASI] score (19.2 vs 16.0, p<0.01), higher Der-
matology Life Quality Index [DLQI] score (11.9 vs 10.4, p<0.01), and higher proportion of patients
with psoriatic arthritis (28% vs 16%, p<0.05). Despite different baseline characteristics, compara-
ble proportions of patients with and without a history of systemic therapy or phototherapy achieved
a PASI 50 response with etanercept therapy at week 12 (62% vs 64%, not significant [ns]) and week
24 (72% vs 83%, ns). PASI 75 response rates also were comparable at week 12 (33% vs 34%, ns)
and week 24 (45% vs 50%, ns), as were mean percent improvements in DLQI at week 12 (60% vs
54%, ns) and week 24 (64% vs 61%, ns). Patients with prior use of methotrexate had more severe
disease at baseline than those without such a history, but all efficacy endpoints indicated the mag-
nitude of improvement with etanercept therapy was similar. Despite having more severe disease at
baseline, psoriasis patients with a history of systemic therapy or phototherapy were able to achieve
a response to etanercept therapy comparable with patients without such a history. 
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Isolation of quinolone resistant ureaplasma urealyticum and identification of gene mutations
in quinolone resistant determining regions
Y Xu,1 D Luo,1 X Miao,1 W Sun2 and X Chen1 1 Dermatology and Venereology, Nanjing Medical
University, Nanjing, Jiangsu, China and 2 Dermatology and Venereology, Yangzhong Renmin
Hospital, Yangzhong, China
Quinolones are often used for clinical therapy of UU (Ureaplasma Urealyticum) infection, but are
not all effective because of drug-resistant isolates.  This research was designed to isolate quinolone-
resistant UU from clinical isolates and further to determine the gene mutations in QRDRs (quinolone-
resistant determining regions) in such resistant isolates. Drug susceptibility test kits and broth dilu-
tion method were used to determine the quinolone-resistant UU isolates from 66 clinical isolates.
PCR was performed by two pairs of specific primers to amplify gyrA and parC, two major genes in
QRDRs, and the expected amplicons for gyrA parC were 336bp and 309bp respectively. The posi-
tive amplicons were sequenced .Of 34 tested isolates, 10 were resistant to both OFX (ofloxacin) and
SPX (sparfloxacin), 15 only resistant to OFX and 1 resistant to SPX. Of another 10 tested isolates,
6 were resistant to CFX (ciprofloxin), and 3 resistant to SPX. For 4 kinds of quinolones tested,
MICs of UU3 reference strain were 1µg/ml for LFX (levofloxacin), 4µg/ml for CFX, 8µg/ml for
NFX and 2µg/ml for SPX. MICs of 2 out of 22 UU isolates were found four times higher than those
of the reference strain and were considered as resistant ones. After PCR the amplified fragments with
336bp (gyrA) and 309bp (parC) were observed .The sequenced results revealed a T to C change at
165nt of gyrA in 2 isolates. It can be implied that resistance of UU to quinolones may have some
relation to the gene mutations in QRDRs such as gyrA and/or parC. The results of drug suscepti-
bility tests are important for clinical therapy of UU infection because of drug-resistant isolates. And
drug susceptibility test kits are easier and more convenient to apply than broth dilution method for
further and wider usage. 
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Contact sensitivity in patients with leg ulcerations: a North American study
LJ Saap,1 S Fahim,2 E Arsenault,1 M Pratt,2 T Pierscianowski,2 V Falanga1,3 and A Pedvis-Leftick1
1 Dermatology and Skin Surgery, Roger Williams Medical Center- Boston University, Providence,
RI, 2 Dermatology, University of Ottawa, Ottawa, ON, Canada and 3 Dermatology and
Biochemistry, Boston University, Boston, MA
Over the last two decades, there have been a number of studies in Europe on contact sensitivity in
patients with chronic leg ulcerations. The frequency of positive patch test results has ranged from
40 to 82.5%. Although several groups have studied this in Europe, the prevalence of sensitization
has not been studied in North America. Furthermore, many of the newer dressings and wound care
products in the market have not been studied for contact sensitivity in patients with chronic wounds.
Our objectives were to 1) determine the prevalence of allergen sensitivity in patients with past or
present leg ulcers in two North American study centers, 2) compare our results to the European
studies and the North American Contact Dermatitis Group (NACDG) database and 3) help delineate
a standard battery of allergens for patch testing in North American leg ulcer patients. Fifty-four
patients with a history of or an active leg ulcer were prospectively entered in the study. The patients
were patch tested to both the NACDG Standard series, as well as, a comprehensive supplemental
series of 48 allergens. 63% (34) of patients had one or multiple positive patch tests and 37% (20)
had no positive patch tests. The most common allergens were Balsam of Peru (29.6%), bacitracin
(24.1%), fragrance mix (20.4%), wood tar mix (20.4%), propylene glycol (13.5%), neomycin sul-
fate (13%), benzalkonium chloride (13%), carba mix (11.1%), nickel sulfate (11.1%) and Duoderm
CGF (11.1%). Duoderm CGF was the most allergenic dressing in our study group. There is a high
incidence of positive patch tests in patients with past or current leg ulcerations. Our results were
comparable to similar studies done in Europe. The incidence of the most common allergens in our
patient population was higher than those seen in the NACDG, with the exception of nickel. 
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Photoaging and expression of retinoic acid receptor α
E Tsoureli-Nikita, RE Watson, JJ Bowden and CE Griffiths Dermatology Centre, University of
Manchester, Manchester, United Kingdom
Cutaneous aging results from the passage of time and from chronic sun exposure (photoaging). We
have previously shown that retinoic acid receptor α (RARα) is significantly increased in intrinsi-
cally aged skin. We investigated whether photoaging was associated with alterations in RARα and
if topical all-trans retinoic acid (t-RA), a treatment for photoaged skin, modulates RARα expres-
sion.
Subjects with clinically moderate photoaging were recruited. In cohort 1 (n=10; age range: 33-65
yrs), 4mm punch biopsies were taken under local anesthesia from: photoaged extensor forearm, pho-
toprotected hip and upper inner arm. In cohort 2 (n=6; age range: 40-51 yrs) Finn chambers con-
taining either 0.025% t-RA (in vehicle: 70% ethanol/30% propylene glycol) or vehicle alone were
applied to photoaged extensor forearm. At day 4, 3mm biopsies were taken from the 2 treated sites
and from a third untreated area. Biopsies were processed and 10µm frozen sections prepared for
either in situ hybridization or immunohistochemistry. RARα mRNA was identified using a biotin-
labeled oligo probe. Protein was identified using standard immunoperoxidase techniques (rabbit anti-
human RARα; Santa Cruz Biotechnology Inc). Sections were randomized, blinded and quantified
(3 high power fields/section; 3 sections/site). RARα mRNA was not identified in photoprotected
sites but expressed in photoaged forearms in all volunteers studied (n=10; p<0.01). Photoaged skin
contained significantly higher numbers of RARα-positive keratinocytes than photoprotected sites
(hip: 45.9±5.5; upper inner arm: 45.6±5.4; forearm: 93.3±9.3; p<0.001). Topical application of t-
RA significantly reduced RARα protein levels as compared to control and vehicle-treated sites (con-
trol: 77.6±8.4; vehicle: 66.9±11.9; t-RA: 35.1±6.5; p<0.01).
These results demonstrate that RARα is over-expressed in the epidermis of photoaged as well as
intrinsically aged skin. Furthermore, topical application of t-RA significantly reduces RARα expres-
sion. We hypothesise that alterations in RARα expression may be a common pathogenic mecha-
nism in intrinsic and extrinsic aging. 
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Proliferation and apoptosis are inversely present in acute chronic wounds
J Butmarc,1 T Yufit,1 P Carson1 and V Falanga1,2 1 Dermatology and Skin Surgery, Roger Williams
Medical Center, Providence, RI and 2 Dermatology and Biochemistry, Boston University School of
Medicine, Boston, MA
The edges of chronic wounds typically show acanthosis with the absence of epidermal migration,
and there are questions about the migratory and proliferative activity of keratinocytes in chronic
wounds. In order to determine the status and contribution of keratinocyte proliferation and apopto-
sis to the wound healing process, we performed immunohistochemistry for a proliferation marker
(Ki-67) and apoptosis (TUNEL) on specimens obtained from the edges of acute wounds and chronic
ulcers. Eighteen patients with chronic venous leg ulcers underwent biopsies of normal thigh skin and
chronic ulcers, and the initial thigh biopsy sites were re-biopsied after 48 hours to create an acute
wound. In eight patients the ulcers were re-biopsied after 3 weeks. The specimens were routinely
processed for histology and immunohistochemistry. Immunostaining for Ki-67 was uniformly
increased after wounding, with marked sparing of the advancing epidermal edge of acute wounds.
However, Ki-67 immunostaining was dramatically increased in non-healing ulcers. Apoptosis stain-
ing was very high at baseline in normal skin, and slightly increased after wounding. It was lower at
baseline in chronic ulcers but increased at the advancing epidermal edge. With wounding, there was
increased keratinocyte migration. The migrating keratinocytes closest to the edge of the wound, how-
ever, showed decreased proliferation as demonstrated by Ki-67 immunostaining. Contrary to what
is commonly thought, chronic wound keratinocytes are actively proliferating. Keratinocyte apopto-
sis continues and in fact increases during healing, suggesting that it is part of the normal mechanism
for wound repair. We propose a model for epithelialization of chronic wounds, whereby the increased
keratinocyte proliferation and the decreased apoptosis of the wound edges have to become inverse,
so as to approximate acute wounds. 
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Bexarotene induces apoptosis of malignant T-cells purified from Sezary syndrome patients and
inhibits IL-4 production: variable susceptibility correlates with clinical response
JB Budgin,2,1 S Newton,1 SK Richardson,1 B Benoit,1 R Ubriani,1 M Wysocka1 and AH Rook1 1
Dermatology, University of Pennsylvania, Philadelphia, PA and 2 Dermatology, University of
Pennsylvania School of Veterinary Medicine, Philadelphia, PA
The RXR specific retinoid bexarotene, which is efficacious in the treatment of cutaneous T-cell
lymphoma (CTCL), has been shown to induce apoptosis in long term transformed cell lines. In an
effort to determine if Sezary T-cells (CD4+/CD26-) exhibit the same sensitivity to bexarotene, puri-
fied malignant T-cells isolated from the peripheral blood of Sezary syndrome (SS) patients were
cultured with bexarotene followed by the performance of a TUNEL assay using flow cytometric
analysis. Dose-dependent apoptosis of malignant T-cells peaked following 72 hours of culture with
bexarotene. Interferon alpha, another active agent for CTCL, although inducing apoptosis of malig-
nant T-cells itself, failed to increase levels of apoptosis when co-cultured with bexarotene. T-cells
from 66% of SS patients (N=9) repeatedly manifested high levels of apoptosis after culture with
bexarotene while cells from 33% of patients consistently failed to demonstrate apoptosis on repeat
assay. Similarly, significant inhibition of in vitro production of IL-4 in response to mitogens, which
correlated with susceptibility to apoptosis, was observed following 48 hours of culture with bexarotene.
Clinical response of patients to systemic bexarotene therapy appeared to correlate with in vitro sus-
ceptibility to apoptosis. Thus, bexarotene exhibits the ability to suppress IL-4 production and to
induce apoptosis in freshly isolated malignant T-cells from SS patients, which correlates with response
to therapy. 
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Double-blind, vehicle-controlled study to evaluate the clinical, histological and confocal
microscopy effects during 4 weeks of treatment for actinic keratoses with imiquimod 5% cream
A Torres and RM Anders Dermatology, Loma Linda University, Loma Linda, CA
The primary objective of this study is to assess the clinical, histological and confocal microscopy
effects of actinic keratoses (AK) lesions treated with imiquimod 5% cream or vehicle cream once
daily 3 times per week for 4 weeks. We studied 16 male subjects with histologically confirmed AK.
Subjects determined to be eligible were randomized to imiquimod or vehicle cream in a 3:1 ratio.
Both creams were supplied in a single-use sachet each with 250mg of cream. Each imiquimod sachet
contained 12.5mg of active drug. Subjects applied 1 sachet of study cream once daily 3 times per
week, for 4 weeks to a defined contiguous 25cm2 treatment area on the balding scalp. Each subject
was seen weekly during treatment period and then 4 weeks after treatment. During the treatment
period each subject underwent clinical, histological and confocal microscopy exams. At the 4 week
post-treatment visit the subjects underwent clinical and confocal microscopy evaluations. For those
subjects using imiquimod, a significant clinical, histological and confocal microscopy improvement
was noted. Results indicate that imiquimod 5% cream is an effective treatment option for AK. 
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Embryonic mouse stem cell migration in the presence of stem cell factor and bioengineered
skin
T Yufit,1 J Butmarc1 and V Falanga1,2 1 Dermatology and Skin Surgery, Roger Williams Medical
Center, Providence, RI and 2 Dermatology and Biochemistry, Boston University School of
Medicine, Boston, MA
Bioengineered skin substitutes have been widely used in the treatment of chronic wounds, but their
mechanisms of action are not completely understood. These constructs are able to synthesize and
release growth factors and cytokines, and are responsible for their stimulation of wound repair.
Chemotaxis is thought to be involved in many biological processes, including healing, inflamma-
tion, immune responses, and embryonic morphogenesis. In this study we used a modified Boyden
chamber assay to assess murine embryonic stem cell migration and how it might be affected by a
living bilayered skin substitute (BSC), consisting of neonatal foreskin keratinocytes and fibroblasts.
The lower well of the modified Boyden chamber contained the BSC with and without stem cell fac-
tor (SCF), and was separated from the upper chamber by a polycarbonate membrane with a pore
size of 8-µm. To evaluate the migration potential of embryonic stem cells (ESC) they were cultured
on a STO feeder layer, separated, and then plated as 105 cells per membrane. After overnight incu-
bation, cells on top of the membranes were scraped and removed, and the remaining cells on the
bottom side of the membranes were fixed, stained, and then counted using light microscopy. We
found up to a 5-fold increase in ESC migration from the upper to the lower chamber where BSC was
placed. The addition of SCF (10,50 and 100ng/ml) prevented the migration of ESC in a dose depend-
ent manner. We conclude that another mechanism of action of skin substitutes may be recruitment
of primordial cells to the site of injury. 
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Uncovering histological criteria with prognostic significance in toxic epidermal necrolysis
A Quinn,1 K Brown,2 KB Gordon,1 J Sinacore,1 R Gamelli2 and BJ Nickoloff1 1 Pathology, Loyola,
Maywood, IL and 2 Surgery, Loyola, Maywood, IL
Toxic epidermal necrolysis (TEN), a frequently lethal disease, usually represents an adverse drug
reaction. While extensive epidermal cell death is always present, a role for immunocytes is unclear.
A search of burn unit database (1992-present) yielded 34 patients with at least 30% surface area
sloughing who underwent punch biopsy of skin immediately following admission. Records and his-
tology slides were reviewed and the following clinical data extracted: age, %TBSA slough at admis-
sion, serum glucose, bicarbonate and BUN values. Each biopsy included a portion of denuded skin
as well as adjacent non-denuded skin. Routinely stained sections were reviewed by two investiga-
tors blinded to clinical data. Extent of dermal inflammation was evaluated at least 2 high power fields
(HPF) away from the perimeter of epidermal detachment, and 5 HPFs were graded as either: sparse
(164+/-34 cells/HPF, n=14), moderate (273 +/-76 cells/HPF, n=15), or extensive (392 +/-141 cells/HPF,
n=5). SCORTEN values were calculated and patients categorized as alive or dead during hospital-
ization. All patients were treated in a uniform fashion by an experienced team of physicians and
nurses. There was good concordance between observers in rating the extent of inflammation
(p=0.0005). While only 22% of patients with sparse inflammation died, 53% with moderate inflam-
mation died, and 80% with extensive inflammation died. Optimal data analysis used to predict patient
outcome with the leave-one-out method revealed similar classification accuracy for the current gold
standard SCORTEN (71%), and histological grade of inflammation (65%). We conclude: a) there is
a histological spectrum of TEN ranging from a pauci-cellular to extensive dermal inflammatory infil-
trate, and b) the degree of cutaneous inflammation in peri-lesional skin predicts clinical outcome as
well as SCORTEN. Future clinical trials should consider the possibility that various patient subsets
exist within TEN, and a role for immunocytes in TEN needs to be critically re-evaluated in this dev-
astating disease. 
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PUVA therapy for early stage cutaneous T cell lymphoma: long-term follow-up, curability, and
carcinogenesis in 67 patients
C Querfeld,1,2 ST Rosen,3,2 TM Kuzel,3,2 KA Kirby,4 HH Roenigk,1 BM Prinz1,2 and J Guitart1,2 1
Dermatology, Northwestern University, Chicago, IL, 2 Robert H. Lurie Comprehensive Cancer
Center, Northwestern University, Chicago, IL, 3 Medicine, Div. of Hematology/Oncology,
Northwestern University, Chicago, IL and 4 Preventive Medicine, Northwestern University,
Chicago, IL
PUVA is probably the preferred treatment option of mycosis fungoides stage IA to IIA with several
long-term studies confirming the efficacy of this treatment. Despite the documented benefits of PUVA
therapy, little data exist on potential long-term remissions or on indications of disease cure. The
objective of our retrospective, nonrandomized, single center study was to investigate the long-term
effects of PUVA therapy, impact of maintenance therapy, and potential curability in early stage CTCL.
We present the follow-up data of 67 patients with clinical stage IA to IIA disease who achieved
complete remission (CR) after treatment with PUVA between 1979 and 1995. Fifty-one percent main-
tained a CR for 81 months (range 0-238 months). Among these non-relapse group 50% of patients
with stage IA, 41% of patients with stage IB, and 9% of patients with stage IIA remained free of
disease. In patients who experienced relapses, the mean disease-free interval was 45 months (range
5-127 months). There were no significant differences in baseline characteristics, PUVA and main-
tenance treatment between the non-relapse and relapse patients. However, PUVA duration and tumor
stage are significant predictors of recurrence when adjusted for age, cumulative dosage, and main-
tenance duration. 27 percent of patients developed secondary cutaneous malignancy. Although ben-
eficial as monotherapy for early stages of the disease, PUVA is also a useful adjunct to other regi-
mens such as interferons, and retinoids to minimize adverse effects and decrease PUVA exposure. 
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Bexarotene blunts trafficking of malignant T cells in Sezary syndrome: reduction of CCR4-
positive lymphocytes and decreased chemotaxis to TARC (Thymus and activation-regulated
chemokine)
SK Richardson, SB Newton, JB Budgin, B Benoit, TL Bach, CS Abrams, M Wysocka and
AH Rook Dept. of Dermatology, University of Pennsylvania, Philadelphia, PA
Malignant cells in Sezary syndrome (SS) preferentially express the chemokine receptor CCR4 which
is involved in mediating lymphocyte trafficking to the skin. High levels of its ligand, TARC, are asso-
ciated with more advanced disease activity. The RXR specific retinoid bexarotene has been shown
to be efficacious among SS patients. To evaluate the effects of bexarotene on CCR4 expression and
chemotaxis to its ligand, peripheral blood mononuclear cells from SS patients and normal controls
were isolated and treated in culture with bexarotene (10uM). Flow cytometric analysis was performed
to determine the percentage of CCR4+ lymphocytes at different post-treatment time-points and
transwell migration assays were performed to evaluate lymphocyte chemotaxis to TARC. At 24hrs,
no change in CCR4 expression was noted among patient (~70% CCR4+) and normal control lym-
phocytes (~8% CCR4+). Approximately 40% of patient lymphocytes, and 4% of normal control lym-
phocytes exhibited chemotaxis to TARC, irrespective of treatment. At 36hrs, an 8% reduction in
CCR4+ lymphocytes was noted among the bexarotene treated patient cells (54% to 46%), with a sig-
nificant reduction in chemotaxis to TARC ligand (from 33% to 23%). The normal controls exhib-
ited no change in chemotaxis to TARC, maintaining a baseline of 2.8%, and no change in CCR4
expression. At 96hrs, a 28% reduction in CCR4+ lymphocytes was noted among the bexarotene
treated patients’ cells (73% to 45%) with a significant reduction in chemotaxis to TARC. Our results
show that the percentage of CCR4+ cells correlates closely with chemotaxis to its ligand. Whether
bexarotene downregulates CCR4 expression among malignant cells, or induces their selective elim-
ination, remains to be determined. In addition to its apoptotic ability, bexarotene may, in part, medi-
ate disease activity in SS through its ability to regulate lymphocyte trafficking patterns. 
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Correlation between single and multiple serological markers of melanoma (CYT-MAA, HMW-
MAA, S100) and the extent of melanoma
IJ Vergilis,1 SR Reynolds,1 KG Bergstrom,1 S Ferrone2 and J Bystryn1 1 Dermatology, NYU School
of Medicine, New York, NY and 2 Immunology, Roswell Park Cancer Institute, Buffalo, NY
Our goal was to examine whether the presence and/or level of several serological markers of melanoma
were correlated with the stage of disease, and whether the sensitivity of these assays can be increased
by multiple marker analysis. We measured the levels of three melanoma-associated antigens (CYT-
MAA, HMW-MAA, and S100) using double-sandwich ELISA in 117 melanoma patients and in 59
age and sex-matched unrelated disease controls. Melanoma patients were randomized into four cat-
egories: 30 with stages IIb/ IIIa, 30 with stages IIc/IIIb/IIIc, 30 with resected stage IV and 27 with
measurable stage IV disease. All three antigens were found more frequently in melanoma patients
than in controls and the differences were statistically significant. Both CYT-MAA and HMW-MAA
were detected more frequently than S100. Among positive patients, there was a correlation between
increasing serum levels of CYT-MAA and HMW-MAA, but not of S100, and more advanced stages
of melanoma.  For example, mean levels of CYT-MAA were 6.0 and 7.3 units in patients with stage
II or III disease but 13.1 units in patients with resected and measurable stage IV disease. There were
no correlations between detection or levels of positive responses and sex or age. Concurrent meas-
urement of multiple antigens increased the sensitivity of detection by approximately a third over
using the single most prevalent antigen (CYT-MAA). These results suggest that the CYT-MAA and
HMW-MAA have the potential to serve as molecular markers for the presence and extent of melanoma
and that measurement of multiple markers improves the sensitivity of this approach. 
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Topical treatment with collagenase accelerates healing in a new model of full thickness tail
wounds in mice
D Shrayer,1 J Butmarc,1 J Cha,1 P Carson1 and V Falanga1,2 1 Dermatology, Roger Williams
Medical Center, Providence, RI and 2 Dermatology and Biochemistry, Boston University School of
Medicine, Boston, MA
The purpose of this study was to determine the effect of topically applied collagenase and the other
debriding agents on the healing process in full thickness wounds in mice. C57BL/6 6 to 8 weeks old
mice were used, with 25 animals for each experimental group. Under general anesthesia full thick-
ness wounds down to fascia and corresponding to a template (15 x 4 mm) were created on the dor-
sal surface of mouse tails 5 mm distal to the base of the tail. Starting on the first post-operative day,
wounds from all mice were treated topically for the next seven days with the following agents: 1)
no treatment (control air-exposed); 2) collagenase ointment; 3) papain-urea ointment; 4) papain-urea
chlorophyllin copper complex sodium ointment. Starting on the day of surgery and every 5 days,
five mice for each group were euthanized by carbon dioxide inhalation. Samples of tails containing
the wounded site were fixed in 10% neutral buffered formalin for 24 hours, decalcified, and processed
for routine histology. The percentage of wound closure was measured by computerized planimetry
of the tissue sections, and was analysed using one way analysis of variance (Anova). Treatment with
collagenase ointment led to faster healing than the control and other debriding agents, and this was
most evident by Day 5 (45.9% and 28.3% closure for collagenase and control, respectively; p<0.005).
There was no difference between control treated wounds and those treated with the other debriding
agents. All wounds healed by 25 days. In conclusion, we report a new model of full thickeness wounds
on the dorsal surface of the mouse tail. This model displays delayed wound closure and shows that
topically applied collagenase ointment is an effective agent for accelerating healing. 
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Tazarotene 0.1% cream is an effective treatment for correcting the multiple morphologic changes
associated with the photoaged face
Y Zhen,1 M Crosby,1 I Sadiq,1 T Stoudemayer1 and AM Kligman1 1 S.K.I.N. Inc., Conshohocken,
PA, 2 S.K.I.N. Inc., Conshohocken, PA, 3 S.K.I.N. Inc., Conshohocken, PA, 4 Research, S.K.I.N.,
Incorporated, Conshohocken, PA and 5 S.K.I.N. Inc., Conshohocken, PA
Tazorac 0.1% cream was applied twice daily for 3 months to the photoaged faces of ten women who
showed wrinkling, dyspigmentation, laxity, sallowness and dry scaling. A variety of sophisticated
techniques were used at baseline and after the end of the treatment to obtain objective data relating
to improvement of the effects of excessive exposure to sunlight in childhood. We were able to quan-
tify the beneficial effects by our techniques. After three months treatment, substantial global improve-
ment of the clinical stigmata of photodamage was observed by clinical assessments and digital pho-
tography. In addition, UVA photographs showed a decrease in dyspigmentation, including solar
lentigines. The improvement of fine wrinkles and microtopographic abnormalities was observed by
using fringe projection technique that showed a smoother surface. Dryness, evaluated by hydration
of the horny layer, based on measurements of conductance and capitance, was considerably relieved.
The use of Tazarotene 0.1% cream is an efficient treatment for photoaging skin and twice daily reg-
imen was well tolerated. 
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Evaluation of a semi-quantitative MRI scoring method in psoriatic arthritis
AP Anandarajah,1 GS Seo,2 JU Monu2 and CT Ritchlin1 1 Rheumatology, University of Rochester
Medical Center, Rochester, NY and 2 Radiology, University of Rochester Medical Center,
Rochester, NY
Plain radiographs are the standard technique for assessing disease progression in psoriatic arthritis
(PsA). Yet, MRI can detect early changes in bone and visualize synovium, tendons and entheses. To
date, no scoring method has been formally evaluated in PsA. In this study, we developed an MRI
scoring system and used it to analyze PsA joints before and 6 months after etanercept therapy. 20
patients with active disease and ≥ 1 erosion on x-rays were selected. Gadolinium enhanced, fat sup-
pressed MRIs (T1 and T2 weighted FSE and GRE sequences) were performed at baseline and after
6 months of etanercept. The images were assessed semi-quantitatively for - bone marrow edema
(BME), cortical erosions, synovial proliferation, joint effusion, bony proliferation and soft tissue
changes. Each feature was graded for contrast enhancement, intensity of T2W signal and size. The
total MRI score is the sum of these scores. Three radiologists scored each MRI independently. The
sum of the tenderness and swelling is the individual joint score (IJS). The MRI score was compared
to the IJS. 13 images were available for analyses. Baseline MRI revealed synovial proliferation and
erosions (100%), marrow edema (81%), soft-tissue swelling and bony proliferation (69%) and
intra-articular effusions (56%). At baseline, the IJS and the MRI scores had a positive correlation
(r=0.41). Mean total MRI score improved from 23.9 ± 8.0 to 19.8 ± 8.5 (p=0.04), after treatment.
Mean IJS improved from 3.54 ± 1.4 to 0.77 ± 1.23(p=0.0001). Improvement in BME and synovial
proliferation scores was significant (p=0.04). Erosion and effusion scores also improved but did not
reach significance. Interobserver reliability between radiologists was 72%. These results show that
synovial proliferation, erosions, marrow edema and soft tissue swelling are frequent findings in PsA.
Bone marrow edema improves with etanercept therapy. This scoring system has good reproducibil-
ity and interobserver reliability. Additional studies are required to validate this scoring system. 
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Skin blanching response to topical corticosteroids reflects ADH allelic haplotype associated
with fast alcohol metabolizing isoforms
LK Pershing,1 Y Chen1 and MR Hobbs2 1 Dermatology, University of Utah, Salt Lake City, UT and
2 Internal Medicine, University of Utah, Salt Lake City, UT
We have previously shown that highly variable human skin blanching responses to topical corticos-
teroids is independent of skin drug content, but correlates with single nucleotide polymorphisms
(SNPs) in alcohol dehydrogenase genes (ADH). The current study determined the allelic haplo-
types of SNPs in three ADH genes: ADH2 exon 3 G143A, ADH3 exon 6 A815G, ADH7 exon 3
G239C, and evaluated their association with skin blanching responses (SBR). Seventy-four male
(23) and female (51) Caucasian (60) and Asian (14) subjects, age 18-65 yrs, were evaluated with
four commercial 0.05% betamethasone dipropionate products containing either no alcohol, or con-
taining propylene glycol (PG), or isopropyl alcohol (IPA), or PG+IPA. Subjects were dosed with 5
mg of all products for 0, 10, 30, 60, 120 and 240 min. SBR was measured by a reflectance colorimeter
1 hr before drug application, at drug removal and 2, 4, 6, 19 and 24 hrs later. Area-under-the-SBR-
time curves were calculated for each dose and individual maximal SBR determined. ADH allelic
haplotype was determined from DNA extracted from peripheral blood using PCR and nucleotide
sequencing. Data demonstrate eleven ADH haplotypes composed of ADH2*2,ADH3*1 and ADH7*1
alleles associated with fast alcohol metabolizing isoforms. Increasing the number of alleles associ-
ated with fast alcohol metabolizing isoforms from 0 to 6 was associated with a 6X increase in SBR
(p< 0.05) to ointment without alcohol in gene order: ADH2 > ADH7 > AHD3. PG, IPA and PG+IPA
increased SBR 2-5X (p< 0.05) in haplotypes containing 0-3 alleles associated with fast alcohol metab-
olism in ADH3 and ADH7, but had little effect on haplotypes containing the ADH2*2 allele. Thus,
SBR is dramatically increased with alcohols in slow alcohol metabolizing haplotypes, but unaffected,
or diminished, in high alcohol metabolizing haplotypes. These data demonstrate the importance of
alcohol metabolism haplotype on local cutaneous SBR phenotype and may be useful in enhancing
individualized therapy with these drug products. 
273
Trapping of bacteria by cadexomer beads
LH Zhou,1 W Nahm,2,4 J Butmarc,1 T Yufit1 and V Falanga1,3 1 Dermatology and Skin Surgery,
Roger Williams Medical Center, Providence, RI, 2 Dermatology, University of California, San
Diego School of Medicine, San Diego, CA, 3 Dermatology and Biochemistry, Boston University
School of Medicine, Boston, MA and 4 Dermatology, VA San Diego Health Care System, San
Diego, CA
Slow-release antiseptics are increasingly being used in the treatment of exudative wounds with a
high bacterial load. One such agent, cadexomer iodine, carries iodine (0.9% weight/weight) immo-
bilized in beads of dextrin and epichlorhydrin and has been demonstrated to be highly effective in
promoting healing of exudative wounds. We reported previously that cadexomer iodine lacks toxi-
city in vivo and in vitro, at least within a certain concentration range. Additionally, we also reported
that, in vivo, bacteria can be found in the cadexomer beads. In this study, to test the hypothesis that
cadexomer beads are capable of trapping bacteria, we used the vehicle cadexomer beads (without
iodine) and exposed it to varying amounts of E. coli in vitro. A number of experiments were per-
formed, testing the optimal exposure time of bacteria to beads (up to 144 hours) and bacterial load
in DMEM plus 10% FBS. In addition, we also incubated cadexomer beads overnight with bacterial
suspensions on glass slides. Both histology with hematoxylin and eosin and gram staining showed
bacteria inside the cadexomer beads and surrounding them. In summary, it appears that cadexomer
beads, in addition to their property of absorbing fluid, can also act as a trap, at least temporary, for
bacterial organisms. These findings may have important clinical implications for treatment of infected
wounds and for the technical development of better agents capable of trapping bacteria and other
microorganisms. 
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Dectin-2 is a pattern recognition receptor for Der p 1, the major allergen in house dust mites
K Sato,1 T Yudate,2 J Chung,1 P Cruz, Jr1 and K Ariizumi1 1 Dermatology, The University of Texas
Southwestern Medical Center, Dallas, TX and 2 Kinki University School of Medicine, Osaka, Japan
Having shown that dectin-2 on dendritic cells (DC) is a pattern recognition receptor (PRR) recog-
nizing mannan-like carbohydrates on hyphae, that induces DC expression of Th2 cytokines, we
posited that dectin-2 may also serve as PRR for other Th2-stimulatory agents. To address this hypoth-
esis, we used affinity chromatography to evaluate the ability of soluble dectin-2 to bind whole extract
of house dust mite. SDS-PAGE analysis of the dectin-2-bound/mannan-eluted fraction revealed 6
separate molecules within the extract. Buoyed by these findings, we specifically determined whether
dectin-2 recognizes Der p 1 (the major allergen). By ELISA, we found dectin-2 (but not controls)
to bind purified native Der p 1 dose-dependently (2.5-20 µg/ml). We also found this binding to be
inhibited completely by mannan (but not other carbohydrates), indicating that dectin-2 recognizes
Der p 1 (like hyphae) via mannan-like carbohydrates. This selective binding was supported by 4-
fold greater binding of dectin-2 to native (than to recombinant) Der p 1, since the two forms contain
identical peptide sequences but disparate carbohydrates. We next employed 125I- Der p 1 and COS-
1 cells altered to express full-length dectin-2 tagged with V5 epitope. COS-1 cells bound Der p 1
(4°C) and also internalized it (37°C). Both processes were blocked completely by preincubation of
COS-1 cells with anti-V5 (but not control) Ab. Finally, we examined binding of bone marrow-derived
DC (constitutively expressing dectin-2) to bind Der p 1 and its effect on DC function. DC bound
and internalized 125I-Der p 1 at appropriate doses and temperatures. Preincubation of DC with man-
nan reduced uptake to 40%. Importantly, Der p 1 stimulated a 20-fold rise in DC expression of IL-
10 mRNA, as measured by real-time PCR. These findings support the concept that dectin-2 acts as
a PRR for pro-Th2 agents (hyphae and house dust mites) by recognizing mannan-like carbohy-
drates on these microbes. 
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Bioengineered skin preservation using epiboly as a measure of construct functionality
H Rausch,1 J Butmarc,1 T Yufit1 and V Falanga1,2 1 Dermatology and Skin Surgery, Roger Williams
Medical Center, Providence, RI and 2 Dermatology and Biochemistry, Boston University School of
Medicine, Boston, MA
A prototypic bioengineered bilayered skin construct (BSC) consisting of human keratinocytes and
dermal fibroblasts is used in the treatment of chronic cutaneous wounds. One disadvantage of this
and other similar products is their limited shelf life, which in the case of BSC is 5 days based on
FDA-approved morphological criteria. The functional viability of the product beyond the expiration
date has not been well studied, and there is a need to determine whether BSC could be used clini-
cally beyond its present expiration criteria.  Here we report on the contructs viability by evaluating
for the capacity for epiboly. Six-mm punch biopsies were made in BSC before and after its mor-
phologically-based expiration date and these samples were floated in multiple culture media and
placed at various temperatures. We found that epiboly, as determined 3 days after harvesting of the
biopsy samples, was consistently present up to 5 days after the expiration date. Epiboly could be
demonstrated at room temperature but not at 4°C and was best in serum-free media (AIM-V). These
results point to the potential for BSC and similar constructs to be functional well after their mor-
phologically-based expiration date and to epiboly as a phenomenon that could be used to determine
construct functionality. 
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Effects of a novel compound, Seletinoid G, on keratinocyte proliferation and differentiation in
aged human skin in vivo
M Cho,2 S Lee,1 M Kim,1 H Rho,3 S Kim,3 I Chang,3 J Seo1 and J Chung1 1 Department of
Dermatology, Seoul National University College of Medicine and Laboratory of Cutaneous Aging
Research, Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea, 2
Department of Dermatology, Soonchunhyang University College of Medicine, Seoul, South Korea
and 3 Skin Research Institute, Amorepacific Corporation R&D Center, Kyounggi, South Korea
Retinoids are natural and synthetic derivatives of vitamin A. It possesses the broad biological activ-
ities such as photoaging prevention, anticancer, acne and psoriasis interference. Although its potent
efficacy has been useful for many skin conditions, the side effect (skin irritation) has been an obsta-
cle for the plentiful application of RA. New pyranone derivative, 2-((3E)-4(2H,3H,-benzo[3,4-d]1,3-
dioxolan-5-yl)-2-oxo-but-3-enyloxy)-5-hydroxy-4H-pyran-4-one(Seletinoid G), was designed as a
novel retinoid on the assumption that the pyranone ring may mimic the carboxylic acid moiety in
retinoid structure. Seletinoid G, retaining similar molecular length and shape to RA, showed exclu-
sive RAR? specific binding affinity. In this study, we investigated the effects of topical Seletinoid G
on the epidermal proliferation and differentiation in aged human skin in vivo. Keratinocyte prolif-
eration was assessed by Ki67 staining and epidermal differentiation was assessed by immunostain-
ing of involucrin, filaggrin, loricrin, K1 proteins. We demonstrated that Seletinoid G cause little
skin irritation and its effects on epidermal proliferation and differentiation were similar to those of
retinoic acid in aged human skin in vivo. Therefore, our data suggests that Seletinoid G is a new
generation of receptor-selective retinoid with low skin irritation and may be a candidate for treat-
ment of intrinsic aging and photoaging like a retinoic acid. 
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Characterization of the chronic wound fibroblast abnormal phenotype
V Falanga,1,2 J Cha,1 T Yufit,1 P Sengupta2 and BD Smith2 1 Dermatology, Roger Williams Medical
Center, Providence, RI and 2 Biochemistry, Boston University School of Medicine, Boston, MA
Dermal fibroblasts cultured from chronic wounds exhibit an abnormal phenotype characterized by
altered morphology, senescence, and poor response to growth factors, including TGF-beta. In these
studies, we have further characterized the morphological, proliferative, and synthetic abnormalities
of ulcer fibroblasts. We compared fibroblasts from the edge of non-healing venous ulcers with those
from acute wound thighs created in the same patients. We show that ulcer fibroblasts have a bizarre
epithelioid morphology with large nuclei and vacuolar changes. An identical and irreversible mor-
phology is obtained when exposing normal control fibroblasts to low (0.5%) serum and TGF-beta
for as short as seven days. This induced phenotype of normal cells also shows decreased expression
of TGF-beta Type II receptors, similar to what is seen with ulcer fibroblasts, which also show decreased
Smad3 and MAPK p42/44 phosphorylation. Failure to increase collagen synthesis in response to
TGF-beta is not due to DNA methylation, which was found to be identical for COL1A1 in normal
and ulcer cells. The poor proliferative response of ulcer fibroblasts could be corrected by transduc-
tion with a constitutively phosphorylated form of the TGF-beta Type I receptor or by simple expo-
sure of ulcer cells to a living bioengineered skin construct. We conclude that the abnormal pheno-
type of chronic wound cells can be reproduced by exposure to low serum and TGF-beta and in an
irreversible manner, and that the decreased Type II receptor expression and transduction abnormal-
ities are critical to the poor response of ulcer fibroblasts to TGF-beta. 
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Targeted inhibition of CCR5 with PSC-RANTES is sufficient to block intravaginal transmis-
sion of SHIV in rhesus macaques
A Blauvelt,1 M Lederman,2 R Veazey,3 D Mosier,4 O Hartley5 and R Offord5 1 Dermatology Br.,
NCI, Bethesda, MD, 2 Dept. of Medicine, Case Western Reserve Univ., Cleveland, OH, 3 Tulane
Natl. Primate Regional Ctr., Tulane Med. School, Covington, LA, 4 Scripps Research Inst., La
Jolla, CA and 5 Dept. de Biochime Medicale, Univ. de Geneve, Geneva, Switzerland
An effective topical microbicide applied intravaginally could protect women from initial HIV infec-
tion and save millions of lives. We are developing microbicides that block HIV infection by bind-
ing to CCR5, a critical HIV co-receptor, on susceptible cells and interfering with HIV attachment
and virus-cell fusion. Since RANTES is a natural ligand for CCR5, we have developed a synthetic
RANTES analogue, called PSC-RANTES, that causes prolonged intracellular sequestration of CCR5
and protection from HIV infection in vitro. To assess the efficacy of PSC-RANTES as a microbi-
cide in vivo, female rhesus macaques were atraumatically and intravaginally treated with 4 mL of
PSC-RANTES diluted in saline at concentrations of 1 mM (n=5), 330 uM (n=5), 100 uM (n=5), or
1-10 uM (n=5), or 4 mL of saline alone (n=5). Fifteen minutes after dosing, animals were intrav-
aginally inoculated with 300 TCID50 of SHIV162P3, a CCR5-utilizing virus that has high relevance
to human HIV transmission. Viral loads in plasma were then monitored weekly by a bDNA assay.
All 5 macaques pretreated with the highest dose (1 mM) and 4 of 5 treated with the 330 uM dose of
PSC-RANTES were completely protected from intravaginal SHIV infection as evidenced by unde-
tectable virus in plasma. By contrast, only 3 of 10 macaques in the low dose groups were protected,
and 4 of 5 in the control group became infected, indicating that protection from vaginal challenge
with virus was dose-dependent. These results clearly demonstrate that topical PSC-RANTES inhibits
vaginal transmission of a CCR5-utilizing SHIV in a dose-related manner in macaques. Since CCR5-
utilizing strains predominate in early mucosal transmission, these results suggest that topically block-
ing the binding of virus to CCR5 may be sufficient to block vaginal transmission of HIV in humans. 
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Quantitative investigation on the progression of acne vulgaris
G Stamatas, J Fong, E Ruvolo, J Liu and N Kollias Johnson & Johnson, Skillman, NJ
Acne vulgaris affects males and females of all ages around the world. The condition manifests itself
in the form of one or more lesions that typically take several days to weeks to resolve if left untreated.
The purpose of this study is to use objective instrumental methods coupled to self and dermatolo-
gist evaluations for quantification of inflammation-related parameters relevant to acne vulgaris in
order to develop fundamental understanding of the progression of the disease. Seventeen subjects
participated with at least one inflammatory acne lesion that was no more than 24 hrs old and had not
been treated with any product. Self-assessment questionnaires were collected and high-resolution
digital images were used for expert grading. Lesion height and volume were measured using 3D
surface profilometry. Erythema intensity, area involved, and interstitial fluid accumulation in the
cases of edematous lesions, were evaluated by hyper-spectral imaging. Study results show that lesion
diameter, elevation, erythema, and peeling increase at 24 and 48 hours after baseline. At 7 days after
baseline erythema and elevation persist. Lesion oxyhemoglobin levels (a component of erythema)
are highest during the first 4 days after baseline. After this point, erythema levels steadily decrease
toward healthy skin levels over 2 weeks. Lesion diameter peaks at 24-48 hours after baseline and
subsequently starts to decrease at day 4. The lesion is still evident at day 14 although elevation and
interstitial fluid accumulation under the lesion may not be present. This indicates that edema and
erythema dynamics follow different patterns. In conclusion, self and dermatologist evaluations cou-
pled with instrumental methods that quantify acne-relevant parameters, such as lesion volume and
diameter, interstitial fluid accumulation, and erythema expressed as increased oxy-hemoglobin con-
centration, have revealed new findings in acne lesion dynamics. Fundamental understanding of the
progression of acne lesions from formation to resolution helps to develop safe and effective treat-
ments for patients and consumers. 
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The sensitivity and specificity of confocal microscopy in the diagnosis of allergic contact der-
matitis: a preliminary study
S Astner,2,1 AC Cheung,2,1 E Gonzalez,1 F Rius-Diaz,2,1 AG Doukas2 and S Gonzalez2,1 1
Dermatology, Massachusetts General Hospital, Boston, MA and 2 Wellman Laboratories of
Photomedicine, Boston, MA
The reproducibility and efficiency of patch testing in the diagnosis of allergic contact dermatitis
(ACD) has been questioned in recent years. Recently, reflectance-mode confocal microscopy (RCM)
has been used for non-invasive evaluation of the histopathological features of ACD. This work was
designed to determine the sensitivity and specificity of RCM as compared to patch testing. 16 sub-
jects with a prior ACD diagnosis were patch-tested with the allergens and appropriate controls.
Clinical scoring, digital photography and RCM evaluation were performed at 72 hours following
patch removal. RCM and clinical images were evaluated and scored by three dermatologists blindly
and independently. The following RCM parameters were assessed: stratum corneum (SC) disrup-
tion, parakeratosis; stratum spinosum (SS) and stratum granulosum (SG) spongiosis, exocytosis and
vesicle formation. Logistic regression analysis was performed on all significant variables, p-values
were determined using Chi-square.
Overall, there is high specificity for all features, ranging from 95.8% - 100%. Sensitivity ranges from
51.9% - 96.3%. Significant parameters with high sensitivity and specificity include spongiosis at
the level of SS (sensitivity: 100%, specificity 92.6%, p <0.05), spongiosis at the level of SG (95.8%,
96.3%, p < 0.05), and exocytosis (100%, 74.1%, p< 0.05). All other parameters are also significant,
with the exception of SC disruption. Furthermore, logistic regression analysis indicates that stratum
spinosum spongiosis is the best predictor for diagnosing allergic contact dermatitis. The compara-
ble sensitivity and specificity of RCM to clinical diagnosis of ACD makes RCM a promising tool in
diagnosing allergic contact dermatitis. In particular, spongiosis at the level of the spinous layer shows
excellent correlation and can be used as a criterion in the detection of ACD using RCM. 
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Phase II randomized bilateral comparison of bexarotene 1% topical gel in alopecia areata
M Duvic,1 R Talpur,1 S Ziari,1 D Persyn1 and V Stevens2 1 Dermatology, MD Anderson, Houston,
TX and 2 Ligand Pharmaceuticals, Inc, San Diego, CA
Alopecia areata (AA) is a T-cell mediated autoimmune disease directed against hair follicles. It can
result in loss of all scalp hair (alopecia totalis, AT) or body hair (alopecia universalis, AU), and is
often refractory to therapy. Bexarotene (bex) is an RXR-selective retinoid (rexinoid) that induces T-
cell apoptosis [CCR 8: 1234-1240, 2002] and is approved for cutaneous T-cell lymphoma.  Follow-
ing our observation that bexarotene reversed alopecia in CTCL patients [Br. J. Derm. 148: 1-4, 2003],
we tested the hypothesis that benign perifollicular T-cell infiltrates could be similarly targeted. We
have conducted Stage I of a Phase II study of AA in 13 of 42 total patients. Thirteen patients include
4 Alopecia Totalis/universalis and 9 patchy AA and 4 males and 9 females. Consenting patients
were randomized to apply topical bex gel to to one half of their scalp once daily x 2 wks then
twice/daily for up to 24 weeks. No other form of oral or topical therapy was allowed for one month
prior to and during the study. Assessment of index lesions, hair growth and density, labs, and adverse
events were evaluated monthly. Four patients had >50% partial hair regrowth, two pts had minor
hair regrowth, two had stable disease, and three progressed while on therapy. One AT pt with 99%
alopecia (AT) for 4 years grew back 88% of her hair by week 8 and one with 78% alopecia achieved
50% hair regrowth by week 16, beginning with the treated side. No grade 3 toxicity occurred but
erythema, scaling, and/or itching due to local irritation at the application site were experienced by
11 pts, and required decreased application frequency in 4 pts.  These data suggest that topical
bexarotene 1% may be effective in treating some patients with alopecia areata with a response rate
of 31%, even in patients with more persistent and severe AA phenotypes. 
282
Juvenile polyposis coli, juvenile polyps and cafe-au-lait macules: is there a relationship?
LH Scatena,1 LA Lee,1 EJ Hoffenberg,2 BJ Bateman3 and TR Pacheco1 1 Dermatology, University
of Colorado, Arvada, CO, 2 Pediatric Gastroenterology, University of Colorado, Denver, CO and
3 Ophthalmology, University of Colorado, Denver, CO
Cafe-au-lait macules (CALMs) and lentigines are associated with the PTEN (CR 10q23) mutation
polyposis syndromes including Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome
(BRR). CALMs have also been associated with a subset of hereditary non-polyposis colorectal can-
cer (HNPCC) with early onset colorectal neoplasia. The extra-colonic phenotypic abnormalities, in
particular cutaneous findings, of two other polyposis syndromes, juvenile polyposis coli (JPC) and
juvenile polyps (JP) have not been well characterized. (JPC is defined as 10 or more juvenile polyps
and often associated with heritable cancer syndromes. In contrast JP is defined as isolated hamar-
tomas not associated with an increased cancer risk and found in 1-2% of children.) Children with
polyps were identified through the clinical practice database of the section of pediatric gastroen-
terology at a single institution. These children and their first-degree relatives were invited to partic-
ipate in this case series. Subjects underwent a comprehensive skin examination by dermatologists
and retinal examinations if pigmented lesions were identified. 9 families consisting of 11 children
(range 10-23 years old) and 17 first-degree family members (range 3-49 years old) participated in
this case series. 4 of 10 subjects with JPC or JP had multiple (>3), large (> 15mm) CALMs identi-
fied, primarily on the trunk. 3 of 17 first-degree relatives of JPC or JP subjects had CALMs identi-
fied. All patients were Caucasian except 1 Hispanic JP patient who did not have a CALM. Patients
with identified CALMs underwent ophthalmologic examinations without identification of retinal
pigmented lesions. In this case series, CALMs were identified at a greater rate in JPC and JP sub-
jects. This data may support a common pathway for hamartomatous polyps (JP/JPC/CS/BRR) as all
may have polyps and CALMs. Perhaps CALMs serve as a cutaneous marker for these syndromes
and could assist in the identification of asymptomatic carriers. 
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A comparison of keratin gene expression between inflamed and control skin obtained by tape
harvest
NR Benson, R Wong and V Tran DermTech International, San Diego, CA
The purpose of this study was to determine if tape-harvested RNA samples could be used to moni-
tor changes in gene expression induced by 1% sodium lauryl sulphate or water compared to normal
skin. An additional objective was to compare keratin expression profiles in biopsy skin samples
with tape-harvested samples. 10 subjects were occlusively patched on the upper back with two 1%
aqueous SLS and two water patches. After 24 hours, patches were removed and one replicate site
was shave biopsied and the other site was tape harvested by application and removal of 4 custom
adhesive tapes (circular 17 mm diameter). Normal, adjacent skin was similarly sampled. mRNAs
for β-actin, keratin-10, keratin-16 and keratin-17 were assayed by semi-quantitative RT-PCR. The
keratin mRNAs were normalized to actin mRNA in each sample. The keratin mRNA / βactin mRNA
ratio in SLS samples was calibrated to that same ratio in water or normal skin samples. Similarly,
the keratin / actin mRNA ratio in water samples was calibrated to normal skin. The results showed
that Krt-10 mRNA decreased relative to b-actin mRNA in both tape and biopsy samples of SLS
treated skin relative to water treated and normal skin (95% confidence interval). Analysis of Krt-16
mRNA expression in SLS relative to normal skin showed the expected increase in biopsy samples.
However, tape-harvested samples showed the opposite results with the Krt-16 / actin mRNA ratio
decreasing. In order to investigate this result further, Krt-17 mRNA (co-regulated with Krt-16) was
analyzed in all samples. The expression of Krt-17 mRNA in biopsies of SLS-treated skin increased
relative to actin while expression of Krt-17 mRNA in tape-harvested samples decreased. Previous
comparison of RNA profiles of tape and biopsy skin samples had suggested that the two methods
were recovering different skin cell populations. This work confirms that hypotheses. This work con-
tinues our efforts to develop tape harvesting as a non-invasive substitute for biopsy, thus allowing
the routine direct qualitative and quantitative assessment of physiologic and pathologic biomarkers
in the skin. 
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Failure of physiologic doses of pure UVB or UVA to induce lesions in photosensitive cutaneous
lupus erythematosus: implications for phototesting and sunblocking strategies
ML Rosenbaum,1 S Billet,1 P Patel,1 E Kwon,1 RM Sayre,3 KE Sullivan4 and VP Werth1,2 1 U. of
Pennsylvania, Philadelphia, PA, 2 VA Hospital, Philadelphia, PA, 3 U. of Tennessee, Knoxville, TN
and 4 Children’s Hospital of Philadelphia, Philadelphia, PA
Subacute cutaneous lupus erythematosus (SCLE) is a photosensitive disease. Several phototesting
studies have identified UVB and UVA as the wavelengths that induce skin lesions. There is a large
difference of results between these studies, which is attributed to non-standardized light testing pro-
tocols. Most of these studies have been performed with doses of UVA and UVB that are above phys-
iologic levels, and some UVB sources may be contaminated with non-physiologic UVC, while
UVA sources often emit substantial amounts of visible light and heat. We phototested SCLE patients
with type 2 skin (n=9) and skin type-matched healthy controls (n=12) with physiological doses of
UV light from controlled irradiation devices. Our UVB source incorporated Kodacel filters to block
all UVC. Our UVA source had a UG11 filter to block the majority of infrared and visible light and
a 3-mm thick 335-nm Schott filter to block all wavelengths shorter than UVA. We correlated the min-
imum erythema doses (MEDs) with the −308 TNF-α promoter genotype (GG wildtype vs GA TNF
overproducer) and examined the induction of LE lesions. Patients had their MED determined, and
were then irradiated with either UVB (1 MED) or UVA (20 J/cm2) daily for 5 days, and then fol-
lowed weekly for 3 weeks. We found that the MED of control GG vs GA patients was 95±6.4 mJ/cm2
(mean±SEM, n=8) vs. 108±9 mJ/cm2 (n=4; NS). In the SCLE patients, the MED was 107±11 mJ/cm2
(n=3) vs 87±7 mJ/cm2 (n=5; NS; the ninth patient was AA). Including one patient with type 3 skin,
we tested a total of 10 SCLE patients with both UVB and UVA. No patient showed induction of skin
lesions with UVB. Only the single AA patient showed UVA-induced skin lesions. We conclude that
pure, physiologically relevant doses of UVB and UVA do not consistently induce lesions under our
conditions. Thus, there must be other factors that contribute to clinical photosensitivity. 
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The biological effects of a novel retinoid, Seletinoid G, in human skin in vivo
M Kim,1 Y Oh,1 S Lee,1 J Seo,1 H Rho,2 D Kim,2 I Chang2 and J Chung1 1 Department of
Dermatology, Seoul National University College of Medicine, Laboratory of Cutaneous Aging
Research, Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea and
2 Skin Research Institute, Amore-Pacific Corporation R&D center, Yongin, South Korea
Retinoids are vitamin A, its naturally occurring and synthetic derivatives. They exert a wide variety
of profound effects in acne, psoriasis, photoaging, and skin cancers. When retinoids are used topi-
cally, they are associated with the development of a local irritative response, referred to as a “retinoid
dermatitis”. New pyranone derivative, 2-((3E)-4(2H,3H,-benzo[3,4-d]1,3-dioxolan-5-yl)-2-oxo-but-
3-enyloxy)-5-hydroxy-4H-pyran-4-one (Seletinoid GTM), was designed as a new retinoid analogue
on the assumption that the pyranone ring may mimic the carboxylic acid moiety in retinoid struc-
ture. In gene transactivation assays, Seletinoid G bound with high affinity to RARg than RARa.
Seletinoid G induced the mRNA expression for specific celluar markers of retinoid action, i.e.
tazarotene-induced gene 1/2, and keratin 4, but not cellular retinoic acid binding protein (CRABP)-
II. Seletinoid G showed little skin irritation at the human primary skin irritation test. We investi-
gated the effects of topical Seletinoid G treatment on the expression of extracellular matrix proteins
and MMP-1 in aged human skin. Seletinoid G increased the expression of type I procollagen, tropoe-
lastin, and fibrillin-1, and decreased the expression of MMP-1. We investigated the inhibitory effects
of Seletinoid G on UV-induced changes of type I procollagen, MMP-1, ERK, and c-Jun expression
in young skin. Seletinoid G not only blocked the UV-induced decrease of type I procollagen but also
UV-induced increase of MMP-1, phospho-ERK, and c-Jun. Therefore, our data suggests that Seletinoid
G is a new generation of receptor-selective retinoid with low skin irritation and may be a candidate
for treatment of intrinsic aging and photoaging like a retinoic acid. 
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Antigen-specific peripheral tolerance induced by topical application of NF-kB decoy
oligodeoxynucleotides
I Isomura and A Morita Dermatology, Nagoya City University Medical School, Nagoya, Aichi-ken,
Japan
Activation and maturation of dendritic cell (DC) are crucial for the establishment of delayed-type
hypersensitivity (DTH). However, antigen presentation by immature dendritic cells (iDC) might lead
peripheral tolerance. iDC are characterized by low surface expression of co-stimulatory molecules,
i.e., B7-1 and B7-2. Recently, nuclear factor kappa B (NF-kB) decoy oligodeoxynucleotides (ODN)
has been used for heart graft transplantation by inhibiting NF-kB-related gene expression. NF-kB
plays significant roles in upregulation of co-stimulatory molecules and immunostimulatory cytokines.
Here we investigated whether NF-kB decoy oligodeoxynucleotide (ODN) could induce tolerance in
DTH. NF-kB decoy ODN ointment (2%) was applied and sensitized by OVA on shaved abdominal
skin of BALB/c mice, and elicited by intradermal injection into footpads 7 days after sensitization.
NF-kB decoy ODN suppressed induction of DTH. Adoptive transfer of the cells from draining lymph
nodes from the tolerant mice suppressed the induction of DTH. Deletion of CD25+ T cell popula-
tion by PC61 mAb abrogated the suppression of DTH. Adoptive transfer of CD4+CD25+ T cell
(Treg) from tolerant mice induced tolerance in the sensitized mice. Furthermore, topical NF-kB decoy
ODN inhibited DC migration and upregulation of co-stimulatory molecules on DC. Antigen cross-
ing assay revealed that the tolerance to OVA is not suppressed by adoptive transfer of lymph node
cells from mice which are tolerant to hen egg lysozyme (HEL). These findings indicate that topical
NF-kB decoy ODN induces antigen-specific peripheral tolerance in DTH in vivo, and this tolerance
is mediated by modulating DC activation and inducing Treg. The topical application of NF-kB decoy
ODN is a new strategy for the induction of antigen specific peripheral tolerance and gives us a new
format for the treatment of allergic diseases. 
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Unique formulation dramatically improves wound closure and healing, by accelerating criti-
cal healing stages
I Solomonik,2 M Yuli,1 Z Dvashi,1 D David-Pur,1 J Aran,1 T Tennenbaum2 and L Braiman-
Wiksman1 1 HealOr Ltd., Ramat-Gan, Israel and 2 Life sciences, Bar-Ilan University, Ramat Gan,
Israel
Effective wound healing requires a highly organized series of events that comprise inflammation,
re-epithelialization, proliferation, angiogenesis and wound contraction. Together, these processes
result in the restoration of tissue integrity and functional healing. The present study investigates the
various stages of acute wound healing and presents a new formulation accelerating this process.
Protein Kinase C is a family of serine/threonine kinases that play a role in skin physiology as well
as in various skin pathologies. We developed effective PKC based formulation consisting of nPKC
activator and cPKC inhibitor which augment wound healing. We have completed preclinical stud-
ies in rodents and pigs. Moreover we developed a unique strategy for wound healing assessment
enabling quantification of critical healing stages. Longitudinal wound incisions (2 or 3 cm) were per-
formed on upper backs of animals. Healing processes were analyzed at critical time points: 1-30 days
post wounding. Assessment was made utilizing antibodies to keratin 14 (basal epidermal layer for-
mation), keratin 1 (spinous layer differentiation), keratin 6 (migration), PCNA (mitosis), H&E (der-
mal contraction and remodeling). Results clearly demonstrate that 100% of HO/03/03 treated mice
exhibit formation of a new epidermal layer at the gap of the wound 7 days post wounding. More-
over the treated animals display full spinous differentiation 9 days post wounding and contraction
of the wound by day 12. In contrast PBS treated control animals display epidermal closure by day
12 and spinous differentiation as well as dermal contraction only by day 18 post wounding. Similar
results were obtained in pig model system. All critical healing stages in pigs are significantly accel-
erated by HealOr’s PKC based formulation. We have completed pre-clinical studies demonstrating
the efficacy of an innovating formulation that accelerates the healing of wounds. 
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Imiquimod treatment of basal cell carcinoma induces expression of a novel tumor antigen, opi-
oid growth factor receptor: direct or IFN-α-mediated effect?
M Urosevic,1 PA Oberholzer,1 E Laine,1 H Slade,2 B Benninghoff,3 G Burg1 and R Dummer1 1
Dermatology, University Hospital Zurich, Zurich, Zurich, Switzerland, 2 3M Pharmaceuticals, St.
Paul, MN and 3 3M Pharmaceuticals, Neuss, Germany
Imiquimod is a synthetic local immune response modifier that has demonstrated efficacy in clear-
ing superficial basal cell carcinoma (sBCC). Via interaction with Toll-like receptor 7 on immune
cells, imiquimod induces local production of cytokines, such as interferon (IFN)-α. To more closely
define and elucidate mechanisms leading to BCC clearance in vivo, we examined gene expression
profiles of skin sBCC before and after treatment with 5% imiquimod cream (Aldara, 3M Pharma-
ceuticals, St. Paul, MN) by using high-density oligonucleotide arrays. We show that imiquimod pre-
dominantly induces genes involved in different aspects of immune response. In addition to effects
on immunity, imiquimod treatment modulates the expression of genes involved in the control of
apoptosis (e.g. bcl-2, bax, various caspases, TRAF1,2) and oncogenesis (e.g. Hedgehog pathway -
PTCH, GLI1,3; Wnt pathway - FZD7, DVL3). Array data indicated that imiquimod treatment induces
expression of opioid growth factor receptor (OGFr), a molecule with anti-proliferative properties
recently reported to be a target for anti-tumor antibody responses. Quantitative PCR confirmed OGFr
up-regulation in Aldara treated sBCC skin samples. Immunohistochemistry revealed in vivo up-reg-
ulation of OGFr protein on tumor and on infiltrating cells after Aldara treatment. By using BCC cell
lines treated with IFN-α or imiquimod, we show that up-regulation of OGFr mRNA as well as
OGFr protein is IFN-α rather then directly imiquimod mediated. Through IFN-α-mediated up-reg-
ulation of OGFr, imiquimod might not be only suppressing tumor growth but it might as well increase
tumor immunogenicity. 
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Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor acti-
vation via specific induction of its ligands heparin binding-EGF and amphiregulin in human
skin in vivo
L Rittie,1 J Varani,2 GJ Fisher1 and JJ Voorhees1 1 Dermatology, University of Michigan, Ann Arbor,
MI and 2 Pathology, University of Michigan, Ann Arbor, MI
Retinoids (RA) are widely used in the treatment of photoaging to stimulate dermal repair. However,
retinoids also induce epidermal hyperplasia, which can lead to excessive scale. Scaling is the major
deterrent to topical RA use. Keratinocyte growth is strongly stimulated via activation of epidermal
growth factor receptor (EGFR). Therefore, we examined the role of EGFR in RA-induced hyper-
plasia. Topical treatment of human skin in vivo with EGFR inhibitor genistein (1%) reduced RA-
induced KC proliferation 55% (n=12, p<0.05), as determined by quantitation of KI67 (proliferation
marker) positive immunostaining. In addition, specific EGFR inhibitor PD169540 completely pre-
vented the stimulation of keratinocyte growth by RA in human skin organ culture. In normal skin in
vivo, RA specifically induced expression of EGFR ligands heparin binding-EGF-like growth factor
(HB-EGF) and amphiregulin (AR). RA had no effect on expression EGFR ligands transforming
growth factor-alpha, epidermal growth factor, or epiregulin, and reduced expression of betacellulin
(80%. p<0.05). HB-EGF and AR mRNAs were increased within 16 hours post-treatment, were max-
imal (9.6-fold and 9.4-fold respectively) 24 hours post-treatment (p<0.05), and remained elevated
for at least 4 days. Laser capture microdissection coupled real-time RT/PCR revealed that HB-EGF
and AR were primarily expressed in suprabasal keratinocytes in normal, untreated human skin. RA
treatment induced HB-EGF in both basal and supra-basal layers, whereas AR induction was limited
to basal KC. These data demonstrate that RA-induced epidermal hyperplasia is mediated by EGFR
activation via induction of its ligands HB-EGF and AR, in both basal and suprabasal epidermal lay-
ers. Inhibition of EGFR activation by compounds such as genistein may mitigate unwanted scaling
caused by topical RA treatment, and thereby improve compliance and resultant efficacy. 
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Universal mechanism of IVIG action in pemphigus and pemphigoid
J Liu,1 M Zhao,1 J Hilario-Vargas,1 N Li,1 P Prisayanh,1 S Warren,1 LA Diaz,1 DC Roopenian2 and
Z Liu1 1 Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC and 2 The
Jackson Laboratory, Bar Harbor, ME
Numerous mechanisms of action have been proposed for IVIG. In this study, we used IgG passive
transfer murine models of bullous pemphigoid (BP), pemphigus foliaceus (PF), and pemphigus vul-
garis (PV) to test the hypothesis that the effect of IVIG in autoantibody-mediated skin bullous dis-
eases is to accelerate the degradation of pathogenic IgG through FcRn, the receptor protecting cir-
culating IgG from catabolism. BP, PF, and PV are organ-specific antibody-mediated autoimmune
diseases in which autoantibodies target BP180, desmoglein-1, and desmoglein-3, respectively. The
serum titers of anti-BP180, anti-dgs1, and anti-Dsg3 IgG autoantibodies correlate with disease activ-
ity. The experimental models of BP, PF, and PV were induced by passive transfer of rabbit anti-
murine BP180, human anti-dsg1, and anti-Dsg3 IgG into neonatal mice, respectively. Pathogenic
IgG levels in circulation were determined by antigen-specific ELISA. We found that FcRn-deficient
mice were resistant to experimental BP, PF, and PV. Circulating levels of pathogenic IgG in FcRn-
deficient mice were significantly reduced compared to wild-type (WT) C57BL/6J mice. Adminis-
tration of IVIG to WT mice prevented blistering triggered by pathogenic IgG. This protection is asso-
ciated with a significant reduction of circulating pathogenic IgG. The protective effect of IVIG
depends on FcRn activity because pathogenic IgG levels at 24 and 48 h post-injection were similar
in FcRn-deficient mice with and without IVIG treatment. These data demonstrate that IVIG treat-
ment leads to increased FcRn-dependent clearance of pathogenic IgG. This mechanism may account
for beneficial effects of IVIG in many autoantibody-mediated inflammatory and autoimmune dis-
eases.
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Strategies for enhancement of the host immune response in cutaneous T cell lymphoma: CpG
Oligonucleotides and IL-15 
M Wysocka,1 BM Benoit,1 S Newton,1 JB Budgin2,1 and AH Rook1 1 Dermatology, University of
Pennsylvania, Philadelphia, PA and 2 School of Veterinary Medicine, University of Pennsylvania,
Philadelphia, PA
Patients with advanced cutaneous T-cell lymphoma (CTCL) exhibit profound defects in cell medi-
ated immunity partially resulting from marked deficiencies in the numbers of peripheral blood den-
dritic cells (DCs) and in their capacity to make DC derived cytokines (IL-12, IL-15 and IFNα).
Because host immune function appears to play an integral role in mediating disease-controlling
responses in CTCL, we investigated the effects of synthetic oligodeoxynucleotides which contain
CpG motifs (CpG-ODN) and which have been recognized as immune stimulatory by virtue of acti-
vation of DCs following binding to Toll like receptor (TLR) 9. CpG-ODN were cultured with freshly
isolated peripheral blood mononuclear cells (PBMC) from patients with advanced CTCL (erythro-
derma with circulating malignant T-cells) and normal volunteers. Patient PBMC exhibited marked
induction of IFNα release by CpG-ODN. Similarly significant activation of NK cells and CD8+ T-
cells occurred as assessed by up-regulation of CD69 expression and by natural killer cell lytic activ-
ity. Nevertheless, patients with a high burden of circulating malignant T-cells (20‰ Sezary cells)
exhibited blunted responses to CpG-ODN compared to normal volunteers. In such cases, IL-15 was
capable of producing levels of activation of NK and CD8+ T-cells that were superior to CpG-ODN,
while the combined effects of CpG-ODN plus IL-15 may synergistically activate NK and CD8+ T-
cells. These findings have important implications for the potential enhancement of anti-tumor immu-
nity among patients with advanced CTCL. 
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Induction of matrix metalloproteinases and inhibition of procollagen synthesis in human skin
in vivo by ultraviolet A1 irradiation is profoundly diminished by skin pigmentation
S Kang, S Cho, T Daley, L Garza, R Kafi, R Wang, JJ Voorhees and GJ Fisher Dermatology,
University of Michigan, Ann Arbor, MI
The ability of UVA1 (340-400nm) to induce matrix metalloproteinases (MMPs) and simultane-
ously inhibit procollagen synthesis without causing sunburn in human skin has been the basis for its
application as an antifibrotic phototherapy.  Extent to which skin pigmentation affects UVA1 responses
is largely unknown. Thus, we investigated the magnitude of MMP induction and procollagen inhi-
bition (mRNAs quantified via real time RT-PCR) as a function of skin pigmentation in 28 normal
subjects. Subjects were stratified into three groups based on surface skin color (determined by col-
orimeter): Light (L value >65, ~skin phototypes [SPT] I/II); Medium (L 65-55; ~SPT III/IV); and
Dark (L<55; ~SPT V/VI). In the Light group, MMP-1, MMP-3, and MMP-9 mRNAs all demon-
strated significant dose-dependent induction with UVA1 (maximum inductions: 1100-fold, 1900-
fold, 6.5-fold, respectively; p<0.05; n=8). In the Dark group, all three MMPs mRNAs were not
induced even at the highest UVA1 dose (150 J/cm2) (n=8). Although MMP-1 mRNA was induced
by 150 J/cm2 UVA1 in the Medium group (p<0.05; n=8), the magnitude (10-fold; p<0.05; n=8) was
less than 1% of that in the Light group. Reduction of type I and III procollagen mRNAs by UVA1
were similarly affected according to skin color. In the Light group, there was a dose-dependent inhi-
bition in both type I and III procollagen mRNA expression (~50% with 150 J/cm2; p<0.05; n=8). In
the Dark group, 150 J/cm2 UVA1 had no effect on procollagen mRNAs. The exposure time for 150
J/cm2 of UVA1, using a high output device takes close to one hour. Therefore, an attempt to deliver
even higher doses of UVA1 for therapeutic purposes is not practical. In conclusion, skin pigmenta-
tion effectively attenuates UVA1-induced responses that lead to increased turnover of dermal colla-
gen. Usefulness of UVA1 as an antifibrotic device is limited to patients with light skin pigmenta-
tion, which likely explains varied clinical responses of scleroderma to UVA1. 
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Innovative PKC modulating formulation dramatically improves the healing of diabetic wounds
M Yuli,1 I Solomonik,2 D David-Pur,1 Z Dvashi,1 J Aran,1 L Braiman-Wiksman1 and
T Tennenbaum2 1 Heal-Or Ltd., Ramat-Gan, Israel and 2 Life Sciences, Bar-Ilan University,
Ramat-Gan, Israel
One of the well known complications associated with the diabetic state is the diabetic foot ulcer.
The impairment of wound healing in diabetes results in high rates of morbidity and mortality. Pro-
tein Kinase C (PKC), a family of serine/threonin kinases affect various physiological and biochem-
ical properties of skin. Keratinocytes express at least five different PKC isoforms which have dis-
tinct roles in skin physiology and pathology. We have developed a novel formulation, we refer to as
HO/03/03, combining nPKC activator and cPKC inhibitor which can specifically regulate distinct
stages of the wound healing process. We demonstrate the effect of our formulation on wounds of dia-
betic NOD and STZ injected C57BL mice, models of type 1 diabetes. These animal models closely
imitate the wound healing impairment as seen in diabetic patients. A longitudinal, 2cm, incision
was made on the upper backs of the diabetic mice. Healing processes were analyzed at critical time
points: 6-15 days post wounding. Assessment was made utilizing antibodies to keratin 14 (basal
epidermal layer formation), keratin 1 (spinous layer differentiation), keratin 6 (migration), PCNA
(mitosis) and H&E (dermal contraction and remodeling). Control (PBS treated) diabetic wounds
exhibit impaired differentiation, proliferation and migration properties. Within 9 days, only 16% of
control wounds exhibited epidermal closure and contraction of the dermis. Conversely, following
topical treatment with HO/03/03, 83% of STZ diabetic mice displayed complete closure of the wound
gap by a newly formed basal epidermal layer. Furthermore 45% of the HO/03/03 treated wounds
displayed significant contraction and remodeling of the dermis similarly to results obtained in non
diabetic mice. Analogous results were obtained in the NOD diabetic model. In conclusion our unique
formulation augments wound healing progression in type 1 diabetic animals, affecting all funda-
mental wound healing parameters. 
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A variable response to pregnancy in psoriasis patients
MS Hoffman, JS Papenfuss, KP Callis, CB Hansen, KL Papenfuss and GG Krueger Dermatology,
University of Utah Health Sciences Center, Salt Lake City, UT
Pregnancy has been shown to have varying effects, either detrimental or beneficial, on a variety of
inflammatory diseases including rheumatoid arthritis, SLE, and psoriasis. We explored the variable
effects of pregnancy on psoriasis severity through analysis of phenotypic information obtained from
patients enrolled in the Utah Psoriasis Initiative (UPI). From the first 351 patients enrolled in the
UPI, we were able to identify 89 women with an onset of psoriasis during the childbearing years of
18-40. These women accounted for a total of 283 children. Of this population of women, 21.1%
reported an improvement in the severity of psoriasis with pregnancy, 12.8% reported a worsening,
with the remainder stating no change. We predicted that a variable response to the pregnancy state
would also correlate with other phenotypic differences between these three groups of patients. Those
women reporting an improvement of psoriasis with pregnancy had a significantly lower age of onset
(p<.001) and a higher incidence of koebnerizing psoriasis (p<.025). There was no significant dif-
ference in the incidence of smoking, obesity, psoriatic nail changes, or palmar/plantar disease between
the three groups. We also evaluated these groups for disease response to stress and infection and
found no significant differences between them. This initial analysis suggests a unique subset of
patients with psoriasis who seem to exhibit pregnancy responsive disease. Follow up questionnaires
have been created and sent out which will validate these findings and further explore the potential
effects of the post partum state, menopause, and hormone replacement therapy on psoriasis sever-
ity. Further characterization of these groups will be followed by genotyping. The expected emer-
gence of unique genotypes will be followed by linkage to the Utah Population Database (UPDB) for
pedigree analysis. 
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Induction of HIV gag-specific cytotoxic T cells by percutaneous peptide immunization in humans 
H Yagi, H Hashizume, A Ohshima, M Takigawa and N Seo Dermatology, Hamamatsu University
school of medicine, Hamamatsu, Japan
Dendritic cell (DC)-based strategies for treatment of cancer and infection have been shown to be
promising in humans. However, intricate in vitro processes are currently used for the generation of
mature DCs. Percutaneous peptide immunization (PPI) is a simple and noninvasive way of deliver-
ing all classes of peptide to skin from which the stratum corneum (SC) is removed by a physical
means. Removal of SC not only enhances permeability of peptide but also mature Langerhans cells
(LCs) to be potent for antigen presentation. We have already demonstrated that this procedure is
highly effective in prophylaxis and therapy to tumor development in mice. The present study was
designed to validate the feasibility of PPI as clinical interventions in humans. Histological exami-
nation of healthy subjects revealed that LC migrated from the epidermis to the upper dermis as early
as at 24 h after stripping of SC. HLA-DR+ cells were found larger and stained more brightly at 6 and
24 h as compared with those in intact skin. HLA-DR, CD80, CD86 and HLA-class I on CD1a+ cells
in epidermal cell suspensions was also up-regulated at 24 h as assessed by flow cytometric analy-
ses. Two volunteers received PPI with HIV gag peptide, and appearance of HIV gag tetramer bind-
ing cells among CD8+ cells was assessed in the peripheral blood. HIV gag-specific CD8+ cells were
successfully induced when assayed 7 days after the fourth PPI and their levels were maintained by
repeated immunizations. HIV gag-specific CD8+ cells were markedly expanded by the in vitro stim-
ulation in an antigen specific manner. In addition, CD8+ T cells positive for intracellular IFN-γ were
expanded after stimulation in vitro with HIV gag peptide. The present study demonstrated that removal
of SC induced LC maturation. Functional HIV gag-specific CTL seemed to be generated and increase
in number by repeated PPI. Based on these results, we propose PPI as new breakthrough in preven-
tive and therapeutic interventions to cancer and microbial infection in clinical settings. 
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Human dectin-2 resembles its mouse counterpart in cell expression profile and pattern recog-
nition receptor function 
A Gavino, J Chung, I Dougherty, P Cruz, Jr and K Ariizumi Dermatology, The University of Texas
Southwestern Medical Center, Dallas, TX
Having identified dectin-2 in mice to be expressed constitutively by Langerhans cells (LC) and den-
dritic cells (DC), to be inducible in macrophages and T cells following activation, to function as a
pattern recognition receptor (PRR) for hyphae (but not yeasts) by binding to mannan-like carbohy-
drates on these fungi, and to mediate Th2 cytokine expression by DC, we identified its human homolog
using lowly stringent RT-PCR cloning. Our work yielded DECTIN-2, a gene encoding a type II-
configured receptor of 209 amino acids, with 66.5% homology (highest in GenBank) and domain
structures similar to mouse dectin-2. We next used RT-PCR and Southern blotting to examine
DECTIN-2 mRNA in various human tissues, and found it expressed most abundantly in peripheral
blood leukocytes (PBL) and spleen, and less in lymph nodes, bone marrow, and lung. Among epi-
dermal cells, DECTIN-2 expression was restricted to CD1a+ LC, which were sorted by anti-CD1a
magnetic beads. Among PBL, DECTIN-2 was expressed constitutively (in decreasing order) by:
CD14+ monocytes > LC-like DC (generated by culture of CD14+ cells with GM-CSF, IL-4, and
TGFβ) > CD8+ T cells > CD19+ B cells. Interestingly, close to background DECTIN-2 expression
in CD4+ T cells was upregulated markedly after activation with concanavalin A, whereas expression
in CD8+ T cells and CD19+ B cells was abrogated by activation with phytohemagglutinin and poke-
weed mitogen, respectively. Finally, we examined the ability of DECTIN-2 to bind hyphae using
125I-binding assays, and showed that soluble DECTIN-2 (V5-tagged extracellular domain) bound C.
albicans hyphae (but not yeasts) and that this binding was inhibited completely by mannan, indi-
cating that the PRR function of mouse dectin-2 is conserved in humans. These findings form the
basis for studying a role for DECTIN-2 in the causation of Th2-dominant diseases and/or treatment
of Th1-dominant disorders. 
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The Utah psoriasis initiative: a tool to investigate phenotypic and genotypic relationships
JS Papenfuss, KP Callis, CB Hansen, MS Hoffman, KL Papenfuss and GG Krueger Dermatology,
University of Utah Health Sciences Center, Salt Lake City, UT
The Utah Psoriasis Initiative (UPI), “a psoriasis registry” was founded on the belief that the pheno-
typic characteristics of psoriasis are a reflection of specific genotypic variants of the disease. The
UPI is designed to facilitate the correlation of phenotypic and genotypic data via the identification
of unique phenotypes with presumed specific genotypes. The UPI collects, through questionnaires
and physical examination, a variety of phenotypic information, including anatomic location, co-mor-
bid conditions, age of onset, response to therapy, body surface area, clinical appearance, etc. on
each patient. DNA from blood is also collected. This process is aided by electronic linkage with the
Utah Population Database (UPDB), a data warehouse that provides access to ≈ 85% of the Utah
population. Over 50% of the UPDB are members of informative kindreds, multigenerational pedi-
grees some with over 20,000 living relatives. In a preliminary analysis it was determined that the >
1000 psoriatics recently seen in the University of Utah clinics distribute in the UPDB in a manner
similar to that of the general population. To date over 450 patients have undergone extensive phe-
notyping.  Analysis of the first 351 patients has demonstrated several unique groups of patients includ-
ing smokers, obese/overweight individuals, those exhibiting inverse disease, and women showing a
change in their disease with pregnancy. Smoking has been shown to associate with an increased
incidence of koebnerization (p<.01), psoriatic nail changes (p<.01), and palmar-plantar disease
(p<.025). The average body mass index of UPI patients is significantly higher than that of age matched
controls, and these overweight/obese patients show a higher incidence of inverse disease. Women
report a variable response to pregnancy, with 21.1% reporting improvement in their disease and
12.8% reporting worsening. These findings have prompted further evaluation of the apparent asso-
ciation between obesity and psoriasis and the effect of pregnancy on psoriasis. 
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Novel germline mutation of c-KIT in familial mastocytosis and gastrointestinal stromal tumors
with positive response to imatinib in vitro
K Hartmann,1 E Wardelmann,2 Y Ma,3 S Merkelbach-Bruse,2 LM Preussner,1 SE Baldus,4
T Heinicke,5 J Thiele,4 R Buettner2 and J Longley3 1 Dermatology, University of Cologne, Cologne,
Germany, 2 Pathology, University of Bonn, Bonn, Germany, 3 Dermatology, University of
Wisconsin, Madison, WI, 4 Pathology, University of Cologne, Cologne, Germany and 5 Internal
Medicine, University of Bonn, Bonn, Germany
Mastocytosis is characterized by accumulation of mast cells in tissues. Sporadic mastocytosis is usu-
ally associated with somatic mutations in the intracellular exon 17 of c-KIT, affecting the enzymatic
site and causing constitutive activation of the KIT tyrosine kinase. In contrast, the cause of familial
mastocytosis is unknown. Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors usually
caused by somatic c-KIT mutations that activate KIT by affecting regulatory portions of the mole-
cule such as the intracellular juxtamembrane exons 11 or 13, leaving the enzymatic site unchanged.
Most GISTs respond to tyrosine kinase inhibitors that bind to the enzymatic site of KIT, unlike most
mastocytosis cases whose modified enzymatic site is not affected by these drugs. In the present study,
three members of a kindred with familial mastocytosis and GISTs were investigated. We identified
a novel germline c-KIT mutation in exon 8, resulting in deletion of codon 419 and affecting the extra-
cellular portion of KIT. In vitro studies showed that this mutation produces constitutively activated
KIT, which is inhibited by the tyrosine kinase inhibitor imatinib. This is the first report of mastocy-
tosis or GISTs associated with an exon 8 mutation and the first demonstration of KIT activation by
a mutation affecting the juxtamembrane extracellular region. In addition, our data strongly suggest
that imatinib is effective in patients whose tumors carry this mutation. 
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Increased reactivity to Candida albicans elicited by atopy patch testing to commensal skin
organisms in patients with symptoms of vulvar itch 
H Ramirez de Knott, S Oshtory and ST Nedorost Dermatology, Case University and University
Hospitals of Cleveland, Cleveland, OH
Allergic response may contribute to idiopathic vulvodynia. In this IRB approved study, 13 patients
with a history of vulvar itch and/or burning were patch tested to a standard series of chemical aller-
gens, a customized vulvar series and commensal organisms. Commensal organisms included UV-
killed Candida albicans (Ca), Malassezia sympodialis (Ms) and dust mite, and were applied topi-
cally under occlusion as in the atopy patch test (APT). The APT sites were examined for reactivity
at 6 hr, 48 hr, and 7days. Comparison was made to a group of 15 female Atopic Dermatitis (AD)
patients. Patients with vulvar symptoms (n=13) were significantly (p=0.0046) more likely to be patch
test positive to Ca than those patients in the comparison group (n=15). Reactivity in vulvodynia
patients was not due to nonspecific reactions to commensals, because Ms and dust mite APT’s did
not show elevated reactivity relative to AD controls (p=0.4577 and p=0.4917). The vulvar series of
chemical allergens demonstrated more relevant patient responses than did a standard series; the vul-
var chemical series included acrylates, clothing dyes and azole antifungals. Interestingly, the Ca
patch tests were inhibited at the highest concentrations even when positive at lower concentrations.
Patients with vulvar symptoms may benefit from patch testing to a customized vulvar series as well
as to low concentration Ca. Six patients who were APT + to Ca completed a 10 week course of flu-
conazole. Of these patients, 2 showed a marked improvement following treatment. Patients with
symptoms of vulvar itch and burning who are Ca APT+ may be a special subgroup of patients who
are allergic to baseline flora of yeast, possibly due to a reversal of tolerance to normal flora burden. 
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Hyperthermia treatment of cancer cells in vitro
Y Shellman,1 D Ribble,1 D Marr,1 M Yi,2 T Pacheco,1 M Hensley,1 D Finch,2 F Kreith,2
RL Mahajan2 and DA Norris1 1 Derm, B153, University of Colorado HSC, Denver, CO and 2
Mechanical Engineering, University of Colorado at Boulder, Boulder, CO
Hyperthermia, the procedure of exposing cells to a temperature between 42 and 49oC, has been shown
in clinical trials to be a promising approach for cancer treatment. However, to understand the under-
lying mechanisms of hyperthermic killing of cancer cells, it is critical to have an accurate tempera-
ture measurement technique and a reproducible heating method. To this end, we have developed a
measurement method using thermocouples to monitor continuously the temperatures in multiple
wells of a 96-well plate. Such a capability gives a complete record of time and temperature for the
treatment procedure, and helps us in defining an accurate thermal dose. We have also compared sev-
eral methods for heating 96-well plates, and found that use of copper blocks in the incubator pro-
vides a highly reproducible heating method. The commonly used method of using water-baths to
heat cells in vitro resulted in a decrease of cell viability even at the control temperature of 370C and
a decrease in the reproducibility of certain biological assays. Using our newly developed tempera-
ture measurement technique and heating method, we then examined the relationship of cell survival
and hyperthermic thermal dose in several cancer cell lines, including melanoma and epithelial can-
cer cells. As expected, the cytotoxicity of hyperthermia was found to depend on the temperature and
time of treatment. The results also clearly establish that hyperthermia kills various cancer cells includ-
ing some that appear to be resistant to other apoptotic triggers, demonstrating the therapeutic poten-
tial for hyperthermia. 
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Expression and potential pathological role of cathelicidin expression in rosacea
K Yamasaki,1 A Barden,1 K Taylor,1 C Wong,1 T Ohtake,3 M Murakami2 and RL Gallo1 1
Medicine/Dermatology, UCSD, San Diego, CA, 2 Dermatology, Asahikawa Medical College,
Asahikawa, Japan and 3 Medicine, Asahikawa Medical College, Asahikawa, Japan
The human cathelicidin antimicrobial peptide gene (CAMP) is expressed in skin by keratinocytes,
mast cells, eccrine glands and infiltrating neutrophils. Expression correlates with resistance to
infection, and increases following injury, infection or in psoriasis. One peptide product of CAMP,
LL-37, has been shown in some systems to be chemotactic and angiogenic. To determine if this
molecule is involved in rosacea, affected and normal facial skin was compared. Immunohistochem-
ical staining showed that LL-37 is abundant in the epidermis of rosacea patients but barely detectable
in normal skin. Dot-blot analysis showed that lesional skin from rosacea patients has 0.02 to 0.04
pmol/ug LL-37 and normal skin less than 0.001 pmol/ug. In situ hybridization revealed that CAMP
mRNA is broadly detected in affected epidermis and neutrophils of rosacea patients. Preliminary
quantitative RT-PCR data show that CAMP is expressed 20 to 30 times more in skin of rosacea
patients compared to normals. The increase in CAMP may be stimulated by bacteria, as extracts from
P. acnes, S. aureus, Group A Streptococcus, S. Epidermis, and Helicobacter pylori increased CAMP
mRNA expression 2 to 4 fold in normal human keratinocytes in vitro. The cathelicidin peptide
found in neutrophils, LL-37, increased IL-8 secretion from normal human keratinocytes 102.8 - 6.7
pg/ml and stimulated human dermal microvascular endothelial cell proliferation (1.1 nM, optimally).
Conversely, cathelicidin peptides found on normal skin (RK-31, KS-30) increase antimicrobial activ-
ity but loose the ability to stimulate IL-8. These data suggest that cathelicidin is persistent in the
skin of rosacea, and an excess of cathelicidin in the form of LL-37 can induce a proinflammatory
chemokines and increase angiogenesis. Proper regulation of cathelicidin expression and processing
may therefore be critical for the development of rosacea. 
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Protein delivery to cells and skin tissue via reversible decoration with transporter peptides
Z Siprashvili,2 J Reuter2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA and 2 Stanford, Stanford,
CA
In spite of numerous attractive intracellular targets, current therapeutic proteins target only the extra-
cellular space due to a lack of a straightforward delivery method to reach cell interiors. Recent efforts
to overcome this problem demonstrated that specific arginine-rich protein transduction (PTD)
sequences from Tat, antennapedia, VP22 and others deliver proteins into cells and tissues. Current
PTD limitations include the need to generate and denature PTD-protein fusions. This labor-inten-
sive process, customized for each protein, often abrogates biologic activity. To address this, we devel-
oped a new approach to protein transfer that relies on a rapid, single-step decoration of any soluble
protein by cysteine-flanked internally spaced arginine-rich (CFIS-R) transporter peptides. Native
globular proteins were reversibly decorated with CFIS-R PTDs via charge interactions and disulfide
bonding. Decoration dramatically enhanced cell and injection-based skin tissue delivery of a vari-
ety of functional proteins, including antibodies and enzymes (beta-galactosidase, PLAP, caspase-3).
Protein transfer approached 100% efficiency within 30 minutes in a variety of cell types in vitro.
Decorated proteins enter cells at low temperature in an energy-independent manner, suggesting min-
imal input from classical endocytic mechanisms. PTD-mediated cellular entry was not a mere fixa-
tion artifact as cellular internalization was clearly observed with fluorescein-conjugated antibodies
to actin, tubulin and the GM130 golgi protein. These antibodies were detected in their appropriate
corresponding subcellular locations in unfixed, living cells in contrast to undecorated antibody which
failed entry. Injection of decorated caspase-3 into subcutaneous tumors in vivo produced a >184-
fold increased apoptotic index over untreated tumors and a >5-fold increase over undecorated cas-
pase-3 alone, confirming retention of decorated protein function in vivo. Decoration with transporter
peptides thus provides an attractive general means of intracellular delivery of functional proteins in
vitro and in tissue. 
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NLite pulsed dye laser therapy for acne vulgaris: a randomized clinical trial
J Orringer, S Kang, S Cho, W Schumacher, D Karimipour and JJ Voorhees Dermatology,
University of Michigan, Ann Arbor, MI
The NLite laser was recently reported to have substantial efficacy in the treatment of acne (The
Lancet, Vol 362, Oct., 2003). We also sought to evaluate this pulsed dye laser therapy for acne. Ours
was a randomized, controlled, split-face clinical trial. Forty subjects with facial acne received 1 or
2 pulsed dye laser treatments to half of the face using the NLite laser (585nm wavelength, 3J/cm2,
350µsec pulse duration). Subjects were serially assessed for 12 weeks. The evaluating physician was
blinded to treatment assignment and did not perform the laser procedures. Subjects were evaluated
for total counts of papules, pustules, cysts, comedones, and red macules. As no difference in effi-
cacy between subjects receiving 1 vs 2 treatments was found, the data were pooled for analysis.
Counts of each type of lesion failed to reveal any statistically significant differences between treated
and untreated skin at any time point. For example, week 12 mean papule counts were increased by
4.3 and 2.0 in treated and untreated skin (p = 0.13), respectively. Other lesion counts similarly revealed
no significant differences as they tended to ebb and flow bilaterally with statistically insignificant
improvements and periods of slight worsening. Three dermatologists, who were blinded to treatment
assignment and who did not participate in either the treatment or assessment of subjects, independ-
ently evaluated standardized bilateral serial subject photographs obtained during the study. Photos
from baseline and weeks 4 and 12 were scored for overall acne severity using the Leeds scale. This
confirmed the clinical findings with no statistically significant differences in acne severity found
between treated and untreated skin. Several lasers have been reported to improve acne; however,
few well-designed clinical trials in this area have been available. While laser therapy may prove
useful, our study does not corroborate the recent report of efficacy of NLite laser therapy for acne,
perhaps due to the presence of differences in study design between the two trials. 
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The efficacy of denileukin diftitox in patients with low expression of CD25: a retrospective
chart review of 16 patients with CTCL
N Mirchandani,1,2 RA Clark1 and TS Kupper1 1 Dermatology, Brigham and Women’s Hospital,
Boston, MA and 2 Brown University School of Medicine, Providence, RI
Denileukin diftitox is thought to selectively target and kill cells with surface expression of CD25, a
component of the high affinity IL-2 receptor. Denileukin diftitox is thought to act in CTCL by
inducing apoptosis of malignant T cells expressing CD25+. Use of this drug has therefore only been
recommended in patients expressing CD25 on >20% of malignant cells. We recently observed com-
plete clearance of recalcitrant stage IVA Sezary syndrome in a patient with <5% CD25+ T cell after
the first two of six cycles of denileukin diftitox, suggesting that levels of lesional CD25 expression
does not accurately predict treatment response. We therefore undertook a retrospective chart review
of 16 CTCL patients treated with denileukin diftitox at our facility with the goal of comparing
CD25 expression and therapeutic response. Patient response was classified into the following four
groups based on changes in tumor burden six weeks after initiation of therapy: Complete response
(CR), partial response (PR), stable disease (SD) and progressive disease (PD). 100% of patients
with CD25 expression greater than 20% experienced a partial or complete clinical response to
denileukin diftitox. Surprisingly, 77% of patients with less than or equal to 20% CD25+ cells also
experienced a positive treatment response. The patient numbers in this retrospective analysis are
small, and definitive conclusions cannot be made. Nevertheless, our study suggests that denileukin
diftitox may be useful in the treatment of patients with CTCL regardless of their levels of CD25
expression. We hypothesize that denileukin diftitox may be acting to kill CD4+CD25+ regulatory T
cells, a subset of cells recently shown to interfere with the successful development of tumor immu-
nity. Removal of these immunosuppressive cells may allow the development of an effective innate
tumor response. Confirmation of this concept could lead to successful use of this drug in patients
with a variety of malignancies. 
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An engineered autologous dendritic cell therapy induces potent tumor specific t-cell activity
and clinical response in a patient with end-stage cutaneous t-cell lymphoma
L Geskin, A Kingston, T Whiteside, S McCann, K Dixon, J Plowey, M Robb and L Falo
Dermatology/UPCI, Univ of Pittsburgh, Pittsburgh, PA
Sezary syndrome (SzS) is an end-stage variant of CTCL with no effective therapeutic options. DC-
based immunization represents a promising new adjuvant immunotherapy for cancer and has been
shown to elicit immune and clinical responses in patients with a variety of malignancies. The devel-
opment of immunotherapy for CTCL has been limited by the lack of identified tumor-specific anti-
gens and tumor induced immune deviation. To develop a tumor-specific DC based autologous
immunotherapy for SzS we derived DCs from peripheral blood precursors of SzS patients, loaded
DCs with antigens derived from whole circulating autologous tumor cells, and engineered the anti-
gen-loaded DCs to express potent Th1-skewing T-cell activation function. In preclinical studies engi-
neered DCs from several SzS patients demonstrated phenotypic characteristics and cytokine pro-
duction characteristic of DC1 function, including upregulation of CD86 expression and secretion of
high levels of IL-12p70. Engineered DCs induced potent Th1-skewed T-cell stimulation in mixed
lymphocyte reactions. Immunization of an end stage SzS patient who had failed all other therapies
with the autologous tumor-DC vaccine correlated with the development of a positive tumor specific
DTH reaction, induction of a tumor specific IFNg producing CD8+ T-cell response (ELISpot assay),
normalization of CD4:CD8 T-cell ratios and reduction of the clonal tumor population in peripheral
blood to below levels of detection, and a dramatic clinical response. These results suggest that DCs
loaded with antigens derived from autologous whole tumor cells and engineered to express potent
Th1 skewing T-cell stimulatory function, can induce potent tumor specific T-cell responses in vitro
and may induce effective anti-tumor immunity in vivo even in the setting of advanced disease.
These preclinical studies and this single clinical application provide important data for the devel-
opment of DC-tumor conjugate vaccines for the immunotherapy of CTCL. 
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Durability of treatment response following withdrawal from etanercept in psoriasis patients
A Gottlieb,1 K Gordon,2 A Wang3 and R Zitnik3 1 UMDNJ-Robert Wood Johnson Medical School,
New Brunswick, NJ, 2 Loyola University Medical Center, Maywood, IL and 3 Amgen Inc.,
Thousand Oaks, CA
Dermatologists may choose to withdraw psoriasis therapies intermittently following a satisfactory
response. Herein we describe disease characteristics and the durability of treatment response in pso-
riasis patients in a phase 3 trial of etanercept, which had a 24-week double-blind period followed by
a study drug withdrawal period. Patients were randomized to receive etanercept (50 mg twice weekly
[BIW], 25 mg BIW, or 25 mg once weekly [QW]), or placebo BIW. Placebo patients began etaner-
cept (25 mg BIW) at week 12 in a blinded fashion. At week 24, all patients who achieved a treat-
ment response (had ≥50% decrease from baseline PASI score) were discontinued from etanercept
and followed until their disease relapsed. Durability of treatment response was defined as the time
period from the discontinuation of etanercept (week 24) until the first visit at which at least 50% of
PASI improvement that occurred between baseline and week 24 was lost. Of 652 patients initiating
this trial, 573 (87.9%) completed 24 weeks of treatment, and 409 (71.4%) achieved a treatment
response (at least PASI 50) at week 24. Upon drug withdrawal, the median time to disease relapse
was 85 days, and 25% of the responders did not relapse until at least 145 days. During the withdrawal
period, only 1 patient (from the 25 mg QW group) met the National Psoriasis Foundation definition
of rebound (return to more than 125% of baseline PASI score within 3 months). No patients rebounded
to 150% or more of their baseline PASI score. Importantly, no serious adverse events or hospital-
izations occurred that were related to worsening psoriasis, and no conversion of psoriasis morphol-
ogy (eg, guttate, erythrodermic, or pustular) occurred during the withdrawal period. When psoria-
sis patients are withdrawn from etanercept, the return of signs and symptoms is gradual and without
untoward events. 
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Merkel cell carcinoma (MCC): a novel treatment for stage III disease and a proposed algo-
rithm for initial management
SG Gupta,1 LC Wang,2 M Longo,3 MH Kulke3 and P Nghiem3 1 Boston Univ School of Medicine,
Boston, MA, 2 Univ of Chicago, Chicago, IL and 3 Dana Farber Cancer Institute, Boston, MA
MCC is a rare (~500 cases/year in US), but lethal skin cancer (~25% mortality) with high rates of
local recurrence and metastasis. Given the rarity of this neuroendocrine malignancy, there is little
data on outcome, and no uniformly accepted treatment recommendations. Based on similarities to
small cell lung cancer (SCLC), another neuroendocrine tumor, MCC has been treated with SCLC
chemotherapy regimens with limited success and significant toxicity. A recent trial with thalido-
mide (putative antiangiogenic agent) and temozolomide (analog of alkylating agent DTIC) demon-
strated efficacy and decreased toxicity in metastatic neuroendocrine tumors. We report two patients
with stage III MCC treated with this combination: 1) 81 year old man who presented with scalp MCC
that metastasized following surgery and during radiotherapy and 2) 51 year old woman with retroperi-
toneal MCC that progressed on irinotecan, cisplatin and radiotherapy. Significant disease regression
was noted in both patients on thalidomide (200 mg po qd) and temozolomide (150 mg/m2 po qd,
every other week). While this combination appears to have activity in patients with metastatic MCC
refractory to more standard treatments, further trials are planned to confirm these observations.
Through our experience with >40 patients and analysis of available literature (>300 patients), we
propose the following working treatment algorithm for MCC: 1) surgery: a margin of >/=2cm,
when possible, 2) sentinel lymph node biopsy: indicated due to high rate of clinical or microscopic
lymph node involvement at presentation (45% in our series), 3) radiotherapy: >/=50Gy to primary
site and draining lymph nodes is associated with a statistically significant decrease of >50% in local
recurrence, and 4) chemotherapy: consider for high-risk patients with good functional status or as
palliative therapy. Especially in the case of adjuvant chemotherapy, multi-institutional randomized
controlled trials must be organized. 
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Aluminum oxide microdermabrasion induces transcription factors, cytokines, and matrix met-
alloproteinases that function in dermal extracellular matrix remodeling in human skin in vivo
DJ Karimipour, S Kang, T Hamilton, TM Johnson, J Orringer, C Hammerberg, GJ Fisher and
JJ Voorhees Dermatology, University of Michigan, Ann Arbor, MI
Microdermabrasion is reported to improve fine wrinkles in photodamaged skin through stimulation
of dermal collagen remodeling. However, molecular mechanisms by which microdermabrasion acts
in skin have not been elucidated. Therefore, we examined biochemical responses, associated with
dermal collagen remodeling, following microdermabrasion in human skin in vivo. A single, standard
microdermabrasion procedure with aluminum oxide crystals was performed at 15 mm Hg for three
passes on the hip of volunteers. Skin samples were obtained 15 min to 16 days post treatment, and
genes of interest were analyzed for alterations of mRNA and protein expression by reverse-tran-
scriptase real time PCR, and immunohistochemistry, respectively. Transcription factors NF-κB and
c-Jun were rapidly activated, within 1 hour of treatment (p<0.05, n=6). Activation was localized to
superficial epidermis or the stratum granulosum. NF-κB and c-Jun-regulated genes include primary
cytokines, IL-1β and TNF-α. Expression of both primary cytokines was elevated within 2 hours
post treatment, and was maximal (9-fold and 4-fold, respectively, n=6, p<0.05) at that time point.
Both IL-1β and TNF-α induce matrix-degrading metalloproteinases (MMP), which were elevated
within four hours post treatment. MMP-1 (collagenase), MMP-3 (stromelysin), and MMP-9 (92kDa
gelatinase) were maximally elevated 300-fold, 350-fold, and 2.5-fold, respectively, within 8 hours
of treatment (n=12, p<0.05). MMP expression occurred focally in epidermis and dermis near the
dermal-epidermal junction. In summary, a single microdermabrasion treatment causes a cascade of
acute molecular alterations that result in increased MMP expression in the upper dermis in human
skin in vivo. Increased MMP expression may degrade damaged collagen, and thereby initiate colla-
gen remodeling in photodamaged skin. 
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Foot ulcers in people with diabetes: signs of infection are the major determinant for use of cul-
tures, antibiotics and x-rays and are associated with amputation
E Rhim,1 GE Reiber,2 DG Smith,3 GJ Raugi4,1 and K Sullivan2 1 Medicine (Dermatology),
University of Washington, Seattle, WA, 2 Health Services and Epidemiology, VA Puget Sound
Health Care, Seattle, WA, 3 Orthopaedic Surgery, University of Washington, Seattle, WA and 4
Medicine (Dermatology), VA Puget Sound Health Care, Seattle, WA
This study describes patients with diabetes and moderately severe foot ulcers, their signs of infec-
tion, patterns of utilization for bacterial cultures, antibiotics, x-rays, and their subsequent associa-
tion with amputation. The diagnostic tests and treatment of patients with new onset diabetic foot
ulcers were prospectively monitored in six hospitals and outpatient settings until ulcer healing, ampu-
tation, or death. Patients were divided into 5 groups (0,1,2,3,4) based on the maximum number of
signs of infection at any given visit during the ulcer episode. The signs of infections were erythema
> 1cm, serosanguineous or purulent drainage, abscess and local peri-ulcer warmth. Percentage of
patients who had cultures, antibiotics, and x-rays in each group were calculated. Amputation rates
were calculated by group. There were 128 patients with foot ulcers of intermediate severity across
groups 0-4. The percentage across groups for bacterial cultures during the episode ranged from 20-
85% and averaged 53% overall. Use of IV and/or oral antibiotics ranged from 75-100% and aver-
aged 84% overall. X-Ray utilization ranged from 60% to 100% and averaged 67% overall. The
overall amputation rate was 23% and showed an increase as number of infection signs increased.
Prognosis for limb survival decreased with increasing signs of infection. Increasing numbers of signs
of infection resulted in an increased utilization of cultures, X-rays and antibiotics. Additional research
is needed to understand why in individuals with new onset foot ulcers and no symptoms of infec-
tion, the use of antibiotics reached 75%. 
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Topical application of a formulation containing the osmoprotectant sorbitol, increases barrier
strength and skin moisturization 
N Muizzuddin, T Mammone, C Fthenakis, ML Ingrassia and D Maes Skin Biology, Estee Lauder
Co., Melville, NY
Cells undergoing hyperosmotic stress accumulate sorbitol, a compatible organic osmolyte. The renal
medulla uses sorbitol, and a host of other organic osmolytes to help cope with a routine exposure to
high extracellular osmolality. Epidermal keratinocytes experience similar high osmolality under dry
environmental conditions, due to increased transepidermal water loss, and a concomitant drying of
the skin. We initially wanted to determine if epidermal keratinocytes, in vitro, could be protected
from high osmotic stress, with the exogenous addition of sorbitol. Additionally, we evaluated the
effects of formulation of topical sorbitol on skin barrier and moisturization. In our in-vitro experi-
ments, 50 mM sorbitol protected epidermal keratinocytes from osmotic toxicity induced by sodium
chloride. In-vivo studies displayed significant increases in both barrier repair and moisturization, in
individuals subjected to arid environmental conditions. 
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Tacrolimus ointment enhances Th1 and Th2 sensitization through the skin
JA Schneider and CA Herrick Yale School of Medicine, New Haven, CT
Topical calcineurin inhibitors, such as FK506 (tacrolimus), are highly effective in the treatment of
atopic dermatitis, presumably due to their ability to inhibit lymphocyte activation. Several groups
have shown that systemic administration of FK506 suppresses both the sensitization and elicitation
phases of Th1-mediated contact hypersensitivity (CHS) responses in mice. However, the effect of
systemic FK506 on Th2 responses induced in the cutaneous environment, such as by epicutaneous
(e.c.) exposure to protein antigen, has not been evaluated. Furthermore, the effect of topical FK506
on generation of either Th1 or Th2 responses to antigens encountered through treated skin has not
been determined. In this study, FK506 ointment, or vaseline as a control, was applied to shaved
back skin of mice on days -4 to -2. Treated areas were covered to prevent ingestion until day -1, when
the ointment was removed. For generation of Th2 responses, mice were then exposed on day 0 to
e.c. ovalbumin (OVA) (100 µg) in PBS at the same site. Skin draining lymph node (LN) cells were
harvested on day 4 and restimulated in vitro with OVA for evaluation of cytokine production. LN
cells from mice pretreated with topical FK506, compared with vaseline controls, produced signifi-
cantly more IL-5 (p=.002) and IL-13 (p<.001) following e.c. exposure to OVA. IFN-γ production by
LN cells was also enhanced (p=.03) in FK506 pretreated mice. Consistent with these results, topi-
cal FK506 pretreated mice had increased OVA-specific IgG1 (p=.006) in serum. For generation of
Th1 type responses, topical FK506 or vaseline pretreated mice were exposed to e.c. DNFB on day
0. CHS to DNFB was also enhanced by pretreatment with topical FK506, as shown by increased ear
swelling responses following challenge on day 5 (p<.001). Of note, systemic treatment with FK506
(5 mg/kg i.p.; day -2 to 6) did suppress CHS responses (p<.001), as reported by others. The data indi-
cate that topical exposure to tacrolimus ointment can enhance both Th1 and Th2 type immune
responses following subsequent encounter with antigen at the same site. 
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The efficacy and safety of etanercept in the retreatment of psoriasis after relapse
C Leonardi,1 B Elewski,2 A Wang3 and R Zitnik3 1 Saint Louis University, St Louis, MO, 2
University of Alabama at Birmingham, Birmingham, AL and 3 Amgen Inc., Thousand Oaks, CA
Dermatologists are sometimes required to use intermittent and/or rotational paradigms when treat-
ing chronic psoriasis patients. Because the safety and efficacy profiles of etanercept used intermit-
tently are unknown, we studied the effects of study drug withdrawal and retreatment in a large phase
3 trial, in which patients were initially treated with etanercept over a 24-week double-blind period
followed by a study drug withdrawal and retreatment period. Patients were randomized to receive
etanercept (50 mg twice weekly [BIW], 25 mg BIW, or 25 mg once weekly [QW]), or placebo BIW.
Placebo patients began etanercept (25 mg BIW) at week 12 in a blinded fashion. At week 24, patients
classified as responders (≥ 50% decrease from baseline PASI) were discontinued from study drug
and followed until their disease relapsed (loss of ≥ 50% of PASI improvement obtained between
baseline and week 24), when they resumed blinded etanercept for up to 24 weeks. Of 652 patients
initiating the trial, 573 (87.9%) completed 24 weeks of treatment, and 409 (71.4%) achieved a treat-
ment response (at least PASI 50) at week 24 (responders) and entered the study drug withdrawal and
retreatment period. Of the 409 patients, 342 relapsed and received at least 1 dose of retreatment, and
297 completed 12 weeks of retreatment. The overall effect of etanercept retreatment was similar to
the initial treatment effect: the mean PASI score was 5.8 at week 12 of initial active treatment and
6.4 at week 12 of retreatment. PASI 75 and PASI 50 response rates also were similar during initial
treatment and retreatment with etanercept. The rates of adverse events, infections, and antibody for-
mation in the 12-week retreatment period were similar to the first 12 weeks of treatment. No neu-
tralizing antibodies to etanercept were noted. These data suggest that etanercept can be used safely
and effectively in an intermittent or rotational paradigm in the treatment of psoriasis. 
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Sustained anti-fibrotic responses to a single UVA1 exposure are attenuated by subsequent expo-
sures in human skin in vivo-implications for phototherapy for fibrotic skin diseases
L Garza, R Wang, S Cho, R Kafi, GJ Fisher, JJ Voorhees and S Kang Dermatology, University of
Michigan, Ann Arbor, MI
UVA1 phototherapy for fibrotic skin diseases such as scleroderma has been reported to show prom-
ise. The ability of UVA1 to soften fibrotic skin is believed to be related to induction of matrix-degrad-
ing metalloproteinases (MMP) and suppression of type I procollagen (COL-I) production. How-
ever, optimal UVA1 dosage and exposure frequency have not been systematically studied. Therefore,
we determined effects of UVA1 dose and exposure frequency on MMP-1 and COL-I expression in
human skin. Pure UVA1 (340-400nm) light source was used to irradiate sun-protected buttock skin
of 36 healthy subjects. All subjects were skin-phototype I or II. MMP-1 and COL-I mRNAs were
measured by quantitative real time RT-PCR. UVA1 induction of MMP-1 and inhibition of COL-I
were dose-dependent, reaching maximum at 130J/cm2 (1149-fold; p<0.05; n=8) and at 150J/cm2
(42%, p<0.05; n=8), respectively, 24 hours post-irradiation. MMP-1 (246-fold induced, p<0.05; n=8),
and COL-I (35% inhibited, p<0.05; n=8) mRNA levels remained significantly altered 7 days after a
single UVA1 exposure (130J/cm2). Surprisingly, intervening UVA1 exposures, given on day 2 and
day 4 after the initial exposure, substantially lessened responses. MMP-1 induction was decreased
from 246-fold to 3-fold, and no inhibition of COL-I was observed, 7 days post the initial exposure.
Thus, within the first week following a single UVA1 exposure, subsequent exposures reduce MMP-
1 and increase COL-I expression. Furthermore, UVA1 (130J/cm2) exposures at weekly intervals
caused successively less responses. MMP-1 induction was reduced from 1149-fold to 59-fold (p<0.05;
n=8), and COL-I reduction was no longer observed, 24 hours post the third weekly exposure. Atten-
uation of responses to successive UVA1 exposures was associated with increased tanning. These data
indicate that UVA1 phototherapy at weekly or greater intervals may be most effective for treating
fibrotic skin diseases. 
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Maintenance of efficacy in patients with psoriasis following dose reduction: results of a global
phase 3 study
B Elewski,1 E Boh,2 K Papp,3 E Rafal,4 R Zitnik5 and A Nakanishi2 1 University of Alabama at
Birmingham, Birmingham, AL, 2 Tulane University Medical School, New Orleans, LA, 3 Probity
Medical Researh, Waterloo, ON, Canada, 4 DermResearchCenter of New York, Inc., Stony Brook,
NY and 5 Amgen Inc., Thousand Oaks, CA
In this global phase 3 study, 583 patients were randomized to receive etanercept 50 mg twice weekly
(BIW, n=194) or 25 mg BIW (n=196) or placebo (n=193) by subcutaneous injection for 12 weeks.
Patients from all 3 groups then received etanercept 25 mg BIW for the next 12 weeks. The primary
endpoint was the proportion of patients who achieved at least a 75% improvement in the Psoriasis
Area and Severity Index (PASI 75) at 12 weeks. At baseline, the groups were balanced for age, dura-
tion of psoriasis, and disease severity. At week 12, 49% of patients in the etanercept 50-mg BIW
group achieved the PASI 75, compared with 34% in the 25-mg BIW group and 3% in the placebo
group (p<0.0001 for each dose group vs. placebo). Statistically significant improvements in physi-
cian’s and patient’s static global assessments and Dermatology Life Quality Index confirmed the
efficacy of etanercept. In a last-observation-carried-forward analysis at week 24, the PASI 75 was
achieved by 54% of patients in the original 50-mg BIW group, 45% in the original 25-mg BIW group,
and 28% in the original placebo group. In the group that received 50 mg BIW for the first 12 weeks
and a reduced dose of 25 mg BIW for the second 12 weeks (n=179 with PASI assessments observed
at both time points), 77% of PASI 75 responders at week 12 maintained the response through week
24, and 32% who had not responded at week 12 achieved a PASI 75 response by week 24. Etaner-
cept was well tolerated. The proportions of patients reporting adverse events and infections were
similar between etanercept and placebo groups throughout the study. In conclusion, etanercept pro-
vided rapid, clinically meaningful benefit to patients with psoriasis. The majority of patients treated
successfully at 50 mg BIW can have their dose reduced to 25 mg BIW after 12 weeks without loss
of treatment response through 24 weeks. 
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Pharmacokinetics of etanercept are unaltered by concurrent administration of methotrexate
in rheumatoid arthritis patients
H Zhou1 and R Zitnik2 1 Wyeth Research, Collegeville, PA and 2 Amgen Inc., Thousand Oaks, CA
Our purpose was to evaluate the potential impact of concurrent administration of methotrexate (MTX)
on the pharmacokinetics (PK) of etanercept in rheumatoid arthritis (RA) patients. As part of a dou-
ble-blind randomized trial of 682 RA patients receiving MTX, etanercept (25 mg twice weekly
[BIW]), or etanercept (25 mg BIW) plus MTX (median: 20 mg once weekly), 50 patients were ran-
domly selected from each of the etanercept-treated groups for analysis of serum samples. A single
blood sample was drawn from each patient at any time after etanercept dose at week 24. A final
covariate population PK model was built based on etanercept data from both healthy subjects (n=53)
and RA patients (n=212) from 10 prior clinical studies. The influence of demographic characteris-
tics on the PK of etanercept was evaluated. The stability of the final model was evaluated using both
internal (bootstrapping) and external (data-splitting) validation approaches. PK parameters were
compared using statistical (bioequivalence) criteria. Data from the prior studies were optimally fit-
ted to a two-compartment model with first-order elimination from the central compartment. Interindi-
vidual variability of the PK parameters was quantified for CL (25.1%), Vc (41.7%), ka (53.1%), and
F (24.2%). Residual variability consisted of a combined additive (11.4 ng/mL) and proportional error
(49.9%). Both age (<17 yrs) and body weight (<60 kg) were found to be important covariates on
clearance (CL). The results of both internal and external validation indicated the validity of the pop-
ulation model. Based on the final population PK model, the individual CL values (mean ± SD, in
L/h) by Bayesian approach were comparable for patients receiving etanercept alone (0.070 ± 0.007)
and those receiving etanercept plus MTX (0.067 ± 0.006). The GLS mean ratio (etanercept plus MTX
/ etanercept alone, mean [90% CI]) was 0.97 (0.94, 1.00). The PK of etanercept are unaltered by con-
current MTX administration in RA patients. Thus, no etanercept dose adjustment is needed for patients
taking MTX. 
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Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid
arthritis
S Prodanovich,1,2 F Ma2,3 and RS Kirsner1,2 1 Dermatology and Cutaneous Surgery, University of
Miami School of Medicine, Miami, FL, 2 Dermatology and Cutaneous Surgery, Miami Veterans
Administration Medical Center, Miami, FL, 3 Epidemiology and Public Health, University of
Miami School of Medicine, Miami, FL and 4 Sylvester Cancer Center, University of Miami School
of Medicine, Miami, FL
Methotrexate (MTX) is used in the treatment of moderate to severe psoriasis and rheumatoid arthri-
tis (RA). As MTX oppositely affects inflammation and hyperhomocysteinemia - two independent
risk factors for vascular disease - it is unclear how it influences the incidence of vascular disease in
these patients. The objective of this study is to determine if long term MTX therapy affects the inci-
dence of vascular disease in patients with psoriasis and rheumatoid arthritis. We conducted a retro-
spective, case-control study of computerized patient records of 7,615 outpatients with psoriasis from
October 1st, 1998 through April 30th, 2003, and 6,707 with RA from October 1st, 1999 through
April 30th, 2003. A total of 14,322 with psoriasis or RA were included in the analysis. After adjust-
ing for age, gender, co-morbidities and confounding medications, patients on MTX had significantly
reduced risk of vascular disease (psoriasis: RR=0.73, 95%CI=0.55-0.98; RA:0.83; 0.71-0.96). MTX
was more beneficial in prevention of vascular disease among patients who took a low to moderate
cumulative dose (psoriasis: 0.50, 0.31-0.79; RA:0.65, 0.52-0.80). We also analyzed effects of com-
bination of MTX and folic acid therapy on the incidence of vascular disease. Multivariate logistic
regression analysis of this subgroup of patients demonstrated a 44% reduction in vascular diseases
for psoriasis patients who were also prescribed MTX (0.56; 0.39-0.80) and a 23% reduction for RA
patients with combined therapy (0.77; 0.38-1.56). MTX reduced the incidence of vascular disease
in veterans with psoriasis and rheumatoid arthritis, especially in low to moderate doses and/or when
used concomitantly with folic acid supplements. Treatment of inflammation in these patients may
have benefit beyond the control of primary disease alone. 
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Achieving target lipid levels in patients with peripheral vascular disease
MR Banta,1 CA Charles,1 F Ma,2 DG Federman3,4 and RS Kirsner1,2 1 Dermatology and Cutaneous
Surgery, University of Miami School of Medicine, Miami, FL, 2 Miami Veterans Affairs Medical
Center, Miami, FL, 3 Medicine, Yale University School of Medicine, New Haven, CT and 4 West
Haven Veterans Affairs Medical Center, West Haven, CT
Peripheral vascular disease (PVD) is an important factor in the development of leg ulcers and is asso-
ciated with a significant increase in mortality, therefore risk factor control is paramount. Current
guidelines recommend that patients with PVD achieve the same low density lipoprotein (LDL) cho-
lesterol goal as patients with coronary artery disease or diabetes mellitus, but often this is not met.
The purpose of this study is to determine if these guidelines are being met and if severity of PVD is
predictive of adherence to target LDL goals. 
We conducted a retrospective chart rev
nosed with PVD in 2001. The population consisted of patients who had undergone non-invasive
vascular studies that year and who had received an ankle-brachial index (ABI) score of less than one
in either extremity. Via a detailed electronic medical record review, data was extracted on patient
demographics, weight, comorbid conditions, vascular procedures, medications, smoking history, and
laboratory results for a follow-up period of 12-18 months. The primary outcome was LDL, with a
target level of less than 100 mg/dl. Student′s t-tests, Fisher Exact tests, and chi-square tests were
performed to associate baseline characteristics with being at goal LDL level. Multivariate logistic
regression modeling also was performed.
A total of 175 patients met the inclus
whom were white, older men. The majority of these patients achieved the recommended goal LDL
cholesterol. We conclude that veterans with PVD and a specific comorbidity profile are likely to have
an LDL cholesterol at goal level. The translation of these findings into improved clinical outcomes
is yet unknown. 
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Phase II trial of oral suberoylanilide hydroxamic acid (SAHA) for cutaneous T-cell lymphomas
R Talpur,1 N Chiao,1 V Richon,2 JH Chiao2 and M Duvic1 1 Dermatology, MD Anderson, Houston,
TX and 2 Aton Pharma Inc, Terrytown, NY
Acetylation of core nucleosomal histones by opposing histone acetyltransferases and histone deacety-
lases (HDACs), regulates chromatin structure and gene transcription. Altered HDAC activity is impli-
cated in malignancy. SAHA, a novel inhibitor of class I &II HDACs, induces growth arrest, differ-
entiation, and apoptosis of transformed cells in vitro and inhibits tumors in xenograft models. To
determine safety and efficacy of SAHA, we enrolled 25 CTCL patients in a phase 2 open-label trial
of oral SAHA, sequentially assigned to either once a day or an intermittent dosing schedule. Patients
had refractory/relapsed disease following prior systemic therapies: Ontak (n=12), Targretin (n=21),
and/or systemic chemotherapy (n=19). Thirteen patients of median age 64 (range 38-83) received
SAHA 400 mg once daily. Their stages were IB (n=1), IIA (n=1), IIB (n=2), IVA (n= 5) or IVB (n
= 4); median treatment duration was 12 weeks (range 4-32 weeks). By Physician Global Assess-
ment (PGA), 5 achieved PR (4 Sezary, 1 transformed MF), five had SD, 3 PD for RR of 38%[95%
CI: 14%, 68%]. Mean duration of response was 15 weeks (range 8-24 weeks); mean time to response
was 10 weeks (range 4-16 weeks). Adenopathy regressed in 7 of 9 in 4 weeks. Two required dose
reductions due to dehydration. Twelve patients received 300 mg bid x 3 consecutive days per week
with a median age of 71 (range 26-80) and stage IB (n=1), IIB (n=1), IVA (n=7), IVB (n=3). Three
patients withdrew at 2-4 weeks: 2 for emboli due to DVT at sub-therapeutic INRs and one for drug
rash. Two SS patients achieved PRs (17%) with duration of 8 & 24 weeks, 3 had SD, & 5 pro-
gressed. A majority, at either dose, reported >50%-100% reduction in pruritus. Adverse side effects
included fatigue, change in taste, GI complaints, shortness of breath, anemia, hypokalemia, increased
creatinine, non-specific EKG changes, and thrombocytopenia. SAHA is a well tolerated, orally
administered HDAC inhibitor that appears to have significant activity in heavily treated advanced
refractory CTCL patients. 
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DNA oligonucleotides therapy for UV-induced squamous cell carcinomas
V Marwaha, B Helms, DA Goukassian and BA Gilchrest Dermatology, Boston University, Boston,
MA
We have previously reported that DNA oligonucleotides homologous to the telomere sequence (T-
oligos) induce multiple cancer prevention responses in normal and malignant cells including tran-
sient growth arrest, enhanced DNA repair capacity, senescence and apoptosis. To determine if T-oli-
gos might be effective in treating human squamous cell carcinomas (SCC) the human SCC12F cell
line was treated with T-oligos (pGTTAGGGTTAG 40 µm) or diluent alone and determined the expres-
sion of selected cell cycle and apoptosis regulating genes (bclx, p21, bax and Mcl-1) using the ribonu-
clease protection assay. Within 24 hr, the mRNA level of bclx was unaffected, but compared to con-
trols (100%), T-oligos up-regulated mRNA levels of p21 (170%), and the proapoptotic genes bax
(190%) and Mcl-1 (260%). To examine the effect of T-oligos on UV-induced SCC in vivo, we UV
irradiated hairless mice using a known carcinogenic protocol. Resulting SCC with diameters <3mm
and 3-7mm were injected (inj) with T-oligos (0.6 nMoles) intralesionally 3 times a week until dis-
appearance or for up to 4 weeks. T-oligos reduced (p<0.005) small SCC volume by 83% on aver-
age, with 4 of 9 disappearing completely, whereas control vehicle (saline) inj SCC doubled in size.
T-oligos reduced larger SCC volume by 30% (p<0.07, n=6), whereas controls enlarged 9-fold. One
day after the last inj all SCC were bisected and stained with TUNEL and Ki67 to evaluate T-oligo
effect on apoptosis and rate of proliferation, respectively. T-oligo led to ∼6-fold increase in the num-
ber of TUNEL + presumably apoptotic cells (2216±326 vs 406±135 per mm2 SCC, p<0.0001). There
was also a 20% decrease in the number of Ki67 + cells in the T-oligo vs. diluent-inj SCC. We pro-
pose that T-oligo activation of DNA damage signaling pathways in UV-induced SCC may provide
a new non-surgical skin cancer therapy. 
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Topical immunomodulators and topical steroids usage in the U.S. for inflammatory dermatoses
FA Nasser, PM Huynh and GJ Murakawa Dermatology, Wayne State University, Detroit, MI
Topical steroids have been the mainstay of therapy for inflammatory dermatoses. In January 2001,
the first of two topical immunomodulators (TIMs), tacrolimus, was introduced into the market for
the treatment of atopic dermatitis and eczema, followed by the distribution of pimecrolimus in Jan-
uary 2002. To determine the impact of these new medications in the treatment of inflammatory der-
matoses, semiannual data from National Data Corporation, an independent data collection company
that gathers information on prescribing trends from participating pharmacies, were analyzed. About
6 million prescriptions for topical steroids are issued semiannually; these numbers have not changed
appreciably over the past 3 years. Interestingly, utilization of TIMs has risen dramatically, with over
1.7 million prescriptions in the first half of 2003, or a 3.5:1 steroid:TIM ratio currently. Dermatol-
ogists utilized TIMs immediately upon availability; whereas other physicians (internists, family prac-
titioners, and pediatricians) lagged behind initially. Non-dermatologists prescribe pimecrolimus more
frequently than tacrolimus, at a ratio exceeding 8:1. In contrast, dermatologists, prescribe at a 3:2
ratio of pimecrolimus to tacrolimus. Moreover, dermatologists account for over 73% of all tacrolimus
prescriptions. The data confirm that topical steroids continue to be the mainstay of treatment of
inflammatory dermatoses in the U.S. Moreover, the data suggests that physicians have embraced
co-utilization of TIMS and topical steroids. Finally, the predominance of pimecrolimus usage may
be attributable to marketing influences, since pimecrolimus is marketed to all physicians, whereas
tacrolimus is marketed primarily to dermatologists. 
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Efficacy of etanercept in an integrated multistudy database of patients with psoriasis
K Gordon,1 N Norman,2 E Frankel,3 R Zitnik,4 S Stevens4 and H Wang4 1 Loyola University,
Maywood, IL, 2 University Hospitals of Cleveland, Cleveland, OH, 3 Clinical Partners, LLC,
Johnston, RI and 4 Amgen Inc., Thousand Oaks, CA
Etanercept has been approved in patients with rheumatoid arthritis (RA), juvenile RA, and psoriatic
arthritis at a subcutaneous dose of 25 mg twice weekly (BIW) and has been studied at doses of 25
mg BIW and 50 mg BIW in patients with psoriasis. Here we report the efficacy of etanercept in
1187 psoriasis patients across one phase 2 and two phase 3 studies. Comparisons presented between
the 25-mg BIW dose (N=415) and placebo (N=414) used data pooled across all 3 studies. Compar-
isons between the 50-mg BIW dose (N=358) and placebo (N=359) used data pooled across the phase
3 studies. Pooled data were analyzed using a 2-sided Cochran-Mantel-Haenszel test stratified by
study. The primary endpoint was ≥75% improvement from baseline in the Psoriasis Area and Sever-
ity Index (PASI) at 12 weeks. Three percent of patients receiving placebo and 33% receiving 25 mg
BlW etanercept achieved a PASI 75 (p<0.0001). In the 2 studies that included the highest dosage,
3% of patients receiving placebo and 49% receiving 50 mg BIW etanercept achieved a PASI 75
(p<0.0001). Highly significant efficacy was also demonstrated for all secondary endpoints at week
12 for both etanercept doses, including PASI 50 and 90 responses, percent improvement from base-
line in PASI score, physician’s static global assessment (clear/almost clear), Dermatology Life Qual-
ity Index, and patient’s global assessment. Patients treated with 50 mg etanercept BIW in the phase
3 studies showed a high degree of clearing at week 12, with PASI 90 response rates of 21% vs 1%
for placebo. In studies where double-blind treatment continued through 24 weeks, responses to
etanercept continued to improve with longer treatment. In conclusion, etanercept 25 mg BIW and
50 mg BIW provided consistent, robust efficacy in the treatment of chronic plaque psoriasis. Etan-
ercept provided a high degree of psoriasis clearing, improvement in both physician- and patient-
reported outcomes, and significant impact on quality of life. 
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Minoxidil promotes hair growth in androgenetic alopecia by increasing the ratio of termi-
nal/vellus hairs and the number of proliferating Ki67-positive hair follicle cells in horizontal
skin sections
RE Schopf and M Bress Dermatology, Johannes Gutenberg Univ., Mainz, Germany
Minoxidil has been shown to promote hair growth. The short-term effects of a 5% solution of minox-
idil on the ratio of terminal/vellus hair and the proliferation marker Ki67 have not been examined
before. We tested the effects of a 5% solution of minoxidil applied twice daily for 12 weeks on the
scalp of 10 women and 9 men with androgenetic alopecia. Hair regrowth was evaluated by histo-
logic analysis of paired 5 mm punch biopsy specimens for horizontal sectioning taken from the
parietal region of the scalp from the right side on week 0 and the contra lateral side on week 12. In
the histologic sections, the diameter of the hair shafts was determined in blinded fashion employing
a micrometer grid; a hair shaft with a diameter of <30 micrometer was defined as vellus hair, a
diameter of > 30 micrometers as a terminal hair; data are presented as the ratio of terminal/vellus
hair. Cellular proliferation in hair follicles was ascertained by Ki67 staining using the alkaline phos-
phatase method by counting the stained nuclei of 5 hair follicles in blinded fashion (Dako, Denmark).
In addition, visual analysis was performed by scalp photography. We found the following ratios of
terminal/vellus hair in women: 2.99 +/- 0.49 (week 0, mean +/- SE) vs. 4.74 +/- 0.54 (week 12, p
<0.05, Wilcoxon test); in men: 2.89 +/- 0.50 vs. 3.59 +/- 0.54 (p <0.05). Ki67 staining in hair folli-
cles in women was: 8.04 +/- 1.45 (week 0) vs. 9.59 +/- 1.62 (week 12, p <0.05); in men: 10.98 +/-
1.53 vs. 11.18 +/- 1.18 (p >0.05, resp.); the combined values of men and women for Ki67 at week
0 were 9.35 +/- 1.08 vs. 11.3 +/- 1.1 at week 12 (p = 0.02). Scalp photography corresponded to
increased hair growth after 12 weeks. These findings show that a twice daily, 12-week treatment with
5% topical solution of minoxidil enhances hair growth by increasing the ratio of terminal/vellus hairs
in both men and women and by increasing Ki67 in hair follicles. 
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Epidermal Genetic Information Retrieval is a non-invasive method of evaluating message
(mRNA) profiles of lesional versus non-lesional skin of psoriatic subjects before and after ini-
tiations of therapy
CM Liu,1 R Wong,2 NR Benson2 and GG Krueger1 1 Dermatology, University of Utah, Salt Lake
City, UT and 2 DermTech International, San Diego, CA
The purpose of this study is to determine the genomic expression in the stratum corneum of lesional
and non-lesional skin and the changes with treatment. A non-invasive retrieval method known as the
Epidermal Genetic Informational Retrieval (EGIR) utilizes a tape to collect the stratum corneum.
Target sites are cleaned with alcohol and tape is applied with repeated pressure for 30 seconds to
standardize collection. Four tape strips are performed at each site. In the current trial, we have 4
cohorts of 7 patients treated with alefacept, etanercept, clobetasol or narrow band UVB.  Patient vis-
its are at week 0, 1, 2, 4, 8, 12 and 24 in all cohorts except the clobetasol group which are at week
0, 2, 5, 8, and 11. Patients are evaluated for body surface area involvement, erythema and thickness
using the National Psoriasis Foundation Score. mRNA is collected from one target psoriatic lesion
and three standard sites. The mRNA is extracted and RT-PCR performed using specific primers. A
minimum of 200 pcg is needed to accurately quantify mRNA relative to b-actin. Results demonstrate
significant differences in message between involved and uninvolved skin. On average, non-lesional
skin yields around 1 ng of mRNA whereas yields in lesional skin are ten-fold higher. Keratin 16,
GAPDH and TNF are elevated in psoriatic skin compared to uninvolved skin while other markers
including CD2 and INF were variable. Data after initiation of therapy are preliminary but do show
a trend in normalization of message in TNF and keratin 16. We expect the changes in message to
correlate and precede the clinical improvement of psoriasis. We predict EGIR will allow us to bet-
ter understand the pharmacodynamics of psoriasis therapy and provide us with a prognostic tool in
evaluating treatment outcomes. 
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Dietary vitamin E: delayed bioavailability in human skin and preferential accumulation of α-
tocopherol in human sebum
S Ekanayake Mudiyanselage,1,2 K Kraemer3 and JJ Thiele1 1 Dermatology, Northwestern
University, Chicago, IL, 2 FSU, Jena, Germany and 3 BASF, Ludwigshafen, Germany
While topical vitamin E has been studied extensively, little is known on the oral bioavailability of
this antioxidant in skin. We have demonstrated that the highest physiological concentrations of vita-
min E are found in facial sebum.1 We hypothesized that the oral bioavailability of vitamin E in human
skin is largely dependent on sebaceous gland secretion and is thus site- and compartment-specific.
To test this, 24 healthy volunteers (30±9 years; means±SD) were subjected to a randomized daily
supplementation with either 400mg RRR-α-tocopheryl acetate (RRR-α-toc) or 400mg all-rac-α-
tocopheryl acetate (all-rac-α-toc) for 14 days. Serum, facial sebum, and lower arm skin surface lipids
(SSL) were collected at 0h, 12h, 1d, 2d, 3d, 7d, 14d and 21d after starting supplementation. Sebum
and SSL were collected using sebutapes and ethanol extraction, respectively, and analyzed by HPLC
using electrochemical detection for α-tocopherol(toc) and UV-detection for squalene.2 Serum α-
toc levels were increased as early as 12h after supplementation of RRR-α-toc or all-rac-α-toc and
peaked on day 7 with an average increase of 76% and 79%, respectively. No significant changes were
observed in lower arm SSL at any time point. Remarkably, while sebum levels remained unchanged
during the first 14 days of supplementation, both the RRR-α-toc and the all-rac-α-toc group showed
increased α-toc levels in sebum of 87% and 92%, respectively. In conclusion, with respect to dietary
supplementation of vitamin E and its bioavailability in human skin these results suggest that a)
sebaceous gland secretion is a major mechanism leading to site-specific differences; b) the bioavail-
ability of RRR-α-toc and the all-rac-α-toc is comparable; c) possible protective effects in the skin
will not be achieved before a supplementation period of 2-3 weeks. 
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Safety of etanercept in an integrated multistudy database of patients with psoriasis
A Gottlieb,1 B Goffe,2 J Veith,3 S Stevens3 and A Nakanishi3 1 UMDNJ-Robert Wood Johnson
Medical School, New Brunswick, NJ, 2 Minor and James Medical, PLLC, Seattle, WA and 3 Amgen
Inc., Thousand Oaks, CA
Etanercept has been approved for the treatment of rheumatoid arthritis (RA), juvenile RA, and pso-
riatic arthritis at a subcutaneous (SC) dose of 25 mg twice weekly (BIW). Here we report the pooled
safety results of 3 randomized, placebo-controlled studies (one phase 2 and two phase 3) of etaner-
cept administered for 12 weeks to 1347 patients with chronic plaque psoriasis. Patients received SC
injections of placebo or etanercept 25 mg once weekly (QW), 25 mg BIW, or 50 mg BIW. Across
the 3 studies, 1261 patients received at least 1 dose of etanercept for a total of 933 patient-years of
exposure. Etanercept was well tolerated at all doses, with an adverse event profile similar to that seen
with placebo. Low-grade injection site reactions were more common with etanercept use (6% placebo,
14% etanercept); however, the rate in the pooled etanercept group was lower than that observed in
RA trials (37%). No clear dose-related trends were observed in rates of adverse events, infections,
serious infections, or laboratory abnormalities. The safety profile in patients receiving etanercept 50
mg BIW was comparable with that of patients receiving 25 mg BIW (approved regimen in RA). At
week 12, 2% of patients in the pooled placebo group (N=414) and 1.8% in the pooled etanercept
group (N=933) had discontinued treatment because of adverse events. Serious adverse events were
experienced by a similar proportion of patients in both groups (1.2% placebo, 1.7% etanercept). Rates
of serious infections (requiring hospitalization) were low (1.0% placebo, 0.3% etanercept), and no
opportunistic infections or tuberculosis were reported. In conclusion, the safety profile of etaner-
cept in patients with psoriasis was similar to the safety profile seen with placebo and was consistent
with experience from RA populations. No new or unanticipated patterns of adverse events were
observed. 
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Clinically meaningful improvements in patient-reported outcomes for patients with moderate
to severe psoriasis receiving etanercept
G Krueger,1 J Woolley2 and R Zitnik2 1 University of Utah, Salt Lake City, UT and 2 Amgen Inc.,
Thousand Oaks, CA
Our objective was to determine if etanercept therapy leads to clinically meaningful improvements
in patient-reported outcomes (PROs) for patients with moderate to severe psoriasis. In a 12-week,
double-blind, multicenter clinical trial, 611 patients with stable moderate to severe psoriasis were
randomized to receive either etanercept (25 mg BIW or 50 mg BIW) or placebo. PROs assessed
included the Dermatology Life Quality Index (DLQI). Two responder analyses were prospectively
identified in the trial. For the first, clinically important improvement was defined as a 5-point improve-
ment (Khilji et al, 2002) or a score of 0 in the DLQI. A second analysis evaluated those who achieved
a 0 score, the best score possible, where patients report that they are “not at all” affected for any of
the domains of the DLQI. All patients who received at least one dose of study drug and provided
baseline PRO assessments (n=581) were included in both analyses. Compared with those on placebo,
a significantly greater proportion of patients on etanercept reported clinically important improve-
ments in DLQI scores. Response rates were superior to placebo at week 2 (p<0.01) for both etaner-
cept treatment groups, and by week 12 response rates were 77% for 50 mg BIW, and 72% for 25 mg
BIW, both of which were statistically significantly (p<0.0001) superior to placebo (26%). Analyses
using the more stringent “not at all affected by their psoriasis” responder definition indicated that
patients on both doses of etanercept were significantly more likely to respond to therapy than those
on placebo (p<0.0001). By this measure, response rates were 25% for 50 mg BIW, 20% for 25 mg
BIW, and 1% for placebo. Patients receiving etanercept therapy were significantly more likely than
placebo-treated patients to achieve a clinically meaningful improvement in the DLQI. These results
imply that in patients with moderate to severe psoriasis, treatment with etanercept leads to mean-
ingful improvements in patient-reported outcomes. 
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Etanercept treatment leads to rapid and sustained improvements in the quality of life of patients
with moderate to severe psoriasis
S Feldman,1 A Kimball,2 J Woolley3 and R Zitnik3 1 Wake-Forest University, Winston-Salem, NC,
2 Stanford University, Stanford, CA and 3 Amgen Inc., Thousand Oaks, CA
Our objective was to determine if etanercept therapy improves health-related quality of life (HRQOL)
of subjects with moderate to severe psoriasis. 652 patients with stable moderate to severe psoriasis
participated in a 24-week, double-blind, multicenter clinical trial of etanercept therapy. Patients were
randomized to receive either one of three doses of etanercept: 25 mg QW, 25 mg BIW, or 50 mg
BIW; or placebo. At week 12, patients on placebo were switched to etanercept 25 mg BIW through
week 24, while other patients continued their original doses. HRQOL was assessed using the Der-
matology Life Quality Index (DLQI). All patients who received at least one dose of study drug and
provided baseline DLQI data (n=649) were included in these analyses and missing data were imputed
using the last observation carried forward. Compared with those receiving placebo, patients receiv-
ing etanercept reported greater improvements in DLQI scores. For each dose of etanercept, improve-
ment in the DLQI was apparent by week 2 (p < 0.01 for comparison with placebo) and continued to
improve through week 24. At week 12, the mean percent improvement in the DLQI was 10.9, 47.2,
50.8, and 61.0 percent for patients on placebo, 25 mg QW, 25 mg BIW, and 50 mg BIW, respec-
tively (for each dose p < 0.001 for comparison with placebo). At week 24 the mean percent improve-
ment in the DLQI was 54.0, 59.4, and 73.8 percent for patients on 25 mg QW, 25 mg BIW, and 50
mg BIW, respectively (there was no placebo group at week 24). Psoriasis patients receiving etaner-
cept therapy have large, rapid and sustained improvements in their quality of life. 
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Oral tazarotene does not affect the pharmacokinetics or efficacy of oral contraceptives
D Yu,1 PS Walker2 and D Tang-Liu1 1 Pharmacokinetics, Allergan, Inc., Irvine, CA and 2 Clinical,
Allergan, Inc., Irvine, CA
Purpose: Determine pharmacokinetic (PK) and pharmacodynamic (PD) interactions between
tazarotene and commonly prescribed oral contraceptives (OCs). Methods: Three clinical studies eval-
uated PK and PD interactions of oral tazarotene and OCs in healthy volunteers. Two studies evalu-
ated daily norethindrone (NE)/ethinyl estradiol(EE)with tazarotene 1.1mg (N=27) or 6 mg (N=29)
and a third study assessed combination norgestimate (NGM)/EE and tazarotene 6 mg (N=26). OCs
were administered for three consecutive menstrual cycles. Tazarotene dosing started in the 2nd
cycle and continued through study ending. PK parameters for EE, NE, levonorgestrel, and deacetyl
NGM (AUC0-24 and Cmax) were determined before and after tazarotene dosing (on day 6 in cycles
2 and 3). Serum concentrations of luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
were evaluated before and after tazarotene dosing (days 2, 4, 6 in cycles 2 and 3). In two studies,
serum progesterone levels were assessed on days 18 and 20 in cycles 2 and 3. Results: The 90%
confidence intervals of AUC0-24 and Cmax for EE, NE, levonorgestrel, and deacetyl NGM were
completely within the 80-125% boundary, indicating tazarotenic acid did not affect the OC PK
components. Similarly, the 90% confidence intervals of progesterone concentrations were totally
within the 80-125% boundary. The 90% confidence intervals of FSH and LH were generally within
the 80-125% boundary except at some timepoints when they were marginally/partially outside this
boundary due to data variability. Mean concentrations of FSH and LH were lower in the 3rd cycle
than the 2nd cycle on some days, indicating OC efficacy was not compromised. Serum FSH and LH
levels remained within normal ranges for healthy women during the follicular phase. Conclusion:
Oral retinoids require female patients of childbearing potential to use reliable birth control meas-
ures during treatment and for varying periods of time after treatment. Oral tazarotene, up to 6 mg
once daily, does not affect the PK or efficacy of NE/EE and NGM/EE oral contraceptives. 
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Combination therapy with retinoid X receptor and peroxisome proliferator-activated recep-
tor gamma agonists for cutaneous T cell lymphoma
RN DuBois,1 RA Gupta1 and JA Zic2 1 Medicine/Gastroenterology, Vanderbilt University School
of Medicine, Nashville, TN and 2 Dermatology, Vanderbilt University School of Medicine,
Nashville, TN
Treatment options for the lymphoproliferative disorder cutaneous T cell lymphoma (CTCL) remain
limited. Recently, the selective retinoid X receptor (RXR) agonist bexarotene was approved for treat-
ment of the cutaneous manifestations of CTCL. One heterodimeric partner of RXR is the nuclear
hormone receptor peroxisome proliferator-activated receptor γ(PPARγ). Activation of PPARγ inhibits
cell growth and induces differentiation of a broad spectrum of epithelial and mesenchymal cell derived
maligancies and in some cases combination therapy with RXR and PPARγ agonists results in syn-
ergistic efficacy. Whether the PPARγ signaling pathway is intact in CTCL and the therapeutic poten-
tial of PPARγ agonists alone or in combination with RXR agonists in patients with CTCL is not
known. PPARγ was expressed at the protein level and was transcriptionally responsive to a high-
affinity, subtype-selective PPARγ agonist in two different CTCL cell lines. Treatment of either cell
line with a PPARγ or RXR agonist resulted in a decrease in cell viability and an increase in apopto-
sis. Treatment with activating ligands for both RXR and PPARγ resulted in a synergisitic decrease
in cell viability. Combination therapy with PPARγ and RXR activators may be a superior treatment
option to bexarotene alone for the cutaneous manifestations of CTCL. 
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Pharmacokinetics of etanercept in patients with psoriasis
I Nestorov, T DeVries and R Zitnik Amgen Inc, Thousand Oaks, CA
Our objective was to characterize the concentration time profiles of etanercept, a TNF antagonist,
in subjects with psoriasis. Pharmacokinetic analyses were conducted in 838 patients with psoriasis
participating in two phase 3 trials with etanercept. Study 1 was a placebo-controlled, randomized
clinical trial of three etanercept dosing regimens: 25 mg once weekly (QW), 25 mg twice weekly
(BIW), or 50 mg BIW, administered by subcutaneous (SC) injection for 24 weeks. Study 2 was a
placebo-controlled, randomized evaluation of two etanercept dosing regimens: 25 mg BIW and 50
mg BIW SC for 12 weeks. Serum samples for analysis of etanercept concentration were taken at
weeks 1, 2, 4, 8, 12, and 24 in study 1 (N = 376) and at weeks 2, 4, 8, and 12 in study 2 (N = 462).
A subset of patients in study 1 (N=41) had additional serum samples for characterization of the
weekly profiles during weeks 1, 12, and 24. In study 1, the mean ± SD steady-state predose serum
concentrations of etanercept at 12 weeks were 768 ± 475 ng/mL for the 25 mg QW regimen, 1990
± 1030 ng/mL for the 25 mg BIW regimen, and 4020 ± 2100 ng/mL for the 50 mg BIW regimen.
In study 2, mean etanercept concentrations at 12 weeks were 1900 ± 1110 ng/mL in the 25 mg BIW
group and 3830 ± 1870 ng/mL in the 50 mg BIW group. All three doses produce modest accumu-
lation after multiple doses with accumulation indices around 2. The mean peak-to-trough ratios at
steady state did not exceed 2. Pharmacokinetic results were highly consistent across the two phase
3 trials and were in good agreement with the results seen in a previous phase 2 psoriasis trial. In
both studies, the concentration time profiles displayed dose proportionality. All doses produce sta-
ble and smooth weekly profiles at steady state. 
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Differential response of normal melanocytes and melanoma cells to proteasome inhibition:
impact on tumor control in vivo
Y Fernandez,1 R Jennifer,2 AW Opipari2 and MS Soengas1 1 Dermatology, University of Michigan,
Ann Arbor, MI and 2 Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI
Melanoma is notorious for an extreme multi-drug resistance. The molecular bases for treatment
failure are largely unknown, but they are generally attributed to defective targeting of the melanoma
cells and/or an excessive toxicity to normal compartments. Here we show that dysfunctional cell
cycle checkpoints and differential responses to stress signals can be exploited by the proteasome
inhibitor bortezomib (Velcade, previously known as PS-341) for a selective killing of melanoma
cells. Comparative analysis of 25 melanoma cell lines and 5 normal melanocyte preparations revealed
a 6-10 fold difference in drug sensitivity (EC50=15±10 nM vs 100±10 nM, respectively). Thus, while
normal melanocytes responded by cell cycle arrest, melanoma cells activated intrinsic and extrinsic
apoptotic pathways. Interestingly, the cytotoxic effect of bortezomib was independent on the status
of p53 and the melanoma associated genes survivin, p16INK4a, p19ARF, Ras or BRAF (p<0.005).
Unexpectedly, and to the contrary to other tumor types, classical proteasome targets such as NF-κB,
Bcl-xL, XIAP, FLIP or TRAF-2 (among others) where not affected by bortezomib. High through-
put functional proteomic analyses indicated that the basis for the selective effect of bortezomib relies
on the capability of melanoma cells (but not normal melanocytes) to mobilize intracellular calcium,
activate the stress kinases p38 and JNK, and promote a massive release of pro-apoptotic inducers
from the mitochondria. Those results underscore the different regulation of survival and apoptotic
signals in melanoma cells and point to “weaknesses”on these tumor cells that can be exploited with
therapeutic intentions. In fact, whole-body tumor imaging systems indicated that the selective effect
of Bortezomib is extensive to in vivo settings (mouse xenograft models), in particular in the control
of melanoma metastasis (p<0.01). We consider these results as the framework for the rational design
of new melanoma therapies. 
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Pharmacokinetics of etanercept in patients with psoriasis after long term intermittent or con-
tinuous treatment
I Nestorov and R Zitnik Amgen, Thousand Oaks, CA
Our objective was to evaluate the concentration time profiles of etanercept in subjects with psoria-
sis during intermittent treatment or during prolonged therapy. After an initial 24 week double-blind
period with etanercept SC doses 25 mg once weekly (QW), 25 mg twice weekly (BIW), 50 mg
BIW, or placebo, patients were classified as responders (≥ 50% decrease from baseline PASI) or
incomplete responders (failed to achieve PASI 50). Responders were discontinued from etanercept
and followed until their disease relapsed, at which time patients either resumed blinded etanercept
therapy or, if initially treated with placebo, began 25 mg BIW treatment. Incomplete responders
began treatment with open-label etanercept 25 mg BIW. Serum samples were collected during both
the double-blind period and the withdrawal and retreatment period. The etanercept concentration
time profiles obtained for intermittent treatment of responders or prolonged treatment of incomplete
responders were consistent with the steady-state pharmacokinetic profiles obtained during the ini-
tial double-blind period of the study. For the responders, the steady-state predose mean (± SD) etan-
ercept concentrations of the 25 mg QW, 25 mg BIW, and 50 mg BIW dose groups were 980 ± 510
ng/mL (N = 18), 2350 ± 760 ng/mL (N = 21), and 3390 ± 1830 ng/mL (N = 29) respectively, after
12 weeks of retreatment following withdrawal and disease relapse. For the incomplete responders,
the steady-state predose mean etanercept concentrations at 12, 24 and 36 weeks after the beginning
of the open-label period with 25 mg BIW were 1930 ± 1150 ng/mL (N = 47), 1800 ± 1410 ng/mL
(N = 34), and 1980 ± 1000 ng/mL (N = 33), respectively. Once or twice-weekly administration of
etanercept in psoriatic patients produces stable steady-state concentration time profiles, maintained
for prolonged periods of time. There is no change in the pharmacokinetics of etanercept after either
intermittent or continuous therapy, supporting the use of etanercept in either treatment paradigm. 
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A randomized, double-blind, placebo-controlled study evaluating the S-CaineTM Patch for
induction of local anesthesia before minor dermatologic procedures in geriatric patients
NS Sadick1 and AK Schecter2 1 Dermatology, Weill Medical College of Cornell University, New
York, NY and 2 Brown Medical School, Providence, RI
Local anesthetics have an obligate role in dermatologic practice. While injectable lidocaine is the
agent of choice for most minor procedures, there is a demand for noninvasive anesthetic delivery
systems. The purpose of this study is to evaluate the efficacy and safety of the S-Caine Patch, a 1:1
(wt:wt) eutectic mixture of 70 mg tetracaine and 70 mg lidocaine, in the induction of local anesthe-
sia before minor dermatologic procedures in geriatric patients. In a multicenter, randomized, dou-
ble-blind, placebo-controlled study, we assign 79 patients over the age of 65 years who require a
shave biopsy, superficial excision, or electrodessication procedure to receive a 30-minute applica-
tion of either the S-Caine Patch or placebo immediately prior to the procedure. The primary meas-
ure of efficacy was patient rating of procedural pain using the Visual Analog Scale. Secondary effi-
cacy endpoints included patient, investigator, and independent observer assessments. There was a
statistically significant difference (p=0.041) in patient ratings of pain by VAS score in the S-Caine
group (9.5 mm) versus placebo group (22.5 mm). When patient data from a center that did not use
the study’s randomization schedule were excluded (n=16), median VAS scores were 7.0 mm for S-
Caine and 24.5 mm for placebo (p=0.020). None of the secondary endpoints showed a statistically
significant difference between S-Caine and placebo. There were no adverse events reported. In con-
clusion, the S-Caine Patch is a safe and effective method for noninvasive induction of local anes-
thesia for minor dermatological procedures in patients over the age of 65 years. 
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Measles virus-mediated oncolytic treatment of cutaneous T cell lymphomas
PA Oberholzer,1 L Heinzerling,1 TM Kuendig,1 V Kuenzi,2 H Naim,2 G Burg1 and R Dummer1 1
Dermatology, University Hospital Zurich, Zurich, Switzerland and 2 Berna Biotech AG, Bern,
Switzerland
Primary cutaneous lymphomas constitute a spectrum of diseases characterized by a clonal accumu-
lation of lymphocytes in the skin. Cutaneous T-cell lymphoma -derived lymphoma cell lines may
present deficient type I IFN signaling, preventing an anti-viral status. Therefore CTCL represent an
attractive target for viral oncolysis. We undertook a phase I, open-label, dose-escalating trial to inves-
tigate the effect of measles vaccine virus (MV) intralesional treatment in patients with advanced cuta-
neous T-cell lymphomas (CTCL). Five CTCL patients have received a total of 13 intratumoral MV
injections (Edmonston-Zagreb strain, provided by Berna Biotech AG, Bern, Switzerland). Injected
doses ranged from 100 TCID50 to 1000 TCID50 MV. Each MV injection was preceded by subcu-
taneous injection of IFN-a (9 Mio Units on day 1 and day 3). Treatment was well tolerated with no
significant treatment-related side effects. Biopsies from injected lesions prior to and after the treat-
ment were analyzed by immunohistochemistry as well as by PCR. The expression of measles recep-
tors CD46 and CD150/SLAM was assessed on tumor cells and found positive in all cases. After ther-
apy measles virus nucleoprotein was detected as well as the formation of syncytia. Quantitative
PCR analysis demonstrated an increase in expression of pro-inflammatory serum cytokines (IL-2)
and of IFN-?/CD8 ratio in tumor biopsies. Systemic immune response with an elevation of anti-
measles antibody titer was detected. Clinical response was observed in 2 out of 5 patients with regres-
sion of injected tumor lesions. Our approach induced local and systemic immunological alteration
after MV in primary CTCL and local tumor regression, providing information that may be of use in
the design of future cancer MV trials. 
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Effects of Chinese natural herbs on skin microcirulation
X Yue,1 W Zhu,1 H Ma1 and P Sun2 1 Department of Dermatology, Nanjing Medical University,
Nanjing, Jiangsu, China and 2 The Procter & Gamble Company, Kobe, Japan
To assess changes of superficial skin capillaries blood velocity and changes of skin microvascular
perfusion due to topical application of different kinds of Chinese natural herb extracts, 20 healthy
subjects were respectively treated with 20 different ointments of natural herb chemicals (0.1%) and
placebo (vehicle). Capillaries blood velocity and skin perfusion of finger nail folds were measured
by capillary microscopy and Laser Doppler flowmetry (LDF) respectively. The measurement was
performed successively and results were recorded every 5 minutes (5 min, 10min, 15min, 20min,
25min and 30min) after treatment. Among the 20 Chinese natural herb chemicals, which were reported
improving microcirculation by systemic administration, Only H-compound can increase the nail fold
microcirculation significantly compared with placebo. The LDF showed a persistent perfusion increase
by 2 to 2.5 times from the fifth minutes and lasted for at least 30 minutes. This perfusion pattern was
not seen with placebo and other invalid herbs. The velocity of erythrocyte shows a positive rela-
tionship with blood perfusion. Under capillary microscopy it increased by 1.8 times compared with
base level. Topical application 0.1% H-compound increases nail fold microcirculation. Further
studies will be required to explore its mechanism and its effect on modulating skin color. 
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Double-blind, placebo-controlled clinical study of cream containing pueraria mirifica for
face and breast skin elasticity
B Kim, S Jung, J Lee and H Ryoo R&D Center of Skin Science and Cosmetics, Enprani CO.,LTD,
Inchon, South Korea
It is well established that body hormones play a central role in skin appearance and are implicated
in skin aging. Recently, along with the remarkable increase in interest in natural products, the appli-
cation of phytoestrogens in anti-aging products has become very important. In this focus, we devel-
oped Pueraria mirifica(PM), following specific extraction procedures in this in vivo study on skin
elasticity, wrinkles, we investigated the anti-aging properties.30 healthy women volunteers, between
the ages of 30 and 60, applied the cream formula with 4% of Pueraria mirifica or placebo, on the
face area twice a day for 16 weeks. The evaluation was made both clinically and by silicon replica
analysis and Cutometer SEM575 and Corneometer followed by statistical treatment using the stu-
dent t- test(p<0.05).Skin elasticity measurement results showed that topical application on the skin
increased the total surface of skin elasticity in comparison with placebo group(p<0.05). However,
PM does not have prominent effect on the depth of wrinkles and skin moisturization. These results
are correlated with breast enlargement and firmness clinical test in 43 women for 8 weeks. the results
were confirmed both clinically and by the impressions of volunteers which indicated a visual improve-
ment of 74%. Skin elasticity increased statistically more significant than before treatment(p=0.038).
But placebo group do not increase skin elasticity(p=0.24). This in vivo study demonstrates that, PM
exhibits a significant skin elasticity increasing effect therefore, is of great interest in anti-aging and
firmness skin care products. 
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PCL-016 gel (NV-02) in the treatment of acne vulgaris: a pilot study
MP Heffernan,1 MJ Anadkat1 and AN Amin2 1 Dermatology, Washington University School of
Medicine, St. Louis, MO and 2 Novactyl, Inc, St. Louis, MO
PCL-016 is a metabolite of tryptophan and is produced via amino acid breakdown in vivo. It affects
zinc binding within zinc finger proteins and has been shown to have antiviral, antibacterial, and
immunomodulatory properties. The primary objective of this open-label, pilot study was to deter-
mine the safety and efficacy of PCL-016 10% gel (NV-02) in the treatment of mild to moderate acne
vulgaris. After obtaining informed consent, male and female patients with mild to moderate acne
vulgaris over the age of 18 were enrolled. Participants were instructed to apply study drug twice daily
to the face for 12 weeks. Facial lesion counts along with photography were performed at each visit.
Adverse events and local skin reactions were assessed at each visit. In addition, routine laboratory
testing (complete blood count, serum chemistry) and plasma levels of PCL-016 were evaluated at
each visit. A total of 20 subjects were enrolled, with 15 subjects completing the study. NV-02 reduced
the mean total lesion count, mean inflammatory lesion count, and mean non-inflammatory lesion
count by 54.3%, 51.4%, and 56%, respectively. A statistically significant reduction in these param-
eters was noted (p = 0.0006, p = 0.001, and p = 0.006, respectively). Application of NV-02 was well
tolerated by most patients in this study. One patient discontinued the study due to burning noted
after application of study drug. There were no significant laboratory abnormalities noted at any visit
for any patient. NV-02 applied topically appears both safe and effective when applied twice daily in
the treatment of mild to moderate acne vulgaris. A double blind, randomized, placebo controlled
study is warranted to further investigate the role of NV-02 as therapy for patients with mild to mod-
erate acne vulgaris. This is the first reported used of NV-02 in humans, and the first reported use of
a zinc finger drug in acne vulgaris. 
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Pharmacological and clinical activities of 5-alpha Avocuta: application for the management of
androgenic disorders
N Piccardi,1 A Piccirilli,1 J Choulot,1 B Chadoutaud2 and P Msika1 1 Laboratoires Expanscience,
Epernon, France and 2 BC Consulting, Toulouse, France
Androgen-dependent disorders, such as seborrhoea, acne and alopecia are among the most common
diseases encountered by dermatologists in daily practice. These pathologies are in part related to an
hyper-activity of 5-alpha reductase, the enzyme that metabolises testosterone into dihydrotestos-
terone (DHT) a major potent androgen in human skin. In this work, we have investigated the effi-
cacy of a lipidic fatty ester : 5-alpha Avocuta (butyl avocadate). Butyl avocadate is obtained from
refined avocado oil through a biotechnological process, and is purified by molecular distillation. 
We have demonstrated using dermal fibroblasts in culture that 5-alpha Avocuta is a potent inhibitors
of 5-alpha reductase type I activity (-49% for the smallest dose tested 0.01%). A multi-centric clin-
ical evaluation, under dermatologist control, was conducted on 27 volunteers. The purpose of this
study was to test the efficiency of a shampoo (1% of 5-alpha Avocuta) after 3 weeks of application
(1 application/2 days). Analysis of sebum secretion (Sebufix F16) by visual scoring and by image
analysis (Skin Visiometer, SV600, CK, Germany) demonstrate that this shampoo is able to signifi-
cantly reduce sebaceous production. Clinical investigations by the dermatologist (analogic scale)
show that the shampoo clearly improves greasy hair aspect, and is able to reduce itching and pruri-
tus, as well as dandruffs. The auto-evaluation by the volunteers confirms these data. 5- alpha Avo-
cuta is a new inhibitor of 5-alpha-reductase type I activity with proven efficiency on human scalp
disorder. This natural active ingredient may open the way to the formulation of original and efficient
products dedicated to the treatment of androgenic disorders. 
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Efficacy and safety outcomes of long-term efalizumab therapy in patients with moderate to
severe chronic plaque psoriasis: an update
AB Gottlieb,1 T Hamilton,2 I Caro3 and K Gordon4 1 UMDNJ-Robert Wood Johnson Medical
School, New Brunswick, NJ, 2 Atlanta Dermatology Vein and Research Center, Atlanta, GA, 3
Genentech, Inc, South San Francisco, CA and 4 Loyola University Medical Center, Maywood, IL
Efalizumab modulates key T-cell events in psoriasis pathogenesis. An ongoing open-label, Phase III
study is assessing weekly efalizumab therapy for up to 3 years for moderate to severe chronic plaque
psoriasis. Weeks 1-12, 339 patients received 2 mg/kg/wk subcutaneous (SC) efalizumab, and fluo-
cinolone acetonide ointment or petrolatum during weeks 9-12. Patients achieving >_50% improve-
ment in Psoriasis Area and Severity Index (PASI-50) or static Physician Global Assessment of Mild,
Minimal, or Clear at week 12 (n=290) entered maintenance treatment (MT) to receive weekly efal-
izumab. During MT, analyses (last observation carried forward imputation) included intent-to-treat
(ITT; n=339) including all patients even if they did not meet the criteria to enter MT and a mainte-
nance group analysis (n=290). An analysis of patients continuing therapy (as-treated) was also con-
ducted. At week 12, 82%, 41%, and 13% of all patients achieved PASI-50, PASI-75, and PASI-90
respectively. Fluocinolone acetonide did not provide additional benefit. Mean trough serum con-
centrations were measured during months 2-14 and were consistent. At month 21, ITT (n=339) PASI-
50, PASI-75, and PASI-90 were 65%, 48%, and 26%, respectively. Maintenance group (n=290) PASI-
50, PASI-75, and PASI-90 responses were 75%, 56% and 30%, respectively. As-treated (n=194)
PASI-50, PASI-75, and PASI-90 responses were 86%, 67%, and 34%, respectively. During MT, com-
mon adverse events (>_5% of patients during any 12-week period) included accidental injury, non-
specific infection (eg, colds), increased cough, rhinitis, and sinusitis. There was no evidence that the
incidence of adverse events increased with time. Up to 21 months of efalizumab therapy was well
tolerated and provided patients with continuous control of psoriasis. Updated results will be pre-
sented.
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A new method in the management of skin neoplasm using a flexible radioactive patch
Y Cho,3 J Lee,2 S Park,3 T Lee1 and M Lee1 1 Dermatology, Brain Korea 21 Project for Medical
Sciences, Yonsei University College of Medicine, Seoul, Korea, South Korea, 2 Division of Nuclear
Medicine, Diagnostic Radiology, Brain Korea 21 Project for Medical Sciences, Yonsei University
College of Medicine, Seoul, Korea, South Korea and 3 Dermatology, Yonsei University College of
Medicine, Seoul, Korea, South Korea
We developed a flexible radioactive polyurethane patch incorporating β–emitting radionuclide (166Ho)
to treat malignant skin lesions. We covered tumor surface (n=133) with the radioactive patch and
plastered tightly for 33.58± 5.33 minutes. Radiation dose delivered was 35 Gy for Bowen′s disease
(n=78), Kaposi sarcoma (n=25) and actinic keratosis (n=5), 50 Gy for BCC (n=17) and squamous
carcinoma (n=8). Complete response was observed in 91.7% after first therapeutic trial, 96.2% after
2nd and 97.7% after 4th trial with excellent cosmetic outcome for 31.15±13.88 months. In conclu-
sion, radioactive patch therapy is effective for superficial skin cancers in impractical location for sur-
gery. 
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Safety of imiquimod 5% cream in subjects with kidney or liver transplants
MJ Anadkat,1 C Tobler2 and MP Heffernan1 1 Dermatology, Washington University School of
Medicine, St. Louis, MO and 2 3M Pharmaceuticals, St. Paul, MN
The primary objective of this phase IV, open-label study was to estimate the acute rejection rate in
otherwise clinically stable liver and kidney allogeneic organ transplant subjects who had external
genital warts (EGW) treated with topical imiquimod 5% cream (AldaraTM). Secondary objectives
for this study were to determine the safety and tolerability of imiquimod 5% cream and to determine
the clearance rates in this subject population following treatment with imiquimod 5% cream. After
obtaining informed consent, subjects 18 years or older with allogeneic kidney or liver transplants
and EGW were planned to be enrolled. Patients received imiquimod 5% cream to be applied 3 times
weekly at night. Subjects were treated for 16 weeks or until genital warts cleared, whichever occurred
first. Adverse events and local skin reactions were assessed at each visit. Vital signs, general physi-
cal examination, total wart area, routine laboratory testing and immunosuppressant drug levels were
also evaluated at each visit. Only 4 patients were enrolled due to difficulty recruiting patients. All
patients had allogeneic kidney transplants and were receiving immunosuppressive therapy with either
cyclosporine or tacrolimus. No deaths or transplant rejections were reported. Two patients experi-
enced 3 serious adverse events, each of which were reported as intercurrent events and probably not
related to study drug. Other adverse events reported were mild to moderate and localized to the appli-
cation site. No significant laboratory abnormalities were noted. One patient experienced clearance
of her EGW and the remaining three each experienced reduction in wart area. Statistical compari-
son was not performed due to the small sample size. Adverse events judged to be drug-related were
mild to moderate, localized to the application site, and similar to those seen in other studies with
imiquimod 5% cream. In addition, all subjects experienced clearance or reduction in wart area. This
is the first reported use of imiquimod 5% cream in organ transplant patients. 
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HuMax-CD4, fully human monoclonal antibody: phase II trial in cutaneous T cell lymphoma 
YH Kim,2 E Obitz,3 L Iversen,3 A Oesterborg,4 S Whittaker,5 TM Illidge,6 T Schwarz,7
R Kaufmann,8 R Gniadecki,9 M Duvic,10 K Cooper,11 P Jensen,1 O Baadsgaard1 and SJ Knox2 1
Genmab, Copenhagen, Denmark, 2 Stanford University School of Medicine, Stanford, CA, 3
Marselisborg Hospital, Aarhus, Denmark, 4 Karolinska Hospital, Stockholm, Sweden, 5 St.
Thomas Hospital, London, United Kingdom, 6 Southampton General Hospital, Southampton,
United Kingdom, 7 Univ. Clinics, Muenster, Germany, 8 University Clinic, Frankfurt aM,
Germany, 9 Bispebjerg Hospital, Copenhagen, Denmark, 10 MD Anderson Cancer Center,
Houston, TX and 11 Case Western Reserve Univ. Hospital of Cleveland, Cleveland, OH
The fully human monoclonal antibody, HuMax-CD4 targeting the CD4 molecule was investigated
for safety and efficacy in the treatment of CTCL. 49 patients with biopsy-proven CD4+ refractory
early or advanced stage CTCL were enrolled in 2 ongoing open-label therapeutic exploratory clin-
ical trials. HuMax-CD4 was infused i.v. at doses of 280 mg (11 early stage, 13 advanced stage
patients), 560mg (15 early stage patients) or 980mg (10 advanced stage patients) once weekly for
16 weeks. Primary endpoint was Composite Assessment of Index Lesion Disease Activity (CA) score.
36 patients evaluable for response after ≥4 infusions are the subject of this report: 280 mg (11 early
stage and 10 advanced stage), 560mg (9 early stage) or 980mg (6 advanced stage). Following 280
mg, 33% of 21 patients obtained a 50% CA score reduction. Following 560mg, 67% (6 of 9 early
stage patients obtained a CA score reduction of > 50%. 2 of 9 obtained a 100% reduction, 4 obtained
a 50% reduction, and 3 patients had stable disease. Following 980mg, 50% (3 of 6) advanced stage
patients obtained a CA score reduction of > 50% and 3 patients had stable disease. Following 280mg,
6 grade 3 adverse events were reported by 4 patients. 5 were unrelated to HuMax-CD4. Following
560 and 980mg, 1 unrelated grade 3 adverse event was reported. No grade 4 events were reported.
CTCL responds to HuMax-CD4 treatment and HuMax-CD4 is safe and well tolerated by patients
with CTCL. 
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Cancer regression induced by TLR9-targeted immunostimulatory CpG treatment in patients
with metastatic melanoma: results of a clinical phase II trial
M Pashenkov,1 G Goess,1 C Wagner,1 A Schneeberger,1 AM Krieg,2 G Stingl,1 SN Wagner1 and for
the C003 Study Group3 1 DIAID, Dept. of Dermatology, Medical University, Vienna, Austria, 2
Coley Pharmaceutical Group, Inc., Wellesley, MA and 3 Depts of Dermatology, Universities, Graz,
Munster, Cologne, Essen, Austria, Germany
Stimulation of Toll-like receptor (TLR) 9 by pathogen-derived compounds leads to direct activation
of human antigen-presenting plasmacytoid dendritic cells (pDC) and B cells and indirectly dramat-
ically increases cytotoxic T and natural killer cell responses. The synthetic oligodeoxynucleotide
CPG 7909 contains CpG motifs optimized to specifically interact with TLR9 and is a strong activa-
tor of both innate and specific immunity. CPG 7909 crossreacts with mouse TLR9 and has shown
impressive antitumor activity in preclinical tumor models when used as monotherapy. 20 patients
with metastatic melanoma (stage IV, no CNS mets) were enrolled into an open-label, multicenter,
single arm study. Pts received 6 mg CPG 7909 weekly SC for 24 weeks or until disease progression.
Disease status was assessed according to RECIST. Two pts achieved a confirmed partial response
(PR, one pt 13+ months), three pts achieved stable disease (SD). CPG 7909 was well tolerated.
Adverse events included transient injection site reactions, fever and arthralgias. Toxicities were lim-
ited, transient and did not result in any withdrawals. 
Phenotyping of PBMC could be performed in 14 patients and revealed (i) activation of BDCA-2+pDC
with increased CD86 and HLA-DR expression consistent with the MOA, and (ii) an increased fre-
quency of CD19+CD38++early plasma cells during therapy. Pts exhibiting PR or SD could be dis-
tinguished from non-R pts by differential dynamics in NK cell-cytotoxicity (1.6xÉ vs. 1.7xÑ in lytic
units, p<0.05) during the first 8 weeks of treatment. Assays to determine frequencies of antigen-spe-
cific T cells are ongoing. We conclude that CPG 7909 exerts objective anti-tumor activity in pts with
metastatic melanoma, can be administered safely and induces a phenotypic signature in PBMC asso-
ciated with exposure and, possibly, response to therapy. 
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Efficacy and safety of infliximab in the treatment of severe or arthropathic psoriasis: prelim-
inary results
A Costanzo, L Bianchi, M Papoutsaki, R Saraceno, M Esposito and S Chimenti Dermatology,
University of Tor Vergata, Rome, Italy
Psoriasis is a physically and psychologically disabling disease that affects 1-3% of caucasian pop-
ulation. About 25% of patients suffer from a moderate to severe plaque psoriasis and about 7%
develop an inflammatory arthritis. Recently, a new therapeutic approach, using antibodies directed
against Tumor Necrosis Factor-a (TNF-a), has been proposed. TNF-a is believed to have a central
role in the pathogenesis of psoriasis.
Aim of our study was to evaluate the efficacy of infliximab in patients with severe plaque psoriasis
or psoriatic arthritis, non-responder to conventional treatments. We enrolled 85 psoriatic patients
(40M and 45F), 46% affected by severe plaque psoriasis (PASI >26), 36% by psoriatic arthritis with
both severe cutaneous (PASI > 25) and articular involvement, and 18% mainly by psoriatic arthritis
at baseline observation, all of them non-responders to conventional therapies (cyclosporin A,
Methotrexate, retinoids) . The therapy consisted in i.v. drip treatment with 5 mg/kg of infliximab, at
week 0, 2 and 6, as induction period, and every 8 weeks as manteinance therapy. The principal end-
point was the evaluation of effectiveness on Psoriasis (assessed by PASI score), and the evaluation
of arthritis at week 22. The 72% (n 61 ) of patients completed the scheduled therapy (second booster
dose of the maintenance period), The first clinical result was the improvement of the articular func-
tion already observed after the first infusion (week 2), as referred by the patients who reported reduc-
tion of pain and improvement of motility. Concerning the skin involvement, all patients achieved an
impressive reduction of PASI score (>75%), mostly before the end of the induction period (week 4).
The articular result is still present after 22 weeks, whereas some cutaneous recurrences have been
observed during this maintenance period.In conclusion, our preliminary therapeutic experience seems
to confirm the effectiveness of this drug in the treatment of severe plaque psoriasis when the official
therapies are contraindicated. 
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Enhancement of human skin barrier integrity by nicotinic acid derivatives
MK Jacobson,1 EL Jacobson,1 H Kim,1 M Kim,1 RL Rizer2 and NS Trookman3 1 University of
Arizona and Niadyne, Inc., Tucson, AZ, 2 TJ Stephens & Associates, Colorado Springs, CO and 3
Rocky Mountain Laser Center, Colorado Springs, CO
A weakened skin barrier is characteristic of numerous dermatology conditions including atopic der-
matitis. In addition, evidence suggests that certain treatments for skin photodamage may result in
decreased barrier integrity and heightened photosensitivity. Derivatives of nicotinic acid tailored for
topical delivery of nicotinic acid to the cellular compartments of skin have been shown to increase
NAD content to support genomic integrity and energy metabolism functions and to stimulate the
release of leptin to stimulate epidermal differentiation. In the present study, a double-blinded pro-
tocol was used to compare placebo and myristyl nicotinate (MN) formulations for effects on skin
barrier integrity. Formulations containing 5% MN increased skin NAD content by an average of
approximately 40% (p=0.001 vs. placebo) and epidermal turnover by 6.3% (p= 0.003). Skin barrier
assessment was made by determination of rates of trans-epidermal water loss (TEWL), effects on
minimal erythemal dose (MED), and analysis of skin biopsies. Over a period of 12 weeks, the placebo
formulation decreased the rates of TEWL by approximately 9% while MN formulations decreased
TEWL rates by nearly 30%, demonstrating a strong effect of MN on barrier integrity (p= 0.006).
Even greater effects of MN on reduction of TEWL were observed in atopic subjects. The presence
of MN also resulted in a photoprotective effect on MED of approximately 9% (p= 0.08). Skin biop-
sies showed that the presence of MN resulted in an increased thickening of the granular and spin-
ous layers and also dramatically increased cellular layers of the stratum corneum. These results
indicate that skin delivery of nicotinic acid may provide clinical benefit to skin conditions that are
characterized as having a partially compromised skin barrier, and may be useful either alone or in
combination with other treatments for such conditions. 
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Cutaneous T cell lymphoma responses to a TLR9 agonist CPG: a phase I/II study
YH Kim,1 M Girardi,2 M Duvic,3 T Kuzel,4 A Rook,5 S McAuley6 and T Schmalbach6 1 Stanford
Univ School of Medicine, Stanford, CA, 2 Yale Univ School of Medicine, New Haven, CT, 3 MD
Anderson Cancer Ctr, Houston, TX, 4 Northwestern Univ, Chicago, IL, 5 Univ of Pennsylvania,
Philadelphia, PA and 6 Coley Pharmaceutical Group Inc., Wellesley, MA
Available systemic therapies for CTCL produce significant clinical responses and may relieve skin
symptoms or complications, but there is a lack of well-tolerated systemic therapies with reliable and
durable responses in patients with recurrent or advanced disease. A new class of chemically defined
CpG immunomodulators target dendritic cell TLR9 receptors with induction of IL12, IFN-gamma,
NK-cell function. In several early trials, CPG 7909 has been well tolerated by weekly s.c. dosing
and has clinical anti-tumor activity. Patients with recurrent/refractory (stages IB-IVA) CTCL were
enrolled to receive weekly s.c. doses of 0.08, 0.16, 0.24, 0.28, or 0.32 mg/kg of CPG 7909. Clinical
response was monitored using the Composite Assessment of Index Lesion Disease Severity Index
and the Physician’s Global Assessment of Clinical Condition. Sixteen patients (8F, 8M) are treated
to date with documented time to response between 4-16 weeks. Responses according to dose level
are: 0.08 mg/kg, 1 stable disease (SD), 2 progressive disease (PD); 0.16 mg/kg, 1 complete response
(CR), 1 partial response (PR), 1 SD; 0.24 mg/kg, 1 PR, 2 SD; 0.28 mg/kg, 1 SD, 2 pending response;
0.32 mg/kg, 1 SD, 3 pending response. Stable disease (SD) and responses (PR/CR) were main-
tained for up to 6 months of treatment. Doses were generally well tolerated; dose-related injection
site reactions and mild-moderate flu-like symptoms were common. CPG 7909 has significant anti-
tumor activity in CTCL. Responses will be correlated with immunomodulator biologic responses
and PK. Enrollment is ongoing with additional dose escalations to optimize response at tolerable
doses.
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Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis
C Leonardi,1 B Goffe,2 J Sobell,3 I Caro,4 X Wang5 and K Papp6 1 Central Dermatology, Inc, St.
Louis, MO, 2 Minor and James Medical Clinic, Seattle, WA, 3 ORA Clinical Research, North
Andover, MA, 4 Genentech, Inc., South San Francisco, CA, 5 Genentech, Inc., South San Francisco,
CA and 6 Probity Medical Research, Waterloo, ON, Canada
Psoriasis is a chronic disease requiring long-term treatment. Traditional options are limited by a
lack of consistent efficacy, inconvenient administration schedules, and cumulative toxicity. As knowl-
edge increases about the role of the immune system in psoriasis pathogenesis, the development of
targeted therapies focusing on immune cells have expanded. Efalizumab, a recombinant humanized
monoclonal IgG1 antibody binds to the CD11a subunit of leukocyte function-associated antigen-1
(LFA-1), inhibiting several key T-cell functions, including initial activation, trafficking, and reacti-
vation. Efalizumab has been studied in over 2,700 patients with psoriasis during 3- and 6-month
treatment periods and up to 24 months in a small group of patients. Safety outcomes have been pooled
for analysis yielding a large cohort of psoriasis patients. Efalizumab was generally well tolerated,
with acute flu-like symptoms (headache, fever, chills, nausea, vomiting, or myalgia, beginning within
48 hours of dosing) observed most frequently during the first 1-2 doses; by the third dose, the inci-
dence was comparable to placebo-treated patients. The adverse events reported most frequently at
week 12 among efalizumab-treated patients included headache, non-specific infection (eg, common
colds), chills, nausea, and generalized pain. During weeks 1-12, serious adverse events occurred
infrequently in efalizumab- and placebo-treated patients (2.2% vs 1.7%). Extended treatment was
not associated with any new common treatment-emergent adverse events. Comparison with patients
receiving placebo and external cohorts of similar psoriasis patients showed that efalizumab did not
appear to be associated with increased risk of infection or malignancy. The favorable efficacy and
safety profiles support continuous use of efalizumab in patients with moderate to severe chronic
plaque psoriasis. 
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Use of alefacept in combination with other psoriasis therapies: a study reflective of clinical
practice
GG Krueger,1 KB Gordon,2 P van de Kerkhof3 and W Sterry4 1 Department of Dermatology,
University of Utah Health Sciences Center, Salt Lake City, UT, 2 Loyola University Medical Center,
Maywood, IL, 3 UMC St Radboud, Nijmegen, Netherlands and 4 University Hospital Charite,
Berlin, Germany
Psoriasis is a T-cell–mediated skin disease that has no cure and typically requires life-long treatment.
Conventional systemic psoriasis therapies, such as methotrexate and cyclosporine, are generalized
immunosuppressants. As a result of their nonselective effects, these agents are associated with sub-
stantial toxicities and dosing limitations. Alefacept selectively targets memory T cells. In multiple
randomized, placebo-controlled studies, alefacept has been shown to improve the symptoms of pso-
riasis without the safety concerns of conventional therapies. To understand the best way to manage
existing therapies during a course of alefacept and evaluate the consequences of combination ther-
apy, an international study is being conducted under conditions that reflect clinical practice. Approx-
imately 400 patients with chronic plaque psoriasis will be enrolled in this open-label study in which
topical treatments, UVB, systemic retinoids, and prednisone will be permitted as concomitant ther-
apies. Cyclosporine and methotrexate will be tapered during alefacept therapy. Patients must be ≥16
years of age, require systemic therapy, have normal CD4+ lymphocyte counts, and be naïve to ale-
facept therapy. In each course, alefacept 15 mg will be administered once weekly by IM injection
for 12 weeks followed by 12 weeks of observation. Currently, over 200 patients have received ≥1
dose of alefacept; topical steroids and methotrexate have been the most common concomitant pso-
riasis therapies. Alefacept consistently reduced circulating CD4+ T-cell counts, regardless of the con-
comitant psoriasis therapy. Nearly two thirds of patients have experienced an improvement in their
physician global assessment with alefacept. These preliminary results suggest that alefacept can be
safely and effectively combined with other psoriasis therapies and there is no interference with the
mechanism of action of alefacept. 
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Severity of rosacea: measurement issues
JT Bamford,1,2 CE Gessert3 and CM Renier3 1 Dermatology, SMDC, Duluth, MN, 2 Family
Practice, University of Minnesota-Duluth Medical School, Duluth, MN and 3 Division of
Education and Research, SMDC (St.Mary’s Hospital/Duluth Clinic), Duluth, MN
Our goal was to determine what signs correlate best with global severity of rosacea and to examine
inter-rater reliability. Four clinicians each made assessments of 82 patients with active signs of rosacea
using 60, 0-to-10, Likert-like scales. Clinician’s assessment of severity correlated strongly with ery-
thema, especially on the cheeks. Subjects’ assessment of severity correlated more strongly with
papules/pustules. Different methods of assessing severity [estimation of area involved, intensity or
lesion counts] did not produce significantly differentresults. Inter-rater reliability was low on 11-
point (0-10) Leikert-like scales, but improved when scales were collapsed to 5 or 4 points. Clinicians
and patients assess overall rosacea severity differently with respect to signs. New instruments for
assessing rosacea severity must address inter-rater reliability. 
351
Impact of health care delivery models on melanoma thickness and stage in a university-based
referral center: an observational study
SM Swetter,2,4 H Cindy,2 S Soon1 and SC Chen1,3 1 Dermatology, Emory University School of
Medicine, Atlanta, GA, 2 Dermatology, Stanford University School of Medicine, Palo Alto, CA, 3
VAMC, Atlanta, GA and 4 VAMC, Palo Alto, CA
To characterize the relationship between melanoma outcome and health care delivery models, in par-
ticular, the gatekeeper (GK) versus direct access (DA) models. Retrospective review of newly-diag-
nosed cutaneous melanoma patients referred to Stanford University Medical Center pigmented lesion
clinic (1996-2000). Data abstracted from medical records included patient age, type of access route
(GK vs DA to dermatology), time in months between the patient first noticing the lesion and med-
ical presentation (patient delay), time in months between medical presentation and biopsy (MD
delay), tumor thickness, histologic ulceration, melanoma subtype, and stage at diagnosis. Descrip-
tive, non-parametric, and chi-square statistics were applied using SAS statistical software. 234 sub-
jects were analyzed: 72% (166/234) employed the DA route and 28% (66/234) employed the GK
route. A significant association existed between MD delay and access route, showing that DA patients
were biopsied sooner (< 3 months vs > 3 months) than their GK counterparts (p<0.0001). However,
no significant difference (p>0.05) was observed in stage at diagnosis (predominantly IA), propor-
tion of nodular melanomas (DA 4% vs GK 2%), patient delay, or median tumor thickness between
DA and GK routes (1.10 mm vs 0.85 mm, respectively). A trend towards a greater proportion of his-
tologically ulcerated melanomas was observed in the DA compared to the GK group (12% vs 5%,
p= 0.06). This pilot study demonstrates no difference in outcome between GK and DA routes as
measured by melanoma thickness and stage. However, DA patients receive biopsy sooner and may
have tumors that are more likely to be ulcerated compared to their GK counterparts. The potential
impact of health care access routes on prompt diagnosis of more aggressive melanoma subtypes
requires further study. 
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Is there a relationship between long-term antibiotic use and urinary tract infections in acne
patients?
WP Bowe, J Filip, O Hoffstad and DJ Margolis Dermatology, Epidemiology & Biostatistics,
University of Pennsylvania, Philadelphia, PA
Individuals with acne are often exposed to antibiotics for prolonged periods of time, thus putting
them at risk for developing resistant strains of pathogenic bacteria as well as the colonization of
their normal flora by pathogenic microbes. The purpose of this retrospective cohort study was to
explore the potential correlation between long-term antibiotic use and the incidence of urinary tract
infections (UTIs) in acne patients. We used a 20% random sample of female acne patients between
15 and 30 years of age (N=4,656) in the General Practice Research Database (GPRD) from the UK
(1991-95). Three cohorts of acne patients were examined: 1) patients on oral antibiotics, 2) patients
on topical antibiotics only, and 3) patients not on antibiotics. An individual was noted as a long-term
acne antibiotic user if she used the drug for more than 4 weeks. All patients were followed for one
year after qualifying for inclusion in a cohort. The outcome was an UTI. Logistic regression was
used to make comparisons between cohorts. For acne patients in the GPRD, 81.7% were using long-
term antibiotic therapy (oral and or topical) to treat their acne and 18.3% were not using antibiotics.
Of those using antibiotics, 67.3% were using oral therapy alone or with topical therapy and 32.7%
were using only topical therapy. The odds ratio of developing a UTI comparing the oral users to those
not exposed to antibiotic therapy was 0.61 (CI=[0.43,0.87], p=0.006). There was no difference in
the risk of developing a UTI after exposure to topical antibiotic therapy (OR=0.92[0.63,1.34]). Adjust-
ing for age did not have a significant effect on these findings. This study demonstrates that long-
term oral antibiotic therapy has a protective effect against the development of UTI in female acne
patients 15-30 years old. Topical antibiotic therapy did not appear to offer this protection. Accord-
ing to these findings, the current degree of physician apprehension regarding long-term antibiotic
therapy may be unwarranted. 
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Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal
cell carcinoma and squamous cell carcinoma)
MJ Eide,1 M Weinstock,1,2 R Dufresne,1 S Neelagaru,1 P Risica,1 G Burkholder,1 D Upegui,1
K Phillips,1 B Armstrong3 and L Robinson-Bostom1 1 Brown Univ, Providence, RI, 2 VA Med Ctr,
Providence, RI and 3 Univ of Sydney Sch of Pub Health, Sydney, NSW, Australia
Keratinocyte carcinoma (KC) is the most common cancer in the United States. Larger KC lesions
are associated with higher recurrence and disfigurement than less advanced disease, yet modifiable
predictors of size are not established. The objective of this study was to determine the association
of potentially modifiable characteristics, including delay in treatment, with KC morbidity, which
we defined as defect size at the time of KC removal by Mohs micrographic surgery (MMS). A strat-
ified random sample of patients treated for KC with MMS during the 12 months beginning Sep-
tember 2000 were selected for interview (n=400). 108 were ineligible for participation. 219 tele-
phone interviews were completed (refusal rate 24%). Interviewed and non-interviewed cases differed
only in mean age (66 vs. 72 years, p<0.0001). Anatomic site, age, histologic subtype, and gender
predicted defect size (R2=0.39). Self-reported delay between initial physician examination and MMS
(“system delay”) predicted defect size (p=0.0004), but delay before initial physician exam did not
independently predict size. The effect on size was attributable to system delay greater than 1 year
(p=0.0016), which was associated with a doubling of defect size (OR 2.0; CI 1.3-3.1). Delays of this
duration were associated with initial examination by a primary care provider (OR 3.9 CI 1.7-8.8),
initial misdiagnosis (OR 6.8 CI 2.5-18.7), treatment performed by the first provider (OR 23.3 CI 6.5-
83.7), and by removal prior to MMS (OR 6.2 CI 2.5-15.5). All but specialty were independent pre-
dictors of delay. Delay greater than 1 year between initial medical evaluation and MMS is associ-
ated with initial diagnosis, treatment and number of prior removals. This “system delay” is an important
predictor of final defect size. Attention to processes of care delivery for KC may have a greater impact
on morbidity than efforts at earlier public detection. 
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A validation study comparing spectrophotometric measurement of skin color to digital col-
orimetry
JL Chan,1 A Ehrlich,2 AN Moshell,3 ML Turner4 and AB Kimball1 1 Stanford Medical School,
Stanford, CA, 2 George Washington University, Washington, DC, 3 National Institute of Arthritis
and Musculoskeletal and Skin Diseases, Bethesda, MD and 4 National Cancer Institute , Bethesda,
MD
Given the limitations of subjective assessments of skin pigmentation, it would be desirable to develop
objective methods to measure skin color. Spectrometry has been used for color measurement but is
limited by several factors. For instance, values are derived from indirect measures of reflectance of
red and green colors only, erythema index becomes skewed at high melanin levels, and spectrome-
ters are not widely available outside research settings. This study was undertaken to test the valid-
ity of digital colorimetry (i.e., color measurements derived from standardized digital photography),
versus the gold standard of spectrometry. 558 subjects had standardized spectrometric and color-
metric readings taken from the inner arm. Melanin and erythema values of spectrometry were com-
pared to red, green, and blue color values. A moderate to high correlation between color and spec-
trometric indices was found (0.67 < R2 < 0.74, p < 0.01), although this relationship tended to be
stronger in more darkly pigmented Fitzpatrick subgroups. Participants with type V skin showed
high correlations between spectrometry and color (0.83 < R2 < 0.99, p < 0.01) while type II sub-
jects (0.29 < R2 < 0.37, p < 0.01) showed much less robust associations. Interestingly, among the
colors, blue correlated best with the spectrometric measures (0.74 < R2 < 0.73, p < 0.01). These
data validate a novel technology utilizing digital colorimetry to measure skin color using commonly
available digital equipment and commercially available software. Furthermore, they suggest that
the color blue, associated with deeper levels of melanin, may be an important element of skin color
assessments. Objective measures that account for chromophore content and light scattering and allow
for simple standardized evaluation of color may enhance subtyping of diverse patient populations
for epidemiological research. 
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Acceptable risk of therapies for psoriasis
DJ Margolis and J Filip Dermatology, Epidemiology & Biostatistics, University of Pennsylvania,
Philadelphia, PA
How physicians make decisions about prescribing medication and how they balance this decision
against the perceived risk of its side effects is not well understood. This may be especially impor-
tant with the advent of new systemic agents to treat severe psoriasis, in that they may be associated
with the onset of cancers or other serious medical conditions. We administered a questionnaire to
59 health care providers attending an annual Dermatology conference at an academic hospital using
a scale that was devised to quantify the risk of developing lymphoma or skin cancer versus the ther-
apeutic benefit of treating an individual with psoriasis and a new therapeutic agent or with standard
therapy (topical steroids). The amount of tolerable risk increased with the likelihood of therapeutic
success. For example, for a new treatment with 10% likelihood of therapeutic success, providers
tolerated a 3 times increased risk for non-melanoma skin cancer, whereas for a 75 % likelihood of
therapeutic success they tolerated a 7 times increased risk of non-melanoma skin cancer versus
standard therapy (and its inherent success and toxicity). As expected, they were less tolerant of an
increased risk of lymphoma. With respect to a drug that has a 10% likelihood of therapeutic success,
providers tolerated a 1.7 times increased risk for lymphoma, whereas for new drug with a 75% chance
of success the tolerable risk as compared to standard therapy was only 4.0 times. For both malig-
nancies, the tolerated increased risk of malignancy due to a new therapy for psoriasis was greater
then we had expected a priori. This study was important in that we were able to measure physician
attitude about acceptable risk versus the benefit of a new therapy for psoriasis. In addition, in the
past studies have been designed to find less than a 2 times increased risk but due to the apparent
acceptance of risk by healthcare providers in our study, physicians may view psoriasis as a more seri-
ous illness than we originally appreciated necessitating a re-evaluation of our trial designs. 
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Patients with more extensive psoriasis have greater reductions in quality of life: female patients
and young patients are affected to a greater extent
JM Gelfand,1 SR Feldman,2 RS Stern,3 J Thomas,4 T Rolstad5 and DJ Margolis1 1 Dermatology and
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA,
2 Departments of Dermatology, Pathology and Public Health Sciences, Wake Forest University
School of Medicine, Wake Forrest, NC, 3 Department of Dermatology, Harvard Medical School,
Boston, MA, 4 LaunchBox, LLC, Portland, OR and 5 National Psoriasis Foundation, Portland, OR
Psoriasis is a common, chronic, immune mediated disease of the skin that can have substantial effects
on quality of life. Quality of life studies have typically been performed in sub-specialty clinic or
patient advocacy group populations. The purpose of this study was to describe quality of life in pso-
riasis patients randomly selected from the United States population. 27,220 patients were randomly
selected from the United States population and interviewed over the telephone. 601 patients who
identified themselves as having been diagnosed with psoriasis by a physician were invited to com-
plete a more detailed telephone survey about quality of life using a modified version of the psoria-
sis disability index. 266 (44%) of people who identified themselves as having been diagnosed with
psoriasis completed the detailed survey. Self report of body surface area of involvement with psori-
asis showed the strongest association with decrements in quality of life (Spearman 0.50, P <0.0001).
Younger patients (Spearman -0.16, P <0.001) and female patients (P=0.02) also had statistically sig-
nificant reductions in quality of life. Increasing psoriasis severity was associated with seeking care
from multiple physicians (Spearman 0.31, P<0.001) and having decrements in income (Spearman -
0.29, P<0.001). These results support that patients with more extensive skin involvement have greater
reductions in quality of life. Female patients and young patients are affected to a greater extent. 
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High levels of UVB exposure increase the risk of nonmelanoma skin cancer in PUVA-treated
patients
JC Lee1 and RS Stern2,1 1 Harvard Medical School, Boston, MA and 2 Dermatology, Beth Israel
Deaconess Medical Center, Boston, MA
Sunlight and PUVA are risk factors for the development of squamous cell carcinoma (SCC) and basal
cell carcinoma (BCC). To quantify the risks due to ultraviolet-B (UVB) therapy, we prospectively
analyzed skin cancer incidence from 1975 to 2001 among a cohort of 1380 patients with exposure
to PUVA, UVB, and other psoriasis therapies. Stratified Poisson regression was used to quantify the
association between UVB and the development of nonmelanoma skin cancer (NMSC), controlling
for PUVA, age, gender, skin type, region of residence, methotrexate use, tar use, and sun exposure.
A stratified analysis limited to patients with <100 PUVA treatments was also performed. We docu-
mented >431,000 UVB treatments among 1130 patients (average per treated subject=381,
median=150, range 14 to 6223). High (>=600 treatments) but not intermediate (300-599 treatments)
UVB exposure was associated with a significant increase in SCC (adjusted RR=1.48 (95% CI=1.23-
1.77)) and BCC (adjusted RR=1.44 (95% CI=1.18-1.78)) risk. In an analysis limited to patients
with <100 PUVA treatments, the risks associated with high levels of UVB were greater. For high
levels of UVB exposure, the adjusted RR= 3.10 (95% CI=1.72-5.57) and 2.04 (95% CI=1.16-3.58)
for SCC and BCC respectively. Intermediate levels of UVB use were a modest risk factor, adjusted
RR= 1.86 (95% CI=1.07-3.21) and 1.79 (95% CI=1.13-2.84) for SCC and BCC respectively. UVB
use was most strongly associated with tumors on the trunk and legs, which are typically exposed
during therapy. For high vs. low UVB, adjusted RR of SCC was 4.88 (95% CI=2.75-8.66) on the
trunk or legs vs. 0.71 (95% CI=0.20-2.56) on the head or neck. For BCC, the adjusted RR was 4.38
(95% CI=2.26-8.50) on the trunk or legs vs. 0.53 (95% CI=0.18-1.53) on the head or neck. These
results demonstrate that compared to PUVA, UVB has substantially lower NMSC risk. The increased
risk of tumors is limited to the highest UVB levels and is predominantly on the anatomic sites typ-
ically exposed during therapy. 
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Profile of 513 patients with alopecia areata in the United States
C Goh,1 M Finkel2 and AA Sinha1 1 Dermatology, Weill Medical College of Cornell University,
New York, NY and 2 Public Health, Weill Medical College of Cornell University, New York, NY
Several lines of evidence support a genetic component to alopecia areata (AA), including differences
in patients based on severity of AA, associated diseases, and family history. Here, we examine epi-
demiological, clinical, and genetic features of patients with AA in the United States. From 1998-
2001, a self-selected sample of 513 patients with AA completed interviews consisting of demographic
information, clinical information specific to the diagnosis of AA, patient’s medical history, and
family history of AA. Forty-one percent of respondents reported 100% scalp hair loss with or with-
out body hair loss (alopecia totalis and universalis (AT/AU)). Of those patients with AT/AU, 64%
reported an age of onset before 20 years vs. 37% of patients with patchy AA (less than 100% scalp
hair loss) (p<0.001). Nail changes were reported more frequently in those with AT/AU (51% vs. 30%
of patchy AA) (p<0.001). Fifty-six percent of participants reported having at least one atopic disor-
der or autoimmune disease, including allergic rhinitis, atopic dermatitis, asthma, thyroid disease,
psoriasis, and diabetes mellitus. Patients with AT/AU as well as those reporting nail changes were
more likely to have at least one associated disease (p=0.047; p<0.001). Thirty-three percent of par-
ticipants reported a positive family history of AA. Duration of disease (p=0.033), number of asso-
ciated diseases (p<0.001), having AT/AU (p<0.05), and having nail changes (p=0.046) were asso-
ciated with the number of relatives affected by AA. Our findings show marked associations between
severity of AA, age of onset, duration of AA, atopy, autoimmune disease, and family history of AA.
Further research in atopy, autoimmunity, and genetics in AA will be helpful in clarifying our under-
standing of AA, leading to improvements in diagnosis and treatment. 
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Statistical reviewing policies in dermatology journals: results of a questionnaire survey of edi-
tors
KA Katz,1 GH Crawford,1 DW Lu,2 J Kantor1 and DJ Margolis1,3 1 Dermatology, University of
Pennsylvania, Philadelphia, PA, 2 Medical School, University of Pennsylvania, Philadelphia, PA
and 3 Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania,
Philadelphia, PA
Problems with statistical methods and reporting have been noted in dermatology journal articles.
Conclusions in published reports may be misleading if based on inappropriate statistical analysis.our
objective was to assess dermatology journal editors’ policies and perceptions regarding statistical
review of submitted manuscripts,using a questionnaire survey 43 editors, representing 36 dermatol-
ogy journals from the USA and abroadwere surveyed. 32 editors (74.4%), representing 30 journals
(83.3%), returned questionnaires. 24 editors (75%) requested statistical reviews on <5% of published
manuscripts containing original quantitative analysis (i.e., excluding reviews and case reports), while
3 editors (9.4%) requested statistical reviews on >75% of such manuscripts. Most editors reported
requesting statistical reviews on a case-by-case basis either after initial favorable review by subject-
matter (non-statistical) reviewers (12 editors, 37.5%) or at the same time that subject matter review
was requested (6 editors, 18.8%). Four editors (12.5 percent) reported requesting statistical review
for all manuscripts at the same time they are sent for subject-matter review. 10 editors (31.3%) said
their journals had no general policy on statistical reviewing, and statistical review is almost never
needed. For 15 editors (46.9%), ideal statistical reviewing policy was identical to their current pol-
icy, while 13 (40.6%) favored a more rigorous and 3 (9.4%) a less rigorous policy. Dermatology jour-
nals infrequently perform statistical reviews of submitted manuscripts. Dermatology journal editors’
statistical review policies range from no general policy to (most frequently) requesting reviews on
a case-by-case basis to reviewing all submitted manuscripts. Many editors favor more rigorous sta-
tistical reviewing policies for their journals. Increased use of statistical reviewing may increase the
reliability of conclusions published in dermatology journals. 
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Pilot study to develop a test of skin self-exam accuracy
M Malik1 and MA Weinstock2,1 1 Dermatology, Brown Medical School, Providence, RI and 2
Dermatoepidemiology Unit, V A Medical Center, Providence, RI
While skin self-examination (SSE) for early detection of melanoma has been associated with lower
incidence and increased survival from melanoma, people’s ability to interpret their own SSE has not
been subject to detailed study. We describe a test to evaluate people’s sensitivity and specificity in
performing SSE through the use of digital photography and computer manipulation of these photo-
graphs. Subjects were administered a short questionnaire regarding attitudes toward skin examina-
tion, were given instructions in how to perform SSE, and were asked to become familiar with their
own skin by practicing SSE at home. Digital photographs were taken of subjects’ backs, and these
photographs were altered using photo-editing software to mimic early changes of melanoma. These
changes included adding a lesion or changing an existing lesion by altering its size or coloration.
Each photograph of a subject’s back was randomized to have a lesion added, to have an existing
lesion changed, or to have no change. At a follow-up visit, subjects were shown the altered photo-
graphs of their own back to identify any changes which may have been introduced. Overall, sensi-
tivity and specificity for detecting these artificially introduced “melanoma” changes were 43% and
71%, respectively. In addition, no correlation existed between performance on the study task and
either having a history of skin cancer, reporting previous SSE of the back, or having performed SSE
during the study period. While this pilot study used a small number of subjects, the preliminary data
from these 37 photographs suggest that this test may provide a useful measure of ability to detect
changes mimicking melanoma by SSE. Further studies are underway to evaluate the use of this tool
in research on early detection of melanoma. 
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Risk factors associated with striae gravidarum
AS Chang, YZ Agredano and AB Kimball Dermatology, Stanford University School of Medicine,
Stanford, CA
Striae gravidarum is a poorly characterized but common disfiguring condition of pregnancy.  Although
a relationship between striae gravidarum and weight gain, hormonal factors or genetics have been
proposed, no reports exist regarding the strength of these associations. The purpose of this study
was to better characterize the epidemiological factors associated with striae gravidarum.  An anony-
mous survey administered at Stanford Ambulatory Clinics sampled 116 women who had given birth.
31 out of 61 women (50.8%) with striae gravidarum had mothers with striae gravidarum; in con-
trast, only 7 out of 55 women (12.7%) without striae gravidarum had mothers with striae gravidarum,
(p<0.001). 34 out of 61 women with striae gravidarum (55.7%) reported additional relatives (sis-
ters, daughters, aunts, cousins) with striae gravidarum; in contrast, 8 out of 55 women without striae
gravidarum (14.5%) reported additional relatives with striae gravidarum, (p<0.001). There were no
statistically significant differences between women with and without striae gravidarum with respect
to percent weight gain in pregnancy (p=0.392) or change in body mass index during pregnancy
(p=.302). Recall between women with and without striae gravidarum were similar between the two
groups with 39.3% of women with striae gravidarum marking unknown with regard to family his-
tory and 38.9% of women without striae gravidarum marking unknown for family history. This study
is the first in the medical literature to suggest that family history, and therefore genetic factors appear
to be more predictive of the development of striae gravidarum than weight gain or changes in body
mass index. 
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The quality and impact of case reports and case series
J Albrecht,1 A Meves2 and ME Bigby3 1 Dermatology, University of Pennsylvania, Philadelphia,
PA, 2 Dermatology, Mayo Clinic, Rochester, MN and 3 Dermatology, Harvard Medical School,
Boston, MA
Case reports and small series are considered weak clinical evidence, but they are often the first indi-
cation of potential usefulness of innovative treatments. We analysed case reports and case series (n
smaller or equal to 10) from the Lancet published from 1 January 1996 to 30 June 1997 in order to
determine the quality and impact of case reports or small series describing innovative treatments.
The quality of papers was evaluated by two independent reviewers according to criteria developed
from available sources. To assess the impact of the papers we investigated how often they were cited
in the literature and how often the suggested treatment was subjected to a clinical trial. We searched
MEDLINE, the register of current controlled clinical trials and the Cochrance controlled clinical tri-
als register to find controlled clinical trials. We also searched the science citation index to determine
how frequently reports were cited. Sixty-four case reports and thirty-nine small case series were iden-
tified. The papers surveyed were quoted on average 17 times (median 6,5; range 0-336). Twenty-
four follow-up trials were identified, nine still in the register of current controlled clinical trials.
Seven papers (7%)reported treatment failure; 50% reported adverse events or lack thereof; and 39
(38%) reported the patient perception of the treatment. We conclude that case reports and small series
published in the Lancet have significant impact on the subsequent literature. They are frequently
cited and many of them lead to clinical trials. Frequently the papers report rare conditions for which
trials may not be feasible. There was a strong publication bias favouring positive results. Less than
half of case reports and series report the patients perception of the treatments outcome. With this
survey we hope to stimulate a discussion of case reporting that may lead to the development of guide-
lines to improve reporting of cases and case series similar to the CONSORT statement for clinical
trials.
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Is Mohs surgery a cost-effective treatment for facial nonmelanoma skin cancer? A decision
analysis
TL Bialy,1 CV Washington,1 H Szeto,3 J Whalen2 and SC Chen1 1 Dermatology, Emory University
SOM, Atlanta, GA, 2 Dermatology, University of Connecticut, Farmington, CT and 3 Kaiser
Permanente, Oakland, CA
The purpose of this study was to determine whether Mohs surgery (Mohs) is a more cost-effective
method of treatment for facial nonmelanoma skin cancer (NMSC) than traditional standard excision
(TSE). Since cost-effectiveness analyses (CEAs) incorporate efficacy and outcomes in addition to
cost, CEAs can quantify the overall value rather than just the costs of one therapeutic strategy over
another. The data from our prospective trial of 98 consecutive patients with primary facial NMSC
was used to obtain baseline cost (Connecticut Medicare 2002 reimbursements) and efficacy (mar-
gin analysis) information for our CEA. We approached the CEA using a decision analysis model via
Treeage Data 4.0 software. Our model also incorporated efficacy using 5-year recurrence rates from
the literature, and outcomes (quality-adjusted-life-years (QALY)) using data from a focus group of
patients. We performed a sensitivity analysis to determine the influence of key estimates in the model.
Our baseline CEA demonstrated Mohs to be less costly and more effective than TSE ($956.60 vs.
$1248.10, and 0.6 QALY gain). The sensitivity analysis showed that varying values for QALYs,
recurrence rates, and percentage of frozen and permanent section margin analysis did not change
the results of our CEA. However, varying the proportion of defect repairs (granulation, primary clo-
sure, flaps, grafts) following the two procedure strategies influenced the results of our CEA such that
TSE was less costly and marginally more effective than Mohs. Therefore, before the most cost-effec-
tive treatment for facial NMSC can be definitively established, further research into actual practice
patterns of defect repair selection for both procedures must be examined. 
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The genetic epidemiology of alopecia areata in Chinese
J Yang ,1,2 S Yang,1,2 J Liu,1,2 H Wang,1,2 Q Yang,1,2 M Gao,1,2 Y Liang,1,2 G Lin,1,2 D Lin,1,2 X Hu,1,2
L Fan 1,2 and X Zhang1,2 1 Institute of Dermatology & Dept.of Dermatology in 1st Affiliated
Hospital, Anhui Medical University, Hefei, Anhui, China and 2 Key Laboratory of Genome
Research at Anhui, Hefei, Anhui, China
Alopecia areata (AA) is hypothesized to be an organ-specific autoimmune disease with genetic pre-
disposition and an environmental trigger. There is few clinical data in Asians. The aim of our study
is to describe the genetic epidemiologic features of AA patients in China and presume the possible
genetic model of AA. Data for 1032 patients with AA was obtained by questionnaire. Complex seg-
regation analysis and heritability were performed using Falconer′s method, Epi Info 6.0 and SAGE-
REGTL programs. We found that the mean age of onset was about 29 years old. About three quar-
ters of all patients experienced their first episode of AA within the first four decades of life. A positive
family history of AA was obtained in 87 patients (8.4%). A greater severity and longer duration of
AA were seen in early onset group than in late onset group. In relatives of AA patients, the Occur-
ring risk of AA increased with increasing blood relatedness. Based on the REGTL results, the best
model was a polygenic additive model for AA with approximately 50% heritability. It can be con-
cluded that effect of genetic factors is strong in the episode of AA, but environmental factors may
still play an important role. Our findings on the genetics of AA are consistent with a polygenic addi-
tive mode of inheritance. 
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Clinical research ethics in dermatology
SC Weiss and AB Kimball Dept of Dermatology, Stanford University, Palo Alto, CA
The word research was introduced in 1639 to describe an investigation directed at the discovery of
a fact through careful consideration of a subject. In dermatology, many therapeutic advances emerge
from the common practice of off-label use of medications. Because the successful application of
innovative therapy is sometimes published as a case study, it becomes important to recognize when
the novel use of therapeutics constitutes research, rather than routine clinical care. For example, if
an innovation is undertaken not simply to offer an alternative therapy, but with the intent to publish,
then it constitutes research, requiring independent review and participants′ informed consent. All
clinical evaluations involving the treatment of human subjects, published during 2002 in the Jour-
nal of the American Academy of Dermatology, the Archives of Dermatology, and Arthritis and
Rheumatism, were reviewed to determine whether institutional review board (IRB) approval was
documented in the methods. Case reports involving only one patient were excluded because these
reports were thought more likely to constitute innovative care, whereas case series were more likely
to have required at least a chart review. Chi square test for proportionality was used to evaluate sig-
nificance. IRB approval was explicitly documented in 34 of the 83 (41.0%) clinical evaluations
involving more than one patient reviewed in the dermatology literature compared to118 of the 198
(59.6%) clinical evaluations of more than one patient reviewed in the rheumatology literature (P=0.04).
Of the clinical evaluations involving more than one patient published during 2002, 80.7% in the der-
matology literature were open label studies compared to 4.5% in the rheumatology literature. There
is a balance between encouraging dissemination of valuable clinical observations and protection of
human subjects′ rights. Under the current approach to evaluating the novel application of therapeu-
tics in dermatology, the ethical requirements for human subjects research are probably being insuf-
ficiently documented and are possibly being inadequately met. 
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Voluntary health advocacy groups: representative? informative? promotional?
T Nijsten1,2 and RS Stern2 1 Dermatology, University Hospital Antwerp, Edegem, Antwerp,
Belgium and 2 Dermatology, Beth Israel Deaconess Medical Center, Boston, MA
Patient advocacy groups have an increasing prominent role in health care. These organizations serve
as advocates and representatives of patients with specific diseases and provide information about
these diseases and their treatments. To assess the extent to which members of a patient advocacy
group are representative of all those affected by a disease and to assess the differences in knowledge
and use of therapies between these two groups. Using random digit dialling, we ascertained psoria-
sis patients ascertained from the general U.S. population whom we interviewed. Randomly selected
members of the Psoriasis Foundation were also interviewed. Main outcome measures: Multivariate
logistic regression models designed for surveys were used to estimate differences (odds ratios and
95%confidence intervals) in demographic and clinical characteristics, and the awareness and use of
therapies between members and others diagnosed with psoriasis. Of 601 individuals with psoriasis
ascertained from the general population survey, 185 provided a second interview and were defined
as nonmembers. We interviewed 289 randomly selected members of the Psoriasis Foundation.
Although members were significantly older, wealthier and more severely affected by the disease,
they reported the disease to be significantly less of a burden and were more satisfied with therapy
than others affected. Compared to nonmembers, members were significantly more likely to have
heard of and used most of 10 therapies assessed. However, the proportion of respondents who were
aware of a therapy who also used it did not differ between both groups. Our findings suggest that
members of this specialty society are older, wealthier, and more medicalized and informed about
therapies but are not more likely to use therapies of which they are aware. These findings support
the premise that patient advocacy groups are generally representative and effective in providing infor-
mation about diseases and treatments. 
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Skin cancer examination teaching in US medical education
MM Moore,1 A Geller,2 Z Zhang,3 K Bergstrom,4 J Graves,5 B Hayes,2 A Kim,6 J Martinez,7
L Shahabi8 and B Gilchrest2 1 Harvard Medical School, Boston, MA, 2 Dermatology, Boston
University School of Medicine, Boston, MA, 3 Massachusetts Department of Public Health, Boston,
MA, 4 Stanford University School of Medicine, Palo Alto, CA, 5 Medical College of Virginia,
Richmond, VA, 6 University of Texas Southwestern Medical School, Dallas, TX, 7 Mayo Medical
School, Rochester, MN and 8 University of Michigan School of Medicine, Ann Arbor, MI
There are more than 1.3 million skin cancers annually in the US, but most physicians report receiv-
ing minimal instruction in its diagnosis. To determine physician preparation for the skin cancer exam-
ination (SCE), we evaluated medical students′ practice of, training in, observation of, and self-reported
skill level for SCE as well as hours spent in a dermatology clinic. Fourth year medical student coor-
dinators were recruited to survey classmates at 7 US medical schools during the 2002-2003 academic
year. All coordinators had input in the final questionnaire. Of the 934 graduating students enrolled
at the 7 schools, 659 (71%) completed surveys: 43% of students graduating from medical school
had never examined a patient for skin cancer, 27% had never been trained to perform a SCE, and
23% had never observed a SCE. Only 28% of graduating students rated themselves as somewhat or
very skilled in the exam. This rate dropped to 19% among those who had not completed a derma-
tology elective (n= 549). However, graduating students who reported having been trained at least
once in the SCE were 8 times more likely to report themselves as somewhat or very skilled as stu-
dents without such training. 68% of students agreed that too little emphasis in their medical train-
ing was placed on learning about the SCE. These results confirm and expand upon previous find-
ings at a single study site. They suggest that even brief curricular additions would boost student skill
level and impact practice patterns and competencies of future physicians. More and better SCE might
result in earlier detection of melanoma and non-melanoma skin cancers by non-dermatologists, and
thus significantly impact public health. 
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Obesity and smoking as risk factors in psoriasis
MD Herron, M Hoffman, J Pappenfuss, C Hansen and GG Krueger Dermatology, University of
Utah, Salt Lake City, UT
The mean weight of patients with psoriasis in recent clinical trials has been over 90 kg. The Utah
Psoriasis Initiative (UPI) carefully phenotypes patients with psoriasis with the intent of genotyping
selected phenotypes. To date we have phenotyped over 350 patients. Data reveals a mean body mass
index (weight/height2) of 29.4, which is greater controls in the Utah population (Behavioral Risk
Factor Surveillance System Prevalence Data, 2002). The prevalence of obesity in the UPI is higher
than the general Utah population (p<0.001). Using a standardized diagram to assess body image,
psoriatic patients viewed themselves as normal weight at 18 and at the onset of their psoriasis (mean
age of 27.3), but perceived themselves as overweight at enrollment into the UPI (mean age 50.6).
This did not support the primary hypothesis, obesity increases the risk of developing psoriasis in
those genetically predisposed. Secondary hypotheses were explored. Patients in the UPI who are
obese have significantly more body surface area covered with disease than their non-obese coun-
terparts. When correcting for weight and height, it is noted that body surface area with psoriasis is
proportional. Obesity does not appear to predispose to arthritis. Obesity did not positively or nega-
tively affect the response or adverse effects of topical corticosteroids, light based treatments, and
systemic therapies. The morbidly obese (BMI > 35) appear to have a higher prevalence of inverse
psoriasis. When compared to the Utah population, there was a higher prevalence of smoking in the
UPI population (p <0.001). Smokers had the same average age of onset and similar amounts of body
covered with disease as non-smokers. There was a higher prevalence of obese smokers in the UPI
compared to obese smokers in the general population (p < 0.001). This causes us to conjecture that
smoking adds additional pressure to emergence of psoriasis in the genetically predisposed. We con-
clude that psoriasis has a pivotal yet unknown role in developing obesity and that smoking may
increase the risk of psoriasis. 
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Prevalence and risk factors of dysplastic nevi in the general population
T Schaefer,1,3 J Merkl,2 E Klemm,2 H Wichmann,3 J Ring2 and KORA study group3 1 Institute of
Social Medicine, Medical University, Luebeck, Germany, 2 Dept. of Dermatology and Allergy,
Technical University, Munich, Germany and 3 Dept. of Epidemiology, GSF National Research
Center for Environment and Health, Neuherberg, Germany
Demographic changes and the significant increase of malignant melanoma point to a need for a
population-based epidemiological investigation of marker lesions, such as dysplastic nevi (DN). Lit-
tle, however, is known on the frequency and associated risk factors of DN in the general population.
For the KORA (Cooperative Health Research in the Augsburg Region) survey 2000 a random sam-
ple, stratified by age (25-74 years) and gender, of registered inhabitants of the City of Augsburg,
Germany and two adjacent counties was drawn. A total of 2822 (response 67%) subjects were
examined dermatologically in a standardised way and dysplastic nevi (DN) were recorded follow-
ing clinical criteria (ABCD rule, computer-assisted epiluminescence). Relevant risk factors were
obtained by a computer-assisted personal interview. A total of 5.2% of the subjects exhibited at least
one DN, whereby men were affected more frequently (6.0% vs. 4.5%). The prevalence of DN (9.1,
5.7, 3.1, 2.1%) decreased with age (25-34, 35-44, 45-54, 55-64, 65-74 years). A familial history of
a skin tumor or frequent (>50) common nevi was associated with a higher prevalence of DN (11.1%
vs. 5.1%, 9.7% vs. 4.7% resp.). Subjects, who used sunblockers or reported sunburns during child-
hood were also affected more frequently (5.7% vs. 3.8%, 5.9% vs. 4.6% resp.). Furthermore the
prevalence of DN depended on the number of weeks which were spent in sunny areas per year
(0=3.1%, 1=6.1%, 2=7.1%, 3=6.3%, >3=4.6%). Multiple regression analysis revealed age (OR 0.74,
0.63-0.86), female gender (OR 0.62, 0.42-0.90), family history (skin tumor: OR 2.42, 1.09-5.36; >50
nevi: OR 1.90, 1.22-2.96) and annual time spent in sunny areas (3 vs. 0 wks.: OR 1.93, 1.02-3.63)
as significant risk factors. DN are frequent in the adult general population and depend on sociode-
mographic and genetic as well as parameters of an individual UV exposure. 
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TIA-1- positive lymphocytes are associated with metastases in patients with melanoma
ME Ming,1 P Van Belle,2 X Xu,2 MC Mihm,3 S Hotz,2 JD Botbyl,5 DE Elder,2 R Elenitsas,1
D Guerry4 and PA Gimotty5 1 Dermatology, Univ of Pennsylvania, Philadelphia, PA, 2 Pathology
and Laboratory Medicine, Univ of Pennsylvania, Philadelphia, PA, 3 Pathology, Massachusetts
General Hospital, Boston, MA, 4 Medicine, Univ of Pennsylvania, Philadelphia, PA and 5
Biostatistics and Epidemiology, Univ of Pennsylvania, Philadelphia, PA
Although factors such as the absence of tumor-infiltrating lymphocytes (TILs) are known to be
associated with a higher risk, assessment of the risk for metastases in melanoma patients using cur-
rent prognostic models is imperfect. We performed a case-control study to determine whether immuno-
histochemical staining for TIA-1, an intracellular protein associated with cytotoxic granules of lym-
phocytes, was associated with metastases and therefore a potential contributor to future prognostic
models. To test our hypothesis, we used CART (Classification and Regression Tree) analysis to define
distinct risk groups based on the number of TIA+ cells and the presence or absence of TILs. The
absolute number of TILs reactive to TIA-1 antibody over a 0.125 mm2 area at the tumor base was
measured using light microscopy in 28 cases who developed metastases and 27 controls who did not
develop metastases over the first 10 years of follow-up. Subjects were chosen so that the distribu-
tion of tumor thickness was similar between the two groups. The number of TIA+ cells within the
designated area ranged from 0-290 (median=10). CART analysis identified 3 risk groups: 1) those
without TILs, in whom 66.7% (14/21) had metastases; 2) those with TILs and a TIA+ cell count of
less than 12, in whom 16.7% (2/12) had metastases; and 3) those with TILs and a TIA+ cell count
of 12 or more, in whom 54.5% (12/22) had metastases. The metastatic rates among the three risk
groups were statistically significantly different (p=0.02 by Fisher exact test). Metastasis was not
associated with TILs alone (p=0.10) nor with TIA+ cell count alone (p=0.43). Using both TIA+ cell
counts and TILs to define risk groups for metastasis appears to be better than using either risk fac-
tor by itself, and TIA+ cell counts could potentially be a useful addition to prognostic models for
metastasis risk in melanoma. 
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Youth access to indoor UV tanning: a telephone survey of operators in Colorado, Texas, Illi-
nois, and Wisconsin
EJ Hester,1 LF Heilig,1 R D’Ambrosia,2 AL Drake1 and RP Dellavalle1 1 Dermatology, University
of Colorado Health Sciences Center, Denver, CO and 2 Louisiana State University School of
Medicine, New Orleans, LA
To describe the compliance of indoor tanning facilities with youth access regulations, we assessed
the youth access practices of indoor tanning facility operators in three states with varying degrees
of youth access regulations (Texas, Illinois, and Wisconsin) and one state without youth access reg-
ulations (Colorado). Using a cross-sectional survey study design, 100 randomly selected licensed
facilities providing non-medical UV tanning in each state were telephoned. Each state was assessed
for the percentage of facilities with an operator reporting permitting indoor UV tanning youth
access in violation of state regulations a) for a potential 12-year-old patron and b) for a potential 15-
year-old patron. For a potential 12-year-old patron, 38% of facilities in states with youth access reg-
ulations had an operator report that they would permit indoor UV tanning youth access in violation
of regulations (Texas 77%, Illinois 26%, Wisconsin 11%). For a potential 15-year-old patron, 44%
of facilities had an operator report that they would permit indoor UV tanning youth access violat-
ing current regulations (89% in Texas would allow access without guardian accompaniment, 20%
in Illinois would allow access without guardian consent, and 23% in Wisconsin would allow access).
Operators in Colorado reported self-governing regulations for 12-year-old (age limits 18%, guardian
consent 62%, and guardian accompaniment 8%) and 15-year-old patrons (age limits 10%, guardian
consent 70%, and guardian accompaniment 6%). Compliance with youth access regulation varied
greatly among states. Higher compliance levels in states with long standing youth access regula-
tions (Illinois and Wisconsin), and frequent self-imposed youth access limitations in Colorado demon-
strate the potential for successful tanning industry youth access regulation, both from outside and
within the tanning industry. 
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Cancer risk and developmental abnormalities in xeroderma pigmentosum patients and het-
erozygotes
R Moslehi,1 JJ DiGiovanna,2,3 AM Goldstein,1 SG Khan,2 MA Tucker,1 DE Schmidt2 and
KH Kraemer2 1 DCEG, NCI, Bethedsa, MD, 2 BRL, NCI, Bethesda, MD and 3 Dermatology,
Brown Med School, Providence, RI
Xeroderma pigmentosum (XP), a rare (about 1 in 106) autosomal recessive disease, is characterized
by severe photosensitivity, abnormal pigmentation and increased risk of skin cancer in association
with defective DNA repair. Eight XP genes [(XPA-XPG) and XP variant (pol-eta)] have been iden-
tified. The frequency of clinically normal appearing XP heterozygotes (about 1 in 300) is much
greater than XP patients but their cancer risk is not well studied. One study (Swift and Chase, 1979)
was performed before the XP genes were identified and reported a 16-fold increase in non-melanoma
skin cancer among the blood relatives of XP patients in 4 families compared to spouse controls
(p=0.0001). For 50 patients ascertained at the NIH we have assigned an XP gene and for 37 we have
identified a causative mutation. The type of skin cancer, frequency of internal tumors and manifes-
tations of neurological or developmental abnormalities differ among these patients. To date, we
have collected 19 detailed multi-generation pedigrees. We are performing a molecular epidemiologic
study of all consenting relatives in these XP kindreds and will determine which relatives are muta-
tion carriers. We plan to obtain information about skin cancer risk factors, and pregnancy outcomes
and confirm reported cancers in study participants. We intend to compare the risk of cancer and devel-
opmental abnormalities in the heterozygote carriers with that of non-carrier relatives, spouse con-
trols and population databases. This study may define the cancer risk of carriers of XP DNA repair
genes. It may provide a model for study of carriers of other recessive disease genes and increase the
understanding of DNA repair mechanisms in cancer and human development. 
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Psoriasis is less common but not rare in African Americans
JM Gelfand,5,6 J Kist,5 T Nijsten,7 SR Feldman,2 RS Stern,1 T Rolstad3 and DJ Margolis5,6 1
Dermatology, Harvard Medical School, Boston, MA, 2 Dermatology Pathology and Public Health
Sciences, Wake Forrest University School of Medicine, Wake Forrest, NC, 3 National Psoriasis
Foundation, Portland, OR, 4 LaunchBox LLC, Portland, OR, 5 Dermatology, University of
Pennsylvania, Philadelphia, PA, 6 Center for Clinical Epidemiology and Biostatistics, University
of Pennsylvania, Philadelphia, PA and 7 Dermatology, University Hospital Antwerp, Edegem,
Belgium
Psoriasis has been described as rare in African Americans, however, to our knowledge, there have
been no population based epidemiologic studies of the impact of race on psoriasis prevalence. The
purpose of this study was to determine the epidemiology of psoriasis in African Americans. 27,220
people were randomly selected from the United States population using a stratified sampling method
and were interviewed over the telephone. Respondents were classified as having psoriasis if they
reported having been diagnosed by a physician as having the disease. 21,921 respondents indicated
that they were white, of which 541 indicated that they had psoriasis. 2,443 respondents indicated
that they were African American, of which 27 reported having been diagnosed by a physician as hav-
ing psoriasis. The prevalence of psoriasis, adjusting for the sampling procedure, was 2.5% (95% CI
2.2, 2.7) in whites and 1.3% (0.7, 1.8) in African Americans. The relative prevalence ratio in African
Americans compared to whites was 0.52 (P< 0.0001, Fishers exact test). The distribution of psoria-
sis based on sex was similar between the two groups, as was impact on quality of life and satisfac-
tion with treatment (based on single global questions). This study suggests that African American
race is protective of developing psoriasis, however psoriasis is not rare in this population. 
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Prevalence and impact of industry funding of dermatology clinical trials
CS Perlis1,3 and RH Perlis2 1 Department of Dermatology, Brown Medical School, Providence, RI,
2 Harvard Bipolar Research Program, Massachusetts General Hospital, Boston, MA and 3
Department of Bioethics, University of Pennsylvania, Philadelphia, PA
Recent studies examined the extent and impact of industry sponsorship of clinical trials in medicine
and raised concern for conflict of interest; there has been little systematic research, however, on its
extent and impact in dermatology. We performed a MEDLINE search of clinical trials published
between October 2002 and 2003 in the four most highly cited dermatology journals. Sponsorship,
author affiliation, study size, Jadad quality score1, and outcome were recorded. The search identi-
fied 61 articles from the Journal of Investigative Dermatology, British Journal of Dermatology,
Archives of Dermatology, and Journal of the American Academy of Dermatology. Sixty-four per-
cent of the studies were sponsored by the company producing the intervention. One or more authors
was an employee of the company in 39% of trials. Twenty of 22 trials in which at least one author
was an employee of the company demonstrated a benefit of the experimental intervention over the
control. This compares to 65% of trials in which none of the authors were employed by the com-
pany (Fisher’s exact p=0.032). Jadad study quality scores were similar in trials with author-employ-
ees and non-employee authors (3.32 vs 3.47, Mann-Whitney p>0.05). The majority of published der-
matology trials rely on industry funding, which is associated with a higher incidence of favorable
findings for the intervention. A greater number of dermatology authors reported industry affiliations
(39%)compared to general medical investigators (23-28%)2. The substantial extent of employee-
authorship in dermatology and its documented influence on trial outcomes merit further critical eval-
uation
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Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Exsudativum Multi-
forme Majus: what is the role of infection?
E Schopf, M Grosber, C Wiesend and M Mockenhaupt Dept. of Dermatology, University, Freiburg,
Germany
Toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS) and erythema exsudativum
multiforme majus (EEMM) are severe, sometimes life-threatening cutaneous adverse reactions.
Besides a number of medications, various infections such as influenza-like illness or mycoplasma
infection are considered as etiologic factors. Often these infections are treated with antiinfective
agents also thought to be associated with severe cutaneous adverse reactions (SCAR). Before large
epidemiologic studies on SCAR were undertaken in different European countries, a consensus def-
inition was established. SJS and TEN develop on a spotty, partly target-like wide-spread exanthema
with various amounts of blisters and erosions (< 10% in SJS; > 30% in TEN; SJS/TEN overlap 10-
30%). In contrast, EEMM presents with target lesions especially on the lower extremities and some-
times also with single lesions disseminated in other parts of the body. The SCAR-study (1989-
1995) revealed that in ca. 65% of SJS- and TEN-cases drugs known to induce SCAR were taken
shortly before the onset of the adverse reaction. In contrast, recent or recurrent herpes could be
identified as a major risk factor for EEMM (46%). The German Registry on severe skin reactions,
an intensive surveillance system operating since 1990, could support these results based on ca. 500
cases of EEMM, and ca. 1,240 cases of SJS, SJS/TEN-overlap and TEN. The recent EuroSCAR-
study (1997-2001) showed a slightly increased relative risk (RR) of 2 (confidence interval (CI) 0.5-
2.8) for infections, which was low compared to the risk of antibiotics (RR 8; CI 2.1-20). Stratified
analysis in the individuals using antiinfective drugs did not show any increased risk for infection
(RR 0.8; CI 0.3-2.2). Whereas infections do not show an increased risk for SJS and TEN, this is dif-
ferent for EEMM. Antiinfective drugs given for these infections are the causative agents. However,
it cannot be ruled out that infections may influence the risk of SJS and TEN imposed by drugs. 
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Atopic dermititis family impact questionnaire development
JC Manuel,1,2 CL Carroll,2 K Mallin3 and AB Fleischer2 1 Public Health Sciences, Wake Forest
University School of Medicine, Winston-Salem, NC, 2 Dermatology, Wake Forest University School
of Medicine, Winston-Salem, NC and 3 Dermatology, University of Miami School of Medicine,
Miami, FL
Childhood atopic dermatitis (AD), or eczema, is very burdensome for the family, and has been asso-
ciated with lower quality of life in parents and children. However, there are no published instruments
validated for the United States that measure the impact of AD on the family. This study was under-
taken to develop such a measure. Initial development began with focus groups of parents with chil-
dren diagnosed with AD to determine areas of life affected by AD. Based upon findings from these
groups and the literature, a preliminary AD Family Impact Questionnaire (54 items) was developed
and tested on 50 parents of children with AD. The scale was then refined, and the resulting 30-item
measure is currently being validated on a larger scale. Two-hundred primary caregivers of chidren
ages 12 or younger with AD are the targeted population. Parents are being recruited through adver-
tisements in national newsletters, skin disease websites, and through a University of Miami derma-
tology clinic. Interested parents directly contact study personnel (by mail, e-mail, or phone) to request
a mail survey. Twenty-five percent of the participants who return the survey are randomly being
called or e-mailed and asked to complete the instrument again one month later for test-retest relia-
bility. Pearson correlations, Cronbach’s alpha, and factor analysis will be used to determin the reli-
ability and validity of the new instrument. To date 109 surveys have been completed. Preliminary
factor analyses has revealed three primary factors: time management (9 items), family lifestyle (8
items), and external social issues (3 items). The alpha reliabilities for these subscales and the over-
all scale are good (.83-.91 for subscales, .94 for overall scale), and initial construct validity is also
promising. Once final analyses are completed, the scale will be useful as a process or outcome
measure for intervention studies on families of children with AD. 
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Nonmelanoma skin cancer mortality in Rhode Island, 1988 through 2000
K Lewis1 and MA Weinstock1,2 1 Department of Dermatology, Brown Medical School and Rhode
Island Hospital, Providence, RI and 2 Dermatoepidemiology Unit, Veterans Affairs Medical Center,
Providence, RI
Nonmelanoma skin cancer (NMSC) is the most commonly diagnosed malignancy in the United
States. Despite the magnitude of the public health burden, investigation of NMSC mortality has been
limited. The purpose of this study was to elucidate the magnitude of, and factors associated with
NMSC mortality. A population-based follow-back study was conducted of Rhode Island residents
whose deaths between 1988 and 2000 were attributed to NMSC. The proportion of misclassified
deaths was significantly higher for nongenital NMSC (57%) than for genital NMSC (18%, p<0.0001).
The majority of deaths misclassified as nongenital NMSC were caused by squamous cell carcinoma
of mucosal surfaces. The age-adjusted NMSC mortality rate was 0.91 (per 100,000 per year) of which
half (0.45) was due to genital carcinoma. NMSC mortality increased sharply with age. The mortal-
ity rate from nongenital NMSC in men was more than twice that in women, but for genital NMSC
this ratio was reversed. Skin cancers originating on the ear were responsible for more than a quar-
ter of all deaths caused by nongenital NMSC. No cases of NMSC mortality occurred in organ trans-
plant recipients. Many individuals had psychiatric comorbidities or evidence of unreasonable delay
in seeking medical care for their lesions. Nongenital NMSC mortality was lower in 1988-2000 than
in 1979-1987. Misclassifying the cause of death as nongenital NMSC accounts for a large source of
error on death certificates in Rhode Island. Overall, mortality from genital cercinoma was about equal
to total nongenital NMSC deaths. The dermatology community has not focused sufficient effort on
prevention of mortality from genital skin cancer. 
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Development of a reliable patient self-rated acne severity questionnaire
SE Bendeck,1 ME Lucero,2 FI Ramos-Ceballos,1 GP Kolm3 and SC Chen1,4 1 Dermatology, Emory
University, Atlanta, GA, 2 School of Medicine, Morehouse University, Atlanta, GA, 3 Cardiology,
Emory University, Atlanta, GA and 4 HSR&D, Division of Dermatology, Atlanta VAMC, Atlanta,
GA
Research in acne outcomes has been limited by the physical requirement that patients visit a trained
specialist for severity assessment. Our goal was to develop a reliable Patient Self-Rated Acne Sever-
ity Questionnaire, by which patients could assess acne severity in a manner similar to that of a
physician, thus obviating the need for the physician visit. From our initial work using standard sur-
vey development and improvement probing techniques, we constructed a 16-item survey for patients
to evaluate 8 acne-associated lesions on their face and on their trunk for the prior seven days. The
survey consisted of pictures and word descriptions of the lesions and was constructed with a 5-point
Likert scale for countable lesions (acne bumps, bumps full of pus, blackheads/whiteheads, scabs,
and nodules/cysts) and a 4-point Likert scale for lesions better measured qualitatively (oiliness, blem-
ishes, and scars). Subjects’ responses were compared to those of a physician rater, who completed
the survey simultaneously. We defined a reliable measurement between subject and physician
responses to be a mean difference and 95% confidence interval (CI) that fell within +/- 1 point.
Twenty-three subjects with mostly mild-moderate acne completed the survey. The mean age was 29
± 8 yrs. Ethnicities included 39% Caucasian, 30% African American, 26% Asian descent, and 5%
Other. Educational levels included 13% high school; 35% college, and 52% post-graduate educa-
tion. We found acceptable differences for all lesions. For example, mean differences (95% CI) for
bumps full of pus were 0.35 (0.10, 0.60) and -0.09 (-0.35, 0.17) for face and chest/back, respec-
tively. These results suggest that there may be no clinically significant difference between patient
and physician rating of acne severity with our questionnaire. Further work is necessary in popula-
tions with more heterogeneous acne lesions and diverse ethnicity and educational levels. 
378
Etanercept in patients with moderate to severe psoriasis who fail methotrexate: a cost-effec-
tiveness analysis 
PG Nallamothu,1 BK Nallamothu2 and HW Lim1 1 Dermatology, Henry Ford Hospital, Detroit, MI
and 2 Medicine, University of Michigan, Ann Arbor, MI
The purpose of this study is to evaluate the cost-effectiveness of etanercept (ETA) in patients with
moderate to severe psoriasis who have failed methotrexate (MTX). We compared 2 treatment strate-
gies: 1) MTX and 2) MTX followed by ETA (MTX-ETA). A computerized decision analytic model
using a Markov process was constructed to assess benefits (in quality-adjusted life-years [QALY])
and costs (2003 US$) for both strategies over 5 years. Clinical inputs for the model were obtained
from a literature review and expert opinion. Cost estimates for medications, laboratory tests, physi-
cian fees and drug-related complications were obtained from Henry Ford Hospital. In the MTX strat-
egy, patients received 20mg of MTX weekly during a 3-month induction phase, and if successful,
they were maintained on 15mg weekly. Treatment failures received repeat induction doses and/or
escape therapy (i.e., topicals/phototherapy). In the MTX-ETA strategy, patients first received MTX;
however, those who failed MTX were started on 25mg twice-a-week of ETA during a 3-month induc-
tion phase and then continued on lower maintenance doses (i.e., 25mg per week). As data are lim-
ited regarding long-term remission rates with MTX and ETA, extensive sensitivity analyses were
performed. In the base-case analysis, we found that the MTX strategy led to approximately $17,400
in costs and 2.8 QALYs. The cost of the MTX-ETA strategy was 44% greater ($25,000), but resulted
in greater benefits (3.1 QALYs). The incremental cost-effectiveness ratio for the MTX-ETA strat-
egy was $25,300 per QALY. Sensitivity analyses suggested this result was sensitive to estimates of
ETA’s long-term efficacy and cost. We conclude that patients with moderate-to-severe psoriasis
who have failed MTX are likely to receive additional benefits with ETA at a reasonable cost. As
expected, better estimates of ETA’s cost-effectiveness will depend on future data regarding its long-
term efficacy and safety in such patients. 
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Association of eyeglass use with periocular keratinocyte carcinoma (BCC or SCC) risk
MA Weinstock,1,2 K Biswas,3 G Cole,4 R Hall,5 D Eilers,6 M Naylor,7 R Kirsner,8 J Kalivas,9
K Marcolivio1 and S Bingham3 1 VA Med Ctr, Providence, RI, 2 Brown Univ, Providence, RI, 3 VA
Coop Studies Coord Ctr, Perry Point, MD, 4 VA Med Ctr, Long Beach, CA, 5 VA Med Ctr, Durham,
NC, 6 VA Med Ctr, Hines, IL, 7 VA Med Ctr, Oklahoma City, OK, 8 VA Med Ctr, Miami, FL and 9
VA Med Ctr, Phoenix, AZ
Eyeglasses have the potential to reduce considerably the flux of ultraviolet light on the periocular
skin, and are commonly used, although adequate empirical support for their use to reduce skin can-
cer risk is lacking. Hence we investigated whether the non-use of eyeglasses was associated with
keratinocyte carcinoma risk. We hypothesized that relatively recent use would be protective against
squamous cell carcinoma (SCC), and more remote use against basal cell carcinoma (BCC). We used
the baseline data of the VATTC Trial, a randomized chemoprevention trial for BCC and SCC among
VA patients at 6 centers who had at least two of these cancers in the 5 prior years. We determined at
baseline whether any of the qualifying cancers arose on periocular skin. We also interviewed par-
ticipants to determine their eyeglass use during leisure and recreational activities at different ages.
1131 participants were randomized, of which 1031 (91%) responded to the questions about eye-
glass use below age 40 and 956 (85%) at ages above 40. Under age 40, 55% reported no use of eye-
glasses, and over age 40, 30% reported no such use. Periocular BCC was diagnosed prior to ran-
domization in 11% and 10% in the under 40 and over 40 respondents, and periocular SCC in 1.5%
and 1.4% respectively. Periocular BCC was not associated with eyeglass use in these data (OR 1.4,
95% CI 0.9-2.0 for use under age 40, and OR 1.3, 95% CI 1.3-2.0 for use after age 40). However,
our data did suggest an association with periocular SCC: OR 3.3, 95% CI 0.9-11.6 for use before
age 40 and OR 3.9, 95% CI 1.3-12.0 for use after age 40. These data provide empirical support for
the association of recent non-usse of eyeglasses with SCC and hence for the use of eyewear to pre-
vent periocular SCC of the skin. 
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Quality-of-life outcomes of treatments for nonmelanoma skin cancer
M Chren,1,2 A Sahay2 and D Bertenthal2 1 University of CA at San Francisco, San Francisco, CA
and 2 San Francisco Veterans Affairs Medical Center, San Francisco, CA
Quality-of-life outcomes are important for patients and physicians choosing therapies for non-fatal
cancers. Nonmelanoma skin cancer (NMSC), which is only rarely fatal, is the most common malig-
nancy. The usual therapies are electrodessication and curettage (ED&C), excision, or Mohs histo-
logically-guided surgery (Mohs); most tumors can be removed effectively by many therapies. To
compare quality-of-life outcomes of NMSC therapy, we performed a prospective cohort study of
consecutive patients with NMSC at a VA and a private practice. Skin-related quality of life was meas-
ured before and 2 years after therapy with Skindex-16, a validated measure. Skindex scores vary
from 0 to 100 (most effect), and are reported in three domains: Symptoms, Emotional effects, and
effects on Functioning. The minimal meaningful change in Skindex scores is 10. To compare dif-
ferences in changes in Skindex scores, we used analysis of covariance models adjusted for pre-
treatment clinical and demographic features, including baseline quality of life. In 838 patients,
treatments were ED&C in 20%, excision in 40%, and Mohs in 40%. 56% of patients responded at
two years after therapy. Patients treated with ED&C improved only minimally in quality of life after
treatment. Patients treated with excision and Mohs improved in all three quality-of-life domains
(the mean change in Symptom scores for both groups was 10; the mean change for Emotions scores
for excision was 18 and for Mohs was 25; changes in Functioning were less). In the multivariable
models, quality-of-life outcomes of patients treated with excision and Mohs improved similarly. We
conclude that quality-of-life outcomes differ among different therapies for nonmelanoma skin can-
cer. Improvements were slight for ED&C, but similar for excision and Mohs. This information must
be combined with data about other outcomes to inform decision-making for these non-fatal cancers. 
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Measuring quality of life of patients with psoriasis using the SF-36
F Sampogna,1 B Soderfeldt,2 B Axtelius,2 P Puddu,1 U Aparo1 and D Abeni1 1 Istituto Dermopatico
dell, Roma, Italy and 2 Dept. of Oral Public Health, Faculty of Odontology, Malmo University,
Malmo, Sweden
This study aimed at describing quality of life (QoL) in patients with psoriasis using the SF-36 ques-
tionnaire. All adults hospitalised with psoriasis at IDI-IRCCS from Jan. 2001 to Feb. 2002 were given
the SF-36, a questionnaire intended to measure QoL in all conditions, including good health. It meas-
ures QoL on eight scales: Physical Functioning (PF), Role-Physical (RP), Bodily Pain (BP), and
General Health (GH) are linked to physical health; Vitality (VT), Social Functioning (SF), Role-
Emotional (RE), and Mental Health (MH) relate to mental health. Lower scores indicate poorer QoL.
Clinical severity was measured using PASI. SF-36 data were available for 380 patients. Overall scores
showed that our study population, compared to the health profiles of US patients had physical health
scores intermediate between minor and serious medical conditions, and mental health worse than
both minor and serious medical conditions and quite similar to psychiatric illnesses. In our study,
women had a significantly poorer QoL on all SF-36 scales (e.g., RP=44 vs. 65, RE=36 vs. 58, in
women vs. men). Patients with age >= 65y had lower scores on all physical health scales and RE
(e.g., RE=39 vs. 58, in older vs. younger). Patients with onset after 39y had poorer QoL on all scales
except SF and MH. Duration of disease (+/- 10y) influenced only GH (58 vs. 64, for 10+ vs. <10y).
As for subtypes of psoriasis, the lowest scores were observed in palmoplantar (RP, BP, and RE),
pustular (PF, VT and MH), generalized (SF), and arthropatic psoriasis (GH and VT). Arthropatic
psoriasis had very poor QoL in all eight scales. No significant differences in SF-36 scores, except
for PF, were seen in quartiles of PASI. SF-36 scores showed that psoriasis is a disease with major
QoL impairment, comparable to that of relevant serious medical conditions. Also, SF-36 seems to
be a useful tool to describe QoL in different sociodemographic and clinical subsets of patients. 
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Sustained improvement in functional status and vitality of psoriatic arthritis patients treated
with etanercept
LA Wanke,1 PJ Mease2 and AB Gottlieb3 1 Amgen, Thousand Oaks, CA, 2 Minor and James
Medical Center, Seattle, WA and 3 UMDNJ Robert Wood Johnson Medical School, New Brunswick,
NJ
The purpose of this study was to determine the sustainability of improvements in the functional sta-
tus and vitality of psoriatic arthritis patients treated with etanercept for up to 72 weeks. 
205 patients with psoriatic arthritis were enrolled in a multicenter, double-blind, placebo-controlled
trial for 24 weeks. After the blinded phase, patients continued to receive etanercept in an open-label
phase of the trial. We reported the preliminary data on the functional status and vitality of the patients
who have received etanercept in both the blinded and open-label phase, as measured by the Health
Assessment Questionnaire (HAQ) and the SF-36 vitality scale. There were 101 patients who were
randomized to etanercept in the blinded phase of the trial. The mean age was 47.6 years and 57% of
the patients were male. Ninety percent of the patients were Caucasian. The mean HAQ disability
index score improved from 1.1 at baseline to 0.5 at 24 weeks and 0.4 at 72 weeks. The change in the
HAQ component scores (dressing and grooming, eating, hygiene, activities, reach, grip, arising and
walking) ranged from negative 0.5 to negative 0.6 units at 24 weeks; these were sustained at 72 weeks.
At 24 weeks, mean improvement in the SF-36 vitality score from baseline was 14.6; at 72 weeks,
the mean improvement from baseline was 15.3. In conclusion, psoriatic arthritis patients treated with
etanercept had clinically meaningful improvements in functional status and vitality and these changes
were sustained for up to 72 weeks. 
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Factors associated with skin self-examination in an intervention study
SA Oliveria,1 SW Dusza,1 J Hay,2 D Phelan1 and AC Halpern1 1 Medicine/Dermatology, Memorial
Sloan-Kettering Cancer Center, New York, NY and 2 Psychiatry, Memorial Sloan Kettering Cancer
Center, New York, NY
Purpose: To identify factors associated with adherence to skin self-examination (SSE) in the con-
text of a study designed to assess the impact of a brief nurse-delivered intervention on patients adher-
ence to performing SSE. Methods: The study population was comprised of 100 patients at high risk
for melanoma skin cancer (five or more dysplastic nevi) from the outpatient Pigmented Lesion Clinic
at Memorial Sloan-Kettering. Patients were randomized to receive either a teaching intervention with
a photobook (personal whole-body photographs compiled in the form of a booklet) or teaching inter-
vention only without a photobook. Self-administered questionnaires were provided at three inter-
vals: baseline, post teaching intervention, and at four months post baseline visit. To assess adher-
ence with SSE, we asked patients, How many times in the past four months did you (or someone
else) thoroughly examine your skin? Information was obtained on demographics, phenotypic char-
acteristics, sun practices, skin cancer knowledge and awareness, personal and family history of can-
cer, psychosocial and behavioral factors, and screening/health behaviors. Logistic regression was
used to model the relationship between the potential predictor variables and adherence with SSE at
the four month follow-up. For these analyses, use of the photobook was evaluated as a dichotomous
predictor variable.  Results: Younger age, use of photobook, higher skin cancer knowledge, higher
self-efficacy at completing SSE, lower cancer worry and lower perceived risk of developing melanoma
were predictors of adherence to SSE. Conclusions: This study included a comprehensive set of poten-
tial predictors of SSE, including psychosocial factors. Identifying predictors of SSE will enable health
care providers at both the clinical and psychosocial level to target individuals who may not be per-
forming SSE but who are at increased risk for developing melanoma and to further enhance behav-
ioral programs aimed at modifying risk behaviors. 
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Cost efficacy comparison of biologics used to treat psoriasis
LA Wanke,1 CF Chiou,2 E Reyes,2 DC Malone3 and M Woolley1 1 Amgen, Thousand Oaks, CA, 2
Zynx Health-A Cerner Company, Beverly Hills, CA and 3 University of Arizona, Tucson, AZ
This study compared the cost-efficacy of three biologics with completed phase III trials in psoria-
sis, using the Psoriasis Area Severity Index (PASI) 50% and 75% response rates as efficacy meas-
ures. We analyzed the three-month cost-efficacy, from a managed care perspective, of the following
treatments: alefacept 15mg weekly, efalizumab 1mg/kg weekly, and etanercept either 25mg twice-
weekly or 50mg twice-weekly. Costs of drugs, physician visits, laboratory tests, and treatment of
adverse events were included. Drug costs were average wholesale price. Other resource costs were
Medicare reimbursement rates and the MEDSTAT DRG Guide. Efficacy measures were percent of
patients achieving PASI 50 and PASI 75 response rates, reported from comparable clinical trials.
Adverse event rates were assumed equal among treatments and 5% of patients were assumed to
drop out at 6 weeks due to adverse events. Total three-month costs were $12,454 for alefacept, $4,372
for efalizumab, $4,326 for etanercept 25mg twice weekly and $8,335 for etanercept 50mg twice
weekly. PASI 50 response rates were 0.42 for alefacept, 0.52 for efalizumab, 0.58 for etanercept
25mg twice weekly, and 0.74 for etanercept 50mg twice weekly. Cost per PASI 50 responder was
$29,652 for alefacept, $8,408 for efalizumab, $7,458 for etanercept 25mg twice weekly and $11,263
for etanercept 50mg twice weekly. PASI 75 response rates were 0.21 for alefacept, 0.22 for efal-
izumab, 0.34 for etanercept 25mg twice weekly and 0.49 for etanercept 50mg twice weekly. Cost
per PASI 75 responder was $59,304 for alefacept, $19,873 for efalizumab, $12,723 for etanercept
25mg twice weekly and $17,010 for etanercept 50mg twice weekly. In conclusion, etanercept 25mg
twice weekly was less costly and more effective compared to alefacept and efalizumab. As a result,
it was the most cost-efficacious treatment option. Efalizumab was the second most cost-efficacious
based on PASI 50 response. Etanercept 50mg twice weekly was the second most cost-efficacious
based on PASI 75 response rate. 
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Declines in air travel cost correlate strongly with increasing melanoma incidence
YZ Agredano, WE Rehmus and AB Kimball Department of Dermatology, Stanford University,
Stanford, CA
Background: A relationship between intermittent high-dose UV radiation leading to sunburn and
melanoma has been reported, but the times between the exposure, development, and diagnosis of
this neoplasm have not been clearly established. As the cost of air travel decreased substantially in
the 1970’s and 1980’s, leisure travel to vacation destinations during winter months expanded. This
recreational trend likely increased the incidence of significant UV exposure and sunburns in a broad
population who could not previously afford this kind of travel. Purpose: The purpose of this study
was to explore the relationship of airfare prices to melanoma incidence. Methods: Mean inflation-
adjusted airfare prices for 4 airports linked to leisure destinations (Miami, Los Angeles, San Diego,
Phoenix) was obtained from The Domestic Airline Fares Consumer Report. Melanoma data was col-
lected from the SEER 9 Registry Database, 1975-2000, which contains a sample of 77,617 individ-
uals diagnosed with melanoma of the skin. Mean age at diagnosis was 54.4 years. The costs of air
travel were compared to melanoma rates. Results: The increase in melanoma rates corresponded
strongly with decreasing airfares, R2=0.92, p<0.01. Modeling a short time lag between airfare and
melanoma diagnosis did not strengthen the association. Longer times lags could not be modeled due
to data limitations. Conclusion: Correlation does not equal causality, but this strong relationship sug-
gests that further research exploring the connection between adult sunburns and development of
melanoma is needed. 
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Decreased incidence of non-melanoma skin cancer in patients with type II diabetes using insulin
T Chuang,2,1 DA Lewis1 and DF Spandau1,3 1 Dermatology, Indiana University School of Medicine,
Indianapolis, IN, 2 Dermatology, Inc, Indianapolis, IN and 3 Biochemistry, Indiana University
School of Medicine, Indianapolis, IN
Keratinocytes in the skin express the receptor for IGF-1 and require IGF-1 for proper maintenance
of the epidermis. Because keratinocytes do not produce IGF-1, they are dependent on dermal fibrob-
lasts to produce IGF-1. As dermal fibroblasts age in vitro, they lose the ability to secrete IGF-1.
Therefore, we hypothesized that in aged skin, keratinocytes are supplied with decreasing levels of
IGF-1. We have previously demonstrated the importance of IGF-1R activation in the response of nor-
mal human keratinocytes to UVB exposure in vitro and we have suggested that this reduced activa-
tion of the IGF-1R may be correlated with an increased susceptibility to skin cancer. A corollary of
this hypothesis would be that individuals with an increased activation of the IGF-1R might have some
protection from UVB-induced skin cancer that could be detected by a decrease in skin cancer inci-
dence. Patients with Type II diabetes mellitus frequently have to take exogenous systemic insulin to
overcome their insulin resistance. We hypothesized that the increased serum levels of insulin in
Type II diabetic patients may activate the IGF-1R in skin and lead to a decreased frequency of skin
cancer in these patients. To test our hypothesis, we compared the frequency of skin cancer of patients
seen at our outpatient clinical facility from 1980 to 1999 that were taking insulin (n=1,440 patients)
with patients from an age-matched control group that were taking cimetidine (used to treat peptic
ulcers; n=4,135 patients). Insulin-using patients had a 1.25% incidence of non-melanoma skin can-
cer compared to a 2.35% incidence in the control group (p=0.016, two-sided, Chi-square test). No
protection from non-melanoma skin cancer was observed in type II diabetic patients that were using
non-insulin therapy (2.4% incidence). These data provide preliminary evidence that high levels of
systemic insulin may provide protection from skin cancer, as suggested by our in vitro data. 
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Epidemiology of pemphigus in Olmsted County, Minnesota from 1950 - 2000
M Alhashimi and MR Pittelkow Dermatology, Mayo Clinic, Rochester, MN
The epidemiology of pemphigus, including its incidence, course and management in Olmsted County
was examined using the unique resource of the Rochester Epidemiology Project (REP). Reviewing
the REP for the time period January 1, 1950 to December 31, 2000, we identified 12 cases. All cases
met one or more diagnostic criteria for pemphigus (histology, direct and indirect immunofluores-
cence [IF]. The overall age- and sex-adjusted incidence was 0.35/100,000 (95% CI, 0.15-0.54). Five
men and seven women from different ethnic backgrounds were affected. The mean age was 60 years
(range, 41-85). Pemphigus subtypes identified included: vulgaris (6), foliaceous (5), and erythe-
matosus (Senear-Usher) (1). Pain, sore throat and pruritus were the most common presenting symp-
toms. The diagnosis was established by histology only (5), histology and direct and indirect IF (4),
and the remainder of the cases diagnosed by IF or histology and either IF method. Erosions and
crusted lesions represented the typical morphology. Face, oral mucosa and extremities were the com-
mon initial sites of disease. The median delay to diagnosis was 4.3 months (range: 13 days to 4 years).
Eight cases eventually completely remitted or were free of signs and symptoms, of which five cases
subsequently relapsed. Therapy was recorded in 11 patients. Therapy in addition to systemic corti-
costeroids was required in seven patients and three patients were managed with local corticosteroid
treatment due to mild disease. Pemphigus occurs in multiple ethnic groups in Olmsted County,
Minnesota with an overall incidence of <1/100,000. Oral corticosteroid and adjuvant therapies pro-
vide remission though relapses were observed. 
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Epidemiology of pemphigoid in Olmsted County, Minnesota: 1950-2000
M Alhashimi and MR Pittelkow Dermatology, Mayo Clinic, Rochester, MN
We investigated the epidemiology of pemphigoid, its course and management in Olmsted County
using the unique resource of the Rochester Epidemiology Project (REP). Reviewing the medical his-
tories of the REP for the time period January 1, 1950 to December 31, 2000, we identified 79 cases.
All cases met one or more laboratory methods to establish the diagnosis (histology, direct and indi-
rect immunofluorescence [IF]). The overall age- and sex-adjusted incidence was 2.4/100,000 (95%
CI, 1.9-3.0). There were 49 women (62%) and 30 men (38%) that developed pemphigoid. The mean
age was 77.4 years (range, 41-98 years). Pruritus and pain were the most common presenting symp-
toms. Histology + direct and indirect IF were used to diagnose 39 cases (49%), 29 cases (37%) were
diagnosed by both histology and direct IF. The remaining 11 (14%) cases were diagnosed by one or
a combination of methods. Blisters, erosions and denuded skin were the most common presenting
features (97%). Blisters alone were rare (3%). The extremities, chest and back, were common ini-
tial sites of the disease. Forty-eight cases (61%) were in remission or free of signs and symptoms,
though 25 of these 48 cases (52%) had relapse at some point. Treatment was recorded for 74 patients.
Adjuvant therapy, in addition to systemic corticosteroids, was required in 78%. The remaining 22%
were managed with local corticosteroid treatment for mild disease. The incidence of pemphigoid is
much more common (5-10 fold) than pemphigus and affects an older age population when com-
paring the epidemiology of these diseases in Olmsted County, Minnesota. 
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Validation of an instrument to collect medically relevant information from psoriasis patients
in a standardized manner
T Koch,1 A Ehrlich,1 M Turner2 and A Blauvelt2 1 Dermatology Dept., George Washington
University, Washington, DC and 2 Dermatology Branch, National Cancer Institute, Bethesda, MD
Establishing well-defined psoriatic phenotypes and collecting detailed medical information impor-
tant for psoriasis pathogenesis is critical for both research on psoriasis genetics and in understand-
ing different individual responses to biologic therapies (i.e., pharmacogenomics). Currently, geneti-
cists and clinical researchers utilize an extremely heterogeneous group of questionnaires to gather
medical information from psoriasis patients. This heterogeneity is problematic in that it complicates
the use and analysis of information collected by different groups in different studies. The purpose
of this investigation was to design and validate a detailed survey instrument that could be uniformly
used in psoriasis genetics and clinical research studies. We used the Delphi method, a multiphase
process through which expert opinions are developed into a consensus, to generate a novel survey
instrument. Fifty subjects with psoriasis were enrolled in the validation study. Each subject was asked
the survey questions by each of 3 investigators. Answers from each subject were recorded by each
investigator and were compared to determine agreement (expressed as Κ). Data showed high agree-
ment for questions relating to place of birth (Κ=0.85-1.0), family origin and psoriasis history (Κ
=0.88-1.0), patient medical history (Κ=0.76-1.0), distribution of lesions (Κ=0.73-1.0), precipitating
factors (Κ=0.79-1.0), joint problems (Κ=0.74-.91), and treatment history, including use of oral
retinoids, methotrexate, and etanercept (Κ=0.73-1.0). Questions with poor to fair agreement between
investigators included past history of alcoholism (Κ=0.16-.30), nature of psoriatic lesions (Κ=0.33-
.66), factors that improve lesions (Κ=0.02-.26), and joint disease diagnosis by a rheumatologist
(Κ=0.2-.54). In conclusion, we developed a novel validated survey instrument that can be used to
gather information from psoriasis patients in a standardized manner. 
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Smoking cessation as a therapeutic intervention for acne: initiation of a Cochrane Collabora-
tion Systematic Review
LF Heilig,1 EJ Hester,1 KR Johnson,1 KZ Kozak,1 AL Drake,1 LM Schilling2 and RP Dellavalle1,3
1 Dermatology, University of Colorado Health Sciences Center, Denver, CO, 2 Preventive
Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, CO and 3
Veterans Affairs Medical Center, Denver, CO
Studies examining the cutaneous effects of smoking on acne have yielded conflicting results (Mills
1993, Schafer 2001, Jemec 2002). Given these mixed results, we have initiated a Cochrane Collab-
oration Systematic Review of the effects of tobacco smoking on acne vulgaris. Inclusion criteria for
candidate trials are: 1) evaluation of efficacy of tobacco cessation modalities and 2) epidemiologi-
cal studies that examine the relationship of acne and tobacco. Case reports, case series, consensus
panels and expert opinion articles will be excluded. Main outcome measures include: 1) the pro-
portion of participants with clinically significant resolution or improvement of acne after smoking
cessation and 2) the association of smoking and acne as determined by epidemiological studies. Data-
bases to be included in this review include: a) The Cochrane Skin Specialised Register, b) The
Cochrane Tobacco Addiction Group’s Specialised Registers, c) The Cochrane Central Register of
Controlled Clinical Trials (CENTRAL), d) MEDLINE, e) EMBASE (from 1980), f) SciSearch (from
1966), g) International Pharmaceutical Abstracts (from 1966), h) PsycInfo (from 1987), i) AMED
(Allied and Complementary Medicine,1985), j) LILACS (Latin American and Caribbean Health Sci-
ence Information database, from 1982), k) the metaRegister of Controlled Trials and l) the NHS
Trusts Clinical Trials Register. Performing the search strategy in MEDLINE resulted in additional
qualifying articles, however the results remain in conflict regarding the relationship of smoking and
acne. We are additionally seeking any unpublished literature and conference proceedings relevant
to this topic known to the membership of the SID. A summary of search outcomes to date will be
presented. Preliminary analysis suggests that the relationship between smoking and acne will need
to be studied prospectively. 
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Dermatological research in Chile
PR Figueroa Dermatology, World Dermatology Institute, Santiago, RM, Chile
An objective assessment of research in dermatology in Chile was done. All the scientific papers in
dermatology originated in Chile published between 1963 and 2003 registered at Medline were
reviewed. In addition, all the abstracts originated in Chile presented at the Society for Investigative
Dermatology between 2000 and 2003 were included. During those years, 47 papers were published.
Less than 20% were published in internationally recognized dermatological journals and most of
them were published in domestic journals in Spanish. Most of the relevant research were focused
on environmetal issues such as ozone and arsenic poisoning and epidemiology. In conclusion, in a
40 year period, there are few papers published suggesting a need to improve the research in derma-
tology in Chile. 
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The impact of managed care to dermatologists when providing care for the indigent popula-
tion
KA Yeung-Yue, R Abdul-Khalek, J Trepte, PJ Aronson and GJ Murakawa Dermatology, Wayne
State University, Detroit, MI
Managed care is growing nationally, causing a shift away from direct access toward the gatekeeper
system. Specialists such as dermatologists express great concerns about managed care due to poor
reimbursement and limitations in clinical decision-making; these issues are compounded by the gen-
erally poor Medicaid fee schedule for Medicaid managed care patients. Studies have shown that
direct access to dermatologists is cost-effective and results in greater patient satisfaction. To deter-
mine who provides dermatological care to the poor regionally and nationally, we surveyed the major
Medicaid HMOs in southeast MI, 249 dermatologists in MI, and 100 academic dermatology pro-
grams. The National Ambulatory Medical Care Survey (NAMCS) provided data regarding outpa-
tient utilization of medical services. Nationally, 55% of Medicaid patients participate in a managed
care program. Nearly 100% of Medicaid patients are enrolled in HMOs in MI, compared to 27% of
the state’s total population that is enrolled in a managed care plan. University Dermatology, the clin-
ical practice of the Department of Dermatology at Wayne State University, was found to be the major
provider for Medicaid HMO patients in southeast MI, comprising 35% of the practice. In nearly 70%
of MI dermatologists, < 1% of their clientele is comprised of Medicaid patients, and even fewer see
Medicaid HMO patients. Nationally, 69% of academic dermatology programs consist of <5% Med-
icaid patients, and most major metropolitans have city, county, or state-funded hospitals. The NAMCS
similarly revealed that dermatologists see a disproportionately low share of patients with managed
care, and to a greater extent, Medicaid managed care. In summary, Medicaid managed care patients
face extreme difficulties in access to dermatological care. Without an appropriate safety net, direct
access for specialty care would cripple those few practices that treat the majority of this patient cohort. 
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Trends in coverage of skin cancer in the print media
C Hazan,2,1 SA Oliveria1 and AC Halpern1 1 Medicine, Memorial Sloan Kettering, New York, NY
and 2 Dermatology, NYU Medical Center, New York, NY
Our purpose was to observe the trends in coverage for skin cancer and related factors in the New
York Times and to analyze the subject content of articles related to skin cancer in fashion maga-
zines, Cosmopolitan and Cosmo Girl. The Lexis-Nexus database, a commercial database that cov-
ers a wide array of news articles on current events, legal, business, and medical issues, was used to
identify and quantify articles related to skin cancer in the New York Times between 1980 and 2002.
The EBSCO Host Master File Premier database, a similar commercial multidisciplinary database,
was used to search and identify articles in Cosmopolitan and Cosmo Girl between 1992 and 2002.
We further classified these articles on subject content as it related to skin cancer and other factors.
The number of articles on skin cancer and related topics such as sunscreen, tanning, and tanning
salons ranged from 2 per year to approximately 30 per year during the 22-year observation period
for the New York Times. We observed a cyclical trend in coverage with a peak in coverage for arti-
cles on basal cell and squamous cell skin cancers in 1985 and melanoma skin cancer in 2000 which
coincided with the diagnosis of skin cancers in public political figures. We reviewed a total of 139
articles in Cosmopolitan over a 10-year period, of which 91 were relevant and further analyzed.
Sixty-four percent (n=58/91) of the articles discussed primary prevention of skin cancer, with 93%
(n=54/58) of these articles promoting the use of sunscreen. Eleven percent (n=10/91) mentioned sec-
ondary prevention of skin cancer, all of which were educational oriented about the ABCD charac-
teristics of melanoma. Although fewer in number, the content of articles and distribution in Cosmo
Girl was similar. Despite the paucity of articles published in Cosmopolitan and Cosmo Girl, we
believe that these magazines made an attempt to educate the adult and teen population about skin
cancer and sun protective behaviors, utilizing cosmetic factors as the driving force in getting the mes-
sage across. 
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Availability of the top 100 prescribed topical medications in private insurance, Medicaid, and
VA formularies in Michigan
KE Quinlan, BD Krasner, KA Yeung-Yue and GJ Murakawa Dermatology, Wayne State University,
Detroit, MI
Medicaid is the largest financial resource for medical services and prescription drug benefits for the
poor and disabled people in the U.S. In Michigan, nearly 100% of Medicaid recipients are enrolled
in a Health Maintenance Organization (HMO). In February 2002, Michigan implemented a Medic-
aid formulary, the Michigan Pharmaceutical Product List (MPPL). Medicaid HMOs are not required
to adhere to this formulary. Only government-selected physicians and pharmacists provided input
in the development of this list; no dermatologists were included. We compiled a list of the top 100
topical medications prescribed by dermatologists and across all specialties in Michigan, as deter-
mined by retail sales. The availability of these medications was determined for two private HMOs,
the MPPL, several Medicaid HMOs, and the VA. Dermatologists prescribe 33% of all topical med-
ications in Michigan. From our data, private insurance covers 61% of the most prescribed topical
medications, compared to 58% by the MPPL, 27% by Medicaid HMOs, and 24% by the VA. In con-
trast to oral medications in which 82% are available on the MPPL, topical medication formularies
are much more restrictive (58% available on the MPPL). Interestingly, access to topical retinoids for
acne (tretinoin, adapalene) is highly restrictive for the MPPL and Medicaid HMOs—only one Med-
icaid HMO has only one of these products available without restrictions. Dermatologists should
participate in the development of topical medication formularies to ensure proper treatment options
for skin conditions. In summary, Medicaid patients face major obstacles in receiving appropriate
medical care; with a severely restrictive formulary, these patients, especially those in managed care,
have the added burden of poor access to topical medications for their skin diseases. 
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A comparison of the accessibility of the top 100 prescribed oral medications in Michigan
GJ Murakawa, KE Quinlan, BD Krasner and PJ Aronson Dermatology, Wayne State University,
Detroit, MI
Medicaid provides health care coverage for disabled and indigent patients, and is subsidized by fed-
eral and state funds. In Michigan, virtually all Medicaid recipients are enrolled in a Health Mainte-
nance Organization (HMO). In February 2002, Michigan created its own Medicaid formulary—the
Michigan Pharmaceutical Product List (MPPL). Medicaid HMOs are not obligated to follow this
formulary. To determine the availability of medications for the Medicaid population, formularies
from two private insurances, the MPPL, several Michigan Medicaid HMOs, and the VA were ana-
lyzed. A list of the top 100 prescribed oral medications across all specialties was compiled, as deter-
mined by retail sales in Michigan. This list was then compared to each formulary to determine the
availability of these medications. Our data reveals that private insurance covers 93% of these med-
ications, compared to 80% by the MPPL, 76% by the Medicaid HMOs, and 73% by the VA. More-
over, 89% of medications are available without restriction by private insurance formularies, as com-
pared to 61% by the MPPL, 55% by the Medicaid HMOs, and 63% by the VA formulary. From
these data, we conclude that private insurances provide the broadest coverage; whereas government
programs have more restricted formularies. Additionally, Medicaid HMOs do not parallel the MPPL,
but rather, deviate extensively. The VA drug list is quite restrictive and heavily based on generic med-
ications. Thus, Medicaid patients face significant challenges not only for access to care, but also,
access to medication. This year, a federal bill passed that allowed prescription drug coverage for
Medicare recipients. Given the difficulty experienced by Medicaid patients and the non-conformity
of Medicaid managed care formularies, these data have profound implications for drug availability
for senior citizens. 
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Effect of an intervention promoting thorough skin self-examination (TSSE) on the use of health
services: the Check-It-Out Project at 6 months
MA Weinstock,1,2 P Risica,2 R Martin,2 K Smith,2 W Rakowski,2 M Berwick,3 M Goldstein,4
T Lasater,2 G Berkholder2 and R Broomfield2 1 VA Medical Center, Providence, RI, 2 Brown Univ.,
Providence, RI, 3 Univ of New Mexico, Albequerque, NM and 4 Bayer Institute, Stamford, CT
The Check-It-Out project was a randomized trial of intervention to encourage TSSE. Participants
were recruited at primary care practices. The intervention included a video, cues, aids, and coun-
seling by an intervention specialist, who asked the participant for their plan of action and placed a
follow-up phone call 3 weeks after enrollment.  The control group received a dietary fat interven-
tion in the same format and intensity. All participants (1356 were randomized) completed a phone
evaluation survey before and at 2, 6, and 12 months after enrollment. Participants were asked if they
underwent a procedure on their skin. Physician records were consulted for the exact date and CPT
code of the procedure(s), which were then associated with the cost of the procedure. Differences in
the costs between groups were assessed by ANOVA with group as the independent variable and
total cost per patient with a verified procedure as the dependent variable. During the 6 months prior
to randomization, 6.5% of the intervention group v. 5.8% of the controls had a verified procedure
on their skin (p=0.6), but during the 6 months after intervention, this was 7.9% v. 3.5% (p=.001).
Among patients with verified procedures, the cost per patient of procedures performed on the skin
was $116 v. $104 respectively (p=.8) during the 6 months prior to randomization, and $219 v. $77
(p=.01) during the 6 months after randomization. If participants without procedures are included,
the average cost was $16.62 for those receiving intervention and $4.83 for the control group. Check-
it-Out successfully encouraged intervention participants to perform TSSE more than controls, and
also caused greater expenditures on skin procedures in the first six months. Further analysis will
assess whether lesions removed were a significant threat to health. 
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The associations of body image, weight status, and health limitations on performance of thor-
ough skin self-examination (TSSE)
PM Risica,1 M Weinstock,2 R Martin,1 K Smith,1 W Rakowski,1 M Berwick,1 M Goldstein1 and
T Lasater1 1 Brown University, Providence, RI and 2 Dept of Dermatology, VA Medical Center,
Providence, RI
Attitudes about weight and body image might influence ones general attitude toward and perform-
ance of TSSE. This hypothesis was explored in the Check-It-Out project, a randomized trial of an
intervention designed to encourage TSSE. All participants who completed the baseline survey, regard-
less of whether they were later randomized into the clinical trial (N=2112) were included in this
analysis. TSSE was defined as having answered yes to all seven questions regarding examining spe-
cific body parts at least once in the previous month; body image was assessed by one question; weight
status calculated as BMI (kg/m2) based on self reported height and weight, and categorized accord-
ing to WHO criteria; health limitations reported as having a condition that makes it difficult to
examine ones skin. Body image, weight status and health limitations were assessed using chi square
analysis, in which all three were associated with one another (p=.0001 for all). TSSE was not asso-
ciated with weight status or health limitations, but was associated with body image (p=.0536) in
univariate logistic regression. To further explore this association, body image, weight status and the
interaction of these variables were entered into a subsequent model, where the interaction term met
a liberal threshold at p=.1539. Separate models were then constructed with body image as the sole
dependent variable. Body image only was associated with TSSE among the highest weight category
(BMI>30), and not associated among any other weight category.  Body image appears to be an impor-
tant factor in TSSE performance among the obese, but not in individuals with weight status. Obe-
sity is associated with many health issues. Infrequent early detection of melanoma may be added to
that list among those with poor body image. Given the epidemic of obesity, interventions promot-
ing TSSE should consider body image as a potential barrier to successful TSSE among the obese. 
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Three-dimensional analysis of human epidermal structure by in vivo reflectance confocal
microscopy
T Kuwahara,1 T Yamashita,1 M Takahashi,1 J Wang,2 H Saito2 and S Ozawa2 1 Shiseido Research
Center (Shin-Yokohama), Yokohama, Japan and 2 Keio University, Yokohama, Japan
in vivo reflectance confocal microscopy (CM) has made it possible to observe non-invasively the
inside of living human skin, mainly epidermal layers. We have developed a method to reconstruct
the three-dimensional (3D) structure of the epidermis from a sequence of automatically obtained
CM images. A new image analysis method of 3D edge detection and 3D reconstruction based on the
Snakes method was used. The Snakes method1) is to evolve a curve, which consists of initial broadly
positioned control points on the image, through an image-derived energy-minimization process so
that it ultimately conforms to the feature of interest, such as the dermo-epidermal junction. To ana-
lyze the volumetric confocal images, we have developed the 3D Snakes method, which uses the same
image-derived energy functions as the Snakes model, but deforms them into 3D space. This new
method makes it possible to detect the surface area of epidermis automatically and to visualize the
precise structure of the epidermis from the surface of the stratum corneum to the dermo-epidermal
junction. This 3D reconstruction of the epidermal structure allows us to analyze the thickness of the
epidermis and the undulation of the dermo-epidermal junction in detail. Our study of the structural
variations of the epidermis in normal skin with this method revealed substantial differences between
subjects of different ages, and between males and females, not only visually, but also quantitatively.
Furthermore, detection of melanin particles, which appear as characteristically bright reflective clus-
ters in the confocal images, was investigated to elucidate the 3D distribution of melanin particles
within the epidermis. We conclude that in vivo CLSM will be a very useful tool for the precise 3D
analysis of epidermal structure. 
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New insights in cutaneous nociception and neurogenic inflammation: expression of the Vanil-
loid receptor subtype 1 in the skin
S Staender,1 C Moormann,1 M Schumacher,2 M Artuc,3 TA Luger,1 D Metze1 and M Steinhoff1 1
Dermatology, University Hospital Muenster, Muenster, Germany, 2 Anesthesia and Perioperative
Care, UCSF, San Francisco, CA and 3 Dermatology, Humboldt-University of Berlin, Berlin,
Germany
The cutaneous genesis of itch and pruritus is not yet fully understood and seems to be regulated by
a variety of mediators. The vanilloid receptor subtype 1 (VR1/TRPV1) is a non-selective cation chan-
nel which is known to modulate nociceptive sensations in the central nervous system. Since the VR1-
ligand capsaicin is known to suppress pruritus after cutaneous long-term administration, it was of
interest to determine the localization of VR1 in the skin. We investigated VR1-immunoreactivity as
well as mRNA and protein expression in a series of normal and capsaicin-treated human skin. VR1
immunoreactivity could be observed in cutaneous sensory dermal and epidermal nerve fibers, mast
cells, as well as appendage and epidermal cells. Upon RT-PCR and Western blot, expression of VR1
was confirmed in primary mast cells and keratinocytes from human skin. During capsaicin therapy,
VR1-receptor distribution was unchanged while a reduction of neuropeptides (substance P, calci-
tonin gene-related peptide) was observed in nerve fibers. After cessation of capsaicin therapy, neu-
ropeptides re-accumulated in skin nerves. In conclusion, VR1 is widely distributed in the skin. Expres-
sion of VR1 on cutaneous sensory nerve fibers supports the notion that vanilloids and their receptors
contribute to the induction and modulation of nociceptive cutaneous sensations such as pain and pru-
ritus.
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Effects of dietary glucosylceramide on the cutaneous functions
J Ishikawa, Y Takagi, S Moriwaki and T Kitahara Kao Corporation, Haga-Gun TOCHIGI, Japan
Ceramides in the epidermis play a critical role in the barrier and water holding functions of the stra-
tum corneum (SC). In atopic dermatitis and in xerosis, there are decreases in ceramide content in
the SC, etiologically leading to the barrier disruptions and dry skin; topical application of ceramides
or enhancement of epidermal ceramide synthesis improve these skin conditions. Recently, the dietary
intake of glucosylceramides has been reported to increase the epidermal water holding capacity, how-
ever this mechanism remains unclear. Here we examined the effect of oral administration of gluco-
sylceramide (derived from plants) on epidermal water holding capacity, cutaneous barrier function,
and sphingolipid content in murine epidermis, including the SC. HR-1 hairless mice were treated
with a single dose of glucosylceramide (plant) or triolein (4mg in sample emulsion) by gavage once
a day for 2 weeks. Following oral administration, skin conductance, an indicator of epidermal water
holding capacity, increased significantly although there were no changes in transepidermal water
loss (TEWL), an indicator of cutaneous barrier function. Following administration of glucosylce-
ramide ceramides, glucosylceramide and sphingomyelin contents increased in whole epidermis, espe-
cially in living cells (Stratum Basale, Stratum Spinosum, Stratum Granulosum).
We then examined the effect of oral glucosylceramide on barrier recovery. Mice were treated with
the diet containing 0.1% of glucosylceramides (maize) for 5 weeks. The recovery rate of barrier per-
turbation induced by tape stripping was enhanced following glucosylceramide treatment. These find-
ings suggest that dietary glucosylceramides increase the epidermal sphingolipids level by absorp-
tion via the intestinal tract and distribution to the epidermis or by enhancement of their de novo
synthesis in the epidermis. The end result is an increase in the epidermal water holding capacity and
an enhancement of the cutaneous barrier function. 
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Keratin expression in epidermal melanocytes of normal human skin
J Bhawan and K Whren Dermatology, Boston University School of Medicine, Boston, MA
Human melanomas occasionally express cytokeratins in addition to traditional markers of differen-
tiation, such as S-100 and melanoma specific antigens.  Also, similarly to melanoma cells in vivo,
several established melanoma cell lines express cytokeratins.  Most recently, keratin expression has
also been detected in cultured melanocytes derived from normal skin.  To determine if normal epi-
dermal melanocytes express cytokeratins in vivo, fifteen samples of normal glabrous adult skin
were first incubated with anti keratin 16 antibodies (LL025, 1:20), specifically chosen for this study
as this keratin is not expressed by keratinocytes of normal epidermis. The reaction was followed by
incubation with the chromogen 3,3’ -diaminobenzidine (DAB). Sections were stained using the Dako
Envision Double Stain System and photographed. The same sections were then reacted with anti
tyrosinase related protein-1 antibodies (Mel-5, 1:15), followed by incubation with the Fast Red chro-
mogen and rephotographed. All specimens showed discrete positive keratin 16 staining of scattered
cells in the basal epidermal layer, consistent with melanocytes, and no staining of keratinocytes.
Indeed, the stained basal cells were also positive for tyrosinase related protein-1 expression, verify-
ing their identity as melanocytes. The specificity of the staining was confirmed using psoriatic skin
from five different donors, as keratinocyte of hyperplastic psoriatic epidermis, known to express ker-
atin 16, positively stained with LL025 antibodies. Conversely, anti CD22 antibodies (B-cell marker),
used as a negative control, did not stain either melanocytes or keratinocytes in five of the fifteen nor-
mal skin specimens, where the melanocytes stained positively for keratin 16. Our study is the first
to show keratin expression in melanocytes of normal human skin. Thus, it appears that melanocytes,
similar to keratinocytes, express and utilize keratin filaments to provide mechanical strength, struc-
tural integrity and assistance in basement membrane and cell-cell adhesion. 
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Sustained increases in stratum corneum pH cause profound alterations in barrier functions
and SC integrity
J Hachem,2,1 M Mao-Quiang,1 D Crumrine,1 Y Uchida,1 D Roseeuw,2 BE Brown,1 KR Feingold1
and PM Elias1 1 Dermatology and Medical Services, VA Medical Center- University of California,
San Francisco, CA and 2 Dermatology, AZ-Vrije Universiteit Brussel, Brussels, Belgium
The function of the acidic pH of the stratum corneum (SC) was largely unknown until recently, when
we showed that transient increases in SC pH are accompanied by transient alterations in both per-
meability barrier homeostasis and SC integrity/cohesion. Yet, sustained pH elevations characterize
clinical situations, such as neonatal and dermatitic skin. Hence, we assessed here whether pro-
longed neutralization of the SC alone, by repeated applications of the superbase, 1,1,3,3-tetram-
ethylguanidine (TMG) (twice daily, 5-16 days), provokes profound alterations in SC function, as
well as their mechanistic basis. In contrast to short-term pH alterations, sustained SC neutralization
profoundly altered not only barrier recovery kinetics, but also basal permeability barrier function.
This barrier abnormality was attributable not only to decreased in β-glucocerebrosidase (β-Glc-
Cerase) and acidic sphingomyelinase (aSMase) catalytic activity, but also to a sustained pH-induced
increase in serine protease (SP) activity, resulting in degradation of both lipid processing enzymes
(shown by immunohistochemistry and Western immunoblotting). The role of SP in this process was
shown by the normalization of both enzyme activities/content by co-applied SP inhibitors (SPI). In
addition, SC integrity/cohesion also deteriorated progressively with sustained SC neutralization,
attributable to SP-mediated degradation of corneodesmosomes (CD) and CD-constituent proteins
(desmoglein 1), extending to the SG-SC interface, abnormalities that all were again reversed by co-
applied SPI. In summary, prolonged SC neutralization provokes profound abnormalities in both
permeability barrier homeostasis and SC integrity/cohesion, resulting from sustained proteolytic
degradation of lipid processing enzymes and CD proteins. These results suggest that the pH abnor-
mality could dictate many of the functional abnormalities in neonatal skin and chronic dermatoses. 
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Molecular cloning and expression of keratinocyte differentiation related protein—a novel dif-
ferentiation marker isolated from primary cultured keratinocytes using suppression subtrac-
tive hybridization
W Lee,1,4 E Seo,2 K Lee,2 G Park,4 J Yang,2 K You,4 J Kim,3 C Kim,1 J Park1 and J Lee1 1
Dermatology, School of Medicine, Chungnam National University, Daejeon, South Korea, 2
Dermatology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul,
South Korea, 3 Pathology, School of Medicine, Chungnam National University, Daejeon, South
Korea and 4 Biology, College of Natural Sciences, Chungnam National University, Daejeon, South
Korea
We describe a novel human cDNA keratinocyte differentiation related protein called KDRP that
was isolated using the suppression subtractive hybridization technique in a calcium-induced ker-
atinocyte differentiation model. The full coding region was obtained using the RACE method.
Sequence analysis against an NCBI Map viewer revealed that the KDRP gene is located on chro-
mosome 1q21 in the region of the epidermal differentiation complex (EDC). Northern blot analysis
showed that the amount of a 2.5 kb mRNA transcript was markedly increased at both 7 and 14 days
after treatment with 1.2 mM calcium in cultured normal human epidermal keratinocytes (NHEK).
A mouse tissue blot assay detected expression of KDRP at 17.5 embryonic days, and seen in stom-
ach and skin tissues. The KDRP geneis predicted to encode a protein of approximately 70 KDa that
consists of 580 amino acids with 18% proline and 11% glutamine. In situ hybridization demonstrated
that the KDRP gene is expressed in the upper granular layer of normal epidermis with a character-
istic intermittent pattern and increasing expression in the psoriatic lesion with a continuous pattern.
Immunohistochemical analysis also showed that the KDRP protein is localized at the granular layer
of both normal and psoriatic epdermis, similar to results from in situ hybridization . Consistent with
this, Western blot analysis revealed that the amount of the 70 KDa KDRP protein was significantly
increased by calcium treatment in a time-dependent manner. KDRP appears to be a novel epidermal
marker that has a potential role in keratinocyte differentiation. 
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Stratum corneum lipid abnormalities in the patient skin with senile xerosis
M Yamanaka,1 S Hamanaka2 and T Tsuchida1 1 Dermatology, Saitama Medical School, Saitama,
Japan and 2 Sphingolipid Expression Laboratory, Riken, Wako, Japan
Stratum corneum (SC) lipids play a predominant role in maintaing the water barrier of the skin. The
protein-enriched corneocytes are embedded in an intercellular lipid matrix which is composed pri-
marily of ceramides, cholesterol and fatty acids together with smaller amounts of cholesterol sul-
phate, glucosylceramides and phospholipids. These lipids form multilamellar sheets within the inter-
cellular spaces of the stratum corneum. Depletions in lipid levels as a result of environmental
challenges can lead to disturbances in skin function. Changes in stratum corneum lipid levels have
been linked with aberrant skin conditions, such as xerosis. The incidence of skin xerosis appears
greater with increasing age. To clarify the relationship between the senile xerosis and lipid abnor-
malities within SC, SC lipids were extracted from the patient skin with senile xerosis and the lipids
were analyzed and compared with those of the young and age matched skin. The extracted lipids
were purified by DEAE A25 column chromatography (acetate form) separating the neutral and acidic
fractions. The neutral fractions contained cholesterol, cholesterol esters and ceramides 1 to 7, which
were analyzed by thin-layer chromatography, and the contents were estimated by a densitometric
method. In the patient SC, the contents of ceramide 2 and ceramide 7 increased while that of cho-
lesterol esters and ceramide 6 decreased significantly. The acidic fraction contained free ω-hydroxy
fatty acids as well as α-hydroxy fatty acids in addition to the several saturated and unsaturated fatty
acids. The spectra obtained by the positive ion mass/mass spectrometry revealed that chain length
of the free ω-hydroxy fatty acids were very long, C30 and C32:1. The lipid abnormalities in the
patients with senile xerosis were different from those of aged skin, suggesting that the different bio-
chemical events may exist in senile xerosis. 
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Barium sulfate with a negative ζ potential, accelerates skin permeable barrier recovery and
prevents epidermal hyperplasia induced by barrier disruption
S Fuziwara, K Ogawa, D Aso, D Yoshizawa, S Takata and M Denda Shiseido Research Center,
Yokohama-shi, Kanagawa-ken, Japan
Barium sulfate a stable inorganic material has been used for contrast media or cosmetic products
because of its stability. In the present study, we demonstrated that barium sulfate particles in aque-
ous solution have different  potentials depending on their surface structure. Since a negative exter-
nal electric potential accelerates the skin barrier repair after barrier disruption, we hypothesized that
topical application of barium sulfate affects the skin barrier recovery rate depending on its ζ poten-
tial. There was a significant correlation between the barrier recovery rate and  potential of barium
sulfate applied topically. Barium sulfate with a negative ζ potential, significantly accelerated barrier
recovery, with a positive potential did not accelerate or even delayed barrier repair. Barium sulfate,
with a negative potential had an X ray refraction pattern different from that with a positive poten-
tial. The distribution of calcium in the epidermis was also influenced by the polarity of ζ potential.
Altogether topical application of barium sulfate with a negative ζ potential, prevented the epidermal
hyperplasia induced by barrier disruption under a dry environment. These findings suggest a new
pharmacological approach toward altering barrier function or epidermal hyperplasia with inorganic
particles in healthy and diseased skin. 
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TNF-α, IL-1α and IFN-α enhance IFN-γ-induced fractalkine production in normal human
keratinocytes
Y Shirakata, M Tohyama, T Tsuda, E Tan, Y Yahata, K Yamasaki, S Tokumaru, Y Hanakawa,
K Sayama and K Hashimoto Dermatology, Ehime University School of Medicine, Ehime, Japan
Fractalkine/CX3CL1, a chemokine, is synthesized as a membrane bound form and converted to a
soluble form by protease(s). Since fractalkine recruits CX3CR1 positive cells such as NK cells and
CD8 T cells, it is supposed to be involved in recruiting these cells into the epidermis in the inflam-
matory reaction. To address this issue, we investigated whether normal human keratinocytes can pro-
duce fractalkine in the presence of cytokines. The production of fractalkine was analyzed using real
time PCR, Western blot and ELISA. The mRNA expression of fractalkine was very low in unstim-
ulated keratinocytes. However, its expression was induced by IFN-γ (50 IU/ml) in a time dependent
manner optimally 67 folds at 24 h. The concentration of fractalkine in the medium was undetectable
at 48 h, but increased to 900 pg/ml after addition of IFN-γ (10 IU/ml). In contrast, either TNF-α (10
ng/ml) or IL-1α (10 ng/ml) had no effects. Interestingly, IFN-γ-induced fractalkine mRNA expres-
sion was synergistically upregulated by TNF-α and IL-1α compared to that treated with IFN-γ alone,
19 and 3.7 folds at 3h, respectively. IFN-γ-induced soluble fractalkine was markedly increased by
IL-1α and TNF-α, 2 and 4 folds, respectively. We also examined the effect of IFN-α on fractalkine
expression. IFN-α (0.5 IU/ml) upregulated fractalkine mRNA optimally 5 folds at 1 h, but did not
induce the production of fractalkine protein in the medium. IFN-α enhanced IFN-γ-induced fractalkine
mRNA expression by 2.5 folds at 1 h. Furthermore, IFN-α increased IFN-γ-induced soluble fractalkine
production in a dose dependent manner. Taking together, TNF-α, IL1-α and IFN-α synergistically
enhanced IFN-γ-induced fractalkine production in normal human keratinocytes. In conclusion, this
is the first report showing that normal human keratinocytes produce soluble fractalkine protein. 
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Peroxisome proliferator-activated receptor(ppar)-γ activation stimulates keratinocyte differ-
entiation
M Man,1,2 AJ Fowler,1 M Schmuth,1 P Lau,1 S Chang,2 BE Brown,1 AH Moser,2,1 L Michalik,4
B Desvergne,4 W Wahli,4 M Li,3 D Metzger,3 PH Chambon,3 PM Elias1,2 and KR Feingold2,1 1
Dermatology and Medicine, UCSF, San Francisco, CA, 2 Dermatology and Medicine, VAMC, San
Francisco, CA, 3 IGBMC, CNRS/INSERM/Universite Louis Pasteur, Illkirch, France and 4 Center
for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
PPARs are nuclear hormone receptors that are activated by endogenous lipid metabolites and thia-
zolidinediones (TZDs). Previous studies have demonstrated that PPARα and δ activation stimulate
keratinocyte differentiation; is anti-inflammatory; and improves barrier homeostasis. Here, a TZD,
ciglitizone, increased involucrin /transglutaminase 1 mRNA levels in cultured human keratinocytes,.
Moreover, topical ciglitazone and troglitazone increases loricrin, involucrin, and filaggrin expres-
sion in hairless mouse. Topical PPARγ activators also improved permeability barrier homeostasis,
indicated by accelerated barrier recovery following acute disruption (tape stripping or acetone).
Further, TZDs reduced the cutaneous inflammation in both the TPA model of irritant contact der-
matitis, and the oxazolone model of allergic contact dermatitis. PPARγ-deficient mice displayed a
modest increase in epidermal thickness, associated with increased PCNA staining, while skin func-
tions, including permeability barrier homeostasis, surface pH, and stratum corneum water content
were similar in PPARγ-deficient and wild-type epidermis. Moreover, PPARγ activators did not
stimulate loricrin and filaggrin expression in PPARγ-deficient mice, indicating that the stimulation
of differentiation by PPARγ activators is mediated by PPARγ. However, TZDs inhibited inflamma-
tion comparably in both PPARγ-deficient and wild-type mouse skin, indicating that the inhibition
of inflammation does not require PPARγ, similar to other studies on macrophages. Together, these
observations predict that TZDs, and perhaps other PPARγ activators, could prove useful for the treat-
ment of skin disorders, characterized by abnormal differentiation, barrier function, and inflamation. 
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Primary isolation and serial propagation of normal human keratinocytes in a defined, animal
product-free cell culture environment
PW Cook, CM Parrish, AK Shipley, EK Tucker, M Van Kleeck and S Li  R&D, Cascade Biologics,
Inc., Portland, OR
Cell culture media for in vitro propagation of human keratinocytes are typically supplemented with
undefined or defined animal-derived products that can include: sera (e.g., FBS), serum proteins (e.g.,
BSA), and/or extracts from pituitary glands (BPE), embryos, brain, or other tissues, and other growth-
promoting factors such as Insulin. Xenotrophic feeder layer cells have also been utilized to promote
the propagation of these cells.  Use of these reagents in cell culture media can increase the risk of
contaminating cell-based and cell-derived therapeutics with infectious agents such as prions (BSE)
and viruses, and can represent a health risk hazard to patients treated with these therapeutic agents.
The efficient primary isolation and serial expansion of normal animal cells in a defined animal
product-free (d-APF) cell culture system has not been previously reported. We have recently dis-
covered that a d-APF supplement containing growth factors, hormones and other proteins (S-70203)
is capable of supporting the primary isolation and serial propagation of adult human epidermal ker-
atinocytes (HEKa). Using the d-APF system, HEKa can be isolated and expanded in primary cul-
ture within 7-9 days. The cells can then be serially propagated for up to 40 post-primary cumulative
population doublings. The d-APF HEKa cultures display initial growth rates that are typically greater
than one population doubling per day, possess normal morphology, express epidermis-specific cytok-
eratins, and can be induced to express Involucrin as well as form a reconstructed human epidermis
ex vivo. Collectively, our results describe a new keratinocyte culture system in which the require-
ments for animal products such as BPE and other undefined reagents, are eliminated, and replaced
by d-APF components. d-APF keratinocyte cell culture systems may eventually allow investigators
to more safely utilize both human keratinocytes and human keratinocyte-derived products for wound
and gene therapy protocols. 
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Vegf is both required for permeability barrier function, and regulated by barrier requirements
PM Elias,1 J Arbiser,2 BE Brown,1 E Choi,1 M Man,1 H Rossiter,3 KR Feingold1 and E Tschachler3
1 Dermatology and Medicine, UCSF, San Francisco, CA, 2 Dermatology, Emory University,
Atlanta, GA and 3 Dermatology, University of Vienna Medical School, Vienna, Austria
Restoration of a competent permeability barrier after external perturbations requires up-regulation
of metabolic responses that lead to normalization of function. We assessed here whether these home-
ostatic responses include the generation of signals that could facilitate nutrient/precursor delivery
from the vascular compartment. Indeed, 2-4hrs after acute barrier perturbation of hairless mouse skin
by either repeated tape stripping or acetone, epidermal mRNA levels of VEGF increased 20-40-
fold. Artificial barrier restoration by the application of a vapor-impermeable wrap blocked the increase
in VEGF specifically linking the increase to barrier requirements. The putative requirements for
VEGF were shown further in transgenic mice with epidermis-localized VEGF k.o. (VEGF-A,K5-
Cre/K5-Cre), which displayed a significant delay in barrier recovery after acute perturbation.
Despite the apparent link between VEGF expression and barrier requirements, we could not detect
increased blood vessel growth after either acute or repeated barrier insults (as changes in CD31 and
factor 8 levels). Moreover, both CD31 and factor 8 expression appeared unchanged in VEGF k.o.
skin. Although these studies clearly demonstrate a link between VEGF and permeability barrier
homeostasis, it is likely that other growth factors (i.e., FGF) sustain vessel growth in the absence of
VEGF. Finally, these studies suggest that VEGF influences barrier homeostasis by mechanisms dis-
tinct from its well-known paracrine effects on vessel growth. 
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Organization of stem cells and their progeny in human epidermis
S Ghazizadeh,1,2 R Harrington2 and LB Taichman2 1 Dermatology, Columbia University, New York,
NY and 2 Oral Biology & Pathology, Stony Brook University, Stony Brook, NY
The epidermis is a self-renewing tissue that consists of stem cells, transit amplifying cells and dif-
ferentiating cells. Histological and genetic labeling studies in mouse epidermis are consistent with
the presence of highly ordered, columnar structures named epidermal proliferative units. Each unit
consists of a stem cell and its descendent amplifying and terminally differentiated cells. In human
epidermis, the larger number of strata, and the undulating basement membrane with rete ridge for-
mation make comparison with mouse difficult. These differences have lead to conflicting reports.
Some reports indicate clustering of human epidermal stem cells (b-1 integrin bright cells) at the top
of the ridges, whereas others show a location at the base of the ridge. To address this issue, we have
genetically labeled epidermal stem cells in adult, human skin xenografts using in vivo lentivirus-
mediated gene transfer. Stem cell transduction was confirmed by long-term non-invasive monitor-
ing of the skin surface for transgene product (Green or Red Fluorescent Protein). Lineage analysis
of serially sectioned skin at 6 months post-transduction indicated the presence of labeled cells organ-
ized into narrow columns extending outward from basal layer. This was consistent with the organi-
zation of stem cells and their progeny into EPUs. The number of basal cells in an EPU however, was
less than that observed for mouse epidermis (10-20 basal cells) ranging from 1 to 4 cells. These EPUs
originated from the top, middle and bottom of the rete ridges. No correlation between b-1 integrin
bright cells and location of stem cells was found. These data confirm columnar organization of stem
cells and their progeny in undulating human epidermis and suggest minimal migration of stem cells
or their progeny along the basal layer. 
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Biochemical basis for accelerated permeability barrier recovery induced by PPAR and LXR
activators
M Man,1,2 S Choi,1,2 KR Feingold1,2 and PM Elias1,2 1 Dermatology and Medicine, UCSF, San
Francisco, CA and 2 Dermatology and Medicine, VAMC, San Francisco, CA
Previous studies from this laboratory have demonstrated that topic applications of peroxisome pro-
liferator activated receptor (PPAR) and liver X receptor(LXR) activators enhance epidermal differ-
entiation and accelerate epidermal permeability barrier recovery as determined by measurement of
transepidermal water loss (TEWL). We determined here whether increased lipid synthesis is a mech-
anism that accounts for the acceleration of barrier recovery by these agents. 6 to 8 week old hairless
mice were topically treated with 10 mM of test compound twice-daily for three days. Control groups
were treated with vehicle (acetone) alone. 14C acetate incorporation into lipids was measured to
assess lipid synthesis rates. Osmium tetroxide post-fixation was used to visualize epidermal lamel-
lar body structure and number (density) by electron microscopy. Topical applications of either PPAR
alpha (WY14643), delta (GW1514), gamma (ciglitazone) or LXR (22(R)-cholesterol) activators, for
3 days significantly increased epidermal cholesterol and fatty acid synthesis as compared to vehi-
cle-treated controls. In addition, both the density of lamellar bodies, the organelle that delivers
lipids to the stratum corneum for barrier formation, and lamellar body secretion following barrier
disruption increase significantly in the activator-treated groups. These studies indicate that topical
administration of PPAR and LXR activators induce an increase in epidermal lipid synthesis and
increased formation of lamellar bodies, which account, at least in part, for the acceleration in epi-
dermal barrier recovery that follows acute barrier disruption. These results further suggest that PPAR
and LXR activators might be useful in the treatment of skin disorders with abnormal barrier func-
tion, or in the development of skin care products that aim to improve epidermal function. 
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Lactate and potassium content in relation to the physical properties of the stratum corneum
in healthy subjects
S Sakai,1 N Nakagawa,1 M Matsumoto,2 K Yamada,2 M Nagano,2 T Yuki,1 Y Sumida2 and
H Uchiwa1 1 Basic Research Laboratory, Kanebo Ltd., Odawara, Japan and 2 Cosmetic
Laboratory, Kanebo Ltd., Odawara, Japan
Natural moisturizing factor (NMF) of the stratum corneum (SC) has been established to play impor-
tant roles in regulating the physical properties of the SC. However, few studies have investigated the
specific influences of NMF components other than the amino acids. In this study we focus on the
relationship between the ion content and physical properties of the SC in 40 healthy subjects. The
hydration, stiffness, and pH of the SC on the forearm were respectively measured by a skin surface
hygrometer (Skicon-200), tactile sensor (Venustron), and flat glass electrode connected to a pH meter.
The ion levels in the SC were measured after water-extraction of tape-stripped SC. All ion quanti-
ties were normalized to the amount of tape-stripped SC. The changes in the physical properties of
the SC induced by the NMF extraction were equivalent to the changes that took place from summer
to winter, thereby demonstrating the important role of NMF in regulating the physical properties of
the SC in healthy subjects. The seasonal changes in the physical properties of the SC from summer
to winter were accompanied by significant decreases in the levels of lactate, potassium, sodium, and
chloride in the SC. Lactate and potassium were the only components that significantly correlated
with the hydration, stiffness, and pH. Interestingly, the lactate and potassium levels of the SC were
also significantly correlated with each other. Moreover, potassium lactate was more effective than
sodium lactate in restoring the SC hydration depleted by the NMF extraction. The ratios of both lac-
tate and potassium to sodium were confirmed to be lower in the sweat than in the SC, showing that
the lactate and potassium in the SC were derived from an epithelium other than the sweat gland.
These results suggest that the movement of lactate and potassium from epithelium to the SC may
play important roles in regulating the physical properties of the SC. 
410
Analysis of N-terminal domain of connexin26: a novel N14Y mutation does not affect second-
ary structure of N-terminal domain, but increases hydrophobic features of intracytoplasmic
head of connexin26
K Arita,1 M Akiyama,1 T Aizawa,2 I Segawa,3 D Sawamura,1 M Demura,2 K Nitta2 and H Shimizu1
1 Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 2 Laboratory
of Structural Bio-Macromolecular Science III, Division of Biological Science, Hokkaido
University, Sapporo, Japan and 3 Dermatology, Iwate Prefectural Central Hospital, Iwate, Japan
Connexins (Cxs) are transmembranous proteins and their hexamer “connexon” constructs channel
structure at the plasma membrane. Connexons form transmembranous channels with adjacent cells,
which are known as gap junctions. Ions and second messengers can permeate through the gap junc-
tion and it is thought that gap junction may have certain roles in cell-cell communication and main-
tenance of tissue homeostasis. The N-terminal 21 amino acids of Cx26 is located at the cytoplasmic
side of the channel pore and is thought to be essential for the regulation of channel selectivity. Mis-
sense mutations of the Cx26 gene have been reported in cases of keratitis-ichthyosis-deafness (KID)
syndrome and two of the four reported mutations to date were at the N-terminus of the Cx26, which
suggest the critical role of this domain for the channel functions. We have found a novel mutation
N14Y in the N-terminal domain of the Cx26 in a case of KID syndrome. In order to elucidate path-
omechanism of KID syndrome, the effect of the mutation on molecular structure and chemical char-
acteristics of the N-terminal domain was investigated using synthetic N-terminus peptides (1-20
residues) of Cx26, both of the wild type and the mutated one. The secondary structures of these two
model peptides are basically the same from the analysis using two dimensional 1H nuclear mag-
netic resonance (NMR) and circular dichroism measurements, though the water solubility of the pep-
tides decreased by the mutation. These results raise the possibility that the amino acid substitution
from a hydrophilic residue to a hydrophobic one induces changes in local conformation and elec-
tronic charge, which might affect ion permeability of gap junctions and result in a phenotype of
KID syndrome. 
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Analysis of profilaggrin N-terminus protein-protein interactions using the yeast two-hybrid
system
O Lawrence1 and RB Presland1,2 1 Oral Biology, University of Washington, Seattle, WA and 2
Medicine (Dermatology), University of Washington, Seattle, WA
In this study, we used the yeast two-hybrid (Y2H) system to examine if the human profilaggrin N-
terminus can form homodimers in vivo. Profilaggrin, a protein expressed in granular cells of epi-
dermis, consists of multiple filaggrin units and N- and C-terminal domains that differ from filag-
grin. The human profilaggrin N-terminus consists of two distinct segments, an acidic A domain that
binds calcium and a basic B domain that includes a nuclear localization signal. The A domain is
homologous to the S100 family of calcium binding proteins. S100 proteins form homodimers, het-
erodimers with other S100 proteins, and also bind additional target proteins in a calcium-dependent
manner. Here, we demonstrate that the human profilaggrin N-terminus containing both the A and B
domains can homodimerize in vivo. However, fusion proteins containing the profilaggrin A domain
(either 91 or 99 amino acids) failed to form homodimers in yeast. The 91-residue fusion protein
includes the high-affinity calcium-binding loop and the adjoining helices, while the 99-residue fusion
protein contains the extended fourth alpha-helix domain. Western blotting showed that both the AB
and A domain fusion proteins were expressed in yeast. A mutant profilaggrin AB fusion protein
with severely reduced calcium-binding capacity formed homodimers in the Y2H assay. This result
is consistent with studies of other S100 proteins, which demonstrated that S100-S100 interactions
do not require calcium-binding to the EF-hands. These results demonstrate the profilaggrin N-ter-
minal domain, unlike the canonical low molecular weight S100 proteins, requires part or all of the
downstream B domain to form homodimers. Western blot data also suggests that progressive exten-
sion of the A domain beyond the S100 domain to include the B domain acts to stabilize the A
domain fusion proteins in yeast. Current studies are directed towards determining the downstream
targets of the profilaggrin N-terminus, and its possible role in nuclear events during epidermal dif-
ferentiation.
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Functional properties of the stratum corneum in patients with diabetes mellitus
T Sugawara,1 K Kikuchi,2 S Sakai,1 M Furukawa,1 J Satoh,3 H Tagami,2 E Takahashi,4
M Yamakado5 and S Inoue1 1 Basic Research Laboratory, Kanebo Ltd., Odawara, Japan, 2
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan, 3 Department
of Diabetes and Metabolism, Iwate Medical University, Morioka, Japan, 4 Department of Hygiene
and Preventive Medicine, Showa University School of Medicine, Tokyo, Japan and 5 Center for
Multiphasic Health Testing and Services, Mitsui Memorial Hospital, Tokyo, Japan
Though earlier studies have confirmed the effects of diabetes mellitus in inducing numerous patho-
physiological changes of the skin, none have focused on the state of the stratum corneum (SC) in
diabetic subjects. The following values were measured in 49 diabetic patients to examine the func-
tional changes of the SC: fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c); the skin sur-
face lipid level on the forehead; and high-frequency conductance (HFC) and transepidermal water
loss (TEWL) of the cheek, volar forearm, and extensor surface of the lower leg. The high-FPG
group (>110 mg/dL) and low-FPG group (<110 mg/dL) exhibited almost identical TEWL values,
though the former exhibited significantly lower skin surface lipids and significantly lower HFC lev-
els on the extensor leg and volar forearm. The HFC did not significantly differ between the high
(>5.8%)- and low (<5.8%)-HbA1c groups. Like patients with senile xerosis, diabetic patients exhib-
ited reductions in both SC hydration and sebaceous gland activity without any impairment of the SC
barrier function. The SC hydration was more influenced by the hyperglycemic condition at the time
of measurement than by the hyperglycemic condition over the 1 to 2 months immediately prior to
the measurement. We also measured the HFC of 9 healthy subjects during the oral glucose tolerance
test to investigate how the SC hydration responded to the change in the blood glucose. The HFC was
significantly decreased when the plasma glucose peaked, suggesting that the SC hydration was influ-
enced by at least a temporal rise in the blood glucose level. 
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CGI-58 protein is involved in formation of the trans-Golgi network- lamellar granules and
caveolae in human differentiating keratinocytes
M Akiyama, JR McMillan, D Sawamura and H Shimizu Department of Dermatology, Hokkaido
University Graduate School of Medicine, Sapporo, Hokkaido, Japan
We have reported that truncation of CGI-58 protein, a member of α/βhydrolase family and a puta-
tive esterase/lipase/thioesterase, results in abnormal LG formation in Dorfman-Chanarin syndrome
(Akiyama et al, JID 2003). LGs have been shown to be a part of TGN and secretion of LG contents
is associated with the formation of caveolae, specialized areas of sphingolipid- and cholesterol-rich
membrane invagination. To clarify the roles of CGI-58 protein, we studied the effects of the com-
plete abolition of CGI-58 protein enzyme activity on the TGN-LG and caveola formation. Homol-
ogy search and conserved domain analysis suggested that a nonsense mutation R184X would abol-
ish the α/βhydrolase CGI-58 activity. In the epidermis harboring such homozygous mutations (CGI-58-
epidermis), the ultrastructural formation of TGN-LG and caveola and the distribution of proteins
associated with TGN-LG and caveolae were investigated. We studied the distribution of TGN-
markers (TGN-46 and protein kinase A type II regulatory subunitα (RIIα)), TGN-LG contents (cathep-
sin C and D, βdefensin 2 and 3) and caveola components (caveolin 1, 2 and 3) using confocal laser
scanning microscopy. TGN-46 was distributed only in the perinuclear area in CGI-58- epidermis,
while it was observed diffusely throughout the cytoplasm in normal epidermis. RIIα and cathepsin
D were distributed normally in CGI-58- epidermis. Cathepsin C expression was seen in the granu-
lar layer of the normal epidermis, but not in CGI-58- epidermis. The expression of both βdefensin 2
and 3 in the upper epidermis was stronger in CGI-58- skin than in normal skin. Caveolin 1, 2 and 3
expression was reduced in CGI-58- epidermis. Ultrastructurally, malformed TGN-LG and caveolae
were seen in the granular layers. These findings suggest that lipid-carrying TGN-LG and caveolae
are specifically affected in CGI-58- epidermis. CGI-58 protein is thought to be involved in forma-
tion of the lipid-transporting TGN-LG and in the caveola-mediated secretion of LG contents. 
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Increased expression of squamous cell carcinoma antigen protects keratinocytes from UV-
induced cell death: critical role of SCCA as a natural inhibitor of the stress kinase JNK/SAPK
C Katagiri, K Kadoya, J Nakanishi and T Hibino Shiseido Life Science Research Center, Yokohama,
Japan
Squamous cell carcinoma antigen (SCCA) belongs to the serpin superfamily and two different gene
products, namely SCCA1 and SCCA2, are known in Homo sapience. Although they have all the
characteristics of inhibitory serpins, their physiological roles in keratinocytes are largely unknown.
Here we show that SCCA1 and SCCA2 are natural inhibitors of the activated JNK and play a criti-
cal role against UV-induced keratinocyte apoptosis. Immunohistochemical and in situ hybridization
analyses demonstrated marked elevation of SCCAs in spinous and granular cells of sun-exposed
skin, whereas they were expressed weakly in upper epidermis of the sun-protected skin. UV irradi-
ation study in vivo on buttock skin confirmed strong up-regulation of SCCAs in spinous and gran-
ular cells. cDNAs for SCCA1 or SCCA2 were stably transfected into 3T3-J2 cells, which do not
express SCCAs. FACS analysis revealed that UVB-induced cell death was significantly suppressed
in SCCA-transfected cells. Furthermore we established an SCCA knockdown cell line using RNA
interference technology. HaCat cells, which express high levels of SCCAs, were stably transfected
with the pSilencer vector containing the siRNA target sequence to SCCA. In this cell line (siSCCA)
more than 90% of SCCA was suppressed as judged by quantitative PCR analysis. UVB irradiation
study (75 mJ/cm2) showed that only 12% of siSCCA survived, while 43% was found alive in con-
trol cells. We then investigated interacting molecules for SCCAs using the Signal Transduction Anti-
body Array (Hypromatrix, Inc). Both SCCAs demonstrated specific binding to active JNK1 but not
to inactive JNK1. These results were confirmed with immunoprecipitation studies. In addition, recom-
binant SCCA1 suppressed kinase activity of JNK1 with a dose dependent manner. These lines of
evidence strongly suggest a novel UV protection mechanism in human epidermis, which SCCA
inhibits the UV-induced apoptotic signal transduction. 
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Decreased hydration and reduced flexibility of strarum corneum are associated with severity
of phenotype in severe ichthyosis
Y Tomita, M Akiyama and H Shimizu Department of Dermatology, Hokkaido University Graduate
School of Medicine, Sapporo, Hokkaido, Japan
Exact pathomechanisms of hyperkeratosis in severe ichthyosis have not been clarified completely
yet. Defective barrier function of stratum corneum is thought to be associated with formation of
ichthyosis phenotype. In order to evaluate the stratum corneum barrier function in severe ichthyosis,
we studied transepidermal water loss (TEWL), stratum corneum hydration and stratum corneum
thickness in the dorsal and volar forearm, the forehead and the back of patients with severe ichthyosis
aged 2 to 46 years (4 males, 3 females) (TEWL was not measured in the back). Seven patients (4
non-bullous congenital ichthyosiform erythroderma, 1 bullous congenital ichthyosiform erythro-
derma, 1 lamellar ichthyosis, 1 ichthyosis bullosa of Siemens) and age- and sex- matched controls
were included in the present study. TEWL was measured using an evaporimeter (AS-TW1, ASAHI
BIOMED, Japan). Stratum corneum hydration was measured as low frequency conductance by a
corneometer (ASA- M2, ASAHI BIOMED). In addition, stratum corneum thickness was also meas-
ured by the corneometer and stratum corneum flexibility was assessed as (stratum corneum hydra-
tion) / (stratum corneum thickness)2. Severity of ichthyosis phenotype was evaluated using a visual
analogue scale (VAS). Stratum corneum hydration and flexibility were significantly reduced in severe
ichthyosis patients as compared to normal control (p<0.005). TEWL was significantly increased in
severe ichthyosis skin (p<0.02), except for the forehead. Positive correlation was observed between
the ichthyosis severity and stratum corneum thickness and negative correlation was confirmed between
ichthyosis severity and stratum corneum hydration and flexibility. These results indicated that per-
meability defects in severe ichthyosis lead to increased TEWL and decreased stratum corneum hydra-
tion and it was suggested that low stratum corneum hydration and decreased flexibility of stratum
corneum are closely associated with severity of ichthyosis phenotype in severe ichthyosis. 
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Serine Proteases alter barrier homeostasis by a protease activated receptor 2-dependent mech-
anism
J Hachem,1,2 Y Uchida,2 D Crumrine,2 T Roelandt,1 BE Brown,2 D Roseeuw,1 KR Feingold2 and
PM Elias2 1 Dermatology, AZ-VUB, Brussels, Belgium and 2 Dermatology and Medical Services
(Metabolism), VA medical center, UCSF, San Francisco, CA
Keratinocytes express protease activated receptor 2 (PAR2) in both the basal layer and stratum gran-
ulosum, where it further co-localizes with the stratum corneum (SC) tryptic and chymotryptic enzymes.
Here, we addressed the effects of serine protease (SP) and PAR2 activation/inhibition on perme-
ability barrier homeostasis in two mouse models of SP activation: 1) transient SC neutralization,
and 2) acute barrier perturbation. To provoke SC neutralization, 1,1,3,3-tetramethylguanidine (TMG,
1/100), a superbase, was applied in propylene glycol:ethanol (7:3) and the downstream effects on
barrier recovery was evaluated in comparison to both neutralized TMG and TMG+co-applied SP
inhibitors (SPI). In parallel, either SPI or PAR2 agonist peptides (SLIGRL, 10mM) were applied to
tape-stripped flanks of hairless mice, and barrier recovery kinetics were compared to vehicle alone
(propylene glycol:ethanol, 3:7), and to stripped skin sites treated with the PAR2 reverse peptide
(LRGILS, 10mM) alone. Both SC neutralization and acute barrier perturbation increased SP activ-
ity, assessed by in situ zymography. Application of either the superbase or the PAR2 agonist peptide
delayed permeability barrier recovery. In contrast, either co-applied SPI, shown to inhibit SP activ-
ity, or applications of the PAR2 reverse peptide, significantly accelerated barrier recovery in tape-
stripped skin. The latter could be further attributed to enhanced generation and secretion of lamel-
lar bodies, observed by electron microscopy. These results provide a mechanism whereby
pH-dependent increases in SP activity perturb barrier function. Finally, blockade of PAR2 represents
a potentially novel form of therapy for dermatoses associated with barrier dysfunction, increased
SC pH, and/or SP activation. 
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RambazoleTM, a potent inhibitor of all-trans retinoic acid metabolism, applied topically to
mouse tail skin exerts retinoid mimetic activity
P Stoppie,1 J Van Wauwe,2 L Wouters1 and M Borgers1 1 Barrier Therapeutics, Geel, Belgium and
2 Johnson&Johnson Pharmaceutical R&D, Beerse, Belgium
Rambazole has been identified in vitro as a potent and selective inhibitor of retinoic acid (RA)
cytochrome P450 4-hydroxylase. Repeated oral administration of Rambazole to mice exerted retinoidal
effects in tail and ear skin. The aim of the present study was to investigate whether topical applica-
tion of Rambazole would also generate retinoidal effects. Mice were treated topically once daily for
14 days on their tail skin with vehicle, RA or Rambazole. 24 hours after 1st, 4, 7, 11 & 14th appli-
cation, tail and ear skin samples were collected for histologic assessment of (1) local drug activity
by quantification of the degree of para- to orthokeratotic conversion of tail epidermis and of (2) sys-
temic drug activity by measuring of pinnal epidermal hyperplasia. Repeated application to tail skin
of either RA (0.5-4 µg) or Rambazole (0.5-16 µg) resulted in a dose-related para- to orthokeratotic
transformation of tail epidermis. The potencies with which RA and Rambazole affected keratosis
were comparable: RA and Rambazole yielded a statistically significant response from 1 µg and 2
µg on, respectively. However, Rambazole caused no thickening of ear epidermis indicating that its
activity is restricted to the application site and that a systemic action of the drug or endogenous RA
can be ruled out. Time-course data reveal a faster onset of action with Rambazole (16 µg) than with
RA (4 µg); the transformation was almost complete at day 8 in Rambazole-treated mice versus at
day 15 in RA-treated mice. The orthokeratotic transformation of mouse tail epidermis by RA (16
µg) and Rambazole (16 µg) was markedly attenuated by concomitant application of the RAR antag-
onist AGN193109 (16 µg). In conclusion, our data provide evidence that topical Rambazole exerts
local retinoidal effects in mice. The observation that its retinoid mimetic activity could be reversed
by RAR antagonism supports the idea that Rambazole′s actions result from enhanced endogenous
RA levels and triggering of RA receptors. 
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A new peptide that displays an uncoupling-like effect on the mitochondrial respiration process
of adipocytes and reduces adipocyte lipid synthesis
E Bauza, G Bressier, E Roux, J Botto, C Dal Farra and N Domloge Skin Research, Vincience,
Sophia Antipolis, Sophia Antipolis, France
Uncoupling is an essential mechanism of respiration and energy dissipation. Data has shown that
animal and plant homologues of uncoupling proteins (UCPs) are universal. Interestingly, recent stud-
ies have noted that these UCPs play a part in fatty acid and glucose utilization, and that they are
involved in thermogenesis and obesity disorder. As we were interested in agents and mechanisms
that can modulate fat cell metabolism in order to reduce adipocyte storage of triglycerides in lipid
droplets, we developed an uncoupling-like peptide with an amino acid sequence similar to a con-
served sequence present in many UCPs, and investigated its effect, in vitro, on lipid synthesis in adi-
pose cells. For these studies, we used established pre-adipocytes 3T3-L1 and studied the effect of
this new UCP-like peptide on their differentiation and formation of lipids. Oil red staining experi-
ments demonstrated that application of 0.5% of the UCP-like peptide on the cells at different times
during their differentiation significantly reduced their lipid droplet content. This effect was signifi-
cant when the active ingredient was applied early in the first hours of their culture, before the begin-
ning of differentiation. In order to confirm that the new peptide mimics the mechanism of action of
UCPs, ATP and cAMP assessment, as well as glycerol release experiments were performed, in com-
parison with an agent that has a lipolysing effect. These experiments confirmed that the new pep-
tide presumably uncouples, or facilitates the uncoupling of the cellular mitochondrial respiration
process from its terminal ATP synthesis step, therefore suppressing lipid droplet accumulation in
the cells, and enhancing energy release, by the ATP-independent pathway. These studies reveal the
interest of using this new UCP-like peptide for reducing adipose cell lipid content, an action which
is of great application in the slimming products of modern cosmetics. 
423
Effect of antioxidants on the wound healing of keratinocyte monolayers
JJ Wille Research Center, Bioderm Technologies, Inc., Trenton, NJ
HaCat keratinocyte confluent monolayers are a useful model to study the effect of antioxidants on
wound healing (WH). They were grown to confluence in DMEM-10% serum medium and a 1.5 mm
wide wound was made along the midline of the monolayer. Immediately, thereafter, hydroalcoholic
extracts prepared from green tea leaves (GTL) or ripe Autumn Olive berries (AOB), were added,
and compared to the effects of addition of a flavonoid antioxidant, quercetin dihydrate (QD)and vita-
min C(ascorbic acid, AA). Untreated and treated wounded monolayers were photographed 24 and
48 hours later using phase contrast optics and again after fixation and crystal violet staining. Untreated
monolayers healed completely along the wound gap, Wound Healing Zone(WHZ) between 24 and
48 hours. The rate of WH was accelerated by treatment with of 12.5mM AA. By contrast, addition
of plant-derived antioxidants inhibited proliferation and WH in a dose dependent manner. Cell migra-
tion into the WHZ was less affected than proliferation at equivalent doses. QD completely inhibited
WH at 20uM; partial closure was seen at 10uM. GTL (1% extract) profoundly inhibited growth and
WH, and induced cornified envelope formation in unwounded cells of the monolayer above 1% of
GTL extract. A 2.5% AOB extract completely inhibited growth and WH, and partially inhibited clo-
sure at 1%. A 5-min exposure of live cultures to 1% SDS revealed that cells in the WHZ are more
sensitive to detergent disruption than surropunding cells. AA treatment decreased the sensitivity of
cells in the WHZ, while plant antioxidants increased their sensitivity. The results suggest that cells
in the WHZ are in a less advanced stage of keratinizing differentiation. Also, vitamin C has the oppo-
site effects on WH than the plant antioxidants tested. These studies are relevant to the use of plant
antioxidants as potential cosmeceutical ingredients. 
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Generation and characterization of constitutively active recombinant human caspase-14
K Park,1 MK Kuechle2 and RB Presland1,2 1 Oral Biology, University of Washington, Seattle, WA
and 2 Medicine/Dermatology, University of Washington, Seattle, WA
Caspase-14 is a member of the caspase family of cysteine proteases, which is expressed and acti-
vated in the granular layer of epidermis and some other keratinizing epithelia. Its substrates, func-
tion, and mode of activation during epidermal terminal differentiation are currently unknown. Cas-
pase-14 possesses a particularly short prodomain of 13 amino acids similar to the caspase 1/3
subfamily. In order to obtain constitutive active recombinant caspase-14 for in vitro studies, we gen-
erated reverse-engineered forms of caspase-14, mimicking an approach used to obtain active pre-
cursors of other short prodomain caspases (J. Biol. Chem. 273:10107, 1998). Both the wild type
enzyme (small subunit-prodomain-large subunit, denoted RevC14) and a second similar but cat-
alytically inactive form with a cysteine to serine mutation (denoted MRevC14), were prepared. The
histidine-tagged proteins were expressed in E. coli and purified by nickel chelate resin affinity chro-
matography. The RevC14 recombinant enzyme showed catalytic activity against a number of fluo-
rogenic caspase substrates, with the highest activity against DEVD-AFC and YVAD-AFC. The
MRevC14 recombinant enzyme showed greatly abrogated activity against all substrates tested, demon-
strating the importance of the active site cysteine for catalytic activity. The autocatalytic activity
towards DEVD-AFC was inhibited by the pan-caspase inhibitor Z-VAD-fmk. Optimal buffer con-
ditions depended on the substrate being tested.  These studies demonstrate that caspase-14 is an aspar-
tate protease indicative of the caspase family. Studies in progress will be directed towards deter-
mining the substrate specificity of caspase-14 and determining its substrates in epidermal keratinocytes. 
424
Pro-differentiating effects of liver X receptor activators in keratinocytes
M Schmuth,1 P Lau,2 DD Bikle,3,2 TM Willson,4 PM Elias2 and KR Feingold3,2 1 Dept. of
Dermatology, University of Innsbruck, Innsbruck, Tyrol, Austria, 2 Dept. of Dermatology,
University of California, San Francisco, San Francisco, CA, 3 Dept. of Medicine, University of
California, San Francisco, San Francisco, CA and 4 Discovery Research, GlaxoSmithKline,
Triangle Park, NC
Oxysterols activate liver X receptor (LXR) stimulating keratinocyte differentiation, which involves
the formation of the cornified envelope on the inner plasma membrane by transglutaminase crosslink-
ing of several constituent proteins. We report here that oxysterols increase the expression of one of
these crosslinked proteins, involucrin, and that this effect can be abolished by mutations of the dis-
tal activator protein (AP)-1 response element in the involucrin promoter. Furthermore, oxysterols
increase AP-1 binding in an electrophoretic gel mobility shift assay and induce the expression of an
AP-1 reporter-luciferase construct. Within the AP-1 DNA binding complex we identified Fra-1 by
super shift analysis of nuclear extracts from oxysterol-treated, cultured keratinocytes. Western blot
analysis demonstrated that oxysterol treatment increased the levels of Fra-1 and Jun-D, while North-
ern analysis revealed that oxysterols increased mRNA levels for Fra-1, c-Fos and Jun-D. Similar
alterations in AP-1 proteins occurred when 25-OH-cholesterol or non-sterol LXR agonists (GW3965,
TO-901317) were used. Together these data indicate that LXR activators stimulate involucrin expres-
sion by increasing the levels of specific proteins of the AP-1 complex. The expression of key pro-
teins required for keratinocyte differentiation, such as transglutaminase 1, involucrin, and loricrin,
are regulated by AP-1 and therefore the LXR induced increase in AP-1 factors could activate many
of the genes required for epidermal differentiation. 
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Sulfur mustard vesicant-induced alterations of laminin 5 and gelatinase in mouse skin
DR Gerecke,1 P Bhatt,1 MK Gordon,1 DV Ajibade,2 DJ Riley2 and MP Shakarjian2 1 Pharmacology
& Toxicology, Rutgers University, Piscataway, NJ and 2 Medicine, UMDNJ/Robert Wood Johnson
Med. School, Piscataway, NJ
Epidermolysis bullosa (EB), a genetic skin disease characterized by skin blistering, may be caused
by mutations in any of a variety of genes that encode proteins required for maintaining the structural
integrity of skin. Three of these genes, laminin-α 3, laminin-β 3, and laminin-γ 2 encode separate
polypeptides that together create a heterotrimer, forming the basement membrane protein, laminin
5. Disruption of the laminin 5 protein causes skin blisters. The chronic structural skin damage observed
in EB may be further exacerbated by the actions of matrix metalloproteinases (MMPs). The chem-
ical warfare agent, bis(2-chloroethyl)sulfide (sulfur mustard, SM), penetrates the skin rapidly and
within several hours causes skin blistering similar to EB. After exposure to liquid SM, mouse ear
skin was examined for upregulation of expression of the laminin 5 polypeptide chains and MMPs 2
and 9 (gelatinase A and B, respectively). Punch biopsies of mouse ear skin were taken at 6, 12, 24,
and 72 hours after SM exposure. They were examined by histology, real-time PCR and gelatinase
activity assays. SM caused a time-dependent increase in skin weight and damage relative to vehicle
controls. Increased mRNA levels for MMP-9, laminin-α 3, laminin-β 3 and laminin-γ 2, were noted
after SM exposure whereas MMP-2 mRNA levels decreased. There was a time-related increase in
overall gelatinase activity observable 6 hours after SM exposure and persisted throughout the study.
Pretreatment with the MMP inhibitor, Ilomastat, appeared to have no effect on the observations.
Taken together, these observations may form the basis for an in vivo assay to test the efficacy of phar-
macological countermeasures useful in preventing or alleviated SM induced skin damage. 
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Comparative analysis of the activity of three generations of retinoic acid metabolism blocking
agents in cultures of differentiating normal human epidermal keratinocytes
C Verfaille,1 L Bols,2 M Borgers,1 K Franssen,1 B Govaerts,2 M Moeremans,2 P Stoppie1 and
J Geysen2 1 Barrier Therapeutics, Geel, Belgium and 2 MAIA Scientific, Geel, Belgium
Retinoic Acid Metabolism Blocking Agents (RAMBAs) enhance (skin) tissue concentrations of
endogenous all-trans retinoic acid (RA) to/or sustain pharmacologically active tissue levels of RA
by blocking cytochrome P450-enzymes. One of these compounds, liarozole, was shown to be effec-
tive in the treatment of psoriasis and ichthyosis. Hence, they represent a novel alternative in the treat-
ment of retinoid sensitive (skin) diseases. RambazoleTM, a new azole derivative with increased potency
and selectivity in a variety of biochemical and animal assays, was identified. RA modulates Ca2+-
induced differentiation of normal human epidermal keratinocytes (NHEK), by downregulating the
expression of transglutaminase(TG)-1. The present study compares, in vitro, the retinoid potentiat-
ing effect of Rambazole with that of its predecessors ketoconazole and liarozole in a culture of dif-
ferentiating NHEK. NHEK, isolated from foreskin, were plated in serum free, low Ca2+, keratinocyte
growth medium. At 60% confluency, the monolayers were switched to high Ca2+ and treated with
RA alone (10-8-10-12 M) or in combination with a RAMBA (10-6-10-8M). At day 5, after monitoring
cell viability with MTT, cells were processed for measurement of TG-1 with an in situ ELISA. RA
dose-dependently downregulated TG-1 expression (IC50= 2-5 nM). Dose-response curves shifted to
the left when RA was combined with each of the 3 RAMBAs. At 1 µM, minor differences in potency
among the 3 compounds were observed. All three lowered the IC50 of RA at least 2000-fold to ≤ 1
pM. The decrease in TG-1 expression by ketoconazole, however, was partially due to toxicity. At
0.1 µM, Rambazole was 5 to 10 times more potent than ketoconazole and liarozole, respectively,
and at 0.01 µM even ~ 100 times. In conclusion, Rambazole is superior to ketoconazole and liaro-
zole in reinforcing the inhibitory effect of RA on TG-1 expression in human keratinocytes. 
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Lack of the mouse channel-activating protease 1 causes epidermal malformations
C Leyvraz,1 S Rotman,2 I Rubera1 and E Hummler1 1 Departement de Pharmacologie et de
Toxicologie, Universite de Lausanne, Lausanne, Switzerland and 2 Institut de Pathologie,
Universite de Lausanne, Lausanne, Switzerland
Serine proteases are proteolytic enzymes involved in the regulation of various physiological processes
such as epidermal remodeling. We recently identified the mouse orthologue of the human serine pro-
tease prostasin as the amiloride-sensitive epithelial sodium channel (ENaC) activating protease 1
(CAP1), thereby presenting a new mechanism for autocrine activation of ion channels. CAP1 is
expressed in different epithelial tissues such as lung, kidney, colon and skin and colocalizes with
ENaC. In order to study the consequences of CAP1 deficiency in epidermal function, we generated
mice harbouring a conditional knockout allele of CAP1 and crossed these mice with mice express-
ing the Cre recombinase under the control of the keratin 14 promoter. In newborn double transgenic
mice, the CAP1 wild type allele is successfully deleted in epidermis, but these mice die within the
first three days after birth. Histological analysis shows that loss of CAP1 in epidermis causes severe
epidermal malformations, suggesting an important role of CAP1 expression in the formation and
maintenance of the epidermal permeability barrier. 
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Automated assessment of cell growth, confluence & compound-induced inhibition using unla-
beled skin-derived cells and brightfield microscopy
J Geysen,1 L Bols,1 K Franssen,2 L Geuens,1 B Govaerts,1 P Stoppie,2 K Ver Donck,1 P Van Osta1
and M Borgers2 1 MAIA Scientific, Geel, Belgium and 2 Barrier Therapeutics, Geel, Belgium
High Information Content Screening (HICS) aims at quantifying the full complexity of biological
phenomena inside cells, such as e.g. protein activity in multiple signalling pathways that execute cell
division, differentiation, motility and cell death. With the advent of microscopy readers, full automa-
tion has been achieved of the image acquisition and image segmentation process, as well as of
image data reduction to quantitative data, predominantly for fluorescent readouts. In spite of this
evolution, very little satisfactory tools have been generated to automate assessment of basic features
of unlabeled cells in culture, still the most commonly used microscopy mode in hands-on cell cul-
ture assessment. A key hurdle is the variable background that results from the air-liquid meniscus
inside wells. This uncontrolled lens over the cells makes it impossible to apply background sub-
traction models or threshold-based image segmentation to images. Cell counting, cell number, con-
fluency of monolayers and colony size of unlabeled living cultures, therefore remains elusive or is
substituted for by surrogate endpoints, such as mitochondrial assays. We have applied automated
full-well, brightfield image acquisition to unlabeled, living cultures of skin-derived primary epider-
mal keratinocytes using the MIAS-2 microscopy reader. Using Scale-Space theory and the eaZYX-
IMAGING software, we have developed image analysis tools for background-independent object
identification, which facilitates image segmentation from tiled images covering the entire well sur-
face. Based on this novel image segmentation technology, brightfield image analysis applications
have been built for cell counting and measuring confluency of monolayers, which are currently
applied to study the modulatory effect of drug-like compounds on growth and cell death of ker-
atinocytes. The developed applications will facilitate complete automation of the cell culture and
compound screening process. 
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Cholesterol sulfotransferase (SULT2B1b) is a late marker of human keratinocyte differentia-
tion
Y Higashi,1,2 T Fukushige,2 T Kanzaki2 and CA Strott1 1 Endocrinology and Reproduction
Research Branch, NICHD,NIH, Bethesda, MD and 2 Dermatology, Kagoshima University School
of Medicine, Kagoshima, Japan
The importance of cholesterol sulfate as an epidermal factor stems from the discovery of high lev-
els of this sulfolipid in the epidermis of patients afflicted with recessive X-linked ichthyosis. Sev-
eral reports have indicated that cholesterol sulfate accumulates during keratinization suggesting that
it plays a role in keratinocyte differentiation and development of the barrier. The enzyme that pro-
duces cholesterol sulfate is as a member of the cytosolic sulfotransferase (SULT) superfamily. We
investigated expression of this enzyme in primary cultures of normal human epidermal keratinocytes
(NHEK) undergoing induction of terminal differentiation by calcium. Importantly, RT-PCR and west-
ern analyses showed that, of the three isozymes known to sulfonate steroids/sterols, only SULT2B1b
was expressed by NHEK. This was also the case for normal human skin. Quantitative real-time
PCR analysis demonstrated significant induction of SULT2B1b mRNA by calcium. Furthermore,
cholesterol sulfotransferase protein and activity paralleled the increase in SULT2B1b mRNA dur-
ing calcium induction of NHEK terminal differentiation. Immunocytochemical analysis revealed
that SULT2B1b was localized to the granular layer of the epidermis of normal human skin suggest-
ing that it is a late marker of keratinocyte differentiation. A similar analysis in disorders involving
the integument revealed striking differences in SULT2B1b expression. 
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Transcriptional profiling of keratinocyte differentiation in culture: the roles of cell conflu-
ency, calcium and detachment from the basement membrane
T Banno,1,2 F Otsuka2 and M Blumenberg1 1 Dermatology, NYU School of Medicine, New York, NY
and 2 Dermatology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
In epidermis, proliferating basal keratinocytes eventually detach from the basement membrane, ter-
minate cell growth and initiate differentiation into cornified cells that protect our body from the envi-
ronment. The factors that initiate and regulate these processes are not known, although cell-cell con-
tacts, calcium and detachment from the basement membrane have been suggested to play a role. To
define comprehensively the transcriptional changes essential for keratinocyte differentiation, we used
large DNA microarrays and profiled the changes in keratinocyte gene expression depending on cul-
ture density, calcium, and detachment from the substratum. Confluent keratinocytes express genes
associated with cornified envelopes, lipid barrier, tight junctions and suprabasal tonofilaments, while
suppressing basal keratins, integrins, ECM proteins, and growth-related, suggesting a spontaneous
maturation of keratinocytes by increased cell density. Suspension cultures, in which keratinocytes
are prevented from attaching to the basement membrane, showed even stronger effects on these genes.
Additionally, our data identify many genes that have not been previously recognized as basal- or
suprabasal-specific. In contrast, addition of 1.2mM calcium, while dramatically altering keratinocyte
morphology and allowing formation of dense colonies, only marginally affected the gene expres-
sion. These results suggest that detachment from the substrate and culture density are much stronger
differentiation stimuli than calcium. 
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Liver X receptor activators accelerate post-natal acidification of the stratum corneum and
improve permeability barrier homeostasis and stratum corneum integrity
JW Fluhr,1,2 D Crumrine,2 PM Elias2,3 and KR Feingold3,2 1 Dermatology, Univ. of Jena, Jena,
Germany, 2 Departments of Dermatology and Medicine, UCSF, San Francisco, CA and 3
Dermatology and Medical Service, Veterans Affairs Medical Center, San Francisco, CA
At birth, mammalian skin displays a near-neutral stratum corneum (SC) pH, which declines gradu-
ally to an acidic pH, comparable to adults. The absence of an acidic pH in neonates has adverse con-
sequences leading to abnormal permeability barrier homeostasis and SC integrity/cohesion. There-
fore, we utilized the neonatal rat model whose SC pH at birth is approximately 6.8 and declines to
adult levels to assess the effects of LXR activators. Topical treatment with several LXR-activators
(22(R)-hydroxycholesterol and the non-sterol activators TO-901317 and GW 3965) accelerated the
acidification of the SC in neonates. The abnormal permeability barrier homeostasis that is charac-
teristically observed in neonates was normalized by treatment with LXR activators. The improved
barrier homeostasis was paralleled by maturation of the extracellular lamellar membranes in the SC.
The biochemical basis for the accelerated maturation could be attributed to an increase in beta-glu-
cocerebrosidase activity. The abnormality in SC integrity/cohesion was improved by treatment with
LXR activators. The improvement in SC integrity/cohesion was associated with increased numbers
of corneodesmosomes and in desmoglein 1 expression. Finally, treatment with LXR activators
increased SC secretory phospholipase A2 activity, which could be one mechanism that accounts for
acceleration of SC acidification. These results demonstrate the beneficial effect of LXR activators
in the post-natal development of an acidic SC pH, and the subsequent improvement in permeability
barrier homeostasis and SC integrity/cohesion. Coupled with the previously described anti-inflam-
matory and pro-differentiating effects of LXR activators, these results further suggest that LXR
activators maybe useful agents in the treatment/prevention of neonatal skin disorders. 
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Ceramide hydrolysis is an important protective mechanism against ceramide-induced apop-
tosis in UVB irradiated keratinocytes 
Y Uchida,1 E Houben,2 V Rogiers,2 PM Elias1 and WM Holleran1 1 Dermatology, UCSF & V.A.
Medical Center, San Francisco, CA and 2 Toxicology, Vrije Univ, Brussels, Belgium
Whereas Ceramide (Cer) are key constituents of the stratum corneum permeability barrier, they also
can function as pro-apoptotic lipid molecules within epidermal keratinocytes. Our prior studies
demonstrated that increased de novo Cer synthesis accounts, in part, for UVB-induced apoptosis in
cultured human keratinocytes (CHK) (Uchida et al., JID, 120: 622, 2003). Since epidermis is con-
tinuously at risk from exposure to UV, we hypothesized that keratinocytes must have mechanisms
that regulate intracellular Cer levels to protect against Cer-induced apoptosis in response to UVB.
We recently demonstrated that acidic ceramidase (aCDase) is expressed in both undifferentiated
and differentiated keratinocytes (concurrently presented at this conference), and therefore, we inves-
tigated here whether aCDase, which hydrolyzes Cer, is an important regulator of intracellular Cer
levels following UVB. Both low dose UVB (low-UVB, <35mJ/cm2) and higher dose UVB (high-
UVB, >45mJcm2) inhibited DNA synthesis of CHK, but apoptosis occurred only in CHK exposed
to high-UVB. Cer synthesis, assessed by [3H]-palmitate incorporation, increased similarly (i.e.,
2.7-fold) in both low-UVB and high-UVB-treated CHK by 6 h following irradiation. While Cer
synthesis returned to normal in low-UVB-CHK, Cer production remained elevated in high-UVB-
CHK even at 24 h (3.3-fold). In addition, although apoptosis (i.e., LDH release and TUNEL-posi-
tive staining) was not evident in CHK treated with either low-UVB or N-oleoylethanolamine (NOE),
an aCDase inhibitor, alone, CHK simultaneously treated with low-UVB plus NOE were sensitized
to apoptosis. Finally, lipid quantification revealed significantly increased Cer content in NOE plus
low-UVB-treated cells (1.8-fold; 6h after exposure), while that of low-UVB or NOE alone-treated
cells were unchanged. Thus, at least one CDase isoform, aCDase, appears to have an important role
in protecting keratinocytes from Cer-induced apoptosis in response to UVB. 
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Wounding-induced up-regulation of hyaluronan in organotypic cultures of keratinocytes
N Sato,1 JA Mack1,2 and EV Maytin1,2 1 Biomedical Engineering, Lerner Research Institute,
Cleveland Clinic Foundation, Cleveland, OH and 2 Dermatology, Cleveland Clinic Foundation,
Cleveland, OH
Hyaluronan (HA), a high molecular weight glycosaminoglycan, is generally regarded as a compo-
nent of connective tissue extracellular matrix. However, epidermal keratinocytes synthesize HA in
the intercellular space between basal and spinous keratinocytes. Recent studies suggest that accu-
mulation of HA is correlated with cell proliferation and migration during skin development and
renewal. To examine the role of epithelial HA after wounding, we investigated HA expression in pin-
pricked organotypic keratinocyte cultures. Rat epidermal keratinocytes (REKs) were grown at the
air-liquid interface in the absence of fibroblasts and, after 5 days a fully differentiated epithelium
was formed. These cultures were pricked with a needle and harvested at 15 min, 6 h, 24 h, and 48
h. Paraffin-embedded sections were stained with HA-binding protein and analyzed by immunoflu-
orescence and computer-assisted image analysis. A significant increase in HA levels was first detected
at 15 min, became maximal at 24 h, and decreased again by 48 h. Induction of HA was seen as far
away as 1 cm from the point of injury, suggesting the production of a soluble paracrine factor. To
test this, we examined the effects of conditioned medium after injury. Media from pricked REKs
were harvested at 15 min, 6 h, 24 h, and 48 h, then transferred into wells of unpricked cultures.
These cultures were analyzed 24 h later. Strong and rapid induction of HA expression was observed,
and was already nearly maximal in cultures exposed to the 15 min harvested medium. These data
indicate that, as observed in skin in vivo [1], upregulation of HA by keratinocytes may be an impor-
tant factor in wound repair. Some diffusible factors, which stimulate keratinocytes to synthesize
HA, may be secreted from keratinocytes in rapid response to focal injury. 
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Stem cell frequency in aged epidermis is increased
CO Barland,1 H Wessendorf,1 Y Lu,2 JH Lawrence3 and R Ghadially1 1 Dermatology, UCSF, San
Francisco, CA, 2 Biostatistics, Comprehensive Cancer Center, UCSF, San Francisco, CA and 3
Medicine, VA Mecial Center, San Francisco, CA
The aim of this study was to determine the stem cell frequency of aged vs. young epidermis. Using
an in vivo competitive repopulation assay and a limiting dilution design we studied the numbers of
long-term repopulating cells in aged (20-24 mo) vs. young epidermis (8-12w). Murine keratinocytes
(follicular and interfollicular) were isolated from GFP transgenic mice. We then implanted various
dilutions of GFP+ test keratinocytes with 1 million GFP- keratinocytes in chambers on the backs of
SCID mice. Numbers of test keratinocytes ranged from 100,000 to 6,250 for aged epidermis, and
from 100,000 to 12,500 for young epidermis. An epidermis formed by 2 weeks. Chambers were
observed at 3 weeks, and every 2 weeks thereafter, with an epifluorescence microscope (Zeiss Stemi
SV) to detect the presence or absence of a GFP+ stem cell and its progeny. Data was analyzed with
the help of limiting dilution analysis software (L-Calc, Stemsoft, Vancouver). GFP+ repopulating
units were observed to disappear at times up until 7 weeks, but not after 7 weeks, suggesting that at
this point we were observing true stem cells rather than transit amplifying cells or early progenitors.
Limiting dilution analysis was therefore performed at 7 weeks, at which point chambers were assessed
as positive or negative for GFP+ competitive repopulating units. Stem cell frequency in aged epi-
dermis was significantly greater than that in young, 1 in 13,200 ( 95% confidence interval 1 in 6,300
to 1 in 27,800), vs. 1 in 28,200 (95% confidence interval 1 in 11,300 to 1 in 75,500) p=0.04. In pre-
vious studies of hematopoietic stem cells (the only other tissue with a quantitative in vivo stem cell
assay) stem cell frequency in aged bone marrow increased 2-5 fold. It has been hypothesized that
stem cell frequency in the aged increases in an attempt to compensate for decreased proliferative
capacity of each stem cell. We will next conduct studies using our assay to determine the prolifera-
tive capacity of individual aged vs. young epidermal stem cells. 
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Breaking the connection: caspase 6 cleaves periplakin releasing the intermediate filament bind-
ing tail region from the actin binding N-terminal domain
AE Kalinin,1 AE Kalinin,1 M Aho,2 J Uitto2 and S Aho2 1 NIAMS, NIH, Bethesda, MD and 2
Dermatology, Thomas Jefferson University, Philadelphia, PA
Periplakin is a member of the plakin family of cytolinkers that connect cytoskeletal networks to
each other as well as to junctional complexes. Here we demonstrate direct binding between the N-
terminal head domain of periplakin and filamentous actin. Furthermore, the C-terminal part of
periplakin binds to and colocalizes with the intermediate filaments. We demonstrate that the speci-
ficity of intermediate filament binding depends on the length of the rod domain attached to periplakin
C-terminal tail domain. Double labeling of the Madin-Darby canine kidney cells expressing the N-
and C-terminally tagged periplakin revealed unexpected lack of colocalization of the two signals.
Although the C-terminal tag colocalized with intermediate filaments both in normal and apoptotic
cells, the N-terminal signal was either absent or was detected as cytoplasmic aggregates in apoptotic
cell remnants. Western analysis revealed that periplakin becomes cleaved close to its C-terminal tail
during apoptosis, leading to loss of cell adhesion. Digestions with active caspases 1-10 in vitro
revealed that caspase 6 only cleaved periplakin, using an unconventional recognition site TVAD-
1603. Collectively, the results emphasize a role for periplakin as a cytolinker and suggest that the
connection mediated by periplakin needs to be broken during programmed cell death. 
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Plakin proteins are coordinately cleaved during apoptosis but preferentially through the action
of different caspases
S Aho Dermatology, Thomas Jefferson University, Philadelphia, PA
In epithelial cells, cell-cell and cell-matrix junctions, desmosomes and hemidesmosomes, provide
anchorage sites for the keratin intermediate filaments. The plakin proteins desmoplakin, plectin and
periplakin represent intracellular constituents of these adhesion junctions. In staurosporine treated
apoptotic HaCaT cells desmoplakin, plectin and periplakin became cleaved coordinately with the
elimination of keratins 10 and 14, while involucrin, actin and keratin 18 displayed considerable sta-
bility. The caspase inhibitor zVAD-fmk prevented both the cell detachment and protein cleavage,
indicating the function of caspases in these events. Closer examination in vitro revealed that while
caspases 2 and 4 most efficiently cleaved desmoplakin, and plectin served as a target for caspases 3
and 7, periplakin as well as keratins were cleaved by caspase 6. The involvement of multiple cas-
pases in the destruction of epithelial cell integrity ensures the efficient elimination of cytoskeleton,
but also provides specificity for selectively targeting individual adhesion molecules. 
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Assessment of cellular turnover by fluorescent staining of stratum corneum with pyranin
I Sadiq, Y Zhen, T Stoudemayer and AM Kligman S.K.I.N. Inc, Conshohocken, PA
Cellular turnover assays have traditionally been conducted using a 24-hour Dansyl Chloride (5% in
petrolatum) patch and then following the decay of the of the fluorescent signal produced by ultra-
violet light, for several weeks. We have used a short-term (2 hours) patch of Pyranin 2% aqueous
and followed the blue-light (417 nm) induced fluorescent signal. To record the fluorescence emis-
sion, a digital camera system was used with blue-cutting filter on the lens and the flash lamps emit-
ting blue-violet light (417 nm) through a band-pass interference filter. To standardize the luminance
measurements on the series of images captured on different days, a rectangular tile painted with
pyranin was placed adjacent to the patch site during all image captures. A computer program was
developed to determine the luminosity values of three sites in each image; the Pyranin-labeled skin,
adjacent control site (background) and the rectangular fluorescent standard. The luminosity of the
Pyranin site, after subtracting the luminosity of the control site, was compared to the luminosity of
the fluorescent standard. This was done to eliminate the errors due to variations in flashlamp inten-
sity and digital camera imaging, from one image capture to the other. Series of images were obtained
over a period of few weeks. When the shape and size of the rectangular tile was similar in all the
images we can measure the extinction of the fluorescence emission very accurately. We have also
observed that adding lactic acid to the Pyranin solution increases the penetration depth which results
in longer extinction times. 
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Overexpression of Hoxb13 in an epidermal organotypic system disrupts hyaluronan distribu-
tion and results in a psoriasiform phenotype
JA Mack,1,2 L Li,3 N Sato,1 VC Hascall1 and EV Maytin1,2 1 Biomedical Engineering ND-20,
Cleveland Clinic Foundation, Cleveland, OH, 2 Dermatology, Cleveland Clinic Foundation,
Cleveland, OH and 3 College of Dental Medicine, Nova Southeastern University, Fort Lauderdale,
FL
Hox genes encode a highly conserved family of transcription factors that function as key regulators
of differentiation and cell fate specification. We recently showed that loss of Hoxb13 function in
murine skin results in increased levels of epidermal hyaluronan (HA; a large extracellular gly-
cosaminoglycan known to inhibit differentiation) and decreased expression of several epidermal
differentiation markers (1). These observations led to the hypothesis that one function of Hoxb13 in
vivo is to promote epidermal differentiation by keeping levels of HA low. The purpose of the pres-
ent study was to evaluate the effects of overexpression of Hoxb13 on differentiation in vitro. To
accomplish this, we utilized a rat epidermal keratinoctye (REK) cell line that, when grown in lift cul-
ture, fully stratifies in 5 days and produces all of the morphological and differentiation markers
observed in vivo. Stably transfected cell lines constitutively expressing Hoxb13 produced several
aberrant differentiation phenotypes reminiscent of psoriatic lesions. Included among these are parak-
eratosis, lack of a granular layer, acanthosis, and suprabasal mitotic figures. In addition, we find that
HA levels, normally high in the basal layer of stratified REK cells, are significantly reduced in strat-
ified REK cells overexpressing Hoxb13. The expression profiles of several epidermal differentia-
tion markers are also abnormal in response to Hoxb13 overexpression. Together, these data support
a role for Hoxb13 in the regulation of HA expression and of differentiation in the epidermis. 
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Keratin expression in cultured skin substitutes suggests a hyperproliferative state that is nor-
malized after grafting to athymic mice
DM Supp,1,2 AC Karpinski1 and ST Boyce2,1 1 Shriners Burns Hospital, Cincinnati, OH and 2
University of Cincinnati College of Medicine, Cincinnati, OH
Cultured skin substitutes (CSS) consisting of fibroblasts and keratinocytes in a biopolymer matrix
are an adjunctive treatment for full thickness burn wounds. A recent cDNA microarray analysis
revealed that several genes characteristic of hyperproliferative epidermis have greater relative expres-
sion in CSS in vitro compared to native human skin (NHS). To examine this phenomenon at the
protein level, immunohistochemistry was used to localize multiple keratin proteins in NHS, and in
CSS in vitro and after grafting to athymic mice. Human skin was obtained from breast tissue and
was imbedded frozen for sectioning, or was used to establish selective cultures of fibroblasts and
keratinocytes. These cells were used to prepare CSS by sequential inoculation of collagen-based sub-
strates with fibroblasts and keratinocytes. After 2 wks culture, CSS were grafted to athymic mice,
and biopsies were collected for immunohistochemistry.    Keratins 6, 16, and 17 were highly expressed
in the epidermis of CSS in vitro. Keratin 16 was localized to the suprabasal epidermis, whereas ker-
atins 6 and 17 appeared more widespread. The levels of these proteins were low or undetectable in
the NHS samples, and were reduced in CSS after grafting. Conversely, keratin 15 was localized to
basal keratinocytes in NHS, but was not detected in CSS in vitro. Expression of keratin 15 in CSS
was up-regulated after grafting to mice. Keratins 6, 16, and 17 are known to be induced following
skin injury and in hyperproliferative skin diseases. Expression of these keratins in CSS in vitro sug-
gests a hyperproliferative or activated state, similar to wounded native skin. Keratin 15, known to
be expressed in basal keratinocytes and down-regulated after wounding, was absent from CSS in
vitro. After grafting to athymic mice, the down-regulation of keratins 6, 16, and 17 and up-regula-
tion of keratin 15 suggests a normalization of CSS to a phenotype more closely resembling unin-
jured human skin. 
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Gene expression by CD34-positive hair follicle bulge keratinocytes and expression patterns of
bulge-specific genes following abrasion-induced epidermal regeneration
C Trempus,1 R Morris,2 M Gerdes,3 J Fostel,1 CD Bortner,4 M Humble,1 S Yuspa3 and R Tennant1
1 NCT/Cancer Biology Group, NIEHS, Research Triangle Park, NC, 2 Department of
Dermatology, Columbia University, New York, NY, 3 LCCTP, National Cancer Institute, Bethesda,
MD and 4 LST, NIEHS, Research Triangle Park, NC
Stratified epidermis is maintained by the continuous loss and replacement of proliferating basal ker-
atinocytes from a pool of pluripotent stem and progenitor cells, including those in the hair follicle
bulge region. The cell surface marker CD34 is expressed on hair follicle bulge cells and can be used
to isolate these cells using fluorescence activated cell sorting for molecular studies, including gene
expression analysis. Keratinocytes were harvested from 7 week-old mice, stained with antibodies to
CD34 and alpha-6 integrin, and CD34 and CD34- keratinocytes were sorted into individual popu-
lations. Total RNA was isolated, and microarray analysis was conducted using three separate plat-
forms, including high density microarray chips and a cDNA nylon array. Included among genes iden-
tified as differentially expressed in CD34 bulge keratinocytes were known bulge markers such as
CD34, S100A4, Tcf3, and Barx2. The bulge-specific profile was characterized by functional cate-
gories including calcium ion binding (S100A4, S100A6, cadherin 13), adhesion (CD34, Ctgf), and
Wnt signaling (Fzd2, Dkk3, Wnt3a, Wnt10), among others. To gain further insights into how bulge-
specific genes behave following an external stimulus, we analyzed their expression patterns follow-
ing epidermal abrasion-induced regeneration. In this context, bulge markers such as CD34 and S100A4
were lost during the massive hyperproliferation, while tenascin C and S100A6, both expressed in
CD34 cells, experienced an overall increase in expression in abraded skin. Thrombospondin 2, down-
regulated in CD34 cells, was increased following abrasion. From these data, we have gained insight
into genes specific to bulge keratinocytes as well as their behavior following abrasion-induced epi-
dermal regeneration. 
441
Assessment of toxicity of sidestream cigarette smoke on HaCaT-keratinocytes with the neu-
tral red release assay
T Reuther, M Kemper and M Kerscher Cosmetic Sciences, University of Hamburg, Hamburg,
Germany
In recent years sidestream cigarette smoke (SS) has been more and more identified as a non-oxida-
tive and oxidative toxic factor altering lipids and membrane functions of the superficial layers of the
skin. Therefore the aim of the present study was to investigate acute toxic effects of SS on HaCaT-
keratinocytes in vitro using the neutral red release assay (NRRA) that particularly reflects cell mem-
brane alteration and leakage. For the experiments HaCaT-keratinocytes were incubated 3h with
neutral red in a phenol red free DMEM-medium and then exposed 15 min under PBS to SS that was
collected from three University of Kentucky research cigarettes (2R4F) immediately before expo-
sure. Finally the cells were destained and the optical density (OD) of the resulting solution was meas-
ured at 540 nm. After determining in a first experiment the optimal amount of PBS overlying the
cells during exposure, cells were exposed to 0,9 and 1,5 µmol sodium lauryl sulfate (SDS) before
smoke exposure, after smoke exposure and to SDS alone. In a further experiment the effects of ascor-
bic acid 50 µg/ml prior to smoke exposure were investigated. The results demonstrate that the OD
was minimal with a supernatant of 1 ml PBS under exposure and was maximal at 0 and 3 ml. Accord-
ing to these results a supernatant of 1 ml was considered to be the best for the further experiments.
Treatment of the cells with SDS before smoke exposure markedly decreased the OD to 0,19 and 0,15
in comparison to 0,57 and 0,45 after treatment with SDS after smoke exposure and 0,89 and 0,81
after SDS alone. The OD after smoke exposure following ascorbic acid was 0,72 and 0,55 without
ascorbic acid. In conclusion using the NRRA profound acute toxic effects of SS associated with cell
membrane damage could be demonstrated. These effects can be markedly increased by pretreat-
ment with the strong detergent SDS. The fact that ascorbic acid increases OD indicates at least in
some extent oxidative damage of the cells through SS. Further studies are necessary to investigate
the molecular mechanisms underlying these findings. 
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Mechanisms by which psychologic stress alters skin barrier homeostasis and stratum corneum
integrity
E Choi, BE Brown, D Crumrine, S Chang, M Man, PM Elias and KR Feingold Dermatology and
Medical Services (Metabolism), VA Medical Center San Francisco and Department of
Dermatology and Medicine, University of California San Francisco, San Francisco, CA
Although many skin disorders, including psoriasis, atopic dermatitis, and healing wounds, are
adversely affected by psychologic stress, the pathophysiologic link is unclear. In contrast to the exten-
sive studies on the effects of psychologic stress on the immune and neuroendocrine systems, few
studies have examined the effects of psychologic stress on epidermal function. Recent studies in both
humans and rodents have shown that psychologic stress alters permeability barrier homeostasis. Here,
we determined the mechanisms by which psychologic stress alters permeability barrier function and
SC integrity (= resistance to mechanical disruption). Insomniac psychologic stress (IPS) sustained
for 42 h in mice altered both barrier homeostasis (i.e., delayed barrier recovery after acute pertur-
bations) and SC integrity (i.e., resistance to tape stripping). IPS mice showed decreased epidermal
cell proliferation, impaired epidermal differentiation, and decreased numbers of corneodesmo-
somes (CD). The IPS-induced decline in integrity, was further linked to degradation of CD proteins
(e.g., DSG1). The secretion and production of lamellar bodies also declined, which in turn, could be
attributed to a global decrease in epidermal de novo cholesterol and fatty acid synthesis. To deter-
mine further whether lipid deficiency accounted for the functional abnormalities in IPS mice, a top-
ical mixture of physiologic lipids (equimolar cholesterol, ceramides, and free fatty acids) was applied
to IPS mice, which normalized both barrier homeostasis and SC integrity.
This study demonstrates that psychologic stress alters permeability barrier homeostasis and SC
integrity by decreasing epidermal lipid synthesis resulting in decreased lamellar body formation,
secretion, and decreased CD. Topical treatment with epidermal physiologic lipids may help stress-
induced, barrier- related skin disorders (e.g., psoriasis and atopic dermatitis). 
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A functional ex vivo quantitative human epidermal stem cell assay
H Wessendorf and R Ghadially Dermatology, UCSF, San Francisco, CA
The aim of these studies was to design a functional ex-vivo quantitative human epidermal stem cell
assay. Previously we designed a functional in-vivo quantitative murine epidermal stem cell assay
using ability for long-term proliferation as a test of stem cell function. We have now developed an
ex-vivo human assay based on the same principles. This assay utilizes HLA A2+ (test) and HLA
A2- (competitor) human foreskin keratinocytes. A fixed number of HLA A2- competitor keratinocytes
are implanted along with variable numbers of HLA A2+ test keratinocytes in a silicone chamber on
the dorsum of a SCID mouse. A complete epidermis is formed by 2 weeks. However, chamber epi-
dermis is analyzed at 9 weeks to ensure that all transit amplifying and differentiated cells have been
lost, and that remaining HLA A2+ repopulation units represent a true long-term repopulating cell
and its progeny. At 9 weeks chamber epidermis is dissociated and analyzed by fluorescence acti-
vated cell sorting as positive or negative for HLA A2+ keratinocytes. Limiting dilution analyses of
different populations of keratinocytes can be analyzed by specific limiting dilution software based
on the Poisson distribution (L-Calc, Stemsoft, Vancouver). In these studies a human epidermis
could be produced in a chamber on the fascia of a SCID mouse and maintained for at least 4 months.
We were able to determine HLA A2 positivity or negativity of fresh foreskin epidermis with MA 2.1
antibody (gift of Stewart Cooper, San Francisco). After growing the HLA A2+ keratinocytes in the
chamber for 9 weeks FACS revealed chambers to be greater than 97% positive for HLA A2. Finally,
we could detect small numbers of HLA A2+ cells (1%) by FACS, such that we can be confident of
detecting a HLA A2+ repopulation unit in this assay. Thus we now have an assay that can assess
human epidermal stem cells by their defining function, namely long-term repopulation. Competi-
tion at limiting dilution allows the quantitation of stem cells in a keratinocyte population. Competi-
tion at non-limiting dilution allows comparison of the proliferative capacity of two different popu-
lations of stem cells. 
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Analysis of calcium-inducible genes in keratinocytes using suppression subtractive hybridiza-
tion and cDNA microarray
J Lee,1 E Seo,2 J Namkung,2 K Lee,2 W Lee,1 M Zhu,1 C Lee,1 G Park,2 J Yang,2 Y Seo,1 C Kim1
and J Park1 1 Chungnam National University, Daejeon, South Korea and 2 Dermatology,
Sungkyunkwan University School of Medicine, Seoul, South Korea
Terminal differentiation of skin keratinocytes is a vertically directed multi-step process that is tightly
controlled by the sequential expression of a variety of genes. To gain further insight into the molec-
ular events involved in this process, we used suppression subtraction hybridization (SSH) and cDNA
microarray analysis. Messenger RNAs were isolated from the primary skin keratinocytes cultured
in vitro after treatment with calcium and/or 12-o-tetradecanoylphorbol-13-acetate (TPA), and then
SSH was performed. A total of 840 cDNA clones were obtained from subtracted libraries, and these
cDNA clones were used to make the microarray slides. Time-course cDNA microarray analysis (1,
3, 7, and 14 days after calcium treatment) revealed the global gene expression profile during ker-
atinocytes differentiation. Of the 840 genes tested, 290 showed a greater than twofold change in
expression level at least once over four time points. The genes were clustered into six groups accord-
ing to their expression pattern using self-organizing maps analysis, and showed the global feature
of function-related regulation. The genes related to keratinocyte differentiation were markedly up-
regulated by calcium treatment. In addition, the unique pattern of increase was seen in the expres-
sion of genes related to ribosomal protein. On the other hand, transcripts involved in metabolism,
DNA repair, transcription, and translation were generally down-regulated. These results demonstrate
the complexity of the gene expression profile that contributes to the spatiotemporal regulation of ker-
atinocytes differentiation. The combination of PCR-based cDNA subtraction and cDNA microarray
analysis in the present study allowed efficient identification and validation of genes thought to play
some roles in keratinocytes differentiation. 
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Regulation of epidermal differentiation and permeability barrier homeostasis: effects of pro-
tein kinase C inhibitors on the skin barrier
S Jeong,1,2 B Ahn,2 H Kim,1 J Seo,3 S Ahn4 and S Lee2 1 Brain Korea 21 Project for Medical
Science, Yonsei University College of Medicine, Seoul, South Korea, 2 Department of Dermatology,
Yonsei University College of Medicine, Seoul, South Korea, 3 Department of Oral Biology, Yonsei
University College of Dentistry, Seoul, South Korea and 4 Department of Dermatology, Yonsei
University Wonju College of Dentistry, Wonju, South Korea
Calcium has an established role in the normal homeostasis of skin and serves as a modulator in ker-
atinocyte proliferation and differentiation. Profiles of calcium concentration across normal skin are
consistent with migration patterns of keratinocyte during terminal differentiation, and previous stud-
ies suggested that the epidermal permeability barrier homeostasis is definitely influenced by the
epidermal calcium gradient. While the role of epidermal calcium gradient in permeability barrier
homeostasis is well studied, few studies about the role of differentiation have been reported.In a
previous study, we reported that topical application of Protein Kinase C (PKC) inhibitors to the bar-
rier disrupted skin induced increase of intracellular calcium ion and significantly delayed the bar-
rier repair. PKC have been implicated in various biological processes, including terminal differen-
tiation of keratinocytes and topical application of PKC inhibitors inhibited the terminal differentiation
processes. In this study, we investigated the effects of PKC inhibitors on epidermal barrier home-
ostasis while the increase of intracellular calcium concentration is prevented by calcium channel
blocker and calcium ion chelating agents. The barrier function of hairless mice skin was disrupted
by tape stripping and PKC inhibitor was topically applied. Calcium channel blockers, calcium ion
chelating agents, and vehicles as a control were topically applied in same site and the recovery rate
was measured. The formation of epidermal calcium gradient in vivo was observed under electron
microscopy and change of intracellular calcium ion in vitro using cultured mouse keratinocytes.
The protein and mRNA expression of differentiation markers after PKC inhibitor treatment were
also measured. 
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Fos and jun proteins are differentially expressed in normal and psoriatic human epidermis
D Mehic,2 L Bakiri,2 EF Wagner2 and E Tschachler1,3 1 Department of Dermatology, University of
Vienna Medical School, Vienna, Austria, 2 Institute of Molecular Pathology (IMP), Vienna, Austria
and 3 Centre de Recherches et d Investigations Epidermiques et Sensorielles (CE.R.I.E.S), Neuilly,
France
Here we studied the expression of AP-1 transcription factors in keratinocytes in monolayer culture,
in differentiating skin organ culture, in normal epidermis and in lesional skin from psoriasis patients.
All Jun and Fos proteins except FosB, which was negative in all models tested, were highly expressed
in proliferating keratinocytes. By contrast in organotypic epidermal culture as well as in normal epi-
dermis the expression was differentiation stage associated. JunB and JunD were expressed in all
layers of normal epidermis whereas, in contrast to what has been reported previously, c-Jun expres-
sion started suprabasally then disappeared and became very strong again in distinct cells of the out-
ermost granular layer. Since Fos proteins were abundantly present in nuclei of basal and suprabasal
keratinocytes our data suggest that in these locations predominantly Jun/Fos heterodimers are formed.
By contrast the strong expression of all Jun family members in subcorneal keratinocytes with a
weak expression (c-Fos, Fra-1) or absence (Fra-2) of Fos proteins suggest that AP-1 dimers in the
last stages of terminal keratinocyte differentiation are mainly composed by Jun proteins. A similar
expression pattern was also detected in organotypic epidermal culture except that c-Jun was also
present in basal keratinocytes. In contrast to normal skin, c-Jun expression was strongly upregulated
in both basal and suprabasal keratinocytes in psoriatic epidermis and JunB expression was dramat-
ically diminished whereas c-Fos expression was unchanged. Our data suggest that Jun proteins in
the relative absence of Fos partners are involved in regulating terminal differentiation of keratinocytes
whereas the induction of c-Jun and the loss of JunB expression in basal and suprabasal keratinocytes
might contribute to the pathogenesis of psoriasis. 
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Lipid synthesis and uptake are differentially regulated in human sebocytes (SEB-1) by retinoids,
adipogenic hormones, fatty acids and culture conditions
D Thiboutot, A Nelson, K Gilliland and Z Cong Dermatology, Penn State University, Hershey, PA
An understanding of the factors that regulate lipid synthesis and uptake in human sebaceous glands
is essential in order to develop therapeutic strategies aimed at reducing sebum production and improv-
ing acne. Human sebocytes are like adipocytes in that they respond to adipogenic hormones and lig-
ands of the peroxisome proliferator-activated receptors. The goal of this study was to compare the
effects of retinoids, adipogenic hormones, fatty acids and culture conditions on the uptake of fatty
acids by immortalized human sebocytes (SEB-1) and on the de novo synthesis of lipids from 14C-
acetate in these cells. The uptake of 14C-oleic acid by SEB-1 cells was significantly lower in medium
containing insulin compared to medium without insulin. Accordingly, treatment of SEB-1 cells with
adipogenic hormones (isobutylmethylxanthine, dexamethasone and insulin) suppressed fatty acid
uptake compared to medium without insulin. Interestingly, treatment with 13-cis retinoic acid (10-
6M, 10-7M) significantly increased fatty acid uptake by SEB-1 cells, which is in agreement with
the recent observation of that 13-cis retinoic acid increases lipid droplets in human ovarian theca
cells. Linoleic acid and palmitic acid did not increase the uptake of 14C-oleic acid by SEB-1 cells.
The incorporation of acetate into sebaceous lipids was increased with adipogenic hormones and
insulin alone whereas isobutylmethylxanthine, dexamethasone and 13-cis retinoic acid decreased
acetate incorporation into lipids. No significant differences in acetate incorporation into lipids were
noted between cells treated with linoleic acid, palmitic acid and medium alone. These data further
support the reliance of sebaceous lipogenesis on the substrate provided. In addition, these data demon-
strate that insulin decreases fatty acid and increases de novo sebaceous lipid synthesis in human sebo-
cytes. Futhermore, 13-cis retinoic acid has effects opposite to insulin on these processes. 
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Stratum corneum penetration by protein transduction domain peptide sequences depends on
secondary structure
LJ Shore, J Loderstedt, P Canatella, M Chan, SB Potterf, MJ Barratt and DJ Moore Unilever
Research & Development, Edgewater, NJ
Protein transduction domains (PTDs), such as that in the HIV tat protein (residues 47-57; YGRKKR-
RQRRR), have been reported to penetrate plasma membranes of a wide range of cell types. How-
ever, while arginine content has been demonstrated to be important for enabling penetration, sec-
ondary structure requirements have not been fully examined. Moreover, there are no published data
on PTD penetration of full-thickness skin or cultured keratinocytes. The current study utilizes con-
focal microscopy to measure the penetration of the tat PTD and variants, into stratum corneum and
cultured keratinocytes. In addition, biophysical infrared (IR) spectroscopy techniques were employed
to determine peptide secondary structure in water and in lipid membranes. These studies demon-
strate that the tat PTD penetrates cultured keratinocytes as well as stratum corneum of intact skin
within minutes of exposure. Furthermore, although unstructured in water, the tat PTD interacts inti-
mately with negatively charged phospholipids, adopting a helical secondary structure. To investi-
gate the role of secondary structure the lysines in the tat PTD were substituted with glycines as well
as acetylated lysines. Confocal microscopy experiments indicated that neither variant peptide pen-
etrates keratinocytes or stratum corneum. Interestingly, although these lysine substitutions did not
significantly affect peptide solubility or secondary structure in water, neither variant interacted with
lipid bilayers or demonstrated any evidence of helical structure in the presence of membranes,
likely explaining their inability to enter cells. These initial findings demonstrate that the PTD sequence
of tat is capable of penetrating stratum corneum and cultured keratinocytes and that helical second-
ary structure is required for membrane and skin penetration. 
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The effect of the epidermal barrier functions and structural changes using high dose systemic
steroid in hairless mice
S Ahn,1 J Lee,1 H Bak,1 E Choi1 and S Lee2 1 Department of Dermatology, Yonsei University Wonju
Colege of Medicine, Wonju, South Korea and 2 Department of Dermatology, Yonsei University
College of Medicine, Seoul, South Korea
Prolonged exposure of skin to corticosteroid can result in cutaneous abnormalities. Skin barrier
impairment is reported as a steroid induced side effect. Here, we determined whether high dose sys-
temic steroid injection would display adverse effects on epidermal functions, permeability barrier
homeostasis. Systemic steroid was administered by injecting each hairless mouse, intraperitoneally
with 0.3 mg triamcinolone, two times per week for five weeks. 0.9% normal saline was adminis-
tered by injecting with same method for the controlled hairless mice. Every week, TEWL was checked
and skin biopsies were taken. Skin specimens were prepared for H&E stain, ion capture cytochem-
istry, immunohistochemistry and electron microscopy. The results were following: High dose sys-
temic steroid produced visible cutaneous changes and increasing TEWL, from about 1 week, in the
group of 0.3 mg triamcinolone injected hairless mice than the control; Light microscopic observa-
tions of steroid-injected hairless mice showed gradually tinning of the epidermis and loss of stratum
corneum from about 2 weeks, compared with the control; Ruthenium tetroxide staining of high dose
systemic steroid treated specimens revealed that the lipid bilayer was impaired and fragmented
from about 3 weeks. Intercellular spaces were widening and the lipid bilayer disappeared or was
damaged compared with the control; Electron microscopic studies revealed not only a marked decrease
in the number of lamellar bodies but also an abnormal transformation of lamellar bodies in the steroid
injected hairless mice compared with the control, from about 3 weeks; For five weeks, gradually,
the calcium gradient was disappeared in 0.3 mg triamcinolone injected hairless mice compared with
the control, from about 3 weeks; Degree of expression of involucrin, loricrin and filaggrin was
decreased in steroid injected hairless mice compared to the control. 
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Keratinocyte differentiation activates mitochondrial-dependent cell death pathway
S Tamiji,1 M Gallego,1 P Formstecher,1 L Mortier,1,2 E Delaporte,2 F Piette,2 M Tual,1 H Obriot,1
E Dhuige,1 N Jouy,3 P Pellerin,4 P Marchetti1 and RR Polakowska1 1 Faculte de Medecine,
INSERM U459, Lille, France, 2 Dermatology, Hopital Huriez, CHRU, Lille, France, 3 Institute of
Cancer Research, Lille, France and 4 Plastic Surgery, Hopital R. Salengro, CHRU, Lille, France
Conversion of live keratinocytes into dead corneocytes involves the destruction of cellular organelles,
degradation of DNA and formation of the cell envelope. Our previous findings suggested that ker-
atinocyte differentiation activates mitochondrial-dependent cell death pathway. In this study, we
induced apoptotic-like mitochondrial changes with protoporphyrin IX, staurosporine and rotenone
in undifferentiated keratinocytes and asked whether these changes can affect keratinocyte differen-
tiation. We showed that all three drugs inhibited cell cycle, decreased mitochondrial membrane poten-
tial, increased reactive oxygen species (ROS) production and induced cytochrome c and apoptosis
inducing factor (AIF) release from mitochondria. These changes preceded or coincided with expres-
sion of keratin 10 (K10) and morphological alterations that normally accompany keratinocyte dif-
ferentiation. A significant apoptosis was observed only at the high levels of the inducers, suggest-
ing that apoptotic-like mitochondrial changes can trigger keratinocyte differentiation without inducing
apoptosis. A kinetic study of mitochondrial alterations and their pharmacological or genetic modu-
lation demonstrated that a decrease in ROS production decreased K10 expression, whereas the exoge-
nous introduction of cytochrome c and AIF into keratinocytes by either microinjection or transfec-
tion induced it. In conclusion, these data showed that keratinocyte differentiation can be induced by
triggering mitochondrial changes associated with apoptosis thus, supporting the hypothesis that
keratinocyte differentiation utilizes mitochondria-dependent machinery of classical apoptosis. 
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Induction of sphingolipid production in cultured human keratinocytes by LXR activators
through increased expression of serine palmitoyltransferase 
S Douangpanya,1 Y Uchida,1 K Mills,2 JA Casiday,1 A Trejo,2 PM Elias1 and WM Holleran1 1
Dermatology (190), UCSF & VA Med Center, San Francisco, CA and 2 Procter & Gamble,
Cincinnati, OH
Activators of the nuclear hormone receptor superfamily, including the liver X receptor (LXR), are
important in the regulation of epidermal differentiation and development (Komuves et al. JID 118:25,
2002). Treatment of cultured human keratinocytes (CHK) as well as murine epidermis with LXR
activators (e.g., oxysterols), increased expression of the differentiation-related structural proteins,
involucrin, loricrin, and profilaggrin. Because lipid formation for the epidermal barrier is also dif-
ferentiation-dependent, we investigated whether LXR activators upregulate the synthesis of sphin-
golipids in differentiated CHK, as well as the mechanism for such increases. The synthetic LXR acti-
vator TO-901317 (5 uM) induced a significant increase in total ceramide synthesis, measured as
incorporation of [3H]-serine over 24 h following treatment. Synthesis of specific ceramides, i.e.
ceramides-2-7, as well as glucosylceramides, increased 1.4- to 1.8-fold; p <0.001, and correspon-
ding elevations in the content of these ceramide fractions were evident 48 h after LXR-activator treat-
ment. Quantitative rt-PCR revealed a near-doubling of mRNA levels encoding for SPT2, the cat-
alytic subunit for SPT, the key regulatory enzyme in ceramide synthesis, while SPT1 mRNA levels
remained unchanged. Likewise, dual-reporter assays with an SPT2-promoter-luciferase construct,
showed a comparable increase in relative luciferase activity; i.e., 1.9-fold for LXR activator-treated
vs. vehicle-treated controls; p<0.005. Together, these studies suggest that LXR activators increase
ceramide production and that the LXR-induced increase results, at least in part, from transcriptional
up-regulation of SPT, a key enzyme in epidermal ceramide synthesis. Combined with the prior
work demonstrating enhanced differentiation induced by LXR agonists, these studies suggest that
LXR activators regulate both the lipid synthetic and protein arms of epidermal differentiation. 
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Desmoplakin phosphorylation and regulated intermediate filament association is required for
its efficient trafficking and incorporation into desmosomes
LM Godsel, SN Hsieh, AC Huen, EV Amargo, LT Pascoe, JK Park, CA Gaudry and KJ Green
Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL
Regulation of intercellular junctions is essential for epithelial morphogenesis and wound healing,
but the dynamic behavior and roles of individual desmosome molecules during junction remodel-
ing are poorly understood. We propose that desmosome remodeling requires regulated interactions
with the intermediate filament cytoskeleton (IF), which is linked to the plaque via desmoplakin (DP).
To test this hypothesis, GFP-tagged molecules including wild type DP (DPSer2849), a series of trun-
cation mutants (DPNTs) lacking the C-terminal IF binding site, two PKA phosphorylation site mutants
(DPGly2849 and DPAla2849) impaired in their ability to reversibly bind IF, and desmoglein2 (Dsg2)
were introduced into cells. Cytoplasmic particles containing DPSer2849, but not DPNTs, were asso-
ciated with IF, whereas DPGly/Ala2849 decorated IF more continuously. To determine if DP parti-
cles are desmosomal precursors, endocytosed desmosomes, or both, live cell imaging was performed
on cells after inducing junction formation. The majority of cytoplasmic DP did not colocalize with
endosomal markers, or the membrane marker DiI, in constrast to desmoglein2. DPSer2849 dots
moved on straight tracks to newly forming cell contacts where they organized into desmosomes,
exhibiting velocities over an order of magnitude slower than the movements of conventional molec-
ular motors. DPGly2849 dramatically suppressed particle motion, resulting in delayed desmosomal
incorporation. Particles that moved did so haltingly, alternately binding and releasing from IF.  DPNT
particles exhibited random cytoplasmic movements before trafficking to newly forming cell-cell bor-
ders. These data support the model that non-membrane bound, cytoplasmic DP complexes are desmo-
some precursors and that efficient incorporation of DP into desmosomes is promoted by Ser2849
phosphorylation and requires regulated interactions with the IF cytoskeleton. 
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Impaired epidermal differentiation including reduced ceramide binding involucrin in atopic
dermatitis
J Jensen,1 R Folster-Holst,1 M Schunck,1 C Neumann,1 S Schutze2 and E Proksch1 1 Dermatology,
University Hospitals of Schleswig-Holstein, Campus Kiel, Kiel, Germany and 2 Immunology,
University Hospitals of Schleswig-Holstein, Campus Kiel, Kiel, Germany
A defective permeability barrier leading to the penetration of environmental allergens into the skin
and initiating immunological reactions and inflammation is crucially involved in the pathogenesis
of atopic dermatitis (AD). Studies have shown that decreased stratum corneum ceramide content
may cause the defect in permeability barrier function consistently found in AD. In addition to lipids,
we have previously shown that epidermal differentiation-related proteins, keratins and cornified enve-
lope proteins are of crucial importance for skin barrier function. In the present work, we determined
involucrin, loricrin, filaggrin, and keratin expression in lesional and non-lesional skin of AD patients
by immunohistochemistry and by western blotting. We found premature, but reduced protein expres-
sion of involucrin and filaggrin in non-lesional and in lesional skin. Involucrin serves as a substrate
for the covalent attachment of ceramides to the cornified envelope. Filaggrin is involved in water-
binding; dry skin is consistently found in AD. Loricrin revealed broadening of the stained band and
an increased protein expression in non-lesional and lesional epidermis as shown by western blot
analysis. Extension of the staining intensity from the basal to suprabasal layers for K 5 and induc-
tion of proliferation associated K 16 were also found in lesional and non-lesional skin. Reduction
of staining for suprabasal K 10 as well as induction of proliferation associated K 6 and inflamma-
tion associated K 17 were found in lesional skin of AD only. We suggest that the pathogenesis of
AD involves both reduction in lipid content and impaired differentiation, including reduced protein
expression of involucrin, which serves as a substrate for covalently binding ceramides, and reduced
filaggrin, which is important for water binding. 
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Differentiation-dependent expression of ceramidase isoforms in human keratinocytes and
epidermis
E Houben,1 Y Uchida,2 T Yaginuma,3 C Mao,4 LM Obeid,4 V Rogiers,1 Y Takagi,3 PM Elias2 and
WM Holleran2 1 Toxicology, Vrije University, Brussels, Belgium, 2 Dermatology (190), UCSF &
VA Med Center, San Francisco, CA, 3 Biological Science Labs, Kao Corporation, Tochigi, Japan
and 4 Medicine, Medical University of South Carolina, Charleston, SC
It is well established that ceramides are key lipid components in the formation and maintenance of
the epidermal permeability barrier, which localizes to the stratum corneum. However, the presence
within the stratum corneum of both ceramidase (CDase) activity, which hydrolyzes ceramides to
their corresponding sphingols (e.g., sphingosine) and free fatty acids, as well as the CDase product,
free sphingol, suggests a role for ceramide hydrolysis in epidermal function(s). Since CDase activ-
ity with a range of pH optima have been reported in homogenates from stratum corneum, epider-
mis, and cultured human keratinocytes (CHK), we investigated whether the expression of four CDase
isoforms is altered during keratinocyte differentiation; i.e., in undifferentiated (serum-free KGM plus
0.07 mM Ca2+); differentiated (KGM 1.2 mM Ca2+); and lamellar body-competent (vitamin C
plus 1.2 mM Ca2+ plus serum-supplementation) cells, in comparison with whole human epidermis.
Normal and quantitative rt-PCR revealed low levels of both acid- and alkaline-CDase mRNA in low
and high Ca2+-containing medium, values that increased significantly in lamellar body-competent
CHK (i.e., 2- and 79-fold over KGM controls for acid- and alkaline CDase, respectively), with whole
epidermis containing even higher expression of both isoforms. Conversely, mRNA levels for phy-
toalkaline-CDase were equivalent for undifferentiated and differentiated CHK, and significantly
lower (i.e., <0.25-fold of control) in lamellar body-competent CHK and whole epidermis. Neutral-
CDase mRNA levels remained comparable at each differentiation state. These results demonstrate
significant alterations in the expression of key CDase isoforms during epidermal differentiation, sug-
gesting specific, localized roles for each isozyme in epidermal structure and/or function. 
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Expression of murine beta-defensins 1-4 depends on epidermal differentiation and stimulation
M Schunck, J Jensen, R Panzer, R Hasler, J Schroder and E Proksch Dermatology, University
Hospitals of Schleswig-Holstein, Campus Kiel, Kiel, Germany
Epidermis is exposed to a wide variety of environmental germs, nevertheless, infections are rare.
Defensins comprise a family of cationic antimicrobial peptides with different specificity against gram
positive and negative bacteria. In PAM212 cells, an immortal keratinocyte cell line, in primary ker-
atinocytes and in hairless mouse skin in vivo, we investigated m-RNA expression of beta-defensin
1, 2, 3, and 4 using micro array and RT-PCR techniques. In addition, defensin proteins were quan-
tified by FACS analysis and the distribution pattern was determined by immunohistochemistry. RT-
PCR revealed constitutive expression of murine beta-defensin 1 in PAM212 keratinocytes, in embry-
onic, neonatal, and adult skin. Immunohistochemistry showed that beta-defensin 1 was equally
distributed in the epidermis. No challenge is necessary to induce beta-defensin 1 expression in unstim-
ulated cultured cells or fetal epidermis. Only in primary keratinocytes does induction with PMA lead
to a significant increase in protein expression. Murine beta-defensins 2 and 3 were not expressed
constitutively, but inducible by phorbol ester PMA stimulation. Immunohistochemistry revealed beta-
defensin 2 and 3 in the outer epidermis, with an expression peak in the stratum granulosum. beta-
defensin 3 showed up-regulation on gene and protein level after PMA stimulation in primary ker-
atinocytes and in PAM212. beta-defensin 4 was constitutively, but weakly expressed and localized
in the stratum granulosum. PAM212, which represent cells from the spinous layer, showed mRNA
up-regulation after PMA stimulation. The results indicate a late expression of beta-defensin 4 in
epidermal differentiation. In summary, antimicrobial peptides provide an innate defense system and
develop during epidermal differentiation and stimulation. 
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Protective effect of tocotrienol on hydrogen peroxide–induced intracellular ROS generation
and cell death on normal human keratinocytes
M Dumas,1 T ZULIANI,1,2 S TALBOURDET,1 C JAYAT,3 S SCHNEBERT1 and M RATINAUD2
1 Laboratoires LVMH, Saint-Jean de Braye, France, 2 UMR CNRS 6101, Faculte de Medecine,
Limoges, France and 3 SUC - Faculte des Sciences, Limoges, France
Epidermal cells are exposed to a large range of oxidative stress i.e. solar radiations, tobacco smoke,
pollutants, and ozone, contributing to chronic skin inflammation and premature aging. One of the
most powerful natural antioxidant is alpha–tocopherol, a lipophilic cell membrane scavenger for
OH° and 1O2. In the present study we investigated the protective effect of the tocopherol derivative,
tocotrienol (2, 5, 7, 8–tetramethyl – 2 – (4″ 8″ 12″ – trimethyltrideca–3″ 7″ 11″ – trienyl) –6–chro-
manol) on intracellular oxidation and cell death induced by H2O2 (1 mM) on normal human ker-
atinocytes. Cell death (apoptosis and necrosis) was measured by following mitochondrial trans-
membrane potential (collapsed in apoptotic and necrotic cells) with the JC–1 probe, and plasma
membrane permeability (maintained in apoptotic and unaltered cells) using the TOTO–3 fluorophore.
Caspase–1 and –3 activity were quantified using specific permeant FITC and rhodamine substrates
respectively. For intracellular oxidation, cells were loaded with dichlorodihydrofluorescein diac-
etate, emitting a green fluorescence when oxidized. We demonstrated that the protective effect of
tocotrienol during accute oxidative stress takes place through: (1) a reduction of intracellular ROS
generation, (2) a protection against cell death with more JC1–high and TOTO3–negative cells, (3)
a reduction of the necrotic vs apototic cell ratio mainly due to a decrease of necrotic cells, (4) a
reduced caspase-1 activity leading to a lower caspase 1/caspase 3 ratio. In the same range of con-
centrations, α–tocopherol failed to protect so efficiently the cells. We conclude that this tocopherol
derivative could be a potent molecule to protect the keratinocytes from oxidative stress–induced intra-
cellular oxidation and death, and improve removal of irreversibly damaged epidermal cells through
a programmed cell death process. 
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Class II PI3-kinase mediates cell cycle inhibition and terminal differentiation in epidermis
T Cai,1,2 K Harada,1,2 E Yang1,2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA, CA and 2 Stanford,
Stanford, CA
The phosphoinositide 3-kinase (PI3K) multi-gene family has been implicated in the regulation of
proliferation, apoptosis and differentiation in various tissues. A role for PI3Ks in epidermal home-
ostasis, however, is undefined. In examining PI3K distribution in epidermis, we found that Class I
PI3K proteins are expressed in all layers while Class II PI3Ks are strikingly localized within suprabasal,
differentiating cells. To explore a potential role for PI3Ks in epidermal growth and differentiation,
we next activated and blocked PI3K function using both genetic and pharmacologic approaches. In
contrast to Class I PI3Ks, active Class II PI3K induced differentiation and growth arrest in ker-
atinocytes in vitro. In genetically engineered human epidermis regenerated on immune-deficient scid
mice in vivo, active Class II PI3K triggered growth inhibition, hypoplasia and premature differenti-
ation. Mutagenesis demonstrated that these effects are dependent on intactness of both the PI3K lipid
kinase and C2 domains. Knocking down Class II PI3K levels in vivo, in contrast, stimulated epi-
dermal hyper-proliferation and hyperplasia while simultaneously down-regulating differentiation
marker expression, indicating that intact Class II PI3K function is required for normal epidermal dif-
ferentiation. Of interest, calcium addition activated Class II PI3K plasma membrane localization and
function while active protein itself elevated intracellular calcium concentration, indicating that Class
II PI3K participates in a calcium-mediated autoregulatory positive feedback mechanism. These data
are the first to identify an important role for Class II PI3Ks in controlling epidermal growth and dif-
ferentiation and indicate that these effects may proceed in part via autoregulatory amplification of
calcium signaling. 
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Mek1, but not Mek2, alters epidermal growth and differentiation
FA Scholl,2 PA Dumesic,2 J Charron3 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA, 2 Stanford,
Stanford, CA and 3 Laval University, Quebec, QC, Canada
The highly homologous kinases, Mek1 and Mek2, act downstream of Ras and Raf to activate ERK
MAP kinases. In epidermis, Ras and Raf promote proliferation and oppose differentiation, however,
they act on multiple Mek-independent effectors and the extent to which Meks can mediate these
effects is unknown. Moreover, despite their similarity, the function of Mek1 and Mek2 is not entirely
redundant and the degree to which either Mek kinase can mediate Ras/Raf effects and alter epider-
mal homeostasis is not defined. To address this, we first examined the necessity of Mek2 for Ras/Raf
effects. Conditionally inducible epidermal Ras mice (K14-ER:Ras) and Raf mice (K14-Raf:ER) were
crossed with MEK2 knock-out mice. Ras induction in K14-ER:Ras/MEK2-/- mice increased pro-
liferation and inhibited differentiation in a manner indistinguishable in kinetics and magnitude from
K14-ER:Ras/MEK2+/+ controls. Similarly, no difference was seen between K14-Raf:ER/MEK2-/-
mice and K14-Raf:ER/MEK2+/+ mice, indicating that MEK2 is dispensable for Ras/Raf-driven epi-
dermal changes. We next examined the effects of epidermal Mek gain-of-function. To do this, we
generated conditionally active Mek fusions to the estrogen receptor ligand-binding domain. ER-
fused Mek1 and Mek2 were then expressed in transgenic murine (3 independent lines each) as well
as in genetically engineered human epidermis regenerated on scid mice. Both Mek1 and Mek2 trig-
gered epidermal ERK phosphorylation in vivo in human and murine skin in response to topical 4-
hydroxytamoxifen. Only Mek1, however, recapitulated Ras/Raf effects in increasing proliferation
and integrin expression while suppressing differentiation. Furthermore, a kinase-dead Mek1 mutant
demonstrated that ERK phosphorylation was dispensable for these features. These data indicate that
Mek1 is sufficient to promote the undifferentiated, proliferative epithelial phenotype in a manner
independent of ERK activation and that Mek2 is dispensable for Ras/Raf-driven changes in epider-
mal growth and differentiation. 
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Influence of keratinocyte culture conditions on development of a senescence phenotype
M Barratt and C Bosko Unilever Research and Development, Edgewater, NJ
It has been reported that with age, keratinocytes in vivo become less proliferative and have a greater
tendency to become growth arrested (senescent). Recently, we cultured neonatal keratinocytes in
vitro in an attempt to elucidate this process. The expression of β-galactosidase, a widely confirmed
marker of senescence, and population doublings were examined as indicators of the replicative capac-
ity of keratinocytes during their cultured life span. Interestingly, it seems that the culture conditions
affect the replicative life span more than the number of actual population doublings on the journey
to senescence in vitro. Specifically, the expression of β-galactosidase and growth arrest was induced
consistently as a function of the number of trypsinizations, irrespective of population doublings. This
trypsin-induced growth arrest could also be altered with a different type of media, bringing into ques-
tion media effects on senescence in vitro. It also appears that differentiated keratinocytes in vitro
develop their β-galactosidase staining properties, while only basal keratinocytes in vivo stain posi-
tive for this enzyme. Collectively, this data highlights using caution when using cell culture models
to measure replicative capacity of keratinocytes. 
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Developmental environments alter the fate of aged epidermal stem cells
JR Bickenbach and M Stern Anatomy and Cell Biology, and Dermatology, The University of Iowa,
Iowa City, IA
Homeostasis of continuously renewing tissues, such as the epidermis of the skin, is maintained by
somatic stem cells. These are undifferentiated, self-renewing cells, which also produce daughter tran-
sit amplifying (TA) cells that make up the majority of the proliferative population. TA cells undergo
a finite number of cell divisions before leaving the proliferative compartment and moving toward
terminal differentiation, whereas it has been assumed that the stem cells persist throughout the life-
time of the organism. Through a series of labeling experiments with tritiated thymidine, we previ-
ously showed that stem cells from adult mouse skin did not divide as often as the other basal cells,
but they did divide at a steady rate in vivo. We also showed that they continued to proliferate in vivo
throughout life, and that they have a high proliferative potential in vitro. Thus, we wondered if epi-
dermal stem cells did not follow the Hayflick theory of aging and possibly lived forever.  Using our
recently redefined sorting method, we isolated epidermal stem and TA cells from the skin of neona-
tal and old mice. The stem cells, but not the TA cells, had the capacity to regenerate an epidermis
with continuously long term expression of a recombinant gene. We also injected both the neonatal
and the aged stem cells into developing mouse embryos and into developing zebrafish embryos. We
found that both ages of stem cells had the remarkable ability to participate in the formation of tis-
sues from all three germ layers when introduced into developmental environments, whereas the TA
cells could not. These data suggest that there may be a fundamental intrinsic difference between
epidermal stem and TA cells, and that the environment, rather than the age of the stem cell, influ-
ences the fate determination of a stem cell. 
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Scanning transmission ion microscopy, particule induced X-ray emission and skin structure
E gontier,1,2 T Pouthier,1 C Habchi,1 P Aguer,1 S Incerti,1 P Barberet,1 A Mavon,3 J Surleve-bazeille
2 and P Moretto1 1 Interface physique biologie, CENBG, Gradignan, France, 2 Labo DMPFCS,
University bordeaux 1, Talence, France and 3 Institut de recherche Pierre FABRE, Castanet
Tolosan, France
Studying the morphology and the chemical composition of human skin, a tissue with a total typical
thickness under a few hundred micrometers, requires techniques working at the microscopic level.
We have developed ion microbeam techniques of imaging and analysis with the capability to deter-
mine mineral ions and exogenous elements in the different strata of native skin. Particle Induced X-
ray Emission (PIXE) and Scanning Ion Transmission Microscopy (STIM) allow respectively to
map most elements present in epidermal sections and to image the skin structure on the basis of its
density contrast. Owing to its multielemental capability, micro-PIXE analysis allows the simulta-
neous mapping of a dozen elements in tissues sections. It is thus particularly well adapted for the
measurement of balanced ions (Na, Mg, S, Cl, K, Ca) which appeared highly compartmentalized in
the different skin strata. STIM delivers image of tissues with sub-micrometer resolution, both rap-
idly and non destructively, authorizing localization of cellular structure. In addition, it allows the
measurement of the sample mass to normalize X-ray data in terms of concentration. Those tech-
niques were carried out in the frame of physiological studies, to highlight for instance the calcium
gradient in the outermost layers of human skin in relationship with the functional barrier effect. The
fact that this method may be applied on un-embedded sections, only cryofixed and freeze-dried is
undoubtedly an advantage when addressing percutaneous penetration studies. The aim of this work
is to show the perfect complementarities of STIM and PIXE when applied to the elucidation of the
elemental content and structure of different models of human and animal skin. The method proved
to be very useful in providing elemental and structural information that allowed a clear identifica-
tion of very thin skin layers such as stratum granulosum. 
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S100A8 and S100A9 in human keratinocytes: a novel secretory mechanism
A Broome1 and RL Eckert1,2 1 Physiology & Biophysics, CWRU School of Medicine, Cleveland,
OH and 2 Dermatology, CWRU School of Medicine, Cleveland, OH
S100 proteins are thought to be important in epidermal differentiation, as they are expressed in epi-
dermis, clustered in the epidermal differentiation complex at 1q21, differentially expressed during
differentiation, and activated by calcium. Moreover, select members of this family are overexpressed
in epidermal disease. S100A8 and S100A9 form a hetero-complex, and are particularly important,
since they are markedly overexpressed in psoriasis. Previously, we mapped S100A8 and S100A9
expression in normal and psoriatic epidermis. In psoriasis, S100A8 and S100A9 expression is markedly
elevated and aberrant expression is detected in the epidermal basal and spinous layers. Secreted S100
proteins are thought to function as chemokines for CD4+ lymphocytes; however, there is no direct
evidence indicating how S100s are released from keratinocytes. In the present studies, we examine
the distribution of S100A8 and S100A9 in cultured normal human epidermal keratinocytes. Our data
demonstrate that S100A8 and S100A9 assume a cytoplasmic distribution in resting cells and are not
present in the Golgi or endoplasmic reticulum. Differentiation of keratinocytes induced by okadaic
acid treatment causes S100A8 and S100A9 to co-localize with β-actin in the cortical actin ring, fol-
lowed by the formation of S100A8 and S100A9-positive cytoplasmic buds that protrude from the
apical cell surface. These blebs are rimmed by actin which appears to sequester the S100A8 and
S100A9-containing cytoplasm. These extrusions appear to release from the surface in a non-classi-
cal secretory mechanism. This study suggests that a novel mechanism whereby S100A8 and S100A9
may be released from keratinocytes is the formation of actin-stabilized cytoplasmic buds. 
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Identification and refinement of a locus for type I punctate palmoplantar keratoderma on chro-
mosome 15q22-24
A Martinez-Mir,1 A Zlotogorski,6 D Londono,4 D Gordon,4 A Grunn,3 E Uribe,5 L Horev,6
IM Ruiz,5 NO Davalos,5 O Alayan,6 J Liu,3 TC Gilliam,3 J Miljkovic,8 A Stanimirovic,9 JC Salas-
Alanis7 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY, 2 Genetics &
Development, Columbia University, New York, NY, 3 Columbia Genome Center, Columbia
University, New York, NY, 4 Rockefeller University, New York, NY, 5 Hospital General Occidente
Zapopan, Jalisco, Mexico, 6 Hadassah Medical Center, Jerusalem, Israel, 7 Servicio Medico
Universidad Autonoma Nuevo Leon, Nuevo Leon, Mexico, 8 Maribor Teaching Hospital, Maribor,
Slovenia and 9 Medical School of Zagreb University, Zagreb, Croatia
Mutations in different components of the intermediate filaments, desmosomes and gap junctions
have been identified underlying several disorders of keratinization. Among them is an extraordinar-
ily heterogeneous group known as palmoplantar keratodermas (PPK), for which only a few molec-
ular defects have been described. Here we report the identification of the first locus for type I punc-
tate PPK. A genomewide scan was performed on an extended autosomal dominant pedigree and
linkage to chromosome 15q22-24 was identified. With the addition of two new PPK families, we
confirmed the mapping of the locus for punctate PPK to a 9.98-cM interval, flanked by markers
D15S534 and D15S818 (maximum two-point LOD score of 4.93 for marker D15S988). In order to
refine the location of the PPK locus, we genotyped all available markers within the region and nar-
rowed the locus to an interval of 8.89 cM. According to the current physical map, the critical link-
age interval identified here corresponds to a region of 3.7 Mb, syntenic to mouse chromosome 9.
We have recently identified three new PPK families from Slovenia, with a total of 10 available fam-
ily members. The common geographical origin of these three pedigrees will be helpful in further
testing the genetic homogeneity of PPK, and also in searching for a possible common haplotype
shared among them. In all, these findings will facilitate the identification of a new gene involved in
skin integrity that could also contribute to the understanding of the multiple organ involvement in
the syndromic forms of PPK. 
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A proteomic characterization of the plasma membrane of human epidermis by high-through-
put mass spectrometry
A Terunuma,1 J Blonder,2 C Yee,1 TP Conrads,2 TD Veenstra2 and JC Vogel1 1 Dermatology, NCI,
Bethesda, MD and 2 Mass Spec Center, NCI, Frederick, MD
Membrane proteins are responsible for many critical cellular functions, and identifying these cell
surface proteins on different keratinocyte populations would improve our understanding on the
biology of the epidermis. However, the characterization of membrane proteins, which are mostly
hydrophobic and incompatible with 2-dimensional gel electrophoresis, has been difficult to accom-
plish because high-throughput analytical methods to analyze membrane proteins do not exist. In
this study, membrane proteins in human epidermis were analyzed using a two-dimensional liquid
chromatography (LC) tandem-mass spectrometry (MS/MS) approach that can identify proteins by
determining both the mass and amino acid sequences of tryptic peptides. From foreskin epidermal
sheets, a highly enriched plasma membrane fraction was prepared using sucrose gradient centrifu-
gation, followed by a single tube membrane protein extraction/solubilization into 60% methanol,
and tryptic digestion. The resultant peptide mixture was fractionated into 80 fractions and analyzed
by strong cation exchange/reversed phase LC-MS/MS. This high-throughput shotgun approach iden-
tified a total of 2,875 unique peptides corresponding to 1,306 proteins, including 1,083 known pro-
teins and 223 novel proteins. Of the known proteins, 600 (55.4%) were annotated membrane pro-
teins, while 104 of the 223 novel proteins (46.6%) were predicted to contain at least one transmembrane
domain, yielding a significantly enriched total membrane proteome of 704 proteins (out of 1,306
proteins; 53.9%). Most known integral membrane proteins, including the cell adhesion complex,
proteins involved in immune responses, neural function and molecular transport, and membrane
caveolae proteins were identified. These results demonstrate identification of a significant number
of the estimated membrane proteins (approximately 1,400 to 2,100) and provide a solid analytical
platform to conduct quantitative comparison of protein expression in different keratinocyte popula-
tions.
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Role of the Ca-binding protein Scarf, during epidermal differentiation
M Hwang, O Kalinin and MI Morasso NIH/NIAMS, Bethesda, MD
During the process of epidermal differentiation, intracellular and extracellular Calcium concentra-
tions induce an array of signaling pathways. Members of the Ca -binding proteins play a central role
in the transduction of Ca  signals. We identified two novel mouse genes, Scarf (skin Calmodulin-
related factor) and Scarf2, which have homology to Calmodulin (CaM)-like Ca -binding protein
genes. Southern blot and computational genome sequence analysis show that three mouse Calmod-
ulin like proteins -mClp, Scarf and Scarf2- are clustered on the end of chromosome 13 long arm.
Scarf2 is expressed at a much lower level than Scarf in differentiated keratinocytes, even though a
high degree of homology between the genes has been found in the upstream regions that contain
potential regulatory sequences. To understand the control elements that confer the distinct expres-
sion patterns to Scarf and Scarf2, we are performing Scarf promoter analysis using a luciferase assay.
Since Ca -binding proteins exert their roles through Ca -dependent interactions with their target pro-
teins, we are in the process of identifying Scarf-interacting factors utilizing yeast II hybrid screens
and affinity chromatography followed by Mass Spectrometry (MS) analysis. The identification of
the interacting factors will aid in understanding the function of Scarf in the Ca -dependent keratinocyte
differentiation. 
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Anti-psoriatic drug Anthralin induces EGF receptor phosphorylation in keratinocytes: require-
ment for H2O2 generation
M Pittelkow, A Meves, D Peus, M Pott and A Beyerle Department of Dermatology, Mayo Clinic,
Rochester, MN
Anthralin is a well-established topical therapeutic agent for psoriasis, although little is known about
its effects and biochemical mechanisms of signal transduction. In contrast to a previous report, we
found that anthralin induced time- and concentration-dependent phosphorylation of epidermal growth
factor receptor in primary human keratinocytes. Combined evidence shows that this process is
mediated by reactive oxygen species. First, we found that anthralin induces time-dependent gener-
ation of H2O2. Second, there is correlation between the time-dependent increase in anthralin-induced
epidermal growth factor receptor phosphorylation and H2O2 generation. Third, structurally differ-
ent antioxidants, n-propyl gallate and N-acetylcysteine inhibited epidermal growth factor receptor
phosphorylation induced by anthralin. Fourth, overexpression of catalase also inhibited this response.
The epidermal growth factor receptor-specific tyrosine kinase inhibitor PD153035 abrogated anthralin-
induced receptor phosphorylation and activation of extracellular-regulated kinase 1/2. These find-
ings link the following sequence of events: (1) H2O2 generation, (2) epidermal growth factor recep-
tor phosphorylation, and (3) extracellular-regulated kinase activation. Our data identify anthralin
induced reactive oxygen species and, more specifically H2O2 as important upstream mediators
required for ligand-independent epidermal growth factor receptor phosphorylation and downstream
signaling.
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Role of erbB3 in proliferation and in stress-response of human keratinocytes
F Gao,1 DA Lewis,1 J Dixon1 and DF Spandau1,2 1 Dermatology, Indiana University School of
Medicine, Indianapolis, IN and 2 Biochemistry, Indiana University School of Medicine,
Indianapolis, IN
Key regulators of both the proliferative and differentiation signal transduction pathways in ker-
atinocytes are members of the erbB family of transmembrane tyrosine kinase receptors. Three of the
four identified erbB family members are expressed in the keratinocytes of the skin, erbB1, erbB2,
and erbB3, and many of their numerous ligands are either produced by keratinocytes or by cells that
are adjacent to keratinocytes. The erbB1 protein is the prototype of the family and has been exten-
sively studied in a variety of cell types. Less is know about the function of erbB2 in skin, but it has
been suggested that expression and activation of the erbB2 receptor is associated with the induction
of differentiation. Although the erbB3 receptor has been shown to be a critical signaling protein in
other cell types, very little is known about the function of the erbB3 receptor in the skin. Previously
reports from our lab have suggested that the erbB receptor family is integrally involved in the stress-
response of keratinocytes induced by exposure to ultraviolet B radiation. To investigate the function
of the erbB receptor family more fully, we have constructed HaCaT cell lines that overexpress either
erbB1, erbB2, or erbB3. Characterization of these cells lines has demonstrated that overexpression
of erbB3 increases keratinocyte proliferation and increases the sensitivity of the cells to UVB-induced
apoptosis. Because the erbB3 receptor is a substrate of both the erbB1 and erbB2 receptors but has
little to no tyrosine kinase activity itself, these observations imply that the phosphorylation of the
erbB3 receptor plays a critical role during proliferation and the response of keratinocytes to UVB
exposure.
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Calcium-induced changes in connexin expression and function in the corneal epithelium
DL Shurman,1 L Glazewski,1 JD Zieske2 and G Richard1 1 Department of Dermatology &
Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 2 Schepens Eye Research
Institute, Boston, MA
The genetic connexin disorder Keratitis-Ichthyosis-Deafness syndrome (KIDS) is caused by domi-
nant missense mutations in the Cx26 gene GJB2, yet the pathomechanisms of corneal disease have
not been elucidated. Therefore, we investigated the expression of Cx26 and 16 other connexin genes
in normal human cornea and cultured primary corneal epithelial cells (PCEC) at different stages of
differentiation. In contrast to human epidermis expressing up 10 different connexins, immunohisto-
chemisty (IHC) of central cornea and limbus revealed 3 major connexins, Cx26, Cx30 and Cx43.
The latter two proteins showed overlapping yet distinct immunostaining in the basal and suprabasal
layer, sparing superficial cells. Cx26 staining was less pronounced and mostly limited to basal cells.
There was no evidence for corneal expression of other connexins. For in vitro studies, PCEC were
obtained from corneal rims and cultured in either keratinocyte serum-free medium or KSFM with
0.3% fetal bovine serum and 1.8 mM Ca2+ to promote epithelial differentiation. Under both condi-
tions, 9 connexin genes were expressed by RT-PCR analysis, of which Cx26, Cx30 and Cx43 were
upregulated after Ca2+ switch. IHC in undifferentiated PCEC showed a characteristic punctate plasma
membrane staining for Cx26 and Cx43. Nevertheless, cells were poorly coupled by gap junctions,
yielding an average dye transfer to 0.86 + 1.0 cells. A switch in Ca2+ concentration resulted in for-
mation of epithelial sheets, strong upregulation of Cx26 and Cx43, and induction of Cx30 staining
as evident by IHC. Gap junction-mediated dye transfer was significantly increased with average dye
spread to 5.72 + 3.1 cells (p<0.00001). Based on these observations, we speculate that KIDS muta-
tions in Cx26 directly or indirectly interfere with the function of co-expressed Cx30, Cx43, or both.
A resulting functional impairment might lead to perpetually induced expression of Cx26 as com-
pensatory mechanism, thus producing the progressive corneal pathology in KIDS. 
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Differential reactivity of basal and suprabasal keratinocytes to H2O2-induced apoptosis in nor-
mal human epidermis: an ex vivo immunohistological study
T Zuliani,1,2 V Denis,2 S Schnebert,1 M Dumas1 and M Ratinaud2 1 Laboratoires LVMH, Saint-
Jean de Braye, France and 2 UMR CNRS 6101 - Faculte de Medecine, Limoges, France
Apoptosis is a physiologic programmed cell death (PCD) that occurs throughout the epidermis. It
contributes to epidermal protection and maintenance by removing damaged or unwanted cells avoid-
ing inflammation. Recent evidences suggest that cell susceptibly to apoptosis is dependant to their
differentiation state. To explore this hypothesis we carried out an ex vivo immunohistological study
of H2O2-induced apoptosis in normal human skin by confocal microscopy. Apoptotic cells were
characterized by two different immunohistological staining of skin cryosections after oxidative stress
exposure of the biopsies. Specific antibodies were used to detect, active caspase-3 and single strands
break DNA. To characterize differentiation state of apoptotic cells in epidermis, double staining were
performed to correlate DNA fragmentation, or active caspase-3 versus beta1-integrin expression, a
marker of basal cells. During the time course of H2O2 induction, apoptotic cells detected by both
methods appeared in a dose dependant manner 24 hours after oxidative stress exposure (0,5 to 5
mM H2O2) and greatly enhanced at 48 hours. In the germinative layer and the next upper layer of
the epidermis, a significant caspase-3 activation occurred without DNA fragmentation (even after
48 hours of H2O2 exposure). Interestingly, single strands break DNA was exclusively restricted to
the most suprabasal layers (essentially granular layers), without activation of caspase-3. We con-
clude that human keratinocytes possess differential reactivity to H2O2-induced apoptosis depend-
ing on their differentiation state and that this sensitivity could be partially explained by activation
of different pathways. On the other hand, in basal cells, caspase-3 activation does not seem to induce
cell death. 
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The unique linear migration of human keratinocytes on collagen is driven by an autocrine
mechanism
J Fan, M Fedesco, M Chen, DT Woodley and W Li Dermatology, University of Southern
California, Los Angeles, CA
We have previously shown that the unique feature of human keratinocyte (HK) migration is the lin-
earity of its migration tracks in response to human serum or bovine pituitary extract (BPE) even in
the absence of a gradient. In contrast, other types of skin cells, such as dermal fibroblasts, melanocytes,
melanomas and microvascular endothelial cells, do not show similar migratory responses to the same
stimuli (Chen, Helmold, Kim, Wynn and Woodley, Clinical and Laboratory Investigation, 188:6-12,
1993). We postulated that the factor(s) that causes the linear migration of HKs is not from serum or
BPE, but is secreted product from the migratory HKs themselves. We investigated this hypothesis
using serum-free conditioned media from HKs (HKCM), prepared from HKs cultured in serum-
free media. Our results showed that the HKCM stimulated linear migration of HKs and, surprisingly,
all other cell types tested. These included dermal fibroblasts, melanocytes and melanoma cells. More
intriguingly, HKCM stimulated migration of these cells even stronger than their published stimuli.
The CM, prepared from cycloheximide-pre-treated HKs, completely lacked the linear migration-
promoting activity. However, GM6001, MMP Inhibitor III and TIMP-1 had no inhibitory effects on
HKCM-stimulated linear migration, indicating that the linear migration-promoting factor is not
related to MMPs. Human Cytokine Array analyses (RayBiotech, Inc) suggested that the linear migra-
tion-promoting factor in HKCM is not among the previously reported pro-motility factors for HKs,
dermal fibroblasts or melanocytes. This study indicates that the unique linear migration by HKs is
driven by an autocrine mechanism. This linear migration-promoting factor from HKs may play an
important role in skin wound re-epithelialization. 
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Transcriptional profiling of aging in photoprotected skin
D Hurwitz,1 M Shibata,1,2 GN Rockwell,3 R Jensen4 and TS Kupper1 1 Dermatology, Harvard Skin
Disease Research Center / Brigham and Women’s Hospital, Boston, MA, 2 Cutaneous Biology
Research Center, Harvard Medical School / MGH, Charlestown, MA, 3 Broad Institute, MIT,
Cambridge, MA and 4 Neurology, Brigham and Women’s Hospital, Boston, MA
Relatively little data quantitative data exists on the molecular biology of human aging. Photopro-
tected skin can provide a window into aging. Prior studies on human aging have used cell-lines,
which can miss in-vivo cell-cell interactions, and which tend to be selected for ability to amplify in
culture. A case-control design was used to compare gene expression among elderly (case) and young
(control) subjects to identify previously unidentified genes displaying differential expression between
young and old photoprotected skin. Subjects were healthy caucasian males between 20 and 25 years
of age (10 younger subjects), or healthy caucasian males over 80 years of age (10 older subjects).
Subjects were excluded for significant skin disease requiring dermatologic treatment, history of
systemic chemotherapy, or other history of chronic disease. To retain near in vivo profiles, speci-
mens of buttock skin were immersed in liquid nitrogen within 60 seconds of removal. Specimens
remained at -170 until RNA was isolated. Labeled RNA was annealed to Affymetrix U133 microar-
rays which can assay 22,000 gene transcripts. 10 subjects (5 younger and 5 older) were initially ana-
lyzed to generate a list of genes showing adequate expression, fold-change, and p-values. Sample
classes were iteratively randomized to generate nominal p-values. This list was then validated with
10 additional subjects (5 younger and 5 older). 12 differentially expressed genes included: (1) genes
known to be associated with skin-aging (e.g. trichohyalin), (2) previously known aging-associated
genes not known to be involved in aging of skin (e.g. thrombospondin 2), and (3) genes previously
not associated with aging (e.g. calgranulin A). Absent photodamage, there are still robust transcrip-
tional differences between young and old skin. 
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Ceramide glucosyltransferase expression is regulated by a MAPK pathway involving non-clas-
sical PKC isoforms, PI3K, MEK1/2, and ERK
G Sando, H Zhu and KC Madison Marshall Dermatology Research Labs, Univ of Iowa, Iowa City,
IA
Ceramide glucosyltransferase (CGT) is required for synthesis of the glucosylceramide (GlcCer) pre-
cursors of ceramides, the dominant lipids of the epidermal permeability barrier. We previously reported
that GlcCer content and CGT activity are induced during keratinocyte culture differentiation, and
that expression of CGT mRNA, protein and activity in low calcium (KGM)-grown keratinocytes is
induced by phorbol ester (PMA)-mediated stimulation of protein kinase C (PKC). We have now stud-
ied the PKC isoform specificity and tested for involvement of a mitogen-activated protein kinase
(MAPK) pathway. Basal or PMA-induced CGT expression in KGM-grown human foreskin ker-
atinocyte cultures was not affected by calcium ionophores or by raising the calcium concentration
of the medium, and the PKC alpha, beta, gamma selective inhibitor, Go 6976, did not inhibit PMA
induction of CGT mRNA, suggesting that the calcium-dependent classical PKC isoforms are not
involved. CGT mRNA induction was suppressed by Go 6983, which inhibits novel, nPKCs and the
atypical, aPKC zeta isoform, and by a pseudosubstrate inhibitor of PKC zeta, but not one specific
for nPKC eta. High concentrations of rottlerin were required to inhibit CGT mRNA induction, sug-
gesting that nPKC delta may have a lesser role than other isoforms. PMA-induced CGT mRNA was
blocked by the MEK1/2 inhibitor, PD98059 and by the phosphatidylinositol 3-kinase (PI3K) inhibitor,
wortmannin, but not by the Raf-1 inhibitor, GW5074.  Induction was blocked by peptide inhibitors
of ERK activation, but weakly inhibited, or activated, by compounds that block p38 (SB203580,
SB202190) and JNK (SP600125, JNK inhibitory peptides) activation. The p38/JNK activator, ani-
somycin, blocked PMA-induced CGT mRNA, in agreement with recent evidence for antagonism of
keratinocyte ERK function by p38. Our results indicate that induction of CGT mRNA by PMA is
mediated by a MAPK pathway that does not include Raf-1, and involves novel, and possibly atypi-
cal, PKC isoforms, PI3K, MEK1/2, and ERK. 
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TIG3 - a novel regulator of keratinocyte differentiation
MT Sturniolo,1 RA Chandraratna2 and RL Eckert1 1 Physiology and Biophysics, Case Western
Reserve University School of Medicine, Cleveland, OH and 2 Allergan, Inc, Irvine, CA
We have identified TIG3 as a novel regulatory protein that reduces keratinocyte viability and pro-
liferation. We recently showed that the TIG3-mediated reduction in viability is associated with acti-
vation of type I transglutaminase (TG1) and increased cornified envelope formation (Sturniolo et.
al., JBC 278, 48066-48073). A key question is whether TG1 activation is required for the biologi-
cal response and whether TIG3 interacts directly with TG1. In the present study we show that TIG3
forms a complex with TG1 and that this interaction is associated with TG1 activation. Moreover, the
reduction in cell viability is specific for TG1 activation, as inhibition of TG1 activity with mon-
odansylcadaverine prevents the TIG3-associated cellular responses, and a TIG3 mutant that does
not interact with TG1 does not increase TG1 activity or produce a biological response. An impor-
tant finding is that these TIG3-dependent changes occur in the absence of elevated extracellular cal-
cium levels, suggesting that TIG3 alters the TG1 requirement for calcium. This is the first evidence
that an agent can activate TG1 in the absence of increased extracellular calcium. TIG3 also serves
as a substrate for TG1, as demonstrated by the TIG3-dependent covalent attachment of the TG1
substrate, biotin-x-cadaverine, to TIG3, and by the formation of high molecular weight TIG3-con-
taining complexes. Microscopic localization and isopeptide crosslinking studies suggest that TIG3
and TG1 co-localize in membranes. In contrast, markers of apoptosis, including caspases and PARP,
are not activated by TIG3, and caspase inhibitors do not stop the TIG3-dependent biological response.
The TIG3-dependent formation of cornified envelope-like structures suggests that TIG3 is an acti-
vator of terminal keratinocyte differentiation. Our studies suggest that TIG3 may serve to facilitate
the terminal steps in keratinocyte differentiation by activating type I transglutaminase. 
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Characterization of new buccal and gingival epithelial tissue models
J Kubilus,1 B Breyfogle,1 PW Wertz,2 BA Dale,3 JR Kimball,3 JE Sheasgreen1 and M Klausner1 1
R & D, MatTek Corporation, Ashland, MA, 2 University of Iowa, Iowa City, IA and 3 University of
Washington, Seattle, WA
Three-dimensional models of the human oral epithelia, exhibiting a buccal or gingival phenotype
have been developed using normal human oral epithelial cells cultured in serum free medium. Two
versions of buccal tissue contain 8-12 and 25-35 cell layers (designated B12 and B35, respectively)
with cells becoming increasingly squamous toward the apical surface have been developed. No evi-
dence of cornification is present in histological slides and immuno-staining shows the expression of
cytokeratin K13 in the suprabasal layers. Cytokeratin K4, the expression partner of K13, has also
been detected by immuno-blotting. These features are characteristic of buccal epithelium. The gin-
gival tissue (G13) has 9-13 layers of viable, nucleated cells and is partially cornified at the apical
surface. When exposed to the surfactant Triton X-100, an exposure time of 52+/-20 minutes (n=31)
reduces the viability of B12 to 50% as determined by an MTT assay. For G13 and B35, a similar
exposure of >8 hours is required to damage the tissue to the same extent. Lipid analysis of B12
revealed that, of the ceramides important in the barrier of epidermis, only ceramide 2 (C2) was pres-
ent, a result which matches that of human buccal tissue. B35 contained ceramides C2 and C3 in a
ratio of 3.1:1 and G13 showed the presence of the three least polar ceramides, C1, C2, C3, in a ratio
of 1: 8.2 : 4.5, respectively. The absolute amounts of ceramide in B12, B35, and G13 also varied sig-
nificantly. Cultures contained 1.0, 4.5, and 8.2 micrograms/cm2, respectively. However, G13 was not
as cornified as human hard palate, which contains all ceramides normally present in epidermis, C1-
C7. The good correspondence between these tissues and those of native oral epithelia leads us to
believe the tissues will be useful for a broad variety of basic and applied oral cavity studies. 
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Keratinocytes act as a source of reactive oxygen species by transferring hydrogen peroxide to
melanocytes
E Pelle,1,2 T Mammone,1 D Maes1 and K Frenkel2 1 Estee Lauder Research Laboratories, Melville,
NY and 2 Environmental Medicine, New York University School of Medicine, New York, NY
Hydrogen peroxide (H2O2) levels in keratinocytes and melanocytes were compared on a per cell
basis and found to be significantly higher in keratinocytes. Since H2O2 is a neutral molecule capa-
ble of permeating through cellular membranes, we then investigated the possibility that H2O2 trans-
fer might occur between these two types of cells. Because the ratio of keratinocytes to melanocytes
in skin is 36:1, keratinocytes may act as a source of reactive oxygen species (ROS) even by passive
diffusion and, thus, affect melanocytic functions. In order to measure H2O2 transfer, a fluores-
cence-based co-culture system was developed in which melanocytes were first pre-labeled with 2’,7’-
dichlorodihydro-fluorescein diacetate (DCFdA). Once inside the melanocyte, non-specific esterases
remove the acetyl moieties leaving 2’,7’-dichlorodihydrofluorescein, a reduced form of DCFdA,
trapped inside the cell. Upon oxidation, fluorescence increases and can be used as a marker of oxi-
dation specific to the melanocyte. When melanocytes were co-cultured with keratinocytes, fluores-
cence increased as a function of keratinocyte cell titer. Thus, for melanocytes incubated with 1-, 1.5-
and 2-fold the number of keratinocytes, fluorescence increased by 22.6 % (+/- 2.8 %), 25.6 % (+/-
4.8%), and 39.9 % (+/- 4.1 %), respectively. Separating the cells with a transwell membrane did not
prevent transfer which indicates that H2O2 migration is not dependent upon direct cell-to-cell con-
tact. To further demonstrate that increased fluorescence was attributable to the transfer of H2O2,
catalase was added to the media of co-cultures and observed to significantly reduce the amount of
H2O2 in melanocytes. In conclusion, keratinocytes appear to be a previously unexamined source of
ROS which may affect neighboring skin cells such as melanocytes and, as a result, may influence
the process of melanogenesis or contribute to the progression of vitiliginous lesions. 
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Analyses of sebosuppressive activities of phosphatidylcholine and its hydrogenated deriva-
tive: a possible molecular mechanism involved by PPARγ
S Nam,2 Y Hwang,2 S Um,1 W Choi,2 T Oh,3 J Kim,2 S Ahn,3 C Park2 and S Lee1 1 Department of
Dermatology, Yonsei University College of Medicine, Seoul, South Korea, 2 Doosan Biotech,
Yongin City, South Korea and 3 Department of Dermatology, Yonsei University Wonju College of
Medicine, Wonju, South Korea
Overproduction of sebum is one of the primary causes of acne development. Therefore attempts to
reduce sebum production are logical approaches for acne treatment. Previous studies showed that
phosphatidylcholine (PC) was effective in the treatment of acne vulgaris. The high content of linoleic
acids in PC was believed to help alleviate acne. Peroxisome proliferator-activated receptor g (PPARg)
is a member of ligand-dependent transcription factors. Linoleic acid is a known ligand and activa-
tor of PPARg. PPARg has recently been found to specifically affect sebocyte growth and differen-
tiation and highly expressed in adipose tissue. It was previously suggested that PPARg antagonist
would seem possible to interfere sebum production without side effects. We have examined several
phospholipids for their sebosuppressive activities and found that hydrogenated PC (HPC) showed
strongest sebosuppressive activity followed by PC using a fuzzy rat model. HPTLC analyses of the
rat skin lipid revealed that total lipid and wax esters were reduced by 45% and 35% respectively from
the HPC treated group. The number of sebaceous gland counted in a same area under light microscopy
was decreased by 45-55%, which indicated the decrease of volume of sebaceous gland after treat-
ment. To observe the effects of HPC in human, 0.5% of HPC cream and placebo cream was applied
to the forehead of 15 volunteers (10 males and 5 females, average age 27) for 6 weeks and the
sebum was extracted using a bentonite clay method. Over 20% reduction of the sebum was observed
compared to that of the control skin. The expression of PPARg expression was markedly suppressed
in HPC treated skin, while a significant stimulation of PPARg was observed in the PC treated skin. 
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Epidermal protein expression in the migrating tongues of normal human incisional wounds,
excisional wounds and diabetic ulcer margins
ML Usui,1 RA Underwood,1 WG Carter2,3 and JE Olerud1 1 Medicine/Div. Dermatology,
University of Washington, Seattle, WA, 2 Pathobiology, University of Washington, Seattle, WA and
3 Fred Hutchinson Cancer Research Center, Seattle, WA
The purpose of this study was to compare protein expression on the migrating tongue of incisional
and excisional wounds, as well as diabetic ulcer margin. Narrow incisional wounds close by 3 days,
3 mm excisional punch wounds close after 7 days and diabetic ulcers may take months to achieve
wound closure. We were interested in studying keratinocyte (KC) activation, differentiation and
proliferation markers as a function of time to epidermal closure and distance of epithelial migration.
Partial-thickness incisional human wounds (narrow normal) were created using a Simplate-II bleed-
ing time device. Excisional human wounds (wide normal) were created using a 3 mm punch biopsy.
Tissue samples were taken from the margin of diabetic ulcers of patients scheduled to undergo leg
amputation. All samples were frozen in O.C.T. for immunohistochemistry. Differences in protein
staining pattern were observed among all three types of wounds. K16 a keratin associated with KC
activation, showed dramatic immunostaining in all wounds studied and appeared to excessively stain
the entire epidermis of the ulcer margin. The adhesion molecule, integrin α3β1 also demonstrated
excessive immunostaining in diabetic ulcers compared with normal wounds. Keratins K10 and K2e,
markers for epidermal differentiation, were present on the migrating epithelial tongue of normal nar-
row wounds but lost in favor of K16 in wide normal wounds and diabetic ulcers. The proliferation
marker (Ki67) showed that the epithelium at the diabetic ulcer margins was actively proliferating
even though the KCs were not migrating. Despite the expression of proteins associated with activa-
tion, migration and proliferation, the KCs of diabetic ulcers often fail to migrate. 
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Salicylic acid induced loss of the epidermal calcium gradient without skin barrier impairment
and increased the expression of epidermal cytokines
S Jeong,1,5 J Ko,2 J Seo,3 S Ahn,4 C Lee2 and S Lee5 1 BK21 Project for Medical Science, Yonsei
University, Seoul, South Korea, 2 Department of Dermatology, Hanyang University College of
Medicine, Seoul, South Korea, 3 Department of Oral Biology, Yonsei University College of
Dentistry, Seoul, South Korea, 4 Department of Dermatology, Yonsei University Wonju College of
Medicine, Wonju, South Korea and 5 Department of Dermatology, Yonsei University College of
Medicine, Seoul, South Korea
In a previous study, we reported that topical treatment of alpha-hydroxy acids (AHAs), such as gly-
colic acid, did not induce any significant increase in transepidermal water loss. However, topical gly-
colic acid induced the loss of epidermal calcium gradient and initiated barrier repair process, such
as lamellar body secretion, without epidermal barrier impairment. An in vitro study using cultured
keratinocytes suggested that glycolic acid could lower the calcium ion concentration, at least in
part, through the chelating effects of the glycolic acid on the cationic ions. Salicylic acid, with its
structural similarity with glycolic acid, can be hypothesized as a chelating agent for calcium ions in
epidermis. In a previous study, we also reported that topical application of salicylic acid did not
induce any significant increase in TEWL. In this study, we examined the secretion of lamellar body
and epidermal calcium gradient in vivo. We also examined the effects of salicylic acid on the intra-
cellular calcium ion concentration in response to extracellular calcium ion concentration changes in
the cultured mouse keratinocyte. In addition, protein and mRNA expression of epidermal cytokines
after salicylic acid treatment were measured. These results suggest that salicylic acid, along with
glycolic acid, can induce the loss of epidermal calcium gradient and initiated barrier repair processes,
such as lamellar body secretion, without epidermal barrier impairment, at least in part, through the
chelating effect of the salicylic acid on the calcium ions. As a conclusion, topical salicylic acid as
well as glycolic acid could be used to improve the epidermal permeability barrier. 
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The aryl hydrocarbon receptor nuclear translocator plays an essential role in epidermal bar-
rier formation in mouse skin
S Geng, I Stomenskaya and AA Panteleyev Dermatology, Columbia University, New York, NY
Arnt is a member of the basic helix-loop-helix PER-ARNT-SIM (PAS) family of proteins which
serve as dimeric transcription factors. Among PAS proteins, Arnt is a central dimerization partner
playing an essential role in mediation of diverse biological functions including xenobiotic metabo-
lism, hypoxic response, and circadian rhythm. Ablation of Arnt activity in mice results in early embry-
onic death. Despite the fact that several molecular targets of Arnt-mediated regulatory pathway are
key elements of skin pathological conditions in humans and most of Arnt dimerization partners are
known to be involved in control of skin homeostasis, still very little is known about possible Arnt
functions in skin. As an initial step in elucidation the functions of Arnt in skin, we generated Arnt
deficient mice using conditional gene targeting strategy. By crossbreeding of Arnt floxed and Cre
transgenic mice carrying Cre transgene under skin-specific Keratin 14 promoter we achieved dis-
ruption of Arnt gene in keratinocyte-specific manner. Keratinocyte-specific ablation of the Arnt
resulted in spatially-specific impairment of epidermal barrier formation during late embryogenesis
which matched spatial patterns of Arnt expression in mouse skin. In addition, while being alive and
active during first hours of their live, Arnt k/o newborns were not able to feed. As a result of exten-
sive dehydration and rapid loss of weight, newborns with skin-specific ablation of the Arnt gene die
in 12-35 hours after birth. The histological analysis of skin in Arnt-deficient and control newborns
revealed no significant difference in hair follicle morphology. At the same time, structure of epi-
dermis in newborns with Arnt deficiency in the skin showed prominent alterations. Thus, generation
of mice with skin-specific ablation of Arnt gene elucidates an essential role of Arnt-dependent reg-
ulatory pathway in control of skin barrier functions and provides a useful model to study other aspects
of Arnt activity in skin. 
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The transcription factors c-rel and relA control epidermal development and homeostasis in
embryonic and adult skin via distinct mechanisms
R Gugasyan,1 G Varigos,1 A Voss,1 T Thomas,1 P Kaur,2 R Grumont1 and S Gerondakis1 1
Immunology, The Walter and Eliza Hall Institue of Medical Research, Melbourne, VIC, Australia
and 2 The Peter MacCallum Cancer Inst., Melbourne, VIC, Australia
Determining the roles of Rel/NF-kB transcription factors in mouse skin development using loss of
function mutants has been limited by redundancy amongst these proteins and by embryonic lethal-
ity associated with the absence of RelA. Utilizing mice lacking RelA and c-Rel, which survive
throughout embryogenesis on a TNF-a deficient background (rela-/-c-rel-/-tnfa-/-), we show that c-
Rel and RelA are required for normal epidermal development. Although mutant fetuses fail to form
tylotrich hair and have a thinner epidermis, mutant keratinocyte progenitors undergo terminal dif-
ferentiation to form an outer cornified layer. Mutant basal keratinocytes are abnormally small, exhibit
a delay in G1 progression and fail to form keratinocyte colonies in culture. In contrast to the reduced
proliferation of mutant keratinocytes during embryogenesis, skin grafting experiments revealed the
mutant epidermis develops a TNF-a dependent hyper-proliferative condition. Collectively, our find-
ings indicate that RelA and c-Rel control the development of the epidermis and associated appendages
during embryogenesis and regulate epidermal homeostasis in a post-natal environment through the
suppression of innate immune mediated inflammation. 
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Characterization of a novel mouse calmodulin-like protein
SA Ray,1 Z Zhou2 and DR Roop2,1 1 Interdepartmental Program in Cell and Molecular Biology,
Baylor College of Medicine, Houston, TX and 2 Molecular and Cellular Biology and Dermatology,
Baylor College of Medicine, Houston, TX
Epidermal differentiation is tightly controlled by a calcium gradient, which increases towards the
surface of the skin. During differentiation, keratinocytes up-regulate specific proteins including cal-
cium-binding proteins, such as the calmodulin-like protein (CLP). Human CLP was shown to share
85% identity with the ubiquitously expressed calmodulin. Unlike calmodulin, human CLP appears
to be expressed specifically in epithelial cells with intense staining in the skin, increasing during ker-
atinocyte differentiation. These studies by M.S. Rogers et al (2001) suggest that CLP may be involved
in the program of keratinocyte differentiation. To further explore the role of calcium signaling dur-
ing this process, we have cloned a potential mouse homologue of human CLP. Mouse CLP shares
89% identity with human CLP. This intronless gene encodes a protein with 149 amino acids, con-
taining four predicted calcium-binding EF-hand motifs, a molecular weight of 16.7kDa, and a pI of
3.9. RNase Protection Assays (RPA) and reverse transcription polymerase chain reactions (RT-
PCR) confirmed that expression of mouse CLP was confined to the epidermis and other stratified
epithelia, e.g. tongue, esophagus and forestomach. Consistent with observations that human CLP
was expressed at an early stage of differentiation, the onset of mouse CLP expression occurred at
embryonic day 15.5. In situ hybridization studies demonstrated restricted expression of mouse CLP
in the suprabasal layers of the epidermis. This preliminary data suggests mouse CLP may be involved
in the process of terminal differentiation. Future interaction studies and mouse models may further
distinguish this protein from calmodulin and help to further elucidate the role of calcium signaling
in skin development and differentiation. 
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Netherton Syndrome: novel and recurrent mutations in SPINK5 and implications for screen-
ing and diagnosis
G Richard,1 PA Ratajczak,1 S Amin,1 H Ilyas,1 A Tesfaye Kedjela,1 EC Siegfried2 and J Uitto1 1
Dermatology & Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 2
Department of Dermatology, St. Louis University, St. Louis, MO
Netherton Syndrome (NTS) is a congenital autosomal recessive ichthyosis often associated with
atopic diathesis and caused by mutations in SPINK5 encoding the lympho-epithelial serine protease
inhibitor, LEKTI. In this study, we examined the SPINK5 gene in 24 patients referred with a diag-
nosis of NTS and 7 patients with severe, generalized atopic dermatitis. In NTS patients, we identi-
fied 17 distinct mutations, 12 of which are novel, thus increasing the total number of distinct SPINK5
mutations to 51. Five mutations were recurrent and appeared to be more common in certain popu-
lations, which could facilitate future diagnostic testing. This is especially important, since the large
number of intragenic polymorphisms, 29 in the coding sequence and 82 in flanking intronic sequences,
disclosed so far, hamper mutation screening by dHPLC. In 12 of 15 patients with characteristic clin-
ical features of NTS pathogenic mutations were detectable, while in 8 patients with uncertain clin-
ical diagnosis only a frameshift deletion mutation and a novel missense mutation were identified.
Together with our previously published data, the overall mutation detection rate in patients with NTS
was 67% by direct DNA sequence analysis, suggesting that the remainder of mutations lie outside
the coding sequence. Although no deleterious mutations were detected in 7 patients with atopic der-
matitis, the allele frequency of Asn368 (0.428), a coding polymorphism previously associated with
atopic eczema in the UK and Japan (allele frequency 0.5), was higher than among NTS patients
(0.333). In addition, all patients with atopic dermatitis carried 2 to 5 other common sequence vari-
ants, including Arg267Gln, Asp386Asn, Val335Ala, Glu420Lys and Arg711Gln, further supporting
that Asn368 alone or in combination with other polymorphisms could play a role in the pathogene-
sis of atopic dermatitis. 
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Locus heterogeneity in cutis laxa
Q Hu, MW Crepeau, V Hucthagowder, Z Szabo, The Cutis Laxa Consortium and Z Urban Matrix
Pathobiology, University of Hawaii, Honolulu, HI
Cutis laxa (CL) is a heterogeneous group of disorders characterized by redundant, sagging and inelas-
tic skin. X-linked recessive, autosomal dominant and autosomal recessive inheritance have been
described for different forms of CL. The goal of our studies was to discover molecular defects in
known loci and in candidate genes in an unselected cohort of CL families. Mutations in the elastin
(ELN) fibulin-5 (FBLN5), lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) genes were ana-
lyzed in probands from 25 CL families using denaturing high-performance liquid chromatography
and direct DNA sequencing. The presence of putative disease alleles was investigated in at least 100
unrelated normal individuals and the segregation of these variants was studied in relatives of the
probands. Six putative disease alleles were identified in ELN and two in FBLN5. Two of the ELN
mutations segregated with CL in families in an autosomal dominant pattern. Two other ELN defects
were identified in sporadic patients one of whom was shown to carry a de novo mutation. One addi-
tional sporadic patient carried two missense alleles in ELN and one missense allele in FBLN5. Fibrob-
lasts from this individual and another patient carrying a FBLN5 mutation in a putative c-Myb fac-
tor-binding site showed dramatically reduced matrix deposition of fibulin-5. No molecular defects
have been found in LOX and LOXL to date. We conclude that defects in both ELN and FBLN5 con-
tribute to the molecular pathology of CL. De novo mutations in ELN and digenic inheritance of
ELN and FBLN5 defects may cause sporadic CL. Multiple families with autosomal dominant CL
lacked mutations in ELN and FBLN5 suggesting the presence of at least one additional major gene
mutated in autosomal dominant CL. 
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Yin-Yang 1 negatively regulates the differentiation-specific expression of loricrin gene in undif-
ferentiated keratinocytes
Y Kawachi,1 X Xu,1 Y Nakamura,1 T Takahashi,1 DR Roop2 and F Otsuka1 1 Dermatology,
University of Tsukuba, Tsukuba, Ibaraki, Japan and 2 Molecular and Cellular Biology, Baylor
College of Medicine, Houston, TX
Loricrin is a major component of the cornified cell envelope, a specialized structure that replaces
the plasma membrane and contributes to the protective barrier function of the stratum corneum, and
loricrin is expressed only in terminal differentiated keratinocytes. This cell differentiation-specific
expression suggests specific suppression of the gene expression in undifferentiated keratinocytes as
well as activation in differentiated keratinocytes. In an effort to locate negative regulatory sequences
involved in suppression of loricrin gene expression in undifferentiated keratinocytes, we have iden-
tified a negative element in the intron 1 of loricrin gene. Deletion analysis in the intron 1 demon-
strated that the region from +398 to +428 is responsible for the suppressive activity of the intron 1.
Transcription factor database search identified the putative inverted binding motif for YY1 in this
sequence. The point-mutated constructs with 2 bp mutation at the putative YY1-binding motif showed
about 50% increase in reporter activity, indicating that YY1 negatively regulate the loricrin gene tran-
scription in keratinocytes. Western blotting and immunohistochemical analysis indicated that YY1
was much more abundant in nuclear extracts of the cells grown in undifferentiating conditions (0.05
mM calcium) than in differentiating conditions (0.12 mM calcium). Luciferase assay demonstrated
that overexpressed YY-1 suppressed the loricrin promoter activitiy. These findings suggest that YY1
contribute to specific expression of loricrin gene in differentiated keratinocytes by suppression of
the gene transcription in undifferentiated keratinocytes. 
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Calcium-fluorescence lifetime imaging in ex vivo skin II
MJ Behne,1 N Barry,2 K Hanson,2 E Gratton2 and T Mauro1 1 Dermatology, UCSF, San Francisco,
CA and 2 Physics - LFD, UIUC, Urbana-Champaign, IL
In our recent publications, we described Fluorescence Lifetime Imaging Microscopy (FLIM) to assess
pH in intact epidermis. Here, we report about our recent progress in measuring and visualizing
Ca2+ in ex-vivo biopsies of unfixed epidermis. In our initial Ca-FLIM studies we used Calcium
Green-5N which is sensitive in the intermediate range of concentrations expected in epidermis and
were able to show overall increasing Ca2+ concentrations from basal (SB) to granular (SG) layers,
confirming our prior PIXE and Calcium-precipitation results. We refined and broadened this method
to cover the full range of epidermal Ca2+ concentrations, from nanomolar to millimolar values. Using
sequential measurements with Calcium Green-1 for low concentrations and Rhod-5N for high con-
centrations, we find highest Ca-concentrations to be limited to the intracellular domain in an ER-
like distribution, specifically in the apical (granulosum and spinosum) layers, while in deeper (basal
to dermal) layers this distinction is partially lost. In addition, FLIM demonstrates a shift in the Ca2+
distribution pattern upon barrier disruption: following tape-stripping, Rhod-5N reveals a partial loss
of compartmentalization in the high concentrations range and across the depth of epidermis. In the
low concentrations range using Calcium Green-1, cells with varying overall Ca-concentration appear,
specifically at the SC/SG interface and partially persisting into the SC. Comparison of localized
changes in Calcium concentrations and their regulation are especially important to assess functional
consequences in barrier homeostasis and repair, differentiation, signaling, and cell adhesion, as well
as various pathologic states, e.g., Darier Disease, Hailey-Hailey Disease, and Psoriasis. As extra-
cellular and intracellular absolute Ca2+ concentrations in tissue are unknown, but can be assessed
with FLIM, we believe that this method will contribute to elucidating basic physiology as well as
pathology in epidermis. 
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Cutis laxa caused by mutation in the tropoelastin gene
Z Szabo,1 MW Crepeau,1 MJ Stephan,2 RA Puntel,2 A Mitchell3 and Z Urban1 1 Laboratory of
Matrix Pathobiology, University of Hawaii, Honolulu, HI, 2 Madigan Army Medical Center,
Tacoma, WA and 3 University of Washington, Seattle, WA
Cutis laxa (CL) is a rare heterogeneous group of disorders characterized by loose inelastic skin that
hangs in folds. Previously, a partial tandem duplication in the tropoelastin gene (ELN) was identi-
fied in a family with autosomal dominant cutis laxa (ADCL). Family members suffered from her-
nias and adult-onset obstructive pulmonary disease characterized by bronchioectasis and emphy-
sema. Our goal was to identify other ADCL patients with mutations in the ELN gene and understand
the underlying molecular mechanisms. Clinical evaluation of a second family with ADCL resulted
in the diagnosis of inguinal hernia, thoracic aortic aneurysms and dissection with varying penetrance.
Blood samples and skin biopsy was collected from family members and the ELN gene was screened
for mutations by DNA sequencing and RT-PCR. Elastic (VVG) staining from the non-aneurysmal
segments of the aorta from the proband showed fragmentation of the internal elastic lamina and
thin, irregular elastic lamellae. Aneurysmal segments of the aorta lacked elastic fibers. Mutational
analysis revealed a 25 base pair deletion in exon 30 (2114-2138del) potentially giving rise to a de
novo protein at the 3 prime end of tropoelastin. Evaluation of ELN transcripts confirmed equal expres-
sion of both normal and mutant alleles. Mutant transcripts comprised 27% of the total. Moreover,
the ratio of a naturally occurring splice variant lacking exons 30 and 32 increased to 13% in patient
samples vs. less than 1% in normal control. We conlude that mutations in the tropoelastin gene may
cause thoracic aortic aneurysms and dissections in autosomal dominant cutis laxa. The 2114-2138del
allele gives rise to the synthesis of stable mutant mRNA and alters the ratio of alternatively spliced
forms or tropoelastin, therefore it may result in the synthesis of mutant tropoelastin and elastic
fibers with compromised biochemical and biophysical properties. 
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Novel cancer- and immortalization-related genes identified in malignant and genetically-engi-
neered human keratinocytes using DNA microarrays
Z Guo,1 RV Jensen,2 S Boches,3,4 SR Gullans2 and JG Rheinwald1 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA, 2 Medicine, Brigham and Women’s Hospital, Boston, MA, 3
Harvard School of Dental Medicine, Boston, MA and 4 Bauer Center for Genomics Research,
Harvard University, Cambridge, MA
Seeking to identify genes involved in neoplastic progression to squamous cell carcinoma (SCC), we
used oligonucleotide microarrays containing coding sequences of 9896 genes to compare transcript
levels among 23 human cell lines of oral and epidermal origin, including six derived from SCCs,
three from premalignant dysplasias, five from normal epithelium, and versions of the latter engi-
neered to express various proteins permitting evasion of senescence arrest mechanisms. A compar-
ison of SCC cells and normal keratinocytes identified 64 genes with expression differences >3-fold
and P values (t-test) <0.015. Quantitative PCR confirmed 30/30 genes tested from this set. The 64
genes included transcription factors, signal pathway proteins, cell cycle regulators, adhesion pro-
teins, enzymes, and RNA-binding proteins. Interestingly, TERT-immortalized keratinocyte lines
showed altered expression, compared with early passage primary cells, of 3 genes common to SCCs:
increase of DHRS2 and decrease of ALEX2 and FL10097. Normal cells engineered to block p53
and either p16 or pRB function were found to overexpress 6 interferon-inducible genes, most of
which were downregulated in SCCs. Using expression levels of the 64 gene SCC vs. normal set, a
hierarchical cluster analysis of all cell lines grouped two premalignant lines with the SCCs, while
most of the lines engineered to evade p53- and p16-/pRB-dependent mechanisms clustered with pri-
mary cells. 3 out of 5 TERT-immortalized lines clustered more closely with SCCs than with primary
cells. Three dimensional clustering by principal component analysis yielded a tight grouping of SCC
and premalignant cells, separate from all lines derived from normal cells. Thus, we have identified
a set of genes that reliably distinguish neoplastic, immortalized, and normal keratinocytes, includ-
ing candidates for previously undetected functions in neoplastic progression. 
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Identification of a novel missense mutation of ATP2A2 in a Chinese family with Darier’s
L Sun,1,2 S Yang,1,2 H Liu,1,2 J Wang,1,2 P He,1,2 M Li,1,2 M Gao,1,2 J Liu,1,2 J Yang,1,2 Z Wang,1,2
Y Zhu,1,2 D Lin1,2 and X Zhang1,2 1 Institute of Dermatology & Dept.of Dermatology in 1st
Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China and 2 Key Laboratory of
Genome Research at Anhui, Hefei, Anhui, China
The objective of this study is to detect the ATP2A2 gene mutations in Chinese Han patients with
Darier′s disease (DD) .DD is an autosomal dominant skin disorder characterized by multiple kera-
totic papules and abnormal keratinization. Mutations in the ATP2A2 gene encoding sarco/endo-
plasmic reticulum calcium pumping ATPase type 2 have been identified as the molecular basis of
DD.The strategy for mutation search included briefly genomic DNA isolated from peripheral blood
was subjected to polymerase chain reaction amplification, followed by direct automated sequecing.
A novel missense mutation AÇG was identified in exon 12, nucleotide 1704 of the ATP2A2 gene,
which predicts to lead to the substitution of lysine by arginine at codon 514 (K514R). This mutation
was not found in 7 normal individuals of this family and 100 unrelated population control and was
not described in previous study. To sum up, in this study, we have reported the first three-generation
of Chinese family with the co-occurrence of the severe classic “seborrheic” form of DD with neu-
ropsychiatric disorders and identified and verified a nove missense mutations. This study will con-
tribute to expand database on ATP2A2 in DD, and further illustrate the extensive diversity of muta-
tional events that led to the different phenotypes of DD. 
489
Plectin is essential for sub-sarcolemmal-cytoskeletal interactions in striated muscle
JR McMillan,1 M Akiyama,1 JE Mellerio,2 IM Leigh,3 M Sato,1 JE Geddes,4 N Fujii,4 RA Eady2
and H Shimizu1 1 Department of Dermatology, Hokkaido University Graduate School of Medicine,
Sapporo, Hokkaido, Japan, 2 Department of Cell and Molecular Pathology, Kings College,
London, United Kingdom, 3 Center for Cutaneous Research and Department of Morbid Anatomy,
Royal London Hospital, London, United Kingdom and 4 Department of Neurology, National
Chikugo Hospital, Fukuoka, Fukuoka-ken, Japan
Epidermolysis bullosa simplex (EBS) associated with muscular dystrophy (MD, MIM#226670) is
a disorder involving defects in certain isoforms of the cytoskeletal protein plectin expressed in skin
and muscle. Immunoperoxidase staining was performed using previously reported EBS-MD patients
skeletal muscle (n=3) together with control muscle (n=4) to determine the pathogenesis of muscu-
lar dystrophy. While plectin monoclonal antibodies 10F6 and HD1-121 both localized to the plasma
membrane (PM) in control skeletal muscle, 10F6 also stained the center of type II muscle fibers.
Conversely, HD1-121 stained the center of type I fibers. EBS-MD muscle demonstrated a loss of all
membrane HD1-121 and 10F6 staining (in 3 cases) but retained some HD1-121 (in 1 case) and
10F6 staining (in 3 cases) within the center of selected muscle fibers. There was normal staining for
dystrophin, β spectrin, vinculin and β1 integrin in all 3 cases of EBS-MD muscle. However, α actinin
and desmin staining in 2 EBS-MD cases was disorganized and lacked the sharp, striated appearance
of control muscle. Electron microscopy showed a widening of the space immediately beneath the
PM with abnormal vacuolization and variation in the number, size and parallel organization of Z-
lines in 2 cases. Postembedding immunogold electron microscopy of control muscle colocalized
plectin and desmin to two main sites: filamentous bridges between Z-lines and to the inner surface
of the PM, in contrast to dystrophin labeling that was restricted to focal densities on the membrane.
We therefore conclude that multiple, distinct fiber-specific plectin isoforms play a role in linking
cytoskeletal elements to Z-lines and more critically to the myocyte PM, analogous to epidermal
hemidesmosome-cytoskeletal anchorage in skin. 
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Identification of seven novel mutations in the ADAR gene among Chinese patients with dyschro-
matosis symmetrica hereditaria
X Zhang,1,2 P He,1,3 M Li,1,2 C He,4 K Yan,1,2 Y Cui,1,2 S Yang,1,2 K Zhang,3 M Gao,1,2 J Chen,1,2
C Li,1,2 L Jin,3 H Chen,4 S Xu3 and W Huang3 1 Institute of Dermatology & Dept.of Dermatology
in 1st Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China, 2 Key Laboratory of
Genome Research at Anhui, Hefei, Anhui, China, 3 Chinese National Human Genome Center at
Shanghai, Shanghai, China and 4 Department of Dermatology, No.1 Hospital of China Medical
University, Shenyang, Liaoning, China
Dyschromatosis symmetrica hereditaria (DSH) is an autosomal dominant pigmentary genodermatosis
characterized by hyperpigmented and hypopigmented macules of on the extremities and caused by
the mutations in the RNA-Specific Adenosine Deaminase Gene (ADAR). Here we reported clinical
and molecular findings of 6 Chinese multi-generation families and 2 sporadic patients with DSH.
We found that the same mutation could lead to different phenotypes even in the same family and we
did not establish a clear correlation between genotypes and phenotypes. Seven novel heterozygous
mutations of ADAR were identified, which were c.2433_2434delAG (T811fsÇ841X), c.2197G>T
(E733X), c.3286C>T (R1096X), c.2897G>T (C966F), c.2797C>T (Q933X), c.2375delT
(L792fsÇ792X) and c.3202-1A>G (IVS12-1A>G) respectively. Our data add new variants to the
repertoire of ADAR mutations in DSH. 
491
Refinement of dyschromatosis symmetrica hereditaria locus to a 9.4-cM interval at 1q21-q22
and a literature review of Chinese patients with this disorder
P He,1,2 C He,3 Y Cui,1,4 S Yang,1,4 H Xu,3 M Li,1,4 W Yuan,2 M Gao,1,4 Y Liang,1,4 C Li,1,4 S Xu,2
J Chen,1,4 H Chen,3 W Huang2 and X Zhang1,4 1 Institute of Dermatology & Dept.of Dermatology
in 1st Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China, 2 Chinese National
Human Genome Center at Shanghai, Shanghai, China, 3 Department of Dermatology, No.1
Hospital of China Medical University, Shenyang, Liaoning, China and 4 Key Laboratory of
Genome Research at Anhui, Hefei, Anhui, China
Dyschromatosis symmetrica hereditaria (DSH) is a pigmentary genodermatosis characterized by
hyperpigmented and hypopigmented macules of on the extremities, which maps to an 11.6-cM inter-
val on chromosome 1q11-21 recently. So far, most cases of DSH have been reported in Japan and
dermatologists in the world could think this disorder mainly occurs in Japan. In fact, there are 17
DSH families including 136 cases reported in China since 1980, but most of them are described in
Chinese. Our purposes are to refine the previously mapped region and delineate the clinical and
genetic features of Chinese DSH cases by a literature review of 136 cases reported in China. We
performed genotyping and linkage analysis using polymorphic microsatellite markers at 1q11-q22
in two Chinese DSH families, and reviewed all of DSH cases reported in China since 1980. A cumu-
lative maximum two-point lod score of 3.68 was produced with marker D1S506 at a recombination
frequency of θ=0.00 in these two families. Haplotype analysis refined DSH locus to a 9.4-cM inter-
val flanked by D1S2343 and D1S2635. This study confirms linkage of DSH to previously mapped
region and refines DSH gene to a 9.4-cM interval at 1q21-q22. Likewise, the literature review indi-
cates that DSH is not an uncommon disorder in China and the differences in the distribution of skin
lesions could be related with race and environment. 
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A refined locus for marie unna hereditary hypotrichosis1.1-cM: interval at 8p21.3
Y Liang, P He, X Zhang, Q Yang, M Li, S Yang, K Yan, Y Cui, Y Shen,1 H Wang, L Sun, W Du,
Y Shen, S Xu1 and W Huang1 1 Chinese National Human Genome Center at Shanghai, Shanghai,
China, 2 Dermatology, 1st Affiliated Hospital, Anhui Medical University, Hefei, China and 3 Key
Laboratory of Genome Research at Anhui, Hefei, China
The aim is to refine the MUHH locus to a narrow chromosome region and make the gene cloning
feasible. We performed genotyping and two-point linkage analysis in a multi-generation Chinese
family with 18 high-density polymorphic microsatellite markers spanning the previously mapped
interval at 8p21. Significant evidence for linkage was observed in this region with a maximum two-
point LOD score of 3.01 (θ=0 ) at D8S298 and D8S1725. Haplotype analysis localized the MUHH
locus within the region defined by D8S282 and D8S1839. This region overlaps by 1.1cM with the
previously reported MUHH region and it represents about 380-Kb physical distance. The HR gene,
which is mutated in congenital atrichia, is critically close to the refined region but sequencing of the
encoding region and intronic splice site revealed no causative mutations. This study provides a refined
map location (1.1cM) for isolation of gene causing MUHH. These data also indicate the existence
of a common MUHH locus at 8p21.3 between the Caucasian and Chinese families and suggest that
MUHH and congenital atrichia could not be allelic disorders that are caused by the mutations in the
HR gene and distinct molecular mechanisms underlie these two diseases. 
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Molecular epidemiology of epidermolysis bullosa in Middle East populations
E Sprecher,1 J Abu Sa’d,2 E Pfendner,3 M Indelman,1 D Ciubutaro,1 M Mizrachi,1 G Lestringant,4
L Pulkkinen,3 G Richard,3 M Kanaan,2 J Uitto3 and R Bergman1 1 Dept. of Dermatology, Rambam
Medical Center, Haifa, Israel, 2 Dept. of Life Sciences, Bethlehem University, Bethlehem,
Palestinian Authority, Israel, 3 Dept. of Dermatology and Cutaneous Biology, Thomas Jefferson
University, Philadelphia, PA and 4 British Forces, Bielefeld, Germany
Epidermolysis bullosa (EB) is a heterogeneous group of inherited mechanobullous skin disorders.
Based upon ultrastructural criteria, EB is classified into simplex (EBS), junctional (JEB) and dys-
trophic (DEB) types, caused by mutations in 10 distinct genes. Although the genetics of these dis-
orders has been extensively investigated in Europe and the US, little is known about the molecular
epidemiology of EB in the Middle East, where EB is considered to be frequent. We established a
collaborative network with the aim to investigate the clinical and molecular features of EB in the
Middle East. We identified a total of 115 families diagnosed with EB over the years in 3 medical
centers located in the Middle East. A total of 53 families gave their informed consent to participate
to this study. Twenty-nine of those families could be unequivocally assigned to one of the major EB
subtypes (48% EBS; 24% JEB; 28% DEB) based on pathological criteria. In each of these 29 fam-
ilies pathogenic mutations were identified, most of which are novel. In contrast with previously
reported observations in studies performed in the US and Europe, we noticed: (1) An increased preva-
lence of recessive EBS cases; (2) An exceptionally high frequency of founder mutations; (3) A lack
of correlation between location/type and phenotypic expression of K5/K14 mutations; (3) Unusual
pathomechanisms including frameshift and hemizygous mutations in EBS; (4) A normal life span
associated with PTC-causing mutations in laminin 5 genes in JEB; (5) No occurrence of previously
reported hot spot mutations. In summary, our results suggest the existence of a unique spectrum of
EB-causing mutations in Middle East populations and emphasize the need for implementation of a
diagnostic strategy tailored to the specific features of EB in this region. 
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Sequence analysis of PSORS1 candidate genes: Only HLA-C and CDSN encode proteins unique
to risk haplotypes
RP Nair,1 P Stuart,1 I Nistor,1 P Kullavanijaya,1 M Weichenthal,2 S Jenisch,3 E Christophers,2
JJ Voorhees1 and JT Elder1 1 Dermatology, Univ Michigan, Ann Arbor, MI, 2 Dermatology, Univ
Kiel, Kiel, Germany and 3 Immunology, Univ Kiel, Kiel, Germany
Previous studies have narrowed the critical interval containing PSORS1, the psoriasis susceptibility
locus on chromosome 6p21.3, to a ~200 kb region containing HLA-C and seven other genes (OTF3,
TCF19, HCR, SPR1, SEEK1, STG and CDSN). In an effort to identify the PSORS1 gene, we have
cloned and sequenced this region from ten chromosomes derived from five individuals, represent-
ing 2 risk and 8 non-risk haplotypes. In the expressed regions of these genes, two missense SNPs
and one silent SNP in exon 2 of HLA-C are unique to risk among the 10 sequenced haplotypes.
OTF3, TCF19, HCR genes do not have any variations unique to risk haplotypes. SPR1 did not have
any protein alleles unique to risk, but has four different pair-wise combinations of mRNA variants
unique to risk. All but one of these pairs involves untranslated regions (UTR) only. SEEK1 also
does not have protein alleles unique to risk, but has one pairwise combination and four 4-way com-
binations of mRNA variants that are unique to risk. The pair-wise combination involves only UTR
variations while the 4-way combinations involve missense mutations also. Two of the 4-way com-
binations shorten the predicted protein by 111 amino acids. CDSN has five different combinations
of missense SNPs that are unique to risk, one of which is the previously reported TTC allele. The
STG gene sequence differs between the two risk haplotypes (Cw6-B50 and Cw6-B57). There are
two repeat units of an 11 amino acid segment on the Cw6-B50 haplotype and three units on the Cw6-
B57 haplotype. Further analysis showed that both alleles are found on other risk and non-risk hap-
lotypes, and is unlikely to be causal in psoriasis. Thus HLA-C and CDSN are the only genes that
have predicted protein alleles unique to psoriasis risk haplotypes. The polymorphisms in these
genes are being examined in a large cohort of approximately 3,000 individuals to discern the con-
tribution of either or both genes to psoriasis susceptibility. 
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Identification of differentially-expressed genes in atopic dermatitis
E Seo,1 J Namkung,1 K Lee,1 G Park1 and J Yang1,2 1 Clincal Research Center, Samsung
Biomedical Research Institute, Seoul, South Korea and 2 Department of Dermatology,
SungKyunkwan University School of Medicine, Seoul, South Korea
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease characterized by typically
distributed eczematous skin lesions with lichenification, pruritic excoriations, severely dry skin,
and a wide variety of pathophysiologic aspects. Many complicated factors, both genetic and envi-
ronmental ones, increase the risk to manifest this disease. A lot of studies have been done to this dis-
eases focusing on cytokine and T cell, however, little is known about molecular mechanism con-
tributing to AD. To gain more insight on molecular event in AD, we used suppression subtractive
hybridization (SSH). RNA was extracted from skin biopsy specimens from 8 AD patients as the tester
against RNA from normal skin tissues as the driver. We obtained about 1000 clones from this exper-
iment and selected 150 cDNA clones through dot blot analysis and sequenced them. Although these
genes could be classified into named genes and unnamed genes, we chose several genes that seemed
to be related with AD and confirmed their expression levels by RT-PCR analysis. These differen-
tially expressed genes may provide significant insight for further understanding of genetic factors
of AD. 
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Molecular chaperones involved in vitamin D receptor-mediated transcription in keratinocytes
Y Oda,1 RJ Chalkley,2 AL Burlingame,2 LP Freedman3 and DD Bikle1 1 Endocrinology, University
of Californi San Francisco/VAMC, San Francisco, CA, 2 Phamaceutical Chemistry, University of
California San Francisco, San Francisco, CA and 3 Bone Biology, Merck Research Laboratories,
West Point, PA
Vitamin D, via its active metabolite 1,25(OH)2D3, controls the proliferation and differentiation of
keratinocytes through the vitamin D receptor (VDR) by directly regulating gene transcription. Using
GST-VDR affinity beads, VDR binding protein complexes were purified from keratinocytes and
identified by mass spectrometry (MS). As reported previously, the VDR binding complex from pro-
liferating keratinocytes contained the coactivator DRIP205, whereas that from more differentiated
cells included the coactivators SRC2 and 3. In addition to DRIP205, chaperone proteins were iden-
tified in the complex from prolifeating keratinocytes. Chaperone proteins are generally known to
maintain the stability of nuclear receptors in cytoplasm, although their role in transcription is not
fully elucidated. In these studies we evaluated the role of chaperone proteins in VDR stimulated tran-
scription. Geldanamycin, which inhibits chaperone function by blocking ATP binding to heat shock
protein 90 (Hsp90), was utilized. Effects on VDR transactivation were examined using a promoter
reporter assay with constructs containing a vitamin D response element (VDRE). Inhibition of
chaperone function by geldanamycin increased 1,25(OH)2D3 stimulated transactivation in a dose
dependent manner, although the basal level of transcription was decreased. Direct binding of chap-
erone proteins to the VDRE was examined using chromatin immuno-precipitation. In response to
1,25(OH)2D3 stimulation, Hsp90 was recruited to VDRE sites in the 24 hydroxylase and keratin 1
promoters. These results suggest that chaperone proteins are involved in VDR mediated transcrip-
tion presumably by mediating active assembly and disassembly of VDR-coactivator complexes on
specific promoter sites. However their continued presence may block transcription following the
assembly of the complex on the VDRE. 
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Homozygosity mapping as a screening tool in the molecular diagnosis of congenital recessive
ichthyoses
M Mizrachi,1 R Bergman,1 O Bitterman2 and E Sprecher1 1 Department of Dermatology, Rambam
Medical Center, Haifa, Israel and 2 Western Galilee Hospital, Naharya, Israel
Congenital recessive ichthyoses (CRI) are characterized by diffuse skin scaling and varying degrees
of erythema. CRI have been mapped to at least 7 distinct chromosomal loci, significantly compli-
cating molecular diagnostics. Unfortunately, no practical screening method prior to mutational analy-
sis is yet available. An elevated rate of consanguineous unions underlies a high prevalence of CRI
in Middle East populations. We attempted to exploit this peculiar demographic feature in order to
facilitate the diagnosis of CRI in the Israeli population. We examined 63 individuals belonging to
12 consanguineous kindreds with CRI, including 19 patients. We developed screening panels com-
prising 57 microsatellite markers encompassing each of the 7 loci previously shown to be associ-
ated with CRI on 2q33-p35, 3p21, 12q11-q13, 14q11.2, 17p13.2-13.1, 19p12-q12, 19p13.2-13.1.
Given the fact that all studied families were consanguineous, we assumed the existence of founder
(homozygous) causative mutations in each kindred. We therefore searched for regions of homozy-
gosity in each family for each of the 7 CRI loci (homozygosity mapping). We identified such regions
in 9 out the 12 families, and identified by mutational analysis novel TGM1 mutations in those fam-
ilies that mapped to 14q11.2. Genotyping yielded uninformative results or ruled out linkage for the
3 remaining families, raising the possibility of additional CRI-associated loci. Results from a com-
plete screen in one family were obtained in less than 3 days. In sum, homozygosity mapping repre-
sents an efficient, unexpensive and rapid screening diagnostic approach in consanguineous families
with CRI; it can be used to direct subsequent mutational analysis as well as serve in prenatal diag-
nosis. It is amenable to semi-automation and could be applicable to additional recessive disorders
characterized by genetic heterogeneity. The present study emphasizes the usefulness in human genet-
ics of diagnostic strategies tailored to the demographic features of target populations. 
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Spectrum of mutations in the KIND1 gene, encoding the focal contact protein KINDLIN-1, in
Kindler syndrome
GH Ashton,1 WH McLean2 and JA McGrath1 1 Genetic Skin Disease Group, St Johns Institute of
Dermatology, London, United Kingdom and 2 Epithelial Genetics Group, Human Genetics Unit,
University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom
Kindler syndrome (OMIM 173650) is an uncommon autosomal recessive genodermatosis clinically
characterised by initial trauma-induced blistering followed by variable photosensitivity, poikiloderma
and an increased risk of mucocutaneous malignancy. The disorder was recently mapped to 20p12.3
and a few pathogenic mutations have been identified in a new gene, KIND1, which encodes the pro-
tein kindlin-1, a component of focal contacts in keratinocytes. In this study, we sequenced genomic
DNA from 16 further affected individuals of various ethnic backgrounds (13 families) to expand the
spectrum of pathogenic KIND1 mutations. We identified 4 recurrent ancestral mutations: Pakistani
(676insC), UK Caucasian (E304X), Omani (W616X) and Italian (958-1G>A). Haplotype analysis,
using 9 intragenic polymorphisms, demonstrated common ancestral mutant alleles for each muta-
tion, apart from one of the 6 Pakistani families in which the mutation 676insC (which occurs in a
repeat of 7 cytosines) was present on a different genetic background. All mutations were homozy-
gous, aside from the 3 UK Caucasian cases that were all compound heterozygotes (second allele
mutations: L302X, 1161delA, 1909delA). Immunolabeling of skin, using a carboxyl-terminus anti-
kindlin-1 antibody, showed complete absence or markedly reduced staining, which in normal skin
was present at the dermal-epidermal junction and within the lower epidermis. Seventeen different
loss-of-function KIND1 mutations have now been elucidated and collectively they demonstrate the
importance of kindlin-1 in maintaining epithelial integrity. Delineation of these new recurrent muta-
tions is also relevant to optimizing mutation detection strategies in Kindler syndrome patients. Fur-
thermore, the new anti-kindlin-1 antibody is a useful probe in establishing an accurate diagnosis of
this syndrome. 
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Defining a role for hairless by analytical comparison of differential gene expression
H Kim, A Engelhard, K Djabali, AA Panteleyev and AM Christiano Dept of Dermatology,
Columbia University, New York, NY
Mutations in the hairless (hr) gene in mouse and humans results in the loss of hair and the integrity
of the hair follicle. The hr protein has been suggested to act as a transcription factor with a critical
role during catagen. hr is transcriptionally regulated by thyroid hormone in the brain, however, recent
data from our laboratory indicates that it is not the major regulator of hr expression in the skin. Mouse
models of other nuclear receptors such as knockouts of VDR and RXR suggest a possible regula-
tory pathway for hr, however, we have not found an interaction between VDR and RXR using mul-
tiple biochemical approaches. In order to better understand the function of hr, we took a global, data
driven approach toward determining hairless target genes and the possible pathway(s) hr functions.
We used Affymetrix microarrays to compare the differential gene expression profiles of wild type
mouse day 2 epidermis and rhino (rhhr-/-) mouse day 2 epidermis. Using MAS5 and IBM
Genes@Work software for supervised analysis, stringent parameters of two-fold or greater statisti-
cally significant values resulted in a list of 58 differentially expressed genes. 51 of these genes were
found to be up-regulated by hr, while 7 genes were found to be down-regulated by hr. hr itself was
found to be differentially regulated between these two populations, serving as an internal control.
These genes can be organized into 9 main categories: extracellular matrix (12), cytoskeletal organ-
ization (4), cell cycle (3), signaling (4), proteolysis and peptidolysis (5), metabolism (4), transcrip-
tional and translational regulation (5), unknown cDNA clones (5) and other (16).  Validation of the
array has been performed using Real-Time PCR, in situ hybridization, and immunoflourescence,
confirming the expression of these genes in murine neonate epidermis. Using pathway building
software, these differentially genes were analyzed for possible pathway or regulatory relationships
to one another as well as to hr in order to place hr in the context of a regulatory pathway. 
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Pathogenesis of hidrotic ectodermal dysplasia: the G11R mutation of Cx30 increases extra-
cellular ATP levels due to abnormal hemichannel permeability
G Munhoz Essenfelder,1,5 J Lamartine,1,5 A Charollais,2 R Bruzzone,3 S Oro,4 C Blanchet-Bardon,4
P Meda2 and G Waksman1,5 1 DSV, CEA, Evry, France, 2 University of Geneva, Geneva,
Switzerland, 3 Institut Pasteur, Paris, France, 4 Saint Louis Hospital, Paris, France and 5 Evry
University, Evry, France
The aim of this study was to analyse the functional consequences of the G11R mutation of human
connexin30 (Cx30), which causes HED (MIM129500), a rare dominant genodermatosis. HeLa
cells were transfected with plasmids driving the expression of the wild type (Cx30wt) and the G11R
form (Cx30G11R) of the protein, either separately or in combination. The cellular localisation of
both proteins was assessed by immunostaining and the dye transfer capacities of the resulting inter-
cellular channels were studied by microinjection of Lucifer Yellow. We tested the capacity of Cx30wt
and Cx30G11R to form connexin hemichannels, by measuring the extracellular ATP levels follow-
ing transfection. Cells transfected with Cx30G11R alone showed an even distribution of the protein
within the cytoplasm, with no obvious localisation at the plasma membrane. In contrast, when co-
transfected with Cx30wt, Cx30G11R was expressed at the membrane interface between adjacent
cells. Microinjection studies showed that the permeability to Lucifer Yellow of Cx30G11R inter-
cellular channels was comparable to that of Cx30wt. These coupling characteristics were not mod-
ified in cells expressing both wild type and mutated forms of the protein. We also demonstrate that
HeLa cells transfected with Cx30G11R either alone or in combination with Cx30wt formed func-
tional connexin hemichannels, that induced ATP release into the extracellular medium, a finding not
observed in cells expressing only Cx30wt. These results suggest that the epidermal manifestations
of the G11R mutation are not due to loss of function of Cx30 intercellular channels between affected
keratinocytes, but rather to an abnormal permeability or regulation of Cx30 hemichannels. Indeed,
increased levels of extracellular ATP induce keratinocyte proliferation, which might explain the
hyperkeratosis observed in the epidermis of HED patients. 
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Hairless contains a novel nuclear matrix targeting signa and colocalizes with histone deacety-
lase 3 in nuclear speckles
K Djabali, N Souleimanian and AM Christiano Dept of Dermatology, Columbia University, New
York, NY
Hair follicle cycling is a highly regulated and dynamic cellular process consisting of phases of growth,
regression and quiescence. The hairless (hr) gene encodes a nuclear factor that is highly expressed
in the skin, where it appears to be an essential regulator during the regression in the catagen hair fol-
licle. In hairless mice, as well as humans with congenital atrichia, the absence of hr protein initiates
a premature and abnormal catagen due defects in the signaling required for hair follicle remodeling.
Here, we report that hr protein is a nuclear protein that is tightly associated with the nuclear matrix
scaffold. Using a series of deletion constructs of the mouse hr gene, we monitored the subcellular
localization of the recombinant protein by in situ immunolocalization and biochemical fractiona-
tion after nuclear matrix extraction of transiently transfected cells. We identified a novel nuclear
matrix-targeting signal (NMTS) in the hr protein and mapped the domain to amino acid residues
111 to 186 of the mouse hr sequence. Furthermore, we provide evidence that this region not only
mediates the interaction of hr with components of the nuclear architecture, but also specifies the sub-
nuclear location of the hr protein to nuclear domains containing deacetylase activity. The N-termi-
nal region directs hr to a speckled nuclear pattern that co-localizes with the histone deacetylase 3
(HDAC), but not with HDAC1 or HDAC7. Based on our findings, we propose that hr protein is part
of a specific multi-protein repressor complex that may be involved in chromatin remodeling. 
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Injection of recombinant human type VII collagen restores type VII collagen expression and
function in dystrophic epidermolysis bullosa in vivo
DT Woodley, T Atha, Y Huang, K Lipman, DR Keene and M Chen Dermatology, University of
Southern California, Los Angeles, CA
Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders caused
by mutations in the type VII collagen gene. The lack of effective treatment for DEB provides an
impetus to develop gene therapy strategies. Prior approaches to gene therapy included the stable inte-
gration of human type VII collagen sequences using both viral- and nonviral-based gene transfers.
To develop a more simplified approach for the treatment of DEB, we evaluated protein-based ther-
apy. In this study, we intradermally injected purified human recombinant type VII collagen into either
immunodeficient or immunocompetent mice and then assessed whether the injected human protein
would incorporate into the mouse basement membrane zone (BMZ). Skin biopsies were obtained
every week after injection and subjected to immunostaining and immunoelectron microscopy using
antibody specific for human type VII collagen. We found that the injected human type VII collagen
transported and incorporated into the mouse BMZ and formed anchoring fibrils (AFs). The human
type VII collagen and AFs were stably retained for at least 2 months (the last time point examined
at this time) after a single intradermal injection. Further, intradermal injection of recombinant type
VII collagen into intact RDEB skin transplanted onto immunodeficient mice also stably restored cor-
rectly localized type VII collagen expression at the BMZ. The restoration of type VII collagen reversed
the RDEB disease features, including dermal-epidermal separation and AF defects. Our studies pro-
vide the first evidence for using protein therapy to correct a skin disease due to a gene defect in a
structural protein. Since dermatologists have great experience and skill injecting type I collagen
into human patients for the improvement of wrinkles and photoaging, this same therapeutic method
using directly injected recombinant type VII collagen may provide a practical approach for restor-
ing type VII collagen in DEB patients. 
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Cloning of the breakpoints of a de novo inversion of chromosome 8 inv (8)(p11.2q22) in a patient
with Ambras syndrome
M Tadin-Strapps,1 D Warburton,2,3 FA Baumeister,5 SG Fischer,4 J Yonan,4 CT Gilliam3,4 and
AM Christiano1,3 1 Dermatology, Columbia University, New York, NY, 2 Pediatrics, Columbia
University, New York, NY, 3 Genetics and Development, Columbia University, New York, NY, 4
Columbia Genome Center, New York, NY and 5 Children’s Hospital of the Technical University,
Munich, Germany
Ambras syndrome (AMS) is a unique form of universal congenital hypertrichosis. In patients with
this syndrome the whole body is covered with fine, long hair except for the areas in which normally
no hair grows. Minor facial dysmorphism and dental anomalies, including retarded first and second
dentition and absence of teeth have been reported as well. Cytogenetic abnormalities of chromosome
8 have been reported in two isolated Ambras syndrome patients. The presence of a common break-
point in 8q22 in both of these cases suggests the presence of a candidate gene(s) in this region of
chromosome 8. In order to precisely determine the nature of the rearrangement in a case of Ambras
syndrome, we have used Fluorescent In Situ Hybridisation (FISH) with YAC and BAC clones from
8q22-q24. We have generated a detailed physical map across the inversion breakpoint interval, cloned
and sequenced inversion breakpoints in this patient, and identified transcripts in the vicinity of the
breakpoints. Genomic sequence analysis of the breakpoint interval revealed that the inversion does
not disrupt a gene and suggests that the phenotype is caused by a position effect. Interestingly, the
breakpoints occurred within a Tigger1 element on the 8p arm, and the LINE1 element on the q arm.
We are currently analysing expression of the genes that map in the vicinity of the inversion break-
points. Identification of the AMS gene will provide new insights into the control of hair growth and
cycling.
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Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermol-
ysis bullosa skin tissue in vivo
T Atha, PB Mukherjee, DR Keene, A Passalacqua, DT Woodley and M Chen Dermatology,
University of Southern California, Los Angeles, CA
Dystrophic epidermolysis bullosa (DEB) is an incurable blistering skin disease caused by mutations
in the type VII collagen (COL VII) gene. These patients lack COL VII and anchoring fibrils, struc-
tures that attach the epidermis and dermis. An ex vivo approach for DEB requires surgical trans-
plantation of gene-corrected cells with potential pain and scarring at the graft sites. Direct vector
administration into skin would permit corrective and long-term gene transfer without the complica-
tions associated with ex vivo therapy. We previously developed a lentiviral vector expressing the full-
length COL VII. In this study, we assessed the ability of lentiviral vectors to achieve COL VII gene
transfer in vivo using a human skin tissue grafted onto immunodeficient mice. We generated and
intradermally injected vesicular stomatitis virus envelop G pseudotyped lentiviral vectors encoding
COL VII transgene into the regenerated DEB skin tissue grafted onto immunodeficient mice. Skin
biopsies were obtained from grafts every week after injection and subjected to immunostaining and
immunoelectron microscopy using an antibody specific for human COL VII. The intradermal injec-
tion of lentiviral vectors into RDEB skin corrected the histological subepidermal blistering and
restored correctly localized COL VII expression at the BMZ, a pattern identical to skin regenerated
from normal control cells. Further, COL VII expression at the BMZ was sustained for at least 2
months after a single vector injection. Immunoelectron microscopy showed restored formation of
anchoring fibrils at the BMZ of RDEB skin, demonstrating correction of the major ultrastructural
RDEB abnormality. We conclude that intradermal injection of lentiviral vectors can stably correct
the abnormal RDEB dermal-epidermal separation and restore COL VII and anchoring fibrils at the
BMZ in vivo. These data indicate that efficient and long-term in vivo gene transfer into skin via direct
lentiviral vector injection may open new perspectives in the treatment of DEB. 
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An identical mutation in the human XPC DNA repair gene in two patients with and without
neurological symptoms
SG Khan,1 K Oh,1 S Emmert,1,2 T Shahlavi,1 CC Baker,3 DE Schmidt,1 JJ DiGiovanna1,4 and
KH Kraemer1 1 BRL, NCI, Bethesda, MD, 2 Derm, Georg-August-Univ Goettingen, Goettingen,
Germany, 3 LCO, NCI, Bethesda, MD and 4 Derm, Brown Med School, Providence, RI
Xeroderma pigmentosum (XP) is a rare, cancer-prone genetic disease with defective DNA repair.
About 20% of XP patients have neurological abnormalities. Most XP patients with neurological
symptoms are in complementation groups XP-A, XP-B, XP-D or XP-G. We now describe two newly
diagnosed XP-C patients with markedly different clinical features but identical genetic defects.
XP21BE, a 23y/o woman with marked freckling, had multiple angiokeratomas, squamous cell car-
cinomas and melanomas. She had sensorineural deafness and learning disabilities which have not
been seen in other XP-C patients. XP329BE, an 8 y/o boy with marked freckling, had multiple basal
cell carcinomas and a normal neurological examination. Both the patients’ cells were hypersensitive
to killing by UV. Host cell reactivation (HCR) of a UV-treated reporter gene plasmid co-transfected
with a vector expressing wild-type XPC cDNA assigned XP21BE and XP329BE cells to XP-C. Using
a real-time quantitative RT-PCR assay, both cells expressed low levels of XPC message. By sequence
analysis, we identified a homozygous T107G mutation in XPC exon 1 in XP21BE cells that abol-
ishes the ATG initiation codon. This identical homozygous mutation was also present in XP329BE.
This allele was inactive since an XPC cDNA expression vector containing this mutation resulted in
no increase in DNA repair activity in XP-C cells in a HCR assay in comparison to the empty vector
control. We will examine microsatellite markers flanking the XPC gene on chromosome 3 to deter-
mine if there is a common ancestor for these two XP patients. These results indicate that this homozy-
gous mutation identified in the XPC gene greatly reduces the DNA repair function of this gene and
is associated with cancer susceptibility in both patients. The neurological symptoms in XP21BE
and the differences in the pattern of skin tumors may be associated with other, presently unidenti-
fied, gene modifying effects. 
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A mouse model for epidermolytic hyperkeratosis that recapitulates the human disease course
MJ Arin,1 M Longley2 and DR Roop2 1 Dermatology, University of Cologne, Cologne, Germany
and 2 Molecular And Cellular Biology, Baylor College of Medicine, Houston, TX
Epidermolytic hyperkeratosis (EHK) is an autosomal-dominant disorder of cornification due to point
mutations in the suprabasal keratins K1 and K10. The onset of the disease phenotype is typically at
birth and affected individuals present with erythroderma, blistering and peeling. Erythroderma and
blistering diminish during the first year of life and hyperkeratoses develop, predominantly over the
flexural areas of the extremities. We recently generated a mouse model for EHK by introducing a
K10 point mutation, which is found in the majority of human cases of EHK, into the mouse germline.
To overcome neonatal lethality, we established an inducible system, that allowed to induce the phe-
notype in a circumscribed area of the skin. Shortly after induction, erythroderma and blisters devel-
oped, resulting in scaling after the blisters had ruptured. With the onset of hair growth, scaling dimin-
ished and thick, brown hyperkeratoses started to form, predominantly in mechanical stressed areas,
like the paws. These hyperkeratoses persisted, to date for over a year. Histological and immunoflu-
oresence analysis confirmed blister formation in the suprabasal layers of the epidermis in newborn
mice and vacuolization and a thickened stratum corneum in adult mice. Phenotypes of the mice
closely resembled those obeserved in humans, both at the early neonatal blistering stage and later at
the adult hyperkeratotic stage. This mouse model will be used to study the mechanisms that under-
lie the disease course in EHK and other genodermatoses. 
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Decolour pigmented rat skin by bombarding agouti signaingl protein cDNA -coated micro-
scopic gold particles via the gene gun technique
C Yang,1 L Yang,2 JC Lee1 and H Hong1 1 Dermatology, Chang Gung Memorial Hospital, Taipei,
Taiwan and 2 Gene therapy Laboratory, Tajen institute of technology, Ping-tung, Taiwan
We developed a gene gun method for the transfer of human agouti signaling protein (ASP) cDNA
to alter rat skin colour in vivo. Human ASP cDNA was cloned into a modified cytomegalovirus
plasmid and delivered to the skin of Long-Evans (LE) rats by gene gun bombardment. Skin pig-
mentation, body weight and blood sugar of ASP cDNA transfected rats were recorded against the
control group, which were injected with plasmids encoding for green fluorescent protein. The treated
skin showed lighter skin colour after three days of ASP gene transfection. This depigmentation effect
was most prominent on day 14 and the skin gradually returned to its original pigmentation by day
28. Successful transfection of ASP gene in skin and hair follicles, as well as downregulation of
melanocortin-1 receptor (MC1R) and tyrosinase expression upon treatment was confirmed using
immunohistochemistry and Western blot analysis. Body weight and blood sugar in the treated rats
did not show statistically significant differences as compared to control groups. These observations
demonstrate that gene transfer using gene gun method can induce high cutaneous ASP production
and facilitate a switch from dark to fair colour without systemic pleiotropic effects. Such colour
switch may be that ASP is acting in a paracrine fashion. In addition, this study verifies that ASP
exerts its functions by acting as an independent ligand that down-regulates the melanocyte MC1R
and tyrosinase protein in an in vivo system. Our result offers new, interesting insights about the effect
of ASP on pigmentation, providing a novel approach to study the molecular mechanisms underly-
ing skin melanogenesis. 
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Regulation of the coproporphyrinogen oxidase gene promoter by C/EBP transcription factors:
insights into enhanced ALA-photodynamic therapy
S Anand,1 BJ Ortel,2 T Hasan2 and EV Maytin1 1 Biomedical Engineering, Lerner Research
Institute, Cleveland Clinic Fndn, Cleveland, OH and 2 Wellman Laboratories of Photomedicine,
Dept. of Dermatology, Harvard Medical School, Boston, MA
Photodynamic therapy (PDT) is an emerging binary treatment for a number of epithelial cancers of
skin and prostate. Aminolevulinic acid (ALA)-mediated PDT involves the administration of a pre-
cursor photosensitizer i.e. ALA, which is selectively accumulated and metabolized in target cells in
the form of protoporphyrin IX (PPIX). The increased production of PPIX in differentiated cells is
the result of increased expression of coproporphyrinogen oxidase (CPO), a heme-synthetic enzyme.
Local irradiation with visible light induces tissue-specific cell death. We previously observed a strong
correlation between increase in expression of CCAAT enhancer binding proteins (C/EBPs) and lev-
els of CPO mRNA. This indicates the possibility of transcriptional regulation of CPO by C/EBPs.
Sequence analysis of the DNA 1 kb upstream to the transcription start site of the CPO gene revealed
8 consensus C/EBP motifs. Nuclear extracts from COS-7 cells overexpressing C/EBP family mem-
bers (LIP, LAP, LAP*, CHOP/gadd153 and C/EBPα) formed specific complexes with radiolabeled
oligos on an electrophoretic mobility shift assay (EMSA). Competition, mutation and supershift
assays defined the specificity of these complexes. A functional analysis was done by cloning 1 kb
promoter region upstream of the luciferase (luc) gene, followed by transient transfection and reporter
assays. Co-transfection of the luc-reporter with vectors expressing C/EBP family members resulted
in up to 7-fold induction of the reporter. Despite considerable variation in the induction among dif-
ferent members of the C/EBP family, maximum induction was achieved by CHOP. A variety of agents
including methotrexate induce the expression of CHOP. These results suggest that use of such agents
to increase the level of CPO expression and thus PPIX prior to PDT will enhance ALA-PDT effi-
cacy. 
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Acatalasemia: identification and characterization of a novel missense mutation
V Wally, B Buchroithner, A Klausegger, M Laimer, H Hintner and JW Bauer Dermatology,
Paracelsus Medical University, Salzburg, Austria
Catalase is an important protein in the context of oxidative stress, disposing of hydrogen peroxide
and therefore protecting cells from oxidant damage. Non-functional enzyme in acatalasemia leads
to oral ulcerations and gangrene induced by hydrogen peroxide. In most cases literature does not
provide clear-cut genotype-phenotype correlation in acatalasemic patients. Therefore we analysed
the catalase gene in an affected family identified by the hydrogen peroxide in vitro blood test. Most
polymorphisms were excluded to be pathogenic due to the pattern of inheritance. Two polymor-
phisms located in the promotor region have already been described to be non-pathogenic elsewhere.
The only remaining polymorphism is a heterozygous missense mutation, located at position 96 of
exon 3, consisting of a C to T substitution and as a consequence replacing an Arginine by a Trypto-
phan. Analyzing 30 nonacatalasemic individuals we could not detect this missense mutation. As the
C to T substitution resulted in a tggt resembling a splice site sequence, exons 3 and 4 of the cDNA
were cloned and analyzed for splicing variants. This analysis excluded a splice variation. Therefore,
it came to our surprise that in the absence of stop codons and splicing variations we found a signif-
icant reduction of catalase-mRNA, suggesting instability of the RNA. Further studies will be nec-
essary to elucidate the correlation between genotype and phenotype of mutated catalase in this fam-
ily. 
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Cycloheximide regulates expression of the alternatively spliced forms of lysyl hydroxylase 2 in
human kidney cells and skin fibroblasts
LC Walker, MA Overstreet and HN Yeowell Medicine, Duke University Medical Center, Durham,
NC
The lysyl hydroxylases comprise a family of post-translational modifying enzymes in collagen biosyn-
thesis. The hydroxylation of specific lysines is a crucial step in the synthesis of collagen crosslinks
required for the integrity of connective tissue. Lysyl hydroxylase 2 (LH2) exists in two alternatively
spliced forms; the major form (expressed ubiquitously) exists as a longer transcript with the inclu-
sion of a 63bp exon (exon 13A) that is spliced out in the short form (expressed in human kidney,
spleen, liver and placenta). These long and short transcripts may have specificity for hydroxylation
of lysines in the telopeptide and helical collagen domains, respectively. Only the long form of LH2
is expressed in confluent human skin fibroblasts (HSF) whereas a lower cell density appears to
favor the expression of the short LH2 transcript. Using semi-quantitative PCR, we have examined
the regulation of this alternate splicing by cycloheximide (CHX) in human kidney cells (HEK293),
in which both LH2 transcripts are expressed, and in confluent HSF. In HEK cells (in 10% FBS),
CHX addition (10ug/ml) virtually eliminated the expression of the long LH2 transcript after 6h,
whereas expression of the short transcript was slightly increased. Although the short form is not
detected in untreated confluent HSF cells, administration of CHX to HSF (in 20% CS) resulted in
preferential expression of the short LH2 transcript with a decrease in the long form. Decreasing the
serum concentration to 1% in HEK and HSF did not change this result. This effect of CHX indicates
that the splicing mechanism for inclusion of exon 13A in LH2 requires a newly-synthesised protein
factor (that is suppressed by CHX). These regulation studies may have an important application in
fibrotic diseases in light of a recent report (Van der Slot et al., JBC 2003:278:40967) showing that
the long form of LH2 is over-expressed in scleroderma cells. 
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Contrasting activities of the alternatively spliced forms of lysyl hydroxylase 2 may result from
collagen domain-specific lysyl hydroxylation
MA Overstreet,1 LC Walker,1 K Takaluoma,2 J Myllyharju2 and HN Yeowell1 1 Medicine, Duke
Univ Med Ctr, Durham, NC and 2 Collagen Research Unit, Univ of Oulu, Oulu, Finland
Lysyl hydroxylases catalyse the hydroxylation of specific lysines in collagen that are precursors for
crosslink formation essential for the tensile strength of collagen. An alternatively spliced, longer
form of lysyl hydroxylase2, isolated from skin, has been shown to be the major transcript of LH2
and is ubiquitously expressed. This longer transcript includes an additional 63bp exon, located between
exons 13 and 14 of the originally-described shorter transcript of LH2 (isolated from kidney). To
determine the function of the alternatively-spliced transcripts, we have expressed constructs for
both forms as secretable recombinant enzymes in a baculoviral system. Their identity was confirmed
by PCR, Northern and Western blots. Under assay conditions in which LH activity was measured
by release of 3H20 from a 4,5-
3H lysine-labeled underhydroxylated collagenous substrate, only trace
activity was measured in the longer transcript whereas the short transcript had high activity compa-
rable to that of recombinant LH1. This activity difference may be explained by a collagen domain-
specific pattern of Lys hydroxylation by the alternate transcripts of LH2. If the short form of LH2
functions as a helical LH and the long form as a telopeptide LH, then based on the 15:1 ratio of
available Lys hydroxylation sites in helical vs telopeptide domains of type I collagen, the relatively
increased hydroxylation of a collagenous substrate by the short form is expected. The viability of
these LH2 recombinants was confirmed in an alternative assay based on the hydroxylation-coupled
decarboxylation of 2-oxo[1-14C] glutarate using a synthetic trimer of Ile-Lys-Gly as substrate, which
showed the long form of LH2 to be more active than the short form. The importance of this study is
that the lysyl hydroxylation of specific collagen domains determines the pattern of collagen crosslink-
ing which, when perturbed, can lead to fibrotic and connective tissue disorders such as Ehlers-Dan-
los syndrome. 
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Mutations in SCN9A encoding a sodium channel alpha subunit in patients with primary ery-
thermalgia
Y Yang,1 Y Wang,1 S Li,1 Z Xu,2 H Li,3 L Ma,2 J Fan,3 X Zhu1 and Y Shen4 1 Dermatology, Peking
University First Hospital, Beijing, China, 2 Dermatology, Beijing Children Hospital Affiliated to
the Capital University of Medical Sciences, Beijing, China, 3 Dermatology, General Hospital of
PLA, Beijing, China and 4 Chinese National Human Genome Center, Beijing, China
Primary erythermalgia is a rare autosomal dominant disease characterized by intermittent burning
pain with redness and heat in extremities. Previous study established the linkage of primary ery-
thermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified. We
performed linkage analysis in a Chinese family with primary erythermalgia, and screened the muta-
tions in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient. Linkage
analysis yielded a maximum lod score of 2.11 both for markers D2S2370 and D2S2330. Based on
critical recombination events in 2 patients in the family, we further limited the genetic region to 5.98
cM between D2S2370 and D2S2345. We then identified two missense mutations in SCN9A in the
family (T2573A) and the sporadic patient (T2543C). Our data suggest that mutations in SCN9A
cause primary erythermalgia. SCN9A, encoding a voltage-gated sodium channel alpha subunit pre-
dominantly expressed in sensory and sympathetic neurons, may play an important role in nocicep-
tion and vasomotor regulation. 
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Compound heterozygosity for unique in-frame insertion and deletion mutations in the plectin
gene in a mild case of epidermolysis bullosa with very late onset muscular dystrophy
J Uitto and EG Pfendner Dermatology, Thomas Jefferson university, Philadelphia, PA
Epidermolysis bullosa with muscular dystrophy (EB-MD) is an autosomal recessive skin blistering
disease characterized by tissue separation within the basal keratinocytes just above the hemidesmo-
somes. The skin blistering phenotype is accompanied by muscle weakness usually noted in child-
hood. A variety of mutations that result in premature termination codons in the plectin gene (PLEC1)
have been identified in patients with childhood onset of EB-MD and low or undetectable expression
of plectin.  Plectin is a component of the hemidesmosomal inner plaque and is also expressed in the
sarcolemma and the Z bands of skeletal muscle. The present patient is a 45-year-old female with a
history of mild skin blistering and nail dystrophy since birth and a very recent complaint of upper
extremity weakness. Staining of a skin biopsy with (HD-1) antibody revealed patchy discontinuous
staining for plectin as well as focal weak staining for type XVII collagen (BPAG2) on the roof of
microvesicles and within the basement membrane zone. Mutation detection performed by dHPLC
separation of heteroduplexed PCR products spanning the entire coding region of PLEC1 followed
by nucleotide sequencing revealed an in-frame 9-bp deletion in exon 22 (2677del9) resulting in the
loss of 3 amino acids (delQEA) and a 36-bp insertion in exon 15 (1541ins36) resulting in the inser-
tion of 12 amino acids (insVCVYPLHERLVA). Both of these mutations are in the B4 integrin bind-
ing domain within the amino terminal globular domain of the protein. The late onset of muscle weak-
ness in the 5th decade of life and very mild skin findings in this patient can be attributed to the
in-frame nature of the mutations, allowing the expression of modified yet partly functional plectin
protein. In addition, the position of these mutations yields information regarding the functional sig-
nificance of these protein segments in the epidermis and muscle. 
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Recurrent and de novo dominant COL7A1 mutations in dystrophic forms of epidermolysis bul-
losa
S Cash, S Sadowski, J Uitto and EG Pfendner Dermatology, Thomas Jefferson University,
Philadelphia, PA
Dystrophic Epidermolysis Bullosa (DEB) is an inherited mucocutaneous blistering disorder char-
acterized by scarring and dystrophic nails. In DEB patients dermo-epidermal tissue separation occurs
below the basement membrane, and reduced or absent immunostaining for type VII collagen and
alterations in anchoring fibrils are diagnostic for this disorder. DEB can manifest with a spectrum
of severity extending from the severe mutilating recessively inherited Hallopeau-Siemens variant to
very mild dominant (DDEB) forms, depending upon the types and combinations of the mutations
and their consequences at the mRNA and/or protein levels. Over the past decade, molecular analy-
ses by several laboratories have identified a number of mutations spanning the COL7A1 gene in
patients with DEB. The DebRA Molecular Diagnostics Laboratory at Jefferson Medical College
has performed mutation detection analyses on 319 patients with biopsy confirmed DEB and dis-
closed 303 mutations in 204 patients. Twenty-eight patients were determined to have autosomal dom-
inant forms of DEB with eleven different autosomal dominant glycine substitution mutations iden-
tified to date. Six different recurrent dominant mutations have been identified (G2034W, G2043R,
G2064R, G2079E, G2079R, G2713D) in 21 of 28 patients, with G2043R being the most prevalent
(9 of 28). Eight DDEB patients had confirmed de novo mutations implying a reduced recurrence
risk in subsequent offspring of the same parents. Based on these data, we estimate the probability
of a new mutation to be at least 2.6% (8/303) for all mutations in COL7A1 and possibly as high as
29% (8/28) for dominant forms of DEB. In addition, the presence of recurrent mutations allows
simple and rapid mutation screening in DDEB. These findings underscore the utility of mutation
detection in the determination of recurrence risk in families with DEB especially when no previous
family history is noted. 
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Recurrent ITGB4 mutations in Hispanic patients with epidermolysis bullosa and pyloric atre-
sia
S Sadowski, J Uitto and EG Pfendner Dermatology, Thomas Jefferson university, Philadelphia, PA
Epidermolysis bullosa with pyloric atresia (EB-PA) is a rare, frequently lethal, inherited disorder
with neonatal onset of blistering skin associated with pyloric atresia. Most of the cases have been
attributed to mutations in the α6 (ITGA6) and β4 (ITGB4) integrin genes and recently a few cases
due to plectin (PLEC1) mutations have been reported. Dermo-epidermal tissue separation occurs in
the lamina lucida in most cases. In patients affected with EB-PA, immunostaining for α6β4 inte-
grin, a transmembrane attachment protein with signaling function, is markedly reduced or absent.
Our laboratory has identified 53 mutations in 36 EB-PA patients. Among them, two patients carried
mutations in the ITGA6 gene and 34 in the ITGB4 gene, and 12 patients were homozygotes for the
same mutation and 24 patients compound heterozygotes. The recurrent mutation C61Y, a result of
a G to A transition at position 182 (TGC->TAC) in the ITGB4 gene was identified in three of five
patients of Hispanic ethnic origin on five of the ten alleles. C61Y was not identified in patients of
other ethnic backgrounds in our cohort. This result emphasizes the usefulness of recognizing the eth-
nic background for mutation detection, and facilitates the mutation analysis in Hispanic patients with
EB-PA. Furthermore, our findings suggest that C61Y is a founder mutation in this population. 
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Novel and recurrent mutations in the keratin 5 and 14 genes in epidermolysis bullosa simplex:
implications for genetic counseling
EG Pfendner and J Uitto Dermatology, Thomas Jefferson university, Philadelphia, PA
Epidermolysis bullosa simplex (EBS) is an inherited mechanobullous skin disorder in which the level
of tissue separation is within the epidermal keratinocyte layer. EBS mutations have been disclosed
in the keratin 5 (KRT5) and 14 (KRT14) genes with both autosomal recessive and, more commonly,
autosomal dominant inheritance patterns.  EBS patients can exhibit a phenotypic spectrum from the
severe, sometimes lethal Dowling-Meara form to the milder Weber-Cockayne form, depending upon
the amino acid substituted and its location in the protein. Using automated DNA sequencing of
selected exons we have identified mutations in eighteen EBS patients with biopsy proven disease.
Of these, nine patients had recurrent mutations that have been previously reported in EBS patients
in the literature (N123S (3), R125C (3), R125H, M119T in KRT14 and P25L in KRT5). Nine patients
had novel mutations, six of which were missense (I467M, I183F, E477K, I161S, S482R, S523G in
KRT5 and Q120P in KRT14), while one nonsense mutation (C512X) and one in frame 3 bp dele-
tion (delI183) were identified in KRT5. Of the eighteen patients analyzed, thirteen patients (72%)
had de novo mutations where neither parent was a carrier. R125C and N123S (both in KRT14) were
found as de novo events in three patients each and represented the most common type of de novo
mutations in our patient population. Of the eighteen families studied, eight prenatal tests have been
requested and correct outcome was predicted in six cases with one pregnancy ongoing and one lost
to follow up. Of the eight prenatal tests performed, in five the affected family member was a parent
of the pregnancy, and of these, two affected fetuses were predicted. No elective terminations were
reported and the most common reason given for the prenatal test was to prepare for an affected
child. This data underscores the high new mutation rate in EBS families seeking genetic testing, and
the use of prenatal testing in EBS families to receive genetic counseling and prepare for an affected
child rather than prevention. 
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dHPLC screening detects novel and recurrent mutations in pseudoxanthoma elasticum
S Fratta,1 F Ringpfeil,1 S Terry,2 P Terry,2 J Uitto1 and EG Pfendner1 1 Dermatology, Thomas
Jefferson university, Philadelphia, PA and 2 PXE International, Washington, DC
Pseudoxanthoma elasticum (PXE) is a heritable connective tissue disorder manifesting with pro-
gressive calcification of elastic fibers in skin, retina and the cardiovascular system. Mutations have
recently been identified in the ABCC6 gene, which encodes the MRP6 protein, whose function is as
yet unknown. Our laboratory has been developing a systematic strategy for screening all 31 exons
and immediate flanking intronic regions of the ABCC6 gene for disease causing mutations in PXE
patients using dHPLC separation of heteroduplexed PCR products, followed by nucleotide sequenc-
ing. Previously, two recurrent mutations were identified, R1141X and del ex 23-29 in approxi-
mately 20% and 11% of PXE patients, respectively. Thus the current mutation detection strategy
begins with restriction enzyme digests designed to detect these two common mutations, followed
by dHPLC screening and DNA sequencing. Using this approach we have analyzed eight patients for
mutations in ABCC6. Eleven mutations were disclosed on sixteen alleles in these patients. Six
mutations have been previously reported: R1141X on five alleles and T1301I on one allele. The five
novel mutations include; three missense (R807Q, R1418P, and L639P), one nonsense (R964X), and
one deletion (3427delC) mutation. The remaining five mutations have not been identified to date and
may represent alterations in the regulatory region of ABCC6 or intronic sequences beyond the regions
examined by the current strategy. The detection rate in this analysis is 69% (11/16 alleles) consis-
tent with published reports (72%) on detection of ABCC6 mutations using dHPLC screening. 
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Treatment of human skin with retinoic acid strongly induces aldehyde dehydrogenase 1A3
K Ulrich,1 S Amatschek,1 A Uthman,1 J Bach1 and E Tschachler1,2 1 Department of Dermatology,
University of Vienna, Medical School, Vienna, Austria and 2 CE.R.I.E.S, Neuilly, France
Retinoids are widely used for topical and systemic treatment of skin disease. In order to study the
effect of retinoic acid, which serves as ligand for nuclear retinoic acid receptor and activates tran-
scription, we treated human keratinocytes in a skin equivalent model with 10-6 M all-trans-retinoic
acid (ATRA) and compared the expression profile with an untreated control sample by hybridiza-
tion of an 11040 spot DNA array. Out of 194 ATRA induced genes (cut off 1,8-fold regulation) alde-
hyde dehydrogenase 1A3 (ALDH1A3) former named aldehyde dehydrogenase 6 (ALDH6) or reti-
naldehyde dehydrogenase 3 (RALDH3) showed highest regulation. When human keratinocytes were
treated with ATRA a rapid induction of this gene could be seen with a maximum of 30-fold up-reg-
ulation as tested by real time PCR. This strong induction was verified by Northern blot and in situ
hybridization of skin equivalents. Interestingly all other class I family members, ALDH1A1,
ALDH1A2 and ALDH1B1 and the tested class 2 and 3 members ALDH2 and ALDH3A2 were not
induced by retinoic acid. The effect of retinoids in activating ALDH1A3 is very likely restricted to
epithelial cells as retinoid-treatment of fibroblasts under the same conditions resulted in no up-reg-
ulation of its expression. Since we could show in addition that ALDH1A3 is also strongly induced
by 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) (30-fold induction), we suggest that ALDH1A3 has
a general detoxifying function in addition to its role in the retinoic acid synthesis pathway. 
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Identification and characterization of the transcriptional control elements that regulate the
expression of ∆Np63 in keratinocytes
R Romano and S Sinha Biochemistry, SUNY at Buffalo, Buffalo, NY
p63, a homolog of the tumor suppressor p53, plays an important role in maintaining the progenitor
cell populations in stratified epithelium such as those in the epidermis of the skin. Indeed, p63-/-
mice exhibit a profound block in development of skin epidermis including abnormal stratification
and failure of keratinocytes to express certain differentiation markers. Interestingly, the p63 gene
gives rise to multiple functionally distinct protein isoforms, including ∆Np63, which lacks the N-
terminal transactivation domain and is synthesized from an internal promoter. ∆Np63 can function
as a dominant-negative and hence, it is likely that the biological activity of p63 is governed in part
by the relative amounts of these isoforms. Therefore, we have initiated a detailed analysis of the tran-
scriptional control mechanisms that govern the expression of ∆Np63 in keratinocytes. In order to
identify the cis-elements that regulate ∆Np63, we have analyzed the chromatin conformation of the
∆Np63 promoter by DNAse I hypersensitive site mapping. These experiments demonstrate that the
promoter region of ∆Np63 as well as an upstream segment, are in open chromatin states in ker-
atinocytes. We have performed transient transfection assays with several 5’serially deleted constructs
containing various segments of the ∆Np63 promoter. These studies have identified a 120 bp frag-
ment that harbors most of the transcriptional activity of the ∆Np63 promoter. Interestingly, this seg-
ment shows remarkable sequence conservation between several species suggesting its functional
importance. Additional studies of this element by gel shift and mutation analysis have revealed crit-
ical roles for CCAAT-box binding factor (CBF/NF-Y), Sp1/Sp3 family of proteins, and GATA-like
proteins. Our data provide novel insights into the regulatory mechanisms that govern the expression
of ∆Np63 and support the notion that the expression of individual p53 family members and their
isoforms is controlled by unique and distinct pathways. 
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Molecular cloning and characterization of alternatively spliced S100A15-isoforms overex-
pressed in psoriatic skin
R Wolf,1 A Mirmohammadsadegh,1 B Lysa,1,2 U Tartler,1 G Michel,1 M Walz1 and T Ruzicka1 1
Dermatology, Heinrich-Heine University, Duesseldorf, Germany and 2 Dermatology, Charles
University Prague, Prague, Czech Republic
In an effort to identify psoriasis-associated genes, we compared gene expression in normal and pso-
riatic skin using differential display RT-PCR technique. Sequence analysis of a 650 bp cDNA frag-
ment (clone 110) that was highly upregulated in lesional skin revealed homology to a non-coding
cDNA (NICE-2). Initial sequence analysis showed high homology to a noncoding cDNA. By sub-
sequent cDNA cloning of psoriatic skin, a corresponding coding region was identified which is
present in two alternatively spliced mRNA-isoforms. The splice variants detected are about 0.5 kb
and 4.4 kb in length and differ in their untranslated regions. Both isoforms share a coding region
predicting a protein of 101 amino acids that shares high homology to the S100A7 protein. Analysis
of the deduced amino acid sequence revealed two potential EF-hand motifs as Ca2+- binding domains.
By sequence comparison, we have mapped the novel gene, named S100A15, within the epidermal
differentiation complex (chromosome 1q21), where other members of the S100 family are clustered.
Analysis of genomic DNA revealed that the S100A15 gene is split into three exons and two introns
spanning a total of about 7 kb. Increased expression of the mRNA-splice variants in psoriatic skin
was confirmed by RT-PCR and Northern blot analysis. In-situ hybridization revealed a markedly
increased number of mRNA molecules in the basal and suprabasal epidermal layers of psoriatic
skin when compared to healthy skin tissue. Our data on expression and distribution of this gene sug-
gest an involvment of the S100A15 in epidermal proliferation and differentiation and might be impor-
tant for the pathogenesis of psoriasis and other diseases. 
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Targeted disruption of Spink5 in mice results in abnormal desquamation and impaired hair
formation reminiscent of Netherton syndrome, in addition to severe skin fragility
P Descargues,1 C Deraison,1 C Bonnart,1 M Kreft,2 A Sonnenberg2 and A Hovnanian1 1 INSERM
U563, Toulouse, France and 2 The Netherlands Cancer Institute, Amsterdam, Netherlands
SPINK5, encoding the putative multi-domain serine protease inhibitor LEKTI, is the defective gene
in the severe autosomal recessive ichthyosiform skin condition, Netherton syndrome. LEKTI is a
marker of epithelial differentiation, strongly expressed in the granular layer of the epidermis. To
investigate its role in vivo, we have genetically engineered mice with a targeted disruption of Spink5.
The targeted locus was confirmed by Southern blot hybridization. Loss of expression of Lekti was
demonstrated by absence of immunostaining in the epidermis of the knockout mice. Homozygous
mutant mice displayed an oedematous skin with loss of elasticity and died shortly after birth. The
animals presented with superficial peeling and suffered from marked cutaneous fragility responsi-
ble for deep skin detachment after mild trauma. These lesions were predominant on the limbs, the
tail and the trunk. Hair development was impaired, resulting in the absence of erupted vibrissae.
Ultrastructural examination of the skin showed detachment of the stratum corneum from the gran-
ular layer where acantholysis was observed. These mice displayed a defect in skin barrier function
as measured by penetration of external dyes and rapid decrease of body weight. At the histological
and ultrastructural level, the dermis of these animals revealed localized oedema and cleavage below
hair follicle bulbs. Our study provides the first in vivo evidence for a role of Spink5 in the desqua-
mation of the epidermis through the regulation of cell-cell adhesion between terminally differenti-
ated keratinocytes. These results also demonstrate that Spink5 is essential for hair development and
surprisingly, disclose a critical role of Lekti in dermal integrity. The Spink5 knockout mice provide
an animal model to study the role of Spink5 in desquamation and hair development, which are abnor-
mal in Netherton syndrome. 
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Transcriptional regulation of ABCC6 gene expression: identification of novel cis-elements, role
of Sp1, and cytokine modulation of the promoter activity
Q Jiang, Y Matsuzaki, K Li and J Uitto Dermatology and Cutaneous Biology, Jefferson Medical
College, Philadelphia, PA
ABCC6, a member of the ATP-binding cassette family of genes, encodes MRP6, a putative trans-
membrane transporter expressed primarily in the liver and to a significantly lower extent in other
tissues. Mutations in ABCC6 result in pseudoxanthoma elasticum, a multi-system heritable con-
nective tissue disorder with variable phenotypic expression. To examine the transcriptional regula-
tion and tissue-specific expression of this gene, we cloned 2.6 kb of human ABCC6 promoter and
developed a series of 5’-deletion constructs linked to luciferase reporter gene. Transient transfec-
tions in a number of cultured cell lines of diverse origin identified a specific NF-κB-like sequence
(-235/-226) which conferred high level of expression in both human (HepG2) and murine (MLE-
10) cells, inferring liver specificity. The human promoter was more active in human cells in com-
parison to mouse cells, also suggesting species specificity. Testing of selected cytokines revealed
that TGF-β upregulated, while TNF-α and interferon-γ downregulated the promoter activity in HepG2
cells. The responsiveness to TGF-β was shown to reside primarily within an Sp1/Sp3 cognate bind-
ing site at -58 to -49. The expression of the ABCC6 promoter was also shown to be markedly enhanced
by Sp1 protein, as demonstrated by co-transfection of ABCC6 promoter-luciferase constructs and
an Sp1 expression vector in Drosophila SL2 cells which are devoid of endogenous Sp1. Collectively,
the results indicate that human ABCC6 displays tissue- and species-specific gene expression which
can be modulated by proinflammatory cytokines. These findings may have implications for pheno-
typic expression of heritable and acquired diseases involving abnormality in the ABCC6 gene. 
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A novel nonsense mutation in Kindler syndrome
C Has and L Bruckner-Tuderman Dermatology, University Freiburg, Freiburg, Germany
Kindler syndrome (KS) is a rare autosomal recessive genodermatosis characterized by skin atrophy
and blistering, photosensitivity and poikiloderma. Recently, mutations in a new gene, designated as
kindlin-1 (KIND1), were reported in patients with KS. Kindlin-1 protein is expressed in keratinocytes
and is implicated in linking the actin cytoskeleton to the plasma membrane. Here we report a novel
homozygous nonsense mutation in the KIND1 gene in a patient previously thought to have epider-
molysis bullosa simplex with mottled pigmentation (EBS-MP). When the clinical diagnosis was
reconsidered and the kindlin-1 gene sequenced, a homozygous nonsense mutation E304X, was iden-
tified. Phenotypic characterization by electron microscopy and immunofluorescence analysis of the
dermal-epidermal junction revealed subnuclear splitting and vacuolisation of basal keratinocytes,
pigmentary incontinence and an inhomogenous staining pattern of basement membrane proteins.
From the biological point of view, the similarity of KS and EBS-MP is intriguing. In both disorders
the linkage between the cytoskeleton and the cell membrane is impaired. In KS, a linker protein is
functionally defective, in EBS-MP a cytoskeletal component, keratin 5. Kindlin-1 is thought to medi-
ate the connection between the actin cytoskeleton and the cell membrane, and keratin 5 is an essen-
tial component of the keratin filaments which are attached to the cell membrane by hemidesmoso-
mal proteins, such as plectin or BP230. Several precedents exist for similar phenotypes caused by
mutations in genes encoding for functionally related molecules in multiprotein complexes. 
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Identification of two keratinocyte stem cell regulatory loci implicated in skin carcinogenesis
NV Popova, KA Teti, KQ Wu and RJ Morris Dermatology, Columbia University, New York, NY
Several converging lines of evidence suggest that the cellular targets for carcinogens and tumor pro-
moters in the cutaneous epithelium are keratinocyte stem cells, including in vitro clonogenic cells
with high proliferative potential. These observations indicate that the identification of the mecha-
nism regulating keratinocyte stem cell frequency and proliferative activity is critical for understanding
the mechanism of skin carcinogenesis. To address this problem and to look toward the identification
of stem cell regulatory genes, we investigated the clonogenic activity of epidermal stem cells iso-
lated from two mouse strains C57BL/6 and BALB/c, and their genetic crosses. We established that
mouse skin have at least two subpopulations of epidermal stem cells able to produce small (less then
2 mm2) and large (more then 2 mm2) colonies in vitro. We found that these two subpopulations were
regulated by different genes: Ksc1 that is situated in the central region of mouse chromosome 9, and
Ksc2 - in the proximal region of mouse chromosome 4. That Ksc1 and several minor loci regulat-
ing frequency of small colonies may be involved in the regulating the susceptibility to skin car-
cinogenesis follows from our data. When we sequenced the Ksc1 region we found several poly-
morphic genes that might influence frequency and proliferative activity of epidermal stem cells. To
confirm the involvement of the genes in the regulation of our phenotype we took evaluated the influ-
ence of these genes on the clonogenic and proliferative activity of epidermal stem cells isolated
from C57BL/6 and BALB/c mice. Investigation of the genes regulating the frequency and prolifer-
ative potential of keratinocyte stem cells may play an important role in the development of stem cell
gene therapy and may help to establish a new view on mechanisms of skin tumor promotion. 
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Procollagen VII self-assembly and its perturbations in dystrophic epidermolysis bullosa
M Colombo,1 RJ Brittingham,1 JF Klement,1 DE Birk,2 J Uitto1 and A Fertala1 1 Dermatology and
Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 2 Anatomy and Cell
Biology, Thomas Jefferson University, Philadelphia, PA
The purpose of the present study was to determine the molecular basis of the collagen VII-collagen
VII dimer formation and to study how single amino acid substitutions found in patients with DEB
alter the process of collagen VII self-assembly. In order to accomplish our aims, we engineered mini
mouse procollagen VII variants consisting of NC1 and NC2 domains and a shortened triple-helix in
which the C-terminal region encompassing Cys-2625 was either preserved or was substituted with
the region encompassing Cys-1448 derived from the N-terminal part of the triple helical domain. To
study the effects of mutations on the formation of collagen VII dimers, the G2575R, R2622Q and
G2623C mutant procollagens were analyzed. Genetically engineered DNA constructs encoding
recombinant procollagen VII variants were expressed in 293 cells. The formation of collagen VII
dimers was analyzed by solid-state binding assays or by the use of an optical biosensor. The physic-
ochemical properties of the interacting regions were determined by homologous molecular model-
ing. As evidenced by biochemical and EM assays, the mini procollagen VII variants were secreted
from cells as intact monomers. Collagen VII-collagen VII binding assays indicate that procollagen
VII self-assembly depends on site-specific interactions between the NC2 domain and the triple hel-
ical region adjacent to the Cys-2625, and that this process is promoted by the cleavage of the NC2
by procollagen C-proteinase. Thus, the molecular mechanism for collagen VII-collagen VII dimer
formation involves site-specific interaction between the NC2 domain and the region adjacent to Cys-
2625 of another procollagen VII molecule. We postulate that the correct structure of this region is
critical for accurate collagen VII self-assembly and that single-base substitutions in COL7A1 may
alter this structure leading to an alteration of dimer formation. 
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Consequences of GABEB mutations on the assembly and stability of the BP180 triple helix 
C Fu,1 F Van den Bergh1 and GJ Giudice1,2 1 Dermatology, Medical College of Wisconsin,
Milwaukee, WI and 2 Biochemistry, Medical College of Wisconsin, Milwaukee, WI
BP180 (type XVII collagen) is a key component of the hemidesmosome and a member of the col-
lagen protein family. BP180 is a transmembrane protein with a long carboxy-terminal collagenous
domain. The purpose of this study was to investigate the structural consequences of the following
BP180 mutations associated with the GABEB phenotype: a) an arginine to glutamine substitution
(R1303Q) in non-collagen domain 4 (NC4); b) a 2-bp deletion (4003delTC) in the coding region of
NC4 which results in a frame-shift and premature termination codon; c) a 2-bp insertion in the cod-
ing region of COL3 (delTC-insGG) that restores the frame-shift of 4003delTC. While most known
GABEB-associated BP180 mutations are of the null type, the R1303Q mutant isoform has been
found to be stably expressed in the patients’ skin. Also previously published, the 4003delTC protein
is not detectable in the skin of GABEB patients; however, in one such patient, there is focal expres-
sion of delTC-insGG in a pattern indicative of revertant mosaicism. In this mutant protein, the stretch
of 25 amino acids spanning the two mutation sites are substituted with amino acids encoded by the
shifted reading frame. To carry out this study, recombinant forms of the BP180 extracellular domain
containing these GABEB-associated mutations were generated using a mammalian expression sys-
tem. These proteins were structurally compared with the wild type protein (sec180e). Cross-link
analysis showed that, like sec180e, all three of the mutant proteins formed stable homo-trimers. By
gel filtration, the three mutant trimers had Stoke’s radii indistinguishable from that of sec180e. The
three mutant recombinant proteins were shown to be resistant to proteolysis, and each of the melt-
ing temperatures fell within the range of 40-46°C. Taken together, these results indicate that protein
structure and stability is not significantly affected by any of these mutations, but rather suggest that
the resulting GABEB phenotype is due to alterations in protein function. 
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CD95/FAS enhancer mutations in mycosis fungoides: a potential mechanism for the acquisi-
tion of tumor clone resistance to apoptosis 
J Siddiqui1,2 and GS Wood1,2 1 Dermatology, UW, Madison, WI and 2 VAMC, Madison, WI
Early MF has many features suggesting it may be predominantly a lymphoaccumulative disorder
rather than a lymphoproliferative disorder. FAS plays a central role in T-cell apoptosis. To deter-
mine the status of FAS genes in MF, we analyzed its 9 exons and selected promoter regions in 12
cases (stages IB-IVA). Using a combination of single stranded conformational polymorphism analy-
sis, DNA elution, restriction enzyme digestion, PCR and nucleotide sequencing, we detected FAS
mutations in 9/12 cases (75%) including six with enhancer mutations, one with enhancer and exon
9 mutation, one with exon 3 and 9 mutation and one with exon 4 mutation. Thus while only 25% of
cases contained coding mutations, a much larger 58% harbored enhancer mutations. We then used
genomic PCR and nucleotide sequencing to assess the enhancer region in additional MF cases. 3/5
showed mutations. Thus the overall prevalence of enhancer mutations was 10/17 (59%). Some of
these mutations fell within known| transcription factor binding sites including GAS (−869) and GABP
(−857, −856, −827). A previously reported polymorphism at −670 within a GAS binding site, was
observed in 4/17 cases (24%). The abnormal FAS proteins resulting from the coding mutations are
predicted to act in a dominant negative manner to impair apoptosis. The enhancer mutations were
clustered in “hot spots” where two or more cases had mutations: −856(2),−810(2), −691(4) and −
626 (3). Because enhancer mutations typically result in diminished function, we hypothesize that
these mutations reduce FAS transcription. This has been proven previously for some GABP and
AP1 sites in the FAS enhancer. Thus the majority of MF cases are likely to have impaired apopto-
sis due to reduced and/or structurally abnormal FAS. The enhancer mutations are particular interest
because they provide a novel genetic mechanism by which a MF tumor clone could acquire resist-
ance to apoptosis via somatic mutations in FAS transcriptional regulatory elements that do not
affect FAS protein structure but do down-regulate its synthesis. 
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Type 2 segmental Hailey-Hailey disease originating from early loss of heterozygosity: molec-
ular confirmation of a novel genetic concept
P Poblete-Gutierrez,1 T Wiederholt,1 A Koenig,2 FK Jugert,1 Y Marquardt,1 HF Merk,1 R Happle2
and J Frank1 1 Dept. of Dermatology and Allergology, University Clinic of the RWTH, Aachen,
Germany and 2 Dept. of Dermatology, Philipp University, Marburg, Germany
Hailey-Hailey disease (HHD) (OMIM 169600) is an autosomal dominant trait characterized by ery-
thematous and oozing skin lesions preponderantly involving the body folds in a symmetrical fash-
ion (diffuse phenotype). In the present unusual case, however, unilateral segmental areas along the
lines of Blaschko showed a rather severe involvement superimposed on the ordinary symmetrical
phenotype. This observation, next to similar ones in various other dominantly inherited cutaneous
disorders, prompted one of us to postulate a novel genetic concept for autosomal dominant skin dis-
eases in which two different forms of segmental involvement can be distinguished. The type 1 man-
ifestation reflects heterozygosity for a de novo postzygotic somatic mutation occurring at an early
stage of embryogenesis thus representing a true cutaneous mosaicism. The cutaneous lesions within
the affected segments reveal a degree of severity that is similar to the clinical expression of the dif-
fuse phenotype caused by a germline mutation. In contrast, the type 2 segmental manifestation would
result from loss of heterozygosity (LOH) occurring in a heterozygous embryo at an early develop-
mental stage, giving rise to an area of homozygous or hemizygous tissue clinically showing rather
pronounced segmental lesions. Accordingly, the linear lesions of the aforementioned patient would
represent a type 2 segmental manifestation of HHD. Using PCR based techniques, we initially detected
a splice site mutation in the germline giving rise to the ordinary symmetrical phenotype. Upon study-
ing whole skin fragments and primary as well as cultured keratinocytes from the segmental lesions
by haplotype analysis, real-time PCR and DNA sequencing we were then able to demonstrate LOH.
Our data for the first time confirm the hypothesis for type 2 segmental skin diseases on the cellular
and molecular level. 
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The ATP2C1 golgi ATPase is required for Ras-driven human epidermal neoplasia
R Kimmel2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA and 2 Stanford, Stanford, CA
Physiologic calcium levels regulate epidermal adhesion and differentiation and are particularly impor-
tant for the formation of intercellular junctions, including desmosomes. Although it is known that
desmosomal protein levels correlate with the malignant potential of epithelial neoplasias, and that
decreased cell adhesion is implicated in tumor invasion and dissemination, the role of calcium home-
ostasis and calcium-dependent adhesion in carcinogenesis has not been clearly demonstrated. Muta-
tions in ATP2C1, which regulates calcium uptake into the golgi, result in altered intracellular cal-
cium regulation and Hailey-Hailey disease, a dominantly inherited blistering disease characterized
by disrupted keratinocyte adhesion, as evidenced by epidermal acantholysis. In order to study the
effects of disrupted calcium homeostasis and calcium-regulated adhesion in epidermal tumorigen-
esis, we compared the neoplastic potential of primary human Hailey-Hailey keratinocytes to a panel
of cells from normal patients. To do this, we co-expressed Ras with the NF-kB inhibitor IkBa in an
approach established to produce invasive epidermal neoplasia indistinguishable from squamous cell
carcinoma (SCC) when human tissue grafted is to immune-deficient mice. While it led to invasive
carcinoma after 2-4 weeks in normal human epidermis regenerated on scid mice as previously reported,
Ras-IkBa co-expression in APT2C1 mutant epidermal tissue from Hailey-Hailey patients (n=3 unre-
lated patients, with triplicate independent grafts) showed acantholysis and blistering, but no neo-
plastic invasion or even hyperplasia over that time period. Moreover, the elevated mitotic index
observed in response to Ras-IkBa in ATP2C1 wild-type tissue was absent in ATP2C1 mutant tissue.
These studies indicate that disordered calcium homeostasis and calcium-regulated adhesion can
inhibit epidermal tumorigenesis and identify disruption of calcium regulation as a potential thera-
peutic target in epidermal neoplasia. 
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Upregulation of the involucrin gene as a response to increased Ca2+ concentration is impaired
in Hailey-Hailey keratinocytes
E Racz, MJ Behne, I Aronchik and T Mauro Dermatology, University of California, San Francisco,
San Francisco, CA
Benign familial chronic pemphigus (morbus Hailey-Hailey, HHD) is a rare hereditary condition char-
acterized by development of blisters at sites of friction and in the intertriginous areas. Mutations in
the ATP2C1 gene have been verified in the background of the disease. Normal and HHD keratinocytes
were cultured in 0.07 mM Ca2+, then increased to 1.2 mM Ca2+ to stimulate the synthesis of
involucrin, a major cytoplasmic protein precursor of the cell envelope and a well established marker
of early keratinocyte differentiation. Involucrin protein levels were determined using Western blot-
ting. HHD keratinocytes synthesized less involucrin than did normal keratinocytes, while filaggrin
synthesis levels were comparable. This decoupling of Ca2+-induced signaling also has been reported
when intracellular Ca2+ stores were depleted with Thapsigargin. In order to investigate the mecha-
nism of impaired involucrin protein synthesis, we tested whether the Ca2+ -induced rise in involu-
crin mRNA was blunted in HHD keratinocytes. Involucrin mRNA levels were compared with SYBR
Green quantitative PCR. The increase in the involucrin mRNA copy number as a response to increased
Ca2+ concentartion was higher in healthy adult keratinocytes than in HHD keratinocytes. We con-
clude that the higher baseline cytoplasmic Ca2+ level and the alterations in the Ca2+ signaling as a
consequence of the Golgi Ca2+ATPase dysfunction results in an impairment of the early keratinocyte
differentiation. This impairment may be due to a decrease in the AP-1 promoter activity. 
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A novel function for p53w/w in DCoH/HNF-1α transcription and its regulation by H2O2
S Kothari,1 SM Picksley,2 JM Wood1 and KU Schallreuter1 1 Clinical and Experimental
Dermatology, Department of Biomedical Sciences, University of Bradford, Bradford, West
Yorkshire, United Kingdom and 2 Biomedical Sciences, University of Bradford, Bradford, West
Yorkshire, United Kingdom
Recently, it has been shown that the human epidermis holds the capacity for DCoH/HNF-1α tran-
scription in melanocytes and keratinocytes. In this context, tyrosinase was recognised as a new tar-
get gene. Using the in vivo model vitiligo, it has been demonstrated that 10-6 M concentration of
hydrogen peroxide (H2O2) upregulated DCoH/HNF-1α. Since p53w/w is also upregulated by 10-6 M
concentration of H2O2, we here asked the question, whether p53
w/w could possibly regulate HNF-
1αtranscription. Analysis of the p53 DNA-binding sequence yielded the putative binding site in the
HNF-1α gene promoter. Using electrophoretic mobility shift assay, we were able to demonstrate for
the first time the binding of p53w/w to the HNF-1α gene promoter. This result indicates that p53w/w
controls DCoH/HNF-1α transcription, including tyrosinase. Moreover, this result also supports the
importance of H2O2 in the regulation of this transcription pathway. 
532
Developing a mouse model of pachyonychia congenita
J Chen,1 Z Den,1 P Koch1,2 and DR Roop1,2 1 Molecular and Cellular Biology, Baylor College of
Medicine, Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
We have previously generated mice with a null mutation in the keratin 6a and 6b genes (MK6a/b-/-
mice). Most of these mice died due to lesions on the dorsal surface of the tongue, which severely
affected feeding. An analysis of these mice also led to the discovery of a third MK6 gene, which was
termed MK6hf. Expression of this protein most likely compensated for the loss of MK6a and MK6b
in skin appendages, in particular hair follicles and nails, and thereby prevented a gross phenotype
in these tissues. To analyze the function of MK6hf in skin appendages, we introduced a dominant-
negative mutation into this gene using mouse embryonic stem cell technology. The mutation, a dele-
tion of asparagine residue 159 in MK6hf, corresponds to the deletion of N171 in the human K6a
gene in Pachyonychia Congenita (PC-1) patients. Transfection experiments demonstrated that expres-
sion of this mutant MK6hf protein leads to a collapse of the intermediate filament cytoskeleton of
cultured epithelial cells. Mutant mice developed a severe hair loss and nail atrophy phenotype sim-
ilar to PC patients. On the basis of these results, we conclude that MK6hf is essential for maintain-
ing structural integrity of hair follicles and nails. We have also generated an inducible mouse model,
which allows focal activation of the mutant MK6hf allele. This model should be useful for studies
directed toward understanding the pathogenesis of PC and for assessment of novel therapeutic
approaches for this disorder. 
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Peroxisome proliferator activated receptor coregulator isolation from epidermal keratinocytes
AM Flores, LE Vasina and BJ Aneskievich Pharmaceutical Sciences, University of Connecticut,
Storrs, CT
Peroxisome proliferator (PP) control of epidermal keratinocyte gene expression and differentiation
is mediated through PP activated receptors (PPARs), members of the nuclear receptor (NR) super-
family of ligand-activated transcription factors. NR function is also governed by coregulator pro-
teins that contribute to either activation or repression of NR-mediated gene transcription. To better
understand PPAR function in keratinocytes, we sought to identify coregulator proteins present in
these cells, define the basis for their interaction with PPAR, and examine their activating or repress-
ing effect on PPAR function. We screened a human keratinocyte cDNA library using the carboxyl
portion of human PPARalpha as bait in a yeast two-hybrid assay. The screen yielded known PPAR-
interacting proteins such as TRAP220, SMRT and RXR. In addition, a new candidate coregulator
was represented nine times among the positive clones. The partial cDNA clones from the screen and
the full-length version interact with PPARs in an isoform-specific fashion. The new coregulator
contains LXXLL (L, leucine; X, any amino acid) domains known in other NR coregulators to medi-
ate interaction with receptors’AF-2 domain. Site directed mutations of the LXXLL or AF-2 domains
significantly decrease interaction of the new coregulator and all three PPARs. In transient transfec-
tions, coexpression of the coregulator clone affects PPAR function at defined PP response elements.
Subcellular localization of the endogenous coregulator protein varies with keratinocyte culture con-
ditions. In epidermis, its distribution is consistent with a differentiation-associated expression pat-
tern. Given these results and its interaction with PPARs, we expect this newly identified nuclear
receptor coregulator may play a role in regulating epidermal keratinocyte response to peroxisome
proliferators.
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Tetracycline-regulated transactivators driven by the involucrin promoter to achieve epider-
mal conditional gene expression
J Segre GMBB, NHGRI/NIH, Bethesda, MD
To achieve conditional gene expression in the differentiated layers of the epidermis, we generated
transgenic mice in which the tetracycline-regulated transactivator proteins, tTA and rtTA, are expressed
from the involucrin promoter.  Interaction with tetracycline turns off or on the tTA and rtTA mole-
cules, respectively, allowing for regulation of downstream target genes during development and post-
natally. These transactivator lines were crossed with reporter mice driving LacZ expression from a
tetracycline response element to analyze the specificity and levels of target gene expression. Quan-
titative b-galactosidase experiments demonstrate a 30 fold level of induction when the lines are
induced specifically in epithelial tissues. Immunohistochemistry results illustrate that the b-galac-
tosidase staining follows that of the endogenous involucrin promoter. We characterize the expres-
sion of these lines during development showing that induction initiates at embryonic day 14.5 with
expression over the entire epidermal surface by day 16.5. Together with other driver lines, express-
ing the tetracycline transactivators in the mitotically active layers of the epidermis, these mice will
allow investigators to specifically modulate the expression of their target genes to specific stages of
epidermal differentiation. 
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Identification of a recurrent frameshift mutation in the hairless gene in a patient with atrichia
with papular lesions
H Lam,1 A Martinez-Mir,1 A Zlotogorski,3 M Geraghty4 and AM Christiano1,2 1 Dermatology,
Columbia University, New York, NY, 2 Genetics & Development, Columbia University, New York,
NY, 3 Hadassah Medical Center, Jerusalem, Israel and 4 Childrens Hospital Eastern Ontario,
Ottawa, ON, Canada
Identification of mutations in the hairless genes in patients with atrichia with papular lesions (APL)
has proven of chief importance because it provides a basis for the differential diagnosis between APL
and alopecia universalis. The definition of the diagnosis criteria of APL (Zlotogorski et al, 2002)
has triggered the identification of a large number of APL patients among those suspected to suffer
from alopecia universalis, and treated accordingly with consistent negative outcomes. This has resulted
in an increasing number of hairless mutations in both consanguineous and non-consanguineous APL
families. We report the identification of a homozygous mutation, 3435delC, in an APL patient of
Arab-Palestinian descent. The proband is a 23-year-old female with generalized scalp and body alope-
cia and absent eyelashes and eyebrows. Soon after birth, she lost all her scalp hair, which never
regrew. At present, she has a papular rash on her arms and legs that started at 3 years of age. The
proband belongs to a consanguineous family (first cousin parents) and no history of hair loss (both
parents and her two sisters are unaffected). In order to confirm the diagnosis of APL and to identify
the specific mutation, we sequenced the hairless gene. We first excluded the presence of the muta-
tion 2147delC, previously described in five Arab Palestinian families (Zlotogorski et al, 1998).
Sequencing of the remaining exons in the hairless gene revealed a homozygous frameshift muta-
tion, 3434delC, in exon 18. Interestingly, the same mutation was previously identified in an Arab-
Israeli family (Sprecher et al, 1999). As is the case for the 2147delC mutation, the data presented
here suggest that the 3434delC mutation most likely represents a founder mutation in this geographical
region. In summary, these findings extend the body of evidence implicating hairless gene mutations
in the pathogenesis of APL. 
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Stable intergration of telomerase in human fibroblasts permits non-malignant growth trans-
formation in vitro that maintains transgene expression in vivo
CM Jorgensen, T Tandeski, M Chen and GG Krueger Dermatology, University of Utah, Salt Lake
City, UT
Genetically modified human fibroblasts (GMFb) lose integrated transgene expression (TGE) in nude
mice in vivo. TGE/S in vivo is modulated by the ECM surrounding the GMFB and the inherent life-
span of the GMFb; inherent life-span = greater effect. GMFb cloned for TGE in a nylon matrix in
vivo are gone by 12 weeks unless transduced with human telomerase (hTERT) via a retroviral vec-
tor (rv). These senescence protected GMFb were cloned and assessed for survival in vitro via pas-
sage. One of the hTERT clones underwent a second transformation, > passage 50, past the passage
limit of normal fibroblasts, < 25 . This GMFb grows more rapidly than other clones transduced with
hTERT. These growth modified GMFb were transduced with lacZ.rv and seeded into a nylon matrix
that had been matured in vivo, transplanted to nude mice, recovered at regular intervals for 16 weeks,
and assessed for TGE/S. The GMFb that have undergone the growth transition have TGE/S that far
exceeds that of all other GMFb sources tested. Two clones that did not undergo growth transforma-
tion process displayed TGE/S of normal transduced GMFb. The experiment was repeated with GMFb
encoded with human transferrin (hTf). This construct shows detectable blood levels as long as the
GMFb.hTf are viable. At 4 weeks hTf levels from non-growth modified cells was 4 x less than growth
modified cells. By 16 weeks there was a 50 x difference, respective deterioration and increased lev-
els in the non-growth modified and growth modified constructs. In contrast to immortalized 3T3 cells
carrying hTf, which form tumors in vivo by week 8, no tumors were seen in the growth modified
constructs in this 20 week experiment. Microarray analysis of message of two senescence protected
growth modified fibroblasts vs two cell lines from the same source that have not undergone growth
modification are substantive. It appears that over-expression of hTERT permits further non-malig-
nant growth modification and that transgene survival and expression is preserved in vivo by these
cells.
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Expression profiling of genes regulated by keratinocyte growth factor in immortalized human
keratinocytes
PS Gill,2,1 CM Jorgensen,1 DM Dunn,3 R Weiss3 and GG Krueger1 1 Dermatology, University of
Utah, Salt Lake City, UT, 2 Medicine, University of Utah, Salt Lake City, UT and 3 Human
Genetics, University of Utah, Salt Lake City, UT
Keratinocytes growth factor (KGF) a member of the fibroblast growth factor (FGF-7) family, and is
strongly expressed at the wound edge after injury. A keratinocytes model system with KGF under
TCN regulation will help us better understand gene expression profile in wound healing process. The
aim of this study was to identify possible gene targets for regulation by KGF in immortalized human
keratinocytes (IMKc). In this study, IMKC were transduced with retroviral vectors of RetroTet-Art
system carrying human KGF cDNA. RT-PCR and real time PCR analysis show regulatable KGF
expression. To identify candidate and novel gene expression patterns, we compared the gene expres-
sion profile of IMKc-hKGF( /-) cells using Affimytrix chip (Human Genome U133 Plus 2.0) carry-
ing 47,000 gene transcripts. Samples with and without doxycycline were run in duplicate and showed
identical clustering pattern. We identified by SAM analysis 42 up-regulated and 2 down-regulated
genes with a significant differential regulation (p<0.05). This study validated the expression pat-
terns for known genes like Activin, Nrf2 and Cox-2. A plausible model of gene interaction (by Path-
wayAssist) is put forth for KGF mediated response in keratinocytes. Most notable were the cascade
of cytokines (vascular endothelial growth factor,tumor necrosis factor SF10, epidermal growth fac-
tor receptor, and diptheria toxin receptor) as they work in a network-fashion. The effect of KGF was
also noticeable for genes involved in adhesion and extracellular matrix (integrin B5, collagen type
XVIII A1, plasminogen activator urokinase and matrix metalloproteinase 14). This up-regulated net-
work of novel gene transcripts could play possible role in understanding the molecular mechanisms
of gene regulation in cell proliferation and /or re-epithelialization in wound healing process. 
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The R683W common mutation occurs in xeroderma pigmentosum group D patients with and
without neurological symptoms
T Ueda,1 V Gonzalez,1 SG Khan,1 K Oh,1 K Imoto,1 T Shahlavi,1 H Inui,1 D Busch,2
JJ DiGiovanna1,3 and KH Kraemer1 1 Basic Research Laboratory, National Institutes of Health,
Bethesda, MD, 2 AFIP, Washington, DC and 3 Derm, Brown Med School, Providence, RI
Xeroderma pigmentosum (XP) is an autosomal recessive disease with markedly increased suscep-
tibility for sun-induced skin cancer in association with defective DNA repair. There are 7 XP nucleotide
excision repair (NER) genes (XPA-XPG) and an XP variant (pol-eta). XPD is a helicase involved in
NER and also in transcription as a member of the basal transcription factor complex, TFIIH. Sur-
prisingly, defects in the XPD gene result in 6 different clinical phenotypes: XP, XP with neurologi-
cal disease, the XP/Cockayne syndrome complex, trichothiodystrophy (TTD) (a disorder with brit-
tle hair without increased cancer susceptibility), XP/TTD and cerebro-ocular-facial-skeletal (COFS)
syndrome. The molecular basis for this phenotypic heterogeneity is not known. We analyzed cells
from patients with reduced post-UV cell survival and used a plasmid host cell reactivation (HCR)
assay to assign 22 cell lines to XP complementation group D. Of these there were 18 XP, 2 XP/CS,
1 TTD, and 1 XP/TTD patients. We found the same R683W mutation in exon 22 of the XPD gene
in 14 (78%) of the 18 XP but not in any of the TTD, XP/TTD or XP/CS patients. The R683W muta-
tion was homozygous or hemizygous in one and heterozygous in 13 XP patients. XP neurological
disease is progressive and may not be manifest in children. We focused on the 7 adult XP-D patients
who were compound heterozygotes for R683W and another allele; 5 had severe neurological dis-
ease and 2 had a normal neurological examination. We plan to test the contribution of the second
allele to the genotype-phenotype correlation by using site directed mutagenesis to create XPD cDNA
sequences containing these mutant alleles and test their DNA repair activity in the HCR assay. 
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The hairless promoter is differentially regulated by thyroid hormone in keratinocytes and neu-
roblastoma cells
A Engelhard,1 M Zhang1 and C Angela1,2 1 Dermatology, Columbia University, New York, NY and
2 Genetics and Development, Columbia University, New York, NY
The hair cycle is an extraordinarily complex process relying on spatially and temporally coordi-
nated intercellular signaling, cell division and death, cell migration, and gene expression. The hair-
less gene, whose mutation is responsible for the hairless phenotype in mice and atrichia with papu-
lar lesions in humans, is expressed with hair cycle-dependent kinetics. A thyroid hormone responsive
element previously identified in the rat hairless promoter confers T3 responsiveness to promoters in
front of which it is placed. However, prior studies have not focused on the hairless promoter itself.
We have cloned the hairless promoter, and here we show that hr promoter activity is transactivated
by T3 in neuroblastoma cells, but not keratinocytes. Therefore, while T3 can have a significant role
in neuronal cell type-specific expression of hairless, upregulation in skin is T3 independent. The inhi-
bition of promoter activity by TR and T3 in keratinocytes is nonspecific and TRE independent. Fur-
thermore, hr is subject to cell type-specific negative autoregulation, inhibiting activity of its promoter
in keratinocytes but not neuroblastoma cells. These findings illustrate a molecular distinction between
the disparate phenotypes caused by thyroid hormone dysregulation and hairless gene mutation. 
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Microarray analysis of gene expression between human CD45RA+ and CD45RO+, CD4+ T
cells
HK Wong, M Hafner and A Wilson Dermatology, Henry Ford Health System, Detroit, MI
Memory T cells induce a greater immune response on re-encounter with an antigen than naive T
cells. Memory T cells express a higher level of cytokines and effector functions. In the human
CD4+ T cell subset, the genes that are differentially expressed in memory T cells are not well iden-
tified. CD4+ T cells can be separated by CD45RA+ for the naive subset and CD45RO+ for the
memory subset. Using these markers, cells were separated for analysis of differential gene expres-
sion between naive and memory T cells. CD45RA+ and CD45RO+ CD4+ cells were purified by
magnetic separation to greater than 95% purity. These were stimulated so that differences in genetic
response between unactivated and activated naive, and unactivated and activated memory popula-
tion could be examined. Highly purified total RNA was isolated and high density oligonucleotide
microarray (Affymetrix) was used to analyze for gene expression differences between naive and
memory T cell subsets. This study revealed genes that were: 1) differentially expressed between naive
and memory T cells at rest, 2) differentially induced between unstimulated and stimulated cells of
the same cell type, and 3) differentially expressed between the stimulated naive and stimulated mem-
ory T cells. For example, a gene known to be expressed higher in the naive population, such as CCR7,
was identified in the naive population. After stimulation, the memory cells showed increased cytokine
expression for IL-2, IL-4 and IFN-gamma in comparison to the stimulated naive cells, indicating
the memory cells functioned as expected for the memory subset. Overall, the study showed that there
were a greater number of genes expressed higher in the memory subset than in the naive subset. A
subset of the differentially expressed genes identified by microarray were confirmed additionally by
RT-PCR. The differences in gene expression should provide insight into the molecular differences
between naive and memory T cells and should lead to understanding of signals and factors that reg-
ulate the development of memory T cells. 
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Apoptotic signaling pathways in Darier’s disease keratinocytes
I Aronchik,1 E Racz,1 L Li,2 M Behne1 and T Mauro1 1 Dermatology, UCSF, San Francisco, CA
and 2 University of Texas Southwest Medical School, Dalls, TX
Darier’s disease (DD) is a rare autosomal dominant disease caused by a mutation of the ATP2A2
gene, encoding the SERCA2 Ca2+ ATPase. The ATP2A2 is localized to the endoplasmic reticulum
of cells and is important in Ca2+ -induced Ca2+ signaling, which controls essential keratinocyte
functions such as differentiation, motility and cell-to-cell adhesion. Previously, we have shown that
Golgi Ca2+ stores, controlled by a similar Ca2+ ATP’ase ATP2C1, are essential for normal Ca2+
signaling and that mutations in the ATP2C1 cause the similar acantholytic disorder Hailey Hailey
disease. However the distinctive feature of Darier’s disease is apoptotic modification of cells carry-
ing DD mutation. To further investigate this feature we compared the levels of apoptosis-associated
proteins, such as caspase 2, BAK, BAX and PARP in healthy human keratinocytes and DD ker-
atinocytes in cell culture. Here we report that the levels of PARP and caspase 2 proteins are elevated
in DD keratinocytes, and the cleavage of both molecules is distinct from that of normal keratinocytes.
The levels of BAK and BAX do not show significant changes in this disease. We have also investi-
gated the role of ATP2C1 Golgi Ca2+ ATPase in regulating Ca2+ in DD keratinocytes. Our findings
suggest that the levels of ATP2C1 are upregulated in DD cells. We are further investigating the pos-
sible translocation of ATP2C1 to the ER in order to compensate for the loss f ATP2A2 function as
the consequence of DD mutation. To locate ATP2C1 within the cellular compartments we employed
the method of Opti-Prep gradient with slight modifications. The gradient allows the separation of
the ER and Golgi, detected by SDS-PAGE analysis of the fractions, and allows for localization of
molecules associated with specific organelles. 
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Expression of bone morphogenetic protein-5 in epidermis and hair follicles of the mouse
EA Stepanova and RJ Morris Dermatology, Columbia University, New York, NY
Bone Morphogenetic Proteins (BMP) and their receptors (BMPR) are members of the Transform-
ing Growth Factor-Beta family of signaling molecules that play an essential role in a variety of mor-
phogenetic processes. Although BMP-2 and -4 expression is known to function in the patterning
and cycling of hair follicles, BMP-5 has been understudied. Therefore, the purpose of this investi-
gation is to characterize BMP-5 messenger RNA and protein expression in mouse skin. RT-PCR
and Western blot analysis were used to detect BMP-5 transcripts and protein, respectively. Immuno-
fluorescence was performed to localize the expression of BMP-5 and BMPR-1A in mouse skin. We
detected BMP-5 messenger RNA and protein in freshly harvested epidermal cells including ker-
atinocytes from the hair follicle bulge isolated by fluorescence activated cell sorting with antibod-
ies directed against alpha-6 integrin and CD34. Immunofluorescence microscopy revealed that BMP-
5 and its receptor localized to the basal layer of the epidermis and outer root sheath of the hair follicles,
including the bulge region throughout the hair growth cycle. These expression studies enable fur-
ther functional analyses of BMP-5 both in vivo and in vitro. We conclude that, like BMP-2 and -4,
BMP-5 may play a role in epidermal growth and morphogenesis. The significance of this work is
that identifying genes responsible for the homeostasis, proliferation, and differentiation of keratinocyte
stem cells would make an important contribution to cancer research and therapy, as well as tissue
engineering and replacement. 
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Analysis of gene expression in primary T cells by radio-frequency (RF) electroporation
C Hedgcock, A Wilson and HK Wong Dermatology, Henry Ford Health System, Detroit, MI
Efficient DNA transfer into primary cells is essential for success in gene therapy, dissecting the func-
tion of gene products, and analyzing the mechanisms of gene regulation in normal cells. Expression
of exogenous DNA in primary lymphocytes has been approached by transduction using viral vec-
tors and by DNA transfection. Viruses have the advantage of efficient gene transfer, but construc-
tion of viruses is inefficient and laborius, thereby rendering high thruput analysis prohibitive. Lipo-
some mediated DNA transfer has been valuable for many cell types, but has not been successful for
primary peripheral blood cells. We describe the optimization of transfection method into primary T
cells using RF electroporation, whereby electrical parameters are precisely controlled.  This approach
permits precise control of voltage, pulse duration, number of pulses, frequency and modulation of
waveform for electroporation. Peripheral blood leukocytes (PBL) were isolated, prepared and the
cells were electroporated after 20 to 24 hours. The green fluorescent protein (GFP) reporter gene
was used to monitor expression of transgene. Using this approach, transfection efficiencies of up to
40% of live cells was achieved with PBL as quantitated by flow cytometry. Expression of GFP was
rapid and could be measured as early as 6 hours after electroporation. These conditions were used
to transfect reporter plasmids for analysis of luciferase expression to measure promoter activity in
T cells. To determine whether all T cell subsets were transfected with equal efficiencies, CD4 and
CD8 cells were separated by magnetic sorting and purified cells were transfected. We found that for
T cells, the CD4 subset was transfected with a higher efficiency than the CD8 subset. Furthermore,
we were able to transfect PBL from patients with mycosis fungoides. The ability to successfully elec-
troporate and analyze gene expression in primary T cells should lead to direct understanding of mech-
anisms of gene expression in normal and abnormal T cells. 
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Inhibition of adenine nucleotide translocator function in the skin of transgenic mice
FQ Zhan1,2 and JE Sligh1,2 1 Division of Dermatology, Department of Medicine, Vanderbilt
University Medical Center, Nashville, TN and 2 VA Tennessee Valley Healthcare System, Nashville,
TN
The adenine nucleotide translocators (ANTs) exchange ADP for ATP across the inner mitochondr-
ial membrane and regulate apoptosis through the mitochondrial permeability transition pore (mtPTP).
Mice have two ANT isoforms: ANT1 found in heart, muscle, and brain and ANT2 found in all tis-
sues except muscle. To examine the role of ANT in the skin, we selectively ablated Ant2 in the epi-
dermis of transgenic mice. The Ant2 gene was targeted in murine embryonic stem cells using the
Cre/Lox strategy, and these cells were injected to generate transgenic mice harboring the floxed Ant2
allele. These mice were mated to mice expressing Cre recombinase under the control of the keratin
5 promoter, which targets the transgene expression to basal keratinocytes. This Cre recombinase is
activated in the presence of 4-hydroxy tamoxifen (OHT). We induced the Cre-mediated excision of
the Ant2 gene using topical OHT dissolved in two different vehicles: ethanol-sunflower oil (ETS)
and dimethyl sulphoxide (DMSO). Topical OHT was applied to shaved back skin of homozygous
and hemizygous Ant2 floxed/Cre mice once daily for 5 days to activate Cre recombinase. We observed
cutaneous inflammatory changes both at the OHT administration site as well as at remote sites, espe-
cially in the ears. One to two weeks following administration of the OHT-ETS preparation, the skin
showed interface dermatitis and focal epithelial necrosis, followed by keratinocyte hyperprolifera-
tion, and focal micro-abscess formation. We also observed severe weight loss and death in mice
treated with OHT dissolved in DMSO 8 to 10 days after drug application. Although topical OHT
treatment was localized to mouse back skin, the presence of weight loss, death, and inflammation
at sites remote from drug application indicates either a systemic absorption of drug or a systemic
response triggered by local administration of drug. Whether these changes are a result of energy
depletion or of alterations of apoptosis through mtPTP is currently under investigation. 
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The wnt pathway effector, Lef-1, regulates human hairless gene expression
A Engelhard,1 RC Bauer1 and AM Christiano1,2 1 Dermatology, Columbia University, New York,
NY and 2 Genetics and Development, Columbia University, New York, NY
The hairless gene encodes a putative zinc-finger transcription factor whose expression is predomi-
nately limited to the developing brain and to skin, where it is expressed in a hair-cycle dependent
manner. The mechanisms coordinating the kinetics of hr gene expression remain largely undefined.
Recently, we showed that a previously identified thyroid hormone responsive element in the human
hr gene is responsible for transactivation of hr gene expression by thyroid hormone in the neurob-
lastoma cell line, SY5Y, but not in primary human keratinocytes or the HaCaT human keratinocyte
cell line, thereby repudiating a role for T3 in the hairless pathway in skin. Scanning of the promoter
sequence for alternative DNA consensus binding sites revealed the presence of 9 putative lef-1
binding sites downstream of the TRE which have a 1bp deviation the canonical lef-1 binding site
and one putative binding site 386bp upstream of the hr mRNA cap site that is a perfect match. To
test the hypothesis that hr is a wnt target gene, expression constructs of the wnt pathway genes
wnt1, beta-catenin, and lef-1 were cotransfected into neuroblastoma cells with hr promoter reporter
constructs or a luciferase reporter driven by 7 upstream concatenated lef-1 binding sites. Here, we
show that hr expression is transactivated by co-expression of wnt pathway genes along with hr-
luciferase reporter genes in SY5Y cells. Furthermore, we show that upregulation of hr expression is
lef-1 dose dependent. Finally, we demonstrate that T3-dependent and lef-1-dependent transactiva-
tion are not synergistic. These findings identify a second pathway in which the hr gene is a down-
stream effector of an extracellular signal. 
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Reporter gene transfer into primary keratinocytes with a parvovirus vector
IH Maxwell, F Maxwell and K Terrell Dermatology and Cancer Center, Colorado Health Sciences
Center, Denver, CO
Parvoviruses are small, non-enveloped viruses which contain a 5 kb single strand DNA genome. We
have previously described vectors based on LuIII, an autonomous parvovirus of the rodent group,
able to infect human cells. The rodent autonomous parvoviruses preferentially replicate in malig-
nantly transformed cells and they have generally been considered only poorly able to infect normal
cells (e.g. fibroblasts) in primary culture. Surprisingly, we have observed efficient transduction of
human primary keratinocytes (KCs) by LuIII vectors carrying luciferase (LUC) or enhanced green
fluorescent protein (eGFP) reporter genes. Previously, we observed high levels of LUC expression
after transduction of several human melanoma and other malignant cell lines but observed much
lower expression in diploid fibroblasts and other primary cell cultures. However, each of several
independent isolates of foreskin KCs showed high expression of LUC and eGFP (up to approx. 30%
of the cells, depending on viral titer) after transduction with these vectors (using parvoviral or CMV
promoters). Frequent green fluorescent cells were seen in the transduced KC cultures for at least 2
weeks. Experiments in progress with tetracycline-inducible LuIII-eGFP vectors should determine
whether the transduced KCs support long-term transcription from the vectors (as opposed to per-
sistence of the stable eGFP reporter protein). In contrast with primary cultures, we observed that
immortalized lines of human KCs (HaCaT and IMKc) were transduced only relatively inefficiently
by LuIII vectors. The reasons for this difference are under investigation. Our results suggest that
autonomous parvovirus vectors may be useful for ex vivo, and possibly in vivo, transduction of KCs
in skin for gene transfer and gene therapy applications. We thank Gary Bellus and Desiree Kelly
(UCHSC) for primary cultures and Prit Gill (Univ. Utah) for IMKc cells. 
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p16 mutational status influences responses to T-oligo-simulated DNA damage
PA Porter-Gill,1,2 HM Erickson,1,2 MS Eller,3 SR Florell,1 BA Gilchrest3 and SA Leachman1,2 1
Dermatology, Univ of Utah, Salt Lake City, UT, 2 Huntsman Cancer Inst, Univ. of Utah, Salt Lake
City, UT and 3 Dermatology, Sch. of Medicine, Boston, MA
Cyclin-dependent kinase inhibitor 2A (p16) germline mutations are associated with a hereditary pre-
disposition to melanoma. A primary function of p16 is the induction of cellular senescence, but the
molecular mechanisms by which p16 mutations lead to melanoma susceptibility are poorly under-
stood. It has been shown that treatment with a DNA oligonucleotide homologous to the telomere 3’
overhang sequence TTAGGG (T-oligo) triggers DNA damage responses in normal neonatal fibrob-
lasts, including an S-phase arrest and induction of senescence. The purpose of our investigation was
to determine whether adult fibroblasts, derived from heterozygous carriers and non-carriers of a p16
mutation, respond to T-oligo in a similar fashion. Carrier and non-carrier fibroblasts were synchro-
nized prior to treatment with either 40 µM T-oligo or diluent control. Cells were harvested at 12, 24,
and 48 hours, stained with propidium iodide and analyzed for DNA content by flow cytometry. Por-
tions of the same cell populations were evaluated for senescence by staining for senescence-associ-
ated β-galactosidase (S.A. β-Gal) activity. Carrier and non-carrier fibroblasts both demonstrated S-
phase arrest of the cell cycle within 1-2 days, and also showed S.A. β-Gal staining by 48 hours. In
contrast, neonatal cells require 5 days to enter senescence. These data suggest that adult fibroblasts
may respond more quickly to telomere-based DNA damage triggers than neonatal fibroblasts. In
addition, it appears that the p16 mutation carriers re-enter the cell cycle more quickly and display a
less striking senescent phenotype than non-carriers. These data support the hypothesis that inheri-
tance of a p16 mutation leads to a diminished capacity to maintain S-phase arrest and enter a senes-
cent state in response to DNA damage. Over time, this propensity could potentially lead to an accu-
mulation of un-repaired DNA damage that may help to explain why mutations in p16 result in a
predisposition toward melanoma. 
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Single chain, variable fragment antibodies to the membrane bound cytochrome P450 CYP2B19
reveal preferential expression in stratified squamous epithelia at the environmental interface
L Du,3 R Mernaugh3 and DS Keeney1,2 1 VA Tennessee Valley Healthcare System, Nashville, TN, 2
Division Dermatology/Medicine, Vanderbilt University, Nashville, TN and 3 Biochemistry,
Vanderbilt University, Nashville, TN
Mouse Cyp2b19 encodes a keratinocyte-specific arachidonic acid monooxygenase expressed in dif-
ferentiated skin keratinocytes. We developed CYP2B19-specific recombinant antibodies to prove
that CYP2B19 is present in epidermal keratinocytes and thus likely responsible for endogenous
epoxyeicosatrienoic acid formation. CYP2B19-specific scFv antibodies interacted with keratinocyte
proteins (55 kDa), which were upregulated during in vitro differentiation. The specificity of these
binding interactions visualized on Western immunoblots was corroborated by the ability of CYP2B19-
specific scFv to capture native CYP2B19 in keratinocyte lysates, determined by mass spectrometry.
On Western immunoblots, CYP2B19-specific scFv antibodies also interacted with oral keratinocyte
proteins (55 kDa), the levels of which varied with the extent of epithelial keratinization in different
regions of the oral cavity. No interactions were detected with liver or eleven recombinant CYP pro-
teins. Cutaneous and oral epithelia interface the environment and function to protect against injury
and dehydration. Preferential expression in these stratified squamous epithelia implies functions for
CYP2B19 catalysis in the type of epithelial barrier formed at these sites. 
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The human K1 gene is regulated by cooperative interactions between multiple regulatory ele-
ments
H Sheng1 and DR Roop1,2 1 MCB, Baylor College of Medicine, Houston, TX and 2 Dermatology,
Baylor College of medicine, Houston, TX
One of the earliest events associated with keratinocyte differentiation is expression of keratin 1 (K1).
In an attempt to identify regulatory elements required for expression of the K1 gene, we initially
prepared a series of reporter constructs consisting of regions flanking the human K1 (HK1) gene.
These constructs were transfected into primary mouse keratinocytes, which were induced to differ-
entiate by increasing the calcium concentration of the medium. Site-directed mutagenesis experi-
ments, coupled with gel-retardation assays, identified a key binding site for AP-2 in the proximal
region of the HK1 promoter. In addition, critical binding sites for Sp1, NFκB and AP1 were found
at distal locations in both the 5’ flanking (Sp1 and NFκB ) and 3 ’ flanking (AP1) regions. Muta-
tions in any of these binding sites caused significant effects on HK1 reporter activity, suggesting
cooperative interactions between both proximal and distal elements. To determine the contribution
of these regulatory elements to both temporal and spatial expression of the HK1 gene in the epider-
mis, we have initiated in vivo studies in transgenic mice. Previous studies have shown that the expres-
sion of short transgenes can be influenced by sequences surrounding the site of integration. To min-
imize positional effects, we used a large BAC clone, containing the HK1 gene surrounded by 87 kb
of 5’ sequence and 117 kb of 3’ sequence. A lacZ reporter gene was inserted into this clone under
the control of the HK1 promoter. Site-directed mutagenesis was then performed for these transcrip-
tion factor binding sites using ET recombination and transgenic mice were then generated with each
BAC construct. The effects of these mutations on tissue- and differentiation-specific expression have
been assessed by β-gal staining of tissue sections, and the effects on expression levels have been
assessed by β-gal assays on skin extracts. Our in vivo results confirm that the HK1 gene is regulated
by complex cooperative interactions between multiple regulatory elements. 
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A novel dominant missense mutation of GJB6 (Cx30) causing KID syndrome with mild cuta-
neous phenotype
DI Wasserman, P Ratajczak, F Ringpfeil and G Richard Department of Dermatology & Cutaneous
Biology, Thomas Jefferson University, Philadelphia, PA
Dominant mutations of the connexin genes GJB2 (Cx26) and GJB6 (Cx30) have been associated
with a broad spectrum of clinical phenotypes involving ectodermal stratifying epithelia. Cx26 muta-
tions may cause Keratitis-Ichthyosis-Deafness (KID) syndrome, Vohwinkel syndrome, and hearing
loss associated with palmoplantar keratoderma or mucocutaneous erythema and hyperkeratosis. Cx30
mutations are responsible for Clouston syndrome, pachyonychia congenita-like nail dystrophy and,
in one case, KID syndrome with atrichia. In this study, we report an eight-year-old boy with con-
genital profound sensorineural hearing loss, palmoplantar keratoderma and symmetric erythroker-
atodermic plaques of the face, features characteristic of KID syndrome. Hair, nails, mucous mem-
branes and the anterior eyes were not involved. The localized facial plaques nearly vanished under
topical treatment with tacrolimus 0.1% ointment. 
In contrast to other KID syndrome patients, no pathogenic mutation was identified in GJB2. How-
ever, the patient harbored a heterozygous 176G>T transversion in GJB6 resulting in a glycine to
valine substitution at codon 59 of Cx30 (G59V). This previously unreported mutation was not detected
in either parent or in 112 control alleles. It affects a highly conserved residue in the second extra-
cellular domain that is invariably present in mammalian connexins. Replacement of the orthologous
residue in Cx26 with alanine has been shown to cause autosomal dominant hearing loss and pal-
moplantar keratoderma. Our finding is the second report of a GJB6 mutation resulting in a KID phe-
notype, which further underscores the genetic heterogeneity of this ectodermal dysplasia. Conse-
quently, we propose screening of multiple epidermal connexin genes, such as Cx26, Cx30, Cx31,
and Cx30.3 in patients presenting with hearing loss and cutaneous findings. 
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Autosomal dominant inheritance in pseudoxanthoma elasticum revisited
F Ringpfeil,1 K McGuigan,1 L Fuchsel,1 H Kozic,1 M Lebwohl2 and J Uitto1 1 Dermatology,
Jefferson Medical College, Philadephia, PA and 2 Mount Sinai School of Medicine, New York, NY
Pseudoxanthoma elasticum has long been considered the prototypic connective tissue disorder, which
occurs sporadically or follows either an autosomal dominant or autosomal recessive mode of trans-
mission. Mutations in the ABCC6 gene, encoding MRP6, an ATP dependent efflux pump in liver
and kidneys, have been causally linked to all types of PXE. Furthermore, molecular genetic analy-
sis of our patient cohort has previously established the inheritance pattern as autosomal recessive.
However, several clinical investigators have reported dominant inheritance in families with affected
individuals in two generations. Also, obligatory heterozygous carriers may have a limited pheno-
type, often reflected only by positive histopathology at predilection sites or by asymptomatic eye
findings. Within our cohort of over 70 PXE families, we have ascertained 7 families that meet these
criteria. Using microsatellite markers and SNPs spanning 3 cM around the ABCC6 locus, we have
haplotyped these families and sequenced the entire coding region of ABCC6 in affected individuals
and presumed carriers with limited phenotype. All affected individuals and those with limited phe-
notype harbored two mutated alleles, most mutations being private and novel. In two of these fam-
ilies, consanguinity in previous generations was detected through haplotype analysis. In the other
families, affected individuals in two generations carried two sets of affected alleles, with a total of
three different mutations in each family. Collectively, these data support pseudodominant inheritance
in these selected families and further emphasize that PXE is an autosomal recessive disease that
requires mutations in both alleles to express even minimal clinical findings. Phenotypic variations
between generations may be attributed to the consequences of mutations (e.g. missense vs. loss of
function) at the level of the encoded protein. Furthermore, our findings suggest a much higher
prevalence of PXE than previously predicted, thus impacting on genetic counseling and disease pre-
vention.
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Gene therapy approaches for epidermolysis bullosa simplex 
WF Buitrago,1 A Terron,3 I McLean3 and DR Roop1,2 1 Molecular & Cellular Biology, Baylor
College of Medicine, Houston, TX, 2 Dermatology, Baylor College of Medicine, Houston, TX and
3 Human Genetics Unit, University of Dundee, Dundee, United Kingdom
The Dowling-Meara variant of epidermolysis bullosa simplex (EBS-DM) is a severe blistering dis-
ease inherited in an autosomal-dominant fashion. No effective therapeutic treatment is available for
EBS making gene therapy the only corrective option for these patients. We previously generated a
transgenic mouse model that mimics EBS-DM at the genetic level. In this model, the expression of
the mutant K14 allele (mtK14) can be restricted to a small area of the skin. Focal activation of the
mtK14 gene by a topically applied inducer results in formation of blisters that heal after a few
weeks and never reappear. We demonstrated that the mtK14 gene is activated in epidermal stem cells,
and that the defective EBS stem cells are replaced by normal ones that migrate from the untreated
areas surrounding the blister. This explains the absence of mosaic forms of EBS and suggests that
if EBS stem cells were removed from a patient, genetically corrected and then returned to a blis-
tered area, they would have a selective growth advantage over defective EBS stem cells. In addition,
we observed that mice expressing the mtK14 allele at levels approximately 50% of wild type K14
(wtK14) fail to exhibit a skin phenotype, suggesting that as long as the wtK14:mtK14 ratio is above
a threshold; the skin will have a normal appearance and be fully functional. Thus, successful gene
therapy may not require correction or complete suppression of the mutant allele. We have developed
a ribozyme that specifically cleaves the mtK14 message in vitro and in vivo. We have also devel-
oped a lentiviral vector carrying the wtK14 gene, and demonstrated that it effectively transduces ker-
atinocytes which retain long-term expression of the transgene in tissue culture and up to 4 weeks
after grafting onto nude mice. Current studies are directed toward determining if the EBS-DM phe-
notype can be corrected by altering the ratio of wtK14 to mtK14. 
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First study on BRAF mutation in the serum of melanoma patients
C Esche,1 C Pföhler,3 N Benoit,2 E Rosenbaum,2 B Wang,1 AJ Mamelak,1 DL Cummins,1 A de
Benedetto,1 I Freed,1 W Tilgen,3 CM Balch,1 DN Sauder1 and D Sidransky2 1 Dermatology, The
Johns Hopkins University, Baltimore, MD, 2 Otolaryngology, The Johns Hopkins University,
Baltimore, MD and 3 Dermatology, The Saarland University Hospital, Homburg, Germany
The BRAF protooncogene encodes a RAS-regulated kinase that mediates cell growth and malig-
nant transformation. A high frequency of activating mutations in BRAF has been identified in nevi
and primary melanoma samples, suggesting involvement of the Ras-RAF-MAPK pathway in
melanocytic tumorigenesis. None of the 25 original research reports on BRAF and melanoma pub-
lished before January 2004 have addressed the issue of potential BRAF gene mutations in the serum.
In order to establish whether there would be circulating tumor cells that express mutated BRAF, we
purified genomic DNA via standard phenol-chloroform extraction followed by ethanol precipita-
tion from the serum of 45 patients with cutaneous melanoma (greater than 10 individuals for each
AJCC stage) and 19 control patients suffering from benign inflammatory dermatologic diseases. An
approximately 100 base-pair oligonucleotide was PCR amplified using primers specific for BRAF
exon 15. Amplification products were evaluated using the colorimetric assay Mutector IM (Trim-
Gen Corp, Sparks, MD), a technology achieving sequencing like accuracy. Mutations in BRAF
exon 15 were detected in 1 of 45 melanoma patients (AJCC stage IA) and 2 of 19 control patients,
one with atopic eczema and another one with erysipelas. We conclude that the prevalence of acti-
vating BRAF mutations found in the serum of melanoma patients appears to be low according to
our assay. We are therefore in the process of applying a more sensitive gap ligase chain reaction to
an extended collection of serum samples. Our observation may have implications for the clinical
use of raf kinase inhibitors and also suggests that mutated BRAF gene may be related to a fraction
of chronic inflammatory states such as atopic eczema and erysipelas. 
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Selective hydrolysis of RAR activator tazarotene by human skin carboxylesterases
Y Wan1 and B Yan2 1 Biology, Providence College, Providence, RI and 2 Biomedical Sciences,
University of Rhode Island, Kingston, RI
Tazarotene is widely used for skin disorders such as plaque psoriasis and acne vulgaris. Upon absorp-
tion, this acetylenic retinoid undergoes rapid hydrolysis in the skin and results in the formation of
tazarotenic acid. The hydrolytic metabolite interacts with the retinoic acid receptors (RAR) and exerts
its therapeutic activity. In human skin, there are multiple forms of carboxylesterases. The aim of this
study was to determine whether these carboxylesterases contribute similarly to the hydrolysis of
tazarotene. Cells were transfected with a cDNA encoding a carboxylesterase and lysates were ana-
lyzed for the ability to hydrolyze tazarotene. Among three carboxylesterases assayed, HCE1 and
HCE3 comparably hydrolyzed this ester whereas HCE2 showed little activity (~40 versus 6%). In
the skin, HCE1 was abundantly expressed compared with HCE2 and HCE3, suggesting that tazarotene
is predominately activated by HCE1 in the skin. A chimeric carboxylesterase containing three quar-
ter sequence of HCE3 showed a comparable activity of the parent enzyme, suggesting that the N-
terminal sequence determines the overall activity toward tazarotene. HCE2, compared with HCE1
and 3, has a 15-amino acid deletion in the so-called acyl pocket. To determine whether this sequence
is actually responsible for higher hydrolytic activity of HCE1 and 3, a deletion mutant prepared
with HCE1 exhibited an ~95% decrease in the hydrolysis of tazarotene, suggesting that the acyl
pocket plays an important role in interacting with tazarotene (Supported by ES07965). 
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Histamine enhances the production of granulocyte-macrophage colony-stimulating factor via
protein kinase Cα and extracellular signal-regulated kinase in human keratinocytes
N Kanda, H Mitsui and S Watanabe Dermatology, Teikyo University, School of Medicine, Tokyo,
Japan
The production of granulocyte-macrophage colony-stimulating factor (GM-CSF) in keratinocytes
is highly related to the chronicity of atopic dermatitis. Histamine released from mast cells contributes
to the cross-talk between mast cells and keratinocytes in skin inflammation. We examined the in vitro
effects of histamine on GM-CSF production in human keratinocytes. Histamine increased GM-CSF
secretion and mRNA level. Both GM-CSF mRNA stability and promoter activity were enhanced by
histamine. The elements homologous to activator protein-1 (AP-1) and nuclear factor-κB (NF-κB)
on the promoter were responsible for the activation by histamine. Histamine enhanced transcrip-
tional activity and DNA binding of AP-1 and NF-κB. In histamine-treated keratinocytes, AP-1 com-
position shifted from c-Jun homodimers to c-Fos/c-Jun heterodimers, and transient expression of c-
Fos protein was revealed. Histamine rapidly induced the phosphorylation and degradation of inhibitory
κB. Conventional protein kinase Cα translocated to membrane in histamine-treated keratinocytes.
Histamine-induced increases of GM-CSF secretion, promoter activity, and mRNA stability were
completely abolished by H1 antagonist pyrilamine and conventional protein kinase C inhibitor
Gö6976, and partially suppressed by PD98059 which inhibits the activation of extracellular signal-
regulated kinase, downstream of protein kinase C. Gö6976 and PD98059 suppressed histamine-
induced c-Fos expression and enhancement of DNA binding and transcriptional activity of AP-1.
Gö6976 completely and PD98059 partially suppressed histamine-induced enhancement of NF-κB
transcriptional activity. Histamine-induced phosphorylation and degradation of inhibitory κB was
suppressed by Gö6976, but not by PD98059. These results suggest that histamine may enhance
GM-CSF production at transcriptional and posttranscriptional levels via H1 receptor, protein kinase
Cα and extracellular signal-regulated kinase. 
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Constitutive phosphorylated Smad3 interacts with Sp1 and p300/CBP in scleroderma fibrob-
lasts
H Ihn, K Yamane, Y Asano, M Jinnin and K Tamaki Dermatology, University of Tokyo, Tokyo,
Japan
Systemic sclerosis (SSc) is characterized by the excessive extracellular matrix (ECM) deposition in
the skin, lung, or other organs, and numerous previous reports indicated the significance of autocrine
TGF-β loop in the pathogenesis of SSc. In this study, we focused on the TGF-β signaling to under-
stand the pathogenesis of SSc. Constitutive increased Smad3 phosphorylation was detected in SSc
fibroblasts compared with normal fibroblasts. Increased interaction of Smad3 with Sp1 as well as
p300 was also detected in SSc fibroblasts. The overexpression of Smad3 caused up to 5-fold increase
in COL1A2 promoter activity in normal fibroblasts, while Smad3 caused a little increase in COL1A2
promoter activity in SSc fibroblasts. However, neither Smad2 nor Smad4 caused significant effects
in COL1A2 promoter activity in normal fibroblasts or SSc fibroblasts. The overexpression of Sp1
caused further increase in COL1A2 promoter activity stimulated by TGF-β in normal fibroblasts,
but did not change COL1A2 promoter activity in the presence of TGF-β in SSc fibroblasts. The com-
binatory overexpression of Smad3 and Sp1 enhanced TGF-β response significantly in normal fibrob-
lasts as well as SSc fibroblasts. These results suggest that constitutive phosphorylated Smad3 inter-
acts with Sp1 and p300/CBP in SSc fibroblasts and that SSc fibroblasts are less sensitive to exogenous
TGF-β stimulation.
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Genotype-phenotype correlation in 62 patients with pseudoxanthoma elasticum
L Fuchsel, H Kozic, K McGuigan, C Skvarka, M Jacobson, J Uitto and F Ringpfeil Dermatology,
Jefferson Medical College, Philadephia, PA
Pseudoxanthoma elasticum (PXE) is a rare heritable connective tissue disorder affecting skin, eyes
and cardiovascular system. Clinical manifestations are protean, displaying both inter- and intrafa-
milial phenotypic variation. Mutations in the ABCC6 gene on the short arm of chromosome 16 are
pathogenic and to date there is no evidence of locus heterogeneity for this autosomal recessive dis-
ease. In the following study, we have ascertained a cohort of 62 PXE families of mostly Northern
European extraction. The coding region as well as exon intron borders of all affected individuals
was subjected to direct sequencing. We have discovered over 10 distinct polymorphisms within the
coding region of ABCC6, and have identified pathogenic mutations on 107 alleles (89%). The spec-
trum of mutations resembled those of previous reports with two recurrent mutations, R1141X and
deletion exon 23-29, and the majority constituting private mutations. Amongst those, we have iden-
tified 25 novel sequence aberrations. Mutations were plotted against the clinical phenotype that was
graded by disease severity in case of skin and specific diagnoses in case of eye and cardiovascular
disease. In addition, exonic polymorphisms were scrutinized in the same manner in order to deter-
mine a disease modifying effect. Compound heterozygotes for two missense mutations had milder
disease in all clinical aspects, often being diagnosed only through biopsy. However, no obvious geno-
type-phenotype correlation was detected despite our extensive clinical and genetic data. In conclu-
sion, PXE may be significantly altered by environmental factors as intrafamilial variability suggests
and secondly, a larger cohort may have to be examined to detect the most discrete genotype pheno-
type correlation. 
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Mechanical pressure-induced phosphorylation of p38 and c-jun NH2-terminal kinase in epithe-
lial cells
M Hofmann,1,2 J Zaper,1,2 A Bernd,1 J Bereiter-Hahn,2 R Kaufmann1 and S Kippenberger1 1
Dermatology and Venerology, University Hospital, Frankfurt/Main, Germany and 2 Kinematic Cell
Research Group, J.W. Goethe University, Frankfurt/Main, Germany
Cells within human skin are permanently targeted by mechanical forces of different qualities (e.g.
stretching and pressure). In contrast to stretching the underlying molecular signaling pathways which
are involved in transduction of mechanical pressure are still enigmatic. In the present in vitro attempt
epithelial cells were mechanically stimulated by teflon weights that were placed into the culture
dishes. Cells were analysed after different time intervals using immunohistochemical methods, SDS-
PAGE and Western blotting. Mechanical pressure applied for a maximum time of 20 min showed a
peak phosphorylation for the stress-kinases p38 and c-jun NH2-terminal kinase-1 (JNK1) between
5 and 10 min. In order to further dissect the signaling cascade, upstream and downstream regulators
of p38 were examined. Downstream of p38 the phosphorylation of the small heat shock protein 27
(HSP27) was shown in response to pressure application. The pressure mediated phosphorylation of
HSP27 could be blocked by p38 specific inhibitors. Additionally, we examined the suppression of
pressure-induced p38 phosphorylation after blocking of protein kinase C by calphostin C. Further-
more, the involvement of small G proteins was investigated in the mechanical induced signaling
cascade. Inhibitor studies dealing with toxin B as well as transient transfection experiments using
dominant-negative constructs of Rac showed no effects on the pressure-induced p38 phosphoryla-
tion. Respectively, the pharmacologic inhibition of Src kinase circumvented the pressure-induced
phosphorylation of JNK1 but not that of p38. These findings indicate that both stress-kinases are
independently phosphorylated by distinct signal transduction pathways. Our experimental results
indicate mechanical pressure as a new type of cellular stress which yields in p38 and JNK phos-
phorylation with implications to (patho)physiological conditions as acanthosis or the Koebner phe-
nomena as well as tumor biology. 
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Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic
receptor subtypes
A Chernyavsky,1 J Arredondo,1 LM Marubio,2 AL Beaudet,2 DE Vetter3 and SA Grando1 1
Dermatology, University of California, Davis, CA, 2 Molecular and Human Genetics, Baylor
College of Medicine, Houston, TX and 3 Neuroscience, Tufts University, Boston, MA
Nicotinergic agents can act as both chemokines and chemoattractants for cell migration. Epidermal
keratinocytes (KCs) both synthesize acetylcholine (ACh) and use it as a paracrine and autocrine
regulator of cell motility. To gain a mechanistic insight into nicotinergic control of KC motility, we
determined types of nicotinic ACh receptors (nAChRs) and signaling pathways regulating KC
chemokinesis and chemotaxis, using respective modifications of the agarose gel KC outgrowth assay.
Random migration of KCs was significantly (p<0.05) inhibited by hemicholinum 3, a metabolic
inhibitor of ACh synthesis, as well as α-conotoxins MII and AuIB preferentially blocking α3-con-
taining nAChRs. The use of nAChR subunit selective antisense oligonucleotides (AsOs) and knock-
out mice demonstrated pivotal role for α3β2 channel in mediating ACh-dependent chemokinesis.
Signaling pathways downstream of α3β2 included activation of the protein kinase C isoform δ, and
RhoA-dependent events. Chemotaxis induced by nicotinergic agents was most pronounced toward
the concentration gradient of choline, a potent agonist of α7 nAChR. The α7-preferring antagonist
α-bungarotoxin significantly (p<0.05) diminished KC chemotaxis, further suggesting a central role
for α7 nAChR. This hypothesis was confirmed in experiments with anti-α7 AsOs, and α7 knock out
mice. The signaling pathway mediating α7-dependent KC chemotaxis included elevation of intra-
cellular calcium, activation of calcium/calmodulin-dependent protein kinase II and conventional iso-
forms of PKC, as well as engagement of Rac/Cdc42. Redistribution of α7 immunoreactivity to the
leading edge of KCs upon exposure to choline preceded that of α3. The obtained results for the first
time identify distinct nAChR types regulating chemokinesis and chemotaxis of KCs, and define sig-
naling pathways mediating each function, which has clinical implications for wound healing and
control of cancer metastases. 
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Activation of store-operated channels in human epidermal keratinocytes requires phospholi-
pase C γ1 and the inositol 1,4,5-trisphosphate receptor
C Tu,1,2 W Chang1,2 and D Bikle1,2 1 Endocrine Unit, VA Medical Center (111N), San Francisco,
CA and 2 Department of Medicine, University of California, San Francisco, CA
Store-operated calcium entry depicts the movement of extracelluar Ca2 + into cells through plasma
membrane Ca2 + channels activated by depletion of intracellular Ca2 + stores. The members of the
canonical subfamily of transient receptor potential channels (TRPC) have long been implicated as
the molecular bases for store-operated channels (SOC). Here we characterize the regulation of native
SOC and the expression of endogenous TRPC in human epidermal keratinocytes. Calcium entry in
response to store depletion with thapsigargin was reversibly blocked by the membrane-permeable
inositol 1,4,5-trisphosphate receptor (IP3R) inhibitor, 2-aminoethoxydiphenyl borane, and suppressed
by the diacylglycerol analogue, 1-oleoyl-2-acetyl-sn-glycerol. Inhibition of phospholipase C (PLC)
with U73122 or transfection of a PLCγ1 antisense cDNA construct completely blocked SOC activ-
ity. These findings indicate a requirement for IP3R and PLC, especially PLCγ1, in the activation of
SOC. RT-PCR and immunoblotting analyses showed that TRPC1, 3, 4, 5 and 6 are expressed in ker-
atinocytes. Knockdown of the level of endogenous TRPC1 or TRPC4 by antisense cDNA transfec-
tion inhibited SOC function, demonstrating their involvement in mediating store-operated calcium
entry. Immunoprecipitation with antibodies against PLCγ1 and IP3R as well as an agarose-conju-
gated peptide containing the SH2SH2SH3 domain of PLCγ1 demonstrated the interaction of PLCγ1
and IP3R with TRPC1, but not with TRPC4. The association of TRPC1 with PLCγ1 and IP3R
decreased in keratinocytes with higher intracellular Ca2 + , coinciding with a down-regulation in SOC
activity. Our results demonstrate that the activation of SOC in keratinocytes depends, at least partly,
on the interaction of TRPC with PLCγ1 and the IP3 receptor. 
561
ERK-independent uPA-stimulated p70 S6 kinase activation is triggered by overexpression of
ganglioside GM3 
X Wang, P Sun, L Go and AS Paller Dermatology and Pediatrics, Northwestern Univ. Med School,
Chicago, IL
Overexpression of GM3, the predominant ganglioside of keratinocyte membranes, inhibits ligand-
dependent and ligand-independent activation of epidermal growth factor receptor, leading to sup-
pression of Ras/extracellular regulated kinase (ERK) signaling and, thus, to inhibition of cell pro-
liferation. Paradoxically, we have recently shown that overexpression of GM3 facilitates proliferation
in the presence of urokinase-type plasminogen activator (uPA). We hypothesized that overexpres-
sion of GM3 triggers ERK-independent signaling as the mechanism to stimulate cell proliferation
in the presence of uPA. Using human squamous carcinoma (SCC12) cells with modulated ganglio-
side expression, we have found that GM3 promotes uPA-induced p70 S6 kinase activation. In con-
trast, depletion of GM3 by either overexpression of sialidase or treatment with PPPP leads to sup-
pression of p70 S6 kinase activation. Inhibition of of p70 S6 kinase, but not Ras/ERK signaling,
suppresses the stimulation of cell proliferation by GM3. In these GM3-overexpressing SCC12 cells,
p70 S6 kinase phosphorylation is stimulated at the Thr-389, Thr-421/Ser-424, and Ser-411 sites of
p70 S6 kinase, and is associated with activation of phosphatidylinositol 3-kinase (PI3K) and protein
kinase C (PKC)-zeta. Phosphorylation of the Thr-389 site requires PI3K activation, of the Ser-411
site PKC-zeta activation, and of the Thr-421/Ser-424 site both PI3K and PKC-zeta activations. These
studies show GM3 to be a novel trigger of p70 S6 kinase activation in the presence of uPA via a
mechanism that is independent of ERK signaling, yet leads to epithelial cell proliferation through
stimulation of PI3K and PKC-zeta. Furthermore, the data regarding site-specific activation impli-
cate PKC-zeta and PI3K as intermediaries in ERK-independent p70 S6 kinase phosphorylation. 
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Tenascin-C up-regulation by transforming growth factor-beta in human dermal fibroblasts
involves Smad3, Sp1, and Ets1
M Jinnin, H Ihn, Y Asano, K Yamane and K Tamaki Department of Dermatology, University of
Tokyo, Tokyo, Japan
In cultured human dermal fibroblasts, transforming Growth Factor (TGF)-beta induced the mRNA
expression of tenascin-C (TN-C). The molecular mechanism(s) underlying this process are not
presently understood. In this study, we performed serial 5’deletion and a transient transfection analy-
sis to define a region in the TN-C promoter mediating the inducible responsiveness to TGF-beta.
This region contains an atypical nucleotide recognition element for the Smad family of transcrip-
tional regulators. A DNA affinity precipitation assay revealed that Smad2/3 bound to this site in a
transient and specific manner. Overexpression of Smad3 or Smad4 activated the TN-C promoter
activity and superinduced TN-C promoter activity stimulated by TGF-beta. Moreover, simultane-
ous co-transfection of Smad3 and Smad4 activated the TN-C promoter activity in a synergistic man-
ner. Mutation of the Smad binding sites, the Ets binding sites or Sp1/3 binding sites in the TN-C
promoter abrogated the TGF-beta/Smad-inducible promoter activity. Immunoprecipitation analysis
revealed that Smad3, Sp1 and Ets1 form a transcriptionally active complex. Furthermore, the inter-
action between Smads and CBP/p300 in TGF-beta signaling was confirmed. These findings demon-
strate the existence of a novel, functional binding element in the proximal region of the TN-C pro-
moter mediating responsiveness to TGF-beta involving Smad3/4, Sp1, Ets1, and CBP/p300. 
563
Cholesterol depletion alters involucrin gene expression in epidermal keratinocytes through
activation of p38
R Jans,1 G Atanasova,1,3 M Jadot2 and Y Poumay1 1 Histology-Embryology, University of Namur,
Namur, Namur, Belgium, 2 Molecular Physiology Research Unit, Department of Physiological
Chemistry, University of Namur, Namur, Namur, Belgium and 3 Biochemistry, University of Sofia,
Sofia, Sofia, Bulgaria
Cholesterol has been recently suggested to regulate the early steps of keratinocyte differentiation
through lipid rafts. In many cell types, depletion of cholesterol activates signaling proteins like EGFR,
HER2 or ERK known to affect cell differentiation. In this study, we explored the effects of choles-
terol depletion on the phenotype of cultured keratinocytes, using a treatment with methyl-beta-
cyclodextrin (MbCD) to extract cholesterol and a treatment with lovastatin to inhibit cholesterol
neosynthesis. Analysis of the expression of differentiation marker genes in early-differentiating con-
fluent cultures reveals that cholesterol depletion induces downregulation of keratin 14 (K14) and
keratin 10 (K10) and upregulation of involucrin. MbCD treatment induces phosphorylation of EGFR,
HER2 and ERK, but not HER3. Inhibition of EGFR with PD153035 impairs the MbCD-induced
phosphorylation of EGFR, HER2 and ERK, but does not impair the alteration of K14, K10 or involu-
crin gene expression, indicating that other signaling proteins regulate this phenomenon. p38 has been
suggested to regulate the expression of involucrin during keratinocyte differentiation. We found that
MbCD treatment induces a prolonged phosphorylation of p38 and that the inhibition of p38 with
PD169316 impairs the upregulation of involucrin mRNAs, which might suggest that cholesterol
depletion alters involucrin gene expression through activation of p38. 
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Constitutive activation of Stat3 in keratinocytes is essential for development of psoriasis
S Sano,1,3 KS Chan,1 M Peavy,1 S Carbajal,1 J Clifford,2 K Kiguchi,1 S Itami3 and J DiGiovanni1 1
Department of Carcinogenesis, The University of Texas, M.D.Anderson Cancer Center, Science
Park-Research Division, Smithville, TX, 2 Department of Clinical Cancer Prevention, The
University of Texas, M.D. Anderson Cancer Center, Houston, TX and 3 Department of
Dermatology, Osaka University Graduate School, Suita, Osaka, Japan
Psoriasis is a common skin disease characterized by epidermal hyperplasia with inflammation and
angiogenesis. Although the pathogenesis remains elusive, it is known that re-epithelizing processes
can recapitulate aspects of psoriasis. Previous studies have shown that Stat3 in keratinocytes is
required for wound healing. In fact, psoriatic lesions from a majority of patients (19/21) demon-
strated activated Stat3 in the epidermis, while Stat3 was inactive in other non-psoriatic inflamma-
tory dermatoses with accompanying epidermal hyperplasia. Transgenic mice whose keratinocytes
expressed a constitutively active Stat3 (K5.Stat3C) developed spontaneous psoriasiform lesions in
the tails as early as two weeks of age. Spontaneous, hyperkeratotic lesions spread to the dorsum and
hind feet in some mice. Furthermore, full thickness wounding, tape-stripping or topical treatment
with 12-O-tetradecanoylphorbol-13-acetate (TPA) induced this phenotype resembling human pso-
riasis. Keratinocytes from K5.Stat3C mice exhibited upregulation of VEGF, TGFα, cyclin D1, I.κBα,
and ICAM-1, which likely contributed to the development of psoriasiform lesions. Targeted inhibi-
tion of Stat3 by topical treatment with a decoy oligonucleotide hindered the development of psori-
asiform lesions. We conclude that constitutive activation of Stat3 in keratinocytes is essential for
development of psoriasis, and that targeting Stat3 may be of potential therapeutic benefit in the
treatment of this disease 
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Characteristics of whole-cell patch clamping in cultured human keratinocytes
WK Nahm,1,2 VB Morhenn,1,2 RL Moy4 and V Falanga3 1 Dermatology, University of California,
San Diego, San Diego, CA, 2 VA San Diego Healthcare System, San Diego, CA, 3 Dermatology,
Boston University School of Medicine, Roger Williams Medical Center, Providence, RI and 4 West
Los Angeles VA Medical Center, Los Angeles, CA
Previous experiments using patch clamping in keratinocytes have revealed the presence of ionic chan-
nels. Recent analyses in these cells with in-vitro Ca2+ imaging and flow cytometry have demon-
strated the functionality of ionic glutamate N-methyl D-aspartate receptors (NMDARs), which was
dependent on the confluency of the cultures. However, no data are present on the whole-cell current
characteristicss in human keratinocytes exposed to NMDA. In order to analyze NMDA-mediated
currents, we performed whole cell patch clamping on cultured human keratinocytes with exposure
to the specific agonist. Bath application of 100 µM NMDA evoked prominent current responses
(peak current 150 pA & duration 1500 ms) in confluently grown keratinocytes voltage-clamped at
+40 mV. Nonconfluently grown keratinocytes with gigaohm seals demonstrated no current responses
to NMDA. The patchability index (the ratio of the number of cells that had gigaohm seals over the
total number of cells that were attempted to be patched clamped), also widely differed between ker-
atinocytes grown in a confluent and nonconfluent cultures. The patchability index was 2/57 (0.03%)
for confluent cells and 6/35 (17.14%) for nonconfluently grown keratinocytes. Upon examining the
differential infrared contrast images while patch clamping, confluently grown cells had a distinct
relief pattern of the nucleus and cytoplasmic structures. However, the nonconfluent cells had a smooth
relief pattern. In summary, confluently grown keratinocytes demonstrate prominent NMDA-medi-
ated currents, while no NMDA-evoked currents are seen in nonconfluent cells. Furthermore, it is
much more difficult to create gigaohm seals in confluent keratinocytes as compared to nonconflu-
ent keratinocytes. This difficulty in patch clamping may arise from the fact that a confluent grown
keratinocyte may have greater surface tension across its cell membrane. 
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Effect of NGF on matrix metalloproteinases and tissue inhibitors of metalloproteinases pro-
duced by human dermal fibroblasts and myofibroblasts
C Gondran,2 M Dumas,2 A Marconi,1 F Truzzi,1 P Atzei,1 F Bonte2 and C Pincelli1 1 Dermatology,
University of Modena and Reggio Emilia, Modena, Italy and 2 Parfums et Cosmetiques, LVMH
Recherche, Saint Jean de Braye, France
Neurotrophin (NT) family comprises a group of functionally and structurally related proteins that
play a key role in the development and survival of neurons. NT family includes nerve growth factor
(NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and NT-4/5. All NT are
produced by keratinocytes, which also express all NT receptors, except for trkB. NT exert prolifer-
ative and antiapoptotic effects on keratinocytes. Little is known however on the expression and
function of NT in other skin cells. The aim of the present study was, at first, to evaluate the expres-
sion and function of NT and their receptors in human dermal fibroblasts (DF) and their differenti-
ated type myofibroblast (MF). DF were cultivated in DMEM with 5% FBS. MF were obtained in
vitro after treating DF with TGFβ1 (1 ng/ml) for 6 days. Both DF and MF synthesize and release all
NT, as shown by RT-PCR and ELISA. In particular, DM express higher amounts of NT, as com-
pared to DF (NGF, NT-3, BDNF p<0.05; NT-4 p<0.01). In addition, DF and MF express all NT
receptors except for trkC. The NT low-affinity receptor p75 is more expressed in MF than in DF, as
shown by western blot. NGF reduces production of collagen I and III by these cells (p<0.05). More-
over, DF release higher levels of matrix metalloproteinases-3 (MMP-3), MMP-10, MMP-13 and
their inhibitors (TIMP-1) than MF (p<0.05), as shown by a proteome ELISA. NGF decreases sig-
nificantly MMP-2 secretion in both DF and MF (p<0.01) since MMP-9 was only decreased in MF
(p<0.01). On the other hand, NGF increases MMP3 in DF (p<0.05) and decreases it in MF (p<0.01).
These results indicate that fibroblast and myofibroblast could participate in the complex NT network
at the skin level either as a target or as a source for NT. In addition, NT are involved in the extra-
cellular matrix remodelling and repair, thus playing a key role in both fibrotic processes and skin
aging.
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Proliferation regulatory signal between SMAD 3 and MAPK p42/44
J Cha,1 D Shrayer,1 J Butmarc,1 P Carson,1 AB Roberts,3 S Kim3 and V Falanga1,2 1 Dermatology
and Skin Surgery, Roger Williams Medical Center, Providence, RI, 2 Biochemistry, Boston
University School of Medicine, Boston, MA and 3 Laboratory of Cell Regulation and
Carcinogenesis, National Institutes of Health, Bethesda, MD
Smad3 and MAPK p42/44 proteins are both transduction signals for TGF-β related factors. There
are no definite answers about the possible crosstalk between these two proteins. We have previously
reported that Smad3 null mice display accelerated healing of incisional wounds. Using this novel
model for delayed wound closure, we studied the effect of wounding in Smad3 null and wild type
mice. Full-thickness wounds measuring 0.3 by 1 cm were made down to fascia on the dorsal aspect
of the mouse tail in Smad3 K-O mice and control littermates, approximately 1cm distal to the body
of the animal. The wounds were left to heal by secondary intention and were assessed histologically
by computerized planimetry for wound closure at various times after wounding. The wounds in wild-
type mice displayed delayed healing, with full closure occurring between 14 and 25 days after wound-
ing. Wounds in Smad3 null mice healed 30% faster (p<0.01). By immunostaining with ki67 a marker
for proliferation, Smad3 null animals showed increased proliferation of dermal wound cells. By
thymidine uptake assay, cultured dermal fibroblasts from Smad3 null mice showed increased base-
line DNA synthesis and interestingly enhanced response to TGF-β1 compared to dermal fibroblasts
from wild-type mice. Using Western blotting, we found that MAPK p42/44 is significantly more
phosphorylated in fibroblasts cultured from Smad 3 K-O mice at baseline and in response to TGF-
β1, suggesting that MAPK overcompensation together with loss of Smad3 may be involved in the
modulation of faster healing. These results point to crosstalk between Smad 3 and MAPK p42/44,
and that these two transduction proteins may control fibroblast proliferation and the response to
injury. 
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Cell cycle arrest by CDK inhibitor CYC 202(R-roscovitine) in normal human keratinocytes is
followed by induction of p38 MAPK phosphorylation and subsequent involucrin expression
G Atanasova,1,2 R Jans,1 N Zhelev,3 V Mitev2 and YG Poumay1 1 Histology-Embryology, FUNDP
(University of Namur), Namur, Namur, Belgium, 2 Biochemistry, Medical University of Sofia, Sofia,
Bulgaria and 3 University of Abertay Dundee, Dundee, Scotland, United Kingdom
The aim of our study was to explore the antiproliferative effect of the CDK inhibitor CYC 202(R-
roscovitine) on normal cultured human keratinocytes. We examined the effect of concentrations
between 0,1mM and 200mM of this cell cycle inhibitor on cell viability, DNA synthesis, as well as
the induction of differentiation and signal transduction in highly proliferative subconfluent ker-
atinocytes and in growth-arrested confluent keratinocytes in autocrine cultures. Proliferative ker-
atinocytes  were more sensitive to this compound in term of cell viability than growth-arrested ker-
atinocytes. In subconfluent conditions, CYC 202 inhibits cell proliferation in a dose-dependent
manner, which is followed by induction of p38 MAPK phosphorylation. Phosphorylation of p38
MAPKis strongest at 20 mM CYC 202, when cell viability is lower and the activity of the other MAP
kinases ERK 1 and 2 is inhibited. Because the natural occurence  of growth arrest in normal epi-
dermal keratinocytes  is linked to the induction of cell differentiation, we analysed also the pheno-
type  after CYC202 treatment. Prolonged inhibition of the cell cycle in subconfluent  keratinocytes
resulted in downregulation of the early  differentiation marker keratin10 and in upregulation of late
differentiation marker involucrin. The connection between p38 kinase activity and the expression of
involucrin has been already suggested. We observe a similar link as a result of the inhibition of cell
cycle progression in proliferating keratinocytes  by the potent CDK inhibitor CYC202. 
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The p75 neurotrophin receptor signals apoptosis in a subpopulation of human keratinocytes
P Atzei, A Marconi, M Pignatti, F Truzzi, A Giannetti and C Pincelli Dermatology, University of
Modena and Reggio Emilia, Modena, Italy
The p75 neurotrophin receptor (p75NTR) belongs to the TNF-receptor superfamily and signals apop-
tosis in many cell settings. Human keratinocytes express both p75NTR and the high affinity neu-
rotrophin receptor trk. While the NT nerve growth factor protects keratinocytes from apoptosis through
trk, nothing is known on the role of p75NTR. The aim of the present study was to evaluate the expres-
sion and function of p75NTR in human keratinocytes. p75NTR was detected in a subpopulation of
basal keratinocytes by single and double immunostaining. In particular, p75NTR staining did not
overlap the expression of transglutaminase and keratin 10 (suprabasal) nor the expression of MIB
(proliferating basal keratinocytes). p75NTR staining was negative in psoriatic lesions. p75NTR was
more expressed in confluent (23.5%) than in subconfluent cells (5.7%), while it was absent in strat-
ified cells, as shown by western blotting and FACS. Addition of Ca++ increased percentage of sub-
confluent keratinocytes expressing p75NTR (44.1%). Moreover, p75NTR was expressed in young
transit amplifying cells while it was nearly absent in stem keratinocytes. Brain-derived neurotrophic
factor (BDNF) and neurotrophin-4, which signal only through p75, induced keratinocyte apoptosis,
as shown by MTT assay and TUNEL (p<0.05). This effect was partially blocked by anti-p75 anti-
body. The trk inhibitor K252 induced a higher rate of apoptosis in keratinocytes retrovirally trans-
fected with p75cDNA than in mock-transfected cells (p<0.01). These results show that p75NTR
signals apoptosis in keratinocytes. It would also appear that apoptosis induced by inhbition of trk is
favored by a strong p75 expression. As trk is overexpressed in psoriasis, the absence of p75NTR
expression could allow the lower rate of cell death observed in this dermatosis. 
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Fatty acids, thiazolidinediones, and VP16-PPARγ activate PPARγ in human keratinocytes and
inhibit keratinocyte cell growth in vitro
C Marcelo,1 RC Reddy,2 VG Keshamouni,2 TH Dunham 1 and RR Gilmont1 1 Surgery, University
of Michigan, Ann Arbor, MI and 2 Internal Medicine, University of Michigan, Ann Arbor, MI
Human keratinocytes (HKC) grow vigorously when rendered essential fatty acid (EFA) deficient and
are growth arrested by the EFAs 18:2 (linoleic acid) and 20:4 (arachidonic acid), n-6. Because fatty
acids and derivatives are ligands for peroxisome proliferator-activated receptor γ (PPARγ), we hypoth-
esize that this nuclear hormone receptor regulates HKC proliferation. Neonatal HKC express PPARγ
mRNA and protein which increase in response to EFAs. HKC were then transfected with a PPAR-
dependent promoter gene construct, FATP3x-tk-luciferase, containing three direct repeats of the
PPAR response element subcloned upstream of the thymidine kinase promotor. Both ciglitazone
(CIG, 10 µM) and troglitazone (TRO, 10 µM) activated transcription of the FATP3x-tk-luciferase
reporter gene (3.5- vs. 6-fold, respectively), while the saturated fatty acid 16:0 (15, 25 and 35 µM),
and the EFAs 20:4 and 18:2 (both at 5, 15 and 25 µM) also resulted in increased luceriferase activ-
ity. HKC were also transfected with a constitutively active form of PPARγ, VP16-PPARγ. Trans-
fection with VP16-PPARγ induced a marked increase in PPRE-dependent luciferase activity when
compared to control treated cells. EFA-supplemented media or CIG (0.1 to 10 µM) inhibited HKC
DNA synthesis 50% (3H-Tdr uptake), with BADGE (0.5 & 1.0 µM), a PPARγ inhibitor, reversing
the inhibition. VP16-PPARγ also inhibited the growth of HKC by approximately 60%. In summary,
we demonstrate that PPARγ is constitutively expressed and is functionally active in HKC. The EFAs
18:2, 20:4 and the synthetic PPARγ ligands, CIG and TRO, inhibit HKC growth. In addition, simi-
lar inhibition of HKC proliferation was achieved using a constitutively-active PPARγ. These data
suggest that PPARγ is an important regulator of HKC proliferation and may serve as a potential
therapeutic target in proliferative skin disorders. 
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The role of telomere-based signaling in the management of metastatic carcinoma
C Rinaldi, MYaar, MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
Telomeres, tandem repeats of TTAGGG that cap chromosomes, are central to senescence and apop-
tosis. Critical telomere shortening during aging leads to irreversible cell cycle arrest, and experi-
mental disruption of the telomere loop induces apoptosis or senescence, depending on the cell type.
To mimic telomere loop disruption, we provided an 11-base DNA oligonucleotide homologous to
the telomere 3’ overhang sequence (T-oligo) to a metastatic carcinoma cell line, PA-1, and com-
pared its effect to a diluent and complementary oligonucleotide (negative control). Within 4 days,
T-oligo (40uM) inhibited cell growth by >15 fold compared with diluent (p<0.001), as determined
by cell yield. In addition, within 48 hrs, T-oligo induced S phase arrest of 43±2% of cells as com-
pared to 14±.01% of diluent (FACScan analysis), and most T-oligo treated cells eventually became
apoptotic (TUNEL). Within 7 days, the few remaining cells displayed large, spread morphology
and positive staining for the senescence associated β-galactosidase activity.  To determine T-oligo
mediated signaling pathways, cells were stimulated as above, total cellular proteins were isolated
for western blotting at different intervals up to 96 hrs after stimulation. Within 24 hrs, T-oligo induced
the level of the tumor suppressor protein p53 as well as the level of active p53 (serine 15 phospho-
rylated), with a maximum of 300% and >30 fold induction respectively, within 72 hrs. Interestingly,
within 96 hrs, T-oligo also induced >250% the level of the p53 homolog protein, p73. Furthermore,
within 24 hrs, T-oligo induced phosphorylation of p95/Nbs1, a protein known to mediate S phase
arrest in response to ATM kinase activation. We conclude that similar to DNA damage, T-oligo induces
its effects on metastatic carcinoma cells via activation of at least three ATM kinase dependent pro-
teins (p53, p73 and p95/Nbs1), leading to cell cycle arrest followed by apoptosis or senescence. Treat-
ment with T-oligo may be a promising novel therapy for metastatic carcinoma. 
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Differential regulation of karyopherin alpha 2 expression by TGF-β1 and IFN-γ in normal
human epidermal keratinocytes
N Umegaki,1 K Tamai,2 H Nakano,1 R Moritsugu,1 T Yamazaki2 and K Hanada1 1 Dermatoligy,
Hirosaki University, Hirosaki, Aomori, Japan and 2 Division of gene therapy science, Osaka uni-
versity medical school, Suita, Osaka, Japan
To investigate the role of nuclear transport regulation, we studied the expression pattern of karyo-
pherin a (KPNA) subtypes 1, 2, 3, 4 and 5, in normal human epidermal keratinocytes (NHEK) and
normal human dermal fibroblasts (NHDF). Northern blot analysis demonstrated that both NHEK
and NHDF expressed all subtypes of KPNAs. In both cell types, KPNA2, 3 and 4 seemed to be the
major subtypes expressed, while KPNA 1 and 5 were minor in terms of relative mRNA expression.
TGF-β1 (5 ng/ml) stimulation of NHEK resulted in the selective down-regulation of KPNA2 mRNA
expression, and a 70% decrease in expression was observed after 24 hours. Conversely, IFN-γ (100
U/ml) stimulation of NHEK cells specifically up-regulated KPNA2 expression. Maximal induction,
about 2.5 times higher than initial expression levels, was observed after 6 hours,and expression grad-
ually declined to approximately 20% of the initial expression level, suggesting dual regulation of
KPNA2 by IFN-γ. Nearly identical data was obtained when protein levels were assessed by West-
ern blotting. Addition of cycloheximide, antagonized the effects of both TGF-β1 and IFN-γ on KPNA2
mRNA expression, indicating the requirement for ongoing protein synthesis. Because no specific
changes were seen in NHDF, these observations suggest a tissue specific regulatory function for
KPNA2 in NHEK. No other KPNAs were modulated by these cytokines. Our data suggest that
KPNA2 may play important roles in the signal transduction pathways related to epidermal prolifer-
ation and differentiation. 
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Inhibition of dermal fibroblast proliferation by phosphatidylethanolamine-binding protein
(PEBP): repression of PEBP correlates with TGF-b-induced fibroblast proliferation
Y Kambe,1 T Yamazaki,2 S Ikenaga,1 N Umegaki,1 H Nakano,1 K Hanada,1 K Tamai1 and
S Tsuchida2 1 Dermatology, Hirosaki University School of Medicine, Hirosaki, Japan and 2 Second
biology, Hirosaki University School of Medicine, Hirosaki, Japan
Phosphatidylethanolamine-binding protein (PEBP) is a basic protein that has been identified as a
novel Raf-kinase inhibitor. Transforming growth factor b (TGF-b) is a multifunctional cytokine that
has proliferative effects on fibroblasts. However, while the most attention has been concentrated on
clarifying the mechanism whereby TGF-b inhibits cell growth, far less attention has been given to
elucidating the mechanism of growth stimulation by TGF-b. In this study, we revealed that overex-
pression of PEBP significantly inhibits serum-induced cell growth of normal human dermal fibrob-
lasts (NHDF), and TGF-b1 significantly promote the proliferation of the NHDF, while both PEBP
mRNA and protein expression were reduced indicating a co-relation between enhancement of cell
growth of NHDF and reduction of PEBP expression by TGF-b1. TGF-b1 induced the phosphoryla-
tion of ERK1/2 in a transient manner, and the activation of ERK1/2 was not observed at the later
time points. We propose that reduced PEBP expression may make fibroblasts susceptible to growth
factors or cytokines. It will be of significance to investigate the molecular status of PEBP in a cer-
tain proliferative disease, such as keloid, in which TGF-b has been reported to play a pathogenic
role for hyperproliferation of dermal fibroblasts. 
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Srcasm modulates EGF signaling and proliferation in human keratinocytes
W Li, C Marshall, L Mei and JT Seykora Department of Dermatology, University of Pennsylvania,
Philadelphia, PA
Srcasm (Sm) is a recently identified molecule containing a VHS membrane binding domain and
several tyrosine motifs which interact with Grb2, PI-3 kinase, and Src-family kinases. To further
characterize the role of Sm in keratinocyte biology, studies using adenoviruses (Ad-Sm or Ad-GFP)
were performed on human primary keratinocytes. Under standard growth conditions with EGF, Sm
is tyrosine phophorylated in human keratinocytes. Growth factor depletion of keratinocytes for 24
hours decreased Sm tyrosine phosphorylation to near undectable levels, while EGF stimulation rap-
idly promotes Sm tyrosine phosphorylation within 5 minutes. The EGF-dependent tyrosine phos-
phorylation of Sm is inhibited by pretreating keratinocytes with AG112, an inhibitor of EGF recep-
tor kinase activity, and PP2, a Src-kinase inhibitor. The appropriate control compounds do not
significantly alter the EGF-induced phosphorylation of Srcasm. Immunoprecipitation of the EGF
receptor from keratinocyte lysates also immunoprecipitated Sm, suggesting that these two molecules
may be part of the same molecular complex. Sm activates Src-kinases in a dose-dependent manner,
and Sm preferentially activates Src and Fyn but not Yes. The ability of Sm to activate Src-kinases is
inhibited by PP2, supporting the hypothesis that Sm phosphorylation at Y457 by Src kinases is impor-
tant for Sm-dependent activation of Src-kinases. Sm also potentiates the EGF-dependent activation
of Src-kinases in keratinocytes. Under standard culture conditions, higher Sm levels increased the
amount of activated p44/42 MAP kinase in keratinocytes; subsequent EGF stimulation led to a rapid
decrease in levels of activated p44/42 within Sm-infected cells. Increased levels of Sm induced
decreased BrdU incorporation in primary keratinocytes, and were associated with an increased per-
centage of cells in G2/M and a decreased percentage of cells in S phase. These results demonstrate
that Sm may modulate growth-regulatory pathways in human keratinocytes and play a role in epi-
dermal homeostasis. 
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Effects of mechanical stimuli on mitogen-activated protein kinases phosphorylation
J Zaper,1,2 M Hofmann,1,2 A Bernd,1 J Bereiter-Hahn,2 R Kaufmann1 and S Kippenberger1 1
Dermatology and Venerology, University Hospital Frankfurt/Main, Frankfurt/Main, Germany and
2 Kinematic Cell Research Group, JW-Goethe University, Frankfurt/Main, Germany
Human skin is exposed to mechanical stimuli such as stretching and consecutive relaxation by mus-
cles induced forces. Epithelial cells were mechanically stimulated in an in vitro stretching device
including silicon rubber chambers. We established three different models (A, B, C) in order to study
the effect of stretching and relaxation on phosphorylation of ERK1/2, p38 and c-jun NH2-terminal
kinase (JNK1/2). In model (A) cell relaxation was studied by withdrawal of stretch. In model (B)
cells were slowly stretched for about 3 hours and then immmediately relaxed. In model (C) a break
of about 4 hours between stretching and relaxation was inserted. Based on the relaxation time pro-
tein lysates were generated and analysed by SDS-PAGE and Western-blotting. In model (A) maxi-
mum phosphorylation of ERK1/2 appeared after 10 min while JNK1/2 peaked after 20 min. In con-
trast to this almost no phosphorylation of p38 was detected. In model (B) equal phosphorylation of
ERK1/2, p38 and JNK1/2 was measured showing a biphasic activation peaking after 5 min and 30
min. In model (C) maximum phosphorylation of ERK1/2 appeared after 10 min while JNK1/2 peaked
at 15 min after relaxation. No phosphorylation of p38 was detected in model (C). Our experimental
results showed that different stretch-relaxation regimes lead to distinct phosphorylation patterns of
ERK1/2, p38 and JNK1/2. These findings indicate that MAPK-signaling is differentally regulated
by mechanical stimuli and may have implication for the molecular understand of abdominal skin
reduction after pregnancy. 
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Calcium induced keratinocyte differentiation requires src and fyn activation of phos-
phatidylinositol 3-kinase
Z Xie, PA Singleton, LY Bourguignon and DD Bikle Endocrine Unit, VA Medical Center / UCSF
and NCIRE, San Francisco, CA
We have previously demonstrated that phospholipase C-γ1 (PLC-γ1) is required for calcium-induced
keratinocyte differentiation. In the present study, we investigated whether the activation of PLC-γ1
by non-receptor kinases such as src and fyn plays a role in mediating calcium-induced keratinocyte
differentiation. We found that treatment of cells with a src family inhibitor PP2 or the expression of
the combination of dominant negative src and fyn prevented the activation of PLC-γ1 as well as the
subsequent induction of the keratinocyte differentiation markers involucrin and transglutaminase by
calcium. The activation of PLC-γ1 by calcium was seen as early as 5 minutes after calcium admin-
istration. The increase in PLC-γ1 activity was accompanied by an increase in the enzymatic activi-
ties of c-src and fyn within minutes, and a subsequent increase in c-src protein level within hours.
However, unlike the activation of PLC-γ1 by epidermal growth factor, calcium activation of PLC-
γ1 was not a result of tyrosine phosphorylation. To determine whether calcium activates PLC-γ1
through a non-phosphorylation mechanism such as phosphatidylinositol trisphosphate (PIP3), we
examined the effects of calcium on phosphatidylinositol 3-kinase (PI3K), the enzyme that produces
PIP3 from PIP2 in the membrane. In particular, we determined whether calcium induced the phos-
phorylation of the p85α regulatory subunit of PI3K, and found that it did. The phosphorylation of
p85α paralleled the increase in PI3K activity as expected. The induction of phosphorylation of
p85α was blocked by the src family inhibitor PP2 or the expression of the combination of dominant
negative src and fyn. Inhibiting PI3K with PI3K inhibitors LY294002 and wortmannin blocked cal-
cium activation of PLC-γ1 as well as the induction of keratinocyte differentiation markers involu-
crin and transglutaminase. These data indicate that calcium activates PLC-γ1 via increased PIP3 medi-
ated by c-src and fyn activated PI3K, and this activation is required for calcium-induced keratinocyte
differentiation. 
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Mouse keratinocytes are relatively resistant to UV-light and chemotherapy-induced apoptosis
compared to human keratinocytes
P Bacon, V Chaturvedi and BJ Nickoloff Oncology Institute, Loyola, Maywood, IL
Despite widespread use of transgenic mouse models to study carcinogenesis, few investigators directly
compare proliferating mouse keratinocytes (mKCs) to human (hKCs). Since many insights into reg-
ulation of apoptosis and pathogenesis of skin cancer have derived from animal models, we charac-
terized apoptotic responses of mKCs versus hKCs using stimuli implicated in either the cause of
cancer (UV-light), or treatment of cancer (adriamycin). mKCs were obtained from CELLnTEC (Bern)
and grown in serum-free medium (CnT-02) yielding dividing cells with doubling time of 24 hrs.
hKCs were grown in serum-free medium (KGM, Clonetics), which had similar morphology and
growth curve to mKCs. However, apoptotic responses of these proliferating cell types were differ-
ent. When hKCs are exposed to UV-light over a dose range of 5 to 100 mJ/cm2 there is progressive
increase in apoptotic cells (24 - 72 hrs) as assessed by annexin staining, or PI staining and DNA
content analysis by FACS with Sub-G0 levels. At 50 mJ/cm
2 over 75% of all hKCs are apoptotic by
48 hrs. By contrast, mKCs are almost completely resistant to apoptosis using UV doses of 15 and
30 mJ/cm2, and even at 50 mJ/cm2 less than 25% of cells are apoptotic after 48 hrs. When KCs were
treated with DNA damaging agent-adriamycin (0.1 µg/ml; 48 hrs), hKCs were approximately 2 fold
more susceptible to apoptosis compared to mKCs. To determine if medium influenced results, murine
KCs were grown in KGM, but this did not enhance their apoptotic responses. To probe the mecha-
nism underlying these unexpected results, we focused on the tumor suppressor gene, p53, as a well-
known regulator of apoptosis in response to UV-light and DNA damage. hKCs contained higher
levels of p53 by Western blot analysis as well as by promoter reporter assays for several target genes
including p21 and GADD45 when compared to mKCs. These results indicate caution is warranted
when extrapolating apoptotic responses from mice to human skin, since cultured mKCs are signif-
icantly more resistant to apoptosis induced by either UV-light or adriamycin. 
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Activation of β-catenin and c-myc inhibits epithelialization in chronic wounds
O Stojadinovic,1 H Brem,2 C Vouthounis,1 B Lee,1 M Stallcup3 and M Tomic1 1 Dermatology, NYU
School of Medicine, New York, NY, 2 Surgery, Mt. Sinai School of Medicine, New York, NY and 3
Pathology, USC, Los Angeles, CA
Lack of understanding of molecular pathogenesis of impaired healing in chronic ulcers leads to a
serious health problem that contributes to excessive limb amputations and mortality. Using biopsies
from patients with chronic wounds, skin organ culture and primary keratinocytes in culture we iden-
tified that β-catenin and its downstream target, c-myc, play important role in development of chronic
wounds. In contrast to normal epidermis, we observed significant nuclearization of β-catenin and
elevated c-myc expression at the non-healing wound edge of patients with chronic ulcers. In vitro
studies indicated that activation and stabilization of nuclear β-catenin inhibits wound healing and
keratinocyte migration by: blocking EGF response and inducing c-myc. Using Affymetrix large scale
microarrays we found that β-catenin downstream target, c-myc, is induced in skin by an inhibitor of
wound healing (glucocorticoids) and repressed in the initial phase of normal wound healing, 4 to
48hr, whereas it becomes de-repressed at 96hr post wounding. Therefore, the activation of β-catenin/c-
myc pathway(s) contributes to impaired healing by inhibiting of keratinocyte migration and alter-
ing keratinocyte differentiation. The presence of activated β-catenin and c-myc in the epidermis of
chronic wounds may serve as molecular markers of impaired healing and future targets for thera-
peutic intervention. While β-catenin signaling has been implicated in epithelial development and
oncogenesis its role in wound healing has never been postulated. This further illustrates the impor-
tance of tissue context specificity, because β-catenin in the context of malignant tissue promotes
invasion whereas in the context of a wound environment does the opposite. 
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O-glycosylation of epidermal catenins: cloning and characterization of the fruit fly and murine
O-GlcNAc transferases
P Hu,1 D McEwen,2,3 P Berkowitz,1 L Seminario,1 M Peifer2,3 and D Rubenstein1 1 Dermatology,
University of North Carolina-Chapel Hill, Chapel Hill, NC, 2 Biology, University of North
Carolina-Chapel Hill, Chapel Hill, NC and 3 Lineberger Comprehensive Cancer Center,
University of North Carolina-Chapel Hill, Chapel Hill, NC
O-glycosylation at serine and threonine residues has been shown to modify and regulate a variety
of intracellular proteins. We describe the cloning and characterization of the Drosophila melanogaster
and Mus muscularis O-glycosyltransferases and their expression in transgenic organisms and cell
lines. Both enzymes are structurally similar. The Drosophila OGT (dOGT) cDNA and the murine
(mOGT) cDNA encode proteins whose predicted amino acid sequences are 73% identical to each
other and 80% and 83% identical to human OGT, respectively. The protein expressed from the dOGT
transgene has an intracellular distribution localizing to both the cell cytoplasm and nucleus. In vivo
expression of the dOGT transgene results in increased O-glycosylation of intracellular proteins. O-
glycosylation of mammalian β-catenin and the Drosophila homolog Armadillo were observed. The
high degree of similarity between the fly and mammalian OGTs implies a fundamentally important
regulatory role. 
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Telomere overhang-induced DNA damage signals involve activation of the Fanconi
anemia/BRCA pathway
TM Ruenger, M Potter and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
Ubiquitylation of the protein FANCD2, which is mutated in the Fanconi anemia (FA) complemen-
tation group D2, marks the activation of the recently described FA/BRCA DNA damage response
pathway, known to be induced by ionizing radiation and DNA crosslinking agents. This pathway
involves gene products of various complementation groups of FA, a cancer-prone chromosome break-
age disorder, and BRCA1 and BRCA2, which are mutated in familial breast cancer. Upon ubiqui-
tylation, FANCD2 forms nuclear foci with BRCA1, NBS1, MRE11, and Rad50, and activates DNA
repair through homologous recombination and DNA end-joining. Until now, the FA/BRCA DNA
damage response pathway has not been clearly linked to the well-characterized DNA damage responses
mediated via p53 and its downstream effectors. Since previous reports from our laboratory demon-
strate that oligonucleotides homologous to the telomere 3′-overhang sequence (T-oligos) activate
p53-mediated DNA damage responses, we studied the effect of T-oligos on the FA/BRCA pathway
and its relation to p53 responses. As early as 12 hours after adding an 11-base T-oligo to cultured
primary human fibroblasts, but not after adding complementary oligonucleotides, a prominent shift
was observed from FANCD2-S-isoforms (non-ubiquitylated) to FANCD2-L-isoforms (ubiquity-
lated) in Western blots, indicating an activation of the FA/BRCA pathway by the T-oligos. Maxi-
mum activation was observed at 24 hours, with degradation of FANCD2 on days 2, 3, and 4. Phos-
phorylation of FANCD2, which is part of a separate, ATM-dependent pathway, was not observed
with the T-oligo, as there were no band shifts and no reactivity with a phospho-specific FANCD2
antibody. Activation (serine-15 phosphorylation) and induction of p53 by T-oligo was significantly
abrogated in primary fibroblasts from FA patients. This indicates that p53-mediated responses and
the FA/BRCA responses, which have been considered to be part of two independent damage sig-
naling pathways, actually act in concert, and suggest that activation of the FA/BRCA pathway has
effects upstream of p53 activation. 
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UV irradiation activates epidermal growth factor receptor via reactive oxygen-mediated inhi-
bition of receptor type protein tyrosine phosphatase
Y Xu, GJ Fisher and JJ Voorhees Dermatology, University of Michigan, Ann Arbor, MI
Ultraviolet (UV) irradiation rapidly activates epidermal growth factor receptor (EGFR) protein
tyrosine kinase (PTK) activity, which drives UV-induced signaling in human keratinocytes (KC).
UV irradiation generates reactive oxygen species (ROS) in cells. All protein tyrosine phosphatases
(PTP) are highly susceptible to inhibition by ROS due to redox-sensitive catalytic cysteine residues.
We investigated the contribution of ROS-mediated PTP inhibition to UV-induced EGFR activation
in KC. Membrane fractions prepared from KC were supplemented with ATP and magnesium, and
EGFR activation was measured by tyrosine autophosphorylation, using Western blot. Addition of
EGF activated EGFR 5-fold (p<0.05) in the membrane fraction. Addition of hydrogen peroxide
activated EGFR 12-fold (p<0.05), and concurrently decreased phosphatase activity 2-fold (p<0.05).
Addition of PTP inhibitors orthovandate or vanadate also activated EGFR 18-fold and 25-fold, respec-
tively (p<0.05), providing evidence that inhibition of membrane-associated PTPs results in EGFR
activation. Specific EGFR kinase inhibitor PD169540 blocked stimulation of EGFR tyrosine phos-
phorylation by both hydrogen peroxide and vanadate, demonstrating that EGFR tyrosine phospho-
rylation was dependent on EGFR tyrosine kinase activity. To further examine the ability of ROS to
activate EGFR and inhibit PTPs, isolated KC membranes were irradiated with visible light in the
presence of rose bengal, which generates singlet oxygen. Irradiation activated EGFR 20-fold, and
coincidently inhibited membrane-associated PTP activity 3-fold (p<0.05). Removal of non-integral
membrane proteins by 0.5M NaCl extraction of the membranes did not alter ROS induction or EGFR
activation. Our data support the concept that UV generated ROS inhibits integral membrane recep-
tor type PTP activity resulting in increased EGFR tyrosine phosphorylation in KC. Receptor type
PTPs are a novel target for antioxidant protection against UV-induced skin damage. 
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Interleukin-1β induce c-fos gene expression through a mechanism involving ERK/p38 mito-
gen-activated protein kinases-MSK1-CREB activation
M Schiller1,2 and A Mauviel2 1 Department of Dermatology, University of Muenster, Muenster,
Germany and 2 Hospital Saint Louis, INSERM U532, Paris, France
Interleukin-1β (IL-1β) plays a central role in acute and chronic inflammation. At the transcriptional
level, IL-1β promotes expression of a variety of immediate-early-response genes like c-fos. In turn,
immediate-early-response genes influence the expression of secondary response genes contributing
to the phenotypic response of the cell to proinflammatory stimuli. It is known that stimulus-depend-
ent gene transcription of c-fos, is mediated via several cis-acting elements, including at least three
cAMP response elements and a serum response element. However, the precise mechanisms by which
IL-1β induce c-fos gene expression remain unclear. Here we show that inhibition of either ERK or
p38 mitogen-activated protein kinases (MAPK) abolished IL-1β-induced c-fos gene expression in
human HaCaT keratinocytes as revealed by northern blotting and by use of a c-fos-promoter-con-
taining reporter construct. We further provide evidence that the p38-MAPK- and ERK-activated
kinase MSK-1 is required for full c-fos gene transcription, as well as for the phosphorylation of
cAMP response element-binding protein (CREB). In contrast, the adenylate cyclase activator forskolin-
, or exogenous prostaglandin E2-induced c-fos gene transcription was barely detectable in HaCaT
keratinocytes, and indomethacin, an inhibitor of cyclo-oxygenase-1/2, only marginally abolished IL-
1β-induced CREB phophorylation and c-fos gene expression. In conclusion, these results show that
MSK1 is an important p38-MAPK- and ERK-activated mediator of IL-1β-stimulated c-fos induc-
tion. In addition, they indicate that MSK1 could act through CREB-phosphorylation to archieve c-
fos promoter activation, while IL-1β-induced prostaglandin secretion may only marginally contribute
to c-fos gene expression. Thus, these studies provide additional insights into the complex molecu-
lar regulation of the prototypical immediate-early-response gene c-fos.
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Urokinase-type plasminogen activator expression by sphingosylphosphorylcholine in cultured
human dermal fibroblasts and its role in wound model
K  Kye, C Kim, K Suhr, Y Seo, J Park and J Lee Chungnam National University, Daejeon, South
Korea
Sphingosylphosphorylcholine (SPC) is a bioactive sphingolipid metabolite that can enhance wound
healing. Although SPC is known to act as a mitogen in wound healing, the precise mechanism under-
lying the acceleration of wound healing remains to be elucidated. Plasminogen activator system is
well known to affect wound healing by regulating the fibrinolytic environment of the wounded area.
In the previous study, we demonstrated the SPC markedly induced the expression of plasminogen
activator inhibitor-1 (PAI-1) in human dermal fibroblasts, at both the transcriptional and translational
levels. In this study, we further examined the effect of SPC on urokinase-type plasminogen activa-
tor (uPA) expression in human dermal fibroblast cultured in vitro. ELISA showed that SPC signifi-
cantly induced the release of uPA from human dermal fibroblasts. Consitent with this, Northern blot
analysis indicated that SPC markedly increased the mRNA level for uPA. In in vitro wound model,
SPC markedly enhanced the proliferation and migration of fibroblast in a time- and dose-dependent
manner, leading to fast closure of wounded area. In addition, SPC-stimulated wound closure was
significantly attenuated by neutralization with anti-uPA antibody. These results suggest that SPC
could enhance the wound healing process through the induction of uPA, with the stimulatory effect
on cell migration. 
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Insulin like growth factor-II-mediated cyclooxygenase-2 gene expression in human keratinocytes
through extracellular signal-regulated kinase pathway
H Kim and T Kim Dermatology, The Catholic University of KOREA, Seoul, South Korea
Psoriasis is a chronic disease characterized by abnormal epidermal proliferation and inflammation.
IGF-II is increased in psoriatic lesions, especially in the serum or blister fluid of psoriasis patients.
To examine the relationship between IGF-II and the inflammatory response involved in psoriasis,
we monitored inflammatory factor COX-2 expression in the IGF-II treated human keratinocytes
and explored the IGF-II signaling pathways with respect to the expression of COX-2. IGF-II induced
COX-2 mRNA and COX-2 protein level in the primary normal keratinocytes and HaCaT. The up-
regulation of COX-2 expression by IGF-II was reduced by pretreatment with inhibitors of tyrosine
kinase, Src and PI3-kinase. The ERK inhibitor, PD98059, also reduced the increased expression of
COX-2 genes by IGF-II, whereas the p38 inhibitor, SB203580, did not. To further examine the roles
of these two MAPKs in IGF-II-induced COX-2 expression, we performed COX-2 promoter analy-
sis using dominant negative plasmids of MEK1 and p38. Although IGF-II increased COX-2 pro-
moter activity approximately 2.5-fold, this increase was blocked by cotransfection with dominant
negative MEK1 mutant. However, dominant negative p38 mutant did not block the IGF-II-induced
COX-2 promoter activity. In addition, inhibition of ERK with PD98059 reduced the increases of
IGF-II-induced PGE2 synthesis or cell proliferation. These results suggest that IGF-II induces COX-
2 expression through the tyrosine kinase-Src-ERK and tyrosine-kinase-PI3-kinase pathways, but not
via the p38 MAPK pathway. 
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Delineating the role of PKCα in skin proliferation, differentiation and wound healing utiliz-
ing PKCα null mice
E Yousufov,1 R Spiro,1 M Gartsbein,1 A Alt,1 M Leitges2 and T Tennenbaum1 1 Faculty of Life
Sciences, Bar Ilan University, Ramat Gan, Israel and 2 Max Planck Institute, Hanover, Germany
PKCα, a classical PKC isoform, is implicated in proliferation and differentiation of keratinocytes
in vitro and in the wound healing process in vivo. We have further delineated the role of PKCα iso-
form in skin, by utilizing PKCα knockout (KOα) mice. The KOα mice are born viable and are fer-
tile. Furthermore, skin gross appearance and morphology is normal. Mouse keratinocytes isolated
from wild type (WT) and KOα mice were characterized in vitro. Both WT and KOα keratinocytes
attached normally to the culture dish. In addition, proliferation of KOα keratinocytes as measured
by thymidine incorporation was similar to WT cells. Next, we studied the differentiation potential
of WT and KOα cells by elevating calcium concentrations in the growth medium. In comparison to
WT cells, differentiating KOα keratinocytes expressed lower levels of spinous markers keratin 1 and
10 with increased expression of Loricrin, a granular differentiation marker. Overexpression (OE) of
PKCα confirmed these results. While OE of PKCα dramatically induced expression of spinous dif-
ferentiation markers Keratin 1 (K1) and Keratin 10 (K10), granular markers expression was abol-
ished. We have next subjected WT and KOα mice to wound healing studies. Full skin incisions were
made on the back of mice and wounds were followed for 7 days. In comparison to WT mice, wounds
of KOα mice induced a marked hyperpalstic response associated with improved epidermal closure.
Improved wound healing parameters were studied by immunohistochemical analysis of serial sec-
tions at the wound gap, including expression of markers of proliferation (PCNA), basal layer for-
mation (K14), differentiation (K1, K10, Loricrin and Filaggrin), migration (K6) and wound strength
(bursting chamber). Altogether, these results suggest PKCα as a main regulator of keratinocyte
spinous differentiation as well as inhibitor of granular differentiation in vitro. Furthermore, PKCα
has an inhibitory role in the epidermal wound healing processes in vivo. 
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Protein kinase Cδ serves as a divergence point in down stream insulin signaling in skin ker-
atinocytes
E Brener,1 M Gartsbein,1 T Kuroki,2 E Wertheimer3 and T Tennenbaum1 1 Faculty of Life Sciences,
Bar Ilan University, Ramat Gan, Israel, 2 Gifu University, Gifu, Japan and 3 Tel Aviv University,
Tel Aviv, Israel
Impaired insulin signaling as occurs in diabetes results in development of skin complications. We
have previously characterized the biological actions of insulin in skin utilizing mouse keratinocytes
and identified a novel role of PKCδ in mediating insulin induced keratinocyte proliferation. Bind-
ing of insulin to the insulin receptor (IR) induces tyrosine phosphorylation and activation of the
receptor. This results in recruitment and activation of the insulin receptor substrate (IRS) family of
proteins represented mainly by IRS1 and IRS2. IRS proteins become platforms for other signaling
molecules, such as PI3K (Phosphoinositide 3-Kinase). We have further characterized the down stream
elements associated with insulin stimulation in primary murine keratinocytes. In Insulin treated ker-
atinocytes IR, IRS1 and IRS2 are phosphorylated and activated in a dose and time dependent man-
ner. In keratinocytes, insulin induces PKCδ association with IR. Overexpressing PKCδ induces
PKCδ-IR association, coupled to activation of IR. Whereas inhibition of PKCδ activity by overex-
pressing D/NPKCδ abolishes PKCδ-IR association and enhances IR activation. In addition, PKCδ
associates with IRS2, but not with IRS1. Furthermore, overexpressing WTPKCδ, inhibits IRS2 phos-
phorylation and induces IRS1 phosphorylation suggesting an inhibitory role for PKCδ in mediating
IRS2 signaling pathway. In concordance with these results inhibiting PKCδ by overexpressing
D/NPKCδ, reduces PKCδ-IRS2 association, induces IRS2 phosphorylation while IRS1 phosphory-
lation is reduced. We also demonstrate that overexpression of WTPKCδ inhibits IRS2-PI3K associ-
ation while D/NPKCδ increases IRS2-PI3K association. In conclusion: Activation of PKCδ drives
insulin signaling toward an IRS1 dependent pathway while blocking PKCδ activity leads to IRS2-
PI3K dependent pathway. These results suggest PKCδ activation as a divergence point in mediating
down stream insulin effects in keratinocyte physiology. 
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Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes
B Bang1,2 and R Gniadecki1 1 Dermatology, Bispebjerg hospital, Copenhagen, Denmark and 2
Dermatology, Gentofte Hospital, Copenhagen, Denmark
Lipid rafts are cholesterol-enriched microdomains in plasma membranes. The functional activity of
many membrane proteins, including death and growth factor receptors, depends on their insertion
in lipid rafts. We have previously demonstrated presence of lipid rafts in keratinocytes and shown
that lipid rafts are involved in the control of keratinocyte proliferation and metabolic activity. In this
work we investigated the effect of lipid raft disruption on HaCaT keratinocyte survival. Lipid rafts
could be disrupted or rearranged with cholesterol targeting detergents: methyl-β-cyclodextrin and
filipin III. Moreover, cholesterol oxidation by a specific oxidase or blocking of cholesterol synthe-
sis by mevastatin had a similar effect on lipid rafts. All cholesterol modifying substances caused cell
death in a concentration-dependent manner. More detailed studies on the effects of cyclodextrin
revealed apoptotic cell death in concentrations >0.5 % (w/v). The molecular mechanism of apopto-
sis precipitated by raft disruption awaits further studies. 
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STAT3 regulates proliferation and differentiation in primary keratinocytes
M Gartsbein,1 A Alt,1 T Kuroki,2 Y Hanakawa,3 K Hashimoto,3 K Nakajima4 and T Tennenbaum1
1 Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel, 2 Gifu University, Gifu, Japan,
3 Ehime University, Ehime, Japan and 4 Osaka City University, Osaka, Japan
STAT3 is a member of a family of Signal Transducers and Activators of Transcription associated
with diverse biological actions. In previous studies we identified STAT3 as a downstream mediator
of insulin and PKCδ signaling in keratinocyte proliferation. Both tyrosine phosphorylation (tyr
705) and serine phosphorylation (ser 727) were shown to be critical in regulation of STAT3 activa-
tion state and the functional consequences associated with induction of transcription. In the present
study we have investigated the contribution of STAT3 expression including the significance of its
serine and tyrosine phosphorylation sites in keratinocyte proliferation and differentiation. Experi-
ment was performed in primary murine keratinocyte cultures utilizing wild-type STAT3 (WTSTAT3),
STAT3 tyrosine inactive mutant (DNSTAT3) and STAT3 serine 727 inactive mutant (SmS) recom-
binant adenoviruses. Differentiation was induced by elevating calcium concentrations in the growth
medium. Overexpression of WTSTAT3 induced proliferation as analyzed by thymidine incorpora-
tion and expression of PCNA, a nuclear marker of cell proliferation. Moreover, overexpression of
WTSTAT3 inhibited expression of calcium induced spinous differentiation markers (Keratin 1 and
Keratin 10) as well as inhibited expression of granular differentiation markers (Loricrin and Filag-
grin). In concordance with these results overexpression of DNSTAT3 increased levels of both spin-
ous differentiation markers ( Keratin 1 and Keratin 10 ) as well as granular differentiation markers
(Loricrin and Filaggrin). Interestingly, serine mutant STAT3 increased spinous differentiation mark-
ers with no changes observed in the levels of Loricrin and Filaggrin expression. Both tyrosine and
serine mutants did not affect keratinocyte proliferation. Altogether these results suggest an active
role for STAT3 in mediating keratinocyte proliferation and initiating the differentiation program in
keratinocyte physiology. 
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The inhibition of mastocytosis mast cell growth using KIT kinase inhibitors
I Chan, S Kasprowicz and MD Tharp Dermatology, Rush University Medical Center, Chicago, IL
The autoactivating (D816V) point mutation in the KIT receptor is associated with adult mastocyto-
sis. One strategy for treating adult mastocytosis is to inhibit the signaling pathways of autoactivated
KIT with protein kinase inhibitors. Our previous studies using Jak3 and MAPK inhibitors (Whi-
P131 and UO126) on human mastocytosis mast cell lines (HMC-1 and RMT) have shown that
JAK3/STAT3 is the predominate signaling pathway in KIT initiated mast cell growth. Addition of
the JAK3 specific inhibitor Whi-p131 (20µM) to cell culture for 3 days reduced the growth of mas-
tocytosis mast cell line HMC-1 to 38±7%, as compared to cells in medium alone. To potentiate this
finding, PKC inhibitors (Safingol and GÖ6976),PI3K inhibitor (Wortmannin) and STAT3 inhibitor
(AG490) were added to mast cell cultures with or without Whi-P131.  The presence of Safingnol
(5µM), Wortmannin (5µM) and GÖ6976 (5µM) in mast cell culture for 3 days inhibited HMC-1
growth by 80±7%, 36±5% and 65±3% respectively. Although, a high concentration of AG490 (50µM)
did not inhibit mast cell growth, a combination of AG490 (50µM) with Whi-P131 (20µM) did enhance
the growth inhibitory effect of Whi-P131 on HMC-1 to 78±11%. The JAK3/STAT3 pathway involves
the activation of JAK3 followed by the activation of STAT3 dimmers, leading to gene expression
and cell proliferation. It appears that a combination of the JAK3 and STAT3 specific inhibitors,
Whi-P131 and AG490 are more effective than each individual drug used alone in the inhibition of
mastocytosis mast cell growth. Moreover, when Whi-P131, AG490 and a combination of the two
inhibitors were added to normal neonatal skin cell culture controls for 3 days, the growth inhibitory
effect was less prevalent, 15±4%, 16±4% and 34±4% respectively. These results further confirm
that the JAK3/STAT3 pathway is important in the transduction of the mutated (D816V) KIT recep-
tor, but not in normal KIT receptors. Thus, targeting mastocytosis mast cells expressing mutated KIT
with a combination of JAK3 and STAT3 specific inhibitors may prove to be useful in the treatment
of adult mastocytosis. 
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Potential downstream targets of over-expressing RhoC in human melanomas
Y Xu, M Fujita, D Marr, D Norris and Y Shellman Dermatology, B153, University of Colorado
HSC, Denver, CO
Over-expression of RhoC in various human cancers has been correlated with metastatic stage of
tumor progression and poor prognosis of cancer patients in most cases. RhoC has also been identi-
fied as one of the genes that enhance metastasis in human melanoma cell line A375, and mouse B16
melanoma cell line (Clark et al. 2000, Nature). The purpose of this work was to understand how
RhoC over-expression contributes to human melanoma metastasis.
We have established stable transfectants over-expressing RhoC, using a human radial growth phase
melanoma cell line, WM35. To identify potential downstream targets of over-expression of RhoC in
WM35 cells in a global way, we performed Affymatrix microarray assays using human U133A
chip. We identified 73 potential genes as downstream targets of RhoC over-expression. Some of these
genes are tumor progression markers, and many have well-defined functions in migration, detach-
ment, and invasion of cells. Unexpectedly, we also found significant changes in some genes involved
in immune surveillance. Our preliminary FACS analysis confirmed that over-expression of RhoC
down-regulated these genes involved in immune surveillance. These data suggest that RhoC over-
expression might promote melanoma metastasis by modulating important functional characteristics
of migration, detachment and invasion, and also by enhancing tumor immune escape. These studies
identified a potential novel mechanism by which RhoC over-expression might promote melanoma
metastasis.
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Blockade of ERK-dependent autocrine keratinocyte proliferation by Src family iinase inhibitors
and calcium
S Kansra,1 SW Stoll,1 JL Johnson1 and JT Elder1,2 1 Dermatology, University of Michigan, Ann
Arbor, MI and 2 VA Medical Center, Ann Arbor, MI
c-Src potentiates proliferation, survival, and invasiveness in response to activation of ErbB1 in human
mammary carcinoma cells overexpressing c-Src and ErbB1. A key mediator of these events is acti-
vation of Tyr 845 of ErbB1 by c-Src, with subsequent activation of STAT5. Here we demonstrate
that normal human keratinocytes (NHK) express c-Src and c-Yes at levels comparable to mammary
carcinoma cells, and that Tyr 845 undergoes phosphorylation in response to high concentrations of
EGF (10-100 ng/ml). Low concentrations of either of two Src family kinase (SFK) inhibitors (PP1
or PD173952) markedly reduced EGF-stimulated Tyr 845 phosphorylation. Both inhibitors also
blocked autocrine proliferation of NHK in a way that could not be overcome by EGF. However,
autocrine growth of NHK is driven by very low concentrations of ErbB ligand(s) (< 1 ng/ml), sug-
gesting that Tyr 845 phosphorylation may not be relevant to the process of autocrine NHK growth.
Interestingly, the MEK activation inhibitor U0126 also inhibited autocrine NHK growth in a way
that could not be overcome by EGF. Moreover, PP1 and PD173952 potently inhibited ErbB-medi-
ated ERK phosphorylation under autocrine conditions and in response to low concentrations of
EGF (1ng/ml). Increasing the calcium concentration from 0.1 to 0.2 mM dramatically inhibited
autocrine ERK activation and autocrine proliferation of NHK. However, unlike the effects of SFK
inhibitors, the effects of calcium on proliferation were readily reversed by EGF. Taken together, these
observations suggest that calcium acts upstream of ErbB1 to inhibit autocrine ERK activation, which
in turn inhibits proliferation. In contrast, SFKs appear to act downstream of ErbB1, coupling acti-
vation of ErbB1 to activation of ERK. By promoting phosphorylation of ErbB1 Tyr 845, overex-
pression of ErbB1 and c-Src may allow carcinoma cells to rewire this highly calcium-sensitive, ERK-
dependent pathway of autocrine proliferation to a STAT-dependent pathway that is calcium-resistant. 
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A potential role for the aquaporin-3/phospholipase D2 signaling module in keratinocyte dif-
ferentiation
WB Bollag,1,2 X Zheng2 and X Zhong2 1 Medicine (Dermatology), Medical College of Georgia,
Augusta, GA and 2 Institute of Molecular Medicine and Genetics, Medical College of Georgia,
Augusta, GA
Aquaporin-3 (AQP3) is a member of the aquaporin family of water channels; however, it belongs to
the subfamily of aquaglyceroporins that also transport glycerol. In fact, AQP3 efficiently transports
glycerol but is quite inefficient in water transport. We recently demonstrated that AQP3 is associ-
ated with phospholipase D2 (PLD2) in caveolin-rich membrane microdomains. PLD is known to
catalyze both a hydrolysis reaction to produce phosphatidic acid and also, in the presence of pri-
mary alcohols, a transphosphatidylation reaction to generate phosphatidylalcohols. We have also
shown that PLD2 can utilize the physiological primary alcohol glycerol to form phosphatidylglyc-
erol (PG) via this transphosphatidylation reaction. We hypothesized that AQP3 provides glycerol to
PLD2 to produce PG and that this signal acts to induce keratinocyte differentiation. Since the trans-
port activity of AQP3 is inhibited at low pH in other systems, we determined the effect of low pH
on radiolabeled glycerol transport and PG production in keratinocytes. Both glycerol uptake and PG
synthesis were inhibited at low pH (pH 4). We also performed co-transfection experiments in which
an empty vector or AQP3 was transiently introduced into keratinocytes simultaneously with reporter
constructs composed of keratinocyte differentiation or proliferation promoters directing expression
of a luciferase reporter gene. Overexpression of AQP3 decreased the promoter activity of the pro-
liferative marker keratin 5 and increased the promoter activities of the differentiative markers, ker-
atin 10 and involucrin. In addition, low concentrations of added glycerol (0.02 to 0.1% volume:vol-
ume) inhibited DNA synthesis. Higher concentrations (0.1 to 1%) also decreased DNA synthesis,
whereas the same concentrations of xylitol, as an osmotic control, had little or no effect. Thus, our
results support the idea that in epidermal keratinocytes AQP3 supplies PLD2 with glycerol for syn-
thesizing PG and that this signaling module may mediate induction of keratinocyte differentiation. 
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JNK activation cooperates with oncogenic Ras to induce invasive human epidermal neoplasia
JY Zhang,2 S Tao2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA and 2 Stanford, Stanford, CA
The c-jun N-terminal kinase (JNK) MAP kinase cascade acts in parallel with the NF-kB pathway
downstream of TNFR1 to regulate morphogenesis in a variety of tissues. In human epidermis, only
2 genetic alterations - NF-kB blockade along with oncogenic Ras - are sufficient to trigger invasive
neoplasia. In mediating these effects, NF-kB inhibition both bypasses Ras-triggered CDK4 down-
regulation and cellular senescence to permit uncontrolled proliferation as well as enables tumor
growth independent of exogenously added matrix. We recently observed that epidermal NF-kB block-
ade leads to JNK activation and that this augmented JNK activity is essential for the increased pro-
liferation seen in this setting. These data raised the possibility that JNK induction represents the
major functional effect of inhibiting epidermal NF-kB function and that activation of the JNK cas-
cade might be sufficient to replace NF-kB blockade as an enabler of Ras-driven epidermal neopla-
sia. To address this, we examined the ability of simultaneous activation of Ras and JNK pathway
elements to drive tumorigenesis in human epidermal tissue grafted to immune-deficient mice. To
induce JNK cascade function, both constitutively active JNK isoforms and active MKK7, the JNK
pathway MAPKK activator immediately upstream of JNK proteins, were used. JNK cascade acti-
vation recapitulated all the effects of NF-kB blockade, with Ras-JNK pathway tumors indistin-
guishable from spontaneous human squamous cell carcinoma (SCC). Tumorigenesis via both Ras-
JNK induction as well as Ras-NF-kB blockade was dependent on intact AP1 function because a
dominant-negative c-jun mutant abrogated tumorigenesis, consistent with a broad role for JNK-
AP1 in Ras-driven human epidermal neoplasia. In spontaneous human SCCs, clear evidence for JNK
activation was also detected in 75% of samples examined (n=12). These data indicate that JNK cas-
cade induction enables Ras-driven human epidermal tumorigenesis and identifies this pathway for
further investigation as a possible therapeutic target in human SCC. 
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Cytokeratin expression in co-culture of bone marrow cells and skin fibroblasts
EV Badiavas,1,2 N Kouttab3,2 and P Quesenberry4,5 1 Dermatology, Roger Williams Medical Center,
Boston University School of Medicine, Providence, RI, 2 Pathology, Roger Williams Medical
Center, Brown University School of Medicine, Providence, RI, 3 Pathology, Roger Williams
Medical Center, Boston University School of Medicine, Providence, RI, 4 Research, Roger Williams
Medical Center, Boston University School of Medicine, Providence, RI and 5
Hematology/Oncology, Roger Williams Medical Center, Boston University School of Medicine,
Providence, RI
We have placed lineage negative (Lin-) selected bone marrow cells obtained from C57BL/6 mice
over adherent feeder cells derived from skin in order to the determine the effect of these feeder cells
on bone marrow cells. The adherent feeder cells were primary fibroblast cultures derived from human
neonatal foreskin. Both early and middle to late passage feeder cultures were used. Feeder cells also
consisted of early passage neonatal foreskin fibroblasts that were previously transduced with a
retroviral vector conferring high level constitutive expression of either Tranforming Growth Factor
beta-1 or Epidermal Growth Factor.  FACS analysis was performed on the adherent and non-adher-
ent cells in culture at 2 and 5 days. Cells were analyzed for expression of cytokeratin, a marker for
epidermal cell differentiation. Cytokeratin expression was detected in the non-adherent cells. No
detectable expression of cytokeratin was noted in the (adherent) feeder cells. The retroviral trans-
duced feeder co-cultures yielded a higher percentage of cytokeratin expression in the non-adherent
cells. These studies indicate that skin fibroblast cultures may have the ability to alter the phenotype
of bone marrow derived cells. 
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Increased apoptosis in cultured fibroblasts from different aged donors
R Foyouzi, D Gan, T Mammone and D Maes Biological Research, Estee Lauder Companies, Inc,
Melville, NY
Aging is characterized by loss of cells in the whole organism. The cause of this decrease in somatic
cell number is unknown. Since somatic cells accumulate damage as we age, one hypothesis for cell
loss is that they undergo programmed cell death. Fibroblasts from different aged donors were inves-
tigated to determine the levels of programmed cell death in the cultures. Caspase-3 activity is a marker
of mitochondrial directed programmed cell death or apoptosis. Using tow different assay, ELISA
and flow cytometric, we observed increased caspase-3 activity in fibroblast from different aged
donors. Mitochondria membrane potential also was lower in the higher donor ages. In addition oxy-
gen consumption decreased with donor age and reactive oxygen species increased with donor age.
These data suggest that the mitochondria function appeared to be defective which occurs during
apoptosis. The increased levels of reactive oxygen species resulted in increased oxidative damage
to DNA and RNA in the form of 8-oxoguanine. The levels of 8-oxoguanine also increased with donor
age. The fibroblasts from increasing donor age were senescencing as demonstrated by increase
beta-galactosidase staining with donor age. Therefore in aging cells we observed increased apopto-
sis
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Overexpression of Smad7 in keratinocytes accelerates cutaneous wound healing
G Han, AG Li, P Owens and X Wang Oregon Health & Science University, Portland, OR
Transforming growth factor-beta (TGF-beta) has both positive and negative effects on cutaneous
wound healing. Smad7 acts as a major downstream antagonist of TGF-beta signaling in keratinocytes
and its role in wound healing has not been defined. We have established a Smad7 transgenic mouse
line using a keratin 5 (K5) promoter (K5.Smad7) which expresses Smad7 transgene at a mild level
(~2 fold of the endogenous Smad7 in the skin). These mice did not have overt skin defects as shown
from our previous Smad7 transgenic mice expressing much higher levels of the Smad7 transgene
(EMBO J 2002, 21:2580-90). K5.Smad7 mice from the above low expressor line and non-trans-
genic littermates were subject to 6-mm full-thickness excisional wounding. K5.Smad7 mice exhib-
ited early scab rejection, reduced inflammation, and accelerated re-epithelialization as compared
with non-transgenic mice. In order to study stage-specific effects of Smad7 on wound healing, we
generated a transgenic model in which Smad7 transgene expression can be induced in the epider-
mis and hair follicles (gene-switch-Smad7) by topical RU486 application. Smad7 induction after
excisional wounding reduced inflammatory responses through suppression of a variety of inflam-
matory cytokines/chemokines in gene-switch-Smad7 mice when compared to control mice. Over-
expression of Smad7 exhibited accelerated re-epithelialization, which likely correlated with increased
expression of metalloproteinases and elevated Erk (extracellular signal-regulated kinases) signaling
in the leading epidermal edges in gene-switch-Smad7 wounds compared to control wounds. Pro-
longed Smad7 induction after excisional wounding reduced dermal fibrotic response and angiogen-
esis in the dermis, resulting in accelerated tissue repair. We conclude that the effects of Smad7 on
wound healing are likely due to blocking the inhibitory effects of TGF-beta on cutaneous wound
healing.
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Smad2 gene deletion in the epidermis and hair follicles causes alopecia in aging mice
AG Li,1 EP Bottinger2 and X Wang1 1 Oregon Health & Science University, Portland, OR and 2
Albert Einstein College of Medicine, Bronx, NY
Smad2 is a major intracellular mediator for the signal transduction of TGFβ, a cytokine that plays
a pivotal role in the maintenance of skin homeostasis. The precise role of Smad2 in the skin remains
largely unknown. Mice carrying germline deletion of the Smad2 gene caused early embryonic lethal-
ity, precluding their usage to further unravel its function in the skin. Taking advantage of a Cre-
LoxP system (K5.CrePR1/Smad2LoxP/LoxP), we have established a conditional knockout model that
allows inducible deletion of the Smad2 gene in the epidermis and follicular epithelia (K5.Smad2-/-)
upon RU486 application. In the present study, RU486 was topically applied to the entire skin of
neonatal K5.CrePR1/Smad2LoxP/LoxP mice to delete the Smad2 gene at birth. These mice did not
exhibit overt phenotypes until they were 6-month-old. By that time most of the K5.Smad2-/- mice
started to develop patchy baldness on the dorsal skin. The bald areas are well circumscribed and have
a clear border with non-alopecia area. This phenotype grossly resembles alopecia areata in humans.
None of control littermates, including wildtype and monogenic mice (K5.CrePR1 or Smad2LoxP/LoxP)
underwent similar hair loss. Histological analysis revealed numerous mononuclear cells infiltrated
into and surrounding telogen hair follcles of the lesional skin. Interestingly, inflammatory cell infil-
tration also existed in the non-lesional area. Immunohistochemistry demonstrated that the infil-
trated mononuclear cells are mainly CD4 lymphocytes and macrophages. In addition, significantly
increased apoptotic cells were found in hair follicles specifically within the areas of hair loss in the
K5.Smad2-/- mice. The epidermis of Smad2 knockout skin was slightly hyperplastic whereas epi-
dermal differentiation remained normal. These phenotypes were similar to those observed in autoim-
mune-associated alopecial areata in humans. Taken together, our study suggests that normal Smad2
involved TGFβ signaling in the epidermis may play an essential role in the maintenance of immune
homeostasis in the skin. 
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Effect of the IGF-1R on UVB-induced signal transduction
DL Farrington,2 DA Lewis,1 F Gao1 and DF Spandau1,2 1 Dermatology, Indiana University School
of Medicine, Indianapolis, IN and 2 Biochemistry, Indiana University School of Medicine,
Indianapolis, IN
UVB irradiation of human keratinocytes causes damage to the cellular genome. How keratinocytes
respond to UVB-irradiation is dependent of a variety of factors, including the UVB dose, cell-cell
interactions, cell-ECM interactions, and the presence of specific growth factors. We have previously
demonstrated at least three distinct responses of keratinocytes to UVB irradiation; 1.) complete repair
of UVB-damaged DNA and continued cellular proliferation; 2.) no repair of UVB-damaged DNA
and induction of apoptosis; or 3.) incomplete repair of UVB-damaged DNA and the induction of
stress-induced senescence. The induction of apoptosis or stress-induced senescence is influenced
by the activation state of the IGF-1R. Keratinocytes with activated IGF-1 receptors are more likely
to be induced to undergo stress-induced senescence following UVB-irradiation, while keratinocytes
irradiated without activated IGF-1R are more likely to undergo apoptosis. In this study, we have
investigated differences in UVB-induced signal transduction pathways in keratinocytes with active
and inactive IGF-1 receptors. When the IGF-1R is inactive in normal keratinocytes and the cells
irradiated with UVB, specific changes in the phosphorylation status of the pro-apoptotic protein BAD
were observed. Phosphorylation of serine 112 of the BAD protein is correlated with inhibition of
apoptosis. In IGF-1R-active keratinocytes, no change in the phosphorylation status of serine 112 of
the BAD protein was observed; however, phosphorylation of serine 112 on the BAD protein was
significantly decreased in UVB-irradiated keratinocytes containing inactive IGF-1 receptors. These
changes in BAD phosphorylation correlate with the increased sensitivity to UVB-induces apoptosis
in IGF-1R-inactive keratinocytes. 
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Mechanisms of HOXA7 and HOXA5 regulation of keratinocyte apoptosis
P LaCelle and L Parker Dermatology, Box 697, University of Rochester School of Medicine,
Rochester, NY
The critical barrier function of the constantly renewing epidermis depends on the character and abun-
dance of cells in each of the layers. The underlying architecture arises from the balance between the
rate of keratinocyte mitosis and cell cycle withdrawal, and by the rate and specific program of dif-
ferentiation. It is therefore important to understand the tight genetic regulation of proliferation, dif-
ferentiation and apoptosis, processes that are perturbed following injury, through the course of inflam-
matory and neoplastic diseases, and through the action of topically applied medications. Homeobox
transcription factors regulate differentiation and cell fate during development, and in tissues under-
going continuous renewal through proliferation and differentiation. Of the clustered, or class I home-
obox genes reportedly expressed in keratinocytes, we detected predominately HOXA7 and HOXA5.
We have documented the inhibition of keratinocyte differentiation by HOXA7, and the activation of
apoptosis by overexpressed HOXA7 and HOXA5. Importantly, transduction with vectors harboring
antisense, or truncated HOXA7 and HOXA5 cDNA attenuate both virally-induced and ultraviolet
light (UV)-induced apoptosis, suggesting a role for the endogenous HOX genes in apoptotic acti-
vation or sensitization. We have now found that the protection against apoptosis by antisense HOXA7
and HOXA5 expression is associated with a concomitant increase in NF-kB expression. HOXA5
and HOXA7 overexpression trigger apoptosis in association with increased p53 activation and p21
expression, elements of the intrinsic apoptosis cascade. In addition, blocking jun-N-terminal kinase
(JNK) activity, a kinase important in the UV induction and activation of p53, substantially blocks
HOX activation of caspase-3, a measure of apoptosis. The HOX-induced apoptotic signal also responds
to abrogation of caspase-8 activity, indicating simultaneous extrinsic, or TNF receptor family-medi-
ated apoptosis activation, or cross-talk between the intrinsic and extrinsic pathways. 
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A single cell suspension of hEGF-transfected autologous keratinocytes can improve reepithe-
lialization of porcine full-thickness wounds
D Hoeller Obrigkeit,2,1 P Velander,1 C Theopold,1 F Yao1 and E Eriksson1 1 Division of Plastic
Surgery, Brigham & Women’s Hospital, Boston, MA and 2 Hautklinik, RWTH Aachen, Aachen,
Germany
In large wounds rapid wound closure is critical to reestablish barrier function of the skin. We inves-
tigated whether a single cell suspension of autologous keratinocytes (KC) applied to porcine full-
thickness wounds can facilitate the formation of a normal epithelium, and serve as gene transfer vehi-
cles. 1.5 x 1.5 cm full-thickness wounds were created in three Yorkshire pigs, 4-months old and filled
with single cell solutions with either 1.25 x 10E5 or 3 x 10E5 autologous, or hEGF-transfected autol-
ogous KC. Control wounds received normal saline. Wounds were covered with vinyl chambers,
ensuring a wet wound environment. Wound fluid was collected daily, wound contraction was meas-
ured every third day. H&E sections from biopsies taken on day 8 to determine re-epithelialization.
EGF in wound fluids was measured by ELISA. The transplantation of 1.25 x 10E5 keratinocytes did
not improve wound healing. However, on day 8, re-epithelialization in wounds transplanted with 3
x 10E5 KC was 46.3% in wounds receiving autologous KC, 58.2% with hEGF-transfected KC, and
39.15% in saline control wounds. Differences between KC treated groups and the saline control,
and between untransfected and EGF-transfected KC wounds were statistically significant. Wound
contraction did not differ between the groups. Wound fluid showed elevated hEGF levels in hEGF-
transfected allogenic KC wounds, ranging from 4574 pg/ml on day 1, 7901 pg/ml on day 2, 2908
pg/ml on day 3 and then reduced on day 4 from 904 pg/ml to 74 pg/ml on day 9. No hEGF expres-
sion could be detected in the untransfected or saline control wounds. We were able to demonstrate
that single cell solutions of KC can function as gene transfer vehicles for EGF cDNA and are able
to further improve the rate of reepithelialization. 
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Resveratrol-induced modulation of MEK-ERK signaling and cell cycle regulation in human
epidermoid carcinoma A431 cells
AL Kim, H Zhu, Y Zhu, M Athar and DR Bickers Dermatology, Columbia University, New York,
NY
Resveratrol (trans-3, 4’, 5-trihydroxystilbene) is a naturally occurring polyphenolic phytoalexin found
in grapes, peanuts, seeds, and berries with promising cancer chemopreventive potential. To probe its
mechanism of action we investigated the effects of resveratrol on cell cycle regulation and prolifer-
ation in the human epidermoid carcinoma A431 cell line. Resveratrol treatment (25 microM - 100
microM) of these cells resulted in a time- and dose-dependent accumulation of cells in G1/S. The
resveratrol-induced G1/S arrest was associated with marked inhibition of cell cycle regulatory pro-
teins, including cyclins A and D1 and cyclin-dependent kinase (cdk) 4 and 6. Cell cycle arrest occurred
concomitantly with the accumulation of hypophosphorylated Rb and induction of p53 and the cdk
inhibitor p21Waf1/Cip1. Resveratrol treatment specifically increased the phosphorylation of p53 at
Ser15, but not at Ser20 or Ser392, residues known to regulate the stability, and thus the level, of the
protein.  p21Waf1/Cip1 was increased as detected by Western Blot and real-time RT-PCR. Resver-
atrol inhibited the proliferation of A431 cells as shown by a 2.5-fold decrease in [3H]-thymidine
incorporation after 48 hours. To further investigate the upstream signaling components underlying
the anti-proliferative effects of resveratrol we assessed the activation of extracellular signal-regu-
lated kinases 1/2 (ERK1/2) that are linked to cell proliferation and survival in various cancers, includ-
ing skin cancer. ERK activation is also shown to transcriptionally induce the cyclin D1 gene. Addi-
tion of resveratrol to A431 cells attenuated the phosphorylation-dependent activation of ERK1/2
through the MEK-ERK signaling pathway. These results suggest that resveratrol may act at multi-
ple sites to inhibit cell proliferation and these effects may underlie its efficacy as a cancer chemo-
preventive agent. 
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Differential roles of insulin and IGF1 in skin—an organotypic coculture model
M Sadagurski,1 G Sizyakov,1 D Breitkreutz2 and E Wertheimer1 1 Sackler Medical School, Tel Aviv,
Israel and 2 DKFZ, Heidelberg, Germany
Diabetes is characterized by impaired insulin signaling, hyperglycemia and development of chronic
complications. Among diabetes chronic complications, skin ulceration takes a staggering cost. Yet
the problem of impaired wound healing is among the least known. In previous studies we have
found that lack of IR expression results in impaired skin proliferation and differentiation, suggest-
ing a role of impaired insulin signaling to the development of skin complications. To further inves-
tigate the role of insulin in skin we have used a unique model of 3D organotypic skin coculture. In
this model murine skin keratinocytes are plated on top of a fibroblasts-containing collagen gel. Within
a couple of weeks the cells reorganize into a skin equivalent structure, obtaining the histological
characteristics of skin in vivo. Using this model we investigated the effects of insulin and IGF1 on
skin organization. Adding insulin to the organizing organotypic coculture resulted in thicker epi-
dermis. In addition, there seem to be an enhanced maturation of the skin, however the polarization
and organization of the insulin treated coculture was maintained. In contrast, adding IGF1 to the
coculture resulted in lack of polarization and abnormally delayed differentiation. The organotypic
coculture shows incomplete polarization; no basal compartment was formed; only an initial organ-
ization of a spinous and granular compartments were identified; and keratin pearls, indicators for
skin immaturity, were observed.
To further support the role of insulin in skin we examined the keratinocytes lacking the expression
of insulin receptor (IR). The organotypic epidermis composted from IR null cells appeared thinner
in comparison to WT coculture. Both insulin and IGF1 stimulation of the IR null organotypic cocul-
ture led to immaturity of the organotypic cocultured skin. These results demonstrate that insulin and
IGF1 have distinct roles in skin, and impairment in their signaling or in the balance between the two
hormonal signals might lead to abnormal wound healing in Diabetes. 
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Metalloproteinase-mediated, context-dependent activation of EGF-like growth factors in human
keratinocytes
SW Stoll1 and JT Elder1,2 1 Dermatology, Univ. of Michigan, Ann Arbor, MI and 2 VA Medical
Center, Ann Arbor, MI
Human keratinocytes (KC) express multiple EGF-like growth factors (EGFs) including amphireg-
ulin (AR), heparin-binding EGF (HB-EGF), TGF-α, betacellulin, and epiregulin in an autocrine fash-
ion. All of these EGF receptor (EGFR) ligands are produced as membrane-bound precursors and
require proteolytic cleavage to produce the soluble, active forms. We hypothesized that the presence
of multiple ligands might reflect the existence of multiple mechanisms that become active in dif-
ferent cellular contexts. To test this hypothesis, we treated GF-deprived KC with the metallopro-
teinase (MP) inhibitor GM6001 (40 µM), the ErbB receptor tyrosine kinase inhibitor PD158780 (1
µM), or neutralizing antibodies (Abs) against various EGFs (5 µg/ml), followed by assays for cell
migration, proliferation and ERK phosphorylation. KC migration in scratch wound assays was
markedly inhibited by GM6001 and PD158780, and additively inhibited by neutralizing Abs against
AR, HB-EGF and TGF-α (total blockade > 90%). Addition of EGF restored KC migration in the
presence of a cocktail of blocking Abs, or GM6001, but not PD158780. Autocrine proliferation of
KC was also blocked by GM6001 and by PD158780. However, in contrast to the involvement of
multiple EGFs in KC migration, autocrine proliferation was selectively blocked by anti-AR Abs.
GM6001, PD158780, and anti-AR mAb each reduced proliferation by more than 78 % (n=2-3). In
contrast, neutralizing Abs against HB-EGF and TGF-α had only modest effects on proliferation (<
15% reduction; n=3). Autocrine ERK phosphorylation was also selectively and potently blocked by
anti-AR Abs. In contrast, lysophosphatidic acid (LPA)-induced ERK phosphorylation was only pre-
vented by anti-HB-EGF Abs. Autocrine and LPA-stimulated ERK phosphorylation could be blocked
by GM6001 and restored by EGF. Taken together, these data indicate that autocrine KC signaling is
strongly dependent upon MP-mediated cleavage of multiple EGFs, and that different ligands (and
possibly different MPs) fulfill this role in different cellular contexts. 
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Opposite migratory responses of human keratinocytes and dermal fibroblasts to serum and
plasma: implications in skin wound re-epithelialization
W Li, B Bandyopadhay, J Fan, M Chen and DT Woodley Dermatology, University of Southern
California, Los Angeles, CA
Human keratinocytes (HKs) and human dermal fibroblasts (HDFs) represent the most abundant cells
in skin. In intact skin, HKs and HDFs are bathed in a filtrate of plasma. In the wound bed, however,
the cells come into contact with serum for the first time. We have recently shown that human serum
promotes polarization and migration of HKs, whereas human plasma does not (LANCET, 361:574-
576). These data suggest that serum factors may be responsible for the transition of HKs from non-
motile to motile cells. In the current study, we found that HDFs and HKs respond to human serum
and human plasma in opposite ways. While human serum promotes HK migration, it shows little
motility-stimulating effect on HDFs. In contrast to its null effect on HKs, plasma significantly stim-
ulates HDFs. TGF-beta inhibits HK division but does not inhibit HK migration (Sarret et al. J Invest
Dermatol, 1991). We found that TGF-beta (3-10 ng/ml) completely blocks both plasma-stimulated
and PDGF-BB-stimulated HDF migration. In contrast, TGF-beta (up to 100 ng/ml) has no inhibitory
effect on human serum-stimulated or bovine pituitary extract (BPE)-stimulated HK migration. Human
Cytokine Array analyses (RayBiotech, Inc.) showed that human serum contains higher amounts of
TGF-beta than human plasma. Blocking TGF-beta in serum with a pan neutralizing anti-TGF-beta
(1, 2 and 3) antibody transforms the serum into a pro-migratory agent for HDFs, just as serum is for
HKs. This study reveals a novel mechanism, by which TGF-beta in human serum may determine
the migratory behaviors of HKs and HDFs. This finding may be relevant to skin wound re-epithe-
lialization.
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βadrenergic signaling pathways regulate dermal fibroblast migration and proliferation
C Pullar and R Isseroff Derm, UCDavis, Davis, CA
Understanding mechanisms that regulate cutaneous cell migration and proliferation is important in
wound healing. Emerging studies point to a role of the adrenergic signaling pathway in this process.
Although earlier work identified a role for catecholamines in vitiligo and atopic dermatitis, our lab-
oratory has focused on their role in wound repair. We recently showed that ERK phosphorylation in
keratinocytes is remarkably attenuated by β2 adrenergic receptor (β2 AR) activation, resulting in
marked diminution of migration and ability to re-epithialize wounds in vitro (Pullar et al, JBC
278:22555, 2003). These findings imply that adrenergic signaling impairs wound healing. However,
dermal fibroblasts are also required for wound repair, thus we extended our studies to these cells. In
contrast to the effect in keratinocytes, we found that the migratory speed of isolated dermal fibrob-
lasts was increased 31% over control in response to βAR activation. Likewise, fibroblast wound heal-
ing in vitro using the scratch assay was increased 23%. βAR activation also resulted in a 55% increase
in fibroblast proliferation. The EGF receptor signaling pathway was transactivated by βAR activa-
tion, with a 2-fold increase in receptor phosphorylation within 15 min after βAR activation, There
was a downstream activation of ERK, which likewise increased 2-3 fold by βAR activation. Cytoskele-
tal consequences of βAR activation included decreased actin and vinculin localization within focal
adhesions, consistent with a more motile phenotype. The active cAMP analog, sp-cAMP, mimicked
the effects of β-agonists on cell proliferation and cytoskeletal rearrangement, whereas the inactive
analog, rp-cAMP, prevented the βagonist-mediated changes in the cytoskeleton and partly pre-
vented the increase in proliferation. In conclusion, βAR activation in dermal fibroblasts is pro-
motogenic and pro-mitogenic and partly cAMP-dependent, in contrast to its effects in keratinocytes,
where it is anti-motogenic and cAMP-independent. Exploiting these divergent β-agonist responses
in cutaneous cells may have novel therapeutic approaches for the control of wound healing. 
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Smad4 is required in the maintenance of hair follicle integrity
P Owens,1 W Qiao,2 C Deng2 and X Wang1 1 CDB, OHSU, Portland, OR and 2 NIH, Bethesda,
MD
Smad4 is a common signaling mediator of the transforming growth factor β (TGFβ) superfamily,
which includes TGFβ, activins, and bone morphogenetic proteins (BMPs). Since the TGFβ super-
family plays a pivotal role in epidermal homeostasis, Smad4 is expected to mediate the functions of
these molecules in the skin. We have generated keratinocyte specific (Keratin 5 promoter) knockout
mice in which the Smad4 gene was deleted in the epidermis and hair follicles. Mice with homozy-
gous Smad4 deletion in embryonic keratinocytes were born normally, but did not develop the first
coat of hair. These mice grew retarded and remained hairless. The numbers of hair follicles in these
mutant mice were similar to those in their wildtype controls, indicating that Smad4 deletion in ker-
atinocytes does not preclude initiation of hair follicle morphogenesis. However, the follicles were
disoriented and disorganized. Smad4 mutant follicles were not observed to form fully differentiated
Inner Root Sheaths (IRS) and hair shafts at any age. The Smad4 mutant follicles were degenerate as
early as 1 week old. In contrast, the sebaceous glands did not regress and accumulated in the skin.
By 30 days, the epidermis of the mutant mice became hyperproliferative, but epidermal differenti-
ation was not altered. At this stage, the hair follicle further degenerated into cysts and canals. Stain-
ing of hair follicle differentiation markers such as hair-specific acidic keratins (AE13), trycohyalin,
and GATA-3 showed a patchy and disintegrated pattern.  Our study suggests that normal Smad4 func-
tion in keratinocytes is essential for hair follicle differentiation and regeneration. 
ABSTRACTS A101VOL. 122, NO. 3 MARCH 2004
607
The initiation, augmentation and directionality signals for human keratinocyte migration
W Li, G Henry, J Fan, S Guan, M Chen, K Pang and DT Woodley Dermatology, University of
Southern California, Los Angeles, CA
Extracellular matrices (ECMs) and growth factors (GFs) are known to act synergistically to stimu-
late cell motility. However, their functional relationships still remain elusive. We investigated the
problem using HK migration driven by type I collagen and a mixture of soluble growth factors (con-
taining bovine pituitary extract, insulin, EGF, transferrin and hydrocortisone) that exhibit optimal
pro-motility activity in our in vitro assays. Our defined migration conditions were: 1) HKs plated
without ECMs in the absence of GFs. 2) HKs plated with ECMs in the presence GFs; 3) HKs plated
on collagen or other pro-motility ECMs without GFs; and 4) HKs plated on the same ECMs with
GFs. Our results show that HKs migrate on a collagen matrix even in the absence of GFs. This indi-
cates that a collagen matrix alone is able to initiate HK migration without any GFs! In contrast,
however, GFs alone cannot initiate HK migration when the HKs are not plated on collagen or any
other ECM. This shows that GFs alone cannot promote HK migration. Nevertheless, GFs do play a
role in HK motility. First, GFs augment collagen-initiated motility by three fold. Further, GFs pro-
vide directionality to HKs migrating on ECM. To gain insights into the specificities of the actions
of a collagen matrix and GFs on HK migration, we compared side-by-side the roles of the three major
MAPK cascades, ERK1/2, p38 and JNK. We found that ERK1/2 mediates collagen and GF signal-
ing. p38 is specific for only GF signaling, but not ECM signaling. JNK signaling does not play a
role in HK motility. Double inhibition of p38 and ERK1/2 additively blocks HK migration. Simul-
taneous activation of p38 and ERK1/2 partially mimics the pro-motility effects of collagen and GFs.
This study clarifies the functional relationships of GFs and ECMs in the control of HK motility and
shows how they differentially regulate major MAPK signaling cascades required for optimal HK
motility. 
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A novel ERK-p38 MAPK complex controls keratinocyte cell death and survival—the role of
individual p38 and ERK isoforms
T Efimova, A Broome and RL Eckert Physiology/Biophysics, Case Medical School, Cleveland, OH
MAP kinase (MAPK) cascades are key regulators of cell growth, differentiation and survival. In
keratinocytes, ERK kinases function to promote cell proliferation and survival. In contrast, p38δ
MAPK drives keratinocyte differentiation and apoptosis. Thus, the interplay between p38δ and
ERK1/2 MAPK isoforms is a critical determiner of keratinocyte fate. Multiprotein complex forma-
tion is an important mechanism for controlling the specificity of the signals transmitted by the MAPK
cascades. An important and unique finding of the present study is the presence, in keratinocytes, of
an ERK1/2-p38δ complex. This complex is constitutively present in both untreated and treated ker-
atinocytes. Significant ERK1/2 activity, but little p38δ activity, is observed in untreated cells; how-
ever, treatment with various stimuli including TPA, okadaic acid or PKCδ overexpression, results in
a reduction in ERK1/2 activity and an increase in p38δ activity within the complex. This finding
alters some common assumptions regarding regulation by MAPKs, as MAPK cascades have been
envisioned as linear regulatory pathways with minimal crosstalk among MAPKs (ERK, p38, JNK,
etc). We now report that p38δ preferentially interacts with ERK1 while p38α interacts with ERK2.
Remarkably, these p38 family members appear to differentially control the activities of the ERK
isoforms - stimulation of p38δ activity results in ERK1 inactivation, whereas p38α activates ERK2.
In addition, p38δ expression correlates with increased ERK1, but not ERK2, protein concentration,
suggesting that p38δ may directly control the level of expression of its binding partner. This is an
interesting observation, as MAPK level is not generally known to be regulated by upstream activa-
tors. Moreover, the p38δ-ERK1 complex translocates to the nucleus in response to p38δ activation
where p38δ remains active and ERK1 is inactive. The biological outcome of this p38δ/ERK1 regu-
latory crosstalk is the cessation of keratinocyte proliferation and induction of apoptosis. 
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Nerve growth factor expression as a requirement for normal skin regeneration
N Konstantinova St. John Medical Hospital, Moscow, Russian Federation
Skin equivalent is a common model to study wound healing, skin function, etc. We construct der-
mal equivalent in triplicate with the use of five psoriatic from plaques and five healthy adult fibrob-
last lines. We placed foreskin epidermis on top of DE (dermal equivalent) after 24 hours. Media was
changed every 24 hours and full skin equivalent was fixed cut and IHS was performed with NGF
antibody on the 7th, 10th and 14th days. The result was assessed on the scale from 1 to 9. Statisti-
cal analysis was performed. We found skin equivalent expresses NGF at the 7th day in the area of
beasel membrane and beasal keratinocytes with 4+ in normal and 7+ in psoriasis. On the 10th day
psoriasis skin equivalent expresses stronger NGF in beasel membrane zone and beasel keratinocytes
8+ and 5+ in beasel area of normal skin equivalent. Mature 14th day psoriatic skin equivalent still
express NGF in the same area 9+ and almost not expressed in mature normal skin equivalent. We
conclude that NGF supports epidermal maturation through internal mechanism. After maturation of
skin NGF is turned off in normal regeneration. In psoriasis automatic switch off of NGF does not
happen supporting the overgrowth of epidermis as a symptom for psoriasis. 
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Insulin signaling is essential for proper wound healing of skin
E Wertheimer,1 G Sizyakov,1 J Takeda,2 C Kahn,3 T Tennenbaum4 and R Shapira5 1 Pathology, Tel
Aviv Sackler Medical School, Tel Aviv, Israel, 2 Osaka University, Osaka, Japan, 3 Joslin Diabetes
Center, Boston, MA, 4 Bar Ilan University, Ramat Gan, Israel and 5 Shaarey Tzedek Hospital,
Jerusalem, Israel
Wound healing of skin involves complex interactions among many cell types, including skin epithe-
lial keratinocytes, dermal fibroblasts and vascular endothelial cells. Any impairment in wound heal-
ing might lead to devastating results. One of the diseases associated with impaired wound healing
is abnormal insulin signaling and diabetes, however the pathogenesis leading to diabetic skin pathol-
ogy is not understood.
Recently, to investigate the role of insulin in skin we have studied insulin signaling in primary murine
skin epidermal keratinocytes and dermal fibroblasts. We have found that insulin is essential for skin
cell proliferation and for epidermal differentiation. Furthermore, lack of insulin receptor (IR) expres-
sion led to decreased proliferation and abnormal differentiation of skin. In order to investigate the
clinical relevancy of these findings we studied the wound healing process in an epidermal skin-spe-
cific IR knockout mouse. Lack of IR expression in the epidermis led to a striking defect in the wound
healing process. The strength of the healed wound was reduced by two folds compared to the nor-
mal littermates. Interestingly, the wound healing process deteriorated with age, worsening in mice
aged 12 months and older. It should be emphasized that the expression of the insulin receptor in the
dermal fibroblasts was normal, and the skin pathology resulted from lack of IR expression only in
the epidermal keratinocytes. In conclusion, our results indicate that insulin signaling is essential for
skin proliferation and differentiation and that impairment in insulin action in keratinocytes might
lead to the development of skin pathologies. The epidermal skin specific IR knockout mouse can
serve as an idle model for identifying the pathological processes leading to impaired diabetic wound
healing, and as a model for testing new treatments for this devastating skin pathology. 
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βadrenergic receptor agonists attenuate the contraction of dermal fibroblast-seeded collagen
gels
RR Isseroff and CE Pullar Derm, UCDavis, Davis, CA
The ability to control wound contraction is important for preventing disfiguring scarring. Dermal
fibroblasts are actively involved in wound healing by migrating to the wound site, synthesizing extra-
cellular matrix, and generating mechanical forces within the wound to initiate wound contraction.
Fibroblast-seeded collagen gels provide an in vitro model to study these processes. We are evaluat-
ing the role of the adrenergic signaling system in cutraneous wound repair, and recently found that
keratinocyte migration, an essential step in wound re-epithelialization, is markedly decreased by
β2-adrenergic receptor (β2AR) activation (JBC 278:22555 2003). As βARs are also expressed on
dermal fibroblasts we initiated a study to determine the effects of β-agonists on dermal fibroblast-
seeded type I collagen gel contraction. Control gels achieved maximum contraction by day 3-4 result-
ing in a 54% reduction in gel diameter. Isoproterenol (ISO), a β-agonist attenuated gel contraction
at day 2 by 15-24%, (10nM - 10µM), respectively. When the cells within the gels were counted, there
was a 2.5-fold increased in the ISO-treated gels, making the ISO-induced decrease in contraction
(which is dependent on cell number) all the more remarkable. A non-specific β-antagonist, timolol
(20µM), reversed the attenuation as did a β2-specific antagonist, ICI 118,551 (10nM), indicating
that the attenuation of gel contraction was mediated by the β2-AR alone. The active cAMP analog,
sp-cAMP, attenuated dermal fibroblast-mediated collagen gel contraction to the same degree as the
β-agonist and when combined with ISO, the attenuation was enhanced suggestive of a cAMP-depend-
ent mechanism. The inactive cAMP analog, rp-cAMP partially reversed the attenuation suggesting
that the *beta*|-agonist-mediated attenuation of dermal fibroblast collagen gel contraction was medi-
ated by the *beta*|2-AR and the mechanism was partly cAMP-dependent. In conclusion, β-agonists
may provide novel therapeutic approaches for the control of wound healing by decreasing keratinocyte
migration and attenuating dermal fibroblast-mediated wound contraction. 
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Okadaic acid-dependent apoptosis in human keratinocytes - p38δ activation and ERK1/2 inac-
tivation
T Efimova and RL Eckert Physiology and Biophysics, Case Western Reserve University School of
Medicine, Cleveland, OH
Okadaic acid is a protein phosphatase inhibitor that serves as a tumor promoter in mouse skin car-
cinogenesis. However, a new role for OA as an inducer of apoptosis in murine keratinocytes has been
recently suggested. In the present study we show that okadaic acid-treated normal human keratinocytes
display characteristic apoptotic features including phosphatidylserine externalization, cytochrome
c release into the cytoplasm, and PARP cleavage. These changes are coupled with a marked change
in keratinocyte morphology including cell rounding, loss of cell-cell contact, and increased cell
detachment. We recently documented a central role for stress-responsive p38δ MAPK in regulating
keratinocyte apoptosis. A remarkable feature of this regulation is the coupling of p38δ activation
with suppression of pro-survival ERK1/2 activity. Our present studies show that OA-mediated ker-
atinocyte death response is associated with concurrent activation of p38δ and inhibition of ERK1/2
activity. These results suggest that OA promotes keratinocyte death by shifting the balance between
p38δ and ERK1/2 activity in favor of p38δ.
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p38 MAP kinase signaling mediates inflammatory responses in UVB-irradiated human skin
Y Zhu, AL Kim, X Tang, M Stiller, C Coppola, F Barsanti, M Athar and DR Bickers Dermatology,
Columbia University, New York, NY
Solar UVB radiation is a potent pro-inflammatory agent and the major causative agent for the devel-
opment of human non-melanoma skin cancer. The p38 Mitogen-Activated Protein Kinase (p38
MAPK) signaling pathway responds to various cytotoxic insults and environmental stresses and is
known to play an important role in photoaging and UVB-induced photocarcinogenesis. In human
epidermal keratinocytes, UVB irradiation increases p38 MAPK activity, and inhibitors of p38 MAPK
abrogate UVB-induced Cyclooxygenase 2 (COX-2) expression in vitro. In this study we assessed
the effects of UVB on the activation of the epidermal p38 MAPK signaling pathway in six human
volunteers with Fitzpatrick Type I and II skin. Relatively non-sun-exposed skin of the lower back of
human subjects was irradiated with two doses of UVB (1 MED and 2 MED) and punch biopsies
were obtained 2, 6, and 24 hours following exposure. The activity of MAP Kinase Activated Protein
Kinase 2 (MAPKAPK-2), a specific substrate and downstream kinase of p38 MAPK, was deter-
mined. UVB irradiation dose-dependently induced MAPKAPK-2 kinase activity that led to the rapid
phosphorylation of heat shock protein 27 (Hsp27), a known substrate for MAPKAPK-2. In the skin
irradiated with 1 MED of UVB, phospho-Hsp27 began to appear at 2 hours and reached a maximum
at 6 hours, whereas irradiation with 2 MEDs showed maximal phosphorylation at 2 hours, which
was sustained for up to 6 hours. No Hsp27 phosphorylation was observed in non-irradiated control
skin. COX-2 expression and the pro-inflammatory cytokine interleukin-8 were increased in human
skin 24 hours after irradiation with 2 MEDs. Our data indicate that UVB irradiation of human skin
activates epidermal p38 MAPK signaling and that COX-2 expression is downstream of p38 MAPK.
Pharmacologic blockade of the p38 MAPK pathway may offer a novel approach to cancer chemo-
prevention by diminishing UVB-induced inflammatory responses that augment tumorigenesis. 
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FasL/Fas-dependent activation of EGFR, ERK, and Akt in keratinocytes: potential implica-
tions for the self-restriction of spongiosis in eczemas
A Sundholm, E Simpson, J Hanifin, B Magun and MS Iordanov Oregon Health & Science
University, Portland, OR
Spongiosis in eczemas is preceded by keratinocyte death. Recent findings have implicated Fas/Fas
ligand (FasL) in mediating the apoptotic death of keratinocytes in spongiotic lesions. Investigating
the involvement of MAP kinases in contact allergy (ACD), we found that spongiosis is character-
ized by an elevated suprabasal activation of the ERK family of MAP kinases. We hypothesize that
the elevated suprabasal ERK activity during ACD is a protective response of the skin to limit the
destruction of the epidermis in the spongiotic areas (by means of ectopic proliferation and/or migra-
tion of unaffected keratinocytes to replace the dead cells in the areas of spongiosis). We postulated
that apoptotic cells are the source of a signal that triggers activation of ERK in the surrounding cells.
Indeed, treatment of keratinocyte cultures in vitro with FasL triggers, in addition to apoptosis, a pro-
found phoshorylation of the Epidermal Growth Factor Receptor (EGFR) and of its downstream effec-
tors ERK and protein kinase B (PKB/Akt). Using a variety of inhibitors and blocking antibodies, we
demonstrated that: (i) apoptosis is required for the generation of the signal(s) leading to the activa-
tion of EGFR, ERK, and Akt; (ii) the activation of EGFR, ERK, and Akt by FasL is indeed medi-
ated by its bona fide receptor Fas; (iii) the activation of EGFR is essential for the subsequent acti-
vation of ERK and Akt; (iv) apoptotic keratinocytes secrete soluble EGFR ligands that are processed
(from membrane-bound proligand forms) by a protease identical or similar to TACE. Our findings
demonstrate for the first time the existence of a program of self-restricting modulation of apoptosis
in the skin. Thus, EGFR, MAP kinases, and/or Akt are potential targets of therapeutic intervention
in eczemas. 
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Langerhans cell differentiation is dependent on integrin-mediated activation of TGF-β1
JJ Sung, JZ Habib and JS Munger Cell Biology, New York University School of Medicine, New York,
NY
Transforming growth factor-beta 1(TGF-β1) has a critical role in the generation of Langerhans cells
(LCs), as evidenced by the striking absence of LCs in TGF-β1 -/- mice. TGF-β is secreted in a latent
form and must be activated (i.e. released from its inhibitory propeptide) in order to bind its recep-
tors and elicit biological functions. The integrin αvβ6, which is expressed in the epidermis, was
recently shown to activate TGF-β1. Therefore, we tested whether αvβ6 also regulates LC differen-
tiation. Epidermal sheets were isolated from the ears and backs of mice with the integrin β6 knock-
out mutation (β6-/-) and were stained with an antibody against MHC-II, which is expressed at high
levels by LCs. β6-/- mice have no LCs in the ear epidermis, whereas back epidermis from these
mice has ~60% reduction in the number of LCs. We also stained β6-/- ear epidermis with an anti-
body against the γδ-T cell receptor to identify dendritic epidermal T cells, immune cells that are not
dependent on TGF-β1 for localization in epidermis, and found normal numbers. Thus, β6-/- mice
do not have a generalized defect in migration of leukocytes into the epidermis. Our results suggest
that integrin-mediated TGF-β1 activation generates the active TGF-β1 required for LC differentia-
tion. In ear epidermis, αvβ6 may be the only integrin involved in LC generation, whereas in back
epidermis other RGD-binding integrins may play a role. Recently, integrin αvβ8 was shown to also
bind and activate latent TGF-β1. Whether this integrin is also involved in LC differentiation will be
assessed in the future. 
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The expression of Aryl hydrocarbon Receptor Nuclear Translocator (Arnt) in human and mouse
skin and its modulation by dioxin in hairless mice
S Geng, I Stomenskaya and AA Panteleyev Dermatology, Columbia University, New York, NY
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has a wide range of skin-specific adverse effects includ-
ing chloracne, hair loss, hyperpigmentation and keratoderma. Among laboratory rodents, only hair-
less mice (hr/hr) are sensitive to TCDD skin toxicity. The major prerequisite of TCDD skin action
is heterodimerization of ligand-activated dioxin receptor (AhR) with Arnt which is a helix-loop-helix
transcription factor. Despite its obvious role in skin homeostasis control, the patterns of Arnt expres-
sion in skin were never assessed. Using immunohistochemistry and RT-PCR we studied Arnt expres-
sion in normal mouse and human skin, in TCDD-treated hairless mouse skin and in TCDD-treated
wt and hr/hr keratinocytes in vitro at both, high and low Ca2++ conditions. In wt mouse epidermis,
Arnt expression was seen in scattered suprabasal cells only, while in human epidermis basal layer
was highly positive. In anagen hair follicle, Arnt expression was detected in ORS and hair matrix,
while IRS, precortex, and follicular papilla cells were negative. In early catagen, Arnt expression
was seen in regressing hair bulb, in ORS and in follicular papilla where it persisted during late cata-
gen-telogen. In contrast to wt mice, in hairless mouse skin extensive Arnt expression was localized
exclusively to the basal layer of epidermis and proliferating part of utricular epithelium with weak
expression in dermal cysts. TCDD treatment of hairless mouse skin resulted in complete loss of
Arnt expression in the basal layer and utriculi along with its upregulation in dermal cysts. Cell cul-
ture studies showed that basal level of Arnt expression is much higher in hr/hr keratinocytes than in
wt cells. TCDD treatment slightly induced Arnt expression in both proliferating and differentiating
wt cultures while hr/hr keratinocytes responded to TCDD differently: differentiated cells appeared
to be much more sensitive to TCDD action than proliferating cells. Collectively, our results provide
insights into the role of Arnt protein in skin and hair follicle biology and toxicology. 
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EGF receptor activation stimulates cutaneous wound reepithelialization via the transcription
factor Slug
LG Hudson,1 C Choi,2 P Savagner3 and DF Kusewitt2 1 College of Pharmacy Toxicology Program,
University of New Mexico, Albuquerque, NM, 2 Department of Veterinary Biosciences, The Ohio
State University, Columbus, OH and 3 Centre de Recherche en Cancerologie, INSERM EMI 0229,
Montpellier, France
Reepithelialization to cover exposed dermis is a crucial component of cutaneous wound repair. Many
growth factors, including ligands for the epidermal growth factor (EGF) receptor, play a role in pro-
moting the reepithelialization process. Expression of the EGF receptor and its ligands are tran-
siently upregulated at the margins of healing wounds. We recently demonstrated that Slug, a protein
belonging to the Snail family of transcription factors, is expressed at wound margins in vitro, ex
vivo and in vivo. Furthermore, ectopic expression of Slug enhanced in vitro wound reepithelializa-
tion. Given the apparent importance of Slug and EGF receptor expression in promoting reepithe-
lialization, we examined interactions of these two factors. We find that EGF receptor activation stim-
ulates Slug, but not Snail, mRNA and protein expression in keratinocytes. Antisense to Slug inhibits
in vitro wound closure. In addition, blockade of EGF receptor tyrosine kinase activity using the spe-
cific inhibitor tyrphostin AG1478 inhibits greater than 90% of basal and EGF-stimulated in vitro
wound closure, indicating that EGF receptor activation is required for reepithelialization. Similarly,
epithelial outgrowth from mouse skin explants ex vivo is reduced by AG1478. Ectopic expression
of Slug reduces the concentration of EGF required for enhanced in vitro wound repair, suggesting
that the two pathways cooperate in reepithelialization. Our findings indicate that Slug and EGF recep-
tor both stimulate reepithelialization. EGF receptor dependent induction of Slug expression is a poten-
tial mechanism underlying EGF-stimulated reepithelialization. 
618
A new method for purifying amelanotic melanocytes from human hair follicles
H Ma, W Zhu, D Wang and X Yue Dermatology of Department, The First Affiliated Hospital of
Nanjing Medical University, Nanjing, Jiangsu Province, China
We report a new method to establish long term pure culture of amelanotic melanocytes derived from
human hair follicles. Normal corpse human scalp, which was taken just after death 1 h, was tran-
sected 1 mm below the epidermis, and hair follicles in the remaining dermis were isolated by two
step enzyme treatment〈first incubated in 0.50% Dispase and second in 0.50% Collagenase V 〉.Hair
follicle cell suspensions were prepared by 0.50% Trypsin treatment for about 30 min, and cultured
in a optimized culture medium. Cells attached to the substratum were mostly amelanotic melanocyte
in early stage, only a few of keratinocytes and none of fibroblasts. The keratinocytes were removed
by differential trypsinization. After the fourth passage, the cells were all amelanotic melanocytes
confirmed by immunostaining with monoclonal antibodies to HMB45 and NKI/beteb melanosomal
antigens and observation with transmission electron microscope. Thus, this new technique is poten-
tially more suitable for cultivated amelanotic melanocytes. The availability of the pure culture of the
hair-follicle amelanotic melanocytes will facilitate investigations of the role of those cells in migra-
tion and differentiation during treatment of vitiligo. 
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Expression of pIRES2-EGFP-hVEGF165 in HaCaT cells and pig hair pappilae cells
W Fan,1 N Zhou,1 Z Bi,1 B Yan2 and Y Wan3 1 Nanjing Medical University, Nanjing, China, 2
University of Rhode Island, Kingston, RI and 3 Biology, Providence College, Providence, RI
Human keratinocytes and dermal papillae cells (DPCs) have been documented to secrete Vascular
Endothelial Growth Factor (VEGF), which plays a significant role in hair growth and if uncon-
trolled relates to hail loss or other hair diseases. In this study, we investigate the feasibility of trans-
fecting VEGF165 gene into HaCaT cells and pig DPCs in vitro. pIRES2-EGFP-hVEGF165, a recently
established fluorescent reporter gene vector containing hVEGF165, was transfected into HaCaT cells
and pig DPCs by lipofectamine 2000. Cells transfected with pIRES2-EGFP-VEGF165 emit green
fluorescence that can be observed clearly under fluorescence microscope. The flow cytometer was
utilized to analyze the efficiency of transient transfection. The expression of VEGF in cultured cells
and supernatants was measured by Streptavidin Biotin Complex kit and ELISA kit respectively. Flow
cytometry was utilized to examine the effect of transfecting pIRES2-EGFP-hVEGF165 on cell apop-
tosis. We found that HaCaT cells and pig DPCs were successfully transfected with IRES2-EGFP-
VEGF165 with lipofectamine 2000. The efficiency of transient transfection in HaCaT cells and pig
DPCs HPC was 9.32% and 3.25% respectively. Compared with negative control, the mean level of
VEGF in cultured supernatants was statistically higher especially in HaCaT cells. Immunohisto-
chemical analysis showed that positive staining was both in cytoplasm and nucleus, with stronger
intensity in the latter. Transfecting cells with pIRES2-EGFP-VEGF165 inhibited cell apoptosis.
Taken together, our data demonstrate that pIRES2-EGFP-VEGF165, successfully transfected into
HaCaT cells and pig DPCs in vitro, promotes the expression of VEGF and prevents the cells from
apoptosis. Since VEGF is an important mediator in hair growth and hair cycle and patients with
androgenic alopecia or alopecia areata usually have low level expression of VEGF in hair follicle,
our study may have potential value for clinical management of hair loss. 
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Spontaneous alopecia and ulcerative dermatitis in C57BL/6J laboratory mice
JP Sundberg,1,4 G Lorch,2 D Taylor,3 KA Silva,1 J Miller,1 LS Bechtold,1 A Nicholson,1 R Vonder
Haar,1 J Fahey,1 AL Smith1 and LE King4 1 The Jackson Laboratory, Bar Harbor, ME, 2 The Ohio
State University, Columbus, OH, 3 University of Michigan, Ann Arbor, MI and 4 Vanderbilt
University, Nashville, TN
C57BL/6J inbred mice and closely related substrains, collectively known as B6 mice, develop tran-
sient alopecia and small, punctate ulcers that wax and wane, sometimes progressing to severe ulcer-
ative dermatitis. Frequency of disease varies between substrains and is modulated by husbandry prac-
tices. Histologic and scanning electron microscopic evaluation of groups of 20 mice at weekly intervals
for 10 weeks after weaning (at 4 weeks) revealed that the first lesion noted was scattered follicular
dystrophy affecting only late anagen and early catagen hair follicles. Degradation of the inner root
sheath resulted in defects in the cuticle and hair fiber. Fibers that twisted within follicles sometimes
punctured the root sheaths and caused hyperplasia of the root sheaths and foreign body granulomas
around free fibers in the dermis and hypodermis. Trauma (scratching) induced small ulcers that either
healed by pseudoepitheliomatous hyperplasia and dermal scarring or expanded into large, coalesc-
ing ulcers with underlying deep beds of granulation tissue. These inner root sheath changes and for-
eign body reactions resemble central centrifugal cicatrical alopecia variants (follicular degeneration
syndrome, pseudopelade, or folliculitis decalvans). To evaluate whether these changes were prima-
rily found in B6 mice, wax stripping was done to simulate excessive grooming behavior. After wax
stripping, C3H/HeJ mice had minor epidermal changes followed by rapid and consistent onset of
anagen within 7 days. By contrast, B6 skin developed follicular dystrophy and ulcers with marked
epidermal hyperplasia. These studies suggest that B6 mice may not be suitable models for certain
skin and hair diseases as they may develop a scarring alopecia similar to human central centrifugal
cicatrical alopecia (follicular degeneration syndrome). 
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Differential expression of a gene homologous to a teashirt gene in neonatal mouse skin during
development of hair follicles
H Su Biotechnology, Pingtung University, Pingtung, Taiwan
Neonatal mouse skin is useful for studying changes in gene expression during development of hair
follicles, as the mitotic activity of skin cells changes shortly after birth. Using RNA differential dis-
play, a 261-nt message has been identified in the skin, specifically on days 3-5 but not on day 2 after
birth. Confirmation of its expression by ribonuclease protection assay showed that stronger expres-
sion is seen on days 3-5 compared with days 1-2. Using RNA ligase-mediated rapid amplification
of 5’ cDNA ends, we have successfully isolated a 3046-bp gene, which has 93% sequence homol-
ogy to a mouse teashirt1 gene. Amino acid analysis showed that it has 73% identity to the mouse
teashirt1 protein and possesses zinc finger motifs 1, 2 and 3. In situ hybridization data revealed that
it is mainly expressed in the follicle bulb including dermal papilla and matrix cells. As the prolifer-
ation of bulb cells is important to follicle development during this period, the finding of its strong
expression on days 3-5, suggests that the identified gene is a potential candidate for follicle growth.
Our current data revealed that a gene homologous to a mouse teashirt gene is differentially expressed
in neonatal skin during development of hair follicles. 
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Adenosine stimulates fibroblast growth factor 7 expression in human dermal papillae cells 
M Iino,1 R Ehama,1 T Iwabuchi,1 Y Nakazawa,1 M Ogo,1 M Tajima1 and S Arase2 1 Shiseido
Research Center, Yokohama, Japan and 2 Dept. Dermatol., Sch. Med., Tokushima Univ.,
Tokushima, Japan
Adenosine (Ado) plays various physiological functions such as cAMP regulation through adeno-
sine receptors known as four subtypes A1, A2a, A2b and A3 (AdoRs). It has been previously reported
that minoxidil up-regulates vascular endothelial growth factor in dermal papillae (DP) cells through
Ado and its receptors pathway, resulting in the activation of hair growth1. Here we studied other bio-
logical functions of Ado in DP cells and the possible involvement of AdoRs in hair growth. Total
RNA isolated from DP cells which exposed to 10µM Ado for 4 hours was served for Human 1 cDNA
Microarray (Agilent technologies). A quantitative RT-PCR of mRNA expression was performed
utilizing LightCycler and FastStart DNA Master SYBR Green I (Roche diagnostics). Immunohis-
tochemistry for AdoR 2b was performed on 5µm formalin fixed sections of human scalp specimen,
with rabbit polyclonal anti-human AdoR 2b antibody (Chemicon International). DNA microarray
analysis revealed a pronounced up-regulation of fibroblast growth factor-7 (FGF-7) mRNA expres-
sion in the DP cells treated with Ado, as compared with control treated DP cells. A quantitative analy-
sis using real time RT-PCR showed that EC50 for the up-regulation of FGF-7 was approximately
5x10-5 M. AdoR 2b specific antagonist alloxazine, but not other antagonists specific for AdoR A1,
A2a, or A3 inhibited the up-regulation of FGF-7 mRNA expression. More, immunohistochemical
stains detected an AdoR 2b in DP cells of human scalp specimen. These data suggest that Ado stim-
ulated FGF-7 mRNA expression via AdoR 2b in DP cells. Previous reports suggest that an FGF-7
expressed in DP cells play a critical role in the control of hair growth2. Taken all together, these data
suggest that Ado might activate hair growth by the stimulation of FGF-7 expression in DP cells.
1) Li et al., J. Invest. Dermatol. 117, 1594-, 2001
2) Kulessa et al., EMBO J. 19, 6664-, 2000 
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Peripheral blood mononuclear cells from patients with advancing alopecia areata exhibit an
activated state and resistance to apoptosis
K McElwee,1 P Freyschmidt-Paul,1 M Zoeller2 and R Hoffmann1 1 Dermatology, Philipp
University, Marburg, Germany and 2 Tumor Progression and Tumor Defense, German Cancer
Research Center, Heidelberg, Germany
Alopecia areata (AA) is a putative hair follicle autoimmune disease. We recently noted in a mouse
model of AA that CD4+CD25+ regulatory T cells (Treg) levels are depressed and that expression of
CD44v7 is transiently upregulated. Here, we explored whether similar patterns are seen in AA patients’
peripheral blood mononuclear cells (PBMC). PBMC of 43 AA patients, 26 treated and 17 untreated,
and of 31 healthy volunteers were tested. AA patients’ PBMC differed from healthy donors’ PBMC
by an increase in CD16 and TNFα expressing cells. These features were independent of the disease
state and treatment. Additional changes in the activation state of PBMC, upregulation of the cos-
timulatory molecules CD40 and CD80, of the accessory molecule CD154 and of IFNγ expression,
were observed only in patients with an advancing disease state while PBMC from stable and suc-
cessfully treated patients did not exhibit activation. PBMC from patients with progressive AA con-
tained an increased percentage of CD4+CD25+ cells. However, the majority of these cells exhibited
a freshly activated phenotype with expression of CD154 and very weakly inhibited T cell prolifer-
ation in in vitro cell stimulation assays. PBMC from patients with progressive AA also displayed
increased resistance towards apoptosis accompanied by a decrease in CD95L+ cells and an increase
in CD44v7+ cells. Notably, the expanded population of CD4+CD25+CD154+ T cells in progres-
sive AA patients’ PBMC was apoptosis resistant and expressed CD44v7. Thus, a progressive state
of AA is accompanied by a systemic activation of potentially pathogenic CD4+CD25+CD154+ T
cells. Survival of activated T cells in progressive AA patients’ PBMC might be sustained by down-
regulation of CD95L and upregulation of CD44v7 which is known to be associated with anti-apop-
totic gene expression. Furthermore, susceptibility to AA may be associated with an increase in CD16+
(candidate NK cell phenotype) and TNFα expressing PBMC. 
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PTHrP influences angiogenesis of the hair follicle
A Diamond, RM Gonterman, TA Gocken and J Foley Medical Sciences and Dermatology, Indiana
Univiersity School of Medicine, Bloomington, IN
In developing organs PTH/PTHrP receptor (PPR) signaling inhibits proliferation and differentiation
of mesenchyme-derived cell types resulting control of morphogenic events. Throughout most of the
hair cycle low levels of PPR transcripts are diffusely expressed in the dermis, but during early ana-
gen cells along the dermal sheath express high levels this mRNA. Treatments of murine skin with
PPR agonists and antagonists as well as transgenic overexpression of the PPR ligand, parathyroid
hormone-related protein (PTHrP), have suggested that this ligand receptor combination might con-
tribute to the regulation of the anagen to catagen transition in the hair cycle. To further the under-
standing of the precise role of PTHrP and the PPR in the hair cycle we have evaluated cellular and
cell fate markers in depilated K14-PTHrP mice and a novel human versican promoter driven PPR1
over expressing line. In the K14-PTHrP mice that exhibit premature catagen, there was a 50% reduc-
tion in proliferating cells in the hair follicle matrix 13 to 15 days after depilation. CD31 staining
revealed a decrease in perifollicular vasculaturization in anagen VI of the K14-PTHrP mice as com-
pared to controls. Immunoblotting and immunohistochemistry indicated that during anagen VI the
outer root sheath of K14-PTHrP hair follicles contained elevated levels of the antiangiogenic factor
thrombospondin-1 but levels of the proangiogenic factor VEGF were not decreased. Surprisingly,
transgenic overexpression of the PPR in the dermal papilla and dermal sheath did not influence hair
shaft length. Taken together, these findings suggest that the influence of PTHrP on the hair cycle is
not mediated by fibroblasts associated with hair follicle but instead the recruitment of sufficient vas-
culature to the structure. Whether the effect of PTHrP on angiogenesis is mediated by direct signal-
ing of the PPR on endothelial cells or by a PPR-independent modulation of antiangiogenic factor
production by the ORS remains to be determined. 
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Foxn1 promotes epithelial morphogenesis by modulating protein kinase C
J Li, RM Baxter, L Weiner, PF Goetinck, E Calautti and JL Brissette Cutaneous Biology Research
Center, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA
Foxn1, the product of the nude locus, is a transcription factor essential for the proper development
of several epithelial tissues or organs, including the epidermis, hair follicles, mammary gland, and
thymus. In mammalian skin, epithelial cells induce Foxn1 during the early stages of terminal dif-
ferentiation. Here, we present evidence that Foxn1 acts as a negative regulator of protein kinase C
(PKC). In the absence of Foxn1, mouse primary keratinocytes upregulated the levels and activity of
several PKC isoforms, resulting in the increased phosphorylation of PKC substrates. This elevated
PKC signaling then led to the overproduction of late markers of keratinocyte differentiation. Con-
sistent with these findings, Foxn1 overexpression rendered keratinocytes resistant to 12-O-tetrade-
canoylphorbol-13-acetate (a PKC activator) and suppressed late differentiation markers. Thus, our
results suggest that Foxn1 downmodulates PKC signaling, enabling Foxn1 to influence the extent
or timing of events in the differentiation program. As PKC is thought to play critical roles in epi-
dermal development and hair growth, the modulation of PKC may explain, at least in part, how Foxn1
promotes the morphogenesis of the epidermis and hair. 
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Cotton honeydew oligo-saccharides yield very interesting results in hair care cosmetics
G Oberto, A Berghi, F Portolan, E Bauza, C Dal Farra and N Domloge Skin Research, Vincience,
Sophia Antipolis, Sophia Antipolis, France
Hair is particularly important for the psychological equilibrium of humans, and the concept of nor-
mal, beautiful hair, takes today a central place in cosmetic products. Cotton honeydew extract is an
original composition of unusual oligo-saccharides, such as fructose, glucose, inositol, melezitose,
saccharose, trehalose and trehalulose. Previous studies have demonstrated very interesting protec-
tive, nutritive and stimulating properties of these oligo-saccharides. Such an original association of
these oligosaccharides is endowed with effect on stimulating keratin synthesis, protecting against
nutrient deprivation and osmotic stress. Therefore, we were interested in studying the effect of these
oligo-saccharides on normal and damaged human hair, by scanning electron microscopy, in order to
study the scale margins which are essential for the shine and feel of the hair. Standardized human
hair samples were used in the first study to determine the effect of a rinse-off mask with 3% of cot-
ton honeydew extract on the hair ultrastructure aspect. In addition, hair samples were submitted to
different aggressions, following different experimental protocols, including exposure to detergent
and to air blowing dryer, in the presence or absence of the cotton honeydew extract mask. Hair sam-
ples were then prepared for scanning ultrastructural studies to evaluate any damage to hair shaft.
Scanning electron micrograph showed that, without extra aggression, in cotton honeydew extract-
treated samples, the cuticle scales appeared lying more smoothly in the hair than in the untreated
samples, they exhibited less lifting from the surface and remained flatter against the hair surface and
so are less prone to chipping. In contrast to the control-untreated hair where the hair kept a dry and
damaged aspect. The cuticle scales appeared significantly lifting from the surface of the hair, mak-
ing them prone to chipping and progressive break off. These results demonstrate a great application
for cotton honeydew extract in hair cosmetics and care products. 
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Oligonucleotide treatment inhibits hair growth and stimulates apoptosis-driven hair follicle
involution
R Atoyan, AA Sharov, M Eller, VA Botchkarev and BA Gilchrest Dermatology, Boston University,
Boston, MA
Increased evidence suggests that telomere homolog oligonucleotides (T-oligos) are capable of induc-
ing a variety of cellular responses in skin including cell cycle arrest and apoptosis. To assess the
effects of T-oligos on hair growth, thymidine dinucleotide (pTT), 1/3rd of the TTAGGG telomere
sequence, were administered intracutaneously at distinct time points of the depilation-induced hair
cycle in mice. Penetration of T-oligos into the hair follicle (HF) was monitored by using FITC-labeled
pTT and confocal microscopy. pTT treatment on days 1-5 after hair growth induction (i.e. at the early
anagen) significantly (p<0.01) retarded anagen development and resulted in formation of the HFs
with the reduced size of proximal hair bulbs, compared to the vehicle-treated controls. pTT treat-
ment on days 12-16 after hair growth induction (i.e. at late anagen-beginning of catagen) signifi-
cantly (p<0.05) accelerated catagen development. Hair growth inhibition and acceleration of HF
involution induced by pTT were accompanied by increased keratinocyte apoptosis in the HFs, as
detected by TUNEL. By Western blot analysis, pTT-treated skin showed marked increase of p53 pro-
tein and several other pro-apoptotic markers (CD95/Fas, Bax, caspase-3), compared to the control
skin. By multi-color immunofluorescence, HFs treated by pTT showed marked increase of p53,
Fas, Bax and caspase-3 expression and co-localization with TUNEL-positive cells. Taken together,
these data suggest that pTT activates a p53-dependent apoptotic response in actively growing HFs,
as well as in regressing HFs. This raises a possibility for using synthetic T-oligos for hair growth
inhibition and for the correction of excessive hair growth (hirsutism) in clinical practice. 
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Desmoglein 4 is expressed in diverse tissue types and is localized to the desmosome
H Bazzi,1 A Kljuic,1 K Djabali,1 V Nguyen,2 Y Hu,3 D Brennan,3 MG Mahoney3 and
AM Christiano1 1 Dept of Dermatology, Columbia University, New York, NY, 2 Dept of
Dermatology, University of California, Davis, CA and 3 Dept of Dermatology and Cutaneous
Biology, Jefferson Medical College, Philadelphia, PA
Recently, we reported cloning of a novel desmosomal cadherin gene, Desmoglein 4 in the human,
mouse and rat genomes. DSG4 is highly expressed in suprabasal layers of the epidermis and through-
out the hair follicle with the exception of the outer root sheath (ORS). Mutations in DSG4 underlie
the human disorder, localized autosomal recessive hypothrichosis (LAH) (OMIM 607903), in which
affected members display hypothrichosis restricted to the scalp, chest, arms, and legs. Furthermore,
mutations in mouse and rat Dsg4 result in lanceolate hair (lah) phenotype. We sought to better
define the role of Dsg4 in the normal epidermis and the hair follicle, and examine its expression pat-
tern in humans and rodents. Using a new reagent, the Imgenex Tissue Array, we analyzed the expres-
sion of human and rat DSG4 in multiple tissues. In both species, we detected cell border expression
of DSG4 in all the epithelial tissues examined including cornea, oral epithelium, transitional blad-
der epithelium, esophagus, tongue, and cervix. Interestingly, between weeks 14 and 18 of early human
fetal skin development, DSG4 is expressed highly throughout all the layers of the epidermis. Dur-
ing the next 12 weeks, the expression of DSG4 becomes diminishingly detectable in the basal layer,
and by week 31, the protein is only present in the suprabasal layers of the epidermis. DSG4 is also
present throughout the epithelial compartment of the developing human fetal hair follicle. We con-
firmed the localization of DSG4 protein to cell borders in cultured keratinocytes, and found that it
co-localizes with desmoplakin. These findings demonstrate that DSG4 is expressed in a diverse range
of mammalian tissues, and raises the possibility of functional roles beyond those defined for DSG4
in epidermis and hair follicle. 
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The role of BMP signalling in the control of ID3 expression in the hair follicle
R O,2,1 AM Christiano3 and C Jahoda2 1 Centre for Cutaneous Research, Queen Mary and Westfield
College, London, London, United Kingdom, 2 School of Biological Sciences, University of
Durham, Durham and 3 Departments of Dermatology and Development, Columbia University,
New York, NY
Both the production of the hair shaft in anagen and the initiation of a new hair cycle at telogen are
the result of reciprocal interactions between the dermal papilla and the overlying epithelial cells.
Secreted factors, such as those of the bone morphogenetic protein (BMP) family, play a crucial role
in moderating these interactions. Analysis of hair follicles in different stages of the hair cycle showed
BMP signalling was only active during anagen and again during telogen. During catagen, no BMP
signalling via SMAD1 occurred in the dermal papilla. ID3, a gene expressed in the dermal papilla
of both vibrissa and pelage follicles, is a BMP target and as such we found that ID3 was expressed
from the earliest stages of morphogenesis. During the hair cycle, ID3 was only expressed in the der-
mal papilla at middle anagen and telogen. To test the significance of ID3 expression in the dermal
papilla, we cultured dermal papilla cells and found that ID3 expression fell significantly after a sin-
gle passage. ID3 expression was returned to in vivo levels in low and high passage cells by cultur-
ing to high confluence or by the addition of BMP4. These studies reinforce the requirement for active
BMP signalling and cell-cell contacts in the dermal papilla during specific stages in the hair cycle. 
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Expression of estrogen receptor α, β and androgen receptor in human follicular dermal papilla
in vivo
K Kim, O Kwon, J Han, H Yoo, S Lee, J Chung, H Eun and K Cho Dermatology, Seoul National
University Hospital, Seoul, South Korea
Hair growth and cycles are under the influence of sex hormones such as androgen and estrogen.
Dermal papilla cells (DPCs) are known to be the target of hair growth regulation by such hormones
affecting the transcription of modulatory signals from these cells and therefore, play an inductive
role in hair follicle morphogenesis and cycling, The aim of this study is to investigate whether there
is a difference in the expression pattern of androgen receptor (AR), estrogen receptor α (ERα) and
β (ERβ) in dermal papillae from vertex and occipital scalp skin. We compared the immunohisto-
chemical staining characteristics of the receptors in dermal papilla from each portion. We also com-
pared the degree of expressions of 3 receptors in DPCs microdissected from hair follicles by West-
ern blot and semi-quantitative RT-PCR. Dermal papilla from vertex scalp showed higher AR positivity
and stronger AR expression than that from occipital scalp. ERα was expressed more in DPCs from
occipital scalp, although rarely detectable by immunohistochemistry. ERβ exhibited a similar pat-
tern of expression to ERα evaluated by Western blotting and RT-PCR. 
The differential expression of AR, ERα and ERβ in dermal papillae from androgen-dependent (ver-
tex scalp) and androgen-independent tissue (occipital scalp) suggests delicate interactions of andro-
gen and estrogen. The expression pattern of estrogen receptors implicate they may have a regulatory
effect on the expression of AR. 
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A novel hair growth promoter, t-flavanone, suppresses membrane bound urokinase on ker-
atinocytes
M Sasajima, M Hotta, S Moriwaki and T Kitahara Biological Science Laboratories, Kao
Corporation, Tochigi, Japan
We have previously reported that trans-3, 4’-dimethyl-3-hydroxyflavanone (t-flavanone) is a novel
hair growth promoter that improves male pattern baldness. TGF-beta has been considered as one of
the critical factors in controlling hair growth. TGF-beta is secreted by follicular papilla upon andro-
genic stimuli and is highly active in inducing the catagen phase of the hair cycle. t-Flavanone reduced
the amount of activated TGF-beta in the mixed cultures of follicular dermal papilla cells and ker-
atinocytes. We investigated the effects of t-flavanone on TGF-beta activation by keratinocyte uroki-
nase. Urokinase inhibition by t-flavanone; 0.1-100 mg/ml t-flavanone was added to mixtures con-
taining commercially available urokinase and a synthetic substrate. Urokinase activities were then
measured using a fluorometer. Effects of t-flavanone on membrane bound urokinase; after ker-
atinocytes were treated with/without 0.1µM t-flavanone for 16 hrs, membrane bound urokinase was
collected by washing with HCl/glycine buffer. Activities and amounts of urokinase were measured
by zymography and by western blotting, respectively. t-Flavanone did not inhibit urokinase directly
in the cell free system. However, t-flavanone decreased the activity and amount of membrane bound
urokinase protein. These findings suggest that t-flavanone promotes hair growth through TGF-beta,
by activating a cascade controlling urokinase activity. 
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Molecular mechanisms of neurotrophin-induced apoptosis in autoreactive CD8 cells in alope-
cia areata
TN Palkina,1,2 AA Sharov,1 MY Fessing,1 JP Sundberg,3 M Yaar,1 BA Gilchrest1 and
VA Botchkarev1 1 Dermatology, Boston University, Boston, MA, 2 Cancer Research Center,
Moscow, Russian Federation and 3 Jackson Laboratory, Bar Harbor, ME
Neurotrophins are a family of structurally and functionally related polypeptides that include nerve
growth factor (NGF) and brain derived neurotrophic factor (BDNF). They bind a 75 kD transmem-
brane receptor (p75), and also each neurotrophin binds a distinct receptor of the Trk family. When
p75 and Trk are coordinately bound by neurotrophins, survival signal is initiated through Trk. How-
ever, in Trk absence, p75 is activated alone to induce apoptosis. Alopecia areata (AA) is an autoim-
mune dermatosis that involves the development of an inflammatory infiltrate, composed primarily
of CD8+ and CD4+ lymphocytes, around and within hair follicles.  Because many autoimmune
conditions involve neurotrophins and their receptors, we asked if neurotrophins may play a role in
AA pathogenesis. CD8 lymphocytes were isolated from involved skin and peripheral blood of AA-
affected C3H/HeJ mice as well as from non-affected control mice. In contrast with peripheral blood
CD8 cells that displayed low p75 levels, cells from AA involved skin expressed significantly higher
p75 level (p<0.001, FACScan analysis). Multi-color immunofluorescence microscopy showed that
p75 positive CD8 cells were assembled specifically around the hair follicles as well as inside the
follicular epithelium. However, by RT-PCR, these cells were negative for Trk (TrkA, TrkB, TrkC)
receptor expression, suggesting that neurotrophin administration could induce apoptosis of these
inflammatory cells.  Consistent with this hypothesis, NGF and BDNF induced apoptosis in CD8 cells
isolated from skin of mice affected by AA and cultured in vitro, as compared to diluent alone. Fur-
thermore, in vivo administration of agarose beads soaked with NGF or BDNF resulted in significant
reduction of CD8 cells (p<0.01) in AA-affected skin. These data suggest that neurotrophins by stim-
ulating p75 mediated signaling in CD8 cells could be used as a novel therapeutic intervention to
arrest the development of AA. 
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Edar signaling is involved in the control of hair shaft formation and catagen development
MY Fessing, TY Sharova, AA Sharov, R Atoyan, BA Gilchrest and VA Botchkarev Dermatology,
Boston University, Boston, MA
Ectodysplasin (Eda) and its receptor (Edar) are required for normal development of several ecto-
dermal derivatives including hair follicles in humans and mice. In order to elucidate the expression
and function of the components of the Eda/Edar signaling pathway during postnatal hair cycle, we
employed the murine depilation model. By RT-PCR, the expression levels of the transcripts for
EdaA1, Edar and its signal transucing components EDARADD and TRAF6 are minimal in the tel-
ogen and maximal in late anagen-catagen skin (days 8-16 post depilation). By in situ hybridization,
EdaA1 mRNA was strongly expressed in the hair matrix, outer and inner root sheaths of late ana-
gen hair follicles. By multi-color immunofluorescence, Edar expression in late anagen follicles was
seen in the uni-lateral cluster of hair follicle matrix cells that also expressed Shh protein. Intracuta-
neous administration of a fusion protein that selectively binds EdaA1 and block Edar signaling
resulted in severe defects of hair shaft formation in late anagen hair follicles and also inhibited cata-
gen development, compared to the skin treated by vehicle control. Hair shaft abnormalities seen after
pharmacological blockade of the Edar signaling were accompanied by alterations in the expression
of the selected hair keratins and other regulatory molecules that are involved in their synthesis (Shh,
Lef-1, Smad1/5). Thus, our data demonstrate that Edar signaling is involved in the control of hair
shaft formation and catagen development in mice. These data also suggest a cross-talk between
Edar signaling and other regulatory pathways (Shh, Wnt, BMP) that are involved in the control of
postnatal hair cycle. 
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An ex vivo human model for chemotherapy-induced hair loss: a role for p53 signaling path-
way in doxorubicin-induced apoptosis in the hair follicle
TY Sharova,1 AA Sharov,1 R Dersarkissian,2 BA Gilchrest1 and VA Botchkarev1 1 Dermatology,
Boston University, Boston, MA and 2 Otolaryngology, Boston University, Boston, MA
Chemotherapeutic agents induce apoptosis in proliferating malignant cells via activation of the p53
signaling pathway. Many side effects of chemotherapy are also mediated by p53, and it was shown
that p53 is essential for chemotherapy-induced hair loss in mice. However, the roles of p53 and its
target genes in the control of apoptosis induced by chemotherapy in human hair follicle appear to
be unknown. To study the effects of chemotherapy on human hair follicles, the ex vivo human
model for chemotherapy-induced hair loss was established. Hair follicles isolated from human
scalp were cultured ex vivo in presence of different concentrations of doxorubicin or vehicle con-
trol. Doxorubicin induced rapid and dose-dependent anagen-catagen transition in human hair folli-
cles, associated with appearance of TUNEL-positive cells in the hair follicle matrix and outer and
inner root sheaths. By multi-color immunofluorescence, doxorubicin-treated hair follicles showed
the increase of p53 protein, compared to control hair follicles. Analyses of the expression of the pro-
teins encoded by p53 target genes showed the increase of Fas and Bax expression and decrease of
Bcl-2 protein in doxorubicin-treated hair follicles, compared to controls. These data suggest that iso-
lated human hair follicles cultured ex vivo may be used as a model for studying the mechanisms of
chemotherapy-induced hair loss and that topical application of p53 inhibitors to the scalp may serve
as a tool for preventing apoptosis in human hair follicles induced by cancer chemotherapy. 
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Transgenic expression of noggin targeted to the hair follicle epithelium or mesenchyme leads
to distinct skin and hair follicle phenotypes
AA Sharov,1 TY Sharova,1 MY Fessing,1 L Weiner,2 J Kishimoto,3 JL Brissette,2 BA Gilchrest1 and
VA Botchkarev1 1 Dermatology, Boston University, Boston, MA, 2 Cutaneous Biology Research
Center, Harvard University, Charlestown, MA and 3 Shiseido Research Center, Yokohama, Japan
Bone morphogenetic proteins (BMPs) and the BMP antagonist noggin are short-range morphogens
that play important roles in the control of hair follicle (HF) development and cycling. To define the
effects of general inhibition of BMP signaling in distinct HF compartments, transgenic mice over-
expressing noggin in the outer root sheath (promoter: keratin 5) or dermal papilla (promoter: versi-
can) were generated. K5-Noggin mice showed both epidermal and hair follicle phenotypes, com-
pared to wild-type (WT) mice. Epidermal phenotypes observed in K5-Noggin mice included the
decrease of keratinocyte apoptosis, retardation of the epidermal differentiation and eyelid opening
accompanied by the reduced expression of apoptotic receptors (Fas, p55TNFR), Id3 protein, involu-
crin and loricrin in the epidermis of neonatal mice. Hair follicles of K5-Noggin mice showed sig-
nificantly accelerated morphogenesis and increased size, failure to generate the zig-zag hairs and
retarded catagen. In contrast to K5-Noggin mice, Ver-Noggin mice did not show changes in epider-
mal apoptosis and differentiation. HFs in Ver-Noggin mice were capable of generating all hair types
including zig-zag hairs. However, HFs in Ver-Noggin mice showed significantly increased hair bulbs
and retarded catagen, compared to WT mice. Expression analyses of the markers involved in the con-
trol of HF development and growth (Lef-1, Foxn1, Shh, Edar) revealed distinct patterns of alterations
specific for the K5-Noggin and Ver-Noggin mice. Thus, inhibiting BMP signaling in specific HF
compartments (epithelium versus mesenchyme) leads to different HF phenotypes, suggesting spe-
cific and local roles for BMP signaling in distinct HF compartments during its development and
cycling.
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Recapitulation of the hair cycle in dermal papilla cells in vitro
H Shimizu1,2 and BA Morgan1 1 Cutaneous Biology Research Center, Mass. General Hospital and
Harvard Medical School, Charlestown, MA and 2 Nihon University, Tokyo, Japan
Transgenic mice expressing GFP under the control of versican regulatory sequences have been
employed to purify a cell population from skin that is enriched for dermal papilla cells. When mixed
with primary keratinocytes and used to reconstitute skin in a grafting assay, these cells promote the
formation of hair follicles in the regenerated skin. Both GFP expression and the ability to promote
hair growth are lost when the sorted GFP-positive population is maintained in culture. We have shown
previously that exposure to Wnt3a maintains both GFP expression and the ability to promote hair
growth in these cells, but it is not sufficient to reactivate GFP expression or hair growth inducing
activity in the population that has lost these properties in vitro. We therefore sought to determine
whether the loss of GFP expression and hair inductive activity from the cultured cells corresponds
to a transition from an “anagen DP “ like population to DP cells with characteristics associated with
the catagen or telogen phase of the hair cycle, or whether the cells were losing DP character alto-
gether. In this work, we report that as the sorted GFP positive population loses GFP expression in
vitro, it also loses the expression of other genes expressed in the anagen DP. However, these cells
activate markers found in DP cells during the catagen or telogen phase, suggesting that they acquire
characteristics associated with the catagen or telogen phase. We further show that in the context of
appropriate inductive signals, these cells reactivate both GFP and other anagen DP gene expression,
suggesting that they retain DP cell character. To assess the inductive properties of these “reactivated”
cells, we have developed an in vitro follicle induction assay and shown that the inductive capacities
of these cells are partially restored. These results demonstrate that this cell preparation may be use-
ful for identifying signals that activate the DP during the hair cycle and may also have application
to the generation of cultures of active DP cells for autograft therapy. 
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Mammary mesenchyme reprograms keratinocytes from hairy regions to form nipple epider-
mis
C Offutt,1 R Contreras,1 G Cotsarelis2 and J Foley1 1 Medical Sciences and Dermatology, Indiana
Univiersity School of Medicine, Bloomington, IN and 2 Dermatology, University of Pennsylvainia
School of Medicine, Philadelphia, PA
The nipple is a specialized epidermal appendage that forms after the development of mammary
epithelium. Emerging evidence suggests that the primary mammary mesenchyme-derived fibrob-
lasts have a central role in the process, but it is unclear what role the epithelial components play in
forming the nipple. We used grafted cellular recombinations of the nipple-like skin from the ventral
surface of the K14-PTHrP mouse and wild type littermates in conjunction with label retaining cell
analysis to address this issue. Combinations of dermal fibroblasts from the dorsal skin of wild type
mice and dorsal or nipple keratinocytes produced a thick tuft of hair. In contrast, grafts that contained
mammary mesenchyme derived fibroblasts and nipple or dorsal keratinocytes lacked hair. Evalua-
tion of the grafts indicated that isolated fibroblasts from the ventral skin of the K14-PTHrP mouse
were sufficient to produce many of the epidermal and connective tissue features of the nipple regard-
less of the source of keratinocytes. However, recombinant grafts derived from fibroblasts from the
ventral skin of the K14-PTHrP mouse and dorsal keratinocytes from wild type mice contained epithe-
lial invaginations that lacked dermal papilla-like structures. Using the labeling windows of nipple
morphogenesis, the early neonatal period and late pregnancy, BrdU retaining cells were never found
within the nipple or the ventral epidermis of the K14-PTHrP mice, but were present in the surrounding
bulge of hair follicles. On the basis of these findings we conclude:1) the mammary mesenchyme-
derived fibroblasts have the capacity to direct interfollicular keratinocytes to nipple-like epidermal
differentiation pattern, 2) mammary mesenchyme-derived fibroblasts cells cannot be reprogrammed
to form dermal papilla cells, 3) nipple keratinocytes can be reprogrammed to produce hair follicles
by dermal papilla cells. 4) hair follicles may be the ultimate source of epidermal stem cells for the
murine nipple. 
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Reprogramming of adult mouse bladder epithelial cells to hair follicle and sebaceous glands
under inductive dermal influences
K Sun,1 CA Jahoda2 and AM Christiano1 1 Dept of Dermatology, Columbia University, New York,
NY and 2 School of Biological Sciences, Durham University, Durham, Durham, United Kingdom
Adult epidermal stem cells renew the epithelial compartment of the skin throughout life and are the
most accessible of all adult stem cells. Most importantly, epidermal stem cells can be efficiently cul-
tivated and transplanted, a significant advantage for cell and gene therapy. Gene therapy in the skin
has been hampered by the inability to target (or identify) a stem cell, and the lack of sustained gene
expression. Several lines of recently emerging evidence about the plasticity of stem cells in general
has prompted our laboratory to consider a novel approach to the treatment of inherited skin disor-
ders. We asked whether we could reprogram other epithelia into skin under the appropriate induc-
tive (dermal) influences in vivo. We reasoned that if the donor cells were taken from an immuno-
logically-compatible individual or did not elicit an immune response, such cells could overcome the
two major obstacles in gene therapy approaches: Extending the previous work of Ferarris et al.(2000),
we previously reported cornea and amnion epithelial cells can reprogram into new skin including
hair follicle and sebaceous glands. In this study, we build upon our earlier work and have used adult
bladder as the source of epithelium. We performed tissue recombination experiments using embry-
onic mouse dermis from day 14.5 embryos combined with adult mouse bladder epithelial cells.
Recombinant grafts were implanted beneath the kidney capsule of normal mice and retrieved after
two weeks. Fully formed pilosebaceous units with mature hair shafts and sebaceous glands had
been induced. We have demonstrated that even differentiated adult cells (bladder) have the capacity
to regenerate epidermis under the appropriate dermal influences. We are currently expanding this
technology to include other sources of donor epithelium, as well as developing methodology to
recapitulate the molecular events of epithelial reprogramming in vitro. 
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Hairless suppresses vitamin D receptor transactivation in human keratinocytes
Z Xie, SM Chang, H Elalieh and DD Bikle Endocrine Unit, VA Medical Center / UCSF and
NCIRE, San Francisco, CA
The phenotypes of vitamin D receptor (VDR) null and Hairless (Hr) null mice (and humans) are very
similar: alopecia beginning with the first postnatal hair follicle cycle. The ligand for VDR, 1,25-dihy-
droxyvitamin D, stimulates epidermal differentiation, but does not appear to be required for hair
follicle cycling. Hr has no known ligand, and its role in the epidermis and hair follicles is poorly
understood. To explore the role of Hr in the epidermis and hair follicles and its potential impact on
VDR regulated transcription, we investigated the interaction between Hr and VDR in both human
and mouse keratinocytes. The Hr antibody was generated by immunizing rabbits using a peptide syn-
thesized based on both human and mouse Hr sequences. The specificity of the antibody was deter-
mined by western analysis and immunohistochemistry with preabsorption of the antibody by the
peptide blocking the reaction. Immunohistochemistry localized Hr and VDR in the nuclei of cells
in the basal layer of the epidermis, the outer root sheath and dermal papilla of hair follicles. Gel shift
analysis showed that Hr antibody enhances the binding of keratinocyte nuclear extracts to the VDR
response elements of 24-hydroxylase, phospholipase C-γ1 and involucrin, suggesting that Hr blocks
the binding of VDR to VDRE. Transfection with antisense constructs of human hairless cDNA in
keratinocytes enhances the induction of vitamin D responsive genes including involucrin, transglu-
taminase and PLC-γ1 by 1,25-dihydroxyvitamin D3. Overexpression of Hr in human keratinocytes
suppresses the induction of these vitamin D responsive genes by 1,25-dihydroxyvitamin D. These
data suggest that Hr suppresses the transcriptional activation of VDR. How the loss of this regula-
tion in the absence of either VDR or Hr results in cessation of hair follicle cycling remains to be
established.
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Interaction of hairless and thyroid hormone receptor is not involved in the pathogenesis of
atrichia with papular lesions
K Djabali,1 A Zlotogorski,2 A Metzker,2 D Ben-Amitai4 and AM Christiano1 1 Dept of
Dermatology, Columbia University, New York, NY, 2 Hadassah-Hebrew University Medical Center,
Hadassah-Hebrew University, Jerusalem, Israel, 3 Sourasky Medical Center, Tel-Aviv, Israel and 4
Rabin Medical Center, Petah-Tikva, Israel
Atrichia with papular lesions (APL, MIM 209500), is a rare autosomal recessive disease character-
ized by early-onset of atrichia, followed by a papular eruption within the first years of life. Recent
studies demonstrating linkage to chromosome 8p21 and further mutation detection in the hairless
gene (HR) have established the molecular basis of APL.  HR has been shown to interact with thy-
roid hormone receptor (TR) via two specific interaction domains in HR. A putative role for hr-TR
in the regulation of hair follicle cycling has been speculated upon, however, several lines of evi-
dence argue against this as a crucial factor in APL observed in human and mouse HR mutants. In
this study, we describe a 16 year-old female with APL due to a missense mutation, D1012N, in the
hr-thyroid hormone receptor interacting domain 2 (TRID2) of the hairless gene. Using functional
and biochemical analysis, we determined that this mutation does not significantly affect hr-thyroid
hormone receptor interaction. Our data suggests that the TRID2 domain is dispensable in the hr-TR
interaction, and does not appear to be involved in the pathogenesis of APL. 
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Epidemiologic and disease associations in participants of the National Alopecia Areata Reg-
istry registrants
JN Breuer-McHam,1 K Hunzicker,1 N Barahmani,1 Q Zhang,2 D Babu,1 A Christiano,3
M Hordinsky,4 D Norris,5 V Price6 and M Duvic1 1 Derm, MD Anderson Cancer Ctr, Houston, TX,
2 Epidem, MDACC, Houston, TX, 3 Derm, Columbia U, New York, NY, 4 Derm, U Minn,
Minneapolis, MN, 5 Derm, U Colorado, Denver, CO and 6 Derm, UCSF, San Francisco, CA
To better understand the pathogenesis of the organ specific autoimmune disease, Alopecia Areata
(AA), a National Alopecia Areata Registry (NAAR) was created to collect epidemiologic data, DNA,
and sera samples from well-characterized subjects. Phase I of the registration process through a web-
site [http://www.AlopeciaAreatarRegistry.org] solicits flare factors and associated diseases from all
registrants who have completed initial questionnaires (n=2900). This is a preliminary analysis of
self-reported data from the first 1,151 AA patients who have registered, of whom 60% are female.
Registrants are divided among clinical phenotypes: severe - universalis or totalis (AU=376, AT =
194), intermediate -(persistent patchy AA= 318), or mild (transient = 263). Seventy-four percent of
all AA patients reported the co-existence of at least one of the following 63 possible autoimmune
diseases.  Forty percent reported some form of allergy, 21% had atopic eczema, and 15% had asthma
with similar distribution in each severity group. Arthritis was reported by 7%. Surprisingly, thyroid
disease was reported only by 13% of all AA but by 19% of AU, and 9-10% of pts. with either AAT
or AAP. As expected, the frequency of reported diabetes was low (2%) in all patients. Thirty-three
percent of patients reported the existence of a possible trigger factor preceding the onset of their hair
loss as follows: stress - 54%, infection - 28%, surgery - 7%, pregnancy - 7%, or vaccination - 4%.
Trigger factors were more commonly reported in 40% of AU patients compared to 22% of AAP
(p=0.03) or 19% of AAT (p = .000, Mann-Whitney). The preliminary self-reported registry data
suggest that patients with severe alopecia universalis are more likely to have a history of thyroid dis-
ease or atopy and to report putative flare factors more commonly than patients who have less severe
phenotypes of the disease. 
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WNT/beta-catenin signaling is required at early stages of tooth development
E Chu,1 T Andl,1 A Glick2 and SE Millar1 1 Dermatology, University of Pennsylvania,
Philadelphia, PA and 2 Laboratory of Cellular Carcinogenesis and Tumor Promotion, National
Cancer Institute, Bethesda, MD
The formation of epidermal appendages, such as hair, teeth and mammary glands, depends on epithe-
lial-mesenchymal interactions. We have previously shown that WNT paracrine intercellular signal-
ing is required for the initiation of hair follicle and mammary placode development. We hypothe-
size that WNT signaling is also necessary for tooth initiation, which would suggest a broad requirement
for WNT signals in the adoption of appendageal fate by embryonic epidermal stem cells. To test this
hypothesis we asked whether WNT pathway genes are expressed, and WNT signaling is active, dur-
ing tooth initiation. We detected expression of beta-catenin and Wnt10b mRNAs in the dental lam-
ina beginning at embryonic day (E) 10.5 and E11.5 of mouse development, respectively. WNT/beta-
catenin signaling activity, revealed by in vivo expression of a WNT reporter transgene, TOPGAL,
was present in the dental lamina and underlying mesenchyme at E11.5, and in tooth buds at E12.5.
To determine whether forced activation of WNT signaling promotes tooth development, mandibles
from E11.5 TOPGAL-transgenic embryos were cultured in the presence or absence of 50 mM LiCl,
which blocks the function of the intracellular WNT antagonist glycogen synthase kinase-3. LiCl-
treated mandibles showed increased levels of TOPGAL expression, indicating elevated WNT sig-
naling. In addition, the TOPGAL expression domains were broader than in controls, suggesting
expansion of incisor and molar tooth rudiments. Conversely, we asked whether inhibition of WNT
signaling blocks tooth formation. We found that in vivo transgenic expression of Dickkopf1 (Dkk1),
a potent secreted WNT inhibitor, under the control of a Keratin 5 promoter causes reduced or absent
TOPGAL activity in the oral cavity at E12.5 and arrest of tooth morphogenesis prior to the bud stage.
These results demonstrate that WNT signaling plays an essential role at early stages of tooth devel-
opment, and suggest that it may act to promote tooth fate in oral epithelium. 
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Hair cycle specific immunolocalization of retinoic acid synthesis markers
HB Everts,1 JP Sundberg,3,2 LE King2 and DE Ong1 1 Biochemistry, Vanderbilt University Medical
Center, Nashville, TN, 2 Medicine (Dermatology), Vanderbilt University Medical Center, Nashville,
TN and 3 The Jackson Laboratory, Bar Harbor, ME
This study was performed to examine the sites of endogenous retinoic acid (RA) synthesis in cycling
hair follicles. C3H/HeJ mice were wax stripped to initiate a synchronized anagen hair cycle and sam-
ples taken at various time points after depilation. Immunohistochemistry was performed with anti-
bodies against one retinol dehydrogenase (eRoldh), two retinal dehydrogenases (Aldh1a2 and Aldh1a3,
formally called Raldh2 and Raldh3), cellular retinol binding protein (Crbp) and cellular RA bind-
ing protein type II (Crabp2) involved in RA synthesis. In early anagen, Crbp, eRoldh, Aldh1a3, and
Crabp2 are expressed in the sebaceous gland or its duct. This expression remains throughout the
hair cycle, except the expression of eRoldh decreases by late anagen, through catagen and increases
again in some telogen hair follicles. In the downward growing hair follicle, eRoldh and Aldh1a2 are
expressed in early anagen, while Crabp2 expression occurs later during anagen at this site. In addi-
tion, expression in the bulb region (precortex and dermal papilla) of Crbp, eRoldh, Aldh1a3, and
Crabp2 begins in mid anagen and extends throughout anagen. Crabp2 is also expressed in the der-
mal papilla during telogen. The inner layer of the outer root sheath expresses Crbp, Aldh1a3, and
Crabp2 once it forms and throughout anagen. Some hair fibers express Aldh1a3 and Crabp2 during
anagen. During catagen the regressing part of the follicle expresses Crbp, Aldh1a2, and eRoldh.
Throughout the hair cycle Aldh1a2 is expressed in the outer root sheath and stratum granulosum,
while Crabp2 is expressed in the stratum corneum. This expression pattern indicates that endoge-
nous RA may be important for: sebaceous gland function, hair follicle growth and regression, hair
fiber growth and release from its sheath, and epidermal barrier function. 
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Structural and molecular hair abnormalities in trichothiodystrophy
CA Liang,1,4 S Schlucker,2 A Morris,1 K Imoto,1 I Levin,2 V Price,3 E Menefee,3 KH Kraemer1 and
JJ DiGiovanna1,4 1 BRL, NCI, Bethesda, MD, 2 Lab Chem Physics, NIDDK, Bethesda, MD, 3
Derm, UCSF, San Francisco, CA and 4 Derm, Brown Med School, Providence, RI
Trichothiodystrophy (TTD) is a rare inherited disorder with brittle hair having low cystine content
and alternating light and dark (tiger tail) bands with polarizing microscopy. To better understand the
clinical and molecular basis of TTD, we examined 13 TTD patients. They exhibited a wide range of
phenotypes, ranging from the hair defect only to PIBIDS [photosensitivity, ichthyosis, brittle hair,
intellectual impairment, decreased fertility, and short stature] with recurrent infections, develop-
mental delay and neurological findings. Light microscopic examination showed tiger tail bands in
all hairs from all patients under polarized light. Shaft abnormalities (trichoschisis, trichorrhexis
nodosa, or ribbon/twist) varied in severity among patients. All hairs had reduced sulfur content. We
observed a significant inverse correlation (Rval=0.9) between hair sulfur content and the percent of
hairs with shaft abnormalities, demonstrating the role of sulfur in hair toughness. There was no cor-
relation between the presence of photosensitivity, neurological or immune findings and the percent
of abnormal hairs. Scanning electron microscopy revealed numerous surface irregularities. Confo-
cal microscopy captured structural features of breaks and hair autofluorescence. Raman spectra of
hair samples of 3 TTD patients and volunteers were recorded. Deconvolution of the disulfide stretch-
ing region yielded the contributions of three individual conformers. For the TTD hairs, a larger con-
tribution of the energetically less favored conformers, (g-g-t) and (t-g-t), was found. Thus our data
indicate that alterations in sulfur content and disulfide conformations contribute to the fragility of
TTD hair; however, there does not appear to be a correlation between severity of hair disease and
clinical phenotype. 
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Role of TSC-22 in homeostasis of murine skin
M Guitard, T Soma, CE Dohrmann, J Brissette and LA Raftery Cutaneous Biology Research
Center, MGH/Harvard Medical School, Charlestown, MA
TSC-22 (TGFbeta-stimulated clone 22) is a member of a poorly understood family of leucine zip-
per transcription factors, the TSC-22/DIP/BUN family. TSC-22 has been implicated in TGFbeta-
regulation of proliferation in osteoblasts and colon epithelia, as well as TGFbeta-induced apoptosis
in human salivary gland tumor cell lines. Another member of the family, GILZ, has been implicated
in differentiation of adipose cells and regulation of activated T cell survival. There are four family
members in mammals, but only one family member, bunched, in the model organism Drosophila.
In Drosophila, the single TSC-22/DIP/BUN gene is essential for embryonic viability. We are inter-
ested in understanding the function of TSC-22 in tissue homeostasis and tumor suppression, so we
have initiated an investigation into its function in mouse skin. Our published data on TSC-22 mRNA
accumulation and immunoreactivity during the murine hair cycle may be consistent with regulation
by TGFbeta2 from the outer root sheath during anagen, but is not consistent with a direct role in
apoptosis during remodeling of the hair follicle at the anagen/catagen transition. We have noted that
TSC-22 immunoreactivity is present in the basal layer of mouse epidermis, but that the level of
nuclear TSC-22 is variable in this population. Given the role of this family in regulation of prolif-
eration and differentiation in other tissues, we wish to determine whether TSC-22 may regulate pro-
liferation in the basal layer or the onset of differentiation. We have generated a TSC-22 knock-out
mouse strain, which is viable with normal appearance. We are presently investigating the role of
TSC-22 in more challenging circumstances, such as cutaneous wound healing. 
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MICA alleles and extended haplotype suggest phenotypic variation in alopecia areata multi-
plex families
N Barahmani,1 M de Andrade,1 J Slusser,1 Q Zhang1 and M Duvic1 1 Dermatology, M.D. Anderson
Cancer Center, Houston, TX, 2 Health Sciences Research, Division of Biostatistics, Mayo Clinic,
Rochester, MN, 3 Health Sciences Research, Division of Biostatistics, Mayo Clinic, Rochester, MN,
4 Epidemiology, MD Anderson Cancer Center, Houston, TX and 5 Dermatology, MD Anderson
Cancer Center, Houston, TX
Alopecia areata (AA) is an autoimmune, T-cell mediated disease directed at the hair follicles and
major histocompatibility complex (MHC) DR and DQ loci associations have been reported. MCH
class I chain related gene-A (MICA) is a stress antigen located 46.5 bp centromeric to the HLA-B
region. Allelic polymorphisms due to variation in number of GCT repeats (A4, 5, 5.1, 6, 9) are
described, and allele 5.1 and 6 are associated with psoriasis and Behcet s syndrome respectively. To
determine whether MICA is associated with AA, DNA from 431 individuals in 100 AA multiplex
families were genotyped using MICA specific PCR amplification, gel electrophoresis, and/or DNA
sequencing. Transmission disequilibrium test (TDT), family based association test (FBAT) and hap-
lotype analysis were applied. Phenotypic severity was defined as mild or patchy alopecia areata (AA)
(85 informative trios) or as severe alopecia totalis (AT)/ alopecia universalis (AU) (83 informative
trios) based on degree and duration of hairloss. Five MICA alleles were detected by genotyping in
AA affected individuals. Family based association test (FBAT) suggests the MICA allele 5.1 is
associated with mild, patchy AA (p= 0.02) while allele 6 is bordline associated with AT/AU (p=
0.087). Two extended haplotypes, HLA-DQ*6, DR6, MICA*5.1 (p=0.004) and DQ1, DR3, MICA*5.1
(p=0.009), were significantly associated with AA (patchy and AT/AU). Differences in MICA alle-
les, in addition to HLA-D loci alleles, may underlie phenotypic severity of alopecia areata in mul-
tiplex families. 
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Phenotype characterization of the rough coat mice
T Cao,1,2 E Pankotai,1 Q He,2 P Racz,1 K Molnarne Szauter,2 G Young,1 DE Ramones1 and
K Csiszar2 1 Pacific Biomedical Research Center, University of Hawaii at Manoa, Honolulu, HI
and 2 John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI
Rough coat arose spontaneously as a recessive mutation in the C57BL/6J strain. Homozygous mice
were born indistinguishable from their normal littermates, but showed unkempt looking coat by
weaning age, and developed cyclic and progressive hair loss. The rough coat locus has been mapped
to chromosome 9, but the gene mutation has not been identified. In this study, we carried out phe-
notype characterization of these mice. Loss of pelage hair and vibrissae was observed during cata-
gen/telogen, and hair re-growth was observed during the subsequent anagen. Scanning electron
microscopy revealed that hair loss in the rough coat mice was not due to hair shaft breakage. How-
ever, the hair shafts from the rough coat mice appeared much smoother than those from normal
C57BL/6J mice. Histological analysis showed severe sebaceous gland hypertrophy. Additionally,
rough coat mice over 10 months old also developed persistent ulcerated lesions in the skin at a high
incidence, suggesting a defect in epidermal maintenance. Because the multipotent keratinocyte
stem cells are the source for the cyclic growth of the hair follicle root sheath and the proliferating
basal cells of the sebaceous glands as well as epidermal maintenance upon wounding, our observa-
tions suggest a possible shift of the stem cells from hair follicle to sebaceous fate in the rough coat
mice.
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Immunohistochemical analysis of bone morphogenetic protein-5 in human skin
G Franklin and RJ Morris Dermatology, Columbia University, New York, NY
Bone morphogenetic proteins (BMPs) are novel subfamily members of the transforming growth
factor beta (TGF-β) supergene family. Originally found to stimulate cartilage and bone formation
in vivo, BMPs are now known to show specific expression patterns in the epidermis, regulate cell
proliferation and differentiation, and have been implicated in hair follicle morphogenesis and cycling.
The patterns of expression of BMP-5 another member of the BMP family has been understudied in
human skin, therefore the objective of this study was to look at the immunohistochemical expres-
sion patterns in normal human skin and hair follicles. Archived paraffin blocks of human skin were
immunostained with anti-human BMP-5 ligand antibody followed by the peroxidase method. Pre-
vious immunohistochemical studies have shown BMP-2/4 to be localized to the cytoplasm of
suprabasal and spinous cells in normal and benign samples of oral mucosa and hard palate, where
as BMP-5 was localized to the cytoplasm of basal cells and some suprabasal cells in samples from
the same locations. Our study results show that BMP-5 is diffusely immunolocalized in the cyto-
plasm of cells in all layers of the epidermis, the external root sheath of the hair follicle, nerve bun-
dles, endothelial cells, and the secretory and ductal elements of eccrine glands. In our opinion
BMP-5 plays a crucial role in hair follicle morphogenesis and cycling. These results enable func-
tional studies of BMP-5 and its receptor in normal and abnormal skin and its appendages. 
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Developmental analysis of nail development
D Pechar,2,1 Z Zhao1,2 and CA Loomis1,2 1 Dermatology, NYU School of Medicine, New York, NY
and 2 Cell Biology, NYU School of Medicine, New York, NY
Skin appendages (nails, hairs, eccrine glands) are micro-organs that convey mechanical and regula-
tory properties to the epidermis and associated dermis. Development of these skin appendages involves
three distinct, yet overlapping, stages: specification, morphogenesis, and differentiation. Our lab
focuses on the genetic regulators that play a role in nail and eccrine gland development during these
3 stages. A developmental foundation crucial to understanding the phenotypes we observe, how-
ever, is unavailable in the literature. The current focus of our work has been the creation of a devel-
opmental timetable for the nail appendage. We have conducted histological and expression analy-
ses of candidate regulatory and differentiation markers in the mouse nail unit. The presumptive nail
is first discernible by a thickening of the epidermis at the dorsal digit tip at E14.5. This region is
delineated by Dlx2 gene expression as indicated by a Dlx2-LacZ allele. Dlx2 continues to be expressed
in the developing nail bed and hyponichium (the ventral component of the nail) until at least P6,
thus serving as a useful marker of the developing nail unit. In addition, the onset of nail develop-
ment coincides with a sharp increase in alkaline phosphatase (AP) activity in the mesenchyme under-
lying the nail field at E14.5 and a loss of AP activity in the remnant apical ectodermal ridge (AER).
AP activity remains robust in the nail mesenchyme postnatally, differentiating it from more proxi-
mal non-appendageal dermal mesenchyme. By E16.5, the progeny of nail bed cells differentiate
into a pre-nail structure (indicated by expression of hard keratins). At the same time, the cells of the
proximal nail epithelium, which include the presumptive nail matrix cells, begin to invaginate. By
birth, the proximal matrix cells are enveloped by mesenchyme and their progeny differentiate into
the mature nail plate, indicated by histological staining and hard keratin expression. We also show
that the transcription factor Engrailed-1 and trichohyalin, a keratin binding protein, are selectively
expressed in the nail hyponichium beginning at E15.5. 
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High commitment of embryonic keratinocytes to terminal differentiation through a Notch1-
caspase 3 regulatory mechanism
R Okuyama,1,2 B Nguyen,2 C Talora,2 M Lioumi,2 G Chiorino,3 E Ogawa,1 H Tagami,1 M Woo4 and
PG Dotto1,5 1 Department of Dermatology, Tohoku University Graduate School of Medicine,
Sendai, Japan, 2 Cutaneous Biology Research Center, Massachusetts General Hospital and
Harvard Medical School, Charlestown, MA, 3 Laboratory of Cancer Pharmacogenomics, Biella,
Italy, 4 Department of Medicine, Ontario Cancer Institute, St. Michael, Toronto, ON, Canada and
5 Institute of Biochemistry, Lausanne University, Epalinges, Switzerland
Embryonic cells are expected to possess high growth/differentiation potential, required for organ
morphogenesis and expansion during development. However, little is known about the intrinsic prop-
erties of embryonic epithelial cells due to difficulties in their isolation and cultivation. We report here
that pure keratinocyte populations from E15.5 mouse embryos commit irreversibly to differentia-
tion much earlier than newborn cells. Notch signaling, which promotes keratinocyte differentiation,
is up-regulated in embryonic keratinocyte and epidermis, and elevated caspase 3 expression, which
we identify as a transcriptional Notch1 target, accounts in part for the high commitment of embry-
onic keratinocytes to terminal differentiation. In vivo, lack of caspase 3 results in increased prolif-
eration and decreased differentiation of interfollicular embryonic keratinocytes, together with
decreased activation of PKC-δ, a caspase 3 substrate which functions as a positive regulator of ker-
atinocyte differentiation. Thus, a novel Notch1-caspase 3 regulatory mechanism underlies the intrin-
sically high commitment of embryonic keratinocytes to terminal differentiation. 
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Vellus versus terminal hair follicle: cytokeratin expression in vitro and in vivo
A Vogt, R Dirsch, S Hadam and U Blume-Peytavi Department of Dermatology, Center of
Experimental and Applied Cutaneous Physiology, University Medicine Berlin, Campus Charite
Berlin, Berlin, Germany
The human hair follicle can undergo transformation from strong terminal hair follicles (THF) to
fine vellus hair follicles (VHF) as in androgenetic alopecia, and conversely, as it occurs in hirsutism.
Although structurally similar to THF, there is evidence for a characteristic histomorphology of
VHF. To better understand the structure and the regulation of the human VHF, fresh skin samples
from different body sites including scalp, face and trunk were stained with a large panel of anti-
cytokeratin (CK) antibodies ranging from CK5 to CK20 and differentiation markers such as tri-
chohyalin. In both THF and VHF, anti-CK19 and anti-CK17 strongly stained the outer root sheath
(ORS), while anti-CK13 and trichohyalin were confirmed as markers of the inner root sheath (IRS).
However, staining was strong and homogenous in VHF, while a spotted pattern was found in THF.
To further investigate this observation, primary keratinocyte cultures were established from THF and
VHF. Consistent with our immunohistochemical data, the percentage of cells positively stained for
cytokeratin 17 and 19, with 80% and 35%, respectively, was higher in VHF-derived keratinocytes
than in THF-derived keratinocytes, yet both cultures only partly expressed outer root sheath mark-
ers. Furthermore, up to 10% of VHF keratinocytes were trichohyalin positive, indicating IRS-like
differentiation, while anti-CK13 stained less than 1% of the cells in all cultures. In contrast to cul-
tured primary keratinocytes, whole organ cultures from THF consistently maintained the physio-
logical expression pattern of cytokeratins over several days in vitro, indicating that models of the
whole hair follicle are essential tools in experimental hair research. Our findings underline the need
of a suitable in vitro model of the whole human vellus hair follicle to further investigate vellus hair
biology and the transformation to terminal hair follicles. 
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Shh and Gli 1 are involved in the control of human hair follicle cycle and growth ex vivo
S Lachgar, C Partesana and M Charveron CERPER, Dermatology, Toulouse, France
Sonic Hedgehog signaling (shh) is implicated in murine hair follicle morphogenesis and growth
through the regulation of the Gli transcription factors. The purpose of this study is firstly to exam-
ine the expression of the mRNAs and proteins of shh and its downstream effector Gli1 in the human
hair follicle at different stages of the hair cycle using immunolabelling and in situ hybridization
with biotin-labelled shh or Gli1 specific probes. 
We demonstrated by these two approaches a same localization of shh and Gli1 in the outer root sheath
keratinocytes near the bulge region at the anagen stage. With transition to catagen and telogen stages,
expression was detected in the lower part of hair follicle. The shh gene presence was investigated
on isolated hair follicle ex vivo. Total RNA was extracted from isolated human anagen hair follicles
and genes (shh, Gli1) expressions were analyzed by semi-quantitative RT-PCR. We found a signif-
icant amount of shh and Gli 1. We then attempted to introduce the shh gene into isolated hair folli-
cle for induction or inhibition of hair shaft growth. Hair follicles were subjected to transfection with
lipofectin. Transfected hair follicles with shh antisense probes show a significant inhibition of hair
shaft elongation ex vivo. Targeting isolated hair follicle with shh or Gli1 encoding mRNAs may find
an application for intervention in hair follicle diseases and/or in alopecia. 
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Semaphorin A is expressed in the bulge region of the hair follicle
K Kajiya,1 Y Tsuji,1 T Souma,1 M Ogo,1 O Moro,1 Y Wada2 and J Kishimoto1 1 Shiseido Research
Center, Yokohama, Japan and 2 Tokyo University, Tokyo, Japan
Semaphorins comprise a large family of cell surface and secreted molecules that play important roles
for neuronal axon guidance. The class III semaphorins are secreted and are also involved in the con-
trol of angiogenesis. Other neuronal factors such as substance P and PDGF and angiogenesis-related
factors such as VEGF and thrombospondin-1 have been shown to be expressed in the hair follicle in
a hair cycle-dependent manner. However, the localization and function of semaphorins in hair biol-
ogy have remained unclear. Using a tyramide-based sensitive in situ hybridization (ISH) technique,
we detected mRNA expression of one of the class III semaphorins, semaphorin A (SemaA), in the
bulge region beneath the sebaceous gland during the telogen phase of the postnatal murine hair cycle.
During the depilation-induced hair cycle in adult mice, SemaA mRNA was selectively expressed by
cells in the bulge region. The ISH results were confirmed by immunostains for class III semaphorins.
Double immunofluorescence stains for class III semaphorins and for BrdU performed in mice that
were exposed to BrdU twice daily from day 3 to day 5 after birth revealed that label-retaining cells
(LRCs) co-localized with class III semaphorin-positive cells. In human skin, immunoreactivity for
keratin15 partially overlapped with class III semaphorin-positive cells in the bulge region of anagen
hair follicles. These data reveal that expression of class III semaphorins is restricted to the bulge
region of hair follicles and they suggest that class III semaphorins might be involved in the control
of the migration of follicular stem cells. 
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In vitro reactivation of inactive dermal papilla cells isolated from mouse whisker follicles
T Iwabuchi, H Shimizu and PF Goetinck Cutaneous Biol Res Ctr, MGH/Harvard, Charlestown,
MA
Dermal papilla cells (DPCs) in anagen phase are a source of inductive signals involved in the for-
mation of hair follicles in vivo. When DPCs from a transgenic mouse line that expresses green flu-
orescent protein (GFP) during anagen are separated from the epithelium and cultured in vitro as
monolayers for several passages, they lose GFP expression and their inductive ability (1). An exoge-
nous source of Wnts can maintain GFP-expression and hair follicle inducing activity of such cul-
tured cells. Wnts, however, cannot re-activate GFP-expression and hair follicle inducing activity of
cultured cells (2). In the present study with manually dissected whisker dermal papillae, GFP expres-
sion could be maintained for as long as one month when the cells were maintained as dermal aggre-
gates. However, GFP expression was lost in cells that migrated out of the dermal papillae as a
monolayer. We have been successful in re-expressing GFP in DPCs that had been cultured as a mono-
layer for several passages by inducing the formation of cellular aggregates in culture. In these
monolayer derived aggregates expression of GFP, HGF and IGF-1 was up-regulated and expression
of BMP-4 was down regulated. When DPCs grew out from the GFP-re-expressing aggregates on cell
culture dishes, GFP expression was again lost in the monolayers. When the GFP-re-expressing DPC
aggregates were combined with normal mouse keratinocytes and grafted to nude mice, one mouse
out of three revealed formation of hair follicles. These results suggest a possibible new technology
for in vitro amplification and reactivation of DPCs for therapeutic purposes in cases such as alope-
cia areata. [1, Kishimoto et al. (1999) PNAS 96:7336; 2, Kishimoto et al. (2000) Genes Dev 14:1181] 
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The morphogenesis of scales in the zebrafish: a model for hair/teeth formation
VH Nguyen,1 X Zhu2 and MC Mullins2 1 Dermatology, University of Pennsylvania, Philadelphia,
PA and 2 Cell & Developmental Biology, University of Pennsylvania School of Medicine,
Philadelphia, PA
The morphogenesis of scales in the zebrafish is analogous to the formation of hair and teeth in mouse
and human. Mesenchymal-epithelial interactions are known to be essential for the development of
hair and teeth. Our recent studies in the zebrafish indicate that the formation of scales likewise involves
molecular signaling between the epithelial and mesenchymal components of scale placodes. We ana-
lyze the in vivo expression of many genes thought to be important in the morphogenesis of hair and
teeth in scale placode development in the zebrafish. These expression studies reveal many similari-
ties between the development of scales, and of hair and teeth. We detect the expression of various
components of the Wnt, Bone Morphogenetic Protein (BMP), Sonic Hedgehog (SHH), and
Notch/Delta signaling pathways in scale placodes many days prior to the appearance of scales. We
utilize a transgenic zebrafish line TOPdGFP (Dorsky RI, et al.), which consists of a destabilized GFP
mutant downstream of a promoter responsive to Wnt signaling, to show that Wnt signaling occurs
during the morphogenesis of scale placodes. We also detect the stabilization of B-catenin protein in
cells of the scale placode. These lines of evidence strongly support the hypothesis that Wnt signal-
ing is involved in the scale formation of scales in the zebrafish, similar to hairs/teeth in mouse and
human. We are analyzing the phenotype of a zebrafish mutant that lacks scales. We confirm that this
mutant does not form scales by alizarin red staining. We have investigated the expression of various
components of the Wnt, BMP, SHH, and Notch/Delta pathways in this mutant during stages of scale
morphogenesis. We report a severe reduction or absence of expression of each and all of these genes
in the scale placodes of this mutant. We conclude that the gene mutated is required at a very early
stage for scale placode development in the zebrafish. 
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Defining the Hedgehog-PTHrP signaling axis in the skin
T Gocken,1 H Sheng,2 R Gonterman,1 SD Billings,1 A Diamond,1 AA Dlugosz2 and J Foley1 1
Medical Sciences and Dermatology, Indiana Univiersity School of Medicine, Bloomington, IN and
2 Dermatolgy, University of Michigan, Ann Arbor, MI
Sustained and orderly growth of long bones depends on a balance between Indian hedgehog-driven
cellular proliferation and differentiation and inhibition of these processes by parathyroid hormone-
related protein (PTHrP), a factor that appears to be indirectly activated downstream of the hedge-
hog-Gli cascade. Using a series of transgenic models that lack or over express components of the
Sonic hedgehog (Shh) signaling pathway or PTHrP, we investigated interactions between these two
pathways in the skin. Using Q-RT-PCR, we found that PTHrP mRNA levels in skin extracts were
modestly decreased in E18.5 Shh null mice but transcripts were increased 10-fold in adult K5-
driven N-terminal deleted Gli2 (K5-Gli2DN2) mice, in which the hedgehog-Gli pathway is mod-
estly upregulated. To determine if PTHrP signaling could influence the consequences of dysregu-
lated hedgehog signaling in skin, we crossed K14-PTHrP mice with K5-Gli2DN2 mice. PTHrP
over expression reduced the length of longer guard hairs that characterize the first hair cycle of K5-
Gli2DN2 mice by 25%. The K5-Gli2DN2 mice do not undergo a normal second hair cycle and pro-
gressively lose hair shafts beginning at 6 weeks. Alopecia in the K14-PTHrP;K5-Gli2DN2 mice is
markedly delayed and greater numbers of the remaining hair follicles attained a normal telogen-like
morphology. At 6 months, the skin of the K5-Gli2DN2 mice had a thickened epidermis that expressed
markers of hyperproliferation, contained many keratinized cysts in the hypodermis and a dense very
cellular dermis. In contrast, the K14-PTHrP;K5-Gli2DN2 mice had few cysts and the epidermis and
dermis were not as severely affected. Thus, in the skin, endogenous PTHrP gene expression appears
to be activated as a consequence of increased Gli2 mediated transcription; however, overexpression
of this calcitropic peptide inhibits Gli2-driven phenotypic alterations, suggesting a functional inter-
action between these signaling pathways in skin. 
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Human hair follicle organ culture as a screening tool for “hair drug” discovery: applications,
limitations and optimization
A Mescalchin,1 M Massironi,1 A Bettermann,2 R Paus2 and P Pertile1 1 Cutech Srl, Padova, Italy
and 2 Dept. of Dermatology, UKE, Hamburg, Germany
Organ culture of human hair follicles, pioneered by Philpott et al. (J Cell Sci 97: 463, 1990), still is
the only reliable in vitro-method for predicting how a test agent might affect human hair growth in
vivo. Here, we reconsider this assay and propose modifications for its optimisation. Microdissected
human scalp hair follicles in anagen VI are cultured up to 10 days during which time hair shaft elon-
gation proceeds at an in vivo-like rate. In its traditional form, this assay is best-suited for testing can-
didate hair growth-inhibitors, since anagen VI hair bulbs show already maximal growth and are highly
susceptible to inhibitory compounds. Also, this assay imitates only systemic drug administration and
is limited in its physiological relevance due to the absence of large portions of the pilosebaceous
apparatus. To overcome these limitations, we have modified and optimised the assay, e.g. by enlarg-
ing and standardizing the read-out parameters for evaluating the modulatory properties of a candi-
date “hair drug”. Besides hair shaft elongation, proliferation and apoptosis of hair matrix cells, hair
cycle stage, hair pigmentation (melanin quantity/distribution and melanocyte detection) and indica-
tions of compound toxicity (signs of follicle dystrophy) are assessed. This allows highly instructive
test compound screening for its effects on spontaneous catagen development, “physiological” cata-
gen development (induced by TGF-beta2), premature “pathological” (i.e. inflammation-associated)
catagen development (induced by IFN-gamma). In parallel, we have applied strict parameters for
quality control of organ-cultured hair follicles and included automatized measurements by customized
digital analysis software. These modifications greatly enhance the instructiveness, sensitivity and
predictive value of this assay as a screening tool for candidate hair growth and/or hair pigmentation-
modulatory molecules, while simultaneously offering indications of a test compound’s potential tox-
icity in the human system. 
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Gene targeting on embryonic skin explants: lessons and outcomes
V Alexeev Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
Continuous renewal of the epidermis is provided by so-called epidermal stem cells that give rise to
the progeny that forms suprabasal layers of the epidermis. Several studies revealed that these line-
age-specific stem cells might reside in the basal layer of epidermis and in the bulge area of the hair
follicles. The absence of any molecular or genetic markers for these stem cells confines further devel-
opment of the applicable gene therapy approaches for treatment of the dermatological disorders. We
sought an approach where subsets of stem cells can be marked directly in developing embryonic
mouse skin by using oligodeoxynucleotide (ODN) mediated gene targeting. We generated a trans-
genic mouse model, where a mutant b-galactosidase with inactivating mutation (G1651A; E523K)
is expressed in the epidermis. When cells containing this mutant reporter gene are corrected by gene
targeting, the enzymatic activity of the b-galactosidase is restored and corrected cells can be visu-
alized by histochemical staining. We hypothesized that ODNs can correct the point mutation in epi-
dermal stem cells and that clonal expansion of corrected cells can be visualized by staining. We
have established appropriate conditions for the in vitro culture of the embryonic mouse skin, where
epidermis and its appendages can be fully differentiated and developed.  Embryonic skin was iso-
lated from the E13 mouse embryos and treated topically with ODNs. Three weeks after the initial
treatment, skin explants were harvested and cryosections were analyzed for the active b-galactosi-
dase. Several positively stained cells were detected in the stratified layer of epidermis. The major-
ity of the b-galactosidase positive cells were detected in conjunction with hair follicles, not with basal
layer of epidermis, suggesting that during embryonic development epidermal stem cells may pri-
marily migrate to the hair follicles. Further optimization of gene targeting on skin explants and live
embryos, as well as histomorphometric analysis may shed important information of the lineage of
epithelial cells. 
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Regeneration of human hair follicles by cellular grafting
R Ehama,1 R Ideta,1 T Soma,1 K Yano,1 S Suzuki,3 Y Shirakata,2 K Hashimoto2 and J Kishimoto1
1 Shiseido Research Center, Yokohama, Japan, 2 Ehime University School of Medicine, Ehime,
Japan and 3 HAB research organization, Chiba, Japan
Our studies have focused on the possibility of human hair follicle regeneration from the view of
epithelial-mesenchymal interactions (EMI). As a first step, we examined the potential of human epi-
dermal keratinocytes for follicular differentiation in combination with mouse dermal papilla (DP)
cells as an active mesenchymal source. We have previously shown that versican-expressing DP cells
possess hair inductivity utilizing a transgenic model. We further applied this finding to establish
large-scale preparation of DP-enriched fraction from non-transgenic mouse skin using a freeze-thaw
procedure. After confirming these DP cells have hair inductivity with both mouse and rat new born
epidermis, fresh epidermal cells or cultured keratinocytes derived from human new born foreskins
were co-grafted with mouse DP-enriched cells. Detection of human originated cells was confirmed
by Hochest 33258 nuclear staining and human specific AluI DNA in situ hybridization. Results
demonstrated follicle-like formation with a keratin fiber-producing hair shaft structure in the graft-
ing area with fresh human epidermal cells. Mouse DP cells recruited to the human follicular epithe-
lial cells were also evident. These characteristics were observed in graft with cultured human ker-
atinocytes as well and were maintained up to the third passage. Furthermore, adult epidermal
keratinocytes both from young human foreskins and from rat dorsal skins were also capable of dif-
ferentiating into hair follicles with mouse DP cells. These results demonstrate that: 1) mouse DP
possess hair follicle inductive properties across the species, 2) epidermal keratinocyes from non-
hair forming skin are capable of differentiating into the follicular epithelium, and 3) epidermal cells
from a mature stage are also capable of differentiating in response to inductive signals from DP cells,
indicating the importance of EMI in follicular generation and the higher differentiation potential of
epidermal keratinocytes than previously thought. 
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Gene expression profile of epithelial stem cells induced by dermal papilla using Genechip
microarrays
C Roh, Q Tao and S Lyle Pathology, Beth Israel Deaconess Medical Center, Boston, MA
The epithelial-mesenchymal interactions between keratinocyte stem cells and dermal papilla cells
are crucial for normal development of the hair follicle as well as during hair cycling. In order to
characterize the events occurring during the process of epithelial stem cell fate determination, we
utilized a co-culture system by incubating human hair follicle keratinocytes stem cells with dermal
papilla cells. Using Genechip microarrays, we analyzed changes in gene expression profiles within
the stem cells upon induction by dermal papilla over a 1, 2 and 5 day time-course. After normaliza-
tion and filtration, 272 genes were up- or down-regulated by >3-fold. Among up-regulated genes,
the hair-specific keratin 6 hair follicle (K6hf) gene increased 7.9 fold, with a resulting 2-3 fold increase
in the protein levels. The up-regulation of K6hf was unique to dermal papilla-induced differentia-
tion since expression of K6hf was not induced by increased calcium. We also found that the more
committed transit-amplifying cells of the hair matrix, are more readily differentiated by the dermal
papilla than epithelial stem cells. For matrix cells the expression of K6hf protein peaked at day 2,
while for stem cells it took 3-4 days. Since the beta-catenin signaling pathway has been implicated
in the initiation of hair follicle development, we also examined the status of beta-catenin in the co-
culture system. Although no changes are seen in beta-catenin gene expression, there was a signifi-
cant increase in nuclear localization indicating that beta-catenin-regulated gene expression is occur-
ring.
Our results show that the co-culture system recapitulates the epithelial-mesenchymal interactions
which induce hair differentiation of the multi-potent keratinocyte stem cells and identify markers of
differentiation as well as pathways involved in fate determination. Our finding also show that K6hf
can be used as a marker for the initiation of dermal papilla-induced hair follicle differentiation of
keratinocyte stem cells. 
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Loss of epithelial Bmpr1a results in continuous proliferation of hair follicle epithelium and the
development of matricomas 
T Andl,1 EY Chu,1 D Metzger,2 P Chambon,2 Y Mishina,3 JT Seykora,1 EB Crenshaw4 and
SE Millar1 1 Department of Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Institut
de Genetique et de Biologie Moleculaire et Cellulaire, Universite Louis Pasteur, Strasbourg,
France, 3 Laboratory of Reproductive and Developmental Toxicology, National Institute of
Environmental Health Sciences, Research Triangle Park, NC and 4 Abramson Research Center,
The Children’s Hospital of Philadelphia, Philadelphia, PA
Signaling by Bone Morphogenic proteins (BMPs) is thought to play important roles in the regula-
tion of hair follicle differentiation and cycling. We have previously reported that Keratin 14-Cre
mediated deletion of the BMP receptor IA (Bmpr1a) gene from the surface epithelium and epider-
mis of mice carrying a floxed allele of Bmpr1a results in reduced or absent expression of several
hair follicle transcription factors and failure of differentiation of the hair shaft and inner root sheath.
These results provided definitive genetic evidence that BMP signaling is required for differentiation
of hair follicle matrix cells. Here we show that Bmpr1a mutant hair follicles also fail to cycle nor-
mally, being maintained in an abnormal, proliferative, anagen-like state. Analysis of older mutant
mice reveals that, while some mutant follicles eventually degenerate to form follicular cysts, a sub-
set of follicles continues to proliferate, forming large benign tumors. The tumor epithelium does not
express keratins, except for very low levels of K17. The lack of follicular differentiation within the
epithelial proliferations, together with absence of epithelial nuclear beta-catenin, indicates that
these tumors are comprised of undifferentiated matrix cells and are similar to human matricomas.
These results demonstrate a novel role for BMPRIA in regulating the proliferation of hair follicle
epithelial cells, and suggest that loss of epithelial BMP signaling may be involved in the etiology of
human matricoma. 
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Cleavage of caspase-14 coincides with stratum corneum formation during development of fetal
mouse skin
H Fischer,1 L Eckhart,1 C Baresi,1 M Ghannadan,1 H Rossiter,1 M Buchberger,1 S Lippens,2
W Declercq2 and E Tschachler1 1 Department of Dermatology, University of Vienna Medical
School, Vienna, Austria and 2 Department of Molecular Biology Research, Flanders
Interuniversity Institute for Biotechnology and Ghent University, Ghent, Belgium
In adult human skin caspase-14, a protease implicated in terminal differentiation of keratinocytes,
is present as complex of large and small subunits indicating catalytic caspase activity. In order to
determine whether cleavage of the proenzyme is a secondary event relative to formation of mature
epidermis or if it represents an integral step within this process, we investigated caspase-14 pro-
cessing during fetal skin development in the mouse. Whole skin was sampled at different days of
embryonic development and analyzed by immunohistochemistry and Western blot. Immunohisto-
chemistry revealed that keratinocytes in suprabasal layers expressed caspase-14 as early as day E14.5
whereas the periderm and all other skin compartments were negative. By Western blot analysis, cas-
pase-14 proenzyme was detected on E14.5 and at all later time points whereas cleavage products of
the same size as those in adult mouse skin appeared on day E16.5. This coincides with the forma-
tion of orthokeratotic stratum corneum, but precedes the establishment of the permeability barrier
and of the epidermal calcium and pH gradient. Our study demonstrates that caspase-14 processing
parallels the development of stratum corneum in utero. These data provide a basis for screening of
potential substrates and activators for caspase-14 that are present in this stage of development. 
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Isolation and characterization of adult hair follicle stem cells
R Morris,2 Y Liu,1 L Marles,1 Z Yang,1 C Trempus,3 S Li,2 J Lin,1 J Sawicki4 and G Cotsarelis1 1
Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Columbia University, New York, NY,
3 NIEHS, Research Triangle Park, NC and 4 Lankenau Medical Institute, Wynewood, PA
The characterization of presumptive hair follicle stem cells in the bulge has been hampered by the
inability to target these cells genetically. Here, we use a keratin (K15) promoter to target bulge cells
in transgenic mice with an inducible Cre recombinase construct or Enhanced Green Fluorescent Pro-
tein (EGFP), which allow for lineage analysis and for isolation of the cells. Lineage analysis demon-
strated that bulge cells in adult mice normally generate all epithelial cell types within the intact fol-
licle during follicle cycling. After isolation, adult bulge cells retained their multipotent nature and
generated all components of the cutaneous epithelium in skin reconstitution assays. Bulge cells also
have an increased in vitro proliferative potential relative to K15-EGFP-negative cells. Genetic pro-
filing of the isolated hair follicle stem cells reveaed differentially expressed genes previously asso-
ciated with inhibition of proliferation and differentiation, as well as novel receptors potentially impor-
tant for maintaining the stem cell phenotype. For example, the inhibitor of differentiation genes, ID-2
and ID-4, Basonuclin, Growth arrest specific 1, Tenascin C, PBSF/SDF-1, Embigin, and the S100
calcium binding proteins have all been associated with quiescent or undifferentiated cells, and were
up-regulated in hair follicle stem cells. Expression of key signaling genes known to be important for
hair growth was downregulated in the stem cell population, suggesting that other downregulated
genes novel to the follicle may represent new targets for hair growth manipulation. For example,
Wnt3a and Wnt10a were depleted while inhibitors of the WNT pathway, including Sfrp-1, disabled
2 and Dkk-3, were prominently expressed. Overall, our findings point to the preferential expression
of a remarkably diverse set of genes with apparently redundant functions related to maintaining the
stem cell phenotype. 
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Feather regeneration—the whole story
P Maderson Biology, Brooklyn College, Quakertown, PA
Appreciation of feathers as model systems for understanding molecular controls of pattern forma-
tion and cytodifferentiation in epidermal appendages is inhibited by the lack of a comprehensive
review of data concerning feather replacement. All recent studies are rooted in a 1972 account that
was conceptually flawed and lacked reference to the presence of both αand βkeratins. For obvious
reasons, it did not include allusion to the advances that have been made in our knowledge of kera-
tinization processes and their control that have appeared over the last 30 years: unfortunately, rele-
vant data for sauropsid (avian and reptilian) epidermis - a system now arguably better known for a
variety of species than for the more familiar mammalian models - have been largely ignored. Feather
anatomy and development can only be understood in the context of “vertical alternation of kerato-
genesis” (Baden and Maderson, J Exp Zool, 1972). This concept, that emphasizes how daughter cells
arising from an apparently homogeneous germinal population may undergo quite distinct protein
synthetic pathways, has been refined and explains how somatic growth accommodates the role of
αkeratogenic tissues in providing a barrier to water loss. A review of studies on sauropsid epider-
mis since 1876, combining classical histology with “modern” ultrastructural, biophysical, physio-
logical, biochemical and molecular data has allowed the preparation of a completely new, compre-
hensive series of graphic representations of stages in feather regeneration that (a) permits comparison
with the cyclic activity of a hair follicle and (b) spotlights a number of significant aspects of ker-
atinocyte behavior during feather morphogenesis that have no counterparts in mammalian epider-
mal appendages. This developmental model emphasizes the single unique feature of feathers - post-
mitotic patterning mechanisms establish spatially organized regions wherein loss of cell-cell adhesion
permits separation of populations of mature keratinocytes resulting in a “branched morphology.”
This model accommodates all known natural feather morphs and explains phenotypes of genetic
mutants and results from experimental perturbations. 
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Expression of an olfactomedin-related gene in cultured rat hair follicular papillary cells
Q Cao,1,3 A Lee,1 D Yu,1 Y Kasai2,1 and T Sun1 1 Dermatology, New York University School of
Medicine, New York, NY, 2 Ophthamology, Kyoto Prefectural Univ. of Medicine, Kyoto, Hirokoji
Kawaramachi Kamigyo-, Japan and 3 Genetics and Complex Diseases, Harvard School of Public
Health, Boston, MA
The proliferating matrix keratinocytes located at the bottom of the hair follicle enclose almost com-
pletely a group of specialized mesenchymal cells called follicular papilla (FP) cells. Earlier studies
showed that FP cells, but not their closely related dermal fibroblasts (DF), can maintain hair growth
suggesting cell type-specific molecular signals. To define the molecular differences between these
two cell types, we generated a subtraction cDNA library highly enriched in follicular papilla-spe-
cific cDNAs. Differential screening identified about 30 EST sequences and known genes that are
preferentially expressed in cultured follicular papilla cells vs. fibroblasts. One of these cDNAs, which
we named FP-1, represents the most abundant sequence in the subtraction library. The full-length
FP-1 cDNA is 2,283 bp, that encodes a protein of 502 amino acids containing a signal peptide, a
collagen-related domain and a olfactomedin-like domain. FD-1 message is highly abundant in cul-
tured rat vibrissa follicular papillary cells, can be detected at low levels in stomach and ovary, but is
absent in cultured dermal fibroblasts and in lung, heart, spleen and other 10 rat tissues. Monospe-
cific rabbit antibodies to FP-1 recognizes in cultured FP cells a single 72kd glycoprotein band. FP-
1 was not detectable in normal follicular papilla in vivo but become upregulated when FP cells were
placed in culture. FP-1 may play a role as an extracelluler matrix protein involved in the reorgani-
zation of dermal papilla during certain phases of normal or pathological hair growth. 
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Human hair follicles display a functional equivalent of the hypothalamic−pituitary−adrenal
axis and synthesize cortisol
N Ito,2,1 T Ito,2,1 A Kromminga,3 A Bettermann,1 M Takigawa2 and R Paus1 1 Dermatology,
University Hospital Hamburg-Eppendorf, Hamburg, Germany, 2 Dermatology, Hamamatsu
University School of Medicine, Hamamatsu, Shizuoka, Japan and 3 Institute for Immunology,
Clinical Pathology & Molecular Medicine, Hamburg, Germany
It has been proposed that mammalian skin contains a peripheral equivalent of the hypothalamic−
pituitary−adrenal (HPA) axis, which controls adrenal cortisol production and serves as a major stress−
response regulator and endocrine integrator system in mammalian organisms. Hypothalamic corti-
cotropin releasing hormone (CRH) is the most proximal element of the HPA axis, and the major
regulator for the pituitary expression of the proopiomelanocortin (POMC) gene and for the pro-
cessing of POMC−derived peptides, such as α−melanocyte stimulating hormone (MSH), β−endor-
phin, and adrenocorticotropic hormone (ACTH), which induces adrenal cortisol production. Human
skin indeed expresses transcripts and/or immunoreactivity (IR) for most of the key components of
the HP axis, including CRH and CRH−receptor, POMC, α−MSH, ACTH and melanocortin recep-
tors and even expresses key enzymes for cortisol synthesis. However, convincing evidence that a
functional equivalent of the HPA axis operates in normal skin in situ and that normal human skin
actually synthesizes cortisol, is still missing. Here, we show that human scalp hair follicles display
a fully functional equivalent of the HPA axis, synthesize cortisol, and recruit classical HPA feed-
back loops. 
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Hair growth control by BMP: more complex than suspected
U Guha,1 L Mecklenburg,2 P Cowin,5 M O Guin,4 D D Vizio,3 RG Pestell,3 R Paus2 and JA Kessler5
1 Neuroscience, Albert Einstein College of Medicine, Bronx, NY, 2 Dermatology, University of
Hamburg, Hamburg, Germany, 3 Oncology, Lombard Comprehensive Cancer Center, Georgetown
University, Washington, DC, 4 Dermatology, NYU Medical Center, New York, NY and 5 Neurology,
Northwestern University Medical School, Chicago, IL
Bone morphogenetic proteins (BMPs) are key regulators of hair follicle morphogenesis and cycling.
Here, we have further investigated this role in transgenic mice that overexpress a potent BMP inhibitor,
noggin, under the control of the neuron−specific enolase (NSE) promoter. Transgene expression was
seen in hair matrix keratinocytes, hair follicle melanocytes, and skin nerve fibers, and appeared only
after the induction of both primary (tylotrich) and secondary (non−tylotrich) pelage hair follicles.
Noggin overexpression resulted in a dramatic loss of hair shafts postnatally, while the density of
developed hair follicles was not significantly different from WT controls. After an apparently nor-
mal but shortened postnatal hair follicle morphogenesis, only secondary hair follicles of NSE−nog-
gin tg mice showed premature onset of catagen (with massive and abnormal intrafollicular apopto-
sis), and sebocyte−like differentiation was frequently seen in the proximal ORS. Noggin tg mice also
showed a much accelerated onset of the first anagen, following an abnormally short first telogen
phase with defective club hair formation. These hairs were subsequently lost by shedding (i.e. were
not retained, as in WT mice), explaining the increasing postnatal alopecia. This supports the con-
cept that BMP signaling is specifically required for proper hair follicle cycling and ORS keratinocyte
differentiation/apoptosis in non−tylotrich hair follicles and that inhibition of BMP signaling stimu-
lates the telogen−anagen switch. Unexpectedly, this also indicates that BMP inhibition can also
trigger premature catagen onset anagen hair follicles. 
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Role of laminin-10 in hair development
J Gao,1 C Chen,1 NT Nguyen,1 PL Leopold,3 RG Crystal,3 JH Miner,2 AE Oro,1 J Li4 and
MP Marinkovich1 1 Derm & PAVA, Stanford Univ, Stanford, CA, 2 Cell Bio, Washington Univ., St.
Louis, MO, 3 Medicine, Cornell Univ, New York, NY and 4 Derm, Univ of Miami, Miami, FL
Previously, we showed that laminin-10 is the primary laminin expressed by elongating hair germs,
and that laminin-10 is required for hair follicle development. In the current study we sought to iden-
tify hair-promoting laminin domains, and to determine the role that laminin-10 plays in hair follicle
formation. Lama5 -/- transgenic mice, which lack laminin-10, do not survive beyond E16.5, how-
ever development of lama5 -/- skin can be studied after grafting E16.5 day skin to nude mice. While
lama5 -/- skin showed a complete lack of hair development after grafting, incubation of lama5 -/-
skin in a laminin-10 solution prior to grafting, restored the development of fully formed hair as shown
16 days after grafting. Two other cutaneous laminins showed profoundly divergent abilities to res-
cue hair formation in lama5 -/- skin. While exogenous laminin-5 restored hair follicle development
to similar levels as that of laminin-10, as shown by quantitative morphometric analysis, exogenous
laminin-1 failed to show any effect. These results suggest that laminin-5 and laminin-10 share com-
mon structural hair promoting domains which laminin-1 lacks. Previously we showed that sonic
hedgehog (SHH) was reduced in lama5 -/- skin, suggesting a role for laminin-10 in the maintenance
of SHH expression. To further examine this, we treated lama5 -/- skin with SHH- adenovirus prior
to grafting. This resulted in the formation of large hair germs, which failed to elongate. These results
suggest that laminin-10 may play a role in hair germ elongation downstream of SHH. Finally, we
studied whether lack of laminin-10 could cause a feedback inhibition of other early markers of hair
follicle formation. By RT-PCR, we found that E16.5 lama5 -/- skin showed downregulation of nog-
gin, Msx1 and Lef-1 at E16.5, however Wnt 10a, Wnt 10b, BMP2, and Msx2 showed normal expres-
sion, compared to wild type controls. These results implicate laminin-10 in the maintenance of expres-
sion of several important early hair markers. 
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Detailed characterization of eccrine gland development
L Sanchez, C Tong and CA Loomis Dermatology and Cell Biology, NYU School of Medicine, New
York, NY
Human disorders in which the eccrine glands are lost or are non-functional can be life threatening
during infancy and childhood due to impaired thermoregulation. In addition, eccrine sweat contains
critical components of the innate immune system and may serve an important role in defense against
skin pathogens. In spite of the clinical significance of eccrine glands, their development has not
been well studied. To provide a foundation for our analyses of mouse mutants displaying eccrine
gland defects similar to those observed in human disorders, we have undertaken a detailed charac-
terization of the morphological and molecular changes that occur during normal gland develop-
ment. Our data show that eccrine glands develop in two waves, one that begins at E14.0 and one that
begins perinatally (E18.5). The first visible sign of insipient gland development is the formation of
elevated dermal pads. Mesenchymal cells of the early pad express high levels of alkaline phosphatase,
differenting them from adjacent non-appendageal dermal cells. A variety of developmental regula-
tors are expressed in volar skin at this time, including the homeobox transcription factors En1 and
Dlx2. The former is throughout volar ectoderm, whereas the latter is restricted to ectoderm overly-
ing the pads and nail field. A day or two later, focal clusters of basal epidermal cells overlying the
pads elongate and become wedge-shaped, forming ectodermal placodes of the presumptive glands.
By birth, the first wave of eccrine glands have developed to the peg stage, characterized by an elon-
gated ectodermal downgrowth with a slightly widened distal tip. By P6, the coiled secretory portion
is visible and by P8 the spiraled duct through the epidermis can be delineated by selective K6 expres-
sion in the suprabasal cells of the epidermis. En1 continues to be expressed by the gland and over-
lying epidermis throughout the animal’s lifetime whereas Dlx2 is restricted to the distal tip of the
elongating gland anlaga and is downregulated upon gland maturity. These studies provide the first
detailed delineation of distinct stages of eccrine gland morphogenesis. 
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Glial cell line-derived neurotrophic factor (GDNF) and neurturin (NRTN) as a new player in
human hair follicle biology
MA Adly,1 H Assaf,1 P Pertile,2 A Bettermann1 and R Paus1 1 Dermatology, University Hospital
Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany and 2 Cutech srl, Padova, Italy
GDNF and another related member of the GDNF family, neurturin (NRTN), as well as their cognate
receptors (GFRα−1, GFRα−2) are essential for nervous system development, and are also involved
in murine hair cycle control (Am J Pathol 156:1041, 2000). However, it is still unknown whether
GDNF and NRTN play any role in human hair biology. As a first step towards to exlpore this, the
immunoreactivity (IR) for GDNF, NRTN, GFRa−1, GFRa−2 and their common signal transduction
element, c−Ret, was studied in human scalp hair follicles (HF) in situ by immunohistology. GDNF
IR was strongest in the ORS, in hair matrix cells, in the dermal papilla (DP) of anagen VI hair fol-
licles, while it was only weak in catagen and telogen HFs. NRTN IR was most prominent in the DP,
CTS, and IRS of human anagen VI scalp hair follicles. Strong GFRα−1 IR was found in the DP,
CTS, ORS, while GFRα−2 IR was also detected the IRS, and the IR for both receptors was weak or
absent during catagen and telogen. c−Ret IR was strongly expressed thoughout the hair follicle.
GDNF mRNA transcripts were detected by RT−PCR in both in isolated hair follicles and human
scalp skin. In vitro, GDNF partially protect human HF from TGFβ2−induced premature catagen
development. These observations provide the first indication that GFRα−mediated signaling plays
an important role not only in murine, but also in human HF biology. 
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The hedgehog target gene BEG4 associates with a Gli signaling complex
CA Callahan, T Ofstad, H Zhen, J Wang, L Horng and AE Oro Program in Epithelial Biology,
Stanford University, Stanford, CA
Hedgehog (hh) signaling has diverse, context-dependent functions while controlling the prolifera-
tion, differentiation and movement of epithelial cells during development.  Unregulated hh signal-
ing has been shown to be an important contributor to epithelial carcinogenesis. While the transcrip-
tional output of the hh pathway is largely governed by the Gli family of transcription factors, how
Gli target genes are selected in different contexts remains largely unknown. We have previously
shown that the novel hh target gene, BEG4, is expressed in both human and mouse transgenic basal
cell carcinomas. When expressed ectopically in keratinocytes with Gli transcription factors, BEG4
alters Gli transcriptional activity and induces epithelial growths in regenerated human skin.  An
important question is whether BEG4 acts directly or indirectly with the Gli signaling complex. Using
GST affinity columns, we find that BEG4 interacts with Gli-containing complexes. BEG4 can also
co-immunoprecipitate Gli in cell extracts. Further, analysis of interactions with other members of
the Gli signaling complex demonstrates BEG4 can also associate with Suppressor of Fused. Together
these data suggest that the BEG4 regulatory effects on Gli transcriptional activity involve (at least
in part) interactions with known regulators of hh signaling. Our data are consistent with the idea that
BEG4 may control organ growth and tumorigenesis by directly regulating the Gli signaling com-
plex. 
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The murine hair follicle is a melatonin target
H Kobayashi,1,2 TW Dunlop,3 B Tychsen,1 F Conrad,1 T Ito,1 N Ito,1 S Aiba,2 C Carlberg3 and
R Paus1 1 Dermatology, Hamburg University, Hamburg, Germany, 2 Dermatology, Tohoku
University, Sendai, Japan and 3 Biochemistry, University of Kuopio, Kuopio, Finland
The aim of this study was to prove that murine and/or human hair follicles in situ are indeed periph-
eral melatonin targets and express melatonin membrane receptors (MT1, MT2) and/or the mediator
of nuclear melatonin signaling, the orphan nuclear receptor RORα. Immunohistochemical exami-
nation of MT1 and RORα on c57BL/6 mouse hair follicle, and semi-quantitive RT-PCR for MT1
and MT2, and quantitive real time PCR for MT1, MT2 and RORα on mouse skin cDNA has been
studied. Short term-mouse skin organ culture stimulated with melatonin was studied to examine the
effect of melatonin on keratinocyte apoptosis. Murine hair follicle keratinocytes show both MT1-
like immunoreactivity (IR) and RORα-like IR, both of which changed substantially in a hair cycle-
dependent manner. Both semi-quantitive RT-PCR for MT1 and MT2, and quantitive real time PCR
for MT1, MT2 and RORα revealed that all three genes are transcribed in normal mouse skin in hair
cycle-dependent manner. Functionally, melatonin (0.01 to 1 nM) significantly inhibited the consti-
tutional level of epidermal and hair follicle keratinocyte apoptosis in short term-mouse skin organ
culture. The prototypic pineal hormone, melatonin reputedly exerts many functional effects on mam-
malian skin and/or its isolated cell populations in culture (e.g., melanogenesis inhibition, melanocyte
growth inhibition, regulation of seasonal changes in the pelage), and is recognized as a potent free
radical scavenger. We here provide evidence that normal murine skin is a prominent target for mela-
tonin bioregulation, that it expresses MT1, MT2 and RORα and that at least some of these regula-
tors are functionally active in situ. 
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Genetic and phenotypic analysis of the near naked (Hrn) phenotype in mice
AA Panteleyev,1 S Geng,1 MJ Zhang,1 A Martinez-Mir,1 M Tadin-Strapps1 and AM Christiano1,2 1
Dermatology, Columbia University, New York, NY and 2 Genetics and Development, Columbia
University, New York, NY
The near naked (Hrn) is a semi-dominant mutation in mice, which is characterized by complete
hairlessness since birth in homozygous animals, and sparse hairs in heterozygotes. The molecular
basis and pathomorphological features of this mutation are unknown. Based on crossbreeding stud-
ies, linkage of this mutation to hairless (hr) locus on chromosome 15 was proposed over 20 years
ago [Stelzner et al., 1983]. In order to assess the possible allelism of Hrn and hr, direct sequencing
of the coding region of the hairless gene in Hrn mutants was performed and no mutation was iden-
tified. The histological studies of skin and hair follicles of mutant mice (Hrn/Hrn and +/ Hrn) at dif-
ferent stages of postnatal development and their comparison to hairless (HRS/J hr/hr) mice revealed
that Hrn phenotype is quite different from hairless. Specifically, the defect in Hrn is characterized
by dramatic abnormalities in the process of differentiation in precortex region and in hair shaft for-
mation, while in contrast the dominant feature of the hairless phenotype is hair follicle disintegra-
tion. We devised a breeding scheme to directly assess the allelic nature of the Hrn and hr. Backcross
breeding of double heterozygotes (+/Hrn:+/hr) to homozygous hairless rhino mice (hrrh/hrrh) resulted
in the absence of wild type offspring in the 176 classified progeny. These data suggest that Hrn and
hr are closely located, but different genes. The Hrn mutation may serve as a model of autosomal
dominant Marie Unne Hypotrichosis in humans, which is closely linked to, but not allelic with the
human hairless gene. 
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Differential expression of p63 isoforms during epidermal development
S Kim,1 MI Koster2 and DR Roop1,3 1 Molecular and cellular biology, Baylor College of Medicine,
Houston, TX, 2 Program in Developmental Biology, Baylor College of Medicine, Houston, TX and
3 Department of Dermatology, Baylor College of Medicine, Houston, TX
p63 is a transcription factor required for the initiation of an epithelial stratification program during
epidermal development. p63 knockout mice have truncated limbs and lack all stratified epithelia
and their derivatives. Alternative promoter usage and alternative splicing give rise to six different
p63 isoforms, three of which contain a transactivation domain (TA isoforms) and three of which
lack this domain (∆N isoforms). In mature epidermis, ∆N isoforms are the predominantly expressed
p63 isoforms. However, the expression patterns and roles of the different p63 isoforms during epi-
dermal development are not known. To determine the expression profile of p63 isoforms during
embryonic development, we performed RT-PCR using primers specific for the TA and ∆N isoforms.
TA isoforms were first detected at E7.5, before the commitment of the single-layered surface ecto-
derm to a stratification program. In contrast, ∆N isoforms were not expressed until E9.5, after com-
mitment to stratification but before the onset of terminal differentiation. These findings support our
model that TAp63α is required for the initiation of stratification and that ∆Np63α counterbalances
the effect of TAp63α such that terminal differentiation can occur. Although the role of p63 in epi-
dermal development has now been established, the target genes that mediate the effects of p63 are
not known. To identify target genes of p63, we have performed gene expression profiling on RNA
isolated from the skin of wild type and p63 knockout mice using Affymetrix microarrays. Putative
target genes of p63 are being validated by Real Time RT-PCR, RNase protection assays and immuno-
histochemistry. The identification of p63 target genes will provide further insight into the molecu-
lar function of p63. 
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c-Myc alters stem cell fate by directly regulating genes involved in WNT and Hedgehog sig-
naling
KA Honeycutt1 and DR Roop1,2 1 Molecular & Cellular Biology, Baylor College of Medicine,
Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
The oncogene c-Myc has recently been shown to be involved in stem cell fate determination. Our
constitutive K14.myc2 mouse model, in which c-Myc expression is targeted to the basal layer of the
epidermis and to multipotent stem cells residing in the bulge region of hair follicles, exhibits an accel-
erated depletion of stem cells and an increase in size and number of sebaceous glands. These results
suggest that deregulated expression of c-Myc may alter the fate of multipotent stem cells. However,
the mechanism by which c-Myc alters the fate of stem cells remains to be resolved. A recent report
suggests that c-Myc alters the expression of cell adhesion molecules, which prevents stem cell migra-
tion and therefore causes the cell to be influenced by fate-determining signals from the surrounding
microenvironment. To further study the fate-determining role of c-Myc, we developed an inducible
mouse model in which c-Myc expression is targeted to epidermal stem cells and is regulated by top-
ical application of RU486. Induction of c-Myc at E14.5 results in an acceleration of sebaceous
gland development, while induction of c-Myc at E10.5 results in a defect in hair follicle develop-
ment and epidermal hyperplasia. The inducible mouse model is an ideal system to identify down-
stream targets of c-Myc in an in vivo environment. Therefore, we subjected RU486-treated skin sam-
ples to microarray analysis and Real Time RT-PCR. One of the potential downstream targets of
c-Myc, DKK1 (dickkopf1), has been shown to prevent hair follicle formation, while other targets of
c-Myc such as IHH (Indian Hedgehog) and Scd1 are involved in sebaceous gland development. Inter-
estingly, the promoters of both DKK1 and IHH contain potential binding sites for c-Myc and chro-
matin immunoprecipitation assays confirmed that c-Myc was bound to these promoters in vivo. These
data suggest that c-Myc alters stem cell fate by activating direct targets involved in both the WNT
and Hedgehog signaling pathways. 
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A cell surface marker for the purification of dermal papilla cells
D Enshell-Seijffers1,2 and B Morgan1,2 1 Dermatology, Harvard Medical School, Boston, MA and
2 CBRC, MGH, Charlestown, MA
The formation of follicles during embryogenesis and regeneration of follicles in the context of the
hair cycle depend on inductive signaling between the epithelial and dermal components of the hair
follicle. In particular, inductive signals from the dermal papilla (DP) are sufficient to drive follicle
formation in competent epidermis and are thought to drive follicular regeneration during the hair
cycle. Therefore, an efficient method for purification of DP-cells may provide an important tool
towards the development of techniques to encourage follicle rejuvenation or formation in the adult
to combat alopecia. We have used a transgenic line expressing GFP under the control of the versi-
can promoter to enrich for dermal papilla cells, and have performed differential expression screens
that identified a number of candidate genes to mediate inductive signaling from the DP. One of these
genes, designated DPS-1 (for Dermal Papilla Specific 1), exhibits the properties required for DP
purification. In the skin, it is expressed specifically and exclusively in the DP. Expression begins dur-
ing embryogenesis at the dermal condensate stage and is maintained throughout the anagen phase
of the hair cycle in both juveniles and adults. However, DPS-1 is not observed in the DP during the
telogen phase, rendering its expression in correlation with hair inductive activity. More important,
DPS-1 encodes for type II transmembrane protein and therefore can be used as a cell-surface marker
to purify DP cells. Antibodies raised against the extra-cellular domain of DPS-1 specifically stain
the DP and can be used to purify this population by FACS. 
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The lowermost portion of the bulge forms the secondary hair germ during late catagen
M Ito,1,2 K Kizawa,2 K Hamada2 and G Cotsarelis1 1 Dermatology, University of Pennsylvania,
Philadelphia, PA and 2 Basic Research Laboratory, Kanebo Ltd, Odawara, Japan
The lowermost portion of the telogen follicle consists of the bulge and secondary hair germ. At ana-
gen onset, cells within both the bulge and secondary hair germ proliferate and form the new lower
follicle, however, the relationship between the bulge and secondary hair germ remains unclear. Are
secondary hair germ cells derived directly from the bulge or do they arise from cells in the anagen
bulb that survive catagen? To address this question, we used bromodeoxyuridine (BrdU) labeling
strategies to follow bulge cells during hair follicle cycling. We administered BrdU twice per day for
three days during anagen onset after hair plucking. This labeled the bulge cells and secondary hair
germ. We then chased for different time periods and collected tissue for detection of BrdU. We found
that in the catagen follicle, 18 days after plucking, labeled cells were present exclusively in a cylin-
drical configuration in the basal outer root sheath of the bulge region. In contrast, after examining
serial sections we could not detect any labeled cells within the catagen bulb at 18 days. In the ensu-
ing telogen stage, the majority of cells in the secondary hair germ were label retaining cells (LRCs),
which could only have originated from the bulge. Careful histological examination of hair follicles
in catagen showed that the secondary hair germ forms at late catagen when the lowermost bulge cells
collapse around the ascending club hair. 
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Microarray analysis of gene expression in the bulge of human anagen hair follicle following
laser capture microdissection
M Ohyama,1 C Tock,1 A Terunuma,1 M Radonovich,2 J Brady2 and J Vogel1 1 Dermatology Branch,
CCR, NCI, NIH, Bethesda, MD and 2 Basic Research Laboratory, CCR, NCI, NIH, Bethesda, MD
To characterize bulge area of human anagen hair follicles (HF), repository of stem cells, we ana-
lyzed and compared its gene expression profile to other portions of the HF using precisely navigated
laser capture microdissection (LCM) and microarray analysis. To isolate the bulge outer root sheath
cells (ORS) by LCM, serial transverse sections of scalp biopsies were made (approximately 40
HF/section). The bulge area was defined by the presence of label-retaining cells in human scalp
xenograft studies and could be identified by high keratin 15 expression in ORS and arrector pili mus-
cle desmin staining, when compared to ORS below the bulge. The bulge ORS and ORS below the
bulge were separately microdissected by LCM from unstained transverse sections. Total RNA was
extracted (11.5-24.7ng), amplified and hybridized with Affymetrix oligonucleotide microarrays (HG-
U133A genechip, gene probe sets n=22283). The quality and comparability of separate and matched
pairs of bulge ORS and below bulge ORS genechips was demonstrated by the 40% gene expression
“present calls” on each chip and by the 89% overlap of gene expression “absent and present calls”
on all chips. Comparing bulge ORS to below bulge ORS from 3 individual biopsies, 45 genes were
upregulated in all 3 chip pairs and 117 genes were upregulated in 2 out of 3. When categorized by
cellular component gene ontology, 40 membrane, 47 intracellular and 15 extracellular genes were
upregulated. Highly expressed bulge ORS genes include those involved in developmental processes
such as epidermal differentiation and neurogenesis. The increased fold changes observed in inhibitors
of the Wnt signaling pathway, negative regulators of cell proliferation, and anti-apoptosis proteins
are consistent with quiescent bulge stem cells in anagen HF. Other upregulated biological processes
include protease inhibition, hormone metabolism, and response to external stress, that may provide
protection and maintenance of this special niche. 
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Increasing cellular energy promotes hair growth in hair follicle explants
D Gan, T Mammone and D Maes Biological Research, Estee Lauder Companies, Inc, Melville, NY
Energy in the form of ATP is required for many processes in the cell. Some of these processes include
DNA synthesis, cell proliferation and active transport. We hypothesized that increasing cellular energy
will lead to an increase in hair follicle cell proliferation, resulting in increased hair growth. Pre-
treatments with AMP or creatine were found to increase human follicle dermal papilla cell DNA syn-
thesis. Furthermore, creatine was found to increase hair growth in human hair follicle explants by
70% compared to the untreated follicles. In addition, this increase in hair follicle growth was up to
250% when creatine was used in combination with N-acetyl carnitine, and nicotinamide adenine din-
ucleotide (NADH). The creatine/creatine kinase system is known to have an important role in mito-
chondrial function, and is one of the cell’s energy(ATP) storage system. Moreover, carnitine is vital
to mitochondrial function, while NADH is vital to the electron transport chain. For those reasons,
we postulate that supplementing hair follicles with creatine, carnitine, and NADH, leads to increased
cellular efficiency in ATP formation, ATP storage, as well as ATP utilization, resulting in increased
cellular proliferation and hair follicle growth. 
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Neuroimmunophilin ligand analogs induce anagen hair growth in C57BL/6J mice
M Hordinsky,1 J Steiner,2 A Guanche,1 J Sundberg3 and M Ericson1 1 Dermatology, University of
Minnesota, Minneapolis, MN, 2 Guilford Pharmaceuticals, Inc., Baltimore, MD and 3 Jackson
Labs, Bar Harbo, ME
Application of topical FK506 has been shown to induce anagen hair growth in C57BL/6J telogen
mice, the C3H/HeJ mouse, and the Dundee Experimental Bald Rat. Hair growth induced by this
naturally-occurring immunophilin ligand has been attributed to its immunosuppressive effects. How-
ever, FK506 which binds to FKBP-12 (a cytosolic protein found in the central and peripheral nerv-
ous system and the immune system) is also neurotrophic. Our goal is to understand the neuronal
component of hair growth and the hair cycle. We examined the effects of topically-applied small
molecule neurotrophic nonimmunosuppressive FKBP-12 immunophilin ligands GPI1046 and
GPI1511 (Guilford Pharmaceuticals, Baltimore, MD), as well as FK506. The backsides of 50 day
old C57BL/6J mice were carefully shaved to remove hair, and these mice were treated with noth-
ing, ethanol vehicle, 1 mol FK506, 1 or 6 mol GPI1046, or 1 or 6 mol GPI1511 three times per week
over 6 weeks. We found that FK506 initiated onset of anagen within 11 days after application whereas
GPI1046 and GPI1511 also initiated onset of anagen but not as quickly as FK506. At 42 days of
treatment, anagen hair growth was greatest and statistically significant with topically applied 1
µmol GPI1511, 1 µmol GPI1046, and 6 µmol GPI1046 vs. 6 µmol GPI1511, 1 µmol FK506, vehi-
cle and shaving only. Percent hair coverage of the treated area at Day 42 was also higher in the
GPI1046-, and GPI1511-treated mice vs. the mice in the FK506, EtOH, or shaved-only groups. This
study suggests a neuronal component may indeed be an important component of hair growth and
the hair cycle in the C57BL/6J mouse model. Clinical application for specific human alopecias can
only be speculated on at this point. We have initiated the use of xenografts (full thickness human
skin grafts onto immunodeficient mice) as a transition model to evaluate the function of these com-
pounds on specific hair diseases. 
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Morpho-regulation of ectodermal organs: pathological changes or phenotypic variations?
M Plikus and C Chuong Pathology, Univ Southern California, Los Angeles, CA
Ectodermal organs are composed of keratinocytes organized in different ways during induction, mor-
phogenesis, differentiation, and regenerative stages. We hypothesize that an imbalance of funda-
mental signaling pathways should affect multiple ectodermal organs in a spatio-temporal depend-
ent manner. We produced a K14-Noggin transgenic mouse to modulate BMP activity and test the
extent of this hypothesis. We observed thickened skin epidermis, increased hair density, altered hair
types, faster anagen re-entry, and formation of compound vibrissa follicles. The eyelid opening was
smaller and ectopic cilia formed at the expense of Meibomian glands. In the distal limb, there were
agenesis and hyper-pigmentation of claws, inter-digital webbing, reduced footpads, and trans-dif-
ferentiation of sweat glands into hairs. The size of external genitalia increased in both sexes, but
they remained fertile. We conclude that modulation of BMP activity can affect the number of ecto-
dermal organs by acting during induction stages, influence the size and shape by acting during mor-
phogenesis stages, change phenotypes by acting during differentiation stages, and facilitate new
growth by acting during regeneration stages. Therefore during organogenesis, BMP antagonists can
produce a spectrum of phenotypes in a stage-dependent manner by adjusting the level of BMP
activity. The distinction between phenotypic variations and pathological changes are discussed. 
682
Role of B cells in leprosy
MT Ochoa,1 JR Bleharski,1 TH Rea2 and RL Modlin1 1 Dermatology, University of California, Los
Angeles, CA and 2 Dermatology, University of Southern California, Los Angeles, CA
Leprosy, is an infectious disease of the skin, where clinical manifestations correlate with the type of
immune response mounted to the pathogen, Mycobacterium leprae. We used DNA microarrays to
characterize gene expression patterns in skin biopsies from individuals with a diagnosis of tubercu-
loid leprosy and compared those to the patterns of gene expression seen in biopsies from leproma-
tous leprosy. We observed that genes characteristically required for B cell activation and function
were significantly up-regulated in lesions of lepromatous patients, those suffering from the dissem-
inated form of the infection. Lepromatous skin lesions exhibited marked up-regulation of genes
related to humoral immunity, including immunoglobulin (Ig) heavy and light chains and molecules
involved in B cell activation as CD19 and CD22. To further investigate the identity and localization
of B lymphocytes in leprosy tissue, immunohistochemistry was performed. We found large clusters
of CD20+ B cells in patients with the diseminated lepromatous as compared with the localized tuber-
culoid form of the disease. We also found an increase in the expression of different markers for B
cells (CD20, CD19, CD22), and plasma cells (CD138) in lepromatous lesions compared with tuber-
culoid lesions.
Our data indicate that B cells are present at the site of disease in leprosy and suggests a role for a B
cell dependant mechanism that contributes to the disease progression and tolerance in leprosy. 
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Pimecrolimus does not affect the migration capacity of cutaneous dendritic cells
W Hoetzenecker,1 JG Meingassner,2 G Stingl,1 A Stuetz2 and A Elbe-Buerger1 1 DIAID,
Department of Dermatology, University of Vienna Medical School, Vienna, Austria and 2 Novartis
Institute for BioMedical Research, Vienna, Austria
Migration of antigen-laden Langerhans cells (LC) into draining lymph nodes is a pivotal step in the
development of the primary immune response in contact hypersensitivity (CH) We have examined
the effects of the calcineurin inhibitor pimecrolimus on the migration and maturation capacity of
LC in a skin organ culture assay and in vivo. Ears of BALB/c mice were treated topically with 10 µl
1% pimecrolimus or with ethanol (vehicle), twice at an interval of 8 h on day 1. Forty hours later,
the ears were dissected and the dorsal, mechanically separated, sides floated on culture medium for
3 days prior to analysis. LC in epidermal/dermal sheets and the migrated LC and dermal dendritic
cells (DDC) in the culture medium of pimecrolimus- and vehicle-treated samples were similar, both
in numbers and degree of maturation. Antigen-induced migration of LC into the draining lymph
nodes was studied in mice treated orally with 90 mg/kg pimecrolimus or placebo (vehicle) 2 h before
and 4 h after FITC application. After 24 h, the numbers of antigen-laden FITC+MHC II+ cells in
lymph nodes were not statistically different in pimecrolimus- and vehicle-treated mice (1.40 vs.
1.54%). In mice treated intraperitoneally with 200 µg anti-LFA-1 antibody (M 17.4), used as a pos-
itive control, only 0.25% FITC+MHC II+ cells were detected (p 〉 0.05). Taken together, our data show
that neither topically nor systemically administered pimecrolimus interferes with the migratory and
maturation capacity of LC/DDC. This is in line with previous data, which showed that oral treat-
ment of mice with doses up to 120 mg/kg pimecrolimus did not impair the induction phase of CH
in contrast to cyclosporine A and tacrolimus, whereas the elicitation phase was potently inhibited
with lower doses (J Invest Dermatol, 121:77-80,2003). In conclusion, the data indicate that pime-
crolimus leaves the indigenous immune system of the skin unaltered. 
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Prevention of UV-induced immunosuppression by IL-12 is dependent on DNA repair
A Schwarz, A Maeda, K Kernebeck and T Schwarz Department of Dermatology, University
Muenster, Muenster, Germany
Ultraviolet radiation (UV) suppresses the induction of contact hypersensitivity (CHS) and induces
hapten-specific tolerance which is mediated via regulatory T cells (Tr). Interleukin (IL)-12 is able
to prevent the suppression of CHS by UV and even to break UV-induced tolerance by yet unknown
mechanisms. IL-12 recently was shown to exhibit the capacity to reduce UV-induced DNA damage
via the induction of nucleotide excision repair (NER). Since UV-induced DNA damage is an impor-
tant molecular trigger for UV-mediated immunosuppression we studied whether the restoring effect
of IL-12 is linked to its capacity to reduce DNA damage. Injection of IL-12 into wild type mice (wt)
which were sensitized through UV-exposed skin restored the CHS response completely. In contrast,
Xpa knock out mice (Xpa-/-) which are deficient in NER were not able to mount an immune response
after UV exposure despite the injection of IL-12. This indicates that the prevention of UV-induced
suppression of CHS by IL-12 is dependent on functioning DNA repair. In contrast, IL-12 was able
to break already established UV-induced tolerance both in wt and Xpa-/-, indicating this effect to be
independent of NER. Accordingly, adoptive transfer of suppression via injection of Tr into naive
recipients was inhibited by IL-12 both in wt and Xpa-/-. Inhibition of sensitization by UV is due to
the depletion of Langerhans cells (LC) which is caused by UV-induced DNA damage. Accordingly,
LC depletion by UV was prevented upon injection of IL-12 into wt but not in Xpa-/-.Taken together,
these data indicate that the prevention of UV-induced inhibition of CHS by IL-12 is linked to its
capacity to induce NER. In contrast, breaking of UV-induced tolerance and the activity of Tr by IL-
12 is independent of NER and mediated via another yet to be determined mechanism. These data
demonstrate for the first time a link between NER and the prevention of UV-induced immunosup-
pression by IL-12. 
A114 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
685
T cells, B cells, and antigen presenting cells are activated, depart from secondary lymphoid
organs, and infiltrate the skin in an animal model of atopic dermatitis
L Chen,1 O Martinez,2 P Venkataramani,1 S Lin,1 BS Prabhakar2 and LS Chan1,2 1 Dermatol, Univ.
of Illinois, Chicago, IL and 2 Microbiol/Immunol, Univ. of Illinois, Chicago, IL
We previously generated an interleukin-4 transgenic (Tg) mouse line that develops a chronic inflam-
matory skin disease, closely resembling human atopic dermatitis. To characterize the activation sta-
tus and the dynamic movement of inflammatory cells involved, we examined the skin, skin-drain-
ing lymph nodes (LNs), and spleen of non-Tg mice and Tg mice before disease onset, at acute and
chronic skin disease stages by flow cytometry (FACS) and immunofluorescence microscopy (IF).
As the disease progresses, T cells, B cells, and antigen-presenting cells (APCs) decrease in the spleen,
while they increase in the LNs, particularly in the chronic disease. The minor cell types, mono-
cytes/macrophages and natural killer cells, slightly increase in both LNs and spleen. Despite their
decrease, T cells and B cells in the spleen are marked by the increase of activating molecules CD44
and CD69, as occurred in LNs, coincided with the disease progression. In LNs, the T cells and
APCs are activated, particularly in chronic disease, marked by increased inducible co-stimulatory
molecules ICOS and PD-1 on T cells and their ligands CD80, CD86, B7h, B7-DC on APCs. APCs
were also found in large number in the skin of Tg mice with disease. T cells in LNs of the Tg mice
with disease proliferate spontaneously and proliferate in a significantly enhanced manner in respond-
ing to anti-CD3, mitogen (PHA), and superantigens (Staphylococcus enterotoxin A & B). By IF,
CD3+, CD4+ and CD8+ T cells were detected in the lesional epidermis of Tg mice. In the dermis
of Tg mice with disease, CD3+, CD4+, CD8+ T cells, B cells, and macrophages were detected in a
significantly increased manner, with CD4+ cells predominate the T cell population. Together, our
data suggest that, as the disease progresses, the helper and cytotoxic T cells, B cells, and APCs are
activated and expanded, departing from secondary lymphoid organs and infiltrating the skin where
they cause inflammatory disease. 
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UV-induced regulatory T cells inhibit the effector phase of contact hypersensitivity only upon
injection into the area of challenge
T Schwarz,1 A Schwarz,1 A Maeda,1 MK Wild,2 K Kernebeck,1 N Gross,1 Y Aragane,3 S Beissert1
and D Vestweber2 1 Department of Dermatology, University Muenster, Muenster, Germany, 2
Institute of Cell Biology, University Muenster, Muenster, Germany and 3 Department of
Dermatology, Kinki University, Osaka, Japan
Epicutaneous application of haptens onto UV-exposed skin induces hapten-specific regulatory T cells
(Tr). Tr inhibit the induction of contact hypersensitivity (CHS) when injected i.v. into naive recipi-
ents, but not the elicitation when injected i.v. into sensitized recipients. In contrast, when UV-induced
Tr were injected intracutaneously (i.c.) into the ears of sensitized mice, elicitation of CHS was sup-
pressed. Depletion of either CD4+ or CD25+ fractions resulted in the loss of transfer of suppression
upon i.v. or i.c. injection, indicating that UV-induced Tr belong to the CD4+CD25+subtype. I.c.
injection of dinitrofluorobencene (DNFB)-specific Tr into the ears of oxazolone (OXA)-sensitized
mice did not affect the challenge with OXA, indicating hapten-specificity. However, when ears of
OXA-sensitized mice were injected with DNFB-specific Tr and painted with DNFB before OXA
challenge, CHS response was suppressed. This indicates that the activation of Tr is hapten-specific,
however, once they are activated their suppressive activity is non-specific (bystander suppression).
The inhibitory effect correlated with the local expression of IL-10. Accordingly, suppression was
blocked by i.c. injection of an anti-IL-10-Ab. Depletion studies also revealed that UV-induced Tr
express the lymph node homing receptor L-selectin (CD62L) which was functionally relevant since
incubation with anti-CD62L-Ab prevented transfer of suppression when injected i.v. into naive mice.
In contrast, FACS analysis demonstrated that Tr do not express the ligands for the skin homing recep-
tors E- and P-selectin. Thus, we conclude that UV-induced Tr though being able to inhibit T effec-
tor cells do not suppress the elicitation of CHS upon i.v. injection since they do not migrate into the
skin due to the expression of lymph node homing but not of skin homing receptors. 
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Generation of regulatory T cells from naive T cells by retroviral gene transfer of Foxp3
K Loser,1 W Hansen,2 AM Westendorf,2 D Bruder,2 J Buer2 and S Beissert1,2 1 Department of
Dermatology, University of Muenster, Muenster, Germany and 2 Department of Cell Biology and
Immunology, German Research Center for Biotechnology, Braunschweig, Germany
Immunological unresponsiveness to self is mediated in part by regulatory CD4+CD25+ T cells (Treg),
which can actively suppress self-reactive T cells that have escaped thymic selection. The isolation
of large numbers of Treg is difficult, since CD4+CD25+ cells constitute only a small subset of
CD4+ T cells. Recently, the transcription factor Foxp3 has been identified to be a key regulatory
gene for the development of Treg. The Foxp3 cDNA was cloned into a MCSV-based retroviral vec-
tor encoding eGFP under control of an IRES site and used to transfect the GPE86 packaging cell
line. For controls a retrovirus containing only eGFP was employed. Retrovirus-containing culture
supernatants were utilized for Foxp3 gene transfer into murine naive CD4+CD25- T cells to inves-
tigate if these cells would develop a regulatory phenotype. Control virus-transfected T cells prolif-
erated, whereas Foxp3 transfected T cells were anergic. Flow cytometry analysis of Foxp3 trans-
fected T cells revealed expression of CD25, CTLA-4, and neuropilin-1, all molecular markers
associated with Treg. Subsequently, GFP+ T cells were added to CD4+CD25- T cells to study their
suppressor function. Naive CD4+CD25- cells that were control virus-treated failed to inhibit T cell
proliferation. In contrast, naive T cells that had been transfected with the Foxp3 containing retro-
virus showed strong suppressor activity. A mechanism by which Treg suppress other T cells is the
production of IL-10. Only Foxp3 gene-transfected T cells but no control virus-treated T cells expressed
IL-10. We are currently using Foxp3 transfected T cells for the treatment of systemic autoimmunity
in K14-CD40L transgenic mice in order to ameliorate disease. Together, gene transfer of Foxp3
converts naive T cells towards a regulatory phenotype similar to that of natural Treg. Furthermore,
Foxp3 gene transfer may be useful to generate large numbers of Treg for immunotherapy of autoim-
mune disorders. 
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Interleukin-4 strongly enhanced eotaxin-3/CCL26, but not eotaxin-2/CCL24, production in a
human keratinocyte cell line, HaCaT cells
S Kagami,1 T Kakinuma,1 H Saeki,1 Y Tsunemi,1 K Nakamura,2 M Komine,1 A Asahina1 and
K Tamaki1 1 Dermatology, University of Tokyo, Tokyo, Japan and 2 Dermatology, Fukushima
Medical University, Fukushima, Japan
Eotaxin-2/CCL24 and eotaxin-3/CCL26 are CC chemokines and their receptor, CC chemokine recep-
tor 3 (CCR3) is preferentially expressed on eosinophils. Previous reports showed the production of
eotaxin-3/CCL26 in vascular endothelial cells and dermal fibroblasts. However, the regulation of
eotaxin-2/CCL24 and eotaxin-3/CCL26 production in keratinocytes (KCs) has not been well docu-
mented. We investigated the expression and production of eotaxin-2/CCL24 and eotaxin-3/CCL26
in a human KC cell line, HaCaT cells. HaCaT cells were cultured with various stimuli for 24 hours.
RT-PCR was performed using these cells and ELISA was carried out using supernatant of HaCaT
cells. The expression and production of eotaxin-2/CCL24 in HaCaT cells was not enhanced by TNF-
α and IFN-γ, but slightly enhanced by IL-4. The expression and production of eotaxin-3/CCL26 in
these cells was not enhanced by TNF-α or IFN-γ, but strongly enhanced by IL-4 in a dose depend-
ent manner. Dexamethasone and IFN-γ inhibited IL-4 enhanced eotaxin-3/CCL26 production in these
cells. These results suggest that KCs may be involved in the migration of CCR3 positive cells such
as eosinophils under the Th2-dominant situation like atopic dermatitis. 
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Th1, Th2, and non-Th cytokines are involved in pathogenesis in an animal model of atopic
dermatitis
L Chen,1 O Martinez,1 S Lin,1 L Overbergh,2 C Mathieu,2 BS Prabhakar1 and LS Chan1 1 Dermatol
& Micro/Immunol, University of Illinois, Chicago, IL and 2 Lab of Exp Med and Endocrinol,
Catholic Univ of Leuven, Leuven, Belgium
We determine the cytokine milieu in an epidermally expressed IL-4 transgenic (Tg) mouse line which
develops a skin inflammatory disease resembling human atopic dermatitis (AD) and fulfills the
clinical diagnostic criteria of human AD. cDNA microarray, reverse transcription (RT)-real time PCR
and flow cytometry (FACS) were utilized to examine the cytokine mRNA and protein expressions
in the skin and skin-draining lymph nodes (LNs). cDNA microarray screening indicated that the
mRNAs encoding IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-13, TNF-α, IFN-γ were up
regulated in the skin of chronic lesion (CL) (n=7) and to a lesser degree in non-lesion (NL) (n=7)
when compared to that of non-Tg mice (n=2), with fold increases range from 1.9 to 23.1. Verifying
the microarray data was carried out by quantitative RT-real time PCR with total RNA (n=10-15) from
the skin of non-Tg mice and skin from Tg mice before onset (BO), NL, acute lesion (AL), and CL.
When compared to Non-Tg mice, the cDNA copy numbers of IL-1β, IL-4, IL-6, IL-10, TNF-α and
IFN-γ from skin of CL, AL and NL significantly increased. IL-2 and IL-12p40 cDNA copy num-
bers were increased in AL, but not in CL. IL-5 and IL-13 cDNAs were increased from 1.3 to 4.4
fold, significantly in the skin of BO, AL, CL and NL. Interestingly, IL-1β, IL-4, IL-5, IL-6, TNF-α,
and IFN-γ cDNAs were increased in skin of Tg mice BO with some (IL-1β, IL-4, IL-6, IFN-γ, TNF-
α) reached statistical significance. FACS analyses showed that the frequency of keratinocytes pro-
ducing IL-4 increased as the disease progressed. The frequencies of Th1 cytokine (IL-2 and IFN-γ)
and Th2 cytokine (IL-4 and IL-10) producing T cells and IL-12-producing antigen-presenting cells
in both LNs and lesional skin also increased, especially in mice with CL. These results suggest that
not only Th2, but also Th1 and non-Th cytokines, play a role in initiating and maintaining the inflam-
matory disease in this animal model. 
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Characterization of necdin expression and interaction with IL-1a in epidermal skin cells
J Murphy,1 M Niinobe2 and T Kupper1 1 Harvard Skin Disease Reseach Center, Brigham and
Women’s Hospital, Boston, MA and 2 Osaka University, Osaka, Japan
The MAGE-related protein necdin was originally identified as a neuronal-specific protein and is
known to be deleted in Prader-Willi syndrome. It was isolated from retinoic acid-treated embryonal
carcinoma cells and is reportedly expressed in postmitotic cells. Expression of necdin induces growth
arrest and it has been shown to interact with the transcription factor E2F, p53 and the p75 neurotropin
receptor. We studied the expression of necdin in skin. Immunofluorescent staining of human face
skin demonstrated that necdin immunoreactivity occurs throughout the epidermis with positive stain-
ing concentrated in the cytoplasm of basal layer keratinocytes. Western blot analysis of human,
mouse, and rat epidermal keratinocytes confirmed the expression of necdin in skin epidermal cells.
Necdin immunoreactivity was also detected in cultured human keratinocytes from human foreskin,
face, and a squamous carcinoma cell line (SCC13). Recently, yeast two hybrid studies have identi-
fied IL-1a as a potential binding partner for necdin. Since we have previously demonstrated high lev-
els of IL-1a in skin, we also examined the cellular localization of 31kDa IL-1a in the cultured ker-
atinocytes to attempt to colocalize necdin and IL-1. Ectopic expression of a 31kDa IL-1a-GFP fusion
protein resulted in nuclear localization in the majority of cells and co-staining for necdin suggested
overlap of the two proteins in vitro. Immunostaining of the human keratinocytes and SCC13 cells
for endogenous IL-1a confirmed the nuclear localization in cultured keratinocytes. While most of
the cultured cells displayed strong nuclear staining, a small fraction exhibited positive staining in
the cytoplasm as well. In larger cells and in calcium-treated cultures, IL1a immunoreactivity shifted
to the cytoplasm, similar to the results observed for necdin. This raises the possibility that the inter-
action of these two proteins may be related to the differentiation state in normal human keratinocytes. 
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TLR5 and TLR9 are expressed in different layers of human skin and are induced in primary
keratinocyte organotypic cultures after TGF-α stimulation
LS Miller,1 OE Sorenson,2 H Jalian,1 PT Liu,1 D Eshtiaghpour,1 A Legaspi,1 PA Sieling,1 T Ganz,2
J Kim1 and RL Modlin1 1 Division of Dermatology and Department of Microbiology and
Immunology, David Geffen School of Medicine at Univeristy of California at Los Angeles (UCLA),
Los Angeles, CA and 2 Department of Medicine, David Geffen School of Medicine at University of
California at Los Angeles (UCLA), Los Angeles, CA
In addition to acting as a barrier against pathogenic microorganisms, epidermal keratinocytes have
been shown to express certain Toll-like receptors (TLR) which can be activated by microbial-derived
components and subsequently elicit immune responses. Here, we investigated TLR5 and TLR9,
which are respectively activated by bacterial flagellin and unmethylated bacterial CpG motifs. Both
TLR5 and TLR9 were detected by immunohistochemistry in epidermal keratinocytes of normal
human skin, verruca vulgaris, condyloma acuminatum, and in psoriasis. However, TLR5 labeling
was greatest in the basal keratinocytes, and in contrast, TLR9 expression was found predominantly
in the upper layers of the epidermis. TLR5 and TLR9 had a similar expression pattern in organ-
otypic air-lifted primary keratinocyte cultures, which form layers simulating normal epidermis. In
addition, TLR5 and TLR9 mRNA levels (qPCR) were increased (2-fold and 3-fold, respectively)
after stimulation with the autocrine keratinocyte growth and differentiation factor TGF-α. The
TLRs in keratinocyte organotypic cultures were functional as indicated by increased levels of IL-8
(2-3 fold) in response to the TLR5 or TLR9 ligands. In summary, the regulated and differential expres-
sion of TLR5 and TLR9 by human epidermal keratinocytes can contribute to host immune mecha-
nisms against microbial pathogens. 
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Production of TARC and MDC by CCR4+ adult T-cell Leukemia cells: an implication for malig-
nant T cell aggregation by chemokine/chemokine receptor paracrine loop
T Shimauchi, S Imai, R Hino and Y Tokura Department of Dermatology, University of
Occupational and Environmental Health, Kitakyusyu, Japan
Adult T-cell leukemia/lymphoma (ATL) is a peripheral CD4+CD25+ T cell malignancy caused by
infection with human T-cell leukemia virus type I. The tumor cells frequently infiltrate in the skin,
lymph nodes, and other organs, especially forming prominent cutaneous masses. However, the cel-
lular and molecular mechanisms underlying the malignant T cell aggregation remains unelucidated.
Recently, ATL cells have been shown to express Th2 chemokine receptor CCR4. Here, we found
that CCR4+ATL cells produce CCR4 ligands TARC and MDC by analyzing peripheral blood CD4+
T cells and skin tumor-infiltrating lymphocytes. By flow cytometry, CD4+CD25+ ATL cells highly
expressed Th2 chemokine receptor CCR4, but not Th1 receptor CXCR3, although they did not nec-
essarily exhibit the Th2 cytokine profile. When these neoplastic cells from peripheral blood and
skin tumors were cultured for 96 h in the presence or absence of anti-CD3 and -CD28 mAbs, they
produced or expressed markedly higher levels of CCR4 ligands TARC and MDC than did normal
subjects′ CD4+ cells, as assessed by ELISA and RT-PCR. Th1 chemokine CXCR3 or MIG was not
produced by peripheral blood tumor cells except for one case. Immunohistochemically, both CCR4
and TARC were expressed in ATL cells infiltrating into the skin. A blocking study revealed that
aggregation of ATL cells enhanced by anti-CD3/CD28 mAbs was significantly inhibited by the addi-
tion of anti-CCR4 mAb to the culture. These findings suggest that the tumor cells aggregate by means




Inhibition of the class II pathway limits induction of a T regulatory phenotype in cutaneous T
cell lymphoma
CL Berger, W Yuan, K Mariwalla and RL Edelson Dermatology, Yale University, New Haven, CT
We have shown that tumor cells cultured from patients with cutaneous T cell lymphoma (CTCL)
adopt a T-regulatory (T-reg) phenotype and function when stimulated with autologous dendritic cells
(DC) that have been pulsed with apoptotic cells. T-reg CTCL cells up-regulate CD25, CTLA-4,
secrete IL10 and TGF-β and suppress normal T cell alloproliferative responses. We propose that
CTCL is a malignancy of T-reg cells whose proliferation is driven by DC presentation of peptides
in class II molecules. To determine if CTCL cell interaction with DC class II molecules was required
for T-reg CTCL cell induction, we tested inhibitors of the class II pathway. CTCL cells were ren-
dered apoptotic by CD3-antibody (3.5µg/ml) binding and fed to autologous DC overnight in the pres-
ence of an anti-DR antibody that binds to class II MHC on DC but does not trigger apoptosis (25µg/m),
and two inhibitors of the class II pathway: Brefeldin A (10µg/ml), and Cystatin C (1µg/ml). CTCL
cells were added to the loaded DC overnight in the presence of the inhibitors and the phenotype com-
pared to non-inhibited cultures.The results demonstrated that class II antibody blocked detection of
84% of the membrane DR molecules on the DC and inhibited approximately half of the CTCL cells
from expressing a Treg phenotype (48% reduction in CTLA-4 and 53% decrease in CD25 expres-
sion). Cystatin also inhibited 48% of CTCL cell CTLA-4 expression, while Brefeldin A treatment
caused a 71% inhibition of CTCL cell CTLA-4 expression and a 57% reduction in CD25 up-regu-
lation. These results demonstrate that inhibitors of DC class II interaction with CTCL cells decrease
CTCL cell expression of a T-reg phenotype, thereby, supporting our hypothesis that DC class II
molecules potentially displaying peptides derived from apoptotic CTCL cells are required for CTCL
cell adoption of T-reg characteristics. Furthermore, these studies indicate that T-reg cell induction
may be limited through interference with the DC class II pathway. 
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Conversion of peripheral blood monocytes to dendritic cells by physical perturbation
K Mariwalla, W Yuan, CL Berger and RL Edelson Dermatology, Yale University, New Haven, CT
Monocytes activated by leukapheresis harvest and passage through a plastic plate transition into the
dendritic cell (DC) pathway. Overnight co-incubation with apoptotic cells results in DC loading and
maturation into semi-mature DC. To determine the factors mediating this rapid monocyte to DC con-
version, methods of physical activation were tested. Normal peripheral blood (PB) was rotated for
2hr. Additionally, leukocytes were isolated, rotated, and passed through a micro-column matrix, and
incubated overnight in the absence of cytokines with or without apoptotic cells. Markers of DC mat-
uration included: semi-mature DC co-expressing membrane class II/CD83; and immature DC co-
expressing membrane CD36 or DR and cytoplasmic CD83. In addition, cutaneous T cell lymphoma
(CTCL) cells were incubated with CD3-beads and passed through a column. D3-separated fractions
were incubated overnight and apoptosis, DC maturation and loading measured by phenotyping. The
results demonstrate that when unseparated whole blood cells were rotated for 2hr and incubated
overnight, 11% of the monocytes became semi-mature DC, while 28% were immature DC. Addi-
tion of apoptotic cells, increased immature DC to 37%. Isolated leukocytes were rotated for 1hr and
incubated overnight driving 14% of the monocytes to co-express markers of semi-mature DC, which
increased to 24% after column passage, with 32% of the monocytes becoming immature DC. CD3-
treated CTCL leukocytes passed over a micro-column became apoptotic (23% annexin+)and 21%
were ingested by activated DC (32% immature DC). These studies confirm overnight induction of
transitioning DC from PB monocytes can be achieved by simple rotation and physical interaction
with a plastic surface. Column passage further promotes acquisition of a DC phenotype. CTCL
cells can be rendered apoptotic and used to directly load activated immature DC in a one-step pro-
cedure. These methods can be used to develop clinically practical means for DC preparation and
loading.
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Development of a dendritic cell-based biosensor system for discovery of novel adjuvants
N Mizumoto, J Gao, D Edelbaum and A Takashima UT Southwestern, Dallas, TX
Dendritic cells (DC) in peripheral tissues require activation signals for their maturation into fully
potent immuno-stimulators, and the nature of such signals governs the resulting immune responses.
We observed that Toll-like receptor ligands (e.g., LPS and CpG oligonucleotides) primarily stimu-
lated NFkB- and AP1-dependent gene transactivation pathways in DC, whereas other DC-stimula-
tory agents (e.g., ATP, ADP, γ-interferon, and necrotic cells) each activated different transcription
regulatory pathways. These agents also differed from each other in their impacts on gene expression
profiles, surface phenotypes, and functions of DC, suggesting that one can control the magnitude,
direction, and class of immune responses by administering rationally selected DC-stimulating agents
as vaccine adjuvants. All the above agents were found to share a common feature of inducing robust
IL-1β mRNA expression in DC. Based on this key finding, we have developed a DC-based biosen-
sor system by engineering our murine skin-derived XS106 DC line to express the yellow fluores-
cence protein (YFP) gene under the control of 4.5 kB IL-1β promoter. All tested DC-stimulatory
agents induced significant YFP expression by the resulting DC clone (XS106-IL1/YFP) in dose-and
time-dependent fashions, with LPS at 10 ng/ml causing >100-fold YFP induction over the baseline
level within 6 hr. By screening 2,000 small chemicals in the NCI library with the XS106-IL1/YFP
biosensor clone, we have identified 6 “hits”. One of them may represent a prime lead for adjuvants
because this small compound (MW = 389) and its three derivatives each triggered, at sub-micro-
molar concentrations, significant (P<0.01) upregulation of I-A and CD40 expression by bone mar-
row-derived DC without causing robust production of a wide array of cytokines and chemokines
(except for IL-1β). The DC biosensor system represents a major breakthrough for the development
of “designer’s adjuvants” that are formulated to selectively activate given arms of DC function for
initiating desired types of protective immunity for individual infectious pathogens and cancer cells. 
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Topical immunization by E. coli vector
Z Shi, J Zhang, CA Elmets and D Tang Dermatology, UAB, Birmingham, AL
Our aim is to develop a simple vaccine delivery system by topical application of recombinant E. coli
encoding foreign antigens. Our hypothesis is that the high expression of antigen by E. coli, the mul-
tiple immune adjuvants of E. coli, and the potent immune induction capability of skin would lead to
strong humoral immune responses. We constructed several E. coli K12 strains expressing tetanus
toxin C-fragment (E. coli-tetC), anthrax protective antigen (E. coli-PA) and lethal factor (E. coli-
LF) respectively. A single topical application of 1010 colony forming unit of E. coli-tetC on mouse
skin elicit robust antibody response and conferred a full protection against lethal challenge. Anti-PA
and anti-LF antibody were also elicited by topical application of E. coli-PA and E. coli-LF. Topical
application of Gamma-irradiated replication-defective E. coli is as effective as its live counterparts,
which enhances the safety margin of the E. coli vector. Topical application of sonicated E. coli cell-
free filtrates can enhance the immune responses against the co-administered prototype antigen hen
egg lysozyme. The IL-4 and INF-? ELISPOT assay indicate that E. coli-vectored topical immu-
nization produce a Th2 biased immune response. While its adenovirus counterpart produce a com-
bined Th1 and Th2 responses. We also found those ??-T cells are rapidly mobilized in skin after top-
ical application of E. coli. After topical application of E. coli expressing fluorescent EGFP, no bacteria
were found in the skin. However, E. coli DNA can be amplified by PCR in internal organs follow-
ing topical application. Using radiolabeled bacteria and autoradiography technique, we found that
radiolabeled compound are trapped and concentrated in hair follicles 4 hours after topical applica-
tion of 35S-labeled E. coli. The radioactivity diminished 48 hours after inoculation, and radioactive
spots presents outside hair follicles in dermis. As the topical application of E. coli-delivered vaccines
is simple, painless, effective, and potentially safe, it may boost the vaccine coverage. 
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Establishment of cutaneous eosinophilic inflammation and its regulation by CpG oligodeoxynu-
cleotide
T Kootiratrakarn,1 T Fujimura,1 K Sano,2 R Okuyama,1 S Aiba1 and T Terui1 1 Dermatology,
Tohoku University school of Medicine, Sendai, Miyagi, Japan and 2 Respiratory and Infectious
Diseases, Tohoku Universitiy school of Medicine, Sendai, Miyagi, Japan
The number of patients with severe atopic dermatitis (AD), who show an eosinophil-related late
phase skin reaction and increased levels of IgE, is increasing, although there is accumulating evi-
dence revealing its pathomechanism. Ag-nonspecific immunosuppressants have been used for the
treatment of AD. These therapeutic agents sometime cause the deterioration of the host immuno-
logic defense. There is a real need for developing an antigen-specific treatment to selectively sup-
press Th2 cell-mediated responses. Oligodeoxynucleotides (ODNs) containing CpG motifs have
recently been highlighted as an immunomodulator that reduces Th2-mediated responses by biasing
the T-cell response toward a Th1-dominant phenotype. To substantiate the effect of CpG ODN in
the Th2-mediated skin inflammation, we introduced a unique cutaneous model of a protein-Ag-
induced eosinophilic inflammation with increased levels of serum IgE in BALB/c by three-time i.p.
priming with ovalbumin (OVA)/alum and following a week-OVA skin patching. Intradermal admin-
istration of CpG ODN diminished the number of infiltrated eosinophils and IgE systemic response.
Interestingly, intradermal CpG ODN administration with OVA significantly augmented the inhibitory
effects on both the eosinophil infiltration and IgE levels. Our data suggest that a cutaneous admin-
istration of CpG ODN with Ag can work as a novel Ag-specific immunomodulatory treatment for
patients with severe AD. 
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Cutaneous and nasal immunity is L-selectin-dependent, whereas cooperation between L-selectin
and β7 integrin is critical for intestinal immunity
T Kadono,1 HF Staats,2 DA Steeber,2 TF Tedder2 and K Tamaki1 1 Dermatology, University of
Tokyo, Tokyo, Japan and 2 Immunology, Duke University Medical Center, Durham, NC
Lymphocyte migration into lymphoreticular tissues is dependent on tissue-specific adhesion mole-
cules such as L-selectin and α4β7 integrin. For migration into skin-draining lymph nodes, L-selectin
is important. Among mucosal sites, migration into nasal mucosal sites is L-selectin-dependent,
whereas for migration into intestinal mucosal sites, α4β7 integrin is more critical than L-selectin.
To address the importance of α4β7 integrin and L-selectin for humoral responses, tetanus toxoid was
immunized to wild type, L-selectin-/-, β7 integrin-/-, and L-selectin/β7 integrin-/- mice. When immu-
nized gastrically, only antigen (Ag)-specific IgA titers in serum and mucosal samples were decreased
in β7 integrin-/- mice. Surprisingly, the deficiency of both L-selectin and β7 integrins lead to severe
impairment of all isotypes of Ag-specific Ig titers in serum and mucosal samples, which correlated
with the number of Ag-specific antibody forming cells in spleen and mesenteric lymph nodes (MLN).
In contrast, Ag-specific Ig responses after nasal immunization required L-selectin and additional
deficiency of β7 integrins further reduced the responses. These responses resembled those after sub-
cutaneous immunization where L-selectin/β7 integrin-/- mice showed even more delayed humoral
responses than L-selectin-/- mice although systemic humoral responses were intact in L-selectin/β7
integrin-/- mice. The deficiency of L-selectin and β7 integrins did not significantly change the num-
ber of CD11c cells in spleen and MLNs, and the number of intraepithelial lymphocytes and lamina
propria lymphocytes. These data suggest that the defective humoral responses after gastric immu-
nization in L-selectin/β7 integrin-/- mice is due to the decreased number of lymphocytes and defec-
tive lymphocyte migration into MLNs and Peyer’s patches. Thus, β7 integrin together with L-selectin
regulates humoral responses in intestinal mucosal tissues. 
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Effect of Epigallocatechin-3-gallate on expression of iNOS mRNA and production of NO in
HaCaT cell
WJ Tak, MN Kim, SJ Seo, BI Ro, CK Lee and CK Hong Dept. of Dermatology, College of
Medicine, Chung-Ang University, Seoul, South Korea
Nitric oxide (NO) plays an important role in inflammation and multiple stages of carcinogenesis.
Green tea (Camellia sinensis) polyphenols are potent antiinflammatory agents and have been shown
to inhibit NO production in tumor cell lines. In the present study, we examined the effect of epigal-
locatechin-3-gallate (EGCG), a green tea polyphenol, on the expression of inducible NO synthase
(iNOS) mRNA and generation of NO in HaCaT cells. HaCaT cells were treated with 10µM EGCG
and 100µM NAC for 1 hour. After 1 hour later, they were irradiated with 50mJ/cm2 UVB and treated
with 200 µg/ml LPS for 12 hours, respectively. The iNOS mRNA was determined by reverse tran-
scription-polymerase chain reaction (RT-PCR) and NO production was assessed by spectrophoto-
metric method based on Griess reaction. Nuclear factor κB (NF-κB) binding activity were deter-
mined by electrophoretic mobility shift assay (EMSA). EGCG inhibited UVB and LPS induced
expression of inducible nitric oxide synthase. HaCaT cells cotreated with EGCG produced signifi-
cantly less iNOS mRNA and NO compared with HaCaT cells stimulated with UVB irradiation or
LPS. The inhibition of iNOS mRNA and NO production correlated with the suppression of expres-
sion of NF-κB dependent gene iNOS. EGCG inhibited the activation and translocation of NF-κB to
the nucleus. Our datas suggest that EGCG inhibits the UVB and LPS-induced production of NO in
HaCaT cells by interfering with the activation of NF-κB through a novel mechanism. Our results
further suggest that EGCG may be a therapeutically effective in UVB and cytokine induced cuta-
neous inflammation. 
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Role of IL-6 in mediating the ability of UV-induced skin iC3b to differentiate precursor mono-
cytes
KQ Lu, X Luo, K Kang, KD Cooper and TS McCormick Dermatology, Case University, Univ.
Hosp. of Cleveland, Cleveland, OH
UV-irradiated skin produces significantly altered immune responses such as tolerance induction
following antigen sensitization. Additionally, the UV-skin micromilieu accumulates bioactive com-
plement product iC3b, which can bind the monocyte (Mo) CD11b receptor and in vitro promote
precursor Mo maturation toward the macrophage (Mac) phenotype, while preventing differentiation
into dendritic cells. In this study, RNA collected from freshly isolated human peripheral blood Mo
treated +/- iC3b was hybridized to oligonucleotide microarrays. At 20 hrs post-iC3b, Mo demon-
strated a 76-fold increase in the suppressor of cytokine signaling 3 gene (SOCS3), confirmed by RT-
PCR to be selectively increased in iC3b-exposed Mo. Because SOCS3 can selectively block IL-6
signaling via binding to STAT3, we examined iC3b/Mo culture supernatants by ELISA, which showed
that IL-6 was produced at 4-8 hrs, and peaked at 12 hrs, with a 61-fold increase compared to con-
trol (726pg/ml, N=4, p=0.017); IL-6 decreased by 24 hrs, at which time SOCS3 has become markedly
increased. Similarly, soluble IL-6 receptor (sIL-6R) had a 2-fold increase at 12 hrs as compared to
control. In chronic inflammation with Mo infiltration, the IL-6/sIL-6R complex induces upregula-
tion of Mac chemotactic protein-1 (MCP-1). ELISA of iC3b/Mo culture supernatants for MCP-1
showed a 33-fold increase at 24 hrs (n=2, p=0.007). Blocking antibodies to either IL-6R or its sig-
naling receptor gp130 drastically diminished MCP-1 (>60%). In summary, cutaneous formation of
iC3b after UV induces IL-6 and sIL-6R in newly infiltrating monocytes, which is critical for subse-
quent MCP-1 production and amplification of Mo recruitment into UV-damaged skin. The robust
SOCS3 induction after iC3b likely represents a compensatory response to IL-6/STAT3 signaling, as
SOCS3 inhibits STAT3. IL-6 is known to upregulate MCSF-R on Mo, activating Mo to drive their
own differentiation. In conclusion, IL-6 signaling may be a critical mediator of iC3b-modified dif-
ferentiation of precursor monocytes entering sunburn skin. 
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The dendritic cell repertoir of atopic dermatitis skin: evidence for two non-indigenous cell pop-
ulations
G Stary, C Bangert, G Stingl and T Kopp Dermatology, Medical University of Vienna, Vienna,
Austria
Because of their unique ability to initiate primary immune responses in T- lymphocytes, dendritic
cells are thought to play a key role in the pathogenesis of atopic dermatitis. To learn more about the
process initiating and propagating the cutaneous allergic reaction, we phenotypically analyzed var-
ious dendritic cell subsets in both skin biopsies (n=6; n=5) and peripheral blood (n=10; n=8) of atopic
dermatitis patients and healthy controls. Our findings confirm the presence of the resident types of
dendritic cells in normal human skin, namely epidermal CD1a+/Langerin+ Langerhans cells and
CD1c+ dermal dendritic cells. In atopic dermatitis lesions two non-indigenous dendritic cell subsets
occurred besides increased numbers of Langerhans cells and dermal dendritic cells: (i)
CD1a+/FcεRI+/CD1c+ DC in the epidermis (inflammatory dendritic epidermal cells) and dermis
and (ii) CD123+/BDCA-2+/CD45RA+/CD68+ cells in the dermis. These latter cells exhibit the phe-
notypic features of plasmacytoid dendritic cells and, interestingly enough, display FcεRI on their
surface. A detailed characterization of dendritic cell subsets in the skin and in the peripheral blood
including their activation status and their ability to bind IgE should form the basis for the investiga-
tion of dendritic cell-mediated events operative in the pathogenesis of the eczematous response. 
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The Propionibacterium acnes mitogen is not a bacterial heat shock protein
U Jappe,1 KT Holland,2 E Ingham,2 C Huebsch-Mueller1 and MD Farrar2 1 Dermatology,
University of Heidelberg, Heidelberg, Germany and 2 Microbiology, University of Leeds, Leeds,
United Kingdom
Propionibacterium acnes has been shown to stimulate lymphocytes via mitogenic mechanisms and
this activity is associated with the bacterial cell wall. It is possible that heat shock proteins (HSP)
may be associated with the cell wall and account for this mitogenicity. Two HSP of P. acnes (HSP60
and HSP70) have been purified. P. acnes HSP were used in a lymphocyte transformation assay time
course experiment from day 3 to 7 with peripheral mononuclear cells (PBMNC) from patients with
inflammatory acne and from cord blood (CBMNC) to investigate their T-cell stimulatory properties.
PBMNC and CBMNC samples were also investigated with and without pre-incubation with TU39,
a monoclonal mouse anti-human MHC class II antibody, to block antigenic stimulation. 9/12 and
10/12 CBMNC were stimulated by HSP 60 and 70, respectively with 5/9 showing an early response.
3/9 samples showed two peaks of stimulation, suggesting two different mechanisms of lymphocyte
activation. In contrast, only 3/11 of the PBMNC samples were stimulated by HSP 60 and 70 from
day 5 onwards. Lymphocyte stimulation could be blocked completely by TU39. It can be concluded
that P. acnes HSP 60 and 70 evoke an antigenic reaction and that other P. acnes products are respon-
sible for the mitogenic activity. This is consistent with reports on immune reactions induced by
mycobacterial HSP, which show a high degree of amino acid sequence homology with P. acnes
HSP. 
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Regulation of interleukin 4 expression by small molecule tyrphostins
L Gu and BE Rich Dermatology, Brigham and Women, Boston, MA
CD4+ T cells can differentiate in a polarized manner into at least two effector cell types character-
ized by distinct cytokine production profiles. T helper type 1 (Th1) cytokines regulate cell-mediated
immune responses and are involved in certain autoimmune diseases including psoriasis and exper-
imental allergic encephalomyelitis. T helper type 2 (Th2) cytokines regulate humoral immune
responses and are involved in allergic disorders such as atopic dermatitis and asthma. Tyrphostins
are a class of small molecule kinase inhibitors. Previous studies have shown that the tyrphostin AG490
diminishes the symptoms of Th1-mediated disease in mice. Interleukin 4 (IL-4) is a potent
immunomodulatory cytokine secreted by Th2 cells and it promotes the differentiation of naive T
cells into Th2 cells. In this study, we utilized a strain of mice carrying a modified IL-4 gene con-
taining green fluorescent protein (GFP) that enables sensitive detection of IL-4 expression to exam-
ine the immunological effects of tyrphostins. Exposure of naive or concanavalin A (ConA)-stimu-
lated CD4+ T cells to tyrphostins in vitro stimulated expression of GFP in a dose-dependent manner.
The correlation of GFP expression with IL-4 expression was confirmed by real-time PCR in cells
from both wild-type and IL4-GFP mice. Tyrphostin 5H4, a derivative of AG490 with increased kinase
inhibitory activity, is also more effective at stimulating IL-4 gene transcription. The increased level
of GFP is sustained for at least 2 days after the removal of tyrphostin molecules. Increased GFP
expression was also detected in CD8+ T cells, although primarily in the absence of stimulation. Tyr-
phostin treatment also increased the GFP expression in non-lymphoid cells, in both non-stimulated
and stimulated conditions. The GFP+ cells do not express the activation marker CD69, indicating
that the effect of tyrphostins on the IL-4 expression is independent of T-cell-receptor (TCR) signal-
ing. These data suggest that tyrphostin molecules have the potential to modulate Th1/Th2 balance
and may be valuable for intervention in Th1 or Th2-mediated immune diseases. 
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Antibody-based targeting of tumor antigens to dendritic cells in vivo induces protective tumor
immunity in a B16 melanoma model
K Mahnke, Y Qian, J Brueck, J Knop and AH Enk University of Mainz, Mainz, Germany
The antigen receptor DEC-205 is exclusively expressed by dendritic cells and enhances antigen pres-
entation up to 500-fold as compared to pinocytosis. We therefore aimed to use antibodies against
DEC-205 to load DCs in situ with antigens. A fusion protein of the tumor antigen TRP-2 and the
green fluorescent protein (EGFP) was coupled to anti-DEC-205 antibodies (αDEC) and injected
together with CpGs into mice.  Lymph node cells (LNC) were prepared from draining LN 2h to 24h
later. FACS analysis revealed that 6h after injection of these conjugates up to 20% of the CD11c+
DCs displayed EGFP fluorescence. B220+as well as CD11b+ cells were negative for EGFP fluores-
cence, indicating that EGFP-TRP2-αDEC conjugates had selectively been taken up by LN DCs. To
test whether this targeting resulted in induction of TRP2 specific CD8+ T cells, spleen cells from
conjugate plus CpG injected mice were restimulated with TRP2-peptide and in ELISPOTs we were
able to detect IFN-γ producing T cells. No IFNγ producers were detected in control samples. More-
over, we demonstrated induction of melanoma specific antibodies in TRP2-αDEC-conjugate injected
mice, whereas mice that received uncoupled TRP2 protein developed only weak antibody responses.
Finally we tested whether immunization with TRP2-αDEC-conjugates plus CpG leads to protective
tumor immunity in a melanoma model. Therefore mice were immunized with TRP2-αDEC-conju-
gates and respective controls and were challenged for tumor growth by injection of 4x105 B16
melanoma cells. 14 days later, mice were sacrificed and lung metastases were counted. These exper-
iments revealed that injection of TRP2-αDEC-conjugates prevented tumor growth in more then 75%
of the mice, whereas no tumor free mice could be detected in untreated - or TRP2 injected groups.
Notably, when CpG was omitted from the immunization, tumor growth was not prevented, indicat-
ing that activated DCs are mandatory for successful immunization. Thus these data show that in
vivo targeting of tumor antigens to activated DCs induces protective tumor immunity. 
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Phenotype and TCR diversity analysis of T cells isolated from normal human skin
RA Clark,1 BF Chong,2 K Yamanaka1 and TS Kupper1 1 Dept of Dermatology, Brigham and
Womens Hospital, Boston, MA and 2 Johns Hopkins School of Medicine, Baltimore, MD
Studies of T cell homing to cutaneous sites have largely focused on T cells isolated from inflamed
skin. The study of normal immunosurveillance mediated by T cell trafficking into non-inflamed
skin has been hampered by difficulties in obtaining sufficient numbers of cells to analyze. We report
here isolation of significant numbers of CLA+ memory T cells from normal human skin by culture
of skin explants on three-dimensional matrices. We performed comprehensive comparisons of these
cells to CLA+ cells derived from blood. We found >90% co-expression of CLA and CCR4 and >80%
co-expression of CLA and CCR6 on skin derived T cells. L-selectin was expressed at lower levels
on skin T cells and CD69 was expressed on skin T cells but was undetectable on blood T cells. Spec-
tratyping analysis of T cells from normal skin demonstrated a highly diverse T cell receptor reper-
toire with no apparent Vβ bias. To establish that lymphocytes produced in our system do not undergo
phenotypic changes in culture, we cultured subsets of CLA+ and CLA- T cells from peripheral blood
in matrices colonized with skin cells for four weeks. Expression of CLA, CCR4, CCR7 and L-selectin
were largely unchanged after culture, suggesting that the phenotype of cells we isolate likely repre-
sents the true phenotype of T cells homing to non-inflamed skin. In summary, we have isolated T
cells from normal skin in meaningful numbers using novel isolation conditions. These cells expressed
high levels of CLA, CCR4, and CCR6, supporting a role for these homing molecules in T cell traf-
ficking to non-inflamed cutaneous sites. TCR spectratyping demonstrated that diverse populations
of CLA+ T cells migrate to and reside in the skin as a part of normal immunosurveillance. Explant
cultures also supported long-term survival and maintenance of CLA phenotype in T cell subsets iso-
lated from blood, suggesting that CLA expression neither increases nor decreases after T cell entry
into skin. 
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Positive selection, negative selection and generation of a diverse TCR repertoire in thymus-
independent T cell development mediated by skin cells in an artificial matrix
RA Clark, K Yamanaka and TS Kupper Dept of Dermatology, Brigham and Womens Hospital,
Boston, MA
T cells require a period of development in the thymus. The complex requirements for T cell devel-
opment have precluded the laboratory production of T cells that can be given to immunocompro-
mised patients to treat infection or malignancies. Utilizing the natural similarities between skin and
the thymus, we have used keratinocytes and fibroblasts in three-dimensional matrix to replicate the
thymus microenvironment, and demonstrated the production of mature T cells from bone marrow
hematopoietic stem cells. However, the potential utility of these T cells for use in patients was
unknown. We report here that T cells developing in our thymus-independent skin constructs suc-
cessfully undergo both positive and negative selection. Successful positive selection is an obligate
requirement for the production of single-positive T cells from double-positive precursors. We observed
transition of double-positive T cell precursors to single-positive, TREC+ T cells, confirming that skin-
derived epithelial cells can support positive selection. Mixed lymphocyte reactions using newly
generated T cells demonstrated that these cells were non-reactive to dendritic cells derived from
autologous bone marrow precursors but reacted normally to dendritic cells derived from allogeneic,
unrelated donors. Spectratyping analyses of newly generated T cells demonstrated a remarkably
diverse T cell repertoire with all Vβ families represented. Lastly, T cell production was augmented
by inclusion of the Notch ligand Delta-1. In summary, we report that human skin cells can replicate
the thymus microenvironment, supporting the development of functionally mature, self-tolerant T
cells with diverse TCR repertoires. This system could be used to produce autologous T cells for use
in patients using only samples of bone marrow and skin. T cells generated in this manner could be
extremely valuable in the treatment of human immunodeficiencies, infections and malignancies 
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The lipid of Malassezia furfur inhibits ligand activation of toll-like receptors 4 and 2
C Oh and J Kim Dermatology, UCLA, Los Angeles, CA
Malassezia is a fungal species that is present as part of the normal cutaneous flora, but it can cause
a wide range of cutaneous inflammatory diseases and even systemic infectious diseases in predis-
posed individuals . Recent studies have demonstrated that Malassezia are capable of suppressing
cytokine release and down-regulating the phagocytic function of monocytes. It is thought that the
lipid-rich layer on the yeast membrane plays a critical role in this suppression. However, the mech-
anism by which Malassezia activates the immune response is not well understood. We compared the
immunomodulatory capacity of normal and lipid-depleted Malassezia furfur (M. furfur). The lipid-
depleted yeasts induced significant cytokine release including TNF-α, IL-6, and IL-1β by primary
human monocytes, while monocytes treated with non-lipid-depleted yeast did not produce signifi-
cant levels of these cytokines. Cytokine production by lipid-depleted yeasts could be inhibited by
the addition of an anti-Toll-like receptor 2 (TLR2) antibody but not with anti-Toll-like receptor 4
(TLR4) antibody, suggesting that M. furfur activation of cytokine production in human monocytes
is at least partially dependent on TLR2. Furthermore, extracted lipid from M. furfur inhibited the
effects of TLR4 and TLR2 ligands to induce cytokine induction in human monocytes. These results
suggest that the lipid of Malassezia may prevent the yeasts from inducing inflammation and also
inhibit the inflammatory effects of TLR2 and TLR4 ligands. 
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Cross-reactivity between C.I. Disperse Blue 106 and paraphenylenediamine
M Sugiura, R Hayakawa, Y Kato and K Sugiura Environmental Dermatology, Nagoya University
School of Medicine, Nagoya, Japan
In this study, we investigated about cross reactivity between C.I. Disperse Blue 106 and para-
phenylenediamine (PPD). Female Hartley strain albino guinea pigs were introduced at 4 weeks of
age. We selected C.I. Disperse Blue 106 and PPD. We decided 5% aq. as intracutaneous and percu-
taneous sensitizing concentration and 1% aq. as challenge concentration to C.I. Disperse Blue 106.
We decided 0.1% ac. as intracutaneous sensitization concentration, 0.1% ac. as percutaneous sensi-
tizing concentration and 0.1% ac. as challenge concentration to PPD. The procedure of the Mag-
nusson & Kligman’s Guinea Pig Maximization Test was followed for induction. Ten animals were
included in the C.I. Disperse Blue 106 sensitized group and the PPD sensitized group. Readings were
made at 24, 48, 72 hours after the challenge, according to the Draize’s criteria. A summation of
numerical scoring of more than 2 was judged as a positive reaction. The positive reaction to C.I.
Disperse Blue 106 was observed in 5 out of 10 animals. All five positive animals showed negative
reaction to PPD. The positive reaction to PPD was observed in 8 out of 10 animals. Four out of 8
positive animals showed positive reaction to C.I. Disperse Blue 106. We concluded sensitized ani-
mals from C.I. Disperse Blue 106 did not cross-react to PPD, while sensitized animals from PPD
cross-reacted to C.I. Disperse Blue 106. 
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Double-blind randomised trial evaluation of a new product containing MMP and PKC inhibitors
in cutaneous contact hypersensitivity
P Msika,1 N Piccardi,1 B Chadoutaud,2 A Piccirilli,1 J Choulot1 and J Nicolas3 1 Laboratoires
Expanscience, Epernon, France, 2 BC Consulting, Toulouse, France and 3 INSERM 503, Lyon,
France
Matrix metalloproteases (MMPs) and PKC are implicated in several skin pathologies, especially
inflammatory cutaneous disorders such as psoriasis and contact hypersensitivity. More over, several
molecules regulate the migration of skin dendritic cells, which are potent antigen presenting cells
implicated in the primary T-cell-mediated
immune response of the skin, among which MMPs and PKC. We have previously shown that MMP
and/or PKC inhibitors are able to modulate the migration of skin dendritic cells both in vitro and in
vivo. Thus the aim of this study was to evaluate the clinical efficiency of an innovative topical prod-
uct containing both MMPs and PKC inhibitors (verum) on cutaneous contact hypersensitivity (CHS).
A double-blind randomised trial was conducted by 12 dermatologists on 50 selected volunteers hav-
ing repeated nickel allergy due to buckles. The panellists have applied products on both ears (placebo
or verum) twice a day during 7 days, and then buckles until CHS appears (at least for 14 days, 8 to
12h per day). An individual board has to be filled by the panellist in order to assess the course and
development of CHS. At day 14, a final examination was performed by the dermatologist. The first
results showed that 75% of the panellists using the placebo developed CHS, while only 37% of the
verum treated one were sensitised. This trial demonstrates that topical applications of both MMP
and PKC inhibitor prior to nickel exposition are able to reduce by 50% the frequency of CHS in aller-
gic patients. 
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The regulation of STAT-1 and NFKB DNA binding activity in human keratinocytes HaCaT
cells
K Nakamura,1 N Oyama,1 F Kaneko,1 Y Tsunemi,2 H Saeki2 and K Tamaki2 1 Dermatology,
Fukushima Medical University, Fukushima, Japan and 2 Dermatology, Tokyo Unversity, Tokyo,
Japan
Psoriasis is a chronic inflammatory skin disease where Th1 cytokines participate in the pathogene-
sis. We have previously shown that CXCR3 positivity was increased in CD4+ CD45RO+ T cells in
psoriatic patients. STAT-1 and NFkB are transcriptional factors which regulate inflammatory cytokine
production such as IL-8 and IP-10/ CXCL10. Immunohistochemical analysis reveals that the lesional
skin of psoriatic patients shows STAT-1 positivity in epidermal keratinocytes. We examined STAT-
1 and NFkB DNA binding activity using human keratinocytes cell lines, HaCaT cells using elec-
trophoretic mobility shift assay. STAT-1 and NFkB DNA activity was enhanced by both TNF-a and
IFN-g at maximum level at 1hr after the stimulation. Cyclosporine did not change the levels of STAT-
1DNA binding activity. VitaminD3 analogue slightly decreased STAT-1 DNA binding activity (10-
8M 92.4%, 10-10M 88.9%, 10-12M 98.7%). NFkB DNA binding activity was partially blocked by
genistein and LY294002. These data suggest that STAT-1 and NFkB activity in keratinocytes was
enhanced in inflammatory skin conditions and its regulation can be the target for the treatment of
inflammatory skin diseases such as psoriasis. 
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Pimecrolimus and tacrolimus show comparable potencies to inhibit the proliferation and
cytokine synthesis of allergen-specific, atopic skin-derived T cell clones in vitro
FS Kalthoff, J Chung, P Musser, S Wang and A Stuetz DI, Novartis Institutes for BioMedical
Research, Vienna, Austria
Pimecrolimus and tacrolimus are in clinical use for treatment of atopic dermatitis. Both compounds
have been shown to share macrophilin-12 (FKBP-12) as intracellular receptor and to inhibit T cell
activation via blockade of calcineurin activity. In this study, we compared the relative potencies of
pimecrolimus and tacrolimus to inhibit the proliferation and synthesis of cytokines from house dust
mite allergen-specific T cell clones derived from the skin of an atopic dermatitis patient. Following
in vitro stimulation by specific antigen presented on the surface of dendritic cells, the IC50 values
for the inhibition of T cell proliferation by pimecrolimus and tacrolimus differed by a factor of less
than two. A ten- to twenty-fold higher IC50 value was obtained for cyclosporin A used as a reference
compound. A similar picture emerged for the inhibition of cytokine synthesis (IL-2, IL-4, IL-5, IL-
10, IFN-γ and TNF-α) by pimecrolimus or tacrolimus. The arithmetic means of the relative ratio IC50
pimecrolimus / IC50 tacrolimus were 1.53 (± 0.26) or 1.66 (± 0.36) when stimulating the T cells by
anti-CD3 monoclonal antibody plus phorbol ester or by antigen-presenting dendritic cells, respec-
tively. Taken together, these data demonstrate that pimecrolimus and tacrolimus have similar poten-
cies to inhibit recall antigen responses of skin-derived T cell clones. 
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Roxithromycin suppression of keratinocyte Th2 chemokine production and Th2 cell chemokine
receptor expression
M Kobayashi, T Shimauchi, R Hino and Y Tokura Dermatology, University of Occupational and
Environmental Health Japan, Kitakyushu, Japan
Recent studies have revealed that macrolide drugs exert a variety of bioactivities to allergic and
inflammatory cells in addition to their antibiotic functions. We investigated the modulatory effects
of roxithromycin (RXM) on keratinocyte production of chemokines and T-lymphocyte expression
of chemokine receptors. Normal human epidermal keratinocytes (NHEK) and HaCaT cells were cul-
tured for 72h with or without RXM at varying concentrations under stimulation with IFN-g and TNF-
a. RXM at 10-4M significantly suppressed the production / expression of MDC and TARC but did
not affect that of IP-10, as assessed by ELISA in the culture supernatants and RT-PCR in the extracted
RNA. To examine the effect on chemokine receptors, Th2-rich peripheral blood mononuclear cells
(PBMC) were isolated from patients with mycosis fungoides and cultured with or without RXM
under stimulation with IL-2 or IL-4. By flow cytometric analysis, RXM down-modulated the expres-
sion of CCR4 on Th2 cells upon stimulation with IL-2 but did not alter the expression of CXCR3.
Thus, RXM down-modulates both Th2 chemokine production and chemokine receptor expression
in cutaneous immunity. These findings suggest that RXM has a beneficial therapeutic effect on Th2-
mediated or allergic skin disorders by suppressing both chemokine production and ligand expres-
sion.
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Shift in the profile of antibodies against desmoglein 3 and 1 with time in pemphigus vulgaris
D Weitz, D Jiao and J Bystryn Dermatology, NYU School of Medicine, New York, NY
The clinical phenotype of pemphigus can shift from that of pemphigus vulgaris (PV) to that of pem-
phigus foliaceus (PF), and this shift is associated with a corresponding shift in the pattern of anti-
dsg antibodies from that seen in PV to that seen in PF. How often this occurs is not known. To eval-
uate how often the change occurs, we examined the ratio of anti-dsg 3 to anti-dsg 1 antibodies over
time in patients with PV. The study was conducted in 37 sequential patients with PV based on clin-
ical, histological, and immunological criteria, who had intercellular antibodies at baseline, and in
whom at least two sera specimen taken at different times were available. Antibodies against desmoglein
3 and 1 were measured by ELISA at baseline and periodically thereafter. At baseline, 29 (78%) of
patients had anti-dsg 3 dominant disease, i.e. the level of anti-dsg 3 antibody was higher than that
of anti-dsg 1; and 7 (19%) had anti-dsg 1 dominant disease. In 3 (8%) of patients, the ratio of anti-
dsg 3 to anti-dsg 1 decreased over time, so that the disease became anti-dsg 1 as opposed to anti-dsg
3 dominant. The clinical manifestations of PV shifted in all three of these patients from the muco-
cutaneous form (oral and skin lesions present) to the cutaneous form, (skin but not oral lesions). By
contrast, among the patients who had anti-dsg 3 dominant disease throughout the course of their ill-
ness, the clinical manifestations of this disease did not shift. In conclusion, serological transition
from anti-dsg 3 dominant to anti-dsg 1 dominant disease occurs in pemphigus vulgaris, but is a rel-
atively rare event. This shift can be associated with shifts in the clinical manifestation of the disease. 
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Differential activation of mast cells by microbial peptides
M Metz,1 K Grote,2 J Knop1 and M Maurer1 1 Dermatology, Johannes Gutenberg-University,
Mainz, Germany and 2 Cardiology and Angiology, Medical School Hannover, Hannover, Germany
Mast cells (MCs) have been shown to play an important role in innate immunity against pathogens.
This view is supported by recent findings showing that MCs express toll like receptors (TLRs) 2, 3,
4, 6, 8, and 9. Furthermore, some bacterial signals, i.e. Staph. aureus peptidoglycans (PGN), have
been shown to activate MCs via TLR2. Here, we asked whether MCs can be activated by Mycoplasma-
derived lipoprotein MALP-2, which requires signalling via TLR2/TLR6. While none of the exam-
ined MC populations (murine skin MCs, peritoneal MCs, C57 MCs) exhibited degranulation upon
stimulation with PGN (via TLR2), LPS (TLR4), or MALP-2 (TLR2/TLR6), activation of MCs via
TLR2 or TLR4 resulted in pronounced release of IL-6 and TNFα (IL-6: 1573 ± 328pg/ml [LPS],
1701 ± 1010 [PGN], TNFα: 140 ± 7.2pg/ml [LPS], 341.6 ± 11.5pg/ml [PGN]). However, stimula-
tion of MCs with MALP-2 failed to induce cytokine release from MCs, suggesting impaired func-
tions of TLR2/TLR6 in MCs. When we performed RT-PCR analyses for TLRs and MyD88, MCs
were, as previously reported, found to express MyD88, TLR4, TLR6 and the extracellular domain
of TLR2. However, MCs failed to express large parts of the TLR2 signalling domain, whereas
macrophages showed full length transcripts for TLR2. These observations are supported by our in
vivo findings showing that MALP-2 induces equally strong inflammatory reactions after intrader-
mal injections in normal or genetically MC-deficient KitW/KitW-v mice (KitW/KitW-v, after 1h: 57.5 ±
12.8µm, vs. Kit+/+: 64.1 ± 11.4µm, p=0.72). These data indicate that MCs express a novel isoform
of TLR2 which is able to exert effects mediated by selective TLR2 ligands, but, unlike other skin
cell populations, does not respond to TLR2/TLR6 mediated stimulation. Since it has been shown
that TLR2 has to be physically associated with TLR6 to exert TLR2/TLR6-mediated effects, this
impaired response could possibly be due to a disturbed interaction of TLR2/TLR6. Further investi-
gations are required to identify the unique structure of MC-TLR2 and its possible functions in MCs. 
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Contrasting roles of TLR2 and MyD88 in an in vivo model of skin infection with Staphylo-
coccus aureus
LS Miller,1 RM O’Connell,2 J Kim,1 G Cheng2 and RL Modlin1 1 Division of Dermatology and
Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of
Medicine University of California at Los Angeles (UCLA), Los Angeles, CA and 2 Department of
Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine University
of California at Los Angeles (UCLA), Los Angeles, CA
The majority of skin infections in humans are due to Staph. aureus. Toll-like receptors (TLRs) have
been shown to be important in host defense against bacteria and other microbial pathogens. How-
ever, to our knowledge, no study to date has evaluated the role of TLRs in skin infection in vivo.
Here, we studied the role of TLR2, which is activated by bacterial peptidoglycan and lipoprotein,
and MyD88, an important signaling molecule for TLRs. We induced skin ulceration in mice by sub-
cutaneous inoculation of Staph. aureus. Mice deficient in TLR2 initially had smaller ulcers than wild-
type mice (day 2: TLR2-/- 0.014 ± 0.008 cm2 vs. WT 0.114 ± .04 cm2 ; mean ± sem, p<0.05, n=7
per group), but healed at approximately the same time (~day 14). Mice deficient in TLR2 had smaller
dermal inflammatory cell infiltrates than wildtype mice according to histologic analysis at 24 h. Sim-
ilarly, MyD88 deficient mice initially had smaller ulcers than wildtype mice (day 3: MyD88-/- 0.02
± 0.016 cm2 vs. WT 0.07 ± .02 cm2; mean ± sem, p<0.05, n=7 and 8, respectively). In contrast to
TLR2 deficient mice, the mean size of ulcers in MyD88 deficient mice continued to increase in size
to 5 times greater than that seen in wildtype mice (MyD88-/- 0.32 ± 0.075 cm2 on day 26 vs. WT
0.07 ± 0.02 cm2 on day 4, p<0.05, n=7 and 8, respectively). In addition, by day 30 only 2 of 7 MyD88
deficient mice healed their ulcers, whereas all wildytpe mice healed by day 14-18. These results
suggest that both TLR2 and MyD88 may be important in initiating early inflammatory signals that
produce skin ulceration and that MyD88 is a critical molecule for resolution of Staph. aureus induced
skin ulceration. 
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Identification of a unique population of regulatory T cells in psoriasis by elimination of tran-
siently activated CD4+CD25+ cells
E Garaczi,1,2 W Goodman,1 H Sugiyama,1,3 R Gyulai,1,2 TS McCormick1 and KD Cooper1,4 1
Dermatology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland,
OH, 2 Dermatology, University of Szeged, Szeged, Hungary, 3 Dermatology, University of
Yamanashi, Yamanashi, Japan and 4 VA Medical Center, Cleveland, OH
CD4+CD25+ regulatory T cells are able to suppress autoreactive T cells and play a unique role in
the control of autoimmune disease in murine models. We previously showed that psoriatic
CD4+CD25+ regulatory T cells are functionally deficient in suppressing effector T cell responses.
The goal of this study was to examine more closely the CD25+ regulatory T cell population in pso-
riatic blood. One challenge in working with regulatory T cells is to distinguish these CD25+ T cells
from transiently activated T cells. Therefore, we used CD71, a transient activation marker with sim-
ilar duration of expression as CD25. CD4+CD25+ regulatory T cells from normal and psoriatic blood
were sorted by magnetic beads and analyzed by flow cytometry. Immediately upon isolation,
CD4+CD25+ cells contained about 15% CD71+ cells in both normal and psoriatic blood; this
decreased to less than 5% after overnight incubation in both groups. In psoriatic volunteers, how-
ever, CD4+ T cells contained a persistent population of CD25high+CD71- non-activated cells, which
remained constitutively CD25high+ for more than 48 hours post-isolation. These cells represent a
high proportion of total CD4+CD25+ T cells in the blood of psoriatics (12.44%± 0.52%), compared
to the blood of normals (3.19%± 0.29%) (n=3, p〈0.05). Thus, in humans, the CD4+CD25+ popula-
tion immediately upon isolation contains significant numbers of activated T cells; upon resting ex
vivo, the expression of CD71 in these cells diminishes, revealing a novel regulatory T cell subset in
psoriasis. We identified a T cell population in psoriatic patients with constitutive and unusually high
CD25 expression not linked to activation. This T cell subset may contribute to the pathogenesis of
psoriasis.
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Synthetic granulysin peptides demonstrate antimicrobial and anti-inflammatory activity against
Propionibacterium acnes
JE McInturff,1,2 S Wang,1 CJ Hertz,1 D Anderson3 and J Kim1 1 Dermatology, UCLA, Los Angeles,
CA, 2 HHMI, Bethesda, MD and 3 HHMI, Los Angeles, CA
Peptides based on the structure of human granulysin were synthesized and subsequently tested for
their abilities to kill P.acnes and modulate the immune response to this microbe. Colony forming
unit assays measured the peptides’ ability to kill P.acnes. The peptides’ effect on inflammation was
assessed by stimulating primary human monocytes with P.acnes sonicate and measuring cytokine
levels by ELISA. Furthermore, the peptides’ effects on monocyte Toll-like receptor expression was
determined by flow cytometry. A peptide possessing a helix-loop-helix motif, peptide 31-50, killed
P. acnes while peptides lacking the motif, including peptide 1-20, were ineffective at killing P.acnes.
Substituting a tryptophan for the valine at amino acid 44 of peptide 31-50 to increase its hydropho-
bic moment increased the antimicrobial activity of this peptide (31-50v44w). Furthermore, addition
of two terminal arginines that may facilitate transport of peptides through the skin did not alter the
antimicrobial activity of the resulting peptide, 31-50v44wRR. Peptides 31-50, 31-50v44w, and 31-
50v44wRR also had anti-inflammatory effects, as demonstrated by the suppression of IL-12p40 pro-
duction in monocytes stimulated with P.acnes sonicate. Peptide 31-50v44w also markedly inhibited
the production of a wide array of inflammatory cytokines and chemokines, though the peptide did
not effect TLR2 expression. Peptides 31-50 and 31-50v44w are not toxic to human monocytes or
keratinocytes at concentrations up to 20µM and exhibit minimal toxicity at higher concentrations.
Moreover, as evidenced by transmission EM, P.acnes develop vacuoles shortly after treatment with
granulysin or peptide 31-50v44w, suggesting their antimicrobial activity may be due to membrane
perturbation. Since the ideal treatment for acne vulgaris would be both antimicrobial and anti-inflam-
matory, these peptides have promise as topical therapeutic agents, providing an alternative to cur-
rent acne therapies. 
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DC-HIL (on antigen presenting cells) is an endogenous ligand of dectin-2 (on activated T cells)
and their binding leads to inhibited CD3-dependent activation of CD4+ T cells
J Chung, K Sato, P Cruz, Jr and K Ariizumi Dermatology, The University of Texas Southwestern
Medical Center, Dallas, TX
Previously, we showed that the C-type lectin, dectin-2, is expressed on mouse Langerhans cells (LC),
dendritic cells (DC), and activated macrophages (MΦ), and that it recognizes hyphae by binding to
mannan-like carbohydrates (exogenous ligand) on these fungi. Postulating that dectin-2 also has
endogenous ligands, we screened leukocytes for binding to soluble dectin-2. By immunofluores-
cence, we showed dectin-2 to bind bone marrow DC and peritoneal and Raw MΦ (but not spleen T
and B cells), indicating that these antigen presenting cells (APC) express dectin-2 ligands. Because
mannan and EDTA were each capable of completely blocking binding of dectin-2 to hyphae, we
tested their effect on binding of dectin-2 to Raw MΦ. By 125I- binding assays, mannan and EDTA
were 50% less-efficient blockers, suggesting that mechanisms of dectin-2 binding to exogenous vs.
endogenous ligands are not identical. In testing other agents, we serendipitously considered a mol-
ecule we identified previously: DC-HIL, a cell adhesion receptor expressed by LC, DC and MΦ.
Again using 125I assays, we found that soluble DC-HIL (but not controls) completely blocked bind-
ing of dectin-2 to Raw MΦ, indicating that DC-HIL is an endogenous ligand of dectin-2. Meanwhile,
by RT-PCR, we discovered that activation with anti-CD3 Ab can induce dectin-2 mRNA in T cells
(CD4+ > CD8+ ). Using binding assays as before, we showed DC-HIL to bind activated (but not rest-
ing) T cells (CD4+ > CD8+). To assess function, we measured proliferation of CD4+ T cells stimu-
lated concurrently with immobilized anti-CD3 Ab and DC-HIL. At suboptimal doses of anti-CD3
Ab, DC-HIL (but not controls) blocked T-cell proliferation (91% inhibition). We conclude that DC-
HIL on APC is an endogenous ligand of dectin-2 on activated T cells and their binding leads to inhib-
ited CD4+ T-cell proliferation. These novel interactions may constitute an important negative regu-
latory feedback between APC and T cells. 
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Downregulation of dendritic cell-bound IgE/FcεRI in anti-IgE-treated patients with atopic der-
matitis
B Hayek,1 M Laimer,1 P Heil,1 D Maurer,1 T Hultsch2,3 and G Stingl1 1 DIAID, Dept. of
Dermatology, University of Vienna Medical School, Vienna, Austria, 2 Dept. of Dermatology,
University Mainz, Mainz, Germany and 3 Novartis Pharmaceuticals, New Jersey, NJ
Omalizumab, a recombinant humanized monoclonal anti-IgE antibody is safe and effective in patients
with severe allergic asthma and allergic rhinoconjunctivitis. This is the first study to investigate to
what extent high IgE-levels play a pathogenetic role in the inflammatory skin reaction in atopic der-
matitis (AD). 20 AD patients (13 omalizumab, 7 placebo) were enrolled into this 16-week double-
blind placebo-controlled study. Omalizumab was dosed according to IgE levels and bodyweight of
the patients. Levels of free and total serum IgE were monitored, and immunohistochemistry stain-
ing of skin biopsies before and after treatment was performed. Basophils, myeloid and plasmacy-
toid dendritic cells (DCs) and monocytes were investigated by Fluorescence activated cell sorter
analysis (FACS) analysis for cell-bound IgE, IgE-binding capacity and FcεRI. Titrated skin prick
tests were performed and clinical outcome was monitored. Serum levels of free IgE decreased sig-
nificantly after the first administration of Omalizumab. Levels of cell-bound IgE and relative expres-
sion of FcεRI as well as IgE-binding capacity and FcεRI receptor saturation also decreased not only
on basophils but also on DCs as measured by FACS analysis. Immunohistochemistry staining revealed
almost complete disappearance of IgE in the dermis of patients of the omalizumab group but no dif-
ference was seen in quality and quantity of the inflammatory infiltrate. A reduction of patients sen-
sitivity in titrated skin prick test could be demonstrated too, but no major clinical effect became
apparent during the treatment period. Treatment of AD patients with omalizumab interrupts the bind-
ing of IgE to the surface of antigen-presenting cells. Although no immediate clinical benefits were
seen, there may be long-term sequelae for the course of this disease. 
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Topical imiquimod prevents UVB-induced tolerance to topical haptens by modulating cytokines
in Langerhans cells
AA Gaspari,1 T Thatcher,2 I Luzina,3 M Tomai4 and RL Miller4 1 Dermatology, University of
Maryland, Baltimore, MD, 2 Pulmonary Medicine, University of Rochester, Rochester, NY, 3
Division of Rheumatology, University of Maryland, Baltimore, MD and 4 Pharmaceutical
Research, 3M Pharmaceuticals, St. Paul, MN
Imiquimod (IMIQ) has direct effects on epidermal Langerhans cells (LC), causing their maturation
and migration from the epidermis. To determine whether IMIQ could prevent the loss of contact
hypersensitivity (CHS) induced by UVB, topical 5% IMIQ cream or vehicle was applied to normal
mouse skin prior to UVB radiation (70mJ/cm2 daily x 4 days), then experimental mice were sensi-
tized with DNFB. Topical IMIQ prior to sensitization prevented the loss of CHS to this hapten in
UV-irradiated mice. Furthermore, only IMIQ treated, UVB irradiated mice were not tolerant to repeat
sensitization and challenge with DNFB, and exhibited significantly higher anti-hapten IgG1 and
IgG2a responses compared to tolerant mice. Although IMIQ prevented UVB-tolerance to hapten, it
did not prevent UVB-induced depletion of epidermal LC, suggesting that IMIQ blunts the damag-
ing effects of UV light on LC function.  This hypothesis was addressed by studying XS52, a LC-
like cell line which express TLR7 mRNA. XS52 respond to IMIQ by rapidly phosphorylating ERK
and JNK, decreasing cytoplasmic IkB, translocation of NFkB to the nucleus and secreting IL-12
and TNF-a.  IMIQ treatment (5 mg/ml) of XS52 prior to UVB radiation maintain their ability to
secrete IL-12 and TNF-a, in contrast to untreated, UVB radiated XS52.   Lastly, local lymph nodes
from IMIQ treated, UVB irradiated mice contain LC that respond to LPS by vigorous secretion of
IL-12; LC in lymph nodes of untreated or vehicle-treated UVB-irradiated mice respond poorly to
LPS.  These data suggest that topical IMIQ preserves CHS by modulating the deleterious effects of
UVB on epidermal LC ability to secrete critical cytokines such as IL-12. This topical agent may
play a role in preventing UVB immune suppression and subsequent skin cancer. 
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Apoptotic cells and tumor cell lysate pulsed CD14+monocyte-derived dendritic cells from cuta-
neous T-cell lymphoma mature and induce allogenic T-cell proliferation in vitro
X Ni,1 X Liao,2 H Segall,3 C Zhang,1 E Shpall3 and M Duvic1 1 Dept. of Dermatology, UT-MD
Anderson Cancer Center, Houston, TX, 2 Dept. of Bioimmunotherapy, UT-MD Anderson Cancer
Center, Houston, TX and 3 Dept. of Bone Marrow Transplantation, UT-MD Anderson Cancer
Center, Houston, TX
Dendritic cells (DCs) are professional antigen-presenting cells that can capture antigens from apop-
totic and necrotic tumor cells and induce MHC class I- and II- restricted responses. However, necrotic
cells are generally considered to be immunogenic, while apoptotic cells are thought to be immuno-
logically innocuous. In certain models, apoptotic cells are shown to be an attractive immunogenic
antigenic source for the cross- priming of cytotoxic T lymphocytes (CTL). The heterogeneity seems
to involve the ability of a given necrotic or apoptotic cell to provide signals that induce activate mature
DCs. In this study, we examined the mature status of CD14+ monocyte-derived DCs from patients
with cutaneous T-cell lymphoma (CTCL) that were pulsed with either UVB-induced apoptotic CTCL
cells or tumor cell lysates. CD14+monocytes were isolated from peripheral blood mononuclear
cells from Sezary syndrome patients, and immature DCs were generating after incubation with
GM-CSF and IL-4; the typical morphology with cytoplasmic projections and immunophenotype
(CD83low, CD80low, CD40low, CD86low, HLA-ABChigh, HLA-DRhigh and CD14low) was con-
firmed. Both apoptotic cells and tumor cell lysate pulsed DCs (Apop-DC and Lysate-DC) exhibited
the typical morphology and immunophenotype of mature DCs (CD83high, CD80high, CD40high,
CD86high, HLA-ABChigh, HLA-DRhigh and CD14low) after maturation cytokines [TNF-α, IL-
1β, IL-6, and PGE2 (ITIP)] were added. Apop-DCs and Lysate-DCs both demonstrated the ability
to stimulate allogenic T-cell proliferation in mixed leukocyte reactions compared to mature DCs
alone. IL-12 secretion was induced when IFN-γ was added to the ITIP maturation cocktail. Our pre-
liminary study indicated that Apop-DCs and Lysate-DCs might be used as therapeutic vaccines for
CTCL. The induction of CTCL-specific CTLs by both Apop-DCs and Lysate-DCs is being investi-
gated.
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Regulatory function of anergic T cells is dependent on p27KIP1-induced cell cycle arrest con-
trolled by activated MAP kinase p38
H Adler,1 S Kubsch,1 S Ludwig,2 E Graulich,1 J Knop1 and K Steinbrink1 1 Department of
Dermatology, University of Mainz, Mainz, Germany and 2 Institute of Molecular Medicine,
University of Duesseldorf, Duesseldorf, Germany
Regulatory T cells are crucial components of the immune system and play an essential role in the
control of self tolerance and processes of adaptive immunity. We previously described that human
IL-10-treated dendritic cells (DC) induce anergic CD4+ T cells with antigen-specific regulatory activ-
ity. Cell cycle analysis in these anergic T cells revealed high levels of cdk inhibitor p27Kip1 in con-
trast to activated control T cells, which was responsible for cell cycle arrest in G1. In this study, we
further studied possible interactions of cell cycle regulation and signal transduction by MAP kinases
in anergic T cells as compared to optimally stimulated T cells, cocultured with mature DC. Kinase-
assays after immunoprecipitation showed a reduced activity of the MAP kinases JNK1/2 and ERK1/2
in anergic T cells compared to control T cells. Notably, we observed an enhanced and sustained activ-
ity of MAP kinase p38 during primary culture as well as after restimulation. The kinase MAPKAP2/3,
the downstream substrate of p38, also showed significantly increased activity, indicating an impor-
tant role of MAP kinase p38-signaling in anergic regulatory T cells. Blocking of p38 with the spe-
cific inhibitor SD203580 completely impaired the induction of anergy in these T cells, as demon-
strated by proliferation assays, IL-2 production and cell cycle analysis. Furthermore, western blots
demonstrated a downregulation of the G1 phase specific cdk inhibitor p27
Kip1 after inhibition of MAP
kinase p38, leading to cell cycle progression in regulatory T cells. Strikingly, after addition of p38-
inhibitor SD203580 these T cells lost their antigen-specific suppressor function, demonstrating a
critical role of p38 for the suppressor function of anergic T cells. In conclusion, our data indicate
that activation of MAP kinase p38 is required for induction of the regulatory activity of anergic T
cells mediated by cdk inhibitor p27Kip1-controlled cell cycle arrest. 
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Diesel exhaust particles and formaldehyde deviate human immune system to Th2-dominant
pattern by affecting both T cells and dendritic cells
T Ohatani, M Mizuashi, S Nakagawa and S Aiba Department of Dermatology, Tohoku University
Graduate School of Medicine, Sendai, Japan
There is growing evidence that environmental pollutants such as diesel exhaust particles (DEP) and
formaldehyde can impact the immunologic processes, which lead to the development of allergic
diseases whose hallmark is increased IgE production and promoted Th2 differentiation. Animal and
human models have also indicated the effects of DEP in enhancing IgE production and promoting
Th2 differentiation, which enhances allergic inflammation. In addition, the children exposed to
formaldehyde at home or school have been reported to increase their risk of asthma. In this study,
we examined the effects of DEP and formaldehyde on the cytokine production by MoDCs stimu-
lated with CD40 ligand and IFN-g and on that by T-cells stimulated with anti-CD3/CD28 antibody.
The cytokines we examined were TNF-a, IL-1b, IL-10, IL-12p35, and IL-12p40 produced by MoDCs
or IFN-g, IL-4, IL-5, IL-8, and IL-10 produced by T-cells, which were evaluated by ELISA of the
supernatants and by real-time PCR analysis for the expression of the mRNA. In MoDCs, DEP and
formaldehyde significantly increased TNF-a and suppressed IL-12p40 in both the protein and mRNA
level. On the other hand, in T cells, they suppressed both the production and mRNA expression of
IFN-g and IL-10, while they did not affect IL-4, IL-5, or IL-8 production. These results show that
Th1 cytokines such as IL-12 and IFN-g were significantly suppressed by DEP and formaldehyde
although Th2 cytokines such as IL-4 and IL-5 were not suppressed by them. These data strongly sup-
port the crucial role of DEP and formaldehyde on deviation of the immune system to Th2-dominant
pattern, which enhances allergic inflammation. 
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Haptens’ potential to activate dendritic cells correlates with their capacity to induce oxidative
stress
M Mizuashi, T Ohtani, S Nakagawa and S Aiba Department of Dermatology, Tohoku University
Graduate School of Medicine, Sendai, Japan
Using human monocyte-derived DCs (MoDCs), we demonstrated that purified MoDCs respond to
haptens such as NiCl2 and DNCB, but not to irritants, by significantly augmenting their expression
of CD54, CD86, and HLA-DR and by increasing their production of proinflammatory cytokines. In
addition, recently we have also reported that, to induce these phenotypic and functional changes,
2,4-dinitrochlorobenzene (DNCB) preferentially stimulated p38 mitogen-activated protein kinase
(MAPK), while NiCl2 activated ERK and NF-kB in addition to p38 MAPK. Although these stud-
ies suggested the crucial role of p38 MAPK in the activation of MoDCs by haptens, the upper stream-
ing signals of p38 MAPK remain undetermined. In this study, we hypothesized that haptens induce
oxidative stress in DCs, which subsequently stimulates p38 MAPK. So, we measured the ratio of
the oxidized (GSSG) vs reduced (GSH) form of cellular glutathione. MoDCs were exposed for 2h
to sublethal concentrations of haptens such as NiCl2, MnCl2, DNCB, diphenylcyclopropenone,
thimerosal, and formaldehyde, and primary irritants such as sodium dodecyl sulfate, and benzalko-
nium chloride, with or without an antioxidant, N-acetyl-L-cysteine (NAC). GSH and GSSG were
measured using colorimetric assays. Without NAC, all haptens lowered GSH-GSSG ratio, while
primary irritants did not. In the presence of NAC, all haptens recovered GSH-GSSG ratio. Further-
more, NAC suppressed the activation of MoDCs by haptens. Using human monocyte cell-line,
THP-1, instead of MoDCs, we could obtain the similar results. These studies revealed the crucial
role of oxidative stress in the activation of DCs by haptens. Furthermore, it suggested that the decreased
GSH-GSSG ratio in MoDCs or even in THP-1 stimulated by simple chemicals can predict the sen-
sitizing potential of these chemicals 
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TNF-a/TNF-receptor-2 signaling is required for low zone tolerance to contact allergens
W Seidel-Guyenot,1 M Maurer,1 R Alt,1 M Metz,1 B Echternacher,2 J Knop1 and K Steinbrink1 1
Department of Dermatology, University of Mainz, Mainz, Germany and 2 Institute of Pathology,
University of Regensburg, Regensburg, Germany
Low zone tolerance (LZT), induced by epicutaneous application of low doses of contact allergens,
depends on the induction of regulatory CD8+ T cells (Tprevs) that inhibit the development of con-
tact hypersensitivity (CHS). Here, we used TNF-a-/- and TNF-a receptor-deficient mice to better
characterize the role of TNF-a in the induction of LZT. Tolerizing doses of the contact allergen TNCB
(0.45 or 4.5 µg per site, 5 times per mouse) were applied epicutaneously. Tolerance induction was
assessed by measuring the inhibition of a contact hypersensitivity reaction (ear swelling). Impor-
tantly, we found that low zone tolerance is TNF-a-dependent as TNF-a-/- and receptor-double-KO-
mice failed to develop LZT. Interestingly, TNFR-1-/- (p55-/-) mice showed normal LZT responses,
whereas TNFR-2-/- (p75-/-) mice did not develop LZT. These findings indicate that TNF-a and its
receptor p75 play an important role in LZT development. In addition, prevention of hapten-specific
clonal expansion of lymph node cells and high levels of IL-4 and IL-10 as typical Tc2 cytokine pat-
tern of LZT did not occur in TNF-a-/-, receptor-double-KO- and p75-/- mice after tolerization as
compared to WT and p55-/- animals. The neutralization of TNF-a in WT by application of mAb
inhibited the tolerance reaction revealing a direct function of TNF-a during LZT development. Adop-
tive transfer experiments of T cells from tolerized TNF-a-/- or WT mice injected vice versa into WT
or TNF-a-/- animals demonstrated that TNF-a is not required for the generation of regulatory CD8+
T cells of LZT (induction phase). Thus, our data demonstrate a critical role of TNF-a via TNFR-2
(p75) in the effector phase of LZT, where it inhibits the generation of CHS-promoting Tc1 cells and
consequently the development of CHS. 
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IgA antibodies to epidermal transglutaminase are elevated in patients with dermatitis her-
petiformis compared to normals and patients with celiac disease
N Hanson,2 L Schmidt,1,2 T Taylor,2 C Hull,1,2 L Meyer1,2 and JJ Zone1,2 1 Medicine, Veterans
Administration Medical Center, Salt Lake City, UT and 2 Dermatology, Univ of Utah, Salt Lake
City, UT
Dermatitis herpetiformis (DH) is a cutaneous manifestation of celiac disease (CD) and is charac-
terized by deposition of granular IgA in dermal papillae. A circulating antibody responsible for this
deposition of IgA in DH skin has not been identified.  Recently, IgA antibodies to epidermal trans-
glutaminase (eTG) have been found in the serum of patients with DH. These antibodies were reported
to be quantitatively the same as those seen in the serum of CD patients but qualitatively of higher
affinity. eTG antigen was also found to co-localize with IgA in DH skin (Sardy, JEM, 2002). We
evaluated IgA eTG and tissue transglutaminase antibody (tTG) levels in the serum of normals (n=57)
as well as untreated DH (n=34), CD(n=34), and psoriasis (n=37) patients with ELISA techniques
which utilize recombinant eTG and tTG in commercial kits. We confirmed our eTG results by indi-
rect immunoflourescence using a separately cloned eukaryotic eTG transfected into HEK cells. DH,
but not CD, sera had quantitatively higher levels of eTG antibodies compared to normals and pso-
riatics (p<.01). tTG antibody levels were elevated in both CD and DH sera compared to normals and
psoriatics (p<.01).  The independent indirect immunofluorescence assay confirmed the ELISA results.
It demonstrated a cellular binding pattern in eTG-HEK cells that was seen using patient serum with
high levels of eTG antibodies on ELISA, but not those with low levels of eTG antibodies on ELISA.
This quantitative serologic difference in IgA eTG, but not tTG, antibodies differentiates patients with
DH from patients with CD alone. IgA antibodies to eTG may be responsible for the cutaneous dep-
osition of IgA in DH skin. 
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Characterization of recombinant soluble mouse Langerin
Y Tada, E Riedl and MC Udey Dermatology Branch, Center for Cancer Research, NCI, NIH,
Bethesda, MD
A range of C-type lectins have recently been shown to be expressed by antigen presenting cells
(APC), including dendritic cells. Several of these C-type lectins recognize and bind pathogens
while others may regulate cell signaling, mediate intercellular interactions or facilitate DC migra-
tion. In any case, C-type lectins likely play important roles in innate and adaptive immunity. Lan-
gerin is a novel type-II Ca2+-dependent C-type lectin with mannose-binding specificity that is thought
to be expressed exclusively by Langerhans cells and related cells. Langerin is constitutively associ-
ated with Birbeck granules (BG) and induces BG formation when overexpressed in fibroblasts. The
Langerin extracellular region is comprised of neck and mannan-binding carbohydrate recognition
domains. We isolated Langerin cDNA from mouse fetal skin-derived DC (FSDDC) by subtractive
cloning and rapid amplification of cDNA ends. When Langerin cDNA was transfected into fibrob-
lasts, BG formation was induced. In order to further characterize Langerin, we expressed soluble
epitope-tagged (Ni++- and S protein-binding) recombinant fragments of mouse Langerin with or
without the neck domain in bacteria, and purified them using Ni++-column and mannan-agarose
affinity chromatography. The neck domain of Langerin was required for efficient interaction of recom-
binant Langerin with mannan. Recombinant Langerin bound to mannan-agarose beads and man-
nose-rich yeast invertase in a calcium-dependent fashion. Langerin-invertase binding could be blocked
with mannan. Recombinant Langerin did not bind to bulk peripheral lymph node cells, splenocytes,
or thymocytes. However, Langerin did bind to mouse lung epithelial tumor (TC-1) cells, and bind-
ing was inhibited by EDTA. A soluble bacterial recombinant fragment of an unrelated mannan-
binding lectin (T14) did not interact withTC-1 cells. Soluble recombinant Langerin may facilitate
identification of additional physiologic Langerin ligands and further our understanding of Langerin
function.
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Secretion and processing of cathelicidin antimicrobials as a paradigm for innate immune defense
M Murakami,2 RA Dorschner,1 H Iizuka2 and RL Gallo1 1 Medicine/Dermatology, UCSD, San
Diego, CA and 2 Dermatology, Asahikawa Medical College, Asahikawa, Japan
Antimicrobial peptides (AMPs) are an essential first line of immune defense against infection.
Recently, the AMP cathelicidin was found in eccrine glands. To be functional, AMPs must be enzy-
matically processed from an inactive precursor protein to the active peptide. We sought to discover
if novel forms of cathelicidin are processed in sweat and determine if other exocrine systems also
produce cathelicidin. In human neutrophils, cathelicidin hCAP18 is processed to a 37 aa peptide
known as LL-37. To identify novel skin AMPs, sweat was collected from healthy volunteers, sepa-
rated by HPLC, and fractions tested by radial diffusion assay against S. aureus (mprF). Candidate
fractions were analyzed by Western blot, MALDI TOF mass spec, and aa sequencing. Mammary
and salivary glands were evaluated by in situ hybridization, RT-PCR, immunostaining and Western
blot. Three novel processed forms of LL-37 were found by this approach, and cathelicidin was
abundantly detected in both mammary and salivary systems. Synthetic versions of the novel sweat
peptides were then tested for antimicrobial activity against S.aureus, E.coli, and Group A Strepto-
coccus.  Cytotoxicity and host immune stimulatory activity were also tested in human blood and ker-
atinocytes. Surprisingly, the forms of cathelicidin in sweat differ from LL-37 in size, antimicrobial
activity and immune stimulatory activity. Two sweat peptides derived from LL-37, RK-31 and KS-
30, increase antimicrobial activity against multiple bacteria (eg. MIC against S. aureus is 8-16 uM
compared to >64uM for LL-37). Conversely, sweat peptides decrease their ability to stimulate IL-8
release from normal human keratinocytes. These results demonstrate that cathelicidin production is
a general exocrine phenomenon and that post-secretory processing has a critical role by modifying
the balance of antimicrobial and inflammatory activity. Our findings suggest that peptide process-
ing is an essential element to innate immune defense. 
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Imiquimod induce increased IL-6 secretion of normal human mixed epidermal cells
X Miao, D Luo, Y Xu and W Min Dermatology, the First Affiliated Hospital of Nanjing Medical
University, Nanjing, Jiangsu Province, China
In order to better understand the mechanism of immune response regulation by imiquimod, we have
investigated the effects of imiquimod on IL-6 secretion from normal human mixed epidermal cells.
Single cell suspensions of normal human epidermal cells were prepared utilizing standard techniques,
then cells were cultured with culture medium alone or with medium containing 5 ug/ml of imiquimod
for 1, 2, 4, 8 and 12 hours, and then cell-free culture supernatants were harvested to assay. IL-6 con-
tents of the supernatants were studied using commercially available ELISA kits. We found that a
low level of IL-6 secreted from mixed epidermal cells treated with single culture medium, but when
incubated with imiquimod, mixed epidermal cells secreted large amounts of IL-6, and at any time
intervals IL-6 secreted from imiquimod treated groups was higher than that from control cells (p<0.01).
IL-6 secretion reached its’ peak at 8 hours, 245.1 pg/ml (imiquimod treated group) compared with
untreated group (97.2 pg/ml).The results demonstrated that imiquimod can enhance the secretion of
IL-6 from normal human mixed epidermal cells. Our data partially explain immune response regu-
latory mechanism of imiquimod. 
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In vivo transfection of a cis element “decoy” against STAT6 binding site ameliorates IgE medi-
ated third phase reaction in an TNP-IgE transgenic mice as an atopic dermatitis mouse model
H Yokozeki,1 Y Kanei,1 K Sumi,1 M Wu,1 K Nishioka,1 H Karasuyama2 and I Katayama3 1
Dermatology, Tokyo Medical and Dental University, Tokyo, Japan, 2 Immune Regulation, Tokyo
Medical and Dental University, Tokyo, Japan and 3 Dermatology, Osaka University, Suita, Japan
We have recently established transgenic mice that carry the genes cording for heavy and light chain
of TNP-IgE and demonstrated that not only immediate and late phase reaction but also third phase
reaction infiltrated tremendous numbers of eosinophils, were elicited at 3-7 days after epicutaneous
challenge in TNP-IgE-transgenic mice as a AD mouse model.  We therefore hypothesized that syn-
thetic double-stranded DNA with a high affinity for Signal Transducers and Activators of Tran-
scription 6 (STAT6) could be introduced in vivo as a decoy cis elements to bind the transcriptional
factor and to block the gene activation of contributing the onset and progression of AD, thus pro-
viding effective therapy for AD.  Treatment by the transfection of STAT6 decoy oligodeoxynucleotides
(ODN), but not scramble decoy ODN in the TNP-IgE transgenic mice,had a significantly inhibitory
effect on not only STAT6 binding to nuclei but also on the third phase response(62% inhibition).  A
histological analysis revealed that both edema and the infiltration of eosinophils and degranulated
mast cells significantly decreased in STAT6 decoy ODN transfected mice.  To examine the mecha-
nism of the in vivo effect of STAT6 decoy ODN, we employed an in vitro mast cells culture system.
After IgE receptor engagement, mast cells transfected by STAT6 decoy ODN exhibited normal his-
tamine release, but their cytokine release (TNF-a, IL-6) markedly decreased.  We herein report the
first successful in vivo transfer of STAT6 decoy ODN to reduce the third phase reaction in TNP-IgE
transgenic mice, thereby providing a new therapeutic strategy for atopic dermatitis. 
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Induction of β-defensin 3 through toll-like receptors 2 in keratinocyte
Y Sumikawa,1 H Asada,3 K Hoshino,2 S Akira2 and S Itami1 1 Department of Dermatology,
Graduate School of Medicine Osaka University, Osaka, Japan, 2 Departmet of Host Defense,
Research Institution for microbial disease Osaka University, Osaka, Japan and 3 Department of
Dermatology, Nara Medical University, Kashihara, Japan
Toll-like receptors (TLRs) play important roles in inate immunity and are expressed not only on the
surface of monocytes but also on keratinocytes. It is well established that peptidoglycan(PG) and
LPS are the ligands for TLR2 and TLR4 and that MyD88 is an adaptor molecule of TLRs. β-Defensins
(BD) working in protection from microbial infection are products of varieties of epithelial cells
including keratinocytes (KC). To examine whether the signals through TLRs - MyD88 regulate
expression of BD, we isolated KC from newborn wild type (WT:C57/B6), TLR2 deficient (TLR2KO),
TLR4deficient (TLR4KO) and MyD88 deficient (MyD88KO) mice. KC cultures were stimulated
with LPS (100ug/ml) or PG (500ug/ml), and TNF-α in the supernatant was measured by ELISA.
TNF-α increased in the WT KC cultures stimulated with LPS or PG, respectively. In contrast, nei-
ther TLR4KO KC stimulated with LPS nor TLR2KO stimulated by PG produced TNF-α. TNF-α
was not detected in MyD88KO KC cultures stimulated by these ligands. These results indicate that
KC recognize LPS through TLR4 and PG through TLR2 and that the production of TNF-α was medi-
ated through TLRs-MyD88 pathway. Next, we studied the expression of mouse BD 3(mBD3) mRNA
in KC after stimulation with LPS or PG by real-time RT-PCR. In WT KC, PG stimulation showed
significant increase of mBD3 mRNA at 6hr. In contrast, LPS stimulation showed no increase. KC
from TLR2KO and MyD88KO mice showed no increase of mBD3 after stimulation with PG. These
results strongly suggest that PG induces the expression of mBD3 through TLR2-MyD88 pathway
in KC. Finally, we studied biological roles of TLRs-MyD88 pathway in KC in vivo. S. aureus were
inoculated on the back skin of WT and MyD88KO mice. The inoculated sites of WT mice showed
marked inflammation, while MyD88KO mice showed slight inflammation. These results suggest
that TLRs on KC have important roles for recognition of S.aureus in vivo. 
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Age-dependent breakdown of peripheral tolerance to the epidermal autoantigen
H Azukizawa, H Kosaka, S Sano and S Itami Department of Dermatology,Course of Molecular
Medicine, Osaka University, Graduate School of Medicine, Suita, Osaka, Japan
We established double transgenic (dTg) mice which carry both the transgene of ovalbumin (OVA)
expressed selectively in the keratinocytes under the keratin 5 (K5) promoter (K5-mOVA) and the
Kb-restricted OVA-specific T cell receptor transgene (OT-I). Thymus-derived CD4+CD25+ regula-
tory T cells (Treg) induced peripheral tolerance of OT-I cells to the epidermal autoantigen in euthymic
dTg mice, while athymic dTg mice developed toxic epidermal necrolysis (TEN) as a consequence
of lacking Treg. Unexpectedly, peripheral tolerance to the epidermal autoantigen was not a particu-
lar event in the skin lymph nodes (LNs). Transferring mesenteric LN cells devoid of OT-I cells from
euthymic dTg mice prevented the skin disease in athymic dTg mice, and sorted OT-I cells from
mesenteric LNs of euthymic dTg mice could induce the skin disease in athymic K5-mOVA mice.
Here we demonstrate that peripheral tolerance to the epidermal autoantigen break down in age-
dependent manner. OT-I cells in euthymic dTg mice was not activated until 6 months of age, how-
ever, naive OT-I cells and activated (CD44high) OT-I cells coexisted in the skin LNs at 8 months of
age. Activated OT-I cells were not found in the mesenteric LNs and emerged selectively in the skin
LNs, although the ratio of OT-I to Treg showed no significant change between skin LNs and mesen-
teric LNs. Euthymic dTg mice developed white hair and mild hair loss over 6 months of age. His-
tological examination of the skin specimen showed apoptosis of some epidermal keratinocytes and
the tissue damage deteriorated in age-dependent manner. These results suggest that peripheral tol-
erance regulating CD8+ T cells specific for epidermal autoantigens may break down in age-depend-
ent manner. 
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Effect of CpG-oligodeoxynucleotides in primary human keratinocytes and in the skin of NC/Nga
mice
H Kwon,2 H Jin,1 K Lee,2 Y Kim,1 W Sohn,2 D Kim2 and T Kim1 1 Dermatology, The Catholic
University of KOREA, Seoul, South Korea and 2 Biochemistry, Yonsei University, Seoul, South
Korea
Immunostimulatory activities of synthetic oligonucleotides containing CpG motifs (CpG-ODN) have
been shown to be useful immunotherapetics due to the stimulating effect of innate immune response.
Toll-like receptor (TLR 9) has been known to play an important role in CpG-ODN induced cellular
responses. Although TLR 9 expression has been demonstrated in cultured primary human ker-
atinocytes, the exact cellular mechanisms are still unknown. In this study, we examined the function
of CpG-oligodeoxynucleotides (CpG-ODN) in human keratinocytes and NC/Nga mouse. CpG-ODNs
stimulated NF-ΚB nuclear localization of human keratinocytes in a CpG-ODN dependent manner
by indirect immunofluorescence assay using confocal microscopy. FITC-labeled CpG-ODN were
applied to the back of NC/Nga mice and topical application of FITC-labeled CpG-ODN resulted in
the accumulation of fluorescence deep in the skin, including in keratinocytes and more in dermal
infiltrated cells and cells comprising hair follicles at day 1. The fluorescence was continued up to at
least 5 days after the topical application, and disappeared with in 1 week after the topical applica-
tion. Furthermore, the fluorescence was discovered in the draining lymph nodes. These results sug-
gested the potential application of CpG-ODN as a modulator for inflammatory disorders of the skin. 
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Plasmacytoid dendritic cells induce hapten-specific Tcell proliferation
C Bangert, S Graffi, S Altrichter, G Stingl and T Kopp Department of Dermatology, Division of
Immunology, Allergy & Infectious Diseases, University Hospital of Vienna, Vienna, Vienna, Austria
Plasmacytoid dendritic cells (pDC), also referred to as type I interferon-producing cells, are known
to play a critical role in the innate and adaptive immune response against viruses. We have recently
detected these cells in the epidermal and dermal infiltrate of allergic contact dermatitis elicited by
epicutaneous patch tests (EPT). In the dermis they represented a substantial proportion of the entire
DC infiltrate and were in close apposition to T-cells, suggesting interactions between pDC and infil-
trating T-cells. In this study, we investigated the capacity of pDC to stimulate hapten specific T-
cells. As a positive control, pDC were compared to CD1c+ myeloid dendritic cells (mDC), which
represent the major dendritic cell population in EPT lesions. Nickel-specific CD4+ T-cell lines from
nickel-allergic individuals were co-cultured with autologous blood-derived pDC and mDC for 72h.
Before co-culture, both pDC and mDC were exposed to nickel and either left immature or matured
by using TNF-α and IL-3 and TNF-α and GM-CSF, respectively. Nickel-pulsed mature, but not
immature mDC acted as strong stimulators of hapten-specific T-cells, thus confirming previous obser-
vations. Importantly, nickel-pulsed mature pDC induced a nickel-specific T-cell response compara-
ble in magnitude to that elicited by mDC. As expected, neither unpulsed mature nor immature pDC
and mDC were able to stimulate hapten-specific T-cells. In conclusion, following exposure to nickel,
mature pDC acquire the capacity of inducing a hapten-specific T-cell proliferation, indicating that
pDC may act as prominent amplifiers of the adaptive immune response in allergic contact dermati-
tis.
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IFN-γ up-regulates the mouse complement Clr expression in mouse keratinocytes
S Byun and T Kim Dermatology, The Catholic University of KOREA, Seoul, South Korea
The complement system provides critical and multifaceted defense system against inflammation and
infection. We have previously reported cloning of the mouse complement C1r mRNA. The present
study analyzes the expression of the complement C1r in mouse keratinocytes by IFN-γ. Northern
blot analysis showed that IFN-γ induced the increase of complement C1r mRNA. To better clarify
the molecular basis of IFN-γ action, the 2200 bp 5’-flanking region of the complement Clr gene was
isolated and characterized. The transcription start point of the complement Clr was identified by a
rapid amplification of cDNA ends assay. This promoter region was ligated to a luciferase reporter
vector to elucidate the molecular basis of the complement Clr up-regulation by IFN-γ. The tran-
scriptional activity of the 2200 bp 5’-flanking region was analyzed by deletion constructs using a
reporter vector transiently transfected into mouse keratinocytes. The results indicated that a -80 bp
to +120 bp fragment including the transcription start point was sufficient for IFN-γ -induced pro-
moter activity and the core promoter activity was not significantly changed by inclusion of upstream
sequences as far as -2100 bp. Taken together, our results demonstrated that the complement C1r
expression in mouse keratinocytes was regulated by the 200 bp proximal promoter region contain-
ing several transcriptional elements responsible for this observation. 
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Lfa-1 function on dendritic cells is regulated by cytip
G Varga,1 S Balkow,1 K Wethmar,2 D Vestweber,2 K Scharffetter-Kochanek,3 W Kolanus4 and
S Grabbe1 1 Dermatology, Cell Biology, Muenster, Germany, 2 ZMBE Muenster, Muenster,
Germany, 3 Dermatology, Dermatology, Ulm, Germany and 4 University of Bonn, Developmental
Biology, Bonn, Germany
The beta2 integrin LFA-1 is important for transendothelial migration of leukocytes as well as for T
cell activation during antigen presentation. To determine the relevance of LFA-1 for antigen pres-
entation of DC, we investigated bone marrow-derived DC (bmDC) from CD18-deficient (-/-) mice,
which lack all functional beta2 integrins, in vitro. Surprisingly, antigen presentation of bmDC from
CD18-/- mice is not impaired as determined by DC-induced T cell activation. T cell proliferation as
well as cytokine production of T cells and DC are similar, when CD18 wt or CD18 (-/-) DC were
used. To determine why LFA-1 does not seem to be active in this process we studied transendothe-
lial migration and performed binding studies to ICAM-1. Migration of DC was dependent on ICAM,
but not on LFA-1 expression. Also LFA-1 expressing mature DC did not bind to ICAM-1, and bind-
ing was not inducible by activation. The binding aviditiy of LFA-1 is regulated by the cytosolic pro-
teins Cytohesin-1 and Cytip. In order to be active, Cytohesin-1 aggregates LFA-1 at the plasma mem-
brane, resulting in enhanced LFA- avidity, whereas Cytip complexes Cytohesin-1 and removes the
complex from the inner membrane, resulting in LFA-1 inactivation. In activated T cells, Cytohesin-
1 is strongly colocalized with LFA-1 in T cells as determined by confocal microscopy, Cytip expres-
sion is not detectable and LFA-1 is active in these cells. In contrast, Cytip expression in DC increases
during maturation and colocalized Cytip-Cytohesin-1 complexes accumulate in the cytosol, thereby
rendering LFA-1 inactive. Thus, LFA-1 function in DC is regulated by Cytip expression. 
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Expression of cytokines and chemokines by human monocyte-derived dendritic cells as valu-
able tool for discriminating potential allergens from non-allergenic compounds
M Aries, C Vaissiere and M Charveron Dermo-Cosmetic, Pierre Fabre Research Institute,
Toulouse, France
In industrial states, the proportion of persons developing contact hypersensitivity growths constantly.
Dendritic cells (DCs), the most potent antigen-presenting cells of the immune system, play an impor-
tant role in the induction phase of contact allergy and several cytokines and chemokines are impli-
cated in this pathology. The aim of the present study was to evaluate the interest of monocyte-derived
DCs (Mo-DCs) and their mediator expression as a predictive in vitro assay system for contact sen-
sitization by molecules. We performed the evaluation of cytokines / chemokines expression in Mo-
DCs exposed to known reference sensitizers vs irritant. Our results have shown that sensitizers can
induce TARC and MDC chemokine expression. These mediators recruit Th2 lymphocytes, to the
detriment of Th1, into the inflammation site. We have also shown that IL-12 (Th1 orientation), IFNg
(Th1 cytokine) and IP-10 (Th1 recruitment) are inhibited suggesting an orientation towards a Th2
response. Ours present results allow to conclude that Mo-DCs represent a cell system well suited
for screening the sensitizing potential of molecules. 
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Molecular insights into infliximab’s impact on gene expression profiles in psoriasis
XR Song,1 L Yieh,2 A Rosenberg,1 A Carmen,2 X Liu,2 A Bittner,2 DE Griswold,1 CL Wagner,1
DG Baker1 and AB Gottlieb3 1 Centocor, Inc, Malvern, PA, 2 Johnson & Johnson Pharmaceutical
Research and Development, San Diego, CA and 3 Clinical Research Center, UMDNJ-Robert Wood
Johnson Medical School, New Brunswick, NJ
Psoriasis is a multifactorial, chronic inflammatory skin disease, with a prevalence of 2.6% in the US
population. Microarray technology has allowed global gene expression studies to reveal disease-
associated gene maps in psoriasis and provided insight into the disease pathogenesis at molecular
level.  A recent placebo-controlled clinical study using a chimeric monoclonal anti-TNFα antibody,
infliximab, showed marked clinical efficacy in treating moderate to severe plaque psoriasis, which
strongly supports the hypothesis that TNFα plays a pivotal role in the pathogenesis of psoriasis. The
purpose of this study is to explore the role that TNFα plays in disease pathology in psoriasis at the
molecular level. Skin biopsy samples obtained from the aforementioned clinical study with inflix-
imab were analyzed for gene expression patterns using cDNA microarray gene chips. Gene expres-
sion profiles were compared between lesional or lesional and non-lesional sites prior to as well as
after infliximab treatment. Differential gene expression data support the notion that aberrant prolif-
eration of keratinocytes and an active inflammatory response are crucial pathways contributing to
the maintenance of psoriatic plaques. Infliximab treatment resulted in a change of gene expression
patterns favoring the reduction of inflammation as reflected by up-regulation of anti-inflammatory
cytokines, down-regulation of pro-inflammatory mediators, repair promotion, and homeostasis restora-
tion. Our study using microarray technology provides insights into the impact of infliximab on gene
expression profiles in psoriasis. In addition, a variety of new therapeutic targets could potentially
emerge from studies using this technology. 
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Differential expression of B7-DC by Langerhans cells and keratinocytes—a duel role for B7-
DC in skin immunity
B Wang,1 T Shin,2 H Watanabe,1 I Freed,1 B Howell,1 A Mamelak,1 C Esche,1 D Kouba,1 A de
Bennedetto,1 D Cummins,1 D Pardoll2 and D Sauder1 1 Dermatology, Johns Hopkins University,
Baltimore, MD and 2 Oncology, Johns Hopkins University, Baltimore, MD
B7 family costimulatory molecules play an important role in the regulation of T cell activation. B7-
DC/PD-L2 is a novel member of the B7 family. It shares an inhibitory receptor, PD-1, with B7-
H1/PD-L1. Studies have demonstrated that B7-DC can bind a stimulatory non-PD-1 receptor as well.
In this study, we sought to examine whether B7-DC is involved in skin immunity. First, we deter-
mined if murine Langerhans cells (LC) and keratinocytes (KC) express B7-DC, comparing with
B7-H1. Immunolabeling of murine epidermal sheets showed that resting LC and KC did not express
B7-H1 or B7-DC. However, they expressed significant levels of these molecules after activation. Ex
vivo and in vivo migratory mature LC expressed B7-DC but not B7-H1, whereas IFN-γ-stimulated
KCs expressed both B7-H1 and B7-DC. Second, we examined the in vivo functions of LC B7-DC
using B7-DC-deficient mice. B7-DC-/- mice demonstrated significantly decreased contact hyper-
sensitivity (CHS) response, supporting that B7-DC plays a stimulatory role in the initiation of pri-
mary immune response via a non-PD-1 pathway. Third, we examined the role of KC-derived B7-
DC in regulating effector T cells through antibody blocking at challenge.  Blockade of B7-DC slightly
enhanced CHS, whereas B7-H1 blocking markedly enhanced CHS responses. However, joint block-
ade of B7-DC and B7-H1 could lead to a greater enhancement of CHS to an extent similar to PD-1
blocking, suggesting that B7-DC, synergetic with B7-H1, down-regulates effector T cell activities
via the PD-1 receptor. Collectively, our studies demonstrate the LC and KC differentially express
B7-DC after activation, which plays a duel role in T cell-mediated immune responses. LC B7-DC
co-stimulates naive T cells via the non-PD-1 pathway, whereas KC B7-DC down-regulates effector
T cell activities via the PD-1 pathway. 
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Identification of CD3+CD4−CD8−T cells as potential regulatory cells in tolerant double trans-
genic mice
F Miyagawa, A Sato and SI Katz Dermatology, NCI/NIH, Bethesda, MD
We have reported that both single [K14-mOVA] transgenic (Tg) and double Tg [K14-mOVA x OT-
I that have a T cell receptor (TCR) that recognizes OVA peptide in association with MHC class I]
mice express membrane-associated ovalbumin (mOVA) under the control of a K14 promoter. When
injected with CD8+ TCR Tg T (Vα2Vβ5+) cells from OT-I mice, single Tg mice develop graft vs.
host disease (GvHD), whereas double Tg mice do not develop disease. This suggests that, in dou-
ble Tg mice, regulatory mechanisms prevent infused OT-I cells from inducing GvHD. Since
CD3+CD4-CD8-(double negative-DN) T cells have been reported in other systems to have regula-
tory functions (Nature Med 2000, p782; PNAS 2002, p2181), we determined whether CD3+DN T
cells exist in these double Tg mice. In lymph nodes (LN) of double Tg mice >80% of cells were
CD4-CD8-, whereas in single Tg mice only 25% of the cells were CD4-CD8-. 20% of these CD4-
CD8- cells were CD3 positive in double Tg mice, whereas only 2.7% of CD4-CD8- cells were CD3
positive in single T g mice. To further characterize this cell population, we purified CD3+DN T
cells from the LNs and spleen of double Tg mice. 95-99% of purified CD3+DN T cells expressed
the same TCR as OT-I cells. These CD3+DN T cells proliferated in response to anti-CD3 mAb but
they did not proliferate in response to antigen (OVA peptide). Strong proliferation (100X baseline)
was observed in response to antigen when IL-2 was added to the cultures. No cytokine was detected
in cultures that were stimulated by antigen in the absence of IL-2, however, when IL-2 was added,
IFN-γ (116 pg/ml) was detected. Ten days after stimulation with anti-CD3 mAb, the cells retained
the CD3+DN phenotype with partial down-regulation of Vα2Vβ5 TCR. The number of CD3+DN
T cells expanded over 20-fold during 10 days of culture and the expanded population expressed
CD62LlowCD25+CD44+CD69+ (activated) phenotypes whereas the initial phenotype was
CD62LhighCD25-CD44-CD69- (naive). The isolation and expansion of these CD3+DN T cells
should facilitate their use as potential regulatory cells in these double Tg mice. 
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Impairment of epicutaneously induced Th2 responses in the absence of MyD88 or Toll-like
receptor (TLR) 2
CA Herrick and K Bottomly Yale School of Medicine, New Haven, CT
We have shown that Th2 responses induced by exposure to inhaled (i.n.) ovalbumin (OVA) are depend-
ent on signaling through Toll-like receptor (TLR) 4, while those induced by epicutaneous (e.c.)
OVA exposure are TLR4 independent. To determine if other innate immune signals are involved in
e.c. Th2 induction, we investigated the role of MyD88, an intracellular adaptor molecule important
for signaling through most TLRs, in these responses. Wildtype (WT) and MyD88 -/- mice were
exposed to e.c. OVA (100 µg) on day 0 and challenged 2 weeks later with i.n. OVA. Compared to
WT, MyD88 -/- mice had decreased OVA-specific IgG1 (p=.01) and total IgE (p=.03) in serum and
decreased airway eosinophils following i.n. OVA challenge (p<.001). To ensure this did not simply
reflect defective recruitment into the lungs, skin draining lymph node (LN) cells were isolated 4 days
after e.c. OVA exposure and restimulated in vitro with OVA for evaluation of cytokine production.
Compared to WT, LN cells from MyD88 -/- mice produced significantly reduced levels of the Th2
cytokines IL-5 (p=.03) and IL-13 (p=.01) and no detectable IFN-γ. These data indicated that a mem-
ber of the IL-1/TLR superfamily, other than TLR4, was required for e.c. Th2 induction. Given the
known expression of TLR2 in skin and the potential role for TLR2 ligands (e.g., cell wall compo-
nents of Gram+ bacteria) in atopic dermatitis, we next exposed WT or TLR2 -/- mice to e.c. OVA.
Compared to WT, LN cells from TLR2 -/- mice also produced significantly less IL-5 (p=.01) and
IL-13 (p=.01) and no detectable IFN-γ. Consistent with our previous findings, IL-5 and IL-13 pro-
duction by LN cells following e.c. OVA exposure of TLR4 defective mice was equivalent to WT.
Taken together, the data indicate that innate immune system signals are important for generation of
Th2 responses in the cutaneous environment, with the TLR2/MyD88 pathway playing a major role.
In contrast to its known role in Th1 generation, dependence on MyD88 for induction of Th2 type
immune responses has not previously been reported. 
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B7H1 co-stimulation mediated by dendritic cells inhibits the function of activated T cells and
suppresses the development of T cell mediated immune responses
H Xu, H Kim, H Guan, G Zu, H Li and CA Elmets Dermatology, University of Alabama at
Birmingham, Birmingham, AL
A line of evidence indicates that PD-1, a molecule expressed by activated T cells, plays an impor-
tant role in the down-regulation of immune responses. However, literature about the effect of its two
defined ligand molecules, B7H1 (PD-L1) and B7-DC (PD-L2), is controversial. The current study
has addressed the role of B7H1 in dendritic cell (DC) mediated regulation of contact hypersensitiv-
ity (CHS). The expression of B7H1 and B7-DC is induced on migratory hapten carrying DC fol-
lowing sensitization while PD-1 is only expressed by primed T cells, both CD4+ and CD8+ sub-
populations. Addition of anti-B7H1 but not anti-B7-DC antibodies increases the cytokine production
by primed T cells in cultures with hapten labeled DC. In vivo administration of anti-B7H1 antibody
increases the magnitude of CHS responses. Accordingly, T cells from anti-B7H1 treated animals
produce a higher level of inflammatory cytokines than those from control animals. The data suggest
that B7H1 may play an inhibitory role in the regulation of CHS responses. To further define the effect
of B7H1 in DC mediated regulation of immune responses, a DC line that expresses a high level of
B7H1 molecules (B7H1/DC) has been generated. Culture with hapten labeled B7H1/DC inhibits
the proliferation of primed T cells. IFN-γ and IL-2 production by both CD4+ and CD8+ T cells is
inhibited. T cell proliferation in the culture with B7H1/DC can be restored by addition of recombi-
nant IL-2, suggesting that the down-regulation of IL-2 may be a major mechanism for B7H1 medi-
ated suppression. Further experiments demonstrate that administration of hapten labeled B7H1/DC
in primed animals inhibits the elicitation of CHS responses in an antigen specific manner. Our stud-
ies have indicated that B7H1 co-stimulation plays inhibitory roles in DC mediated regulation of T
cell activation and immune responses. The ability of B7H1/DC to inhibit the elicitation of immune
responses may be exploited to develop new strategies for treatment of immune response mediated
disorders.
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Differential Langerhans cell gene expression profiling during the induction of contact hyper-
sensitivity 
F Takeuchi, S Takeuchi and SI Katz Dermatology Branch, NCI, Bethesda, MD
To identify genes involved in the induction of contact hypersensitivity (CH), we examined epider-
mal gene expression after hapten (3% TNCB) painting of naive mice using array technology. Total
RNA was prepared from the epidermis (either sheets or suspensions) of BALB/c mice two hours
after either hapten or vehicle painting and differential gene expression was examined using the
GeneChip®. The two hour time was chosen because of the lack of inflammatory cells in the epi-
dermis. To confirm the chip findings results and to identify the cellular sources of hapten-induced
genes, semi-quantitative RT-PCR was performed with or without magnetic bead cell separation. After
hapten painting epidermal cell suspensions were depleted by either CD45 or MHC-class II beads
and gene expression levels of these CD45- depleted (Langerhans cell [LC] and dendritic epidermal
T cell depleted at <0.04% and <0.013%, respectively), MHC-class II-depleted (only LC depleted at
<0.01%) and each positive fraction after depletion were examined together with non-treated, vehi-
cle- and hapten- (non-separated) painted samples. 14 of the 15 genes that were consistently upreg-
ulated (3-fold increases) in two independent chip experiments were also shown to be upregulated by
semi-quantitative RT-PCR. Among these, the combination of RT-PCR and the two cell separation
techniques revealed that only two of these genes (Interleukin 1β [IL-1β] and Macrophage inflam-
matory protein-2 [MIP-2] )were preferentially upregulated by LC. In keeping with prior studies a
time-course study of IL-1β upregulation showed fold increases of 1.1, 52.8, 38.8, 25.1 and 6.3 at 1,
2, 4, 8, and 24 h after hapten painting. The time-course for the upregulation of MIP-2 showed fold
changes of 3.2, 70.0, 77.5, 103.3 and 6.4 at the various times after hapten painting. In mice, MIP-2
has been shown to be abundant in mast cells and has been shown to be a chemoattractant for neu-
trophils in the elicitation phase of CH. Our finding that MIP-2 is derived from LC during the induc-
tion phase suggests its potential importance in the generation of the early events in CH. 
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Engraftment of Langerhans cells, as compared to plasmacytoid- or lymphoid-dendritic cells,
occurs in an interleukin 7 receptor-independent manner 
S Takeuchi and SI Katz Dermatology, NCI, Bethesda, MD
We have demonstrated that Langerhans cells (LC) can be derived from thymocytes suggesting that
LC may have a lymphoid origin. To directly address the question of whether LC are of lymphoid
origin, we used bone marrow (BM) cells from interleukin 7 receptor (IL-7R) knockout mice (-/-) (in
which lymphopoiesis is impaired) as donor cells and used X-irradiated recipient mice. Ears of
recipient were painted with TNCB to enhance LC repopulation. If LC were of lymphoid origin,
engraftment would be negatively affected by the IL-7R defect of donor cells. Percent chimerism of
epidermal LC, various dendritic cells (DC) and other cells was assessed in recipient spleen, lymph
nodes (LN), thymus and BM by flow cytometry 4 weeks after cell transfer. Recipient BM was
>90% chimerized when either BM-/-or BM from wild type (BMwt) cells were used. In contrast, in
the thymus there was <10% chimerism when BM-/- cells were used, as opposed to >99% chimerism
when BMwt was used. With BM-/- transfer, myeloid (monocyte and neutrophil, roughly 83-99%),
but not lymphoid (B and T lymphocyte, 0.4-3.5%) lineage cells were efficiently reconstituted in the
spleen or LN as expected. In skin, there was no significant difference in epidermal LC engraftment
between BM-/- (34.3±9.0%) and BMwt (36.8±20.4%) transfer. Repopulation of splenic CD8a+DC
(lymphoid) and B220+DC (plasmacytoid) was reduced in BM-/- (66.0±2.5, 48.1±7.0%, respectively)
reconstituted, compared to BMwt (83.8±8.0, 92.0±1.7%) reconstituted mice. These reductions were
also observed in peripheral LNs (34.6±7.8, 79.8±8.6% with BM-/- compared to 61.7±2.8, 97.1±0.7%
with BMwt). Thus, lymphoid and plasmacytoid DC reconstitution is enhanced in LN and spleen in
the presence of the IL-7R. CD11b+ (myeloid) DC were chimerized in the spleen by >85% when eiher
BM-/- or BMwt were used. Taken together, the absence of IL-7R seems to affect development of sev-
eral DC types depending on their phenotype and the location, but does not affect LC development.
These findings suggest that LC originate from cells that do not require IL-7R-mediated lymphopoiesis. 
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Inhibition of lymphotoxin signaling blocks the clinical expression of murine graft-versus-host
skin disease by altering the microenvironment within secondary lymphoid organs
RD Sontheimer and Q Wu Dept. of Dermatology, University of Iowa Carver College of Medicine,
Iowa City, IA
Lymphotoxin (LT) signaling is essential for maintaining the organized structural microenvironment
within secondary lymphoid organs (lymph nodes, spleen) that is required for the induction of effec-
tive adaptive immune responses to exogenous antigens. We have previously demonstrated that inhi-
bition of LT signaling via treatment with a LTβ receptor-Fc Ig fusion protein (LTβR-Ig) can markedly
ameliorate the development of murine graft-versus-host skin disease (GVHSD) (JID: 121[#1], July,
2003, Abstract #0910; manuscript in press, J. Immunology). We have more recently questioned
whether the LT signaling-mediated microenvironment of secondary lymphoid organs might play an
important role in alloreactive T cell activation and proliferation observed in GVHSD. In the present
study, we blocked LT signaling in a murine model of minor histocompatibility antigen (mHA) mis-
match GVHSD (LP/JÇ B6) by using LTβR-Ig. The number of dendritic cells (DCs) in the spleen
and lymph nodes of LTβR-Ig treated recipient B6 mice was greatly reduced, especially for the
CD11c(high),class II(high) DC subset. The reduced numbers of DCs in lymphoid tissues of LTβR-
Ig treated-receipt B6 mice exhibited a decreased ability to stimulate allogenic T cells in vivo and in
vitro. Passive transfer of splenocytes and bone marrow cells from LP/JÇB6 chimeras displaying
severe clinical GVH skin lesions into lethally irradiated naive B6 recipient mice resulted in severe
GVH skin lesions on the posterior aspect of the neck within two weeks. Strikingly, the administra-
tion of LTβR-Ig prevented skin lesions resulting from such passively transferred primary alloreac-
tive T cells. These data suggest that DCs play an important role in the LT signaling dependent microen-
vironment of secondary lymphoid organs that is critical for the development of GVHSD. 
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The balance between nuclear factor-kappaB and c-Jun N-terminal protein kinase activity con-
trols dendritic cell life and death
E Kriehuber, W Bauer, D Winter, G Stingl and D Maurer DIAID, Universy of Vienna Medical
School, Vienna, Austria
Survival and death of dendritic cells (DCs) must be delicately regulated for proper function of adap-
tive immunity. While a pathway signaling survival in DCs (i.e. NF-kB) has been identified, signals
that actively mediate DC death remain enigmatic. To elucidate how decisions on the DCs fate are
made at the molecular level we aimed at identifying transcriptional activators that mediate survival
and death in human DCs. Triggering of TNF-R-superfamily members (TNFR-SF) on DCs (CD40,
CD95, TRAIL-R) or cognate DC-T cell contact resulted in parallel NF-kB and c-Jun N-terminal
kinase (JNK)-mediated AP-1 activation and strongly enhanced DC longevity. When NF-kB activa-
tion was experimentally blocked by endogenous inhibitors, JNK-dependent AP-1 activity was dras-
tically augmented and TNFR-SF triggering and cognate T cell encounter resulted in cell death.
Pharmacologic and genetic inhibition of the JNK-AP-1 pathway completely restored receptor and
T cell-mediated death in NF-kB-deficient DCs. We conclude that the JNK-AP-1-dependent death
pathway is subject to feedback inhibition by NF-kB transcriptional activity in DCs. Thus the rela-
tive strength and cross-talk of two transcriptional pathways following surface receptor triggering
decide upon the fate of a DC. 
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Spontaneous in vivo presentation of a model melanoma antigen to CD8 T cells : a variable event
occuring in the absence of CD4 T cell activation
O Preynat-Seauve, E Contassot, P Schuler, L French and B Huard Dermatology, Hospital, Geneva,
Switzerland
(a) Observations such as immune cell infiltration of tumors, recognition of tumor antigens by T
lymphocytes and spontaneous clinical regression in cancer patients suggest the development of a
spontaneous immunological response against tumor cells. This spontaneous immune response remains
poorly characterized. (b) Here we analyzed in vivo the presentation of a model melanoma tumor anti-
gen, ovalbumin (OVA), to CD8+ and CD4+ T lymphocytes. (c) In regional lymph nodes draining
the tumor, OVA was spontaneously presented to CD8+ T lymphocytes in 65% of mice bearing sub-
cutaneous B16 melanoma. In the remaining 35% of mice, OVA was not presented to CD8+ T cells,
despite the fact that the investigated lymph nodes in these mice were tumor-draining (as visualized
by intratumoral injection of evans blue). It is noteworthy that OVA expressed in the cytoplasm of
melanoma cells was more potently presented to CD8+ T cells than a membrane or a secreted form
as assessed by using B16 cells stably transfected with the appropriate constructs. When detected,
spontaneous OVA presentation to T cells was shown to be dependent on host bone marrow-derived
cells, indicating a cross-presentation mechanism. Importantly, the cross-presentation of melanoma-
associated OVA to CD8+ T cells was achieved in the absence of any detectable presentation to CD4+
helper T cells. (d) Taken together, these data indicate that the spontaneous cross-presentation of
melanoma antigens to T lymphocytes is a variable event that favors presentation on MHC class I
molecules. The absence of MHC class II presentation and CD4+ T cell activation highly suggest
that spontaneous recognition of melanoma tumor antigens may lead to CD8+ T cell tolerance. 
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Early interleukin-4 administration promotes TH1-driven, protective anti-cancer immunity
P Luehrs,1 T Biedermann,2,1 W Schmidt,3 G Stingl,1 M Roecken2 and A Schneeberger1 1 DIAID,
Dept. of Dermatology, Univ. of Vienna Medical School, Vienna, Austria, 2 Dept. of Dermatology,
University of Tuebingen Medical School, Tuebingen, Germany and 3 Intercell, Vienna, Austria
Recently, we found that the co-administration of the polycation poly-L-arginine (pR) and β-galac-
tosidase (βgal; thereafter referred to as pR-PV) yields substantially higher numbers of specific,
IFN-γ-secreting, CD8+ T cells than the s.c. application of βgal alone. In addition, there are studies
showing that IL-4 is capable of promoting the activation of TH1 lymphocytes provided that it is
applied early after the induction of the immune response and at high doses. Based on these obser-
vations, we asked whether IL-4 can be used to augment the immunological as well as clinical effi-
cacy of the pR-PV. To test this hypothesis, BALB/c mice were injected s.c. with the pR-PV either
alone or admixed with IL-4. Seven days later, CD8+ T cells producing either IFN-γ or IL-4 in response
to βgal were quantified by ELISPOT analysis. Results obtained showed that co-administration of
IL-4 significantly enhances the number of vaccine-induced, specific CD8+ T lymphocytes that pro-
duce IFN-γ. In addition, we found the IL-4 treatment used to shift the specific immune response
towards a TH1 phenotype. To investigate the effect of IL-4 administration on the clinical efficacy of
the pR-PV, BALB/c mice were injected on days 0 and 14 with pR-PV +/- IL-4 and challenged on
day 24 by the s.c. inoculation bgal-expressing RENCA cells. None of the naive controls (n=6) rejected
the tumor inoculum. S.c. administration of the pR-PV protected 3/6 (50%) animals. The highest
protection rate (5/6; 83%) was obtained by the combined use of the pR-PV and IL-4. Together, these
results demonstrate that IL-4 has the potential to act as a natural adjuvant capable of inducing a pro-
tective TH1-driven anti-cancer immune response. 
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Epinephrine inhibits the migration of epidermal I-A+ cells to draining lymph nodes
K Seiffert,1 W Ding,1 JA Wagner2 and RD Granstein1 1 Dermatology, Weill Medical College of
Cornell University, New York, NY and 2 Neurology, Weill Medical College of Cornell University,
New York, NY
We have previously shown that intradermal injection of epinephrine inhibits the induction of con-
tact hypersensitivity. In accordance with this observation, in vitro exposure of purified LCs to epi-
nephrine (EPI) or norepinephrine (NE) inhibits presentation of a defined antigen to a responsive T
cell clone. Furthermore, in vitro exposure of epidermal cells enriched for LC content to EPI or NE
inhibited the elicitation of delayed-type hypersensitivity by injection of antigen-pulsed LCs into pre-
viously sensitized mice in a β-adrenoceptor mediated manner. In an effort to delineate the mecha-
nisms of action, we found that EPI downregulates LPS-induced tumor necrosis factor (TNF)-α expres-
sion by the LC-like cell line XS106 and purified LCs, as shown by real-time PCR and ELISA. At
the protein level, this effect can be specifically blocked by a β-adrenergic antagonist. TNF-α has
been shown to play an important role in the mobilization of LCs from human epidermis and, thus,
we investigated whether EPI affects migration of LC. EPI was injected intradermally into BALB/c
mice 15 min prior to epicutaneous sensitization with 1% FITC or diluent alone. Twenty-four hours
later draining lymph nodes were harvested and gently disrupted. To enrich for DC, cell suspensions
were layered onto a 14.5% Nycodenz gradient and separated by centrifugation. Cells at the inter-
face were collected, stained with PE-conjugated anti-I-Ad antibodies, and analyzed by flow cytom-
etry. Cells labeled with both FITC and PE were quantified as migrated LC. In mice sensitized with-
out EPI, 5.70% of cells were double-positive for FITC and I-A while 2.58% were FITC+/I-A-. Injection
of EPI led to a marked reduction of FITC+ positive cells (4.64% FITC+/I-A+; 1.34 FITC+/I-A-). These
preliminary experiments suggest that intradermal injection of EPI reduces migration of epidermal
LCs to draining lymph nodes. 
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Lentiviral mediated transduction of dendritic cell progenitors does not alter the plasticity or
antigen presentation function of dendritic cells
Y He,1 J Zhang,1 M Zhibao,2 P Robbins2 and L Falo 1 1 Dermatology, Univ of Pittsburgh,
Pittsburgh, PA and 2 MGB, Univ. of Pittsburgh, Pittsburgh, PA
Introduction of antigen encoding genes into dendritic cells (DCs) without skewing or limiting their
intrinsic function remains a critical challenge for the design of immunotherapies for the treatment
of and prevention of infection, neoplasms, and autoimmune diseases. We investigated the effect of
lentiviral vector transduction on the phenotype and function of murine bone marrow derived DCs
(BMDCs). We found that although maturing DCs could be transduced using lentiviral vectors, tar-
geting DC progenitor or immature DCs resulted in improved transduction efficiency, reproducibly
enabling 50% of transduction of resulting DC populations. Importantly, transduction of early imma-
ture DCs or DC progenitors with lentiviral vector did not affect their maturation and antigen pres-
entation function. Significant amount of IL-12p70 could be produced by both lentiviral vector-
transduced and mock-transduced BMDCs in response to the stimulation by CpG oligonucleotides.
Furthermore, transduction did not affect the DCs capacity to stimulate T cells as reflected by allo-
genic T cell proliferation (MLR) and had no effect on skewing Th1/Th2 cytokines of effector cells.
Transduced BMDCs efficiently processed and presented both MHC I and II restricted epitopes from
expressed transgenic antigens. Animals vaccinated with transduced BMDCs developed CTL activ-
ity and were completely protected from tumor cell challenge. Our data suggest that lentiviral vector
can effectively introduce antigen genes into DCs without interfering with their antigen presentation
function and Th1/Th2 cytokine skewing capability. 
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Keratinocytes express nucleotide-binding oligomerization domain (NOD) 1 and 2: implications
for cutaneous innate immunity
PI Song, R Prado, Y Kang, A Kolot, CA Armstrong and JC Ansel Dermatology, Northwestern
University Feinberg School of Medicine, Chicago, IL
Recent evidence indicates that mammalian NOD proteins are intracelluar molecules that function
as cytosolic sensors for the recognition and response to intracellular microorganisms. NOD proteins
appear to function in a manner similar to Toll-like receptors which are typically located on the cell
surface membrane. Previous reports indicate NOD1 is expressed in most adult tissues whereas NOD2
expression is detected principally on certain epithelial cells and myeloid lineage cells. The expres-
sion and biological function of NOD in keratinocytes has not been previously reported. In the cur-
rent study, we examined the expression of NOD1 and NOD2 in normal human keratinocytes and in
the murine keratinocyte cell line PAM212. Our results indicated that both NOD1 and NOD2 are con-
stitutively expressed in human keratinocytes and PAM212 cells. We found that keratinocyte NOD1
and NOD2 mRNA expression was augmented by exposure to bacterial derived peptidoglycan (PGN)
and this resulted in the induction of the proinflammatory cytokine IL-6. The results of these studies
indicate for the first time that in addition to TLR, keratinocytes also express NOD which may func-
tion as an intracellular sensor of microbes and microbial derived products. We propose that ker-
atinocyte NOD may be an important component of the cutaneous innate immune response to a vari-
ety of infectious agents in the skin. 
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IL-7 promotes Th1 cell differentiation
BE Rich Dermatology, BWH, Boston, MA
IL-7 is principally a product of non-lymphoid cells that regulates the expansion of lymphocytes prior
to and during antigen receptor gene recombination. It promotes the proliferation of T cells, supports
their effector functions, and may also regulate their homeostasis. IL-7 deficient (IL7KO) mice have
dramatically reduced but not eliminated populations of lymphocytes (2-4 % of WT) that retain the
ability to respond to antigens. Immunization of IL7KO mice with ovalbumin (OVA) in complete Fre-
und’s adjuvant (CFA) provokes reduced, but detectable levels of antigen-specific reactive T cells.
However, in contrast to wild-type (WT) mice, which mount a response to antigens in the presence
of fixed mycobacteria that is dominated by type 1 T helper cells (Th1), the responsive cells in IL7KO
mice are primarily type 2 T helper (Th2) cells. Splenocytes from immunized WT mice cultured with
antigen produce interferon-γ (IFN-γ) but very little IL-4 while those from immunized IL7KO mice
cultured with antigen produce IL-4 and very little IFN-γ. To study the effect of IL-7 on Th1 and Th2
cell differentiation, lymphocytes from Balb/c mice carrying the DO11.10 anti-OVA T cell receptor
transgene and a modified IL-4 gene in which green fluorescent protein (GFP) is expressed when the
IL-4 gene is transcribed (4get) were introduced into WT and IL7KO Balb/c mice by adoptive trans-
fer. Transferred T cells can be readily identified by flow cytometry using a clonotypic antibody and
expression of the IL-4 gene in individual cells is measured as green fluorescence. Few T cells trans-
ferred to WT mice that were subsequently immunized with antigen in CFA had detectable GFP while
a prominent population of T cells transferred to IL7KO mice expressed GFP. Remarkably, in the
absence of immunization, T cells that have circulated in IL7KO mice for one week are predomi-
nately predisposed to express GFP in response to non-specific activation while half or fewer of
those that circulated in WT mice express GFP. Thus it appears that an IL-7-mediated signal predis-
poses naive CD4 T cells to differentiate to Th1 cells while the absence of that signal enables them
to differentiate to Th2 cells. 
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Blockade of skin dendritic cell migration by topical application of MMP- and PKC-inhibitors
is associated with inhibition of allergic contact dermatitis in vivo
F Berard,1 P Saint-Mezard,1 K Rodet,1 N Piccardi,2 A Piccirilli,2 P Msika2 and J Nicolas1 1
INSERM 503, Lyon, France and 2 Laboratoires Expanscience, Epernon, France
Epidermal langerhans cells (LC) and skin dendritic cells (DCs) are potent antigen presenting cell
(APC) in the induction of primary T cell-mediated immune responses in the skin. They capture for-
eign antigens (Ags) and migrate to regional lymph nodes (LNs) to carry and present this antigen to
naive T cell. This mechanism is critical in the initiation of different cutaneous pathology such as Pso-
riasis, Contact Dermatitis or Contact Hypersensitivity. Several molecules regulate the migration of
skin DC, among which metalloproteinase (MMPs) and protein kinase C (PKC). We have previously
shown that topical application of MMP or PKC inhibitors on the skin once a day for 4 consecutive
days induced a dose-dependant reduction in the number of FITC+ migrating DC (around 30% of
inhibition for the optimal dose), compared to placebo application. The aim of this study was to eval-
uate the effect of MMPs and PKC inhibitors in a in vivo model of primary ACD (1). Naive mice
were sensitised by a single application of DNFB 0.3%. Ear thickness was measured each day after
sensitisation until day 10. Topical application of MMP and/or PKC inhibitors on the ear once a day
for 3 consecutive days before sensitisation induced a significant reduction of the ear swelling response
to hapten. These data suggest that inhibition of PKC/MMP could be of value in the treatment of skin
inflammatory diseases which are mediated by DC-T cell interactions. 
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Immunology of the human nail apparatus: evidence that the infantile nail matrix is a site of
relative immune privilege
T Ito,2,1 N Ito,2,1 B Stampachiacchiere,4 A Bettermann,1 M Takigawa,2 BJ Nickoloff3 and R Paus1
1 Dermatology, University Hospital Hamburg-Eppendorf, Hamburg, Germany, 2 Dermatology,
Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan, 3 Pathology, Oncology
institute, Loyola University, Chicago, IL and 4 Istituto di neurobiologi, Consiglio Nazionale delle
Ricerche, Roma, Italy
The nail apparatus is prominently exposed to environmental damage and infection, and thus requires
a well−functioning immune system. However, our knowledge of nail immunology is still extremely
fragmentary, and it is essentially unknown how the nail immune system differs from the skin or hair
follicle immune system. Therefore, we have investigated the normal nail immune system of human
infants by immunohistology (3 males, 3 months). Surprisingly, HLA−A/B/C expression is promi-
nently downregulated on both keratinocytes and melanocytes of the proximal nail matrix (PNM),
compared to other regions of the nail epithelium. The PNM also is HLA−G+, has unusually few
CD1a+, CD4+ or CD8+ cells, shows strong immunoreactivity for locally generated immunosup-
pressants such as TGF−β1, α−MSH and ACTH and for inhibitors of NK cell activity (MIF). Den-
dritic cells in/around the human nail apparatus show reduced MHC class II expression. This sug-
gests that the nail immune system strikingly differs from the skin immune system, but shows intriguing
similarities to the hair follicle immune system, including the establishment of an area of relative
immune privilege in the PNM. The latter may explain the notorious chronicity and therapy−resist-
ance of nail infections. 
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Listeria monocytogenes expressing murine TRP2 induces anti-melanoma protection that is
enhanced by topical imiquimod
N Craft,2,1 K Bruhn,2 B Nguyen,2 J Yip2 and JF Miller2 1 Speciaty Training and Advanced Research
(STAR) Program in Dermatology, UCLA School of Medicine, Los Angeles, CA and 2 Microbiology,
Immunology, and Molecular Genetics, UCLA School of Medicine, Los Angeles, CA
Mechanisms maintaining tolerance to ‘self’ antigens represent a major obstacle to developing
immunotherapies targeting nonmutated, tumor-associated antigens. One potential approach to acti-
vate tumor-specific T cells is to use live bacterial vectors that deliver heterologous antigens in a highly
immunostimulatory context. We constructed a recombinant strain of Listeria monocytogenes (rLM)
expressing murine tyrosinase-related-protein 2 (TRP2), a nonmutated, melanocyte-derived differ-
entiation antigen highly expressed in melanomas. We used this rLM-TRP2 strain to immunize mice
and then challenged the mice with B16 melanoma cells with or without adjuvant topical imiquimod.
Immunization of C57Bl/6 mice with rLM-TRP2 efficiently primed CD8 T cells to recognize the
MHC class I-restricted TRP2180-188 epitope and express IFN-γ upon in vitro peptide stimulation.  Pep-
tide-loaded target cells were lysed in vitro by TRP2-specific T cells in cytotoxicity assays. As evi-
dence of the in vivo functionality of these T cells, mice immunized and boosted with rLM-TRP2
were protected from subcutaneous challenge with B16 melanoma cells. To further explore the pro-
tective efficacy of rLM-TRP2, we adapted an optical imaging system to monitor bioluminescent
tumor cells growing in vivo. In addition to protecting against subcutaneous challenge, rLM-TRP2
vaccination also protected against B16 lung metastases following systemic challenge. Lastly, daily
application of the topical immunomodulator imiquimod to subcutaneous tumor sites greatly enhanced
protection induced by rLM-TRP2. These results indicate that murine TRP2-expressing rLM can stim-
ulate anti-tumor immunity directed against an endogenously expressed, nonmutated tumor antigen.
They also suggest that direct tumoral stimulation with the toll-like receptor 7 (TLR-7) agonist
imiquimod may enhance anti-tumor immunity after vaccination against tumor specific antigens. 
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Combination of benzo[a]pyrene and ultraviolet A promotes tumor propagation
D Gao, D Guevara, X Zhou, Y Wang, Y Zhu, M Lebwohl and H Wei Dermatology, Mount Sinai
School of Medicine, New York, NY
We previously reported that benzo[a]pyrene (BaP) and ultraviolet A (UVA) irradiation synergisti-
cally increased oxidative DNA damage in vitro and tumorigenesis in vivo. It has been reported that
BaP and UV radiation can both affect humural and cellular immunity in several animal species. The
present study has investigated the effect of BaP and UVA on immune surveillance in mice. SKH1
mice were treated with subcarcinogenic dose of BaP (8 nmol/mouse) and UVA (20 KJ/m2) for 30
weeks. The tumor-free mice were subcutaneously inoculated with 5 x 105 of B16 murine melanoma
cells. The tumor in BaP plus UVA treated mice showed approximately 4-fold larger than untreated
and UVA treated groups. In addition, in vitro experiments demonstrated that BaP plus UVA was
much more cytotoxic to lymphocyte cell lines than BaP or UVA alone, probably through the apop-
totic pathway. The present study suggests that BaP and UVA may synergistically promote tumor
cell propagation by inducing immunosuppression and compromising immunosurveillance. 
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Reinforcement of innate host defense via induction of anti-microbial peptides
E Goyarts, M Sullivan, N Muizzuddin, S Schnittger, T Mammone and D Maes Skin Biology, Estee
Lauder Companies, Melville, NY
Anti-microbial peptides are an important weapon of the innate immune response arsenal. The large
surface area of the skin provides an easy target for microbial colonization. Keratinocytes monitor
the surface of the skin for potential hazards. When a potential pathogen is encountered, keratinocytes
release anti-microbial peptides. We investigated a battery of substances for inducing NHEKs to release
anti-microbial peptides. Human β-defensin-2 mRNA levels were monitored by real-time RT-PCR.
Treatment of NHEK monolayers with proinflammatory cytokines up-regulates hBD-2 mRNA lev-
els after 24hrs. Polysaccharides up-regulate hBD-2 mRNA levels after 48hrs. Staphyloccocus aureus,
Pseudomonas aeriginosa and Lactobacillus plantarum stimulated NHEK monolayers to synthesize
hBD-2 mRNA after 48hrs. Studies with Lactobacillus, an accepted probiotic for gastrointestinal
infections, were extended to the skin. Clinical studies investigated whether heat-killed Lactobacil-
lus alters several skin parameters. An increase in barrier strength and barrier repair was observed. A
reduction in microbial growth was also observed. One mechanism accounting for the improvements
in skin quality is a reduction in bacterial colonization resulting from keratinocytes releasing anti-
microbial peptides. 
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Real-time, multi-photon confocal imaging of epidermal Langerhans cells
BR Ward,1 JV Jester,1 HL Ploegh,2 M Boes2 and A Takashima1 1 UT Southwestern, Dallas, TX and
2 Harvard, Boston, MA
The biology of Langerhans cells (LC) has been studied in fixed tissues or with LC preparations iso-
lated from skin or generated in vitro from their progenitors. These studies, however, have provided
no insights into dynamic behaviors of LC in living tissues. By reconstituting the corneal LC with
EGFP-transgenic bone marrow cells, we have recently reported 4D images of EGFP+ corneal LC.
Because these EGFP bone marrow chimeric mice showed only partial reconstitution of LC net-
works in the epidermis, we employed in this study the I-A/EGFP knock-in mice in which the endoge-
nous MHC class II molecule is replaced by an EGFP-tagged version (Nature 418:983,2002). Multi-
photon confocal microscopy (Leica SP2/Coherent Ti:Sapphire femtosecond pulsed laser) revealed
the presence of large numbers of EGFP+ LC within the epidermal compartment (as defined by the
lack of collagen-generated second harmonic signals). As has been observed in fixed tissues, LC were
found to extend long, branched dendritic processes both laterally and apically up toward the surface
in living skin. To study their in situ behaviors, we placed freshly harvested skin samples in a tem-
perature-controlled chamber with circulation of aerated culture media and recorded 3D multi-pho-
ton confocal images of EGFP+ LC every 2 min for up to 4 hr. 4D movies were then reconstructed
from these data sets. Although no lateral or axial movement of cell bodies was detected, EGFP+ LC
exhibited a unique behavior, termed dendrite surveillance extension and retraction cycling habitude
(dSEARCH), characterized by rhythmic and repetitive extension and retraction cycles of dendritic
processes. All EGFP+ LC observed in three independent experiments showed dSEARCH exercise,
primarily in the secondary branched dendrites. Although the physiological function of this behavior
remains unknown, it is tempting to speculate that dSEARCH may facilitate two important tasks of
LC at the environmental interface, i.e., antigen sampling and detection of microbial and inflamma-
tory signals. This is the first report showing in situ behaviors of epidermal LC in intact skin. 
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Cathelicidin antimicrobial peptides modulate antigen presentation. Innate immune regulation
of the adaptive allergic response
RL Gallo,1 A Di Nardo,2,1 A Vitiello,3 RD Granstein4 and S Kodali4 1 Medicine/Dermatology,
UCSD, San Diego, CA, 2 San Gallicano Derm Inst., Rome, Italy, 3 Infectious Disease, Johnson &
Johnson Pharm. R&D, San Diego, CA and 4 Dermatology, Weill Medical College of Cornell U.,
New York, NY
Antimicrobial peptides (AMPs) are essential to innate immunity through their action as natural antibi-
otics but can also alter host behaviors such as chemotaxis and cell proliferation. Cathelicidin (cath)
AMPs are released in proximity to dendritic cells (DC) in the skin. To study if caths directly influ-
ence DC function we treated bone marrow-derived DC with cath peptides for up to 2hr, then removed
the peptide prior to stimulation. Cath was applied at physiologic concentrations (<20uM) and was
not toxic to DC as determined by LDH release. Cath blocked the response to LPS by inhibiting 100%
of cytokine release (IL-6, TNF-a, IL-8, IL-10) but not (GMCSF, IL-4, IL-5, INF-g) and blocked an
increase in CD40 expression at the cell surface by at least 75%. Cath at 1uM also inhibited antigen
presentation of KLH by epidermal cells to a specific TH1 clone as seen by a 75% decrease in g-INF
release. In mice, intradermal injection of cath inhibited sensitization with DNCB as measured by a
50% decrease ear swelling and diminished inflammatory infiltrate. Further support for the ability of
cath to suppress antigen presentation was obtained with cath knock-out mice that showed an sig-
nificant increase (p<0.05) in ear swelling following DNCB sensitization compared to wild-type lit-
termates. These data suggest that the presence of cath inhibits DC maturation and the ability to pres-
ent antigen. This mechanism suggests that innate immune effectors simultaneously kill pathogens
while inhibiting development of an unnecessary allergic response to superficial microbial antigens.
Speculatively, the lack of cath expression by patients with atopic dermatitis could partially explain
the enhanced inflammation observed in this disease. 
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Identification of novel genes regulated by alpha-melanocyte-stimulating hormone in murine
bone marrow-derived dendritic cells
T Brzoska,1 J Ehrchen,2 TA Luger1 and M Boehm1 1 Dept. of Dermatology, University of Muenster,
Muenster, Germany and 2 Dept. of Experimental Dermatology, University of Muenster, Muenster,
Germany
Many strains of evidence indicate that alpha-melanocyte-stimulating hormone (alpha-MSH) elicits
its immunomodulatory activity via binding to melanocortin receptors (MC-Rs) expressed on mono-
cytes and dendritic cells. In order to identify novel target genes regulated by alpha-MSH in these
cells, we prepared bone marrow-derived dendritic cell precursors from Balb/c mice and treated
them with GM-CSF and IL-4 for 6 days. The MC-R profile on these immature dendritic cells was
first determined by quantitative RT-PCR. Both transcripts for MC-1R and MC-5R were detected in
these cells. Cells were subsequently stimulated with dinitrobenzene sulfonic acid (DNBS), alpha-
MSH or both substances for 2 or 16 hours. After RNA preparation, cDNA synthesis and in vitro
transcripton hybridization of biotinylated cRNA samples was performed on MG U74A Affymetrix
gene chips. Data evaluation, cleansing, extraction and analysis of the more than 12 000 cloned
genes and expressed sequence tags were performed using the Gene Data Analyst vs.1 Expression-
ist software. Filter criteria included a minimum threshold of 100, normalization by the logarithmic
mean and a quality setting of p<0,04. Changes with a change factor of >2 were regarded as signifi-
cant. As expected, stimulation with DNBS resulted in induction or upregulation of genes encoding
proinflammatory cytokines, growth factors, signal transduction intermediates and transcription fac-
tors. Treatment with alpha-MSH blocked the DNBS-driven upregulation of several known genes
such as IL-1 or CD86. On the other hand, alpha-MSH modulated the expression of several novel
genes implicated in immunomodulation, e. g. IL-1beta converting enzyme, IFN-gamma receptor,
FK506 binding proteins or several neuropeptides and their receptors. These data indicate novel molec-
ular targets by which alpha-MSH exerts its immunomodulatory activities in immunocompetent cells. 
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T cells in patients with Netherton syndrome and atopic dermatitis show a Th-2 bias
C Ong, C Banfield, H Uronen, J Allen, J Mazereeuw, R Callard and J Harper Immunobiology and
paediatric dermatology, Institute of Child Health and Great Ormond Street Hospital, London,
United Kingdom
Netherton syndrome (NS) is a rare skin disorder characterised by ichthyosis erythroderma, trichor-
rhexis invaginata, atopy with universally high IgE level and severe infections. Mutations in SPINK5
on chromosome 5q32, encoding for LEKTI (Lympho-epithelial Kazal type serine protease inhibitor),
are associated with NS. LEKTI is expressed in the skin and thymus. Genetic polymorphisms in
SPINK5 are associated with atopic dermatitis (AD). T-cells in AD were previously shown to have a
Th2 bias. In view of the high IgE and atopic features, T-cells in NS were also thought likely to have
a Th2 profile. Blood from children of similar age distribution with NS with confirmed SPINK5 muta-
tions (n=6), AD (n=10) and controls (n=14) was stimulated with Phorbol 12-myristate 13-acetate
(PMA), Calcium ionophore and Brefeldin A for 5h. T-cells were then stained for CD3, CD4 or CD8,
fixed and permeabilized and the intracellular cytokines IL-4, IFN-γ and TNF-α measured by flow-
cytometry. Results from NS and AD were compared to controls using the Mann-Whitney non-para-
metric statistical analysis. CD4 T-cells from NS and AD produced significantly higher IL-4 com-
pared to controls (p=0.03 and p=0.05). CD8 T-cells from NS but not AD also produced higher IFN-γ
(p= 0.05). All other cytokines did not show significant differences between patients and controls.
Our data firstly confirmed the previously observed Th2 bias in AD (increased CD4 IL4 production).
Interestingly, T-cells from NS not only produced more Th2 cytokines when compared to controls
but also to AD. This may account for the extremely high IgE level and severe atopy in NS. With the
recent localisation of LEKTI to the skin and thymus and its genetic association with AD, our data
suggests that LEKTI may have an important role in the pathogenesis of atopic diseases. The signif-
icantly higher CD8 IFNγ in NS but not AD may reflect more severe ongoing infections. Our data
show that T-cells from both AD and NS have a Th-2 bias. 
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Modification of IL-7 to enhance bioavailability
SV Shulga-Morskoy and BE Rich Dermatology, Brigham and Women’s Hospital, Boston, MA
Interleukin-7 (IL-7) is an essential regulator of lymphocyte development and homeostasis that also
enhances certain immune responses. As such IL-7 is being investigated as a therapeutic agent for
the management of lymphoid deficiencies and as an immunostimulant for the treatment of cancers
and other diseases. However, a major factor limiting the therapeutic development of IL-7 and cer-
tain other cytokines is their rapid clearance from circulation. Optimal biological activity in animals
requires continuous infusions or frequent injections of large doses of IL-7. Previous studies have
demonstrated that the half-lives of various proteins can be greatly increased by attaching them to the
constant region of an immunoglobulin molecule (Fc). In an effort to enhance the bioactivity of IL-
7 by increasing its half-life, we have created a fusion protein consisting of Fc and IL-7. A cDNA
encoding the fusion protein was constitutively expressed at high levels in CHO cells. Fc-IL7 protein
produced in this system was purified and characterized in vitro and shown to be comparable with
native IL-7. In vivo experiments to compare the bioavailability of the fusion protein with native IL-
7 are currently underway. 
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Activated ras downregulates Fas expression in mouse melanoma with H-rasG12V transgene
J Takao,1 K VanBuskirk,1 Y Shellman,1 DA Norris,1 L Chin,2 C Yee3 and M Fujita1 1 Dermatology,
University of Colorado Health Sciences Center, Denver, CO, 2 Dermatology, Harvard Medical
School, Boston, MA and 3 Clinical research division, Fred Hutchinson Cancer Research Center,
Seattle, WA
Malignant melanoma grows and progresses despite the fact that the immune system can recognize
melanocyte/melanoma differentiation antigens expressed by melanoma cells. In order to elucidate
the mechanisms of immune escape in malignant melanoma, we analyzed host-melanoma interac-
tion using genetically engineered mice with melanocyte-specific H-rasG12V expression on an Ink4a/Arf-
deficient background that mimics the gene alterations in human melanoma. Our transgenic mice
developed multiple spontaneous melanomas around several months of age despite the fact that tumors
expressed all melanocyte differentiation antigens (tyrosinase, TRP-1, TRP-2, MART-1, and gp100).
Immunohistochemical study showed significantly reduced Bcl-2 and undetectable levels of Bax and
Fas expression in tumor cells. Further analysis of the melanoma cell lines from our transgenic mice
showed that activated ras downregulated Fas expression at the transcriptional level and that the down-
regulation of Fas was reversed by the treatment with FTI-277, a farnesylation inhibitor. The tran-
script of Fas L was not detected in the melanoma cell lines and was not affected by FTI-277. The
effect of FTI-277 on Fas upregulation was not observed in B16/F10 murine melanoma cells, sug-
gesting that the downregulation or loss of Fas expression in B16/F10 melanoma cells was not reg-
ulated by farnesylated proteins. These results suggest that activated ras downregulates Fas expres-
sion in malignant melanomas with ras mutation, contributing to the tumor escape from the immune
system.
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Variable expression of the B7 costimulatory molecule family on normal human keratinocytes
A De Benedetto,1 AJ Mamelak,1 B Wang,1 T Shin,2 DL Cummins,1 DJ Kouba,1 C Esche,1 I Freed,1
A Tulli,3 L Beck,1 DM Pardoll2 and DN Sauder1 1 Dermatology, Johns Hopkins University,
Baltimore, MD, 2 Oncology, Johns Hopkins University, Baltimore, MD and 3 Dermatology, G.
d’Annunzio University, Chieti, Italy
Interactions between costimulatory molecules and their receptors on T cells play a critical role in
growth, differentiation, and death of T cells. During an inflammatory response, optimal T cell acti-
vation requires a costimulatory signal beyond antigen-MHC II recognition by the T cell receptor
(TCR). B7 signaling is one of the best-characterized T cell co-stimulatory pathways. The B7 fam-
ily has expanded in recent years and now includes the B7-1, B7-2, B7-H1, B7-DC, B7-H2 (ICOS-
L), B7-H3 and B7-H4 family members. These proteins are expressed on professional APCs, as well
as on multiple cells not classically thought to have immune functions, such as epidermal keratinocytes.
Growing evidence suggests that keratinocytes play a key role in the pathogenesis of inflammatory
and T cell-mediated dermatoses. Keratinocytes can produce inflammatory cytokines, and express
both MHC II molecules and ICAM-1. But, little is known about the expression of co-stimulatory
molecules on keratinocytes. This study investigated the expression of B7 costimulatory molecules
on normal human keratinocytes. We found variable transcription of the B7 genes with different
stimuli. Following UVB irradiation (20 mJ/cm2), keratinocytes demonstrated induction of B7-H1
and B7-H2; whereas stimulation with IFN-γ had minor effect on these molecules. Our findings are
consistent with the immunosuppressive effects of UVB, and further support the role for B7-H1 and
B7-H2 in dampening the T cell immune response. Altered expression of B7 molecules on keratinocytes
may suggest the potential for further peripherial immunomodulatory functions of epidermal ker-
atinocytes. 
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Novel yeast-based immunotherapeutic vaccines expressing human MART-1 elicit anti-melanoma
immunity in mice
J Takao,1 L Yingnian,2 DA Norris,1 D Bellgrau,2,3 A Franzusoff2 and M Fujita1 1 Dermatology,
University of Colorado Health Sciences Center, Denver, CO, 2 GlobeImmune Inc., Aurora, CO and
3 Immunology and Medical Oncology, University of Colorado Health Sciences Center, Denver, CO
Despite recent advances in molecular and cellular immunology, the development of therapeutic
cancer vaccines has proven to be an enormous challenge. Whole recombinant yeast represents a plat-
form as a vehicle with the ability to deliver melanoma antigens to antigen-presenting cells and with
immunostimulatory and adjuvant features needed as an immunotherapeutic product to circumvent
obstacles seen in previous vaccines. In previous work, we demonstrated that the whole recombinant
yeast expressing chicken ovalbumin (OVA) mediated DC maturation (i.e. IL-12 production), effi-
cient priming of MHC class I- and class II- restricted antigen-specific responses, and protection from
OVA-expressing tumor challenge. In this study, human MART-1 (melanocyte/melanoma antigen rec-
ognized by T cells) was engineered for expression as a tumor antigen in Saccharomyces cervisiae
yeast (yeast-based human MART-1-immunotherapeutic, or hMART-IT) and was tested for protec-
tive immune responses against mouse MART-1-expressing B16F10 melanoma cells. Immunization
of naive C57BL/6 mice with the yeast-based MART-IT triggered protection against challenge with
a lethal dose of B16F10 tumor cells implanted subcutaneously (4/5 mice are tumor-free and alive),
compared to PBS-immunized animals (1/5 is tumor-free and alive). Cytokine analysis of spleens
showed induction of IFN-gamma in some hMART-IT-immunized mice. These results validate that
human MART-1 serves as an appropriate antigen for eliciting protective cell-mediated immune
responses, even against mouse MART-1 expressing tumor cells. These results indicate that the yeast-
based strategy has the potential for providing immunotherapeutic protection against melanoma. 
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Langerhans cells are susceptible to apoptosis via Type II signaling pathways in response to
antigen-specific T cell interaction
J Genebriera,1 K Felix,1 S Pradhan1 and L Timares1,2 1 Dermatology, University of Alabama at
Birmingham, Birmingham, AL and 2 Cell Biology, University of Alabama at Birmingham,
Birmingham, AL
Antigen presenting cells (APC) susceptibility to apoptotic signals remains controversial. We demon-
strate that one APC member, the skin derived Langerhans cell (LC), is exquisitely sensitive to apop-
totic stimuli, significantly, in the presence of antigen-specific T cells. Two models of activation-
induced apoptosis exists utilizing different pathways of caspase activation, revealing Type I (extrinsic
pathway signaling via caspase 8) or Type II cell responses (requiring both extrinsic and intrinsic
pathways, via caspases 8, 9 & Bid). The nature of the caspase activation pathways used in LC was
examined. We determined that primary LC as well as XS106 cells are highly susceptible to apopto-
sis by Fas cross-linking or by antigen-specific interaction with T cells. Apoptosis occurred when
XS106 were cultured for 20 hours in the presence of the model antigen hen egg lysozyme (HEL)
and HEL-specific 3A9 T cells. To test the role of caspase activation in regulating LC death, caspase-
specific peptide inhibitors were utilized. XS106-GFP clones exhibited resistance to antigen-specific
T cell-mediated apoptosis in the presence of inhibitor peptides for caspase-3, caspase-8 or caspase-
9, each resulting in 60%-80% inhibition. Western blot analysis demonstrated that Bid protein levels
were elevated (2-fold) in XS106 cells as compared to T cell lines or splenocytes and was cleaved in
response to apoptotic stimuli. These data indicate that LC utilizes the Type II apoptosis signaling
pathway. 
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Mechanisms of immune evasion in malignant melanoma: reduced expression of E-selectin
and ICAM-1 in melanoma vasculature
E Buzney, BE Chong, TS Kupper and RC Fuhlbrigge Dermatology, Brigham and Women, Boston,
MA
Despite aggressive therapy, survival of patients with metastatic malignant melanoma remains poor.
Both the presence of tumor infiltrating T cells and the observation of occasional striking tumor regres-
sion suggest that host immune responses may influence the course; however, attempts at exploiting
these responses via vaccination have yielded limited success. T cell recruitment and emigration into
tissues is mediated by the interaction of leukocyte homing receptors with ligands expressed on tis-
sue endothelia. In this study we sought to establish whether dysregulation of leukocyte adhesion to
melanoma vasculature may be responsible, in part, for the ineffective immune response to this tumor.
Tissue (n=34) and blood (n=14) specimens were obtained from patients undergoing surgery for malig-
nant melanoma. Control tissue and blood specimens were obtained from normal donors. Immuno-
chemical staining of melanoma metastases showed little or no E-selectin expression on CD31-pos-
itive vessels within the tumor mass, despite strong E-selectin expression on vessels within adjacent
tissue. Melanoma metastases showed diffuse ICAM-1 staining; however, no vascular staining of
ICAM-1 was observed within the tumors. Flow cytometry of peripheral blood T cells, in contrast,
showed no significant shift in the percentage of skin-homing phenotype T cells or in the naive/mem-
ory T cell distribution of patients compared with normal controls. Interestingly, tumor infiltrating T
cells expressed surface receptor phenotypes similar to T cells isolated from comparable normal tis-
sues (skin, lymph node, tonsil), despite the lack of counter-ligands on the local endothelia, suggest-
ing these cells may have been recruited in adjacent tissue sites and migrated into the tumors or that
alternate recruitment pathways exist. We hypothesize that the lack of E-selectin and ICAM-1 expres-
sion on tumor vasculature may reflect a block to tissue specific leukocyte homing. Intervention to
increase expression of endothelial homing components could augment existing tumor vaccination
strategies. 
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The transcriptome of psoriatic epidermis is suggestive of an innate rather than an acquired
immune response
J Mee, N Morar and RW Groves START Labs, Imperial College London, London, United Kingdom
Studies comparing non-lesional and lesional psoriatic epidermis using oligonucleotide microarrays
have defined a consistent transcriptome profile of established psoriatic plaques. However, the con-
tribution of various cytokines known to be implicated in psoriasis to this transcriptome remains to
be established. To expand these studies, we were interested to explore the relative contribution of
cytokines implicated in the innate (IL-1α) and acquired (IFN-γ) immune responses in the develop-
ment of psoriatic plaques by in vitro modeling utilizing cytokine-stimulated keratinocytes. Second
passage human keratinocytes derived from unrelated, non-psoriatic adult donors were stimulated
with either IL-1α (100 ng/ml) or IFN-γ (20 ng/ml) for 24 hours prior to isolation of total RNA and
preparation of biotinylated cRNA (n=3). Samples were subsequently hybridized to Affymetrix U133A
human microarrays (containing oligonucleotides representing approximately 22,000 transcripts),
scanned and analyzed. Consistent strong induction (>5 fold) of a number of chemokines (e.g. CXCL9,
CXCL10, CXCL11 and fractalkine) and class II MHC genes (e.g. DRα, DRβ5 and DPα1) was
observed following stimulation with IFN-γ, a product of activated T-helper cells and associated with
acquired immune responses. By contrast, the keratinocyte transcriptome resulting from IL-1α stim-
ulation demonstrated induction of a distinct transcript set including IL-8, S100 proteins (most notably
S100 A7, psoriasin), the proteinase inhibitors skin-derived antileukoproteinase (SKALP) and PI13,
and β2 defensin. Thus the keratinocyte IL-1 transcriptome was markedly different from that asso-
ciated with IFN-γ stimulation and closely mirrored that previously identified in samples derived from
psoriatic lesional skin. These findings demonstrate a marked difference in the transcriptome of ker-
atinocytes stimulated with two functionally distinct cytokines and suggest that the inflammatory
milieu in psoriatic epidermis is more dependent upon an innate rather than an acquired type immune
response.
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E-selectin ligand up-regulation on CD8+ T cells encountering antigen in skin-draining lymph
nodes
LB Pincus, BE Rich, R Krzysiek, RC Fuhlbrigge and TS Kupper Dermatology, Brigham and
Women, Boston, MA
The aim of this study was to test the hypothesis that T cells activated by antigen in lymph nodes
draining skin are induced to express homing molecules that influence subsequent trafficking to
skin. We analyzed the induction of skin-homing molecules on memory CD8+ T cells in an in vivo
model of cutaneous autoimmunity. In this model, CFSE-loaded naive CD8+ T cells specific for oval-
bumin (OVA) derived from OT-1 transgenic mice were transferred to mice expressing a membrane-
bound form of OVA under the control of the keratin-14 promoter (K14mOVA). Transferred T cells
distributed rapidly to secondary lymphoid organs and proliferated within the skin-draining lymph
nodes (SDLNs). Proliferating T cells adopted an activated/memory phenotype, upregulating CD69,
CD44, and CD43 levels, while down-regulating L-selectin expression. Surprisingly, proliferating
OT-1 CD8+ T cells were also observed in non-skin draining lymph nodes and spleens in K14mOVA
mice. However, levels of E-selectin ligand activity (a murine surrogate of CLA expression) appeared
earlier and were significantly higher on OT-1 cells in SDLNs than on OT-1 T cells in noncutaneous
secondary lymphoid organs. When antigen expression was limited to small grafts of K14mOVA
skin placed on the flanks of WT mice, E-selectin ligand activity increased progressively as a func-
tion of division in the ipsilateral lymph node draining that skin region and not in the contralateral
nodes or those draining other tissues. Our data demonstrate that while CD8+ T cells are induced to
express E-selectin ligand activity in SDLNs, measurable levels of E selectin ligand can be generated
in noncutaneous secondary lymphoid organs, suggesting a significant degree of overlap of homing
capacity exists between T cells encountering antigen in anatomically distinct regions. 
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Characterization and evaluation of CD34+ generated Langerhans cells for tissue engineering
S Ayehunie, S Lamore, K Bellevance, R Lappen, J Sheasgreen and M Klausner R & D, MatTek
Corporation, Ashland, MA
Specialized antigen-presenting cells, particularly Langerhans cells (LC), residing in the skin, mucosa,
and lymphoid tissues play a key role in sensitization and other immunological reactions of the body.
However, difficulty in harvesting, short survival time in culture, and variability in cytokine produc-
tion of cultured LC has prevented researchers from widespread use of LC for allergenicity and
immunogenicity studies. Likewise, these problems have hampered the development of in vitro tis-
sue models containing LC. Recently, we have developed a new culture method to generate large num-
bers of LC from umbilical cord blood (UCB). UCB derived CD34+ progenitor cells are expanded
to produce up to 200 million LC per 60 ml UCB sample. The generated LC express CD1a, HLA-
DR, CD209 (DC SIGN), and CD206 (mannose receptor), all characteristic of LC. Transmission elec-
tron microscopy shows the presence of Birbeck granules, a key ultrastructural marker of LC. The
lifespan of these cells has been extended to 41 days with very little change in surface marker expres-
sion or phenotype. Upon stimulation with lipopolysaccharide (LPS) and phorbol-12-myristate-13-
acetate (PMA), the LC show a reproducible, high level release of IL-12, MIP-1α, MIP-3α, IL-6,
RANTES, and IL-6. In addition, recent experiments demonstrate that these cells can be incorpo-
rated into MatTek’s reconstructed skin model, EpiDermTM, and its ectocervical-vaginal tissue model,
EpiVaginalTM. LC within these tissue constructs are detected by immunostaining for HLA DR anti-
gens. These new tissue models and the isolated LC alone will likely be useful in a variety of studies
related to: 1) allergenicity, 2) microbial infection, 3) neutralizing antibodies, 4) antigen presenta-
tion, and 5) immuno-therapy, amongst others. 
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Decreased TRECS in cutaneous T cell lymphoma
KYamanaka, DA Jones, NYawalkar and TS Kupper Dermatology, Brigham and Women’s Hospital,
Boston, MA
We recently reported that there is a dramatic reduction in the complexity of the T cell repertoire in
patients with all stages of CTCL. However, absolute numbers of T cells generally remain normal.
Because of this, we hypothesized that nonmalignant T cells proliferate to fill the empty space cre-
ated by this depletion of T cells. We here test this hypothesis by examining T cell receptor excision
circles (TRECs). TRECs are DNA episomes which are formed during recombination of the T cell
receptor gene complex in the thymus, and do not replicate during T cell division. The number of
TRECs in a population of T cells is therefore an index of how many naive T cells are present. We
reasoned that TRECs should be lower in peripheral blood of CTCL patients, as they would be diluted
out as surviving T cells proliferate and expand. We examined TRECs from purified peripheral blood
T cells of 62 patients with CTCL. They included patients with Stage 1 (n=37), Stage II (n=6), Stage
III (n=12), and Stage IV (n=7) disease. In control experiments, TRECs decreased with PHA expan-
sion in cell culture and also decreased with age, as expected. We found a significant decrease in
TRECs with increasing stage of CTCL for stages I, III, and IV (P<0.05), and furthermore found a
significant correlation between decreased TRECs and diminished complexity of the T cell repertoire,
as judged by CDR3 spectratyping (P<0.0001). In patients with Sezary syndrome, when the domi-
nant clone cells were excluded from the analysis, the remaining T cells also had significantly fewer
TRECs than controls (p<0.05). This decrease in TRECs in CTCL is consistent with our hypothesis
that normal T cells that are not deleted in CTCL expand to fill the space created by the diminished
T cell repertoire. 
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Chemokine MRNA expression in acne vulgaris
P Mouser, P Seldon, E Seaton and A Chu Dermatology, Imperial college, London, United Kingdom
Chemokines play important roles in the different activation, effector function, migration and local-
isation of cell types that mediate inflammatory reactions and immune responses. However, despite
this, no study has previously been undertaken to investigate comprehensively the expression of
chemokines in acne vulgaris. Recent immunohistochemical studies have indicated that inflamma-
tory acne is a CD4+ lymphocyte/macrophage led response. We have investigated the expression of
chemokine mRNA in acne skin lesions using a highly sensitive and specific multi-probe ribonucle-
ase protection assay (RPA). Skin biopsies of early inflamed papular lesions from 8 acne patients
were examined for the expression of the chemokines; interferon-inducible protein-10 (IP-10),
macrophage inflammatory protein-1 alpha and 1 beta (MIP-1α and MIP-1β) regulated on activa-
tion, normal T-cell expressed and secreted (RANTES), Lymphotactin (Ltn), Interleukin (IL)-8, I-
309 and monocyte chemotacic protein (MCP-1) and compared to normal skin from 12 normal donors.
Briefly, a mixture of [32P] UTP—labeled antisense riboprobes were generated from a cDNA tem-
plate set. Tissue RNA was hybridized with 32P antisense riboprobe and after purification, the result-
ing protected probes were visualized following denaturing gel electrophoresis by autoradiography.
The mRNA level of each chemokine was represented as a percentage of GAPDH. Levels of MIP-
1Β, MCP-1, IL-8 and I-309 (P < 0.01) and to a lesser extent RANTES, IP-10 and MIP-1α (P < 0.05)
were elevated significantly in acne skin compared to normal skin, but there was no significant dif-
ference in the expression of mRNA for Ltn. IL-8 was the most dominant chemokine expressed in
acne skin. These data suggest that the above chemokines play an important part in the immunopatho-
genesis of acne vulgaris and may account for the large CD4+/macrophage presence in early inflamed
acne lesions. 
774
Mouse beta defensin-3 is strongly induced in a mouse model with a skin barrier defect
Z Zhou,1 P Koch1,2 and D Roop1,2 1 Molecular & Cellular Biology, Baylor College of Medicine,
Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
We have demonstrated that a defect in skin barrier function resulting from the loss of loricrin, a major
cornified envelope (CE) protein, induces a compensatory response that activates the expression of
known and novel CE components. A recent analysis of cDNA microarray data has shown that beta
defensin-3 expression is also dramatically increased in the epidermis of newborn loricrin null mice.
Defensins are major antimicrobial peptides, synthesized by epidermal keratinocytes, that are impor-
tant components of the innate host response to microbial infections. To determine whether beta
defensin-3 induction is a general response to skin barrier defects or specific to loricrin null mice, we
tested a second mutant mouse line with a skin barrier defect; RAR 403 transgenic mice express a
dominant-negative RAR receptor and show a severe skin barrier defect at birth due to defects in the
lipid component of the CE. Surprisingly, we did not detect up-regulation of beta defensin-3 in these
mice, suggesting that this response is specific to loricrin null mice. Interestingly, we have previ-
ously demonstrated that the compensatory response which re-establishes skin barrier function of
loricrin null mice begins in utero. The up-regulation of beta defensin-3 was only observed in the
epidermis of newborn loricrin mutants, not in utero. It has been shown that beta defensin-3 is regu-
lated by the NF kappa B pathway. Factors that activate NF-kappa B include TNF, IL-1 and Toll-like
receptors. Current studies are directed toward identifying the signaling pathway responsible for induc-
tion of beta defensin-3 in loricrin null epidermis. 
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CCR7+ central memory T cells significantly express organ-specific coding molecules including
cutaneous lymphocyte antigen
K Hirahara, RC Fuhlbrigge and TS Kupper Dermatology, Brigham and Women’s Hospital, Boston,
MA
Central memory T cells are defined as CD45RO+ memory T cells expressing CD62L, CCR7, and
LFA-1, allowing them to access lymph nodes from blood through high endothelial venules. It was
originally proposed that these cells lacked peripheral non-lymphoid tissue homing molecules. In the
present study, we investigated expression of skin- and gut-homing receptors on highly purified periph-
eral blood central memory T cells by flow cytometry. CCR7+ T cells were further isolated by mag-
netic cell sorting. These cells were stained with specific antibodies to CD45RO, CD45RA, cutaneous
lymphocyte antigen (CLA), chemokine receptors including CCR4, andβ7 integrin as well as other
T cell-related markers such as CD4, CD8, and CD25. Purity of central memory T cells was more
than 97%, and they co-expressed L -selectin/CD62L. Central memory T cells purified this way were
almost exclusively CD4+ T cells (>95%), and 48% (range 39-63%) co-expressed CD25. This result
suggests that a significant fraction of the pool of central memory T cells are in fact CD4/CD25+ T
cells, a population recently associated with immunoregulation. We further showed clear cut expres-
sion of peripheral tissue trafficking molecules on central memory T cells. We found that 47% (range
39- 56) of the central memory T cells expressed CLA, 75% (range 64-83) expressed CCR4, and
30% (range 19-40) expressed β7 integrin. Our results indicate that many cells with the phenotype
of regulatory T cells reside within the central memory population, and that, contrary to current dogma,
these cells have the requisite cell surface molecules to enter skin and GI tract from blood. A model
where these cells mediate tolerance to peripheral tissues is consistent with these findings. 
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Major histocompatibility class I processing of recombinant yeast antigens by dendritic cells
AC Stubbs,1 S Pan2 and CC Wilson2 1 Dept. of Dermatology, University of Colorado Health
Sciences Center, Denver, CO and 2 Division Of Infectious Diseases, University of Colorado Health
Sciences Center, Denver, CO
We have previously demonstrated the vaccine potential of recombinant yeast in mediating MHC
class I-resricted CD8+ cytotoxic T lymphocyte (CTL) responses. DCs may process exogenous anti-
gen for MHC class I presentation via a transporter associated with antigen processing (TAP)-depend-
ent cytosolic pathway, or a vesicular TAP-independent pathway. Since differences in these path-
ways might qualitatively and quantitatively effect the subsequent CTL response, we sought to
determine the relative use made by DCs of each pathway in the MHC class I processing of recom-
binant yeast-derived antigens, and the effect of processing via each pathway on priming naive, ver-
sus activation of memory CD8+ T cells. Naive T cell priming was investigated using naive MHC
class I-restricted antigen-specific T cells obtained from OT-I transgenic mice, whereas an antigen-
specific MHC class I-restricted T cell hybridoma served as a surrogate memory T cell. T cells were
co-cultured with recombinant yeast-pulsed DCs from normal or TAP-deficient mice in the presence
or absence of various inhibitors of either the cytosolic or vesicular pathways. The relative ability to
stimulate T cell activity was measured as a function of T cell proliferation (naive T cell priming),or
IFN-γ secretion memory T cell activation). We show that DCs employ both the cytosolic TAP-depend-
ent, and vesicular TAP-independent pathways in processing yeast-derived recombinant Ag for pres-
entation via the MHC class I pathway, although in both cases the cytosolic TAP-dependent route is
dominant. However, since the kinetics of MHC class I processing via the TAP-independent vesicu-
lar pathway is considerably faster than the cytosolic TAP-dependent pathway, and occurs prior to
DC maturation and co-stimulatory potential, we hypothesize that Ag processing via the vesicular
TAP-independent route might represent a conserved mechanism for rapid activation of memory T
cells that are less dependent on co-stimulation than naive T cells. 
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CXCR6 and its ligand are constitutively expressed in skin
K Ferenczi, J Murphy, R Krzysiek and TS Kupper Dermatology, Brigham and Women’s Hospital,
Boston, MA
Chemokine signaling is an essential component of T cell homing to tissues. BONZO/CXCR6 express-
ing lymphocytes have been currently identified as a subset of T cells specialized in homing to inflamed
tissues, such as rheumatoid joint and inflamed liver. However, the expression of CXCR6 and its lig-
and CXCL16 in the skin has not been characterized. In this study we analyzed the expression of
BONZO/CXCR6 on T cells in the peripheral blood and normal uninflamed skin. Our data showed
that in the peripheral blood only a very small subset (3%) of T cells expressed Bonzo, and 19% of
this small CXCR6+ T cell subset expressed CLA. In contrast, approximately 50% of T cells in the
skin were CXCR6 positive, and more than half of these Bonzo/CXCR6+ T cell expressed high lev-
els of CLA. By immunohistochemistry, normal skin showed abundant expression of CXCL16, its
chemokine ligand, by epidermal cells and endothelial cells. These data suggest that the role of this
chemokine receptor-ligand pair is not restricted to inflamed tissue. Whether CXCR6/CXCL16
interactions play a role in constitutive T cell trafficking to the skin and normal immune surveillance
remains to be determined, as does its expression in various inflammatory skin diseases. 
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Ultraviolet B irradiation impairs immune response to epicutaneous protein immunization via
antigen-specific CD4 /CD25 suppressor T cells
M Gohreishi1,2 and JP Dutz1,2 1 Department of Medicine, Division of Dermatology, University of
British Columbia, Vancouver, BC, Canada and 2 BC Research Institute for Children’s and Women’s
Health, University of British Columbia, Vancouver, BC, Canada
In a murine model, repeated cutaneous exposure to low doses of ultraviolet B impairs the induction
of contact hypersensitivity response to haptens and induces hapten-specific suppressor T lympho-
cytes. This study investigates whether exposure to UVB can impair the T cell response to peptide or
protein antigen. Using an adoptive transfer model, we have determined that UVB induces suppres-
sion of antigen-specific CD8 T cell proliferation and IFNg production in response to OVA protein
immunization in C57BL/6 mice. Epidermal sheet staining of mouse skin after UV irradiation shows
depletion of IA Langerhans cells in the basal epidermis. Nevertheless, UVB failed to induce sup-
pression of CD8 T cell priming in mice immunized only with the immunodominant MHC I restricted
OVA peptide suggesting that priming of CD8 T cells in the lymph nodes was unaffected by UVB in
the absence of antigen-related CD4 T cell epitopes. Suppression of protein antigen-specific CD8 T
cell priming was mediated by CD4 T cells since transfer of CD4 T cells from UVB irradiated and
OVA-immunized mice can induce the suppression of response to OVA immunization in a non-irra-
diated mouse. Functional analysis of CD4 T cell subsets using adoptive transfer reveals that the sup-
pressor effect of CD4 /CD25 T cells is dominant and depletion of this subset, abrogates suppression.
Conversely, adoptive transfer of this subset mediates suppression. We suggest that UVB promotes
the induction of antigen-specific CD4 /CD25 suppressor T cells. These in turn inhibit protein anti-
gen-specific CD8 T cell priming. The ability to generate antigen-specific suppression using UVB to
limit CD8 T cell responses may be of therapeutic value to prevent CD8 T cell mediated autoimmune
disease.
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Itraconazole suppresses an elicitation phase of a contact hypersensitivity reaction
T Yudate,1 K Ueno,1 MS Ashenager,1 T Markova,2 A Kawada,1 H Higashino2 and Y Aragane1 1
Dermatology, Kinki University School of Medicine, Osakasayama, Japan and 2 Pharmacology,
Kinki University School of Medicine, Osakasayama, Japan
Contact dermatitis is caused by epicutaneous exposure to environmemtally and/or industrially-derived
allergens. Since the exposure is unavoidable for many instances, therepeutic suppression of allergic
inflammation appears to be of clinical relvance. Recently, it is reported that itraconazole, an anti-
fungal agent, may be of therapeutic impact on allergic skin diseases. Therefore, we were interested
to study the effect of itracinazole on contact hypersensitivity. Mice(C3H/HeN or Balb/c) were admin-
istered with itraconazole orally before sensitization or challenge with haptens (dinitrofluoroben-
zene or oxazolon). Consequently, the administration of itraconazole before challenge but not before
sensitization, significantly suppressed the reaction. Intriguingly, itraconazole failed to suppress the
irritant dermatitis induced by croton oil or benzalkonium chloride, suggesting that it may affect
molecule(s) rather selectively involved in the elicitation of contact hypersensitivity. To further ana-
lyze mechanisms involved, splenic T cells obtained from sensitized or naive mice were stimulated
with plate-bound anti-CD3 in the presence or the absence of itraconozale and release of cytokines
was tested by ELISA assays. T cells from hapten-immunized mice produced a signifizant amount
of IFN-γ, which was merkedly suppressed by itraconazole. Together, the present study demon-
strates that itraconazole rather selectively suppresses the elicitation phase of contact hypersensitiv-
ity possibly via down-modulation of IFN-γ.
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Intradermal administration of a purinergic agonist augments the induction of immunity in
mice
RD Granstein,1 W Ding,1 S Kodali,1 A Holzer,1 K Seiffert,1 A Di Nardo,2 RL Gallo2 and
JA Wagner3 1 Dermatology, Weill Medical College of Cornell University, New York, NY, 2
Medicine, UCSD School of Medicine, San Diego, CA and 3 Neurology, Weill Medical College of
Cornell University, New York, NY
ATP signals through cell surface receptors that are either ionotrophic (P2X) or G-protein linked (P2Y)
and has been shown to modulate aspects of dendritic cell function. We have recently shown that the
murine Langerhans cell (LC)-like cell line XS106 responds to purinergic agonists with increased
expression of I-A, CD80 and C86. Also, secretion of IL-1β and IL-12 stimulated by GM-CSF/LPS
was augmented by a purinergic agonist while IL-10 secretion was decreased. Additionally, the hydrol-
ysis-resistant ATP analogue ATPγS significantly augmented the ability of BALB/c (H-2d) epidermal
cells to present antigen (KLH) to a responsive T cell clone [HDK-1 (H-2d)]. We have now examined
the ability of ATPγS to enhance vaccination of mice against tumor antigens and bacteria. CAF1 mice
(H-2a/d) were injected intradermally with a soluble extract of the S1509a spindle cell tumor (H-2a)
(TAA) mixed with 700 nanomoles of ATPγS or medium alone 3 times at 7-day intervals. One week
after the last immunization a hind footpad of each mouse was injected with TAA and 24-hour swelling
assessed as a measure of delayed-type hypersensitivity (DTH). ATPγS significantly increased the
DTH response. BALB/c mice were injected intradermally with 108 killed (freeze-thaw x 4) group A
streptococcus (GAS) mixed with 700 nanomoles of ATPγS or medium alone 3 times at 7-day inter-
vals. One week after the last immunization each mouse was challenged on the dorsum with live
GAS and lesion size scored over time. In preliminary experiments GAS alone led to the develop-
ment of larger lesions while immunization with ATPγS resulted in greatly decreased lesion size.
Purinergic agonists hold great promise as a new class of immunologic adjuvants. 
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Langerhans cells apoptosis mediated by CD4 T cells requires antigen specific cell contact
DT Warren,1,3 L Dandridge,3 J Genebriera,1 S Pradhan1 and L Timares1,2 1 Dermatology, University
of Alabama at Birmingham, Birmingham, AL, 2 Cell Biology, University of Alabama at
Birmingham, Birmingham, AL and 3 School of Medicine, University of Alabama at Bimingham,
Birmingham, AL
Antigen presenting cells (APC) susceptibility to apoptotic signals remains controversial. We demon-
strate that one APC member, the skin derived Langerhans cell (LC), is exquisitely sensitive to apop-
totic stimuli, significantly, in the presence of antigen-specific T cells. Apoptosis, detected by annexin
V and 7-AAD staining, occurred when murine LC or the LC line XS106 cells were cultured for 20
hours in the presence of the model antigen hen egg lysozyme (HEL) and HEL-specific 3A9 T cell
hybridoma lines but not other T cell lines. Apoptosis of HEL-pulsed LC was also observed in the
presence of naive CD4 T cells from 3A9 TCR transgenic mice and occurred concomitant with T cell
activation, as determined by blast formation, CD69 expression and IL-2 production. Apoptosis of
LC was preceded by LC activation as detected by increased surface staining for I-A, CD40 and CD69.
To test the requirement of LC-T cell interaction in mediating LC apoptosis, we cultured cells in the
presence of blocking antibodies to CD18 (LFA-1) and MHC-II. XS106-GFP clones exhibited resist-
ance to antigen-specific T cell-mediated apoptosis in the presence of inhibitor antibodies to LFA-1
and MCH II, resulting in 60%-90% inhibition. Significant levels of inhibition was also observed after
DC pre-treatment with blocking antibodies, however anti-I-A antibody pretreatment was not suffi-
cient to block apoptosis of LC by 3A9 T cells when cultured with LPS. To test the role of soluble or
membrane bound cytotoxic factors in mediating T cell-dependent LC apoptosis, specific antago-
nists for Fas or Trail were added during LC-T cell culture but had no effect. These data suggest that
LC-T cell contact and antigen-specific interaction is necessary and sufficient for inducing LC mat-
uration and subsequent LC apoptosis. 
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Targeting Notch in Kaposi’s sarcoma inhibits tumorigenesis
CL Curry,1,2 LL Reed,1 BJ Nickoloff1,2 and KE Foreman1,2 1 Oncology Institute, Loyola University,
Maywood, IL and 2 Microbiology/Immunology, Loyola University, Maywood, IL
Kaposi’s sarcoma (KS) is a common neoplasm in HIV-infected individuals causing significant mor-
bidity and mortality. The etiologic agent in this tumor is KSHV (KS-associated herpesvirus); how-
ever, it is currently unknown how KSHV causes KS. Notch proteins are a family of evolutionarily
conserved transmembrane receptors that play a fundamental role in cell fate decisions including pro-
liferation, differentiation and apoptosis. It is, therefore, not surprising that Notch proteins have been
implicated in tumorigenesis and appear to function as either oncogenes or tumor suppressors. In this
report, we demonstrate elevated expression of activated Notch-1, -2 and -4 in KS cells in vivo and/or
in vitro compared to normal endothelial cells (ECs), the precursor of KS cells. Notch activation was
confirmed through detection of Hes-1 (a primary target of the Notch pathway) in nuclei of KS cells
in vivo. KSHV infection may be partially responsible for altered Notch expression in KS as expres-
sion of the KSHV-encoded latency associated nuclear antigen (LANA) in ECs resulted in a 3-fold
increase in Notch-1 and -2 protein, but had no effect on Notch-4. To determine if Notch activation
was critical to KS cell proliferation, various immortalized KS cells were treated in culture with GSI-
I (gamma-secretase inhibitor-I), a small molecule inhibitor blocking Notch activation. GSI-I resulted
in either G2/M growth arrest or apoptosis depending on the KS cell line. Similar studies injecting
GSI-I into tumors composed of immortalized KS cells established on nude mice (n=7) demon-
strated a 58.7% reduction in tumor size (average: 2.2±0.4 cm3 reduced to 0.9±0.2 cm3; p=0.02).
This growth inhibition was characterized by the induction of apoptosis (detection of activated cas-
pase 3 and TUNEL positive cells) in treated, but not control tumors. We conclude: a) KS cells over-
express activated Notch compared to ECs, b) KSHV-LANA can enhance Notch expression, and c)
interrupting Notch signaling inhibits KS cell growth in vitro and in vivo. Thus, targeting Notch sig-
naling may be of therapeutic value in KS patients. 
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Cloning and expression of E6 and E7 gene of human papilloma virus type II in E. coli
F Wang,1 Z Bi,1 Q Wang,1 G Li,1 X Wang,1 Z Zhang,1 B Yan2 and Y Wan3 1 Nanjing Medical
University, Nanjing, China, 2 University of Rhode Island, Kingston, RI and 3 Biology, Providence
College, Providence, RI
Human papilloma virus (HPV) has been implicated in various types of human skin disorders. Emerg-
ing evidence indicates that infection with HPV is a necessary risk factor for the development of cer-
vical cancer. However, the molecular mechanisms through which HPV induces skin disorders or can-
cer remain to be elucidated. This project was designed to clone and express the genes encoding E6
and E7 protein of human papilloma virus type II (HPV II). The gene encoding for E6 and E7 of
HPV II was amplified by PCR from condyloma accuminatun samples, cloned into vector PGEX-
6P-1, pET-32a respectfully to form recombinant plasmid PGEX-6P-1/E7, pET-32a/E6, and then
two recombinant plasmids were transfected into E. coli BL21. The glutathione S-transferase-E7
(GST-E7) and thioredoxin-E6 (Trx-E6) fusion protein was expressed when induced by IPTG and
purified with Glutathione Sepharose 4B affinity column and 3S NTA resin affinity column. SDS-
PAGE and Western blotting were used to detect the expressed protein. The recombinant plasmid
was identified and confirmed with enzyme digestion and sequencing. A high level expression of
GST-E7, Trx-E6 fusion protein was obtained and purified successfully. The results from SDS-
PAGE and Western Blotting analysis suggest that molecular weights of E6 and E7 are 18 and 11
kDa respectively. We conclude that E6, E7 protein of HPV II could be expressed with high efficiency
in prokaryotic expression system and could be applied for characterization of HPV II and are use-
ful for further understanding of the mechanism of induction of skin disorders and cancer. 
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Construction of full-length cDNA differential display libraries for genital warts based on long
template PCR and full-length cDNA suppression subtractive hybridization
Q Wang,1 Z Bi,2 B Yan3 and Y Wan4 1 Guangdong Provincial Hospital, Guangzhou, China, 2
Nanjing Medical University, Nanjing, China, 3 University of Rhode Island, Kingston, RI and 4
Providence College, Providence, RI
FL-cDNA-SSH was performed between genital warts and normal skin. In the forward subtraction,
genital warts was used as tester and normal skin as driver for genes expressed highly or specifically
in genital warts lesions, whereas in the reverse subtraction, genital warts was the driver and normal
skin the tester for normal genes of high suppression because of HPV infection. The total RNA was
extracted and first-strand cDNA was synthesized directly from 10 µg total RNA. And the second-
strand cDNA was generated with Klenow fragment and T4 DNA ligase. The dscDNA was ligated
to the linker which included site digested EcoR I. Two tester populations were created with differ-
ent adaptors, but no adaptors with driver; the adaptors were used for subsequent PCR amplification.
The first hybridization was carried out with each tester population and the driver. After this first
hybridization, the two samples were combined and a fresh portion of heat-denatured driver was
added. The second hybridization generates templates for PCR amplification from differentially
expressed sequences between tester and driver. The products of secondary PCR were digested by
EcoR I and Sal I. This process produced DNA with 5’- EcoR I sticky end and 3’- Sal I sticky end,
which was directionally ligated with the EcoR I- Xho I arms of λ ZAP II vector followed by DNA
packaging and infecting host bacterial strain XL1-Blue MRF. According to plate plaques blue/clear
selection in presence of IPTG and X-gal, the percentage of recombinant plaques in both forward
and reverse differential display libraries of genital warts is 100%, while the cloning efficiency is high
too: 8.1x107 and 1.28x108, respectively. We used primer set of λ ZAP II 01 and λ ZAP II 02 on λ
ZAP II arm several bases outer the insert position by PCR. About 20 positive plaques which were
selected randomly have PCR products, varying from 1200bp to 7000bp. 
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Activation of liver X receptors inhibits the production of inflammatory cytokines by mono-
cytes in response to Propionibacterium acnes
GS Van Dyke and J Kim Division of Dermatology, UCLA School of Medicine, Los Angeles, CA
Propionibacterium acnes contributes to the pathogenesis of acne vulgaris, in part, by inducing mono-
cytes/macrophages to secrete proinflammatory cytokines. Previous studies have demonstrated that
P. acnes induces monocyte activation through NF-KB and that P. acnes induction of monocyte cytokine
production occurs through Toll-like receptor (TLR)2. Several therapeutic agents used in acne are
thought to act through anti-inflammatory mechanisms. Liver X receptors (LXRs) are nuclear recep-
tors activated by oxysterols, and their ligation has been shown to decrease the production of NF-
KB-induced proinflammatory cytokines in macrophages. Agonists of LXR have been shown to effec-
tive in decreasing inflammation in murine models of contact dermatitis. We undertook studies to
determine whether activation of LXR diminishes inflammatory cytokine production induced by P.
acnes. Adherent human peripheral blood mononuclear cells cultured in the presence of P. acnes pro-
duced decreased amounts of proinflammatory cytokines (e.g. IL-12) following pre-treatment with
the LXR agonist GW3965. These findings suggest a potential novel class of therapeutic agents for
acne.
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Malassezia laccase melanization, a novel mechanism for seborrhoeic dermatitis pathogenesis.
G Gaitanis,1 P Menounos2 and A Velegraki1 1 Mycology Reference Laboratory, Microbiology
Department, Medical School, University of Athens, Athens, Greece and 2 Molecular Biology
Laboratory, Military School of Nursing, Athens, Greece
Involvement of Malassezia yeasts in the pathogenesis of seborrhoeic dermatitis is well established
but no melanin associated mechanism has ever been proposed before. The purpose of the study was
to investigate the existence of laccase controlled melanization in Malassezia species by conventional
and molecular methods. Pigment production by Malassezia yeasts was assessed in 67 strains of M.
furfur, M. sympodialis, M. slooffiae, M. globosa, M. restricta, M. dermatis, M. obtusa and M. pachy-
dermatis in lipid supplemented Staib agar with or without KH2PO4 and creatine and L-DOPA agar
at 28oC, 32oC and 35oC. PCR amplification of sequences coding for laccase was performed with M.
sympodialis CBS 8741 reference strain DNA. The PCR amplification product was sequenced, aligned
and compared with laccase gene from the phylogenetically close Filobasidiella (Cryptococcus) neo-
formans. L-DOPA agar was the most suitable medium detecting melanization at 35oC. Different
melanization rates were detected in all Malassezia species, with M. furfur colonies producing less
pigment while M. dermatis colonies produced the most prominent brown color effect after 6 days
incubation at 35oC. Melanization is a well studied virulence factor in F. neoformans. The close homol-
ogy of the amplified gene sequences with those of F. neoformans denotes similar virulence and patho-
genetic laccase-associated mechanisms. Triggering of the immune response in seborrhoeic dermatitis
by Malassezia yeasts is well established although the exact pathogenetic mechanism has not been
defined. Malassezia melanization is a candidate mechanism through the ability of fungal melanins
to activate complement and to assist immune system evasion. 
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Analysis of the prevalence and genotyping of Borrelia burgdorferi sensu lato in Ixodes ricinus
ticks demonstrate for the first time the presence of B. valaisiana in Austria
M Glatz,1 B Baeck,1 V Fingerle,2 B Wilske,2 H Kerl1 and R Muellegger1 1 Department of
Dermatology, Medical University Graz, Graz, Austria and 2 Max-von-Pettenkofer-Institute,
Ludwig Maximilians University, Munich, Germany
(i) To determine the prevalence of Borrelia burgdorferi (Bb) sensu lato, the causative agent of Lyme
borreliosis (LB), in Ixodes ricinus tick vectors in an endemic area in Austria. (ii) To identify the Bb
genotypes present in those ticks. 518 ticks were collected in the summers of 2002 and 2003 by the
flagging method in a woodland recreation area of the city of Graz, Austria. All ticks were placed
into humidified tubes and stored at 4dgrC until separate DNA extraction for each tick with a com-
mercial preparation kit (QIAamp DNA mini Kit; Qiagen, Hilden, GER). Extracted DNA was ana-
lyzed using a two-step semi-nested polymerase chain reaction (PCR) to detect infection of ticks.
Primers were designed to amplify an 818bp fragment of the Bb ospA gene. PCR was followed by
restriction fragment length polymorphism (RFLP) analysis with 5 endonucleases (SfuI, SspI, BglII,
HindIII, Roche, Penzberg, GER; Kpn2I, Fermentas, St. Leon-Rot, GER) for genotype identification
of positive samples. 133/518 (26%) ticks were found to be positive for Bb, 65 (49%) of which were
nymphs and 68 (51%) were adults. RFLP analysis revealed 96 (72%) ticks to be infected with the
genotype B.afzelii, 20 (15%) with Bb sensu stricto (ss), 8 (6%) with B.garinii, and 3 (2%) with
B.valaisiana. 6 ticks (5%) were coinfected with B.afzelii and Bbss (5) or B.valaisiana (1), respec-
tively. We conclude that (i) a high percentage of ticks is infected with Bb, indicating a considerable
risk to contract LB after a tick bite in the study area. (ii) Tick nymphs may transmit Bb, which is of
practical importance as they are hardly visible by the naked eye. (iii) B.afzelii, the main pathogen
of dermatoborrelioses, is the most prevalent genotype in ticks, consistent with the predominance of
dermatological manifestations of LB in Europe. (iv) B.valaisiana, which may have the potential to
cause LB, was detected for the first time in Austria in this study. 
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Studies on skin vaccination via proteomic profiling of murine skin
C Huang, T DeSilva, K Van Kampen, CA Elmets and D Tang Dermotology, UAB, Birmingham AL,
AL
We have established a reference proteome map of murine skin allowing the resolution of greater than
five hundred protein spots in a single two-dimensional polyacrylamide gel. Forty-four protein spots,
corresponding to 28 different cutaneous proteins, were identified using MALDI-TOF MS and the
Mascot online database searching algorithm. Five molecular chaperones including ER60, GRP78,
HSP60, HSP70, and HSP27 were also identified. Of these, HSP27 expression was confined mainly
to the epidermis. We have demonstrated that HSP27 in mice skin was up-regulated and phosphory-
latd after epicutaneous application of an adenovirus vector encoding the tetanus toxin C fragment,
suggesting that HSP27 may be involved in the adenovirus-mediated skin vaccination. 
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Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4 T cells in
patients with hypersensitivity to mosquito bite
H Asada, M Saito, H Niizeki and S Miyagawa Dermatology, Nara Medical University, Kashihara,
Nara, Japan
Severe hypersensitivity to mosquito bites (HMB) is characterized by intense local skin reactions
and systemic symptoms such as high fever, lymphadenopathy, and hepatosplenomegaly. The patients
with HMB often have NK cell lymphocytosis associated with Epstein-Barr virus (EBV) infection.
We previously demonstrated that CD4 T cells of the patients proliferated well in response to mos-
quito salivary gland extracts and played a key role in EBV reactivation from latent state in NK cells.
Here we investigated whether mosquito antigen-stimulated CD4 T cells have any influence on
oncogenesis of EBV-infected NK cells in the patients. Purified CD4 T and NK cells of HMB patients
were cocultured in the presence of mosquito salivary gland extracts (4ug/ml), and the expression of
viral oncogenes (LMP1, EBNA2) was sequentially assessed by RT-PCR and immunostaining. The
expression of LMP1 mRNA remarkably increased at 12-168 hrs, and LMP1 antigen expression was
also enhanced from day 3 to day 7. In contrast, another viral oncogene EBNA2 expression was not
detected. To investigate whether mosquito antigen-stimulated CD4 T cells can induce NK cell lym-
phocytosis, PBMCs were stimulated with mosquito salivary gland extracts once per week and the
NK cell number was counted sequentially. In result, NK cell number on day 14 increased one and a
half times as many as the number at the beginning of the culture, and the number on day 28 was
equivalent to the number at the beginning. In contrast, NK cell number reduced to almost zero on
day 28 in culture without mosquito antigen or in culture without CD4 T cells. Furthermore, to know
whether viral oncogene was actually expressed in the mosquito bite sites, we examined mRNA expres-
sion of LMP1 in the skin lesions. In result, LMP1 mRNA was detected in the biopsy specimens taken
from the mosquito bite sites. These results suggest that CD4 T cells stimulated with mosquito sali-
vary gland extracts can induce expression of viral oncogene LMP1 in the NK cells and is involved
in NK cell oncogenesis. 
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SOCS-1 negative feedback mechanism of STAT1 activation is a key pathway in the dsRNA-
induced innate immune response of human keratinocytes
K Sayama, X Dai, M Tohyama, K Yamasaki, Y Shirakata, S Tokumaru, Y Yahata and K Hashimoto
Dermatology, Ehime University School of Medicine, Shigenobucho, Ehime, Japan
Toll-like receptor 3 recognizes virus-associated double-stranded RNA (dsRNA) and mediates innate
immune response in virus infection. dsRNA stimulates two intracellular signaling pathways: the
MyD88-dependent and -independent pathways. Previously, we showed that keratinocytes produce
various chemokines in response to dsRNA. However, the mechanism regulating the excessive innate
immune reaction is still unknown. We hypothesized that a signal transducer and activator of tran-
scription (STATs)-suppressors of cytokine signaling (SOCSs) systems regulate this innate immune
response in normal human keratinocytes, as STATs are key mediators in the MyD88-independent
pathway. Exposure to 10 mg/ml poly(I;C) induced normal human keratinocytes to produce MIP-1α,
MIP-1β, TNFα, IL-15, and IL-6. Since poly(I;C) phosphorylated STAT1 and STAT3, we studied
whether STAT1 or STAT3 are involved in this response using the dominant negative forms of STAT1
(STAT1F) and STAT3 (STAT3F). Transfection of STAT1F using adenovirus vector significantly
reduced the induction of these genes by poly(I;C), while STAT3F had a minimal effect. This indi-
cates that STAT1 primarily mediates the induction of these genes. Since SOCS-1 is a negative feed-
back regulator of STAT1 signaling and poly(I;C) enhanced SOCS-1 expression, SOCS-1 may neg-
atively regulate this poly(I;C)-induced gene expression. Transfection of SOCS1 inhibited the
phosphorylation of STAT1 and STAT3, and significantly reduced the induction of these genes by
poly(I;C). However, transfection of SOCS1 did not affect the activation of NF-kB by poly(I;C),
indicating that the inhibitory effect of SOCS-1 is not via NF-kB. Although poly(I;C) activated p38
and JNK, inhibitors of these pathways had no effects on the induction of these genes. In conclusion,
the SOCS-1 negative feedback mechanism of STAT1 activation is a key pathway in dsRNA-induced
MIP-1α, MIP-1β, TNFα, IL-15, and IL-6 production via the MyD88-independent pathway in nor-
mal human keratinocytes. 
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In vivo activity of soluble factor/s by Candida albicans that inhibit macrophagic IL-12 pro-
duction
N Tang,1,3 K Kang,1,3 P Mukherjee,1,3 M Hossain,1,3 T McCormick,1 K Cooper1,2 and
M Ghannoum1,3 1 Dermatology, University Hospitals of Cleveland, Cleveland, OH, 2
Dermatology, VA Medical Center, Cleveland, OH and 3 Center for Medical Mycology, Case
Western Reserve Universtiy, Cleveland, OH
We have previously demonstrated that culture supernatants of C.albicans (CA) can effectively inhibit
IL-12 production by human monocytes induced by lipopolysaccharide (LPS) and interferon γ (γ-
IFN) in vitro, although monocyte MCP-1, IL-1β, TNFα and IL-10 were induced. The IL-12 inhibi-
tion is mediated through stimulation of ERK MAPK and inhibition of p38. We next investigated the
in vivo impact of CA supernatants on macrophage IL-12 production. To determine the in vivo con-
sequence of secreted immunomodulatory CA factor, we transferred to a murine system. Macrophages
were prepared from C57BL/6 mice elicited by thioglycollate and IL-12 production induced by LPS
and γ-IFN. CA culture supernatants inhibited IL-12p70 (ELISA) by 32 % from 571 pg/ml to 387
pg/ml (p<0.05, n=3) .This indicated that macrophage in addition to human monocyte was attributed
to IL-12 inhibition by CA supernatants. IL-12 production in vivo was optimized using C57BL/6 mice
pretreated for 5 days with thioglycollate peritoneally (ip) and combining a priming ip injection with
100 ng LPS with an iv injection of 1µg LPS 1 h later . CA supernatant was injected in prior to LPS,
and six hours later, serum was collected. Our data showed that the levels of IL-12 detected in the
sera of mice with CA culture supernatant were significantly inhibited from 216pg/ml to 81pg/ml
(p<0.005). In conclusion, our findings demonstrated that the CA soluble factors are an important
IL-12 inhibitor both in vitro and in vivo, and may modulate immune responsiveness of already
immunocompromised hosts at sites distant from the priming inhibition as well as locally. 
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Lymphatic reprogramming of blood vascular endothelial cells by Kaposi′s sarcoma-associated
herpes virus
Y Hong,1 K Foreman,3 J Shin,1 S Hirakawa,1 CL Curry,3 DR Sage,2 T Liberman,2 BJ Dezube,2
JD Fingeroth2 and M Detmar1 1 Massachusetts General Hospital/Harvard Medical School,
Charlestown, MA, 2 Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA
and 3 Loyola University Medical Center, Maywood, IL
Kaposi′s sarcoma (KS) is the most frequent cancers in HIV positive patients. KS-associated herpes
virus (KSHV) is essential for the tumor formation and development of KS. KSHV infected cells are
associated with slit-like vessels that often contain red blood cells. KS is generally considered as a
neoplasm of KSHV-infected lymphatic endothelium, due to the expression of lymphatic markers
such as VEGFR-3 and podoplanin by the tumor cells. However, KS cells also express some blood
vascular markers and, therefore, the histogenetic origin of KS remained unknown. Previously we
defined the transcription factor Prox1, essential for the lymphatic vessel development from embry-
onic veins, as a master control gene that mediates lymphatic endothelial differentiation. Ectopic
expression of Prox1 in blood vascular endothelium resulted in re-programming of these cells to adopt
lymphatic endothelial cell differentiation. This switch was associated with the inhibition of blood
vessel-specific markers and with the induction of lymphatic markers, including LYVE-1, VEGFR-
3 and podoplanin. Importantly, we found that infection of cultured human cutaneous blood vascu-
lar endothelial cells with KSHV re-programs these cells to express lymphatic endothelial markers,
including Prox1, LYVE-1, VEGFR-3 and podoplanin. Immunocytochemical study shows that more
than 90% vascular endothelial cells positive for KSHV latency associated nuclear antigen (LANA)
strongly express Prox1. These results were confirmed by immunostains of KS tissue samples. Fur-
thermore, expressions of some blood vessel specific markers, such as endoglin and collagen type
IV, are still maintained in KSHV-infected blood vascular endothelial cells in vitro as well as in
tumor biopsy samples. Based on these findings, we hypothesize that KSHV induces lymphatic re-
programming of blood vascular endothelial cells in KS tumor lesions. 
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Skin microenvironment dictates susceptibility of bacteria to antimicrobial peptides
RA Dorschner, B Lopez-Garcia and RL Gallo Medicine/Dermatology, UCSD, San Diego, CA
A contradiction exists between in vivo and in vitro observations of antimicrobial peptide (AMP)
activity. In bacterial culture media AMPs are inactivated in the presence of 125mM NaCl and 10%
serum, nevertheless they function well in vivo. Expression of AMP correlates with innate antibiotic
activity in plants, insects and mammals. To understand how human AMPs can function in vivo, we
investigated bacteriacidal action in a culture environment resembling mammalian skin and found
that AMPs remain active in the presence of NaCl and serum. Bacteria such as Staph. aureus and
MRSA, previously reported to be resistant to the human cathelicidin LL-37, become highly sus-
ceptible to LL-37 in this environment. Sequential analysis revealed that carbonate anion is an essen-
tial antimicrobial enhancing factor (AEF) normally present in the host microenvironment. AEF
increases the susceptibility of many Gram negative and positive bacteria and Candida albicans to
multiple AMPs, including cathelicidins, alpha and beta defensins. This occurs at physiological pH
and at physiologically relevant concentrations of carbonate, but not with other anions or buffers. Bac-
terial susceptibility persists for at least 2 hrs after removal of AEF, indicating that the effect of AEF
is on the target bacteria and not peptide structure. Kinetic analysis of killing and electron microscopy
confirmed these observations. Membrane permeability assays and gene chip analysis demonstrated
that AEF causes an increase in the permeability of the E. coli inner membranes and influences expres-
sion of the regulatory gene, Bar-A. This controls OmpR, a global transcription factor critical for
stress response. The alteration in expression of some or all of these genes is therefore an important
determinant in bacterial resistance AMPs. These findings illustrate how AMPs, molecules that have
evolved to kill potential pathogens, have done this in the unique mammalian microenvironment. Such
a strategy inactivates natural AMPs outside of the host and minimizes pressure for the microbe to
develop resistance. 
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Subsets of murine blood monocytes—Trojan horses in infection
CH Sunderkoetter,1,4 D Drevets,3 J Ehrchen,4 T Nicolic2 and P Leenen2 1 Dermatology, Univ. of
Ulm, Ulm, Germany, 2 Immunology, Erasmus MC, Rotterdam, Netherlands, 3 Medicine, Oklahoma
Univ, Oklahoma City, OK and 4 Exp Dermatol, Muenster Univ, Muenster, Germany
In some infections phagocytic cells transport microbes through the blood and enable their entry into
certain organs. The exact identity of these phagocytes is not known. Different monocyte subsets have
been characterized in the human, but not yet in the murine system. Our goal was to identify mono-
cyte subsets in the mouse, to analyze their differeniation and their role in infections with Listeria
monoctyogenes or L.major. We found that differential expression of Ly-6C divides mouse mono-
cytes into three subsets, i.e. into Ly-6Chi / med / low. In addition, these subsets also show differen-
tial expression of CD43, CD11c and CD62L. By cell sorting we revealed that these subsets all express
MCSF-R (CD115), and that they can develop into both macrophages or dendritic cells, depending
on added growth factors. By eliminating blood monocytes with clodronate-loaded liposomes and
monitoring their repopulation we showed that monocytes reappearing in circulation were all of the
immature Ly-6Chi subset which presented the subset released from bone marrow. In circulation their
expression of Ly-6C was downregulated. Chronic infection with L. major and acute infection with
Listeria monocytogenes resulted in significant increase of immature Ly-6Chi monocytes, similar to
the inflammatory “left shift” of granulocytes. We found that Ly-6Cmed/hi monocytes were the ones
preferentially recruited to inflamed tissue sites. In blood this subset also harbored the majority of
Listeria and, unexpectedly, sometimes even L. major. Importantly, in Listeriosis it was this subset
that transported bacteria into the brain. There are distinct developmental subsets of murine blood
monocytes of which Ly-6Chi monocytes are preferentially recruited to inflammatory sites; These
subtypes harbor certain pathogens during experimental infection; The Ly-6Chi subset is a Trojan
horse which carries L. monocytogenes into the brain. 
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Expression of Toll-like receptors in human and mouse keratinocyte cell lines and in normal
and diseased skin
H Jang1 and CL Reardon2 1 Dermatology, Pusan National University Hospital, Pusan, South Korea
and 2 Dermatology, University of Colorado Health Science Center, Denver, CO
Toll-like receptors (TLRs) recognize conserved molecular structures in microbes called pathogen-
associated molecular patterns and play critical roles in the induction of antimicrobial responses against
microbial invasion in host cells.  TLRs are abundantly expressed on monocytes/macrophages and
neutrophils.  Keratinocytes, the major constituent of the epidermis, interact directly with pathogenic
bacteria and their constituents in the external environment.  Recently, human keratinocytes have been
suggested to participate in innate host responses to bacterial products and invasive bacteria.  How-
ever, expression of TLRs in keratinocytes and in normal and diseased skin still is not well defined.
By using the human (U937) and mouse (RAW264.7) macrophage cell lines as positive controls,
expression of TLRs was investigated in human (CL-22) and mouse (Balbc/MK) keratinocyte cell
lines and in whole normal and diseased skin. Using RT-PCR, U937 cells expressed TLR1,2,4,5,6
mRNAs.  CL-22 cells expressed TLR1,2,3,5,6 mRNAs.  RAW264.7 and Balbc/MK cells expressed
all 6 TLR mRNAs.  Whole normal human skin expressed TLR1,2,4,5,6 mRNAs that were mostly
expressed by the epidermis. Immunohistochemistry of normal skin showed expression of TLR1,2,3,5,6
in the epidermis with different staining patterns.  In addition to the epidermis, eccrine sweat glands
expressed TLR1,2,4,5 and follicular structures expressed TLR1,2,3,5,6.  Psoriatic and S. aureus-
infected skin showed increased expression of TLR1,2,5,6 compared to normal skin.  These results
help support the notion that keratinocytes have a role in innate immune host responses of the skin. 
796
Virus replication begins in Langerhans cells and not in dermal dendritic cells during trans-
mission of HIV from skin emigrants to T cells
T Kawamura,1 T Iwamoto,1 Y Koyanagi,2 M Ito,3 A Blauvelt4 and S Shimada1 1 Dermatology,
University of Yamanashi, Nakakoma, Yamanashi, Japan, 2 Microbiology, Tohoku University,
Sendai, Miyagi, Japan, 3 Microbiology, University of Yamanashi, Nakakoma, Yamanashi, Japan
and 4 Dermatology Branch, NCI, Bethesda, MD
Mucosal Langerhans cells (LC) or sub-mucosal dendritic cells (DC) are suspected to be the initial
cells that support HIV replication following sexual exposure to virus. Recently, novel C-type lectins,
Langerin and DC-SIGN expressed on LC and DC respectively, have been shown to bind HIV and
facilitate viral infection of resting T cells in trans. Therefore, we studied relevant host molecular tar-
gets utilized for acquisition of HIV infection using a skin explant model system. HIVBaL (a proto-
typic CCR5-using isolate) was applied to the abraded epidermal surface of skin explants. After 3
days, emigrant cells from skin explants were co-cultured with allogeneic T cells. HIV p24 levels in
culture supernatants were monitored by ELISA. Interestingly, pre-incubation of skin explants with
PSC-RANTES, a CCR5 inhibitor, completely blocked subsequent HIV transmission from emigrant
cells to T cells, whereas anti-DC-SIGN mAb, or mannan, a potent C-type lectin inhibitor, did not.
Strikingly, when infection levels of single LC or DC within emigrant cells were determined by flow
cytometry 3 days following HIV exposure, HIV p24+ cells were detected only in LC, but not in DC.
To further test whether HIV could replicate within LC, skin explants were exposed to HIV variants
that were engineered to express GFP during productive infection of cells. Interestingly, HLA-DR+/
Langerin+/ GFP+ emigrated cells were detected in LC-T cell conjugates, when a CCR5-using HIV
isolate (NLCSFV3EGFP), but not a CXCR4-using HIV isolate (NL43EGFP), was applied to skin.
Thus, CCR5-mediated productive HIV infection of LC, and not C-type lectin-mediated capture of
virus by DC, may provide a biologic basis for understanding susceptibility to initial infection by
CCR5-using strains of HIV in humans. 
794
Staphylococcal lipotechoic acid inhibits delayed type hypersensitivy reactions via the platelet
activating factor receptor: a novel mechanism by which staphylococcal infections can worsen
atopic dermatitis
N Mousdicas, Q Zhang and JB Travers Dermatology, Indiana University, Indianapolis, IN
Bacterial skin infections with Staphylococcus aureus cause significant morbidity and can even result
in mortality. Skin infection or even colonization with staphylococcus aureus is a known trigger for
inflammatory skin diseases, especially atopic dermatitis. Thus, the mechanisms by which staphylo-
coccal infections can modulate immune responses are an active area of study. Recent studies have
suggested that staphylococcal lipotechoic acid, a constituent of the cell wall of this Gram-positive
bacteria, can act as an agonist for the receptor for the lipid mediator platelet-activating factor (PAF-
R). The objective of the present studies was to use model systems consisting of PAF-R-positive and
negative cells and mice deficient in PAF-Rs to demonstrate that lipotechoic acid is a potent PAF-R
agonist. Treatment of the PAF-R-negative human epithelial cell line KB transduced with PAF-R
(KBP) cells with lipotechoic acid resulted in an intracellular calcium mobilization and enhanced
cytokine (IL-8, TNF) production over retroviral control transduced (KBM) cells. Similarly, lipote-
choic acid-mediated signaling in the PAF-R-positive keratinocyte-derived cell line HaCaT was inhib-
ited by pretreatment with PAF-R antagonists. Intradermal injection of lipotechoic acid resulted in
an urticarial reaction in wild-type C57BL6 but not PAF-R-/- mice. Because the PAF-R upregulates
a number of immunomodulatory compounds, including interleukin-10 and prostaglandin E2, the
hypothesis that lipotechoic acid could inhibit delayed type hypersensitivity (DTH) reactions in vivo
was assessed. Exposure to a PAF-R agonist or lipotechoic acid suppressed DTH reactions due to top-
ical DNFB in wild-type, but not in PAF-R-/- mice. We propose that lipotechoic acid exerts inflam-
matory and immunomodulatory effects via the PAF-R. This finding could potentially provide a novel
mechanism for how staphylococcal infections can inhibit TH1 reactions and thus worsen TH2 skin
diseases such as atopic dermatitis. 
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Susceptibility in BALB/c mice is not the result of diminished recruitment of CD4+ or CD8+ T-
cells to Leishmania lesions
K Moelle, S Lopez, J Knop and E von Stebut Department of Dermatology, Johannes Gutenberg-
University, Mainz, Germany
Healing in leishmaniasis is associated with IFNγ-production by CD4+/Th1-cells. Recently, the induc-
tion of CD8+ cells during infection and thus their physiological relevance in resistant C57BL/6 was
shown. We previously described that fusion proteins composed of HIV-1 TAT and Leishmania-anti-
gen LACK efficiently vaccinate against progressive disease in otherwise Th2-prone BALB/c mice
by facilitating MHC class I-antigen presentation. Thus, priming of Leishmania-specific CD8+ cells
is beneficial for protective immunity. In contrast to CD4+ cells, the role of CD8+ cells in infected
BALB/c mice is not known. Therefore, we now investigated the frequency of CD8+ T-cells in L.
major lesions. BALB/c or C57BL/6 ear skin was infected with 2x105 promastigotes. At multiple time
points, lesional inflammatory cells were isolated and characterized by FACS. As described previ-
ously, BALB/c mice showed progressive disease from wk3 on, whereas lesions in C57BL/6 mice
peaked at wk4 and resolved by wk7. BALB/c lesions contained significantly more total cells than
C57BL/6 ears from wk3 on (e.g. 12±1 vs. 5±1x106, wk5, p<0.002) with most dramatic differences
in the number of neutrophils. Furthermore, an increase in CD4+ cells was observed starting at wk3
reaching 1x105 cells. In contrast, the number of CD8+ cells was significantly lower (30±5 vs.
100±17x103, wk4, p<0.05) and immigration of CD8+ cells was delayed (starting at wk5 vs. wk3).
No strain-specific differences were found regarding the numbers of recruited T-cells. In contrast,
accumulation of CD11c+ DC in BALB/c skin was higher than in C57BL/6 lesions (e.g. 3±0.2 vs.
0.5±0.2x106, wk6, p<0.002) confirming our previous finding that DC alone are not sufficient for
mediating protection. In summary, our results demonstrate that, although BALB/c mice are unable
to heal, CD4+ and CD8+ T-cell recruitment to lesional skin is not different from C57BL/6 mice. Thus,
further studies have to explore the nature of these CD8+ cells (Tc1 vs. Tc2) in BALB/c mice and their
potential use for vaccination strategies. 
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An important role of IL-27 for the development of protective Th1-immunity against Leishma-
nia major
S Zahn,1 S Wirtz,2 J Knop,1 MF Neurath2 and E von Stebut1 1 Department of Dermatology,
Johannes Gutenberg-University, Mainz, Germany and 2 1st Department of Medicine, Johannes
Gutenberg-University, Mainz, Germany
Leishmania major-infected dendritic cells (DC) release IL-12 and facilitate the development of pro-
tective immunity against L. major infections, which is strictly dependent on IFNγ-producing CD4+
Th1 or CD8+ Tc1 cells. Resolution of cutaneous lesions in leishmaniasis is mediated by IFNγ-acti-
vated macrophages that eliminate the intracellular parasite via NO2-. A novel IL-12 family member,
IL-27, is a heterodimer composed of the p40-related protein Epstein-Barr virus-induced gene 3 (EBI3)
and p35-related protein p28. IL-27 binds to the WSX-1 receptor on Th0/Th1 cells and is produced
by activated DC. Here, we utilized EBI3-deficient (C57BL/6) mice to investigate the role of IL-27
in cutaneous leishmaniasis. We used the more physiologically relevant low dose infection model
(1,000 infectious stage metacyclic promastigotes injected i.d.) that closely mimics natural trans-
missions by the sandfly. Lesions in EBI3-/- mice were significantly larger between wk 3-10 post
infection, most dramatic differences were found between wk 6-8 reaching ~3-fold increased lesion
volumes compared to wild type (WT) controls (34±4 vs. 12±1 mm3 at wk 6, n≥10, p<0.002). The
lesions of EBI3-/- mice also contained greater numbers of parasites reaching a peak load of 9x106
parasites/ear at wk 6 (WT mice: 1x105 parasites/ear, n=10, p<0.05). In accordance with WT C57BL/6
mice, lesions in EBI3-/- mice resolved after 10-12 wks. Antigen-specific restimulation of draining
lymph node cells revealed that in the early phase of the infection (up to 6 wks post infection) EBI3-
/- mice showed impaired IFNγ production (0.3±0.1 vs. 1.7±0.6 ng/ml at wk 2, n=10, p<0.05) and
increased levels of IL-4 (195±47 vs. 57±7 pg/ml) as compared to WT controls. This was restored to
the WT level at 8 wks post infection. In summary, our data suggest that – in addition to IL-12 – IL-
27 plays a critical role for the establishment of Th1 immunity in this model of an important human
infectious disease. 
800
Transgenic delivery of an antimicrobial propeptide protects against bacterial skin infection:
making Mighty Mouse
PA Lee,1 T Ohtake,3 M Zaiou,1 M Murakami,2 JA Rudisill1 and RL Gallo1 1
Medicine/Dermatology, UCSD, San Diego, CA, 2 Dermatology, Asahikawa Medical College,
Asahikawa, Japan and 3 Medicine, Asahikawa Medical College, Asahikawa, Japan
Cathelicidin antimicrobial peptides are essential for skin defense against microbial pathogens.
However, unlike other mammals, humans and mice have only one cathelicidin gene. We hypothe-
sized that supplementing the native human or mouse cathelicidins (LL-37 and mCRAMP respec-
tively) with a xenobiotic cathelicidin (pig PR-39) would enhance resistance against infection. In bac-
terial culture, PR-39 was found to act synergistically with mCRAMP to kill Group A Streptococcus
(GAS). In cells, human keratinocytes normally producing LL-37 were engineered to also express
PR-39 by lentivirus and killed 1000X more GAS than vector controls. In mice, transgenes were engi-
neered to constitutively express either PR-39 or mCRAMP in basal keratinocytes using a K14 pro-
moter. These constructs were designed to express the inactive precursor form of PR-39 or mCRAMP
since injection of PR-39 in mouse skin induced a leukocytic infiltrate when applied in its mature
form. Transgenic mice were evaluated by Southern blot, RT-PCR, immunohistochemistry and West-
ern blot, and 2 independent lines were selected for analysis of each construct. Both K14-mCRAMP
and K14-PR-39 transgenic mice were indistinguishable from wild-type littermates when housed
under sterile conditions. K14-PR-39 transgenic mice processed the precursor to the mature form
and showed increased resistance to skin infection when inoculated with GAS (50% smaller necrotic
ulcers and 90% fewer surviving bacteria in the skin). By comparison, K14-mCRAMP transgenic
mice did not show increased resistance to infection. Therefore, we show that targeted gene transfer
of an inactive xenobiotic cathelicidin precursor confers resistance against invasive bacterial infec-
tion. This approach enhances immune defense by adopting the innate defense strategy of requiring
proteolytic processing for activation and mimicking the synergistic expression of antimicrobial pep-
tides that has evolved in some mammals. 
801
Bacterial lipopolysaccharide induces human β defensin 2 expression in cultured human der-
mal endothelial cells
A Shibaki, D Sawamura, H Nakamura, K Sakai and H Shimizu Department of Dermatology,
Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
Skin is the first line of defense against the invasion of microbial agents. A number of endogenous
antimicrobial peptides, including β defensins, are produced by keratinocytes, and play an integral
part in innate skin immunity. Once the epidermis is breached after injury, infiltrating leukocytes (neu-
trophils and macrophages) act against this invasion using anti-microbial agents. In addition, resi-
dent dermal cells, including the dermal microvasculature endothelial cells, may play an important
role in the innate cutaneous immunity. The aim of this study is to investigate whether human der-
mal microvasculature endothelial cells play a role in the defense against microbial agents, by pro-
ducing any antimicrobial peptides, such as the β defensins. Immortalized human dermal microvas-
culature endothelial cells (HMVEC) were cultured with various concentrations of stimulatory reagents
(lipopolysaccharide (LPS), human β defensins 2 and 3). At different time points, total RNAs were
prepared from the samples, and the expression of target mRNA was analyzed by RT-PCR. In addi-
tion, HMVEC were cultured on type I collagen coated slide glasses with or without various con-
centrations of LPS. The expression of β defensin 2 was analyzed at different time points by fluo-
rescence immunohistochemistry using a confocal microscope. LPS induced β defensin 2 HMVEC
mRNA expression, at a maximum of 24 hours after stimulation. All of the tested stimuli failed to
induce β defensin 3 mRNA expression in HMVECs. HMVEC produced β defensin 2 peptide that
was detected as early as 24 hours after LPS stimulation. In conclusion, human dermal microvascu-
lature endothelial cells may play a role in the defense against microbial agents, by producing the
antimicrobial peptide, β defensin 2. 
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Introduction to beta-defensin-3 to epidermal keratinocytes
D Sawamura, M Goto, A Shibaki, KC Sato-Matsumura, JR McMillan, M Akiyama and H Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Defensins are small cationic proteins that directly kill a broad spectrum of microbes. In the epider-
mis, 3 types of human beta-defensins (HBD), HBD1-3, have been well characterized so far. HBD1
and HBD2 show antimicrobial activity predominantly against Gram-negative bacteria, while HDB3
kills both Gram-negative and Gram-positive bacteria. An increase of resistant bacteria against con-
ventional antibiotics requests to develop a new strategy for anti-infection therapies, and antimicro-
bial gene therapy using defensin genes can be one of potential choices in the near future. In this study
we first examined the localization of HBD3 in the normal skin. Immunohistochemical staining found
HBD3 in granular and horny layers, and further immnoelectron microscopy detected HBD3 in the
lamellar bodies and the intercellular space. Next, we introduced the HBD3 gene to cultured HaCaT
cells to generate a keratinocyte cell line stably expressing HBD3. The transduced cells produced
detectable HBD3, which showed strong antimicrobial activity in bacterial colony-forming unit analy-
sis. Furthermore, we then grafted those HBD3-engineered HaCaT cells to skin defect of the nude
athymic rats, and then applied bacteria onto the HaCaT-cell stratified epidermis. The number of
recovering bacteria in the skin with the HBD3 gene was significantly lower than that in control skin.
These findings suggest that introduction of the HBD3 gene to keratinocytes is great potential for
controlling bacterial infections in the skin. 
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Small interfering RNA (siRNA) inhibition of Kaposi’s sarcoma-associated herpes virus (KSHV)
latency-associated nuclear antigen (LANA)
A Niedermeier, R Sells and A Blauvelt Dermatology Br., NCI, Bethesda, MD
KSHV is a human γ-herpesvirus that is found in all clinical forms of Kaposi’s sarcoma (KS) as well
as primary effusion cell lymphoma (PEL) and the plasmablastic variant of Castleman’s disease.
LANA is a KSHV gene that is expressed in virtually all cells latently infected with KSHV, includ-
ing all KS tumor cells. LANA is likely to be important, if not critical, in KS pathogenesis since it
binds to and interferes functionally with both p53 and pRb. In addition, LANA tethers episomal
KSHV DNA to chromosomal DNA, thus ensuring viral propagation into daughter cells during
mitosis. The objectives of this study were to 1) inhibit LANA by siRNA and 2) to examine the viral
and biologic consequences of inhibiting LANA in KSHV-infected cells. We designed a number of
double-stranded 21-nucleotide RNA oligomers targeting LANA and assessed their silencing effects
in an in vitro test system. siRNA nucleotides were transfected into BHK cells together with a plas-
mid encoding an EGFP-LANA fusion protein (pEGFP-LANA). Using flow cytometry to detect
EGFP+ cells, we discovered up to 80% silencing of LANA compared to cells that were either trans-
fected with pEGFP-LANA alone or with pEGFP-LANA and a commercially available non-specific
control siRNA. To further assess the specificity of our siRNAs, we designed control siRNAs with 1
or 3 base pair mutations located at or around position #11 and assessed these siRNAs for their gene
silencing effects. Dramatically, 1 or 3 base pair mutations in the target sequence of the siRNA led
to a 63-94% reduction of silencing compared to the unaltered siRNAs. Next, we established opti-
mal electroporation conditions for transfection of BCBL-1, a PEL cell line latently infected with
KSHV, using pEGFP-C1 (a plasmid encoding EGFP). Currently, experiments are underway to silence
endogenous expression of LANA in BCBL-1. Assessing the virologic and biologic effects of inhibit-
ing LANA in KSHV-infected cells should allow us to determine whether LANA represents an attrac-
tive therapeutic target for patients with KS and other KSHV-related diseases. 
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Control of skin infection with Pseudomonas aeruginosa is mast cells dependent
W Syska, J Knop and M Maurer Dermatology, Johannes Gutenberg-University, Mainz, Germany
We and others have previously shown that mast cells (MC) are essential for initiating efficient
innate immune response in murine sepsis. Here we asked whether MC are involved in controlling
bacterial skin infections to Pseudomonas aeruginosa (PA). Genetically MC-deficient Kitw/Kitw-v mice
and normal Kit+/+ mice were subjected to infections with PA by s.c. injection of 6.5x106 colony
forming units (CFU) (0.1 ml, shaved lower back). Developing skin lesions characterized by infil-
tration and subsequent necrosis were markedly larger (up to 2 fold as assesed by planimetric analy-
sis) in Kitw/Kitw-v mice than in Kit+/+ mice at all time points studied (every 2-6h, for 72h). Kitw/Kitw-
v mice skin lesion size reached a maximum at 36h after infection (1.8 cm2 vs. 1.0cm2 in Kit+/+ mice).
Local MC-reconstitution of Kitw/Kitw-v mice resulted in normally controlled PA infections that were
virtually indistinguishable from those in Kit+/+ mice, indicating that immune responses to PA are
MC-dependent. Furthermore, skin infection sites of more than 50% of Kit+/+ mice and MC-recon-
stituted Kitw/Kitw-v mice were found to be cleared from PA 24h after infection, whereas large num-
bers of PA (up to 10.000 CFU/cm2) were detected in skin infection sites in nearly all Kitw/Kitw-v
mice tested. By histomorphometric analysis we found significantly increased numbers of degranu-
lated MC at sites of infection. To test whether activated MC can recruit neutrophils to sites of PA
infection we assessed myeloperoxidase (MPO) levels in PA infected skin of Kit+/+ and Kitw/Kitw-v
mice. MPO levels were increased in both groups of mice 3 hours after infection, but levels of MPO
in Kit+/+ mice were significantly higher (up to 2 fold) than in Kitw/Kitw-v mice. Our data suggest
that activated MC induce neutrophil influx, control skin lesion size and promote containment of
bacteria at sites of skin infections with PA. 
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Papillomavirus-like particle amyloid beta vaccine induces strong antibody response
A Handisurya,1 S Shafti-Keramat,1 E Zamora,2 JC Troncoso2 and R Kirnbauer1 1 Dermatology,
Univ. of Vienna Medical School, Vienna, Austria and 2 Neurology, Johns Hopkins Univ., Baltimore,
MD
The non-infectious virus-like particles (VLP) composed of major capsid protein L1 of papillo-
maviruses are successfully being tested in humans as vaccine to prevent HPV infection and associ-
ated neoplasia. In addition, chimeric VLP have been generated that incorporate foreign or self-anti-
gens, and immunizations have induced high levels of (auto-)antibodies (ab), whereas immunizations
with linear peptides were less effective. Ab were long-lasting and functionally active in experimen-
tal animal models. The neuro-degenerative disorder Alzheimer`s disease (AD), is characterized by
neurofibrillary tangles and amyloid plaques, consisting of amyloid-beta (Abeta) fibrils. There is no
effective therapy to prevent/cure AD. Recent studies have focused on anti-Abeta ab to inhibit fibril
formation and/or to resolve Abeta-aggregates. Using the baculovirus system, chimeric bovine papil-
lomavirus (BPV1) L1 (Abeta-VLP) was generated inserting 9 amino acid (aa) N-terminal peptide
of Abeta into an immunogenic VLP surface loop. Electron micrographs demonstrated efficient self-
assembly into capsomeric VLP. Expression of inserted Abeta epitope was verified by Western blot.
This peptide shows aa sequence identity in human and rabbit representing a self-antigen for both
species. To examine whether Abeta-VLP are capable to break B-cell tolerance, NZW rabbits were
immunized with Abeta-VLP using Freunds adjuvans. After five months no signs of toxicity were
observed. By ELISA, rabbit inoculated with Abeta-VLP developed strong ab response (titer>10.000)
to Abeta peptide 1-9, whereas control rabbit did not. Reactivity was specific for the Abeta epitope
and blocked by homologous, but not control peptide. Immune sera recognized amyloid plaques in
post mortem brains sections of AD patients. These data support VLP as a tool to overcome tolerance
to self-antigens with potential of inducing therapeutically useful auto-ab responses in humans. This
hypothesis is currently evaluated by in vitro and in vivo models of AD. 
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Specification of Staphylococcus aureus infection requirements for TNF-α induction
BM Aufiero, Z Duanmu and GJ Murakawa Dermatology, Wayne State University, Detroit, MI
Tumor necrosis factor- alpha (TNF-α) is a pleiotropic cytokine and is responsible for a diverse
range of biological processes including the inflammatory immune response, apoptosis and tumor
necrosis. We have shown that S. aureus induces TNF-α rapidly (2h) and robustly (55x) and is one
of the first cytokines induced, suggesting direct activation by S. aureus infection. To further under-
stand the mechanism by which S. aureus elicits the TNF-α response, we examined infection prop-
erties, such as bacterial invasion. To determine whether invasion is required for TNF-α induction,
keratinocytes were treated with cytochalasin D, an inhibitor of actin polymerization and S. aureus
invasion. Cytochalasin D treatment failed to block TNF-α induction. To determine whether bacter-
ial components on the cell surface are sufficient to induce TNF-α expression, we infected keratinocytes
with live versus dead bacteria. UV- and heat-killed bacteria were incubated for 4 hours with ker-
atinocytes at 1000-fold higher concentrations than live bacteria. We found that only live, not dead,
bacteria induced TNF-α. As a control, we observed that dead bacteria were capable of keratinocyte
invasion, indicating that structural integrity was maintained after UV and heat treatments. To test
whether de novo bacterial protein synthesis is required for S. aureus-mediated TNF-α induction,
gentamycin, an inhibitor of protein translation, was pre-incubated with S. aureus at concentrations
sufficient to prevent bacterial growth but not to cause bacterial death. Gentamycin treatment of S.
aureus also failed to induce TNF-α induction. Taken together, these data indicate that S. aureus-medi-
ated TNF-α requires bacterial adherence (not invasion) and live bacteria to carry out de novo bac-
terial protein synthesis during the course of keratinocyte infection. These findings demonstrate that
TNF-α-induction, in vitro, is blocked by selective and robust antibiotic treatment. Studies, like these,
to understand the mechanism of TNF-α induction will ultimately lead to more effective treatment
modalities for TNF-α-based inflammatory reactions. 
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IL-12p40 homodimer, the natural IL-12 antagonist, released from L. major-infected DC con-
tributes to susceptibility in cutaneous leishmaniasis
A Nigg, S Zahn, F Woelbing, J Knop and E von Stebut Department of Dermatology, Johannes
Gutenberg-University, Mainz, Germany
Protection against Leishmania major (e.g. in resistant C57BL/6 mice) is the result of Th1-immu-
nity, whereas susceptible BALB/c mice develop Th2-responses. IL-12 release of L. major-infected
dendritic cells (DC) is critically involved in Th1-education. Bioactive IL-12p70 is a heterodimer
composed of p35 and p40, whereas p40 alone – generally produced in excess to p70 – can be released
as inactive monomeric p40 or as p40 homodimer (p40)2 with inhibitory activity on the IL-12 recep-
tor. We now analysed strain-dependent differences in the release of IL-12 by DC in more detail. As
described previously, in the presence of IL-4, L. major-infected or LPS-stimulated bone marrow-
derived DC (generated with GM-CSF) from both resistant and susceptible mice released compara-
ble amounts of IL-12p70 and p40. However, without IL-4 (representing more physiological condi-
tions), BALB/c-derived DC released significantly more p40 than C57BL/6-DC (LPS: 24±0.4 vs.
9.3±2.7 ng/ml, n=3, p<0.005; L. major: 6.3±2.1 vs. 3.3±1.5 ng/ml, n=4), whereas no differences in
p70 production were found. We next determined, whether IL-12 was released as inactive monomeric
p40 or in the form of the natural inhibitor (p40)2. Interestingly, in western blot analyses of DC-super-
natants a large proportion of anti-IL-12p40 reactivity was detected at 80kDa. We found substan-
tially more (p40)2 in BALB/c DC-supernatants suggesting that BALB/c-DC produce more homod-
imer than C57BL/6-DC. To determine the physiological role of IL-12(p40)2 in cutaneous leishmaniasis,
C57BL/6 and BALB/c mice were treated locally with 1 µg recombinant (p40)2 or PBS intrader-
mally during T-cell priming (d1-3 post infection with 2x105 L. major). Lesions in (p40)2-treated
groups were significantly larger in both mouse strains compared to PBS-treated controls from wk3
on (e.g. BALB/c mice: 125±20 vs. 63±16 mm3 at wk4, n≥7, p<0.01). In summary, genetical differ-
ences in the production of IL-12p40 homodimer from infected DC may contribute to disease out-
come in cutaneous leishmaniasis. 
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Oncostatin M-stimulated endothelial cells, endothelial cells infected with Kaposi’s sarcoma-
associated herpesvirus, and KS tumor cells express CCL21
M Sugaya, W Liao and A Blauvelt Dermatology Branch, National Cancer Institute, Bethesda, MD
CCL21, also known as secondary lymphoid chemokine, is a ligand for CCR7 and is expressed by
lymphatics, high endothelial venules, and T cell areas of lymphoid organs. This chemokine plays a
critical role in the homing of CCR7+ leukocytes to lymphoid tissues, but little is known about reg-
ulation of CCL21 expression. Since KS tumor cells express markers specific for lymphatic endothe-
lial cells, we examined CCL21 expression in KS tumor cells and in endothelial cells relevant to KS
pathogenesis. We first cultured human dermal microvascular endothelial cells (HDMEC) with onco-
statin M (OSM), a major growth factor for KS. By real-time RT-PCR, OSM markedly increased
CCL21 mRNA (max.15-fold increase) in HDMEC in a dose-dependent manner (0.01-100 ng/ml).
Phosphorylated (p)-STAT3 was localized to both cytoplasm and nucleus in unstimulated HDMEC,
yet became detectable only within nuclei of HDMEC stimulated for 30 min by 100 ng/ml of OSM.
AG490, a JAK2/STAT3 inhibitor, blocked nuclear transport of p-STAT3 and inhibited up-regulation
of CCL21 mRNA by OSM. We then compared CCL21 expression levels in uninfected versus KSHV-
infected HDMEC. KSHV infection of HDMEC in vitro led to a 5-fold induction of CCL21 mRNA
within 5 days of infection. Lastly, using immunohistochemistry, we discovered that KS tumor cells
were strongly positive for CCL21 protein. In summary, KS tumor cells and endothelial cells highly
relevant to KS pathogenesis expressed CCL21, the latter via a STAT3-dependent pathway. CCL21
expression by KS tumor cells lends further support to the hypothesis that these cells are of lym-
phatic origin. In addition, tumor-derived CCL21 may be an important mechanism by which KS
tumors chemoattract CCR7+ inflammatory cells, which could be a rich source of pro-inflammatory
cytokines necessary to promote tumor maintenance and growth. 
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Mast cells control and contain infection with Leishmania major
M Maurer, M Metz, S Lopez, J Knop and E von Stebut Department of Dermatology, Johannes
Gutenberg-University, Mainz, Germany
Mast cells (MC) initiate protective innate immune responses against bacteria. Here, we asked whether
MC are also involved in the control of skin infections by the intracellular protozoan parasite Leish-
mania major (L. major). Injection of L. major (2x105 promastigotes) into the ears of C57BL/6 mice
resulted in increased numbers of degranulated MC as soon as 6 hours after inoculation. Genetically
MC-deficient KitW/KitW-v-mice subjected to skin infections with L. major developed markedly larger
skin lesions as compared to normal Kit+/+ mice (~3-fold). Local and selective adoptive transfer of
in vitro-derived MC to the ear skin of KitW/KitW-v-mice repaired their MC deficiency and resulted in
the normalization of skin lesion development after L. major infections. Notably, KitW/KitW-v lesions
contained significantly more parasites as compared to Kit+/+ mice (27 vs. 3 x103/ear 5 wks post
infection, p<0.01). In addition, L. major infections in KitW/KitW-v-mice resulted in enhanced systemic
disease, i.e. spreading of parasites to the spleens, whereas Kit+/+ mice exhibited only occasional and
transient systemic infections. After antigen-specific restimulation, IFNγ release of lymph node cells
obtained from infected KitW/KitW-v mice was markedly reduced (e.g. 4.7±0.9 vs. 11.9±3.3 ng/ml at
wk 1, n=8, p<0.05) and IL-4 levels were increased as compared to Kit+/+ mice (e.g. 143±29 vs.
86±13 pg/ml at wk 1, n=8). This indicates that MC-mediated control and containment of L. major
infections are not limited to the induction of local inflammation and recruitment of proinflamma-
tory cells to sites of L. major inoculation. These findings extend the view of MC as salient sentinels
to innate host defense reactions against intracellular pathogens. 
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Immobilized molecular beacon bosensors for normal and methicillin-resistant Staphylococcus
aureus
BL Miller,1,2 TD Krauss,3,2 D Hui3,2 and CM Strohsahl4,2 1 Department of Dermatology, University
of Rochester, Rochester, NY, 2 Center for Future Health, University of Rochester, Rochester, NY, 3
Department of Chemistry, University of Rochester, Rochester, NY and 4 Department of
Biochemistry and Biophysics, University of Rochester, Rochester, NY
Molecular Beacons, or DNA hairpin probes bearing a fluorescent group at one end and a quenching
group at the other end, have become widely used in solution-phase genetic assays. In part, this is
because the molecular beacon is a label free assay: in the absence of the target DNA strand, the
molecular beacon probe is non-fluorescent, because of the proximity of the quenching group and
fluorophore. We have developed an immobilized version of the molecular beacon concept, using a
thin gold film both as underlying substrate and as the quenching group. This allows for the very
simple preparation of immobilized hairpins, or biosensors, for a broad range of targets. In particu-
lar, we designed two molecular beacon probes for the FemA and mecR (methicillin resistance) genes
of Staphylococcus aureus, each bearing a 5-prime thiol and a 3-prime fluorophore (tetramethylrho-
damine). After immobilizing these individually on gold films, we observed very little fluorescence.
Addition of the complementary DNA strand in either case resulted in as much as a 20-fold increase
in fluorescence. Importantly, one chip exhibits a 6:1 selectivity for the fully complementary sequence
over a single base mismatch, without increasing the stringency of the assay. We have also designed
molecular beacon probes for methicillin-sensitive staphylococcus, and have demonstrated that the
immobilized versions of these probes are effective biosensors for staphylococcus DNA. 
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Specific toll receptor agonists mediate opposing regulatory effects on cutaneous infection with
Leishmania major in susceptible BALB/c mice
Z Darejeh,1 TS McCormick,1,3 KD Cooper3,4 and FP Heinzel2,4 1 Dermatology, Case University,
Cleveland, OH, 2 Center for Global Health and Diseases, Case University, Cleveland, OH, 3
Dermatology, University Hospitals of Cleveland, Cleveland, OH and 4 VA Medical Center,
Cleveland, OH
Activation of innate immunity can regulate the extent and cytokine phenotype of developing adap-
tive T cells responding to microbial infection. Although the parasitic pathogen, Leishmania major,
is not known to possess toll agonists, we confirmed that a single intralesional injection with 100 µg
of CpG oligonucleotide eliminates cutaneous infection in normally susceptible BALB/c mice. In
contrast, injection of 40 µg of either TLR4 or TLR2 agonists, lipopolysaccharide (Salmonella enteridi-
tis) and bacterial lipopeptide (Pam3CysSerLys4), significantly accelerated lesion development.
Furthermore, single-dose injection of LPS completely reversed the curative effect of rFlt3L pre-
treatment in infected BALB/c mice. Whereas CpG promotes cure in association with enhanced Th1
and reduced Th2 cytokine production, LPS and Pam3Cys failed to prevent lymph node Th2 devel-
opment as measured by IL-4 ELISPOT. LPS and Pam3Cys, but not CpG, deplete splenic DC in nor-
mal mice and reduce IL-12 p70 production, suggesting a possible mechanism of action. We con-
firmed that rIL-12 treatment restores curative immunity in L. major-infected BALB/c mice that were
also co-injected with LPS. Addition of LPS to CpG injection of infected mice failed to reverse the
protective effects of CpG, indicating a response to CpG that exceeds LPS effects. These findings
show that different TLR agonists promote dramatically different developmental outcomes for Th1
or Th2 antimicrobial T cell responses. This has potential therapeutic relevance, but also highlights
the distinct biological role of different toll receptor mediated responses despite the sharing of com-
mon transduction pathways. 
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Staphylococcus aureus induced apoptosis in primary human keratinocytes
CN Young, BM Aufiero and GJ Murakawa Dermatology, Wayne State University, Detroit, MI
Infection of human keratinocytes by S. aureus leads to activation of a variety of immune-mediated
responses, which are often followed by tissue invasion, cell damage and cell death. Cell death by
apoptosis is widely recognized as an important control mechanism in the maintenance of tissue home-
ostasis and in the elimination of cells damaged by mutagens or infectious agents. S. Aureus-medi-
ated apoptosis in primary keratinocytes has been observed, but the induction and characteristics of
this process are poorly understood. In this study, the effects of S. aureus as an inducer of apoptosis
in primary human keratinocytes were tested and compared to Camptothecin (CAM), a classic chem-
ical inducer of apoptosis. Keratinocytes were infected with S. aureus at a multiplicity of infection
(MOI) of 10:1 and 100:1 (bacteria: keratinocytes) for a range of times (t = 0, 6, 12, 18 and 24 h).
Genomic DNA was extracted, and assayed by agarose gel electrophoresis for DNA fragmentation.
This fragmentation is a classic feature of apoptosis, and appeared at 18 and 24 hours post-infection.
Furthermore, DNA fragmentation was prevented by pretreatment of keratinocytes with a general cas-
pase inhibitor (Z-VAD-FMK), indicating that apoptotic, effector molecules are activated upon S.
aureus infection. Similarly DNA fragmentation was observed as a result of CAM treatment. Immuno-
fluorescent microscopy of fluorescein-tagged TdT (TUNEL assay) to detect DNA fragments revealed
that the extent of apoptosis occurring in 24 hours in S. aureus infected and CAM treated cells was
about 25%. Viability assays performed with trypan blue exclusion dye gave results consistent with
those from immunofluorescent experiments. Taken together, S. aureus caused apoptotic morpho-
logical changes in keratinocytes, similar to those produced by CAM. These findings indicate that
apoptosis plays an important part of the keratinocyte response to S. aureus infection. Future studies
will test whether elevated rates of apoptosis is one mechanism by which S. aureus infection leads to
skin disease. 
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Swimming pool flotation devices: a possible source of molluscum contagiosum infection
A Braue,1,2 G Varigos,1 S Bowden2 and H Kelly2 1 Dermatology, Royal Melbourne Hospital,
Parkville, VIC, Australia and 2 Victorian Infectious Disease and Reference Laboratory, Melbourne,
VIC, Australia
The current research was designed to assess whether fomites (inanimate objects capable of trans-
mitting infections between individuals) in swimming pool water could harbor and transmit Mollus-
cum contagiosum virus (MCV). Molluscum contagiosum (MC) outbreaks have been linked to the
use of public and school swimming pools, however the exact source of infection is unknown. Clin-
ical observations at the Department of Dermatology, Royal Melbourne Hospital have noted patterns
of MC infection consistent with the use of swimming pool flotation devices. Creation of in-house
and quantitative real-time polymerase chain reaction (PCR) assays provided a diagnostic tool for
detection of MCV. Probes were designed for specificity, and MCV was cloned and used as a stan-
dard for quantification. Fomites were spiked and exposed to a variety of chlorine dilutions simulat-
ing swimming pool water. MCV DNA was recovered in every instance. These results suggest that
swimming pool fomites could be a common source of MCV infection. Given the popularity of swim-
ming pool use among young people — and the fact that MCV is the most common poxvirus affect-
ing humans — MC is a significant public health issue. Better understanding its mode of transmis-
sion will guide the improvement of best practices in swimming pool management. 
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Infection of microvascular endothelium by Anaplasma phagocytophilum; an important first
step in pathogenesis and persistence of anaplasmosis
M Ericson,1 M Herron2 and U Munderloh2 1 Dermatology, U of MN, Minneapolis, MN and 2
Entomology, U of MN, Minneapolis, MN
The skin is the major interface between vertebrates and their environment, and thus regulates inter-
action with ectoparasites as well as the pathogens they transmit. Blood-feeding ticks create an intra-
dermal lesion, an inflammatory focus which attracts first-line immune responders such as neu-
trophil granulocytes. The human granulocytic anaplasmosis agent, Anaplasma phagocytophilum, is
a tick-borne emerging rickettsial pathogen in the U.S. and Europe that utilizes PSGL-1, a receptor
found on neutrophils, to enter human neutrophils.  We present in vitro and in vivo evidence that infec-
tion of microvascular endothelium may be an important step during early pathogenesis and persist-
ence of anaplasmosis. A. phagocytophilum invades human and primate primary cell cultures and
immortal cell lines of microvascular endothelium. These microbes replicate to form large inclusions
(morulae) that eventually rupture to infect other cells. Morulae may contain only a few or large
numbers of bacteria of widely differing morphology and size. Infected endothelial cells upregulate
CD54 and uptake of acLDL-containing cholesterol, an essential component of the anaplasma mem-
brane. Uninfected neutrophils or HL-60 cells avidly adhere to infected endothelial cells, and the
microbes are rapidly transferred to them. We hypothesize that this involves engagement of selectins
and integrins that mediate neutrophil-endothelium interactions. In mice infected with A. phagocy-
tophilum for 6 weeks, microvascular endothelium of heart muscle and liver contained morulae as
demonstrated by colocalization of antibody to an endothelial marker (von Willebrand factor VIII)
and to a major surface protein (MSP2/p44) of A. phagocytophilum. Likely, endothelial cells play a
role in maintaining chronic infections, both as host cells, and as antigen presenting cells. 
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Design of porous silicon biosensors for optical detection of pathogenic organisms causing skin
infection
LA DeLouise,1,2 BL Miller1,2 and C Haidaris3 1 Dermatology, University of Rochester Medical
Center, Rochester, NY, 2 Center for Future Health, University of Rochester Medical Center,
Rochester, NY and 3 Microbiology and Immunology, University of Rochester Medical Center,
Rochester, NY
We are developing a relatively new and innovative label-free optical biosensor technology based on
porous silicon microcavities.  This technology is intended for use as a non-invasive rapid detect sen-
sor to aid in the clinical diagnosis of species specific pathogenic organisms that invade skin and cause
infection. Current research has focused mainly on the material science aspects of designing sensors.
Our preliminary research on developing a proteomic sensor for enteropathogenic strain of E. coli
has provided a high a level of expertise in device fabrication and has enabled us to explore the rela-
tionships between the porous 3D microstructure, device sensitivity and sensor operation. Addition-
ally, we have developed a solid phase immobilize enzyme assay using Glutathione-S-Transfersase
(GST) to probe the porous microstructure. This work has enhanced our understanding of pore infil-
tration and results corroborate optical measurements pointing to the practical limits of utilizing porous
silicon microcavities as a diagnostic devices in dermatological medicine. Our current focus is to
develop a sensor for the detection of Candida, which is an opportunistic organism, and the causative
agent of dermatological disease ranging from annoying or painful cutaneous mycoses to serious
systemic disease. Prototype devices will utilize recombinant human antibody single-chain variable
fragments (svFv) specific for hyphae to differentiate Candida albicans and Candida dubliniensis. 
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Dendritic cell mediated killing of HPV E6 and E7 expressing keratinocytes
TM Kroll,1 W El Masri,2 H Bommiasamy,1 PK Das,3 W Kast4 and IC Le Poole1 1 Pathology/Onc.
Institute, Loyola University Chicago, Maywood, IL, 2 Obstetrics and Gynecology, Loyola
University Chicago, Maywood, IL, 3 Pathology, Amsterdam University, Amsterdam, Netherlands
and 4 Immunology, University of Southern California, Los Angeles, CA
Immature dendritic cells (DCs) are thought to have cytotoxic effector functions targeting HPV express-
ing tumors. These effector functions may also be important to combat genital warts caused by Human
Papilloma Virus (HPV). To investigate cytotoxic efficacy against HPV infected cells, we analyzed
infiltration of HPV expressing mouse tumors by CD3+, CD11c+, S-100+, CD14+ and CD68+ cells.
Results were correlated to treatment of the mice with effective (encoding HPV-derived proteins) or
ineffective (encoding GFP) vaccines (n=5). Immunostaining to detect these markers demonstrated
that tumor shrinkage correlated mostly with infiltration by CD11c and S100 expressing cells. Sim-
ilarly, tissue from human genital warts infected with HPV type 6 as shown by in situ hybridization
displayed little infiltration by T cells. It is possible that the DCs present in HPV infected tissue con-
tribute to killing of HPV infected cells. To study this process in vitro, the E6 and/or E7 genes of
HPV 16 were introduced into keratinocytes by retroviral infection and effector functions of mono-
cyte-derived immature DCs or DCs activated by exposure to heat shock proteins or IFN-gamma cells
was measured in JAM assays. Results showed that DC mediated killing was most effective towards
cells that express both E6 and E7, whereas normal keratinocytes were not killed. Also, DC effector
functions were enhanced by exposure to IFN-gamma or HSPs, which elevated membrane TRAIL
expression as shown by FACS analysis. Interestingly, keratinocytes expressing both E6 and E7 dis-
played reduced expression of decoy receptors for TRAIL, correlating with enhanced sensitivity to
DC mediated killing. These studies demonstrate that immortalized keratinocytes expressing HPV
encoded E6 and E7 genes are sensitized to dendritic cell mediated killing. It is possible that this
mechanism can be exploited for shrinkage of warts and HPV expressing tumors. 
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Confocal microscopy study of the effects of UVA radiation on the skin
T Yamashita,1,2 H Akita,1 E Lerner,3 M Takahashi2 and S Gonzalez1 1 Wellman Laboratories of
Photomedicine, Massachusetts General Hospital, Boston, MA, 2 Shiseido Research Center,
Yokohama, Kanagawa, Japan and 3 Cutaneous Biology Research Center, Massachusetts General
Hospital, Boston, MA
Skin exposure to UVA (320 - 400 nm) results in various biological responses, cutaneous tanning
being the major one. When human skin is exposed to UVA, immediate pigment darkening (IPD)
reaction occurs soon after exposure. In the case of high dose-UVA exposure, IPD seems to turn into
a delayed pigment darkening reaction. For a better understanding of the UVA tanning mechanisms,
we performed the present human study in 27 healthy volunteers with Fitzpatrick’s skin phototype 2
to 5. Inner forearms from the subjects were exposed to 15- and 25-J/cm2 UVA. Skin sites were pho-
tographed by a digital camera and imaged using reflectance-mode confocal microscopy (RCM) focus-
ing on melanin distribution at the baseline and at several time points (from 0-30 min to 1 week) after
UVA exposure. Two 3-mm punch biopsies were also taken from the UVA-exposed or non-exposed
sites, either immediately or 1 week post-exposure. Furthermore, in order to investigate the effects
of blood flow on IPD, intradermal anesthesia with or without the epinephrine was administered. Skin
sections were stained with Fontana-Masson and assayed by a sensitive tyrosinase assay, for com-
parison with RCM images. Our results showed that the IPD response was present in the subjects of
skin phototype 3 to 5. Skin phototype 2, however, showed only erythema. By CM image analysis,
dendritic melanocytes were clearly visible at 1 week after UVA exposure in subjects of skin photo-
type 5, while no morphologic changes were observed immediately after exposure. The Fontana-Mas-
son stained sections correlated well with CM images. A tyrosinase activity peak was also observed
1 week after the exposure. On the other hand, the epinephrine-induced reductions of blood flow as
seen by CM in vivo led to a partially or completely diminished IPD response. These results indicate
that blood flow may be an important factor for the development of the IPD response. 
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EGCG inhibits UV-induced NF-κ B nuclear translocation and IL-6 secretion in cultured human
keratinocytes
J Xia,1 X Song,1 Z Bi,1 B Yan2 and Y Wan3 1 Nanjing Medical University , Nanjing, China, 2
University of Rhode Island, Kingston, RI and 3 Providence College, Providence, RI
Ultraviolet (UV) radiation from the sun is widely considered as a major cause of human skin pho-
toaging and skin cancer. UV radiation-induced proinflammatory cytokines mediated by NF-κ B
reportedly play important roles in human skin photoaging and skin cancer. NF-κ B and cytokines
have been thus perceived as molecular targets for pharmacological intervention. With increasing
amount of knowledge of the actions of green tea at cellular and molecular level, the beneficial effect
of drinking green tea has become well recognized if not completely accepted. The components in
green tea have even been added to skin care products unregulated, while the molecular mechanisms
of the actions of those components on human skin are being unraveled. Using cultured human ker-
atinocytes, we investigated the effects of (-)-epigallocatechin-3-gallate (EGCG), a major polyphe-
nolic constituent in green tea, on UV-induced activation of transcription factor NF-κ B and proin-
flammatory pathway by measuring nuclear translocation of NF- κB and IL-6 secretion in vitro. p65,
one of the subunits of NF-κ B was determined by immunohistochemical and Western blot analysis.
IL-6 protein level in cell culture medium was measured by ELISA. The results showed that both
nuclear p65 and secreted IL-6 were significantly (p<0.05) induced by UVB irradiation (20, 30 mJ/cm2)
and UVA irradiation (10, 20 J/cm2). IL-6 secretion and NF-κ B nuclear translocation induced by
UVB and UVA was dramatically inhibited by pretreatment of EGCG (0.15 and 0.3 mM) (p<0.05).
Taken together, we conclude that EGCG inhibits UVB- and UVA-induced proinflammatory path-
way in vitro and may be added to cosmetic or skin care products for prevention from UV-induced
skin photoaging and skin cancer if this activity can be further confirmed and no cytotoxicity is reported
in human skin in vivo. 
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In vivo and in vitro evaluation of lycopene as antioxidant substance
M Andreassi,1 A Ettorre,2 E Stanghellini,1 A Di Stefano2 and L Andreassi1 1 Departemt of
Dermatology, University of Siena, Siena, Italy and 2 Departement of Molecular Biology, University
of Siena, Siena, Italy
The aim of the present investigation was to study antioxidant activity of lycopene in vivo and on cell
system. The in-vivo activity was studied on 3 preparations containing respectively: a) lycopene 0.03%
(Lycopersicon Esculentum extract); b) alpha-tocopherol acetate (0.5%) and ascorbic acid (1%); c)
a mixture of the 3 substances at the above concentrations. Photostimulation was performed on ten
healthy volunteers with phototype II or III with a solar simulator (Multiport Solar UV Simulator)
on the flexural surface of forearm with doses ranging from 20 to 80 mJ/cm2. The cutaneous response
was evaluated instrumentally, measuring erythema and trans epidermal water loss before UV expo-
sure and after 24 and 48 hours. Erythema was measured with tristimulus colorimeter (Chroma
Meter Minolta). The in-vitro investigation was performed on HaCat cell cultures, that were grown
for 48 hrs until 75-80% confluence. Cells were incubated 30 min in PBS containing different con-
centrations of Vitamin E, Vitamin C, Lycopene as extract and Lycopene as pure substance (Sigma),
then exposed to 150 mJ/cm2 of UV light (Solar Simulator, Thermo-Oriel). After irradiation, cells
were again incubated with fresh medium and maintained at 370C until further analysis. The forma-
tion of intracellular ROS was measured using 2’,7’-dichlorofluorescin diacetate (DCFH-DA). The
cells were analyzed with a FACSCalibur flow cytometer (Becton Dickinson) equipped with an exci-
tation laser line at 488 nm and Cell Quest software (Becton Dickinson). The DCF (green fluores-
cence) was collected in a log scale through a 530±20 band pass filter. Monoparametric histograms
of the fluorescence distribution were plotted for the estimation of ROS production. The in-vivo inves-
tigation demonstrated that lycopene-based preparations had a higher protective ability than the prod-
ucts containing the mixture of vitamins. In vitro experiments showed that lycopene in able to pro-
tect HaCat cell only when employed as extract. Further investigation is required to clarify such data. 
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Aloin attenuates UVA-induced AP1 activation and MMP expression in cultured human skin
fibroblasts
X Song,1 J Xia,1 Z Bi,1 B Yan2 and Y Wan3 1 Nanjing Medical University, Nanjing, China, 2
University of Rhode Island, Kingston, RI and 3 Biology, Providence College, Providence, RI
Mounting evidence has indicated that excessive exposure of human skin to UVA radiation causes
photoaging, leading to skin cancer if unattended. Cellular and molecular studies have demonstrated
that UVA radiation induces generation of reactive oxygen species at high concentration leading to
skin cell damage and at sub-cellular level resulting in activation of cell signaling components and
consequently degeneration of collagen. Aloin, as a major antioxidant and widely used in skin care
products, has been shown to have photo protective properties, and yet the molecular mechanisms of
its action were only sporadically reported. Using cultured human skin fibroblasts we investigated
the protective effects of Aloin on UVA-induced activation of the key components of AP1 transcrip-
tion factor, C-Jun and C-Fos and expression of matrix metalloproteinases (MMPs) that are respon-
sible for the degradation of collagen knowingly leading to cutaneous aging. Western blot analysis
revealed that C-Jun protein increased 1.6, 2.3, 3.1 folds following UVA irradiation (10, 20 and 30
KJ/m2), while C-Fos protein expression did not change significantly. The results by RT-PCR and
ELISA utilized to measure mRNA and protein expression of MMP1 and MMP3 showed that UVA
treatment induced mRNA and protein expression of both MMP1 and MMP3 in a time and dose
dependent manner in cultured human fibroblasts. Pretreatment with Aloin (10-5M) prior to UVA irra-
diation (30 KJ/m2) reduced C-Jun expression to basal level and accordingly decreased mRNA and
protein expression of MMP1 and MMP3 induced by UVA radiation. The protective effects of Aloin
(10-6 to 10-4 M) were dose dependent. Collectively, our data indicate that Aloin can be applied to
attenuate UVA-induced skin fibroblasts damage due to its effect on reduction of C-Jun protein and
inhibition of MMP1 and MMP3 expression. 
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Combined multiphoton excitation, polarization and second harmonic generation for imaging
of biological specimens
S Lin,1 C Dong,2 Y Sun,2 J Su,2 W Lo2 and S Jee1,3 1 Department of Dermatology, National Taiwan
University Hospital, Taipei, Taiwan, 2 Department of Physics, National Taiwan University, Taipei,
Taiwan and 3 Department of Dermatology, National Taiwan University College of Medicine,
Taipei, Taiwan
Multiphoton microscopy is a powerful tool for real-time noninvasive imaging of biological speci-
mens. In this work, we demonstrate the application of multiphoton microscopy to analyzing the ultra-
structures of biological specimens, especially the alignments of lipid bilayers of stratum corneum,
the dermal fibers and temperature-dependent structural changes of collagen. Combined multipho-
ton excitation, polarization and second harmonic generqation were employed for imaging of the
structures in ex-vivo human skin and bovine tendons. Stratum corneum was labeled with laurdan
and bovine tendon was incubated in water of various temperatures prior to the imaging process. Our
results show that both the excitation and emission dipoles of laurdan molecules are preferentially
oriented perpendicular to the surface of corneocytes. Because the excitation dipole moment of lau-
rdan is perpendicular to the lipid bilayer, the results are consistant with the molecular orientation of
the lipid molecules in the intercellular space of stratum corneum. Furthermore, our results show that
the fibrous structures in the dermis generate emission along the excitation polarization. The second
harmonic signals decrease sharply when bovine tendens are heated up to 65oC, indicating that the
molecular organization of collagen fibers was changed above this temperature. This work shows
that combined multiphoton excitation, polarization and second harmonic generation can be a pow-
erful imaging tool in monitoring structural orientation and molecular organization in skin and other
biological specimens. 
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Infusion of apoptotic cells induced by experimental photopheresis induces antigen specific reg-
ulatory cells
A Maeda,1 A Schwarz,1 K Kernebeck,1 D Peritt2 and T Schwarz1 1 Department of Dermatology,
University Muenster, Muenster, Germany and 2 Therakos, Johnson & Johnson Company, Exton, PA
The basis of extracorporeal photopheresis is the reinfusion of leukocytes, which have been exposed
to 8-methoxypsoralen (8-MOP) and UVA. This treatment induces annexin V+ apoptosis of nearly
all leukocytes. Photopheresis is approved for the treatment of CTCL and has shown evidence of
benefit for the treatment of autoimmune diseases, organ transplant rejection, atopic dermatitis and
GvHD. However, the underlying mechanism remains unresolved. Since UV radiation of the skin
causes immune tolerance via induction of regulatory T cells, we studied whether photopheresis exerts
a similar effect extracorporeally. Thus, we utilized a murine model of contact hypersensitivity (CHS).
Splenocytes and lymph node cells of mice which were sensitized with dinitrofluorobenzene (DNFB)
were exposed to 8-MOP plus UVA in vitro. 8-MOP/UVA-treated cells were injected i.v. into naive
mice which were subsequently sensitized with DNFB and ear thickening measured following ear
challenge. Animals which had received 8-MOP/UVA-treated cells were suppressed in their CHS
response. In contrast, mice which received cells which were untreated or exposed to UVA or 8-
MOP alone were not suppressed. Induction of suppression was lost when lymph node cells were
depleted of CD11c+ cells. Suppression was cell-mediated and antigen specific as demonstrated by
the ability to transfer tolerance to naive animals which could, however, properly respond to the
unrelated hapten oxazalone. Transfer of tolerance was lost when cells were depleted of CD4+ or
CD25+ subpopulations. As few as 100,000 unfractionated cells could protect a naive animal. The
generation of increased number and activity of regulatory cells was evident when animals were
boosted with antigen and this protection was dose dependent. Together these data suggest that infu-
sion of experimental ECP induced apoptotic cells produces antigen specific regulatory cells. Fur-
ther studies are underway to better understand the nature of these regulatory cells and their mecha-
nism of induction. 
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Reducing p53 in human keratinocytes using siRNA delays onset of senescence, but increases
susceptibility to apoptosis in response to UV-light
V Chaturvedi, P Bacon, B Bodner and BJ Nickoloff Oncology Institute, Loyola, Maywood, IL
Mice in which p53 is eliminated or enhanced reveal important roles in mediating apoptosis and senes-
cence, respectively. While many mechanisms are evoked to explain these roles for p53, a pro-sur-
vival role for p53 in human keratinocytes (KCs) remains undefined. Rather than eliminating p53,
we used siRNA to knockdown p53 levels in normal KCs. Compared to scrambled control (SC) treated
KCs, p53 siRNA treated proliferating KCs expressed 70% lower constitutive p53 levels as deter-
mined by Western blots, and exhibited reduced transcriptional activity using promoter-reporter assays
for p53 target genes (p21, GADD45). When SC-treated KCs reached confluency, they up-regulated
CDKI (p21) and underwent premature senescence. By contrast, p53 siRNA treated KCs had reduced
CDKI expression at confluency and underwent additional (6-8) population doublings, following con-
fluency, consistent with delay in onset of senescence. As demonstrated, confluent/senescent KCs
are relatively resistant to UV-light induced apoptosis compared to proliferating KCs, a potential role
for p53 in regulating KC death was examined. When proliferating KCs were exposed to 15 mJ/cm2
or 30 mJ/cm2 (18 hrs, UV-B), siRNA treated KCs were approximately 2-fold more sensitive to induc-
tion of apoptosis than SC treated cells (using Annexin staining, or PI staining and Sub-G0 DNA con-
tent by FACS). This enhanced apoptotic response was even greater (4-fold) when cultures became
confluent. To determine the mechanism by which lower p53 bearing KCs underwent greater, rather
than reduced apoptotic responses, Western blots revealed enhanced E2F1 levels in confluent siRNA
treated versus SC-treated KCs. Since E2F1 can promote apoptosis, KCs with lower E2F1 levels
may be less vulnerable to apoptosis. In conclusion: a) siRNA can be used to target specific genes in
human KCs, b) caution is necessary in extrapolating results using knockout mouse models in which
all p53 is abolished, c) p53 functions not only to promote senescence and apoptosis, but survival
pathways are also regulated by p53. 
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The osmolyte taurine is critically involved in photoprotection against ultraviolet B radiation-
induced immunosuppression
N Schade,1 I Felsner,1 U Warskulat,3 A Schwarz,2 T Schwarz,2 S Grether-Beck,1 C Esser,1
D Haeussinger3 and J Krutmann1 1 Research Inst. for Environmental Health (IUF) at the University
of Duesseldorf gGmbH, Duesseldorf, Germany, 2 Dermatology, University of Muenster, Muenster,
Germany and 3 Hepatology, Gastroenterology and Infectiology, University of Duesseldorf,
Duesseldorf, Germany
Uptake of osmolytes such as taurine could be part of the stress response of human epidermal ker-
atinocytes induced by ultraviolet (UV) B radiation. This hypothesis is based on the observation that
(i) ultraviolet (UV) B radiation induced the expression of TAUT, the specific transporter for taurine,
in longterm cultured normal human keratinocytes (HNK) and that (ii) this upregulation was associ-
ated with an increased uptake of taurine into irradiated cells. In support of this hypothesis we now
report that taurine uptake protects human skin cells against UVB radiation-induced immunosup-
pressive effects. Accordingly, preloading of HNK in-vitro with taurine completely prevented both
hyperosmotic stress- and UVB radiation-induced gene expression including intercellular adhesion
molecule-1 (ICAM-1). These studies indicated that taurine uptake might be critical in determining
the susceptibility towards UVB radiation-induced immunosuppression. Moreover, we used TAUT
deficient mice, which had been generated through disruption of exon 1 of the murine TAUT gene,
to further test this possibility. We compared UVB radiation-induced immunosuppression in wildtype
mice versus heterozygous versus homozygous TAUT knockout mice. Their response in a contact
hypersensitivity assay was measured after exposure to increasing doses of UVB radiation. The
result showed that homozygous, but not heterozygous TAUT knockout mice were more susceptible
towards UVB radiation-induced immunosuppression than wildtype mice. Taken together these
studies suggest that taurine uptake, similar to DNA repair and pigmentation, is critically involved in
endogenous photoprotection of skin cells against UVB radiation-induced detrimental effects. 
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Increase of dermal collagen fibrils diameter with uvb exposure: an optical and ultrastructural
study in albino Balb/c mice
S Carneiro,1 F Lisboa,1 B Pascarelli,2 S Souza,3 M Ramos-e-Silva1 and C Takiya 2 1 Sector of
Dermatology - HUCFF, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 2 Department
of Histology and Embriology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil and 3
Sector of Pathology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Cutaneous aging is a complex biological phenomenon which depends not only of innate or intrin-
sic process (biologic clock) but also of extrinsic elements, primarily chronic sun exposure (pho-
toaging). In order to verify the morphological changes of dermis (elastic fiber system and collagen)
associated with aged skin we performed a light and electron microscopical study on irradiated, shaved
albino mice ocurring after irradiation disruption (0,30,60 and 90 days). Experimental group con-
sisted of 48 irradiated animals, which were divided into other three groups and submitted to differ-
ent radiation doses (A-28800 J/m2, B-57600 J/m2, and C- 86400 J/m2). As controls, non irradiated
shaved and non shaved animals were included. Since the day of disruption, and subsequently, elas-
tic system and collagen network were progressively modified. Increase of collagen fibrils diameter
was prominent in the 60 and 90 day groups (p<0.05), aspect verified in the ultrastructural observa-
tions. Elastogenesis figures were also seen in deep dermis. We found that collagen metabolism is
profoundly altered after UVB irradiation and that it is progressive even after UVB disruption. Our
comparative study of groups disclosed the clear relationship between dose and “elastotic changes”
and also that chronological aging of mice skin apparently was intensified after UVB irradiation. Skin
elastogenesis seems to be a major consequence of UVB irradiation, apart from elastolysis, and occurs
not only in humans but also in hairless mice submitted to continuous, long-term UVB exposition. 
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Variable pulsed light for the treatment of hypertrichosis: a pilot clinical study
R Knobler, H Nahavandi, G Holzer, R Neumann and N Sandor Div. of Special Dermatology,
University of Vienna, Vienna, Austria
The aim of the present study was to evaluate the efficacy and safety of variable pulsed light (VPL,
Elite Plus, Energist Ltd. U.K.), an alternative to intense pulsed light,in the treatment of hypertri-
chosis. Eighty-four(84)otherwise healthy volunteers(skin types II-VI) with previously treated or
untreated hypertrichosis were included in this study.Treatment was performed with a variable pulsed
610nm light source with an off-delay time ranging from 1 to 20ms; the spot size was 5cm x 1cm.
Clinical evaluation was done on an individual basis and exact photographic documentation was per-
formed using the Teach-screen-monitoring system (Foto-finder-mediscope, Germany). Prior to every
treatment procedure the area to be treated was covered with a refrigerator cooled (4 Deg. C)optical
coupling gel(Energist Ltd., U.K.). Determination of fluence used was based on the individual’s sen-
sitivity to pain; this depended to a great extent on the specific skin type and coarseness. The aver-
age fluence used was 36.5 J/cm2(range :13.7-45 J/cm2). Eighty-two percent of the areas treated
showed hair clearance of over 50%, thirty-five percent showed hair clearance of over 75% while
fourty-seven percent had clearance between 50-75%. The side effects associated with the treated
areas included transient erythema(43%) and leucotrichia(15%). Side effects were minimal and in no
patient were cause for exclusion from the study. Transient pigmentary changes were not observed.
The variable pulse light system (VPL) used in this trial presents itself as an effective and safe method
for hair removal due to hypertrichosis. It is particularly effective in fair-skinned individuals with dark
hair(skin type II-VI). Adverse effects are minimal and transient and in no patient sigificant enough
to interrupt treatment. 
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Transactivation of EGFR via HB-EGF shedding protects human keratinocytes from UV-irra-
diation-induced apoptosis
S Tokumaru, Y Shirakata, M Tohyama, T Tsuda, E Tan, Y Yahata, K Yamasaki, Y Hanakawa,
K Sayama and K Hashimoto Dermatology, Ehime University, Ehime, Ehime, Japan
We reported last year that UVB irradiation triggered EGF receptor (EGFR) phosphorylation by EGFR
transactivation mechanism through HB-EGF shedding, the conversion of HB-EGF from a mem-
brane-anchored form to a soluble form by shedding protease(s). Since EGF has an anti-apoptotic
effect through EGFR phophorylation, we hypothesized that EGFR transactivation through HB-EGF
shedding works as an anti-apoptotic intrinsic mechanism. Evaluation of apoptosis was performed
by measurement of lactic dehydrogenase activity (LDH); we quantitated the apoptosis as the per-
centage of LDH activity of UVB-irradiated keratinocytes in the presence of various reagents to that
of Tween 20-treated keratinocytes after deduction of LDH activity of non-irradiated keratinocytes
from each activity. UVB irradiation at 50 mJ/cm2 induced 6.9% of apoptosis. Next, we examined
the effect of reagents that blocks each step of EGFR transactivation through HB-EGF shedding:
Addition of KB-R8301 (10 µM), a shedding inhibitor, increased the apoptosis to 16.9 % (2.8 fold).
Anti-HB-EGF neutralizing antibody also increased the apoptosis to 15.3 % (2.5 fold). AG1478, an
EGFR kinase inhibitor, enhanced the apoptosis to 18.0 % (3.0 fold). This indicates the blockage of
EGFR transactivation through HB-EGF shedding results in enhancement of UVB-induced apopto-
sis. Furthermore, addition of exogenous soluble HB-EGF (100 ng/ml) rescued the apoptosis enhanced
by KB-R8301 markedly, but not the apoptosis enhaced by AG1478 at all. This also confirms the
involvement of EGFR transactivation through HB-EGF shedding mechanism in anti-apoptotic intrin-
sic mechanism. Taken together, this study reveals for the first time the new role of EGFR transacti-
vation through HB-EGF shedding in normal human keratinocytes, namely the intrinsic protection
mechanism for UVB-induced apoptosis. 
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Enhancement of ultraviolet-induced apoptosis by NF-kB decoy oligonucleotides
S Yokoyama,1 H Nakano,1 T Yamazaki,1 K Tamai,1 K Hanada1 and G Takahashi2 1 Dermatology,
Hirosaki University School of Medicine, Hirosaki, Aomori, Japan and 2 Second Anatomy, Hirosaki
University School of Medicine, Hirosaki, Aomori, Japan
A decoy strategy utilizing oligonucleotides (ODN) containing the specific binding sequence of a cer-
tain transcription factor has been developed and is considered to be a potential new class of anti-gene
therapy. However, the application of this new therapeutic modality to skin diseases has not been fully
documented.The aim of this work was to examine the effects of the NF-kB decoy ODN on UV-
elicited skin change.Mouse keratinocyte Pam 212 cells were transfected with NF-kB decoy ODN to
examine the effects of the decoy ODN on UVB-induced apoptosis. Tape-stripped rat dorsal skin
was treated with an ointment containing NF-kB decoy ODN for the examination of the in vivo impact
of the decoy ODN on sunburned cell (SBC) formation and UVB erythema.NF-kB decoy ODN specif-
ically induced apoptosis of Pam 212 cells, and SBC formation was significantly enhanced by topi-
cal NF-kB decoy ODN ointment, while UV-induced erythema was not affected.These data suggest
that enhancement of UV-induced apoptosis by NF-kB decoy ODN may play a cancer-preventive role
by further eliminating photo-damaged keratinocytes. 
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Low dose ultraviolet-B radiation renders resistant melanoma cells sensitive to TRAIL-induced
apoptosis
B Poepppelmann,1 E Zeise,1 M Weichenthal,2 T Schwarz1 and D Kulms1 1 Department of
Dermatology, University Muenster, Muenster, Germany and 2 Department of Dermatology,
University Kiel, Kiel, Germany
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) is a potential anticancer drug since
it has been initially described to induce apoptosis preferentially in malignant but not in normal cells.
However, it has turned out that not all cancer cells are susceptible to TRAIL. Among eight melanoma
cell lines tested, only three turned out to be sensitive towards treatment with TRAIL, whereas five
cell lines remained resistant. Chemotherapeutic drugs and ionizing radiation have been found to be
able to sensitize resistant tumor cells to TRAIL-induced cell death. Since ultraviolet B radiation
(UVB) is a potent inducer of apoptosis but exhibits much less adverse effects than chemotherapeu-
tics and ionizing radiation, we studied whether UVB may switch melanoma cells from a TRAIL-
resistant into a TRAIL-susceptible state. Therefore, we analyzed the TRAIL-sensitive human
melanoma cell line A-375 in comparison to the resistant cell line IGR-37. Differences in the response
to TRAIL were not due to differences in the expression pattern of TRAIL receptors or of compo-
nents of the death inducing signalling complex. Both cell lines showed expression of the long form
of the antiapoptotic FLICE inhibitory protein (FLIPL), but none of the short splicing variant FLIPS.
Only in TRAIL-sensitive A-375 cells most of the 55 kDa FLIPL had been cleaved preapoptotically
into the 43 kDa form, indicating basal caspase activation even in unstimulated cells. Upon exposure
to sublethal UVB-doses, TRAIL-treated IGR-37 cells underwent pronounced apoptosis, and TRAIL-
sensitivity of A-375 cells was dramatically increased. In both cases UVB caused an inhibition of
flip transcription. Taken together the study indicates that i) the expression level and the processing
status of FLIP plays a crucial role in determining the sensitivity of melanoma cells towards TRAIL
treatment and ii) expression of FLIP is regulated by UVB. 
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Bax activation and induction of apoptosis in human keratinocytes by the protein kinase C δ
catalytic domain
LA Sitailo, SS Tibudan and MF Denning Oncology Institute, Loyola University Chicago,
Maywood, IL
The induction of apoptosis by UV radiation protects keratinocytes from the carcinogenic effects of
sunlight. Protein kinase C (PKC) δ is a required effector molecule for UV-induced apoptosis, and is
activated by caspase-3 cleavage to generate an active catalytic domain fragment. The PKCδ catalytic
domain induces apoptosis when ectopically expressed in keratinocytes, however the mechanism of
apoptosis induction is unclear. We constructed a chimeric protein encoding the PKCδ catalytic domain
fused to a mutant estrogen receptor ligand-binding domain in order to selectively activate the PKCδ
catalytic domain. The enzymatic activity of the PKCδ catalytic domain/ER fusion protein was induced
in human keratinocytes (HaCaT) treated with 4-hydroxytamoxifen, and its activation triggered loss
of mitochondrial membrane potential and apoptosis. The apoptosis was associated with release of
cytochrome c from the mitochondria and caspase activation, and was blocked by caspase inhibitors
(59% inhibition) and the anti-apoptotic proteins Bcl-2, and Bcl-xL (59-82% inhibition), suggesting
a role for mitochondrial pore formation. Consistent with this, the active PKCδ catalytic domain dis-
rupted mitochondrial architecture and triggered the redistribution and activation (oligomerization)
of Bax, a Bcl-2 family protein that can directly induce cytochrome c release. Bax is activated by BH3
domain-only proteins that are normally sequestered by anti-apoptotic Bcl-2 family members such
as Mcl-1. Activation of PKCδ catalytic domain reduced Mcl-1 levels, and the PKCδ catalytic domain
directly phosphorylated Mcl-1, potentially at a PKCδ phosphorylation site in its BH3 domain.
These results suggest that Mcl-1 may be the direct target of PKCδ responsible for Bax activation,
release of cytochrome c, and induction of apoptosis. In summary, despite being an effector activated
late in in the UV apoptotic cascade, PKCδ also activates upstream components of the UV death effec-
tor pathway to insure the demise of cells unable to repair damage induced by genotoxic doses of UV
radiation.
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Photoprotective mechanisms of hydroxychloroqine and TCMs on ultraviolet B-induced human
keratinocytes damage
W Min, D Luo, X Lin and D Wu Dermatology and Venereology, Nanjing Medical University,
Nanjing, Jiangsu, China
Hydroxychloroqine and the TCMs[EGCG( Epigallocatechin-3-gallate), baikal skullcap root and
szechwan lovge rhizome] have photo-protective, anti-inflammatory and anti-oxidant effects on UV-
irradiated keratinocytes. P53-p21 expression halt cell division so that DNA damage can be repaired
or cause damaged cells to undergo apoptosis. C-fos could be a target gene for chemoprevention of
UVB-induced skin cancer. In our study, we investigate the influence of the above drugs on UV-
induced cytotoxicity, apoptosis and expression of p53,p21,c-fos genes to clarify the correlative pho-
toprotective mechanisms. Human keratinocyte HaCaT cells were cultured in 1640 medium with 10%
fetal bovine serum. The cells were treated/pre-treated and exposed to UVB(0, 30, 60 and 90 mJ/cm2).
The apoptotic cells or debris were detected by flow cytometric analysis. The mRNA level of p53-
p21 and c-fos were also detected through everse-transcriptase-polymerase chain reaction (RT-PCR).
The apoptosis and debris rate of HaCaT cells was dependent on the irradiated dosages. When the
UVB dosages changed from 0 to 90 mJ/cm2, the apoptotic cells increased from 0.21% to 71.18%
and the debris from 1.57% to 73.01%. The intervention of the above drugs may reduced the apop-
tosis and debris rate, respectively 8% ~96.8% and 0%~86.5%.The level of each gene mRNA expres-
sion was also down-regulated with treation/pre-treation of the drugs. These results suggest that
hydroxychloroqine and the TCMs may blocked the UVB-induced of apoptosis and cytotoxicity
through reducing of p53-p2l and c-fos expression to inhibit the development of UVB-induced skin
tumor. 
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Release potency and photoprotection by tocopherol nanoemulsion against UV-mediated dam-
age in HaCaT keratinocytes
D Luo,1 X Lin,1 W Min,1 D Wu,1 Q Ma2 and N Gu2 1 Dermatology and Venereology, Nanjing
Medical University, Nanjing, Jiangsu, China and 2 Chemistry, Southeast University, Nanjing,
China
Alpha-Tocopherol (vitamin E) is a lipophilic vitamin that exhibits an antioxidative activity, antiag-
ing and antiphotodamage. The study was to clarify the release feature of tocopherol in nanoemul-
sion vehicle (vit E NM) in HaCaT culture system and photoprotection effect of vit E NM on UVB-
induced damage in HaCaT keratinocytes.Tocopherol nanoemulsion (vitE NM) was prepared by high
pressure homogenization methods. HaCaT keratinocytes were incubated in the culture medium
supplied with 1/200 and 1/400 of vit E NM before different dosages of UVB irradiation. Cell growth
and cellular activity was detected. The vitamin E level left in the culture medium was measured by
HPLC. The photoprotection effect of vit E NM on cultured HaCaT cells was detected by MTT
assay. HaCaT KC could proliferated normally and no cytotoxicity effect of vitE NM on HaCaT KC
was observed. With prolonging the culture time, the vitamin E amount remained in the culture medium
decreased from 93.38 µg/ml at 0h to 5.36 µg/ml at 24h. Although photodamage to HaCaT KC was
dependent on the irradiated dosages (25%~80% decrease of cellular activity), pre-incubation with
Tocopherol NM may reduce such UV-induced injury. Anyway the photoprotection of tocopherol NM
was reduced because of increasing UVB irradiation from 30 mJ/cm2 (1.38 at 4h) to 90 mJ/cm2
(0.68 at 4h ), but the cellular activity still increased after prolonging culture time to 24 h (2.46 at 30
mJ/cm2 and 1.22 at 90 mJ/cm2).Compared with the control group, vitE NM is characterized by sta-
ble penetration and release potency which is of high importance for vitamin E to function on pho-
todamage in cultured KC for the first step. Pre-exposure of HaCaT KC to alpha-tocopherol could
improve the cellular activity decreased by UVB irradiation. The photoprotection efficiency is related
to both the released level of vitamin E and to the UVB dosage within 24h. 
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Synthetic dipeptide (Cys-Gly): a new antioxidant active ingredient that can be of great use in
anti-aging skin care products
E Bauza, T Marchand, E Roux, C Dal Farra and N Domloge Skin Research, Vincience, Sophia
Antipolis, Sophia Antipolis, France
The skin is constantly exposed to environmental stress such as UV irradiation. Therefore, the skin
is the primary target for oxidative stress and reactive oxygen species (ROS) formation. Moreover,
free radical damage to proteins causes cross-linking, carbonyl formation and protein denaturation.
In the skin, protection from oxidative stress is ensured by enzymatic (SOD, catalase, Glutathion
reductase and peroxydase) and non-enzymatic antioxidants. Catalase has become increasingly rec-
ognized as being an enzyme centrally involved in the aging process of skin, and it has also been rec-
ognized that catalase plays an important role in protecting the skin from UV-oxidative stress. As
recent data has demonstrated a significant decline of antioxidant enzyme activity in photoaged skin,
we were interested in investigating the anti-oxidative stress effect of the synthetic dipeptide (Cys-
Gly) at 1%, on cultured human fibroblasts. To accomplish this, we studied the expression of SOD
and catalase after UVB stress (100 mJ/cm2), and evaluated the outcome on protein carbonylation
and cell viability. Our studies showed that on SOD gels, the application of Cys-Gly dipeptide at 1%
enhanced SOD expression in UV-stressed cells, compared to the controls. This result corroborates
the findings of catalase assays that showed that dipeptide-treated cells exhibited a higher level of
catalase activity in response to UV stress. Interestingly, the protective anti-oxidative stress effect of
the Cys-Gly dipeptide was supported by other studies that showed a significant decrease in protein
carbonylation, and an enhanced cell viability in the dipeptide-treated cells. Comet assay confirmed
this protective effect and showed a remarkable decrease (73%) of DNA damage in dipeptide-treated
cells. These results demonstrate the great anti-oxidative effect of the synthetic dipeptide, an active
ingredient that can be of considerable application in skin care and anti-aging products. 
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Narrow band UVB–induced oxidative DNA base damage in human keratinocytes
O Hiroshi,1,2 K Hiroshi2 and T Yoshiki1 1 Department of Dermatology, University of Occupational
and Environmental Health, Kitakyushu, Japan and 2 Department of Environmetal Oncology,
University of Occupational and Environmental Health, Kitakyushu, Japan
Oxygen radicals are produced by ultraviolet B (UVB) irradiation as well as many other environ-
mental carcinogens. They are also endogenously produced in cells by the oxygen metabolism. In
1984, Kasai reported the formation of 8–hydroxy–2’–deoxyguanosine (8–OH–dG) in DNA by oxy-
gen radicals. Recently, narrow band UVB (311–313nm) has greatly improved the therapeutic effi-
cacy and safety of phototherapy compared to the conventional broad band UVB (290–320nm). In
order to evaluate the narrow band UVB–induced oxidative DNA damage, we digested cellular DNA
with nuclease P1 and alkaline phosphatase, and analyzed the released 8–OH–dG using a high–per-
formance liquid chromatography system equipped with an electrochemical detector (HPLC–ECD).
By this method, non–irradiated human keratinocytes (HaCaT) contained 1.48 (±0.22) 8–OH–dG
per 106 2’–deoxyguanosine (dG) residues in cellular DNA, which increased linearly to as high as
10.97 (±0.44) 8–OH–dG per 106 dG after broad band UVB irradiation at 1000mJ per cm2. The
lower level of 8–OH–dG (2.06±0.31 residues per 106 dG) was also detected in HaCaT cells after nar-
row band UVB irradiation at 1000mJ per cm2. This lower level of oxidative DNA damage suggests
that narrow band UVB phototherapy may be less potent in UVB–induced skin carcinogenesis. 
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Elastin exon 26A-containing primary transcript and 26A protein are induced by UV irradia-
tion and heat treatment in human skin in vivo
Z Chen,1,2 J Seo,1,2 S Lee,1,2 Y Kim,1,2 J Seo,1,2 K Kim,1,2 H Eun1,2 and J Chung1,2 1 Dermatoloty,
Seoul National University College of Medicine, Seoul, South Korea and 2 Laboratory of Cutaneous
Aging Research, Clinical Research Institute, Seoul National University Hospital, Seoul, South
Korea
Photoaged skin contains elastotic materials in the upper reticular dermis. This phenomenon is com-
monly known as solar elastosis. In our previous report, it was demonstrated that UV irradiation
induced tropoelastin mRNA expression in the epidermis of human skin in vivo and also in the cul-
tured keratinocytes in vitro. It was also known that the primary transcript of elastin undergoes exten-
sive alternative splicing resulting in the translation of multiple heterogeneous protein isoforms. In
this study, we found that UV irradiation and heat treatment increased the levels of elastin transcript
containing exon 26A and its encoding elastin isoform (26A protein) in the epidermis of human skin
in vivo and in cultured human keratinocytes in vitro by nested RT-PCR, Western blot analysis and
immunohistochemical staining. It was also shown that there was increased elastin transcript con-
taining exon 26A in the forearm (sun-exposed) skin of elderly persons, compared with upper-inner
arm (sun-protected) skin of the same individuals. These data suggest that elastin containing exon
26A peptide induced by UV irradiation and heat treatment in human skin in vivo, plays some roles
in the development of solar elastosis 
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Adaptive response of human keratinocytes to UVB damage: effect of dose fractionation
D Decraene,1 D Gan,2 T Mammone,2 D Maes,2 L Declercq3 and M Garmyn1 1 Department of
Dermatology, University of Leuven, Leuven, Belgium, 2 Estee Lauder Companies, Melville, NY and
3 Estee Lauder Coordination Center, Oevel, Belgium
UVB induces DNA damage and the most important DNA lesions are cyclobutane pyrimidine dimers
(CPDs) and (6-4) photoproducts. The cell will be able to repair these lesions after a low UVB dose.
When damage is too high (after a high dose) cells go into apoptosis. The aim of this project is to
study the effect of repetitive UVB damage on survival (MTT assay), apoptosis (PARP cleavage) and
DNA repair (detection of the induction and removal of CPDs by southwestern blot analysis). Pre-
exposure to a low UVB dose (8 mJ/cm2) will significantly increase survival, when the second dose
is apoptotic and time interval is 24 hrs. Increase in survival is paralleled with decrease in apoptosis
as determined by PARP cleavage. Dose fractionation of 24 mJ/cm2 to 3x 8 mJ/cm2 increases sur-
vival and changes the response from apoptosis to repair, with a repair capacity comparable to cells
only exposed once to 8 mJ/cm2. This adaptive response is only observed when time-interval between
the fractionated doses is long enough (24 h). Dose fractionation (3x 8mJ/cm2) with shorter time
intervals (30 min, 1 h, and 3 h), results in accumulation of damage. These cells fail to repair dam-
age 24 hrs after the last exposure and lose gain in survival, observed with fractionated doses with
long time intervals (24 h). We conclude that dose fractionation induces an adaptive response, but
only when time-interval between the fractionated doses is long, allowing more time for DNA repair
and thereby preventing accumulation of DNA damage. 
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Further analysis of Infrared A (IRA) radiation-induced MMP-1 expression
P Schroeder, S Wild, SM Schieke and J Krutmann Research Inst. for Environmental Health (IUF)
at the H.-H.-University of Duesseldorf gGmbH, Duesseldorf, Germany
Human skin is increasingly exposed to IRA radiation, which is not only the major part of natural
sunlight but also emitted by artificial irradiation devices used for reasons of lifestyle or therapeutic
purposes. There is, however, evidence from animal as well as in-vitro studies that IRA radiation
causes premature skin aging. Accordingly, we have previously shown that IR-A radiation leads to
an induction of matrixmetalloproteinase-1 (MMP-1) expression in human dermal fibroblasts in-vitro
via the ERK-MAPKinase pathway. We now report that physiologically relevant doses of IRA radi-
ation cause MMP-1 expression in-vivo in the skin of human volunteers (n=3) as well. Realtime-
PCR analysis revealed a 3 - 14 fold upregulation of MMP-1 mRNA levels in IRA-irradiated skin,
which was associated with a concomitant increase in MMP-1 protein expression (immunohisto-
chemistry). In additional in-vitro studies we have also obtained first evidence for the involvement
of reactive oxygen species (ROS) in IRA radiation-induced signalling. This conclusion is based on
the following observations which were made in cultured human dermal fibroblasts: (i) IRA irradia-
tion affected intracellular ROS levels as assessed by means of oxidation-sensitive fluorescent dyes;
(ii) IRA irradiation shifted the balance between oxidized and reduced cellular glutathione towards
the oxidized form and, most importantly (iii) IRA radiation-induced MMP-1 expression could be
partially prevented when glutathione levels were increased prior to irradiation by treatment of cells
with N-acetylcystein. These studies demonstrate the in-vivo relevance of IRA radiation-induced
MMP-1 expression and indicate that antioxidative strategies may be used to protect human skin
against IRA-radiation-induced detrimental effects. 
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Ultraviolet B radiation up-regulates expression of dectin-2 on epidermal Langerhans cells
M Bonkobara,2 T Washizu,2 P Bergstresser,1 P Cruz, Jr1 and K Ariizumi1 1 Dermatology, The
University of Texas Southwestern Medical Center, Dallas, TX and 2 Veterinary Clinical Pathology,
Nippon Veterinary & Animal Science Univ, Tokyo, Japan
Since ultraviolet B (UVB) irradiation of mouse skin alters the antigen presenting cell (APC) func-
tion of epidermal Langerhans cells (LC), leading to suppressed Th1, but activated Th2 responses,
and because dectin-2 is a pattern recognition receptor (PRR) on LC and dendritic cells (DC) shown
to mediate suppression of contact hypersensitivity responses by UVB and is required for DC expres-
sion of Th2 cytokines, we hypothesized that UVB may upregulate dectin-2 expression on LC and
DC. To address this hypothesis, we cultured mouse bone marrow cells with GM-CSF for 6 days to
produce DC and then treated these cells with sham or UVB radiation (up to 300 J/m2). A day after,
we assayed dectin-2 mRNA by RT-PCR/Southern blotting, and found it to be 3.5-fold greater in
UVB-irradiated (vs. sham-irradiated) DC. We also treated DC with various doses of IFNγ, PMA,
and LPS, and found none of these factors (known to stimulate APC function) to augment dectin-2
mRNA expression. Next, we examined effects in vivo using a conventional protocol for inducing
UVB-induced immunosuppression. BALB/c mouse right ears were treated with UVB (1 kJ/m2/day)
and left ears with sham irradiation for 4 consecutive days. A day after the last irradiation, we iso-
lated epidermal cells from ear skin and used anti-Ia+ magnetic beads to sort Ia+ LC from Ia- cells.
We confirmed dectin-2 mRNA expression to be restricted to Ia+ LC. Moreover, dectin-2 mRNA was
3-fold greater in UVB-irradiated (vs. sham-irradiated) LC. By contrast, mRNA expression of other
PRR (e.g., TLR-2, TLR-4, dectin-1) were unaffected. Finally, using Western blotting and anti-dectin-
2 Ab, we found UVB to also upregulate dectin-2 protein expression. These findings lead us to con-
clude that UVB is uniquely capable of augmenting dectin-2 expression on LC and DC, and to hypoth-
esize that such augmentation may be an important mechanism accounting for the immunosuppressive
and Th2-polarizing properties of UVB radiation. 
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Detecting reactive oxygen species in skin using two-photon fluorescence imaging microscopy
KM Hanson,1 PJ Hayden,2 J Kubilus2 and RM Clegg1 1 Lab for Fluorescence Dyanmics, Physics,
University of Illinois at Urbana-Champaign, Urbana, IL and 2 MatTek Corp., Ashland, MA
Reactive oxygen species (ROS) contribute to skin photodamage including photoaging, immunomod-
ulation, actinic keratosis and skin cancers. Because these highly-reactive derivatives of molecular
oxygen are extremely short-lived and essentially non-emissive, they are difficult to detect directly.
In addition, until recently with the realization of two-photon excited fluorescence (TPEF) imaging,
the opaque and heterogeneous environment of the skin has inhibited detection and quantification of
UV-induced ROS within the skin. We have developed a TPEF imaging method to detect the pres-
ence of ROS with 0.5 m spatial resolution and >100 m depth penetration. Dihydrorhodamine (DHR,
100 uL, 50 uM) is applied to the skin surface (Epiderm-200 (epidermis) and Epiderm-200FT (epi-
dermis/dermis) (MatTek Corp.)) and incubated for 1 hr (37 oC, 5% CO2). DHR is non-fluorescent
until it reacts with ROS and forms fluorescent rhodamine-123 (R123).  Samples are imaged before
and after UV irradiation (200-1600 J m2, 280-400 nm, solar simulator, Solar Light Co.). A detailed
description of the instrument and experimental parameters will be presented. ROS are generated pre-
dominately in the lipid rich extracellular matrix of the corneocytes. With increasing depth, R123
fluorescence is detected primarily in the cytoplasm of the keratinocytes within each epidermal
layer.  In the dermis, fibrous regions of R123 fluorescence are detected. The data show that at com-
monly obtained UV doses, detectable ROS are generated within all layers of the epidermis and in
the dermis. Both ex vivo and skin equivalent tissues yield similar results, with the advantage of the
latter being reduced variability (scattering coefficients, pigmentation differences) between samples
that ex vivo tissue affords. By coupling the TPEF microscopy method with skin equivalent tissue,
the effects of topical applications like antioxidants and sunscreens upon UV-induced ROS levels
can be studied. 
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Heat shock-induced expression of matrix metalloproteinase-1 is mediated by activation of extra-
cellular signal-regulated kinase and c-Jun N-terminal kinase and via an interleukin 6-depend-
ent autocrine mechanism in human skin fibroblasts
C Park, M Lee, J Ahn, S Kim, M Shin, K Kim, H Eun and J Chung Department of Dermatology,
Seoul National University, College of Medicine, Laboratory of Cutaneous Aging Research, Clinical
Research Institute, Seoul National University Hospital, Seoul, South Korea
Repetitive exposure of human skin to sunlight has been suggested to be a major factor for prema-
ture skin aging. Infrared irradiation as well as ultraviolet irradiation of human skin cells was shown
to induce matrix-metalloproteinases (MMPs), which degrade extracellular matrix. Infrared irradia-
tion leads to the generation of heat. Heat shock is widely considered as one of environmental stresses.
Here we have investigated the effect of heat shock on the expression of MMP-1 and MMP-2 in cul-
tured human skin fibroblasts. Heat shock induced the expression of MMP-1, but not MMP-2, at the
mRNA and protein levels in a dose-dependent manner. Heat shock caused the rapid activation of
three types of mitogen-activated protein (MAP) kinase. The heat shock-induced MMP-1 expression
was inhibited by treatment of skin fibroblasts with a MEK inhibitor, U0126 and a JNK inhibitor,
SP600125, but not a p38 MAP kinase inhibitor, SB203580. Furthermore, heat shock increased the
synthesis and release of interleukin-6 (IL-6) into the culture media. The induction of IL-6 mRNA
by heat shock preceded the increase of MMP-1 mRNA expression. The specific inhibition of IL-6
using a monoclonal antibody against IL-6 greatly reduced the expression of MMP-1 induced by
heat shock.
Taken together, our results suggest that ERK and JNK, but not p38 MAP kinase, play an important
role in the induction of MMP-1 by heat shock and that the heat shock-induced expression of MMP-
1 is mediated via an IL-6-dependent autocrine mechanism. 
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Ultraviolet radiation and oxidative stress in hairless rats. Photoprotective effect of a Polypodium
leucotomos extract
J Mallol,1 M Giralt,1 MR Nogues,1 M Mulero,1 M Romeu,1 FX Sureda,1 J Folch,1 V Linares1 and
S Gonzalez2 1 Pharmacology, School of Medicine, REUS, Spain and 2 Harvard University, Boston,
MA
Previous studies demonstrated the antioxidant and photoprotective properties of an extract of the
fern Polypodium leucotomos (PL). In the present work we evaluated the photoprotective effects of
PL on hairless rats exposed to ultraviolet radiation (UVR). Male hairless rats were divided into four
groups (n=8 each) as follows: control non-irradiated; control non-irradiated and pretreated with PL;
irradiated; irradiated and pretreated with PL. PL doses of 30 mg/kg p.o. were given once daily for
seven days; last dose two hours before UVR. Two UVR schedules were applied (UVB/UVA lamps;
B/A ratio = 0.9) on the dorsal skin: 1.25 MED for biochemical assays and 2.5 MED for morpho-
logical analysis. Samples were obtained 48 hours after. The following parameters were determined
in plasma, erythrocytes and soluble extract of epidermis as described previously (Romeu et al., Life
Sciences, 2002): GSH, GSSG, GST, CAT, SOD, GSH reductase (GR), GSH peroxidase, and TBARS.
Langerhans cells (LC) were stained with a fluorescent anti-S-100 antibody and their morphology
was blindly evaluated by five observers. The linear general multivariate model (SPSS, 11.0) revealed
that PL had several protective effects. In erythrocytes of irradiated rats pretreated with PL the
GSH/GSSG ratio was increased by 20% and GR activity decreased a 22%, in comparison with irra-
diated but not pretreated with PL rats. In epidermis, rats irradiated and pre-treated with PL showed
a SOD activity 51% higher than those only irradiated.
Morphological analysis revealed strong disturbances in LC of irradiated animals without preteat-
ment with PL. The goodness of the model was checked by a χ2 analysis: χ2=32.47; p<0.001; κ=0.8;
global predictive value=90%. Using this model, the morphology of LC of rats pretreated with PL
was indistinguishable from that of the control non-irradiated rats. These results support the benefi-
cial photoprotective properties of PL after oral intake, probably due to its antioxidant and anti-rad-
ical activities. 
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Epidermal peroxisome proliferator-activated receptor gamma (PPARγ) as a target for UVB
radiation
Q Zhang, R Konger and JB Travers Dermatology, Indiana University, Indianapolis, IN
Ultraviolet B radiation (UVB) is a pro-oxidative stressor with profound effects on skin in part through
its ability to stimulate cytokine production and induce toxicity. Peroxisome proliferator-activated
receptor gamma (PPARγ) has been shown to regulate inflammatory processes and cytokine release
in several cell types; however, its effects on human epidermal cells have not been examined. The
present studies demonstrate the presence of PPARγ mRNA and functional protein in human ker-
atinocytes and epithelial cell lines HaCaT and KB. Moreover, treatment of epidermal cells with the
PPARγ specific agonists ciglitazone and the natural oxidized lipid 1-hexadecyl-2-azelaoyl glyc-
erophosphocholine (azPC) alone did not affect cyclooxygenase-2 (COX-2) levels, but augmented
COX-2 expression and enzyme activity induced by phorbol 12-myristate-13-acetate (PMA) and IL-
1. Since UVB has pro-oxidative effects, and oxidative stress has been shown to produce the potent
PPARγ agonist azPC, we then assessed whether UVB treatment of epidermal cells resulted in a
PPARγ activity. Lipid extracts from UVB-irradiated, but not control cells, contained a PPARγ activ-
ity identified by PPRE reporter studies and this activity upregulated COX-2 expression induced by
PMA. Use of the PPARγ inhibitor GW9662 and cells expressing a dominant-negative PPARγ mutant
confirmed that the lipid extracts from UVB-irradiated cells augmented COX-2 expression through
their ability to act as a PPARγ agonist.  Several separate lines of evidence suggest that UVB-gener-
ated PPARγ agonistic activity was due to free-radical mediated cleavage of endogenous glyc-
erosphosphocholines. First, pretreatment of epidermal cells with antioxidants ablated UVB-gener-
ated PPARγ activity. Second, subjecting purified 1-hexadecyl-2-arachidonoyl-glycerophosphocholine
to UVB irradiation generated a PPARγ activity, confirming a non-enzymatic process. These studies
suggest that epithelial cells contain a functional PPARγ system, and this system is a target for UVB
through the production of novel oxidatively modified endogenous phospholipids. 
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No major role for 8-oxoguanine in UVA-mutagenesis
UP Kappes and TM Ruenger Dermatology, Boston University School of Medicine, Boston, MA
Oxidative DNA damage, in particular 8-oxoguanine (8-oxoG), has been suggested to mediate muta-
tion formation and malignant transformation following exposure to UVA. It is processed primarily
by the base excision repair pathway (BER). The initial step of BER is the removal of the damaged
base by a damage-specific DNA-glycosylase, which is 8-oxoG DNA glycosylase (OGG1) for 8-
oxoG. In order to study the contribution of 8-oxoG to UVA-mutagenesis, we compared UVA- and
UVB-induced mutation frequencies in mouse embryonal fibroblasts from OGG1-knockout mice and
their OGG1-intact littermates, using the ouabain-mutagenesis assay. Following irradiation with var-
ious doses of UVA or UVB, mutations in the Na,K-ATPase gene were detected by colony forming
ability in a selective medium containing 3 mM ouabain and counted. In three independent experi-
ments, OGG1-/- cells did not exhibit an increased frequency of UV-induced mutations, as compared
to OGG1+/+ cells, either with UVA, or UVB. This indicates that 8-oxoG, which is processed by OGG1,
does not contribute significantly to either UVA- or UVB-mutagenesis. This is consistent with our
database of UVA- and UVB-induced hprt-mutations in primary human fibroblasts, now much extended
and based on sequencing in 2 directions of a total of 90 mutants. There we find that G to T trans-
versions, which are considered signature mutations for 8-oxoG, constituted only 13 % of UVA-
induced point mutations. This low frequency is similar to what we found in UVB-induced muta-
tions (15 %). Our new data also shows that C to T transitions, including CC to TT tandem mutations,
are the most common type of mutation not only with UVB (58 %), but also with UVA (48 %). These
C to T transitions are considered signature mutations for pyrimidine dimers, which therefore appear
to be major contributors not only to UVB-mutagenesis, as is well established, but also to UVA-muta-
genesis. In addition, UVB- and UVA-induced C to T transitions were located at largely the same
sites and hot spots, suggesting that UVA- and UVB-induced pyrimidine dimers are being formed
through the same or similar mechanisms of DNA damage formation. 
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UVA and UVB activate the Fanconi anemia/BRCA DNA damage response pathway
M Potter and TM Ruenger Dermatology, Boston University School of Medicine, Boston, MA
The identification of genes defective in the chromosome breakage disorder Fanconi anemia (FA)
has recently facilitated the elucidation of a novel DNA damage signaling pathway. Central to this
pathway is the ubiquitylation of the FANCD2 protein, which then forms nuclear foci with BRCA1,
NBS1, MRE11, and Rad50, and activates DNA repair through recombination and DNA end-join-
ing. So far, an activation of this pathway has only been described after exposure to DNA-crosslink-
ing agents or ionizing radiation (IR), but not after exposure to UVA or UVB. Following exposure to
IR, FANCD2 is also phosphorylated, which is part of a separate, ATM-dependent DNA damage
response pathway. In order to elucidate whether these DNA damage response pathways are also acti-
vated by UV, we exposed primary human fibroblasts to various doses of UVA or UVB and assessed
FANCD2-isoforms by immunoblotting at several time points. As early as two hours after irradia-
tion, clear shifts to the activated, ubiquitylated L-isoforms were detected in a dose-dependent man-
ner, with subsequent degradation of FANCD2 after 24 and 48 hours. This clearly indicates that the
FA/BRCA DNA damage response pathway is activated by UVA and UVB. The same activation was
also detectable in UVA- and UVB-irradiated xeroderma pigmentosum A cells, indicating that the
nucleotide excision repair of DNA photoproducts is not the upstream signal for UV-activation of
this pathway. Either UV-induced DNA damage itself, or stalled replication forks at sites of DNA
damage might mediate the FA/BRCA pathway activation. Activation of p53, as detected by phos-
phorylation of p53 at serine-15, was seen as early as FANCD2-ubiquitylation, but persisted longer.
Unlike IR, UV-irradiation did not result in band shifts or reactivity with a phospho-specific FANCD2-
antibody, indicating that UV does not induce phosphorylation of FANCD2. Since the FA/BRCA
pathway activates recombination repair and DNA strand break repair, we hypothesize that both UVA
and UVB generate a biologically relevant amount of DNA strand breaks, e.g. through oxygen radi-
cals, to require activation of this pathway. 
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Wound healing response of a full thickness in vitro human skin equivalent (EpiDerm-FT 200)
after solar UV-irradiation
PJ Hayden, B Burnham, J Kubilus, M Klausner and JE Sheasgreen MatTek Corp., Ashland, MA
Normal human epidermal keratinocytes (KC) and dermal fibroblasts (FB) were cultured to produce
full-thickness skin equivalents with FB-containing dermal and stratified epidermal components and
fully developed basement membrane at the dermal/epidermal junction (EpiDerm-FT 200, EFT). The
wound healing response of EFT after solar UV-irradiation was compared to excised human skin.
H&E stained paraffin sections of EFT showed a dose-dependent increase in apoptotic sunburn cells
at 24 h post-irradiation. After 48 h, high dose (61 J/cm2, metal halide lamp) samples showed exten-
sive epidermal damage and some dermal damage. At 72 h, sunburn cells still persisted in mid dose
samples (40 J/cm2), which were thinner than controls (indicating decreased KC proliferation) but
still without major epidermal damage. Epidermal destruction of high dose samples was nearly com-
plete at 72 h with loss of dermal matrix also evident. However viable basal cells remained in some
areas, with signs of proliferation and epidermal regeneration. Between days 5-7, substantial regen-
eration of the epidermis had occurred. Active MMP-1 protein in the culture media was also evalu-
ated by ELISA. A 50% increase in MMP-1 was observed in irradiated samples at 24 h. By 48 h, mid
dose samples showed a 2-fold increase in active MMP-1 protein, while high dose samples showed
a 3-fold increase. At 72 h, mid dose sample MMP-1 protein was comparable to controls, while high
dose sample activity remained elevated by 3-fold. Similar experiments were conducted with excised
human skin. The response was similar to EFT. The earliest response was increased sunburn cell for-
mation, with tissue thinning at 40 J/cm2 and extensive damage at 61 J/cm2. A viable, regenerative
basal epidermal cell layer was also observed in the excised human skin at 72 h in high dose sam-
ples. These results show that the EFT human skin equivalent behaves similarly to excised human
skin in terms of solar UV induced damage and wound healing. The model may thus prove useful for
additional applications in dermal/epidermal wound healing phenomena. 
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Removal of oxidative DNA damage is imapired in xeroderma pigmentosum group A (XPA) 
C Nishigori,1 Y Arima2 and Y Miyachi2 1 Dermatology, Kobe University, Kobe, Japan and 2
Dermatology, Kyoto University, Kyoto, Japan
Patients with XP have deficiency in repairing DNA damage caused by UV such as pyrimidine dimers
and are susceptible to developing skin cancers on the sun-exposed area. However, the patients with
XPA, B, D, G have neurological abnormalities, which cannot be explained by pyrmidine photo-
products caused by UV. We tested whether XP cells are impaired in removing oxidative stress. We
assayed the kinetics of 8-hydroxydeoxyguanosine (8OHdG) produced by UVB using XPA cells
because 8OHdG is recognized as a sensitive marker of oxidative stress. DNA was isolated anaero-
bically and 8OHdG was measured by HPLC using electrochemical detector. Preliminary study
revealed that UVB most effectively produced 8OHdG among UVB, UVA and UVA+riboflavin and
cellular survival 24 hr after 800 J/m2 of UVB was 90 % by trepan blue staining, most studies have
been done using UVB, mainly at the dose of 800 J/m2. (1) 8OHdG increased dose dependently up
to 3200 J/m2 both in XPA and normal cells. Yield of 8OHdG was 3/109dG/J/m2. (2) The removal of
8OHdG was statistically significantly impaired in XPA cells : 8OHdG remained twice the basal level
24 hr after irradiation in XPA cells, whereas in normal cells it returned to the basal level at 24 hrs.
(3) 8OHdG in XPA cells 24 hr after UV irradiation reduced by additng SOD, catalase, deferoax-
amine into the medium. In in vivo study pcHA-XPA, which contains human XPA gnee and hemag-
ultinin gene as a tag was introduced into XPA model mice skin. pcHA-XPA was treated 24 hr before
4 kJ/m2 of UVB irradiation.(4) Recovery of removing/repairng UV induced 8OHdG by human XPA
gene in XPA model mice in vivo was shown by staining the mice skin using monoclonal antibody
against 8OHdG. These results demonstrated that XPA gene is involved in removing/repairing oxida-
tive stress, which can be produced many environmental materials and by living cells. It might explain
some of the reasons why XPA patients have neurological abnormalities. 
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UVB substantially suppresses the expression of Interleukin-1 receptor antagonist in human
dermal fibroblasts: a likely mechanism to enhance inflammatory effects of IL-α and IL-β in
the dermis
MM Bashir,1 W Zhang,1 J Lin1 and VP Werth1,2 1 University of Pennsylvania, Phildelphia, PA and
2 Philadelphia V.A. Hospital, Phola, PA
Cytokines are important immune modulators, and ultraviolet-B (UVB) is a major environmental reg-
ulator of their expression. Previously, we and others showed that tumor necrosis factor alpha (TNF-
α), a pivotal proinflammatory cytokine, is upregulated in adult dermal fibroblasts (FBs) and neona-
tal keratinocytes (KCs) in response to UVB exposure, and that this upregulation is augmented by
interleukin-1 (IL-1α). In the present study, we sought additional factors that may play a role in UVB
effects on TNF-α production. Ribonuclease protection assays (RPA) for multiple cytokines on RNA
samples from FBs and KCs after sham irradiation (control) or 30mJ/cm2 UVB indicated that UVB
suppressed the IL-1 receptor antagonist (IL-1ra) mRNA to ~7% of the control value. In FBs treated
with UVB plus recombinant IL-1α, IL-1ra mRNA levels were 15-30% of control. UVB irradiation
of KCs produced small increases in IL-1ra mRNA (40-60% over control). Because the IL-1ra blocks
both IL-1α and IL-1β, and both of these molecules are upregulated by UVB, we sought to compare
their relative effects on TNFα production. UVB-induced upregulation of TNF-α mRNA was syn-
ergistically increased 30-40 fold, as shown by real time PCR, in the presence of IL-1β. ELISA data
showed that UVB alone increased TNF-α protein levels to 3.5-fold over sham-irradiated control
cells. There was an increase of 14 -fold in the presence of IL-1α??and 38-fold in the presence of IL-
1β. When both cytokines IL-1α and IL-1β were administered together, no additive effects were found
(32-fold as compare to 38 fold with IL-1β alone). Overall, our data indicate that UVB produces a
large inhibition of IL-1ra mRNA levels in FBs, and that this inhibition is likely to enhance IL-1α
and IL-1β mediated pro-inflammatory effects in the dermis. 
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Optical coherence tomography (OCT) for noninvasive quantification of dermal ageing
J Strasswimmer, MC Pierce, B Park and JF deBoer Dermatology, Wellman Center-Mass. Gen.
Hosp.-Harvard, Boston, MA
Purpose: To describe OCT for non-invasive imaging of aged skin Background: Current methods to
measure aged skin rely on external assessment of visible signs of ageing, are difficult to quantify;
skin biopsy is still the only method to quantitatively measure alteration in the dermis. Optical coher-
ence tomography (OCT) is an optical biopsy method which produces high-resolution vertical images
of skin in vivo in real time. One can reliably visualize 5mm x 1.5 mm portions of skin in under one
second. OCT produces architectural information with clear demarcation of the epidermis, papillary
dermis, and reticular dermis. A new modification, polarization-sensitive OCT (PS-OCT), quantita-
tively measures dermal collagen birefringence. We hypothesized that PS-OCT can quantitatively
measure changes in chronologic ageing and photoageing, as a potential optical biopsy method to
replace invasive tissue biopsy. Method: We designed and built a unique device with several OCT
enhancements, including improved image quality, Doppler information, polarization sensitivity,
and real-time imaging. We carried out a pilot study to examine features of chronologically aged and
photoaged skin. Results: Imaging of non-aged skin revealed a strong dermal birefringence signal
present in the upper dermis. In chronologically aged skin, there is a total decrease in dermal bire-
fringence. In photoaged skin, there is a further decrease in dermal birefringence. Quantitative analy-
sis allows one to measure these changes without tissue biopsy. Conclusion: OCT, when polariza-
tion-sensitivity is incorporated, has the potential to become a useful and practical tool for noninvasive
quantitative measurement of dermal ageing. It may serve to guide laser or other skin rejuvenation
interventions over time 
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Eicosapentaenoic acid inhibits the UV-induced MMP-1 expression through JNK inhibition in
human dermal fibroblasts
H Kim, C Shin, M Shin, K Kim, K Cho and J Chung Department of Dermatology, Seoul National
University College of Medicine, Laboratory of Cutaneous Aging Research, Clinical Research
Institute, Seoul National University Hospital, Seoul, South Korea
UV radiation induces delayed UV-responsive genes, including matrix metalloproteinase (MMPs),
which degrade extracellular matrix proteins (ECMs). UV-induced MMP-1 expression resulted in
procollagen deficiency and wrinkle formation. UV radiation activates JNK and phosphorylates
transcription factor c-Jun. Phosphorylated c-Jun formed activator protein-1 (AP-1) complex with
constitutively expressed c-Fos. As the promoter of MMP-1 carries AP-1 site, UV-induced AP-1 acti-
vation increases MMP-1 expression. In this report, we investigated the mechanism of EPA to inhibit
UV-induced MMP-1 expression. EPA is a dietary w-3 fatty acid and produces 3-series PGs (PGE3)
by COX-2. EPA is used for modulation of inflammation and immunoresponsiveness. UV (75 mJ/cm2)
radiation increased MMP-1 expression at 72 hr and pretreatment of EPA inhibited the UV-induced
MMP-1 expression in a dose-dependent manner. EPA inhibited UV-induced MAPKs activation and
c-Jun phosphorylation. EPA also inhibited UV-induced AP-1 activation. Inhibition of AP-1 activity
resulted from decrease of c-Jun phosphorylation and c-Fos expression. Our results show that EPA
inhibited UV-induced MMP-1 expression through inhibition of AP-1 activity. 
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Ultraviolet radiation upregulates vascular endothelial growth factor production and down-
regulates thrombospondin production in human skin epidermis
Y Oh, M Kim, S Lee, M Shin, K Kim, H Eun and J Chung Department of Dermatology, Seoul
National University College of Medicine, Laboratory of Cutaneous Aging Research, Clinical
Research Institute, Seoul National University Hospital, Seoul, South Korea
Vascular endothelial growth factor (VEGF) is a major skin angiogenic factor and thrombospondin
(TSP)-1/2 are endogeneous inhibitors of skin angiogenesis. UV irradiation has been shown to be an
inducer of VEGF in keratinocytes in vitro and mouse models in vivo. To determine the UV-induced
cutaneous angiogenesis in human skin in vivo, we performed quantitative analysis of cutaneous blood
vessels with immunostaining for the endothelial cell marker CD31, and determined the expression
pattern of VEGF and TSP-1/2 with immunostaining and RT-PCR. We found that skin vasculariza-
tion was greatly increased after UV exposure (2 MED) with an increase of both the number and the
size of dermal blood vessels in human skin. After UV irradiation, the expression of VEGF increased
and that of TSP-1/2 decreased in immunostaining. In RT-PCR, mRNA expression of VEGF was
increased about 20% at 24 hr after UV irradiation compared with control skin. Maximal inhibition
of TSP-1 and TSP-2 expression was about 60% and 40% at 24 hr, respectively, compared with con-
trol skin. The ratio of VEGF to TSP-1 expression was increased about 3 folds and might be an impor-
tant factor in UVB-induced angiogenesis in vivo. We also confirmed the regulation of VEGF and
TSP-1/2 in keratinocyte-derived cell line HaCaT. Irradiation with physiologic UV dose (40 mJ/cm2)
substantially induced the expression of VEGF, whereas blocked the expression of TSP-1/2 in HaCaT.
Our results demonstrate that VEGF production is upregulated and TSPs are downregulated in UV-
induced angiogenesis in human skin, and the regulation of this balance may be a potential thera-




Effects of different ultraviolet spectra on apoptosis pathways
C- Tuchinda, HW Lim, FM Strickland and HK Wong Dermatology, Henry Ford Health System,
Detroit, MI
Ultraviolet (UV) radiation has profound effects on cellular function, which includes carcinogenic as
well as immunomodulatory properties on the immune system. A primary effect of UV is to cause
cell death by inducing apoptosis. However, the mechanism of different ultraviolet wavelengths on
apoptosis pathway remains unclear. Ultraviolet radiation is separated into UVA(320-400 nm), UVB
(280-320 nm) and UVC (200-280 nm). We studied the effects of different clinically relevant UV
spectra to better understand how specific wavelengths of UV initiate apoptosis in primary T cells.
We exposed peripheral blood mononuclear cells (PBMC) from normal volunteers to FS40 (61%UVB,
28.5%UVA and 0.5%UVC) and FS351 (80.1% UVA1, 18.5%UVA2 and 1.4%UVB) lamps. Both
UV sources induced apoptosis in PBMC as determined by immunocytochemistry, flow cytometry,
agarose gel electrophoresis for DNA laddering and Western blotting. The apoptotic processes are
UV-dose dependent. For FS40, we demonstrated DNA laddering and detected cleaved caspase-3 at
a total UV dose as low as 7.5 mJ/cm2, while the cleaved caspase-3 was detected at UV dose of 6
J/cm2 of using FS351. We also found that there was a progressive increase for cytochrome C, trun-
cated BID (Bcl-2 Interacting Domain), cleaved caspase-3, cleaved caspase-8 and cleaved caspase-
9 with increasing UV dose of FS40. For FS351 a progressive increase for cytochrome C and cleaved
caspase-9 was detected, while truncated BID and cleaved caspase-8 was not detected in UV-treated
PBMC for up to 8 J/cm2. Our data show that both UVA and UVB can induce apoptosis in PBMC
and the process proceeds through caspases. UVB induced-PBMC apoptosis is mediated through
members of the extrinsic and intrinsic pathway. The lack of truncated BID and cleaved caspase-8
detected, while the presence of cytochrome C and cleaved caspase-9 detected in FS351-treated PBMC
suggested a difference in the mechanism of UVA and UVB in inducing PBMC apoptosis. This may
lead to a better understanding of the therapeutic mechanism of UVA and UVB. 
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Ultraviolet A -radiation destroys the architecture of plasma membrane -associated rafts in
human keratinocytes
S Grether-Beck, M Salahshour-Fard, I Felsner, H Brenden and J Krutmann Cell Biology, Institut
fuer Umweltmedizinische Forschung, Duesseldorf, Germany
We have shown that UVA-induced signaling in HKs is triggered by the release of ceramide from
plasma membrane localized sphingomyelin (SM). Within the plasma membrane of mammalian cells,
SM together with cholesterol (Chol) form microdomains (rafts) which differ according to structure
and fluidity from the remaining plasma membrane and build up platforms, which are involved in sig-
nal transduction. They contain proteins including caveolin-1 (Cav1), which has been shown to be
functionally involved in raft-mediated signaling. In this study, rafts were isolated from HKs which
had been sham-irradiated or exposed to 30 J/cm2 of UVAR. This dose induces intracellular signal-
ing and gene expression, but not apoptosis or necrosis. Analysis of the lipid composition of the iso-
lated rafts revealed dramatic changes: the SM content decreased to a third of that observed in con-
trols, corroborating previous observations that UVA-induced ceramide formation results from SM
hydrolysis. In addition, the Chol of rafts from irradiated cells was decreased by more than 50%.
This UVA-induced decrease in SM and Chol content in rafts was associated with a concomitant
increase of those lipids in non-raft membrane fractions of the same cells. UVAR also markedly
decreased Cav1 in rafts from irradiated cells, in comparison to untreated controls as shown in west-
ern blot. In order to follow the fate of Cav1 in irradiated HKs other cellular compartments were ana-
lyzed for Cav1 expression. Neither the cytosolic fraction of HKs which, in contrast to most other
cell types, contain Cav1, nor mitochondria contained increased amounts of Cav1; in fact, in both
cell compartments, Cav1 expression was decreased upon UVA treatment. In marked contrast, sig-
nificantly increased amounts of Cav1 could be detected in the nuclear fraction of irradiated cells.
Our studies indicate that UVA-induced signaling is associated with a profound disturbance in the
architecture of rafts and the translocation of Cav1 from the plasma membrane into the nucleus. 
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Potentiation of ultraviolet B-induced apoptosis by novel phytosphingosine derivatives, tetraacetyl
phytosphingosine in HaCaT cell line and mouse skin
H Kim, S Kim and T Kim Dermatology, The Catholic University of KOREA, Seoul, South Korea
We previously demonstrated that the novel phytosphingosine derivatives, tetraacetyl phytosphingo-
sine (TAPS) induced apoptosis in HaCaT. In this study, in order to reduce cumulative UV dose and
to enhance apoptosis, we investigated to examine the effect of combination of the low dose irradia-
tion of UVB and the phytosphingosine derivatives, TAPS on the induction of apoptosis. 10 mJ/cm2
UVB or 10 ?M TAPS alone showed a weak cytotoxicity, respectively, but combination of 10 mJ/cm2
UVB with 10 ?M TAPS dramatically enhanced cytotoxicity and apoptosis in HaCaT measured by
MTT assay, TUNEL assay and FACS analysis. Western blot analysis showed that cells cotreated with
UVB and TAPS showed higher cleaved levels of caspase-3, caspase-8 and caspase-9 than treatment
with UVB or TAPS alone, suggesting that combination of UVB with TAPS synergistically induced
apoptosis via extrinsic and mitochondrial apoptotic pathway. In the hairless mice, UVB irradiation
alone caused to increase apoptotic cells in the epidermis and TAPS-treated mice skin showed the
increased apoptotic cells in dermis as well as in epidermis. As in vitro assay, the level of cleaved
caspase-3 was more effectively induced in the mice skin cotreated with UVB and TAPS than single
treatment of UVB or TAPS. Then, we investigated the role of mitogen-activated protein kinases
(MAPKs) in the enhancement of UVB-induced apoptosis by the TAPS. We found that UVB irradi-
ation gradually activated phospho-ERK1/2, plateau at 6 h, and thereafter returned to control level.
TAPS strongly induced ERK1/2 phosphorylation and lasted 24 hr later. However, combination of
UVB with TAPS prevented TAPS induced- or UVB induced-ERK1/2 phosphorylation, suggesting
enhanced apoptosis by the combination of UVB with TAPS may be due to reduction of ERK1/2
phosphorylation. These data showing the synergic apoptotic effect of the UVB and phytosphingo-
sine derivatives shed a light on their potential use as a drug against hyperproliferative diseases like
psoriasis.
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Protective role of extracellular superoxide dismutase on ultraviolet irradiation
B Choung and T Kim Dermatology, The Catholic University of KOREA, Seoul, South Korea
Superoxide dismutases (SOD) are believed to play a crucial role in protecting cells against oxygen
toxicity. In human, there are three forms of SOD: cytosolic Cu, Zn-SOD, mitocondrial Mn-SOD
and extracellular SOD (EC-SOD). EC SOD is primarily a tissue enzyme but the role of EC SOD in
skin is unclear. In this study, we have investigated the distribution of EC SOD in the skin using
immunohistochemistry and established EC SOD gene expression systems in MEF/3T3 cell and
HaCaT cell lines to analyze the functional significance of EC SOD gene expression in skin. In addi-
tion, Human EC SOD was fused with a gene fragment encoding transduction domain of the HIV-1
Tat protein (RKKRRQRRR) for development of a noble material preventing from the UV-induced
deterious effects of UV irradiaion. Immunohistochemical analysis showed the EC SOD was abun-
dantly located in the epidermis as well as in the dermis. Intracellular ROS was decreased and cell
death was diminished following UV irradiation in EC SOD-overexpressed cell lines. Also, the puri-
fied fusion proteins trasduced effectively into HaCaT cell in dose-dependent manner and had their
activities when added exogenously in culture medium. This study demonstrate that EC SOD have
the defensive roles against UV-induced injury of the skin and EC SOD fusion protein may provide
a therapeutic strategy for treatment of ROS-induced skin disease or cosmetics for protection from
chronological ageing and photoaging. 
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Cellular protein changes in vitro following recovery from mild/moderate oxidative stress and
in ex vivo photodamaged skin tissue
AD Heath, H Muir-Howie, LP Watson and MR Green Life Sciences, Unilever R&D, Sharnbrook,
BEDS, United Kingdom
It is well known that oxidative stress contributes to human ageing and photodamage. However the
long-term effects of oxidative stress remain to be fully evaluated on cell phenotype after recovery
from acute stress. We treated normal human dermal fibroblasts (HDF) with 450µΜ hydrogen  per-
oxide(H2O2) for 7 days followed by a 7-day recovery period. Cell extracts from neonatal HDF were
studied by 2-D-gel/MALDI-TOF mass spectrometry and from adult HDF by western blot arrays (BD
Bioscience, PowerBlot™). Protein expression changes along with other potential candidates, were
examined by immunocytochemical analysis in H2O2 treated HDFs and in paired samples of sun-
protected and photodamaged human skin sections. The latter sections provide a comparative ex vivo
model for normal and in vivo recovered, oxidative stressed tissues. Proteome analysis revealed sev-
eral proteins that changed in HDFs in response to H2O2 treatment. A number of these showed altered
staining by immunocytochemistry in H2O2 treated cells: transgelin (Smooth Muscle (SM)22), ninein,
vimentin, tropomyosin, DNA excision repair protein ERCC-1, fragile histidine triad (FHIT), and
lens epithelium-derived growth factor (LEDGF/transcription factor p52/p75). With the exception of
SM22 these changes have not previously been noted in other proteomic or geonomic studies. Of
several candidate biomarkers selected following literature analysis, the fibronectin splice variant
ED (extra domain)-A, osteonectin, thrombospondin, integrin, transglutaminase II and procollagen I
also showed marked altered expression on treated cells. However, for only procollagen 1 was good
discrimination observed between sun protected and photodamaged skin. The protein changes fall
into two strong themes, those of cytoskeletal and myofibroblast change. In addition we confirm the
importance of putative in vivo collagen synthesis in photodamage repair following UV linked oxida-
tive stress. 
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Inhibition of UV-induced MMP-1 expression by selective COX-2 inhibitor, celecoxib, in human
dermal fibroblasts
J Chung, H Kim, C Shin, J Seo, K Kim and H Eun Department of Dermatology, Seoul National
University College of Medicine, Laboratory of Cutaneous Aging Research, Clinical Research
Institute, Seoul National University Hospital, Seoul, South Korea
Exposure to UV radiation induces various responses in human skin. Among these responses, UV-
induced MMP-1 expression resulted in procollagen deficiency and wrinkle formation. Also, UV radi-
ation induced expression of cyclooxygenase-2 (COX-2) and secretion of prostagladins (PGs). In
recent reposts, prostaglandin E2 (PGE2) has an ability to amplify its own production by inducing
COX-2 expression. But, relationship of PGE2 and MMP-1 expression was not clear. In this report,
we investigated whether selective COX-2 inhibitors inhibit UV-induced MMP-1 expression. UV
radiation induced COX-2 expression and PGE2 production and decreased procollagen expression
in a dose- and time-dependent manner. Pretreatment of celecoxib inhibited UVB-induced MMP-1
expression. In stable MMP-1 luciferase reporter plasmid-transfected NIH3T3 cells, celecoxib inhib-
ited UVB-induced MMP-1 promoter activation. Celecoxib inhibited UV-induced AP-1 activation
and c-Jun phosphorylation. Phosphorylation of c-Jun is required for formation of AP-1 complex and
results from stress-activated protein kinases, especially JNK (c-Jun N-terminal kinase). Although
celecoxib inhibited c-Jun phosphorylation, it did not inhibit UV-induced JNK activation. Our results
demonstrate that celecoxib inhibited UV-induced AP-1 activation, thereby inhibited MMP-1 expres-
sion in a JNK-independent manner. 
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Protective effect of IL-4 on UVB-induced apoptosis
H Hwang, S Kim and T Kim Dermatology, The Catholic University of KOREA, Seoul, South Korea
A crucial event following exposure of skin to UVB is the formation of sunburn cells within the epi-
dermis, which are UV-damaged cells that undergo apoptosis. Induction of apoptosis following UVB
exposure has been considered to be protective mechanism, getting rid off damaged cells that bear
the risk of becoming malignant. IL-4, is a cytokine with various biological activities, improves the
antigen presenting capacity on B cells by inducing the expression of MHC class II gene, induces the
isotype switching, promotes growth and increases survival of B cells. Furthermore, IL-4 induces the
proliferation and maturation of mast cells, macrophages and prolongs the survival of particular T
cell clones. In this study, we generated transgenic mice that over-expressed IL-4 specifically in skin
using keratin 14 promoter to investigate the effect of IL-4 in UVB-induced apoptosis. We irradiated
UVB (2kJ/m2) and detected apoptosis using TUNEL assay. As the result, apoptosis in epidermis was
decreased in transgenic mice compared with that in normal mice. In addition, the expression of cas-
pase 3 was decreased in transgenic mice compared with that in normal mice after UVB irradiation.
Next, to investigate whether IL-4 has the protective effect in keratinocyte directly or not, we pre-
pared stable cell line which over-expressed IL-4 constitutively using mouse keratinocyte cell line,
Pam212. The results of TUNEL assay and FACS analysis showed that apoptosis induced by UVB
(200J/m2) was remarkably decreased in IL-4 over-expressed Pam212 compared with that in normal
Pam212. In summary, the results in this study show that IL-4 has the protective effect on UVB-
induced apoptosis and suggest that IL-4 may be an important regulator in skin-immune system against
UVB.
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Antioxidative capacity, absorption and metabolism of aromatic components of an extract of
Polypodium leucotomos
L Gombau,1 F Garcia,3 A Lahoz,1 M Fabre,1 P Roda,2 A Brieva,3 JL Alonso,3 R Tejedor,3 JP Pivel,3
JV Castell,1 MJ Gomez-Lechon1 and S Gonzalez4,5 1 Advancell, Barcelona, Spain, 2 B.Molecular,
Hospital de la Princesa, Madrid, Spain, 3 IFC, Madrid, Spain, 4 Dermatology, Harvard
University, Boston, MA and 5 Dermatology, Memorial Sloan-Kettering Cancer Center, New York,
NY
An oral photoprotectant (Fernblock® from the fern Polypodium Leucotomos) has been shown to
exhibit strong photoprotective properties. Recently, studies have been performed to define its chem-
ical composition. 4-hydroxycinnamic acid (p-cumaric), 3 methoxy-4-hydroxycinnamic acid (fer-
ulic), 3,4-dihydroxycinnamic acid (caffeic), 3-methoxy-4-hydroxybenzoic acid (vanillic) and 3-caf-
feoilquinic acid (chlorogenic) have been found among the major components. Despite their
chemopreventive role no conclusive data exist on its antioxidative capacity in skin cells or its absorp-
tion and metabolism after an oral intake. Antioxidative capacity was evaluated by using luminol/H2O2
in vitro assay. Cytoskeleton protection in human fibroblasts was analyzed by indirect immunofluo-
rescent assays. To study compound absorption an adenoma-derived cell (Caco-2) was used to resem-
bled the intestinal barrier. Finally, compound metabolism was investigated by using cultured primary
rat hepatocytes. As expected, antioxidative and photoprotective properties was observed in a dose
dependent fashion, being caffeic acid the most powerful antioxidant molecule. Apparent permeability
resulted in a value that correlate with a 70 to 100% oral human absorption for all tested substances.
Cumaric, Ferulic and Vanillic acids were metabolized and conjugated to glucuronic acid and sulfate
in a 35%, 50%, and 10%, respectively. Serum esterases did not participate in their metabolism. No
binding to cell proteins was observed. In conclusion, we showed first evidences of antioxidant and
photoprotective activity of some constituent molecules of Fernblock®, and their absorption and
metabolism properties. These results may help to optimize the benefits of this photochemopreven-
tive agent. 
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Cockayne Syndrome A and B proteins and repair of oxidative damage to mitochondrial DNA:
mechanism of import and functional relevance in vivo
M Fousteri,1 V Kuerten,2 M Roecken,3 L Mullenders,1 J Krutmann2 and M Berneburg3 1 Silvius
Laboratory, Leiden University Medical School, Leiden, Netherlands, 2 Institut fuer
Umweltmedizinische Forschung, Heinrich Heine University, Duesseldorf, Germany and 3
Molecular Oncology and Aging, Dept. of Dermatology, Eberhard Karls University, Tuebingen,
Germany
Cockayne Syndrome (CS), characterised by neurodegeneration, photosensitivity and premature aging,
is caused by mutations in the CSA and CSB gene. We have shown that the CSA and CSB proteins
are localised in the mitochondrion (mt) and involved in the repair of oxidative mtDNA deletions.
However, their import into mt, exact type of repaired damage and functional relevance in vivo are
unclear. For localisation, CSA and CSB miss a mt leader sequence but computer based k-NN sequence
analysis predicted 52.2 % and 30.4 % mt localisation for CSA and CSB, respectively. Furthermore,
co-immunoprecipitation showed requirement of CSA/CSB proteins in a heterodimeric state to allow
mt import. Employing a reconstituted in vitro repair assay comprising fapy-glycosylase and endo
III as reporter enzymes for oxidative damage in pyrimidines and purines, respectively, we could show
that, after repetitive sublethal UVA irradiation, removal of thymine glycol from mtDNA was defec-
tive in fibroblasts from CS patients. However, stable transfection of the CSB gene reconstituted this
defect. Semiquantitative PCR showed increased levels of mtDNA deletions in CSB knockout mice
in vivo compared to wild-type littermates in the brain but not in muscle, cartilage spleen or testis,
correlating with the neurodegenerative changes found in aging animals. In aggregate, these results
strengthen the role of CS proteins in the repair of oxidative damage to mtDNA and indicate a het-
erodimeric composition of both proteins as requirement for mt import. Furthermore, the correlation
of neurodegenerative symptoms and defective removal of oxidatively induced mtDNA deletions in
CS knockout mice indicates a close relationship of oxidative stress, its repair by CSA and CSB and
processes such as neurodegeneration and aging. 
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Protective effect of commercially available sunscreens with respect to UVA-radiation
M Moksnes1 and TO Fotland2 1 National Veterinary Institute, Oslo, Norway and 2 Norwegian Food
Safety Authority, Oslo, Norway
The aim of this study was to establish the extent of protection against UVA-radiation provided by
sunscreens available on the Norwegian market in 2002 and 2003. At this time, there are no defined
standards for either declaration or control of UVA protection in Europe or the USA. The American
Academy of Dermatology Association (AADA) has recently sent its recommendations to the U.S.
Food and Drug Administration (FDA) for measurement methods and requirements for UVA pro-
tection. In this project we have used those recommended in vitro adapted methods. In addition, the
products were tested in compliance with the Australian standard (AS/NZS 2604). A selection of sam-
ples was also tested for UVA protection at the Australian Photobiology Testing Facility, University
of Sydney. The specification of UVA protection on the packaging/container was also checked and
controlled. Of the sunscreens analysed (54) for UVA protection, 47 products (87 %) satisfied the
requirements of the Australian standard. 40 products (74 %) satisfied the requirement for a critical
wavelength ≥ 370 nm, which indicated that they give broad-spectrum protection. With reference to
the results for all the UVA indicators and criteria used, we have evaluated seven sunscreens to give
very weak or no protection against UVA radiation. All the products claimed to protect against UVA
radiation. 25 products were labelled with a quantitative UVA protection indicator. Five of these are
considered to be incorrectly labelled with respect to UVA factor. 29 products were labelled with a
general UVA protection indicator. Our results show that seven of these do not give sufficient UVA
protection and could be also regarded as incorrectly labelled. From our study, we can conclude that
the recommended measurement criteria from AADA give a reasonably good evaluation of the pro-
tection afforded by sunscreens against UVA radiation. By using the requirement for broad-spectrum
protection (critical wavelength ≥ 370 nm) we have shown that 26% of the products do not protect
sufficiently against UVA. 
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Regulation of UV-mediated activation of the transcription factors AP1 and NF-kB by an extract
of Polypodium leucotomos
JL Alonso,2 I Benedicto,1 M Gomez-Gonzalo,1 JP Pivel,2 S Gonzalez3,4 and M Lopez-Cabrera1 1
B.Molecular, Hospital de la Princesa, Madrid, Spain, 2 IFC, Madrid, Spain, 3 Dermatology,
Harvard University, Boston, MA and 4 Dermatology, Memorial Sloan-Kettering Cancer Center,
New York, NY
We have previously described that an extract of Polypodium leucotomos (PL) (FERNBLOCK®),
mainly composed by antioxidative phenolics, has beneficial effects in preventing acute sunburn in
humans. PL has also been reported to inhibit the formation of reactive oxygen species induced by
UV light and to possess anti-inflammatory properties. Skin exposure to UV light may promote the
depletion of cutaneous antioxidants, leading to altered gene expression programme and finally to
development of skin diseases. The redox status of the cell has been shown to be involved in the reg-
ulation of the activity and/or expression of transcription factors such as AP1 and NF-kB, whose
inhibition has been demonstrated to suppress human keratinocytes transformation. The aim of the
present study was to investigate its possible effect in UV-induced activation of AP1 and NF-kB in
the HaCaT keratinocyte cell line. The activities of these transcription factors were analyzed by reporter
gene and electrophoretic mobility shift assays. Our results showed that when PL was removed from
the culture medium before irradiation, an increase of the UV-induced AP1 transcriptional activity
was observed, whereas NF-kB activity remained unaffected. In contrast, both AP1- and NF-kB-
dependent reporter gene transcription induced by UV radiation were significantly blocked by PL
when cells were treated before and after UV light stimulation. Interestingly, when nuclear extracts
of cells pre- and post-treated with PL were analyzed for AP1 by mobility shift assays, a cooperative
effect of UV stimulation and PL treatment on AP1 DNA-binding activity was observed. These results
suggest that PL modulates the redox state of the cells and may avoid keratinocyte transformation. 
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The proactive effects of lipopolysaccharide and UV-induced cell damage by saccharomycop-
sis ferment filtrate in human 3D skin model
S Shen,1 W Lee2 and T Yoshii Takashi3 1 Dermatology, Taipei Municipal Wan-Fang Hospital-
Affiliated to Taipei Medical University, Taipei, Taiwan, 2 Taipei Medical University Hospital,
Dermatology, Taipei, Taiwan and 3 Kobe Technical Center, Procter& Gamble, Kobe, Japan
The development of new skin care formulations requires precise assessment of their safety and effi-
cacy. Today, legislation demands quality control combined with severe safety measures, as well as
a limited use of animals for such testing. Consequently, safety assessment protocols are oriented
towards in vivo tests on human volunteers and in vitro alternative methods to animal use, especially
tissue engineered skin substitutes. Our previous studies demonstrate that yeast extract SFF are able
to inhibit lipopolysaccharide (LPS)-induced nitric oxide (NO) production in a concentration-depend-
ent manner without notable cytotoxic effects in vitro. A decrease in NO production by saccha-
romycopsis ferment filtrate (SFF) was associated with an induction of heme oxygenase-1 (HO-1)
protein expression and an inhibition in iNOS protein by Western blotting. There is an interesting cor-
relation between HO-1 induction and NO inhibition. Besides, UV-induced cell damage was also pre-
vented by SFF pretreatment. In order to further conform the protective effect of yeast extract SFF
in vivo, the human 3D skin model were selected. The present study was performed to assess mor-
phologically the effect of SFF on human bioengineered skin. Upon LPS and UV treatment, cells in
human 3D model were obtained and detected by HE stain, electron microscopy and immunohisto-
chemistry. Our data shows that SFF can prevent cells from UV and reactive oxygen species induced
cell damage on human bioengineered skin. The proactive effects of SFF are conformed in vitro or
in bioengineered skin models. 
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Targeted inactivation of vascular endothelial growth factor sensitizes mouse skin to UVB-
induced cutaneous photo-damage
C Barresi, H Rossiter, M Ghannadan and E Tschachler Dermatology, University of Vienna Medical
School, Vienna, Austria
Exposure of skin to UVB results in erythema, dilation of dermal blood vessels and vascular hyper-
permeability. Vascular Endothelial Growth Factor (VEGF) is one of several pro-angiogenic factors
that are induced in skin after UVB irradiation, and epidermal keratinocytes (KC) are the major source
of VEGF in skin.
Using the Cre/LoxP system under the control of the Keratin 5 promoter, we have generated mice in
which VEGF has been inactivated in epidermal KC (VEGF-A-/-), and used these animals to study
the contribution of KC-derived VEGF to acute and chronic UVB-induced photo-damage. We found
that VEGF-A-/- mice developed burn-like lesions after a single UVB irradiation, whereas the con-
trol mice were unaffected. Microscopic examination of the irradiated skin showed photo-damage
characterized by erythema, loss of the epidermis, increased inflammatory cell infiltration and impared
vascularization in the upper dermis of VEGF-A-/-. Double immunofluorescent stains for CD31 and
active Caspase 3 revealed increased numbers of apoptotic endothelial cells in UVB irradiated VEGF-
A-/- mice and differential immunofluorescent stains for CD31 and Ki67 demostrated reduced num-
bers of proliferating endothelial cells in VEGF-A-/- mice. Quantitative analysis of cutaneous blood
vessels of mice after 10 weeks of UVB irradiation showed that cutaneous vascularization was greatly
diminished in mutant mice with a prominent effect on large-sized vessels and impaired endothelial
cell proliferation. Several reports have implicated VEGF as a major survival factor for endothelial
cells exposed to stress stimuli. Exposure of HDMVEC to UVB irradiation in the presence or absence
of VEGF showed that this cytokine (100ng/ml) significantly protected the cells from death, sug-
gesting that this may be a mechanism for maintaining the integrity of UVB irradiated skin. 
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A novel role of the melanocortin 1 receptor in repair of UV-induced DNA damage and sur-
vival of human melanocytes: implications on melanoma susceptibility
ZA Abdel-Malek,1 A Kadekaro,1 RJ Kavanagh,1 S Schwemberger2,3 and G Babcock2,3 1
Dermatology, University of Cincinnati, Cincinnati, OH, 2 Surgery, University of Cincinnati,
Cincinnati, OH and 3 Shriners Hospital, Cincinnati, OH
A new role for melanocortins and the melanocortin 1 receptor (MC1R) in human melanocyte sur-
vival and the repair of UV-induced photoproducts is hereby described. The MC1R gene is a major
contributor to the diversity of human pigmentation. Specific allelic variants of the MC1R, namely
Arg151Cys, Arg160Trp, and Asp294His, are associated with red hair phenotype, poor tanning abil-
ity and risk for melanoma. We have demonstrated that these variants represent loss of function
mutations in the MC1R. We have shown that activation of the MC1R by its ligands α-melanocortin
(α-MSH) or ACTH stimulates human melanocytes proliferation and melanogenesis, and enables
melanocytes to overcome the UV-induced growth arrest. Recently, we found that α-MSH promotes
melanocyte survival after UV irradiation by suppressing UV-induced apoptosis and activating the
Akt/PKB pathway and the transcription factor Mitf. The survival effect of α-MSH is absent with loss
of function of MC1R, and is independent of melanogenesis, since it is evident in tyrosinase-nega-
tive albino melanocytes.  α-MSH enhances the repair of UV-induced cyclobutane pyrimidine dimers
and pyrimidine (6-4) pyrimidone photoproducts. These novel findings ascribe a new role for α-MSH
as a survival factor that restores the genomic stability for human melanocytes. Our results explain
why loss-of-function mutations in the MC1R increase the risk for melanoma. 
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COX-1 deletion enhances apoptosis but does not protect against ultraviolet light tumor induc-
tion
S Brouxhon,2,1 G Scott,1 J VanBuskirk,1 C Tanck1 and AP Pentland (SID)1 1 Dermatology,
University of Rochester, Rochester, NY and 2 Emergency Medicine, University of Rochester,
Rochester, NY
Squamous cell cancer growth is influenced by cyclooxygenase (COX-2) activity in many mouse
models: COX-2 deletion, overexpression, and COX-2 selective inhibitors. Concurrent changes in
apoptosis and proliferation due to altered COX-2 activity are seen when both have been studied, sug-
gesting each contribute to the chemoprotective effect of selective COX-2 inhibition. Recent work
has shown that COX-1 deletion may be nearly as protective. In this study, we used SKH hairless
mice with a selective deletion in COX-1 to examine its role in photocarcinogenesis. Wild-type, COX-
1 +/- or COX-1 -/- mice were exposed to broad spectrum ultraviolet light (UV) acutely or chroni-
cally (15 weeks). For 15 weeks following UV exposure, tumor number and size were measured. 24h
after cessation of chronic UV, or at the end of the experiment, proliferation (BrDU incorporation),
apoptosis (TUNEL staining) and prostaglandin (PG) synthesis (ELISA) were also measured. After
acute or chronic (UV) exposure, induction of PGE2 and PGF2a in epidermal extracts were ~40% less
in COX1 -/- animals than in wild-type controls. A four-fold induction of keratinocyte apoptosis in
COX1 -/- animals was also observed. However, only a minimal decrease in epidermal keratinocyte
proliferation occurred in COX-1 -/- animals. When susceptibility to tumor formation was studied,
tumor number and incidence in COX-1 -/- animals were identical to wild type controls, although
average tumor size was decreased in COX-1 -/- mice.  Thus, enhanced apoptosis did not protect COX-
1 -/- animals against UV-induced skin cancer, suggesting other effects are most important in NSAID
chemoprevention. In addition, these data contrast sharply with data obtained using the classic
DMBA/TPA cancer model in which a prominent protective effect of COX-1 -/- is present. This indi-
cates cancer mechanisms are distinct in UV- and tumor promotor-induced cancer models, and that
chemoprevention strategies must specifically address cancer causes. 
869
UV irradiation reduces type I procollagen production by transcriptional repression through
a 90 base pair sequence in the promoter of TGF-β type II receptor in human skin fibroblasts
T He, TH Quan, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor, MI
Transforming growth factor-β (TGF-β) is a major regulator of collagen gene expression in human
skin fibroblasts. Cellular responses to TGF-β are mediated primarily through its cell surface recep-
tor complex, composed of type I (TβRI) and type II (TβRII) receptors. Ultraviolet (UV) irradiation
reduces TβRII expression, thereby decreasing type I procollagen synthesis, in human skin fibrob-
lasts. We have investigated the mechanisms by which UV irradiation decreases TβRII. UV irradia-
tion did not alter either TβRII mRNA (t1/2=4 hrs, n=3) or protein (t1/2=2.5 hrs, n=3) stability, meas-
ured 2 to 8 hours after UV irradiation in the presence of transcription inhibitor actinomycin D, or
protein synthesis inhibitor cycloheximide, respectively. These data indicate that UV reduction of
TβRII expression likely results from transcriptional repression, rather than increased turnover of
either TβRII mRNA or protein. Two transcription factors implicated in regulation of TGF-β signal-
ing are early growth response-1 (Egr-1), and c-Jun. We utilized separate Egr-1 or c-Jun knockout
cells to examine the roles of these two transcription factors in TβRII down regulation. UV irradia-
tion strongly induced both EGR-1 and c-Jun in the respective wildtype cells. However, neither loss
of EGR-1, nor c-Jun prevented UV reduction of TβRII in knockout cells. Using a series of TβRII
promoter-luciferase 5’-deletion constructs (covering 2kb of the TβRII promoter) we identified a short
sequence in the promoter region that was strongly regulated by UV irradiation. This promoter region
exhibited high promoter activity that was inhibited 80% (p<0.05, n=6) by UV irradiation. Further
5’-deletion resulted in 90% (n=6, p<0.05) loss of UV responsiveness. Taken together, these data indi-
cate that UV irradiation reduces TβRII expression by transcriptional repression. This repression is
mediated by a 90bp region in TβRII promoter, in human skin fibroblasts. 
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Proteomic analysis of keratinocyte responses to single and combined chemical and UV expo-
sures
L Liu,1 K Kang,1 S Chen,2 Q Yang,2 T McCormick1 and K Cooper1,3 1 Dermatology, Case Western
Reserve University, Cleveland, OH, 2 Pathology, Case Western Reserve University, Cleveland, OH
and 3 Dermatology, VA Medical Center, Cleveland, OH
Environmental agents modify the skin through complex mechanisms. Some of these are reflected in
mRNA expression, but transcriptional profiling does not capture many of the alterations that can
occur in the proteome. In order to investigate the proteomic response of keratinocytes to environ-
mental modification, we used DNBS (2, 4-Dintrobenzenesulfonic acid) and UVB radiation on the
HaCaT cell line. HaCaT cells were treated with UV plus DNBS, UV, DNBS and control media. Con-
fluent HaCaT cells were cultured in EpiLife medium (150x25 mm2 dishes) for 18h post UV irradi-
ation with Kodacel-filtered FS40 sunlamps (20mj/cm2), with DNBS (final concentration 0.05%)
for 2h. For combined exposure, DNBS was added 18h post UVB, for 2h. The cells were then washed
and cultured in fresh medium for another six hours. The soluble/cytoplasmic proteins were extracted
with Sigma ProteoPrep Universal Extraction Kit. Four hundred micrograms of protein were used to
perform 2D gel assays. Coomassie and/or silver staining were prepared with BioRad kits. Quantity
One (BioRad) and PD quest software are used to analyze protein spots on the 2D gels. Thirty eight
protein spots that were well defined and approximately equal density on the gels from each of the
four conditions were identified using matrix-assisted laser desporption/ionization time-of-flight mass
spectrometry. The Mascot online database searching algorithm identified proteins with probability
scores > 57 and which matched in each of the 4 gels for 38 of 108 spots. The density of these spots
was within 15% of control cultures in 35/38 of the proteins, indicating robust consistency at both
the analytic and quantitative levels. Although these spots were selected for homogeneity, glutathione
transferase and the PDX6 antioxidant proteins appeared to be modestly induced by these environ-
mental stimuli. These data validate the application of 2D gel analysis to select a full range of pro-
teins for establishment of a functional proteomic profile. 
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Inhibition of ultraviolet B-mediated activation of nuclear factor κB and phosphorylation of
MAPKs in normal human epidermal keratinocytes by pomegranate fruit extract
F Afaq,1 A Malik,1 MS Matsui,2 D Maes2 and H Mukhtar1 1 Dermatology, University of Wisconsin,
Madison, WI and 2 Biological Research Department, Estee Lauder Companies, Inc., Melville, NY
Solar ultraviolet (UV) radiation, particularly its UVB component causes many adverse effects that
include hyperpigmentation, photoaging, immunosuppression and skin cancer. Pomegranate fruit
extract (PFE) derived from the tree Punica granatum contains several polyphenols and anthocyani-
dins and possesses strong antioxidant and anti-inflammatory properties. Previously it has been shown
that PFE possesses anti-tumor promoting effects in a mouse model of chemical carcinogenesis. In
this study, we determined the effect of PFE on UVB-induced adverse effects in normal human epi-
dermal keratinocytes (NHEK). Studies have shown that nuclear factor kappa B (NF-κB), plays an
important role in inflammation, cell proliferation and UVB-induced effects on the skin. In dose- and
time-dependent studies, we evaluated the effect of PFE on UVB-mediated modulation of the NF-
κB pathway. Immunoblot analysis demonstrated that the treatment of NHEK with PFE (10-40 µg/ml)
for 24 hrs before UVB (40 mJ/cm2) exposure dose-dependently inhibited UVB-mediated degrada-
tion and phosphorylation of IκBα, activation of IKKα and NF-κB/p65. We also observed that PFE
(10 µg/ml) inhibited UVB-mediated degradation and phosphorylation of IκBα, activation of IKKα,
nuclear translocation and phosphorylation of NF-κB/p65 in a time-dependent manner. Because of
the role of MAPK in inflammatory responses, cell growth and proliferation, we next assessed the
effect PFE on UVB-mediated activation of MAPK pathway in NHEK. Employing western blot analy-
sis, we found that PFE treatment of NHEK resulted in a dose- and time-dependent inhibition of UVB-
induced phosphorylation of ERKl/2, JNKs and p38 protein. Taken together, the data shows that PFE
protects against the adverse effects of UVB radiation by inhibiting UVB-induced modulation of
NF-κB and MAPK pathways and provides a molecular basis for the photochemopreventive effects
of PFE. 
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Oral administration of green tea polyphenols inhibits ultraviolet radiation-induced oxidative
damage and expression of matrix metalloproteinases in mouse skin which may lead to pre-
vention of photoaging
A Mittal, PK Vayalil, CA Elmets and SK Katiyar Dermatology, University of Alabama at
Birmingham, Birmingham, AL
Chronic exposure of solar ultraviolet (UV) radiation to skin results in premature aging of the skin
or photoaging. UV-induced oxidative stress and induction of matrix metalloproteinases (MMP) have
been implicated in this process. The use of dietary botanical supplements has received considerable
interest to prevent solar UV radiation induced skin photodamage. Since polyphenols from green tea
(GTP) prevent several UV-induced adverse effects in the skin, we determined whether multiple UV
irradiation-induced oxidative stress and induction of MMP can be prevented in in vivo mouse skin
by oral administration of GTP. GTP was administered in drinking water (0.2%, w/v) to SKH-1 hair-
less mice which were then exposed to multiple doses of UVB (90mJ/cm2, for two months on alter-
nate days) following in vivo skin photoaging protocol. Oral administration of GTP resulted in inhi-
bition of UVB-induced hydrogen peroxide production (54-73%), and prevention of UVB-induced
depletion of antioxidant defense enzymes like glutathione peroxidase (37%), catalase (41%) and
endogenous antioxidant glutathione (51%) in the skin. Treatment of GTP inhibited UV-induced
protein oxidation in vivo, a hallmark of photoaging, when analyzed biochemically, by Western blot-
ting and immunohistochemistry. In in vitro treatment of GTP to human skin fibroblast HS68 cells
also prevented UV-induced oxidation of proteins, thus further support the inhibition of photooxida-
tive damage of the skin by GTP. Additionally, treatment of GTP resulted in inhibition of UVB-induced
expression of matrix degrading MMPs, such as MMP-2 (67%), MMP-3 (63%), MMP-7 (62%) and
MMP-9 (60%) which are critically involved in photoaging of the skin or wrinkling of the skin.
These data suggest that GTP as a dietary supplement could be useful to attenuate solar UVB radia-
tion-induced premature aging of the skin. 
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Reduced fibroblast interaction with intact collagen as a mechanism for depressed collagen syn-
thesis in photodamaged skin
J Varani,1 S Kang,2 GJ Fisher2 and JJ Voorhees2 1 Pathology, University of Michigan, Ann Arbor,
MI and 2 Dermatology, University of Michigan, Ann Arbor, MI
The present study provides evidence from a number of different approaches (i.e., comparison of cell
shape in 1-µm sections of photodamaged versus healthy skin at the light microscopic level; com-
parison of cell shape and attachment to collagen fibrils in ultrathin sections of the same tissues exam-
ined by transmission electron microscopy; and confocal fluorescence analysis of cells stained for
attachment-site and cytoskeletal proteins including β1 integrin, vinculin, focal adhesion kinase and
actin) that dermal cells in healthy skin are attached to collagen fibrils over a large part of the cell
border, have a flattened/spread (two-dimensional) appearance, have a large number of well-organ-
ized focal adhesion sites and have abundant actin in their cytoplasm. In contrast, cells in photo-
damaged skin are often in contact with fragmented collagen or amorphous debris rather than intact
collagen, have a collapsed/elongated shape with few organized adhesion sites, and have a lower
amount of actin. Collagen synthesis is reduced in severely photodamaged skin relative to collagen
synthesis in corresponding sun-protected skin (New Eng. J. Med. 329:530, 1993). We hypothesize
that fibroblasts in severely damaged skin have less interaction with intact collagen and as a result
experience a reduction in mechanical tension. Decreased collagen synthesis is (presumed to be) the
result.
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A novel class of chemopreventive agents for topical suppression of skin photodamage: quenchers
of photoexcited states
GT Wondrak, MK Jacobson and EL Jacobson College of Pharmacy, Arizona Cancer Center,
University of Arizona and Niadyne, Inc., Tucson, AZ
Based on our previous research on the role of photoexcited states of endogenous skin chromophores
as sensitizers of photooxidative stress we have developed a novel class of chemopreventive agents
for topical skin photoprotection: quenchers of photoexcited states (QPES). Photoexcited states of
endogenous UVA-chromophores such as porphyrins, melanin precursors, and crosslink-fluorophores
of skin collagen exert skin photodamage by direct reaction with substrate molecules (type I photo-
sensitization) or molecular oxygen (type II photosensitization) leading to downstream formation of
reactive oxygen species. QPES compounds antagonize the harmful excited state chemistry of endoge-
nous sensitizers by physical quenching, facilitating the harmless return of the sensitizer excited
state to the electronic ground state by energy dissipation. To develop QPES compounds for photo-
protection, a primary screening assay was based on QPES-suppression of photosensitized plasmid
cleavage under anaerobic conditions excluding compounds that are only antioxidants. A secondary
screen tests non-sacrificial quenching of dye-sensitized singlet oxygen (1O2) formation using ESR
detection of 2,2,6,6-tetramethyl-piperidine-1-oxyl [TEMPO], a 1O2-specific stable free radical. We
identified a pyrrolidine-pharmacophore with pronounced QPES activity and non-cytotoxic deriva-
tives were selected for efficacy studies in cellular models of sensitized photodamage. Protection
against dye-sensitized apoptosis and suppression of proliferation was achieved in cultured human
skin fibroblasts when cell exposure to light and sensitizer occurred in the presence of QPES com-
pounds. In support of our hypothesis that direct molecular antagonism of photoexcited states by phys-
ical quenching is a unique mechanism of action for chemoprevention of skin photodamage we report
here results demonstrating QPES-photoprotection of reconstructed full thickness human skin exposed
to solar simulated light. Supported in part by grants from NIH (CA-43894) and Niadyne, Inc. 
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Creatine enhances DNA repair in human keratinocytes and living skin equivalents
D Gan, T Mammone and D Maes Biological Research, Estee Lauder Companies, Melville, NY
The creatine/creatine kinase system is known to play an important role in mitochondrial function
and is one of the cell’s energy (ATP) storage systems. Recent work suggests that creatine induces
cellular protection of neuronal cells from energy depleting agents known to cause neuronal apopto-
sis. Ultraviolet radiation induces ATP depleting processes, some which are consequences of oxida-
tive, DNA, and mitochondrial damage in keratinocytes. Therefore, we hypothesized that by increas-
ing cellular energy reserves, creatine supplementation will protect the skin from UV insults. Using
different model systems, we observed that creatine treatments reduce sunburn cell formation in liv-
ing skin equivalents, increase DNA repair capabilities, and increased UVB survival in human epi-
dermal keratinocytes. Creatine reduced the number of UVB induced apoptotic bodies in Organo-
genesis living skin equivalents by 50%. This may be attributed to increased DNA repair as creatine
was found to improve the ability of normal human epidermal keratinocytes to remove UVB induced
TT dimers. In cells exposed to 24mJ/cm2 UVB, those treated with creatine showed approximately
50% of initial TT dimers to be removed, compared with no TT dimer removal in untreated cells. Cre-
atine may enhance DNA repair processes by stabilizing or increasing the energy levels of the cell
during or after environmental insults. As a result, creatine may be a valuable agent for topical use to
protect the skin from UV damage because it increases the capacity of the tissue for cellular and
DNA repair. 
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Successful penetration of topically-applied silicon phthalocyanine photosensitizer Pc 4 and new
Pc 4 salts into human skin
AR Swick,1 M Camouse,1 TS McCormick,1 N Oleinick,2 J Berlin,3 M Kenney,3 KD Cooper1 and
ED Baron1 1 Dermatology, Case University, Univ. Hosp. of Cleveland, Cleveland, OH, 2 Radiation
Biology, Case University, Cleveland, OH and 3 Chemistry, Case University, Cleveland, OH
Photodynamic therapy (PDT) combines a photosensitizing agent and visible light to elicit an oxida-
tive stress mediated apoptotic response, and has been used to treat various solid organ malignancies.
Phthalocyanine (Pc) 4 is the first organosilicon photosensitizing agent in Phase 1 trials. Pc 4 exhibits
low toxicity and, upon I.V. infusion, is readily metabolized and cleared. To determine if Pc 4 and
newly-synthesized Pc 4 salts penetrates epidermal skin, we analyzed Pc 4 fluorescence by confocal
microscopy. Penetration of Pc 4 was detected using a 650nm long pass filter following laser activa-
tion at 633nm. Briefly, Pc 4 (vehicle of 70% EtOH and 30% propylene glycol) was applied epider-
mally to 0.4 mm thick keratomes obtained from normal human volunteers for 1, 2 and 4 hrs. Pc 4
was also prepared as Pc 4 Pyruvate and Pc 4 HCL and applied epidermally (same vehicle). Con-
centrations of 0.1, 0.05, and 0.01 mg/ml were tested per Pc 4 formulation. Confocal analysis of all
formulations revealed Pc 4 fluorescence in membrane and/or peripheral cytoplasmic patterns at the
stratum granulosum with cytoplasmic patterns in the basal layer. Maximum fluorescence was detected
using a laser transmission output of 3% for the 0.1 mg/ml and 30% for the 0.01 mg/ml for Pc 4.
Both Pc 4 pyruvate and Pc 4 HCl could be visualized with a laser transmission output of 2-3% for
the 0.1 mg/ml and 7-9% for the 0.01 mg/ml concentrations. Because fluorescence was inversely
proportional to the laser transmission at a constant laser gain, we conclude that all Pc 4 formulations
successfully penetrated the skin to the basal layer in a dose dependent fashion and that the salts may
have enhanced penetration capacity. Epidermal penetration is one important aspect for development
of Pc 4 compounds as topical PDT drugs for epithelial cancers and inflammatory disorders. 
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Effects of T4 endonuclease liposomes and RNA fragments on UV-induced DNA damage
MS Ke,1 MM Camouse,1 S Oshtory,1 T McCormick,1 M Matsui,2 T Mammone,2 K Marenus,2
D Maes,2 K Cooper,1 S Stevens1 and ED Baron1 1 Dermatology, Case University/University
Hospitals of Cleveland, Cleveland, OH and 2 Estee Lauder Companies, Melville, NY
We have previously demonstrated that a single, suberythemogenic dose of 0.75 MED from simu-
lated solar radiation (SSR) is sufficient to cause significant cutaneous immune suppression (65%)
as measured by in vivo contact hypersensitivity (CHS) response to dinitrochlorobenzene (DNCB).
RNA fragments and T4 endonuclease liposomes were significantly protective against such UV-
induced suppression when applied as lotions to healthy volunteers. We next aimed to determine the
effects of these topical formulations on cutaneous thymine dimer formation and oxidized guanine,
following exposure to SSR using a Xenon arc lamp filtered to produce an output that is 95% UVA
and 5% UVB. Data from eight subjects revealed that T4 endonuclease liposomes induced partial pre-
vention of thymine dimer formation relative to untreated controls (28% decrease; p=0.004). This
effect was not observed in vehicle treated skin. RNA fragments also provided protection against
thymine dimmers induced by SSR, albeit to a lesser extent (14% decrease in thymine dimer forma-
tion as compared to untreated skin; p=0.04). The T4 endonuclease liposome and RNA fragment for-
mulations were determined to have SPF’s of 1, suggesting that their benefits can not be attributed to
UV absorption. We conclude that T4 endonuclease liposomes, which are currently in clinical trials
for enhancing DNA repair in patients with xeroderma pigmentosum, may be active in prevention of
UV damage in skin of normal individuals as well. The mechanism of photoprotection by RNA frag-
ments remains speculative. 
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Eukarion 134 increases removal of damaged DNA in skin
D Gan, T Mammone and D Maes Biological Research, Estee Lauder Companies, Inc, Melville, NY
Eukarion 134, a SOD/catalase mimic, has been reported to have cytoprotective effects in several
different model systems. We observed that pre-treatment with Euk-134 increases the removal of UVB
induced TT dimers, and decreases UVB induced toxicity in human epidermal keratinocytes. Addi-
tionally, we further observed that pre-treatment with Euk-134 led to accelerated removal of UVB
induced TT dimers and reduced levels of UVB induced sunburn cells in living skin equivalents. Clas-
sically, DNA repair pathways are not associated with cellular anti-oxidant defense pathways. How-
ever, these results suggest that Euk-134, a SOD/catalase mimic, may have a direct or indirect effect
in upregulating cellular DNA repair mechanisms. These findings suggest that Euk-134 may possess
properties beyond classical SOD or catalase analogues, further enhancing its ability as a cytopro-
tective compound. 
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Chemoprevention of ultraviolet radiation-mediated skin cancer development by resveratrol:
involvement of survivin
MH Aziz, AS Ghotra, SR Reagan-Shaw and N Ahmad Dermatology, University of Wisconsin,
Madison, WI
Chemoprevention by naturally occurring plan-based agents is a newer dimension in the management
of neoplasia, including skin cancer. Here, we evaluated the protective effects of trans-resveratrol
(trans-3,4’,5-trihydroxystilbene), a potent antioxidant found in grapes and red wine, against UVB
radiation-mediated skin tumorigenesis in SKH-1 hairless mice. For our studies, we employed UVB
initiation-promotion protocol where the control mice were subjected to chronic UVB exposure (180
mJ/cm2, twice weekly, for 28 weeks). The experimental animals received either a pre-treatment (30
minutes prior to each UVB) or post-treatment (5 minutes after UVB) of resveratrol (25 and 50 µ
mole/0.2 ml acetone/mouse). The mice were followed for skin tumorigenesis and were sacrificed at
24 h after the last UVB exposure, for further studies. Resveratrol treatment (both pre- and post-)
resulted in a significant reduction in tumor incidence, tumor multiplicity and tumor volume/mouse.
The onset of tumor was also significantly delayed by resveratrol. Interestingly, the post-treatment
of resveratrol was found to impart equal, if not better, protection than the pre-treatment; suggesting
that the effects of resveratrol are systemic rather than sunscreen effects. Because survivin is a criti-
cal regulator of survival/death of cells and its over-expression has been implicated in several can-
cers, we evaluated the involvement of survivin in chemoprevention of UVB-mediated skin carcino-
genesis by resveratrol. The Western blot and Real Time-PCR analyses demonstrated a significant
over-expression of survivin and phospho-survivin in skin tumors whereas treatment with resveratrol
resulted in a significant inhibition in these critical molecules. The levels of Smac/DIABLO, a pro-
apoptotic protein, were found to decrease in UVB-induced tumors and pre-treatment with resvera-
trol reversed the response. Our study demonstrated that resveratrol imparts strong chemopreventive
effects against UVB exposure-mediated skin carcinogenesis (relevant to human skin cancers) via
inhibiting survivin-pathway. 
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UV-B irradiation differentially affects VEGF production in human microvascular endothelial
cells and keratinocytes
K Seiffert,1 S Fimmel,2 CC Zouboulis2 and RD Granstein1 1 Dermatology, Weill Medical College
of Cornell University, New York, NY and 2 Dermatology, Charite University Medicine Berlin,
Campus Benjamin Franklin, Berlin, Germany
An increased vascular response to noxious stimuli such as sunlight and emotional stress is a major
characteristic of rosacea. UV-irradiation and neuropeptides, such as substance P (SP), vasoactive
intestinal polypeptide (VIP) and somatostatin (SOM) have been implicated in the pathogenesis of
rosacea in part by affecting vasodilatation and inflammation. Also, a possible role for vascular endothe-
lial growth factor (VEGF) in the vascular response in rosacea has been suggested. Therefore, we
aimed to define how neuropeptides alone or in combination with UV-irradiation affect VEGF pro-
duction by human microvascular endothelial cells (HMEC) and keratinocytes. The HMEC-1 cell
line and fresh human keratinocytes were plated at 2x106 and 0.5 or 0.25x106 cells/well, respectively,
in 12 well plates and irradiated with UV-B doses from 5 to 30 mJ/cm2. Cells were then cultured for
24 h and conditioned supernatants collected to assess VEGF production by ELISA. In HMEC-1, UV-
B significantly upregulates VEGF-production at low doses (5-15 mJ/cm2), while it downregulates
at higher doses (25-30 mJ/cm2). Although UV-B dose-dependently kills a small number of cells
within 24 h, the effects on VEGF production remain the same when adjusted for the number of liv-
ing cells. VIP and SP have no additional effect on VEGF production, while SOM may downregu-
late VEGF. In fresh keratinocytes we found a dose dependent downregulation of VEGF production
in concentrations from 7.5 to 30 mJ/cm2, even when adjusted for 24h cell death. In a preliminary
experiment with cells plated at 0.5x106, SOM decreased VEGF production significantly in both
irradiated and non-irradiated cells, while there was no significant effect at lower density. We con-
clude that UV-B irradiation differentially influences the production of VEGF in endothelial cells
and keratinocytes, while the role of neuropeptides needs further clarification. 
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Transcriptional profiling of chronically sun-damaged human skin
J Urschitz,1 GS Okimoto,1 S Iobst,2 K Schilling2 and CD Boyd1 1 John A. Burns School of
Medicine, University of Hawaii, Honolulu, HI and 2 Unilever Research U.S., Inc., Edgewater, NJ
Intrinsic, environmental, and lifestyle factors all contribute to the process of skin aging. Photoag-
ing, a remodeling of the dermis that arises as a result of repeated exposure of skin to UV-light has
been identified as the predominant contributing factor to the prematurely aged appearance of sun-
exposed skin.
To study the phenotypic changes in human skin associated with chronic sun exposure at the tran-
scription level, we had previously undertaken a Serial Analysis of Gene Expression (SAGE) of sun-
damaged and sun-protected skin from a single patient undergoing elective facial plasty. We found
34 genes with at least a 4-fold difference in mRNA levels between the two full-thickness skin sam-
ples. Prior to a detailed study of the functional relevance to photoaging of some of these genes and
the proteins these genes encode, it was critical to determine the inter-individual differences in gene
expression profiles. To undertake this study of inter-individual differences, we have used RNA prepa-
rations from skin obtained from 11 Caucasian patients with moderate sun-damage and analyzed the
changes in mRNA levels encoded by more than 22,000 different genes represented on the Affymetrix
U133A chip. We developed an algorithm that exploits dependencies between control and test chips
by computing a paired t-statistic for each gene as a measure of differential expression and a false
discovery rate for lists of genes called significantly changed based on permutation testing. Using this
algorithm, we were able to identify 566 mRNAs with consistently altered steady-state levels as a
consequence of chronic sun exposure.
In conclusion, in this study, we were not only able to expand the number of genes assed to more
than 22,000, but also confirm our prior findings, indicating that many of transcript levels identified
in the SAGE study are indeed altered as a consequence to chronic sun exposure. 
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IGF-1R influences the response of NF-kB in UVB-irradiated keratinocytes
DA Lewis,1 F Gao,1 S Hengeltraub1 and DF Spandau1,2 1 Dermatology, Indiana University School
of Medicine, Indianapolis, IN and 2 Biochemistry, Indiana University School of Medicine,
Indianapolis, IN
Activation of the IGF-1R is essential for keratinocyte survival and has been demonstrated to protect
normal human keratinocytes from UVB-induced apoptosis. NF-kB consists of a family of inducible
transcription factors involved in a variety of cellular signaling pathways, including survival follow-
ing cytotoxic stress. In the epidermis, NF-kB regulation is important for normal keratinocyte pro-
liferation and differentiation. In this study, we have investigated whether the survival function of the
IGF-1R following UVB exposure involved NF-kB. Normal human keratinocytes containing acti-
vated or inactive IGF-1R were irradiated with increasing doses of UVB. At specific times following
irradiation, the keratinocytes were harvested and cell lysates analyzed for NF-kB DNA-binding activ-
ity using electrophoretic gel mobility shift assays (EMSA). Specific NF-kB DNA-binding activity
was induced in a time- and dose-dependent manner in both IGF-1R-active and IGF-1R inactive cells.
However, the specific pattern of NF-kB binding was different in UVB-irradiated IGF-1R-activated
cells compared to UVB-irradiated IGF-1R-inactive cells. We hypothesize that distinct NF-kB sub-
units bind to NF-kB consensus sequences following UVB-irradiation depending on the activation
status of the IGF-1R. 
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T-oligo treatment enhances UV-induced DNA repair capacity in human skin explants
S Arad,1 DA Goukassian,1 R Der Sarkissian2 and BA Gilchrest1 1 Dermatology, Boston University,
Boston, MA and 2 Plastic and Reconstructive Surgery, Boston University, Boston, MA
UV irradiation causes DNA mutations that may lead to skin cancer. We have shown that DNA oligonu-
cleotides substantially homologous to the telomere sequence (T-oligos) increase DNA repair capac-
ity (DRC) in cultured human cells. To investigate the effect of T-oligos on DRC in intact skin, we
treated human skin explants obtained from sun protected areas of 12 donors aged 52.5±17.2 yrs
with T-oligos (pTT and pGAGTATGAG) or diluent alone. After 24 hr, paired explants from each
donor were UVB- or sham irradiated and processed after 16, 24, 48 and 72 hr for histologic analy-
sis (at least 600 linear µm skin surface/donor at 400x). There was no deterioration in sham irradi-
ated T-oligo- or diluent-treated explants for up to 160 hr. TUNEL + cells indicating apoptosis were
comparable in diluent- and T-oligo-treated UV-irradiated skin through 72 hr. Proliferating (Ki67+)
cells were sparse in sham irradiated skin and absent at 16 and 24 hr after UV. Compared to diluent
controls, at 48 and 72 hrs there was ∼50% inhibition of UV-induced hyperproliferation in T-oligo-
treated skin as measured by Ki67 + nuclei; with maximal difference at 48hr: 13±2 vs 24.7±3 (per
200 µm epidermal length/3 areas/treatment) (p<0.03, n=3 donors). Maximum and comparable cyclobu-
tane pyrimidine dimers (CPD) were detected by antibody staining immediately after UV irradiation
(time 0) in diluent- vs T-oligos-treated skin (n=10 donors), confirming no sun screen effect of T-oli-
gos. CPD + cells were ∼50% less in T-oligo- vs diluent-treated skin through 48 hr: 27±3% vs 51±9%
at 24 hr (p<0.001) and 6±4% vs 12±2% at 48 hr (p<0.05) of all epidermal cells. At 72 hr there were
0 vs 7±2% CPD + cells (p<0.001). There was also increased immunostaining of epidermal nuclei
for total p53 protein. Compared to controls, T-oligo-treated skin had 52% and 28% more total p53
+ nuclei at 6 and 24 hr post-UV (p<0.001). We conclude that T-oligo treatment enhances DRC in
intact human skin by prolonging UV-induced epidermal growth arrest and accelerating CPD removal. 
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Effects of topical white tea and green tea in UV-induced erythema and immunosuppression in
human skin
MM Camouse,1 H Scull,1 M Matsui,2 D Maes,2 S Stevens,1 K Cooper1 and ED Baron1 1
Dermatology, Case University/University Hospitals of Cleveland, Cleveland, OH and 2 Estee
Lauder Companies, Melville, NY
There is growing interest in the cutaneous photoprotective effects of antioxidants. In a previous study,
we found that topically applied white tea and green tea extracts partially prevent UV-induced Langer-
hans cell depletion and oxidative DNA damage, after irradiating with 2 MED of simulated solar radi-
ation (SSR). We next aimed to determine whether these protective effects were secondary to direct
UV absorption by these formulations. We performed a sun protection factor (SPF) analysis in five
healthy volunteers with Fitzpatrick skin types I-III (MED range 20-50; mean 34). Data showed an
SPF of 1.21 (range 0.75-1.57) for the white tea and and SPF of 1.05 (range 0.73-1.42) for green tea.
These indicate that the photoprotective benefits observed from these formulations can not be attrib-
uted to sunscreen effects. Studies are underway to evaluate whether topical green tea and/or white
tea would prevent UV-induced suppression of contact hypersensitivity responses to dini-
trochlorobenzene (DNCB) in vivo. 
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A topical antioxidant solution containing vitamin C, vitamin E, and ferulic acid prevents ultra-
violet radiation-induced caspase-3 induction in skin
J Lin,1 NA Monteiro-Riviere,2 JM Grichnik,1 JE Zielinski3 and SR Pinnell1 1 Duke, Durham, NC,
2 NC State, Raleigh, NC and 3 Zielinski Lab, San Diego, CA
New photoprotection methods are necessary to prevent ultraviolet injury to skin resulting in skin
cancer and photoaging changes. We have previously reported the photoprotective effect of topical
application of 15% L-ascorbic acid and 1% α-tocopherol (JAAD 48:866, 2003). The solution pro-
vided fourfold protection against ultraviolet irradiation and reduced cellular apoptosis measured as
sunburn cells. The stability and photoprotection of 15% L-ascorbic acid and 1% α-tocopherol has
been augmented by addition of 0.5% ferulic acid. This natural plant antioxidant increases the sta-
bility of L-ascorbic acid approximately threefold and doubles photoprotection of the solution against
solar-simulated irradiation. In this study, we further explored the mechanism of antioxidant photo-
protection by measuring caspase-3 induction. 15% L-ascorbic acid, 1% α-tocopherol, or 15% L-
ascorbic acid, 1% α-tocopherol, 0.5% ferulic acid antioxidant solutions were applied daily for four
days to pig skin, 0.5ml to a 7.5 x 10 cm patch. Antioxidant-treated and untreated skin was irradiated
(4 minimal erythema doses) with a solar simulator fitted with a 295nm band pass filter. Twenty four
hours later the irradiated skin was biopsied, frozen in liquid nitrogen and shattered. Cell protein was
extracted with detergents in the presence of protease inhibitors and electrophoresed in 12% SDS-
polyacrylamide gel, transferred to PVDF membranes and treated with rabbit anti-human cleaved cas-
pase-3 antibody. Levels of activated caspase-3 in control or vehicle-treated skin were 78±42%, in
skin treated with 15% L-ascorbic acid, 1% α-tocopherol were 22±16% and in skin treated with 15%
L-ascorbic acid, 1% α-tocopherol, 0.5% ferulic acid were 3±2%. All values are significant when
compared to each other group (p≤0.05, t-test, 2-tailed). Ferulic acid stabilizes an antioxidant solu-
tion of 15% L-ascorbic acid, 1% α-tocopherol and provides added photoprotection resulting in
reduced activation of caspase-3 and subsequent apoptosis. 
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Ferulic acid stabilizes a topical solution containing vitamins C & E and doubles its photopro-
tection for skin
JY Lin,1 F Lin,2 J Burch,2 JM Grichnik,2 R Gupta,2 NA Monteiro-Riviere,3 JA Zielinski4 and
SR Pinnell2 1 Chung Gung Mem Hosp, Taipei, Taiwan, 2 Duke, Durham, NC, 3 NC State, Raleigh,
NC and 4 Zielinski Lab, San Diego, CA
Skin protects itself from UV injury with antioxidants Tissue fluids are predominantly protected by
vitamin C;lipid structures by vitamin E. These vitamins are delivered to skin following absorption
from the gastrointestinal tract, but controls of absorption, transport, tissue uptake and metabolism
limit skin tissue levels. We have previously reported that L-ascorbic acid, protonated at pH 〈3.5, is
absorbed into skin and can augment skin’s natural antioxidant protection (Derm Surg 27:137, 2001).
We demonstrated that a solution of 15% L-ascorbic acid augmented with 1% α-tocopherol can pro-
vide a 4-fold increase in protection from photoinjury to skin caused by UV irradiation (JAAD
48:866,2003). The combination of antioxidants was synergistic and resulted in unexpected protec-
tion against thymine dimer formation. We have recently discovered that the stability of a solution of
15% L-ascorbic acid and 1% α-tocopherol could be increased threefold by 0.5% ferulic acid, a
ubiquitous natural plant antioxidant. Thus, stability at 45 degrees C at 1 month (considered equiva-
lent to room temperature for 1 year) was greater than 90% for L-ascorbic acid and 100% for α-toco-
pherol. We tested photoprotection of 15% L-ascorbic acid, 1% α-tocopherol, 0.5% ferulic acid against
15% L-ascorbic acid, 1% α-tocopherol. Solutions were applied 0.5 ml to a 10 x 7.5 cm area of shaved
pig skin daily for four days. Control and antioxidant-treated skin were irradiated with a solar simu-
lator with a 295 nm band pass filter. 24 hrs later, erythema was evaluated with a chromameter and
sunburn cells were enumerated in H&E-stained sections of skin (n=3). After 4 MEDs of irradiation,
erythema measured was 33.3±2.6, 26.1±0.4 and 10.8±2.7 and sunburn cells were 35±0, 24.7±8.6
and 5.0±4.6 for control, C+E, and C+E+ferulic acid respectively. Ferulic acid increased stability of
a solution of vitamins C&E 3-fold and provided approximately 8-fold photoprotection against solar-
simulated irradiation. 
885
UV-induced tolerance is thymus-dependent
Y Aragane,1 T Yudate,1 A Kawada1 and T Schwarz2 1 Kinki University School of Medicine,
Osakasayama, Japan and 2 University of Muenster, Muenster, Germany
Application of haptens onto UV-exposed skin does not result in induction of contact hypersensitiv-
ity (CHS) but induces hapten specific tolerance which can be adoptively transferred. This is medi-
ated by the generation of suppressor T cells belonging to the CD4+CD25+ sybtype of regulatory T
cells (Tr). In general, Tr have been recognized to play an important role in preventing the develop-
ment of various autoimmune disorders, including diabetes and thyroiditis. Thus, the primary func-
tion of Tr appears to be the inhibition of autoreactive T cells which have not been eliminated by neg-
ative selection in the thymus (central tolerance). Therefore, Tr are important components of peripheral
tolerance. Although the involvement of Tr in UV-induced tolerance is undisputed, it is still unclear
how and where UV-induced Tr are generated. To study whether the thymus is involved in this process,
C3H/HeN mice were thymectomized at day 3 after birth. At the age of 8 to 10 weeks, CHS against
dinitrofluorobenzene (DNFB) was induced by epicutaneous application. In comparison to sensitized
control mice, thymectomized mice showed a more pronounced CHS response, implying that the gen-
eration of negative regulatory T cells but not T effector cells may be impaired by thymectomy. Appli-
cation of haptens onto UV-exposed skin did not result in sensitization in control mice, while the CHS
response was not suppressed in UV-exposed thymectomized mice. resensitization of the mice after
2 weeks with the same hapten did not cause sensitization in control mice, indicating that tolerance
had developed. In contrast, thymectomized mice showed an unimpaired ear swelling response upon
resensitization, suggesting that UV-induced tolerance does not develop in thymectomized mice.
Finally mice which were thymectomized into kidney capsules at week 8. Upon thymus retrans-
plantation to originally thymectomized mice regained the ability to develop UV-induced tolerance.
Taken together, the data demonstrate that development of UV-induced tolerance and consequently
the generation of UV-induced Tr is thymus dependent. 
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Contribution of pheomelanin and eumelanin to ultraviolet-induced apoptosis
S Takeuchi,1 KH Kraemer2 and DE Brash1 1 Therapeutic Radiology, Genetics, and Dermatology,
Yale School of Medicine, New Haven, CT and 2 Basic Research Laboratory, National Cancer
Institute, Bethesda, MD
Red- or blonde-haired individuals are typically sensitive to sunlight. We investigated the role of
pheomelanin and eumelanin on skin responses to UV by using three strains of mice with the same
genetic background. Black (C57BL/6J) and albino (C57BL/6-Tyrc-2J/Tyrc-2J ) strains differ by
one amino acid in the tyrosinase gene. The heterozygous lethal yellow strain (B6.Cg-Ay ) has one
normal allele and one containing a mutation in the A locus resulting in a high level of pheomelanin
in the hair shafts. Fontana-Masson staining showed that eumelanin in black and yellow mice was
concentrated in dermal papilla and hair shafts. No eumelanin was seen in the skin of the albino mouse
or in the interfollicular epidermis of black or yellow mice. After UVB exposure (1250 J/m2) of shaved
back skin, antibody detection of thymine dimers revealed a similar depth of UVB penetration in all
3 genotypes. To assess genotypic differences in UV-induced cell death, we counted sunburn cells
and performed TUNEL and caspase 3 assays. All 3 genotypes had a similar frequency of sunburn
cells and caspase 3 positive cells after UVB irradiation. The TUNEL assay also corresponded to
these frequencies in albino mice. Surprisingly, black and yellow mice had 3 fold more TUNEL-pos-
itive cells in the hair follicles and peri-follicular epidermis than did albino mice. Performing TUNEL
assays on epidermal sheets confirmed the geographical distribution of dead cells adjacent to hair
shafts. These results indicate that both eumelanin and pheomelanin promote cell death of epidermis
resulting from UVB irradiation in murine skin. We conclude that one effect of melanin (eumelanin
and pheomelanin) on the response of mouse dorsal skin to UV exposure could be to enhance UV
damage.
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Peptide methionine sulfoxide reductase (MsrA), a protein oxidation repair enzyme, is expressed
in human epidermis and upregulated by solar simulated UV irradiation
JJ Thiele,1 CS Sander,3 F Ogawa,3 W Oehrl,3 P Elsner,3 S Jung,2 A Hansel2 and SH Heinemann2 1
Dermatology, Northwestern University, Chicago, IL, 2 Molecular and Cellular Biophysics, FSU,
Jena, Germany and 3 Dermatology, FSU, Jena, Germany
Recently, we have reported that photoaging correlates well with the amount of protein oxidation
accumulated in the upper dermis, while protein oxidation levels found in the viable epidermis are
generally very low1. We hypothesized that this might be due to preferential epidermal expression of
the peptide methionine sulfoxide reductase (MsrA), which is able to reverse methionine oxidation
and thus to repair oxidized proteins. To test this, MsrA was investigated on the levels of mRNA (RT-
PCR), enzyme activity (3H N-acetyl methionine assay), and protein (Western blot and immunohis-
tochemistry) in primary human keratinocytes and human skin. Indeed, high mRNA, protein and activ-
ity levels of MsrA were found in keratinocytes and human epidermal skin extracts and confirmed
by immunohistochemical staining of skin biopsies (n=10). Furthermore, to investigate the impact of
solar exposure on epidermal MsrA in vivo, gluteal skin of 10 human subjects was repetitively irra-
diated with suberythemogenic doses of solar simulated light (SSUV; n=10). Non-UV-treated con-
tra-lateral sites served as internal controls. Remarkably, in contrast to the previously investigated
enzymatic antioxidants catalase and superoxide dismutase, epidermal MsrA levels were strongly
upregulated (3-fold), while dermal levels remained very low. In conclusion, this is the first report of
MsrA expression in human skin and thus extends the cutaneous antioxidant network. In analogy to
DNA repair systems, MsrA appears to be upregulated by acute solar UV stress and thus may play
an important role in maintaining the structural and functional protein integrity of the epidermis. The
lack of MsrA in dermal skin, however, might contribute to the accumulation of oxidized proteins and
thus makes it a susceptible target for the aging process.
1. Sander, Chang, Salzmann, Muller, Ekanayake-Mudiyanselage, Elsner,and Thiele JJ. J Invest
Dermatol, 2002;118(4):618-25
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Expression and activation of protease-activated receptor-2 correlate with skin color
L Babiarz-Magee, N Chen, M Kizoulis, M Seiberg and CB Lin Skin Research Center, Johnson &
Johnson, Skillman, NJ
The protease-activated receptor (PAR-2), a seven transmembrane G-protein coupled receptor, is acti-
vated by proteolytic cleavage of its N-terminus. Activation of PAR-2 is involved in skin pigmenta-
tion by increasing melanosome transfer via phagocytosis of keratinocytes. Previous studies have
shown that the pattern of melanosome distribution within the epidermis is skin color-dependent.  In
vitro, this distribution pattern is regulated by the ethnic origin of the keratinocytes, not the melanocytes.
In vivo, kinetics of PAR-2 upregulation by UV radiation is also different in skin of color. Therefore,
we hypothesized that PAR-2 may play a role in the modulation of pigmentation in a skin-type depend-
ent manner. We examined the expression of PAR-2 and its activator, trypsin, in human skins with
different pigmentary levels using Western blot analysis and immunohistochemistry staining. Here
we show that PAR-2 and trypsin are expressed in higher levels, and are differentially localized in
highly pigmented relative to lightly pigmented skins. Moreover, highly pigmented skins exhibit an
increased protease cleavage ability specific to a peptide containing the PAR-2 cleavage site. Micros-
phere phagocytosis was found to be more efficient in keratinocytes from highly pigmented skins,
and PAR-2 induced phagocytosis resulted in more profound microsphere ingestion and cap forma-
tion in dark skin-derived keratinocytes. These results demonstrate that expression and activation of
PAR-2 correlate with skin color, suggesting the involvement of PAR-2 in ethnic skin color pheno-
types.
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12-O-tetradecanoylphorbol-13-acetate suppresses melanogenesis by proteasomal degradation
of tyrosinase via activation of phospholipase D2 in mouse B16 melanoma cells
A Kageyama, M Oka and C Nishigori Department of Dermatology, Kobe University Graduate
School of Medicine, Kobe, Japan
The involvement of phospholipase D (PLD) isoforms in regulating melanogenesis in mouse B16
melanoma cells was examined. Treatment of the cells with 12-O- tetradecanoylphorbol-13-acetate
(TPA) induced the activation of PLD and reduced melanin content. 1-butanol, but not 2-butanol,
completely blocked the TPA-induced inhibition of melanogenesis. Reverse transcription-polymerase
chain reaction revealed the existence of two PLD isoforms, PLD1 and PLD2, in B16 cells. Using
cells in which PLD1 or PLD2 had been introduced by adenovirus vectors, it was shown that both
PLD1 and PLD2 are activated by TPA. When PLD1 or PLD2 was over-expressed following infec-
tion with the adenovirus vectors, the basal PLD activity was enhanced whilst the melanin content
decreased in a virus dose-dependent manner. The effect of PLD2 on the melanin content was much
greater than that of PLD1. Also, the PLD2-induced decrease in melanin content was accompanied
by a decrease in the expression and activity of tyrosinase, the key enzyme in melanin synthesis.
Northern blot analysis revealed that the mRNA level of tyrosinase was not altered by over-expres-
sion of PLD2. Treatment with the proteasome inhibitor MG132 completely blocked the PLD2-induced
inhibition of melanogenesis. When B16 cells were infected with an adenovirus vector encoding the
catalytically inactive mutant of PLD1 or PLD2, the melanin content was slightly increased in the
cells containing PLD2 but not with those containing PLD1. Furthermore, the TPA-induced decrease
in melanin content was not observed in cells expressing the catalytically inactive mutant of PLD2.
These results indicate that activation of PLD1 or PLD2 reduces melanin synthesis but that these
enzymes are independently involved in the regulation of melanogenesis. Further, our results suggest
that TPA inhibits melanogenesis by activating PLD2 via acceleration of the proteolytic degradation
of tyrosinase. 
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Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmo-
plantar fibroblasts inhibits melanocyte growth and differentiation
Y Yamaguchi,1 S Itami,2 H Watabe,1 K Yasumoto,1 F Rouzaud,1 ZA Abdel-Malek,3 T Kubo,2
A Tanemura,2 K Yoshikawa2 and VJ Hearing1 1 Laboratory of Cell Biology, National Cancer
Institute, Bethesda, MD, 2 Dermatology, Osaka University Graduate School of Medicine, Suita,
Osaka, Japan and 3 Dermatology, University of Cincinnati, Cincinnati, OH
We investigated whether the topographic regulation of melanocyte differentiation is determined by
mesenchymal-epithelial interactions via fibroblast-derived factors. The melanocyte density in pal-
moplantar human skin (i.e. skin on the palms and the soles) is 5 times lower than that found in non-
palmoplantar sites. Palmoplantar fibroblasts co-cultured with melanocytes significantly decreased
their proliferation and differentiation when both types of cells were in close apposition, suggesting
that a juxtacrine rather than a paracrine factor is involved. Using cDNA microarray analysis, fibrob-
lasts derived from palmoplantar skin expressed high levels of dickkopf 1 while non-palmoplantar
fibroblasts expressed higher levels of dickkopf 3. Transfection studies revealed that dickkopf 1
decreased melanocyte function, probably via the inactivation of microphthalmia-associated tran-
scription factor (MITF). Thus, our results provide a basis to explain why skin on the palms and the
soles is generally hypopigmented compared to other areas of the body, and might explain why
melanocytes stop migrating in the palmoplantar area during human embryogenesis. 
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Association of HLA-A, B, C alleles with vitiligo in Chinese population
H Liu,1,2 X Zhang,1,2 L Sun,1,2 J Wang,1,2 S Yang,1,2 J Liu,1,2 Y Liang,1,2 M Gao,1,2 P He,1,2
A Zhang1,2 and Y Cui1,2 1 Institute of Dermatology & Dept.of Dermatology in 1st Affiliated
Hospital, Anhui Medical University, Hefei, Anhui, China and 2 Key Laboratory of Genome
Research at Anhui, Hefei, Anhui, China
Vitiligo is an acquired, sometimes familial depigmentary disorder of the skin and hair that results
from selective destruction of melanocytes. Serological typing of HLA has shown discrepancies in
HLA associated with vitiligo in different ethnic population. To identify HLA alleles that may be
involved in the genetic susceptibility to vitiligo. We determined the distributions of HLA-A, -B and
-C allelic frequencies by using polymerase chain reaction with sequence-specific primers (PCR-SSP)
in 187 Chinese Han patients with vitiligo and 204 healthy controls. The distribution of HLA allelic
frequencies was further analyzed according to the age of onset and types of vitiligo. The Results as
follows: (1) The frequencies of HLA-A*2501 (14.4% vs. 3.5%, OR=4.95, Pc<0.00001), -A*30 (4.4%
vs. 1.5%, OR=7.33, Pc<0.001), -B*13 (28.0% vs. 14.8%, OR=2.45, Pc<0.01), -B*27 (11.3% vs.
4.0%, OR=3.20, Pc<0.01) and -Cw*0602 (16.0% vs. 5.3%, OR=3.63, Pc<0.0001) were significantly
increased in the patients, while the frequency of HLA-A*66 (1.9% vs. 9.8%, OR=0.17, Pc<0.01)
was decreased, when compared with the controls. (2) HLA-A*2501, -A*30, -B*13, -B*27 and -
Cw*0602 were strongly associated with the childhood vitiligo. (3) HLA-A*2501, -B*13, -B*27
and -Cw*0602 were strongly associated with the generalized vitiligo. This study demonstrated the
positive associations of HLA class I alleles with vitiligo, and there may be a different genetic back-
ground among different phenotypes of vitiligo in Chinese Hans. 
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Human leukocyte antigen DQA1 and DQB1 alleles are associated with genetic susceptibility
to vitiligo in Chinese
J Wang,1,2 S Yang,1,2 M Gao,1,2 H Liu,1,2 L Sun,1,2 P He,1,2 J Liu,1,2 A Zhang,1,2 Y Cui,1,2 Y Liang,1,2
Z Wang1,2 and X Zhang1,2 1 Institute of Dermatology & Dept.of Dermatology in 1st Affiliated
Hospital, Anhui Medical University, Hefei, Anhui, China, 2 Key Laboratory of Genome Research
at Anhui, Hefei, Anhui, China and 3 Institute of Prevention & Cure of Skin Diseases in Anhui,
Hefei, Anhui, China
To identify susceptible and protective HLA alleles involved in vitiligo, we performed genotyping of
HLA-DQA1 and -DQB1 genes in Chinese Han population. Polymerase chain reaction sequence-
specific primer (PCR-SSP) method was used to analyze the distribution of HLA-DQA1 and -DQB1
alleles among 187 vitiligo patients and 273 healthy controls through Epi Info version 6 package.
The frequencies of HLA-DQA1*0302 (OR=1.98, Pc<0.01), -DQB1*0303 (OR=3.14, Pc<0.001), -
DQB1*0503 (OR=3.36, Pc<0.05) alleles were significantly increased in patients with vitiligo vs.
the controls, and HLA-DQA1*0501 (OR=0.40, Pc<0.01) allele frequency was highly decreased.
HLA-DQA1*0302 (OR=5.19, Pc<0.001), -DQA1*0601(OR=2.95, Pc<0.05), -DQB1*0303
(OR=4.50, Pc<0.001), -DQB1*0503 (OR=6.69, Pc<0.001) alleles were positively associated, whereas
HLA-DQA1*0501 (OR=0.05, Pc<0.001) allele was negatively associated with childhood vitiligo
patients, and HLA-DQB1*0303 (OR=2.76, Pc<0.001) allele was positively associated with adult
vitiligo patients vs. the controls. The frequency of HLA-DQB1*0303 (OR=3.72, Pc<0.001) allele
was significantly increased in localized vitiligo patients vs. the controls, whereas HLA-DQA1*0302
(OR=2.47, Pc<0.01), -DQB1*0303 (OR=2.67, Pc<0.01), -DQB1*0503 (OR=4.46, Pc<0.01) alle-
les frequencies were significantly increased and -DQA1*0501 (OR=0.27, Pc<0.01) allele frequency
was highly decreased in generalized vitiligo patients. HLA-DQA1*0302, -DQA1*0601, -DQB1*0303
and -DQB1*0503 alleles could be susceptible alleles of vitiligo, while HLA-DQA1*0501 allele could
be protective allele in Chinese Hans. There may be different genetic backgrounds between vitiligo
patients of childhood and adult, localized and generalized. 
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Proteinase activated receptor-2 stimulates prostaglandin synthesis in keratinocytes: analysis
of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2a on
melanocyte dendricity
G Scott1 1 Dermatology, U. of Rochester, Rochester, NY, 2 Pathology, U. of Rochester, Rochester,
NY and 3 Johnson and Johnson, Skin Research Center, Skillman, NJ
Reports suggest that prostaglandins (PGs) mediate post-inflammatory & ultraviolet radiation (UVR)-
induced pigmentation through effects on melanocyte (MC) dendricity & melanin synthesis. Pro-
teinase activated-receptor 2 (PAR-2) is expressed by keratinocytes (KC) & we’ve shown that PAR-
2 stimulates melanosome uptake in a Rho-dependent manner. We now show that PAR-2 activation
stimulates the release of PGE2 & PGF2a in KC, HaCat, & in an epithelial cell line genetically engi-
neered to express PAR-2, but not in vector expressing cells. We examined the effect of PGs & PG
receptor expression in MC. Of the 4 PGE2 receptors (EP1-EP4) MC express EP1 & EP3, as well as
the PGF2a receptor (FP) at the protein & mRNA level. PGE2 & PGF2a both significantly stimu-
lated MC dendricity at physiologic doses & treatment of MC with EP1 & EP3 receptor agonists
increased dendricity, indicating that both EP1 & EP3 receptor signaling contribute to PGE2 medi-
ated dendricity. Western blotting for EP1-EP4 & FP receptors following UVR showed that the FP
receptor is upregulated by UVR (2 J/cm2 from a solar simulator) in MC, which peaked at 18 hrs.
Real-time PCR showed that regulation of FP receptor occurs at the transcriptional level. EP1 & EP3
levels were not changed by UVR & de novo expression of EP2 & EP4 was not observed. We exam-
ined the potential production of eicosinoids by MC & show that MC produce PGF2a in an UVR-
dependent manner. MC do not produce PGE2, leukotriene C4 or 5-HETE. The cAMP/PKA path-
way modulates MC dendricity however treatment of MC with PGF2a or PGE2 did not elevate cAMP,
showing that PG-dependent dendricity is cAMP-independent. Our data suggest that PAR-2 medi-
ates cutaneous pigmentation through increased uptake of melanosomes by KC, as well as by release
of PGE2 & PGF2a that stimulate melanocyte dendricity through EP1, EP3 & FP receptors. Further,
UVR-dependent regulation of FP receptors & PGF2a production in MC may mediate effects of UVR
in MC dendricity. 
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The genetic epidemiology and the mode of inheritance of vitiligo
J Liu,1,2 M Li,1,2 J Gui,3 Q Xiong,3 S Yang,1,2 H Wang,1,2 M Gao,1,2 J Yang,1,2 Q Yang1,2 and
X Zhang1,2 1 Institute of Dermatology & Dept.of Dermatology in 1st Affiliated Hospital, Anhui
Medical University, Hefei, Anhui, China, 2 Key Laboratory of Genome Research at Anhui, Hefei,
Anhui, China and 3 Institute of Vitiligo, the Xiangfan Railway Hospital, Xiangfan, Hubei, China
Vitiligo occurs with a frequency of 0.1%-2% in various populations and is classified into several sub-
types by its clinical presentation. Although genetic factors are thought to be involved in the etiology
of vitiligo, the genetic models for different phenotypes of vitiligo are unknown. Our purpose was to
explore potential genetic models for different phenotypes of vitiligo and analyze genetic epidemio-
logical characteristics of vitiligo in Chinese people. Concerned information from 2247 patients and
members in their families was collected using a uniform questionnaire. Patients” clinical character-
istics and their family history were analyzed using programs concerned in SPSS 10.0 and Epi Info
6.0. A complex segregation analysis was conducted to propose potential genetic models for vitiligo.
We found a consistent distribution of ages of vitiligo onset between males and females. However,
different subtypes of vitiligo had different ages of disease onset. The mean onset age of segmental
vitiligo was approximate 15 years old, which was significant earlier than those of the other types of
vitiligo. In relatives of vitiligo patients, the risk of developing vitiligo increased with increasing blood
relatedness to the vitiligo patients. According to the results of complex segregation analysis, the poly-
genic additive model was the best model for focal vitiligo, vitiligo vulgaris, acrofacial vitiligo and
segmental vitiligo with approximately 50% heritability in each. For universal vitiligo, the best model
was an environmental model. This study indicate that regardless of the genders, the onset ages of
vitiligo might be associated with both the patients” clinical subtype of vitiligo and the family his-
tory of vitiligo. Different phenotypes of vitiligo might have different pathogeneses and genetic back-
grounds. Onset of vitiligo is possibly affected by both genetic backgrounds and environmental fac-
tors.
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All-trans retinoic acid induces differentiation of amelanotic melanocytes of human hair folli-
cle
D Wang, W Zhu, H Ma and C Li Department of Dermatology, the First Affiliated Hospital of
Nanjing Medical University, Nanjing, Jiangsu province, China
Retinoids has been shown to induce the differentiaton and inhibit the growth of melanoma cells in
vitro.On the other hand,they can induce differentiation and apoptosis of murine melanocyte precur-
sors. There is a group of amelanotic melanocytes(AMMC) which localize in the outer root
sheath(ORS) of hair follicles. AMMC has been cultured successfully,and been demonstrated to be
melanocyte precursors in vitro. In this study,we investigated the effects of all-trans retinoic acid
(ATA) on the differention and proliferation of AMMC. AMMC were incubated with ATA of differ-
ent concentrations (0,10-4,10-6,10-8M). The morphological transformation of cells was observed by
using invert microscope, and the proliferation was tested by accounting cells. Laser scanning
microscopy(LSM) was employed to carry out semi-quantitive analysis of expression of tyrosinase
(TYR), tyrosinase realated protein-1 (TRP-1) and tyrosinase realated protein-2 (TRP-2) after indi-
rect immunofluorescence staining. The change of melanosomes was observed by transmission elec-
tron microscopy(TEM). Before the treatment with ATA, the AMMC were small and bipolar, and con-
tained lots of stage I and II melanosomes. After treatment with ATA, Lots of AMMC showed dendrite
formation, and became larger. All melanosomes in the treated AMMC were showed in stage III and
IV . It has been demonstrated that ATA increased expression of TYR and TRP-1, but had no effect
on that of TRP-2. ATA inhibited proliferation of AMMC in dose dependent manner. All results sug-
gested ATA could induce differentiation and inhibit proliferation of AMMC. In the study about tumor
cells, ATA can induce apoptosis. So we assumed that inhibition of proliferation is related to apop-
tosis.
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Cytokine and melanogenetic marker profiles in vitiligo vulgaris: therapeutic effects of narrow
band UVB
K Kikuchi,1 E Kato,1 M Komine,1 K Tamaki,1 T Hoashi2,1 and VJ Hearing2 1 Department of
Dermatology, University of Tokyo, Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan and 2
Laboratory of Cell Biology, National Cancer Institute, Bethesda, MD
Vitiligo vulgaris is a major medical problem especially for pigmented races including Japanese that
can result in severe difficulties in social adjustment. Therefore, it is important for dermatologists to
be aware of the various options for controls of this disease. Narrow-band UVB 311 nm, new light
source, which is not available widely, is fairly effective without the use of psoralens. Three repre-
sentative case are 64 year-old male, 20 year-old male and 19 year-old female had been diagnosed as
vitiligo vulgaris. Well-demarcated depigmented spots existed on their face, neck, back and the periph-
ery of their fingers and toes. Histological examination revealed that melanin granules in the basal
layer of the epidermis were decreased. Narrow-band UVB (0.3 J/cm2/day, 5 days/week, 8 weeks,total
12 J/cm2) and topical calcipotriol therapy was started, and after 2 weeks, dotted pigmentation appeared
in the depigmented spots especially on their face. Melanin granules in the epidermis and S 100-pos-
itive melanocytes in the basal layer were increased after 8 weeks of the treatment. The relative expres-
sion of a number of key mediators of pigmentation including tyrosinase, endothelin-1, c-kit and basic
fibroblast growth factor (bFGF) were analysed and quantified in immunohistochemically stained
skin sections using semiquantitative image analysis. Melanocyet number was increased about three-
fold in the treated skin. Tyrosinase protein expression in melanocytes in each case was significantly
elevated after the traeatment. Interestingly, the higher expression of bFGF, a natural mitogen for
melanocytes, were found in vitiligo skin. After the treatment, bFGF protein decreased to the level
of normal control. bFGF might be in involved in the pathogenic chain of events leading to vitiligo. 
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Apoptotic cleavage of livin in melanoma cells
B Brouha,1 T Liu,2 A Hanks,2 H Yan2 and D Grossman1,2 1 Dermatology, University of Utah, Salt
Lake City, UT and 2 Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
The inhibitor of apoptosis (IAP) protein Livin is highly expressed in melanoma, and has been shown
to function as a caspase inhibitor in vitro and an immunologic target in some patients. We have
reported that UVB treatment of YUSAC2 melanoma cells results in Livin cleavage, generating a 30-
kD fragment visualized by Western blotting (JID 120:48). To further characterize this cleavage event,
we examined multiple apoptotic stimuli and cell lines and investigated potential proteolytic mech-
anisms. In addition to UVB, treatment with 4-TBP or cisplatin under apoptosis-inducing conditions
resulted in Livin cleavage in multiple melanoma lines. Additional stimuli activating death receptor
or endogenous (mitochondrial) apoptotic pathways were also tested. None of the melanoma lines
were responsive to TRAIL, but forced Bax expression produced cleavage. A Livin cDNA tagged
with a C-terminal V5 epitope was transiently transfected into HeLa cells, and the expressed protein
was cleaved upon exposure to TRAIL as well as other stimuli. The 30-kD fragment was visualized
with an anti-V5 antibody, localizing the cleavage site to the amino-terminal third of the molecule.
Although this region contains a putative caspase recognition homology domain, neither mutation of
this site nor addition of the pan-caspase inhibitor z-VAD-fmk blocked apoptotic cleavage in melanoma
cells. By contrast XIAP, a related IAP protein, was cleaved in apoptotic melanoma cells in a cas-
pase-dependent manner. Screening of other protease inhibitors demonstrated that Livin cleavage
could be blocked by the serine protease inhibitor AEBSF. The serine protease HtrA2/Omi, known
to be involved in many apoptotic responses, was detected in mitochondria and found translocated to
cytosol in apoptotic melanoma cells with kinetics similar to that of Livin cleavage. These studies
demonstrate that although multiple apoptotic stimuli can cause Livin cleavage, activation of the mito-
chondrial apoptotic pathway in melanoma cells is sufficient for this proteolytic event which appears
distinct from XIAP and may be mediated by HtrA2/Omi. 
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Connexins are differentially expressed in melanoma and adjacent epidermis
NK Haass,1,2 JM Brandner,2 PA Brafford,1 E Wladykowski,2 S Kazianis,1 KS Smalley,1 I Moll2 and
M Herlyn1 1 The Wistar Institute, Philadelphia, PA and 2 Dermatology and Venerology, University
Hospital Hamburg-Eppendorf, Hamburg, Germany
Melanocyte growth is controlled by keratinocytes through paracrine growth factors and cell adhe-
sion molecules. Disruption of this balance can alter the expression of cell adhesion and cell-cell com-
munication molecules and lead to development of melanoma. Gap junctional intercellular commu-
nication (GJIC) plays an important role in maintaining tissue homeostasis and is a critical factor in
the life and death balance of cells. In the skin GJIC is involved in the regulation of keratinocyte
growth, differentiation and migration as well as in keratinocyte-melanocyte interactions. Changes
in connexin (Cx) expression, in particular loss of Cx43, may result in a reduction or a loss of gap
junctional activity, which contributes to tumor progression. Using microarrays and RT-PCR we show
that Cx43 is not expressed in 14 of 28 melanoma cell lines and only weakly in the other 14, but is
highly expressed in melanocytes, keratinocytes, fibroblasts and endothelial cells. Cx32 is expressed
in 24/28 melanoma lines and, at a lower level, in all melanocytes, but not in keratinocytes, fibrob-
lasts and endothelial cells. Cx26 is weakly expressed in 12/28 melanoma lines. In contrast, Cx30 is
only weakly expressed in 3/28 melanoma lines, which were also positive for Cx43 and Cx26 and
were derived from the same patient. Using immunofluorescence on human tissue sections, we did
not detect Cx43, Cx26 and Cx30 in melanoma (n=8). However, we show an induction of Cx26 and
Cx30 in the epidermis adjacent to melanoma, while both are not detectable in the epidermis adja-
cent to benign non-epithelial skin tumors (melanocytic nevi and angioma). As the expression pat-
terns of Cx26 and Cx30 are not identical with CK6, a marker for hyperproliferation, and CK17, a
marker of trauma, we suggest that the induction of these gap junctional proteins is not a reflection
of reactive hyperproliferative or traumatized epidermis. We instead discuss the putative roles of these
gap junctional proteins in tumor progression. 
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25-Hydroxycholesterol acts in the Golgi compartment to induce degradation of tyrosinase
AM Hall,1 L Krishnamoorthy1 and SJ Orlow1,2 1 Ronald O. Perelman Department of Dermatology,
NYU Medical Center, New York, NY and 2 Department of Cell Biology, NYU School of Medicine,
New York, NY
In addition to its well-known effects on cholesterol trafficking, the androstenedione U18666A alters
the trafficking of tyrosinase. Because oxysterols play a significant role in cholesterol homeostasis
we examined the effects of 25-hydroxycholesterol on murine melanocytes. Within the family of oxys-
terols, 25-hydroxycholesterol in particular has been demonstrated to regulate cholesterol homeostasis
via oxysterol-binding protein and oxysterol-related proteins, the sterol regulatory element binding
protein, and the rate-limiting enzyme of cholesterol biosynthesis, hydroxymethylglutaryl coenzyme
A reductase. Incubation of cultured murine melanocytes with 25-hydroxycholesterol induced a
decrease in pigmentation with an IC50 of 0.34 µM and a significant diminution in levels of tyrosi-
nase, the rate-limiting enzyme of melanin synthesis. Pulse chase studies of 25-hydroxycholesterol-
treated cells demonstrated enhanced degradation of tyrosinase following ER and Golgi maturation.
Protein levels of GS28, a member of an ER/cis-Golgi SNARE protein complex, were also dimin-
ished in 25HC-treated melanocytes, however levels of the ER chaperone calnexin and the cis-Golgi
matrix protein GM130 were unaffected. Effects of 25-hydroxycholesterol on tyrosinase were com-
pletely reversed by 4α-allylcholestan-3α-ol, a sterol identified by its ability to reverse effects of 25-
hydroxycholesterol on cholesterol homeostasis. Interestingly, incubation of cells in the absence of
exogenous cholesterol altered tyrosinase processing in a manner similar to 25-hydroxycholesterol
in the presence of exogenous cholesterol. We conclude that 25-hydroxycholesterol acts in the Golgi
compartment to modulate pigmentation. These data further support a link between cholesterol home-
ostasis and pigmentation in murine melanocytes. 
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Flotillin-2 transformation of a non-metastatic melanoma line to highly metastatic phenotype
is associated with thrombin activated receptor PAR-1
P Hazarika,1 D Babu,1 D Koul2 and M Duvic1 1 Dermatology, MD Anderson Cancer Center,
Houston, TX and 2 Neuro-Oncology, MD Anderson Cancer Center, Houston, TX
Flotillin-2 (flot-2) is a 41.7 kDa, highly conserved, caveolae/lipid raft associated protein of unknown
function. We have previously demonstrated that more aggressive, metastatic melanoma cell lines and
metastatic lesions have increased flot-2 expression. When flot-2 was transfected into a non-metasta-
tic melanoma line (SB2), two transformed SB2 flot-2 clones with properties of vasculogenesis in
Matrigel were highly tumorigenic and metastasic in the nude mouse xenograft model. To determine
how over-expression of flot-2 is involved in progression of MM, we compared differential gene
expression of flot-2 transfected SB2 cells by microarray analysis. When mRNA was hybridized to
a cancer related DNA pathway array (CG-8) of 1100 unique sequenced 75-oligomers, the thrombin
receptor (Protease Activated Receptor, PAR-1) was upregulated, and this was confirmed by quanti-
tative RT-PCR and Western blotting. PAR-1 plays a key role in both invasion and angiogenesis lead-
ing to the metastatic melanoma phenotype. PAR-1 and flot-2 protein expression were increased in
metastatic melanoma lines compared to non-metastatic lines and PAR-1 was co-immunoprecipitated
with flot-2, suggesting they bind to each other. The rate of invasion of SB2 flot-2 cells through
Matrigel was significantly increased (p= 0.002) if cells were pre-activated with thrombin. Small
interfering flot-2 RNAs down-regulated both flot-2 and PAR-1 mRNA expression in SB2 flot-2 cells.
In conclusion, flot-2 modulates expression of the thrombin receptor, PAR-1 that is implicated in
progression to a metastatic phenotype, controlling invasion, angiogenesis, and actin cytoskeleton
reorganization. Understanding the relationship of flot-2 and PAR-1 in melanoma progression may
be of general importance for understanding tumor progression and may result in novel therapeutic
intervention for the treatment of malignant melanoma. 
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Proliferation, apoptosis and survivin expression in benign melanocytic neoplasms
SR Florell,1 AR Bowen,1 AN Hanks,2 KJ Murphy2 and D Grossman1,2 1 Dermatology, University
of Utah, Salt Lake City, UT and 2 Huntsman Cancer Institute, University of Utah, Salt Lake City,
UT
Apoptosis, as a counterbalance to proliferation, is important in the maintenance of tissue homeostasis
and dysregulation of apoptosis likely occurs in the development of cutaneous neoplasms. We have
shown previously that survivin, a member of the inhibitor of apoptosis (IAP) family, is absent in
normal skin but expressed in melanoma, non-melanoma skin cancers, and benign keratinocytic
lesions. We determined its pattern of expression in various types of melanocytic nevi, and attempted
to correlate expression with apoptotic and proliferation markers. Six cases of each of the following
nevus subtypes were retrieved from our dermatopathology archive: compound dysplastic/atypical
nevus, compound nevus, intradermal nevus, neurotized intradermal nevus, and Spitz nevus. Survivin
expression was evaluated by in situ hybridization using a full length biotinylated riboprobe. Prolif-
eration and apoptotic indices were calculated by counting immunoreactive cells in TUNEL- and
PCNA-immunostained sections, respectively. All nevi, regardless of histologic type, expressed sur-
vivin. Compound melanocytic lesions expressed survivin in both the epidermal and dermal com-
partments. Positive staining in neurotized melanocytes was seen in four of six cases (67%). The apop-
totic rate was low with only rare positive cells identified in the epidermal and dermal compartments
of dysplastic, compound, and Spitz nevi. Apoptotic cells were not identified in any of the neurotized
nevi. The proliferative index was highest for Spitz nevi (16.6% epidermal component, 11.3% der-
mal component), while dysplastic/atypical, compound, intradermal, and neurotized nevi demon-
strated only rare PCNA positive cells (<1% positively staining cells). This study demonstrates that
survivin is consistently expressed in benign melanocytic lesions, while apoptotic cells are rarely iden-
tified suggesting dysregulation of the apoptotic pathway leads to accumulation of cells in these neo-
plasms.
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CP-31398 induced apoptosis in human melanoma cells is p53 mutation dependent
CK Ho, Y Lu and G Li Medicine, University of British Columbia, Vancouver, BC, Canada
p53, a tumour suppressor gene, has the ability to induce cell cycle arrest, DNA repair and apopto-
sis. It is also one of the most commonly mutated genes in human cancers. A small pharmacological
compound, CP-31398, was recently shown to have the ability to promote proper folding and stabi-
lize the active conformation of p53 protein, enabling it to activate transcription and slow tumour
growth in mice. Here we examine the effect of CP-31398 in human melanoma cell lines with dif-
ferent p53 status. Five p53 wild type and three p53 mutant melanoma cell lines were screened ini-
tially for apoptotic response. All cell lines responded to CP-31398 at high concentration (≥30µg/mL),
but only three were sensitive at lower concentrations (≤15µg/mL). We hypothesize that the ability
of CP-31398 to induce apoptosis is p53 mutation dependent in melanoma cells. Using one p53 wild
type (MMRU) and two p53 mutant (MEWO and SK-110) cell lines, we demonstrated by flow cytom-
etry that at a moderate CP-31398 concentration (14µg/mL) only MMRU and MEWO cells undergo
apoptosis but not SK-110 cells. Upon CP-31398 treatment, we showed that MMRU and MEWO
cells exhibited apoptotic characteristics including DNA condensation and fragmentation but not in
SK-110 cells. Immunofluorescence staining confirmed that CP-31398 enhanced p53 protein level
in all three melanoma cell lines yet lacking the ability to induce apoptosis in mutant-p53 SK-110
cells. We also found that CP-31398 had the ability to alter mitochondrial membrane potential and
induce the release of cytochrome c in both MMRU and MEWO cells but not in SK-110 cells. Fur-
thermore, western blots showed that p21 upregulation after CP-31398 treatment in SK-110 is slower
than CP-31398 responsive MMRU and MEWO cells, suggesting that CP-31398 may be involved in
cell cycle arrest. Taken together, our results indicate that CP-31398-induced cell death is p53 muta-
tion dependent. Elucidating the molecular mechanism by which CP-31398 induces cell death may
lead to better utilization and application of this compound as an anit-cancer drug for various forms
of cancer. 
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Slow-binding inhibition of tyrosinase by Zn2+
Y Park,1 S Kim,1 H Park2 and J Yang1,2 1 Clinical Research Center, Samsung Biomedical Research
Institute, Seoul, South Korea and 2 Department of Dermatology, Sungkyunkwan University School
of Medicine, Seoul, South Korea
Many physiological roles of Zn2+ in human tissues including skin have been well elucidated. In the
present study, we uncovered that Zn2+ could act as a tyrosinase inhibitor. Zn2+ inhibited tyrosinase
in the manner of slow-binding inhibition observed by continuous substrate reaction. Sequential stud-
ies showed that apparent rate constants were not changed by different concentrations of Zn2+, how-
ever, inhibition rate constants were linearly increased by substrate with a dose-dependent manner,
which is a rarely observed phenomenon in general inhibition mechanisms. In equilibrium state after
slow binding, most of enzyme activity was completely inactivated by Zn2+ even under the low con-
centrations. Zn2+ may interact with His residues existed in the active-site pocket of tyrosinase and
this ligand-binding affect the substrate accessibility to Cu2+ of the active site. Zn2+ directly bound
with bovine serum albumin as well as gamma immunoglobulin observed by complete activity pro-
tection from Zn2+ inhibition. This result indicated that prior to applying on pigment cell, interfer-
ences of most abundant proteins in normal culture system should be considered. The general utility
of Zn2+ as a whitening agent is currently under investigation. 
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Chloride induced inhibition of tyrosinase
Y Park1 and J Yang1,2 1 Clinical Research Center, Samsung Biomedical Research Institute, Seoul,
South Korea and 2 Department of Dermatology, Sungkyunkwan University School of Medicine,
Seoul, South Korea
Tyrosinase inhibition by halide ions has been reported hitherto and the results implied that a differ-
ent manner of inhibition mechanism on tyrosinase from various sources could exist. In this study,
Cl- induced inhibition of tyrosinase was kinetically analyzed to elucidate Cl- as a potent regulatory
factor in melanogenesis. Inhibition kinetic studies were carried out on mushroom tyrosinase which
is commercially available as well as on human tyrosinase which is transiently over-expressed in
HEK293. Chloride bound compounds such as NaCl, KCl, and NH4Cl2 were applied for Cl
- source.
Kinetic analyses showed reversible complex inhibitions of tyrosinase by Cl-: partial hyperbolic
uncompetitive inhibition for mushroom tyrosinase and slope-parabolic competitive inhibition for
human tyrosinase expressed in HEK293, respectively. In case of mushroom tyrosinase, Cl- inhibited
tyrosinase activity at ES complex state, indicating that Cl- binding site was induced after substrate
binding to enzyme. Intrinsic fluorescence study confirmed this phenomenon. For human tyrosinase,
apparent Km values were significantly changed accompanying parabolic apparent Vmax changes,
showing that Cl- binding to Cu2+ at the active site induced competition with DOPA substrate as a
mixed-type. Kinetic results indicated that physiological concentrations of Cl- and its related chan-
nel might regulate the melanogenesis. It is worth notice that high content of Cl- exists physiologi-
cally and tyrosinase reacts sensitively to Cl- in the manner of complex interactions. 
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The effects of arsenic trioxide on mouse malignant melanoma growth in vivo and vitro
M Hou,1,5 W Zhu,1 X Lu,2 H He,3 J Wang,4 X Lin1 and X Yue1 1 dermatology, the first affiliated
hospital of Nanjing Medical University, Nanjing, Jiangsu, China, 2 Cardiology, the first affiliated
hospital of Nanjing Medical University, Nanjing, Jiangsu, China, 3 Urology, the first affiliated hos-
pital of Nanjing Medical University, Nanjing, Jiangsu, China, 4 Pathology, The Affiliated Gulou
Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China and 5 Rheumatology, The
Affiliated Gulou Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China
Arsenic trioxide (As2O3) induces clinical remission of patients with acute promyelocytic leukemia,
but its effects on melanoma are not clear. In this study, murine melanoma cell line, Cloundman S91
was examined as cellular model for As2O3 treatment, andAs2O3 induced cell death and inhibition of
cell growth and colony formation were evaluated. Finally, As2O3 (1mg/kg/d) was administered to
C57BL/6 mice inoculated with murine melanoma B16 cells to estimate in vivo efficacy, the inocu-
lated skin tumors were identified macroscopically and were confirmed by histochemical analysis
with hematoxylin and eosin staining. The S91, at high concentrations (2-16*10-6M), As2O3 induced
apoptosis and, at low concentrations (0.5-2*10-6M), growth inhibition, which were enhanced by
Acorbic acid (AA). The murine melanoma model showed in vivo tumor growth inhibition in implanted
tumors with no signs of toxicity. It was found melanoma tissue necrosis increased significantly and
tumor cells reduced apparently than control, the remains enlarging, cytoplasm loosening, nucleus
dwindling or disappearing, presenting a typical partly differentiation shape. Our results suggest that
As2O3 could induce mouse melanoma apoptosis, differentiation and growth inhibition, but in vivo
tumor growth inhibition indicates the limit of monotherapy with As2O3 because it could not induce
total cell death and combinated AA with As2O3 at clinically obtained concentrations may be a use-
ful, novel therapy for melanoma. 
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Reversible pigmentation of TXM 13 human melanoma cell line
Y Park,1 D Lee2 and J Yang1,2 1 Clinical Research Center, Samsung Biomedical Research Institute,
Seoul, South Korea and 2 Department of Dermatology, Sungkyunkwan University School of
Medicine, Seoul, South Korea
A suitable pigment production cell line is essential to screening and exploiting an effective whiten-
ing agent in respect of low cost, rapid growing, easy treatment, and maintaining pigmentation. In
this regard, we found that TXM 13, a human melanoma cell line is a good candidate to fit these
requirements. Recently, we isolated several pigmented cell clones from TXM 13 where non-pig-
mented cells mostly existed with pigmented cells by using limiting-dilution method. Repeated sub-
cultures rapidly amplified non-pigmented cells compared to pigmented cells. Therefore, specific
cloning of pigmented cell was needed to maintain pigmentation. Interestingly, long-term culture after
confluency on plastic dish, even mostly non-pigmented cells could reversibly produce pigment con-
spicuously. This result indicated that the extent of confluency and incubation time were directly
involved in repigmentation. From the kinetic analysis of tyrosinase activity, we found that melano-
genesis was resumed by tyrosinase catalysis. We also tested other melanoma cell lines, such as
TXM 1, TXM 18, TXM 40, A375SM and A375P, respectively. However, these cell lines did not
produce pigment. Consequently, TXM 13 could be usefully applied to develop further whitening
agents.
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Tyrosinase inhibition of active site-targeted Cu2 + chelators
S Kim,1 Y Park1 and J Yang1,2 1 Clinical Research Center, Samsung Biomedical Research Institute,
Seoul, South Korea and 2 Department of Dermatology, Sungkyunkwan University School of
Medicine, Seoul, South Korea
Tyrosinase is ubiquitously distributed in organisms and has the nature of multi-catalytic function
since it has two Cu2+ connected individually with three histidines at the active site. Therefore, Cu2+
of the active site has been targeted to inhibit tyrosinase activity. DETC (diethyldithiocarbamate)
was detected as a potent tyrosinase inhibitor among several Cu2+ chelators tested in this study. DETC
significantly inhibited tyrosinase activity (IC50 = 53 mM) irreversibly, which was measured by the
plot of v (∆OD/min) vs. [E]. Subsequent kinetic analyses showed that parabolic competitive inter-
action between DETC and Cu2+ of the active site was observed. The secondary replot of Ki slope vs.
[DETC] evaluated parameters as Ki = 46.8 mM and α = 0.0662, respectively. These results indi-
cated that DETC has a relative high affinity to Cu2+ at the active site of tyrosinase and effectively
retard catalysis. Cell viability was tested by MTT assay in the presence of various concentrations of
DETC. The result showed that viability was not affected in less than 25 mM of additive DETC. In
summary, we found that DETC is a potent whitening agent to inhibit the tyrosinase active site and
its kinetic behavior can be unique comparative to other well-known inhibitors. 
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Effct of Aloesin on melanogenesis of human epidermal melanocytes
C Li, W Zhu, D Wang, H Ma and X Yue Dermatology, The Affiliated Hospital of Nanjing Medical
University, Nanjing, Jiangsu, China
Aloesin [2-acetonyl-8-b-D-glucopyranosyl-7-hydroxy-5-methylchromone], a compound isolated
from the Aloe plant, has been used for centuries in cosmetics. The mechanism for bleaching of Aloesin
is not clear as a compound of cosmitic. In this study, the different concentrations of Aloesin (0.01,
0.1, 1, 10mM ) were incubated with human epidermal melanocyte. The cell proliferation rates, tyrosi-
nase acitivity and melanin levels of melanocytes were determined after treatment of Aloesin, then
the results of Aloesin groups were compared with the control group. Aloesin induced the death of
melanocytes in high concentration (10mM), and had no effect on proliferation rates in low concen-
trations(0.01 mM, 0.1 mM, 1mM). We found Aloesin obviously inhibit tyrosinase activity and melano-
genesis in 0.1 mM and 1mM concentrations. There was no difference of the tyrosinase activity and
melanin levels between in 0.01 mM Aloesin group and the control. Our results suggest that Aloesin
shows promise as a pigmentation altering agent for cosmetic or therapeutic applications.Its mecha-
nism for depigmentation would be mainly inhibited tyrosinase acitivity. 
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Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous
malignant melanoma: a case-control study
S Blankenburg,1 IR Koenig,2 P Laspe,1 K Thoms,1 U Krueger,1 R Moessner,1 G Westphal,3
M Volkenandt,4 K Reich,1 C Neumann,1 A Ziegler2 and S Emmert1 1 Dermatology, University
Goettingen, Goettingen, Germany, 2 Medical Biometry and Statistics, University Schleswig-
Holstein-Campus Luebeck, Luebeck, Germany, 3 Occupational and Social Medicine, University
Goettingen, Goettingen, Germany and 4 Dermatology, LMU Munich, Munich, Germany
Xeroderma pigmentosum (XP) patients exhibit a 1000-fold increased risk for developing skin can-
cers including malignant melanoma. Inherited polymorphisms of XP genes may, thus, contribute to
subtle variations in DNA repair capacity and genetic susceptibility to melanoma. We investigated
the role of three newly identified variant alleles of the DNA repair gene XPC in a hospital-based
case-control study of 294 caucasian patients from Germany with malignant melanoma and 375 healthy
control individuals from the same area matched by age and sex. We confirmed that the PAT+, Intron
11A, and the exon 15C polymorphisms are in linkage disequilibrium. The allele frequencies (cases
: controls) were for PAT+ 41.7% : 36.9%, for Intron 11A 41.8% : 37.0%, and for exon 15C 41.3%
: 37.3%. The observed genotype distributions matched the expected genotype distributions as pre-
dicted by the Hardy-Weinberg theory. The homozygous PAT, Intron 11, and exon 15 genotypes
were associated with nonsignificantly increased risks of melanoma: OR 1.527 (95%-CI: 0.967-2.418),
OR 1.526 (95%-CI: 0.966-2.414), and OR 1.425 (95%-CI: 0.906-2.246), respectively. Exploratory
analyses of subgroups revealed that these genotypes might be associated with significantly increased
risks for the development of multiple primary melanomas (n=28), melanomas in individuals with a
low number of nevi (n=273), melanomas in individuals older than 60 years (n=100), and melanomas
thicker than 1mm (n=126). Our case-control findings support the hypothesis that the PAT+, Intron
11A, exon 15C haplotype may contribute to the risk of developing and progression of malignant
melanoma by increasing the rate of an alternatively spliced XPC mRNA isoform that skipped exon
12 and leads to a reduced DNA repair function. 
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Brassicaceae extract exhibits lightening effect on human skin, and reduces UV-induced tan-
ning in skin samples: ex vivo studies
E Bauza, G Bressier, D Peyronel, C Dal Farra and N Domloge Skin Research, Vincience, Sophia
Antipolis, Sophia Antipolis, France
Skin researchers are very interested in modulating melanin synthesis in the skin given that increased
skin pigmentation is found in many skin disorders, and also because hyperpigmentations have psy-
chosocial and cosmetic effects, as well as cultural impacts, particularly in Asian countries. In order
to respond to this current search for new lightening compounds for the skin, we developed an extract
of fermented and hydrolyzed proteins of Brassicaceae (mustard family), and investigated its effect
on melanin synthesis in ex vivo human skin. Ex vivo samples of different types of caucasian skin
were submitted or not to UVB irradiatiation and to treatment with different concentrations of the
extract, twice a day, for different periods of time (2-5 days). Melanin synthesis in the skin was then
evaluated histologically after Fontana-Masson staining of the samples. The results of these samples
showed that, compared to the untreated control skin, application of Brassicaceae extract on the skin
reduced melanin level, and this effect was seen with different applied doses. Moreover, when skin
samples were irradiated with 100 mJ/cm2 of UVB and then treated with Brassicaceae extract, twice
a day, for 2-5 days, the results showed that application of the extract restrained UV-induced melanin
synthesis, in contrast to what was observed in the UV control skin. Interestingly, this effect was more
evident in skin samples that were treated for 24 hours (2 applications) with the Brassicaceae extract,
prior to UV irradiation. These results were time-independent, and the effect of the extract on melanin
synthesis was consistent in the different studied skin types. These studies highlight the interest of
using Brassicaceae extract in skin care products and cosmetics designed for lightening purposes and
for the treatment of pigmentation disorders, as well as for moderation of UV-induced tanning. 
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Role of p150Glued and microtubules in perinuclear maintenance of phagocytosed melanosomes
in human keratinocytes
HR Byers and SG Dykstra Dermatology, Boston Univ Sch Medicine, Boston, MA
The intermediate chain of cytoplasmic dynein links the retrograde microtubular motor to the p150Glued
subunit of the dynactin complex that associates with membrane-bound organelles. We have demon-
strated that cytoplasmic dynein intermediate chain in human keratinocytes is involved in the perin-
uclear-directed aggregation of phagocytosed melanosomes. We hypothesize that the p150Glued sub-
unit of the dynactin complex localizes to the melano-phagolysosome- and microtubule- rich perinuclear
region and that disruption of microtubules releases melano-phagolysosomes from the perinuclear
region. The p150Glued subunit was identified in extracts of isolated human keratinocytes. Double-
label immunofluorescent confocal microscopy demonstrated p150Glued and tubulin colocalization in
the melano-phagolysosome-rich perinuclear region. Time-lapse video microscopy in cultured ker-
atinocytes were performed in controls or after 2, 10, or 20 minutes after 1 µM nocodazole and cold
induced depolymerization of microtubules. Depolymerization of the microtubules by cold and noco-
dazole induced early dispersion of melano-phagolysosomes from the perinuclear region in well-
spread cultured keratinocytes situated at the periphery of keratinocyte colonies. Taken together, these
findings provide further evidence for the p150Glued/dynactin complex linkage of melano-phagolyso-
somes and microtubules, and their role in maintaining perinuclear aggregation to protect the nucleus
from UV-induced DNA damage. 
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Gene expression profiling and tissue microarray analyses reveal osteopontin as a major inva-
sive melanoma associated protein
Y Zhou,1 D Dai,1 M Martinka,2 M Su,1 E Campos,1 N Makretsov,1 D Huntsman,2 I Dorocicz,1
L Tang,1 C Nelson,3 V Ho1 and G Li1 1 Medicine, University of British Columbia, Vancouver, BC,
Canada, 2 Pathology, University of British Columbia, Vancouver, BC, Canada and 3 Surgery,
University of British Columbia, Vancouver, BC, Canada
Existing therapies for metastatic melanomas remain unsatisfactory. Improved understanding of the
abnormal genes expressed in metastatic melanomas may reveal new targets for therapeutic devel-
opment. Previous studies using DNA microarray technology have led to discovery of critical genes
involved in melanoma metastasis and invasion. However, more advanced microarray technology is
available that can provide a more complete molecular portrait of melanoma that was not possible
with older versions of the technology used previously. Therefore, we compared the transcriptome of
metastatic melanoma nodules and normal intradermal nevi using oligo arrays with more than 20,000
gene probes. Selected genes were confirmed using tissue microarrays consisting of multiple cores
of melanoma samples corresponding to different Breslow thickness. Over 160 genes were signifi-
cantly over expressed in metastatic melanoma nodules compared with benign intradermal nevi (>2
fold, p<0.05). Most of the genes were not reported before to be melanoma associated. The most abun-
dantly and specifically expressed gene is a secretary adhesion molecule, osteopontin (OPN). Using
tissue microarray analysis, OPN was observed to be present in most melanoma biopsies, regardless
of the thickness. In contrast, benign or dysplastic nevi or melanoma in situ did not express signifi-
cant amount of OPN. Osteopontin has been implicated in various biological processes including
cell adhesion, migration, and anti-apoptosis. Our data indicates that the aberrant OPN expression is
associated with development of invasiveness of melanocytic lesions. Thus, abnormality in this gene
occurs early in the progression of melanoma. It may serve as a target for future melanoma thera-
peutic development. 
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Fate of melanocytes during murine hair follicle involution (catagen): leads and lessons from
TRP2-LacZ transgenic mice
AA Sharov,1 DJ Tobin,2 TY Sharova,1 R Atoyan,1 BA Gilchrest1 and VA Botchkarev1 1
Dermatology, Boston University, Boston, MA and 2 Biomedical Sciences, Bradford University,
Bradford, United Kingdom
Melanin synthesis in hair follicle (HF) melanocytes (MCs) is strictly coupled to the growth stage of
the hair cycle (anagen) and is interrupted during follicle regression (catagen) and resting (telogen).
Using TRP2-LacZ transgenic mice as a model, we investigated the MC fate during catagen. In ana-
gen HF, melanogenically active MCs are located above the dermal papilla (DP), while amelanotic
MCs are seen in the outer root sheath (ORS) and bulge. During catagen, melanogenic and amelan-
otic MCs show distinct patterns of migration, survival and apoptosis. MCs located in the ORS moved
upward in the regressing HF, were TUNEL-negative and most likely represented surviving MCs.
MC population located above the DP became divided into two distinct sub-populations heteroge-
neous in their fate. The MC sub-population closest to the hair shaft moved upward in the regressing
HF and underwent apoptosis. These MCs also expressed Fas and lacked p55TNFR, p75NTR and
p53 expressions suggesting the involvement of Fas in apoptosis of these cells. The second MC sub-
population located close to the DP migrated downward through the basal lamina into the DP, which
was also supported by electron microscopic studies. These cells also showed the expression of c-kit
receptor, were TUNEL-negative and subsequently could be seen in the HF connective tissue sheath
and/or neighboring dermis. During subsequent hair cycle, restoration of HF pigmentary unit occurs
most likely from the amelanotic MCs that survive catagen and are located in the secondary hair
germ of telogen HF, as well as from the MC stem cells located in the bulge. Taken together, these
data provide a possible scenario and mechanisms of the remodeling of the follicular pigmentary
during HF anagen-catagen-telogen transition and may be used for the establishing in vivo models
for pharmacological modulation of MC apoptosis and survival during the hair cycle. 
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Evaluation of genetic melanoma vaccines in cdk4 mutant mice
J steitz,1 J Lenz,1 S Buechs,1 C Huber,2 T Woelfel,2 M Barbacid,3 M Malumbres3 and T Tueting1 1
Experimental dermatology, University Bonn, Bonn, Germany, 2 Hemato-oncology, University
Mainz, Mainz, Germany and 3 Experimental oncology, CNIO, Madrid, Spain
Until recently, the development of melanoma vaccines in mice was performed in experimental mod-
els involving transplantable melanoma cells. In patients however, melanoma arises autochthonously
in the skin and subsequently metastasizes to other organs. In order to more adequately model the
expected clinical situation, we set out to evaluate the efficacy of a candidate vaccine approach in
mice harboring an oncogenic mutation (R24C) in the germline sequence of the cyclin dependent
kinase 4 (cdk4), a protein critically involved in cell cycle regulation. These mice are genetically prone
to develop melanoma following carcinogen treatment of the skin. A genetic prime-boost strategy
stimulated melanoma antigen-specific cellular immune responses in cdk4-mutant mice, which were
associated with localized autoimmune destruction of melanocytes. However, we did not observe
significant destruction of carcinogen-induced melanocytic neoplasms in the skin with this immu-
nization strategy which was optimized for rejection of B16 melanoma cells. We conclude that exper-
imental melanoma vaccines need to be evaluated in novel melanoma models against autochthonously
developing melanomas in order to identify strategies, which eventually may be of clinical benefit
for melanoma patients. 
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Modulation of PKC-β expression by bone morphogenic protein-4
H Park, C Wu, C Howard, M Yaar and BA Gilchrest Dermatology, Boston University School of
Medicine, Boston, MA
Bone morphogenic protein-4 (BMP-4), a small secreted molecule belonging to the members of the
transforming growth factor -β family, when added to cultured human melanocytes (hMcytes), was
shown to decrease the level of melanin and the expression of tyrosinase, the key enzyme in melano-
genesis. To further delineate the mechanism by which BMP-4 regulates melanogenesis, we investi-
gated effects of BMP-4 on the expression of protein kinase C- β (PKC-β), the enzyme that activates
(phosphorylates) tyrosinase. Paired cultures of primary hMcytes were treated with either vehicle or
BMP-4 (25 ng/ml media) and cells were harvested after 24 and 48 hours. Immunoblot analysis
using a monoclonal antibody specific for PKC- β revealed that BMP-4 reduced the level of PKC-β
by 50-70% at both 24 and 48 hrs after the treatment. To determine the level at which BMP-4 regu-
lates the expression of PKC-β, paired cultures of melanocytes were treated with vehicle or BMP-4
for 72 hrs and northern blot analysis was performed using specific cDNA against PKC-bβ. BMP-4
treatment reduced the mRNA level of PKC-β was by 50-70%. To determine whether BMP-4 could
directly suppress the promoter activity of PKC-β, a PKC-β promoter-CAT reporter construct was
transfected into LH human melanoma cells. A Renilla-luciferase promoter construct was co-trans-
fected to assess relative transfection efficiency between the plates. 20-24 hours after the transfec-
tion, cells were treated with BMP-4 (25 ng/ml media) or vehicle alone and cells were harvested 48
hours after the treatment. CAT activity was normalized against luciferase activity. Compared to vehi-
cle, BMP-4 significantly suppressed PKC-β promoter activity (2.96±2.6 vs. 3.69±2.6, p<.01), sug-
gesting the BMP-4 may transcriptionally suppress PKC-β gene expression. These results further sup-
port the concept that PKC-β is regulated in parallel with the melanogenic genes and suggest that
BMP-4 may be an attractive therapeutic target for disorders of pigmentation. 
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Pep-1 as a novel probe for the detection of melanoma
JM Zmolik and ME Mummert Dermatology, UT Southwestern Medical Center, Dallas, TX
Many cutaneous melanomas express the glycosaminoglycan hyaluronan (HA) abundantly on their
cell surfaces suggesting its potential to serve as a tumor marker. However, in order for HA to be a
reliable marker, it is necessary to identify probes that provide contrast between melanoma cells and
HA in the surrounding extracellular matrix. As a first step in identifying probes for melanoma, we
compared the staining patterns of two currently available HA probes (HABP and Pep-1) using cryo-
stat sections of normal human foreskin and normal murine ear skin. HABP (Hyaluronan Binding
Protein) is a complex of the aggrecan domain and link protein while Pep-1 is a synthetic peptide
(GAHWQFNALTVR) isolated from a phage display library. We observed that: 1) HABP uniformly
stained both the epidermis and the dermis of human and mouse skin, and 2) Pep-1, but not a scram-
bled peptide control (WRHGFALTAVNQ), stained HA associated with keratinocytes in the epider-
mis but showed weak to no staining in the dermal matrix. Moreover, pretreatment with hyaluronidase
abrogated Pep-1 staining showing HA specificity. Pep-1 staining profiles were similar in human and
mouse skin. These findings may suggest that Pep-1 binds preferentially to cell associated HA. Fur-
thermore, Pep-1 has the ideal properties for the in situ detection of HA expressed by melanoma (i.e.,
strong cellular staining and weak extracellular staining). To test Pep-1 as a melanoma probe, we
assessed its binding to HA expressed on the surface of B16-F1 melanoma cells. Pep-1, but not a
scrambled peptide control, bound B16-F1 cells. Binding of Pep-1 to B16-F1 melanoma cells was
abrogated by pretreatment with hyaluronidase showing HA specificity. Next, we established cuta-
neous tumors in the ears of syngeneic mice by local inoculation of B16-F1 melanoma. Pep-1, but
not a scrambled peptide control, detected HA associated with melanoma cells in the dermis of cryo-
stat sections. Again, Pep-1 staining was abrogated by pretreatment with hyaluronidase showing HA
specificity. These results suggest that Pep-1 may represent a novel probe for in situ detection of
melanoma.
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Molecular control of hair pigmentation by BMP signaling: evidence for the cross-talk between
the BMP and melanocortin receptor type 1 signaling pathways
AA Sharov,1 TY Sharova,1 R Atoyan,1 L Weiner,2 MY Fessing,1 JL Brissette,2 BA Gilchrest1 and
VA Botchkarev1 1 Dermatology, Boston University, Boston, MA and 2 Cutaneous Biology Research
Center, Harvard University, Charlestown, MA
Hair pigmentation is controlled by tightly coordinated programs of melanin synthesis and transport
from the follicular melanocytes to hair shaft keratinocytes. This process requires the involvement of
signaling through the melanocortin type 1 receptor (MC-1R) that regulates the switch between pheo-
and eu-melanogenesis. However, the involvement of other signaling systems, including the BMP
pathway in the control of hair pigmentation remains to be elucidated. To assess the effects of BMP
signaling on hair pigmentation, transgenic mice overexpressing the BMP antagonist noggin (pro-
moter: keratin 5) were generated. Dorsal hairs of wild-type (WT) mice showed a yellow band near
the tips followed by the brown-black pigmented central/proximal portions. In contrast to WT mice,
K5-Noggin mice showed darkening of the dorsal hairs characterized by the absence of yellow band
and by the predominance of brown-black pigment in the hair shaft. To assess the putative involve-
ment of MC-1R signaling in these alterations of hair pigmentation, the expression levels of MC-1R,
agouti signaling protein (ASP) and attractin were compared in the dorsal skin of K5-Noggin versus
WT mice. By RT-PCR, MC-1R transcripts were upregulated in K5-Noggin skin, while attractin tran-
scripts were unchanged, compared to WT skin. By Western blot analysis, K5-Noggin skin had reduced
levels of ASP, compared to the WT skin. By in situ hybridization, decreased levels of ASP transcripts
were observed in the matrix and outer root sheath of hair follicles of K5-Noggin mice, compared to
WT hair follicles. This suggests the direct or indirect involvement of BMP signaling in controlling
the expression of MC-1R and ASP in anagen hair follicle. Taken together, these data provide evi-
dence for the cross-talk between BMP and MC-1R signaling pathways in controlling hair pigmen-
tation and in the switch between pheo- and eu-melanogenesis during hair growth. 
918
Expression of multiple isoforms of MITF in cultured human pigment cells
A Lebow, H Park, C Howard, U Kappes and BA Gilchrest Dermatology, Boston University School
of Medicine, Boston, MA
Microphthalmia-associated transcription factor (MITF), a basic-helix-loop-helix (bHLH) and bHLH-
leucine zipper transcription factor, has been implicated as the master gene for survival of melanocytes
and the key transcription factor for regulating the expression of tyrosinase, the rate limiting
melanogenic protein. MITF was originally identified in pigment cells (MITF-M), but subsequent
studies revealed that MITF is a family of multiple isoforms whose exact individual biological func-
tions are yet to be elucidated. MITF-A, -B, -E and -H isoforms were shown to be expressed in var-
ious cell types such as heart tissues, mast cells, Hela and Cos-7 cells, and the expression of MITF-
M was thought to be restricted to melanocytes. To determine if isoforms of MITF, other than the M
isoform, are expressed in human melanocytes, primers specific for each of MITF-M, -A, -B, -E and
-H were generated and RT-PCR was performed using RNA isolated from cultured human melanocytes.
RNA isolated from Hela and Cos-7 cells were used as positive controls for the expression of MITF-
A, -B, -E and -H isoforms. RT-PCR revealed that melanocytes readily expressed MITF-M, as expected,
and also expressed MITF-A, -B and -E isoforms. Interestingly, MITF-H isoform was not detected.
To examine whether melanoma cells express similar type of MITF isoforms, RT-PCR was performed
using RNA isolated from non-pigmented human melanoma cells (NP-MM4) with the specific primers
of each isoform. In NP-MM4 cells, MITF-M was readily detected and MITF-B, -E and -H isoform
were detected as well. However, MITF-A, which was readily detected in normal melanocytes, was
not detected. These results suggest that further understanding of function of each MITF isoform may
be important in deciphering the biology of melanocytes. In particular, MITF isoforms may subserve
critical functions that distinguish benign from malignant pigment cells. 
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T-oligos induce MITF and tyrosinase in cultured human melanocytes
C Wu, S Marks, H Park, C Howard and BA Gilchrest Dermatology, Boston University School of
Medicine, Boston, MA
Oligonucleotides homologous to the telomeric 3’ overhang (T-oligos), repeats of TTAGGG, have
been shown to induce a more differentiated phenotype in several cell types, including pigment cells.
To investigate the mechanism by which T-oligos induce differentiation in human melanocytes, effects
of T-oligos on the levels of tyrosinase, the key and the rate-limiting enzyme in melanogenesis, and
microphthalmia-associated transcription factor (MITF), a key transcription factor for the tyrosinase
gene, were examined. Paired cultures of subconfluent primary human melanocytes supplemented
once with either the T-oligo pGTTAGGGTTAG (40 µM) or control (complementary) oligonucleotide
pCAATCCCAATC (40 µM), then harvested at days 2,3,4 and 5 after treatment, and immunoblot
analysis was performed using specific monoclonal antibody against tyrosinase. The level of tyrosi-
nase protein in T-oligo treated samples remained unchanged at day 2, but were induced by 2-4 folds
at days 3, 4, and 5, compared to the control. To assess if T-oligos could also induce the level of
MITF, paired melanocyte cultures were treated once with T-oligos (40 µM) or control oligonucleotides
(40 µM) and harvested on days 3 and 5. T-oligo similarly induced the protein level of MITF by 2-3
folds at days 3 and 5, compared to control samples. These data expand earlier studies demonstrat-
ing that thymidine dinucleotides (pTT, identical to one-third of the telomere repeat sequence), induce
tanning (increased melanogenesis) by upregulating mRNA and protein levels of tyrosinase, acting
in part through p53 activation. In combination, the data support the concept that tanning is largely
a DNA damage response in which UV-induced DNA photoproducts lead to telomere loop disrup-
tion and consequent exposure of the 3’ overhang sequence, a signal mimicked by providing T-oli-
gos to cultured melanocytes. 
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The Foxn1 transcription factor converts epithelial cells into targets for pigmentation
L Weiner, R Han, BM Scicchitano, D Lee and JL Brissette Cutaneous Biology Research Center,
Massachusetts General Hospital/Harvard Medical School, Charlestown, MA
Foxn1 (Whn, Hfh11) is a transcription factor containing a winged-helix DNA-binding domain and
a negatively charged transactivation domain. In rodents, the loss of Foxn1 function causes the nude
phenotype, which is characterized by the lack of visible hair, structural abnormalities in the epider-
mis, defects in lactation, and the absence of a thymus. To assess the effects of a gain of Foxn1 func-
tion, we generated transgenic mice that express Foxn1 from the keratin 5 (Krt5) promoter. This pro-
moter targets Foxn1 to basal epithelial cells of the epidermis and hair follicles, cell types generally
lacking endogenous Foxn1. In three independent lines of mice, the Krt5-Foxn1 transgene caused
changes in skin pigmentation. In contrast to wild-type epidermis, transgenic epidermis contained
melanin, and the basal layer exhibited numerous melanocytes. At the same time, the transgenics
showed no abnormalities in coat color or density, suggesting that melanocytes entered the hair fol-
licles in normal numbers. Consistent with its effects on pigmentation, the transgene induced ker-
atinocytes to secrete at least one diffusible factor known to regulate melanocyte behavior. Thus, the
transgene broadened the actions of the pigmentary system and made it more human-like, as the epi-
dermis joined the hair as a target for melanization. In wild-type hair follicles, Foxn1 was most abun-
dant in the differentiating precursors of the cortex, which receive pigment from melanocytes. To a
lesser extent, Foxn1 was also detected in the differentiating medulla, the other melanized structure
of the hair. Consistent with this distribution of Foxn1, nude mice exhibited a deficiency of pigment
in the hair cortex. Thus, at specific sites in the skin, Foxn1 confers on epithelial cells the properties
necessary for a functional association with melanocytes. In all, the results suggest a mechanism by
which epithelial cells signal to melanocytes, identify themselves as pigment recipients, and attract
the dendrites, thereby inducing their own pigmentation. 
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Combined modality in vivo confocal laser scanning microscopy for imaging melanoma pro-
gression in murine skin
Y Li,1 S Gonzalez,1 R Toledo-Crow2 and AC Halpern1 1 Dermatology, Memorial Sloan-Kettering
Cancer Center, New York, NY and 2 Research Engineering Core Lab, Memorial Sloan-Kettering
Cancer Center, New York, NY
This study was aimed to develop and assess a non-invasive imaging system for in vivo evaluation of
the growth and progression of melanoma in murine skin. A system was designed and developed for
simultaneous fluorescence and reflectance mode in vivo confocal imaging of murine skin utilizing
a 488nm (fluorescence mode) and 820nm (reflectance mode) light source. B16 melanoma cell lines
were inoculated intradermally into transgenic C57BL/6-TgN (ACTbEGFP) 10sb mice (Jax Labo-
ratories). The inoculation sites were imaged sequentially over a two week period. Intravascular injec-
tion of fluorescein dextran was used to assess tumor associated changes in the microvasculature. The
in-vivo confocal images were correlated with ex-vivo conventional and fluorescence microscopy.
The combined modality system provided single cell resolution and adequate image registration. In
fluorescence mode the melanoma appears as a negative image within the background of GFP express-
ing murine cells. A population of fluorescent dendritic cells was observed in close apposition to the
tumoral cells. The dermal microvasculature was readily assessed. In conclusion, combined
reflectance/fluorescence in vivo confocal laser scanning microscopy holds significant promise for
studies of tumor progression in murine skin. 
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Reflectance spectrophotometry: a rapid, standardized and objective measure of phototype
LK Pershing,1 VP Tirumala,1 JL Nelson,1 LJ Meyer2,1 and SA Leachman1 1 Dermatology, Univ. of
Utah, Salt Lake City, UT and 2 GRECC, Veterans Admin. Medical Center, Salt Lake City, UT
The purpose of this study was to develop an objective measure of skin phototype by reflectance spec-
trophotometry and evaluate how well it correlates with subjective assessments. Male and female
healthy (85) and familial melanoma subjects (85), ages 18-72 yrs from varied racial and ethnic
backgrounds were evaluated for skin phototype by trained investigators according to Fitzpatrick skin
types (FST) I-VI criteria vs. the area-under-the-reflected light intensity over the 450-615 nm spec-
trum interval curve (AUIC) measured by a reflectance spectrophotometer. AUIC was calculated for
the upper inner arm (photo-protected) and the dorsal forearm (photo-exposed) in all subjects. Inner
arm had higher AUIC than dorsal arm and correlated well (r=0.9) as a function of clinician-assessed
FST and ethnicity. Dorsal arm AUIC values changed as a function of season over a 2 yr period, with
highest values in winter and lowest values in summer and thus, did not provide a consistent tempo-
ral site for skin phototyping. In contrast, the upper inner arm produced discriminating AUIC values
between known FST I-VI (highest AUIC values in FST I, lowest AUIC values in FST VI) with the
lowest within-subject (3% RSD), between-site, same region (5% RSD), and temporal variability (8%
RSD). Clinician-assessed FST vs. inner arm AUIC fit a quadratic equation (r2=0.81), in which cli-
nician and back-calculated instrument skin type agree +/- 1 FST. Self-assessment FST agreed <25%
with instrument-determined skin phototype in FST I-III, but agreed 50-100% in FST IV-VI. Skin
typing 279 healthy subjects using the instrument method alone fit a quadratic equation (r2=0.94) and
90% confidence interval that statistically differentiated between skin types I-VI. Thus, the reflectance
spectrophotometric measure of the upper inner arm provides a rapid, easily accessible, noninvasive,
reproducible and accurate method to objectively determine skin phototype. Whether this objective
method is predictive of skin cancer risk remains to be elucidated. 
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The role of Apaf-1 expression in human melanoma progression
DL Dai,1 M Martinka,2 EI Campos1 and G Li1 1 Medicine, the University of British Columbia,
Vancouver, BC, Canada and 2 Pathology, the University of British Columbia, Vancouver, BC,
Canada
Malignant melanoma is a life-threatening skin cancer due to its highly metastatic character and resist-
ance to radio- and chemo-therapy. It is believed that the ability to avoid apoptosis is the key mech-
anism for the rapid growth of cancer cells. However, the exact mechanism for failure in apoptosis
pathway in melanoma cells is unclear. P53, a tumor suppressor gene which is the most frequently
mutated gene, is a key apoptosis inducer. However, p53 mutation is only found in 15-20% of melanoma
biopsies.  Recently, it was found that Apaf-1, a downstream target of p53, is inactivated in metasta-
tic melanoma. Specifically, loss of heterozygosity (LOH) of the Apaf-1 gene was found in 40% of
metastatic melanoma. To determine if loss of Apaf-1 expression is indeed involved in melanoma pro-
gression, we employed the tissue microarray technology and examined Apaf-1 expression in 71
human primary malignant melanoma biopsies by immunohistochemistry. Our data showed that Apaf-
1 expression is significantly reduced in melanoma cells compared with normal epidermis (P<0.005).
Moreover, 17 of 71 (24%) melanoma biopsies showed loss of Apaf-1 expression and this Apaf-1 loss
is significantly associated with the locations of the tumors. Fifty percent of the tumors grown in
sun-exposed sites, whereas only 18% of the tumors in sun-protected sites, show loss of Apaf-1(P<0.05).
Our data also revealed that loss of Apaf-1 was not associated with the tumor thickness or subtype,
patients gender, age, or 5-year survival. Taken together, our data indicate that Apaf-1 expression is
significantly reduced in human melanoma and loss of Apaf-1 could be caused by sun exposure.
Loss of Apaf-1 expression may play a role in the initiation rather than progression in melanoma
development. 
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ING2 enhancement of apoptosis in melanoma cells after UV irradiation 
M Chin and G Li Medicine, University of British Columbia, Vancouver, BC, Canada
ING2, a recently cloned gene, is a homologue of the novel tumor suppressor gene, ING1b, which
has been shown to enhance UV-induced apoptosis synergistically with functional p53 in melanoma
cells. Recently, it has been shown that the ability of ING2 to induce apoptosis requires an intact
PHD finger. However, the molecular mechanisms by which ING2 mediates apoptosis are yet to be
determined. We hypothesized that ING2 enhances apoptosis after UV irradiation in a p53-depend-
ent manner in melanoma cells. We found that overexpression of ING2 enhanced UV-induced cell
death in MMRU cells compared to the control by flow cytometry and trypan blue exclusion assay.
Induction of cell death by UV was further confirmed by propidium iodide (PI) staining. Upon UV
irradiation, MMRU cells clearly showed apoptotic characteristics such as nuclear condensation.
The enhancement of UV-induced apoptosis was abolished when we co-transfected MMRU with
ING2 and mutant p53. Furthermore, this enhancement was not observed in the mutant p53 cell line
MEWO. These observations strongly suggested that ING2-mediated apoptosis after UV irradiation
is dependent of p53 in melanoma cells. We also found that ING2 altered the mitochondrial mem-
brane potential of the UV-irradiated cells. Moreover, overexpression of ING2 enhanced the expres-
sion of endogenous Bax. Upon UV irradiation, Bax translocated to mitochondria and cytochrome c
was released into cytosol. However, cells overexpressing ING2 were shown to have a minimal
effect in these processes. Similarly, cells overexpressing ING2 showed little increment of the cleav-
age of caspase 9 and 3 after UV irradiation. These observations suggested that ING2 enhanced UV-
induced cell death via mitochondrial apoptotic pathway, although alternative pathway may be involved. 
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XPA gene polymorphism is associated with risk of cutaneous melanoma
SR Lessin,1,2 E Ross,2 M Clapper2 and CS Spittle2 1 Medical Science, Fox Chase Cancer Center,
Philadelphia, PA and 2 Population Science, Fox Chase Cancer Center, Philadelphia, PA
Sun exposure is widely accepted as the major environmental risk factor associated with skin cancer,
including cutaneous melanoma. UV rays from sunlight cause DNA damage, including the forma-
tion of pyrimidine dimers, i.e., photoadducts. Lesions of this type are repaired through the nucleotide
excision repair (NER) pathway. Proteins encoded by the xeroderma pigmentosum (XP) gene fam-
ily are critically involved in NER. Polymorphic variants of the XP genes may influence an individ-
ual’s inherent DNA repair capacity (DRC) and thereby affect the level of UV-induced DNA damage
accumulated in melanocytes. In an ongoing study, we are examining the relationship between eight
single nucleotide polymophisms (SNPs) in five of the XP genes and risk of developing cutaneous
melanoma. Peripheral lymphocyte DNA has been obtained from ninety-six invasive cutaneous
melanoma cases recruited from the Fox Chase Cancer Center (FCCC) Melanoma Family Risk Assess-
ment Program. DNA from cancer-free controls, matched to cases for age, gender, and ethnicity, was
obtained from the FCCC Biosample Repository. SNPs are being typed utilizing pyrosequencing or
PCR-RFLP assays. A significantly increased risk for melanoma has been found to be associated with
the XPA 23 G allele (odds ratio=1.66; 95% confidence interval 1.1-2.5). This risk is enhanced in
females and individuals with green or blue eyes. No increased risk for cutaneous melanoma has been
found to be associated with SNPs in the XPC, XPD, XPF or XPG genes. These results suggest that
the XPA A23G polymorphism contributes to genetic susceptibility to melanoma and differences in
DRC may influence individual melanoma risk. 
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Contribution of melanocortin 1 receptor gene variants to cutaneous sporadic melanoma risk
in an Italian population
M Fargnoli,1 E Altobelli,2 G Keller,3 S Chimenti,4 H Hoefler3 and K Peris1 1 Department of
Dermatology, University of L’Aquila, L’Aquila, Italy, 2 Department of Internal Medicine and
Public Health, University of L’Aquila, L’Aquila, Italy, 3 Department of Pathology, Technical
University of Munich, Munich, Germany and 4 Department of Dermatology, University of Rome
“Tor Vergata”, Rome, Italy
Melanocortin 1 receptor (MC1R) gene variants have been recently shown to be low-penetrance
melanoma susceptibility alleles in fair-skinned Australian and Northern European populations. We
analyzed the contribution of the MC1R genotype to melanoma risk in an Italian population of 100
patients with cutaneous sporadic melanoma and 100 control subjects. The entire coding sequence
of the MC1R gene was investigated by DNA sequence analysis and logistic regression models were
used to evaluate the association between allelic variants of the MC1R gene and risk of cutaneous
sporadic melanoma. We detected a total of 30 MC1R variants, including six novel low-frequency
alleles (R34R, A111V, V119V, R213W, C315R, 123_124insT), with the V60L variant being the most
frequent allele in our population. When the different variants were analyzed separately, the R151C
and V60L variants, in heterozygous form, were significantly associated with cutaneous melanoma
with OR= 3.57 (95% CI 1.22-13.11) and 1.82 (95% CI 1.03-3.27), respectively. The D294H allele
was detected exclusively among individuals with melanoma, occurring in 6 melanoma cases and in
none of the control subjects. No relationship between the V92M, R142H and R160W variants and
melanoma could be demonstrated. No differences in the ORs were found after adjustment for skin
type, hair color and eye color. These results provide evidence for a predisposing role of the V60L,
R151C and D294H MC1R variant alleles to cutaneous sporadic melanoma risk in an Italian popu-
lation.
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PIGMENT: a community-based trial of a new triple-combination agent for the treatment of
facial melasma
HM Torok,1 P Grimes,2 P Kelly3 and I Willis4 1 Trillium Creek Dermatology, Medina, OH, 2
University of California, Los Angeles, CA, 3 Martin Luther King Hospital, Los Angeles, CA and 4
Northwest Medical Center, Atlanta, GA
An 8-week, multicenter, open-label, community-based study evaluated a newer therapeutic approach
to the treatment of recalcitrant melasma. The study drug was a combination of tretinoin 0.05%, hydro-
quinone 4.0%, and fluocinolone acetonide 0.01% in a hydrophilic cream formulation (Tri-Luma
cream). The trial enrolled 1290 patients of diverse races and ethnicities as well as the full range of
Fitzpatrick skin types (I through VI). The cream was applied to the affected areas of the face once
daily for 8 weeks. Evaluation of melasma was performed at baseline, week 4, and week 8, using the
Melasma Area and Severity Index (MASI) and Investigator Global Assessment of Improvement.
Patients also completed a quality of life (QOL) questionnaire at baseline and endpoint to determine
the impact of melasma and its treatment. The mean Melasma Area and Severity Index (MASI)
decreased significantly (P<.0001) at both weeks 4 and 8 compared to baseline in the overall study
population and across all Fitzpatrick skin types and races/ethnicities. The mean MASI darkness and
homogeneity scores likewise fell significantly (P<.0001) at weeks 4 and 8 in all facial regions of
interest and all Fitzpatrick skin types. By week 8, investigators global evaluations showed that 75%
of patients had Moderate or Marked Improvement or were Almost Clear or Clear. The QOL param-
eters generally improved: for example, 67% of patients indicated they were less embarrassed or
self-conscious and 58% were less likely to spend time hiding hyperpigmentation. The most com-
mon adverse events were skin irritation (6%) and erythema (4%). No serious adverse events were
reported and discontinuation due to an adverse event was rare (3%). Tri-Luma cream was found to
be safe and well tolerated. The study results demonstrate that this new triple formulation produces
rapid, significant improvement of melasma across the range of patients seen in daily practice. 
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Telomere-homologue oligonucleotides induce apoptosis in human melanoma cells; co-treat-
ment with all-trans retinoic acid or 1,25-dihydroxy-vitamin D3 potentiates this effect
IM Hadshiew,1 K Barre,1 A Thies2 and I Moll1 1 Dept. of Dermatology, University Hospital
Eppendorf, Hamburg, Germany and 2 Institute for Neuroanatomy, University Hospital Eppendorf,
Hamburg, Germany
Disruption of the telomere loop structure and exposure of the 3′telomere overhang TTAGGG tan-
dem repeat sequence induces a senescent phenotype as well as DNA-damage responses in human
cells. Single-stranded DNA-oligonucleotides, homologue to the 3′overhang of human telomeres (T-
oligos), have been shown to mimic these responses in the absence of telomere disruption in normal
human cells as well as Jurkat cells. Here, we investigate whether three highly metastatic human
melanoma cell lines (MV3, G361 and UISO-Mel6) undergo apoptosis after treatment with an 11-
base long T-oligo and compare this to treatment with all-trans retinoic acid (ATRA), 1,25 dihydroxy-
Vitamin D3 (VitD3) as well as combination of these compounds. Cells were incubated with either
20µM T-oligo, 10nM VitD3 or 1µM ATRA alone or with a combination of T-oligo/VitD3 or T-
oligo/ATRA with the same concentrations. After 48 hours, cells were collected and processed for
TUNEL-assay, FACS analysis and fluorescence microscopy. While treatment with the T-oligo led
to a 1.7-fold increase compared to diluent treated cells, VitD3 and ATRA resulted in a 1.3-fold increase
in apoptosis, respectively. The combined treatment with T-oligo/VitD3 led to an 11.9-fold increase
and for T-oligo/ATRA a 9.4-fold increase compared to diluent. Thus, combining these treatments
potentiates the pro-apoptotic effects. Nuclear receptors and mechanisms by which ATRA and VitD3
regulate cellular differentiation and apoptosis have been characterized, however, little is known for
T-oligos. So far, no specific receptor has been identified; yet, it has been shown that they localize to
the nucleus and share common downstream regulators such as p21 and the E2F transcription factor.
Further studies are needed to elucidate the spectrum of cellular interactions for T-oligos. Combin-
ing T-oligos with ATRA or VitD3 or with cytotoxic agents might enhance therapeutic options for
malignant melanoma. 
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Nuclear reduction of X-linked inhibitor of apoptosis protein-associated factor 1 in cutaneous
malignant melanoma
KP Ng,1 EI Campos,1 DL Dai,1 M Martinka2 and G Li1 1 Department of Medicine, University of
British Columbia, Vancouver, BC, Canada and 2 Department of Pathology, University of British
Columbia, Vancouver, BC, Canada
Dysregulation of apoptotic processes is likely one of the key factors contributing to the malignant
nature of melanoma marked by strong chemoresistance. X-linked inhibitor of apoptosis protein
(XIAP) suppresses apoptosis through the inhibition of activities of various caspases. Recently, XIAP-
associated factor 1 (XAF1) has been identified as a nuclear protein that antagonizes the anti-apop-
totic activity of XIAP by nuclear translocation of XIAP. In this study, we want to determine whether
XAF1 plays a role in melanoma progression. Immunohistochemistry were performed on tissue
microarray representing 73 primary melanomas to evaluate the expression of XAF1. We show that
greater than 70% of the tumor tissues have reduced expression of XAF1 in nucleus and cytoplasm
when compared to adjacent normal tissue. Specifically, 7 of 73 (10%) tumor tissues show loss of
XAF1 expression. The percentage of nucleus and cytoplasm stained positive for XAF1 is signifi-
cantly less in tumor tissue. In addition, thicker tumors are associated with a decrease in XAF-posi-
tive nucleus (P < 0.05, chi-square test). No correlation is found between XAF1 expression with age,
gender, histological subtype and location of tumors. Our results suggest that nuclear loss of XAF1
may contribute to melanoma progression. Further study is required to understand the molecular mech-
anisms governing the selective loss of XAF1 expression in the nucleus of tumor tissue. 
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A novel role for prohibitin in melanogenesis discovered using small-molecule probes
JR Snyder,1 A Hall,1 S Khersonsky,2 Y Chang2 and SJ Orlow1 1 Dermatology & Cell Biology, New
York University, New York, NY and 2 Chemistry, New York University, New York, NY
Pigmentation is a complex cellular process involving multiple regulatory elements. Many of the
genes involved in this biological pathway remain to be identified. An attractive gene-identification
approach known as “chemical genetics” involves the screening, based on observable phenotypic
properties, of small molecules in cells. This approach mimics the logic of classical genetic screens;
however, instead of creating a mutation in a known protein, small molecules bound to affinity matri-
ces are employed to isolate the target protein responsible for the cellular phenotype without prior
knowledge of what that target would be. Here we describe the use of a chemical genetic approach
to dissect the mammalian pigmentation pathway and identify novel protein participants. Using this
approach we have screened a library of 1,200 triazine-based small-molecules and discovered a new
class of potent pigment enhancing chemicals. From this class of promoters we have characterized
the small-molecule melanogenin. Melanogenin enhances pigmentation in cultured wild-type
melanocytes up to 4-fold at noncytotoxic concentrations (2.5-5µM). Using melanogenin bound to
an affinity matrix and microsequencing, we have identified its specific intracellular binding target
as the mitochondrial protein prohibitin. Subsequent studies employing siRNA have demonstrated
that prohibitin is required for melanogenin to exert its pro-pigmentary cellular effects and reveal an
unsuspected functional role for this protein in mammalian melanin induction. This represents a novel
mechanism by which pro-pigmentary signals are transduced. Melanogenin itself may also serve as
a new structural basis for designing future therapeutics to treat hypopigmentation. In conclusion, this
work provides strong proof-of-concept for the “chemical genetic” approach to the dissection of mam-
malian melanogenesis, the identification of a novel role for prohibitin in the regulation of pigmen-
tation and the discovery of a new class of research tools and potential therapeutic molecules. 
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PC cell-derived growth factor in melanocytic tumors: a potential role in melanoma and other
melanocytic neoplasms
SD Billings, CP Hans, L Cheng and JB Travers Indiana University School of Medicine,
Indianapolis, IN
PC cell derived growth factor (PCDGF), also known as progranulin, is the precursor of granulin, a
novel growth factor. PCDGF has been shown to stimulate cellular proliferation, confer epithelial
tumorigenesis, and promote tumor invasion. Previous work has focused on PCDGF in epithelial
tumors. To our knowledge, this is the first study on the expression of PCDGF in melanocytic tumors.
Melanocytic tumors including 13 common nevi, 12 Spitz nevi, 10 dysplastic nevi, 9 superficial spread-
ing melanomas, 5 desmoplastic melanomas, and 10 in-transit metastatic melanomas were examined
using a monoclonal anti-PCDGF. Immunoreactivity was scored based on the number of tumor cells
positive (0+ <5%, 1+ 5-25%, 2+ 26-50%, 3+ >50%). Strong PCDGF expression (2-3+) was seen in
the majority of dysplastic nevi, Spitz nevi, superficial spreading melanoma, desmoplastic melanoma,
and metastatic melanoma. The strongest expression was seen in Spitz nevi and the melanoma groups.
Common nevi were essentially negative with only 1/12 showing 1+ immunoreactivity. There were
some qualitative differences in the staining patterns. In some cases of Spitz and dysplastic nevi, the
immunoreactivity was concentrated in the junctional component; PCDGF expression was more uni-
form in the melanoma groups. PCDGF is strongly expressed in melanoma, dysplastic nevi and Spitz
nevi. Although it is only rarely expressed in common nevi, the expression of PCDGF may be a com-
mon growth factor involved in tumorigenesis of other melanocytic neoplasms. Interestingly, the
strongest expression was seen in Spitz nevi and melanoma. Expression of PCDGF may provide new
insights in the molecular events leading to the development of melanoma and other melanocytic
tumors. Theoretically, PCDGF could provide a molecular target for treatment of melanoma as more
is learned about the role of PCDGF in melanocytic neoplasia. 
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Inhibition of NF κ B, ERK, and p38 pathways affects the pigmentation processes in three-
dimensional epidermal models containing melanocytes, possibly through inhibition of melano-
genic factors produced from keratinocytes
M Komine,1 E Kato,1 K Kikuchi,1 H Okochi2 and K Tamaki1 1 Dermatology, University of Tokyo,
Tokyo, Tokyo, Japan and 2 Cell and Tissue Regeneration, Research Institute of International
Medical Center of Japan, Tokyo, Tokyo, Japan
Melanocytes of the in vivo epidermis are under the influences from surrounding epidermal
kerastinocytes. Keratinocytes produce various melano-genic factors including stem cell factor (SCF),
basic fibroblast growth factor (bFGF), endothelin-1 (ET-1), and prostaglandin E2 (PGE2). The pur-
pose of this study is to test the effect of inhibitors of signaling molecules on pigmentation and pro-
duction of these factors produced by keratinocytes. We treated three dimensional epidermal models
containing melanocytes, and cultured human keratinocyte cell line, HaCaT, with PD98059, PD153035,
parthenolide, Bay 11-7085, and SB202190, the inhibitors for ERK, EGF receptor, NF κ B, I κ B
kinase, and p38 MAP kinase, respectively. Melanocytes in the three dimensional epidermal models
were observed and photographed with digital camera from above, and the extent of pigmentation
was assessed with digital image analysis software. Concentrations of SCF, bFGF, ET-1, and PGE2
in the supernatant of HaCaT keratinocytes were measured with ELISA. All of these inhibitors sig-
nificantly suppressed pigmentation. Dopa reaction revealed that the numbers of melanocytes did
not change by the treatment with these inhibitors. MTT assay revealed that none of these inhibitors
affects cell viability in three dimensional epidermal models. Parthenolide, and Bay 11-7085 inhib-
ited the production of ET-1 from HaCaT keratinocytes induced by TNFα and IFNγ, but did not inhibit
bFGF, PGE2 or SCF production. SB202190 and PD98059 inhibited the production of PGE2 from
HaCaT keratinocytes while they did not inhibit ET-1, bFGF, or SCF production. PD153035 did not
inhibit either of the factors tested. These results indicate that inhibition of NF κ B, ERK, and p38
can suppress the melanization processes, which could be partially explained by the inhibition of
kerainocyte-derived melano-genic factors. 
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Cytogenetic characterization of mucosa-associated malignant melanomas
S Regauer,1 W Emberger,2 O Reich,3 B Liegl1 and R Pfragner4 1 Pathology, Medical University of
Graz, Graz, Austria, 2 Medical Biology and Human Genetics, Medical University of Graz, Graz,
Austria, 3 Gynecology and Obstetrics, Medical University of Graz, Graz, Austria and 4
Pathophysiology, Medical University of Graz, Graz, Austria
Mucosa-associated malignant melanomas (MM) are extremely rare tumors. While cutaneous malig-
nant melanomas are common UV-light induced neoplasms which metastasize to lymph nodes, mucosa
melanomas arise independently of UV-light exposure and are characterized by a highly aggressive
clinical course with early hematogenous metastases. Little information is available about these tumors
regarding their etiology and pathophysiology. For sinonasal MM, comparative genomic hybridiza-
tion studies showed complex cytogenetic aberrations involving chromosomes 1, 6 and 8. For vulvar
MM, detailed cytogenetic analyses are lacking. Design: Three cases of vulvar MM and two cases of
sinunasal MM were cultured and characterized cytogenetically. Molecular cytogenetic analysis using
multicolor in situ-hybridization (M-FISH) was performed for detailed characterisation. Results:
The results of combined analyses of G-banded metaphases and M-FISH staining showed complex
chromosomal aberrations involving chromosomes 1, 6, 8, 10, 12, 13, 17, and 21. When drawn into
an aberration map for efficient comparison of breakpoints gains and losses, a high grade of similar-
ity of breakpoints gains and losses was observed. The hotspots were identified on chromosomes 1,
6, 8, but also on chromosomes 10, 12, 13, 17, and 21. Particularily the aberrations on chromosome
1q, 6 and 8 are similar to those described for sinonasal MM. The pattern of chromosomal abnor-
malities in vulvar and sinonasal MM is distinct from the common variants of cutaneous melanoma
and is similar to the described gains and losses of chromosomes 1, 6 and 8 in sinonasal MM. Our
preliminary cytogenetic analyses suggest that the chromosomal changes in mucosal malignant
melanomas are similar, independent of the anatomic site in which they arise. 
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Lack of BRAF mutations in Spitz nevi
M Gill,2 DN Silvers1,2 and JT Celebi1 1 Dermatology, Columbia University, New York, NY and 2
Pathology, Columbia University, New York, NY
RAF proteins are serine/threonine kinases that mediate cellular responses to growth signals by acti-
vating the mitogen-activated protein kinase pathway. A high frequency of activating mutations in
the BRAF gene has been identified in melanoma (59-80%) and common melanocytic nevi (73-82%),
including junctional, compound, intradermal, congenital and dysplastic nevi. More than 90% of
mutations in melanoma and nevi involve codon V599 in exon 15 of BRAF. Spitz nevi are benign
melanocytic neoplasms that can histologically resemble melanoma. There is good documentation in
the literature of metastatic melanomas that had been originally misdiagnosed as Spitz nevi. In this
study, we have investigated the frequency of BRAF mutations in Spitz nevi and melanoma, using
laser capture microdissection, PCR amplification and direct sequencing. None of the 30 Spitz nevi
showed sequence alterations in exon 15 of the BRAF gene. In contrast, mutations affecting exon 15
were found in 13 of 23 (57%) melanomas. Although the mutational profile of BRAF in melanoma
with Spitz-like features needs to be established, these data suggest that in some cases mutations in
BRAF may be used to differentiate Spitz nevus from melanoma. 
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Potential role of stem cells in melanoma development
JM Grichnik, JA Burch and F Lin Medicine/Dermatology, Duke University Medical Center,
Durham, NC
Melanoma progression is thought to occur through a stepwise “dedifferentiation” process from an
epidermal melanocyte. Recent developments in stem-cell biology led us to re-evaluate these con-
cepts. We evaluated melanoma cultures to discern whether cells with stem-cell-like features were
present. A subpopulation of small-ovoid cells were identified and clonally purified from metastatic
melanoma. These clonally purified cells had the capacity to self-propagate and differentiate into a
secondary cell population with an increased proliferative rate, increased Tyrosinase-Related-Protein-
1 expression, and increased numbers and maturation of melanosomes. The behavior of these small-
ovoid melanoma cells is more consistent with that expected of a stem-cell based biologic process
than that expected of a “dedifferentiation” process. Antigenic markers preferentially identifying the
small-ovoid melanoma cells were found to identify a subpopulation of neoplastic melanocytic cells
in tissue sections, but not normal appearing epidermal melanocytes. These findings suggest that
events leading to melanoma (and nevus development) may first occur in a stem-cell compartment,
not through a process of “de-differentiation”, and challenge us to reconsider some of our tightly
held beliefs regarding the development of melanocytic neoplasias. 
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Immunophenotypic expression patterns of cutaneous in situ melanomas and conjunctival pri-
mary acquired melanosis with atypia
S Iwamoto,1,2 R Burrows,3 R Schmidt,3 H Grossniklaus,4 M Bothwell3 and Z Argenyi3 1 Roger
Williams Medical Center, Providence, RI, 2 Boston University, Boston, MA, 3 University of
Washington, Seattle, WA and 4 Emory University, Atlanta, GA
Our prior immunophenotypic comparisons of melanomas, which had revealed significant differences
between those of the skin and the eye, were extended to include in situ melanomas. The results were
intended for use in our intraoperative imaging system for the evaluation of surgical margins. We com-
pared cases of cutaneous melanoma in situ with their conjunctival counterparts, primary acquired
melanosis with atypia (PAM with atypia). The immunophenotypic expression patterns of tissue from
18 patients with cutaneous melanoma in situ (including lentigo maligna melanoma in situ and
superficial spreading melanomas) and two cases of PAM with atypia were quantitated. Controls con-
sisted of cases of benign melanocytic hyperplasia and primary acquired melanosis without atypia.
All cases were immunolabeled with a panel of antibodies that included S100, tyrosinase, melan-A,
HMB-45 and HMB-50 combination, microphthalmia transcription factor, p75 neurotrophin recep-
tor, and MIB-1. The results were statistically tabulated by intensity and pervasiveness of labeling.
S100, tyrosinase, melan-A, HMB-45 and HMB-50 combination, and microphthalmia transcription
factor immunolabeled all of the melanocytic lesions, with tyrosinase and melan-A yielding the
highest levels. P75 neurotrophin receptor was expressed at very low levels, if at all. Cutaneous
melanomas in situ were similar in immunophenotype to PAM with atypia. 
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Post-transcriptional control of melanocyte differentiation markers
R Merat, H Sutterluty, J Burch, R Streilein, S Stephens, R Hall, J Keene and J Grichnik DUMC,
Durham, NC
Post-transcriptional mechanisms are emerging as effectors of gene expression that allow mammalian
cells to implement adaptive modifications. These regulatory processes involve the interactions of
RNA-binding proteins with cis AU-rich elements (AREs) of untranslated regions (UTR) in mRNAs.
HuA (HuR), a member of the ELAV family of RNA-binding proteins, influences gene expression
following cell exposure to UV light and stress, and because of the presence of AREs in the 3′UTRs
of Tyrosinase, dopachrome tautomerase (TRP-2) and Tyrosinase related protein-1 (TRP-1) genes,
we examine if HuA modulates the expression of these genes. We first demonstrate the in vivo pres-
ence of these mRNAs in immunoprecipitated HuA mRNP complexes and then modulate the expres-
sion level of HuA using both siRNA mediated knockdown in the B16 melanoma cell line and ade-
novirus mediated overexpression in human normal melanocytes. We show that tyrosinase and TRP-2
protein level are decreased upon HuA knockdown and TRP-2 is significantly upregulated upon
HuA overexpression. Interestingly none of the effects are associated with variation in the mRNAs
steady-state level as assessed by quantitative real-time RT-PCR. We then use sucrose density gradi-
ents cell fractionation to show that upon HuA overexpression, TRP-2 mRNA is relative to Tyrosi-
nase and TRP-1 mRNAs, more efficiently recruited to heavy polysomes where the most actively
translated mRNAs are located. This indicates an increase in translational initiation of TRP-2 mRNA.
Finally we show the general effect of HuA as a differentiating factor, a consistent delay in pigment
accumulation into the medium of the B16 melanoma cell line is observed upon HuA knockdown
and HuA overexpression induces an increase in the number of large dendritic melanocytes. These
findings demonstrate that post-transcriptional regulation of gene expression and variation in trans-
lational efficiency as mediated by HuA, known to redistribute between the nucleus and cytoplasm
of cells submitted to stress or UV light, affect the expression of genes involved in melanin synthe-
sis and melanocyte differentiation. 
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A natural new active whitening molecule
C Daffix,1 A Lemesle,1 C Robert,1 C Rabhi,2 M Pouligon,2 D Jean2,1 and V Schwaab1 1 Biology,
LMD Pharmacognosie, Veyre-Monton, France and 2 Chemistry, LMD Pharmacognosie, Veyre-
Monton, France
Tyrosinase has long been commonly considered as the sole enzyme involved in melanogenesis and
has served as target to develop whitening agents. But, over the past decade, it has become well
accepted that melanins pathways involve many other enzymes such as Nitric Oxide Synthase (NOS)
and/or peroxidase-H2O2 as well as many integrative phenomena such as the cross-talk between
keratinocytes and melanocytes including the paracrine factor Nitric Oxide Radical. The aim of this
study was to search for natural active molecules with a complete depigmenting approach. LMD Phar-
macognosie investigations supported by ethnobotanical data showed that a product extracted from
a Brassicaceae plant was able to prevent vegetable browning. Phytochemical screening and chemi-
cal synthesis were performed to determine the active molecules. Their potential inhibition of the
melanins synthesis enzymatic pathways and their depigmenting effect on melanoma cell culture
and skin equivalent tissue model were studied. One molecule from the plant extract was highlighted
for its significant ability to inhibit pigmentation. The results show that this molecule is an inhibitor
of NOS, peroxidase and tyrosinase. Regarding its action on cell culture, the inhibitory effect can
reach 6% versus 4% for the ascorbic acid control and, on skin equivalent, 30% with no cytotoxic
effects compared with kojic acid and ascorbic acid that both show a significant cytotoxic effect.
Moreover, we showed that this molecule protects keratinocytes against UV-mutagenic effects. All
data argue that depigmenting effects are explained in part by inhibition of the major enzymes involved
in melanogenesis and especially, inhibition of the NO synthesis with respect to its central role in the
regulation of the melanogenesis. This new molecule represents a safe and efficient alternative to
reduce skin pigmentation. 
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Epigallocatechin-3-gallate (EGCG) causes cell cycle arrest and apoptosis in human melanoma
cells via modulation of the cyclin kinase inhibitor (cki)-cyclin dependent kinase (cdk) network
and Bcl2 family proteins
M NIhal,1 H Mukhtar1 and GS Wood1,2 1 Dermatology, UW-Madsion, Madison, WI and 2
Dermatolgy, Wm. S. Middleton VAMC, Madison, WI
The antioxidant polyphenolic constituent of green tea, EGCG, has been shown to prevent several
cancers including skin cancer. Earlier, we demonstrated that EGCG inhibits the growth and prolif-
eration of human melanoma cells via induction of apoptosis. However, the normal human melanocytes
were not affected at similar concentration of EGCG. Here, we demonstrate that EGCG, via modu-
lation of cki-cyclin-cdk machinery, results in cell cycle arrest followed by apoptotic death of human
melanoma cells. EGCG treatment (1-80 microgram/ml for 24-48 hours) of human melanoma cells
(A-375, Hs-294T and G-361) resulted in a dose-dependent i) inhibition of cell growth as shown by
MTT assay, ii) cell cycle arrest (G0-G1 phase arrest in A-375 cells and S-phase arrest in Hs-294T
cells) as shown by DNA cell cycle analysis, and iii) induction of apoptosis as assessed by flow
cytomety. Immunoblot analysis revealed that EGCG treatment caused a significant dose- dependent
i) decrease in PCNA and Ki-67 (markers of proliferation), ii) induction of p16, WAF1/p21 and
KIP1/p27, iii) decrease in cyclin D1 and cdk2 protein expression. EGCG treatment of melanoma
cells also resulted in a down-modulation of anti-apoptotic protein Bcl2 and an up-regulation of pro-
apoptotic proteins Bax and Bak. EGCG treatment resulted in significant activation of caspase-3,-7,
and -9. Taken together, our study suggests that EGCG treatment of melanoma cells results in cell
cycle blockade and induction of apoptosis via modulation of the cki-cyclin-cdk network and Bcl2
family proteins. To our knowledge, this is the first study showing the involvement of each compo-
nent of the cki-cyclin-cdk machinery and Bcl2 family of proteins during cell cycle arrest and apop-
tosis of human melanoma cells by a chemopreventive agent. We suggest that EGCG could be devel-
oped for the management of melanoma as an alternative approach or in conjunction with current
therapies.
940
Clinical and in vitro investigation of the effects of ferulic acid on human skin pigmentation
M Chan,1 S Rocha,1 M Lehman,1 S White,1 I Santana,1 J Nip,1 C Iwasaki,2 T Usui,2 MJ Barratt,1
SB Potterf1 and LJ Shore1 1 Unilever Research and Development, Edgewater, NJ and 2 Nippon
Lever, Utsunomiya, Japan
Our clinical studies have implicated ferulic acid (FA), an antioxidant and free radical scavenger, as
a potential modulator of skin pigmentation. Using the murine B16 melanoma cell line, we investi-
gated the effects of FA on tyrosinase and other proteins involved in melanogenesis. Western blot
analyses demonstrated biphasic responses in tyrosinase protein levels to FA treatment. Lower doses
reduced tyrosinase protein levels to 80% of untreated controls, resulting in reduced pigmentation,
whereas at higher doses the protein levels were observed to be 20% greater than untreated controls.
Real Time PCR analysis confirmed this modulatory effect of FA on endogenous tyrosinase gene
expression. In addition, FA had no effect on the glycosylation pattern of tyrosinase. The data sug-
gested that FA may modulate pigmentation through an indirect action on tyrosinase expression.
Indeed, microphthalmia-associated transcription factor, a major regulator of tyrosinase, was reduced
50% upon FA treatment. Utilizing an acute UVR pigmentation clinical model, biopsies from human
subjects revealed that FA functions through down-regulation of factors related to melanin produc-
tion, including tyrosinase and inducible nitric oxide synthase, suggesting NO as a critical compo-
nent for the induction of in vivo pigmentation.
938
What is the maximum tolerated dose of NB-UVB for patients with vitiligo?
I Hamzavi, S Deleon, K Yeung-Yue and G Murakawa Dermatology, Wayne State University,
Detroit, MI
There is limited data on the maximum amount of ultraviolet light that narrow-band UVB (NB-
UVB) treated vitiligo patients can tolerate. In addition, the effect of repigmentation on tolerance to
NB-UVB light has yet to be defined. The objective of this study was to determine whether or not
there is a difference in the maximum dose of NB-UVB irradiation between patients with vitiligo who
respond and those who do not respond to treatment. This is a single-center retrospective study on
patients with vitiligo who were treated at least 20 times with NB-UVB between April 2001 to July
2003. Patients were treated 2-3 times per week, on non-consecutive days. Patients initial dose of light
was anywhere from 35 mJ/cm2 to 750 mJ/cm2 with 10% dose increments until patients developed
phototoxicity such as erythema or pruritus. Twenty-three patients were able to be evaluated for this
study. Their ages ranged from 6 to 91 years (mean=38 years; SD=25). Duration of disease ranged
from 3 months to 27 years (mean=7 years; SD=7.2). Of the 23 patients, 15 responded with repig-
mentation and 8 did NOT respond with repigmentation and/or acquired new depigmented lesions.
Maximum tolerated dose for the “responders” was 7479 mJ/cm2 (mean=2142 mJ/cm2; SD=2166.1).
Maximum dose for the “non-responders” was 6011 mJ/cm2 (mean=2240 mJ/cm2; SD= 2191.9). The
difference in the maximum tolerated light dose between the two groups was not significant. (p=0.9,
Mann-Whitney test) Vitiligo patients are able to tolerate significantly higher doses of irradiation with
NB-UVB light than the literature suggests. Repigmentation does not appear to influence the maxi-
mum amount of NB-UVB irradiation tolerated. 
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Invasive human melanocytic neoplasia generated using defined genetic elements
Y Chudnovsky,2 AE Adams,2 Q Lin,2 PB Robbins2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA
and 2 Stanford, Stanford, CA
Genetic evidence links constitutive activation of the Ras cascade (Ras-Raf-MEK-ERK) and hypo-
function of the Rb (p16INK4a/CDK4/Rb) and p53 (p14ARF/HDM2/p53) pathways to human
melanoma pathogenesis. The Ras cascade may be activated via mutation of RAS or, most frequently,
RAF isoform genes. The Rb and p53 tumor suppressor pathways are often inactivated via mutations
or deletions at the CDKN2A locus, which encodes both p16INK4a and p14ARF. Other genetic alter-
ations, such as telomerase activation and PTEN inactivation, have also been implicated in melanoma
progression. To investigate directly the contributions of specific genes to human melanoma devel-
opment, we engineered primary human melanocytes to express one or more genes of interest, specif-
ically, different combinations of oncogenic Ras, CDK4R24C (a constitutively active mutant found
in a subset of melanoma-prone families), dominant-negative p53R248W, and hTERT (the catalytic
subunit of human telomerase), and combined them with normal human keratinocytes to regenerate
human skin on immune-deficient mice. In the context of hTERT, co-expression of CDK4R24C and
p53R248W produced normal skin, while Ras expression alone induced junctional melanocytic hyper-
plasia resembling a dysplastic nevus. Most interestingly, expression of oncogenic Ras together with
inactivation of either Rb or p53 pathways led to invasive melanocytic neoplasia displaying the car-
dinal features of malignant melanoma, including cytologic atypia, pagetoid scatter, deep dermal inva-
sion and ulceration. Ras-driven melanocytic tumors were polyclonal and expressed a number of
melanocyte and melanoma markers, including Melan-A, S100 and HMB-45, as well as the genes
originally introduced into the melanocytes. Further experiments showed that hTERT expression
was dispensable for early-stage melanocytic hyperplasia but greatly accelerated progression to
invasive melanocytic neoplasia. Current studies address the sufficiency of Ras effectors to induce
melanocytic neoplasia and the identification of potential therapeutic targets using this human can-
cer model. 
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Center-based approach for computerized analysis of non-uniform growth patterns in
melanocytic lesions
P Venkatesan,1 A Gupte,2 C Tomasi2 and JM Grichnik1 1 Medicine/Dermatology, Duke University
Medical Center, Durham, NC and 2 Computer Science, Duke University Medical Center, Durham,
NC
The diagnosis of early melanoma is a challenging problem for dermatologists and pathologists alike.
Large numbers of benign lesions are biopsied every year in the pursuit of malignant melanoma,
contributing to health care costs and patient morbidity. Numerous efforts are underway to use com-
puter-based algorithms to increase the accuracy of melanoma detection. These approaches vary from
neural networks to genetic algorithms, and emphasize feature detection similar to that utilized by
the ABCD and 7 point checklist methods. We hypothesize that all melanocytic lesions originate from
a single mutated cell and therefore have a biologically determined center. Furthermore, we believe
that malignant melanocytic lesions acquire subsequent mutations which result in greater pigment
asymmetry and nonuniform distribution than that seen in benign lesions. Thus the definition of cen-
ter may be useful to assess a lesion’s uniformity as one moves radially out from the defined center.
There are many ways to calculate center, including geometrical mean, median of the coordinates of
the lesion, etc. We found that two methods of defining center - the centroid of the lesion (calculated
as an average or median) and the center of the lesion’s convex hull - most closely matched the cen-
ters identified clinically. Furthermore, the centroid and convex hull centers had optimal symmetry
of the lesion border, computed as a radial symmetry measurement. We also compared a pigmented-
weighted center with the centers described. Our sigmoidal pigment-weighting algorithm is a two-
step approach that emphasizes the darkest and lightest regions of an image. When this weighting was
applied to nonuniform lesions, the pigment-weighted center had greater deviation from the cen-
troid/convex hull center. Thus an algorithm that incorporates definition of center with deviation of
a pigment-weighted center distinguishes uniform from nonuniform melanocytic lesions, and thus
has potential diagnostic value in melanoma detection. 
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Overcoming resistance of melanoma cells to TRAIL-induced apoptosis by modulating inter-
feron signaling pathways
J Qin, P Bacon, B Bodner, L Stennett and BJ Nickoloff Oncology Institute, Loyola, Maywood, IL
Malignant melanoma (MM) cells are notoriously resistant to apoptosis. As TRAIL and interferon
(IFN) represent therapeutic agents in oncology, we sought to identify molecular cross-talk between
TRAIL and IFN pathways to facilitate more effective treatment protocols for MM. Compared to
cultured normal human melanocytes (n=6), which constitutively express low or absent levels of IFN
inducible protein-16 (IFI-16), numerous MM lines (n=6) express high nuclear levels by immunos-
taining and Western blotting. Elevated constitutive IFI-16 levels were not further augmented in MM
cells by exogenous IFN-α (103 U/ml) or IFN-γ (103 U/ml) treatment (24 hrs). Treating MM cells
with siRNA targeting IFI-16 revealed significant (>70%) reduction in IFI-16 levels compared to
scrambled control (SC) siRNA. While exposure of SC treated MM cells to TRAIL (100 ng/ml; 24
hrs) produced less than 20% apoptosis (PI staining with sub-G0 DNA content; FACS analysis), MM
cells with reduced IFI-16 levels contained 2-3 fold greater apoptotic responses in 2 different MM
cell lines (p<0.05). Apoptotic machinery activated included cleavage of caspases 8, 3, and 9. Enhanced
apoptotic susceptibility in IFI-16 siRNA treated MM cells was not related to alterations in TRAIL
death or decoy receptor expression, or changes in levels of survival proteins such as c-FLIP, Bcl-2,
or XIAP.  By contrast, when IFN-α (103 U/ml) or IFN-γ (103 U/ml) was simultaneously combined
with TRAIL, synergistic induction of apoptosis was observed (greater than 50%) in MM cells. We
conclude that at least two distinct IFN signaling pathways are operative in MM cells. The IFI-16
related pathway mediates survival signaling providing resistance to TRAIL-induced apoptosis;
whereas the second pathway is dependent on IFN-α/IFN-γ and produces enhanced apoptotic responses
to TRAIL.  Taken together, these results reflect molecular cross-talk between IFN signaling path-
ways and TRAIL. Further studies targeting IFI-16 are indicated to devise new and more effective
combination therapeutic strategies to combat this deadly neoplasm. 
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Human melanoma development in reconstructed skin models
J Kubilus, P Neal, Y Kaluzhny, G Sur and M Klausner R & D, MatTek Corporation, Ashland, MA
Human skin reconstructs are three dimensional in vitro models consisting of a co-culture of epider-
mal keratinocytes and melanocytes plated onto a dermal substrate. In contrast to cells in monolayer
culture, tissue-engineered skin equivalents contain well-developed epidermal layers with normal
melanocytes being distributed at the basement membrane that separates the epidermis from the der-
mis. The incidence of cutaneous melanoma (CM) has increased dramatically in the last few decades.
Development of specific CM stage models (e.g. radial or vertical growth phases) with their specific
microenvironments and cell-matrix and cell-cell communication are crucial for understanding changes
leading to the metastatic CM phenotype and for the development of CM therapies. A serum-free (SF)
culture system, in which the precise effects of growth factors and chemo-therapeutic compounds can
be tested without interference from the multitude of undetermined components in serum, is pre-
sented. Single cell suspensions of normal human epidermal keratinocytes and melanoma cells from
different stages of melanoma progression are seeded on acellular or fibroblast-contracted collagen
gels and induced to differentiate in SF medium. Incorporation of the metastatic melanoma cell lines,
A375 and SK-MEL-28, into the epidermal/acellular dermal cultures results in progressively grow-
ing clusters of melanoma cells in the basal/spinous layers. Similarly, when A375 cells are added to
MatTek’s full thickness skin model (FTSM), nodes of melanoma cells develop in the epidermis by
day 10. These clusters begin to invade the dermis by day 14. Incorporation of SK-MEL-28 into FTSM
shows progressive disruption of the basement membrane. Finally, the Wistar metastatic cells (WM852)
yielded a tumor invading the dermis on day 16. The development of three dimensional, serum-free
tissue culture models, containing melanocytes at different stages of CM malignancy, will provide
researchers with valuable tools to study, understand, and develop preventative and therapeutic treat-
ments for this most serious cutaneous malignancy. 
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Ribozyme-mediated inhibition of telomerase activity suppresses in vitro & in vivo growth and
metastatic potential of murine melanoma cells
S Bagheri,1 S Li,1 M Nosrati,1 S Fong,2 RR LaPosa,1 JE Cleaver,1 RJ Debs,2 EH Blackburn1 and
M Kashani-Sabet1 1 UCSF, San Francisco, CA and 2 California Pacific Medical Center, San
Francisco, CA
While normal human somatic cells have diminished telomerase activity, telomerase activity is com-
monly high in human cancer cells. Abnormal expression of this ribonucleoprotein complex confers
an unlimited potential for growth and division to transformed cells, and has therefore been recog-
nized to be an important molecular target in cancer therapy. Recent studies in our laboratory showed
that systemic administration of cationic liposome:DNA complexes encoding anti-telomerase RNA
(TER) ribozymes reduced the metastatic progression of B16-F10 murine melanoma in vivo. In this
study, we developed stable transformant B16-F10 melanoma clones expressing ribozymes targeting
TER at position 180 (TER 180 Rz) under the regulation of a U6 promoter. Analysis of TER expres-
sion levels by TaqMan revealed TER levels to be down-regulated by > 70% in the TER 180 Rz-
expressing clones, as compared to vector-only controls. Analysis of telomerase functional activity
by TRAP revealed 60-90% lower telomerase activity in TER 180 Rz clones, as compared to vector-
only controls. In vivo experiments involving injection of B16-F10 clones by tail vein revealed 85%
reduction in number of metastatic melanoma lung tumors in the TER 180 Rz group as compared to
vector-only controls. To elucidate the mechanism by which down-regulated telomerase activity results
in reduced metastatic potential, several functional assays were performed. FACS-based TUNEL
assays revealed increased apoptosis in the TER 180 Rz group as compared to vector-only controls.
In vitro observations of the lower growth rate of TER 180 Rz transformants were confirmed by FACS-
based BrdU incorporation assays that revealed up to 50% reduction in the percentage of TER 180
Rz cells in S phase as compared to vector-only controls. These results assign a pro-metastatic func-
tion to telomerase, and demonstrate the therapeutic utility of anti-TER ribozymes given their anti-
metastatic activity. 
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Activating mutations of BRAF in melanoma and benign nevi
A Sekulic,1 M Mai,2 KC Halling2 and MR Pittelkow1 1 Dermatology, E5, Mayo Clinic, Rochester,
MN and 2 Pathology, Mayo Clinic, Rochester, MN
We examined the frequency of V599E BRAF mutations in paraffin-embedded samples of melanoma
and melanocytic nevi. Previous studies have reported widely varying frequencies of V599E muta-
tion in melanomas and nevi; hence, the significance of this mutation in melanoma development is
unclear. Our study included 73 melanoma samples. In addition, we analyzed 52 dermal nevi, 9 com-
pound nevi and 15 junctional nevi, which are considered precursor lesions for melanoma. To assess
the specificity of our assay for the presence V599E mutations, we included 18 normal blood sam-
ples and 20 normal, paraffin embedded colon tissue samples. Paraffin blocks were sectioned, areas
containing lesions of interest were isolated and DNA extracted. Mutation detection was performed
by allele-specific polymerase chain reaction (AS-PCR) using oligonucleotides with 3’ ends com-
plementary to mutant BRAF sequence. The analytical sensitivity of this assay for the detection of
cells with a BRAF mutation was 1 in 10,000. As a control, PCR of a larger segment of exon 15 of
BRAF or PCR of a GAPDH gene segment was performed. All AS-PCR results were confirmed by
sequencing. Our study revealed V599E BRAF mutations in 13/72 (18%) malignant melanomas,
48/52 (92%) dermal nevi and 9/9 (100%) compound nevi but none of 15 junctional nevi. All con-
trol samples (18 blood samples and 20 colon) were negative for the mutation. Our results suggest
that V599E activating mutations might play a role in the genesis of benign melanocytic nevi with a
significant dermal component but not in those without a significant dermal component (i.e. junc-
tional nevi). In addition, a lower frequency of V599E BRAF mutations in melanomas in our study
suggests that this genetic alteration might not play as predominant a role in development of sporadic
malignant melanoma as initially speculated. 
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Puma expression is significantly reduced in human cutaneous melanomas
AM Karst,1 DL Dai,1 M Martinka2 and G Li1 1 Medicine, University of British Columbia,
Vancouver, BC, Canada and 2 Pathology, Vancouver Hospital and Health Sciences Centre,
Vancouver, BC, Canada
Cutaneous malignant melanoma is an aggressive form of skin cancer, characterized by strong chemore-
sistance and poor patient prognosis. The molecular mechanisms underlying its resistance to chemother-
apy remain unclear but are speculated to involve the dysregulation of apoptotic pathways. In this
study, we aim to determine whether expression of PUMA (p53 upregulated modulator of apoptosis)
plays a role in human melanoma formation, tumor progression, and survival. We used tissue microar-
ray technology to examine PUMA expression in 60 human melanoma biopsies. We show that the
majority (>80%) of melanoma tumor tissues exhibit reduced PUMA expression compared to adja-
cent normal tissue. However, reduced PUMA expression is not correlated with tumor thickness, sug-
gesting PUMA reduction is an early event in melanomagenesis. Our results also demonstrate that
PUMA loss is more prevalent in the tumors of older patients (age of diagnosis >60 years) (P=0.036),
despite a lack of correlation between age and PUMA expression in normal tissue. In addition, we
found that patients with negative or reduced PUMA expression in their tumor tissue tend to have a
poorer prognosis (P=0.1). Finally, we show that age of diagnosis is a strong determinant of both over-
all (P<0.01) and disease-specific (P<0.05) 5-year survival, and that this is not the result of delayed
diagnosis or differences in stage of tumor progression. Therefore, in patients diagnosed after age 60,
both PUMA expression and survival are significantly compromised. 
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Improved detection of the V599E Braf mutation in clinical specimens by allele specific PCR
M Iqbal, R Darvish and M Kolodney Harbor UCLA Medical Center, Torrence, CA
Recent studies have found a high frequency of acquired B-raf gene mutations in melanoma. B-raf
encodes a serine/threonine kinase in the MAPK pathway, which is important in melanocytic prolif-
eration. A V599E missense mutation accounts for 92% of the Braf mutations detected in melanoma,
and the mutated gene product has a 10 fold greater basal kinase activity relative to wild type B-raf.
The significance of this mutation in predicting clinical outcomes and therapeutic response is cur-
rently a subject of interest. To determine B-raf mutation status in thin primary melanomas an assay
must be able to detect mutated melanoma cells in the presence of excess epidermal keratinocytes
containing wild type B-raf. We developed a specific and sensitive assay to detect V599E B-raf
mutations in the presence of excess wild type B-raf by allele specific competitive PCR. To deter-
mine the sensitivity of this assay, we extracted genomic DNA from cell cultures homozygous for
mutant B-raf and from wild type cells. The genomic DNA containing mutant B-raf was serially
diluted with the wild type DNA. These samples were then analyzed by allele specific, competitive
PCR. One primer set amplified a housekeeping gene. A second competing primer set amplifed mutant
BRAF but was unable to amplify the wild type gene because of a substitution of two bases at the 5
prime end. This protocol for the allele specific PCR was found to have the capacity to pick up
V599E mutant cells at a frequency of 0.01% of total cells. We are currently using this assay to
screen large numbers of clinical specimens in order to determine the predictive value of the V599E
mutation.
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MEK inhibition kills melanoma cells with constitutively elevated ERK activity
H Suzuki, M Iqbal and MS Kolodney Harbor-UCLA REI, Torrance, CA
A large fraction of metastatic melanomas carry oncogenic mutations in the ras-raf-MEK-ERK kinase
cascade with most of these mutations in B-raf. The MEK kinase is an attractive therapeutic target
for melanoma because this molecule lies immediately downstream of B-raf. Moreover, we have
shown that CI 1040, a well-tolerated, orally available MEK inhibitor, causes rapid regression of
human melanoma lung metastases in a mouse xenograft model [Collisson, 2003]. However, the mech-
anism of cell death due to CI 1040 remains unknown. We tested the efficacy of CI 1040 in several
melanoma cell lines. We found that cell lines carrying the most common B-raf mutation (V599E)
showed constitutive ERK activation in the absence of serum stimulation. We also demonstrated that
ERK phosphorylation of these cell lines was equally down-regulated by CI 1040 regardless of
serum presence. One cell line was homozygous for the V599E B-raf mutation and underwent CI
1040 mediated cell death within 24 hours. Cell lines heterozygous for the V599E B-raf mutation
underwent CI 1040 mediated cell death within four days. Of the cell lines tested, those without B-
raf mutations did not show constitutive ERK activation and did not undergo cell death in response
to CI 1040. All the CI 1040 sensitive cell lines underwent cell death more rapidly under low serum
conditions. These results suggest that B-raf mutation status may indicate melanoma sensitivity to
therapeutic MEK inhibitors. 
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Identification of cells of presumed melanocyte lineage in the dermis of melanoma in situ using
multiple melanocytic markers: a retrospective study
P Chern, LA Cornelius and M Hurt Dermatology, Washington University School of Medicine, Saint
Louis, MO
In order to determine the frequency of inconspicuous dermal cells of melanocytic lineage found in
tumors previously diagnosed as melanoma in situ (MIS), we re-examined 30 cases of MIS using
immunohistochemical staining on sequential sections with four melanocyte markers: S100, HMB45,
anti-Melan-A and Microphthalmia transcription factor (Mitf). Lichenoid keratoses, large cell acan-
thomas and normal skin served as negative controls. 7% (n = 2) of MIS examined showed dermal
cells positive for HMB45, 27% (n = 8) for MelanA and 30% (n = 9) for Mitf. S100 stained numer-
ous non-melanocytic dermal cells; findings deemed non-specific. In certain cases, nests of positive
cells in the dermis adjacent to areas of adnexal structures were found to be contiguous with adnexa
on serial sectioning. Only one MIS had a positive dermal tumor cell nest (Melan-A, HMB-45 and
Mitf) thought to be significant for melanoma in the dermis. Interestingly, this tumor had a robust der-
mal inflammatory infiltrate. Four cases (13%) had cells in the dermis positive for two markers (Melan-
A/Mitf [n=3] or Melan-A/HMB45 [n=1]). Control cases of lichenoid keratosis also revealed Melan-
A and Mitf positive cells within the dermis, similar in appearance to those in cases of MIS, while
large cell acanthoma and normal skin did not. We conclude that since solitary cells staining posi-
tively for Melan-A and Mitf are seen within the dermis of benign lesions (lichenoid keratosis), sim-
ilarly staining cells in MIS are not necessarily indicative of dermal melanoma. Our data support using
caution in interpreting lesions as melanoma with a dermal component when additional staining is
performed, particularly when evaluated by a single melanocytic marker. We suggest that, when per-
formed, multiple markers should be used; and that dermal cells staining positively for  2 markers
(i.e.,Melan-A/Mitf) may have greater specificity and greater prognostic significance when evalu-
ated in conjunction with cell morphology. 
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Frequent alteration of the p16INK4A tumor suppressor gene by deletion, promotoer methy-
lation, and point mutation in human melanoma metastases
D Polsky,1 D Freedberg,1 J Russak,1 M Kaplow,1 K Busam2 and I Osman1 1 Dermatology, New York
University School of Medicine, New York, NY and 2 Memorial Sloan-Kettering Cancer Center, New
York, NY
Studies of the p16INK4A tumor suppressor gene in human melanoma have shown significantly
higher rates of inactivation in cell lines than in tissue specimens. One explanation is that deletion,
the predominant mechanism of inactivation in cell lines, is difficult to detect in tissue specimens
using PCR-based techniques. This study compares the rates of p16INK4A inactivation by mutation,
methylation and gene deletion in a cohort of metastatic melanoma tissue specimens. We used a
combination of sequencing, methylation-specific PCR, microsatellite analysis, and a novel fluores-
cence-based semi-quantitative comparative multiplex PCR to determine the frequency and patterns
of gene inactivation in a cohort of 60 metastatic melanoma specimens from 58 patients with Stage
III and IV disease. The INK4A locus was altered by deletion in 15/58 (26%) unique tumors, pro-
moter methylation in 14/58 (24%), and mutation in 6/58 (10%). Deletions involving exon 2 were
sustained in 13/15 deleted cases, including 8/15 cases in which both exons 1 & 2 were deleted. Two
mutations were observed in exon 1, including a 4-base pair microdeletion (43/46del4) previously
described in pancreatic and esophageal carcinomas (1 case each). Four mutations were detected in
exon 2, including a novel substitution Pro81His, which would also produce an Arg96Ser change in
p14ARF (which shares exon 2 with p16INK4A). Two cases demonstrated INK4A alteration by two
mechanisms, namely deletion and methylation or mutation. Interestingly, INK4A alterations were
more frequent among patients with visceral metastases (15/22, 68%) in comparison to patients with
lymph node and subcutaneous metastases (17/38, 45%). In conclusion, multiple genetic and epige-
netic mechanisms altered the p16INK4A tumor suppressor locus in 33/58 (57%) melanoma metas-
tases. This frequency is substantially higher than previous reports analyzing alteration of this gene
in human melanoma metastatic tissues. 
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Human keratinocytes secrete a potent pro-motility factor for human melanomas: implica-
tions in melanoma development
M Fedesco, J Fan, Y De Clerk, DT Woodley and W Li Dermatology, University of Southern
California, Los Angeles, CA
Development of solid tumors is a combination of gene mutations and altered interactions with the
adjacent normal cells in their immediate microenvironment. Melanocytes and the early-stage
melanomas are surrounded by keratinocytes and a fibroblast-rich stroma. Little is known about the
role of melanoma interactions with its surrounding cells during the process of melanoma develop-
ment. While human melanoma cells, M21 and M24, have constitutively activated Ras and ERK1/2,
under serum-free conditions, these cells are unable to migrate on ECM-coated substratum. There-
fore, the genetic mutations alone in melanomas may be necessary but are clearly not sufficient for
initiating cell migration. We then focused on the possible contributions of secreted factors from sur-
rounding keratinocytes or fibroblasts. We found that serum-free conditioned medium (CM) from
HKs induced dramatic migration of the melanoma cells on various ECMs. The CM pro-motility
activity was 2-4 fold greater than published pro-motility factors for melanoma cells such as serum,
EGF, VEGF, HGF and serum-enriched CM from NIH3T3 cells. In contrast, similarly prepared CM
from cultures of HDFs, melanocytes, M21 or M24 cells showed minimal pro-motility activity. To
study whether the secretion by HKs would be increased by the co-presence of melanoma cells, we
found that serum-free CM from M21/HK or M24/HK co-culture did not show significantly higher
pro-motility activity than the origicnal HK CM. Interestingly, GFP-labeled melanoma cells, co-cul-
tured on a HK monolayer, show marked cellular proliferation compared with co-culture experiments
using non-HK cell monolayers. Human Cytokine Array analyses (to detect 75 known growth fac-
tors/cytokines, RayBiotech, Inc) suggested that the HK-secreted factor(s) is not among the growth
factors/cytokines tested. Thus, molecular identification of this potentially novel motility and inva-
sion-promoting factor(s) from HKs may gain new insights into the ontogenesis of human melanomas. 
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Molecular imaging of murine melanoma using αv β3-directed contrast
GC Bowers,1 L Yin,1 A Scmeider,2 S Wickline,2 G Lanza2 and LA Cornelius1 1 Dermatology,
Washington University School of Medicine, St. Louis, MO and 2 Cardiology, Washington
University School of Medicine, St. Louis, MO
It is well established that tumor survival, growth and metastasis is dependent upon the establish-
ment of new vasculature, or tumor angiogenesis.|alpha*|v β3-integrin is a biomarker of angiogene-
sis expressed on the surface of both endothelial cells involved in active angiogenesis as well as inva-
sive tumor cells. In certain malignancies, αv β3-integrin expression correlates with tumor grade.
αvβ3-targeted nanoparticles have been developed to specifically and sensitively detect nascent tumors
with clinically relevant 1.5 T MRI scanner. However, the ability of this molecular imaging agent to
phenotypically differentiate aggressive from indolent tumor grades is unknown. In the present
study, a variety of human melanoma lines were screened and variably aggressive murine melanoma
tumor models were developed. Murine melanoma models were created in nude mice by subcuta-
neous injection of the human cell lines C32, MeWo, A2058 and A375 (ATCC) characterized for
MAPKK, phospho-MAPKK, MAPK and phospho-MAPK protein. Tumors were harvested at days
7, 14, 21 and 28. By Western analysis, A2058 and A375 cell lysates demonstrated increased expres-
sion of phospho-MAPK, MAPK, phospho MAPKK relative to MeWo. Tumor growth (A2058 and
A375 tumors (0.054g, 018g day 7; 0.18g, 0.06g day14, respectively) and MeWo (0.005g day 7, 0.02g
day 14) correlated with phospho-MAPK expression and earlier formation of new vessels (β3 expres-
sion by immunohistochemistry). In sum, we have shown that tumor growth is correlated with MAPK
expression and angiogenesis in this murine model. These models will challenge the sensitivity of
MR αv β3-integrin imaging to phenotypically characterize and distinguish related tumors with dif-
ferent development patterns. We propose that these biochemicall characterized models will advance
the development of MR molecular imaging agents and techniques required to diagnose, character-
ize, grade and stage primary and metastatic tumors, including melanoma, in clinical practice. 
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Preclinical studies of contrast-enhanced magnetic resonance imaging for sentinel lymph node
analysis in melanoma
DA Jones,1 DS Goddard,2 S Patz,2 F Rybicki2 and TS Kupper1 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA and 2 Radiology, Brigham and Women’s Hospital, Boston, MA
Staging of invasive melanoma increasingly relies on surgical sentinel lymph node biopsy (SLNB),
which is an improvement over complete lymphadenectomy, but still has a significant morbidity rate
of 5-10%. Contrast-enhanced magnetic resonance imaging (MRI) has shown promise in the non-
invasive imaging of lymph node metastases in several cancers, and melanoma is a particularly attrac-
tive application for this for two reasons: (1) contrast can be injected in the tumor site to achieve high
concentrations in the sentinel lymph node, and (2) the draining lymph node basins are generally
superficial, allowing high resolution imaging with phased array surface coils. In this work, we
tested three contrast agents for suitability in this application: gadolinium (Gd-DTPA), ultrasmall
superparamagnetic iron oxide nanoparticles (USPIO), and perfluoro-15-crown-5-ether (PFCE), a
perfluorocarbon similar to artificial blood substitutes and imaged using F-19 MRI. These were tested
with B16/F1 melanoma metastasizing to inguinal nodes of C57/Bl6 mice and imaged at 4.7 Tesla.
Gd-DTPA was found to flow through nodes too rapidly to allow sufficient accumulation for tumor
contrast. USPIO and PFCE provide contrast by accumulation in macrophages of normal node tis-
sue but not tumor, and we achieved high level accumulation of these agents as demonstrated by his-
tology. Imaging with these two agents provided comparable results, with 0.1x0.1x0.5 mm voxel res-
olution each. Extrapolating this to the anticipated resolution achievable in human clinical MRI, and
using the known size distribution of human SLN metastases, we calculate that contrast-enhanced
MRI can identify metastases with a false negative rate only 6% worse than surgical SLNB. Given
the small but significant morbidity of SLNB and the fact that sentinel node analysis provides impor-
tant prognostic information but little therapeutic benefit, these results suggest that contrast enhanced
MRI may prove to be an important alternative to surgical SLNB and that further clinical studies are
warranted.
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Topical formulation of coenzyme Q10 inhibits the growth of melanoma tumors
NR Narain, J Li, J He, LH Malik, KJ Russell, KV Woan, I Persaud and SL Hsia Dermatology &
Cutaneous Surgery, University of Miami School of Medicine, Miami, FL
Treatment for skin cancer may require surgery, chemotherapy and/or radiation, all of which cause
severe discomfort to the patient. These modalities usually result in some damage to normal, healthy
cells. As evidenced by our in vitro data, Coenzyme Q10 (Q10) selectively inhibits the proliferation
of cancer cells. Our laboratory has developed a liposome-encapsulated Q10 cream that facilitates the
topical delivery of Q10 to underlying tissues.  Moreover, oral administration is one of the least
effective modes of delivery due to uncertainties of absorption and inactivation in the gastrointesti-
nal system. In contrast, percutaneous application is more pharmacologically advantageous due to a
more specific and direct delivery to the point of interest, resulting in a higher absorption/dosage
ratio of Q10. In animal studies, melanoma tumors were induced in nude, athymic mice by subcuta-
neous injection of SKMEL28 cells. Each mouse was inoculated with two tumors (7x106 cells/tumor)
on the superior dorsal region. A liposome-encapsulated formulation of Q10 (10%) was applied to
the treatment group daily for 30 days. Following treatment, the mice were sacrificed and the tumors
excised and weighed prior to histological analysis. The mean mass for all tumors in each group was
determined and the results showed a 52.3% decrease in tumor mass in the treatment group as com-
pared to the control. These results were replicated using a slightly higher concentration of Q10 (15%),
yielding a 54.0% decrease in tumor mass. Prior in vitro data suggest that a dysfunction in the apop-
totic pathway is involved in the pathogenesis of melanoma, possibly playing a crucial role in tumori-
genesis. In conclusion, Q10 may induce apoptosis in malignant cells leading to an inhibition of tumor
growth. Furthermore, it is highly probable that individuals diagnosed with melanoma or other skin
tumors could use our Q10 delivery system to selectively treat and inhibit the growth of their malig-
nancies without the side effects of current modes of treatment. 
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BRAF point mutations in primary malignant melanoma show different prevalences by sub-
types
Y Sasaki,1 C Niu,2 R Makino,2 C Kudo,2 C Sun,2 H Tagami,1 S Aiba1 and A Horii2 1 Department
of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan and 2 Department
of Molecular Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
Recently, frequent somatic mutations of BRAF were reported in malignant melanoma (MM). So, at
first, we performed a mutation analysis using 43 cell lines established from tumors that had devel-
oped in several kinds of human organs, to elucidate the biological significance of activating muta-
tions of the BRAF gene in human malignant tumors. Interestingly, in spite of the fact that the same
V599E point mutation was observed in three of six MM cell lines, no such mutations were observed
in other types of cancers. Next, to examine the biological significance of V599E point mutation in
MM, we added mutation analyses of NRAS, KRAS, b-catenin and p16/p14ARF genes in these 6
MM cell lines, and found three p16/p14ARF mutation, two of which were overlapped with BRAF
mutation. We further searched for mutations of BRAF in 35 primary sporadic malignant melanomas
from 35 Japanese patients by direct sequencing and allele specific oligonucleotide hybidization and
detected the V599E BRAF point mutation in only nine (26%) of them. Significant differences in
mutation frequency were observed among four histological subtypes; four (50%) of eight superfi-
cially spreading melanoma (SSM) and five (33%) of 15 acral lentiginous melanoma (ALM) had the
mutation, whereas none of twelve other types (six nodular melanoma, five lentigo malignant
melanoma, and one mucosal melanoma) had it. The BRAF mutation was observed frequently even
in thin lesions, indicating that activation of this gene may be one of the early events in the patho-
genesis of some melanomas. 
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Coenzyme Q10 induces apoptosis in human melanoma cells
NR Narain,1 J Li,1 KV Woan,1 KJ Russell,1 MS Ochoa,2 I Persaud,1 ES Fenjves2 and SL Hsia1 1
Dermatology & Cutaneous Surgery, University of Miami School of Medicine, Miami, FL and 2
Diabetes Research Institute, University of Miami School of Medicine, Miami, FL
Coenzyme Q10 (Q10) is a naturally occurring component of the inner mitochondrial membrane,
which plays a crucial role in the intrinsic pathway of apoptosis. Our in vitro studies showed that
Q10 exerts an inhibitory effect on melanoma cells, however no adverse effects were observed on
normal cells. It was hypothesized that the decreased proliferation in melanoma cells was either directly
or indirectly related to the function of Q10 in the mechanism of apoptosis. Studies have demonstrated
that the intrinsic pathway of apoptosis is often altered in melanoma due to mitochondrial abnor-
malities. We therefore investigated the involvement of Q10 with respect to apoptosis in melanoma
cells. Both melanoma SKMEL28 cells and human neonatal fibroblasts (nFIB) were incubated in the
presence and absence of 50µM Q10 for 48hrs. The cells were trypsinized and subjected to annexin
V-PE staining for indication of apoptosis. 7-AAD was used to determine the level of necrosis given
that annexin may also stain necrotic cells. Subsequently, the cells were analyzed using flow cytom-
etry. Incubation with Q10 elicited a significant (p<0.01) reduction of apoptosis in nFIB, 58.5%
decrease as compared to the control. On the contrary, the SKMEL 28 cells treated with Q10 showed
a 77.5% increase in apoptosis. Current studies are ongoing to elucidate the mechanism by which
Q10 exerts the aforementioned effect on cells. Concordantly, Q10 selectively restores the apoptotic
potential in malignant melanoma while rendering slight support to normal fibroblasts. These data
suggest a potential use for Q10 either alone or as an adjuvant therapy for the treatment of melanoma. 
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A gene locus responsible for non-syndromic multiple lentigines maps to chromosome 6(q24-
25)
T Pacheco,1 J Collyer1 and P Fain2 1 Dermatology, UCHSC, Aurora, CO and 2 Medicine and
Human Medical Genetics, UCHSC, Denver, CO
Multiple Lentigines syndrome (MLS) is a rare autosomal dominant disorder, characterized by dif-
fuse cutaneous lentigines. Significant clinical overlap exists between Noonan syndrome and ML,
and it is not surprising some identified cases of LEOPARD syndrome are a subtype of the Noonan
syndrome, caused by mutations in the PTPN11 gene. Other groups suggest that distinct mutations
affecting the PTPN11 phosphotyrosine phosphatase domain explain the cutaneous anomalies seen
in ML/LEOPARD syndrome, where the majority of mutations are found in the amino N-SH2 domains.
While this could account for a fraction of phenotypic variation seen in NS and overlap with the LEOP-
ARD syndrome, our findings indicate this does not necessarily extend to ML in general. Our research
suggests that the MLS manifesting with diffuse cutaneous lentigines without non-cutaneous mani-
festations, is not a subtype of either Noonan or LEOPARD syndrome and should be classified as
non-syndromic ML. This work extends previous studies in the same family in which we excluded
PTPN11 as well as the genes for other clinically overlapping disorders, including von Reckling-
hausen neurofibromatosis (NF1), Carney syndrome types I and II (CNC1 and CNC2), Peutz-Jeghers
syndrome (PJS), and Cowden disease (CD). Linkage informativeness is definitive in positioning the
MLS locus in the 5-cM region between markers D6S1703 and D6S411. Know genes involved in pig-
mentation, such as RAB32, are being studied with wave analysis and sequencing to determine poten-
tial mutations. Further work on identification of the gene for non-syndrome ML will allow further
exploration of the genetics of pigmentation. 
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Phenolic stress induced autoimmune reactivity to melanocytes
I Le Poole,1 TM Kroll,1 H Bommiasamy,1 LS Stennett,1 BJ Nickoloff,1 RE Boissy2 and R Mestril3
1 Pathology/Onc. Institute, Loyola University Chicago, Maywood, IL, 2 Dermatology, University
of Cincinnati, Cincinnati, OH and 3 Cardiovascular Institute, Loyola University Chicago,
Maywood, IL
Exposure to 4-tertiary butyl phenol (4-TBP) can cause depigmentation in humans handling phenols.
We hypothesized that skin bleaching is mediated in part by a stress response causing autoimmune
reactivity to melanocytes. 4-TBP induced expression of stress protein HSP70 was evaluated by ELISA
and Western blotting, and the cytoprotective effect of adenoviral HSP70 overexpression against 4-
TBP exposure was measured. The effect of 4-TBP exposure and HSP70 overexpression on immune
related markers was assessed by FACS analysis, and the cytotoxic responses of T cells and dendritic
cells to stressed melanocytes were quantified. Immunohistology was performed to investigate the in
vivo relevance. It was observed that PIG3V vitiligo melanocytes generate increased amounts of
HSP70 in reponse to 4-TBP as compared to normal melanocytes or fibroblasts. Cells overexpress-
ing HSP70 were not protected from 4-TBP induced cell death, and a >30% decrease in viability was
noted at 62.5 mM 4-TBP for PIG3V melanocytes versus 125 mM for PIG1 control melanocytes.
MHC class I molecule expression was elevated by 25% in response to adenoviral HSP70 overex-
pression, accompanied by a 20% increase in HLA-matched T cell mediated killing of 4-TBP exposed
melanocytes. Interestingly, 4-TBP exposed melanocytes were sensitized 5-fold to dendritic cell effec-
tor functions and DC effector functions were enhanced by exposure to HSPs. Preliminary data sug-
gest that DC cytotoxicity may be mediated by surface expression of TNF Related Apoptosis Induc-
ing Ligand (TRAIL), accompanied by elevated TRAIL receptor expression by melanocytes following
4-TBP exposure. TRAIL and CD91 stress protein receptor expressing DCs were observed in depig-
menting vitiligo skin. In combination with our reports of aberrant stress protein expression in vitiligo
skin, the data support that 4-TBP induced expression of HSP70 can evoke an autoimmune response
to melanocytes. 
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